PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Widmark, A; Sagredo, EAA; Karlstroem, V; Behm, M; Biryukova, I; Friedlaender, MRR; Daniel, C; Oehman, M				Widmark, Albin; Sagredo, Eduardo A. A.; Karlstroem, Victor; Behm, Mikaela; Biryukova, Inna; Friedlaender, Marc R. R.; Daniel, Chammiran; oehman, Marie			ADAR1-and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRODUCIBLE CHANGES; GENE-CLUSTER; RNA; MICRORNAS; STRAND; DICER; IDENTIFICATION; EXPRESSION; CYTOSCAPE; ABUNDANCE	miRNAs are short noncoding RNA molecules that regulate gene expression by inhibiting translation or inducing degradation of target mRNAs. miRNAs are often expressed as polycistronic transcripts, so-called miRNA clusters, containing several miRNA precursors. The largest mammalian miRNA cluster, the miR-379-410 cluster, is expressed primarily during embryonic development and in the adult brain; however, downstream regulation of this cluster is not well understood. Here, we investigated adenosine deamination to inosine (RNA editing) in the miR-379-410 cluster by adenosine deaminase acting on RNA (ADAR) enzymes as a possible mechanism modulating the expression and activity of these miRNAs in a brain-specific manner. We show that the levels of editing in the majority of mature miRNAs are lower than the editing levels of the corresponding site in primary miRNA precursors. However, for one miRNA, miR-376b-3p, editing was significantly higher in the mature form than in the primary precursor. We found miR-376b-3p maturation is negatively regulated by ADAR2 in an editing activity-independent manner, whereas ADAR1-mediated and ADAR2-mediated editing were observed to be competitive. In addition, the edited miR-376b-3p targets a different set of mRNAs than unedited miR-376b-3p, including 4-aminobutyrate aminotransferase, encoding the enzyme responsible for the catabolism of the neurotransmitter gamma aminobutyric acid (GABA). Expression of edited miR-376b-3p led to increased intracellular GABA levels as well as increased cell surface presentation of GABA type A receptors. Our results indicate that both editing and editing-independent effects modulate the expression of miR-376b-3p, with the potential to regulate GABAergic signaling in the brain.	[Widmark, Albin; Sagredo, Eduardo A. A.; Karlstroem, Victor; Behm, Mikaela; Daniel, Chammiran; oehman, Marie] Stockholm Univ, Dept Mol Biosci, Stockholm, Sweden; [Sagredo, Eduardo A. A.; Biryukova, Inna; Friedlaender, Marc R. R.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Sci Life Lab, Stockholm, Sweden; [Behm, Mikaela] German Canc Res Ctr Deutsch Krebsforschungszentrum, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	Stockholm University; Stockholm University	Widmark, A (corresponding author), Stockholm Univ, Dept Mol Biosci, Stockholm, Sweden.	albin.widmark@su.se		Friedlander, Marc/0000-0001-6577-4363; karlstrom, victor/0000-0002-6985-0308; Biryukova, Inna/0000-0003-0701-2808; Sagredo, Eduardo/0000-0001-9984-2985	Swedish Research Council [2015-04611, 2018-03823]; European Research Council [758397]; Strategic Research Area (SFO) program of the Swedish Research Council through Stockholm University	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Strategic Research Area (SFO) program of the Swedish Research Council through Stockholm University	M. OE. has been supported by grant from the Swedish Research Council (grant no.: 2018-03823) . I. B. and M. R. F. acknowledge the following funding sources: Euro-pean Research Council starting grant (grant no.: 758397) , miRCell; Swedish Research Council (grant no.: 2015-04611) , MapToCleave; and funding from the Strategic Research Area (SFO) program of the Swedish Research Council through Stockholm University.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behm M, 2017, J CELL SCI, V130, P745, DOI 10.1242/jcs.200055; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Cruz PHC, 2020, RNA, V26, P454, DOI 10.1261/rna.072728.119; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Eshaq RS, 2010, BRAIN RES, V1346, P1, DOI 10.1016/j.brainres.2010.05.030; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kume H, 2014, NUCLEIC ACIDS RES, V42, P10050, DOI 10.1093/nar/gku662; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Lackinger M, 2019, EMBO REP, V20, DOI 10.15252/embr.201846429; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LS, 2018, GENOME RES, V28, P132, DOI 10.1101/gr.224386.117; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lundin E, 2020, BMC BIOL, V18, DOI 10.1186/s12915-019-0736-3; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Marty V, 2016, HUM MOL GENET, V25, P728, DOI 10.1093/hmg/ddv510; Marvin JS, 2019, NAT METHODS, V16, P763, DOI 10.1038/s41592-019-0471-2; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Michlewski G, 2019, RNA, V25, P1, DOI 10.1261/rna.068692.118; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Tian S, 2020, RNA BIOL, V17, P264, DOI 10.1080/15476286.2019.1678364; van der Kwast RVCT, 2020, MOL THER-NUCL ACIDS, V21, P932, DOI 10.1016/j.omtn.2020.07.020; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Wang P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00188; Whipple AJ, 2020, MOL CELL, V78, P85, DOI 10.1016/j.molcel.2020.01.020; Winter Jennifer, 2015, Neurogenesis (Austin), V2, pe1004970, DOI 10.1080/23262133.2015.1004970; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	52	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101682	10.1016/j.jbc.2022.101682	http://dx.doi.org/10.1016/j.jbc.2022.101682			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124003	Green Published, gold			2022-12-26	WOS:000789400700009
J	Kumanomido, T; Kamiya, K; Takahashi, M; Tsujisawa, T; Hayakawa, H; Ando, W; Utsumi, Y; Shoji, N				Kumanomido, Takashi; Kamiya, Kazutaka; Takahashi, Masahide; Tsujisawa, Tatsuhiko; Hayakawa, Hideki; Ando, Wakako; Utsumi, Yoshikazu; Shoji, Nobuyuki			Clinical evaluation of flat peripheral curve design with aspherical-curve and multi-curve hard contact lenses for keratoconus	PLOS ONE			English	Article							HIGH MYOPIC ASTIGMATISM; EYES; IMPLANTATION	Aspherical- and multi-curve rigid gas-permeable hard contact lenses (HCLs) have a flattened curve in the peripheral zone and are mostly used for patients with keratoconus who cannot wear glasses, soft contact lenses, or spherical HCLs. In this retrospective study, a total of 95 eyes of 77 patients who used aspherical- or multi-curve HCLs (mean age: 40.0 +/- 11.0 years) were evaluated. This study examined the types of aspherical- and multi-curve HCLs, best-corrected visual acuity (BCVA) values before and after wearing HCLs, the association with the Amsler-Krumeich classification, duration of wear, corneal/conjunctival disorder, and the frequency of changing HCLs. There were 78 eyes that used aspherical-curve HCLs and 17 that used multi-curve HCLs. BCVA significantly improved from 0.42 logMAR to 0.06 logMAR after wearing either form of HCL. The Amsler-Krumeich classification showed that aspherical-curve HCLs were commonly used for patients with stage 2 keratoconus, and multi-curve HCLs were commonly used for stage 4 patients. The BCVA values were worse when the disease stage was more severe (stages 3 and 4) regardless of HCL type. The mean base curve of the lenses was steeper in multi-curve HCLs than in aspherical-curve HCLs. The more severe the disease stage, the steeper the base curve in both aspherical- and multi-curve HCLs. The duration of wear significantly improved from 2.1 h to 10.2 h, and corneal/conjunctival disorder similarly improved. The mean frequency of changing HCL types was 1.1 times. This study suggests that a flat peripheral curve design with aspherical- and multi-curve HCLs is useful for patients with keratoconus.	[Kumanomido, Takashi; Takahashi, Masahide; Tsujisawa, Tatsuhiko; Hayakawa, Hideki; Ando, Wakako; Utsumi, Yoshikazu; Shoji, Nobuyuki] Kitasato Univ Hosp, Dept Ophthalmol, Sagamihara, Kanagawa, Japan; [Kamiya, Kazutaka] Kitasato Univ, Sch Allied Hlth Sci, Dept Visual Physiol, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University	Kumanomido, T (corresponding author), Kitasato Univ Hosp, Dept Ophthalmol, Sagamihara, Kanagawa, Japan.	t-2001@gb3.so-net.ne.jp						Dikmetas O, 2020, CORNEA, V39, P1366, DOI 10.1097/ICO.0000000000002438; Downie LE, 2015, CLIN EXP OPTOM, V98, P299, DOI 10.1111/cxo.12300; Elbendary AM, 2013, GRAEF ARCH CLIN EXP, V251, P1565, DOI 10.1007/s00417-013-2271-1; Galvis V, 2015, EYE, V29, P843, DOI 10.1038/eye.2015.63; Godefrooij DA, 2017, AM J OPHTHALMOL, V175, P169, DOI 10.1016/j.ajo.2016.12.015; Gomes JAP, 2015, CORNEA, V34, P359, DOI 10.1097/ICO.0000000000000408; Kamiya K, 2008, J REFRACT SURG, V24, P840, DOI 10.3928/1081597X-20081001-12; Kamiya K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031313; Kamiya K, 2015, BRIT J OPHTHALMOL, V99, P177, DOI 10.1136/bjophthalmol-2014-305612; Kazanci B, 2014, EUR J OPHTHALMOL, V24, P835, DOI 10.5301/ejo.5000449; Khaled ML, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7803029; Krumeich JH, 1998, J CATARACT REFR SURG, V24, P456, DOI 10.1016/S0886-3350(98)80284-8; Lee Jae Lim, 2004, Eye Contact Lens, V30, P20, DOI 10.1097/01.ICL.0000095230.24618.03; Lunardi LH, 2016, ARQ BRAS OFTALMOL, V79, P82, DOI 10.5935/0004-2749.20160025; MAEDA N, 1995, ARCH OPHTHALMOL-CHIC, V113, P870, DOI 10.1001/archopht.1995.01100070044023; Naderan M, 2015, CORNEA, V34, P1005, DOI 10.1097/ICO.0000000000000537; Negishi K, 2007, AM J OPHTHALMOL, V144, P924, DOI 10.1016/j.ajo.2007.08.004; Ozkurt Yelda Buyru, 2008, International Ophthalmology, V28, P395, DOI 10.1007/s10792-007-9156-4; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rathi VM, 2015, CLIN OPHTHALMOL, V9, P2013, DOI 10.2147/OPTH.S52483; Rathi VM, 2013, INDIAN J OPHTHALMOL, V61, P410, DOI 10.4103/0301-4738.116066; Sorkhabi R, 2015, INT OPHTHALMOL, V35, P467, DOI 10.1007/s10792-014-9971-3; Suzaki A, 2017, INVEST OPHTH VIS SCI, V58, P2899, DOI 10.1167/iovs.16-21296; Szczotka-Flynn LB, 2008, EYE CONTACT LENS, V34, P254, DOI 10.1097/ICL.0b013e31817f6db0; Wei RH, 2011, EYE CONTACT LENS, V37, P307, DOI 10.1097/ICL.0b013e3182254e7d; Yanai R, 2013, JPN J OPHTHALMOL, V57, P199, DOI 10.1007/s10384-012-0216-6; Yanai R, 2010, EYE CONTACT LENS, V36, P86, DOI 10.1097/ICL.0b013e3181d13a90	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263506	10.1371/journal.pone.0263506	http://dx.doi.org/10.1371/journal.pone.0263506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134078	Green Published, gold			2022-12-26	WOS:000798968600015
J	Lam, IPY; Sung, YH; Fong, JJ				Lam, Ivan P. Y.; Sung, Yik-Hei; Fong, Jonathan J.			Using eDNA techniques to find the endangered big-headed turtle (Platysternon megacephalum)	PLOS ONE			English	Article							FRESH-WATER TURTLES; ENVIRONMENTAL DNA; FISH ABUNDANCE; DEGRADATION; BIOMASS; TRADE; CONSERVATION; TEMPERATURE	We evaluate the efficacy of environmental DNA (eDNA) techniques to locate wild populations and estimate the population size of the endangered big-headed turtle (Platysternon megacephalum) in Hong Kong. The results from this study are important for identifying priority sites for protection and further research. Additionally, we assess the impact of two environmental variables (temperature and pH) on eDNA quantity. We surveyed 34 streams for three years, sampling four times each year. Four new populations were first identified with eDNA analysis, and then verified by field surveys. Our multi-year survey highlights that eDNA detection can be inconsistent over time, even in streams with known populations. There was no significant relationship between eDNA quantity and the environmental variables tested. Lastly, our results suggest that eDNA methods remain promising to estimate population size, since number of positive detections were positively correlated with population size in streams with known populations. We conclude that eDNA methods are powerful, but care must be taken when interpreting field results as they are affected by species ecology and environmental conditions.	[Lam, Ivan P. Y.; Sung, Yik-Hei; Fong, Jonathan J.] Lingnan Univ, Sci Unit, Hong Kong, Peoples R China	Lingnan University	Fong, JJ (corresponding author), Lingnan Univ, Sci Unit, Hong Kong, Peoples R China.	jonfong@ln.edu.hk		Sung, Yik Hei/0000-0003-0026-8624; FONG, Jonathan/0000-0002-3648-6730	Research Grants Council of Hong Kong [23100216]; Government of Hong Kong Special Administrative Region; Environment and Conservation Fund [ECF2017-04]; Ocean Park Conservation Foundation Conservation Fund [RP01.1718]; Ocean Park Conservation Fundation Hong Kong; Croucher Foundation Chinese Visitorship [870026]; Croucher Foundation	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Government of Hong Kong Special Administrative Region; Environment and Conservation Fund; Ocean Park Conservation Foundation Conservation Fund; Ocean Park Conservation Fundation Hong Kong; Croucher Foundation Chinese Visitorship; Croucher Foundation	The sources of funding of the work submitted are as follows: 1. Research Grants Council of Hong Kong (Early Career Scheme #23100216), from The Government of Hong Kong Special Administrative Region; received by J.J.F. (URL: https://www.ugc.edu.hk/eng/rgc/) 2. Environment and Conservation Fund (#ECF2017-04), from The Government of Hong Kong Special Administrative Region; received by Y.H.S. (URL: https://www.ecf.gov.hk/en/home/index.html) 3. Ocean Park Conservation Foundation Conservation Fund (#RP01.1718), from Ocean Park Conservation Fundation Hong Kong; received by Y. H.S. (URL: https://www.opcf.org.hk/en/) 4. Croucher Foundation Chinese Visitorship (#870026), from Croucher Foundation; received by J.J.F. (URL: https://croucher.org.hk/funding/enabling-the-exchange-of-ideas-between-hong-kong-scientists-and-their-counterparts-in-mainland-china-and-overseas/croucher-chinese-visitorships) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CIM, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11040050; Adams CIM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030192; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bonin F, 2006, TURTLES WORLD; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cantera I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39399-5; Carim KJ., 2019, ENV DNA, V1, P215, DOI [10.1002/edn3.22, DOI 10.1002/EDN3.22]; Civade R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157366; Collins RA, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0192-6; Curtis AN, 2021, DIVERS DISTRIB, V27, P1918, DOI 10.1111/ddi.13196; Davy CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130965; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dudgeon D., 2004, ECOLOGY BIODIVERSITY; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fong J., 2021, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2021-2.RLTS.T17585A1423706.en, DOI 10.2305/IUCN.UK.2021-2.RLTS.T17585A1423706.EN]; Goldberg CS, 2018, SCI TOTAL ENVIRON, V633, P695, DOI 10.1016/j.scitotenv.2018.02.295; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gong SP, 2006, ORYX, V40, P331, DOI 10.1017/S0030605306000949; Harrison JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1409; Hendrie DB, 2000, CHELON RES MONOGR, P63; Hoang Ha, 2021, Herpetology Notes, V14, P1077; Horne B., 2012, CONSERVATION ASIAN T; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jo T, 2019, ECOL EVOL, V9, P1135, DOI 10.1002/ece3.4802; Kasai A, 2020, FISHERIES SCI, V86, P465, DOI 10.1007/s12562-020-01409-1; Kessler E.J., 2020, ENV DNA, V2, P13, DOI [10.1002/edn3.42, DOI 10.1002/EDN3.42]; Kirtane AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222883; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lacoursiere-Roussel A, 2016, MOL ECOL RESOUR, V16, P1401, DOI 10.1111/1755-0998.12522; Lacoursiere-Roussel A, 2016, GENOME, V59, P991, DOI 10.1139/gen-2015-0218; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Lam IPY, 2020, CONSERV GENET RESOUR, V12, P293, DOI 10.1007/s12686-019-01103-0; Laramie MB., 2015, ENV DNA SAMPLING PRO, DOI [10.3133/tm2A13, DOI 10.3133/TM2A13]; Li J., 2019, ENV DNA, V1, P238, DOI [10.1002/edn3.24, DOI 10.1002/EDN3.24]; Lougheed W, 2020, ENV DNA, V2, P200, DOI [10.1002/edn3.58, DOI 10.1002/EDN3.58]; Ma HJ, 2016, CONSERV GENET RESOUR, V8, P561, DOI 10.1007/s12686-016-0597-9; Machler E, 2016, ENVIRON SCI TECHNOL, V50, P305, DOI 10.1021/acs.est.5b04188; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Minamoto T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173073; Nevers MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191720; Parsons KM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180537; Perez CR, 2017, N AM J FISH MANAGE, V37, P1010, DOI 10.1080/02755947.2017.1342721; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Piggott MP, 2016, ECOL EVOL, V6, P2739, DOI 10.1002/ece3.2083; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; R Core Team, 2020, R LANG ENV STAT COMP; Raemy M, 2018, AMPHIBIA-REPTILIA, V39, P135, DOI 10.1163/15685381-17000025; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; RStudio Team, 2020, RSTUDIO INTEGRATED D; Ruiz-Villalba Adrian, 2017, Biomol Detect Quantif, V14, P7, DOI 10.1016/j.bdq.2017.10.001; Sakai Y., 2019, ENV DNA, V1, P281, DOI [10.1002/edn3.31, DOI 10.1002/EDN3.31]; Sakata MK, 2021, LIMNOLOGY, V22, P221, DOI 10.1007/s10201-020-00645-9; Salter I, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0696-8; Sepulveda A.J., 2019, ENV DNA, V1, P227, DOI [10.1002/edn3.23, DOI 10.1002/EDN3.23]; Shogren AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05223-1; Sigsgaard EE, 2020, EVOL APPL, V13, P245, DOI 10.1111/eva.12882; So KYK, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3193; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Sung YH, 2015, J WILDLIFE MANAGE, V79, P537, DOI 10.1002/jwmg.861; Sung YH, 2014, ACTA HERPETOL, V9, P243; Sung YH, 2013, CONSERV BIOL, V27, P1421, DOI 10.1111/cobi.12102; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Tana TS, 2000, CHELON RES MONOGR, P55; Thalinger B., 2020, ENV DNA, V3, P823, DOI DOI 10.1002/EDN3.189; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Ulibarri RM, 2017, N AM J FISH MANAGE, V37, P644, DOI 10.1080/02755947.2017.1306005; UNEP-WCMC, 2019, CHECKL CITES SPEC; Ushio M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22817-5; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Wacker S., 2019, ENV DNA, V1, P64, DOI [10.1002/edn3.10, DOI 10.1002/EDN3.10]; Wang H., 2010, CHINESE J WILDLIFE, V31, P110; Wineland SM., 2019, ENV DNA, V1, P86, DOI [10.1002/edn3.9, DOI 10.1002/EDN3.9]	77	1	1	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262015	10.1371/journal.pone.0262015	http://dx.doi.org/10.1371/journal.pone.0262015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130297	Green Published, gold			2022-12-26	WOS:000805530700005
J	Liao, CG; Liang, XH; Ke, Y; Yao, L; Liu, M; Liu, ZK; He, L; Guo, YX; Bian, HJ; Chen, ZN; Kong, LM				Liao, Cheng-Gong; Liang, Xiao-Hua; Ke, Yuan; Yao, Li; Liu, Man; Liu, Ze-Kun; He, Lin; Guo, Yi-Xiao; Bian, Huijie; Chen, Zhi-Nan; Kong, Ling-Min			Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis	ONCOGENE			English	Article							TARGETED DNA DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE SIGNATURES; BONE METASTASIS; POOR-PROGNOSIS; 5-METHYLCYTOSINE; HYPOMETHYLATION; PROLIFERATION; RECRUITMENT; METHYLATION; MECHANISMS	Non-small cell lung cancer (NSCLC) is a fatal disease, and its metastatic process is poorly understood. Although aberrant methylation is involved in tumor progression, the mechanisms underlying dynamic DNA methylation remain to be elucidated. It is significant to study the molecular mechanism of NSCLC metastasis and identify new biomarkers for NSCLC early diagnosis. Here, we performed MeDIP-seq and hMeDIP-seq analyses to detect the genes regulated by dynamic DNA methylation. Comparison of the 5mC and 5hmC sites revealed that the CD147 gene underwent active demethylation in NSCLC tissues compared with normal tissues, and this demethylation upregulated CD147 expression. Significantly high levels of CD147 expression and low levels of promoter methylation were observed in NSCLC tissues. Then, we identified the CD147 promoter as a target of KLF6, MeCP2, and DNMT3A. Treatment of cells with TGF-beta triggered active demethylation involving loss of KLF6/MeCP2/DNMT3A and recruitment of Sp1, Tet1, TDG, and SMAD2/3 transcription complexes. A dCas9-SunTag-DNMAT3A-sgCD147-targeted methylation system was constructed to reverse CD147 expression. The targeted methylation system downregulated CD147 expression and inhibited NSCLC proliferation and metastasis in vitro and in vivo. Accordingly, we used cfDNA to detect the levels of CD147 methylation in NSCLC tissues and found that the CD147 methylation levels exhibited an inverse relationship with tumor size, lymphatic metastasis, and TNM stage. In conclusion, this study clarified the mechanism of active demethylation of CD147 and suggested that the targeted methylation of CD147 could inhibit NSCLC invasion and metastasis, providing a highly promising therapeutic target for NSCLC.	[Liao, Cheng-Gong; Ke, Yuan] Fourth Mil Med Univ, Tangdu Hosp, Dept Oncol, Xian 710038, Peoples R China; [Liang, Xiao-Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710038, Peoples R China; [Yao, Li] Northwest Univ, Dept Pathol, Xian 3 Hosp, Affiliated Hosp, Xian 710018, Peoples R China; [Liu, Man; Liu, Ze-Kun; He, Lin; Guo, Yi-Xiao; Bian, Huijie; Chen, Zhi-Nan; Kong, Ling-Min] Fourth Mil Med Univ, Natl Translat Sci Ctr Mol Med, Dept Cell Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Northwest University Xi'an; Air Force Military Medical University	Bian, HJ; Chen, ZN; Kong, LM (corresponding author), Fourth Mil Med Univ, Natl Translat Sci Ctr Mol Med, Dept Cell Biol, Xian 710032, Peoples R China.	hjbian@fmmu.edu.cn; znchen@fmmu.edu.cn; konglingmin81@163.com		Chen, Zhi-Nan/0000-0001-5512-4623; Cheng-Gong, Liao/0000-0002-7624-0196	Basic Research Plan of Natural Science in Shaanxi Province [2020JM-326]; National Natural Science Foundation of China [8217111294]; Social Talent Fund Supporting Scheme of Tangdu Hospital [2021SHRC001]; National Key Research [2018YFA0109000]; Development Program of China [2019YFC1316303]	Basic Research Plan of Natural Science in Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Talent Fund Supporting Scheme of Tangdu Hospital; National Key Research; Development Program of China	This study was supported by grants from the Basic Research Plan of Natural Science in Shaanxi Province (2020JM-326), the National Natural Science Foundation of China (8217111294), the Social Talent Fund Supporting Scheme of Tangdu Hospital (2021SHRC001), the National Key Research (2018YFA0109000) and the Development Program of China (2019YFC1316303).	Anton T, 2017, NUCLEUS-PHILA, V8, P279, DOI 10.1080/19491034.2017.1292194; CHEN Z-N, 1992, Zhonghua Zhongliu Zazhi, V14, P9; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Duruisseaux M, 2018, SEMIN CANCER BIOL, V51, P116, DOI 10.1016/j.semcancer.2017.09.005; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Escudero L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19175-0; Fei F, 2014, ANN SURG ONCOL, V21, P4359, DOI 10.1245/s10434-014-3816-1; Ge JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19366; Goulet CR, 2021, ADV EXP MED BIOL, V1270, P89, DOI 10.1007/978-3-030-47189-7_6; Guler GD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18965-w; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hassan HM, 2017, CELL REP, V19, P1685, DOI 10.1016/j.celrep.2017.05.007; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Huang YH, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1248-5; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jeschke J, 2017, J CLIN INVEST, V127, P3090, DOI 10.1172/JCI91095; Jin L, 2012, CELL RES, V22, P1356, DOI 10.1038/cr.2012.90; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Kim BN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67325-7; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kong LM, 2016, ONCOTARGET, V7, P27975, DOI 10.18632/oncotarget.8564; Kong LM, 2014, CANCER RES, V74, P3764, DOI 10.1158/0008-5472.CAN-13-3555; Kong LM, 2011, J CELL MOL MED, V15, P1415, DOI 10.1111/j.1582-4934.2010.01124.x; Ku XM, 2007, SCAND J IMMUNOL, V65, P435, DOI 10.1111/j.1365-3083.2007.01930.x; Li HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16552; Li WS, 2017, CELL RES, V27, P1243, DOI 10.1038/cr.2017.121; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Moreira EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12861; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; O'Leary K, 2018, CURR CANCER DRUG TAR, V18, P89, DOI 10.2174/1568009617666170203162556; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pflueger C, 2018, GENOME RES, V28, P1193, DOI 10.1101/gr.233049.117; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song CX, 2017, CELL RES, V27, P1231, DOI 10.1038/cr.2017.106; Stevens LE., 2018, JOVE-J VIS EXP, V136, P56650; Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Tseng HC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18444-2; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Wang H, 2017, FUTURE ONCOL, V13, P695, DOI 10.2217/fon-2016-0237; Wang K, 2021, CELL METAB, V33, P160, DOI 10.1016/j.cmet.2020.12.010; Wang Q, 2019, CANCER LETT, V448, P132, DOI 10.1016/j.canlet.2019.01.040; Wang SJ, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01647-2; Warton K, 2016, ENDOCR-RELAT CANCER, V23, pR157, DOI 10.1530/ERC-15-0369; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu J, 2016, ONCOGENE, V35, P5468, DOI 10.1038/onc.2016.89; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Zhang JN, 2020, INT J GEN MED, V13, P1115, DOI 10.2147/IJGM.S279023; Zhang RY, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00233	57	4	4	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1780	1794		10.1038/s41388-022-02213-0	http://dx.doi.org/10.1038/s41388-022-02213-0		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35132181	hybrid, Green Published			2022-12-26	WOS:000752288100001
J	Ripoche, M; Bouchard, C; Irace-Cima, A; Leighton, P; Thivierge, K				Ripoche, Marion; Bouchard, Catherine; Irace-Cima, Alejandra; Leighton, Patrick; Thivierge, Karine			Current and future distribution of Ixodes scapularis ticks in Quebec: Field validation of a predictive model	PLOS ONE			English	Article							LYME-DISEASE; BORRELIA-BURGDORFERI; RANGE EXPANSION; ACARI IXODIDAE; CLIMATE; RISK; HABITAT; VECTOR	The incidence of Lyme disease is increasing in Quebec and is closely linked to the distribution of Ixodes scapularis ticks. A time-to-establishment model developed in 2012 by Leighton and colleagues predicted the year of tick population establishment for each municipality in eastern Canada. To validate if this model correctly predicted tick distribution in Quebec, predicted tick establishment was compared to field data from active tick surveillance (2010-2018) using two criteria: i) the detection of at least one tick and ii) the detection of the three questing stages of the tick. The speed of tick establishment and the increase in the exposed human population by 2100 were predicted with the time-to-establishment model. Field observations were consistent with model predictions. Ticks were detected on average 3 years after the predicted year. The probability of tick detection is significantly higher after the predicted year than before (61% vs 27% of collections). The trend was similar for the detection of three tick stages (16% vs 9% of collections). The average speed of tick range expansion was estimated by the model to be 18 km/year in Quebec, with 90% of the human population exposed by 2027. The validation of the time-to-establishment model using field data confirmed that it could be used to project I. scapularis range expansion in Quebec, and consequently the increase in Lyme disease risk over the coming decades. This will help public health authorities anticipate and adapt preventive measures, especially in areas not yet affected by Lyme disease.	[Ripoche, Marion; Irace-Cima, Alejandra] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Montreal, PQ, Canada; [Bouchard, Catherine] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Natl Microbiol, St Hyacinthe, PQ, Canada; [Leighton, Patrick] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Thivierge, Karine] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Public Health Agency of Canada; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ)	Ripoche, M (corresponding author), Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Montreal, PQ, Canada.	marion.ripoche@inspo.qc.ca		Ripoche, Marion/0000-0002-9923-8806	Public Health Agency of Canada	Public Health Agency of Canada	MR was provided with stipend support from by the Public Health Agency of Canada. No funders, except researchers from the Public Health Agency of Canada, had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard C, 2019, Can Commun Dis Rep, V45, P83, DOI 10.14745/ccdr.v45i04a02; Bouchard C, 2015, CAN VET J, V56, P693; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CLIFFORD CM, 1978, J MED ENTOMOL, V15, P57, DOI 10.1093/jmedent/15.1.57; Clow KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189393; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; Daniels TJ, 1998, APPL ENVIRON MICROB, V64, P4663; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Institut national de sante publique du Quebec, 2016, PLAN AN SURV INT MAL, P89; Institut national de sante publique du Quebec, 2016, RAPPORT SURVEILLANCE, P8; Institut national de sante publique du Quebec, 2016, RAPPORT SURVEILLANCE, P10; Institut national de sante publique du Quebec, 2015, PROP PROG SURV INT M, P45; Institut national de sante publique du Quebec, 2019, RES SURV MAL LYM ANN; Institut national de sante publique du Quebec, 2018, RAPPORT SURVEILLANCE; Institut national de sante publique du Quebec, 2020, RES ANN SURV MAL LYM; Keirans JE, 1996, J MED ENTOMOL, V33, P297, DOI 10.1093/jmedent/33.3.297; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindsay LR, 1999, J MED ENTOMOL, V36, P255, DOI 10.1093/jmedent/36.3.255; Ministere de la Sante et des Services Sociaux (MSSS), 2021, MAL LYM TABL HUM ARC; Ogden N, 2014, ASSESSMENT SCREENING, P1; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Ostfeld RS, 1996, J MED ENTOMOL, V33, P90, DOI 10.1093/jmedent/33.1.90; Pardanani N, 2004, J MED ENTOMOL, V41, P861, DOI 10.1603/0022-2585-41.5.861; PAULSON E, 1991, CAN MED ASSOC J, V144, P1627; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Public Health Agency of Canada, 2020, SURV MAL LYM; R Core Team, 2020, R LANG ENV STAT COMP; Ripoche M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040603; Scott JD, 2016, TICKS TICK-BORNE DIS, V7, P327, DOI 10.1016/j.ttbdis.2015.12.001; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Statistics Canada, 2017, CENS PROF 2016 CENS; Wilson ML, 1998, J MED ENTOMOL, V35, P446, DOI 10.1093/jmedent/35.4.446	37	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263243	10.1371/journal.pone.0263243	http://dx.doi.org/10.1371/journal.pone.0263243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113941	Green Published, gold			2022-12-26	WOS:000823694700067
J	Schindel, D; Mandl, L; Schilling, R; Meisel, A; Schenk, L				Schindel, Daniel; Mandl, Lena; Schilling, Ralph; Meisel, Andreas; Schenk, Liane			Guideline adherence in speech and language therapy in stroke aftercare. A health insurance claims data analysis	PLOS ONE			English	Article							CLINICAL GUIDELINES; SOCIAL-PARTICIPATION; PATHOLOGY SERVICES; APHASIA; CARE; REHABILITATION; PREDICTORS; RECOVERY; OUTCOMES; DISEASE	Background Impairments to comprehension and production of speech (aphasia, dysarthria) and swallowing disorders (dysphagia) are common sequelae of stroke, reducing patients' quality of life and social participation. Treatment oriented on evidence-based guidelines seems likely to improve outcomes. Currently, little is known about guideline adherence in stroke aftercare for the above-mentioned sequelae. This study aims to analyse guideline adherence in the treatment of aphasia, dysarthria and dysphagia after stroke, based on suitable test parameters, and to determine factors that influence the implementation of recommended therapies. Methods Six test parameters were defined, based on systematic study of guidelines for the treatment of speech impairments and swallowing disorders (e.g. comprehensive diagnostics, early initiation and continuity). Guideline adherence in treatment was tested using claims data from four statutory health insurance companies. Multivariate logistic and linear regression analyses were performed in order to test the outcomes. Results 4,486 stroke patients who were diagnosed with specific disorders or received speech therapy were included in the study. The median age was 78 years; the proportion of women was 55.9%. Within the first year after the stroke, 90.3% of patients were diagnosed with speech impairments and swallowing disorders. Overall, 44.1% of patients received outpatient speech and language therapy aftercare. Women were less frequently diagnosed with specific disorders (OR 0.70 [95%CI:0.55/0.88], p = 0.003) and less frequently received longer PLOS therapy sessions (OR 0.64 [95%CI:0.43/0.94], p = 0.022). Older age and longer hospitalization duration increased the likelihood of guideline recommendations being implemented and of earlier initiation of stroke aftercare measures. Conclusions Our observations indicate deficits in the implementation of guideline recommendations in stroke aftercare. At the same time, they underscore the need for regular monitoring of implementation measures in stroke aftercare to address group-based disparities in care.	[Schindel, Daniel; Mandl, Lena; Schenk, Liane] Charite Univ Med Berlin, Inst Med Sociol & Rehabil Sci, Berlin, Germany; [Schindel, Daniel; Mandl, Lena; Schilling, Ralph; Meisel, Andreas; Schenk, Liane] Free Univ Berlin, Berlin, Germany; [Schindel, Daniel; Mandl, Lena; Schilling, Ralph; Meisel, Andreas; Schenk, Liane] Humboldt Univ, Berlin, Germany; [Schilling, Ralph] Charite Univ Med Berlin, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Schilling, Ralph] Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Meisel, Andreas] Charite Unv Med Berlin, NeuroCure Clin Res Ctr, Ctr Stroke Res Berlin, Berlin, Germany; [Meisel, Andreas] Charite Unv Med Berlin, Dept Neurol Expt Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schindel, D (corresponding author), Charite Univ Med Berlin, Inst Med Sociol & Rehabil Sci, Berlin, Germany.; Schindel, D (corresponding author), Free Univ Berlin, Berlin, Germany.; Schindel, D (corresponding author), Humboldt Univ, Berlin, Germany.	daniel.schindel@charite.de		Schindel, Daniel/0000-0003-3351-8378	German Federal Ministry of Education and Research [01GY1601]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	LS recieved funding for this study through the German Federal Ministry of Education and Research [Project NAVICARE, 01GY1601, https://www.bmbf.de/].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, BERLIN STROKE REGIST; [Anonymous], 2015, EVALUATION 2014; [Anonymous], 1999, EPIDEMIOLOGIC METHOD; Ayerbe L, 2011, STROKE, V42, P1907, DOI 10.1161/STROKEAHA.110.605808; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Brady MC, 2011, DISABIL REHABIL, V33, P178, DOI 10.3109/09638288.2010.517897; Bushnell CD, 2018, J CEREBR BLOOD F MET, V38, P2179, DOI 10.1177/0271678X18793324; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cherney LR, 2012, INT J SPEECH-LANG PA, V14, P424, DOI 10.3109/17549507.2012.686629; Code C, 2003, DISABIL REHABIL, V25, P1231, DOI 10.1080/09638280310001599961; Code C, 2011, INT J SPEECH-LANG PA, V13, P3, DOI 10.3109/17549507.2010.520090; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; Ferro JM, 1999, CEREBROVASC DIS, V9, P6, DOI 10.1159/000047571; Field MJ, 1990, CLIN PRACTICE GUIDEL; Flowers HL, 2013, J COMMUN DISORD, V46, P238, DOI 10.1016/j.jcomdis.2013.04.001; Fridriksson J, 2012, NEUROIMAGE, V60, P854, DOI 10.1016/j.neuroimage.2011.12.057; Gall SL, 2012, STROKE, V43, P1982, DOI 10.1161/STROKEAHA.111.632547; Gonzalez-Fernandez M, 2009, DYSPHAGIA, V24, P398, DOI 10.1007/s00455-009-9216-1; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Guo YE, 2014, DISABIL REHABIL, V36, P691, DOI 10.3109/09638288.2013.804597; Heuschmann PU, 2010, AKTUEL NEUROL, V37, P333, DOI 10.1055/s-0030-1248611; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; Hotter B, 2018, EUR STROKE J, V3, P237, DOI 10.1177/2396987318771174; Hotter B, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0989-9; Hubbard IJ, 2012, ARCH PHYS MED REHAB, V93, P965, DOI 10.1016/j.apmr.2012.01.011; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Katz RC, 2000, INT J LANG COMM DIS, V35, P303; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Lam JMC, 2010, MED CARE, V48, P380, DOI 10.1097/MLR.0b013e3181ca2647; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Linder R, 2018, EUR J HEALTH ECON, V19, P821, DOI 10.1007/s10198-017-0924-4; Mackenzie C, 1992, Disabil Rehabil, V14, P146; Mandl L, 2019, REHABILITATION, V58, P331, DOI 10.1055/a-0651-9838; McNaughton H, 2014, NEW ZEAL MED J, V127, P10; Mitchell C, 2021, APHASIOLOGY, V35, P950, DOI 10.1080/02687038.2020.1759772; Nelson Michelle L A, 2016, J Comorb, V6, P35, DOI 10.15256/joc.2016.6.63; Nishimura A, 2019, CIRC J, V83, P2292, DOI 10.1253/circj.CJ-19-0089; Ostwald SK, 2009, TOP STROKE REHABIL, V16, P80, DOI 10.1310/tsr1601-80; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Phan HT, 2019, STROKE, V50, P2299, DOI 10.1161/STROKEAHA.118.024437; Pindus DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192533; Plowman E, 2012, J EVAL CLIN PRACT, V18, P689, DOI 10.1111/j.1365-2753.2011.01650.x; Reinecke H, 2015, EUR HEART J, V36, P932, DOI 10.1093/eurheartj/ehv006; Reker DM, 2002, ARCH PHYS MED REHAB, V83, P750, DOI 10.1053/apmr.2002.99736; Rohde A, 2013, J EVAL CLIN PRACT, V19, P994, DOI 10.1111/jep.12023; Rose M, 2014, INT J SPEECH-LANG PA, V16, P169, DOI 10.3109/17549507.2013.794474; Rudberg AS, 2021, TOP STROKE REHABIL, V28, P153, DOI 10.1080/10749357.2020.1789829; Schindel D, 2021, DISABIL REHABIL, V43, P2332, DOI 10.1080/09638288.2019.1699173; Schubert I, 2017, Z EVIDENZ FORTBILD Q, V126, P66, DOI 10.1016/j.zefq.2017.06.008; Shrubsole K, 2017, APHASIOLOGY, V31, P1, DOI 10.1080/02687038.2016.1143083; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; Statistics, 2021, BOTTL AN; Sung SF, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1769-8; Sung SF, 2016, PHARMACOEPIDEM DR S, V25, P438, DOI 10.1002/pds.3944; Tenforde AS, 2020, AM J PHYS MED REHAB, V99, P977, DOI 10.1097/PHM.0000000000001571; Thomas L, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Tyson S, 2000, CLIN REHABIL, V14, P381, DOI 10.1191/0269215500cr331oa; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Verna A, 2009, INT J SPEECH-LANG PA, V11, P191, DOI 10.1080/17549500902726059; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796	66	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263397	10.1371/journal.pone.0263397	http://dx.doi.org/10.1371/journal.pone.0263397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113968	Green Published, gold			2022-12-26	WOS:000823694700091
J	Suenaga, R; Takemoto, M; Inoue, A; Ishitani, R; Nureki, O				Suenaga, Rieko; Takemoto, Mizuki; Inoue, Asuka; Ishitani, Ryuichiro; Nureki, Osamu			Lateral access mechanism of LPA receptor probed by molecular dynamics simulation	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STATE	G-protein-coupled receptors (GPCR) are a family of membrane receptors that play important roles in the regulation of various physiological phenomena. LPA receptors (LPA(1-6)) are members of the class A GPCRs, which transduce a lysophosphatidic acid (LPA) signal across the cell membrane and evoke various responses, including cellular survival, proliferation, differentiation, and migration. The crystal structure of LPA(6) revealed a gap between its transmembrane helices (TMs), which is opened toward the membrane side. This led to the proposal of the "lateral access model," in which its lipophilic ligand directly enters the binding pocket through the gap structure at the membrane. In this study, we performed molecular dynamics (MD) simulations and Markov state model (MSM) analyses of LPA(6) and LPA, to elucidate the long timescale dynamics of the ligand binding process. The results from the 71.4-mu s MD simulation suggested that the flexibility of the TMs constituting the gap structure enables the lateral entrance of the ligand, and the key interactions between the receptor and ligand facilitate the transition state of the ligand binding process.	[Suenaga, Rieko; Takemoto, Mizuki; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo, Japan; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi, Japan; [Takemoto, Mizuki] Preferred Networks Inc, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Tohoku University	Ishitani, R; Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo, Japan.	ishitani@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp		Takemoto, Mizuki/0000-0002-6339-6431	Japan Society for the Promotion of Science [17K08264, 25291011, 16H06294]; Japan Agency for Medical Research and Development (AMED) [JP18gm0010004, JP18gm5910013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	R.I. Grant-in-Aid for Scientific Research (B) (25291011), Japan Society for the Promotion of Science, No O.N. Grant-in-Aid for Specially Promoted Research (16H06294), Japan Society for the Promotion of Science, No A.I. PRIME grant (JP18gm5910013), Japan Agency for Medical Research and Development (AMED), No A.I. LEAP grant (JP18gm0010004), Japan Agency for Medical Research and Development (AMED), No A. I. KAKENHI grant (17K08264), Japan Society for the Promotion of Science, No.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Bai QF, 2014, PHYS CHEM CHEM PHYS, V16, P15874, DOI 10.1039/c4cp01185f; Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Cao C, 2018, NAT STRUCT MOL BIOL, V25, P488, DOI 10.1038/s41594-018-0068-y; Decherchi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7155; Ehlert FJ, 1999, J PHARMACOL EXP THER, V289, P981; Fan HX, 2019, NAT CHEM BIOL, V15, P27, DOI 10.1038/s41589-018-0170-9; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hernandez C. X, 2017, J OPEN SOURCE SOFTW, V2, P188; Ho JD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-01240-w; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Ketscher A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.34; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Lane TJ, 2013, CURR OPIN STRUC BIOL, V23, P58, DOI 10.1016/j.sbi.2012.11.002; Luginina A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2518; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Roblitz S, 2013, ADV DATA ANAL CLASSI, V7, P147, DOI 10.1007/s11634-013-0134-6; Shao ZH, 2016, NATURE, V540, P602, DOI 10.1038/nature20613; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Stansfeld PJ, 2015, STRUCTURE, V23, P1350, DOI 10.1016/j.str.2015.05.006; Taniguchi R, 2017, NATURE, V548, P356, DOI 10.1038/nature23448; Toyoda Y, 2019, NAT CHEM BIOL, V15, P18, DOI 10.1038/s41589-018-0131-3; Wang L, 2018, MOL CELL, V72, P48, DOI 10.1016/j.molcel.2018.08.009	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263296	10.1371/journal.pone.0263296	http://dx.doi.org/10.1371/journal.pone.0263296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113924	gold, Green Published			2022-12-26	WOS:000823694700075
J	Cory, AB; Chanton, JP; Spencer, RGM; Ogles, OC; Rich, VI; McCalley, CK; Wilson, RM				Cory, Alexandra B.; Chanton, Jeffrey P.; Spencer, Robert G. M.; Ogles, Olivia C.; Rich, Virginia, I; McCalley, Carmody K.; Wilson, Rachel M.		IsoGenie Project Coordinators; EMERGE 2021 Field Team	Quantifying the inhibitory impact of soluble phenolics on anaerobic carbon mineralization in a thawing permafrost peatland	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; NORTHERN PEATLAND; ENZYME-ACTIVITIES; METHANE DYNAMICS; CLIMATE; LIGNIN; LATCH; DECOMPOSITION; RESPIRATION; CHEMISTRY	The mechanisms controlling the extraordinarily slow carbon (C) mineralization rates characteristic of Sphagnum-rich peatlands ("bogs") are not fully understood, despite decades of research on this topic. Soluble phenolic compounds have been invoked as potentially significant contributors to bog peat recalcitrance due to their affinity to slow microbial metabolism and cell growth. Despite this potentially significant role, the effects of soluble phenolic compounds on bog peat C mineralization remain unclear. We analyzed this effect by manipulating the concentration of free soluble phenolics in anaerobic bog and fen peat incubations using water-soluble polyvinylpyrrolidone ("PVP"), a compound that binds with and inactivates phenolics, preventing phenolic-enzyme interactions. CO2 and CH4 production rates (end-products of anaerobic C mineralization) generally correlated positively with PVP concentration following Michaelis-Menten (M.M.) saturation functions. Using M.M. parameters, we estimated that the extent to which phenolics inhibit anaerobic CO2 production was significantly higher in the bog-62 +/- 16%-than the fen-14 +/- 4%. This difference was found to be more substantial with regards to methane production-wherein phenolic inhibition for the bog was estimated at 54 +/- 19%, while the fen demonstrated no apparent inhibition. Consistent with this habitat difference, we observed significantly higher soluble phenolic content in bog vs. fen pore-water. Together, these findings suggest that soluble phenolics could contribute to bogs' extraordinary recalcitrance and high (relative to other peatland habitats) CO2:CH4 production ratios.	[Cory, Alexandra B.; Chanton, Jeffrey P.; Spencer, Robert G. M.; Ogles, Olivia C.; Wilson, Rachel M.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Rich, Virginia, I] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [McCalley, Carmody K.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA	State University System of Florida; Florida State University; University System of Ohio; Ohio State University; Rochester Institute of Technology	Cory, AB (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	alexandra.cory.b@gmail.com		Cory, Alexandra/0000-0001-5525-7119	Genomic Science Program of the United States Department of Energy Office of Biological and Environmental Research Grants [DE-SC0010580, DE-SC0016440]; EMERGE Biology Integration Institute of the National Science Foundation [2022070]	Genomic Science Program of the United States Department of Energy Office of Biological and Environmental Research Grants(United States Department of Energy (DOE)); EMERGE Biology Integration Institute of the National Science Foundation	Grant 1 Recipient: V.I.R. Grant number: DE-SC0010580 Funding Source: the Genomic Science Program of the United States Department of Energy Office of Biological and Environmental Research Grants URL: https://genomicscience.energy.gov/Grant 2 Recipient: V.I.R. Grant number: DE-SC0016440 Funding Source: the Genomic Science Program of the United States Department of Energy Office of Biological and Environmental Research Grants URL: https://genomicscience.energy.gov/Grant 3 Recipient: V.I. R. Grant Number: 2022070 Funding Source: the EMERGE Biology Integration Institute of the National Science Foundation URL: https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505684 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AminiTabrizi R, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.557961; Backstrand K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000703; Bancuta OR, 2016, ROM J PHYS, V61, P1255; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; BORNEMAN WS, 1986, APPL ENVIRON MICROB, V52, P1331, DOI 10.1128/AEM.52.6.1331-1339.1986; Brouns K, 2016, SOIL BIOL BIOCHEM, V95, P144, DOI 10.1016/j.soilbio.2015.11.018; Brouns K, 2014, SCI TOTAL ENVIRON, V481, P61, DOI 10.1016/j.scitotenv.2014.02.030; Bundhoo MAZ, 2016, INT J HYDROGEN ENERG, V41, P6713, DOI 10.1016/j.ijhydene.2016.03.057; Chang KY, 2019, CRYOSPHERE, V13, P647, DOI 10.5194/tc-13-647-2019; CLYMO RS, 1987, SCI PROG, V71, P593; Corbett JE, 2013, BIOGEOCHEMISTRY, V114, P327, DOI 10.1007/s10533-012-9813-1; Dunn C, 2014, WETLANDS, V34, P9, DOI 10.1007/s13157-013-0475-0; Fenner N, 2005, SOIL BIOL BIOCHEM, V37, P1277, DOI 10.1016/j.soilbio.2004.11.024; Fenner N, 2011, NAT GEOSCI, V4, P895, DOI [10.1038/ngeo1323, 10.1038/NGEO1323]; FIELD JA, 1992, BASIC LIFE SCI, V59, P673; Freeman C, 2004, SOIL BIOL BIOCHEM, V36, P1663, DOI 10.1016/j.soilbio.2004.07.012; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; Frolking S, 2007, GLOBAL CHANGE BIOL, V13, P1079, DOI 10.1111/j.1365-2486.2007.01339.x; Frolking S, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000091; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; GILBERT P, 1990, J APPL BACTERIOL, V69, P585, DOI 10.1111/j.1365-2672.1990.tb01552.x; Glaser PH, 1987, SERVICE; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Guo FF, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-38; Hierholtzer A, 2013, J APPL MICROBIOL, V114, P964, DOI 10.1111/jam.12114; Hodgkins SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06050-2; Hodgkins SB, 2016, GEOCHIM COSMOCHIM AC, V187, P123, DOI 10.1016/j.gca.2016.05.015; Hodgkins SB, 2015, BIOGEOCHEMISTRY, V126, P241, DOI 10.1007/s10533-015-0142-z; Hodgkins SB, 2014, P NATL ACAD SCI USA, V111, P5819, DOI 10.1073/pnas.1314641111; Hough MA, 2020, TRACING NEW CARBON C; Hugelius G, 2020, P NATL ACAD SCI USA, V117, P20438, DOI 10.1073/pnas.1916387117; Johansson T, 2006, GLOBAL CHANGE BIOL, V12, P2352, DOI 10.1111/j.1365-2486.2006.01267.x; Kamra D.N., 2006, INT C SER, V1293, P156, DOI [DOI 10.1016/J.ICS.2006.02.002, 10.1016/j.ics.2006.02.002]; Liebner S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00356; Lin X, 2012, APPL ENVIRON MICROB, V78, P7023, DOI 10.1128/AEM.01750-12; Mann PJ, 2014, GLOBAL CHANGE BIOL, V20, P1089, DOI 10.1111/gcb.12416; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268, DOI 10.2134/jeq1998.00472425002700050036x; Minderlein S, 2010, SOIL BIOL BIOCHEM, V42, P2078, DOI 10.1016/j.soilbio.2010.08.002; MOLYNEUX P, 1986, J CHEM SOC FARAD T 1, V82, P291, DOI 10.1039/f19868200291; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Nakagame S, 2010, BIOTECHNOL BIOENG, V105, P871, DOI 10.1002/bit.22626; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Nichols JE, 2019, NAT GEOSCI, V12, P917, DOI 10.1038/s41561-019-0454-z; Norby RJ, 2019, ECOL EVOL, V9, P12571, DOI 10.1002/ece3.5722; Oskoueian E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/349129; PAINTER TJ, 1991, CARBOHYD POLYM, V15, P123, DOI 10.1016/0144-8617(91)90028-B; Pan XJ, 2008, J BIOBASED MATER BIO, V2, P25, DOI 10.1166/jbmb.2008.005; Qin L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0485-2; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V133, P270, DOI 10.1016/j.biortech.2013.01.075; RASMUSSEN S, 1995, PHYTOCHEMISTRY, V38, P35, DOI 10.1016/0031-9422(94)00650-I; Romanowicz KJ, 2015, PLANT SOIL, V397, P371, DOI 10.1007/s11104-015-2746-4; Rudolph H, 1992, CRYPTOGAMIC BOT; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; SHOTYK W, 1988, EARTH-SCI REV, V25, P95, DOI 10.1016/0012-8252(88)90067-0; Sun XT, 2010, FRONT EARTH SCI-PRC, V4, P463, DOI 10.1007/s11707-010-0140-3; Treat CC, 2019, P NATL ACAD SCI USA, V116, P4822, DOI 10.1073/pnas.1813305116; Turetsky MR, 2015, NAT GEOSCI, V8, P11, DOI [10.1038/ngeo2325, 10.1038/NGEO2325]; Urbanova Z, 2021, SCI TOTAL ENVIRON, V779, DOI 10.1016/j.scitotenv.2021.146384; Urbanova Z, 2016, SOIL BIOL BIOCHEM, V92, P16, DOI 10.1016/j.soilbio.2015.09.017; Ussiri D. A. N., 2017, CARBON SEQUESTRATION, P77, DOI DOI 10.1016/J.CHEMOSPHERE.2017.05.165; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Voigt C, 2019, GLOBAL CHANGE BIOL, V25, P1746, DOI 10.1111/gcb.14574; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; WILSCHKE J, 1989, PHYTOCHEMISTRY, V28, P1725, DOI 10.1016/S0031-9422(00)97833-6; Wilson RM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245857; Wilson RM, 2017, J GEOPHYS RES-BIOGEO, V122, P387, DOI 10.1002/2016JG003600; Wilson RM, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00059; Wilson RM, 2017, ORG GEOCHEM, V112, P22, DOI 10.1016/j.orggeochem.2017.06.011	70	1	1	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0252743	10.1371/journal.pone.0252743	http://dx.doi.org/10.1371/journal.pone.0252743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108267	Green Published, gold			2022-12-26	WOS:000775890100002
J	Korunes, KL; Liu, J; Huang, RL; Xia, MH; Houck, KA; Corton, JC				Korunes, Katharine L.; Liu, Jie; Huang, Ruili; Xia, Menghang; Houck, Keith A.; Corton, J. Christopher			A gene expression biomarker for predictive toxicology to identify chemical modulators of NF-kappa B	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; IDENTIFICATION; RECEPTOR; PATHWAYS; MACROPHAGES; MECHANISMS; INDUCTION; EXPOSURE; PROTEIN; KINASE	The nuclear factor-kappa B (NF-kappa B) is a transcription factor with important roles in inflammation, immune response, and oncogenesis. Dysregulation of NF-kappa B signaling is associated with inflammation and certain cancers. We developed a gene expression biomarker predictive of NF-kappa B modulation and used the biomarker to screen a large compendia of gene expression data. The biomarker consists of 108 genes responsive to tumor necrosis factor a in the absence but not the presence of I kappa B, an inhibitor of NF-kappa B. Using a set of 450 profiles from cells treated with immunomodulatory factors with known NF-kappa B activity, the balanced accuracy for prediction of NF-kappa B activation was > 90%. The biomarker was used to screen a microarray compendium consisting of 12,061 microarray comparisons from human cells exposed to 2,672 individual chemicals to identify chemicals that could cause toxic effects through NF-kappa B. There were 215 and 49 chemicals that were identified as putative or known NF-kappa B activators or suppressors, respectively. NF-kappa B activators were also identified using two high-throughput screening assays; 165 out of the similar to 3,800 chemicals (ToxCast assay) and 55 out of similar to 7,500 unique compounds (Tox21 assay) were identified as potential activators. A set of 32 chemicals not previously associated with NF-kappa B activation and which partially overlapped between the different screens were selected for validation in wild-type and NFKB1-null HeLa cells. Using RT-qPCR and targeted RNA-Seq, 31 of the 32 chemicals were confirmed to be NF-kappa B activators. These results comprehensively identify a set of chemicals that could cause toxic effects through NF-kappa B.	[Korunes, Katharine L.; Liu, Jie; Houck, Keith A.; Corton, J. Christopher] US EPA, Ctr Computat Toxicol & Exposure, Res Triangle Pk, NC 27711 USA; [Korunes, Katharine L.] Duke Univ, Biol Dept, Durham, NC USA; [Huang, Ruili; Xia, Menghang] Natl Ctr Adv Translat Sci, NIH, Bethesda, MD USA; [Korunes, Katharine L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	United States Environmental Protection Agency; Duke University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Duke University	Corton, JC (corresponding author), US EPA, Ctr Computat Toxicol & Exposure, Res Triangle Pk, NC 27711 USA.	corton.chris@epa.gov			U.S. Environmental Protection Agency Office of Research and Development; National Science Foundation [DGE-1644868]; National Institute of Environmental Health Sciences/Division of the National Toxicology Program [NTR12003]	U.S. Environmental Protection Agency Office of Research and Development(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences/Division of the National Toxicology Program	Funding for this study came from the U.S. Environmental Protection Agency Office of Research and Development to JL, KAH, JCC. KLK was supported by the National Science Foundation Graduate Research Fellowship Program under grant no. DGE-1644868. This work was also supported in part by Interagency Agreement IAA No. NTR12003 from the National Institute of Environmental Health Sciences/Division of the National Toxicology Program to the NCATS, National Institutes of Health to RH and MX.	Alsina L, 2014, NAT IMMUNOL, V15, P1134, DOI 10.1038/ni.3028; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Blom T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-45; Boghdadi Ghada, 2014, Inflammation & Allergy Drug Targets, V13, P144; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Burkly LC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00092; Cheng N, 2001, J BIOL CHEM, V276, P13771, DOI 10.1074/jbc.M009147200; Cho E, 2019, ENVIRON MOL MUTAGEN, V60, P122, DOI 10.1002/em.22257; Corton JC, 2019, TOXICOL APPL PHARM, V380, DOI 10.1016/j.taap.2019.114683; Corton JC, 2018, ENVIRON MOL MUTAGEN, V59, P772, DOI 10.1002/em.22243; De Abrew KN, 2016, TOXICOL SCI, V151, P447, DOI 10.1093/toxsci/kfw058; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Guo HR, 2015, ONCOTARGET, V6, P28607, DOI 10.18632/oncotarget.5759; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang RL, 2016, METHODS MOL BIOL, V1473, P111, DOI 10.1007/978-1-4939-6346-1_12; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Jackson AC, 2020, METALLOMICS, V12, P1400, DOI 10.1039/d0mt00071j; Janssen YMW, 1997, AM J PATHOL, V151, P389; Johnson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114017; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lei FX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0714-7; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Liu JT, 2015, TOXICOL LETT, V239, P97, DOI 10.1016/j.toxlet.2015.09.015; Liu XD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-66; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Mav D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191105; Meyerovich K, 2018, J MOL ENDOCRINOL, V61, pF1, DOI 10.1530/JME-16-0183; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Nelson G, 2003, J CELL SCI, V116, P2495, DOI 10.1242/jcs.00461; Nishanth RP, 2011, NANOTOXICOLOGY, V5, P502, DOI 10.3109/17435390.2010.541604; Nymark P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-62; Oeder S, 2012, AM J RESP CELL MOL, V47, P575, DOI 10.1165/rcmb.2012-0139OC; Oshida K, 2015, TOXICOLOGY, V336, P99, DOI 10.1016/j.tox.2015.07.005; Oshida Keiyu, 2015, Nucl Recept Signal, V13, pe002, DOI 10.1621/nrs.13002; Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655; Pisani C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1521-5; Rand TG, 2013, ARCH TOXICOL, V87, P1841, DOI 10.1007/s00204-013-1042-4; Rooney J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200004; Rooney JP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239367; Rooney JP, 2018, TOXICOL SCI, V166, P146, DOI 10.1093/toxsci/kfy187; Ryan N, 2016, TOXICOL SCI, V151, P88, DOI 10.1093/toxsci/kfw026; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Sellamuthu R, 2011, INHAL TOXICOL, V23, P927, DOI 10.3109/08958378.2011.625995; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; Thomas RS, 2019, TOXICOL SCI, V169, P317, DOI 10.1093/toxsci/kfz058; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tsumagari K, 2015, CANCER LETT, V368, P46, DOI 10.1016/j.canlet.2015.07.011; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wong F, 2004, BLOOD, V103, P4520, DOI 10.1182/blood-2003-06-2118; Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5; Yeakley JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178302; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	61	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0261854	10.1371/journal.pone.0261854	http://dx.doi.org/10.1371/journal.pone.0261854			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108274	gold, Green Published			2022-12-26	WOS:000775890100016
J	Wambacq, E; Alloul, A; Grunert, O; Carrette, J; Vermeir, P; Spanoghe, J; Sakarika, M; Vlaeminck, SE; Haesaert, G				Wambacq, Eva; Alloul, Abbas; Grunert, Oliver; Carrette, Jasper; Vermeir, Pieter; Spanoghe, Janne; Sakarika, Myrsini; Vlaeminck, Siegfried E.; Haesaert, Geert			Aerobes and phototrophs as microbial organic fertilizers: Exploring mineralization, fertilization and plant protection features	PLOS ONE			English	Article							NITROGEN MINERALIZATION; AMENDMENTS; BIOSOLIDS; SOIL	Organic fertilizers and especially microbial biomass, also known as microbial fertilizer, can enable a paradigm shift to the conventional fertilizer-to-food chain, particularly when produced on secondary resources. Microbial fertilizers are already common practice (e.g. Bloom (R) and Synagro); yet microbial fertilizer blends to align the nutrient release profile to the plant's needs are, thus far, unexplored. Moreover, most research only focuses on direct fertilization effects without considering added value properties, such as disease prevention. This study has explored three promising types of microbial fertilizers, namely dried biomass from a consortium of aerobic heterotrophic bacteria, a microalga (Arthrospira platensis) and a purple non-sulfur bacterium (Rhodobacter sphaeroides). Mineralization and nitrification experiments showed that the nitrogen mineralization profile can be tuned to the plant's needs by blending microbial fertilizers, without having toxic ammonium peaks. In a pot trial with perennial ryegrass (Lolium perenne L.), the performance of microbial fertilizers was similar to the reference organic fertilizer, with cumulative dry matter yields of 5.6-6.7 g per pot. This was confirmed in a pot trial with tomato (Solanum lycopersicum L.), showing an average total plant length of 90-99 cm after a growing period of 62 days for the reference organic fertilizer and the microbial fertilizers. Moreover, tomato plants artificially infected with powdery mildew (Oidium neolycopersici), a devastating disease for the horticultural industry, showed reduced disease symptoms when A. platensis was present in the growing medium. These findings strengthen the application potential of this novel class of organic fertilizers in the bioeconomy, with a promising match between nutrient mineralization and plant requirements as well as added value in crop protection.	[Wambacq, Eva; Haesaert, Geert] Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Ghent, Belgium; [Wambacq, Eva; Carrette, Jasper; Haesaert, Geert] Univ Appl Sci & Arts, Res Ctr AgroFoodNat, Sch Biosci & Ind Technol, Ghent, Belgium; [Alloul, Abbas; Spanoghe, Janne; Sakarika, Myrsini; Vlaeminck, Siegfried E.] Univ Antwerp, Fac Sci, Dept Biosci Engn, Res Grp Sustainable Energy Air & Water Technol, Antwerp, Belgium; [Grunert, Oliver] Greenyard Hort Belgium, Ghent, Belgium; [Vermeir, Pieter] Univ Ghent, Fac Biosci Engn, Dept Green Chem & Technol, Ghent, Belgium; [Grunert, Oliver] Aphea Bio, Zwijnaarde, Belgium	Ghent University; University of Antwerp; Ghent University	Wambacq, E; Haesaert, G (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Ghent, Belgium.; Wambacq, E; Haesaert, G (corresponding author), Univ Appl Sci & Arts, Res Ctr AgroFoodNat, Sch Biosci & Ind Technol, Ghent, Belgium.; Alloul, A (corresponding author), Univ Antwerp, Fac Sci, Dept Biosci Engn, Res Grp Sustainable Energy Air & Water Technol, Antwerp, Belgium.	eva.wambacq@hogent.be; Abbas.Alloul@uantwerpen.be; geert.haesaert@ugent.be	Sakarika, Myrsini/GQQ-1185-2022; Vlaeminck, Siegfried E./B-4203-2014	Sakarika, Myrsini/0000-0003-2098-8688; Vlaeminck, Siegfried E./0000-0002-2596-8857	MIPi-Cleantech Flanders (Milieu-innovatieplatform; Environment innovation platform) project Microbial Nutrients on Demand (MicroNOD); European Union's Horizon 2020 Research and Innovation programme [821427]; IOF (Industrieel onderzoeksfonds) from the University of Antwerp [40207]; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek -Vlaanderen) [12W0522N]; BOF (Bijzonder onderzoeksfonds; Special research fund) from the University of Antwerp	MIPi-Cleantech Flanders (Milieu-innovatieplatform; Environment innovation platform) project Microbial Nutrients on Demand (MicroNOD); European Union's Horizon 2020 Research and Innovation programme; IOF (Industrieel onderzoeksfonds) from the University of Antwerp; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek -Vlaanderen)(FWO); BOF (Bijzonder onderzoeksfonds; Special research fund) from the University of Antwerp	The authors kindly acknowledge (i) the MIPi-Cleantech Flanders (Milieu-innovatieplatform; Environment innovation platform) project Microbial Nutrients on Demand (MicroNOD) for financial support, (ii) the project 'Saraswati 2.0' (821427) funded by the European Union's Horizon 2020 Research and Innovation programme, for financial support of A.A., (iii) the project 'PurpleRace'(40207) funded by IOF (Industrieel onderzoeksfonds) from the University of Antwerp for financial support of A.A, (iv) the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek -Vlaanderen) for supporting A.A. with a postdoctoral fellowship (12W0522N) and (v) the DOCPRO4project 'PurpleTech', funded by the BOF (Bijzonder onderzoeksfonds; Special research fund) from the University of Antwerp for financially supporting J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LK, 2018, AGR ECOSYST ENVIRON, V256, P34, DOI 10.1016/j.agee.2017.12.021; Abdel-Monaim M.F., 2016, RES J INT, V16, P1, DOI [10.9734/BMRJ/2016/27883, DOI 10.9734/BMRJ/2016/27883]; Ahmed M, 2010, J MICROBIOL BIOTECHN, V20, P1259, DOI 10.4014/jmb.1004.04033; Alloul A, 2021, ENVIRON SCI TECHNOL, V55, P8278, DOI 10.1021/acs.est.0c08204; Alloul A, 2021, AQUACULTURE, V530, DOI 10.1016/j.aquaculture.2020.735788; Alloul A, 2019, WATER RES, V152, P138, DOI 10.1016/j.watres.2018.12.025; Alloul A, 2018, ENVIRON SCI TECHNOL, V52, P6729, DOI 10.1021/acs.est.7b05712; Bardgett RD, 2014, TRENDS ECOL EVOL, V29, P692, DOI 10.1016/j.tree.2014.10.006; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Coppens J, 2016, RESOUR CONSERV RECY, V115, P9, DOI 10.1016/j.resconrec.2016.08.006; Coppens J, 2016, J APPL PHYCOL, V28, P2367, DOI 10.1007/s10811-015-0775-2; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Cornel P, 2011, TREATISE ON WATER SCIENCE, VOL 4: WATER-QUALITY ENGINEERING, P337; Diacono M, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P761, DOI 10.1007/978-94-007-0394-0_34; El Diwani G, 2007, DESALINATION, V214, P200, DOI 10.1016/j.desal.2006.08.019; El-Haggar S.M., 2010, SUSTAINABLE IND DESI; FAO, 2019, WORLD FERT TRENDS OU; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Goncalves AL, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11020871; Grunert O, 2017, MICROBIALLY MANAGED; Grunert O, 2016, MICROB BIOTECHNOL, V9, P389, DOI 10.1111/1751-7915.12354; Haifa-Group, CROP GUID TOM PLANT; IFA-International Fertilizer Association, 2019, P IFA ANN C MONTR QC, P1; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P41, DOI 10.1007/0-387-30745-1_2; Jie Chen, 2006, 2006 First Bio-Inspired Models of Network, Information and Computing Systems (IEEE Cat No. 06EX1490), P1; Kepczynska E, 2012, J PLANT INTERACT, V7, P307, DOI 10.1080/17429145.2011.645169; KOBAYASHI M, 1973, WATER RES, V7, P1219, DOI 10.1016/0043-1354(73)90075-4; Kobayashi M., 1995, Anoxygenic photosynthetic bacteria., P1269; Kondo K, 2010, J FOOD AGRIC ENVIRON, V8, P743; Marschner P, 2005, APPL SOIL ECOL, V28, P191, DOI 10.1016/j.apsoil.2004.09.001; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Masunga RH, 2016, APPL SOIL ECOL, V101, P185, DOI 10.1016/j.apsoil.2016.01.006; Metcalf, 2003, WASTEWATER ENG TREAT; Milieu Ltd, 2008, ENV EC SOCIAL IMPACT; Mulbry W., 2006, Journal of Vegetable Science, V12, P107, DOI 10.1300/J484v12n04_08; Mulbry W, 2005, BIORESOURCE TECHNOL, V96, P451, DOI 10.1016/j.biortech.2004.05.026; Paungfoo-Lonhienne C, 2012, PLANT SOIL, V359, P1, DOI 10.1007/s11104-012-1357-6; Pikaar I, 2017, ENVIRON SCI TECHNOL, V51, P7297, DOI 10.1021/acs.est.7b00916; Renuka N, 2018, BIOTECHNOL ADV, V36, P1255, DOI 10.1016/j.biotechadv.2018.04.004; Rigby H, 2016, SCI TOTAL ENVIRON, V541, P1310, DOI 10.1016/j.scitotenv.2015.08.089; Romanenko E. A., 2015, International Journal on Algae, V17, P275, DOI 10.1615/InterJAlgae.v17.i3.80; Ronga D, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9040192; Sakarika M, 2020, MICROB BIOTECHNOL, V13, P1336, DOI 10.1111/1751-7915.13474; Sharma B, 2017, WASTE MANAGE, V64, P117, DOI 10.1016/j.wasman.2017.03.002; Spanoghe J, 2020, MICROB BIOTECHNOL, V13, P1377, DOI 10.1111/1751-7915.13554; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Statistics Market Research Consulting Pvt Ltd, 2018, ORGANIC FERTILIZERS; Sutton M. A., 2013, OUR NUTR WORLD CHALL; Tarakhovskaya ER, 2007, RUSS J PLANT PHYSL+, V54, P163, DOI 10.1134/S1021443707020021; UEDA J, 1991, Bulletin of the University of Osaka Prefecture Series B Agriculture and Life Sciences, V43, P103; Zarezadeh S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01193; Zarrouk C., 1966, CONTRIBUTION LETUDE	52	2	2	14	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262497	10.1371/journal.pone.0262497	http://dx.doi.org/10.1371/journal.pone.0262497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108295	Green Published, gold			2022-12-26	WOS:000775890100025
J	Prasanna, L; Dangi, KS; Raju, CHD; Jagadeeshwar, R; Rekha, G; Sinha, P; Aleena, D; Harika, G; Mastanbee, SK; Ravindra, S; Kousik, MBVN; Swamy, HKM; Anila, M; Kale, RRRR; Kumar, D; Punniakotti, E; Hajira, SK; Bhadana, VP; Sundaram, RM				Prasanna B, Laxmi; Dangi, K. S.; Raju, Damodar C. H.; Jagadeeshwar, R.; Rekha, G.; Sinha, Pragya; Aleena, D.; Harika, G.; Mastanbee, S. K.; Ravindra K, Swapnil; Kousik, M. B. V. N.; Swamy, Mahadeva H. K.; Anila, M.; Kale, R. R. R. R.; Kumar T, Dilip; Punniakotti, E.; Hajira, S. K.; Bhadana, V. P.; Sundaram, R. M.			Marker assisted pedigree breeding based improvement of the Indian mega variety of rice MTU1010 for resistance against bacterial blight and blast and tolerance to low soil phosphorus	PLOS ONE			English	Article							IDENTIFICATION	Rice production is affected by many biotic and abiotic stresses; among them, bacterial blight (BB) and blast diseases and low soil phosphorous stress cause significant yield losses. The present study was carried out with the objective of combining the BB resistance gene, Xa21, the blast resistance gene, Pi54, and the low soil phosphorous tolerance QTL/gene, Pup1, into the genetic background of the Indian mega-rice variety, MTU1010 (Cottondora Sannalu), through marker-assisted pedigree breeding. RP5973-20-9-8-24-12-7 [a near isogenic line (NIL) of MTU1010 possessing Pup1] and RP6132 [a NIL of Akshayadhan possessing Xa21 + Pi54] were crossed and 'true' F(1)s were identified, using the target gene-specific markers and selfed. F-2 plants, which are homozygous for all the three target genes/QTLs, were identified using PCR based markers and were advanced further through the pedigree method of breeding, with selection based on phenotypic traits specific for MTU1010. At the F-5 generation, a set of 15 promising triple positive homozygous lines were identified and screened for their resistance against BB and blast diseases and tolerance to low soil P. Among them, two lines (LPK 30-18-16 and LPK 49-15-22) showed higher yields as compared to MTU1010, along with the desirable long slender grain type in both low soil P and normal soil P plots, and also exhibited high levels of resistance against BB and blast diseases, with lesser grain shattering as compared to MTU1010. These lines are being advanced for multi-location trials for validating their performance.	[Prasanna B, Laxmi] PJTSAU, Reg Agr Res Stn, Jagtial, India; [Dangi, K. S.; Raju, Damodar C. H.; Jagadeeshwar, R.] Prof Jayashankar Telangana State Agr Univ, Hyderabad, India; [Rekha, G.; Sinha, Pragya; Aleena, D.; Harika, G.; Mastanbee, S. K.; Ravindra K, Swapnil; Kousik, M. B. V. N.; Anila, M.; Kale, R. R. R. R.; Kumar T, Dilip; Punniakotti, E.; Hajira, S. K.; Sundaram, R. M.] Indian Inst Rice Res, Hyderabad, India; [Swamy, Mahadeva H. K.] ICAR Sugarcane Breeding Inst, Coimbatore, Tamil Nadu, India; [Bhadana, V. P.] ICAR Indian Inst Agr Biotechnol IIAB, Ranchi, Bihar, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; Indian Council of Agricultural Research (ICAR); ICAR - Sugarcane Breeding Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Agricultural Biotechnology	Sundaram, RM (corresponding author), Indian Inst Rice Res, Hyderabad, India.	rms_28@rediffmail.com			 [RGNF-2012-13-SC-AND-30298]		The first author would like to thank RAJIV GANDHI NATIONAL FELLOWSHIP (2012-13) with award no RGNF-2012-13-SC-AND-30298 for the funding support provided for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash Kumar V, 2016, J PLANT BIOCHEM BIOT, DOI [10.1007/s13562-016-0352z, DOI 10.1007/S13562-016-0352Z]; Anila M, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0903-1; Balconi C., 2012, CROP PRODUCTION AGR, P57; Bhaskar Naik S., 2015, INT J CURRENT RES, V7, P18943; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Dixit S., 2020, RICE, P13, DOI [10.1186/s12284-020-0373-z, DOI 10.1186/S12284-020-0373-Z]; Hari Y, 2013, PLANT BREEDING, V132, P586, DOI 10.1111/pbr.12056; International Rice Research Institute (IRRI), 2013, STAND EV SYST RIC; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khush G. S., 1989, BACTERIAL BLIGHT RIC, P207; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Laha GS, 2009, DRR TECHNICAL B, V41; Mangrauthia SK., 2011, TECHNICAL B ICAR; Mishra KK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-12; Ou S. H., 1985, Rice diseases.; Ramkumar G, 2011, MOL BREEDING, V27, P129, DOI 10.1007/s11032-010-9538-6; Rekha G, 2018, J PHARM PHYTOCHEM, V4, P1182; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Sharma TR, 2010, J PLANT BIOCHEM BIOT, V19, P87, DOI 10.1007/BF03323441; Srinivasan B, 2005, CURR SCI INDIA, V88, P1229; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Swamy HKM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78186-5; Swamy HKM, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2443-0; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Zhang F, 2015, PLANT PATHOL, V64, P568, DOI 10.1111/ppa.12283; Zheng K., 1995, RICE GENET NEWSLETT, V12, P255	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0260535	10.1371/journal.pone.0260535	http://dx.doi.org/10.1371/journal.pone.0260535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100268	Green Published, gold			2022-12-26	WOS:000801937600008
J	Yakovlev, A; Tulin, D; Savva, A; Kruglikova, A				Yakovlev, Andrey; Tulin, Dmitry; Savva, Anna; Kruglikova, Anastasia			The possibility of using xenogeneic phagocytes in wound treatment	PLOS ONE			English	Article							LARVAL; METAMORPHOSIS; HEMOCYTES; DIPTERA; PH	Metamorphosis in the insect larva is associated with disintegration, engulf and digestion of larval tissues. These processes are accompanied by a significant shift in physiological parameters like high activity of hydrolytic enzymes and decrease of pH. In the way, the metamorphosing larva resembles the processes occurring in the wound at the stage of inflammation. Based on this thesis, we put forward the idea of the possibility of using insect phagocytes in the wound treatment. The search for a suitable insect cell line and the study of its properties were the purpose of the work. The abilities of insect phagocytes to retain viability and functional activity under conditions physiological for humans were also investigated. We found that blue blowfly Calliphora vicina larvae had histolysocytes, a specialized population of professional phagocytes involved in the histolysis. In vitro, histolysocytes possess high phagocytic activity to fragments of vertebrate soft tissues and debris. These cells retain viability and functional activity for a long time under conditions that are physiological for vertebrate cells. Moreover histolysocytes can realize the humoral control over the bacteria through the synthesis of antimicrobial peptides. So histolysocytes have the potential to be used as xenogeneic phagocytes in the wound treatment. The data obtained allow proceeding to experiments on laboratory animals for studying the effect of such therapy on the wound healing process.	[Yakovlev, Andrey; Tulin, Dmitry; Savva, Anna; Kruglikova, Anastasia] St Petersburg Univ, Lab Insect Biopharmacol & Immunol, St Petersburg, Russia	Saint Petersburg State University	Kruglikova, A (corresponding author), St Petersburg Univ, Lab Insect Biopharmacol & Immunol, St Petersburg, Russia.	a.kruglikova@spbu.ru	Tulin, Dmitry/N-1039-2013	Tulin, Dmitry/0000-0001-6357-0228	Russian Science Foundation [19-75-00032]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by a grant from Russian Science Foundation (grant number 19-75-00032). The funder had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript. https://www.rscf.ru/en/.	Andrews T, 2003, CLIN MICROBIOL REV, V16, P597, DOI 10.1128/CMR.16.4.597-621.2003; ARMBRUSTER L, 1986, COMP BIOCHEM PHYS B, V84, P349, DOI 10.1016/0305-0491(86)90088-X; BAUTZ AM, 1981, INT J INSECT MORPHOL, V10, P173, DOI 10.1016/S0020-7322(81)80021-9; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; Cascalho M., 2008, CLIN IMMUNOL, P1215, DOI [10.1016/B978-0-323-04404-2.10081-8, DOI 10.1016/B978-0-323-04404-2.10081-8]; Chaen J., 1969, GUIDE PRACTICA LN HI; Chernysh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130788; Chernysh Sergey I., 2000, Entomological Science, V3, P139; Desowitz RS., 1988, THORN STARFISH IMMUN; Donovan SE, 2006, MED VET ENTOMOL, V20, P106, DOI 10.1111/j.1365-2915.2006.00600.x; Fishman JA, 2012, XENOTRANSPLANTATION, V19, P72, DOI 10.1111/j.1399-3089.2012.00693.x; Gasz NE, 2017, MED VET ENTOMOL, V31, P299, DOI 10.1111/mve.12232; Goldsby R., 2003, IMMUNOLOGY, V5th, P765; Gordya N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173559; Histolysis AgrellI, 1953, DEVELOPMENT, V1, P279; Hori S, 2000, EUR J BIOCHEM, V267, P5397, DOI 10.1046/j.1432-1327.2000.01578.x; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Johnson C.G., 1974, P279; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kruglikova A., 2012, ENTOMOL REV, V93, P667; LIN CW, 1991, CANCER RES, V51, P2710; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mohd Masri S., 2005, Tropical Biomedicine, V22, P185; Mulisch M, 2015, ROMEIS MIKROSKOPISCH, DOI [10.1007/978-3-642-55190-1, DOI 10.1007/978-3-642-55190-1]; Nadtochii L., 2019, Agronomy Research, V17, P2359, DOI 10.15159/AR.19.209; Nagoba BS, 2015, WOUNDS, V27, P5; Naik G, 2017, CHRONIC WOUND CARE M, V4, P121, DOI 10.2147/CWCMR.S117271; NESIN AP, 1995, APPL ENTOMOL ZOOL, V30, P351; Rabossi A, 2000, ENTOMOL EXP APPL, V94, P57, DOI 10.1023/A:1003977726908; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; ROWLEY AF, 1976, TISSUE CELL, V8, P437, DOI 10.1016/0040-8166(76)90004-5; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Sherman RA, 1996, AM J TROP MED HYG, V54, P38, DOI 10.4269/ajtmh.1996.54.38; Shtilman MI., 2003, VSP INT SCI, P305; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; SMITH E, 1972, INSECT BIOCHEM, V2, P218, DOI 10.1016/0020-1790(72)90056-X; Sommer C, 2005, NEUROLOGY, V65, P1924, DOI 10.1212/01.wnl.0000188879.19900.b7; Watanabe C, 2001, BONE MARROW TRANSPL, V28, P83, DOI 10.1038/sj.bmt.1703086; Wissing F, 2002, J BIOL CHEM, V277, P37747, DOI 10.1074/jbc.M204845200; World Health Organization, 1998, DIV EM OTH COMM DIS	40	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263256	10.1371/journal.pone.0263256	http://dx.doi.org/10.1371/journal.pone.0263256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100296	Green Published, gold			2022-12-26	WOS:000801937600040
J	Mijovic, B; Masic, S; Petkovic, M; Knezevic, D; Acimovic, J; Djakovic-Devic, J; Puhalo-Sladoje, D; Zeljkovic, B; Spaic, D; Bokonjic, D; Skrbic, R				Mijovic, Biljana; Masic, Srdjan; Petkovic, Miroslav; Knezevic, Darija; Acimovic, Jela; Djakovic-Devic, Jelena; Puhalo-Sladoje, Dragana; Zeljkovic, Branislav; Spaic, Dragan; Bokonjic, Dejan; Skrbic, Ranko			Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study	PLOS ONE			English	Article								The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals from all municipalities from 1 December 2020 to 15 January 2021. All individuals were asked to sign a consent form and to fill in a questionnaire, following which a blood samples were collected. Total anti-SARS-CoV-2 antibodies were determined in serum specimens using the total Ab ELISA assay. The overall seroprevalence rate was 40.3%. Subjects aged <65 years were 2.06 times more likely to be seropositive than those aged <greater than or equal to>65, and 30% of seropositive individuals presented no COVID-19 symptoms. The household members of seropositive individuals were 2.24 times more likely to develop COVID-19 symptoms than the household members of seronegative individuals. More than 95% of respondents believe that preventive measures are very important to control the infection transmission. Majority of respondents wear the masks properly, maintain the required physical distance whenever possible and wash hands with soap. Nearly 50% of individuals were of the opinion that the vaccine could prevent the infection. This study showed that an overall SARS-CoV-2 seropositivity rate by the middle of January 2021 was very high. Attitudes and practices regarding the COVID-19 indicate that additional efforts should be taken in order to improve the health education with a focus on preventive measures and vaccination.	[Mijovic, Biljana; Masic, Srdjan; Spaic, Dragan] Univ East Sarajevo, Dept Primary Hlth Care & Publ Hlth, Fac Med, Foca, Bosnia & Herceg; [Mijovic, Biljana; Djakovic-Devic, Jelena; Zeljkovic, Branislav] Inst Publ Hlth, Banja Luka, Bosnia & Herceg; [Petkovic, Miroslav; Knezevic, Darija; Skrbic, Ranko] Univ Banja Luka, Ctr Biomed Res, Fac Med, Banja Luka, Bosnia & Herceg; [Puhalo-Sladoje, Dragana] Univ East Sarajevo, Ctr Biomed Res, Fac Med, Foca, Bosnia & Herceg; [Bokonjic, Dejan] Univ East Sarajevo, Dept Paediat, Fac Med, Foca, Bosnia & Herceg	University of Banja Luka (UNIBL)	Skrbic, R (corresponding author), Univ Banja Luka, Ctr Biomed Res, Fac Med, Banja Luka, Bosnia & Herceg.	ranko.skrbic@med.unibl.org	Mijovic, Biljana/AAC-4298-2020	Masic, Srdjan/0000-0001-8852-2054; Knezevic, Darija/0000-0001-7771-902X				Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Oliveira LMD, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062091, 10.1590/s1678-9946202062091]; Dehaghi BF, 2020, INVESTIG EDUC ENFERM, V38, DOI 10.17533/udea.iee.v38n2e13; Fuhrer A, 2020, Z EVIDENZ FORTBILD Q, V153, P32, DOI 10.1016/j.zefq.2020.06.002; Garcia-Basteiro AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17318-x; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Institut za javno zdravstvo Republike Srpske, COVID 19 EP SIT REP; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; Lai CC, 2020, INT J INFECT DIS, V101, P314, DOI 10.1016/j.ijid.2020.10.011; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Republika Srpska, REPUBLICKI ZAVOD STA; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Shakiba M, 2021, EMERG INFECT DIS, V27, P636, DOI 10.3201/eid2702.201960; Slot E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19481-7; Stefanelli P, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.11.013; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00797-20; Valenti L, 2021, BLOOD TRANSFUS-ITALY, V19, P181, DOI 10.2450/2021.0324-20; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; WHO, POP BAS AG STRAT SER; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262738	10.1371/journal.pone.0262738	http://dx.doi.org/10.1371/journal.pone.0262738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089944	gold, Green Published			2022-12-26	WOS:000769158400021
J	Assefa, M; Tigabu, A; Belachew, T; Tessema, B				Assefa, Muluneh; Tigabu, Abiye; Belachew, Teshome; Tessema, Belay			Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; VIRULENCE FACTORS; RISK-FACTORS; ETIOLOGY	IntroductionCommunity-acquired pneumonia is associated with higher morbidity, hospitalization, and mortality in adults. Likewise, antimicrobial resistance has increased in recent decades in Ethiopia. Therefore, this study was aimed to determine the bacterial isolates, their antimicrobial susceptibility patterns, and factors associated with community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia. Materials and methodsThis institutional-based cross-sectional study was conducted from April to June 2021. Sociodemographic, clinical, and other relevant data were collected using a pre-tested questionnaire. A total of 312 sputum specimens were collected using sputum cups and inoculated into blood agar, chocolate agar, mannitol salt agar, and MacConkey agar plates, which were then incubated at 37 degrees C for 24 hours. The bacterial isolates were identified based on Gram staining, colony characteristics, and biochemical tests. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method. Inducible clindamycin resistance among the S. aureus isolates was detected by the D-test. Data were entered using EPI data version 4.6 and analyzed using SPSS version 20. P-value <= 0.05 at 95% CI was considered statistically significant. ResultsOf 312 cases, 39.4% (n = 123; 95% CI: 34.1%-44.9%) were found to have culture-confirmed pneumonia. The most common isolates were K. pneumoniae (31.0%, n = 39), S. pneumoniae (26.2%, n = 33), and S. aureus (20.6%, n = 26). The gram-positive bacteria were susceptible to chloramphenicol (100%) and clindamycin (96.6%). Gram-negative bacteria were susceptible to gentamicin (87.5%), azithromycin (87.1%), ciprofloxacin (86.6%), and ceftriaxone (79.0%) but highly resistant to ampicillin (100%), followed by tetracycline (87.1%), doxycycline (86.4%), co-trimoxazole (80.6%), and amoxicillin-clavulanic acid (79.0%). Overall, 72.2% of the isolates were multi-drug resistant to K. pneumoniae (94.9%, n = 37), E. coli (93.8%, n = 15), and S. pneumoniae (72.7%, n = 24). Only, 7.7% of S. aureus isolates showed inducible clindamycin resistance. Aging (AOR: 3.248, 95% CI: 1.001-10.545, p = 0.050), a history of pneumonia (AOR: 7.004, 95% CI: 3.591-13.658, p = 0.001), alcohol use (AOR: 6.614, 95% CI: 3.399-12.872, p < 0.001), and overcrowded living conditions (AOR: 4.348, 95% CI: 1.964-9.624, p = 0.001) were significantly associated with culture-positive sputum. Conclusion and recommendationsThis study found a high prevalence of bacteria-caused community-acquired pneumonia among adults and low susceptibility to ampicillin, tetracyclines, and amoxicillin-clavulanic acid. Therefore, culture-based bacterial identification and local antibiotic susceptibility testing should be performed regularly. Additionally, new insights into vaccine coverage against highly multi-drug resistant bacteria, particularly K. pneumoniae, are necessary.	[Assefa, Muluneh; Tigabu, Abiye; Belachew, Teshome; Tessema, Belay] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia	University of Gondar	Assefa, M (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia.	mulunehassefa2010@gmail.com	Assefa, Muluneh/HDN-8225-2022	Assefa, Muluneh/0000-0003-0241-8809; Tigabu, Abiye/0000-0002-4160-1094				Abolghait SK, 2020, INT J FOOD MICROBIOL, V328, DOI 10.1016/j.ijfoodmicro.2020.108669; Acharya VK, 2014, J CLIN DIAGN RES, V8, pMC4, DOI 10.7860/JCDR/2014/7426.4446; Adhanom G, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8768439; Ahmed JU., 2017, BIRDEM MED J, V7, P101; Akter S, 2014, MALAY J PATHOL, V36, P97; Algammal AM, 2022, AQUACULTURE, V548, DOI 10.1016/j.aquaculture.2021.737643; Algammal AM, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02287-y; Algammal AM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88861-w; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, INFECT DRUG RESIST, V13, P3255, DOI 10.2147/IDR.S272733; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; Almirall J, 2017, RESPIRATION, V94, P299, DOI 10.1159/000479089; Almirall J, 2015, ARCH BRONCONEUMOL, V51, P627, DOI 10.1016/j.arbres.2014.10.003; Aston SJ, 2019, AM J RESP CRIT CARE, V200, P359, DOI 10.1164/rccm.201807-1333OC; Ayukekbong JA, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0208-x; Bathala NS., 2017, INT J SCI RES, V6, P1940; Batool S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13667; Belayneh Regasa, 2014, Journal of Medical Microbiology and Diagnosis, V3, P151; Bimal KK., 2021, INT J HLTH CLIN RES, V4, P288; Blejan IE, 2020, FARMACIA, V68, P512, DOI 10.31925/farmacia.2020.3.17; Bradshaw JL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75988-5; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; Cherazard R, 2017, AM J THER, V24, pE361, DOI 10.1097/MJT.0000000000000551; Cilloniz C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122120; Dessie T, 2021, INT J MICROBIOL, V2021, DOI 10.1155/2021/6680343; El-Sokkary RH, 2018, INFECT DRUG RESIST, V11, P2141, DOI 10.2147/IDR.S182777; Enany ME, 2018, PAK J PHARM SCI, V31, P1865; Feldman C, 2020, CURR OPIN PULM MED, V26, P222, DOI 10.1097/MCP.0000000000000674; Gebru HB, 2018, J CLIN DIAGN RES, V12, pLG1, DOI 10.7860/JCDR/2018/31150.11506; Ghia CJ, 2019, CLIN MED INSIGHTS-CI, V13, DOI 10.1177/1179548419862790; Huijskens EGW, 2014, J MED MICROBIOL, V63, P441, DOI 10.1099/jmm.0.067108-0; Ibrahim A., 2018, SUDAN MED LAB J, V6, P78; Joseph AM, 2019, J EVOL MED DENT SCI-, V8, P3323, DOI 10.14260/jemds/2019/721; Kadry NA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019923118; Kishimbo P, 2020, PNEUMONIA, V12, DOI 10.1186/s41479-020-00069-0; Li B, 2014, FUTURE MICROBIOL, V9, P1071, DOI [10.2217/FMB.14.48, 10.2217/fmb.14.48]; Luan Y, 2018, J INT MED RES, V46, P4596, DOI 10.1177/0300060518786915; Mabey D, 2013, PRINCIPLES MED AFRIC; Makharita RR, 2020, INFECT DRUG RESIST, V13, P3991, DOI 10.2147/IDR.S276975; Mandell LA, 2015, POSTGRAD MED, V127, P607, DOI 10.1080/00325481.2015.1074030; Metlay JP, 2020, CURR OPIN PULM MED, V26, P203, DOI 10.1097/MCP.0000000000000671; Mittal AK., 2020, OPEN BIOTECHNOLOGY J, V14, P107; Mousumi Paul DTM., 2020, SCHOLARS J APPL MED, V8, P1901; Muthumbi E, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0041-2; Ojuawo OB, 2020, AFR HEALTH SCI, V20, P1655, DOI 10.4314/ahs.v20i4.18; Peto L, 2014, T ROY SOC TROP MED H, V108, P326, DOI 10.1093/trstmh/tru058; Peyrani P, 2019, EXPERT REV RESP MED, V13, P139, DOI 10.1080/17476348.2019.1562339; Prasad P, 2017, LUNG INDIA, V34, P491, DOI 10.4103/lungindia.lungindia_89_17; Regasa B, 2014, SCIENCE, V3, P33; Rivero-Calle I, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2018-000359; Samuelson DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006426; Sewunet T., 2015, SAUDI J HLTH SCI, V4, P59, DOI [10.4103/2278-0521.151411, DOI 10.4103/2278-0521.151411]; Sharma R, 2020, CLIN DRUG INVEST, V40, P947, DOI 10.1007/s40261-020-00953-z; Temesgen D, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0560-0; Thapa D, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00392-2; Torres A., 2015, CLIN MANAGEMENT BACT, P29; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Wang GY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176278; Wayne P.A, 2021, INF SUPPL, V31, P100; Zakharenkov IA, 2020, TERAPEVT ARKH, V92, P36, DOI 10.26442/00403660.2020.01.000491; Zambare KK., 2019, ASIAN J PHARM RES, V9, P177	61	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0262956	10.1371/journal.pone.0262956	http://dx.doi.org/10.1371/journal.pone.0262956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104293	Green Published, gold			2022-12-26	WOS:000749789300005
J	Lopez, AIM; Fregoso, DR; Gallegos, A; Yoon, DJ; Fuentes, JJ; Crawford, R; Kaba, H; Yang, HY; Isseroff, RR				Lopez, Andrea I. Medina; Fregoso, Daniel R.; Gallegos, Anthony; Yoon, Daniel J.; Fuentes, Jaime J.; Crawford, Robert; Kaba, Hawa; Yang, Hsin-ya; Isseroff, R. Rivkah			Beta adrenergic receptor antagonist can modify Pseudomonas aeruginosa biofilm formation in vitro: Implications for chronic wounds	FASEB JOURNAL			English	Article						antagonist for adrenergic receptors; biofilm; chronic wounds; infection	DIABETIC FOOT ULCER; TOPICAL TIMOLOL; NEUTROPHIL APOPTOSIS; HOST COMMUNICATION; PYOCYANIN; IDENTIFICATION; VIRULENCE; BACTERIA; CULTURE; STAPHYLOCOCCI	Non-healing wounds are a major medical challenge, affecting over 6.5 million people in the US alone, with associated healthcare costs of about $16 billion annually. They can result in prolonged hospitalizations, work loss, disability, poor quality of life, and in diabetic patients with foot ulcers, amputation of the affected limb in 25% of patients. Though chronic ulcers may arise from different underlying diseases, the unifying feature is chronic infection, driving persistent inflammation that prolongs the healing process. One of the most frequently cultured or genetically identified pathogens in skin wounds is Pseudomonas aeruginosa. This species avidly forms biofilms in the wound that impede bacterial eradication by the host's immune mechanisms and limit efficacy of systemic antibiotics. Thus, non-antibiotic approaches to limit the growth and biofilm formation of this wound pathogen would be an advance in the treatment of chronic wounds. Prior work has demonstrated that the growth of other microbial species can be modulated by catecholamine agonists and antagonists of the adrenergic receptors (ARs). Here, we demonstrate that not only can the growth of this common wound pathogen be modulated by catecholamines, but also that the beta-AR antagonists can significantly decrease their growth, and importantly, limit their ability to form biofilms. These findings suggest that beta adrenergic antagonists may have a therapeutic role in the treatment of chronic skin wounds.	[Lopez, Andrea I. Medina; Fregoso, Daniel R.; Gallegos, Anthony; Yoon, Daniel J.; Kaba, Hawa; Yang, Hsin-ya] Univ Calif Davis, Dept Dermatol, Davis, CA 95816 USA; [Fuentes, Jaime J.; Crawford, Robert] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA; [Isseroff, R. Rivkah] VA Northern Calif Hlth Care Syst, Dermatol Sect, Mather, CA USA	University of California System; University of California Davis; California State University System; California State University Sacramento	Isseroff, RR (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, 3301 C St,Suite 1400, Sacramento, CA 95816 USA.	rrisseroff@ucdavis.edu	Isseroff, Roslyn Rivkah/AAD-8478-2021	Isseroff, Roslyn Rivkah/0000-0001-7813-0858; Yang, Hsin-ya/0000-0002-5325-494X	California Institute for Regenerative Medicine (CIRM) [PC1-08118]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	California Institute for Regenerative Medicine (CIRM), Grant/Award Number: PC1-08118	Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Beroukhim K, 2014, DERMATOL SURG, V40, P924, DOI 10.1111/DSU.0000000000000054; Birkenhauer E, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-191; Braun LR, 2013, JAMA DERMATOL, V149, P1400, DOI 10.1001/jamadermatol.2013.7135; BRITIGAN BE, 1992, J CLIN INVEST, V90, P2187, DOI 10.1172/JCI116104; Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11; Cambronel M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01501; Cambronel M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56666-7; Castaneda-Tamez P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01348; CDC, 2020, NAT DIAB STAT REP 20; Chiaverini C, 2016, J AM ACAD DERMATOL, V75, pE223, DOI 10.1016/j.jaad.2016.08.005; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; ClinicalTrials.gov, 2018, NCT03282981 BETA ADR; Dasu MR, 2014, STEM CELL TRANSL MED, V3, P745, DOI 10.5966/sctm.2013-0200; de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Dickson RP, 2015, AM J RESP CRIT CARE, V192, P257, DOI 10.1164/rccm.201502-0326LE; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Feraco D, 2016, MICROB PATHOGENESIS, V99, P253, DOI 10.1016/j.micpath.2016.08.015; Freestone PP, 2012, CHEST, V142, P1200, DOI 10.1378/chest.11-2614; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Golovkine G, 2018, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00532; Hegde M, 2009, APPL MICROBIOL BIOT, V84, P763, DOI 10.1007/s00253-009-2045-1; Hoegy F, 2014, METHODS MOL BIOL, V1149, P293, DOI 10.1007/978-1-4939-0473-0_24; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Kang D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02048; Karavolos MH, 2014, ADV EXP MED BIOL, V817, P241, DOI 10.1007/978-1-4939-0897-4_11; Karavolos MH, 2013, MOL MICROBIOL, V87, P455, DOI 10.1111/mmi.12110; Karavolos MH, 2011, EMBO REP, V12, P252, DOI 10.1038/embor.2011.4; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kim MH, 2014, J INVEST DERMATOL, V134, P809, DOI 10.1038/jid.2013.415; Kragh KN, 2019, BIOFILM, V1, DOI 10.1016/j.bioflm.2019.100006; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Larsen L, 2018, J TISSUE ENG REGEN M, V12, P186, DOI 10.1002/term.2390; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lev-Tov H, 2013, J AM ACAD DERMATOL, V69, pE204, DOI 10.1016/j.jaad.2013.06.003; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Luqman A, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1000-7; Luqman A, 2018, CELL REP, V22, P535, DOI 10.1016/j.celrep.2017.12.058; LYTE M, 1992, LIFE SCI, V50, P203, DOI 10.1016/0024-3205(92)90273-R; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Martins-Mendes D, 2014, J DIABETES COMPLICAT, V28, P632, DOI 10.1016/j.jdiacomp.2014.04.011; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Mihai MM, 2014, ROM J MORPHOL EMBRYO, V55, P1401; Murakami K, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02587-16; Ndosi M, 2018, DIABETIC MED, V35, P78, DOI 10.1111/dme.13537; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Pasupuleti S, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00564-17; Perraud Q, 2022, ENVIRON MICROBIOL, V24, P878, DOI 10.1111/1462-2920.15372; Powers JG, 2016, J AM ACAD DERMATOL, V74, P607, DOI 10.1016/j.jaad.2015.08.070; Prince LR, 2008, J IMMUNOL, V180, P3502, DOI 10.4049/jimmunol.180.5.3502; Pullar CE, 2008, PHARMACOL RES, V58, P158, DOI 10.1016/j.phrs.2008.07.012; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Roberts AEL, 2015, J MOL BIOL, V427, P3646, DOI 10.1016/j.jmb.2015.09.002; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Seleem NM, 2020, EUR J CLIN MICROBIOL, V39, P1687, DOI 10.1007/s10096-020-03882-z; Shishov VA, 2009, APPL BIOCHEM MICRO+, V45, P494, DOI 10.1134/S0003683809050068; Sivamani RK, 2014, J INVEST DERMATOL, V134, P2258, DOI 10.1038/jid.2014.137; Sivamani RK, 2009, PLOS MED, V6, P105, DOI 10.1371/journal.pmed.1000012; Snyder D., 2020, SKIN SUBSTITUTES TRE; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tang JC, 2012, DERMATOL SURG, V38, P135, DOI 10.1111/j.1524-4725.2011.02200.x; Thomsen TR, 2010, WOUND REPAIR REGEN, V18, P38, DOI 10.1111/j.1524-475X.2009.00561.x; Trivedi U, 2014, J PATHOG, V2014, DOI 10.1155/2014/173053; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P229, DOI 10.1134/S000368380603001X; Tsavkelova E A, 2000, Dokl Biochem, V372, P115; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Wilson Christina, 2017, Res Rev J Eng Technol, V6; Yoon DJ, 2021, J INVEST DERMATOL, V141, P1608, DOI 10.1016/j.jid.2020.11.016; Zhao G, 2013, ADV WOUND CARE, V2, P389, DOI 10.1089/wound.2012.0381; Zhao G, 2012, WOUND REPAIR REGEN, V20, P342, DOI 10.1111/j.1524-475X.2012.00793.x; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085	91	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22057	10.1096/fj.202100717RR	http://dx.doi.org/10.1096/fj.202100717RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35133020				2022-12-26	WOS:000761250800043
J	Osuka, RF; Hirata, T; Nagae, M; Nakano, M; Shibata, H; Okamoto, R; Kizuka, Y				Osuka, Reina F.; Hirata, Tetsuya; Nagae, Masamichi; Nakano, Miyako; Shibata, Hiroyuki; Okamoto, Ryo; Kizuka, Yasuhiko			N-acetylglucosaminyltransferase-V requires a specific noncatalytic luminal domain for its activity toward glycoprotein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM REGION; GLYCOSYLATION; PURIFICATION; LOCALIZATION; REVEALS; ENZYMES; GLYCANS; POMGNT1; MUTANT; SPPL3	N-acetylglucosaminyltransferase-V (GnT-V or MGAT5) catalyzes the formation of an N-glycan beta 1,6-GlcNAc branch on selective target proteins in the Golgi apparatus and is involved in cancer malignancy and autoimmune disease etiology. Several three-dimensional structures of GnT-V were recently solved, and the recognition mechanism of the oligosaccharide sub-strate was clarified. However, it is still unclear how GnT-V selectively acts on glycoprotein substrates. In this study, we focused on an uncharacterized domain at the N-terminal side of the luminal region (N domain) of GnT-V, which was previ-ously identified in a crystal structure, and aimed to reveal its role in GnT-V action. Using lectin blotting and fluorescence assisted cell sorting analysis, we found that a GnT-V & UDelta;N mutant lacking the N domain showed impaired biosynthetic activity in cells, indicating that the N domain is required for efficient glycosylation. To clarify this mechanism, we measured the in vitro activity of purified GnT-V & UDelta;N toward various kinds of substrates (oligosaccharide, glycohexapeptide, and glycopro-tein) using HPLC and a UDP-Glo assay. Surprisingly, GnT-V & UDelta;N showed substantially reduced activity toward the glyco-protein substrates, whereas it almost fully maintained its ac-tivity toward the oligosaccharides and the glycopeptide substrates. Finally, docking models of GnT-V with substrate glycoproteins suggested that the N domain could interact with the substrate polypeptide directly. Our findings suggest that the N domain of GnT-V plays a critical role in the recognition of glycoprotein substrates, providing new insights into the mechanism of substrate-selective biosynthesis of N-glycans.	[Osuka, Reina F.; Kizuka, Yasuhiko] Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan; [Hirata, Tetsuya; Kizuka, Yasuhiko] Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan; [Nagae, Masamichi] Osaka Univ, Res Inst Microbial Dis, Dept Mol Immunol, Suita, Japan; [Nagae, Masamichi] Osaka Univ, Immunol Frontier Res Ctr IFReC, Lab Mol Immunol, Suita, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Shibata, Hiroyuki; Okamoto, Ryo] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Japan	Gifu University; Gifu University; Osaka University; Osaka University; Hiroshima University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan.; Kizuka, Y (corresponding author), Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan.	kizuka@gifu-u.ac.jp		Nagae, Masamichi/0000-0002-5470-3807; Kizuka, Yasuhiko/0000-0002-3181-9743	Japan Society for the Promotion of Science (JSPS) [20H03207]; JST [[18070267]; Takeda Science Foundation; MEXT WISE program; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT WISE program; Tokyo Biochemical Research Foundation	This work was partially supported by a Grant-in-Aid for Scientific Research (B) to Y. K. [20H03207] , a Leading Initiative for Excellent Young Researchers (LEADER) project (Y. K.) from the Japan Society for the Promotion of Science (JSPS) , a CREST grant ( [18070267] to Y. K.) from JST, a grant from the Takeda Science Foundation to Y. K., Nagoya Uni-versity CIBoG program from MEXT WISE program to R. F. O., and a grant from the Tokyo Biochemical Research Foundation to Y. K.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Carvalho S, 2016, ONCOGENE, V35, P1619, DOI 10.1038/onc.2015.225; CHANEY W, 1989, J CELL BIOL, V109, P2089, DOI 10.1083/jcb.109.5.2089; Coddeville B, 1998, GLYCOCONJUGATE J, V15, P265, DOI 10.1023/A:1006997012617; Darby JF, 2020, ACS CATAL, V10, P8590, DOI 10.1021/acscatal.0c02222; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DO KY, 1994, J BIOL CHEM, V269, P23456; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Granovsky M, 2000, NAT MED, V6, P306; GREEN ED, 1988, J BIOL CHEM, V263, P18253; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hirata T, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129726; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Murata K, 2000, CLIN CANCER RES, V6, P1772; Nagae M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020437; Nagae M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05931-w; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Okamoto R, 2014, ANGEW CHEM INT EDIT, V53, P5194, DOI 10.1002/anie.201400679; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Rodriguez AC, 2015, J BIOL CHEM, V290, P22638, DOI 10.1074/jbc.M115.667006; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; TAKESADA H, 1992, J BIOCHEM-TOKYO, V112, P143, DOI 10.1093/oxfordjournals.jbchem.a123854; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; Tomida S, 2020, J BIOL CHEM, V295, P7992, DOI 10.1074/jbc.RA120.013079; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yamamoto K, 1993, Methods Mol Biol, V14, P17; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	49	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101666	10.1016/j.jbc.2022.101666	http://dx.doi.org/10.1016/j.jbc.2022.101666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35104505	gold, Green Published			2022-12-26	WOS:000791230900006
J	Nicolaou, V; Soepnel, L; Huddle, K; Klipstein-Grobusch, K; Levitt, NS; Norris, SA				Nicolaou, Veronique; Soepnel, Larske; Huddle, Kenneth; Klipstein-Grobusch, Kerstin; Levitt, Naomi S.; Norris, Shane A.			Cardiometabolic outcomes of women exposed to hyperglycaemia first detected in pregnancy at 3-6 years post-partum in an urban South African setting	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; INTIMA-MEDIA THICKNESS; LONG-TERM RISK; ADIPOSE-TISSUE; PREVALENCE; DISEASE; WEIGHT; WAIST; BMI	Background Hyperglycaemia first detected during pregnancy(HFDP) has far-reaching maternal consequences beyond the pregnancy. Our study evaluated the cardiometabolic outcomes in women with prior HFDP versus women without HFDP 3-6 years post-partum in urban South Africa. Design and methods A prospective cohort study was performed of 103 black African women with prior HFDP and 101 without HFDP, 3-6 years post-partum at Chris Hani Baragwanath Academic Hospital, Soweto. Index pregnancy data was obtained from medical records. Post-partum, participants were re-evaluated for anthropometric measurements, body composition utilizing dual energy X-ray absorptiometry(DXA) and biochemical analysis (two-hour 75gm OGTT fasting insulin, lipids, creatinine levels and glucose levels). Cardiovascular risk was assessed by Framingham risk score(FRS). Carotid intima media thickness(cIMT) was used as a surrogate marker for subclinical atherosclerosis. Factors associated with progression to cardiometabolic outcomes were assessed using multivariable logistic and linear regression models. Results Forty-six(45.1%) HFDP women progressed to diabetes compared to 5(4.9%) in non HFDP group(p<0.001); only 20(43.4%) were aware of their diabetic status in the whole group. The odds(OR, 95% confidence interval(CI)) of progressing to type 2 diabetes(T2DM) and metabolic syndrome(MetS) after correcting for confounders in the HFDP group was 10.5(95% CI 3.7-29.5) and 6.3(95%CI 2.2-18.1), respectively. All visceral fat indices were found to be significantly higher in the HFDP group after adjusting for baseline body mass index. Ten-year estimated cardiovascular risk(FRS) and mean cIMT was statistically higher in the HFDP group(8.46 IQR 4.9-14.4; 0.48 mm IQR 0.44-0.53 respectively) compared to the non-HFDP group(3.48 IQR 2.1-5.7; 0.46mm IQR 0.42-0.50) respectively and this remained significant for FRS but was attenuated for cIMT after correcting for confounders. HIV did not play a role in progression to any of these outcomes. Conclusion Women with a history of HFDP have a higher risk of cardiometabolic conditions within 6 years post-partum in an urban sub-Saharan African setting.	[Nicolaou, Veronique; Soepnel, Larske; Norris, Shane A.] Univ Witwatersrand, Fac Hlth Sci, SAMRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Johannesburg, South Africa; [Nicolaou, Veronique; Huddle, Kenneth] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Soepnel, Larske; Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Div Epidemiol & Biostat, Sch Publ Hlth, Johannesburg, South Africa; [Levitt, Naomi S.] Univ Cape Town, Fac Hlth Sci, Chron Dis Initiat Africa, Dept Med, Cape Town, South Africa; [Norris, Shane A.] Univ Southampton, Global Hlth Res Inst, Sch Human Dev & Hlth, Southampton, Hants, England	University of Witwatersrand; University of Witwatersrand; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; University of Cape Town; University of Southampton	Nicolaou, V (corresponding author), Univ Witwatersrand, Fac Hlth Sci, SAMRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Johannesburg, South Africa.; Nicolaou, V (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa.	docvic9@gmail.com	Norris, Shane/C-4664-2014; Klipstein-Grobusch, Kerstin/F-5555-2016	Norris, Shane/0000-0001-7124-3788; Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Soepnel, Larske M/0000-0002-0076-7477; Levitt, Naomi/0000-0001-6480-8066				Adam S, 2017, SAMJ S AFR MED J, V107, P523, DOI [10.7196/samj.2017.v107i6.12043, 10.7196/SAMJ.2017.v107i6.12043]; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], CENSUS QUESTIONNAIRE; Bao W, 2015, DIABETOLOGIA, V58, P1212, DOI 10.1007/s00125-015-3537-4; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Black SA, 2002, AM J PUBLIC HEALTH, V92, P543, DOI 10.2105/AJPH.92.4.543; Chantler S, 2015, METAB SYNDR RELAT D, V13, P381, DOI 10.1089/met.2015.0021; Chivese T, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000740; Chivese T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002865; Coetzee A, 2018, INT J GYNECOL OBSTET, V142, P54, DOI 10.1002/ijgo.12494; Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5; Eades CE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0457-8; Feng LJ, 2018, J DIABETES INVEST, V9, P1360, DOI 10.1111/jdi.12838; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Framingham Risk Score, 2008, QXMD; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Goedecke JH, 2009, OBESITY, V17, P1506, DOI 10.1038/oby.2009.73; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herath H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179647; Inoue H, 2018, DIABETES RES CLIN PR, V140, P1, DOI 10.1016/j.diabres.2018.03.031; Joubert J, 2007, SAMJ S AFR MED J, V97, P725; Kramer CK, 2019, DIABETOLOGIA, V62, P905, DOI 10.1007/s00125-019-4840-2; Labadarios D, 2014, SAMJ S AFR MED J, V104, P675, DOI [10.7196/SAMJ.8842, 10.7196/samj.8842]; Macaulay S, 2018, DIABETES RES CLIN PR, V139, P278, DOI 10.1016/j.diabres.2018.03.012; Mamabolo RL, 2007, DIABETIC MED, V24, P233, DOI 10.1111/j.1464-5491.2006.02073.x; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Mtintsilana A, 2019, NUTR DIABETES, V9, DOI 10.1038/s41387-019-0079-8; Prioreschi A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013953; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Soepnel LM, 2021, ANN HUM BIOL, V48, P81, DOI 10.1080/03014460.2021.1918245; Soepnel LM, 2019, INT J GYNECOL OBSTET, V147, P404, DOI 10.1002/ijgo.12956; Song C, 2018, OBES REV, V19, P421, DOI 10.1111/obr.12645; StataCorp, 2013, STATA STAT SOFTW REL; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Sumner AE, 2011, OBESITY, V19, P671, DOI 10.1038/oby.2010.201; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Willeit P, 2020, CIRCULATION, V142, P621, DOI 10.1161/CIRCULATIONAHA.120.046361; World Health Organization, 2006, DEF DIAGN DIAB MELL; Xiang AH, 2011, DIABETOLOGIA, V54, P3016, DOI 10.1007/s00125-011-2330-2; Xu YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086685, 10.1371/journal.pone.0087863]	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263529	10.1371/journal.pone.0263529	http://dx.doi.org/10.1371/journal.pone.0263529			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139085	Green Published, gold			2022-12-26	WOS:000821499100032
J	Lo, M; Aughey, RJ; Hopkins, WG; Gill, N; Stewart, AM				Lo, Michele; Aughey, Robert J.; Hopkins, William G.; Gill, Nicholas; Stewart, Andrew M.			The impact of matches and travel on rugby players' sleep, wellness and training	PLOS ONE			English	Article							JET-LAG; ELITE; INTERVENTIONS; EXERCISE; TEAM	Matches and travel, which are common in professional team sports, may have a negative impact on players. The aim of this study was to quantify the impact on sleep, wellness and training of Super Rugby players. Sleep of 122 players from four teams was monitored using activity monitors for up to three nights before and after matches played at home and overseas. Wellness and internal training load (questionnaires) and external training load (GPS/accelerometer) were also recorded. Separate analyses were performed for each team using a general linear mixed model to estimate the mean effects of travel (translocation overseas and return to the home country) on sleep, wellness and training. The mean effects of matches on sleep and wellness on the nights before, of and after matches. were also estimated. Teams generally experienced small to large reductions in sleep and wellness when overseas; on return, sleep and wellness recovered somewhat. The impact of matches on sleep and wellness differed in magnitude and direction (large reductions to small increases) between teams. External load overseas and upon return was reduced for three of the four teams, whilst internal load was reduced for the three teams that measured it. The changes in sleep, wellness and training can be explained by a combination of travel- and match-related stressors that differed between teams. Teams should consider remediation strategies to mitigate the effects of travel.	[Lo, Michele; Aughey, Robert J.; Hopkins, William G.; Stewart, Andrew M.] Victoria Univ, Inst Hlth & Sport iHeS, Melbourne, Vic, Australia; [Gill, Nicholas] Univ Waikato, Adams Ctr High Performance, Tauranga, New Zealand; [Gill, Nicholas] New Zealand Rugby Union, Wellington, New Zealand	Victoria University; University of Waikato	Stewart, AM (corresponding author), Victoria Univ, Inst Hlth & Sport iHeS, Melbourne, Vic, Australia.	Andrew.Stewart@vu.edu.au		Lo, Michele/0000-0002-5534-7736; Aughey, Robert/0000-0002-0285-8516				Aisbett J., 2020, MAGNITUDE BASED INFE, DOI 10.31236/osf.io/pn9-3; Barr M., 2017, J STRENGTH CONDITION; Buchheit M, 2014, J SPORT SCI, V32, P1844, DOI 10.1080/02640414.2014.942687; Camfield L, 2008, J HEALTH PSYCHOL, V13, P764, DOI 10.1177/1359105308093860; Forbes-Robertson S, 2012, SPORTS MED, V42, P185, DOI 10.2165/11596850-000000000-00000; FOSTER C, 1995, EUR J APPL PHYSIOL O, V70, P367, DOI 10.1007/BF00865035; Fowler P, 2015, INT J SPORT PHYSIOL, V10, P648, DOI 10.1123/ijspp.2014-0490; Fowler P, 2015, INT J SPORT PHYSIOL, V10, P546, DOI 10.1123/ijspp.2014-0266; Fowler PM, 2017, J SCI MED SPORT, V20, P322, DOI 10.1016/j.jsams.2016.08.021; Fullagar H., 2015, INT J SPORTS PHYSL P; Fullagar HHK, 2016, J SPORT SCI, V34, P1333, DOI 10.1080/02640414.2015.1135249; Gastin PB, 2013, J STRENGTH COND RES, V27, P2518, DOI 10.1519/JSC.0b013e31827fd600; Greenland S, 2006, INT J EPIDEMIOL, V35, P765, DOI 10.1093/ije/dyi312; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Herxheimer A, 2002, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001520, DOI 10.1002/14651858.CD001520]; Hopkins W.G., 2019, SPORTSCIENCE, V23, P5; Hopkins W.G., 2020, SPORTSCIENCE, V24, P1; Hopkins WG, 2010, SPORT SCI, V14, P49; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Juliff LE, 2015, J SCI MED SPORT, V18, P13, DOI 10.1016/j.jsams.2014.02.007; Lastella M, 2015, EUR J SPORT SCI, V15, P94, DOI 10.1080/17461391.2014.932016; Leatherwood WE, 2013, BRIT J SPORT MED, V47, P561, DOI 10.1136/bjsports-2012-091449; Lo MC, 2021, J SPORT SCI, V39, P289, DOI 10.1080/02640414.2020.1816290; MONROE LJ, 1967, J ABNORM PSYCHOL, V72, P255, DOI 10.1037/h0024563; Nicolella DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191823; Reilly T, 1997, J SPORT SCI, V15, P365, DOI 10.1080/026404197367371; Richmond L, 2004, J SCI MED SPORT, V7, P186, DOI 10.1016/S1440-2440(04)80008-2; Sargent C, 2014, EUR J SPORT SCI, V14, pS310, DOI 10.1080/17461391.2012.696711; Shearer DA, 2015, EUR J SPORT SCI, V15, P681, DOI 10.1080/17461391.2015.1053419; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0261517	10.1371/journal.pone.0261517	http://dx.doi.org/10.1371/journal.pone.0261517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134058	Green Accepted, gold, Green Published			2022-12-26	WOS:000798968600002
J	Alaqbi, SS; Burke, L; Guterman, I; Green, C; West, K; Palacios-Gallego, R; Cai, H; Alexandrou, C; Myint, NNM; Parrott, E; Howells, LM; Higgins, JA; Jones, DJL; Singh, R; Britton, RG; Tufarelli, C; Thomas, A; Rufini, A				Alaqbi, Saif Sattar; Burke, Lynsey; Guterman, Inna; Green, Caleb; West, Kevin; Palacios-Gallego, Raquel; Cai, Hong; Alexandrou, Constantinos; Myint, Ni Ni Moe; Parrott, Emma; Howells, Lynne M.; Higgins, Jennifer A.; Jones, Donald J. L.; Singh, Rajinder; Britton, Robert G.; Tufarelli, Cristina; Thomas, Anne; Rufini, Alessandro			Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells	PLOS ONE			English	Article							STEM-CELLS; PROMOTES; COLON; PYCR1; INTERCONVERSIONS; PROGRESSION; APOPTOSIS	Research into the metabolism of the non-essential amino acid (NEAA) proline in cancer has gained traction in recent years. The last step in the proline biosynthesis pathway is catalyzed by pyrroline-5-carboxylate reductase (PYCR) enzymes. There are three PYCR enzymes: mitochondrial PYCR1 and 2 and cytosolic PYCR3 encoded by separate genes. The expression of the PYCR1 gene is increased in numerous malignancies and correlates with poor prognosis. PYCR1 expression sustains cancer cells' proliferation and survival and several mechanisms have been implicated to explain its oncogenic role. It has been suggested that the biosynthesis of proline is key to sustain protein synthesis, support mitochondrial function and nucleotide biosynthesis. However, the links between proline metabolism and cancer remain ill-defined and are likely to be tissue specific. Here we use a combination of human dataset, human tissue and mouse models to show that the expression levels of the proline biosynthesis enzymes are significantly increased during colorectal tumorigenesis. Functionally, the expression of mitochondrial PYCRs is necessary for cancer cells' survival and proliferation. However, the phenotypic consequences of PYCRs depletion could not be rescued by external supplementation with either proline or nucleotides. Overall, our data suggest that, despite the mechanisms underlying the role of proline metabolism in colorectal tumorigenesis remain elusive, targeting the proline biosynthesis pathway is a suitable approach for the development of novel anti-cancer therapies.	[Alaqbi, Saif Sattar; Burke, Lynsey; Guterman, Inna; Green, Caleb; Palacios-Gallego, Raquel; Cai, Hong; Alexandrou, Constantinos; Myint, Ni Ni Moe; Parrott, Emma; Howells, Lynne M.; Higgins, Jennifer A.; Jones, Donald J. L.; Singh, Rajinder; Britton, Robert G.; Tufarelli, Cristina; Thomas, Anne; Rufini, Alessandro] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England; [Alaqbi, Saif Sattar] Univ Kufa, Fac Vet Med, Dept Pathol & Poultry Dis, Kufa, Iraq; [West, Kevin] Univ Hosp Leicester, Dept Cellular Pathol, Leicester, Leics, England; [Jones, Donald J. L.; Singh, Rajinder] Leicester van Geest Multi OMICS Facil, Leicester, Leics, England; [Alexandrou, Constantinos] CRUK Beatson Inst, Glasgow, Lanark, Scotland	University of Leicester; University of Kufa; University Hospitals of Leicester NHS Trust; University of Leicester; Beatson Institute	Rufini, A (corresponding author), Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England.	ar230@le.ac.uk			Cancer Prevention Research Trust (CPRT); Cancer Research UK; Department of Health, an ECMC grant [C325/A15575]; CPRT [TM60004-CPRT, RM60G0499, RM60G0665-CPRT]; Iraqi Government [YM60RT115]; Medical Research Council Doctoral Training Grant; Wellcome Trust [210911/Z/18/Z]; charity Hope Against Cancer [RM60G0751]; National Institute for Health Research Leicester Biomedical Research Centre	Cancer Prevention Research Trust (CPRT); Cancer Research UK(Cancer Research UK); Department of Health, an ECMC grant; CPRT; Iraqi Government; Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); charity Hope Against Cancer; National Institute for Health Research Leicester Biomedical Research Centre	This work was supported by the Cancer Prevention Research Trust (CPRT), with assistance from Cancer Research UK in conjunction with the Department of Health as part of an ECMC grant [C325/A15575]. L.B. and C. A. were funded by PhD fellowships from the CPRT (grant code TM60004-CPRT and RM60G0499), S.S.A. was funded by a studentship from the Iraqi Government (grant code YM60RT115), and I.G. was funded by a grant from the CPRT (grant code RM60G0665-CPRT). C.G. and N.N.M.M were supported by a Medical Research Council Doctoral Training Grant. C.T. is supported by a Wellcome Trust Research Career Re-entry Fellowship (210911/Z/18/Z, 'Exploiting transcription of repetitive DNA to study early events in colorectal cancer'). R.P.G. is supported through a Development Grant to A.R. and C.T. from the charity Hope Against Cancer (https://www.hopeagainstcancer.org.uk/, grant code RM60G0751). D.J.L.J. is supported by the National Institute for Health Research Leicester Biomedical Research Centre.	Ackermann T, 2019, TRENDS CANCER, V5, P329, DOI 10.1016/j.trecan.2019.05.004; Alexandrou C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30591-7; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bogner AN, 2021, AMINO ACIDS, V53, P1817, DOI 10.1007/s00726-021-02999-5; Burke L, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00341-8; Cai F, 2018, ONCOL LETT, V15, P731, DOI 10.3892/ol.2017.7400; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Caravagna G, 2018, NAT METHODS, V15, P707, DOI 10.1038/s41592-018-0108-x; Choi BH, 2019, CANCERS, V11, DOI 10.3390/cancers11050675; Christensen EM, 2017, J BIOL CHEM, V292, P7233, DOI 10.1074/jbc.M117.780288; Cross W, 2018, NAT ECOL EVOL, V2, P1661, DOI 10.1038/s41559-018-0642-z; D'Aniello C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00776; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; Ding JF, 2017, CARCINOGENESIS, V38, P519, DOI 10.1093/carcin/bgx022; Ding ZB, 2020, J HEPATOL, V72, P725, DOI 10.1016/j.jhep.2019.10.026; EGGLESTON LV, 1974, BIOCHEM J, V138, P425, DOI 10.1042/bj1380425; Fu WJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016384; Guo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08772-3; HAGEDORN CH, 1986, ARCH BIOCHEM BIOPHYS, V248, P166, DOI 10.1016/0003-9861(86)90413-3; HAGEDORN CH, 1983, ARCH BIOCHEM BIOPHYS, V225, P95, DOI 10.1016/0003-9861(83)90010-3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hollinshead KER, 2018, CELL REP, V22, P3107, DOI 10.1016/j.celrep.2018.02.084; Kay EJ, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.719922; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Myint NNM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0934-x; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Ryan MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-313; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Satoh K, 2017, P NATL ACAD SCI USA, V114, pE7697, DOI 10.1073/pnas.1710366114; Tanner JJ, 2018, BIOCHEMISTRY-US, V57, P3433, DOI 10.1021/acs.biochem.8b00215; Tran DH, 2021, NAT METAB, V3, P571, DOI 10.1038/s42255-021-00374-y; Voorde JV, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7314; Wang DC, 2019, BIOMED PHARMACOTHER, V111, P588, DOI 10.1016/j.biopha.2018.12.089; Wang QL, 2019, OPEN MED-WARSAW, V14, P586, DOI 10.1515/med-2019-0066; Wang ST, 2021, BIOCHEM BIOPH RES CO, V572, P20, DOI 10.1016/j.bbrc.2021.07.084; Xiong GF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06893-9; Yan K, 2019, BIOCHEM BIOPH RES CO, V520, P486, DOI 10.1016/j.bbrc.2019.10.059; Ye YY, 2018, CANCER MANAG RES, V10, P6399, DOI 10.2147/CMAR.S166711; YEH GC, 1988, J BIOL CHEM, V263, P13083; Zeng TY, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0870-5	47	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262364	10.1371/journal.pone.0262364	http://dx.doi.org/10.1371/journal.pone.0262364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130302	Green Published, gold			2022-12-26	WOS:000805530700007
J	Bula, AK; Lee, F; Chapola, J; Mapanje, C; Tsidya, M; Thom, A; Tang, JH; Chinula, L				Bula, Agatha K.; Lee, Fan; Chapola, John; Mapanje, Clement; Tsidya, Mercy; Thom, Annie; Tang, Jennifer H.; Chinula, Lameck			Perceptions of cervical cancer and motivation for screening among women in Rural Lilongwe, Malawi: A qualitative study	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES; BARRIERS; RISK	Introduction Cervical cancer is the leading cause of cancer death among women in Malawi. Low awareness of cervical cancer and negative perceptions of screening can prevent women from participating in preventative strategies. We sought to explore perceptions and motivations for screening among women who participated in a cervical cancer screen-and-treat pilot study in rural Malawi. Materials and methods We conducted a qualitative sub-study of a community-based cervical cancer screen-and-treat pilot study in rural Lilongwe between July-August 2017. From October 2017-February 2018, 17 women who underwent screening using visual inspection with acetic acid (VIA) and same-day thermal ablation treatment were recruited at their 12-week follow-up visit post treatment to participate in this qualitative sub-study. Semi-structured interview guides that explored baseline knowledge of cervical cancer, perceptions, and motivation for screening were used for in-depth interviews (IDIs). IDIs were conducted in the local language, Chi-chewa, translated and transcribed to English. Data was analyzed using NVivo (R) V12.0. Results Findings included fatalistic views on cancer, but limited knowledge specific to cervical cancer. Misconceptions of cervical cancer screening were common; however, there was a unique understanding of screening as prevention (i.e., finding and treating early disease to prevent progression to worsening disease). This understanding appeared to stem from HIV prevention concepts known to the community. Motivations for screening included desire to know one's health status, convenience of community-based screening, and peer encouragement. Conclusion Despite limited knowledge of cervical cancer and misconceptions of screening, the concept of screening for prevention, desire to know one's health status, convenient access, and peers' influence were motivators for participation in screening. Cervical cancer screen-and-treat programs in high HIV prevalence areas should consider utilizing language that parallels HIV prevention language to communicate the need for cervical cancer screening and treatment and utilize prevention concepts that may already be familiar to women living there.	[Bula, Agatha K.; Chapola, John; Mapanje, Clement; Tsidya, Mercy; Thom, Annie; Tang, Jennifer H.; Chinula, Lameck] UNC Project Malawi, Lilongwe, Malawi; [Lee, Fan; Tang, Jennifer H.; Chinula, Lameck] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Chinula, Lameck] Univ Malawi, Coll Med, Dept Obstet & Gynecol, Zomba, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of Malawi	Bula, AK (corresponding author), UNC Project Malawi, Lilongwe, Malawi.	abula@unclilongwe.org	; Tang, Jennifer/K-9974-2017	Chapola, John/0000-0002-6669-6499; Tang, Jennifer/0000-0003-4238-2791	National Institute of Health (NIH) [U54CA190152]; NIH Fogarty International Center [R25TW009340]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was co-funded by National Institute of Health (NIH) U54CA190152 Malawi Cancer Consortium Grant and NIH Fogarty International Center Grant #R25TW009340.	Africa BN, 2017, BBC NEWS AFRICA; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Bank W, 2019, US; Bukirwa A, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0243-9; Chidyaonga-Maseko F, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.231.6350; Chinula L, 2021, INT J CANCER, V149, P371, DOI 10.1002/ijc.33549; Clifford GM, 2016, INT J CANCER, V138, P1732, DOI 10.1002/ijc.29913; Coleman JS, 2016, J LOW GENIT TRACT DI, V20, P31, DOI 10.1097/LGT.0000000000000165; Ebu NI, 2015, INT J WOMENS HEALTH, V7, P31, DOI 10.2147/IJWH.S71797; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fort VK, 2011, PATIENT PREFER ADHER, V5, P125, DOI 10.2147/PPA.S17317; Gatumo M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4642-9; Getachew S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216522; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; GLOBOCAN, 2019, EST CANC INC MORT PR; Lipworth WL, 2010, HEALTH EXPECT, V13, P113, DOI 10.1111/j.1369-7625.2010.00601.x; Maseko FC, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26282; Massad LS, 2014, AIDS, V28, P2601, DOI 10.1097/QAD.0000000000000455; Mitiku I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163136; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Morema EN, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-335; Moucheraud C, 2020, PREV MED REP, V18, DOI 10.1016/j.pmedr.2020.101093; Msyamboza KP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3530-y; Msyamboza KP, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.234.4675; National Statistical Office, 2019, 2018 MAL POP HOUS CE; Nigussie T, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0826-y; Nyabadza F, 2011, J THEOR BIOL, V280, P167, DOI 10.1016/j.jtbi.2011.04.021; Nyambe A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6874-2; Oketch SY, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0778-2; Ports KA, 2015, J HEALTH COMMUN, V20, P97, DOI 10.1080/10810730.2014.908986; Sudenga SL, 2013, INT J GYNECOL CANCER, V23, P895, DOI 10.1097/IGC.0b013e31828e425c; Touch S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4198-8; UNAIDS, UNAIDS COUNTR FACTSH; United Nations, 2017, WORLD POPULATION PRO	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262590	10.1371/journal.pone.0262590	http://dx.doi.org/10.1371/journal.pone.0262590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130305	gold, Green Published			2022-12-26	WOS:000805530700010
J	Schroder, CC; Breckenkamp, J; du Prel, JB				Schroeder, Chloe Charlotte; Breckenkamp, Juergen; du Prel, Jean-Baptist			Medical rehabilitation of older employees with migrant background in Germany: Does the utilization meet the needs?	PLOS ONE			English	Article							DISABILITY; WORK; RISK; EMPLOYMENT; EXPOSURES; HEALTH; IMPACT; INDEX; ICF	Due to demographic change with an ageing workforce, the proportion of employees with poor health and a need for medical rehabilitation is increasing. The aim was to investigate if older employees with migrant background have a different need for and utilization of medical rehabilitation than employees without migrant background. To investigate this, self-reported data from older German employees born in 1959 or 1965 of the first and second study wave of the lidA cohort study were exploratory analyzed (n = 3897). Subgroups of employees with migrant background were separated as first-generation, which had either German or foreign nationality, and second-generation vs. the rest as non-migrants. All subgroups were examined for their need for and utilization of medical rehabilitation with descriptive and bivariate statistics (chi-square, F- and post-hoc tests). Furthermore, multiple logistic regressions and average marginal effects were calculated for each migrant group separately to assess the effect of need for utilization of rehabilitation. According to our operationalizations, the foreign and German first-generation migrants had the highest need for medical rehabilitation while the German first- and second-generation migrants had the highest utilization in the bivariate analysis. However, the multiple logistic model showed significant positive associations between their needs and utilization of rehabilitation for all subgroups. Further in-depth analysis of the need showed that something like under- and oversupply co-exist in migrant groups, while the foreign first-generation migrants with lower need were the only ones without rehabilitation usage. However, undersupply exists in all groups independent of migrant status. Concluding, all subgroups showed suitable use of rehabilitation according to their needs at first sight. Nevertheless, the utilization does not appear to have met all needs, and therefore, the need-oriented utilization of rehabilitation should be increased among all employees, e.g. by providing more information, removing barriers or identifying official need with uniform standards.	[Schroeder, Chloe Charlotte; du Prel, Jean-Baptist] Univ Wuppertal, Dept Occupat Hlth Sci, Wuppertal, Germany; [Breckenkamp, Juergen] Bielefeld Univ, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, Bielefeld, Germany	University of Wuppertal; University of Bielefeld	Schroder, CC (corresponding author), Univ Wuppertal, Dept Occupat Hlth Sci, Wuppertal, Germany.	cschroeder@uni-wuppertal.de		Schroder, Chloe Charlotte/0000-0002-4259-5319	 [0421/40-64-50-61 lidA]		This research was funded by the Deutsche Rentenversicherung Bund (grant number/funding code 0421/40-64-50-61 lidA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck L, 2011, REHABILITATION, V50, P11, DOI 10.1055/s-0030-1270433; Bethge M, 2011, BUNDESGESUNDHEITSBLA, V54, P1221, DOI 10.1007/s00103-011-1366-2; Bethge M, 2021, J OCCUP REHABIL, V31, P376, DOI 10.1007/s10926-020-09926-7; Bethge M, 2018, J OCCUP REHABIL, V28, P495, DOI 10.1007/s10926-017-9733-y; Bethge M, 2012, J REHABIL MED, V44, P980, DOI 10.2340/16501977-1063; Brzoska P, 2013, MIGRATION MEDIZINISC, P49; Brzoska P., 2011, PUBLIC HLTH FORUM, V19, P651, DOI [10.1016/j.phf.2011.10.003, DOI 10.1016/J.PHF.2011.10.003]; Brzoska P, 2017, INT J PUBLIC HEALTH, V62, P517, DOI 10.1007/s00038-016-0918-5; Brzoska P, 2010, EUR J EPIDEMIOL, V25, P651, DOI 10.1007/s10654-010-9468-y; Buschmann-Steinhage R., 2016, PSYCHOLOGIE MEDIZINI, P13; Deck R, 2009, REHABILITATION, V48, P73, DOI 10.1055/s-0028-1102952; Deutsche Rentenversicherung Nord, 2019, CHECKL FR BEH RZTE F; Dragano N, 2011, REHABILITATION, V50, P28, DOI 10.1055/s-0030-1270431; Dyck M, 2020, PUBLIC HEALTH REV, V41, DOI 10.1186/s40985-020-00134-5; Ebener M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183386; Ehrmann C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021696; Eurofound, 2020, SOCIAL ENTERPRISES T, DOI DOI 10.2785/78529; Fuchs H., 2017, ERMITTLUNG REHABILIT; Hasselhorn HM, 2014, INT J EPIDEMIOL, V43, P1736, DOI 10.1093/ije/dyu021; Ju┬ckel KH., 1998, MESSUNG SOZIODEMOGRA, P7; Klein J, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0876-z; Kleudgen M, 2015, 072015 FDZ FORSCH BU; Kroll LE, 2011, ARBEITSBELASTUNGEN G, V2; Kuo BCH, 2014, HEALTH PSYCHOL BEHAV, V2, P16, DOI 10.1080/21642850.2013.843459; Labriola M, 2009, ERGONOMICS, V52, P1419, DOI 10.1080/00140130903067771; Liu SG, 2019, ARCH PHYS MED REHAB, V100, P1450, DOI 10.1016/j.apmr.2018.11.014; Meng K, 2007, Rehabilitation (Stuttg), V46, P41; Morfeld M., 2015, RETURN WORK ARBEIT F, V1st ed, P179; Nubling M, 2006, 16 DIW DAT; Prodinger B, 2019, DISABIL REHABIL, V41, P541, DOI 10.1080/09638288.2017.1381186; Prodinger B, 2016, J REHABIL MED, V48, P508, DOI 10.2340/16501977-2066; Raspe H, 2005, Rehabilitation (Stuttg), V44, P325; Perez ER, 2012, ETHNIC HEALTH, V17, P563, DOI 10.1080/13557858.2012.730606; rztliches Zentrum fr Qualitt in der Medizin, 2019, NVL CHRON KHK WAS I; Schenk L, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P853, DOI 10.1007/s00103-006-0018-4; Schloffel M, 2021, REHABILITATION, V60, P243, DOI 10.1055/a-1282-8564; Schonfeld S., 2021, GESUNDHEITSWESEN, V83, P1; Schroder CC, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-019-4845-z; Schwarz B, 2015, REHABILITATION, V54, P362, DOI 10.1055/s-0041-108279; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 1996, THEORIE GESUNDHEITSF; Spallek J.., 2016, SOZIOLOGIE GESUNDHEI, P153, DOI [10.1007/978-3-658-11010-9_10, DOI 10.1007/978-3-658-11010-9_10]; Spanier K., 2018, J QUANTITATIVE RES R, V1, P21; Spanier K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0968-7; Statistisches Bundesamt, 2017, BEVLK MIGR ERG MIKR; Statistisches Bundesamt, 2020, BEVLK ERW BEVLK MIGR; Steinwede, 2013, 012013 FDZ; Steinwede J, 2018, PREPRINT; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Sundstrup E, 2017, SCAND J WORK ENV HEA, V43, P415, DOI 10.5271/sjweh.3663; Thielgen G., 2018, REHABILITATION ANTRA, P409; van den Berg T, 2010, OCCUP ENVIRON MED, V67, P845, DOI 10.1136/oem.2009.051730; Viehmeier S., 2018, REHABILITATION ANTRA, P181; Voigtlander S., 2013, MIGRATION MEDIZINISC, P92; Wahrendorf M., 2019, ARBEITSBEDINGUNGEN L; Ware J. E., 2005, SCORE VERSION 2 SF 1; Wenzel TR, 2017, BUNDESGESUNDHEITSBLA, V60, P386, DOI 10.1007/s00103-017-2517-x; World Health Organization(WHO), 2001, INT CLASS FUNCT DIS	59	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263643	10.1371/journal.pone.0263643	http://dx.doi.org/10.1371/journal.pone.0263643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130330	gold, Green Published			2022-12-26	WOS:000805530700042
J	Molina, MS; Rocamora, EN; Bendicho, AI; Vazquez, EG; Zorio, E; Rodriguez, FD; Ortuno, CG; Rodriguez, AI; Sanchez-Lopez, AJ; Rubio, RJ; Moreno-Docon, A; Marcos, PJ; Pavia, PG; Villa, RB; Blanes, JRG				Sabater Molina, Maria; Nicolas Rocamora, Elisa; Iborra Bendicho, Asuncion; Garcia Vazquez, Elisa; Zorio, Esther; Dominguez Rodriguez, Fernando; Gil Ortuno, Cristina; Isabel Rodriguez, Ana; Sanchez-Lopez, Antonio J.; Jara Rubio, Ruben; Moreno-Docon, Antonio; Marcos, Pedro J.; Garcia Pavia, Pablo; Barriales Villa, Roberto; Gimeno Blanes, Juan R.			Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease	PLOS ONE			English	Article							CONVERTING-ENZYME GENE; INSERTION DELETION POLYMORPHISM; TYPE-1 RECEPTOR GENE; I/D POLYMORPHISM; ASSOCIATION; CORONAVIRUS; SUSCEPTIBILITY; PNEUMONIA	Background Infection by the SARS-Cov-2 virus produces in humans a disease of highly variable and unpredictable severity. The presence of frequent genetic single nucleotide polymorphisms (SNPs) in the population might lead to a greater susceptibility to infection or an exaggerated inflammatory response. SARS-CoV-2 requires the presence of the ACE2 protein to enter in the cell and ACE2 is a regulator of the renin-angiotensin system. Accordingly, we studied the associations between 8 SNPs from AGTR1, ACE2 and ACE genes and the severity of the disease produced by the SARS-Cov-2 virus. Methods 318 (aged 59.6 +/- 17.3 years, males 62.6%) COVID-19 patients were grouped based on the severity of symptoms: Outpatients (n = 104, 32.7%), hospitalized on the wards (n = 73, 23.0%), Intensive Care Unit (ICU) (n = 84, 26.4%) and deceased (n = 57, 17.9%). Comorbidity data (diabetes, hypertension, obesity, lung disease and cancer) were collected for adjustment. Genotype distribution of 8 selected SNPs among the severity groups was analyzed. Results Four SNPs in ACE2 were associated with the severity of disease. While rs2074192 and rs1978124 showed a protector effect assuming an overdominant model of inheritance (G/A vs. GG-AA, OR = 0.32, 95%CI = 0.12-0.82; p = 0.016 and A/G vs. AA-GG, OR = 0.37, 95%CI: 0.14-0.96; p = 0.038, respectively); the SNPs rs2106809 and rs2285666were associated with an increased risk of being hospitalized and a severity course of the disease with recessive models of inheritance (C/C vs. T/C-T/T, OR = 11.41, 95% CI: 1.12-115.91; p = 0.012) and (A/A vs. GG-G/A, OR = 12.61, 95% CI: 1.26-125.87; p = 0.0081). As expected, an older age (OR = 1.47), male gender (OR = 1.98) and comorbidities (OR = 2.52) increased the risk of being admitted to ICU or death vs more benign outpatient course. Multivariable analysis demonstrated the role of the certain genotypes (ACE2) with the severity of COVID19 (OR: 0.31, OR 0.37 for rs2074192 and rs1978124, and OR = 2.67, OR = 2.70 for rs2106809 and rs2285666, respectively). Hardy-Weinberg equilibrium in hospitalized group for I/D SNP in ACE was not showed (p<0.05), which might be due to the association with the disease. No association between COVID-19 disease and the different AGTR1 SNPs was evidenced on multivariable, nevertheless the A/A genotype for rs5183 showed an higher hospitalization risk in patients with comorbidities. Conclusions Different genetic variants in ACE2 were associated with a severe clinical course and death groups of patients with COVID-19. ACE2 common SNPs in the population might modulate severity of COVID-19 infection independently of other known markers like gender, age and comorbidities.	[Sabater Molina, Maria; Nicolas Rocamora, Elisa; Gil Ortuno, Cristina; Isabel Rodriguez, Ana; Gimeno Blanes, Juan R.] Hosp Univ Virgen de la Arrixaca, Dept Cardiac, Murcia, Spain; [Sabater Molina, Maria; Gil Ortuno, Cristina; Gimeno Blanes, Juan R.] Inst Murciano Invest Biosanitaria, Cardiogenet Lab, Murcia, Spain; [Sabater Molina, Maria; Zorio, Esther; Dominguez Rodriguez, Fernando; Marcos, Pedro J.; Garcia Pavia, Pablo; Barriales Villa, Roberto; Gimeno Blanes, Juan R.] Ctr Invest Biomed Red Cardiovasc CIBERCV, Madrid, Spain; [Sabater Molina, Maria; Dominguez Rodriguez, Fernando; Garcia Pavia, Pablo; Gimeno Blanes, Juan R.] European Reference Network Rare & Low Prevalence, Madrid, Spain; [Iborra Bendicho, Asuncion; Moreno-Docon, Antonio] Hosp Univ Virgen de la Arrixaca, Dept Microbiol, Murcia, Spain; [Garcia Vazquez, Elisa] Hosp Univ Virgen de la Arrixaca, Dept Infect Dis, Murcia, Spain; [Zorio, Esther] Hosp Univ & Politecn La Fe, Dept Cardiol, Unidad Cardiopatias Familiares & Muerte Subita, Valencia, Spain; [Dominguez Rodriguez, Fernando; Garcia Pavia, Pablo] Hosp Univ Puerta de Hierro, Dept Cardiol, Madrid, Spain; [Sanchez-Lopez, Antonio J.] Biobanco Hosp Univ Puerta de Hierro, Inst Invest Sanitaria Puerta de Hierro Segovia de, Madrid, Spain; [Jara Rubio, Ruben] Hosp Univ Virgen de la Arrixaca, IntensiveCareUnit, Murcia, Spain; [Marcos, Pedro J.] Complejo Hosp Univ A Coruna CHUAC, Direcc Asistencial, Serv Neumol, Inst Invest Biomed A Coruna INIBIC, La Coruna, Spain; [Garcia Pavia, Pablo] Univ Francisco Vitoria UFV, Madrid, Spain; [Barriales Villa, Roberto] Complejo Hosp Univ A Coruna, Dept Cardiac, La Coruna, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitari i Politecnic La Fe; Hospital Puerta de Hierro-Majadahonda; Hospital Clinico Universitario Virgen de la Arrixaca; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidad Francisco de Vitoria; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna	Molina, MS (corresponding author), Hosp Univ Virgen de la Arrixaca, Dept Cardiac, Murcia, Spain.; Molina, MS (corresponding author), Inst Murciano Invest Biosanitaria, Cardiogenet Lab, Murcia, Spain.; Molina, MS (corresponding author), Ctr Invest Biomed Red Cardiovasc CIBERCV, Madrid, Spain.; Molina, MS (corresponding author), European Reference Network Rare & Low Prevalence, Madrid, Spain.	mariasm79es@hotmail.com	Sánchez-López, Antonio J./AAF-3383-2021; Marcos, Pedro J/K-9965-2015; Sabater-Molina, Maria/I-2722-2015	Sánchez-López, Antonio J./0000-0001-7168-6175; Marcos, Pedro J/0000-0001-9600-3537; Gil Ortuno, Cristina/0000-0001-7296-3445; Sabater-Molina, Maria/0000-0003-1352-1748	Instituto de Salud Carlos III; FEDER Union Europea, Una forma de hacer Europa [FONDO-COVID19 COV20/00420]; BIOBANC-Mur/Instituto Murciano de Investigacion Biosanitaria [PT20/00109]; Biobank Hospital Universitario La Fe [PT17/0015/0043]; Biobank Hospital UniversitarioPuertade Hierro Majadahonda (HUPHM)/Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA) in the Spanish National Biobanks Network [PT17/0015/0020]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER Union Europea, Una forma de hacer Europa; BIOBANC-Mur/Instituto Murciano de Investigacion Biosanitaria; Biobank Hospital Universitario La Fe; Biobank Hospital UniversitarioPuertade Hierro Majadahonda (HUPHM)/Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA) in the Spanish National Biobanks Network	The work was in part supported by grants from Instituto de Salud Carlos III and FEDER Union Europea, Una forma de hacer Europa (FONDO-COVID19 COV20/00420). The group of researchers is part of the Cardiovascular Research Network (CIBERCV) and the CIBER of Rare Diseases (CIBERER). The research group in "Hereditary Heart Diseases and Sudden Death" is registered at the University of Murcia and the IMIB. The Family Heart Disease Unit of the Virgen de la Arrixaca University Clinical Hospital is accredited as a Reference Unit (CSUR) by the Ministry of Health and is part of the network of European reference centers included in Guard-Heart (ERN). Maria Sabater has a research contract from the FFIS (Foundation for Sanitary Training and Research).; The authors wish to thank the participating centers' biobanks (BIOBANC-Mur/Instituto Murciano de Investigacion Biosanitaria, PT20/00109; Biobank Hospital Universitario La Fe, PT17/0015/0043; Biobank Hospital UniversitarioPuertade Hierro Majadahonda (HUPHM)/Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), PT17/0015/0020 in the Spanish National Biobanks Network) for the human specimens used in this study.	Abassi ZA, 2020, AM J PHYSIOL-LUNG C, V318, pL1020, DOI 10.1152/ajplung.00097.2020; Abdi E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73682-0; Anastassopoulou C, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00290-4; Asselta R, 2020, AGING-US, V12, P10087, DOI 10.18632/aging.103415; Baudin B, 2005, EXP PHYSIOL, V90, P277, DOI 10.1113/expphysiol.2004.028456; Bellone M, 2020, J MOL MED, V98, P1505, DOI 10.1007/s00109-020-01981-0; Benigni A, 2013, AGE, V35, P993, DOI 10.1007/s11357-012-9408-8; Berge KE, 1997, CLIN GENET, V52, P422; Busse LW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02862-1; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Celik SK, 2021, J MED VIROL, V93, P5947, DOI 10.1002/jmv.27160; Chen YY, 2016, J HUM HYPERTENS, V30, P766, DOI 10.1038/jhh.2016.24; Choudhary S, 2021, ANN LAB MED, V41, P129, DOI 10.3343/alm.2021.41.2.129; Delanghe JR, 2020, CLIN CHEM LAB MED, V58, P1125, DOI 10.1515/cclm-2020-0425; Duan LJ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017457; Fan ZM, 2019, LIFE SCI, V225, P39, DOI 10.1016/j.lfs.2019.03.059; Feng W, 2017, PHARMAZIE, V72, P17, DOI 10.1691/ph.2017.6752; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219; He QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075870; Jacobs M, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00940-2020; Kouhpayeh Hamid Reza, 2021, Transl Med Commun, V6, P26, DOI 10.1186/s41231-021-00106-0; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kucukarabaci B, 2008, ANATOL J CARDIOL, V8, P65; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Luo Y, 2019, HYPERTENS RES, V42, P681, DOI 10.1038/s41440-018-0166-6; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Matsuda A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-76; Mehrabadi ME, 2021, BIOMED PHARMACOTHER, V137, DOI 10.1016/j.biopha.2021.111363; Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002; Musso G, 2019, AM J GASTROENTEROL, V114, P607, DOI 10.14309/ajg.0000000000000154; Parchwani DN, 2018, INDIAN J CLIN BIOCHE, V33, P53, DOI 10.1007/s12291-017-0644-7; Philipp CS, 1998, THROMB HAEMOSTASIS, V80, P869; Riera-Fortuny C, 2005, INT J OBESITY, V29, P78, DOI 10.1038/sj.ijo.0802829; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Prestes TRR, 2017, CURR DRUG TARGETS, V18, P1301, DOI 10.2174/1389450117666160727142401; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sommerstein R, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016509; Srivastava A, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.564741; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Yamamoto N, 2020, GENE, V758, DOI 10.1016/j.gene.2020.144944; Zhong J, 2006, J LAB CLIN MED, V147, P91, DOI 10.1016/j.lab.2005.10.001; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	47	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263140	10.1371/journal.pone.0263140	http://dx.doi.org/10.1371/journal.pone.0263140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120165	Green Published, gold			2022-12-26	WOS:000789273600023
J	Bearth, A; Berthold, A; Siegrist, M				Bearth, Angela; Berthold, Anne; Siegrist, Michael			People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats	PLOS ONE			English	Article							SUPPLEMENTS; KNOWLEDGE; HESITANCY	Pandemics, such as the current SARS-CoV-2 pandemic, represents a health threat to humans worldwide. During times of heightened health risks, the public's perceptions, and acceptance of evidence-based preventive measures, such as vaccines, is of high relevance. Moreover, people might seek other preventive remedies to protect themselves from getting infected (e.g., herbal remedies, nutritional supplements). A recent study on consumers' preference for naturalness showed that people put more weight on perceived naturalness of a preventive remedy compared to a curative one. This result was attributed to the increased focus on perceived effectiveness as opposed to perceived risk. This raises the question whether the current pandemic would shift people's perceptions from prevention to curing and thus, exhibit a preference for synthetic remedies because they are seen as more effective. The present online experiment (conducted in April 2021) investigated people's perceptions of vaccines and remedies within the context of the current SARS-CoV-2 pandemic. A 2x2 between-subject design with type of remedy (natural vs. synthetic) and salience of SARS-CoV-2 pandemic (high vs. low) was conducted in Switzerland in spring 2021 (N = 452). The data did not provide evidence of a curative mindset for preventive remedies, as the participants exhibited a clear preference for the natural remedy compared to the synthetic remedy. Our study stresses the importance of understanding people's mindsets on how to protect themselves from infection with a virus during an ongoing pandemic to tackle misinformation and vaccine hesitancy.	[Bearth, Angela; Berthold, Anne; Siegrist, Michael] Swiss Fed Inst Technol, Inst Environm Decis IED, Consumer Behav, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bearth, A (corresponding author), Swiss Fed Inst Technol, Inst Environm Decis IED, Consumer Behav, Zurich, Switzerland.	angela.bearth@hest.ethz.ch	Bearth, Angela/GNP-4621-2022; Berthold, Anne/X-1860-2019; Siegrist, Michael/A-1032-2008; Bearth, Angela/I-5288-2018	Berthold, Anne/0000-0001-6268-4960; Siegrist, Michael/0000-0002-6139-7190; Bearth, Angela/0000-0003-1270-6468				Alba JW, 2000, J CONSUM RES, V27, P123, DOI 10.1086/314317; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bearth A, 2021, SOC SCI MED, V280, DOI 10.1016/j.socscimed.2021.114039; Bell S, 2020, VACCINE, V38, P7789, DOI 10.1016/j.vaccine.2020.10.027; Berg-Weger M, 2020, J NUTR HEALTH AGING, V24, P456, DOI 10.1007/s12603-020-1366-8; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Campbell MC, 2020, J CONSUM RES, V47, P311, DOI 10.1093/jcr/ucaa036; Caserotti M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113688; Cummings CL, 2021, RISK ANAL, V41, P204, DOI 10.1111/risa.13573; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernbach PM, 2019, NAT HUM BEHAV, V3, P251, DOI 10.1038/s41562-018-0520-3; Fleming N, 2020, NATURE, V583, P155, DOI 10.1038/d41586-020-01834-3; Freeman D, 2021, LANCET PUBLIC HEALTH, V6, pE416, DOI 10.1016/S2468-2667(21)00096-7; Hartmann C, 2016, APPETITE, V103, P229, DOI 10.1016/j.appet.2016.04.020; IBM Corp, 2017, IBM STAT MAC VERS 26; Konakci G, 2020, COMPLEMENT THER MED, V53, DOI 10.1016/j.ctim.2020.102545; Kreps SE, 2021, VACCINE, V39, P3250, DOI 10.1016/j.vaccine.2021.04.044; Larson HJ, 2020, NAT REV IMMUNOL, V20, P449, DOI 10.1038/s41577-020-0380-8; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Li M, 2012, J APPL SOC PSYCHOL, V42, P2859, DOI 10.1111/j.1559-1816.2012.00964.x; Machingaidze S, 2021, NAT MED, V27, P1338, DOI 10.1038/s41591-021-01459-7; Michel F, 2019, APPETITE, V140, P298, DOI 10.1016/j.appet.2019.05.019; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Pajor EM, 2017, APPETITE, V114, P161, DOI 10.1016/j.appet.2017.03.036; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Retzbach J, 2016, PUBLIC UNDERST SCI, V25, P638, DOI 10.1177/0963662515575253; Rozin P, 2004, APPETITE, V43, P147, DOI 10.1016/j.appet.2004.03.005; Scott SE, 2020, J CONSUM RES, V47, P454, DOI 10.1093/jcr/ucaa034; Scott SE, 2020, NAT HUM BEHAV, V4, P989, DOI 10.1038/s41562-020-0891-0; Siedlecka E, 2019, EMOT REV, V11, P87, DOI 10.1177/1754073917749016; Siegrist M, 2021, RISK ANAL, V41, P787, DOI 10.1111/risa.13675; Signer J, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01401-2; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; swissmedic, ECH SUPP REM NEW COR; Wakefield JRH, 2021, J COMMUNITY APPL SOC, V31, P603, DOI 10.1002/casp.2542; Zhang X, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00689; Zingg A, 2012, VACCINE, V30, P3771, DOI 10.1016/j.vaccine.2012.03.014	39	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263351	10.1371/journal.pone.0263351	http://dx.doi.org/10.1371/journal.pone.0263351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108313	Green Published, gold			2022-12-26	WOS:000775890100060
J	Karadzovska-Kotevska, M; Brunnstrom, H; Kosieradzki, J; Ek, L; Estberg, C; Staaf, J; Barath, S; Planck, M				Karadzovska-Kotevska, Marija; Brunnstrom, Hans; Kosieradzki, Jaroslaw; Ek, Lars; Estberg, Christel; Staaf, Johan; Barath, Stefan; Planck, Maria			Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience	PLOS ONE			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; CELL LUNG-CANCER; INTERNATIONAL ASSOCIATION; CYTOLOGY SPECIMENS; SMALL BIOPSIES; ULTRASOUND; CLASSIFICATION; TISSUE	Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive bronchoscopic procedure, well established as a diagnostic modality of first choice for diagnosis and staging of non-small cell lung cancer (NSCLC). The therapeutic decisions for advanced NSCLC require comprehensive profiling of actionable mutations, which is currently considered to be an essential part of the diagnostic process. The purpose of this study was to evaluate the utility of EBUS-TBNA cytology specimen for histological subtyping, molecular profiling of NSCLC by massive parallel sequencing (MPS), as well as for PD-L1 analysis. A retrospective review of 806 EBUS bronchoscopies was performed, resulting in a cohort of 132 consecutive patients with EBUS-TBNA specimens showing NSCLC cells in lymph nodes. Data on patient demographics, radiology features of the suspected tumor and mediastinal engagement, lymph nodes sampled, the histopathological subtype of NSCLC, and performed molecular analysis were collected. The EBUS-TBNA specimen proved sufficient for subtyping NSCLC in 83% and analysis of treatment predictive biomarkers in 77% (MPS in 53%). The adequacy of the EBUS-TBNA specimen was 69% for EGFR gene mutation analysis, 49% for analysis of ALK rearrangement, 36% for ROS1 rearrangement, and 33% for analysis of PD-L1. The findings of our study confirm that EBUS-TBNA cytology aspirate is appropriate for diagnosis and subtyping of NSCLC and largely also for treatment predictive molecular testing, although more data is needed on the utility of EBUS cytology specimen for MPS and PD-L1 analysis.	[Karadzovska-Kotevska, Marija; Kosieradzki, Jaroslaw; Ek, Lars; Estberg, Christel; Barath, Stefan; Planck, Maria] Skane Univ Hosp Lund, Dept Resp Dis & Allergol, Lund, Sweden; [Karadzovska-Kotevska, Marija; Staaf, Johan; Planck, Maria] Lund Univ, Dept Clin Sci Lund, Div Oncol, Medicon Village, Lund, Sweden; [Brunnstrom, Hans] Reg Skane, Div Lab Med, Dept Genet & Pathol, Lund, Sweden; [Brunnstrom, Hans] Lund Univ, Dept Clin Sci Lund, Div Pathol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University	Karadzovska-Kotevska, M (corresponding author), Skane Univ Hosp Lund, Dept Resp Dis & Allergol, Lund, Sweden.; Karadzovska-Kotevska, M (corresponding author), Lund Univ, Dept Clin Sci Lund, Div Oncol, Medicon Village, Lund, Sweden.	Marija.Kotevska@med.lu.se		Brunnstrom, Hans/0000-0001-7402-138X	Swedish Cancer society [190473PjO1H]; Mrs. Berta Kamprads Foundation [FBKS-2020-7]; Crafoord's Foundation [20209975]; Sjoberg's Foundation	Swedish Cancer society(Swedish Cancer Society); Mrs. Berta Kamprads Foundation; Crafoord's Foundation; Sjoberg's Foundation	MP (Maria Planck) received grants from Swedish Cancer society (190473PjO1H), Mrs. Berta Kamprads Foundation (FBKS-2020-7), Crafoord's Foundation (20209975), and Sjoberg's Foundation (2019-2011). The funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. https://www.cancerfonden.se https://www.frubertakampradsstiftelse.se https://www.crafoord.se https://sjobergstiftelsen.se.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chaddha U, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.03.35; Cicek T, 2019, CLIN RESPIR J, V13, P92, DOI 10.1111/crj.12985; De Leyn P, 2014, EUR J CARDIO-THORAC, V45, P787, DOI 10.1093/ejcts/ezu028; Dooms C, 2018, RESPIRATION, V96, P275, DOI 10.1159/000489473; Dooms C, 2014, RESPIRATION, V88, P371, DOI 10.1159/000366136; Ettinger DS, 2018, J NATL COMPR CANC NE, V16, P807, DOI 10.6004/jnccn.2018.0062; Evans M, 2020, PATHOL ONCOL RES, V26, P79, DOI 10.1007/s12253-018-0469-6; Fernandez-Bussy S, ARCH BRONCONEUMOL; Fernandez-Bussy S, 2018, ARCH BRONCONEUMOL, V54, P290, DOI [10.1016/j.arbr.2017.10.019, 10.1016/j.arbres.2017.10.008]; Garcia-Olive I, 2010, EUR RESPIR J, V35, P391, DOI 10.1183/09031936.00028109; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Herth FJF, 2006, EUR RESPIR J, V28, P1264, DOI 10.1183/09031936.00013806; Isaksson Sofi, 2020, JTO Clin Res Rep, V1, P100013, DOI 10.1016/j.jtocrr.2020.100013; Jeyabalan A, 2016, MOL CLIN ONCOL, V4, P119, DOI 10.3892/mco.2015.672; Jose RJ, 2014, QJM-INT J MED, V107, P201, DOI 10.1093/qjmed/hct233; Kage H, 2019, CANCER SCI, V110, P2652, DOI 10.1111/cas.14112; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Labarca G, 2018, ANN AM THORAC SOC, V15, P1205, DOI 10.1513/AnnalsATS.201801-045OC; Michael CW, 2018, DIAGN CYTOPATHOL, V46, P815, DOI 10.1002/dc.23975; Murthi M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00118; Navani N, 2015, LANCET RESP MED, V3, P282, DOI 10.1016/S2213-2600(15)00029-6; Rooper LM, 2016, HUM PATHOL, V51, P139, DOI 10.1016/j.humpath.2015.12.025; Sakata KK, 2018, CHEST, V154, P827, DOI 10.1016/j.chest.2018.07.017; Schuurbiers OCJ, 2010, J THORAC ONCOL, V5, P1664, DOI 10.1097/JTO.0b013e3181f0bd93; Silvestri GA, 2013, CHEST, V143, pE211, DOI 10.1378/chest.12-2355; Stoy SP, 2018, CLIN LUNG CANCER, V19, P230, DOI 10.1016/j.cllc.2017.11.010; Stoy SP, 2018, CANCER CYTOPATHOL, V126, P122, DOI 10.1002/cncy.21941; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; Travis WD, 2011, SEMIN RESP CRIT CARE, V32, P22, DOI 10.1055/s-0031-1272866; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Turner SR, 2018, LUNG CANCER, V119, P85, DOI 10.1016/j.lungcan.2018.03.003; Vaidya PJ, 2017, RESPIROLOGY, V22, P1093, DOI 10.1111/resp.13094; van der Heijden EHFM, 2014, RESPIRATION, V88, P500, DOI 10.1159/000368857; Varela-Lema L, 2009, EUR RESPIR J, V33, P1156, DOI 10.1183/09031936.00097908; Velcheti V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206370; Xie FF, 2019, ANN THORAC SURG, V108, P219, DOI 10.1016/j.athoracsur.2019.02.010	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263342	10.1371/journal.pone.0263342	http://dx.doi.org/10.1371/journal.pone.0263342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108331	Green Published, gold			2022-12-26	WOS:000775890100059
J	White, DE; Bartley, J; Whittington, C; Garcia, L; Chand, K; Turangi, C				White, David E.; Bartley, Jim; Whittington, Christopher; Garcia, Lorenzo; Chand, Kaushik; Turangi, Celine			Pilot study: Post-surgical infections could be related with lack of sharpness in surgical tools	PLOS ONE			English	Article							STERILIZATION; PREVENTION	Despite rigorous sterilization protocols placed in surgical procedures, there is demonstrated evidence that show patients contract infections while hospitalized. This study aims to investigate the presence of biological materials in osteotome surgical tools after sterilization processes, determine the relationship between lack of sharpness and cross-contamination, and evaluate the influence of materials surface coating as a potential contamination preventive. Three commercially available osteotomes with different surface coatings were studied and submitted to a procedure of bone-cutting cycles. After use, each was sterilized and examined under SEM and EDS. Bone contaminants were detected in each osteotome although the PVD coated osteotome demonstrated significantly less contamination than either the as-supplied or electroless nickel coated one. According to the results, there is an association between blade sharpness and post-sterilization bone contamination. These findings suggest either disposable osteotomes should be used in surgical procedures, or an effective sharpen process should both be established and monitored to minimise post-operative infections.	[White, David E.; Whittington, Christopher; Garcia, Lorenzo; Chand, Kaushik; Turangi, Celine] Auckland Univ Technol, Sch Engn Comp & Math Sci, BioDesign Lab, Auckland, New Zealand; [Bartley, Jim] Univ Auckland, Dept Surg, Auckland, New Zealand	Auckland University of Technology; University of Auckland	Garcia, L (corresponding author), Auckland Univ Technol, Sch Engn Comp & Math Sci, BioDesign Lab, Auckland, New Zealand.	lorenzo.garcia@aut.ac.nz						Bullock M.W., 2016, J ARTHROPLASTY, V30, P1; Gaston RG, 2012, CRIT CARE NURS CLIN, V24, P323, DOI 10.1016/j.ccell.2012.03.007; Gruskay J, 2012, SPINE, V37, P1170, DOI 10.1097/BRS.0b013e3182407859; McCarthy CT, 2007, ENG FRACT MECH, V74, P2205, DOI 10.1016/j.engfracmech.2006.10.015; Nania P, 2013, ASSOC OPER ROOM NURS, V98, P32, DOI 10.1016/j.aorn.2013.05.003; Schneider PM, 2013, AM J INFECT CONTROL, V41, pS81, DOI 10.1016/j.ajic.2012.12.007; Spry Cynthia, 2008, AORN J, V88, P537, DOI 10.1016/j.aorn.2008.06.016; White DE, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01768-6; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033; Yasuhara H, 2012, SURGERY, V151, P153, DOI 10.1016/j.surg.2011.06.029	10	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0261322	10.1371/journal.pone.0261322	http://dx.doi.org/10.1371/journal.pone.0261322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108280	gold, Green Published			2022-12-26	WOS:000775890100008
J	Zhang, SG; Khattak, A; Matara, CM; Hussain, A; Farooq, A				Zhang, Shuguang; Khattak, Afaq; Matara, Caroline Mongina; Hussain, Arshad; Farooq, Asim			Hybrid feature selection-based machine learning Classification system for the prediction of injury severity in single and multiple-vehicle accidents	PLOS ONE			English	Article							MIXED LOGIT MODEL; PRINCIPAL COMPONENT; CRASHES; TIME	To undertake a reliable analysis of injury severity in road traffic accidents, a complete understanding of important attributes is essential. As a result of the shift from traditional statistical parametric procedures to computer-aided methods, machine learning approaches have become an important aspect in predicting the severity of road traffic injuries. The paper presents a hybrid feature selection-based machine learning classification approach for detecting significant attributes and predicting injury severity in single and multiple-vehicle accidents. To begin, we employed a Random Forests (RF) classifier in conjunction with an intrinsic wrapper-based feature selection approach called the Boruta Algorithm (BA) to find the relevant important attributes that determine injury severity. The influential attributes were then fed into a set of four classifiers to accurately predict injury severity (Naive Bayes (NB), K-Nearest Neighbor (K-NN), Binary Logistic Regression (BLR), and Extreme Gradient Boosting (XGBoost)). According to BA's experimental investigation, the vehicle type was the most influential factor, followed by the month of the year, the driver's age, and the alignment of the road segment. The driver's gender, the presence of a median, and the presence of a shoulder were all found to be unimportant. According to classifier performance measures, XGBoost surpasses the other classifiers in terms of prediction performance. Using the specified attributes, the accuracy, Cohen's Kappa, F1-Measure, and AUC-ROC values of the XGBoost were 82.10%, 0.607, 0.776, and 0.880 for single vehicle accidents and 79.52%, 0.569, 0.752, and 0.86 for multiple-vehicle accidents, respectively.	[Zhang, Shuguang] CCCC Southwest Investment & Dev Co Ltd, Beijing, Peoples R China; [Khattak, Afaq] Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China; [Matara, Caroline Mongina] Univ Nairobi, Dept Civil & Construct Engn, Nairobi, Kenya; [Hussain, Arshad] Natl Univ Sci & Technol, NUST Inst Civil Engn, Islamabad, Pakistan; [Farooq, Asim] Inst Appl Sci, Ctr Excellence Transportat Engn, Pak Austria Facshhoule, Haripur, Pakistan	Tongji University; University of Nairobi; National University of Sciences & Technology - Pakistan	Khattak, A (corresponding author), Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China.	khattak@tongji.edu.cn		Farooq, Asim/0000-0003-1116-0846	Department of Transport of Yunnan Province Science and Technology Innovation Demonstration Project (2019) [16]	Department of Transport of Yunnan Province Science and Technology Innovation Demonstration Project (2019)	This research was funded by the Department of Transport of Yunnan Province Science and Technology Innovation Demonstration Project (2019 No. 16).	Abdel-Aty M, 2003, J SAFETY RES, V34, P597, DOI 10.1016/j.jsr.2003.05.009; Abdul-Wahab SA, 2005, ENVIRON MODELL SOFTW, V20, P1263, DOI 10.1016/j.envsoft.2004.09.001; Ahmadi A, 2020, J TRANSP SAF SECUR, V12, P522, DOI 10.1080/19439962.2018.1505793; Ahmed AAM, 2021, J HYDROL, V599, DOI 10.1016/j.jhydrol.2021.126350; AlMamlook RE, 2019, 2019 IEEE JORDAN INTERNATIONAL JOINT CONFERENCE ON ELECTRICAL ENGINEERING AND INFORMATION TECHNOLOGY (JEEIT), P272, DOI 10.1109/JEEIT.2019.8717393; Beryl Princess P. Joyce, 2021, Advances in Artificial Intelligence and Data Engineering. Select Proceedings of AIDE 2019. Advances in Intelligent Systems and Computing (AISC 1133), P27, DOI 10.1007/978-981-15-3514-7_3; Bham GH, 2019, J TRANSP SAF SECUR, V11, P225, DOI 10.1080/19439962.2017.1384417; Bhowmik TK, 2015, INTELIGENCIA ARTIFIC, V18, P14; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen HR, 2020, J ADV TRANSPORT, V2020, DOI 10.1155/2020/8881545; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cheng L., 2010, ICCTP 2010 INT TRANS, P2739; Fiorentini N, 2020, INFRASTRUCTURES-BASE, V5, DOI 10.3390/infrastructures5070061; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; Garrido R, 2014, TRANSP RES PROC, V3, P214, DOI 10.1016/j.trpro.2014.10.107; Geedipally SR, 2011, TRANSPORT RES REC, P62, DOI 10.3141/2265-07; Guillen-Casla V, 2011, J FOOD COMPOS ANAL, V24, P456, DOI 10.1016/j.jfca.2010.11.010; He F, 2010, COMPUT ELECTRON AGR, V71, pS19, DOI 10.1016/j.compag.2009.07.011; Jalali-Heravi M, 2004, J CHEM INF COMP SCI, V44, P1328, DOI 10.1021/ci0342270; Jeong H, 2018, ACCIDENT ANAL PREV, V120, P250, DOI 10.1016/j.aap.2018.08.025; Ji A, 2020, IEEE OPEN J INTEL TR, V1, P217, DOI 10.1109/OJITS.2020.3033523; Jiang L, 2019, P TRANSP RES BOARD 9; Kalvapalli SPK, 2019, ADV INTELL SYST, V740, P341, DOI 10.1007/978-981-13-1280-9_32; Kassu A, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1796-2; Khattak AJ, 2002, J TRANSP ENG, V128, P243, DOI 10.1061/(ASCE)0733-947X(2002)128:3(243); Kockelman KM, 2002, ACCIDENT ANAL PREV, V34, P313, DOI 10.1016/S0001-4575(01)00028-8; Li ZL, 2017, INT J DISTRIB SENS N, V13, DOI 10.1177/1550147717733391; [李振龙 Li Zhenlong], 2015, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V15, P246; Lin CY, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051675; Liu PF, 2019, CAN J CIVIL ENG, V46, P322, DOI 10.1139/cjce-2018-0262; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Mohd Fahmi M. N., 2011, World Applied Sciences Journal, V14, P73; Omid M, 2010, EXPERT SYST APPL, V37, P7205, DOI 10.1016/j.eswa.2010.04.008; Organization W.H, 2015, GLOBAL STATUS REPORT; Rahim MA, 2021, ACCIDENT ANAL PREV, V154, DOI 10.1016/j.aap.2021.106090; Rezapour M, 2019, J SAFETY RES, V68, P107, DOI 10.1016/j.jsr.2018.12.006; Rifaat SM, 2007, J ADV TRANSPORT, V41, P91, DOI 10.1002/atr.5670410107; Shi R, 2021, APPL SOFT COMPUT, V109, DOI 10.1016/j.asoc.2021.107538; Vajari MA, 2020, J SAFETY RES, V73, P17, DOI 10.1016/j.jsr.2020.02.008; Wahab L, 2020, INT J CRASHWORTHINES, V25, P485, DOI 10.1080/13588265.2019.1616885; Wang CY, 2015, GENET MOL RES, V14, P123, DOI 10.4238/2015.January.15.15; Wu Q, 2014, ACCIDENT ANAL PREV, V72, P105, DOI 10.1016/j.aap.2014.06.014; Xie YC, 2009, J TRANSP ENG, V135, P18, DOI 10.1061/(ASCE)0733-947X(2009)135:1(18); Yang C, 2021, ACCIDENT ANAL PREV, V158, DOI 10.1016/j.aap.2021.106153; Zhang J, 2018, IEEE ACCESS, V6, P60079, DOI 10.1109/ACCESS.2018.2874979; Zhen Chen, 2019, International Journal of Transportation Science and Technology, V8, P43, DOI 10.1016/j.ijtst.2018.10.001	47	1	1	8	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262941	10.1371/journal.pone.0262941	http://dx.doi.org/10.1371/journal.pone.0262941			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108288	gold, Green Published			2022-12-26	WOS:000775890100042
J	Chen, TC; Yao, CY; Chen, YR; Yuan, CT; Lin, CC; Hsu, YC; Chuang, PH; Kao, CJ; Li, YH; Hou, HA; Chou, WC; Tien, HF				Chen, Tsung-Chih; Yao, Chi-Yuan; Chen, Yu-Ren; Yuan, Chang-Tsu; Lin, Chien-Chin; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Li, Yi-Hung; Hou, Hsin-An; Chou, Wen-Chien; Tien, Hwei-Fang			Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; NETWORKS; ATM	The pathogenesis of acute leukemia involves interaction among genetic alterations. Mutations of IDH1/2 and PHF6 are common and co-exist in some patients of hematopoietic malignancies, but their cooperative effects remain unexplored. In this study, we addressed the question by characterizing the hematopoietic phenotypes of mice harboring neither, Phf6 knockout, Idh2 R172K, or combined mutations. We found that the combined Phf6(KO)Idh2(R172K) mice showed biased hematopoietic differentiation toward myeloid lineages and reduced long-term hematopoietic stem cells. They rapidly developed neoplasms of myeloid and lymphoid lineages, with much shorter survival compared with single mutated and wild-type mice. The marrow and spleen cells of the combined mutated mice produced a drastically increased amount of 2-hydroxyglutarate compared with mice harboring Idh2 R172K. Single-cell RNA sequencing revealed distinct patterns of transcriptome of the hematopoietic stem/progenitor cells from the combined mutated mice, including aberrant expression of metabolic enzymes, increased expression of several oncogenes, and impairment of DNA repairs, as confirmed by the enhanced gamma H2AX expression in the marrow and spleen cells. We conclude that Idh2 and Phf6 mutations are synergistic in leukemogenesis, at least through overproduction of 2-hydroxyglutarate and impairment of DNA repairs.	[Chen, Tsung-Chih] Taichung Vet Gen Hosp, Dept Internal Med, Div Hematol Med Oncol, Taichung, Taiwan; [Chen, Tsung-Chih; Yao, Chi-Yuan; Yuan, Chang-Tsu; Lin, Chien-Chin; Chuang, Po-Han] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Yao, Chi-Yuan; Chen, Yu-Ren; Lin, Chien-Chin; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Chou, Wen-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Yuan, Chang-Tsu; Chou, Wen-Chien] Natl Taiwan Univ, Dept Pathol, Canc Ctr, Taipei, Taiwan; [Yuan, Chang-Tsu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Li, Yi-Hung] Chinese Culture Univ, Dept Anim Sci, Taipei, Taiwan; [Hou, Hsin-An; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei, Taiwan	Taichung Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chinese Culture University; National Taiwan University; National Taiwan University Hospital	Chou, WC (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.; Chou, WC (corresponding author), Natl Taiwan Univ, Dept Pathol, Canc Ctr, Taipei, Taiwan.	wchou@ntu.edu.tw		Yuan, Chang-Tsu/0000-0003-1438-9187; LIN, CHIEN-CHIN/0000-0001-7160-2285; CHOU, WEN-CHIEN/0000-0003-2967-698X	Ministry of Science and Technology of Taiwan [MOST 106-2314-B-002-224-MY3, MOST 106-2314-B-002-152-, MOST 107-2314-B-075A-010-, MOST 108-2314-B-075A-007-, MOST 109-2314-B-002 -221-, MOST 109-2314-B-075A-008-MY2]; Ministry of Health and Welfare [MOHW109-TDU-B-211-134009];  [TCVGH-1093702B];  [TCVGH-1103701B]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); ; 	We thank the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, the Animal Resources Laboratory of National Taiwan University Centers of Genomic and Precision Medicine, the Metabolomics Core Laboratory of National Taiwan University Center of Genomic Medicine, and the National Center for Genome Medicine. We thank the technical help from the Genomics Core Facility of the Institute of Molecular Biology, Academia Sinica. We would like to acknowledge the service provided by the Flow Cytometric Analyzing and Sorting Core Facilities at National Taiwan University Hospital and First Core Laboratory of National Taiwan University College of Medicine. The study was supported by research grants including TCVGH-1093702B, TCVGH-1103701B, Ministry of Science and Technology of Taiwan (MOST 106-2314-B-002-224-MY3, MOST 106-2314-B-002-152-, MOST 107-2314-B-075A-010-, MOST 108-2314-B-075A-007-, MOST 109-2314-B-002 -221- and MOST 109-2314-B-075A-008-MY2-), and Ministry of Health and Welfare (MOHW109-TDU-B-211-134009).	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bommer UA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071632; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chan SM, 2015, NAT MED, V21, P178, DOI 10.1038/nm.3788; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dahlin JS, 2018, BLOOD, V131, pE1, DOI 10.1182/blood-2017-12-821413; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Rooij JDE, 2016, BRIT J HAEMATOL, V175, P967, DOI 10.1111/bjh.13891; Dekker LJM, 2020, FASEB J, V34, P3646, DOI 10.1096/fj.201902352R; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; Duan L, 2019, CANCER BIOL THER, V20, P252, DOI 10.1080/15384047.2018.1523858; Gan LH, 2020, CELL REP, V30, P3717, DOI 10.1016/j.celrep.2020.02.085; Holmfeldt L, 2010, PEDIATR BLOOD CANCER, V55, P595, DOI 10.1002/pbc.22661; Hsu YC, 2019, BLOOD ADV, V3, P2355, DOI 10.1182/bloodadvances.2019000391; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lemonnier F, 2016, P NATL ACAD SCI USA, V113, P15084, DOI 10.1073/pnas.1617929114; Lin CC, 2014, AM J HEMATOL, V89, P137, DOI 10.1002/ajh.23596; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McRae HM, 2019, BLOOD, V133, P1729, DOI 10.1182/blood-2018-07-860726; Miyagi S, 2019, BLOOD, V133, P2495, DOI 10.1182/blood.2019000468; Molenaar RJ, 2018, ONCOGENE, V37, P1949, DOI 10.1038/s41388-017-0077-z; Mori T, 2016, LEUKEMIA, V30, P2270, DOI 10.1038/leu.2016.212; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Oh S, 2020, NUCLEIC ACIDS RES, V48, P9037, DOI 10.1093/nar/gkaa626; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Psaila B, 2020, MOL CELL, V78, P477, DOI 10.1016/j.molcel.2020.04.008; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Soto-Feliciano YM, 2017, GENE DEV, V31, P973, DOI 10.1101/gad.295857.117; Sulkowski PL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2463; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wang P, 2015, CELL REP, V13, P2353, DOI 10.1016/j.celrep.2015.11.029; Wang Q, 2011, HAEMATOL-HEMATOL J, V96, P1808, DOI 10.3324/haematol.2011.043083; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Warmerdam DO, 2020, EMBO REP, V21, DOI 10.15252/embr.201948460; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wendorff AA, 2019, CANCER DISCOV, V9, P436, DOI 10.1158/2159-8290.CD-18-1005; Xia D, 2017, LEUKEMIA LYMPHOMA, V58, P2208, DOI 10.1080/10428194.2017.1287358; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang H, 2013, CANCER CELL, V24, P575, DOI 10.1016/j.ccr.2013.09.018; Zhang XT, 2020, BLOOD, V135, P845, DOI 10.1182/blood.2019003330; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou C, 2017, LEUKEMIA, V31, P1196, DOI 10.1038/leu.2016.329	56	1	1	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1576	1588		10.1038/s41388-022-02193-1	http://dx.doi.org/10.1038/s41388-022-02193-1		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35091680				2022-12-26	WOS:000749073300002
J	Jagroep, W; Cramm, JM; Denktas, S; Nieboer, AP				Jagroep, Warsha; Cramm, Jane M.; Denktas, Semiha; Nieboer, Anna P.			Age-friendly neighbourhoods and physical activity of older Surinamese individuals in Rotterdam, the Netherlands	PLOS ONE			English	Article							BUILT ENVIRONMENT; PRIMARY-CARE; ACTIVITY INTERVENTIONS; HOME MODIFICATION; MIGRANT GROUPS; ETHNIC-GROUPS; OPEN SPACE; ADULTS; HEALTH; PEOPLE	Background Age-friendly neighbourhoods seem to promote physical activity among older individuals. Physical activity is especially important for chronically ill individuals. In the Netherlands, older Surinamese individuals are more likely to have chronic diseases than are their native Dutch counterparts. This study examined relationships of neighbourhood characteristics with physical activity among older Surinamese individuals in Rotterdam, the Netherlands. Methods Of 2749 potential participants, 697 (25%) community-dwelling older (age >= 70 years) Surinamese individuals living in Rotterdam, the Netherlands, completed a questionnaire on personal and neighbourhood characteristics between March and June 2020. Correlation and multilevel regression analyses were performed to identify associations between missing neighbourhood characteristics for ageing in place and physical activity. Results Scores for the neighbourhood domains communication and information (r = -0.099, p <= 0.05), community support and health services (r = -0.139, p <= 0.001), and respect and social inclusion (r = -0.141, p <= 0.001), correlated negatively with participants' PA. In the multilevel analysis, overall missing neighbourhood characteristics to age in place scores were associated negatively with physical activity (p <= 0.05). Conclusion This study showed the importance of age-friendly neighbourhoods for physical activity among older Surinamese individuals in Rotterdam, the Netherlands. Our findings suggest that the neighbourhood plays an important role in supporting older individuals' leading of physically active lifestyles. Further research is needed to support the development of interventions to create age-friendly neighbourhoods.	[Jagroep, Warsha; Cramm, Jane M.; Nieboer, Anna P.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Dept Sociomed Sci, Rotterdam, Netherlands; [Denktas, Semiha] Erasmus Univ, Erasmus Sch Social & Behav Sci, Dept Psychol Educ & Child Studies, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam	Jagroep, W (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Dept Sociomed Sci, Rotterdam, Netherlands.	jagroep@eshpm.eur.nl			Erasmus University Rotterdam as part of the Vital Cities and Citizens Initiative program	Erasmus University Rotterdam as part of the Vital Cities and Citizens Initiative program	This study is financed by the Erasmus University Rotterdam as part of the Vital Cities and Citizens Initiative program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy CL, 2004, AM J PUBLIC HEALTH, V94, P440, DOI 10.2105/AJPH.94.3.440; Agyemang C, 2014, STROKE, V45, P2397, DOI 10.1161/STROKEAHA.114.005505; Alley D, 2007, J GERONTOL SOC WORK, V49, P1, DOI 10.1300/J083v49n01_01; Annear MJ, 2009, HEALTH PLACE, V15, P482, DOI 10.1016/j.healthplace.2008.09.005; [Anonymous], 2020, BEVOLKING 1 JANUARI; [Anonymous], 2019, GLOBAL ACTION PLAN P; [Anonymous], 2020, WONEN LEVEN WONINGAA; [Anonymous], 2001, AGEING TRANSPORT MOB; [Anonymous], 2011, GEZONDE STAD KADERNO, P50; [Anonymous], 2003, NEIGHBORHOODS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195138382.003.0014; Aspinall PA, 2010, ENVIRON PLANN B, V37, P1022, DOI 10.1068/b36024; Atkinson R, 2004, SOCIOLOGY, V38, P437, DOI 10.1177/0038038504043211; Bailey M, 2005, AGING MENT HEALTH, V9, P82, DOI 10.1080/13607860512331334031; Barnett A, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0377-7; Barnett DW, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0558-z; Barrett J, 2005, APPL ERGON, V36, P177, DOI 10.1016/j.apergo.2004.10.006; Belza Basia, 2004, Prev Chronic Dis, V1, pA09; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Blijham N, 2008, FACTSHEET ZORG TECHN; Boakye-Dankwa E, 2019, CITIES, V84, P23, DOI 10.1016/j.cities.2018.07.002; Bolt G, 2008, URBAN STUD, V45, P1359, DOI 10.1177/0042098008090678; Bonaccorsi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176127; Booth ML, 1997, PREV MED, V26, P131, DOI 10.1006/pmed.1996.9982; Brawley LR, 2003, AM J PREV MED, V25, P172, DOI 10.1016/S0749-3797(03)00182-X; Brookfield K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020190; Buffel T, 2012, INT J LIFELONG EDUC, V31, P13, DOI 10.1080/02601370.2012.636577; Buffel T, 2012, CRIT SOC POLICY, V32, P597, DOI 10.1177/0261018311430457; Bull FC, 1998, AM J PREV MED, V15, P85, DOI 10.1016/S0749-3797(98)00040-3; Burton NW, 2012, BRIT J SPORT MED, V46, P1125, DOI 10.1136/bjsports-2011-090554; Caperchione CM, 2009, SPORTS MED, V39, P167, DOI 10.2165/00007256-200939030-00001; Carpiano RM, 2011, HEALTH PLACE, V17, P606, DOI 10.1016/j.healthplace.2010.12.018; Carr Kelly, 2013, J Aging Res, V2013, P324624, DOI 10.1155/2013/324624; Castellucci HI, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01512-z; Cawthra L, 1999, Health Libr Rev, V16, P97, DOI 10.1046/j.1365-2532.1999.00212.x; Chase CA, 2012, AM J OCCUP THER, V66, P284, DOI 10.5014/ajot.2012.005017; Christman ZJ, 2020, GERONTOLOGIST, V60, P651, DOI 10.1093/geront/gnz093; Clarke P, 2009, MATURITAS, V64, P14, DOI 10.1016/j.maturitas.2009.07.011; Codogno JS, 2020, J AGING PHYS ACTIV, V28, P634, DOI 10.1123/japa.2019-0219; Cramm JM, 2018, AGEING SOC, V38, P700, DOI 10.1017/S0144686X16001240; Cyril S, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.29842; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Denton M, 2008, CAN J AGING, V27, P359, DOI 10.3138/cja.27.4.359; Devereux-Fitzgerald A, 2016, SOC SCI MED, V158, P14, DOI 10.1016/j.socscimed.2016.04.006; Devos H, 2013, MOVEMENT DISORD, V28, P671, DOI 10.1002/mds.25387; Dool Rvd, 2013, TRENDRAPPORT BEWEGEN, P71; DOWSE GK, 1991, DIABETES CARE, V14, P271, DOI 10.2337/diacare.14.4.271; Eakin EG, 2004, AM J PREV MED, V27, P297, DOI 10.1016/j.amepre.2004.07.012; Elley Raina, 2004, N Z Med J, V117, pU1216; Erdem O, 2019, ETHNIC HEALTH, V24, P287, DOI 10.1080/13557858.2017.1346181; Evans JMM, 2018, HEALTH EDUC J, V77, P377, DOI 10.1177/0017896917741150; Fisher KJ, 2004, J AGING PHYS ACTIV, V12, P45, DOI 10.1123/japa.12.1.45; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Franse CB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022241; Fried LP, 2004, J URBAN HEALTH, V81, P64, DOI 10.1093/jurban/jth094; Gao J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0715-z; Geerling R, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000701; Gharaveis A, 2020, FACILITIES, V38, P625, DOI 10.1108/F-08-2018-0094; Ginis KAM, 2013, TRANSL BEHAV MED, V3, P434, DOI 10.1007/s13142-013-0215-2; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN., 1999, TECHNOL DISABIL, V10, P141, DOI DOI 10.3233/TAD-1999-10302; Goodall KT, 2014, EUR J CANCER CARE, V23, P728, DOI 10.1111/ecc.12241; Goodall Ken, 2010, Qual Prim Care, V18, P27; Grandes G, 2009, ARCH INTERN MED, V169, P694, DOI 10.1001/archinternmed.2009.23; Halonen JI, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038673; Hanson D, 2006, FAM COMMUNITY HEALTH, V29, P266, DOI 10.1097/00003727-200610000-00005; Hardy S, 2009, J HEALTH PSYCHOL, V14, P1036, DOI 10.1177/1359105309342298; Harrison EL, 2010, ACT ADAPT AGING, V34, P98, DOI 10.1080/01924781003773807; Hartley SE, 2015, AGEING SOC, V35, P1635, DOI 10.1017/S0144686X14000464; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Hegde SM, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0588-3; Hinrichs Timo, 2009, BMC Geriatr, V9, P37, DOI 10.1186/1471-2318-9-37; Hirvensalo M, 2003, SCAND J MED SCI SPOR, V13, P231, DOI 10.1034/j.1600-0838.2003.00313.x; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Ikram UZ, 2014, EUR J PUBLIC HEALTH, V24, P600, DOI 10.1093/eurpub/ckt136; Joseph A, 2007, ENVIRON BEHAV, V39, P75, DOI 10.1177/0013916506295572; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Karmeniemi M, 2018, ANN BEHAV MED, V52, P239, DOI 10.1093/abm/kax043; Kelly J-F., 2012, SOCIAL CITIES; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Kerr J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0658-4; Killingback C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4049-6; King D, 2008, J AGING PHYS ACTIV, V16, P144, DOI 10.1123/japa.16.2.144; Kirchner CE, 2008, AM J PREV MED, V34, P349, DOI 10.1016/j.amepre.2008.01.005; Kitchen P, 2012, SOC INDIC RES, V107, P103, DOI 10.1007/s11205-011-9830-9; Kleinhans R, 2014, AGEING LONG TERM REG; Kwan RYC, 2019, GERIATR NURS, V40, P320, DOI 10.1016/j.gerinurse.2018.12.011; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; Leach C., 2019, AGING CENTERED OUTRE; Lee C, 2008, BUILD RES INF, V36, P395, DOI 10.1080/09613210802045547; Levy-Storms L, 2018, J AGING PHYS ACTIV, V26, P682, DOI 10.1123/japa.2016-0354; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Lui CW, 2009, AUSTRALAS J AGEING, V28, P116, DOI 10.1111/j.1741-6612.2009.00355.x; Luiu C, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061982; Mathews AE, 2010, J AGING PHYS ACTIV, V18, P119, DOI 10.1123/japa.18.2.119; Menec VH, 2011, CAN J AGING, V30, P479, DOI 10.1017/S0714980811000237; Michael YL, 2006, HEALTH PLACE, V12, P734, DOI 10.1016/j.healthplace.2005.08.002; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Mowen A. J., 2003, Journal of Park and Recreation Administration, V21, P58; Mowen Andrew, 2007, J Phys Act Health, V4, P167; Nieboer AP, 2018, J HAPPINESS STUD, V19, P2405, DOI 10.1007/s10902-017-9923-5; Nitsche B, 2003, ALLOCHTONE OUDEREN W; O'Driscoll T, 2014, J IMMIGR MINOR HEALT, V16, P515, DOI 10.1007/s10903-013-9857-x; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Oedekoven M, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0975-y; Officer A, 2016, B WORLD HEALTH ORGAN, V94, P710, DOI 10.2471/BLT.16.184960; Oudhof K, 2011, OMVANG SPREIDING SUR; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Peace S., 2007, AGEING SOC, P209; Petersson I, 2008, J REHABIL MED, V40, P253, DOI 10.2340/16501977-0160; Pettigrew KE, 2000, LIBR QUART, V70, P47; Piro FN, 2006, J EPIDEMIOL COMMUN H, V60, P626, DOI 10.1136/jech.2005.042697; Plouffe L, 2010, J URBAN HEALTH, V87, P733, DOI 10.1007/s11524-010-9466-0; Prins RG., 2019, NEWROADS WERKBLAD BE; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Rosenbloom S., 2004, TRANSPORTATION AGEND; Rosso Andrea L, 2011, J Aging Res, V2011, P816106, DOI 10.4061/2011/816106; Sales M., 2018, J AGING SOC CHANGE, V8, P61, DOI [10.18848/2576-5310/CGP/v08i01/61-78, DOI 10.18848/2576-5310/CGP/V08I01/61-78]; Short CE, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-25; Smith BJ, 2019, J HUM HYPERTENS, V33, P50, DOI 10.1038/s41371-018-0098-2; Smith M, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0613-9; Stirbu I, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-78; Su CL, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019613; Sugiyama Takemi, 2008, Urban Forestry & Urban Greening, V7, P41, DOI 10.1016/j.ufug.2007.12.002; Sugiyama T, 2007, LANDSCAPE URBAN PLAN, V83, P168, DOI 10.1016/j.landurbplan.2007.04.002; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Swift H.J., 2020, EXPLORING REPRESENTA; Tesch-Romer, 2006, NEW DYNAMICS OLD AGE, P127; Toepoel V, 2013, SOC INDIC RES, V113, P355, DOI 10.1007/s11205-012-0097-6; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19; Uc EY, 2006, ANN NEUROL, V60, P407, DOI 10.1002/ana.20958; Van Cauwenberg J, 2018, SPORTS MED, V48, P1635, DOI 10.1007/s40279-018-0917-1; van de Vijver PL, 2018, TRANSL BEHAV MED, V8, P204, DOI 10.1093/tbm/ibx035; van Dijk Hanna M, 2016, BMC Res Notes, V9, P450; Van Dijk HM, 2015, AGEING SOC, V35, P1771, DOI 10.1017/S0144686X14000622; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0110-3; van Huis M, 2004, MIGRATION 4 LARGEST; van Laer SD, 2018, EUR J PREV CARDIOL, V25, P1914, DOI 10.1177/2047487318803241; Vancampfort D, 2018, INT PSYCHOGERIATR, V30, P705, DOI 10.1017/S1041610217002216; Vancampfort D, 2018, INT J GERIATR PSYCH, V33, pE314, DOI 10.1002/gps.4796; Verest WJGM, 2019, EUR J PUBLIC HEALTH, V29, P687, DOI 10.1093/eurpub/ckz012; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wang Z, 2010, HEALTH PLACE, V16, P1268, DOI 10.1016/j.healthplace.2010.08.015; Ward M, 2020, J AGING PHYS ACTIV, V28, P140, DOI 10.1123/japa.2019-0012; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Westerterp K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P485, DOI 10.1097/00075197-200011000-00011; Wood L, 2010, SOC SCI MED, V70, P1381, DOI 10.1016/j.socscimed.2010.01.021; World Health Organization, 2007, GLOB AG FRIENDL CIT; Wu YT, 2015, J PUBLIC HEALTH-UK, V37, P480, DOI 10.1093/pubmed/fdv050; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022; Yoshida Y, 2020, SOC SCI MED, V253, DOI 10.1016/j.socscimed.2020.112959	152	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261998	10.1371/journal.pone.0261998	http://dx.doi.org/10.1371/journal.pone.0261998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0I4GM	35085282	Green Published, gold			2022-12-26	WOS:000779379600035
J	Melnyk, JE; Steri, V; Nguyen, HG; Hwang, YC; Gordan, JD; Hann, B; Feng, FY; Shokat, KM				Melnyk, James E.; Steri, Veronica; Nguyen, Hao G.; Hwang, Y. Christina; Gordan, John D.; Hann, Byron; Feng, Felix Y.; Shokat, Kevan M.			Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKC beta 1	ONCOGENE			English	Article							ANDROGEN-RECEPTOR; ENZALUTAMIDE RESISTANCE; DOWN-REGULATION; VARIANTS; ENZASTAURIN; EXPRESSION; DOMAIN; PHOSPHORYLATION; OLIGONUCLEOTIDE; ANTIANDROGEN	The androgen receptor (AR) is a central driver of aggressive prostate cancer. After initial treatment with androgen receptor signaling inhibitors (ARSi), reactivation of AR signaling leads to resistance. Alternative splicing of AR mRNA yields the AR-V7 splice variant, which is currently an undruggable mechanism of ARSi resistance: AR-V7 lacks a ligand binding domain, where hormones and anti-androgen antagonists act, but still activates AR signaling. We reveal PKC beta as a druggable regulator of transcription and splicing at the AR genomic locus. We identify a clinical PKC beta inhibitor in combination with an FDA-approved anti-androgen as an approach for repressing AR genomic locus expression, including expression of AR-V7, while antagonizing full-length AR. PKC beta inhibition reduces total AR gene expression, thus reducing AR-V7 protein levels and sensitizing prostate cancer cells to current anti-androgen therapies. We demonstrate that this combination may be a viable therapeutic strategy for AR-V7-positive prostate cancer.	[Melnyk, James E.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Steri, Veronica; Nguyen, Hao G.; Hwang, Y. Christina; Gordan, John D.; Hann, Byron; Feng, Felix Y.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Steri, Veronica; Hann, Byron] Univ Calif San Francisco, Preclin Therapeut Core, San Francisco, CA 94158 USA; [Nguyen, Hao G.; Feng, Felix Y.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Hwang, Y. Christina; Gordan, John D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Hwang, Y. Christina; Gordan, John D.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94158 USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Kevan.shokat@ucsf.edu		Melnyk, James/0000-0003-1915-8089	NIH [1F32CA236347-01, R01 CA227025, 1R01CA221969-01, 1R01CA244550]; PCF YI; Burroughs Wellcome Fund Career Award; Benioff Initiative for Prostate Cancer Research; Howard Hughes Medical Institute; Samuel Waxman Cancer Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCF YI; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Benioff Initiative for Prostate Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Samuel Waxman Cancer Research Foundation	We thank Davide Ruggero, the UCSF Preclinical Therapeutics Core and the UCSF/Gladstone Institutes Thermo Fisher Scientific Proteomics Facility for research assistance and discussion. We thank Amy Crossan, Shizong A. Dai, Douglas Wassarman, and Jack Stevenson for critical reading of this paper. Portions of Fig. 1A and Fig. 6A were created with BioRender.com. This work is supported by NIH grant 1F32CA236347-01 (to J.E.M.); PCF YI and Challenge grants (to H.G.N.); Burroughs Wellcome Fund Career Award (to J.D. G.); NIH R01 CA227025 and the Benioff Initiative for Prostate Cancer Research (to F.Y.F.), the Howard Hughes Medical Institute, Samuel Waxman Cancer Research Foundation, NIH 1R01CA221969-01 and NIH 1R01CA244550 (to K.M.S.).	An SA, 2018, EBIOMEDICINE, V36, P553, DOI 10.1016/j.ebiom.2018.09.005; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Armstrong CM, 2019, ASIAN J UROL, V6, P42, DOI 10.1016/j.ajur.2018.07.003; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Beretta GL, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00369; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bianchini D, 2013, BRIT J CANCER, V109, P2579, DOI 10.1038/bjc.2013.619; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Carabet LA, 2019, MOLECULES, V24, DOI 10.3390/molecules24040763; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; De Mol E, 2016, ACS CHEM BIOL, V11, P2499, DOI 10.1021/acschembio.6b00182; De Velasco MA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122688; Dreicer R, 2013, INVEST NEW DRUG, V31, P1044, DOI 10.1007/s10637-013-9940-0; Dreicer R, 2011, INVEST NEW DRUG, V29, P1441, DOI 10.1007/s10637-010-9428-0; Gao S, 2016, CELL REP, V17, P966, DOI 10.1016/j.celrep.2016.09.064; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Han D, 2019, CANCER RES, V79, P5260, DOI 10.1158/0008-5472.CAN-19-0815; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; HUANG FL, 1989, J BIOL CHEM, V264, P4238; Hwang DJ, 2019, J MED CHEM, V62, P491, DOI 10.1021/acs.jmedchem.8b00973; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Khurana N, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010068; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kwegyir-Afful AK, 2015, ONCOTARGET, V6, P27440, DOI 10.18632/oncotarget.4578; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Li HF, 2014, J MED CHEM, V57, P6458, DOI 10.1021/jm500802j; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Loberg RD, 2006, UROL ONCOL-SEMIN ORI, V24, P161, DOI 10.1016/j.urolonc.2005.11.005; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Maurer U, 2014, J CELL SCI, V127, P1369, DOI 10.1242/jcs.138057; Melnyk JE, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115712; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Ponnusamy S, 2019, CLIN CANCER RES, V25, P6764, DOI 10.1158/1078-0432.CCR-19-1458; Prekovic S, 2016, MOL CANCER THER, V15, P1702, DOI 10.1158/1535-7163.MCT-15-0892; Putney James W, 2012, Adv Biol Regul, V52, P152; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Saha SK, 2016, CANCER DISCOV, V6, P727, DOI 10.1158/2159-8290.CD-15-1442; Salami J, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0105-8; Scher Howard I, 2016, JAMA Oncol, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Shiota M, 2014, CLIN CANCER RES, V20, P951, DOI 10.1158/1078-0432.CCR-13-1809; Thorne CA, 2015, NAT CHEM BIOL, V11, P58, DOI 10.1038/nchembio.1690; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Velez MVL, 2019, ONCOGENE, V38, P3696, DOI 10.1038/s41388-019-0696-7; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Xiao LB, 2018, CANCER RES, V78, P5731, DOI 10.1158/0008-5472.CAN-18-0941; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001; Yang ZY, 2020, MOL CANCER THER, V19, P75, DOI 10.1158/1535-7163.MCT-19-0489; Yu ZY, 2014, CLIN CANCER RES, V20, P1590, DOI 10.1158/1078-0432.CCR-13-1863; Zhang XW, 2017, MOL THER, V25, P79, DOI 10.1016/j.ymthe.2016.10.017	68	0	0	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1536	1549		10.1038/s41388-022-02179-z	http://dx.doi.org/10.1038/s41388-022-02179-z		JAN 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35087237	Green Published, hybrid			2022-12-26	WOS:000749068200001
J	Vinayagam, A; Othman, ML; Veerasamy, V; Balaji, SS; Ramaiyan, K; Radhakrishnan, P; Das Raman, M; Wahab, NIA				Vinayagam, Arangarajan; Othman, Mohammad Lutfi; Veerasamy, Veerapandiyan; Balaji, Suganthi Saravan; Ramaiyan, Kalaivani; Radhakrishnan, Padmavathi; Das Raman, Mohan; Wahab, Noor Izzri Abdul			A random subspace ensemble classification model for discrimination of power quality events in solar PV microgrid power network	PLOS ONE			English	Article							S-TRANSFORM; FAULT-DETECTION; RANDOM FORESTS; DISTURBANCES; RECOGNITION; SYSTEM	This study proposes SVM based Random Subspace (RS) ensemble classifier to discriminate different Power Quality Events (PQEs) in a photovoltaic (PV) connected Microgrid (MG) model. The MG model is developed and simulated with the presence of different PQEs (voltage and harmonic related signals and distinctive transients) in both on-grid and off-grid modes of MG network, respectively. In the pre-stage of classification, the features are extracted from numerous PQE signals by Discrete Wavelet Transform (DWT) analysis, and the extracted features are used to learn the classifiers at the final stage. In this study, first three Kernel types of SVM classifiers (Linear, Quadratic, and Cubic) are used to predict the different PQEs. Among the results that Cubic kernel SVM classifier offers higher accuracy and better performance than other kernel types (Linear and Quadradic). Further, to enhance the accuracy of SVM classifiers, a SVM based RS ensemble model is proposed and its effectiveness is verified with the results of kernel based SVM classifiers under the standard test condition (STC) and varying solar irradiance of PV in real time. From the final results, it can be concluded that the proposed method is more robust and offers superior performance with higher accuracy of classification than kernel based SVM classifiers.	[Vinayagam, Arangarajan; Das Raman, Mohan] New Horizon Coll Engn, Dept Elect & Elect Engn, Bangalore, Karnataka, India; [Othman, Mohammad Lutfi; Wahab, Noor Izzri Abdul] Univ Putra Malaysia UPM, Dept Elect & Elect Engn, Adv Lightning Power & Energy Res ALPER, Seri Kembangan, Selangor, Malaysia; [Veerasamy, Veerapandiyan] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Balaji, Suganthi Saravan] Lebanese French Univ, Coll Engn & Comp Sci, Dept Informat Technol, Erbil, Kurdistan Regio, Iraq; [Ramaiyan, Kalaivani; Radhakrishnan, Padmavathi] Rajalakshmi Engn Coll, Dept Elect & Elect Engn, Chennai, Tamil Nadu, India	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Rajalakshmi Engineering College	Othman, ML (corresponding author), Univ Putra Malaysia UPM, Dept Elect & Elect Engn, Adv Lightning Power & Energy Res ALPER, Seri Kembangan, Selangor, Malaysia.	lutfi@upm.edu.my	, Mohandas/ABB-6048-2020; Othman, Mohammad Lutfi/E-7731-2016	, Mohandas/0000-0003-2768-8442; Othman, Mohammad Lutfi/0000-0003-0382-8666; Veerasamy, Veerapandiyan/0000-0002-7887-2613	Universiti Putra Malaysia (GPB UPM) [UPM/800-3/3/1/GPB/2019/9671700]	Universiti Putra Malaysia (GPB UPM)	This work was supported by the Geran Putra Berimpak from the Universiti Putra Malaysia (GPB UPM) under Grant UPM/800-3/3/1/GPB/2019/9671700. The grant was received by Dr Mohammad Lutfi Othman. The funder had role in designing of novel classifier and helped in drafting the novel methodology in the manuscript.	[Anonymous], 2009, 11592009 IEEE, P1, DOI 10.1109/pes.2009.5275322; Babu NR, 2017, AIN SHAMS ENG J, V8, P103, DOI 10.1016/j.asej.2015.08.005; Bashawyah DA, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON ENVIRONMENT AND ELECTRICAL ENGINEERING AND 2019 IEEE INDUSTRIAL AND COMMERCIAL POWER SYSTEMS EUROPE (EEEIC / I&CPS EUROPE); Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Biswal B, 2013, NEUROCOMPUTING, V103, P75, DOI 10.1016/j.neucom.2012.08.031; Cai KW, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183681; Bravo-Rodriguez JC, 2020, ENERGIES, V13, DOI 10.3390/en13112761; Chakravorti Tatiana, 2019, Renewable Energy Focus, V28, P78, DOI 10.1016/j.ref.2018.12.002; Cheng Reynold., 2014, DATA CLASSIFICATION; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortes-Robles O, 2020, MEASUREMENT, V154, DOI 10.1016/j.measurement.2019.107453; Daho ME, 2015, J MED IMAG HEALTH IN, V5, P539, DOI 10.1166/jmihi.2015.1423; Decanini JGMS, 2011, ELECTR POW SYST RES, V81, P2057, DOI 10.1016/j.epsr.2011.07.018; Dehghani H, 2013, INT J ELEC POWER, V47, P368, DOI 10.1016/j.ijepes.2012.11.005; Dekhandji FZ, 2017, 2017 5TH INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING - BOUMERDES (ICEE-B); Eristi H, 2010, EXPERT SYST APPL, V37, P4094, DOI 10.1016/j.eswa.2009.11.015; Haider NS, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1388-0; Hatziargyriou N., 2014, MICROGRIDS ARCHITECT; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hutter F, 2019, SPRING SER CHALLENGE, P1, DOI 10.1007/978-3-030-05318-5; Janik P, 2006, IEEE T POWER DELIVER, V21, P1663, DOI 10.1109/TPWRD.2006.874114; Kanirajan P, 2015, INT J FUZZY SYST, V17, P623, DOI 10.1007/s40815-015-0045-0; Kiruthiga B, 2020, SOFT COMPUT, V24, P10351, DOI 10.1007/s00500-019-04538-7; Kumar R, 2015, IEEE T IND APPL, V51, P1249, DOI 10.1109/TIA.2014.2356639; Kuncheva LI, 2010, IEEE T MED IMAGING, V29, P531, DOI 10.1109/TMI.2009.2037756; Kuncheva LudmilaI., 2010, INT WORKSH MULT CLAS; Li JM, 2016, IEEE T INSTRUM MEAS, V65, P2302, DOI 10.1109/TIM.2016.2578518; Liu ZG, 2015, IEEE T SMART GRID, V6, P1678, DOI 10.1109/TSG.2015.2397431; Lopez-Fernandez X.M., 2012, COMPEL; Manimala K., 2015, Journal of the Institution of Engineers (India): Series B (Electrical, Electronics & Telecommunication and Computer Engineering), V96, P283, DOI 10.1007/s40031-014-0144-6; Khoa NM, 2020, ENERGIES, V13, DOI 10.3390/en13143623; Mishra M, 2019, INT T ELECTR ENERGY, V29, DOI 10.1002/2050-7038.12008; Ngo T., 2011, ACM SIGSOFT SOFTW EN, V36, P51; Nolasco DHS, 2019, ENG APPL ARTIF INTEL, V85, P284, DOI 10.1016/j.engappai.2019.05.016; Prakash S, 2020, ARAB J SCI ENG, V45, P6297, DOI 10.1007/s13369-020-04378-w; Qu N, 2020, IEEE ACCESS, V8, P87060, DOI 10.1109/ACCESS.2020.2992790; Radhakrishnan P, 2021, MEASUREMENT, V175, DOI 10.1016/j.measurement.2021.109025; Ranjbar S, 2020, INT T ELECTR ENERGY, V30, DOI 10.1002/2050-7038.12274; Ray PK, 2019, OPTIK, V180, P691, DOI 10.1016/j.ijleo.2018.11.041; Reddy MV, 2018, IEEE T INSTRUM MEAS, V67, P78, DOI 10.1109/TIM.2017.2761239; Reddy MV, 2016, ELECTR POW SYST RES, V134, P66, DOI 10.1016/j.epsr.2016.01.003; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Sammut C., 2011, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8-469, DOI 10.1007/978-0-387-30164-8_469, DOI 10.1007/978-0-387-30164-8469]; Santoso S, 2000, IEEE T POWER DELIVER, V15, P247, DOI 10.1109/61.847259; Silva LOLA, 2013, COMPUT ELECTRON AGR, V97, P47, DOI 10.1016/j.compag.2013.07.001; Singh OJ, 2019, AUTOMATIKA, V60, P11, DOI 10.1080/00051144.2019.1565337; Skurichina M, 2002, PATTERN ANAL APPL, V5, P121, DOI 10.1007/s100440200011; Szmajda M, 2007, PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON ELECTRICAL POWER QUALITY AND UTILISATION, VOLS 1 AND 2, P300; Tharwat A, 2019, KNOWL INF SYST, V61, P1269, DOI 10.1007/s10115-019-01335-4; Thirumala K, 2019, NEUROCOMPUTING, V334, P265, DOI 10.1016/j.neucom.2019.01.038; Tun TP, 2021, 2021 56TH INTERNATIONAL UNIVERSITIES POWER ENGINEERING CONFERENCE (UPEC 2021): POWERING NET ZERO EMISSIONS, DOI 10.1109/UPEC50034.2021.9548222; Vapnik V., 2013, NATURE STAT LAERNING; Veerasamy V, 2020, INT T ELECTR ENERGY, V30, DOI 10.1002/2050-7038.12378; Veerasamy V, 2019, NEURAL COMPUT APPL, V31, P9127, DOI 10.1007/s00521-019-04445-w; Vinayagam A, 2021, APPL SOFT COMPUT, V106, DOI 10.1016/j.asoc.2021.107294; Wang JD, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112315; Wang YQ, 2019, J ENG-JOE, P5284, DOI 10.1049/joe.2018.9362; Wilkinson WA, 1996, IEEE T POWER SYST, V11, P2038, DOI 10.1109/59.544682; Yaman MA, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10110651; Yang LY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4596326; Zhao CHH, 2013, NEURAL COMPUT APPL, V22, pS175, DOI 10.1007/s00521-012-1057-4; Zhao LQ, 2019, J INF PROCESS SYST, V15, P422, DOI 10.3745/JIPS.04.0112; Zhou Luowei, 2011, Proceedings of the CSEE, V31, P45; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799	64	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262570	10.1371/journal.pone.0262570	http://dx.doi.org/10.1371/journal.pone.0262570			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085307	gold, Green Published			2022-12-26	WOS:000779379600065
J	Kawase, N; Sugihara, A; Kajiwara, K; Hiroshima, M; Akamatsu, K; Nada, S; Matsumoto, K; Ueda, M; Okada, M				Kawase, Naoyuki; Sugihara, Atsuya; Kajiwara, Kentaro; Hiroshima, Michio; Akamatsu, Kanako; Nada, Shigeyuki; Matsumoto, Kunio; Ueda, Masahiro; Okada, Masato			SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN-1; PLECKSTRIN HOMOLOGY DOMAIN; NUCLEOTIDE EXCHANGE FACTOR; RECEPTOR; EXPRESSION; CARCINOMA; INVASION; RAC	Cancer invasion and metastasis are the major causes of cancer patient mortality. Various growth factors, including hepatocyte growth factor (HGF), are known to promote cancer invasion and metastasis, but the regulatory mechanisms involved are not fully understood. Here, we show that HGF-promoted migration and invasion of breast cancer cells are regulated by CUB domain-containing protein 1 (CDCP1), a transmembrane activator of SRC kinase. In metastatic human breast cancer cell line MDA-MB-231, which highly expresses the HGF receptor MET and CDCP1, we show that CDCP1 knockdown attenuated HGF-induced MET activation, followed by suppression of lamellipodia formation and cell migration/invasion. In contrast, in the low invasive/nonmetastatic breast cancer cell line T47D, which had no detectable MET and CDCP1 expression, ectopic MET expression stimulated the HGF-dependent activation of invasive activity, and concomitant CDCP1 expression activated SRC and further promoted invasive activity. In these cells, CDCP1 expression dramatically activated HGF-induced membrane remodeling, which was accompanied by activation of the small GTPase Racl. Analysis of guanine nucleotide exchange factors revealed that ARHGEF7 was specifically required for CDCP1-dependent induction of HGF-induced invasive ability. Furthermore, immunofluorescence staining demonstrated that CDCP1 coaccumulated with ARHGEF7. Finally, we confirmed that the CDCP1-SRC axis was also crucial for HGF and ARHGEF7RAC1 signaling in MDA-MB-231 cells. Altogether, these results demonstrate that the CDCP1-SRC-ARHGEF7-RAC1 pathway plays an important role in the HGF-induced invasion of a subset of breast cancer cells.	[Kawase, Naoyuki; Sugihara, Atsuya; Kajiwara, Kentaro; Akamatsu, Kanako; Nada, Shigeyuki; Okada, Masato] Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka, Japan; [Hiroshima, Michio; Ueda, Masahiro] RIKEN, Ctr Biosyst Dynam Res, Lab Cell Signaling Dynam, Suita, Osaka, Japan; [Akamatsu, Kanako; Okada, Masato] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Oncogene Res, Suita, Osaka, Japan; [Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa, Japan; [Ueda, Masahiro] Osaka Univ, Grad Sch Frontier Biosci, Lab Single Mol Biol, Suita, Osaka, Japan; [Okada, Masato] Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Osaka, Japan	Osaka University; RIKEN; Osaka University; Kanazawa University; Osaka University; Osaka University	Okada, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka, Japan.; Okada, M (corresponding author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Oncogene Res, Suita, Osaka, Japan.; Okada, M (corresponding author), Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Osaka, Japan.	okadam@biken.osaka-u.ac.jp		Nada, Shigeyuki/0000-0002-1103-6119; Kajiwara, Kentaro/0000-0001-7574-4010; Ueda, Masahiro/0000-0002-9354-3404	JPSP KAKENHI [19H03504, 19H04962, 19K07639]	JPSP KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JPSP KAKENHI (Grant numbers 19H03504 and 19H04962 to M. O., 19K07639, to K. K.).	Alajati A, 2015, CELL REP, V11, P564, DOI 10.1016/j.celrep.2015.03.044; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Campa F, 2006, CELL RES, V16, P759, DOI 10.1038/sj.cr.7310091; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Clague MJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002422; Comoglio PM, 2018, NAT REV CANCER, V18, P341, DOI 10.1038/s41568-018-0002-y; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; He Y, 2016, ONCOGENE, V35, P468, DOI 10.1038/onc.2015.101; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Kajiwara K, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000832; Koh CG, 2001, J CELL SCI, V114, P4239; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; Leroy C, 2015, ONCOGENE, V34, P5593, DOI 10.1038/onc.2015.19; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Matsumoto K, 2017, CANCER SCI, V108, P296, DOI 10.1111/cas.13156; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Munoz-Bellvis L, 2012, MODERN PATHOL, V25, P590, DOI 10.1038/modpathol.2011.195; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Omelchenko T, 2014, GENE DEV, V28, P2764, DOI 10.1101/gad.251371.114; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turdo F, 2016, ONCOTARGET, V7, P69649, DOI 10.18632/oncotarget.11935; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wang H, 2014, ONCOGENE, V33, P1558, DOI 10.1038/onc.2013.97; Weidner C, 1999, J NEUROSCI, V19, P10184; Wright HJ, 2016, ONCOGENE, V35, P4762, DOI 10.1038/onc.2016.7	41	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101630	10.1016/j.jbc.2022.101630	http://dx.doi.org/10.1016/j.jbc.2022.101630			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35085554	Green Published, gold			2022-12-26	WOS:000821051800012
J	Mizuno, T; Satoh, N; Horita, S; Tsukada, H; Takagi, M; Sato, Y; Kume, H; Nangaku, M; Nakamura, M				Mizuno, Tomohito; Satoh, Nobuhiko; Horita, Shoko; Tsukada, Hiroyuki; Takagi, Mayuko; Sato, Yusuke; Kume, Haruki; Nangaku, Masaomi; Nakamura, Motonobu			Oxidized alkyl phospholipids stimulate sodium transport in proximal tubules via a nongenomic PPAR gamma-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; BICARBONATE REABSORPTION; BIPHASIC REGULATION; HEART-FAILURE; FATTY-ACIDS; IN-VIVO; MECHANISMS; LIGANDS; NHE3; ROSIGLITAZONE	Oxidized phospholipids have been shown to exhibit pleiotropic effects in numerous biological contexts. For example, 1-O-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine (azPC), an oxidized phospholipid formed from alkyl phosphatidylcholines, is a peroxisome proliferator-activated receptor gamma (PPAR gamma) nuclear receptor agonist. Although it has been reported that PPAR gamma agonists including thiazolidinediones can induce plasma volume expansion by enhancing renal sodium and water retention, the role of azPC in renal transport functions is unknown. In the present study, we investigated the effect of azPC on renal proximal tubule (PT) transport using isolated PTs and kidney cortex tissues and also investigated the effect of azPC on renal sodium handling in vivo. We showed using a microperfusion technique that azPC rapidly stimulated Na+/HCO3- cotransporter 1 (NBCe1) and luminal Na+/H+ exchanger (NHE) activities in a dose-dependent manner at submicromolar concentrations in isolated PTs from rats and humans. The rapid effects (within a few minutes) suggest that azPC activates NBCe1 and NHE via nongenomic signaling. The stimulatory effects were completely blocked by specific PPAR gamma antagonist GW9662, ERK kinase inhibitor PD98059, and CD36 inhibitor sulfosuccinimidyl oleate. Treatment with an siRNA against PPAR gamma completely blocked the stimulation of both NBCe1 and NHE by azPC. Moreover, azPC induced ERK phosphorylation in rat and human kidney cortex tissues, which were completely suppressed by GW9662 and PD98059 treatments. These results suggest that azPC stimulates renal PT sodium-coupled bicarbonate transport via a CD36/PPAR gamma/ mitogen-activated protein/ERK kinase/ERK pathway. We conclude that the stimulatory effects of azPC on PT transport may be partially involved in volume expansion.	[Mizuno, Tomohito; Satoh, Nobuhiko; Horita, Shoko; Tsukada, Hiroyuki; Takagi, Mayuko; Nangaku, Masaomi; Nakamura, Motonobu] Univ Tokyo, Div Nephrol & Endocrinol, Tokyo, Japan; [Sato, Yusuke; Kume, Haruki] Univ Tokyo, Dept Urol, Tokyo, Japan	University of Tokyo; University of Tokyo	Nakamura, M (corresponding author), Univ Tokyo, Div Nephrol & Endocrinol, Tokyo, Japan.	nakamura-stm@umin.ac.jp	Horita, Shoko/AFK-0949-2022	Horita, Shoko/0000-0003-2103-3605; zhong cun, yuan xin/0000-0002-5379-4305; Nangaku, Masaomi/0000-0001-7401-2934	Daiichi Sankyo Co, Ltd [A20-1972]; Japan Society for the Promotion of Science KAKENHI [19K08671, 19K17698]	Daiichi Sankyo Co, Ltd(Daiichi Sankyo Company Limited); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Dr Masashi Suzuki for helpful discussions on this work. The study was supported by Daiichi Sankyo Co, Ltd (grant number: A20-1972) and Japan Society for the Promotion of Science KAKENHI (grant numbers: 19K08671 and 19K17698) .	Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Bailey MA, 2004, AM J PHYSIOL-RENAL, V287, pF789, DOI 10.1152/ajprenal.00033.2004; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Cantini G, 2010, EUR J CELL BIOL, V89, P645, DOI 10.1016/j.ejcb.2010.04.002; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Choi JY, 2000, J CLIN INVEST, V105, P1141, DOI 10.1172/JCI9260; Chou TC, 2014, BIOMEDICINE-TAIWAN, V4, P17, DOI 10.7603/s40681-014-0024-z; Collino M, 2005, KIDNEY INT, V68, P529, DOI 10.1111/j.1523-1755.2005.00430.x; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Davidson MA, 2018, CRIT REV TOXICOL, V48, P52, DOI 10.1080/10408444.2017.1351420; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Endo Y, 2011, CELL METAB, V13, P550, DOI 10.1016/j.cmet.2011.02.015; Frey B, 2000, J LIPID RES, V41, P1145; Gao X, 2014, INT J MOL MED, V34, P564, DOI 10.3892/ijmm.2014.1799; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Greig FH, 2012, FREE RADICAL BIO MED, V52, P266, DOI 10.1016/j.freeradbiomed.2011.10.481; Griggs RB, 2015, PAIN, V156, P469, DOI 10.1097/01.j.pain.0000460333.79127.be; Guo YM, 2017, J AM SOC NEPHROL, V28, P2409, DOI 10.1681/ASN.2016080930; Horita S, 2002, HYPERTENSION, V40, P707, DOI 10.1161/01.HYP.0000036449.70110.DE; Horita S, 2015, PPAR RES, V2015, DOI 10.1155/2015/646423; Hsueh WA, 2001, DIABETES CARE, V24, P392, DOI 10.2337/diacare.24.2.392; Hua W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127507; Johnstone SR, 2009, AM J PATHOL, V175, P916, DOI 10.2353/ajpath.2009.090160; Komajda M, 2010, EUR HEART J, V31, P824, DOI 10.1093/eurheartj/ehp604; Kurtz I, 2014, COMPR PHYSIOL, V4, P1737, DOI 10.1002/cphy.c140021; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Li XC, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0668-z; Li Y, 2008, J AM SOC NEPHROL, V19, P252, DOI 10.1681/ASN.2007030289; Lo YF, 2011, KIDNEY INT, V79, P730, DOI 10.1038/ki.2010.523; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Marion-Letellier R, 2016, EUR J PHARMACOL, V785, P44, DOI 10.1016/j.ejphar.2015.11.004; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Moraes LA, 2010, J THROMB HAEMOST, V8, P577, DOI 10.1111/j.1538-7836.2009.03732.x; Morita H, 1998, J CARDIOVASC PHARM, V31, pS557, DOI 10.1097/00005344-199800001-00161; Muto S, 2001, EXP NEPHROL, V9, P191; Nakamura M, 2020, PHYSIOL INT, V107, P376, DOI 10.1556/2060.2020.00030; Nakamura M, 2020, KIDNEY INT, V97, P316, DOI 10.1016/j.kint.2019.08.021; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Pan WH, 1997, STROKE, V28, P88, DOI 10.1161/01.STR.28.1.88; Papageorgiou E, 2008, MOL MED, V14, P403, DOI 10.2119/2008-00021.Papageorgiou; Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071; Parker MD, 2015, CELL MOL LIFE SCI, V72, P2061, DOI 10.1007/s00018-015-1848-8; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Pinto V, 2008, MOL CELL BIOCHEM, V310, P191, DOI 10.1007/s11010-007-9680-6; Pontsler AV, 2002, J BIOL CHEM, V277, P13029, DOI 10.1074/jbc.M109546200; Prevoo B, 2011, J PHARMACOL EXP THER, V338, P362, DOI 10.1124/jpet.111.179689; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Saad S, 2009, NEPHROL DIAL TRANSPL, V24, P1130, DOI 10.1093/ndt/gfn614; Sato K, 2004, HYPERTENS RES, V27, P417, DOI 10.1291/hypres.27.417; Satoh N, 2016, PFLUG ARCH EUR J PHY, V468, P1183, DOI 10.1007/s00424-016-1808-7; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shirai A, 2014, J AM SOC NEPHROL, V25, P1523, DOI 10.1681/ASN.2013060596; Soi V, 2017, ADV CHRONIC KIDNEY D, V24, P325, DOI 10.1053/j.ackd.2017.08.001; Song J, 2004, J PHARMACOL EXP THER, V308, P426, DOI 10.1124/jpet.103.058008; Thornell IM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00166; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; Wang T, 2001, AM J PHYSIOL-RENAL, V281, pF1117, DOI 10.1152/ajprenal.2001.281.6.F1117; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Yamada Hideomi, 1996, American Journal of Physiology, V271, pF1068; Yang XC, 2017, NAT REV NEPHROL, V13, P769, DOI 10.1038/nrneph.2017.126; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhang QW, 2005, J BIOL CHEM, V280, P73, DOI 10.1074/jbc.M409795200; Zheng YN, 2005, J AM SOC NEPHROL, V16, P2288, DOI 10.1681/ASN.2005020193; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061; Ziegler T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010050	71	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101681	10.1016/j.jbc.2022.101681	http://dx.doi.org/10.1016/j.jbc.2022.101681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124009	gold, Green Published			2022-12-26	WOS:000789400700004
J	Govers, LL; Heusinkveld, JHT; Grafnings, MLE; Smeele, Q; van der Heide, T				Govers, Laura L.; Heusinkveld, Jannes H. T.; Graefnings, Max L. E.; Smeele, Quirin; van der Heide, Tjisse			Adaptive intertidal seed-based seagrass restoration in the Dutch Wadden Sea	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CHESAPEAKE BAY; ARENICOLA-MARINA; SEDIMENT TYPE; GERMINATION; DENSITY; L.; DISPERSAL; ECOSYSTEM; SALINITY	Seagrasses form the foundation of many coastal ecosystems but are rapidly declining on a global scale. The Dutch Wadden Sea once supported extensive subtidal seagrass meadows that have all disappeared. Here, we report on the setbacks and successes of intertidal seed-based restoration experiments in the Dutch Wadden Sea between 2014-2017. Our main goals were to 1) optimize plant densities, and 2) reduce seed losses. To achieve our goals, we conducted research-based, adaptive seagrass (Zostera marina) restoration, adjusting methods yearly based on previous results. We applied various seeding methods in three subsequent years-from Buoy Deployed Seeding (BuDS), and 'BuDS-in-frame' in fall, to a newly developed 'Dispenser Injection Seeding' (DIS) method. Our adaptive experimental approach revealed high seed losses between seeding and seedling establishment of the BuDS methods (>99.9%), which we mitigated by controlled harvest and storage of seeds throughout fall and winter, followed by DIS-seeding in spring. These iterative innovations resulted in 83 times higher plant densities in the field (0.012 to 1.00 plants m(-2)) and a small reduction in seed loss (99.94 to 99.75%) between 2015-2017. Although these developments have not yet resulted in self-sustaining seagrass populations, we are one step closer towards upscaling seagrass restoration in the Dutch Wadden Sea. Our outcomes suggest that an iterative, research-based restoration approach that focuses on technological advancement of precision-seeding may result in advancing knowledge and improved seed-based seagrass restoration successes.	[Govers, Laura L.; Graefnings, Max L. E.; van der Heide, Tjisse] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands; [Govers, Laura L.; van der Heide, Tjisse] Radboud Univ Nijmegen, Inst Water & Wetland Res IWWR, Dept Aquat Ecol & Environm Biol, Nijmegen, Netherlands; [Govers, Laura L.; van der Heide, Tjisse] Royal NIOZ, Dept Coastal Syst, Den Burg, Netherlands; [Govers, Laura L.; van der Heide, Tjisse] Univ Utrecht, Den Burg, Netherlands; [Heusinkveld, Jannes H. T.] Fieldwork Co, Groningen, Netherlands; [Smeele, Quirin] Natuurmonumenten, Paterswolde, Netherlands	University of Groningen; Radboud University Nijmegen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Grafnings, MLE (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands.	m.l.e.grafnings@rug.nl	van der Heide, Tjisse/M-3000-2013	Grafnings, Max/0000-0002-8463-876X	Waddenfonds; NWO VENI grant [016. veni.181.087]; H2020 European Research Council [689518]	Waddenfonds; NWO VENI grant; H2020 European Research Council	This study has been financially supported by Waddenfonds. Grant name:"Zeegras: herstel van een biobouwer I & II"(https://waddenfonds.nl/).LLG was supported by NWO VENI grant 016. veni.181.087. TvdH was funded by H2020 European Research Council (Grant agreement ID: 689518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BATCHELER C. L., 1970, Proceedings of the New Zealand Ecological Society, V17, P111; Batcheler C.L., 1973, Proceedings of the New Zealand Ecological Society, V20, P131; Bayraktarov E, 2016, ECOL APPL, V26, P1055, DOI 10.1890/15-1077; Bos AR, 2007, MAR ECOL PROG SER, V336, P121, DOI 10.3354/meps336121; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; Busch KE, 2010, RESTOR ECOL, V18, P490, DOI 10.1111/j.1526-100X.2010.00690.x; Carr J, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001103; Compton TJ, 2013, J SEA RES, V82, P103, DOI 10.1016/j.seares.2013.02.002; de Jong DJ., 2005, KANSENKAART ZEEGRAS; de los Santos CB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11340-4; DECOCK AWAM, 1980, AQUAT BOT, V9, P201, DOI 10.1016/0304-3770(80)90023-6; Delefosse M, 2012, J SEA RES, V71, P41, DOI 10.1016/j.seares.2012.04.006; den Hartog C., 1975, AQUAT BOT, V1, P141, DOI DOI 10.1016/0304-3770(75)90019-4; Dolch T., 2017, WADDEN SEA QUALITY S; Dolch T, 2013, J SEA RES, V82, P134, DOI 10.1016/j.seares.2012.04.007; Dunic JC, 2021, GLOBAL CHANGE BIOL, V27, P4096, DOI 10.1111/gcb.15684; Erftemeijer PLA, 2008, MAR ECOL PROG SER, V358, P115, DOI 10.3354/meps07304; Erftemeijer PLA., 2004, HERSTEL ZEEGRASVELDE; Erftemeijer PLA., 2010, DELTARES; Eriander L, 2016, J EXP MAR BIOL ECOL, V479, P76, DOI 10.1016/j.jembe.2016.03.005; Eriksson BK, 2010, ECOSYSTEMS, V13, P752, DOI 10.1007/s10021-010-9352-3; Floor JR, 2018, OCEAN COAST MANAGE, V157, P227, DOI 10.1016/j.ocecoaman.2018.02.016; Folmer EO, 2016, J APPL ECOL, V53, P1800, DOI 10.1111/1365-2664.12681; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Fraser MW, 2014, J ECOL, V102, P1528, DOI 10.1111/1365-2745.12300; Furman BT, 2015, LIMNOL OCEANOGR, V60, P584, DOI 10.1002/lno.10043; GIESEN WBJT, 1990, NETH J SEA RES, V25, P395, DOI 10.1016/0077-7579(90)90047-K; Golden RR, 2010, RESTOR ECOL, V18, P501, DOI 10.1111/j.1526-100X.2010.00691.x; Govers LL, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43172; Govers LL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0812; Granger SL., 2000, BIOL MAR MEDITERR, V7, P55; Green E.P., 2003, WORLD ATLAS SEAGRASS; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Infantes E, 2018, AQUAT BOT, V144, P9, DOI 10.1016/j.aquabot.2017.10.002; Infantes E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168128; Infantes E, 2016, MAR ECOL PROG SER, V546, P31, DOI 10.3354/meps11615; Keeneleyside KA., 2012, ECOLOGICAL RESTORATI, DOI [10.25607/OBP-171, DOI 10.25607/OBP-171]; Kuusemae K, 2018, ECOL MODEL, V371, P60, DOI 10.1016/j.ecolmodel.2018.01.001; Liu YL, 2016, ACTA OCEANOL SIN, V35, P99, DOI 10.1007/s13131-016-0866-1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marion SR, 2010, RESTOR ECOL, V18, P514, DOI 10.1111/j.1526-100X.2010.00692.x; Maxwell PS, 2017, BIOL REV, V92, P1521, DOI 10.1111/brv.12294; Ort BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089316; Orth RJ, 2003, MAR ECOL PROG SER, V250, P71, DOI 10.3354/meps250071; Orth RJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc6434; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Orth RJ, 2012, MAR ECOL PROG SER, V448, P177, DOI 10.3354/meps09522; Orth RJ, 2009, AQUAT BOT, V90, P204, DOI 10.1016/j.aquabot.2008.07.004; Palmer MA., 2016, RESTORATION SFE, V2nd ed; Paulo D, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00052; Pereda-Briones L, 2018, MAR ECOL PROG SER, V593, P47, DOI 10.3354/meps12518; PHILIPPART CJM, 1994, MAR ECOL PROG SER, V111, P251, DOI 10.3354/meps111251; Pickerell CH, 2005, ECOL ENG, V25, P127, DOI 10.1016/j.ecoleng.2005.03.005; Pranger DP., 2014, ZEEGRASKARTERING MWT, DOI [10.3109/09638288.2014.947441, DOI 10.3109/09638288.2014.947441]; Rempel RS, 2012, CAN J FOREST RES, V42, P2052, DOI 10.1139/x2012-146; Reusch TBH, 2003, J ECOL, V91, P610, DOI 10.1046/j.1365-2745.2003.00787.x; Reynolds LK, 2013, J ECOL, V101, P1288, DOI 10.1111/1365-2745.12116; Statton J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13833-y; Suykerbuyk W., 2018, J APPL ECOL; Suykerbuyk W, 2016, ECOSYSTEMS, V19, P296, DOI 10.1007/s10021-015-9932-3; Tan YM, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00617; Tolman ME., 2011, EGG CONSULT PRANGER; Valdemarsen T, 2011, J EXP MAR BIOL ECOL, V410, P45, DOI 10.1016/j.jembe.2011.10.006; van Beusekom JEE, 2017, WADDEN SEA QUALITY S; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van Duren L., 2015, DELTARES; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; van Katwijk MM, 2016, J APPL ECOL, V53, P567, DOI 10.1111/1365-2664.12562; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; van Katwijk MM, 2004, AQUAT BOT, V80, P1, DOI 10.1016/j.aquabot.2004.04.003; van Katwijk MM, 1998, AQUAT BOT, V60, P283, DOI 10.1016/S0304-3770(98)00053-9; Wang M, 2016, AQUAT BOT, V134, P68, DOI 10.1016/j.aquabot.2016.07.003; Wang ZB, 2012, OCEAN COAST MANAGE, V68, P39, DOI 10.1016/j.ocecoaman.2011.12.022; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wolff WJ., 1983, ECOLOGY WADDEN SEA A; Xu SC, 2016, PEERJ, V4, DOI 10.7717/peerj.2697; Yang CJ, 2016, ECOL ENG, V92, P1, DOI 10.1016/j.ecoleng.2016.03.039; Zhao JS, 2016, BOT MAR, V59, P259, DOI 10.1515/bot-2016-0028	80	2	2	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262845	10.1371/journal.pone.0262845	http://dx.doi.org/10.1371/journal.pone.0262845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139086	gold, Green Published			2022-12-26	WOS:000821499100013
J	van Hout, D; Hutchinson, P; Wanat, M; Pilbeam, C; Goossens, H; Anthierens, S; Tonkin-Crine, S; Gobat, N				van Hout, Denise; Hutchinson, Paul; Wanat, Marta; Pilbeam, Caitlin; Goossens, Herman; Anthierens, Sibyl; Tonkin-Crine, Sarah; Gobat, Nina			The experience of European hospital-based health care workers on following infection prevention and control procedures and their wellbeing during the first wave of the COVID-19 pandemic	PLOS ONE			English	Article								Background Working under pandemic conditions exposes health care workers (HCWs) to infection risk and psychological strain. A better understanding of HCWs' experiences of following local infection prevention and control (IPC) procedures during COVID-19 is urgently needed to inform strategies for protecting the psychical and psychological health of HCWs. The objective of this study was therefore to capture the perceptions of hospital HCWs on local IPC procedures and the impact on their emotional wellbeing during the first wave of the COVID-19 pandemic in Europe. Methods Participants were recruited in two sampling rounds of an international cross-sectional survey. Sampling took place between 31 March and 17 April 2020 via existing research networks and between 14 May and 31 August 2020 via online convenience sampling. Main outcome measures were behavioural determinants of HCWs' adherence to IPC guidelines and the WHO-5 Well-Being Index, a validated scale of 0-100 reflecting emotional wellbeing. The WHO-5 was interpreted as a score below or above 50 points, a cut-off score used in previous literature to screen for depression. Results 2289 HCWs from 40 countries in Europe participated. Mean age was 42 (+/- 11) years, 66% were female, 47% and 39% were medical doctors and nurses, respectively. 74% (n = 1699) of HCWs were directly treating patients with COVID-19, of which 32% (n = 527) reported they were fearful of caring for these patients. HCWs reported high levels of concern about COVID-19 infection risk to themselves (71%) and their family (82%) as a result of their job. 40% of HCWs considered that getting infected with COVID-19 was not within their control. This feeling was more common among junior than senior HCWs (46% versus 38%, P value < .01). Sufficient COVID-19-specific IPC training, confidence in PPE use and institutional trust were positively associated with the feeling that becoming infected with COVID-19 was within their control. Female HCWs were more likely than males to report a WHO-5 score below 50 points (aOR 1.5 (95% confidence interval (CI) 1.2-1.8). Conclusions In Europe, the COVID-19 pandemic has had a differential impact on those providing direct COVID-19 patient care, junior staff and women. Health facilities must be aware of these differential impacts, build trust and provide tailored support for this vital workforce during the current COVID-19 pandemic.	[van Hout, Denise] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Hutchinson, Paul] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Wanat, Marta; Pilbeam, Caitlin; Tonkin-Crine, Sarah; Gobat, Nina] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Goossens, Herman] Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, Antwerp, Belgium; [Anthierens, Sibyl] Univ Antwerp, Dept Family Med & Populat Hlth FAMPOP, Antwerp, Belgium; [Tonkin-Crine, Sarah] Univ Oxford, Natl Inst Hlth Res Hlth Protect Res Unit Healthca, Oxford, England; [van Hout, Denise] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Tulane University; University of Oxford; University of Antwerp; University of Antwerp; University of Oxford; Netherlands National Institute for Public Health & the Environment	van Hout, D (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; van Hout, D (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands.	denise.van.hout@rivm.nl	Pilbeam, Caitlin/HHN-8536-2022	Pilbeam, Caitlin/0000-0001-7247-7674; van Hout, Denise/0000-0003-0579-8149; Anthierens, Sibyl/0000-0003-4762-1907	EU [101003589]; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford; Public Health England (PHE)	EU(European Commission); NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford; Public Health England (PHE)	This manuscript is part of the output from RECOVER (Rapid European COVID-19 Emergency research Response), which has received funding from the EU Horizon 2020 research and innovation programme (grant agreement number 101003589). The funder had no role in the writing of the manuscript or the decision to submit for publication. STC received additional funding from the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health and Social Care, or PHE.	50/50 GH, 2019, GLOB HLTH 50 50 2019; [Anonymous], 2020, R D BLU PERC HEALTHC; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Azcona G., 2020, SPOTLIGHT GENDER COV; Bielicki JA, 2020, LANCET INFECT DIS, V20, pE261, DOI 10.1016/S1473-3099(20)30458-8; Brooks SK, 2018, J OCCUP ENVIRON MED, V60, P248, DOI 10.1097/JOM.0000000000001235; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Collantoni E, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071465; Denning M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0238666; Du J, 2020, GEN HOSP PSYCHIAT, V67, P144, DOI 10.1016/j.genhosppsych.2020.03.011; Freimuth VS, 2014, J HEALTH COMMUN, V19, P321, DOI 10.1080/10810730.2013.811323; Gee Stephanie, 2017, Glob Health Res Policy, V2, P21, DOI 10.1186/s41256-017-0042-y; Gorini A, 2020, ARCH PSYCHIAT NURS, V34, P537, DOI 10.1016/j.apnu.2020.10.007; Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582; Imai T, 2005, EMERG INFECT DIS, V11, P404; Jonsdottir IH, 2021, J PUBLIC HEALTH RES, V10, DOI 10.4081/jphr.2021.2329; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Man MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134899; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; Matsuo T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17271; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Patel RS, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8110098; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Sikkema RS, 2020, LANCET INFECT DIS, V20, P1273, DOI 10.1016/S1473-3099(20)30527-2; Southwick FS, 2018, JAMA PSYCHIAT, V75, P665, DOI 10.1001/jamapsychiatry.2018.0566; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Gonzalez-Gil MT, 2021, INTENS CRIT CARE NUR, V62, DOI 10.1016/j.iccn.2020.102966; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; United Nations Statistics DivisionStandard, COUNTR AR COD CLASS; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; WHO, 2020, RAT US PERS PROT EQ; WHO) WHO. World Health Organization, 2020, INF PREV CONTR HLTH, Vfirst; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639	42	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0245182	10.1371/journal.pone.0245182	http://dx.doi.org/10.1371/journal.pone.0245182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130294	Green Published, gold			2022-12-26	WOS:000805530700001
J	Aller, SG; Segrest, JP				Aller, Stephen G.; Segrest, Jere P.			The regulatory domains of the lipid exporter ABCA1 form domain swapped latches	PLOS ONE			English	Article							BINDING CASSETTE DIMER; CRYSTAL-STRUCTURE; MALTOSE TRANSPORTER; STRUCTURAL BASIS; MOLECULAR-PROPERTIES; RECEPTOR; COMPLEX; INTERMEDIATE; TOOLS; MODEL	ABCA1 and ABCA4 are enigmatic because they transport substrates in opposite directions yet share >50% amino acid identity. ABCA4 imports lipid conjugates but ABCA1 exports lipids. Both hydrolyze ATP to drive transport, and both contain cytoplasmic regulatory domains (RDs) following nucleotide-binding domains (NBDs) in the primary structure. The tertiary structures of several ABC importers, including ABCA4, show that each RD forms a domain-swapped latch that locks onto the opposing RD and holds the NBDs close together. Crucially, sequences encoding the RDs and their bridges are among the most conserved in the entire ABC-A subfamily. In the original cryo-EM structure of ABCA1, the RDs were modeled without crossover. After close inspection of that cryo-EM density map and the recent structure of ABCA4, we propose that the RDs of ABCA1 also form a domain-swapped latch. A refined ABCA1 model containing latches exhibited significantly improved overall protein geometry. Critically, the conserved crossover sequence leading to the RD-domain swap is directly supported by the original cryo-EM density map of ABCA1 and appears to have been overlooked. Our refined ABCA1 model suggests the possibility that ABCA1, despite being an exporter, has highly restrained NBDs that suggest a transport mechanism that is distinct from 'alternating access'.	[Aller, Stephen G.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA; [Segrest, Jere P.] Vanderbilt Univ, Div Cardiovasc Med, Dept Med, Med Ctr, Nashville, TN USA	University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Aller, SG (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA.	sgaller@uab.edu		Aller, Stephen/0000-0003-0379-5534	NIH [P01HL128203]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH grant P01HL128203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bhanot S, 2021, AM J PHYSIOL-CELL PH, V320, pC892, DOI 10.1152/ajpcell.00481.2020; Bickers SC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025853118; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Liu FY, 2021, ELIFE, V10, DOI 10.7554/eLife.63524; Liu FJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9833; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Molday RS, 2015, PROG MOL BIOL TRANSL, V134, P415, DOI 10.1016/bs.pmbts.2015.06.008; Naoe Y, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms13411; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Qian HW, 2017, CELL, V169, P1228, DOI 10.1016/j.cell.2017.05.020; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sikkema HR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd7697; Stockner T, 2020, FEBS LETT, V594, P3815, DOI 10.1002/1873-3468.13997; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thomas C, 2020, FEBS LETT, V594, P3767, DOI 10.1002/1873-3468.13935; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Wang ZM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay7997; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Xie T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24194-6; Yu J, 2015, P NATL ACAD SCI USA, V112, P5243, DOI 10.1073/pnas.1415037112	43	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262746	10.1371/journal.pone.0262746	http://dx.doi.org/10.1371/journal.pone.0262746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120130	Green Published, gold			2022-12-26	WOS:000789273600013
J	Aslam, S; Khan, SH; Ahmad, A; Walawage, SL; Dandekar, AM				Aslam, Sabin; Khan, Sultan Habibullah; Ahmad, Aftab; Walawage, Sriema Lalani; Dandekar, Abhaya M.			Founder transformants of cotton (Gossypium hirsutum L.) obtained through the introduction of DS-Red, Rec, Rep and CRISPR/Cas9 expressing constructs for developing base lines of recombinase mediated gene stacking	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFORMATION; LEAF CURL DISEASE; AGROBACTERIUM-TUMEFACIENS; TRANSGENIC COTTON; PLANT-REGENERATION; EMBRYOGENIC CALLI; VIRUS; BETASATELLITE; PROTEIN; PROTOPLASTS	Cotton being the major fiber crop across the world is exposed to numerous biotic and abiotic stresses. Genetic transformation of cotton is vital to meet the world's food, feed and fiber demands. Genetic manipulation by randomly transferring the genes emanate variable gene expression. Targeted gene insertion by latest genome editing tools results in predictable expression of genes at a specified location. Gene stacking technology emerged as an adaptive strategy to combat biotic and abiotic stresses by integrating 2-3 genes simultaneously and at a specific site to avoid variable gene expression at diverse locations. This study explains the development of cotton's founder transformants to be used as a base line for multiple gene stacking projects. We introduced Cre and PhiC31 mediated recombination sites to specify the locus of incoming genes. CRISPR-Cas9 gene was integrated for developing CRISPR based founder lines of cotton. Cas9 gene along with gRNA was integrated to target Rep (replication) region of cotton leaf curl virus. Replication region of virus was specifically targeted to diminish further proliferation and preventing the virus to develop new strains. To successfully develop these primary transformants, a model transformation system has been optimized with the red color visualization (DS-Red). Following red color transformation system, three baselines with recombination specified site (Rec), targeted replication region (Rep) and Cas9 founder lines have been developed. These founder transformants are useful for developing recombinase mediated and CRISPR/Cas9 based originator lines of cotton. Moreover, these transformants will set up a base system for all the recombinase mediated gene stacking projects.	[Aslam, Sabin; Khan, Sultan Habibullah] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol CABB, Faisalabad, Pakistan; [Khan, Sultan Habibullah; Ahmad, Aftab] Univ Agr Faisalabad, Ctr Adv Studies Agr & Food Secur CAS AFS, Faisalabad, Pakistan; [Ahmad, Aftab] Univ Agr Faisalabad, Fac Sci, Dept Biochem, Faisalabad, Pakistan; [Walawage, Sriema Lalani; Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Sch Biol Sci, Davis, CA 95616 USA	University of Agriculture Faisalabad; University of Agriculture Faisalabad; University of Agriculture Faisalabad; University of California System; University of California Davis	Aslam, S (corresponding author), Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol CABB, Faisalabad, Pakistan.	sabinaslam@gmail.com	Khan, Sultan Habibullah/GXM-4574-2022; Ahmad, Aftab/L-9718-2015	Khan, Sultan Habibullah/0000-0002-3200-5151; Aslam, Sabin/0000-0003-2897-1549; Ahmad, Aftab/0000-0002-2792-9771	USAID-CAS at UC-DAVIS	USAID-CAS at UC-DAVIS	PhD research fellowship awarded to Sabin Aslam by USAID-CAS at UC-DAVIS.	Ali I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-231; Ali M, 1995, COTTON LEAF CURL VIR, P7; Ali R. M., 2004, Pakistan Journal of Biological Sciences, V7, P1371, DOI 10.3923/pjbs.2004.1371.1375; Amin I, 2011, MOL PLANT MICROBE IN, V24, P973, DOI 10.1094/MPMI-01-11-0001; Amudha J, 2011, CURR SCI INDIA, V101, P300; Aslam S, 2019, INT J AGRIC BIOL, V21, P429, DOI 10.17957/IJAB/15.0911; Bajwa KS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00838; Brown J. K., 1992, P275; Cao JingLin, 2008, Acta Agronomica Sinica, V34, P224, DOI 10.3724/SP.J.1006.2008.00224; CAUQUIL J, 1983, COTON FIBRES TROP, V38, P293; Chen TZ, 2010, BIOTECHNOL LETT, V32, P547, DOI 10.1007/s10529-009-0179-y; Chen WQ, 2017, BIOENGINEERED, V8, P451, DOI 10.1080/21655979.2016.1276679; CHLAN CA, 1995, PLANT MOL BIOL REP, V13, P31, DOI 10.1007/BF02668391; COUSINS YL, 1991, AUST J PLANT PHYSIOL, V18, P481, DOI 10.1071/PP9910481; Daljeet Singh, 2006, Indian Phytopathology, V59, P148; Farquarson CO, 1918, REPORT MYCOLOGIST, P196; Farquharson CO., 1912, ANN REPORT; fas, COTTON WORLD MARKETS; Fauquet C, 1987, PLANT VIRAL DIS IVOR; FINER JJ, 1990, PLANT CELL REP, V8, P586, DOI 10.1007/BF00270059; FIROOZABADY E, 1987, PLANT MOL BIOL, V10, P105, DOI 10.1007/BF00016148; GOLDING F. D., 1930, Empire Cotton Growing Review, V7, P120; HAMEED S, 1994, PLANT DIS, V78, P529; HOHN B, 1989, GENOME, V31, P987, DOI 10.1139/g89-172; Hussain T., 1975, Pakistan Cottons, V19, P71; Ikram-Ul-Haq, 2004, PLANT MOL BIOL REP, V22, P279, DOI 10.1007/BF02773138; Janga MR, 2017, PLANT MOL BIOL, V94, P349, DOI 10.1007/s11103-017-0599-3; Jin SX, 2012, J INTEGR AGR, V11, P1433; Jin SX, 2005, PLANT CELL TISS ORG, V81, P229, DOI 10.1007/s11240-004-5209-9; Jones GH, 1926, ANN BOT-LONDON, V40, P759, DOI 10.1093/oxfordjournals.aob.a090049; Keller G, 1997, TRANSGENIC RES, V6, P385, DOI 10.1023/A:1018483300902; Keshamma E, 2008, J COTTON SCI, V12, P264; Khan Z, 2019, INT J AGRIC BIOL, V21, P711, DOI 10.17957/IJAB/15.0948; KIRKPATRICK T. W., 1931, BULL ENT RES [LONDON], V22, P323, DOI 10.1017/S0007485300029862; Kirkpatrick TL, 2001, COMPENDIUM COTTON DI; Kumar A, 2010, VIRUS GENES, V40, P282, DOI 10.1007/s11262-009-0439-x; Leelavathi S, 2004, PLANT CELL REP, V22, P465, DOI 10.1007/s00299-003-0710-x; Majeed K., 2012, THESIS U AGR FAISALA; MANSOOR S, 1993, PAKISTAN J BOT, V25, P105; MASSEY R. E., 1934, Annual Report Gezira Agriculture Research Service for the year ended 31st December, 1933, P126; MinFAL, 1992, ANN REPORT; Mishra R, 2003, PLANT CELL TISS ORG, V73, P21, DOI 10.1023/A:1022666822274; Monga D., 2005, Journal of Cotton Research and Development, V19, P105; Morre JL, 1998, PLANT CELL TISS ORG, V54, P131, DOI 10.1023/A:1006170529397; NAGATA T, 1971, PLANTA, V99, P12, DOI 10.1007/BF00392116; Ow DW, 2005, IN VITRO CELL DEV-PL, V41, P213, DOI 10.1079/IVP2004610; Ow DW, 2003, PLANT BIOTECHNOLOGY 2002 AND BEYOND, P215; Peng B, 2020, NAT PLANTS, V6, P338, DOI 10.1038/s41477-020-0625-3; Rahman M, 2005, PLANT PATHOL, V54, P764, DOI 10.1111/j.1365-3059.2005.01280.x; Raj SK, 2006, PLANT DIS, V90, P975, DOI 10.1094/PD-90-0975C; Rajasekaran K, 2000, PLANT CELL REP, V19, P539, DOI 10.1007/s002990050770; Rech EL, 2008, NAT PROTOC, V3, P410, DOI 10.1038/nprot.2008.9; Riely BK, 2007, PLANT J, V49, P208, DOI 10.1111/j.1365-313X.2006.02957.x; Schilling RK, 2017, TRENDS PLANT SCI, V22, P154, DOI 10.1016/j.tplants.2016.11.012; SHNEYOUR Y, 1984, PLANT SCI LETT, V33, P293, DOI 10.1016/0304-4211(84)90020-8; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Sohrab SS, 2014, SAUDI J BIOL SCI, V21, P626, DOI 10.1016/j.sjbs.2014.11.006; Srivastava V, 2001, PLANT MOL BIOL, V46, P561, DOI 10.1023/A:1010646100261; statista, WORLDWIDE OILSEED PR; Sunilkumar G, 2001, MOL BREEDING, V8, P37, DOI 10.1023/A:1011906701925; Thomson JG, 2006, GENESIS, V44, P465, DOI 10.1002/dvg.20237; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Tsien RY, 1999, NAT BIOTECHNOL, V17, P956, DOI 10.1038/13648; UMBECK P, 1987, BIO-TECHNOL, V5, P263, DOI 10.1038/nbt0387-263; Wang PC, 2018, PLANT BIOTECHNOL J, V16, P137, DOI 10.1111/pbi.12755; Wildt S, 1999, NAT BIOTECHNOL, V17, P1175, DOI 10.1038/70713; Wilkins TA, 2004, J FOOD AGRIC ENVIRON, V2, P179; Wu J, 2005, PLANT BREEDING, V124, P142, DOI 10.1111/j.1439-0523.2004.01056.x; Xiong Z, 2004, COTTON LEAF CURL VIR, P25; Yau YY, 2011, METHODS MOL BIOL, V701, P147, DOI 10.1007/978-1-61737-957-4_8; Zhang BH, 2009, PLANT OMICS, V2, P259; Zia-Ur-Rehman M, 2013, PLANT DIS, V97, P1122, DOI 10.1094/PDIS-12-12-1159-PDN	72	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263219	10.1371/journal.pone.0263219	http://dx.doi.org/10.1371/journal.pone.0263219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113911	gold, Green Published			2022-12-26	WOS:000823694700062
J	Celik, E; Nelles, C; Kottlors, J; Fervers, P; Goertz, L; dos Santos, DP; Achenbach, T; Maintz, D; Persigehl, T				Celik, Erkan; Nelles, Christian; Kottlors, Jonathan; Fervers, Philipp; Goertz, Lukas; dos Santos, Daniel Pinto; Achenbach, Tobias; Maintz, David; Persigehl, Thorsten			Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection	PLOS ONE			English	Article								Purpose To evaluate the association between the coronavirus disease 2019 (COVID-19) and post-inflammatory emphysematous lung alterations on follow-up low-dose CT scans. Methods Consecutive patients with proven COVID-19 infection and a follow-up CT were retrospectively reviewed. The severity of pulmonary involvement was classified as mild, moderate and severe. Total lung volume, emphysema volume and the ratio of emphysema/-to-lung volume were quantified semi-automatically and compared inter-individually between initial and follow-up CT and to a control group of healthy, age- and sex-matched patients. Lung density was further assessed by drawing circular regions of interest (ROIs) into non-affected regions of the upper lobes. Results A total of 32 individuals (mean age: 64 +/- 13 years, 12 females) with at least one follow-up CT (mean: 52 +/- 66 days, range: 5-259) were included. In the overall cohort, total lung volume, emphysema volume and the ratio of lung-to-emphysema volume did not differ significantly between the initial and follow-up scans. In the subgroup of COVID-19 patients with > 30 days of follow-up, the emphysema volume was significantly larger as compared to the subgroup with a follow-up < 30 days (p = 0.045). Manually measured single ROls generally yielded lower attenuation values prior to COVID-19 pneumonia, but the difference was not significant between groups (all p > 0.05). Conclusion COVID-19 patients with a follow-up CT >30 days showed significant emphysematous lung alterations. These findings may help to explain the long-term effect of COVID-19 on pulmonary function and warrant validation by further studies.	[Celik, Erkan; Nelles, Christian; Kottlors, Jonathan; Fervers, Philipp; Goertz, Lukas; dos Santos, Daniel Pinto; Maintz, David; Persigehl, Thorsten] Univ Cologne, Fac Med, Cologne, Germany; [Celik, Erkan; Nelles, Christian; Kottlors, Jonathan; Fervers, Philipp; Goertz, Lukas; dos Santos, Daniel Pinto; Maintz, David; Persigehl, Thorsten] Univ Cologne, Univ Hosp Cologne, Dept Diagnost & Intervent Radiol, Cologne, Germany; [Achenbach, Tobias] Lahn Dill Kliniken, Dept Diagnost & Intervent Radiol, Wetzlar, Germany	University of Cologne; University of Cologne	Celik, E (corresponding author), Univ Cologne, Fac Med, Cologne, Germany.; Celik, E (corresponding author), Univ Cologne, Univ Hosp Cologne, Dept Diagnost & Intervent Radiol, Cologne, Germany.	Erkan.Celik@uk-koeln.de		Celik, Erkan/0000-0001-5687-7707				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Allam Z, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010046; Bae K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005494; Bandirali M, 2020, RADIOLOGY, V295, pE7, DOI 10.1148/radiol.2020201102; Borczuk AC, 2020, MODERN PATHOL, V33, P2156, DOI 10.1038/s41379-020-00661-1; Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230; Colombi D, 2020, RADIOLOGY, V296, pE86, DOI 10.1148/radiol.2020201433; Cottin V, 2013, EUR RESPIR REV, V22, P153, DOI 10.1183/09059180.00000813; Egger Bernard, 2005, Rev Med Suisse, V1, P2665; George PM, 2020, THORAX, V75, P1009, DOI 10.1136/thoraxjnl-2020-215314; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gozes O., 2020, ARXIV ABS200305037; Grassi R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186914; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Han XY, 2021, RADIOLOGY, V299, pE177, DOI 10.1148/radiol.2021203153; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Kommoss FKF, 2020, DTSCH ARZTEBL INT, V117, P500, DOI 10.3238/arztebl.2020.0500; Kwee TC, 2020, RADIOGRAPHICS, V40, P1848, DOI 10.1148/rg.2020200159; Lee SC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83226-9; Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Maldonado F, 2014, EUR RESPIR J, V43, P204, DOI 10.1183/09031936.00071812; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Neri E, 2020, RADIOL MED, V125, P517, DOI 10.1007/s11547-020-01135-9; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1016/j.chest.2020.04.003, 10.1148/radiol.2020201365]; Xu YH, 2020, J INFECTION, V80, P394, DOI 10.1016/j.jinf.2020.02.017; Yong SJ, 2021, INFECT DIS-NOR, V53, P737, DOI 10.1080/23744235.2021.1924397	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263261	10.1371/journal.pone.0263261	http://dx.doi.org/10.1371/journal.pone.0263261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113939	gold, Green Published			2022-12-26	WOS:000823694700070
J	Ilic-Zivojinovic, J; Krdzic, I; Jovanovic, A; Vukasinovic, D; Ilic, B; Gavrilovic, A; Soldatovic, I				Ilic-Zivojinovic, Jelena; Krdzic, Igor; Jovanovic, Ana; Vukasinovic, Danka; Ilic, Branislav; Gavrilovic, Aleksandar; Soldatovic, Ivan			Transcultural adaptation and validation of the Serbian version of the colorectal-specific quality of life questionnaire FACT-C	PLOS ONE			English	Article							FUNCTIONAL ASSESSMENT; CANCER INCIDENCE; EORTC; RELIABILITY; MORTALITY	Objective Transcultural adaptation and validation of the FACT-C questionnaire to Serbian language. Methods The study included 131 patients with colorectal cancer. Translation included standard forward and backward translation from original language to Serbian and back. Pilot testing of the questionnaire was conducted on 10 patients with diagnosed colorectal cancer. The questionnaires EORTC-QLQ-C30 and DASS will be used as validated tools to evaluate validity of examined, FACT-C questionnaire. Results The FACT-C demonstrated satisfactory construct validity using Cronbach's alpha. Satisfactory concurrent validity was demonstrated using correlations with EORTC-QLQ-C30 and DASS questionnaires. High reproducibility was demonstrated using repeated question-naires on 30 patients two weeks after the first interview. Conclusion The Serbian version of the FACT-C was demonstrated to have satisfactory applicability, reliability and validity in Serbian patients with colorectal cancer. It can be considered as a valid colorectal cancer specific health related quality of life tool for the Serbian population.	[Ilic-Zivojinovic, Jelena; Jovanovic, Ana; Vukasinovic, Danka] Univ Belgrade, Fac Med, Inst Hyg & Med Ecol, Belgrade, Serbia; [Krdzic, Igor] Univ Clin Hosp Ctr Zvezdara, Dept Colorectal Surg, Surg Clin Nikola Spasi, Belgrade, Serbia; [Ilic, Branislav] Univ Belgrade, Sch Dent Med, Clin Oral Surg, Belgrade, Serbia; [Gavrilovic, Aleksandar] Univ Kragujevac, Fac Med Sci, Dept Neurol, Kragujevac, Serbia; [Gavrilovic, Aleksandar] Univ Clin Ctr Kragujevac, Clin Neurol, Kragujevac, Serbia; [Soldatovic, Ivan] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Kragujevac; University of Belgrade	Soldatovic, I (corresponding author), Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia.	ivan.soldatovic@med.bg.ac.rs		Soldatovic, Ivan/0000-0003-4893-1683				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bankovic Lazarevic D, 2016, VOJNOSANIT PREGL, V73, P360, DOI 10.2298/VSP150421113B; Bhandari A, 2017, J INVEST MED, V65, P311, DOI 10.1136/jim-2016-000229; Cella D, 1998, MED CARE, V36, P1407, DOI 10.1097/00005650-199809000-00012; Cella D, 1997, MANUAL FUNCTIONAL AS; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; de Souza AC, 2017, EPIDEMIOL SERV SAUDE, V26, P649, DOI 10.5123/S1679-49742017000300022; Fayers P, 2002, EUR J CANCER, V38, pS125; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Institute of Public Health of Serbia, 2021, HLTH STAT YB REPUBLI; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lovibond S.H., 1995, MANUAL DEPRESSION AN, V2 nd ed; Marventano S, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S15; Rotonda C, 2008, QUAL LIFE RES, V17, P437, DOI 10.1007/s11136-008-9322-9; Scepanovic M, 2017, EUR J CANCER PREV, V26, P195, DOI 10.1097/CEJ.0000000000000247; Sprangers MAG, 1999, EUR J CANCER, V35, P238, DOI 10.1016/S0959-8049(98)00357-8; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Velikova G., 2012, EJC Supplements, V10, P141; Veljko Jovanovic., 2014, PSIHOLOGIJA, V47, P93; Ward WL, 1999, QUAL LIFE RES, V8, P181, DOI 10.1023/A:1008821826499; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1186, DOI 10.1111/j.1365-2753.2011.01753.x; Yoo HJ, 2005, J PAIN SYMPTOM MANAG, V30, P24, DOI 10.1016/j.jpainsymman.2004.12.009	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263110	10.1371/journal.pone.0263110	http://dx.doi.org/10.1371/journal.pone.0263110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113936	gold, Green Published			2022-12-26	WOS:000823694700055
J	Jolayemi, O; Bogart, LM; Storholm, ED; Goodman-Meza, D; Rosenberg-Carlson, E; Cohen, R; Kao, U; Shoptaw, S; Landovitz, RJ				Jolayemi, Oluwadamilola; Bogart, Laura M.; Storholm, Erik D.; Goodman-Meza, David; Rosenberg-Carlson, Elena; Cohen, Rebecca; Kao, Uyen; Shoptaw, Steve; Landovitz, Raphael J.			Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County	PLOS ONE			English	Article							MEDICAL MISTRUST; ANTIRETROVIRAL THERAPY; TREATMENT ADHERENCE; PRIMARY-CARE; AFRICAN-AMERICAN; SUBSTANCE USE; PEOPLE; SATISFACTION; ENGAGEMENT; PREVENTION	Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clinical and non-clinical stakeholders to catalog anticipated individual-consumer, healthcare system, and structural levels barriers and facilitators to LAI ART implementation in Los Angeles County, California. Thematic analysis was guided by the CFIR implementation science model. CFIR constructs of intervention characteristics, individual characteristics, outer and inner setting, intervention characteristics, and implementation process emerged in analysis. Under intervention characteristics, anticipated facilitators included the relative advantage of LAI ART over pills for adherence and reduced treatment management burden and related anxiety; anticipated barriers included non-adherence to injection appointments, concerns of developing HIV resistance, discomfort with injection and cost. Anticipated facilitators based on individual characteristics included overall acceptability based on knowledge and positive beliefs about LAI ART. Participant noted several characteristics of the outer setting that could negatively impact implementation, such as medical mistrust, external policies, and LAI ART eligibility (i.e., to be virally suppressed prior to initiation). Participants were optimistic about the potential to decrease stigma but expressed that provider willingness for adoption could be hindered by challenges in organizational inner setting related to payment authorizations, increased staffing needs, medication procurement and storage, and provider and healthcare system readiness. Results from this pre-implementation study may inform rollout and scale-up of LAI ART in Los Angeles County.	[Jolayemi, Oluwadamilola; Rosenberg-Carlson, Elena; Kao, Uyen; Shoptaw, Steve] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA; [Bogart, Laura M.; Storholm, Erik D.] RAND Corp, Santa Monica, CA USA; [Storholm, Erik D.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Goodman-Meza, David; Landovitz, Raphael J.] UCLA, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Cohen, Rebecca] Cty Los Angeles Dept Publ Hlth, Div HIV & STD Programs, Los Angeles, CA USA; [Landovitz, Raphael J.] Univ Calif Los Angeles, UCLA Ctr Clin AIDS Res & Educ, Los Angeles, CA USA	University of California System; University of California Los Angeles; RAND Corporation; California State University System; San Diego State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Los Angeles County Department of Public Health; University of California System; University of California Los Angeles	Jolayemi, O (corresponding author), Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA.	ojolayemi@mednet.ucla.edu		Jolayemi, Oluwadamilola/0000-0002-2668-0177; Shoptaw, Steven/0000-0002-3583-0026; Goodman, David/0000-0001-9382-3564	National Institute of Mental Health (NIMH) [P30MH058107-23S2]	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funds provided by the National Institute of Mental Health (NIMH) grant (P30MH058107-23S2). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.	Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; [Anonymous], GUIDELINES USE ANTIR; [Anonymous], VIIV HEALTHCARE ANNO; [Anonymous], SELF EFFICACY THE CO; [Anonymous], CONSTRUCTS THE CONSO; Barker C, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21648; Beer L, 2014, AIDS EDUC PREV, V26, P521, DOI 10.1521/aeap.2014.26.6.521; Benkert R, 2006, J NATL MED ASSOC, V98, P1532; Birken SA, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0534-z; Bleich SN, 2019, HEALTH SERV RES, V54, P1399, DOI 10.1111/1475-6773.13220; Bogart LM, 2019, BEHAV MED, V45, P134, DOI 10.1080/08964289.2019.1585324; Bogart LM, 2016, SOC SCI MED, V164, P133, DOI 10.1016/j.socscimed.2016.03.028; Bogart LM., 2021, HIV US COMMUNITIES C, P207, DOI DOI 10.1007/978-3-030-48744-7_12; Brincks AM, 2019, AIDS BEHAV, V23, P2859, DOI 10.1007/s10461-019-02464-1; Cabral HJ, 2018, AIDS BEHAV, V22, P2627, DOI 10.1007/s10461-017-1999-8; Dailey A., 2018, HIV SURVEILLANCE REP; DeHaan, 2021, USE INJECTABLE CABRP; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Feldstein AC., 2008, JOINT COMMISSION J Q, V34; Feller Daniel J, 2017, J Int Assoc Provid AIDS Care, V16, P23, DOI 10.1177/2325957416667488; Fernandez C, 2019, HIV AIDS-RES PALLIAT, V11, P179, DOI 10.2147/HIV.S184642; Ferrer B, 2020, HIV SURVEILLANCE ANN; Friedman MS, 2009, AIDS CARE, V21, P692, DOI 10.1080/09540120802513709; Hammond WP, 2010, AM J COMMUN PSYCHOL, V45, P87, DOI 10.1007/s10464-009-9280-6; Henny KD, 2019, AIDS BEHAV, V23, P2926, DOI 10.1007/s10461-019-02545-1; Higashi RT, 2022, AIDS CARE, V34, P220, DOI 10.1080/09540121.2021.1883512; Horvath KJ, 2013, AIDS BEHAV, V17, P2031, DOI 10.1007/s10461-013-0469-1; Jaiswal J, 2019, BEHAV MED, V45, P79, DOI 10.1080/08964289.2019.1619511; Kalichman S, 2016, PSYCHOL HEALTH, V31, P383, DOI 10.1080/08870446.2015.1111371; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Keith RE, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0550-7; Kerrigan D, 2018, AIDS BEHAV, V22, P3540, DOI 10.1007/s10461-017-2017-x; Kerrigan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190487; LACounty, HIV LOS ANGELES COUN; Larson BA, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25541; LaVeist TA, 2000, MED CARE RES REV, V57, P146, DOI 10.1177/107755800773743637; LaVeist TA, 2009, HEALTH SERV RES, V44, P2093, DOI 10.1111/j.1475-6773.2009.01017.x; Lee WK, 2016, HEALTH PSYCHOL, V35, P290, DOI 10.1037/hea0000310; Mantsios A, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06214-9; Mantsios A, 2020, AIDS BEHAV, V24, P3473, DOI 10.1007/s10461-020-02918-x; Map-AIDSVu, 2020, RATES PERSONS LIVING; Marino P, 2007, SOC WORK HEALTH CARE, V45, P67, DOI 10.1300/J010v45n01_05; McCree DH, 2020, AIDS BEHAV, V24, P2451, DOI 10.1007/s10461-020-02805-5; McCreight MS, 2019, TRANSL BEHAV MED, V9, P1002, DOI 10.1093/tbm/ibz085; Miles M.B., 1994, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Muddu M., 2020, IMPLEMENT SCI COMMUN, V1; Murray M, 2020, HIV RES CLIN PRACT, V21, P105, DOI 10.1080/25787489.2020.1824718; Murray M, 2020, AIDS BEHAV, V24, P3533, DOI 10.1007/s10461-020-02929-8; Myers JE, 2019, AM J PUBLIC HEALTH, V109, P859, DOI 10.2105/AJPH.2019.305057; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Ojikutu BO, 2021, AM J PUBLIC HEALTH, V111, P366, DOI 10.2105/AJPH.2020.306087; Orkin C, 2021, LANCET HIV, V8, pE668, DOI 10.1016/S2352-3018(21)00184-3; Orkin C, 2020, NEW ENGL J MED, V382, P1124, DOI 10.1056/NEJMoa1909512; Overton ET, 2020, LANCET, V396, P1994, DOI 10.1016/S0140-6736(20)32666-0; Palepu A, 2011, J URBAN HEALTH, V88, P545, DOI 10.1007/s11524-011-9562-9; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; Philbin MM, 2021, AIDS PATIENT CARE ST, V35, P23, DOI 10.1089/apc.2020.0164; Philbin MM, 2020, JAIDS-J ACQ IMM DEF, V84, P263, DOI 10.1097/QAI.0000000000002337; Rackal JM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003938.pub2; Raj A, 2018, AIDS PATIENT CARE ST, V32, P438, DOI 10.1089/apc.2018.0128; Remien RH, 2015, JAIDS-J ACQ IMM DEF, V69, pS16, DOI 10.1097/QAI.0000000000000577; Reza-Paul S., 2019, GATES OPEN RES, V3; Rothman J, 2007, J URBAN HEALTH, V84, P226, DOI 10.1007/s11524-006-9137-3; Roy M, 2019, CURR HIV-AIDS REP, V16, P324, DOI 10.1007/s11904-019-00454-5; Ryan G.W., 2000, DATA MANAGEMENT ANAL; Sahay Seema, 2011, East J Med, V16, P168; Salam RA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-26; Simoni JM, 2019, AIDS PATIENT CARE ST, V33, P104, DOI 10.1089/apc.2018.0198; Simoni JM, 2011, AIDS BEHAV, V15, P1589, DOI 10.1007/s10461-011-9963-5; Solomon DA, 2015, CURR OPIN HIV AIDS, V10, P219, DOI 10.1097/COH.0000000000000165; Sullivan LM, 2000, J GEN INTERN MED, V15, P462, DOI 10.1046/j.1525-1497.2000.03359.x; Swindells S, 2020, NEW ENGL J MED, V382, P1112, DOI 10.1056/NEJMoa1904398; US Food and Drug and Drug Administration, FDA APPROVES 1 EXTEN; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020; Young CA., 2021, PHARM TODAY, V27, P15; Zhang C, 2020, AIDS PATIENT CARE ST, V34, P27, DOI 10.1089/apc.2019.0200	78	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262926	10.1371/journal.pone.0262926	http://dx.doi.org/10.1371/journal.pone.0262926			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113892	Green Published, gold			2022-12-26	WOS:000823694700043
J	Marmai, N; Villoria, MF; Guerzoni, M				Marmai, Nadine; Villoria, Maria Franco; Guerzoni, Marco			How the Black Swan damages the harvest: Extreme weather events and the fragility of agriculture in development countries	PLOS ONE			English	Article							MAIZE PRODUCTION; CLIMATE-CHANGE; YIELD; TEMPERATURE; VARIABILITY; IMPACTS; WHEAT; TRENDS; HEAT	Climate change constitutes a rising challenge to the agricultural base of developing countries. Most of the literature has focused on the impact of changes in the means of weather variables on mean changes in production and has found very little impact of weather upon agricultural production. Instead, we focus on the relationship between extreme events in weather and extreme losses in crop production. Indeed, extreme events are of the greatest interest for scholars and policy makers only when they carry extraordinary negative effects. We build on this idea and for the first time, we adopt a conditional dependence model for multivariate extreme values to understand the impact of extreme weather on agricultural production. Specifically, we look at the probability that an extreme event drastically reduces the harvest of any of the major crops. This analysis, which is run on data for six different crops and four different weather variables in a vast array of countries in Africa, Asia and Latin America, shows that extremes in weather and yield losses of major staples are associated events. We find a high heterogeneity across both countries and crops and we are able to predict per country and per crop the risk of a yield reduction above 90% when extreme events occur. As policy implication, we can thus assess which major crop in each country is less resilient to climate shocks.	[Marmai, Nadine] Univ Turin, DESPINA Dept Econ & Stat Cognetti de Martiis, Turin, Italy; [Villoria, Maria Franco] Univ Modena & Reggio Emilia, Modena, Italy; [Guerzoni, Marco] DEMS Univ Milan, Bicocca, Italy	University of Turin; Universita di Modena e Reggio Emilia	Guerzoni, M (corresponding author), DEMS Univ Milan, Bicocca, Italy.	marco.guerzoni@unimib.it						Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coles S., 2001, INTRO STAT MODELING, DOI [10.1007/978-1-4471-3675-0, DOI 10.1007/978-1-4471-3675-0]; Das B, 2018, INT J BIOMETEOROL, V62, P1809, DOI 10.1007/s00484-018-1583-6; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Fontes F, 2021, CLIMATIC CHANGE, V165, DOI 10.1007/s10584-021-03051-x; Galindo LM, 2010, AGR MARKETS CROP PRO; Jones PG, 2003, GLOBAL ENVIRON CHANG, V13, P51, DOI 10.1016/S0959-3780(02)00090-0; Keef C, 2013, J MULTIVARIATE ANAL, V115, P396, DOI 10.1016/j.jmva.2012.10.012; Keef C, 2009, J R STAT SOC C-APPL, V58, P601, DOI 10.1111/j.1467-9876.2009.00672.x; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Kristensen K, 2011, J AGR SCI-CAMBRIDGE, V149, P33, DOI 10.1017/S0021859610000675; Kucharik CJ, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034003; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Maclean J, 2013, RICE ALMANAC SOURCE; Marmai N, 2016, DEP EC STAT COGNETTI; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Moriondo M, 2011, CLIMATIC CHANGE, V104, P679, DOI 10.1007/s10584-010-9871-0; Paulo MJ, 2006, FOOD CHEM TOXICOL, V44, P994, DOI 10.1016/j.fct.2005.12.003; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Rowhani P, 2011, AGR FOREST METEOROL, V151, P449, DOI 10.1016/j.agrformet.2010.12.002; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schewe J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08745-6; Schlenker W, 2006, REV AGR ECON, V28, P391, DOI 10.1111/j.1467-9353.2006.00304.x; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Semenov MA, 2007, AGR FOREST METEOROL, V144, P127, DOI 10.1016/j.agrformet.2007.02.003; South A., 2016, MAPPING GLOBAL DATA; Southworth H, 2013, STATISTICS-ABINGDON; Southworth J Harry, 2013, TEXMEX STAT MODELLIN; Stephenson A, 2015, EVD FUNCTIONS EXTREM; Taleb NN, 2010, BLACK SWAN IMPACT HI, V2; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Taylor J, 2003, P AFRIPRO WORKSH PRO, V9; United Nations, 2014, WORLD EC SIT PROSP 2; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; Wani S.P., 2009, ICISAT ARCH REP, V7; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Wheeler TR, 2000, AGR ECOSYST ENVIRON, V82, P159, DOI 10.1016/S0167-8809(00)00224-3; WickhamWHadley Chang, 2015, GGPLOT2 IMPLEMENTATI; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]; Zampieri M, 2019, EARTHS FUTURE, V7, P113, DOI 10.1029/2018EF000995; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114	51	0	0	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0261839	10.1371/journal.pone.0261839	http://dx.doi.org/10.1371/journal.pone.0261839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108276	Green Published, gold			2022-12-26	WOS:000775890100015
J	Llobet, SG; Bhattacharya, A; Everts, M; van der Vegt, B; Fehrmann, RSN; van Vugt, MATM; Kok, K				Llobet, Sergi Guerrero; Bhattacharya, Arkajyoti; Everts, Marieke; van der Vegt, Bert; Fehrmann, Rudolf S. N.; van Vugt, Marcel A. T. M.; Kok, Klaas			An mRNA expression-based signature for oncogene-induced replication-stress	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; OVARIAN-CANCER; GENOMIC INSTABILITY; INDUCED SENESCENCE; NAT10; CELLS; ACETYLATION; ACTIVATION; RESISTANT; BARRIER	Oncogene-induced replication stress characterizes many aggressive cancers. Several treatments are being developed that target replication stress, however, identification of tumors with high levels of replication stress remains challenging. We describe a gene expression signature of oncogene-induced replication stress. A panel of triple-negative breast cancer (TNBC) and non-transformed cell lines were engineered to overexpress CDC25A, CCNE1 or MYC, which resulted in slower replication kinetics. RNA sequencing analysis revealed a set of 52 commonly upregulated genes. In parallel, mRNA expression analysis of patient-derived tumor samples (TCGA, n = 10,592) also revealed differential gene expression in tumors with amplification of oncogenes that trigger replication stress (CDC25A, CCNE1, MYC, CCND1, MYB, MOS, KRAS, ERBB2, and E2F1). Upon integration, we identified a six-gene signature of oncogene-induced replication stress (NAT10, DDX27, ZNF48, C8ORF33, MOCS3, and MPP6). Immunohistochemical analysis of NAT10 in breast cancer samples (n = 330) showed strong correlation with expression of phospho-RPA (R = 0.451, p = 1.82 x 10(-20)) and gamma H2AX (R = 0.304, p = 2.95 x 10(-9)). Finally, we applied our oncogene-induced replication stress signature to patient samples from TCGA (n = 8,862) and GEO (n = 13,912) to define the levels of replication stress across 27 tumor subtypes, identifying diffuse large B cell lymphoma, ovarian cancer, TNBC and colorectal carcinoma as cancer subtypes with high levels of oncogene-induced replication stress.	[Llobet, Sergi Guerrero; Bhattacharya, Arkajyoti; Everts, Marieke; Fehrmann, Rudolf S. N.; van Vugt, Marcel A. T. M.] Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Kok, Klaas] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Vegt, Bert] Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Vugt, MATM (corresponding author), Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	m.vugt@umcg.nl	van der Vegt, Bert/G-5887-2014; Fehrmann, Rudolf/E-2551-2011	van der Vegt, Bert/0000-0002-2613-1506; van Vugt, Marcel/0000-0002-3202-4678; Guerrero Llobet, Sergi/0000-0003-2776-8610; Bhattacharya, Arkajyoti/0000-0003-1479-0739; Fehrmann, Rudolf/0000-0002-7516-315X	Netherlands Organization for Scientific Research (NWO-VIDI) [917.13334]; Netherlands Organization for Scientific Research (NWO-VENI) [916-16025]; Dutch Cancer Society [RUG 2013-5960, 11352]; European Research Council (ERC)	Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO-VENI)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); European Research Council (ERC)(European Research Council (ERC)European Commission)	We thank members of the Medical Oncology laboratory for fruitful discussions. This work was financially supported by grant from the Netherlands Organization for Scientific Research (NWO-VIDI #917.13334 to M.A.T.M.v.V. and NWO-VENI #916-16025 to R.S.N.F.), the Dutch Cancer Society (RUG 2013-5960 to R.S.N.F and #11352 to M.A.T.M.v.V.) and from the European Research Council (ERC-Consolidator grant "TENSION" to M.A.T.M.v.V.).	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Arango D, 2018, CELL, V175, P1872, DOI 10.1016/j.cell.2018.10.030; Aziz K, 2019, GASTROENTEROLOGY, V157, P210, DOI 10.1053/j.gastro.2019.03.016; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Chen X, 2018, CLIN CANCER RES, V24, P6594, DOI 10.1158/1078-0432.CCR-18-1446; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Jong MRW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193098; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominissini D, 2018, CELL, V175, P1725, DOI 10.1016/j.cell.2018.11.037; Espana-Agusti J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02245-1; Farshidfar F, 2017, CELL REP, V18, P2780, DOI 10.1016/j.celrep.2017.02.033; Ferrao PT, 2012, ONCOGENE, V31, P1661, DOI 10.1038/onc.2011.358; Gadhikar MA, 2018, CANCER RES, V78, P781, DOI 10.1158/0008-5472.CAN-17-2802; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Llobet SG, 2020, NPJ BREAST CANCER, V6, DOI 10.1038/s41523-020-00181-w; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Heijink AM, 2015, P NATL ACAD SCI USA, V112, P15160, DOI 10.1073/pnas.1505283112; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Italiano A, 2018, ANN ONCOL, V29, P1304, DOI 10.1093/annonc/mdy076; Joseph NM, 2019, J PATHOL, V248, P164, DOI 10.1002/path.5243; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kok YP, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-00270-2; Konstantinopoulos PA, 2020, LANCET ONCOL, V21, P957, DOI 10.1016/S1470-2045(20)30180-7; Leijen S, 2016, J CLIN ONCOL, V34, P4354, DOI 10.1200/JCO.2016.67.5942; Liu HY, 2020, NUCLEIC ACIDS RES, V48, P3638, DOI 10.1093/nar/gkaa130; Liu XF, 2016, EMBO REP, V17, P349, DOI 10.15252/embr.201540505; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Calzetta NL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc8257; Macheret M, 2018, NATURE, V555, P112, DOI 10.1038/nature25507; Maya-Mendoza A, 2015, MOL ONCOL, V9, P601, DOI 10.1016/j.molonc.2014.11.001; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Pillay N, 2019, CANCER CELL, V35, P519, DOI 10.1016/j.ccell.2019.02.004; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Shimura T, 2013, CELL CYCLE, V12, P773, DOI 10.4161/cc.23719; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Urzua-Traslavina CG, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21671-w; Wengner AM, 2020, MOL CANCER THER, V19, P26, DOI 10.1158/1535-7163.MCT-19-0019; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; Young LA, 2019, CANCER RES, V79, P3762, DOI 10.1158/0008-5472.CAN-18-2480; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	50	3	3	3	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2022	41	8					1216	1224		10.1038/s41388-021-02162-0	http://dx.doi.org/10.1038/s41388-021-02162-0		JAN 2022	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZC9WS	35091678	Green Submitted, Green Accepted			2022-12-26	WOS:000749073200001
J	Yi, Y; Li, YQ; Li, C; Wu, LX; Zhao, DY; Li, FX; Fazli, LD; Wang, R; Wang, L; Dong, XS; Zhao, W; Chen, KF; Cao, Q				Yi, Yang; Li, Yanqiang; Li, Chao; Wu, Longxiang; Zhao, Dongyu; Li, Fuxi; Fazli, Ladan; Wang, Rui; Wang, Long; Dong, Xuesen; Zhao, Wei; Chen, Kaifu; Cao, Qi			Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer	ONCOGENE			English	Article							HISTONE METHYLTRANSFERASE EZH2; GENE-EXPRESSION; PROTEIN EZH2; POLYCOMB; RECEPTOR; PROGRESSION; PACKAGE; GROWTH; CELLS	Cell division cycle-associated 8 (CDCA8) is a component of chromosomal passenger complex (CPC) that participates in mitotic regulation. Although cancer-related CDCA8 hyperactivation has been widely observed, its molecular mechanism remains elusive. Here, we report that CDCA8 overexpression maintains tumorigenicity and is associated with poor clinical outcome in patients with prostate cancer (PCa). Notably, enhancer of zeste homolog 2 (EZH2) is identified to be responsible for CDCA8 activation in PCa. Genome-wide assays revealed that EZH2-induced H3K27 trimethylation represses let-7b expression and thus protects the let-7b-targeting CDCA8 transcripts. More importantly, EZH2 facilitates the self-activation of E2F1 by recruiting E2F1 to its own promoter region in a methylation-independent manner. The high level of E2F1 further promotes transcription of CDCA8 along with the other CPC subunits. Taken together, our study suggests that EZH2-mediated cell cycle regulation in PCa relies on both its methyltransferase and non-methyltransferase activities.	[Yi, Yang; Li, Chao; Wu, Longxiang; Wang, Rui; Cao, Qi] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Yi, Yang; Li, Chao; Cao, Qi] Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Li, Yanqiang; Zhao, Dongyu; Chen, Kaifu] Boston Childrens Hosp, Dept Cardiol, Basic & Translat Res Div, Boston, MA 02115 USA; [Li, Yanqiang; Zhao, Dongyu; Chen, Kaifu] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Li, Chao; Wang, Long] Cent South Univ, Xiangya Hosp 3, Dept Urol, Changsha 410013, Peoples R China; [Wu, Longxiang] Cent South Univ, Dept Urol, Xiangya Hosp, Changsha 410008, Peoples R China; [Li, Fuxi; Zhao, Wei] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Peoples R China; [Fazli, Ladan; Dong, Xuesen] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Fazli, Ladan; Dong, Xuesen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Chen, Kaifu] Dana Farber Harvard Canc Ctr, Prostate Canc Program, 450 Brookline Ave,BP332A, Boston, MA 02215 USA; [Cao, Qi] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Central South University; Central South University; Sun Yat Sen University; University of British Columbia; University of British Columbia; Harvard University; Dana-Farber Cancer Institute; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Cao, Q (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.; Cao, Q (corresponding author), Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA.; Chen, KF (corresponding author), Boston Childrens Hosp, Dept Cardiol, Basic & Translat Res Div, Boston, MA 02115 USA.; Chen, KF (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Chen, KF (corresponding author), Dana Farber Harvard Canc Ctr, Prostate Canc Program, 450 Brookline Ave,BP332A, Boston, MA 02215 USA.; Cao, Q (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA.	kaifu.chen@childrens.harvard.edu; qi.cao@northwestern.edu	Dong, Xuesen/AGF-9228-2022; Cao, Qi/A-5517-2010	Yi, Yang/0000-0002-1958-7249; Cao, Qi/0000-0002-5140-3681; Dong, Xuesen/0000-0002-3115-3371	American Cancer Society [RSG-15-192-01]; Northwestern University; Northwestern University, U.S. Department of Defense [W81XWH-17-1-0357, W81XWH-19-1-0563, W81XWH-20-1-0504]; NIH/NCI [R01CA208257, R01CA256741]; Prostate SPORE [P50CA180995]; Polsky Urologic Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital	American Cancer Society(American Cancer Society); Northwestern University; Northwestern University, U.S. Department of Defense; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate SPORE; Polsky Urologic Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital	This work was supported by American Cancer Society (RSG-15-192-01) and a startup funding provided by the Northwestern University. Part of effort for QC was supported by Northwestern University, U.S. Department of Defense (W81XWH-17-1-0357, W81XWH-19-1-0563 and W81XWH-20-1-0504), NIH/NCI (R01CA208257, R01CA256741 and Prostate SPORE P50CA180995 Development Research Program) and Polsky Urologic Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Asenjo HG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4768; Ben-Salem S, 2021, ENDOCR-RELAT CANCER, V28, pR141, DOI 10.1530/ERC-20-0517; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chirshev E, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0240-y; Chun JN, 2020, BBA-REV CANCER, V1873, DOI 10.1016/j.bbcan.2019.188336; Dai C, 2015, J BIOL CHEM, V290, P22423, DOI 10.1074/jbc.M115.642710; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fillmore CM, 2015, NATURE, V520, P239, DOI 10.1038/nature14122; Gao X, 2020, PEERJ, V8, DOI 10.7717/peerj.9078; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Gonzalez ME, 2011, CANCER RES, V71, P2360, DOI 10.1158/0008-5472.CAN-10-1933; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez J, 2004, CANCER-AM CANCER SOC, V101, P894, DOI 10.1002/cncr.20480; Huang HY, 2020, NUCLEIC ACIDS RES, V48, pD148, DOI 10.1093/nar/gkz896; Ishak CA, 2016, MOL CELL, V64, P1074, DOI 10.1016/j.molcel.2016.10.021; Jeon T, 2021, CANCERS, V13, DOI 10.3390/cancers13051055; Kim J, 2018, CELL REP, V25, P2808, DOI 10.1016/j.celrep.2018.11.035; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Koyen AE, 2020, ONCOGENE, V39, P4798, DOI 10.1038/s41388-020-1332-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu T, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.608393; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Park SH, 2021, ONCOGENE, V40, P5788, DOI 10.1038/s41388-021-01982-4; Park SH, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe2261; Qi Gonghua, 2021, Am J Cancer Res, V11, P389; Rastgoo N, 2018, LEUKEMIA, V32, P2471, DOI 10.1038/s41375-018-0140-y; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tabbal H, 2019, BRIT J CANCER, V121, P384, DOI 10.1038/s41416-019-0538-y; Tang C, 2021, BIOL REPROD, V105, P267, DOI 10.1093/biolre/ioab062; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wu Z, 2011, CELL DEATH DIFFER, V18, P1771, DOI 10.1038/cdd.2011.48; Xie N, 2015, INT J CANCER, V136, pE27, DOI 10.1002/ijc.29147; Xu H, 2016, MOL CANCER RES, V14, P163, DOI 10.1158/1541-7786.MCR-15-0313; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Yi Y, 2021, NAT CELL BIOL, V23, P341, DOI 10.1038/s41556-021-00653-6; Yin HL, 2020, THERANOSTICS, V10, P8494, DOI 10.7150/thno.44849; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu Y, 2015, PROSTATE, V75, P1043, DOI 10.1002/pros.22988; Zhao DY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18913-8; Zhuang CB, 2016, INT J ONCOL, V48, P1195, DOI 10.3892/ijo.2016.3336	54	1	1	5	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1610	1621		10.1038/s41388-022-02208-x	http://dx.doi.org/10.1038/s41388-022-02208-x		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35094010				2022-12-26	WOS:000750486500001
J	Naserrudin, NA; Jeffree, MS; Kaur, N; Syed Abdul Rahim, SS; Ibrahim, MY				Naserrudin, Nurul Athirah; Jeffree, Mohammad Saffree; Kaur, Nirmal; Syed Abdul Rahim, Syed Sharizman; Ibrahim, Mohd Yusof			Diabetic retinopathy among type 2 diabetes mellitus patients in Sabah primary health clinics-Addressing the underlying factors	PLOS ONE			English	Article							RISK-FACTORS; COMPLICATIONS; ASSOCIATION; PREVALENCE; PROGRAM	Every person diagnosed with diabetes mellitus (T2DM) is at risk of developing Diabetic retinopathy (DR). Thus, DR is one of the major chronic microvascular complications of T2DM. However, in Malaysia, research about DR is still scarce. This study aimed to determine the prevalence of DR among diabetic patients across 46 primary healthcare clinics in Sabah, Malaysia. Secondly, it purported to identify the factors influencing the development of DR. This cross-sectional study involved a total of 22,345 Type 2 diabetes mellitus (T2DM) patients in the Sabah Diabetic Registry from 2008 to 2015. Of the 22,345 T2DM patients, 13.5% (n = 3,029) of them were diagnosed with DR. Multiple logistic regression revealed seven major risk factors of DR, i.e. patients with diabetic foot ulcer [aOR: 95% CI 3.08 (1.96-4.85)], patients with diabetic nephropathy [aOR: 95% CI 2.47 (2.13-2.86)], hypertension [aOR: 95% CI 1.63 (1.43-1.87)], dyslipidaemia [aOR: 95% CI 1.30 (1.17-1.44)], glycated haemoglobin [(HbA1c) > 6.5 (aOR: 95% CI 1.25 (1.14-1.38)], duration of diabetes mellitus (T2DM) [aOR: 95% CI 1.06 (1.05-1.07)] and age of patient [aOR: 95% CI 1.01 (1.00-1.02)] respectively. DR is a preventable complication. The effective glycaemic control is crucial in preventing DR. In minimizing the prevalence of DR, the healthcare authorities should institute programmes to induce awareness on the management of DR's risk factors among patient and practitioner.	[Naserrudin, Nurul Athirah] Natl Univ Malaysia, Dept Commun Hlth, Fac Med, Kuala Lumpur, Malaysia; [Naserrudin, Nurul Athirah; Kaur, Nirmal] Sabah State Hlth Dept, Sabah, Malaysia; [Jeffree, Mohammad Saffree; Syed Abdul Rahim, Syed Sharizman; Ibrahim, Mohd Yusof] Univ Malaysia Sabah, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaysia Sabah	Naserrudin, NA (corresponding author), Natl Univ Malaysia, Dept Commun Hlth, Fac Med, Kuala Lumpur, Malaysia.; Naserrudin, NA (corresponding author), Sabah State Hlth Dept, Sabah, Malaysia.	drathirah85@gmail.com	; Jeffree, Mohammad Saffree/G-1156-2017	Naserrudin, Nurul Athirah/0000-0002-9578-9782; Jeffree, Mohammad Saffree/0000-0002-0373-4451				Abougalambou SSI, 2015, DIABETES METAB SYND, V9, P98, DOI 10.1016/j.dsx.2014.04.019; Aljunid SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211248; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Chew FLM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198799; Clinical Practice Guidelines M of HM, 2011, SCREEN DIAB RET; Corcostegui B, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/8234186; Curtis TM, 2009, EYE, V23, P1496, DOI 10.1038/eye.2009.108; Dahlui M, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022067; Database NE, 2007, NAT EYE DAT; Ferris FL, 2016, OPHTHALMOLOGY, V123, P1840, DOI 10.1016/j.ophtha.2016.05.039; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Kharroubi AT, 2015, WORLD J DIABETES, V6, P850, DOI 10.4239/wjd.v6.i6.850; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; Kumar N., 2014, INT J RES MED SCI, V2, P1045; Lee WJ, 2014, INVEST OPHTH VIS SCI, V55, P6547, DOI 10.1167/iovs.14-15001; Lim MCC, 2008, ANN ACAD MED SINGAP, V37, P753; Lima Vinicius Carriero, 2016, Int J Retina Vitreous, V2, P21; Lin XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71908-9; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Ngah NF, 2020, INT J OPHTHALMOL-CHI, V13, P1808, DOI 10.18240/ijo.2020.11.19; Piyasena MMPN, 2018, JMIR RES PROTOC, V7, DOI 10.2196/10900; Raman R, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000005; Raman R, 2009, OPHTHALMOLOGY, V116, P311, DOI 10.1016/j.ophtha.2008.09.010; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Scanlon PH, 2008, J MED SCREEN, V15, P1, DOI 10.1258/jms.2008.008015; Skaggs Julie B, 2017, N C Med J, V78, P121, DOI 10.18043/ncm.78.2.121; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tsuzura S, 2004, METABOLISM, V53, P297, DOI 10.1016/j.metabol.2003.10.009; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; World Health Organization, 2006, VIS 2020 RIGHT SIGHT; World Health Organization W, 2002, PRIOR EYE DIS; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zabeen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153033	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0261249	10.1371/journal.pone.0261249	http://dx.doi.org/10.1371/journal.pone.0261249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089931	gold, Green Published			2022-12-26	WOS:000769158400006
J	van der Vusse, GJ; Arts, T; Bassingthwaighte, JB; Reneman, RS				van der Vusse, Ger J.; Arts, Theo; Bassingthwaighte, James B.; Reneman, Robert S.			Intra-cardiac transfer of fatty acids from capillary to cardiomyocyte	PLOS ONE			English	Article							BINDING PROTEINS; LIGAND-BINDING; SERUM-ALBUMIN; HEART; TRANSPORT; MEMBRANE; LIVER; DISSOCIATION; METABOLISM; ADIPOCYTE	Blood-borne fatty acids (Fa) are important substrates for energy conversion in the mammalian heart. After release from plasma albumin, Fa traverse the endothelium and the interstitial compartment to cross the sarcolemma prior to oxidation in the cardiomyocytal mitochondria. The aims of the present study were to elucidate the site with lowest Fa permeability (i.e., highest Fa resistance) in the overall Fa trajectory from capillary to cardiomyocyte and the relative contribution of unbound Fa (detach pathway, characterized by the dissociation time constant tau (AlbFa)) and albumin-bound Fa (contact pathway, characterized by the membrane reaction rate parameter d(Alb)) in delivering Fa to the cellular membranes. In this study, an extensive set of 34 multiple indicator dilution experiments with radiolabeled albumin and palmitate on isolated rabbit hearts was analysed by means of a previously developed mathematical model of Fa transfer dynamics. In these experiments, the ratio of the concentration of palmitate to albumin was set at 0.91. The analysis shows that total cardiac Fa permeability, P-tot, is indeed related to the albumin concentration in the extracellular compartment as predicted by the mathematical model. The analysis also reveals that the lowest permeability may reside in the boundary zones containing albumin in the microvascular and interstitial compartment. However, the permeability of the endothelial cytoplasm, P-ec,P- may influence overall Fa permeability, P-tot, as well. The model analysis predicts that the most likely value of tau (AlbFa) ranges from about 200 to 400 ms. In case tau (AlbFa) is fast, i.e., about 200 ms, the extracellular contact pathway appears to be of minor importance in delivering Fa to the cell membrane. If Fa dissociation from albumin is slower, e.g. tau (AlbFa) equals 400 ms, the contribution of the contact pathway may vary from minimal (d(Alb)<= 5 nm) to substantial (d(Alb) about 100 nm). In the latter case, the permeability of the endothelial cytoplasm varies from infinite (no hindrance) to low (substantial hindrance) to keep the overall Fa flux at a fixed level. Definitive estimation of the impact of endothelial permeability on P-tot and the precise contribution of the contact pathway to overall transfer of Fa in boundary zones containing albumin requires adequate physicochemical experimentation to delineate the true value of, among others, tau (AlbFa), under physiologically relevant circumstances. Our analysis also implies that concentration differences of unbound Fa are the driving force of intra-cardiac Fa transfer; an active, energy requiring transport mechanism is not necessarily involved. Membrane-associated proteins may facilitate Fa transfer in the boundary zones containing albumin by modulating the membrane reaction rate parameter, d(Alb), and, hence, the contribution of the contact pathway to intra-cardiac Fa transfer.	[van der Vusse, Ger J.; Reneman, Robert S.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [van der Vusse, Ger J.; Bassingthwaighte, James B.; Reneman, Robert S.] Univ Washington, Ctr Bioengn, Seattle, WA 98195 USA; [Arts, Theo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biomed Engn, Maastricht, Netherlands	Maastricht University; University of Washington; University of Washington Seattle; Maastricht University	van der Vusse, GJ (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands.; van der Vusse, GJ (corresponding author), Univ Washington, Ctr Bioengn, Seattle, WA 98195 USA.	vandervusse@maastrichtuniversity.nl						Abumrad NA, 2016, BBA-MOL CELL BIOL L, V1861, P1442, DOI 10.1016/j.bbalip.2016.03.015; Antohe F, 1998, EUR J CELL BIOL, V76, P102, DOI 10.1016/S0171-9335(98)80022-8; Arts T., 2015, PLOS COMPUT BIOL, V11; Barta E, 2017, J MEMBRANE BIOL, V250, P103, DOI 10.1007/s00232-016-9941-y; Barta E, 2015, J MEMBRANE BIOL, V248, P783, DOI 10.1007/s00232-015-9795-8; Bassingthwaighte James B, 1981, Bibl Anat, V20, P493; BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P997, DOI 10.1161/01.RES.65.4.997; Beedle AEM, 2015, CURR OPIN CHEM BIOL, V29, P87, DOI 10.1016/j.cbpa.2015.09.019; Bojesen E, 1996, J PHYS CHEM-US, V100, P17981, DOI 10.1021/jp962141m; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Carley AN, 2011, J BIOL CHEM, V286, P4589, DOI 10.1074/jbc.M110.182162; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Demant EJF, 2002, BIOCHEM J, V363, P809, DOI 10.1042/0264-6021:3630809; FOURNIER NC, 1985, BIOCHEMISTRY-US, V24, P2387, DOI 10.1021/bi00330a039; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; GORESKY CA, 1994, CIRC RES, V74, P1015, DOI 10.1161/01.RES.74.6.1015; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kleinfeld AM, 1998, BIOCHEMISTRY-US, V37, P8011, DOI 10.1021/bi980301+; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Musters MWJM, 2006, BIOCHEM J, V393, P669, DOI 10.1042/BJ20050869; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; PAULUSSEN RJA, 1990, INT J BIOCHEM, V22, P393, DOI 10.1016/0020-711X(90)90142-P; RICHIERI GV, 1994, J BIOL CHEM, V269, P23918; ROSE CP, 1977, CIRC RES, V41, P534, DOI 10.1161/01.RES.41.4.534; SCHEIDER W, 1979, P NATL ACAD SCI USA, V76, P2283, DOI 10.1073/pnas.76.5.2283; SMITS G, 1976, J AM OIL CHEM SOC, V53, P122, DOI 10.1007/BF02586347; STREMMEL W, 1988, J CLIN INVEST, V81, P844, DOI 10.1172/JCI113393; TSCHUBAR F, 1993, J MOL CELL CARDIOL, V25, P355, DOI 10.1006/jmcc.1993.1042; van der Vusse GJ, 2016, HISTOL HISTOPATHOL, V31, P51, DOI 10:14670/HH-11-661; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; VANDERVUSSE GJ, 1982, CIRC RES, V50, P538, DOI 10.1161/01.RES.50.4.538; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; VANNIEUWENHOVEN FA, 1994, J MOL CELL CARDIOL, V26, P1635, DOI 10.1006/jmcc.1994.1183; VORK MM, 1993, J THEOR BIOL, V160, P207, DOI 10.1006/jtbi.1993.1014; WEISIGER RA, 1987, J CLIN INVEST, V79, P1070, DOI 10.1172/JCI112920; WEISIGER RA, 1991, AM J PHYSIOL, V261, pG872, DOI 10.1152/ajpgi.1991.261.5.G872	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0261288	10.1371/journal.pone.0261288	http://dx.doi.org/10.1371/journal.pone.0261288			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089937	gold, Green Published			2022-12-26	WOS:000769158400007
J	Ghosh, D; Brahmachari, K; Skalicky, M; Roy, D; Das, A; Sarkar, S; Moulick, D; Brestic, M; Hejnak, V; Vachova, P; Hassan, MM; Hossain, A				Ghosh, Dibakar; Brahmachari, Koushik; Skalicky, Milan; Roy, Dibakar; Das, Anupam; Sarkar, Sukamal; Moulick, Debojyoti; Brestic, Marian; Hejnak, Vaclav; Vachova, Pavla; Hassan, Mohamed M.; Hossain, Akbar			The combination of organic and inorganic fertilizers influence the weed growth, productivity and soil fertility of monsoon rice	PLOS ONE			English	Article							INTEGRATED NUTRIENT MANAGEMENT; CROPPING SYSTEMS; ALLUVIAL SOILS; USE EFFICIENCY; WINTER-WHEAT; YIELD; INDICATORS; QUALITY; MATTER; AMENDMENTS	Synthetic fertilizer and herbicides encompass the largest share in nutrient and weed management on food grain crops that create serious environmental issues. Integrated nutrient and non-chemical weed management approaches may help to reduce the chemical load in the environment, maintaining higher weed control efficiency and yield. A field experiment was conducted for two consecutive monsoon seasons during 2015 and 2016 in farm fields to develop a profitable and sustainable rice production system through integrated nutrient and weed management practices. A varied combination of nutrients either alone or integrated with chemical and non-chemical weed management were tested on transplanted rice in a factorial randomized block design with three replications. The results showed that the integration of concentrated organic manures with chemical fertilizer effectively inhibited weed growth and nutrient removal. Integration of nutrient and weed management practices significantly enhanced 9% biomass growth, 10% yield of the rice crop along with 3-7% higher nutrient uptake. Brassicaceous seed meal (BSM) and neem cake also had some influence on weed suppression and economic return. Thus, the integrated nutrient and weed management practices in rice cultivation might be an effective way to achieve economic sustainability and efficient rice cultivation in eastern India. Shortages of farmyard manure and vermicompost could be supplemented by BSM and neem cake in the integrated module.	[Ghosh, Dibakar] ICAR Indian Inst Water Management, Bhubaneswar, India; [Ghosh, Dibakar; Brahmachari, Koushik; Sarkar, Sukamal] Bidhan Chandra Krishi Viswavidyalaya, Dept Agron, Nadia, India; [Skalicky, Milan; Brestic, Marian; Hejnak, Vaclav; Vachova, Pavla] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Bot & Plant Physiol, Prague, Czech Republic; [Roy, Dibakar] ICAR Directorate Weed Res, Jabalpur, India; [Das, Anupam] Bihar Agr Univ, Dept Soil Sci & Agr Chem, Bhagalpur, India; [Sarkar, Sukamal] Govt West Bengal, Off Assistant Director Agr, Agr, Bhagawangola 2 Block, Murshidabad, India; [Moulick, Debojyoti] Assam Univ, Plant Stress Biol & Metabol Lab, Silchar, India; [Moulick, Debojyoti] Univ Kalyani, Dept Environm Sci, Nadia, W Bengal, India; [Brestic, Marian] Slovak Univ Agr, Dept Plant Physiol, Nitra, Slovakia; [Hassan, Mohamed M.] Taif Univ, Coll Sci, Dept Biol, At Taif, Saudi Arabia; [Hossain, Akbar] Bangladesh Wheat & Maize Res Inst, Nashipur, Dinajpur, Bangladesh	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Water Management; Bidhan Chandra Agricultural University; Czech University of Life Sciences Prague; Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Weed Research; Assam University; Kalyani University; Slovak University of Agriculture Nitra; Taif University	Hossain, A (corresponding author), Bangladesh Wheat & Maize Res Inst, Nashipur, Dinajpur, Bangladesh.	akbarhossainwrc@gmail.com	Brestic, Marian/A-8263-2012; Skalicky, Milan/B-2449-2009; Sarkar, Sukamal/D-5994-2017; DAS, ANUPAM/G-4698-2018	Brestic, Marian/0000-0003-3470-6100; Skalicky, Milan/0000-0002-4114-6909; Sarkar, Sukamal/0000-0002-1438-1778; DAS, ANUPAM/0000-0002-0063-7197; Ghosh, Dr. Dibakar/0000-0002-9715-4932; Moulick, Dr.Debojyoti/0000-0002-2189-132X	Ministry of Education, Youth and Sports of the Czech Republic through Czech University of Life Sciences Prague, Kamycka, Prague, Czechia	Ministry of Education, Youth and Sports of the Czech Republic through Czech University of Life Sciences Prague, Kamycka, Prague, Czechia	This study was supported by an S-grant from the Ministry of Education, Youth and Sports of the Czech Republic through Czech University of Life Sciences Prague, Kamycka 129, 165 00, Prague, Czechia.	Ahmed S., 2014, ANN PLANT SOIL RES, V16, P192; [Anonymous], 2018, FAO STAT DAT; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Ashrafi Z.Y., 2009, INT J BIOL, V1, P71, DOI [10.5539/ijb.v1n1p71, DOI 10.5539/IJB.V1N1P71]; Bandyopadhyay PK, 2010, GEODERMA, V154, P379, DOI 10.1016/j.geoderma.2009.11.011; Bejbaruha R, 2009, J SUSTAIN AGR, V33, P674, DOI 10.1080/10440040903073826; Biswas S, 2017, GEODERMA, V292, P34, DOI 10.1016/j.geoderma.2017.01.003; Blackshaw RE, 2005, CROP PROT, V24, P971, DOI 10.1016/j.cropro.2005.01.021; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Borah D., 2015, INT J BIORES ENV AGR, V1, P77; Chaudhary M., ARCH AGRON SOIL SCI, V51, P351; Chaudhury M, 2005, COMMUN SOIL SCI PLAN, V36, P1141, DOI 10.1081/CSS-200056885; DASTGHEIB F, 1989, WEED RES, V29, P113, DOI 10.1111/j.1365-3180.1989.tb00848.x; Davis AS, 2001, WEED SCI, V49, P558, DOI 10.1614/0043-1745(2001)049[0558:NSIWMG]2.0.CO;2; Dhekale BS, 2018, THEOR APPL CLIMATOL, V133, P1075, DOI 10.1007/s00704-017-2232-4; Dibakar Ghosh, 2018, Indian Journal of Weed Science, V50, P287, DOI 10.5958/0974-8164.2018.00061.8; Dobermann A, 1996, NUTR CYCL AGROECOSYS, V46, P1, DOI 10.1007/BF00210219; Efthimiadou A, 2012, INT J PLANT PROD, V6, P291; Fageria NK, 2012, COMMUN SOIL SCI PLAN, V43, P2063, DOI 10.1080/00103624.2012.697234; Gastal F, 2002, J EXP BOT, V53, P789, DOI 10.1093/jexbot/53.370.789; Geng YH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219512; Ghosh D, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10121906; Ghosh D, 2020, MOLECULES, V25, DOI 10.3390/molecules25214924; Ghosh D, 2017, CROP PROT, V100, P106, DOI 10.1016/j.cropro.2017.06.011; Ghosh D, 2017, INT J PEST MANAGE, V63, P37, DOI 10.1080/09670874.2016.1213460; Ghosh D, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016142-8773; HALLSWORTH E. G., 1958, JOUR AGRIC SCI, V51, P1, DOI 10.1017/S0021859600032743; Haramoto ER, 2005, WEED SCI, V53, P695, DOI 10.1614/WS-04-162R.1; Hirak Banerjee, 2019, Indian Journal of Weed Science, V51, P246, DOI 10.5958/0974-8164.2019.00052.2; Hoagland L, 2008, SOIL BIOL BIOCHEM, V40, P1689, DOI 10.1016/j.soilbio.2008.02.003; Hunt R., 1978, PLANT GROWTH ANAL ST, V96, P26; Jabran K, 2017, SPRINGERBR PLANT SCI, P21, DOI 10.1007/978-3-319-53186-1_3; Jackson M.L., 1978, SOIL CHEM ANAL, P183; Jha MN, 2013, COMMUN SOIL SCI PLAN, V44, P1961, DOI 10.1080/00103624.2013.794821; Khan A., 2004, ARCH AGRON SOIL SCI, V50, P161, DOI DOI 10.1080/03650340310001612988; Kumar Adyant, 2016, Indian Journal of Agronomy, V61, P75; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Li S., 1999, ACTA U AGR BOREALI O, V27, P1; Lu CQ, 2017, EARTH SYST SCI DATA, V9, P181, DOI 10.5194/essd-9-181-2017; Magne C, 2006, CHEMOSPHERE, V62, P650, DOI 10.1016/j.chemosphere.2005.04.119; Mahajan G, 2009, J CROP IMPROV, V23, P366, DOI 10.1080/15427520902970458; Mahajan G, 2014, RECENT ADV WEED MANA, P125; Majumder B, 2007, PLANT SOIL, V297, P53, DOI 10.1007/s11104-007-9319-0; Manoj Kumar, 2018, Indian Journal of Weed Science, V50, P129; Milberg P, 2004, FIELD CROP RES, V86, P199, DOI 10.1016/j.fcr.2003.08.006; Mishra P. K., 2003, Annals of Agricultural Research, V24, P411; Mishra V.K., 1997, J INDIAN SOC SOIL SC, V41, P84; Moe K., 2017, American Journal of Plant Sciences, V8, P1043, DOI 10.4236/ajps.2017.85069; Mohanty M, 2013, AGR RES, V2, P99, DOI 10.1007/s40003-013-0052-z; Mondal S, 2016, ARCH AGRON SOIL SCI, V62, P1521, DOI 10.1080/03650340.2016.1148808; Mondal S, 2014, ENVIRON MONIT ASSESS, V186, P5199, DOI 10.1007/s10661-014-3769-7; Murphy B, 2015, IOP C SERIES EARTH E, V25, P1; OADES JM, 1993, GEODERMA, V56, P377, DOI 10.1016/0016-7061(93)90123-3; ODonovan JT, 1997, WEED TECHNOL, V11, P502, DOI 10.1017/S0890037X00045322; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pathak H, 2003, NUTR CYCL AGROECOSYS, V65, P105, DOI 10.1023/A:1022177231332; Paul J, 2014, COMMUN SOIL SCI PLAN, V45, P912, DOI 10.1080/00103624.2013.867051; Qi DL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66757-5; Raghwendra Singh, 2018, Indian Journal of Weed Science, V50, P91, DOI 10.5958/0974-8164.2018.00022.9; Rajeev Padbhushan, 2015, The Bioscan, V10, P1237; Rajib Kundu, 2020, Indian Journal of Weed Science, V52, P160, DOI 10.5958/0974-8164.2020.00029.5; Rakshit R., J INDIAN SOC SOIL SC, V66, P166; Romheld V, 2010, PLANT SOIL, V335, P155, DOI 10.1007/s11104-010-0520-1; Saha PK, 2007, COMMUN SOIL SCI PLAN, V38, P579, DOI 10.1080/00103620701215718; Sarkar M.A.R., 2017, ARCH AGR ENV SCI, V2, P325; Sarkar S, 2016, COMMUN SOIL SCI PLAN, V47, P2053, DOI 10.1080/00103624.2016.1225075; Satyanarayana V, 2002, J PLANT NUTR, V25, P2081, DOI 10.1081/PLN-120014062; Sharma KL, 2015, ARCH AGRON SOIL SCI, V61, P313, DOI 10.1080/03650340.2014.933319; Singh Chandra Vir, 2008, Archives of Agronomy and Soil Science, V54, P203, DOI 10.1080/03650340701790666; Singh YV, 2013, RICE SCI, V20, P129, DOI 10.1016/S1672-6308(13)60113-4; Srinivasarao C, 2013, ADV AGRON, V121, P253, DOI 10.1016/B978-0-12-407685-3.00005-0; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; Tang LL, 2014, J PLANT ECOL, V7, P39, DOI 10.1093/jpe/rtt018; Thiyagarajan T.M., 2009, SRI NEWSLETTER, P2; Tilahun Tadesse, 2013, American Journal of Plant Sciences, V4, P309, DOI 10.4236/ajps.2013.42041; Timsina J, 2001, FIELD CROP RES, V69, P93, DOI 10.1016/S0378-4290(00)00143-X; van der Meulen A, 2017, CROP PROT, V95, P38, DOI 10.1016/j.cropro.2016.08.004; VARADE P A, 1982, Journal of the Indian Society of Soil Science, V30, P97; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Walsh E, 2012, ARCH AGRON SOIL SCI, V58, pS201, DOI 10.1080/03650340.2012.697999; Wang JY, 2013, J SOIL SEDIMENT, V13, P1408, DOI 10.1007/s11368-013-0731-1; WATSON DJ, 1953, ANN APPL BIOL, V40, P1, DOI 10.1111/j.1744-7348.1953.tb02364.x; Yadav RL, 2000, FIELD CROP RES, V65, P15, DOI 10.1016/S0378-4290(99)00066-0; Yogita Gharde, 2017, Indian Journal of Weed Science, V49, P165, DOI 10.5958/0974-8164.2017.00042.9; Yu W, 2013, J SOIL SCI PLANT NUT, V13, P1003, DOI 10.4067/S0718-95162013005000079; Zhang YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171022	86	6	6	13	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262586	10.1371/journal.pone.0262586	http://dx.doi.org/10.1371/journal.pone.0262586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085310	Green Published, gold			2022-12-26	WOS:000779379600066
J	Kojima, K; Sunagawa, N; Mikkelsen, NE; Hansson, H; Karkehabadi, S; Samejima, M; Sandgren, M; Igarashi, K				Kojima, Keisuke; Sunagawa, Naoki; Mikkelsen, Nils Egil; Hansson, Henrik; Karkehabadi, Saeid; Samejima, Masahiro; Sandgren, Mats; Igarashi, Kiyohiko			Comparison of glycoside hydrolase family 3 beta-xylosidases from basidiomycetes and ascomycetes reveals evolutionarily distinct xylan degradation systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DATA-BANK; TRICHODERMA-REESEI; SUBSITE AFFINITIES; SUBSTRATE-SPECIFICITY; STRUCTURE REFINEMENT; DEGRADING ENZYMES; CCP4 SUITE; GLUCOSIDASE; GLUCURONOXYLAN; TRANSGLYCOSYLATION	Xylan is the most common hemicellulose in plant cell walls, though the structure of xylan polymers differs between plant species. Here, to gain a better understanding of fungal xylan degradation systems, which can enhance enzymatic saccharification of plant cell walls in industrial processes, we conducted a comparative study of two glycoside hydrolase family 3 (GH3) beta-xylosidases (Bxls), one from the basidiomycete Phanerochaete chrysosporium (PcBxl3), and the other from the ascomycete Trichoderma reesei (TrXyl3A). A comparison of the crystal structures of the two enzymes, both with saccharide bound at the catalytic center, provided insight into the basis of substrate binding at each subsite. PcBxl3 has a substrate binding pocket at subsite-1, while TrXyl3A has an extra loop that contains additional binding subsites. Furthermore, kinetic experiments revealed that PcBxl3 degraded xylooligosaccharides faster than TrXyl3A, while the K-M values of TrXyl3A were lower than those of PcBxl3. The relationship between substrate specificity and degree of polymerization of substrates suggested that PcBxl3 preferentially degrades xylobiose (X-2), while TrXyl3A degrades longer xylooligosaccharides. Moreover, docking simulation supported the existence of extended positive subsites of TrXyl3A in the extra loop located at the N-terminus of the protein. Finally, phylogenetic analysis suggests that wood-decaying basidiomycetes use Bxls such as PcBxl3 that act efficiently on xylan structures from woody plants, whereas molds use instead Bxls that efficiently degrade xylan from grass. Our results provide added insights into fungal efficient xylan degradation systems.	[Kojima, Keisuke; Sunagawa, Naoki; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan; [Mikkelsen, Nils Egil; Hansson, Henrik; Karkehabadi, Saeid; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Samejima, Masahiro] Shinshu Univ, Fac Engn, Nagano, Japan; [Igarashi, Kiyohiko] VTT Tech Res Ctr Finland, Espoo, Finland	University of Tokyo; Swedish University of Agricultural Sciences; Shinshu University; VTT Technical Research Center Finland	Igarashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan.; Igarashi, K (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	aquarius@mail.ecc.u-tokyo.ac.jp		Sunagawa, Naoki/0000-0002-0382-6671; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534; Igarashi, Kiyohiko/0000-0001-5152-7177	Japan Society for the Promotion of Science (JSPS) [19H03013, 19K15884]; Ministry of Education, Culture, Sports, and Technology (MEXT) , Japan [18H05494]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Technology (MEXT) , Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) 19H03013 (to K. I.) , a Grant-in-Aid for Early-Career Scientists 19K15884 (to N. S.) from the Japan Society for the Promotion of Science (JSPS) , and a Grant-in-Aid for Innovative Areas 18H05494 (to K. I.) from the Ministry of Education, Culture, Sports, and Technology (MEXT) , Japan.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson D. A., 2013, GENBANK NUCL ACIDS R, V41, p36?42; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BIELY P, 1985, FEBS LETT, V186, P80, DOI 10.1016/0014-5793(85)81343-0; Biely P, 2016, BIOTECHNOL ADV, V34, P1260, DOI 10.1016/j.biotechadv.2016.09.001; Biely P, 2014, FEBS J, V281, P3894, DOI 10.1111/febs.12925; Biely P, 2013, BBA-GEN SUBJECTS, V1830, P5075, DOI 10.1016/j.bbagen.2013.07.018; Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6; Bohne A, 1998, J MOL MODEL, V4, P33, DOI 10.1007/s008940050068; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Bonnin E, 1997, ENZYME MICROB TECH, V20, P516, DOI 10.1016/S0141-0229(96)00188-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromley JR, 2013, PLANT J, V74, P423, DOI 10.1111/tpj.12135; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Busse-Wicher M, 2016, PLANT PHYSIOL, V171, P2418, DOI 10.1104/pp.16.00539; Carafa A, 2005, NEW PHYTOL, V168, P231, DOI 10.1111/j.1469-8137.2005.01483.x; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Herrmann MC, 1997, BIOCHEM J, V321, P375, DOI 10.1042/bj3210375; HIROMI K, 1970, BIOCHEM BIOPH RES CO, V40, P1, DOI 10.1016/0006-291X(70)91037-5; HIROMI K, 1983, MOL CELL BIOCHEM, V51, P79, DOI 10.1007/BF00215589; HIROMI K, 1973, BIOCHIM BIOPHYS ACTA, V302, P362, DOI 10.1016/0005-2744(73)90164-2; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Igarashi K., 2012, Journal of Applied Glycoscience, V59, P105, DOI 10.5458/jag.jag.JAG-2011_029; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; Ishiguro R, 2017, FEBS LETT, V591, P3926, DOI 10.1002/1873-3468.12911; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Keller PA, 1998, ACTA CRYSTALLOGR D, V54, P1105, DOI 10.1107/S0907444998008464; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Kulminskaya AA, 2001, EUR J BIOCHEM, V268, P6123, DOI 10.1046/j.0014-2956.2001.02558.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Martinez-Abad A, 2017, PLANT PHYSIOL, V175, P1579, DOI 10.1104/pp.17.01184; Matsuyama K, 2020, PLANT BIOTECHNOL-NAR, V37, P397, DOI 10.5511/plantbiotechnology.20.0713a; Matsuzawa T, 2019, J STRUCT BIOL, V205, P84, DOI 10.1016/j.jsb.2018.11.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Ogasawara W, 2006, APPL MICROBIOL BIOT, V72, P995, DOI 10.1007/s00253-006-0365-y; Opassiri R, 2004, BIOCHEM J, V379, P125, DOI 10.1042/BJ20031485; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RHO D, 1982, J BACTERIOL, V149, P47, DOI 10.1128/JB.149.1.47-53.1982; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROSE IA, 1980, P NATL ACAD SCI-BIOL, V77, P2439, DOI 10.1073/pnas.77.5.2439; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sakuragi K, 2018, J WOOD SCI, V64, P845, DOI 10.1007/s10086-018-1770-4; Schroder SP, 2019, ACS CENTRAL SCI, V5, P1067, DOI 10.1021/acscentsci.9b00221; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tenkanen M, 1996, FEBS LETT, V399, P303, DOI 10.1016/S0014-5793(96)01313-0; TENKANEN M, 1992, ENZYME MICROB TECH, V14, P566, DOI 10.1016/0141-0229(92)90128-B; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurman-Rodrich J., 2017, THESIS U CAMBRIDGE; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351	67	0	0	11	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101670	10.1016/j.jbc.2022.101670	http://dx.doi.org/10.1016/j.jbc.2022.101670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120929	Green Published, gold			2022-12-26	WOS:000791230900001
J	Green, CP; Ratcliffe, N; Mattern, T; Thompson, D; Lea, MA; Wotherspoon, S; Borboroglu, PG; Ellenberg, U; Morrison, KW; Putz, K; Sagar, PM; Seddon, PJ; Torres, LG; Hindell, MA				Green, Cara-Paige; Ratcliffe, Norman; Mattern, Thomas; Thompson, David; Lea, Mary-Anne; Wotherspoon, Simon; Borboroglu, Pablo Garcia; Ellenberg, Ursula; Morrison, Kyle W.; Puetz, Klemens; Sagar, Paul M.; Seddon, Philip J.; Torres, Leigh G.; Hindell, Mark A.			The role of allochrony in influencing interspecific differences in foraging distribution during the non-breeding season between two congeneric crested penguin species	PLOS ONE			English	Article							EUDYPTES-CHRYSOLOPHUS; ROCKHOPPER PENGUINS; CHRYSOCOME PENGUINS; MARINE HABITAT; SEGREGATION; POPULATION; ECOLOGY; NICHE; ZOOPLANKTON; COMMUNITIES	Mechanisms promoting coexistence between closely related species are fundamental for maintaining species diversity. Mechanisms of niche differentiation include allochrony which offsets the peak timing of resource utilisation between species. Many studies focus on spatial and temporal niche partitioning during the breeding season, few have investigated the role allochrony plays in influencing interspecific segregation of foraging distribution and ecology between congeneric species during the non-breeding season. We investigated the non-breeding migrations of Snares (Eudyptes robustus) and Fiordland penguins (Eudyptes pachyrhynchus), closely related species breeding between 100-350 km apart whose migration phenology differs by two months. Using light geolocation tracking, we examined the degree of overlap given the observed allochrony and a hypothetical scenario where the species commence migration simultaneously. We found that Fiordland penguins migrated to the Sub-Antarctic Frontal Zone and Polar Frontal Zone in the austral autumn whereas Snares penguins disperse westwards staying north of the Sub-Tropical Front in the austral winter. Our results suggest that allochrony is likely to be at the root of segregation because the relative profitability of the different water masses that the penguins forage in changes seasonally which results in the two species utilising different areas over their core non-breeding periods. Furthermore, allochrony reduces relatively higher levels of spatiotemporal overlap during the departure and arrival periods, when the close proximity of the two species' colonies would cause the birds to congregate in similar areas, resulting in high interspecific competition just before the breeding season. Available evidence from other studies suggests that the shift in phenology between these species has arisen from adaptive radiation and phenological matching to the seasonality of local resource availability during the breeding season and reduced competitive overlap over the non-breeding season is likely to be an incidental outcome.	[Green, Cara-Paige; Lea, Mary-Anne; Wotherspoon, Simon; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Ratcliffe, Norman] British Antarctic Survey, Cambridge, England; [Mattern, Thomas; Borboroglu, Pablo Garcia] New Zealand Penguin Initiat, Dunedin, New Zealand; [Mattern, Thomas; Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Mattern, Thomas; Borboroglu, Pablo Garcia; Ellenberg, Ursula] Global Penguin Soc, Puerto Madryn, Chubut, Argentina; [Thompson, David; Morrison, Kyle W.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Lea, Mary-Anne; Hindell, Mark A.] Univ Tasmania, Australian Ctr Excellence Antarctic Sci, Hobart, Tas, Australia; [Wotherspoon, Simon] Australian Antarctic Div, Dept Agr Water & Environm, Kingston, Tas, Australia; [Borboroglu, Pablo Garcia] Consejo Nacl Invest Cient & Tecn, CESIMAR, Ctr El Estudio Sistemas Marinos, Puerto Madryn, Chubut, Argentina; [Ellenberg, Ursula] La Trobe Univ, Dept Ecol Environm & Evolut, Melbourne, Vic, Australia; [Puetz, Klemens] Antarctic Res Trust, Bremervorde, Germany; [Sagar, Paul M.] Natl Inst Water & Atmospher Res Ltd, Christchurch, New Zealand; [Torres, Leigh G.] Oregon State Univ, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR USA	University of Tasmania; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Tasmania; Australian Antarctic Division; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); La Trobe University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Oregon State University	Green, CP (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	carapaige.green@utas.edu.au	; Seddon, Philip/G-8659-2011; Lea, Mary-Anne/E-9054-2013	Mattern, Thomas/0000-0003-0745-8180; Seddon, Philip/0000-0001-9076-9566; Green, Cara-Paige/0000-0002-3582-8321; Lea, Mary-Anne/0000-0001-8318-9299	Global Penguin Society; National Geographic; British Ornithologists' Union (BOU) John & Pat Warham Studentship	Global Penguin Society; National Geographic(National Geographic Society); British Ornithologists' Union (BOU) John & Pat Warham Studentship	This work was supported by donations from the Antarctic Research Trust, Global Penguin Society and National Geographic. The funders provided support in the form of salaries and/or by covering the costs of field work for authors KP, PGB and KWM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Authors' contributions" section. This study forms part of a PhD funded by a British Ornithologists' Union (BOU) John & Pat Warham Studentship from a bequest left to the BOU by the late John and Pat Warham for the study of Sphenisciform and Procellariiform seabirds by a student from Commonwealth countries.	Bindoff AD, 2018, METHODS ECOL EVOL, V9, P1190, DOI 10.1111/2041-210X.12953; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; BROWN CR, 1987, J ZOOL, V212, P7, DOI 10.1111/j.1469-7998.1987.tb05111.x; Burke CM, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00063; Chapman CC, 2020, NAT CLIM CHANGE, V10, P209, DOI 10.1038/s41558-020-0705-4; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clay TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29932; Clewlow HL, 2019, J ANIM ECOL, V88, P223, DOI 10.1111/1365-2656.12919; Cole TL, 2019, MOL BIOL EVOL, V36, P784, DOI 10.1093/molbev/msz017; Cooper J., 1990, P131; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Davis LS., 2012, PENGUIN BIOL; de Dinechin M, 2009, J BIOGEOGR, V36, P693, DOI 10.1111/j.1365-2699.2008.02014.x; Dehnhard N, 2020, J ANIM ECOL, V89, P104, DOI 10.1111/1365-2656.13078; Dong F, 2020, MOL PHYLOGENET EVOL, V143, DOI 10.1016/j.ympev.2019.106671; Dufour CMS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117750; Dunn RE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62842-x; FENWICK GD, 1978, NEW ZEAL J MAR FRESH, V12, P205, DOI 10.1080/00288330.1978.9515742; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Friesen VL, 2015, J ORNITHOL, V156, pS27, DOI 10.1007/s10336-015-1235-0; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Granroth-Wilding HMV, 2019, IBIS, V161, P101, DOI 10.1111/ibi.12584; Green JA, 2005, MAR ECOL PROG SER, V296, P183, DOI 10.3354/meps296183; Hart KM, 2018, ECOL EVOL, V8, P12656, DOI 10.1002/ece3.4691; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Hindell MA, 2020, NATURE, V580, P87, DOI 10.1038/s41586-020-2126-y; Hindell MA, 2012, ECOL EVOL, V2, P1563, DOI 10.1002/ece3.281; Hiscock JA, 2014, NEW ZEAL J ECOL, V38, P124; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hull CL, 1999, WILDLIFE RES, V26, P789, DOI 10.1071/WR98028; Hull CL, 2000, CAN J ZOOL, V78, P333, DOI 10.1139/cjz-78-3-333; Hunt BPV, 2005, DEEP-SEA RES PT I, V52, P1241, DOI 10.1016/j.dsr.2004.11.019; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jones CW, 2020, MAR BIOL, V167, DOI 10.1007/s00227-020-3645-7; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Mattern T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198688; Mattern T, 2015, METHODS ECOL EVOL, V6, P859, DOI 10.1111/2041-210X.12398; Mattern T, 2009, EMU, V109, P204, DOI 10.1071/MU08001; Mattlin RH., 1985, NAFO STUD, V9, P39; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; Nakano S, 1999, J ANIM ECOL, V68, P1079, DOI 10.1046/j.1365-2656.1999.00355.x; Nardelli BB, 2017, J GEOPHYS RES-OCEANS, V122, P10042, DOI 10.1002/2017JC013314; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Poupart TA, 2019, MAR ECOL PROG SER, V614, P183, DOI 10.3354/meps12910; Pratte I, 2017, MAR ECOL PROG SER, V572, P243, DOI 10.3354/meps12144; Quillfeldt P, 2020, MOV ECOL, V8, DOI 10.1186/s40462-020-00212-y; Quillfeldt P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-15; Ratcliffe Norman, 2014, Marine Ornithology, V42, P23; Reif J, 2018, J ANIM ECOL, V87, P774, DOI 10.1111/1365-2656.12808; Reisinger RR, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200649; Robinson SA., 2001, U TASMANIA; Seyer Y, 2020, J ANIM ECOL, V89, P2934, DOI 10.1111/1365-2656.13346; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; SWALES M. K., 1965, IBIS, V107, P215, DOI 10.1111/j.1474-919X.1965.tb07297.x; Thiebot JB, 2020, J ORNITHOL, V161, P1033, DOI 10.1007/s10336-020-01791-8; Thiebot JB, 2014, IBIS, V156, P511, DOI 10.1111/ibi.12151; Thiebot JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071429; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; Thiebot JB, 2011, ANTARCT SCI, V23, P117, DOI 10.1017/S0954102010000957; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; van Heezik Y.M., 1989, Notornis, V36, P151; Venables H, 2012, DEEP-SEA RES PT II, V59, P14, DOI 10.1016/j.dsr2.2011.08.012; WARHAM J, 1974, Journal of the Royal Society of New Zealand, V4, P63; WARHAM J, 1974, IBIS, V116, P1, DOI 10.1111/j.1474-919X.1974.tb00220.x; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; Whitehead TO, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2794-6; Whitehead TO., 2017, U CAPE TOWN; WIENS JA, 1977, AM SCI, V65, P590; Young JW, 1996, MAR ECOL PROG SER, V138, P1, DOI 10.3354/meps138001	71	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262901	10.1371/journal.pone.0262901	http://dx.doi.org/10.1371/journal.pone.0262901			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139102	gold, Green Accepted, Green Published			2022-12-26	WOS:000821499100015
J	Kranz, S; Lukacs, J; Bishop, J; Block, ME				Kranz, Sibylle; Lukacs, Julia; Bishop, Jason; Block, Martin E.			Intergeneration transfer of diet patterns? Parental self-report of diet and their report of their young adult children with ASD	PLOS ONE			English	Article							FOOD SELECTIVITY; AUTISM; OBESITY	Autism Spectrum Disorder (ASD) affects two percent of American children and often results in neophobia, hypersensitivity to foods, and firmly set food preferences, leading to higher proportions of individuals suffering from diet-related chronic diseases. Our objective was to conduct an explorative pilot study to examine parents' perception of food intake for themselves and their young adult children with ASD. We employed comparative analysis to discover potential pathways to improve diet quality and lower the risk for chronic disease in individuals with ASD. Data from an online survey in n = 493 parent-child dyads on parentally reported intake patterns, food group, and food consumption was analyzed using kappa statistics to determine the level of agreement between reported parental and child intake patterns, body weight status and activity level. Average age was 48 years for parents and 22 years for their children, respectively. Parent-child agreement for obesity was high. We found very strong agreement between the reported diet variety (kappa = 0.82) and changing daily intake (kappa = 0.63) and strong agreement for some vegetable intake patterns (kappa = 0.61 for orange, white, and starchy vegetables) but not in meat intake (no agreement). Results of this study indicate evidence for perceived intergenerational transfer of dietary intake patterns, which may offer effective approaches to change parental diet, to subsequently improve diet quality in young adults with ASD and prevent diet-related chronic diseases in individuals with ASD.	[Kranz, Sibylle; Lukacs, Julia; Block, Martin E.] Univ Virginia, Dept Kinesiol, Charlottesville, VA 22904 USA; [Bishop, Jason] Auburn Univ, Dept Phys Educ, Montgomery, AL 36117 USA; [Kranz, Sibylle] Univ Virginia, Sch Educ & Human Dev, Dept Kinesiol, Charlottesville, VA 22904 USA	University of Virginia; Auburn University System; Auburn University; University of Virginia	Kranz, S (corresponding author), Univ Virginia, Dept Kinesiol, Charlottesville, VA 22904 USA.; Kranz, S (corresponding author), Univ Virginia, Sch Educ & Human Dev, Dept Kinesiol, Charlottesville, VA 22904 USA.	sibylle.kranz@virigina.edu	Kranz, Sibylle/G-1728-2017	Kranz, Sibylle/0000-0001-5637-1706	University of Virginia "Supporting Transformative Autism Research (STAR) Initiative	University of Virginia "Supporting Transformative Autism Research (STAR) Initiative	This study was funded by a pilot fund of the University of Virginia "Supporting Transformative Autism Research (STAR) Initiative to SK and MB.	Allison Robert L, 2017, S D Med, VSpec No, P10; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Anglesea MM, 2008, J APPL BEHAV ANAL, V41, P107, DOI 10.1901/jaba.2008.41-107; [Anonymous], 2020, COMM REP AUT; Beighley JS, 2013, RES DEV DISABIL, V34, P3497, DOI 10.1016/j.ridd.2013.07.026; Berding K, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00515; Center for Disease Control and Prevention, 2020, BEN QUITT; Chistol LT, 2018, J AUTISM DEV DISORD, V48, P583, DOI 10.1007/s10803-017-3340-9; Esteban-Figuerola P, 2019, AUTISM, V23, P1079, DOI 10.1177/1362361318794179; Hill AP, 2015, PEDIATRICS, V136, P1051, DOI 10.1542/peds.2015-1437; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meier AE, 2012, J APPL BEHAV ANAL, V45, P149, DOI 10.1901/jaba.2012.45-149; Mozaffari H, 2021, OBES REV, V22, DOI 10.1111/obr.13174; Neumeyer AM, 2018, J ACAD NUTR DIET, V118, P865, DOI 10.1016/j.jand.2017.11.006; Panossian C, 2021, J AUTISM DEV DISORD, V51, P685, DOI 10.1007/s10803-020-04567-4; Park HJ, 2021, FOODS, V10, DOI 10.3390/foods10010049; Ranjan S, 2015, ADV NUTR, V6, P397, DOI 10.3945/an.114.007914; Sanctuary MR, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00040; Singh RK, 2017, CR BIOL, V340, P87, DOI [10.1016/j.crvi.2016.11.007, 10.1016/j.crvi.2016.1]; Viera AJ, 2005, FAM MED, V37, P360; Volkert VM, 2010, J APPL BEHAV ANAL, V43, P155, DOI 10.1901/jaba.2010.43-155; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X; Yee AZH, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0501-3	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263445	10.1371/journal.pone.0263445	http://dx.doi.org/10.1371/journal.pone.0263445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134082	Green Published, gold			2022-12-26	WOS:000798968600014
J	McGuire, KDF; Schmidt, KT; Ta, P; Long, JJ; Yurko, M; Kimball, S				McGuire, Kylie D. F.; Schmidt, Katharina T.; Ta, Priscilla; Long, Jennifer J.; Yurko, Matthew; Kimball, Sarah			Is it best to add native shrubs to a coastal sage scrub restoration project as seeds or as seedlings?	PLOS ONE			English	Article							MANAGEMENT; PLANTS; COSTS; RATES; ESTABLISHMENT; COMPETITION; DATABASE; DENSITY; CLIMATE; GROWTH	Ecological restoration frequently involves the addition of native plants, but the effectiveness (in terms of plant growth, plant survival, and cost) of using seeds versus container plants has not been studied in many plant communities. It is also not known if plant success would vary by species or based on functional traits. To answer these questions, we added several shrub species to a coastal sage scrub restoration site as seeds or as seedlings in a randomized block design. We measured percent cover, density, species richness, size, survival, and costs. Over the two years of the study, shrubs added to the site as seeds grew more and continued to have greater density than plants added from containers. Seeded plots also had greater native species richness than planted plots. However, shrubs from containers had higher survival rates, and percent cover was comparable between the planted and seeded treatments. Responses varied by species depending on functional traits, with deep-rooted evergreen species establishing better from container plants. Our cost analysis showed that it is more expensive to use container plants than seed, with most of the costs attributed to labor and supplies needed to grow plants. Our measurements of shrub density, survival, species richness, and growth in two years in our experimental plots lead us to conclude that coastal sage scrub restoration with seeds is optimal for increasing density and species richness with limited funds, yet the addition of some species from container plants may be necessary if key species are desired as part of the project objectives.	[McGuire, Kylie D. F.; Schmidt, Katharina T.; Ta, Priscilla; Long, Jennifer J.; Kimball, Sarah] Univ Calif Irvine, Ctr Environm Biol, Irvine, CA 92697 USA; [Yurko, Matthew] Back Bay Sci Ctr, Project Grow Calif Coastal Commiss, Newport Beach, CA USA	University of California System; University of California Irvine	McGuire, KDF (corresponding author), Univ Calif Irvine, Ctr Environm Biol, Irvine, CA 92697 USA.	kdmcguire@uci.edu			Center for Environmental Biology (CEB) at the University of California, Irvine (UCI); Project Grow, a non-profit project of the California Coastal Commission; Tides Center	Center for Environmental Biology (CEB) at the University of California, Irvine (UCI); Project Grow, a non-profit project of the California Coastal Commission; Tides Center	This study was supported by the Center for Environmental Biology (CEB) at the University of California, Irvine (UCI) and by Project Grow, a non-profit project of the California Coastal Commission and the Tides Center.	Adams J, 2017, GRANADA NATIVE GARDE; [Anonymous], 2016, SAS VERS 9 4; Applestein C, 2018, NAT AREA J, V38, P347, DOI 10.3375/043.038.0504; Aprahamian AM, 2016, BOTANY, V94, P493, DOI 10.1139/cjb-2015-0226; Averett DE, 2012, SALVIA MELLIFERA; Balshor BJ, 2017, BOTANY, V95, P469, DOI 10.1139/cjb-2016-0248; Barr S, 2017, RESTOR ECOL, V25, P396, DOI 10.1111/rec.12445; Bell MD, 2019, RESTOR ECOL, V27, P298, DOI 10.1111/rec.12851; Bogler D, 2012, BACCHARIS SALICINA; Brauer CJ, 2020, EVOL APPL, V13, P2857, DOI 10.1111/eva.13128; Broadhurst LM, 2016, BIOSCIENCE, V66, P73, DOI 10.1093/biosci/biv155; Brouillet L, 2012, ACMISPON GLABER VAR; Busnardo MJ, 2017, ECOL RESTOR, V35, P354, DOI 10.3368/er.35.4.354; California Native Plant Society, CALSCAPE; California Native Plant Society, MANUAL CALIFORNIA VE; Clark Curtis, 2012, ENCELIA CALIFORNICA; Cleland EE, 2016, ECOSYSTEMS OF CALIFORNIA, P429; Corbin JD, 2004, ECOLOGY, V85, P1273, DOI 10.1890/02-0744; Palma AC, 2015, APPL VEG SCI, V18, P561, DOI 10.1111/avsc.12173; de Souza DC, 2018, ECOL ENG, V116, P35, DOI 10.1016/j.ecoleng.2018.02.019; Doust SJ, 2006, FOREST ECOL MANAG, V234, P333, DOI 10.1016/j.foreco.2006.07.014; Erickson VJ, 2020, RESTOR ECOL, V28, pS216, DOI 10.1111/rec.13199; Fan Y, 2017, P NATL ACAD SCI USA, V114, P10572, DOI 10.1073/pnas.1712381114; Goldstein LJ, 2014, ECOLOGY, V95, P425, DOI 10.1890/12-0651.1; Gould E., 2020, STATE WORKING AM WAG; Greet J, 2020, ECOL MANAG RESTOR, V21, P58, DOI 10.1111/emr.12396; Guinon M., 1989, ECOL RESTOR, V7, P56, DOI [10.3368/er.7.2.56, DOI 10.3368/ER.7.2.56]; Hanan EJ, 2017, ECOL MONOGR, V87, P76, DOI 10.1002/ecm.1234; Hardegree SP, 2012, CABI INVASIVE SER, P107, DOI 10.1079/9781845938116.0107; Holl KD, 2000, RESTOR ECOL, V8, P260, DOI 10.1046/j.1526-100x.2000.80037.x; Howard JL., 1992, MALOSMA LAURINA FIRE; Iversen CM, 2017, NEW PHYTOL, V215, P15, DOI 10.1111/nph.14486; James M. L., 2014, Monographs of the Western North American Naturalist, V7, P477, DOI 10.3398/042.007.0137; Janzen DH, 2020, BIOTROPICA, V52, P1017, DOI 10.1111/btp.12755; Jepson Flora Project, 2020, JEPSON EFLORA; Jonason D, 2014, ECOL EVOL, V4, P4287, DOI 10.1002/ece3.1288; Kattge J, 2020, GLOBAL CHANGE BIOL, V26, P119, DOI 10.1111/gcb.14904; Keil DJ, 2012, ISOCOMA MENZIESII VA; Kimball S, 2015, RESTOR ECOL, V23, P800, DOI 10.1111/rec.12261; Kimball S, 2019, PLANT ECOL, V220, P171, DOI 10.1007/s11258-018-0856-9; Kimball S, 2014, RESTOR ECOL, V22, P81, DOI 10.1111/rec.12022; Knapp WM, 2021, CONSERV BIOL, V35, P360, DOI 10.1111/cobi.13621; LEHOUEROU HN, 1992, AGROFOREST SYST, V18, P107, DOI 10.1007/BF00115408; Lesage JC, 2018, RESTOR ECOL, V26, P1061, DOI 10.1111/rec.12887; Li YM, 2020, RESTOR ECOL, V28, P1296, DOI 10.1111/rec.13221; Lima P, 2019, CIENC FLOREST, V29, P27, DOI 10.5902/1980509819340; Marushia RG, 2010, J APPL ECOL, V47, P1290, DOI 10.1111/j.1365-2664.2010.01881.x; Mathers HM, 2007, HORTTECHNOLOGY, V17, P151, DOI 10.21273/HORTTECH.17.2.151; MCKELL C M, 1966, California Agriculture, V20, P8; Meyer R., 2005, FIRE EFFECTS INFORM; Middleton EL, 2010, RESTOR ECOL, V18, P181, DOI 10.1111/j.1526-100X.2008.00501.x; Miller JM, 2012, MALOSMA LAURINA; Miller JM, 2012, RHUS INTEGRIFOLIA; Monaco T. A., 2012, Invasive plant ecology and management: linking processes to practice, DOI 10.1079/9781845938116.0000; Montalvo A. M., 2017, PLANT PROFILE RHUS O; Montalvo AM, 2000, CONSERV BIOL, V14, P1034, DOI 10.1046/j.1523-1739.2000.99250.x; Montalvo AM, 2002, RESTOR ECOL, V10, P52, DOI 10.1046/j.1526-100X.2002.10106.x; Montalvo AM., 2010, PLANT PROFILE ISOCOM; Montalvo AM., 2017, PLANT PROFILE ACMISP; Montalvo AM., 2017, PLANT PROFILE MALOSM; Montalvo AM., 2010, PLANT PROFILE SALVIA; Montalvo AM., 2018, PLANT PROFILE ERIOGO; Montalvo AM., 2017, PLANT PROFILE ARTEMI; Mortlock BW., 2000, ECOLOGICAL MANAGEMEN, V1, P93, DOI [10.1046/j.1442-8903.2000.00029.x, DOI 10.1046/J.1442-8903.2000.00029.X]; Nancy E.M., 1990, SALVIA MELLIFERA FIR; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Palmerlee A. P., 2010, Native Plants Journal, V11, P89, DOI 10.2979/NPJ.2010.11.2.89; Passaretti RA, 2020, APPL VEG SCI, V23, P406, DOI 10.1111/avsc.12495; Perez DR, 2019, RESTOR ECOL, V27, P1105, DOI 10.1111/rec.12961; R Core Team, 2021, R LANGUAGE ENV STAT; Raupp PP, 2020, ECOL ENG, V148, DOI 10.1016/j.ecoleng.2020.105788; Reveal JL, 2012, ERIOGONUM FASCICULAT; Shaw N, 2020, RESTOR ECOL, V28, pS276, DOI 10.1111/rec.13210; Shultz LM, 2012, ARTEMISIA CALIFORNIC; Smith JP, 2012, ELYMUS CONDENSATUS; Steinberg PD., 2002, BACCHARIS PILULARIS; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Stover HJ, 2018, ECOL RESTOR, V36, P19, DOI 10.3368/er.36.1.19; Stuble KL, 2017, J APPL ECOL, V54, P1051, DOI 10.1111/1365-2664.12861; Stylinski CD, 1999, J APPL ECOL, V36, P544, DOI 10.1046/j.1365-2664.1999.00423.x; Tamura N, 2017, RESTOR ECOL, V25, P942, DOI 10.1111/rec.12515; Tesky JL., 1993, ENCELIA FARINOSA FIR; *USDA, 2019, PLANTS DAT; USDA NRCS, PLANTS PROF LEYM CON; USDA NRCS, PLANTS PROF CLEOM IS; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Vanderpool SS, 2012, PERITOMA ARBOREA VAR; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Welch BL, 1997, J RANGE MANAGE, V50, P611, DOI 10.2307/4003456; WENT FW, 1952, ECOLOGY, V33, P351, DOI 10.2307/1932831; Wilkerson ML, 2014, RESTOR ECOL, V22, P782, DOI 10.1111/rec.12141; Williams MI, 2002, RESTOR ECOL, V10, P385, DOI 10.1046/j.1526-100X.2002.01025.x; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028; Young-Matthews A., 2010, PLANT GUIDE CALIFORN; Zacharias EH, 2013, ATRIPLEX LENTIFORMIS; Zahawi RA, 2014, RESTOR ECOL, V22, P284, DOI 10.1111/rec.12098; Zahawi RA, 2009, RESTOR ECOL, V17, P854, DOI 10.1111/j.1526-100X.2008.00423.x	98	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0262410	10.1371/journal.pone.0262410	http://dx.doi.org/10.1371/journal.pone.0262410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134054	Green Published, gold			2022-12-26	WOS:000798968600005
J	Heitz, F; Lakis, S; Harter, P; Heikaus, S; Sehouli, J; Talwar, J; Menon, R; Ataseven, B; Bertrand, M; Schneider, S; Mariotti, E; Bommert, M; Muller, JN; Prader, S; Leenders, F; Hengsbach, A; Gloeckner, C; Braicu, EI; Heukamp, LC; du Bois, A; Heuckmann, JM				Heitz, Florian; Lakis, Sotirios; Harter, Philipp; Heikaus, Sebastian; Sehouli, Jalid; Talwar, Jatin; Menon, Roopika; Ataseven, Beyhan; Bertrand, Miriam; Schneider, Stephanie; Mariotti, Erika; Bommert, Mareike; Mueller, Judith N.; Prader, Sonia; Leenders, Frauke; Hengsbach, Alexandra; Gloeckner, Christian; Braicu, Elena Ioana; Heukamp, Lukas C.; du Bois, Andreas; Heuckmann, Johannes M.			Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer	PLOS ONE			English	Article							TP53 MUTATIONS; 1ST CYCLE; CA-125; CHEMOTHERAPY; CARCINOMA; STATISTICS; DIAGNOSIS; KINETICS; DISEASE	Background The present prospective study aimed at determining the impact of cell-free tumor DNA (ct-DNA), CA125 and HE4 from blood and ascites for quantification of tumor burden in patients with advanced high-grade serous epithelial ovarian cancer (EOC). Methods Genomic DNA was extracted from tumor FFPE and ct-DNA from plasma before surgery and on subsequent post-surgical days. Extracted DNA was subjected to hybrid-capture based next generation sequencing. Blood and ascites were sampled before surgery and on subsequent post-surgical days. 20 patients (10 undergoing complete resection (TR0), 10 undergoing incomplete resection (TR>0)) were included. Results The minor allele frequency (MAF) of TP53 mutations in ct-DNA of all patients with TR0 decreased significantly, compared to only one patient with TR>0. It was not possible to distinguish between patients with TR0 and patients with TR>0, using CA125 and HE4 from blood and ascites. Conclusions Based upon the present findings, ct-DNA assessment in patients with high-grade serous EOC might help to better determine disease burden compared to standard tumor markers. Further studies should prospectively evaluate whether this enhancement of accuracy can help to optimize management of patients with EOC.	[Heitz, Florian; Harter, Philipp; Ataseven, Beyhan; Schneider, Stephanie; Bommert, Mareike; Prader, Sonia; Hengsbach, Alexandra; du Bois, Andreas] Evangel Kliniken Essen Mitte, Klin Gynakol & Gynakol Onkol, Essen, Germany; [Heitz, Florian; Sehouli, Jalid] Charite Univ Med Berlin, Charite Campus Virchow Klinikum, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany; [Heitz, Florian; Sehouli, Jalid] Free Univ Berlin, Berlin, Germany; [Heitz, Florian; Sehouli, Jalid] Humboldt Univ, Berlin Inst Hlth, Berlin, Germany; [Lakis, Sotirios; Talwar, Jatin; Menon, Roopika; Bertrand, Miriam; Mariotti, Erika; Mueller, Judith N.; Leenders, Frauke; Gloeckner, Christian; Heukamp, Lukas C.; Heuckmann, Johannes M.] NEO New Oncol GmbH, Cologne, Germany; [Lakis, Sotirios] ULTIVUE, Segrate, Italy; [Heikaus, Sebastian; Braicu, Elena Ioana] Evangel Kliniken Essen Mitte, Ctr Pathol, Essen, Germany; [Ataseven, Beyhan] Ludwig Maximilians Univ Munchen, Dept Obstet & Gynecol, Univ Hosp, Munich, Germany; [Bertrand, Miriam] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Prader, Sonia] Gen Hosp SABES ASDAA, Dept Obstet & Gynecol, Brixen Bres Sanone, Italy; [Prader, Sonia] Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria; [Heuckmann, Johannes M.] PearlRiver Bio GmbH, Dortmund, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Berlin Institute of Health; Humboldt University of Berlin; University of Munich; Eberhard Karls University of Tubingen; Medical University of Innsbruck	Heitz, F (corresponding author), Evangel Kliniken Essen Mitte, Klin Gynakol & Gynakol Onkol, Essen, Germany.; Heitz, F (corresponding author), Charite Univ Med Berlin, Charite Campus Virchow Klinikum, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany.; Heitz, F (corresponding author), Free Univ Berlin, Berlin, Germany.; Heitz, F (corresponding author), Humboldt Univ, Berlin Inst Hlth, Berlin, Germany.	florian.heitz@gmx.net		Braicu, Ioana/0000-0001-5357-6001; Ataseven, Beyhan/0000-0002-2823-7590	NewOncology, Cologne, Germany	NewOncology, Cologne, Germany	This study was supported by NewOncology, Cologne, Germany. The funders played a role in study design, and analysis, and preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Bidart JM, 1999, CLIN CHEM, V45, P1695; Cheng ML, 2021, CA-CANCER J CLIN, V71, P176, DOI 10.3322/caac.21650; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Edula RGR, 2018, J CLIN TRANSL HEPATO, V6, P241, DOI 10.14218/JCTH.2017.00070; Ferraro S, 2013, J CLIN PATHOL, V66, P273, DOI 10.1136/jclinpath-2012-201031; Fleming ND, 2011, GYNECOL ONCOL, V121, P249, DOI 10.1016/j.ygyno.2011.01.014; Goodall J, 2017, CANCER DISCOV, V7, P1006, DOI 10.1158/2159-8290.CD-17-0261; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Heitz F, 2019, GYNECOL ONCOL, V152, P235, DOI 10.1016/j.ygyno.2018.11.008; Heitz F, 2016, GYNECOL ONCOL, V141, P264, DOI 10.1016/j.ygyno.2016.03.015; Khier S, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0140; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Lee M, 2016, YONSEI MED J, V57, P580, DOI 10.3349/ymj.2016.57.3.580; Lindemann K, 2016, ANN ONCOL, V27, P1505, DOI 10.1093/annonc/mdw238; Merker JD, 2018, J CLIN ONCOL, V36, P1631, DOI 10.1200/JCO.2017.76.8671; Osumi H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53711-3; Paramasivam S, 2005, J CLIN ONCOL, V23, P5938, DOI 10.1200/JCO.2005.08.151; Parkinson CA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002198; Pereira B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23394-4; Ray-Coquard I, 2019, NEW ENGL J MED, V381, P2416, DOI 10.1056/NEJMoa1911361; Riedinger JM, 2007, ANN ONCOL, V18, P881, DOI 10.1093/annonc/mdl500; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; Scaletta G, 2017, EXPERT REV ANTICANC, V17, P827, DOI 10.1080/14737140.2017.1360138; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Vang R, 2016, INT J GYNECOL PATHOL, V35, P48, DOI 10.1097/PGP.0000000000000207; Weiss GJ, 2017, CLIN CANCER RES, V23, P5074, DOI 10.1158/1078-0432.CCR-17-0231; Wilbaux M, 2014, BRIT J CANCER, V110, P1517, DOI 10.1038/bjc.2014.75; Yu S, 2012, CLIN CHEM LAB MED, V50, P1439, DOI 10.1515/cclm-2011-0477; Yuan CZ, 2018, CLIN CHEM LAB MED, V56, P1026, DOI 10.1515/cclm-2017-1176; Zhang Y, 2016, TRANSL CANCER RES, V5, P650, DOI 10.21037/tcr.2016.08.40	33	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262770	10.1371/journal.pone.0262770	http://dx.doi.org/10.1371/journal.pone.0262770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130283	Green Published, gold			2022-12-26	WOS:000805530700011
J	Simieneh, A; Tadesse, M; Kebede, W; Gashaw, M; Abebe, G				Simieneh, Asnake; Tadesse, Mulualem; Kebede, Wakjira; Gashaw, Mulatu; Abebe, Gemeda			Combination of Xpert (R) MTB/RIF and Determine (TM) TB-LAM Ag improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Oromia, Ethiopia	PLOS ONE			English	Article							LIPOARABINOMANNAN LAM; URINE; HIV; ACCURACY	Background Ethiopia is one of the high burden countries for extrapulmonary tuberculosis (EPTB); however, the prompt diagnosis of EPTB remains challenging. This study is aimed to evaluate the diagnostic performance of Xpert MTB/RIF and Determine (TM) TB-LAM Ag (TB-LAM) for the prompt diagnosis of EPTB in Ethiopia. Methods A total of 147 presumptive EPTB patients, including 23 HIV- positive participants were enrolled. Extra-pulmonary samples were collected from all presumptive EPTB cases and tested for Mycobacterium tuberculosis complex (MTBC) using fluorescent microscopy, Xpert MTB/RIF, and culture. Additionally, urine samples were also collected from 126 participants and were tested by Determine (TM) TB-LAM Ag (Alere Inc, Waltham, USA). The Sensitivity and specificity of Xpert and TB- LAM tests were calculated by comparing with a composite reference standard (CRS), which comprises smear microscopy, culture and response to empirical anti-TB treatment. Results Of 147 patients, 23 (15.6%) were confirmed EPTB cases (culture-positive), 14 (9.5%) were probable EPTB (clinically, radiologically or cytologically positive and received anti-TB treatment with good response), and 110 (74.8%) were classified as "non- TB" cases. Compared to the composite reference standard (CRS), the overall sensitivity and specificity of Xpert MTB/RIF were 43.2% and 100%, respectively with the highest sensitivity for Lymph node aspirate (85.7%) and lower sensitivity for pleural fluid (14.3%) and 100% specificity for all specimen types. The sensitivity and specificity of TB-LAM were 33.3% and 94.4% respectively with the highest sensitivity for HIV co-infected participants (83.3%). The sensitivity of the combination of Xpert MTB/RIF and TB-LAM tests regardless of HIV status was 61.1% whereas the sensitivity was improved to 83.3% for HIV-positive cases. Conclusion TB-LAM alone has low sensitivity for EPTB diagnosis; however, the combination of TB-LAM and Xpert MTB/RIF improves the diagnosis of EPTB particularly for countries with high EPTB and HIV cases.	[Simieneh, Asnake; Tadesse, Mulualem; Kebede, Wakjira; Abebe, Gemeda] Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Simieneh, Asnake; Tadesse, Mulualem; Kebede, Wakjira; Gashaw, Mulatu; Abebe, Gemeda] Jimma Univ, Fac Hlth Sci, Sch Med Lab Sci, Jimma, Ethiopia; [Simieneh, Asnake] Mizan Tepi Univ, Dept Med Lab Sci, Mizan, Ethiopia	Jimma University; Jimma University	Tadesse, M (corresponding author), Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia.; Tadesse, M (corresponding author), Jimma Univ, Fac Hlth Sci, Sch Med Lab Sci, Jimma, Ethiopia.	mulualemt.tadesse@gmail.com	Abebe, Gemeda/AAB-8789-2019	Abebe, Gemeda/0000-0002-7172-9136; Adbaru, Mulatu Gashaw/0000-0002-2299-7863	Jimma University-Mycobacteriology Research Center, Jimma, Ethiopia	Jimma University-Mycobacteriology Research Center, Jimma, Ethiopia	This work was supported by Jimma University-Mycobacteriology Research Center, Jimma, Ethiopia. The funders had no role in study design, data acquisition, analysis and interpretation, or the decision to prepare the manuscript and submit for publication.	[Anonymous], 2020, MOL ASS INT IN TESTS; Atherton RR, 2018, INT J INFECT DIS, V75, P92, DOI 10.1016/j.ijid.2018.07.007; Berg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0846-7; Bisognin F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201934; Bjerrum S, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub3; Boyles TH, 2018, INT J INFECT DIS, V75, P67, DOI 10.1016/j.ijid.2018.08.005; Center for Disease Control and Prevention, 2014, NAT CTR HIV AIDS VIR; Chakravorty S, 2017, MBIO, V8, DOI [10.1128/mBio.00812-17, 10.1128/mbio.00812-17]; Correia-Neves M, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00115-2018; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Doublier S, 2007, AIDS, V21, P423, DOI 10.1097/QAD.0b013e328012c522; Global Laboratory Initiative, 2014, MYC LAB MAN, P154; Hamasur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123457; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Huddart S., 2016, J HLTH SPECIALTIES, V4, P230, DOI [10.4103/2468-6360.191903, DOI 10.4103/2468-6360.191903]; Huerga H, 2020, JAIDS-J ACQ IMM DEF, V83, P24, DOI 10.1097/QAI.0000000000002206; Huerga H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170976; Juma FO, 2017, J INFECTION, V75, P583, DOI 10.1016/j.jinf.2017.08.011; Kerkhoff AD, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01259-2019; Kroidl I, 2014, SCAND J INFECT DIS, V46, P144, DOI 10.3109/00365548.2013.853133; Lawn SD, 2016, T ROY SOC TROP MED H, V110, P180, DOI 10.1093/trstmh/trw008; Li H, 2016, NATURE, V530, P233, DOI 10.1038/nature16936; Linda M., 2011, CLIN MICROBIOL REV, V24; Murray P. R., 2020, MED MICROBIOLOGY, V9th; Norbis L, 2014, EXPERT REV ANTI-INFE, V12, P633, DOI 10.1586/14787210.2014.899900; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Purohit MR, 2017, APPL IMMUNOHISTO M M, V25, P282, DOI 10.1097/PAI.0000000000000300; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Selam N., 2017, BMC RES NOTES, V74; Solovic I., 2013, CHALLENGES DIAGNOSIN; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Suwanpimolkul G, 2017, INT J INFECT DIS, V59, P96, DOI 10.1016/j.ijid.2017.04.017; Tadesse M, 2019, CLIN MICROBIOL INFEC, V25, P1000, DOI 10.1016/j.cmi.2018.12.018; Timothy DM, 2014, GLOBAL ALLIANCE TB D; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; World Health O, 2015, USE LATERAL FLOW URI; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2011, AUT REAL TIM NUCL AC; World Health Organization, 2019, GLOB TUB REP	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263172	10.1371/journal.pone.0263172	http://dx.doi.org/10.1371/journal.pone.0263172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113917	Green Published, gold			2022-12-26	WOS:000823694700058
J	Broccia, G; Carter, J; Ozsin-Ozler, C; Meloni, F; De Matteis, S; Cocco, P				Broccia, Giorgio; Carter, Jonathan; Ozsin-Ozler, Cansu; Meloni, Federico; De Matteis, Sara; Cocco, Pierluigi			Incidence of non-Hodgkin's lymphoma among adults in Sardinia, Italy	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; MALIGNANT-LYMPHOMA; KAPOSIS-SARCOMA; VIRUS INFECTION; CANCER REGISTRY; RISK; EPIDEMIOLOGY; SURVIVAL; SUBTYPES; TRENDS	The causes of the peculiar time trend in the incidence of non-Hodgkin's lymphoma (NHL) in most parts of the world and of its geographic distribution are still unknown. We used the data base of 1974-2003 incident cases of hematological malignancies to explore the time trend of NHL incidence in the region of Sardinia, Italy, and we used Bayesian methods to plot the probability of NHL incidence by residential unit on the regional map. In 1974-2003, 4109 NHL cases were diagnosed among resident adults in Sardinia, with an incidence rate of 13.38 x 10(-5) (95% CI 12.97-13.80). NHL incidence showed an upward trend along the study period with an average annual percent change (APC) of 4.94 (95% CI -5.39-16.4), which did not vary by gender or by age-group. Cancer registry data, covering part of the region starting from 1993, suggest that the increasing trend did not persist in the subsequent years. Areas with the highest probability of an excess incidence tended to cluster in the north-eastern part of the region and in two major urban centers, with the low incidence areas located in the south, confirming previous observations. Prevalence of viral infections, environmental and occupational exposures, or socio-economic deprivation would not explain the peculiar geographic distribution we observed. These findings provide convincing arguments for extending the coverage of routine cancer registration over the whole Sardinian population, while prompting further research on the genetic and environmental determinants of NHL in the risk areas.	[Broccia, Giorgio] Hosp A Businco, Dept Haematol & Bone Marrow Transplants, Cagliari, Italy; [Carter, Jonathan] Univ Coventry, Coventry, W Midlands, England; [Ozsin-Ozler, Cansu] Hacettepe Univ, Fac Dent, Dept Paediat Dent, Ankara, Turkey; [Meloni, Federico; De Matteis, Sara; Cocco, Pierluigi] Univ Cagliari, Dept Med Sci & Publ Hlth, Monserrato, Italy; [Cocco, Pierluigi] Univ Manchester, Ctr Occupat & Environm Hlth, Div Populat Hlth, Manchester, Lancs, England	Coventry University; Hacettepe University; University of Cagliari; University of Manchester	Cocco, P (corresponding author), Univ Cagliari, Dept Med Sci & Publ Hlth, Monserrato, Italy.; Cocco, P (corresponding author), Univ Manchester, Ctr Occupat & Environm Hlth, Div Populat Hlth, Manchester, Lancs, England.	pcocco@unica.it	Cocco, Pierluigi/GRY-6549-2022	Cocco, Pierluigi/0000-0001-8256-7614				[Anonymous], 2021, CANC INCIDENCE 5 CON; Atzori L, 2004, BRIT J CANCER, V91, P1261, DOI 10.1038/sj.bjc.6602159; Becker N, 2012, J CANCER RES CLIN, V138, P1993, DOI 10.1007/s00432-012-1279-y; Bernardinelli L, 1994, ATLAS CANC MORTALITY; Biggeri Annibale, 2006, Epidemiol Prev, V30, P5; Bray F, 2017, CANC INCIDENCE 5 CON, VXI; Broccia G, 2014, ANN HEMATOL, V93, P1041, DOI 10.1007/s00277-013-2002-z; Broccia G, 2001, HAEMATOLOGICA, V86, P58; CAO A, 1978, J MED GENET, V15, P443, DOI 10.1136/jmg.15.6.443; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Cerhan JR, 2015, BLOOD, V126, P2265, DOI 10.1182/blood-2015-04-537498; Cocco P, 2008, OCCUP ENVIRON MED, V65, P132, DOI 10.1136/oem.2007.033548; Cocco P, 2010, OCCUP ENVIRON MED, V67, P341, DOI 10.1136/oem.2009.046839; Cocco P, 2008, INT J HEMATOL, V87, P474, DOI 10.1007/s12185-008-0086-3; Cocco P, 2013, OCCUP ENVIRON MED, V70, P91, DOI 10.1136/oemed-2012-100845; Cocco P, 2012, EPIDEMIOL PREV, V36, P41; Dal Maso L, 2003, LANCET ONCOL, V4, P110, DOI 10.1016/S1470-2045(03)00983-5; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; de Sanjose S, 2007, INT J CANCER, V121, P1806, DOI 10.1002/ijc.22857; Engels EA, 2003, MODERN PATHOL, V16, P424, DOI 10.1097/01.MP.0000056629.62148.55; Fazia T, 2018, MULT SCLER J, V24, P1815, DOI 10.1177/1352458517732841; Gombe Mbalawa C, 2014, CANC INCIDENCE 5 CON, V164; Green A, 2000, LANCET, V355, P873; Ingram Deborah D, 2018, Vital Health Stat 2, P1; ISAACSON PG, 1987, HISTOPATHOLOGY, V11, P445, DOI 10.1111/j.1365-2559.1987.tb02654.x; Italian Society of Doctors for the Environment Italian National Institute of Health Tuscany regionDepartment of the Environment, 1999, AV MORT PROV CAP; Keating P, 2003, MED HIST, V47, P291, DOI 10.1017/S0025727300057021; Kiran S, 2010, EPIDEMIOLOGY, V21, P905, DOI 10.1097/EDE.0b013e3181f4cc0f; Koenig R, 2001, SCIENCE, V291, P2074, DOI 10.1126/science.291.5511.2074; Lim RBT, 2015, INT J CANCER, V137, P2674, DOI 10.1002/ijc.29635; Luminari S, 2007, HEMATOL ONCOL, V25, P189, DOI 10.1002/hon.826; Minerba L, DEPRIVATION INDEXES; Miranda-Filho A, 2019, CANCER CAUSE CONTROL, V30, P489, DOI 10.1007/s10552-019-01155-5; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Sivia Devinderjit, 2006, DATA ANAL BAYESIAN T, DOI DOI 10.1007/10201161_90; van Leeuwen MT, 2014, INT J CANCER, V135, P2146, DOI 10.1002/ijc.28849; Ye XB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015106	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0260078	10.1371/journal.pone.0260078	http://dx.doi.org/10.1371/journal.pone.0260078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108286	Green Published, gold			2022-12-26	WOS:000775890100004
J	Kiffner, C; Paciencia, FMD; Henrich, G; Kaitila, R; Chuma, IS; Mbaryo, P; Knauf, S; Kioko, J; Zinner, D				Kiffner, Christian; Paciencia, Filipa M. D.; Henrich, Grace; Kaitila, Rehema; Chuma, Idrissa S.; Mbaryo, Pay; Knauf, Sascha; Kioko, John; Zinner, Dietmar			Road-based line distance surveys overestimate densities of olive baboons	PLOS ONE			English	Article							NATIONAL-PARK; PREY PREFERENCES; HABITAT USE; SPECIES RICHNESS; TRANSECT SURVEYS; PLANT PHENOLOGY; SEED DISPERSAL; LARGER MAMMALS; PAPIO-ANUBIS; FOREST	Estimating population density and population dynamics is essential for understanding primate ecology and relies on robust methods. While distance sampling theory provides a robust framework for estimating animal abundance, implementing a constrained, non-systematic transect design could bias density estimates. Here, we assessed potential bias associated with line distance sampling surveys along roads based on a case study with olive baboons (Papio anubis) in Lake Manyara National Park (Tanzania). This was achieved by comparing density estimates of olive baboons derived from road transect surveys with density estimates derived from estimating the maximum number of social groups (via sleeping site counts) and multiplying this metric with the estimated average size of social groups. From 2011 to 2019, we counted olive baboons along road transects, estimated survey-specific densities in a distance sampling framework, and assessed temporal population trends. Based on the fitted half-normal detection function, the mean density was 132.5 baboons km(-2) (95% CI: 110.4-159.2), however, detection models did not fit well due to heaping of sightings on and near the transects. Density estimates were associated with relatively wide confidence intervals that were mostly caused by encounter rate variance. Based on a generalized additive model, baboon densities were greater during the rainy seasons compared to the dry seasons but did not show marked annual trends. Compared to estimates derived from the alternative method (sleeping site survey), distance sampling along road transects overestimated the abundance of baboons more than threefold. Possibly, this overestimation was caused by the preferred use of roads by baboons. While being a frequently used technique (due to its relative ease of implementation compared to spatially randomized survey techniques), inferring population density of baboons (and possibly other species) based on road transects should be treated with caution. Beyond these methodological concerns and considering only the most conservative estimates, baboon densities in LMNP are among the highest across their geographic distribution range.	[Kiffner, Christian; Kioko, John] Ctr Wildlife Management Studies, Sch Field Studies, Karatu, Tanzania; [Kiffner, Christian] Max Planck Inst Evolutionary Anthropol Ecol & Cul, Dept Human Behav, Leipzig, Germany; [Kiffner, Christian] Leibniz Ctr Agr Landscape Res ZALF, Jr Res Grp Human Wildlife Conflict & Coexistence, Muncheberg, Germany; [Paciencia, Filipa M. D.; Zinner, Dietmar] Leibniz Inst Primate Res, Germany Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Henrich, Grace] Vassar Coll, Poughkeepsie, NY 12601 USA; [Kaitila, Rehema; Chuma, Idrissa S.; Mbaryo, Pay] Tanzania Natl Pk, Conservat Sci Unit Vet, Arusha, Tanzania; [Knauf, Sascha] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Int Anim Hlth One Hlth, Greifswald, Rise Riems, Germany; [Knauf, Sascha] Leibniz Inst Primate Res, Germany Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Zinner, Dietmar] Georg August Univ Gottingen, Dept Primate Cognit, Gottingen, Germany; [Zinner, Dietmar] Leibniz ScienceCampus Primate Cognit, Gottingen, Germany	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Deutsches Primatenzentrum (DPZ); Vassar College; Friedrich Loeffler Institute; Deutsches Primatenzentrum (DPZ); University of Gottingen	Zinner, D (corresponding author), Leibniz Inst Primate Res, Germany Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.; Zinner, D (corresponding author), Georg August Univ Gottingen, Dept Primate Cognit, Gottingen, Germany.; Zinner, D (corresponding author), Leibniz ScienceCampus Primate Cognit, Gottingen, Germany.	dzinner@gwdg.de	Kiffner, Christian/F-4088-2012	Kiffner, Christian/0000-0002-7475-9023; Zinner, Dietmar/0000-0003-3967-8014	Deutsche Forschungsgemeinschaft (DFG) [KN1097/4-1, ZI548/5-1]; DFG CK research funds of the The School for Field Studies	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG CK research funds of the The School for Field Studies	SK Deutsche Forschungsgemeinschaft (DFG) KN1097/4-1 DZ Deutsche Forschungsgemeinschaft (DFG) ZI548/5-1 DFG CK research funds of the The School for Field Studies.	Anandam MV, 2013, HDB MAMMALS WORLD, V3, P628; Araldi A, 2014, INT J PRIMATOL, V35, P941, DOI 10.1007/s10764-014-9772-6; Bapureddy G, 2015, CURR SCI INDIA, V108, P118; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; Beaver JT, 2014, WILDLIFE SOC B, V38, P419, DOI 10.1002/wsb.410; Bidner LR, 2018, AM J PRIMATOL, V80, DOI 10.1002/ajp.22932; Brashares Justin S., 2010, P221; Brugiere D, 2000, PRIMATES, V41, P373, DOI 10.1007/BF02557648; Buckland S.T., 2001, pi; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Cappelle N, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22962; Caro TM, 1999, J APPL ECOL, V36, P205, DOI 10.1046/j.1365-2664.1999.00392.x; Cavada N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148289; Chapman CA, 2018, INT J PRIMATOL, V39, P427, DOI 10.1007/s10764-018-0049-3; Chapman Colin A., 1999, P1, DOI 10.1017/CBO9780511542381.002; Chiarello AG, 2017, MAMMALIA, V81, P489, DOI 10.1515/mammalia-2015-0134; Chuma IS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50779-9; Clauss M, 2021, ECOL EVOL, V11, P13846, DOI 10.1002/ece3.8090; DeVore I., 1963, Publications in Anthropology Viking Fund, V36, P335; DeVore I., 1965, P20; Dudenhoeffer M, 2018, AFR J ECOL, V56, P179, DOI 10.1111/aje.12504; DUNBAR RIM, 1974, FOLIA PRIMATOL, V21, P36, DOI 10.1159/000155595; Foxcroft LC, 2007, APPL VEG SCI, V10, P265, DOI 10.1111/j.1654-109X.2007.tb00525.x; GREEN AA, 1979, MAMMALIA, V43, P59, DOI 10.1515/mamm.1979.43.1.59; GREENWAY PJ, 1969, J ECOL, V57, P127, DOI 10.2307/2258212; Hall JS, 2003, AFR PRIMATES, V6, P35; Hallmaier-Wacker LK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.65; HAMILTON WJ, 1982, AM J PRIMATOL, V3, P41, DOI 10.1002/ajp.1350030104; HARDING RSO, 1976, FOLIA PRIMATOL, V25, P143, DOI 10.1159/000155711; HAUSFATER G, 1982, Primates, V23, P287, DOI 10.1007/BF02381167; Havmoller RW, 2021, AFR J ECOL, V59, P37, DOI 10.1111/aje.12817; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Kasozi H, 2020, ECOL EVOL, V10, P6881, DOI 10.1002/ece3.6463; Kiffner C, 2020, ECOL INDIC, V110, DOI 10.1016/j.ecolind.2019.105903; Kiffner C, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2027; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; Knauf S, 2011, CLIN MANIFESTATION A; Knauf S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0156-4; Kunz BK, 2008, FOLIA PRIMATOL, V79, P31, DOI 10.1159/000108384; Kunz BK, 2008, J TROP ECOL, V24, P235, DOI 10.1017/S0266467408005014; LIEBERMAN D, 1979, ECOLOGY, V60, P65, DOI 10.2307/1936469; Markham AC, 2016, BEHAV ECOL, V27, P29, DOI 10.1093/beheco/arv118; Marks M, 2015, LANCET INFECT DIS, V15, P1220, DOI 10.1016/S1473-3099(15)00136-X; Marques TA, 2010, BIOMETRICS, V66, P1247, DOI 10.1111/j.1541-0420.2009.01381.x; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Mitani JC, 2000, INT J PRIMATOL, V21, P269, DOI 10.1023/A:1005477504728; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Msoffe F. U., 2011, International Journal of Biodiversity and Conservation, V3, P280; Mungure SA., 1980, MANYARA MONTHLY REPO; NAGEL U, 1973, FOLIA PRIMATOL, V19, P104, DOI 10.1159/000155536; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; Ogutu JO, 2006, J ZOOL, V269, P149, DOI 10.1111/j.1469-7998.2006.00055.x; Paciencia FMD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw9724; Paciencia FMD, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0261894; Paddock CL, 2020, AM J PRIMATOL, V82, DOI 10.1002/ajp.23083; Plumptre AJ, 2006, PRIMATES, V47, P65, DOI 10.1007/s10329-005-0146-8; PLUMPTRE AJ, 1994, J APPL ECOL, V31, P631, DOI 10.2307/2404154; Plumptre AJ, 2013, TECH ECOL CONSERVAT, P10; Prins H.H.T., 1986, ITC J, V2, P115; PRINS HHT, 1990, OECOLOGIA, V83, P392, DOI 10.1007/BF00317566; PRINS HHT, 1988, J BIOGEOGR, V15, P465, DOI 10.2307/2845276; PRINS HHT, 1988, J BIOGEOGR, V15, P451, DOI 10.2307/2845275; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; R Core Team, 2021, R LANG ENV STAT; Ransom TW., 1981, BEACH TROOP GOMBE; ROWELL TE, 1966, J ZOOL, V149, P344, DOI 10.1111/j.1469-7998.1966.tb04054.x; SAPOLSKY RM, 1987, J MED PRIMATOL, V16, P229; Sinsin B, 2002, MAMMALIA, V66, P369, DOI 10.1515/mamm.2002.66.3.369; Steinbeiser CM, 2019, J MAMMAL, V100, P192, DOI 10.1093/jmammal/gyy175; Strandburg-Peshkin A, 2017, ELIFE, V6, DOI 10.7554/eLife.19505; Strum SC, 2015, J ARID ENVIRON, V118, P37, DOI 10.1016/j.jaridenv.2015.02.015; Taylor RA, 2016, ECOLOGY, V97, P951, DOI 10.1890/15-0885.1; Tew E, 2018, AFR J WILDL RES, V48, DOI 10.3957/056.048.023002; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Timoteo S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02658-y; Vink DN, 2020, INT J PRIMATOL, V41, P901, DOI 10.1007/s10764-020-00142-x; Wallis J., PAPIO ANUBIS IUCN RE, DOI [10.2305/IUCN.UK.2020-2.RLTS.T40647A17953200.en, DOI 10.2305/IUCN.UK.2020-2.RLTS.T40647A17953200.EN]; Waltert M, 2008, J WILDLIFE MANAGE, V72, P603, DOI 10.2193/2006-456; Warren Y, 2011, DEV PRIMATOL-PROG PR, P307, DOI 10.1007/978-1-4419-7403-7_8; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood S., 2020, MGCV MIXED GAM COMPU; Wuesthoff EF, 2021, J MAMMAL, V102, P1266, DOI 10.1093/jmammal/gyab082; Zinner D, GOTTINGEN RES ONLINE, P2021, DOI [10. 25625/6FJPIG, DOI 10.25625/6FJPIG]	87	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263314	10.1371/journal.pone.0263314	http://dx.doi.org/10.1371/journal.pone.0263314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108346	Green Published, gold			2022-12-26	WOS:000775890100056
J	Morna, MT; Tuoyire, DA; Jimah, BB; Eliason, S; Appiah, AB; Rahman, GA				Morna, Martin Tangnaa; Tuoyire, Derek Anamaale; Jimah, Bashiru Babatunde; Eliason, Sebastian; Appiah, Anthony Baffour; Rahman, Ganiyu Adebisi			Prevalence and characterization of asymptomatic thyroid nodules in Assin North District, Ghana	PLOS ONE			English	Article							ULTRASOUND; RISK; ULTRASONOGRAPHY; INCIDENTALOMAS; MALIGNANCY; FREQUENCY	Background Ultrasound is now the initial imaging modality of choice for detection and characterization of lesions of the thyroid gland. Ultrasound imaging studies of the thyroid gland report varied prevalence of asymptomatic thyroid nodules (ATN), ranging from 20 to 67%. This study estimated the prevalence, characterized and determined factors associated with ATN in selected communities in the Assin North Municipality, Central Region, Ghana. Methods The study was a cross-sectional design, involving 320 participants from six (6) communities in the Assin North District of the Central Region of Ghana. Socio-demographic data and data from ultrasound examination of the thyroid gland were analyzed using descriptive and inferential statistical techniques. Results The prevalence of ATN was 11.3% among 320 participants with the mean age of 56.53 (+/- 16.5) years. ATNs were common in the left lobe (69%) and predominantly solitary (64%). ATNs increased with age and body mass index (BMI). Those aged 60 years and above had significantly higher odds (OR = 24.40, 95% CI = 2.59-229.86) of having ATNs, likewise overweigh (OR = 5.32, 95% CI = 1.12-25.20) and obese (OR = 12.51, 95% CI = 1.47-106.58) individuals. Conclusion The prevalence of ATN in our study population was relatively low, and more predictable among those 60 years or older, those in unhealthy BMI categories. There is the need for the reinforcement and intensification of educational campaigns on the consumption of iodized dietary salt as well as the consumption of foods rich in iodine content, particularly among older individuals.	[Morna, Martin Tangnaa; Appiah, Anthony Baffour; Rahman, Ganiyu Adebisi] Univ Cape Coast, Sch Med Sci, Dept Surg, Cape Coast, Ghana; [Tuoyire, Derek Anamaale; Eliason, Sebastian] Univ Cape Coast, Sch Med Sci, Dept Community Med, Cape Coast, Ghana; [Jimah, Bashiru Babatunde] Univ Cape Coast, Sch Med Sci, Dept Med Imaging, Cape Coast, Ghana; [Appiah, Anthony Baffour] Univ Ghana, Sch Publ Hlth, Ghana Field Epidemiol & Lab Training Programme GF, Accra, Ghana	University of Cape Coast; University of Cape Coast; University of Cape Coast; University of Ghana	Morna, MT (corresponding author), Univ Cape Coast, Sch Med Sci, Dept Surg, Cape Coast, Ghana.	drmorna@yahoo.com	Jimah, Bashiru/GON-6978-2022	JIMAH, BASHIRU/0000-0002-6101-6546; Baffour Appiah, Anthony/0000-0001-6559-8507; Morna, Martin Tangnaa/0000-0001-7366-6215				Andrioli M, 2013, EUR THYROID J, V2, P37, DOI 10.1159/000347144; Der EM, 2013, J MED BIOMED SCI, V2, P1; Der EM, 2018, J CANC SCI CLIN ONCO, V5, P1; Diab N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49540-z; Gallo Marco, 2003, Endocr Pract, V9, P194; Ivanac G, 2004, COLLEGIUM ANTROPOL, V28, P287; Jeffery RW, 2002, OBES RES, V10, P809, DOI 10.1038/oby.2002.109; Kamran M, 2014, PAK J MED SCI, V30, P793; Kang HW, 2004, THYROID, V14, P29, DOI 10.1089/105072504322783812; Karaszewski Bartosz, 2006, Endokrynol Pol, V57, P196; Kayastha P, 2010, J I MED, V32, P36; Kim DL, 2008, ENDOCR J, V55, P135, DOI 10.1507/endocrj.K07-120; Liebeskind A, 2005, J ULTRAS MED, V24, P629, DOI 10.7863/jum.2005.24.5.629; Mihailescu DV, 2008, J CLIN ENDOCR METAB, V93, P2188, DOI 10.1210/jc.2008-0055; Mirowsky J, 2005, LOND REV EDUC, V3, P205, DOI 10.1080/14748460500372366; Mohammadi A, 2009, IRAN J RADIOL, V6, P65; Moifo B, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0194-8; Moon JH, 2018, KOREAN J INTERN MED, V33, P753, DOI 10.3904/kjim.2015.273; Nutrition Department-GHS GAIN U., 2017, NAT IOD SURV REP GHA; Olusola-Bello M A, 2013, Afr J Med Med Sci, V42, P125; Primary Health Care Performance Initiative, 2020, UT PRIM HLTH CAR COV; Puca E, 2016, INT J LIFE SCI RES, V4, P138; Rad MP, 2015, J MED ULTRASOUND, V23, P25, DOI 10.1016/j.jmu.2014.04.005; Russ G, 2014, EUR THYROID J, V3, P154, DOI 10.1159/000365289; Sarfo-Kantanka O, 2017, J THROID RES, V2017, DOI 10.1155/2017/7843972; Shao FF, 2017, INT J CLIN EXP MED, V10, P10890; Shayeb M Al, 2018, CLIN PRACT, V15, P873, DOI [10.4172/clinical-practice.100, DOI 10.4172/CLINICAL-PRACTICE.100]; Suliman AAAE, 2018, AUSTIN J OBSTET GYNE, V5, P1, DOI [10.26420/austinjobstetgynecol.2018.1121, DOI 10.26420/AUSTINJOBSTETGYNECOL.2018.1121]; Suzuki S, 2015, ENDOCR J, V62, P261, DOI 10.1507/endocrj.EJ14-0478; Taheri MS, 2008, IRAN J RADIOL, V5, P19; Welker MJ, 2003, AM FAM PHYSICIAN, V67, P559; Wiest PW, 1998, J ULTRAS MED, V17, P487	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263365	10.1371/journal.pone.0263365	http://dx.doi.org/10.1371/journal.pone.0263365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108333	gold, Green Published			2022-12-26	WOS:000775890100063
J	Hirata Sanches, V; Adams, C; Ferreira, FF				Sanches, Vitor Hirata; Adams, Cristina; Ferreira, Fernando Fagundes			An integrated model to study varietal diversity in traditional agroecosystems	PLOS ONE			English	Article							SEED EXCHANGE; MANIHOT-ESCULENTA; MAIZE; AGROBIODIVERSITY; MANAGEMENT; CONSERVATION; ECOLOGY; CASSAVA; DOMESTICATION; BIODIVERSITY	Agricultural diversity is one of the bases of traditional agroecosystems, having great environmental and cultural importance. The current loss of agricultural diversity is causing serious concern, mainly because of its essential role in supporting global and local food security. Stopping this loss requires a better understanding of how diversity is managed locally and what mechanisms sustain agricultural diversity. Here we propose a generalist agent-based model that couples biological, cultural, and social dynamics to obtain varietal diversity as an emergent phenomenon at the community level. With a mechanistic approach, we explore how four of the model dynamics can shape systems diversity. To validate the model, we performed a bibliographic review on Manihot esculenta and Zea mays case studies. The model yielded compatible results for manioc and maize varietal richness at both community and household levels.	[Sanches, Vitor Hirata; Adams, Cristina; Ferreira, Fernando Fagundes] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil; [Adams, Cristina] Univ Sao Paulo, Inst Energy & Environm, Sao Paulo, SP, Brazil; [Ferreira, Fernando Fagundes] Univ Sao Paulo, Dept Phys, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Hirata Sanches, V (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil.	vitors.hirata@gmail.com		Hirata Sanches, Vitor/0000-0002-9555-799X				Abizaid C, 2016, HUM ECOL, V44, P577, DOI 10.1007/s10745-016-9852-7; Adams C, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P281, DOI 10.1007/978-1-4020-9283-1_13; Barbillon P, 2015, J THEOR BIOL, V365, P365, DOI 10.1016/j.jtbi.2014.10.032; Beillouin D, 2021, GLOBAL CHANGE BIOL, V27, P4697, DOI 10.1111/gcb.15747; Belem M, 2018, JASSS-J ARTIF SOC S, V21, DOI 10.18564/jasss.3690; Bongaarts J, 2019, POPUL DEV REV, V45, P680, DOI 10.1111/padr.12283; Bonneuil C, 2012, ECOL INDIC, V23, P280, DOI 10.1016/j.ecolind.2012.04.002; Brush SB, 2004, YALA AGRARIAN STUDIE; Cash DW, 2006, ECOL SOC, V11; Clement C. R., 2010, Diversity, V2, P72; CONABIO, 2017, EC AGR SMALL LARG SC; Coomes OT, 2010, PROF GEOGR, V62, P323, DOI 10.1080/00330124.2010.483628; de Souza MB, 2014, PHYSICA A, V393, P312, DOI 10.1016/j.physa.2013.08.045; Dyer GA, 2018, GENET RESOUR CROP EV, V65, P29, DOI 10.1007/s10722-017-0507-3; Dyer GA, 2014, P NATL ACAD SCI USA, V111, P14094, DOI 10.1073/pnas.1407033111; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; Emperaire L, 2005, REV PATRIMONIO HIST, V32, P30; Emperaire L, 2003, ACTES BRG, V4, P247; Emperaire L., 2001, BIODIVERSIDADE AMAZO, P225; Emperaire L, 2007, HUM ECOL, V35, P761, DOI 10.1007/s10745-007-9121-x; Epstein J. M., 1999, Complexity, V4, P41, DOI 10.1002/(SICI)1099-0526(199905/06)4:5<41::AID-CPLX9>3.0.CO;2-F; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; FAO, 2014, BIOD FOOD AGR CONTR; FAO, 2010, 2 REP STAT WORLDS PL; FAO, 1997, STAT WORLDS PLANT GE; FAO, 1999, AGR BIOD MULT CHAR A; Fraser JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043636; Heckler S, 2008, HUM ECOL, V36, P679, DOI 10.1007/s10745-008-9193-2; IPBES, 2021, COR GLOSS; Isendahl C, 2011, LAT AM ANTIQ, V22, P452, DOI 10.7183/1045-6635.22.4.452; Jackson L, 2005, AGROBIODIVERSITY NEW, P4; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Kato Yamakake TA., 2009, ORIGEN DIVERSIFICAIO; Kistler L, 2018, SCIENCE, V362, P1309, DOI 10.1126/science.aav0207; Labeyrie V, 2021, AGRON SUSTAIN DEV, V41, DOI 10.1007/s13593-020-00662-z; Leclerc C., 2011, DIVERSITY, V4, P1, DOI [DOI 10.3390/D4010001, 10.3390/d4010001]; Legovic T, 1997, ECOL MODEL, V99, P19, DOI 10.1016/S0304-3800(96)01919-9; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Marston JM, 2011, J ANTHROPOL ARCHAEOL, V30, P190, DOI 10.1016/j.jaa.2011.01.002; May R.M., 2007, THEOR ECOL-NETH; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Mir C, 2013, THEOR APPL GENET, V126, P2671, DOI 10.1007/s00122-013-2164-z; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Nazarea VD., 2006, CULTURAL MEMORY BIOD; Netting R. M., 1993, SMALLHOLDERS HOUSEHO, DOI DOI 10.1111/j.1558-5646.2009.00817.x; Newman M.E.J., 2010, NETWORKS INTRO; Oliveira Alessandro Roberto de, 2019, Vibrant, Virtual Braz. Anthr., V16, pe16552, DOI 10.1590/1809-43412019v16d552; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Orozco-Ramirez Q, 2017, AGR HUM VALUES, V34, P377, DOI 10.1007/s10460-016-9720-5; Pascual U, 2011, ECON AGRAR RECUR NAT, V11, P191, DOI 10.7201/earn.2011.01.09; Pautasso M, 2015, AGRON SUSTAIN DEV, V35, P145, DOI 10.1007/s13593-014-0222-9; Pautasso M, 2013, AGRON SUSTAIN DEV, V33, P151, DOI 10.1007/s13593-012-0089-6; Pena-Venegas CP, 2017, CULT AGRIC FOOD ENVI, V39, P127, DOI 10.1111/cuag.12087; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Perez D, 2019, ACTA BIOL COLOMB, V24, P202, DOI 10.15446/abc.v24n2.75428; Pimbert M., 1999, GATEKEEPER SERIES, V88; Pinton F, 2001, GENET SEL EVOL, V33, pS491, DOI 10.1186/BF03500896; Sadiki M., 2007, Managing biodiversity in agricultural ecosystems, P34; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Schluter M, 2019, ECOL SOC, V24, DOI 10.5751/ES-11012-240311; Thomas M, 2011, GENET RESOUR CROP EV, V58, P321, DOI 10.1007/s10722-011-9662-0; Thrupp LA., 1998, CULTIVATING DIVERSIT; Veteto JR, 2009, CULT AGRIC FOOD ENVI, V31, P73, DOI 10.1111/j.1556-486X.2009.01022.x; Williams NE, 2016, J POLIT ECOL, V23, P223, DOI 10.2458/v23i1.20210; Winterhalder B, 1999, J ARCHAEOL RES, V7, P301, DOI 10.1023/A:1021910301700	66	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263064	10.1371/journal.pone.0263064	http://dx.doi.org/10.1371/journal.pone.0263064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089959	Green Published, gold			2022-12-26	WOS:000769158400037
J	Ijdi, RE; Tumlinson, K; Curtis, SL				Ijdi, Rashida-E; Tumlinson, Katherine; Curtis, Sian L.			Exploring association between place of delivery and newborn care with early-neonatal mortality in Bangladesh	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; INFANT-MORTALITY; DEATHS; STILLBIRTHS; HEALTH; QUALITY; INDIA; RISK	Objective Bangladesh achieved the fourth Millennium Development Goal well ahead of schedule, with a significant reduction in under-5 mortality between 1990 and 2015. However, the reduction in neonatal mortality has been stagnant in recent years. The purpose of this study is to explore the association between place of delivery and newborn care with early neonatal mortality (ENNM), which represents more than 80% of total neonatal mortality in Bangladesh. Methods In this study, 2014 Bangladesh Demographic and Health Survey data were used to assess early neonatal survival in children born in the three years preceding the survey. The roles of place of the delivery and newborn care in ENNM were examined using multivariable logistic regression models adjusted for clustering and relevant socio-economic, pregnancy, and newborn characteristics. Results Between 2012 and 2014, there were 4,624 deliveries in 17,863 sampled households, 39% of which were delivered at health facilities. The estimated early neonatal mortality rate during this period was 15 deaths per 1,000 live births. We found that newborns who had received at least 3 components of essential newborn care (ENC) were 56% less likely to die during the first seven days of their lives compared to their counterparts who received 0-2 components of ENC (aOR: 0.44; 95% CI: 0.24-0.81). In addition, newborns who had received any postnatal care (PNC) were 68% less likely to die in the early neonatal period than those who had not received any PNC (aOR: 0.32; 95% CI: 0.16-0.64). Facility delivery was not significantly associated with the risk of early newborn death in any of the models. Conclusion Our study findings highlight the importance of newborn and postnatal care in preventing early neonatal deaths. Further, findings suggest that increasing the proportion of women who give birth in a healthcare facility is not sufficient to reduce ENNM by itself; to realize the theoretical potential of facility delivery to avert neonatal deaths, we must also ensure quality of care during delivery, guarantee all components of ENC, and provide high-quality early PNC. Therefore, sustained efforts to expand access to high-quality ENC and PNC are needed in health facilities, particularly in facilities serving low-income populations.	[Ijdi, Rashida-E; Tumlinson, Katherine; Curtis, Sian L.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27515 USA; [Ijdi, Rashida-E; Tumlinson, Katherine; Curtis, Sian L.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ijdi, RE (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27515 USA.; Ijdi, RE (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA.	rashida.ijdi@gmail.com	Tumlinson, Katherine/E-6975-2013	Tumlinson, Katherine/0000-0001-8314-8219				Abir T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187090; Akter T, 2016, J PERINATOL, V36, P225, DOI 10.1038/jp.2015.181; Al Kibria GM, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0363-8; Alam N, 2007, TROP MED INT HEALTH, V12, P1506, DOI 10.1111/j.1365-3156.2007.01959.x; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Belizan JM, 2012, AM J PERINAT, V29, P649, DOI 10.1055/s-0032-1314885; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Blanc AK, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010405; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Fikree Fariyal F., 2006, JPMA Journal of the Pakistan Medical Association, V56, P156; Fottrell E, 2015, ARCH DIS CHILD-FETAL, V100, pF439, DOI 10.1136/archdischild-2014-307636; Government of the People's Republic of Bangladesh, 2016, MILLENNIUM DEV GOALS; Greenland S., 2012, MODERN EPIDEMIOLOGY, V2nd; Halim A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159388; Hossain MB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221503; Kamal S. M. M., 2012, Journal of Nepal Paediatric Society, V32, P37, DOI 10.3126/jnps.v32i1.4845; Kim E, 2017, MATERN CHILD HLTH J, V21, P2078, DOI 10.1007/s10995-017-2319-7; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Kunkel M, 2019, SEMIN PERINATOL, V43, P252, DOI 10.1053/j.semperi.2019.03.014; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lehtonen L, 2017, SEMIN FETAL NEONAT M, V22, P153, DOI 10.1016/j.siny.2017.02.006; Lohela TJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45148-5; Luke B, 2006, PEDIATRICS, V118, P2488, DOI 10.1542/peds.2006-1824; Malqvist M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-762; National Institute of Population Research and Training (NIPORT) Association for Community and Population Research (ACPR) and ICF International, 2016, 2014 BANGL HLTH FAC; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Ngoc NTN, 2006, B WORLD HEALTH ORGAN, V84, P699, DOI 10.2471/BLT.05.027300; NIPORT. & ICF, 2019, BANGL HLTH FAC SURV; Pullum TW, 2014, DHS METHODOLOGICAL R, V11; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Sven K., 2010, EPIDEMIOLOGY, V21, P159, DOI [10.1097/EDE.0b013e3181c307ce, DOI 10.1097/EDE.0B013E3181C307CE]; Titaley CR, 2012, HEALTH POLICY PLANN, V27, P405, DOI 10.1093/heapol/czr053; United Nations Population Division, LEV TRENDS CHILD MOR; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; World Health Organization, 2013, SERVICE AVAILABILITY; World Health Organization, 2006, NEONATAL PERINATAL M; World Health Organization (WHO), 2017, WORLD HLTH ORG WHO R; World Health Organization (WHO) The United Nations Children's Fund (UNICEF), 2014, EV NEWB ACT END PREV	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262408	10.1371/journal.pone.0262408	http://dx.doi.org/10.1371/journal.pone.0262408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085299	Green Published, gold			2022-12-26	WOS:000779379600052
J	Liang, QL; Wei, LX; Xu, BL; Liu, J; Zhang, SW; Liu, LL				Liang, Qiaolan; Wei, Liexin; Xu, Bingliang; Liu, Jia; Zhang, Shuwu; Liu, Lilong			Induction of resistance of Podosphaera xanthii (hull-less pumpkin powdery mildew) to triazole fungicides and its resistance mechanism	PLOS ONE			English	Article							1ST REPORT; SECHIUM-EDULE; GENE	The aim of this study was to uncover the molecular mechanism through which fungicide resistance develops in Podosphaera xanthii, a fungi that causes powdery mildew in hull-less pumpkin. Treatments of inoculated P. xanthii were carried out on leaves of hull-less pumpkin and subsequently treated with kinds of triazole fungicide for seven generations. Resistant strains of P. xanthii thus obtained were evaluated for their resistance levels. The resistance levels of the fungi to four fungicides of were high except that of the propiconazole-resistant strain, which showed moderate resistance. The F7 generations of five resistant strains thus obtained were cultured continuously for five generations without fungicide induction, and their resistance level were found to be relatively stable. The DNA of the sensitive strain and the five kinds of resistant strains were extracted by the sodium dodecyl sulfate (SDS) method and its internal transcribed spacer (ITS) region was amplified by using ITS1/ITS4 primer and specific primer F/R and they were sequenced respectively. The DNA sequence comparison of resistant and sensitive strains showed that the base pairs of tebuconazole-resistant strains and flusilazole-resistant strains were mutated, with mutation rates of 4.8% and 1.6%, respectively. The base pairs of the other three resistant strains did not change.	[Liang, Qiaolan; Wei, Liexin; Xu, Bingliang; Liu, Jia; Zhang, Shuwu; Liu, Lilong] Gansu Agr Univ, Coll Plant Protect, Lanzhou, Peoples R China; [Liang, Qiaolan; Wei, Liexin; Xu, Bingliang; Liu, Jia; Zhang, Shuwu; Liu, Lilong] Biocontrol Engn Lab Crop Dis & Pests Gansu Prov, Lanzhou, Peoples R China	Gansu Agricultural University	Liang, QL (corresponding author), Gansu Agr Univ, Coll Plant Protect, Lanzhou, Peoples R China.; Liang, QL (corresponding author), Biocontrol Engn Lab Crop Dis & Pests Gansu Prov, Lanzhou, Peoples R China.	liangqiaolan@126.com			Special Funds for Discipline Construction of Gansu Agricultural University [GAU-XKJS-2018-155]; Lanzhou Science and Technology Bureau Project [2018-4-78]	Special Funds for Discipline Construction of Gansu Agricultural University; Lanzhou Science and Technology Bureau Project	We are grateful for the assistance of all staff and students in the Biocontrol Engineering Laboratory of Crop Diseases and Pests of Gansu Province, College of Plant Protection, Gansu Agricultural University, Lanzhou, China. We would like to thank Editage (www.editage.cn) for English language editing.	Bahadori MH, 2021, ANAT CELL BIOL, V54, P104, DOI 10.5115/acb.20.228; Braun U, 2019, MYCOL PROG, V18, P335, DOI 10.1007/s11557-018-1453-y; Chi WJ, 2009, GENETIC DIVERSITY MO; Choi IY, 2015, PLANT DIS, V99, P162, DOI 10.1094/PDIS-10-14-1011-PDN; Choi IY, 2020, J PLANT PATHOL, V102, P599, DOI 10.1007/s42161-019-00482-5; Cui H, 2018, PLANT DIS, V102, P2374, DOI 10.1094/PDIS-12-17-1993-PDN; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Delye C, 1997, APPL ENVIRON MICROB, V63, P2966; [韩欢欢 Han Huanhuan], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P124; Kami D, 2016, ACTA HORTIC, V1127, P415, DOI 10.17660/ActaHortic.2016.1127.64; Kousik CS, 2011, PLANT DIS, V95, P1586, DOI 10.1094/PDIS-06-11-0521; Lebeda A, 2016, EUR J PLANT PATHOL, V144, P399, DOI 10.1007/s10658-015-0776-7; Li FK., 2020, CHINA VEGETABLES, P56; Liang QL, 2021, PLANT DIS, V105, DOI 10.1094/PDIS-04-20-0703-PDN; [梁巧兰 Liang Qiaolan], 2018, [植物保护, Plant Protection], V44, P87; Liang QiaoLan, 2010, Mycosystema, V29, P636; Liu LiLong, 2019, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V40, P101; Liu XB., 2006, CHINA WATERMELON MUS, V1, P10; McGrath MT, 2003, PLANT DIS, V87, P1007, DOI 10.1094/PDIS.2003.87.8.1007A; Musa S., 2015, J AM OIL CHEM SOC, V93, P1095; Parker Josie E., 2014, Journal of Chemical Biology, V7, P143, DOI 10.1007/s12154-014-0121-1; Pirondi A, 2014, PLANT DIS, V98, P1581, DOI 10.1094/PDIS-02-14-0210-PDN; Radocaj O, 2017, AGRO FOOD IND HI TEC, V28, P63; Singh R, 2009, PLANT DIS, V93, P1348, DOI 10.1094/PDIS-93-12-1348A; Tanska M, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10081104; Van de Wouw AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188106; Vanden Bossche H, 1994, Trends Microbiol, V2, P393, DOI 10.1016/0966-842X(94)90618-1; Wang HW., 2004, FOOD MACHINEY, V20, P55; Wang L, 2011, SENSITIVITY POPULATI, P22; Wang M, 2002, CHINESE WATERMELON M, P42; Yang P., 2010, SENSITIVITY POPULATI, P23	31	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263068	10.1371/journal.pone.0263068	http://dx.doi.org/10.1371/journal.pone.0263068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104292	Green Published, gold			2022-12-26	WOS:000749789300010
J	Boscaro, C; Baggio, C; Carotti, M; Sandona, D; Trevisi, L; Cignarella, A; Bolego, C				Boscaro, Carlotta; Baggio, Chiara; Carotti, Marcello; Sandona, Dorianna; Trevisi, Lucia; Cignarella, Andrea; Bolego, Chiara			Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation	FASEB JOURNAL			English	Article						FAK; miR-206; miR-26b; ovarian cancer cells; PFKFB3	FOCAL ADHESION KINASE; MESSENGER-RNA; ER-ALPHA; EXPRESSION; INVASION; GLYCOLYSIS; OVEREXPRESSION; METABOLISM; ACTIVATION; CARCINOMA	Few studies explored the role of microRNAs (miRNAs) in the post-transcriptional regulation of glycolytic proteins and downstream effectors in ovarian cancer cells. We recently showed that the functional activation of the cytoskeletal regulator FAK in endothelial cells is fostered by the glycolytic enhancer 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). We tested the hypothesis that miR-206 and mir-26b, emerging onco-suppressors targeting PFKFB3 in estrogen-dependent tumors, would regulate proliferation and migration of serous epithelial ovarian cancer (EOC) cells via common glycolytic proteins, i.e., GLUT1 and PFKFB3, and downstream FAK. PFKFB3 was overexpressed in SKOV3, and its pharmacological inhibition with 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) significantly reduced cell proliferation and motility. Both miR-206 and miR-26b directly targeted PFKFB3 as evaluated by a luciferase reporter assay. However, endogenous levels of miR-26b were higher than those of miR-206, which was barely detectable in SKOV3 as well as OVCAR5 and CAOV3 cells. Accordingly, only the anti-miR-26b inhibitor concentration-dependently increased PFKFB3 levels. While miR-206 overexpression impaired proliferation and migration by downregulating PFKFB3 levels, the decreased PFKFB3 protein levels related to miR-26 overexpression had no functional consequences in all EOC cell lines. Finally, consistent with the migration outcome, exogenous miR-206 and miR-26b induced opposite effects on the levels of total FAK and of its phosphorylated form at Tyr576/577. 3PO did not prevent miR-26b-induced SKOV3 migration. Overall, these results support the inverse relation between endogenous miRNA levels and their tumor-suppressive effects and suggest that restoring miR-206 expression represents a potential dual anti-PFKFB3/FAK strategy to control ovarian cancer progression.	[Boscaro, Carlotta; Baggio, Chiara; Trevisi, Lucia; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy; [Carotti, Marcello; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, Padua, Italy; [Cignarella, Andrea] Univ Padua, Dept Med, Padua, Italy	University of Padua; University of Padua; University of Padua	Bolego, C (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy.	chiara.bolego@unipd.it			Universita degli Studi di Padova (University of Padova) [PRID 2018]; Muscular Dystrophy Association (MDA) [577888]	Universita degli Studi di Padova (University of Padova); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	Universita degli Studi di Padova (University of Padova), Grant/Award Number: PRID 2018; Muscular Dystrophy Association (MDA), Grant/Award Number: 577888	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Adorno-Cruz V, 2021, GENES DIS, V8, P493, DOI 10.1016/j.gendis.2020.01.015; Atsumi T, 2002, CANCER RES, V62, P5881; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bolego C, 2006, BIOCHEM BIOPH RES CO, V339, P188, DOI 10.1016/j.bbrc.2005.11.017; Boscaro C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.587221; Boscaro C, 2020, FASEB J, V34, P12768, DOI 10.1096/fj.202001130R; Cantuaria G, 2001, CANCER-AM CANCER SOC, V92, P1144, DOI 10.1002/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Cho H, 2013, CANCER INVEST, V31, P607, DOI 10.3109/07357907.2013.849722; Dai CX, 2018, BIOMED PHARMACOTHER, V104, P763, DOI 10.1016/j.biopha.2018.05.077; Diaz Osterman CJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47327; Du JY, 2015, ONCOL REP, V33, P1890, DOI 10.3892/or.2015.3797; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Fan JY, 2016, TUMOR BIOL, V37, P6855, DOI 10.1007/s13277-015-4558-9; Fan YB, 2016, ONCOL LETT, V12, P1113, DOI 10.3892/ol.2016.4730; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gajek A, 2021, CANCERS, V13, DOI 10.3390/cancers13112690; Ge X, 2015, BIOCHEM BIOPH RES CO, V463, P1115, DOI 10.1016/j.bbrc.2015.06.068; Ghafouri-Fard S, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104381; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/ol.2012.1057; He YJ, 2019, EPIGENOMICS-UK, V11, P1021, DOI 10.2217/epi-2019-0072; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kotowski K, 2021, CANCERS, V13, DOI 10.3390/cancers13040909; Levy A, 2019, CURR CANCER DRUG TAR, V19, P179, DOI 10.2174/1568009618666180706165222; Lin JX, 2015, ONCOTARGET, V6, P23793, DOI 10.18632/oncotarget.4363; Mondal S, 2019, INT J CANCER, V144, P178, DOI 10.1002/ijc.31868; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Murphy JM, 2020, EXP MOL MED, V52, P877, DOI 10.1038/s12276-020-0447-4; Naser R, 2018, CANCERS, V10, DOI 10.3390/cancers10060196; Nguyen N, 2014, J BIOL CHEM, V289, P3209, DOI 10.1074/jbc.M113.525154; Nowak N, 2018, OPEN LIFE SCI, V13, P569, DOI 10.1515/biol-2018-0068; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Qi C, 1999, BIOCHEM BIOPH RES CO, V263, P265, DOI 10.1006/bbrc.1999.1328; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sheng N, 2018, CELL PHYSIOL BIOCHEM, V50, P810, DOI 10.1159/000494467; Shi LL, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.44; Singh Pankaj K, 2011, Mol Cell Pharmacol, V3, P125; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Subramaniam S, 2019, CLIN CHEM, V65, P1090, DOI 10.1373/clinchem.2018.299651; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Taylor C, 2017, ONCOTARGET, V8, P17960, DOI 10.18632/oncotarget.14910; Trenti A, 2017, J PHARMACOL EXP THER, V361, P398, DOI 10.1124/jpet.116.238212; Tyagi K, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188563; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wu Q, 2019, TOXICOL APPL PHARM, V367, P12, DOI 10.1016/j.taap.2019.01.016; Xintaropoulou C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4521-4; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhao HY, 2019, J CANCER, V10, P4989, DOI 10.7150/jca.30772; Zhu AS, 2016, J CELL BIOCHEM, V117, P1370, DOI 10.1002/jcb.25428; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163768	55	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22140	10.1096/fj.202101222R	http://dx.doi.org/10.1096/fj.202101222R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35107852				2022-12-26	WOS:000761250800019
J	Urena, F; Ma, C; Hoffmann, FW; Urschitz, J; Moisyadi, S; Khadka, VS; Deng, YP; Hoffmann, PR; Nunes, LGA				Urena, Frank; Ma, Chi; Hoffmann, FuKun W.; Urschitz, Johann; Moisyadi, Stefan; Khadka, Vedbar S.; Deng, Youping; Hoffmann, Peter R.; Nunes, Lance G. A.			T-cell activation decreases miRNA-15a/16 levels to promote MEK1-ERK1/2-Elk1 signaling and proliferative capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MIR-15/16; PIGGYBAC; ELK-1; PATHOGENESIS; EXPRESSION; PATHWAYS; LIGATION; MICRORNA	While miRs have been extensively studied in the context of malignancy and tumor progression, their functions in regulating T-cell activation are less clear. In initial studies, we found reduced levels of miR-15a/16 at 3 to 18 h post-T-cell receptor (TCR) stimulation, suggesting a role for decreased levels of this miR pair in shaping T-cell activation. To further explore this, we developed an inducible miR15a/16 transgenic mouse model to determine how elevating miR-15a/16 levels during early stages of activation would affect T-cell proliferation and to identify TCR signaling pathways regulated by this miR pair. Doxycycline (DOX)-induced expression of miR-15a/ 16 from 0 to 18 h post-TCR stimulation decreased ex vivo T-cell proliferation as well as in vivo antigen-specific T-cell proliferation. We also combined bioinformatics and proteomics approaches to identify the mitogen-activated protein kinase kinase 1 (MEK1) (Map2k1) as a target of miR-15a/16. MEK1 targeting by miR-15a/16 was confirmed using miR mimics that decreased Map2k1 mRNA containing the 30-UTR target nucleotide sequence (UGCUGCUA) but did not decrease Map2k1 containing a mutated control sequence (AAAAA AAA). Phosphorylation of downstream signaling molecules, extracellular signal-regulated protein kinase 1/2 (ERK1/2) and Elk1, was also decreased by DOX-induced miR-15a/16 expression. In addition to MEK1, ERK1 was subsequently found to be targeted by miR-15a/16, with DOX-induced miR15a/16 reducing total ERK1 levels in T cells. These findings show that TCR stimulation reduces miR-15a/16 levels at early stages of T-cell activation to facilitate increased MEK1 and ERK1, which promotes the sustained MEK1-ERK1/2-Elk1 signaling required for optimal proliferation.	[Urena, Frank; Ma, Chi; Hoffmann, FuKun W.; Hoffmann, Peter R.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI USA; [Urena, Frank] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI USA; [Urschitz, Johann; Moisyadi, Stefan; Nunes, Lance G. A.] Univ Hawaii, Dept Anat Physiol & Biochem, John A Burns Schoolof Med, Honolulu, HI USA; [Khadka, Vedbar S.; Deng, Youping] Univ Hawaii, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA	University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii System	Hoffmann, PR (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI USA.	peterrh@hawaii.edu	; Khadka, Vedbar/O-4156-2018	/0000-0002-0589-2963; Khadka, Vedbar/0000-0002-8652-2904	National Institutes of Health [R01AI147496, P20GM103466, P20GM103457, R24GM137786]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health grants R01AI147496, P20GM103466, P20GM103457, and R24GM137786. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Chetoui N, 2011, J CELL BIOCHEM, V112, P3666, DOI 10.1002/jcb.23300; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dzafo E, 2021, IMMUNOL REV, V300, P181, DOI 10.1111/imr.12932; Tapeh BEG, 2020, J CELL PHYSIOL, V235, P8461, DOI 10.1002/jcp.29689; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Gagnon JD, 2019, CELL REP, V28, P2169, DOI 10.1016/j.celrep.2019.07.064; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang EY, 2015, FUTURE ONCOL, V11, P2351, DOI 10.2217/fon.15.101; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Liang QL, 2010, J IMMUNOL, V185, P5704, DOI 10.4049/jimmunol.1000690; Lovat F, 2020, P NATL ACAD SCI USA, V117, P12332, DOI 10.1073/pnas.2003597117; Lovat F, 2015, P NATL ACAD SCI USA, V112, P11636, DOI 10.1073/pnas.1514954112; Ma C, 2021, MOL METAB, V47, DOI 10.1016/j.molmet.2021.101170; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Mut M, 2012, INT J BIOCHEM CELL B, V44, P302, DOI 10.1016/j.biocel.2011.10.025; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Pekarsky Y, 2015, CELL DEATH DIFFER, V22, P6, DOI 10.1038/cdd.2014.87; Pekarsky Y, 2018, CELL DEATH DIFFER, V25, P21, DOI 10.1038/cdd.2017.159; RAO VN, 1994, ONCOGENE, V9, P1855; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Scherm MG, 2020, CURR DIABETES REP, V20, DOI 10.1007/s11892-020-01325-9; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Tagawa H, 2013, CANCER SCI, V104, P801, DOI 10.1111/cas.12160; Teteloshvili Nato, 2015, Microrna, V4, P117; Tsukamoto H, 2004, J BIOL CHEM, V279, P48457, DOI 10.1074/jbc.M403087200; Urschitz J, 2010, P NATL ACAD SCI USA, V107, P8117, DOI 10.1073/pnas.1003674107; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	33	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101634	10.1016/j.jbc.2022.101634	http://dx.doi.org/10.1016/j.jbc.2022.101634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085550	Green Published, gold			2022-12-26	WOS:000789261900013
J	Walklate, J; Kao, KRY; Regnier, M; Geeves, MAA				Walklate, Jonathan; Kao, Kerry; Regnier, Michael; Geeves, Michael A. A.			Exploring the super-relaxed state of myosin in myofibrils from fast-twitch, slow-twitch, and cardiac muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP TURNOVER; MECHANISM; HEADS; CONFORMATION; MOLECULE; KINETICS; CONTRACTILITY; TEMPERATURE; INHIBITION; EXPRESSION	Muscle myosin heads, in the absence of actin, have been shown to exist in two states, the relaxed (turnover similar to 0.05 s(-1)) and super-relaxed states (SRX, 0.005 s(-1)) using a simple fluo-rescent ATP chase assay (Hooijman, P. et al (2011) Biophys. J. 100, 1969-1976). Studies have normally used purified proteins, myosin filaments, or muscle fibers. Here we use muscle myofibrils, which retain most of the ancillary proteins and 3-D architecture of muscle and can be used with rapid mixing methods. Recording timescales from 0.1 to 1000 s provides a precise measure of the two populations of myosin heads present in relaxed myofibrils. We demonstrate that the population of SRX states is formed from rigor cross bridges within 0.2 s of relaxing with fluorescently labeled ATP, and the population of SRX states is relatively constant over the temperature range of 5 & nbsp;C-30 & nbsp;C. The SRX population is enhanced in the presence of mavacamten and reduced in the presence of deoxy-ATP. Compared with myofibrils from fast-twitch muscle, slow twitch muscle, and cardiac muscles, myofibrils require a tenfold lower concentration of mavacamten to be effective, and mavacamten induced a larger increase in the population of the SRX state. Mavacamten is less effective, however, at stabilizing the SRX state at physiological temperatures than at 5 & nbsp;C. These assays require small quantities of myofibrils, making them suitable for studies of model organism muscles, human biopsies, or human-derived iPSCs.	[Walklate, Jonathan; Geeves, Michael A. A.] Univ Kent, Sch Biosci, Div Nat Sci, Canterbury, Kent, England; [Kao, Kerry; Regnier, Michael] Univ Washington, Dept Bioengn, Seattle, WA USA	University of Kent; University of Washington; University of Washington Seattle	Geeves, MAA (corresponding author), Univ Kent, Sch Biosci, Div Nat Sci, Canterbury, Kent, England.	m.a.geeves@kent.ac.uk		Geeves, Michael/0000-0002-9364-8898	European Unions Horizon 2020 research and innovation programme [777204]; NIH [RM1 GM131981, R01HL128368]	European Unions Horizon 2020 research and innovation programme; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 777204 (M. A. G., M. R) . Additional funding was provided by NIH R01HL128368 (M. R.) and NIH RM1 GM131981 (M. R.) .	Alamo L, 2016, J MOL BIOL, V428, P1142, DOI 10.1016/j.jmb.2016.01.027; Anderson RL, 2018, P NATL ACAD SCI USA, V115, pEB143, DOI 10.1073/pnas.1809540115; Caremani M, 2019, J GEN PHYSIOL, V151, P1272, DOI 10.1085/jgp.201912424; Chu SM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101157; Cooke Roger, 2011, Biophys Rev, V3, P33; Fusi L, 2015, BIOPHYS J, V109, P783, DOI 10.1016/j.bpj.2015.06.038; Gollapudi SK, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016506; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; JACKSON AP, 1988, BIOCHEM J, V251, P527, DOI 10.1042/bj2510527; Kawas RF, 2017, J BIOL CHEM, V292, P16571, DOI 10.1074/jbc.M117.776815; Korte FS, 2011, J MOL CELL CARDIOL, V51, P894, DOI 10.1016/j.yjmcc.2011.08.026; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Lee KH, 2018, P NATL ACAD SCI USA, V115, pE1991, DOI 10.1073/pnas.1715247115; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lionne C, 2003, J MUSCLE RES CELL M, V24, P139, DOI 10.1023/A:1026045328949; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Locher MR, 2011, AM J PHYSIOL-HEART C, V300, pH869, DOI 10.1152/ajpheart.00452.2010; Ma WK, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012780; Ma WK, 2020, J PHYSIOL-LONDON, V598, P5165, DOI 10.1113/JP280402; MA YZ, 1994, BIOPHYS J, V66, P1542, DOI 10.1016/S0006-3495(94)80945-2; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; MYBURGH KH, 1995, J GEN PHYSIOL, V106, P957, DOI 10.1085/jgp.106.5.957; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; Nag S, 2021, ELIFE, V10, DOI 10.7554/eLife.63703; Nelson SR, 2020, BIOPHYS J, V119, P1050, DOI 10.1016/j.bpj.2020.07.036; Nowakowski SG, 2013, P NATL ACAD SCI USA, V110, P6187, DOI 10.1073/pnas.1220693110; Nyitrai M, 2003, BIOPHYS J, V85, P1053, DOI 10.1016/S0006-3495(03)74544-5; Padron R, 2020, P NATL ACAD SCI USA, V117, P11865, DOI 10.1073/pnas.1921312117; Palpant NJ, 2015, DEVELOPMENT, V142, P3198, DOI 10.1242/dev.117010; Park-Holohan SJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023706118; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Rohde JA, 2018, P NATL ACAD SCI USA, V115, pE7486, DOI 10.1073/pnas.1720342115; Scarff CA, 2020, NATURE, V588, P515, DOI 10.1038/s41586-020-2990-5; Scellini B, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012789; Schmid M, 2021, BIOL OPEN, V10, DOI 10.1242/bio.057646; Schoffstall B, 2006, BIOPHYS J, V91, P2216, DOI [10.1529/biophysj.105.079061, 10.1529/biophysj.107.079061]; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Sitbon YH, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012801; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; Tikunov BA, 2001, J APPL PHYSIOL, V90, P1927, DOI 10.1152/jappl.2001.90.5.1927; Toepfer CN, 2020, CIRCULATION, V141, P828, DOI 10.1161/CIRCULATIONAHA.119.042339; Toniolo L, 2005, J EXP BIOL, V208, P4243, DOI 10.1242/jeb.01904; Walklate J, 2019, ANAL BIOCHEM, V581, DOI 10.1016/j.ab.2019.06.009; Walklate J, 2015, ANAL BIOCHEM, V476, P11, DOI 10.1016/j.ab.2015.01.020; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wilson C, 2014, BIOPHYS J, V107, P1637, DOI 10.1016/j.bpj.2014.07.075; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Xu S, 2003, BIOCHEMISTRY-US, V42, P390, DOI 10.1021/bi026085t; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; Yang SX, 2020, NATURE, V588, P521, DOI 10.1038/s41586-020-3007-0	53	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101640	10.1016/j.jbc.2022.101640	http://dx.doi.org/10.1016/j.jbc.2022.101640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090895	Green Published, gold, Green Accepted			2022-12-26	WOS:000789261900005
J	Sanchez-Samaniego, G; Mausezahl, D; Carcamo, C; Probst-Hensch, N; Verastegui, H; Hartinger, SM				Sanchez-Samaniego, Giuliana; Maeusezahl, Daniel; Carcamo, Cesar; Probst-Hensch, Nicole; Verastegui, Hector; Hartinger, Stella Maria			Metabolic syndrome in rural Peruvian adults living at high altitudes using different cookstoves	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; STOVE INTERVENTION; BLOOD-PRESSURE; SYSTEM; WOMEN; URBANIZATION; CONSUMPTION; IMPACT; SMOKE	This study determined the prevalence of metabolic syndrome (MetS) in open fire stoves and improved cookstoves users (ICS) in the rural Peruvian Andes. Participants answered a socioeconomic questionnaire, one 24-hour food recall and underwent a physical examination. We analysed data from 385 participants, 190 (112 women and 78 men) were ICS users and 195 (123 women and 72 men) were open fire stove users. The prevalence of MetS was 21.3, 26.4% in women and 13.3% in men. We found no statistically significant association between the type of cookstove and MetS. Body mass index and altitude were important determinants of MetS. Research on cardiometabolic diseases and open fire stove use contributes to understanding the effect of household air pollution on health in high altitude populations.	[Sanchez-Samaniego, Giuliana; Maeusezahl, Daniel; Probst-Hensch, Nicole; Hartinger, Stella Maria] Swiss TPH, Dept Epidemiol & Publ Hlth, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Sanchez-Samaniego, Giuliana; Maeusezahl, Daniel; Probst-Hensch, Nicole; Hartinger, Stella Maria] Univ Basel, Basel, Switzerland; [Sanchez-Samaniego, Giuliana; Carcamo, Cesar; Verastegui, Hector; Hartinger, Stella Maria] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, UPCH, Lima, Peru; [Sanchez-Samaniego, Giuliana] Univ Geneva, Fac Sci, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidad Peruana Cayetano Heredia; University of Geneva	Mausezahl, D (corresponding author), Swiss TPH, Dept Epidemiol & Publ Hlth, Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Mausezahl, D (corresponding author), Univ Basel, Basel, Switzerland.	daniel.maeusezahl@unibas.ch		Probst-Hensch, Nicole/0000-0001-8561-5976; /0000-0001-5639-5337	Fondation Ernst et Lucie Schmidheiny; Fogarty International Center of the National Institutes of Health [D43TW009375]; GeoHealth Hub Peru [U01TW010107]; SwissPeruvian Health Research Platform of Swiss Tropical and Public Health Institute and Universidad Peruana Cayetano Heredia	Fondation Ernst et Lucie Schmidheiny; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); GeoHealth Hub Peru; SwissPeruvian Health Research Platform of Swiss Tropical and Public Health Institute and Universidad Peruana Cayetano Heredia	This work was supported by the Fondation Ernst et Lucie Schmidheiny, the Groupe de Recherche en Environnement et Sante ' (University of Geneva) and by the Fogarty International Center of the National Institutes of Health under Kuskaya: An Interdisciplinary Training Program for Innovation in Global Health (Award Number D43TW009375) and under GeoHealth Hub Peru (Award Number. U01TW010107). The SwissPeruvian Health Research Platform of Swiss Tropical and Public Health Institute and Universidad Peruana Cayetano Heredia hosted the project providing housing, transport, personnel and accommodation for the team. The content of the article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alcala HE, 2015, MEDICINE, V94, P1, DOI 10.1097/MD.0000000000001441; Alexander D, 2015, AIR QUAL ATMOS HLTH, V8, P47, DOI 10.1007/s11869-014-0267-6; Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Anonymous, 2006, Metabolic Syndrome and Related Disorders, V4, P1, DOI 10.1089/met.2006.4.1; [Anonymous], 2015, PER ENF TRANSM TRANS; Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; Baracco Rossana, 2007, Metabolic Syndrome and Related Disorders, V5, P55, DOI 10.1089/met.2006.0019; Benziger CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138968; Bernabe-Ortiz A, 2017, HEART, V103, P827, DOI 10.1136/heartjnl-2016-310347; Chaturvedi N, 2003, HEART, V89, P681, DOI 10.1136/heart.89.6.681; Commodore AA, 2013, INT J OCCUP ENV HEAL, V19, P43, DOI 10.1179/2049396712Y.0000000014; Cosselman KE, 2015, NAT REV CARDIOL, V12, P627, DOI 10.1038/nrcardio.2015.152; Crdenas MK, 2014, IDENTIFICANDO BARRER; D'Orazio P, 2005, CLIN CHEM, V51, P1573, DOI 10.1373/clinchem.2005.051979; Dhingra R, 2012, MED CLIN N AM, V96, P87, DOI 10.1016/j.mcna.2011.11.003; Djousse L, 2008, CURR ATHEROSCLER REP, V10, P117, DOI 10.1007/s11883-008-0017-z; Ferreira CED, 2015, CLIN CHIM ACTA, V446, P263, DOI 10.1016/j.cca.2015.04.036; Du YX, 2016, J THORAC DIS, V8, pE8, DOI 10.3978/j.issn.2072-1439.2015.11.37; Dutta A, 2011, INDOOR AIR, V21, P165, DOI 10.1111/j.1600-0668.2010.00694.x; Escobar-Agreda Stefan, 2021, J Migr Health, V3, P100015, DOI 10.1016/j.jmh.2020.100015; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Eze IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130337; Garcia-Perez I, 2017, LANCET DIABETES ENDO, V5, P184, DOI 10.1016/S2213-8587(16)30419-3; Goryakin Y, 2017, ECON HUM BIOL, V26, P151, DOI 10.1016/j.ehb.2017.03.004; Hartinger SM, 2013, INDOOR AIR, V23, P342, DOI 10.1111/ina.12027; Hartinger SM, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00950-y; Huicho L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-47; ICF, 2012, HOUS US SOL FUEL COO; IHME, 2018, COUNTR PROF PER; INEI, 2015, PER PRINC IND DEP 20; INEI, 1993, MAPA NECESIDADES BSI; Kuhnlein HV, 2004, DOCUMENTING TRADITIO; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Lopez-Pascual A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00658; McCracken JP, 2007, ENVIRON HEALTH PERSP, V115, P996, DOI 10.1289/ehp.9888; Mendoza W, 2017, CARDIOL CLIN, V35, P1, DOI 10.1016/j.ccl.2016.08.004; Miranda J Jaime, 2012, BMJ Open, V2, pe000610, DOI 10.1136/bmjopen-2011-000610; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Naghavi M., 2017, LANCET, V390, P1151, DOI [10.1016/S0140-6736(17)32152-9, DOI 10.1016/S0140-6736(17)32152-9]; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Olopade CO, 2017, ENVIRON INT, V98, P181, DOI 10.1016/j.envint.2016.11.004; Pistrosch F, 2011, DIABETES CARE, V34, pS128, DOI 10.2337/dc11-s207; Pradhan AD, 2014, CLIN CHEM, V60, P44, DOI 10.1373/clinchem.2013.202549; Rajkumar S, 2019, ENVIRON RES, V170, P46, DOI 10.1016/j.envres.2018.12.010; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Sanchez-Samaniego G, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.1604117; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Villafuerte FC, 2016, HIGH ALT MED BIOL, V17, P61, DOI 10.1089/ham.2016.0031; WHO, 2005, WHO AIR QUAL GUID PA; Wolf J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070745; World Health Organization, 2021, CONSOLIDATED GUIDELI; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	54	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263415	10.1371/journal.pone.0263415	http://dx.doi.org/10.1371/journal.pone.0263415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134083	gold, Green Published			2022-12-26	WOS:000798968600013
J	Arsiccio, A; Metcalfe, C; Pisano, R; Raut, S; Coxon, C				Arsiccio, Andrea; Metcalfe, Clive; Pisano, Roberto; Raut, Sanj; Coxon, Carmen			A proximity-based in silico approach to identify redox-labile disulfide bonds: The example of FVIII	PLOS ONE			English	Article							COAGULATION-FACTOR-VIII; VON-WILLEBRAND-FACTOR; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ENHANCED ACTIVATION; FACTOR IXA; FACTOR-XI; THIOREDOXIN; ISOMERASE; DOMAIN	Allosteric disulfide bonds permit highly responsive, transient 'switch-like' properties that are ideal for processes like coagulation and inflammation that require rapid and localised responses to damage or injury. Haemophilia A (HA) is a rare bleeding disorder managed with exogenous coagulation factor(F) VIII products. FVIII has eight disulfide bonds and is known to be redox labile, but it is not known how reduction/oxidation affects the structure-function relationship, or its immunogenicity-a serious complication for 30% severe HA patients. Understanding how redox-mediated changes influence FVIII can inform molecular engineering strategies aimed at improving activity and stability, and reducing immunogenicity. FVIII is a challenging molecule to work with owing to its poor expression and instability so, in a proof-of-concept study, we used molecular dynamics (MD) to identify which disulfide bonds were most likely to be reduced and how this would affect structure/function; results were then experimentally verified. MD identified Cys1899-Cys1903 disulfide as the most likely to undergo reduction based on energy and proximity criteria. Further MD suggested this reduction led to a more open conformation. Here we present our findings and highlight the value of MD approaches.	[Arsiccio, Andrea; Pisano, Roberto] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Metcalfe, Clive; Raut, Sanj; Coxon, Carmen] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England	Polytechnic University of Turin; National Institute for Biological Standards & Control	Metcalfe, C (corresponding author), Natl Inst Biol Stand & Controls, Potters Bar, Herts, England.	clive.metcalfe@nibsc.org		Coxon, Carmen/0000-0001-8694-4894				[Anonymous], METHODS MOL BIOL EJM, VXI, P327; Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Bekendam RH, 2016, BASIC CLIN PHARMACOL, V119, P42, DOI 10.1111/bcpt.12573; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Cerutti N, 2014, J BIOL CHEM, V289, P10455, DOI 10.1074/jbc.M113.539353; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; Chen VM, 2013, J THROMB HAEMOST, V11, P277, DOI 10.1111/jth.12228; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Cook K.M., 2019, BIORXIV, DOI [10.1101/515718, DOI 10.1101/515718]; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Flaumenhaft R, 2015, ARTERIOSCL THROM VAS, V35, P16, DOI 10.1161/ATVBAHA.114.303410; Gale AJ, 2006, J THROMB HAEMOST, V4, P1315, DOI 10.1111/j.1538-7836.2006.01951.x; Giannakopoulos B, 2012, J AUTOIMMUN, V39, P121, DOI 10.1016/j.jaut.2012.05.005; Hahm E, 2013, BLOOD, V121, P3789, DOI 10.1182/blood-2012-11-467985; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; Heim K, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.69; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Kellett-Clarke H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138137; Knudsen TT, 2005, GUT, V54, P515, DOI 10.1136/gut.2004.043505; Kolsek K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07501-4; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lippok S, 2016, BLOOD, V127, P1183, DOI 10.1182/blood-2015-04-641902; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MCMULLEN BA, 1995, PROTEIN SCI, V4, P740; Metcalfe C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163006; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Miao HZ, 2005, PEDIATR RES, V58, P816, DOI 10.1203/00006450-200510000-00031; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Passam Freda J, 2019, Biophys Rev, V11, P419, DOI 10.1007/s12551-019-00543-0; Pijning AE, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171058; Pipe SW, 2016, BLOOD, V128, P2007, DOI 10.1182/blood-2016-04-713289; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SAVIDGE G, 1979, THROMB RES, V16, P587, DOI 10.1016/0049-3848(79)90204-4; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Selvaraj SR, 2008, PEDIATR RES, V64, P443; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Shelar SB, 2015, FREE RADICAL BIO MED, V87, P125, DOI 10.1016/j.freeradbiomed.2015.06.029; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Stegmann M, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180079; Stopa JD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89373; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Venkateswarlu D, 2014, BIOCHEM BIOPH RES CO, V452, P408, DOI 10.1016/j.bbrc.2014.08.078; Wong J.W., 2010, J THROMB HAEMOST, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Zucker M, 2016, J THROMB HAEMOST, V14, P2202, DOI 10.1111/jth.13488	67	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262409	10.1371/journal.pone.0262409	http://dx.doi.org/10.1371/journal.pone.0262409			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130281	gold, Green Published			2022-12-26	WOS:000805530700008
J	Buchwaldt, L; Garg, H; Puri, KD; Durkin, J; Adam, J; Harrington, M; Liabeuf, D; Davies, A; Hegedus, DD; Sharpe, AG; Gali, KK				Buchwaldt, Lone; Garg, Harsh; Puri, Krishna D.; Durkin, Jonathan; Adam, Jennifer; Harrington, Myrtle; Liabeuf, Debora; Davies, Alan; Hegedus, Dwayne D.; Sharpe, Andrew G.; Gali, Krishna Kishore			Sources of genomic diversity in the self-fertile plant pathogen, Sclerotinia scierotiorum, and consequences for resistance breeding	PLOS ONE			English	Article							POPULATION-STRUCTURE; BRASSICA-NAPUS; CANOLA; COMPATIBILITY; INFECTION; SOFTWARE; FIELD	The ascomycete, Sclerotinia scierotiorum, has a broad host range and causes yield loss in dicotyledonous crops world wide. Genomic diversity was determined in a population of 127 isolates obtained from individual canola (Brassica napus) fields in western Canada. Genotyping with 39 simple sequence repeat (SSR) markers revealed each isolate was a unique haplotype. Analysis of molecular variance showed 97% was due to isolate and 3% due to geographical location. Testing of mycelium compatibility among 133 isolates identified clones of mutually compatible isolates with 86-95% similar SSR haplotype, whereas incompatible isolates were highly diverse. In the Province of Manitoba, 61% of isolates were compatible forming clones and stings of pairwise compatible isolates not described before. In contrast, only 35% of isolates were compatible in Alberta without forming clones and strings, while 39% were compatible in Saskatchewan with a single clone, but no strings. These difference can be explained by wetter growing seasons and more susceptible crop species in Manitoba favouring frequent mycelium interaction and more life cycles over time, which might also explain similar differences observed in other geographical areas and host crops. Analysis of linkage disequilibrium rejected random recombination, consistent with a self-fertile fungus, restricted outcrossing due to mycelium incompatibility, and only a single annual opportunity for genomic recombination during meiosis in the ascospore stage between nonsister chromatids in the rare event nuclei from different isolates come together. More probable sources of genomic diversity is slippage during DNA replication and point mutation affecting single nucleotides that accumulate and likely increase mycelium incompatibility in a population over time. A phylogenetic tree based on SSR haplotype grouped isolates into 17 sub-populations. Aggressiveness was tested by inoculating one isolate from each subpopulation onto B. napus lines with quantitative resistance. Analysis of variance was significant for isolate, line, and isolate by line interaction. These isolates represent the genomic and pathogenic diversity in western Canada, and are suitable for resistance screening in canola breeding programs.	[Buchwaldt, Lone; Garg, Harsh; Puri, Krishna D.; Durkin, Jonathan; Adam, Jennifer; Harrington, Myrtle; Liabeuf, Debora; Davies, Alan; Hegedus, Dwayne D.] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Sharpe, Andrew G.] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada; [Gali, Krishna Kishore] Univ Saskatchewan, Crop Dev Ctr, Dept Plant Sci, Saskatoon, SK, Canada; [Garg, Harsh] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Puri, Krishna D.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Liabeuf, Debora] Driscolls, Watsonville, CA USA	Agriculture & Agri Food Canada; University of Saskatchewan; University of Saskatchewan; University of Sydney; University of California System; University of California Davis	Buchwaldt, L (corresponding author), Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada.	Lone.Buchwaldt@agr.gc.ca	; Puri, Krishna/O-6089-2014	Durkin, Jon/0000-0003-3656-7693; Puri, Krishna/0000-0001-9165-3282	Saskatchewan Canola Development Commision, Saskatoon, Canada	Saskatchewan Canola Development Commision, Saskatoon, Canada	This work was funded by the Saskatchewan Canola Development Commision, Saskatoon, Canada. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Akem C., 2006, Plant Pathology Journal (Faisalabad), V5, P67; Aldrich-Wolfe L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139188; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Zancan WLA, 2015, BIOSCI J, V31, P1143, DOI 10.14393/BJ-v31n4a2015-26247; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Attanayake RN, 2013, PHYTOPATHOLOGY, V103, P750, DOI 10.1094/PHYTO-07-12-0159-R; Badet T, 2017, ELIFE, V6, DOI 10.7554/eLife.22472; Benham J., 1999, Journal of Agricultural Genomics, V4, P1; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Bradley CA, 2006, PLANT DIS, V90, P215, DOI 10.1094/PD-90-0215; CALONGE FD, 1970, ARCH MIKROBIOL, V71, P191, DOI 10.1007/BF00417741; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Davar R, 2011, PHYTOPATHOL MEDITERR, V50, P442; Denton-Giles M, 2018, CAN J PLANT PATHOL, V40, P551, DOI 10.1080/07060661.2018.1516699; Derbyshire MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214201; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ekins M., 1999, THESIS, P202; FORD EJ, 1995, MYCOL RES, V99, P241, DOI 10.1016/S0953-7562(09)80893-9; Ge XT, 2012, FIELD CROP RES, V127, P248, DOI 10.1016/j.fcr.2011.11.022; Gyawali S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0496-5; Hemmati R, 2009, EUR J PLANT PATHOL, V125, P617, DOI 10.1007/s10658-009-9510-7; KOHLI Y, 1995, MOL ECOL, V4, P69, DOI 10.1111/j.1365-294X.1995.tb00193.x; KOHN LM, 1990, EXP MYCOL, V14, P255, DOI 10.1016/0147-5975(90)90023-M; KOSASIH BD, 1975, ANN BOT-LONDON, V39, P185, DOI 10.1093/oxfordjournals.aob.a084928; Lehner MS, 2015, PLANT PATHOL, V64, P921, DOI 10.1111/ppa.12322; Lehner MD, 2016, SCI AGR, V73, P184, DOI 10.1590/0103-9016-2015-0085; Lehner MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173915; LUMSDEN RD, 1979, PHYTOPATHOLOGY, V69, P890, DOI 10.1094/Phyto-69-890; LUMSDEN RD, 1980, MYCOLOGIA, V72, P1200, DOI 10.2307/3759575; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Monahan WB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-20; Pannullo A, 2019, TROP PLANT PATHOL, V44, P53, DOI 10.1007/s40858-018-0266-5; Park SDE,, 2008, COMPUTER PROGRAM DOC; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Sexton AC, 2006, GENOME, V49, P1408, DOI 10.1139/G06-101; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Taylor A, 2015, PLANT PATHOL, V64, P932, DOI 10.1111/ppa.12327; UHM JY, 1986, T MYCOL SOC JPN, V27, P129; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wilbur JF, 2017, PLANT DIS, V101, P344, DOI 10.1094/PDIS-07-16-1055-RE; WONG JAL, 1979, J GEN MICROBIOL, V112, P29, DOI 10.1099/00221287-112-1-29	47	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262891	10.1371/journal.pone.026289	http://dx.doi.org/10.1371/journal.pone.026289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130285				2022-12-26	WOS:000805530700014
J	Lerkvaleekul, B; Apiwattanakul, N; Tangnararatchakit, K; Jirapattananon, N; Srisala, S; Vilaiyuk, S				Lerkvaleekul, Butsabong; Apiwattanakul, Nopporn; Tangnararatchakit, Kanchana; Jirapattananon, Nisa; Srisala, Supanart; Vilaiyuk, Soamarat			Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus	PLOS ONE			English	Article							REGULATORY T-CELLS; NATURAL-KILLER-CELLS; GAMMA-DELTA; DISEASE-ACTIVITY; DOWN-REGULATION; SLE PATIENTS; SUBSETS; SUPPRESSION; RITUXIMAB; EFFICACY	Objective Juvenile-onset systemic lupus erythematosus (JSLE) is a complex and heterogeneous immune-mediated disease. Cellular components have crucial roles in disease phenotypes and outcomes. We aimed to determine the associations of lymphocyte subsets with clinical manifestations and long-term outcomes in JSLE patients. Methods A cohort of 60 JSLE patients provided blood samples during active disease, of whom 34 provided further samples during inactive disease. In a longitudinal study, blood samples were obtained from 49 of the JSLE patients at 0, 3, and 6 months. The healthy control (HC) group consisted of 42 age-matched children. Lymphocyte subsets were analyzed by flow cytometry. Results The percentages of CD4(+) T, gamma delta T, and NK cells were significantly decreased in JSLE patients compared with HC, while the percentages of CD8(+) T, NKT, and CD19(+) B cells were significantly increased. The percentage of regulatory T cells (Tregs) was significantly lower in JSLE patients with lupus nephritis (LN) than in non-LN JSLE patients and HC. The patients were stratified into high and low groups by the median frequency of each lymphocyte subset. The gamma delta T cells high group and NK cells high group were significantly related to mucosal ulcer. The CD4(+) T cells high group was significantly associated with arthritis, and the NKT cells high group was substantially linked with autoimmune hemolytic anemia. The CD8(+) T cells low group was mainly related to vasculitis, and the Tregs low group was significantly associated with LN. The percentage of Tregs was significantly increased at 6 months of follow-up, and the LN JSLE group had a lower Treg percentage than the non-LN JSLE group. Predictors of remission on therapy were high Tregs, high absolute lymphocyte count, direct Coombs test positivity, and LN absence at enrollment. Conclusion JSLE patients exhibited altered lymphocyte subsets, which were strongly associated with clinical phenotypes and long-term outcomes.	[Lerkvaleekul, Butsabong; Vilaiyuk, Soamarat] Mahidol Univ, Fac Med, Dept Pediat, Div Rheumatol,Ramathibodi Hosp, Bangkok, Thailand; [Apiwattanakul, Nopporn] Mahidol Univ, Fac Med, Dept Pediat, Div Infect Dis,Ramathibodi Hosp, Bangkok, Thailand; [Tangnararatchakit, Kanchana] Mahidol Univ, Fac Med, Dept Pediat, Div Nephrol,Ramathibodi Hosp, Bangkok, Thailand; [Jirapattananon, Nisa] Mahidol Univ, Fac Med, Dept Pediat, Ramathibodi Hosp, Bangkok, Thailand; [Srisala, Supanart] Mahidol Univ, Fac Med, Res Ctr, Ramathibodi Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Vilaiyuk, S (corresponding author), Mahidol Univ, Fac Med, Dept Pediat, Div Rheumatol,Ramathibodi Hosp, Bangkok, Thailand.	soamarat21@hotmail.com			Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand [RF_59002]	Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand	SV received funding support from the Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (RF_59002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (URL funder website https://www.rama.mahidol.ac.th/en).	Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; Azab NA, 2008, CLIN IMMUNOL, V127, P151, DOI 10.1016/j.clim.2007.12.010; Bacher N, 2013, CANCER RES, V73, P5647, DOI 10.1158/0008-5472.CAN-12-3788; Edelbauer M, 2012, J CLIN IMMUNOL, V32, P477, DOI 10.1007/s10875-011-9637-0; ERKELLERYUKSEL F, 1993, LUPUS, V2, P227, DOI 10.1177/096120339300200404; ErkellerYuksel FM, 1997, LUPUS, V6, P708, DOI 10.1177/096120339700600905; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gravano DM, 2013, J AUTOIMMUN, V45, P68, DOI 10.1016/j.jaut.2013.06.004; Greenan-Barrett J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147619; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kamphuis S, 2010, NAT REV RHEUMATOL, V6, P538, DOI 10.1038/nrrheum.2010.121; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lerkvaleekul B, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23156; Li WL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00159; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lu ZM, 2021, CLIN RHEUMATOL, V40, P1835, DOI 10.1007/s10067-020-05480-y; Lu ZM, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198131, 10.1590/1414-431x20198131]; LUNARDI C, 1991, CLIN EXP IMMUNOL, V86, P203; Ma HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157772; Malattia C, 2013, BEST PRACT RES CL RH, V27, P351, DOI 10.1016/j.berh.2013.07.007; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Manzi S, 2012, ANN RHEUM DIS, V71, P1833, DOI 10.1136/annrheumdis-2011-200831; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mizui M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00786; Moulton VR, 2017, TRENDS MOL MED, V23, P615, DOI 10.1016/j.molmed.2017.05.006; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; Ohl K, 2015, EUR J IMMUNOL, V45, P344, DOI 10.1002/eji.201344280; Park YW, 2009, ARTHRITIS RHEUM-US, V60, P1753, DOI 10.1002/art.24556; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Riccieri V, 2000, LUPUS, V9, P333, DOI 10.1191/096120300678828460; Robak E, 2001, MEDIAT INFLAMM, V10, P179, DOI 10.1080/09629350120080300; Robinson GA, 2020, LANCET RHEUMATOL, V2, pE485, DOI 10.1016/S2665-9913(20)30168-5; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ryba-Stanislawowska M, 2019, EXPERT REV CLIN IMMU, V15, P777, DOI 10.1080/1744666X.2019.1620602; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Smith EMD, 2019, CLIN IMMUNOL, V209, DOI 10.1016/j.clim.2019.108274; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Suarez A, 2006, ANN RHEUM DIS, V65, P1512, DOI 10.1136/ard.2005.049924; Taddio A, 2010, J PEDIATR-US, V156, P972, DOI 10.1016/j.jpeds.2009.12.022; TING CK, 1992, ANN RHEUM DIS, V51, P45, DOI 10.1136/ard.51.1.45; Torres-Ruiz J, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03144; Tselios K, 2014, CLIN EXP RHEUMATOL, V32, P630; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; van Vollenhoven R, 2017, ANN RHEUM DIS, V76, P554, DOI 10.1136/annrheumdis-2016-209519; Vargas-Rojas MI, 2008, LUPUS, V17, P289, DOI 10.1177/0961203307088307; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; VOLCPLATZER B, 1993, J INVEST DERMATOL, V100, pS84, DOI 10.1111/1523-1747.ep12356084; Wang L, 2012, SCAND J IMMUNOL, V76, P62, DOI 10.1111/j.1365-3083.2012.02705.x; Weigert O, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4188; Wouters CHP, 2004, BRIT J DERMATOL, V150, P693, DOI 10.1111/j.0007-0963.2004.05883.x; Wu M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2932531; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Yang XF, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.01.38; Yang YY, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1250; Yates J, 2008, CLIN EXP IMMUNOL, V153, P44, DOI 10.1111/j.1365-2249.2008.03665.x; Yin ZJ, 2018, LUPUS, V27, P2057, DOI 10.1177/0961203318804881; Zabinska M, 2016, ARCH IMMUNOL THER EX, V64, P399, DOI 10.1007/s00005-016-0399-5; Zahran AM, 2019, ARCH IMMUNOL THER EX, V67, P161, DOI 10.1007/s00005-019-00537-6; Zhang B, 2008, ANN RHEUM DIS, V67, P1037, DOI 10.1136/ard.2007.083543; Zhang SX, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7103219	64	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263536	10.1371/journal.pone.0263536	http://dx.doi.org/10.1371/journal.pone.0263536			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130317	gold, Green Published			2022-12-26	WOS:000805530700036
J	Hagum, CN; Tonnessen, E; Shalfawi, SAI				Hagum, Cathrine Nyhus; Tonnessen, Espen; Shalfawi, Shaher A. I.			Progression in training volume and perceived psychological and physiological training distress in Norwegian student athletes: A cross-sectional study	PLOS ONE			English	Article							COMMITTEE CONSENSUS STATEMENT; SAMPLE-SIZE; INTENSITY DISTRIBUTION; ADOLESCENT GIRLS; SLEEP QUALITY; LOAD; STRESS; SPORT; PERFORMANCE; RESISTANCE	This cross-sectional study examined self-reported weekly training volume and perceived training distress in Norwegian student athletes according to gender, type of sport, school program, and school year. The Norwegian version of the Multicomponent Training Distress Scale (MTDS-N) was completed by 608 student athletes (M age = 17.29 +/- .94). Univariate and multivariate techniques were used in data analyses. Results revealed significant differences in weekly training volume between sport types. No significant differences in weekly training volume were found for gender, school year, or school program. However, a multivariate effect was found for gender, with females perceiving higher levels of training distress than males. A multivariate interaction effect between school year and training volume was also observed. We recommend that practitioners use a conceptual framework to periodize training and monitor training distress in student athletes, particularly in females, to preserve physiological and psychological well-being and ensure a progressive training overload leading to positive performance development.	[Hagum, Cathrine Nyhus; Shalfawi, Shaher A. I.] Univ Stavanger, Dept Educ & Sports Sci, Stavanger, Norway; [Tonnessen, Espen] Kristiania Univ Coll, Fac Hlth Sci, Oslo, Norway	Universitetet i Stavanger; Kristiania University College	Hagum, CN (corresponding author), Univ Stavanger, Dept Educ & Sports Sci, Stavanger, Norway.	cathrine.n.hagum@uis.no		Shalfawi, Shaher/0000-0002-5164-0230; Nyhus Hagum, Cathrine/0000-0002-6192-3453				Armstrong N., 2019, DEV YOUTH ATHLETE; Armstrong N, 2019, EUR J APPL PHYSIOL, V119, P801, DOI 10.1007/s00421-019-04071-3; Barton M, 2016, RES Q EXERCISE SPORT, V87, P365, DOI 10.1080/02701367.2016.1213352; Bjorndal CT, 2017, SPORT EDUC SOC, V22, P864, DOI 10.1080/13573322.2015.1087398; Bjorndal CT., 2016, TALENT DEV EXCELLENC, V8; Borresen J, 2009, SPORTS MED, V39, P779, DOI 10.2165/11317780-000000000-00000; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/IJSPP.2017-0208; Bourgois J, 2014, INT J SPORT PHYSIOL, V9, P723, DOI [10.1123/ijspp.2013-0267, 10.1123/IJSPP.2013-0267]; Brandt R, 2017, J STRENGTH COND RES, V31, P1033, DOI 10.1519/JSC.0000000000001551; Brown KA, 2017, TRANSL PEDIATR, V6, P150, DOI 10.21037/tp.2017.04.03; Caine D, 2013, GYMNASTICS HDB SPORT, P111; Casado A., 2019, J STRENGTH COND RES; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis P., 2019, FRONT PSYCHOL, V10, P1641, DOI [10.3389/fpsyg.2019.01641, DOI 10.3389/FPSYG.2019.01641]; Elferink-Gemser MT., 2012, J SPORT SCI, V30, P1581, DOI [10.1080/02640414.2012.725854, DOI 10.1080/02640414.2012.725854]; Enders CK, 2003, MEAS EVAL COUNS DEV, V36, P40, DOI 10.1080/07481756.2003.12069079; Finch H., 2013, J MOD APPL STAT METH, V12, P4; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Funder DC, 2019, ADV METH PRACT PSYCH, V2, P156, DOI 10.1177/2515245919847202; Galland BC, 2017, SLEEP HEALTH, V3, P77, DOI 10.1016/j.sleh.2017.02.001; Gerber M, 2011, PERCEPT MOTOR SKILL, V112, P581, DOI 10.2466/02.05.10.PMS.112.2.581-599; Hagum CN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207603; Halson Shona L, 2014, Sports Med, V44 Suppl 2, pS139, DOI 10.1007/s40279-014-0253-z; Handelsman DJ, 2017, CLIN ENDOCRINOL, V87, P68, DOI 10.1111/cen.13350; Henson RK, 2006, COUNS PSYCHOL, V34, P601, DOI 10.1177/0011000005283558; Hirschfeld G, 2014, J RES PERS, V53, P54, DOI 10.1016/j.jrp.2014.08.003; Hysing M, 2013, J SLEEP RES, V22, P549, DOI 10.1111/jsr.12055; Impellizzeri FM, 2020, J ATHL TRAINING, V55, P885, DOI 10.4085/1062-6050-500-19; Impellizzeri FM, 2019, INT J SPORT PHYSIOL, V14, P270, DOI 10.1123/ijspp.2018-0935; Ingebrigtsen J, 2013, J STRENGTH COND RES, V27, P302, DOI 10.1519/JSC.0b013e318254899f; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Kellmann M, 2018, INT J SPORT PHYSIOL, V13, P240, DOI 10.1123/ijspp.2017-0759; Kenneally M., 2020, EUR J SPORT SCI, P1, DOI [10.1080/17461391.2020.1773934, DOI 10.1080/17461391.2020.1773934]; Knechtle B., 2015, OPEN ACCESS J SPORTS, V6, P277, DOI [10.2147/OAJSM.S85310, DOI 10.2147/OAJSM.S85310]; Kraemer WJ, 2004, MED SCI SPORT EXER, V36, P674, DOI 10.1249/01.MSS.0000121945.36635.61; Kretzschmar A, 2019, J RES PERS, V80, P17, DOI 10.1016/j.jrp.2019.03.007; Lee SY, 2013, AM J HEALTH BEHAV, V37, P851, DOI 10.5993/AJHB.37.6.14; Lien L, 2010, SOC SCI MED, V71, P529, DOI 10.1016/j.socscimed.2010.05.003; Lyakh V, 2016, J HUM KINET, V54, P173, DOI 10.1515/hukin-2016-0053; Main L, 2009, EUR J SPORT SCI, V9, P195, DOI 10.1080/17461390902818260; Malek MH., 2019, ADV STAT KINESIOLOGY; Mendle J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1703; Mood D., 2020, INTRO STAT HUMAN PER; Moseid CH, 2019, SCAND J MED SCI SPOR, V29, P1736, DOI 10.1111/sms.13498; Myakinchenko EB., 2020, ONE YEAR PERIODIZATI; Panza MJ, 2020, J SPORT EXERCISE PSY, V42, P201, DOI 10.1123/jsep.2019-0235; Pearson D, 2000, STRENGTH COND J, V22, P14; Ramboll, SURVEYXACT; Reynoso-Sanchez LF, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.627828; Rhea MR, 2003, MED SCI SPORT EXER, V35, P456, DOI 10.1249/01.MSS.0000053727.63505.D4; Rosenvinge JH, 2018, OPEN ACCESS J SPORTS, V9, DOI 10.2147/OAJSM.S156658; Saavedra J., 2018, MONTENEGRIN J SPORT, P7; Sabato TM, 2016, OPEN ACCESS J SPORTS, V7, DOI 10.2147/OAJSM.S96821; Sallen J, 2018, EUR J SPORT SCI, V18, P112, DOI 10.1080/17461391.2017.1407363; Sandbakk O, 2016, MED SCI SPORT EXER, V48, P1091, DOI 10.1249/MSS.0000000000000862; Sarma KVS., 2018, MULTIVARIATE STAT MA; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Schwellnus M, 2016, BRIT J SPORT MED, V50, P1043, DOI 10.1136/bjsports-2016-096572; SELYE H, 1951, ANNU REV MED, V2, P327, DOI 10.1146/annurev.me.02.020151.001551; SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383; Skattebo O, 2019, INT J SPORT PHYSIOL, V14, P1190, DOI 10.1123/ijspp.2018-0471; Smith KN., 2019, GIFTED CHILD QUART, V64, P41; Soligard T, 2016, BRIT J SPORT MED, V50, P1030, DOI 10.1136/bjsports-2016-096581; Sousa A., 2019, SPORTS MED PHYS, P37; Stambulova NB, 2021, INT J SPORT EXERC PS, V19, P524, DOI 10.1080/1612197X.2020.1737836; Stice E, 2002, DEV PSYCHOL, V38, P669, DOI 10.1037//0012-1649.38.5.669; Sullivan P, 2019, CAN J HIGH EDUC, V49, P47, DOI 10.7202/1060823ar; Tenenbaum G., 2006, ESSENTIAL PROCESSES; Tonnessen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101796; Tran J., 2013, ECSS 2013 UN SPORT S; Treff G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00515; Verkhoshansky Y., 1988, PROGRAMMING ORG TRAI; Verkhoshansky Y., 1979, LEGAYA ATHLETICKA, V8, P8; Verma JP., 2015, REPEATED MEASURES DE; Walsh NP, 2021, BRIT J SPORT MED, V55, P356, DOI 10.1136/bjsports-2020-102025; Wik EH, 2020, SCAND J MED SCI SPOR, V30, P894, DOI 10.1111/sms.13635; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Woods AL., 2018, EFFECTS INTENSIFIED, V13, DOI [10.1371/journal.pone.0191644, DOI 10.1371/JOURNAL.PONE.0191644]; Woods AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173807	79	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263575	10.1371/journal.pone.0263575	http://dx.doi.org/10.1371/journal.pone.0263575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120187	Green Published, gold			2022-12-26	WOS:000789273600055
J	Roy, S; Gupta, D				Roy, Shikha; Gupta, Dinesh			DriverFuse: An R package for analysis of next- generation sequencing datasets to identify cancer driver fusion genes	PLOS ONE			English	Article								We developed the DriverFuse package to integrate orthogonal data types such as Structural Variants (SV) and Copy Number Variations (CNV) to characterize fusion genes in cancer datasets. A fusion gene is reported as a driver or passenger fusion gene, based on mapping SV and CNV profiles. DriverFuse generates a fusion plot of fusion genes with their mapping SV, CNV profile, domain architecture and classification of its role in cancer. The analysis facilitates discrimination of driver fusions from passenger fusions. To demonstrate the utility of DriverFuse, we analyzed two datasets, one each for CCLE (Cancer Cell Line Encyclopedia) for lung cancer and HCC1395BL for breast cancer. The analysis validates the driver fusion genes that are already reported for the datasets. Thus, DriverFuse is a valuable tool for studying the driver fusion genes in cancers, enabling the identification of recurrent complex rearrangements that provide intuitive insights into disease driver events.	[Roy, Shikha; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Translat Bioinformat Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Gupta, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Translat Bioinformat Grp, New Delhi, India.	dinesh@icgeb.res.in	Gupta, Dinesh/C-1079-2009	Gupta, Dinesh/0000-0002-7548-8835	Department of Biotechnology, Ministry of Science and Technology (India) [BT/PR40151/BTIS/137/5/2021]	Department of Biotechnology, Ministry of Science and Technology (India)	We acknowledge support by Department of Biotechnology, Ministry of Science and Technology (India), grant: BT/PR40151/BTIS/137/5/2021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaei-Mahabadi B, 2016, P NATL ACAD SCI USA, V113, P13768, DOI 10.1073/pnas.1606220113; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Drusbosky LM, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01063-9; Holt R, 2012, EUR J HUM GENET, V20, P1141, DOI 10.1038/ejhg.2012.73; Lopez G, 2021, BIOINFORMATICS, V37, P1912, DOI 10.1093/bioinformatics/btaa878; Nattestad M, 2018, GENOME RES, V28, P1126, DOI 10.1101/gr.231100.117; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Tian LQ, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02043-x; Wang WJ, 2020, EPIGENET CHROMATIN, V13, DOI 10.1186/s13072-020-00371-7; Yu YP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38550-6; Zhang SQ, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00407	12	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262686	10.1371/journal.pone.0262686	http://dx.doi.org/10.1371/journal.pone.0262686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113898	Green Published, gold			2022-12-26	WOS:000823694700032
J	Choi, BJ; Koo, Y; Kim, TY; Lim, HS; Yoon, D				Choi, Byung Jin; Koo, Yeryung; Kim, Tae Young; Lim, Hong-Seok; Yoon, Dukyong			Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INTERVAL; DISEASE; WOMEN; RISK; MEN	Drug-induced QT prolongation is one of the most common side effects of drug use and can cause fatal outcomes such as sudden cardiac arrest. This study adopts the data-driven approach to assess the QT prolongation risk of all the frequently used drugs in a tertiary teaching hospital using both standard 12-lead ECGs and intensive care unit (ICU) continuous ECGs. We used the standard 12-lead ECG results (n = 1,040,752) measured in the hospital during 1994-2019 and the continuous ECG results (n = 4,835) extracted from the ICU's patient-monitoring devices during 2016-2019. Based on the drug prescription frequency, 167 drugs were analyzed using 12-lead ECG data under the case-control study design and 60 using continuous ECG data under the retrospective cohort study design. Whereas the case-control study yielded the odds ratio, the cohort study generated the hazard ratio for each candidate drug. Further, we observed the possibility of inducing QT prolongation in 38 drugs in the 12-lead ECG analysis and 7 drugs in the continuous ECG analysis. The seven drugs (vasopressin, vecuronium, midazolam, levetiracetam, ipratropium bromide, nifedipine, and chlorpheniramine) that showed a significantly higher risk of QT prolongation in the continuous ECG analysis were also identified in the 12-lead ECG data analysis. The use of two different ECG sources enabled us to confidently assess drug-induced QT prolongation risk in clinical practice. In this study, seven drugs showed QT prolongation risk in both study designs.	[Choi, Byung Jin] Ajou Univ, Dept Biomed Informat, Sch Med, Suwon, Gyeonggi Do, South Korea; [Koo, Yeryung; Kim, Tae Young; Yoon, Dukyong] BUDon Inc, Jeonju, Jeollabuk Do, South Korea; [Lim, Hong-Seok] Ajou Univ, Dept Cardiol, Sch Med, Suwon, Gyeonggi Do, South Korea; [Yoon, Dukyong] Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Yongin, Gyeonggi Do, South Korea; [Yoon, Dukyong] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Ctr Digital Hlth, Yongin, Gyeonggi Do, South Korea	Ajou University; Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, D (corresponding author), BUDon Inc, Jeonju, Jeollabuk Do, South Korea.; Yoon, D (corresponding author), Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Yongin, Gyeonggi Do, South Korea.; Yoon, D (corresponding author), Yonsei Univ Hlth Syst, Yongin Severance Hosp, Ctr Digital Hlth, Yongin, Gyeonggi Do, South Korea.	dukyong.yoon@yonsei.ac.kr		Yoon, Dukyong/0000-0003-1635-8376; Lim, Hong-Seok/0000-0002-3127-2071	Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT) [1711138152, KMDF_PR_20200901_0095]; Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry, and Energy) [1711138152, KMDF_PR_20200901_0095]; Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare) [1711138152, KMDF_PR_20200901_0095]; Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [1711138152, KMDF_PR_20200901_0095]; Ministry of Food and Drug Safety [19182MFDS406]; BUD.on Inc.	Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry, and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety); Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); BUD.on Inc.	This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT; Ministry of Trade, Industry, and Energy; Ministry of Health & Welfare; and Ministry of Food and Drug Safety) and awarded to DY (Project Number: 1711138152, KMDF_PR_20200901_0095). This research was also supported by a grant from Ministry of Food and Drug Safety in 2020, awarded to DY (19182MFDS406). BUD.on Inc. provided support in the form of salaries for authors YK and TYK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. BUD.on Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi BJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86321-z; Choi Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1574806; Cubeddu Luigi X, 2003, Am J Ther, V10, P452, DOI 10.1097/00045391-200311000-00013; Darpo B, 2014, BRIT J CLIN PHARMACO, V77, P522, DOI 10.1111/bcp.12201; DAY CP, 1993, LANCET, V341, P1423; De Ponti F, 2002, BRIT J CLIN PHARMACO, V54, P171, DOI 10.1046/j.1365-2125.2002.01617.x; Funk KA, 2013, ANN PHARMACOTHER, V47, P1330, DOI 10.1177/1060028013501994; Hage FG, 2009, J AM COLL CARDIOL, V53, P2129, DOI 10.1016/j.jacc.2009.02.047; Harrahill NJ, 2021, AM J CARDIOL, V140, P118, DOI 10.1016/j.amjcard.2020.09.061; Kim TY, 2021, HEALTHC INFORM RES, V27, P182, DOI 10.4258/hir.2021.27.3.182; Kim YG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176222; Kosar F, 2007, ANGIOLOGY, V58, P218, DOI 10.1177/0003319707300368; Minhaj MM., 2019, ICU MANAGEMENT CARDI; Owens RC, 2004, DRUGS, V64, P1091, DOI 10.2165/00003495-200464100-00005; Panicker GK, 2014, J ELECTROCARDIOL, V47, P155, DOI 10.1016/j.jelectrocard.2013.11.004; Plasencia-Garcia BO, 2021, PSYCHOPHARMACOLOGY, V238, P329, DOI 10.1007/s00213-020-05716-4; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Shah RR, 2018, THER ADV DRUG SAF, V9, P475, DOI 10.1177/2042098618780854; TARAN LM, 1947, AM HEART J, V33, P14, DOI 10.1016/0002-8703(47)90421-3; Taylor DM, 2003, ACTA PSYCHIAT SCAND, V107, P85, DOI 10.1034/j.1600-0447.2003.02078.x; Vanham D, 2017, J CRIT CARE, V38, P97, DOI 10.1016/j.jcrc.2016.09.014; Woosley RL, 2018, TRENDS CARDIOVAS MED, V28, P94, DOI 10.1016/j.tcm.2017.07.010; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; YOKOYAMA A, 1992, ALCOHOL CLIN EXP RES, V16, P1090, DOI 10.1111/j.1530-0277.1992.tb00703.x	24	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263117	10.1371/journal.pone.0263117	http://dx.doi.org/10.1371/journal.pone.0263117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100302	gold, Green Published			2022-12-26	WOS:000801937600034
J	Rzhevskiy, A; Popov, A; Pavlov, C; Anissimov, Y; Zvyagin, A; Levin, Y; Kochba, E				Rzhevskiy, Alexey; Popov, Andrei; Pavlov, Chavdar; Anissimov, Yuri; Zvyagin, Andrei; Levin, Yotam; Kochba, Efrat			Intradermal injection of lidocaine with a microneedle device to provide rapid local anaesthesia for peripheral intravenous cannulation: A randomised open-label placebo-controlled clinical trial	PLOS ONE			English	Article							VISUAL ANALOG SCALE; INFLUENZA VACCINE; JET-INJECTION; IMMUNOGENICITY; DELIVERY; SAFETY; PAIN; CHILDREN; COMPARE; SYSTEM	Background Peripheral venous cannulation is one of the most common procedures in medicine. It is associated with noticeable pain and apprehension, although in most cases it is performed without any anesthesia due to lack of a painless, cost-effective option, which would provide rapid local anesthesia with subsequent significant reduction in the experienced pain. We conducted an open-label placebo-controlled clinical trial to evaluate the efficacy and safety of a 2% lidocaine injection using the commercially available microneedle device Minron-Jet600 (NanoPass Technologies Ltd, Israel) to achieve rapid local anesthesia prior to peripheral venous cannulation. Methods One hundred and two subjects were randomly allocated into two groups. In the first group, 100 mu L of lidocaine hydrochloride (2%) was injected intradermally to subjects using the MicronJet600 device in the left arm (MJ-Lido) and 100 mu L of saline was injected intradermally using the device in the right arm (MJ-Saline). In the second group, 100 mu L of lidocaine hydrochloride (2%) was injected using the MicronJet600 device into the left arm (MJ-Lido), with no injection into the right arm of subjects (No pretreatment). In both groups the intradermal injection was performed at the cannulation site prior to insertion of a 18G cannula into a median cubital vein in both arms. As a primary variable, a score of cannulation-induced pain was indicated by subjects using a 100-point visual analog scale immediately after cannulation. As a secondary variable, subjects in Group 2 also indicated their preference to receive the anaesthetic injection with MicronJet600 in the future by using the 5-point Likert scale. Also, as a secondary variable, the duration of skin numbness after lidocaine injection was indicated by performing a superficial pin-prick with a 27G needle at 15, 30 and 45 minutes, at distances of 1, 2 and 3 centimeters from the injection site. Results A significant pain reduction (11.0-fold) was achieved due to the lidocaine injection compared to the cannulation without any pretreatment (p< 0.005). After the lidocaine injection the anesthesia was effective up to 2 centimeters from the injection site and remained for up to 30 minutes. Eighty percent of subjects from the second group preferred cannulation after the lidocaine injection over cannulation without any pretreatment. No significant side effects were identified. Conclusion Intradermal injection of anaesthetic with Micronjet600 was found to be a safe and effective option for providing rapid local anesthesia for peripheral intravenous cannulation.	[Rzhevskiy, Alexey; Popov, Andrei; Zvyagin, Andrei] Sechenov First Moscow State Med Univ, Ctr Biomed Engn, Moscow, Russia; [Pavlov, Chavdar] Sechenov First Moscow State Med Univ, Clin Internal Dis Propedeut, Moscow, Russia; [Anissimov, Yuri] Griffith Univ, Sch Nat Sci, Gold Coast, Qld, Australia; [Levin, Yotam; Kochba, Efrat] NanoPass Technol, Ness Ziona, Israel	Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University; Griffith University	Rzhevskiy, A (corresponding author), Sechenov First Moscow State Med Univ, Ctr Biomed Engn, Moscow, Russia.	rzhevskiy01@gmail.com	Rzehvskiy, Alexey Sergey/T-4939-2017	Rzehvskiy, Alexey Sergey/0000-0002-4042-7813	Ministry of Education and Science of the Russian Federation [075-15-2019-192]; NanoPass Technologies Ltd.	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NanoPass Technologies Ltd.	The work was supported by the Ministry of Education and Science of the Russian Federation, grant No. 075-15-2019-192. NanoPass Technologies Ltd. provided support in the form of salary for authors EK and YL. A payment for labour of the nurse who participated in the study was covered by NanoPass Technologies Ltd. as well. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	Anand A, 2015, VACCINE, V33, P6816, DOI 10.1016/j.vaccine.2015.09.039; Azagury A, 2014, ADV DRUG DELIVER REV, V72, P127, DOI 10.1016/j.addr.2014.01.007; Beals CR, 2016, LANCET INFECT DIS, V16, P915, DOI 10.1016/S1473-3099(16)00133-X; Bond M, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0252-8; Della Cioppa G, 2014, HUM VACC IMMUNOTHER, V10, P1701, DOI 10.4161/hv.28618; Houck Constance S, 2005, Expert Rev Neurother, V5, P625, DOI 10.1586/14737175.5.5.625; Hung IFN, 2012, VACCINE, V30, P6427, DOI 10.1016/j.vaccine.2012.08.014; Hung IFN, 2012, VACCINE, V30, P2707, DOI 10.1016/j.vaccine.2011.12.069; Kelly AM, 1998, ACAD EMERG MED, V5, P1086, DOI 10.1111/j.1553-2712.1998.tb02667.x; Kochba E, 2016, DIABETES TECHNOL THE, V18, P525, DOI 10.1089/dia.2016.0156; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; Levin Y, 2016, VACCINE, V34, P5262, DOI 10.1016/j.vaccine.2016.09.008; Levin Y, 2014, VACCINE, V32, P4249, DOI 10.1016/j.vaccine.2014.03.024; Lysakowski C, 2003, ANESTH ANALG, V96, P215, DOI 10.1097/00000539-200301000-00044; Murthy SN, 2010, J CONTROL RELEASE, V148, P197, DOI 10.1016/j.jconrel.2010.08.015; Oni G, 2012, LASER SURG MED, V44, P168, DOI 10.1002/lsm.21130; Reis EC, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.6.e5; Rzhevskiy AS, 2018, J CONTROL RELEASE, V270, P184, DOI 10.1016/j.jconrel.2017.11.048; Spanos S, 2008, PEDIATR EMERG CARE, V24, P511, DOI 10.1097/PEC.0b013e31816a8d5b; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Troy SB, 2015, J INFECT DIS, V211, P1969, DOI 10.1093/infdis/jiu841; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; Zempsky WT, 2004, CLIN THER, V26, P1110, DOI 10.1016/S0149-2918(04)90183-X	23	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0261641	10.1371/journal.pone.0261641	http://dx.doi.org/10.1371/journal.pone.0261641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100279	Green Published, gold			2022-12-26	WOS:000801937600009
J	Ward, SJ; McMahan, CD; Khakurel, B; Wright, AM; Piller, KR				Ward, Sarah J.; McMahan, Caleb D.; Khakurel, Basanta; Wright, April M.; Piller, Kyle R.			Genomic data support the taxonomic validity of Middle American livebearers Poeciliopsis gracilis and Poeciliopsis pleurospilus (Cyprinodontiformes: Poeciliidae)	PLOS ONE			English	Article							FISH GENUS POECILIOPSIS; FRESH-WATER FISHES; HISTORICAL BIOGEOGRAPHY; COMPARATIVE PHYLOGEOGRAPHY; EVOLUTIONARY HISTORY; DIVERGENCE; ISTHMUS; MODEL; PHYLOGENY; CHECKLIST	Poeciliopsis (Cyprinodontiformes: Poeciliidae) is a genus comprised of 25 species of freshwater fishes. Several well-known taxonomic uncertainties exist within the genus, especially in relation to the taxonomic status of Poeciliopsis pleurospilus and P. gracilis. However, to date, no studies have been conducted to specifically address the taxonomic status of these two species. The goal of this study was to examine the taxonomic validity of P. pleurospilus and P. gracilis using genomic data (ddRADseq) in phylogenetic, population genetic, and species delimitation frameworks. Multiple analyses support the recognition of both taxa as distinct species and also permits us to revise their respective distributions. A species delimitation analysis indicates that P. pleurospilus and P. gracilis are distinct species, each of which consists of two distinct lineages that are geographically structured. Phylogenetic and population genetic analyses provide clear evidence that individuals of P. gracilis are distributed north and west of the Isthmus of Tehuantepec in both Pacific and Atlantic river systems in Mexico, whereas individuals of P. pleurospilus are distributed in both Atlantic and Pacific river systems south and east of the Isthmus of Tehuantepec, from southern Mexico to Honduras.	[Ward, Sarah J.; Khakurel, Basanta; Wright, April M.; Piller, Kyle R.] Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA; [Ward, Sarah J.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [McMahan, Caleb D.] Field Museum Nat Hist, Chicago, IL 60605 USA	University of Louisiana System; Southeastern Louisiana University; University of Oklahoma System; University of Oklahoma - Norman; Field Museum of Natural History (Chicago)	Ward, SJ (corresponding author), Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA.; Ward, SJ (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	sarah.ward@ou.edu		Khakurel, Basanta/0000-0003-0511-2215; Ward, Sarah/0000-0003-0299-7337	Theodore Roosevelt Memorial Grant from the American Museum of Natural History; National Institute of General Medical Sciences of the National Institutes of Health [P2O GM103424-20]; NSF [2113424]; Edward Schlieder Professorship	Theodore Roosevelt Memorial Grant from the American Museum of Natural History; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Edward Schlieder Professorship	This study was supported by a Theodore Roosevelt Memorial Grant to Sarah J. Ward from the American Museum of Natural History and an Edward Schlieder Professorship to Kyle R. Piller. April M. Wright and Basanta Khakurel were supported by the National Institute of General Medical Sciences of the National Institutes of Health under grant number P2O GM103424-20 and NSF 2113424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS., 2005, SYSTEM BIODIVERS, V4, P375, DOI DOI 10.1017/S1477200004001574; Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Andrews S., 2010, FASTQC QUALITY CONTR; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Bagley JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121139; Barts N, 2018, GENOME, V61, P273, DOI 10.1139/gen-2017-0051; Bonaparte CL., 1831, GIORNALE ARCADICO SC; Braganca PHN, 2018, ZOOSYST EVOL, V94, P137, DOI 10.3897/zse.94.22173; BRIGGS JC, 1984, SYST ZOOL, V33, P428, DOI 10.2307/2413095; Bussing W, 2002, PECES AGUAS CONTINEN; BUSSING WA, 1985, GREAT AM BIOTIC INTE, P453, DOI DOI 10.1007/978-1-4684-9181-4_; Choudhury A., 2016, J HELMINTHOL, V91, P1, DOI [10.1017/S0022149X1500108X, DOI 10.1017/S0022149X1500108X]; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Coates Anthony G., 1996, P21; Contreras-B. S., 1984, P102; Contreras-MacBeath Topiltzin, 1998, Aquarium Sciences and Conservation, V2, P67; ContrerasMacBeath T, 1996, J FRESHWATER ECOL, V11, P327, DOI 10.1080/02705060.1996.9664455; Conway KW, 2019, ZOOKEYS, P91, DOI 10.3897/zookeys.883.37586; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; dos Reis M., 2021, BPPR FUNCTIONS WORK; Eaton DAR, 2020, BIOINFORMATICS, V36, P2592, DOI 10.1093/bioinformatics/btz966; Enrique Gomez-Gonzalez Adan, 2015, Check List, V11, P1726; Esri, 2021, WORLD DARK GRAY BAS; Ferrusquia-Villafranca I., 1993, BIOL DIVERSITY MEXIC, P3107; Fricke R, 2020, ESCHMEYERS CATALOG F; Beltran-Lopez RG, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1172-7; Grnwald NJ, 2016, GRNWALDLAB POPULATIO; Gunther A., 1866, CATALOGUE FISHES BRI, V6, P368; Harris RB, 2018, MOL PHYLOGENET EVOL, V120, P183, DOI 10.1016/j.ympev.2017.11.020; Heckel J.J., 1848, SITZ KAIS AKAD WISS, V1, P289; Ho ALFC, 2016, MOL PHYLOGENET EVOL, V101, P32, DOI 10.1016/j.ympev.2016.04.032; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Huidobro L, 2006, J BIOGEOGR, V33, P731, DOI 10.1111/j.1365-2699.2005.01400.x; Zuniga-Vega JJ, 2014, BIOL J LINN SOC, V112, P399, DOI 10.1111/bij.12289; Jombart T., 2015, TUTORIAL DISCRIMINAN; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kamvar ZN, 2016, GBS ANAL; Lal MM, 2016, MAR GENOM, V25, P57, DOI 10.1016/j.margen.2015.10.010; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larson AD, 2012, J FISH BIOL, V80, P728, DOI 10.1111/j.1095-8649.2011.03213.x; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lucinda P.H.F., 2003, CHECK LIST FRESHWATE, P555; Lucinda Paulo Henrique Franco, 2005, Neotrop. ichthyol., V3, P1, DOI 10.1590/S1679-62252005000100001; Lundberg John G., 1998, P13; Mann P, 2007, GEOL SOC AM SPEC PAP, V428, P1, DOI 10.1130/2007.2428(01); Marshall JS, 2007, CENTRAL AM GEOLOGY R, V1, P1; Martinez-Aquino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101700; Mastretta-Yanes A, 2015, J BIOGEOGR, V42, P1586, DOI 10.1111/jbi.12546; Matamoros WA, 2015, CLADISTICS, V31, P177, DOI 10.1111/cla.12081; Matamoros WA, 2009, ZOOTAXA, P1; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; Mateos M, 2002, EVOLUTION, V56, P972; Mateos M, 2019, ECOL EVOL, V9, P1845, DOI 10.1002/ece3.4874; McMahan CD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178439; Mcmahan CD, 2013, ZOOTAXA, V3608, P440, DOI 10.11646/zootaxa.3608.6.2; MILLER RR, 1966, COPEIA, P773, DOI 10.2307/1441406; Morcillo F, 2016, MOL PHYLOGENET EVOL, V94, P242, DOI 10.1016/j.ympev.2015.09.002; Mulcahy DG, 2006, J BIOGEOGR, V33, P1889, DOI 10.1111/j.1365-2699.2006.01546.x; MYERS GS, 1966, COPEIA, P766; NORRIS S. M., 2005, FRESHWATER FISHES ME; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Perez-Rodriguez R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-223; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Rambaut A, 2018, FIGTREE MOL EVOLUTIO; Rannala B, 2017, SYST BIOL, V66, P823, DOI 10.1093/sysbio/syw119; RAUCHENBERGER M, 1988, SYST ZOOL, V37, P356, DOI 10.2307/2992198; Regan CT, 1913, P ZOOL SOC LOND, V1913, P977; Reznick DN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172546; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; Rodriguez-Silva R, 2020, J FISH BIOL, V96, P1360, DOI 10.1111/jfb.14301; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Rstudio T, 2020, RSTUDIO INT DEV R; Schmidt DN, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P427; Thomaz AT, 2019, MOL PHYLOGENET EVOL, V132, P265, DOI 10.1016/j.ympev.2018.12.008; Tonzo V, 2020, MOL ECOL, V29, P2254, DOI 10.1111/mec.15475; van Kruistum H, 2020, MOL BIOL EVOL, V37, P1376, DOI 10.1093/molbev/msaa011; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weaver PF, 2016, J BIOGEOGR, V43, P1808, DOI 10.1111/jbi.12798; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WELCOMME RL, 1992, ICES MAR SC, V194, P3; Winker K, 2011, CONDOR, V113, P5, DOI 10.1525/cond.2011.100093; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854	89	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262687	10.1371/journal.pone.0262687	http://dx.doi.org/10.1371/journal.pone.0262687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100283	Green Published, gold, Green Submitted			2022-12-26	WOS:000801937600018
J	Milevska-Kostova, N; Karanfilski, B; Knowles, J; Codling, K; Lazarus, JH				Milevska-Kostova, Neda; Karanfilski, Borislav; Knowles, Jacky; Codling, Karen; Lazarus, John H.			Modelling the contribution of iodised salt in industrially processed foods to iodine intake in Macedonia	PLOS ONE			English	Article							CONSUMPTION; IODIZATION; NUTRITION	Evidence from the 1950s showed that Macedonia was iodine deficient. After the introduction of mandatory universal salt iodisation, the country saw a steady increase in iodine intake and decline in goitre prevalence, earning iodine-deficiency free status in 2003. Iodine status assessments in 2007 and 2016 showed adequate iodine intake among school age children (median urinary iodine concentration of 241 mu g/L and 236 mu g/L respectively). Macedonia participated in piloting the Iodine Global Network Programme Guidance on the use of iodised salt in industrially processed foods to better understand potential iodised salt intake from processed foods. One objective of implementation was to identify the need, opportunities, and required actions to strengthen the processed food component of the national salt iodisation policy. Data from the 2017 Household Consumption and Expenditure Survey (HCES) was used to determine household salt consumption, to identify widely-consumed, salt-containing industrially processed foods, and estimate typical daily intake of these foods. Their estimated contribution to iodine intake was estimated based on their salt content and the percentage of food industry salt that is iodised. Although the study has limitations, including a relatively small selection of foods, the results indicate potential iodine intake from iodised household salt and iodised salt in the selected foods of nearly 300% of the Estimated Average Requirement and over 220% of the Recommended Nutrient Intake for adults. This was approximately 50% of the tolerable safe Upper Level for iodine intake. The study confirmed high daily salt intake (11.2 grams from household salt only). Successful salt reduction would be expected to reduce iodine intake, however, modelling with 10% and 30% reduction implied this is unlikely to put any population group at risk of deficiency. It is recommended that implementation of salt iodisation and salt reduction policies are harmonized, alongside continued regular iodine status monitoring for different population groups.	[Milevska-Kostova, Neda] Inst Social Innovat, Skopje, North Macedonia; [Karanfilski, Borislav] Natl Comm Iodine Deficiency, Minist Hlth, Skopje, North Macedonia; [Knowles, Jacky; Codling, Karen] Iodine Global Network, Toronto, ON, Canada; [Lazarus, John H.] Cardiff Univ, Cardiff, Wales	Cardiff University	Milevska-Kostova, N (corresponding author), Inst Social Innovat, Skopje, North Macedonia.	nmilevska@studiorum.org.mk	Kostova, Neda Milevska/E-9151-2017	Kostova, Neda Milevska/0000-0003-1596-9036				Allen LH, 2020, ADV NUTR, V11, P469, DOI 10.1093/advances/nmz096; [Anonymous], 2019, EXT TRAD ENT CHAR; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BUZINA R, 1970, AM J CLIN NUTR, V23, P1085; Center of Research Excellence in Nutrition and Metabolism, 2021, SERB FOOD NUTR DAT; Dold S, 2018, J NUTR, V148, P587, DOI 10.1093/jn/nxy015; Esche J, 2020, EUR J NUTR, V59, P3163, DOI 10.1007/s00394-019-02154-7; Gurinovic M, 2016, FOOD CHEM, V193, P173, DOI 10.1016/j.foodchem.2015.03.103; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He FJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h770; Iacone R, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103486; IGN, 2021, GLOB SCOR IOD NUTR 2; Karanfilski B, 2003, J PEDIATR ENDOCR MET, V16, P1041; Karanfilski B, 1993, Med Pregl, V46 Suppl 1, P77; Karanfilski B., 2018, IDD NEWSLETTER, P4; Karanfilski Be, 2018, IODINE THYROID STATU; Kuzmanovska S., 2019, MACEDONIAN MED PREVI; Majstorov V, 2020, J ENDOCRINOL INVEST, V43, P1073, DOI 10.1007/s40618-020-01189-6; Milevska-Kostova N., 2020, UNIVERSAL SALT IODIZ; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Rasmussen LB, 2007, INT J FOOD SCI NUTR, V58, P231, DOI 10.1080/09637480701198117; Santa D., 2018, J AGR FOOD ENV SCI, V72, P64; SSO, 2018, HOUSEHOLD CONSUMPTIO; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; WHO, 2013, WHO ISS NEW GUID DIE; World Health Organization, 2014, GUID FORT FOODGR SAL; World Health Organization, 2014, SERUM TRANSFERRIN RE, DOI DOI 10.3109/09540261.2014.928270	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263225	10.1371/journal.pone.0263225	http://dx.doi.org/10.1371/journal.pone.0263225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089975	Green Published, gold, Green Submitted			2022-12-26	WOS:000769158400046
J	Vandenbon, A				Vandenbon, Alexis			Evaluation of critical data processing steps for reliable prediction of gene co-expression from large collections of RNA-seq data	PLOS ONE			English	Article								Motivation Gene co-expression analysis is an attractive tool for leveraging enormous amounts of public RNA-seq datasets for the prediction of gene functions and regulatory mechanisms. However, the optimal data processing steps for the accurate prediction of gene co-expression from such large datasets remain unclear. Especially the importance of batch effect correction is understudied. Results We processed RNA-seq data of 68 human and 76 mouse cell types and tissues using 50 different workflows into 7,200 genome-wide gene co-expression networks. We then conducted a systematic analysis of the factors that result in high-quality co-expression predictions, focusing on normalization, batch effect correction, and measure of correlation. We confirmed the key importance of high sample counts for high-quality predictions. However, choosing a suitable normalization approach and applying batch effect correction can further improve the quality of co-expression estimates, equivalent to a >80% and >40% increase in samples. In larger datasets, batch effect removal was equivalent to a more than doubling of the sample size. Finally, Pearson correlation appears more suitable than Spearman correlation, except for smaller datasets. Conclusion A key point for accurate prediction of gene co-expression is the collection of many samples. However, paying attention to data normalization, batch effects, and the measure of correlation can significantly improve the quality of co-expression estimates.	[Vandenbon, Alexis] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan; [Vandenbon, Alexis] Kyoto Univ, Inst Liberal Arts & Sci, Kyoto, Japan	Kyoto University; Kyoto University	Vandenbon, A (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan.; Vandenbon, A (corresponding author), Kyoto Univ, Inst Liberal Arts & Sci, Kyoto, Japan.	alexisvdb@infront.kyoto-u.ac.jp						Abbas-Aghababazadeh F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206312; Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118; Ballouz S, 2017, BIOINFORMATICS, V33, P612, DOI 10.1093/bioinformatics/btw695; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Corchete LA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76881-x; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Harper KN, 2013, CANCER EPIDEM BIOMAR, V22, P1052, DOI 10.1158/1055-9965.EPI-13-0114; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0778-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Nygaard V, 2016, BIOSTATISTICS, V17, P29, DOI 10.1093/biostatistics/kxv027; Obayashi T, 2019, NUCLEIC ACIDS RES, V47, pD55, DOI 10.1093/nar/gky1155; Petryszak R, 2017, BIOINFORMATICS, V33, P2218, DOI 10.1093/bioinformatics/btx143; Price EM, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00083; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Serin EAR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00444; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; van Dam S, 2015, NUCLEIC ACIDS RES, V43, pD1124, DOI 10.1093/nar/gku1042; Vandenbon A, 2016, P NATL ACAD SCI USA, V113, pE2393, DOI 10.1073/pnas.1604351113; Verleyen W, 2015, BIOINFORMATICS, V31, P745, DOI 10.1093/bioinformatics/btu715; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yamamoto H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-51; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YQ, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa078; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zindler T, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03559-6	33	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263344	10.1371/journal.pone.0263344	http://dx.doi.org/10.1371/journal.pone.0263344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089979	Green Submitted, Green Published, gold			2022-12-26	WOS:000769158400057
J	Khalofah, A; Ghramh, HA; Al-Qthanin, RN; L'taief, B				Khalofah, Ahlam; Ghramh, Hamed A.; Al-Qthanin, Rahmah N.; L'taief, Boullbaba			The impact of NPK fertilizer on growth and nutrient accumulation in juniper (Juniperus procera) trees grown on fire-damaged and intact soils	PLOS ONE			English	Article							MEDITERRANEAN BASIN; LAND-USE; RECOVERY; SYSTEM; REGION	Wildfires significantly alter soil properties and result in vegetation shifts; therefore, rapid reforestation activities are needed in the forests affected by wildfires. The decreased nutrient in the soil is the obvious effect of wildfires; however, little is known about the reforestation of Juniper (Juniperus procera) forests with application of NPK fertilizers. Juniper forests are common in Asir and Taif regions of Saudi Arabia and vulnerable to wildfires; thus, reforestation is needed after the onset of fires. This study assessed the impact of different doses of organic NPK fertilizer (0, 5 and 10 g/L) on growth and nutrient accumulation of Juniper trees grown on fire-damaged and intact soils. Data relating to tree height, number of leaves per plant, fresh and dry biomass accumulation in shoot and root, chlorophyll contents and uptake of N, P, K, and Na were recorded. Individual and interactive effects of soil types and fertilizer doses significantly altered all measured traits with minor exceptions. Overall, higher values of the measured traits were recorded for intact soil and 10 g/L fertilize dose. The increasing fertilizer doses improved the growth and nutrient acquisition and application of 10 g/L fertilizer on intact soil recorded the highest values of growth traits. Juniper trees grown on fire-damaged soil accumulated higher amount of nitrogen than intact soil. Similarly, the trees grown on intact soil accumulated lower amount of Na and maintained comparable K/Na ratio to intact soil. It is concluded that supplying 10 g/L fertilizer could improve the establishment of Juniper trees on fire-damaged soil. Therefore, organic fertilizer can be used to improve the reforestation of wildfire-affected Juniper forests in the Asir province.	[Khalofah, Ahlam; Ghramh, Hamed A.; Al-Qthanin, Rahmah N.; L'taief, Boullbaba] King Khalid Univ, Fac Sci, Biol Dept, Abha, Saudi Arabia; [Khalofah, Ahlam; Ghramh, Hamed A.] King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia; [Ghramh, Hamed A.] King Khalid Univ, Fac Sci, Unit Bee Res & Honey Prod, Abha, Saudi Arabia; [Al-Qthanin, Rahmah N.] King Khalid Univ, Prince Sultan Bin Abdul Aziz Ctr Environm & Touri, Abha, Saudi Arabia; [L'taief, Boullbaba] Univ Carthage, Natl Inst Agron Res Tunisia INRAT, Lab Agron Sci & Technol LR16INRAT03, Tunis, Tunisia	King Khalid University; King Khalid University; King Khalid University; King Khalid University; Universite de Carthage	Khalofah, A (corresponding author), King Khalid Univ, Fac Sci, Biol Dept, Abha, Saudi Arabia.; Khalofah, A (corresponding author), King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia.	aalshayeed@kku.edu.sa	Khalofah, Ahlam/GPP-3951-2022; Khalofah, Ahlam/GQO-8938-2022	Khalofah, Ahlam/0000-0002-0005-504X; Khalofah, Ahlam/0000-0002-0005-504X	Research Center of Advanced Materials-King Khalid University, Saudi Arabia [RCAMS/KKU/G001/21]	Research Center of Advanced Materials-King Khalid University, Saudi Arabia	The authors would like to express their gratitude to the Research Center of Advanced Materials-King Khalid University, Saudi Arabia for support by grant number (RCAMS/KKU/G001/21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2014, JUNIPERS WORLD GENUS; Al-Ghamdi A. A. M., 2013, African Journal of Microbiology Research, V7, P996; AL-Ghamdi AAM., 2011, J ECOL NAT ENV, V4, P212; Al-Ghamdi AAM, 2012, INT J AGRIC BIOL, V14, P69; Alcasena FJ, 2018, SCI TOTAL ENVIRON, V621, P872, DOI 10.1016/j.scitotenv.2017.11.297; Andersson F., 2006, ECOSYST WORLD, V6, P1; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BREMNER J. M., 1960, JOUR AGRIC SCI, V55, P11, DOI 10.1017/S0021859600021572; Carson PL, 1975, RECOMMENDED POTASSIU; Doblas-Miranda E, 2015, GLOBAL ECOL BIOGEOGR, V24, P25, DOI 10.1111/geb.12224; Duarah I, 2011, 3 BIOTECH, V1, P227, DOI 10.1007/s13205-011-0028-2; El Atta HA, 2010, INT J ENVIRON SCI TE, V7, P59; El-Juhany L. I., 2008, Research Journal of Agriculture and Biological Sciences, V4, P126; Farooq S, 2015, J AGRON CROP SCI, V201, P173, DOI 10.1111/jac.12093; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Ghorbanzadeh A, 2021, PHYTOCHEMISTRY, V186, DOI 10.1016/j.phytochem.2021.112737; Gioria M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00501; Hai L, 2010, SOIL BIOL BIOCHEM, V42, P253, DOI 10.1016/j.soilbio.2009.10.023; IBM C IBM SPSS Inc, 2012, SPSS STAT WIND; Jain TB, 2008, AMBIO, V37, P563, DOI 10.1579/0044-7447-37.7.563; Jhariya MK, 2021, INT J ENVIRON SCI TE, V18, P3967, DOI 10.1007/s13762-020-03062-8; Jhariya MK, 2021, ENVIRON DEV SUSTAIN, V23, P6800, DOI 10.1007/s10668-020-00892-x; Khan MB, 2012, J ANIM PLANT SCI, V22, P309; Khoshhal Sarmast M, 2018, ECOL IRAN FOR; Lundgren MR, 2004, NORTHEAST NAT, V11, P313, DOI 10.1656/1092-6194(2004)011[0313:IOLUAS]2.0.CO;2; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Ne'eman G, 2012, ISR J ECOL EVOL, V58, P103, DOI 10.1560/IJEE.58.2-3.103; Negash L, 1995, INDIGENOUS TREES ETH; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Onen H, 2017, WEED SCI, V65, P115, DOI 10.1614/WS-D-16-00011.1; Page SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0176; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1074, DOI 10.1111/j.1466-8238.2012.00769.x; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Puerta-Pinero C, 2012, FOREST ECOL MANAG, V279, P121, DOI 10.1016/j.foreco.2012.05.020; Rhoades J. D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P149; Rumeu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027697; Santin C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0171; Satyam Verma, 2012, Proceedings of the International Academy of Ecology and Environmental Sciences, V2, P168; Savoy H., 1999, PB1637 AGR EXT SERV; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Singh AK, 2017, FOREST ECOL MANAG, V391, P458, DOI 10.1016/j.foreco.2017.02.042; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Su YZ, 2007, ECOL ENG, V29, P117, DOI 10.1016/j.ecoleng.2005.10.015; Taboada A, 2017, FOREST ECOL MANAG, V402, P63, DOI 10.1016/j.foreco.2017.07.029; Torres I, 2016, FOREST ECOL MANAG, V361, P309, DOI 10.1016/j.foreco.2015.11.027; van Kleunen M, 2015, MOL ECOL, V24, P1954, DOI 10.1111/mec.13013; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Venkatesh MS, 2017, ARCH AGRON SOIL SCI, V63, P2007, DOI 10.1080/03650340.2017.1320392; Zhan Y, 2020, J SOIL WATER CONSERV, V75, P166, DOI 10.2489/jswc.75.2.166	52	2	2	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262685	10.1371/journal.pone.0262685	http://dx.doi.org/10.1371/journal.pone.0262685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085316	gold, Green Published			2022-12-26	WOS:000779379600074
J	Wu, RMX; Zhang, ZW; Yan, WJ; Fan, JF; Gou, JW; Liu, B; Gide, EG; Soar, J; Shen, B; Fazal-E-Hasan, S; Liu, ZQ; Zhang, P; Wang, PL; Cui, XX; Peng, ZF; Wang, Y				Wu, Robert M. X.; Zhang, Zhongwu; Yan, Wanjun; Fan, Jianfeng; Gou, Jinwen; Liu, Bao; Gide, Ergun; Soar, Jeffrey; Shen, Bo; Fazal-E-Hasan, Syed; Liu, Zengquan; Zhang, Peng; Wang, Peilin; Cui, Xinxin; Peng, Zhanfei; Wang, Ya			A comparative analysis of the principal component analysis and entropy weight methods to establish the indexing measurement	PLOS ONE			English	Article							OPTIMIZATION; SYSTEM	Background As the world's largest coal producer, China was accounted for about 46% of global coal production. Among present coal mining risks, methane gas (called gas in this paper) explosion or ignition in an underground mine remains ever-present. Although many techniques have been used, gas accidents associated with the complex elements of underground gassy mines need more robust monitoring or warning systems to identify risks. This paper aimed to determine which single method between the PCA and Entropy methods better establishes a responsive weighted indexing measurement to improve coal mining safety. Methods Qualitative and quantitative mixed research methodologies were adopted for this research, including analysis of two case studies, correlation analysis, and comparative analysis. The literature reviewed the most-used multi-criteria decision making (MCDM) methods, including subjective methods and objective methods. The advantages and disadvantages of each MCDM method were briefly discussed. One more round literature review was conducted to search publications between 2017 and 2019 in CNKI. Followed two case studies, correlation analysis and comparative analysis were then conducted. Research ethics was approved by the Shanxi Coking Coal Group Research Committee. Results The literature searched a total of 25,831publications and found that the PCA method was the predominant method adopted, and the Entropy method was the second most widely adopted method. Two weighting methods were compared using two case studies. For the comparative analysis of Case Study 1, the PCA method appeared to be more responsive than the Entropy. For Case Study 2, the Entropy method is more responsive than the PCA. As a result, both methods were adopted for different cases in the case study mine and finally deployed for user acceptance testing on 5 November 2020. Conclusions The findings and suggestions were provided as further scopes for further research. This research indicated that no single method could be adopted as the better option for establishing indexing measurement in all cases. The practical implication suggests that comparative analysis should always be conducted on each case and determine the appropriate weighting method to the relevant case. This research recommended that the PCA method was a dimension reduction technique that could be handy for identifying the critical variables or factors and effectively used in hazard, risk, and emergency assessment. The PCA method might also be well-applied for developing predicting and forecasting systems as it was sensitive to outliers. The Entropy method might be suitable for all the cases requiring the MCDM. There is also a need to conduct further research to probe the causal reasons why the PCA and Entropy methods were applied to each case and not the other way round. This research found that the Entropy method provides higher accuracy than the PCA method. This research also found that the Entropy method demonstrated to assess the weights of the higher dimension dataset was higher sensitivity than the lower dimensions. Finally, the comprehensive analysis indicates a need to explore a more responsive method for establishing a weighted indexing measurement for warning applications in hazard, risk, and emergency assessments.	[Wu, Robert M. X.; Gide, Ergun] Cent Queensland Univ, Sch Engn & Technol, Sydney, NSW, Australia; [Wu, Robert M. X.; Zhang, Zhongwu; Fan, Jianfeng] Shanxi Normal Univ, Xian, Peoples R China; [Yan, Wanjun; Gou, Jinwen; Liu, Bao; Liu, Zengquan; Zhang, Peng] Shanxi Fenxi Min Zhongxing Coal Ind Co Ltd, Lvliang, Peoples R China; [Soar, Jeffrey] Univ Southern Queensland, Sch Business, Ipswich, Qld, Australia; [Shen, Bo] GENEW Technol Co Ltd, Shenzhen, Peoples R China; [Fazal-E-Hasan, Syed] Australian Catholic Univ, Peter Faber Business Sch, Blacktown, NSW, Australia; [Wang, Peilin; Peng, Zhanfei; Wang, Ya] Shanxi Kailain Technol Co Ltd, Taiyuan, Shanxi, Peoples R China; [Cui, Xinxin] NetEase Inc, Hangzhou, Zhejiang, Peoples R China	Central Queensland University; Shaanxi Normal University; Shanxi Normal University; University of Southern Queensland; Australian Catholic University	Wu, RMX (corresponding author), Cent Queensland Univ, Sch Engn & Technol, Sydney, NSW, Australia.; Wu, RMX (corresponding author), Shanxi Normal Univ, Xian, Peoples R China.	robert_wumx@hotmail.com	Wu, Robert/O-3572-2017	Wu, Robert M.X./0000-0002-1735-6797	Shanxi Coking Coal Project [201809fx03]; Shanxi Social Science Federation [SSKLZDKT2019053]	Shanxi Coking Coal Project; Shanxi Social Science Federation	Dr.Robert M.X. Wu received the funds of the Shanxi Coking Coal Project (201809fx03) for this work. Dr.Robert M.X. Wu received the funds of the Shanxi Social Science Federation (SSKLZDKT2019053).	Abdel-Fattah MK, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13041824; Acuna-Soto C, 2021, ANN OPER RES, V296, P541, DOI 10.1007/s10479-018-2945-5; Ahmad N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239140; AL-Rousan N, 2021, INT J ENERG RES, V45, P453, DOI 10.1002/er.5676; Asri MNM, 2018, J FORENSIC SCI, V63, P285, DOI 10.1111/1556-4029.13522; Babura BI, 2018, J PHYS CONF SER, V1132, DOI 10.1088/1742-6596/1132/1/012078; Barlow AM, 2020, J R STAT SOC C-APPL, V69, P765, DOI 10.1111/rssc.12420; Chao YS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183997; China Coal Safety, 2019, PREV REG COAL GAS OU; CNKI, 2019, CHIN NAT KNOWL INFR; Conlon KC, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP4030; Davari SA, 2021, IEEE T IND INFORM, V17, P31, DOI 10.1109/TII.2020.2981039; Dragicevic T, 2019, IEEE T IND ELECTRON, V66, P8870, DOI 10.1109/TIE.2018.2875660; Ecer F, 2021, RENEW ENERG, V170, P1156, DOI 10.1016/j.renene.2021.02.004; Glen S, 2020, PERCENT ERROR PERCEN; Hansen TM, 2021, MATH GEOSCI, V53, P163, DOI 10.1007/s11004-020-09876-z; Hong JH, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081277; Hutzler M., 2020, POWERMAG; IEA, 2020, AN FOR 2025; Jellali A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13020722; Jo BW, 2019, J AMB INTEL SMART EN, V11, P183, DOI 10.3233/AIS-190518; Kolagar M, 2021, INT J QUAL RELIAB MA, V38, P273, DOI 10.1108/IJQRM-09-2018-0230; Kolagar M, 2019, SMART CITIES-BASEL, V2, P31, DOI 10.3390/smartcities2010003; Kumar R, 2021, J MATER RES TECHNOL, V10, P1471, DOI 10.1016/j.jmrt.2020.12.114; Kumar R, 2017, J CLEAN PROD, V164, P45, DOI 10.1016/j.jclepro.2017.06.077; Larriva-Novo X, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21020656; Lin H, 2021, AIR QUAL ATMOS HLTH, V14, P251, DOI 10.1007/s11869-020-00930-7; Liu Q, 2017, KNOWLEDGE MANAGEMENT, V2, P500; Luana LM., 2021, WATER-SUI, V13, P1, DOI [10.3390/w13223310, DOI 10.3390/W13223310]; Luft P, 2018, J DEAF STUD DEAF EDU, V23, P148, DOI 10.1093/deafed/enx057; Maciejowska K, 2020, ENERGIES, V13, DOI 10.3390/en13143530; Mahmood T, 2021, SOFT COMPUT, V25, P1249, DOI 10.1007/s00500-020-05218-7; Medina N, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041452; Mishra AR, 2022, J AMB INTEL HUM COMP, V13, P295, DOI 10.1007/s12652-021-02902-w; Mukhametzyanov I., 2021, DECIS MAKING, V4, P76; Nahm FS, 2017, KOREAN J PAIN, V30, P241, DOI 10.3344/kjp.2017.30.4.241; Nemeth B, 2019, J COMP EFFECT RES, V8, P195, DOI 10.2217/cer-2018-0102; Neogi D, 2021, CIENC SAUDE COLETIVA, V26, P1419, DOI 10.1590/1413-81232021264.43132020; Neumayer S, 2020, APPL MATH OPT, V82, P1017, DOI 10.1007/s00245-019-09566-1; Nyimbili PH, 2021, NAT HAZARDS, V105, P1031, DOI 10.1007/s11069-020-04348-3; Pamucar D, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10090393; Peng XD, 2022, ARTIF INTELL REV, V55, P1567, DOI 10.1007/s10462-021-09995-x; Petridis K, 2021, ANN OPER RES, V296, P513, DOI 10.1007/s10479-019-03307-x; Prentkovskis O, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10120757; Price PC, 2017, RES METHODS PSYCHOL, V3rd; Roy PK, 2022, INT J SUST DEV WORLD, V29, P195, DOI 10.1080/13504509.2021.1935360; Saccenti E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57247-4; Srdjevic B., 2003, VODOPRIVREDA, V35, P163; Rao NS, 2020, ENVIRON GEOCHEM HLTH, V42, P579, DOI 10.1007/s10653-019-00393-5; Tan RP, 2021, APPL INTELL, V51, P283, DOI 10.1007/s10489-020-01706-3; Teixeira SJ, 2021, TOURISM ECON, V27, P23, DOI 10.1177/1354816619878995; Tutak M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081406; Viswasmayee P., 2018, I MANAGERS J DIGITAL, V6, P1, DOI DOI 10.26634/JDP.6.4.16096; Wang ZG, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010347; Watrobski J, 2019, OMEGA-INT J MANAGE S, V86, P107, DOI 10.1016/j.omega.2018.07.004; Wei AH, 2021, NAT HAZARDS, V105, P405, DOI 10.1007/s11069-020-04317-w; Wu RMX, 2021, GEOMAT NAT HAZ RISK, V12, P3175, DOI 10.1080/19475705.2021.2002953; Xian SD, 2020, INT J INTELL SYST, V35, P2049, DOI 10.1002/int.22284; Yu LL, 2020, INT J PHOTOENERGY, V2020, DOI 10.1155/2020/5251431; Zagradjanin N, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11101241; Zhang XY, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/6210569; Zhao XS, 2020, ENERGY SCI ENG, V8, P1980, DOI 10.1002/ese3.642; Ziarh GF, 2021, J FLOOD RISK MANAG, V14, DOI 10.1111/jfr3.12686; Zou QL, 2020, SAFETY SCI, V122, DOI 10.1016/j.ssci.2019.104515; zovic M. Zi., 2019, DECIS MAK APPL MANAG, V2, P126	65	2	2	9	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262261	10.1371/journal.pone.0262261	http://dx.doi.org/10.1371/journal.pone.0262261			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085274	gold, Green Published, Green Accepted			2022-12-26	WOS:000779379600045
J	Gullett, JM; Cuypers, MG; Grace, CR; Pant, S; Subramanian, C; Tajkhorshid, E; Rock, CO; White, SW				Gullett, Jessica M.; Cuypers, Maxime G.; Grace, Christy R.; Pant, Shashank; Subramanian, Chitra; Tajkhorshid, Emad; Rock, Charles O.; White, Stephen W.			Identification of structural transitions in bacterial fatty acid binding proteins that permit ligand entry and exit at membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CHEMICAL-EXCHANGE; LYSINE RESIDUES; APO; BACKBONE; RELAXATION; MECHANISMS; INSERTION; INSIGHTS; STATE	Fatty acid (FA) transfer proteins extract FA from membranes and sequester them to facilitate their movement through the cytosol. Detailed structural information is available for these soluble protein-FA complexes, but the structure of the protein conformation responsible for FA exchange at the membrane is unknown. Staphylococcus aureus FakB1 is a prototypical bacterial FA transfer protein that binds palmitate within a narrow, buried tunnel. Here, we define the conformational change from a "closed " FakB1 state to an "open " state that associates with the membrane and provides a path for entry and egress of the FA. Using NMR spectroscopy, we identified a conformationally flexible dynamic region in FakB1, and X-ray crystallography of FakB1 mutants captured the conformation of the open state. In addition, molecular dynamics simulations show that the new amphipathic alpha-helix formed in the open state inserts below the phosphate plane of the bilayer to create a diffusion channel for the hydrophobic FA tail to access the hydrocarbon core and place the carboxyl group at the phosphate layer. The membrane binding and catalytic properties of site-directed mutants were consistent with the proposed membrane docked structure predicted by our molecular dynamics simulations. Finally, the structure of the bilayer-associated conformation of FakB1 has local similarities with mammalian FA binding proteins and provides a conceptual framework for how these proteins interact with the membrane to create a diffusion channel from the FA location in the bilayer to the protein interior.	[Gullett, Jessica M.; Subramanian, Chitra; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Cuypers, Maxime G.; Grace, Christy R.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, NIH Ctr Macromol Modeling & Bioinformat, Dept Biochem,Theoreti & Computat Biophys Grp, Urbana, IL USA; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.; White, SW (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA.	charles.rock@stjude.org; stevew.white@stjude.org	; Rock, Charles/N-2256-2018	Royappa, Grace/0000-0002-1600-5610; Cuypers, Maxime/0000-0002-8826-2317; Rock, Charles/0000-0001-8648-4189; Pant, Shashank/0000-0002-8222-3616; Gullett, Jessica/0000-0003-3996-9110; White, Stephen/0000-0001-8188-5944	National Institutes of Health [GM034496, P41-GM104601, R01-GM123455]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; U.S. Department of Energy [W-31-109-Eng-38]; XSEDE allocation [MCA06N060];  [. W-31-109-Eng-38]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Energy(United States Department of Energy (DOE)); XSEDE allocation; 	This work was supported by National Institutes of Health grants GM034496 (C. O. R.) , and P41-GM104601 and R01-GM123455 (E. T.) , Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. Use of the Advanced Photon Source is supported by the U.S. Department of Energy under Contract No. W-31-109-Eng-38. The simulations reported in this study are supported by XSEDE allocation (grant MCA06N060 to E. T.) , Microsoft Azure, and Blue Waters at the National Supercomputing Application at the Uni-versity of Illinois at Urbana-Champaign. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bakowies D, 2002, J MOL BIOL, V315, P713, DOI 10.1006/jmbi.2001.5202; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Blanchard AE, 2014, BIOPHYS J, V107, P2112, DOI 10.1016/j.bpj.2014.09.013; Broussard TC, 2016, J BIOL CHEM, V291, P6292, DOI 10.1074/jbc.M115.706820; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Cuypers MG, 2019, J BIOL CHEM, V294, P38, DOI 10.1074/jbc.RA118.006160; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericson ME, 2017, MBIO, V8, DOI 10.1128/mBio.00988-17; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Frank MW, 2020, MBIO, V11, DOI 10.1128/mBio.00920-20; Friedman R, 2006, BIOPHYS J, V90, P1535, DOI 10.1529/biophysj.105.071571; Gullett JM, 2019, J BIOL CHEM, V294, P16416, DOI 10.1074/jbc.RA119.010659; Guo Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143476; Herr FM, 1996, BIOCHEMISTRY-US, V35, P1296, DOI 10.1021/bi952204b; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li Y, 2015, PHYS CHEM CHEM PHYS, V17, P32257, DOI 10.1039/c5cp04784f; Likic VA, 1999, PROTEIN SCI, V8, P1649, DOI 10.1110/ps.8.8.1649; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Long D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006081; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Matsuoka D, 2015, J PHYS CHEM B, V119, P114, DOI 10.1021/jp510384f; Mihajlovic M, 2007, PROTEIN SCI, V16, P2042, DOI 10.1110/ps.072875307; Ohkubo YZ, 2012, BIOPHYS J, V102, P2130, DOI 10.1016/j.bpj.2012.03.015; Pant S, 2020, J COMPUT CHEM, V41, P489, DOI 10.1002/jcc.26109; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Pashkovskaya AA, 2018, BIOPHYS J, V114, P2142, DOI 10.1016/j.bpj.2018.04.011; Pogorelov TV, 2014, J PHYS CHEM B, V118, P1481, DOI 10.1021/jp4089113; SACCHETTINI JC, 1988, J BIOL CHEM, V263, P5815; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Soubias O, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd1882; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tsfadia Y, 2007, FEBS LETT, V581, P1243, DOI 10.1016/j.febslet.2007.02.033; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Xiao TS, 2020, BIOPHYS J, V118, P396, DOI 10.1016/j.bpj.2019.12.005; Xiao TS, 2016, ANGEW CHEM INT EDIT, V55, P6869, DOI 10.1002/anie.201601326; Zhang FL, 1997, J BIOMOL NMR, V9, P213, DOI 10.1023/A:1018666522787; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	49	2	2	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101676	10.1016/j.jbc.2022.101676	http://dx.doi.org/10.1016/j.jbc.2022.101676			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35122790	Green Published, gold			2022-12-26	WOS:000791230900015
J	Scheck, MK; Lehmann, L; Zaucha, M; Schwarzlmueller, P; Huber, K; Pritsch, M; Barba-Spaeth, G; Thorn-Seshold, O; Krug, AB; Endres, S; Rothenfusser, S; Thorn-Seshold, J				Scheck, Magdalena K.; Lehmann, Lisa; Zaucha, Magdalena; Schwarzlmueller, Paul; Huber, Kristina; Pritsch, Michael; Barba-Spaeth, Giovanna; Thorn-Seshold, Oliver; Krug, Anne B.; Endres, Stefan; Rothenfusser, Simon; Thorn-Seshold, Julia			FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D	PLOS ONE			English	Article							VACCINE; IMMUNOGENICITY	There is an urgent need for better diagnostic and analytical methods for vaccine research and infection control in virology. This has been highlighted by recently emerging viral epidemics and pandemics (Zika, SARS-CoV-2), and recurring viral outbreaks like the yellow fever outbreaks in Angola and the Democratic Republic of Congo (2016) and in Brazil (2016-2018). Current assays to determine neutralising activity against viral infections in sera are costly in time and equipment and suffer from high variability. Therefore, both basic infection research and diagnostic population screenings would benefit from improved methods to determine virus-neutralising activity in patient samples. Here we describe a robust, objective, and scalable Fluorescence Reduction Neutralisation Test (FluoRNT) for yellow fever virus, relying on flow cytometric detection of cells infected with a fluorescent Venus reporter containing variant of the yellow fever vaccine strain 17D (YF-17D-Venus). It accurately measures neutralising antibody titres in human serum samples within as little as 24 h. Samples from 32 vaccinees immunised with YF-17D were tested for neutralising activity by both a conventional focus reduction neutralisation test (FRNT) and FluoRNT. Both types of tests proved to be equally reliable for the detection of neutralising activity, however, FluoRNT is significantly more precise and reproducible with a greater dynamic range than conventional FRNT. The FluoRNT assay protocol is substantially faster, easier to control, and cheaper in per-assay costs. FluoRNT additionally reduces handling time minimising exposure of personnel to patient samples. FluoRNT thus brings a range of desirable features that can accelerate and standardise the measurement of neutralising anti-yellow fever virus antibodies. It could be used in applications ranging from vaccine testing to large cohort studies in systems virology and vaccinology. We also anticipate the potential to translate the methodology and analysis of FluoRNT to other flaviviruses such as West Nile, Dengue and Zika or to RNA viruses more generally.	[Scheck, Magdalena K.; Lehmann, Lisa; Zaucha, Magdalena; Schwarzlmueller, Paul; Endres, Stefan; Rothenfusser, Simon; Thorn-Seshold, Julia] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Clin Pharmacol, Munich, Germany; [Huber, Kristina; Pritsch, Michael] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Infect Dis & Trop Med, Munich, Germany; [Pritsch, Michael] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Barba-Spaeth, Giovanna] Inst Pasteur, Dept Virol, Struct Virol Unit, Paris, France; [Barba-Spaeth, Giovanna] Inst Pasteur, Dept Virol, CNRS UMR 3569, Paris, France; [Thorn-Seshold, Oliver; Thorn-Seshold, Julia] Ludwig Maximilians Univ Munchen, Fac Chem & Pharm, Munich, Germany; [Krug, Anne B.] Ludwig Maximilians Univ Munchen, Inst Immunol, Biomed Ctr, Fac Med, Planegg Martinsried, Germany; [Endres, Stefan; Rothenfusser, Simon; Thorn-Seshold, Julia] Helmholtz Ctr Environm Hlth, Unit Clin Pharmacol EKliP, Munich, Germany	University of Munich; University of Munich; German Center for Infection Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Rothenfusser, S; Thorn-Seshold, J (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Div Clin Pharmacol, Munich, Germany.; Thorn-Seshold, J (corresponding author), Ludwig Maximilians Univ Munchen, Fac Chem & Pharm, Munich, Germany.; Rothenfusser, S; Thorn-Seshold, J (corresponding author), Helmholtz Ctr Environm Hlth, Unit Clin Pharmacol EKliP, Munich, Germany.	simon.rothenfusser@med.uni-muenchen.de; julia.thorn-seshold@cup.lmu.de	Thorn-Seshold, Oliver/AAA-3382-2021	Thorn-Seshold, Oliver/0000-0003-3981-651X; Lehmann, Lisa/0000-0002-5153-3371; Barba Spaeth, Giovanna/0000-0003-2069-9501; Zaucha, Magdalena/0000-0002-3590-1525; Pritsch, Michael/0000-0001-7383-8750	Einheit fur Klinische Pharmakologie (EKliP), Helmholtz Center Munich, Neuherberg, Germany; LMU Center for Integrated Protein Science Munich (CIPSMwomen); German Research Foundation (DFG) [TH2231/1-1]; Friedrich Baur Foundation (FBS) [Ro 25257/-1, 391217598, KR2199/10-1, SFB/TR-237-B14, 369799452]; international doctoral program "iTarget: Immunotargeting of cancer" - Elite Network of Bavaria; MaxWeber Foundation; LMU; Medical Faculty of the LMU Munich	Einheit fur Klinische Pharmakologie (EKliP), Helmholtz Center Munich, Neuherberg, Germany; LMU Center for Integrated Protein Science Munich (CIPSMwomen); German Research Foundation (DFG)(German Research Foundation (DFG)); Friedrich Baur Foundation (FBS); international doctoral program "iTarget: Immunotargeting of cancer" - Elite Network of Bavaria; MaxWeber Foundation; LMU; Medical Faculty of the LMU Munich	This research was supported by funds from: -Einheit fur Klinische Pharmakologie (EKliP), Helmholtz Center Munich, Neuherberg, Germany (https://www.helmholtz muenchen.de/forschung/forschungseinrichtungen/klinische kooperationen/klinische pharmakologie/forschung/index.html), to JTS, SE and SR; -LMU Center for Integrated Protein Science Munich (CIPSMwomen) to JTS German Research Foundation (DFG): Emmy Noether grant TH2231/1-1 to OTS (https://gepris.dfg.de/gepris/projekt/400324123) -Friedrich Baur Foundation (FBS) to JTS -Ro 25257/-1 grant number 391217598 (https://gepris.dfg.de/gepris/projekt/391217598) KR2199/10-1 to SR and ABK SFB/TR-237-B14 Grant No. 369799452 (https://gepris.dfg.de/gepris/projekt/404450088) to SR and ABK Furthermore, we would also like to acknowledge support from the international doctoral program "iTarget: Immunotargeting of cancer" funded by the Elite Network of Bavaria to MKS, MZ, LL, and SE. MKS gratefully acknowledges a PhD fellowship from the MaxWeber Foundation (https://www.elitenetzwerk.bayern.de/start/foerderangebote/max-weberprogramm) and support from the LMU Fo<spacing diaeresis> FoLe and Lehre@LMUprogrammes.MP was supported by a Metiphys fellowship of the Medical Faculty of the LMU Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JTS was receiving salary from the Einheit fu<spacing diaeresis>r Klinische Pharmakologie (EKliP), Helmholtz Center Munich at the time the work was performed. OTS is receiving salary from German Research Foundation (DFG).	Adungo F, 2016, CLIN VACCINE IMMUNOL, V23, P689, DOI 10.1128/CVI.00209-16; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269; Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Casey RM, 2019, NEW ENGL J MED, V381, P444, DOI 10.1056/NEJMoa1710430; Chen LH, 2020, TROP DIS TRAVEL MED, V6, DOI 10.1186/s40794-020-0101-0; Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9; Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264; Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9; Hammarlund E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041707; Huber JE, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1129; Kimathi Derick, 2019, Wellcome Open Res, V4, P182, DOI 10.12688/wellcomeopenres.15579.1; Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y; Mercier-Delarue S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177882; Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Rosenstein MD, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab126; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1; Tan JL, 2014, METHODS MOL BIOL, V1138, P41, DOI 10.1007/978-1-4939-0348-1_4; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; Whiteman MC, 2018, AM J TROP MED HYG, V99, P1430, DOI 10.4269/ajtmh.17-0948; Wieten RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149871; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262149	10.1371/journal.pone.0262149	http://dx.doi.org/10.1371/journal.pone.0262149			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139078	Green Published, gold			2022-12-26	WOS:000821499100005
J	Black, JL; Clark, MK; Sword, GA				Black, Joseph L.; Clark, Mason K.; Sword, Gregory A.			Physiological and transcriptional immune responses of a non-model arthropod to infection with different entomopathogenic groups	PLOS ONE			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; CELLULAR DEFENSE-MECHANISM; RNA INTERFERENCE; BEAUVERIA-BASSIANA; ANTIVIRAL DEFENSE; INNATE IMMUNITY; HELIOTHIS-VIRESCENS; GALLERIA-MELLONELLA; INSECT IMMUNITY; NEMATODE	Insect immune responses to multiple pathogen groups including viruses, bacteria, fungi, and entomopathogenic nematodes have traditionally been documented in model insects such as Drosophila melanogaster, or medically important insects such as Aedes aegypti. Despite their potential importance in understanding the efficacy of pathogens as biological control agents, these responses are infrequently studied in agriculturally important pests. Additionally, studies that investigate responses of a host species to different pathogen groups are uncommon, and typically focus on only a single time point during infection. As such, a robust understanding of immune system responses over the time of infection is often lacking in many pest species. This study was conducted to understand how 3rd instar larvae of the major insect pest Helicoverpa zea responded through the course of an infection by four different pathogenic groups: viruses, bacteria, fungi, and entomopathogenic nematodes; by sampling at three different times post-inoculation. Physiological immune responses were assessed at 4-, 24-, and 48-hours post-infection by measuring hemolymph phenoloxidase concentrations, hemolymph prophenoloxidase concentrations, hemocyte counts, and encapsulation ability. Transcriptional immune responses were measured at 24-, 48-, and 72-hours post-infection by quantifying the expression of PPO2, Argonaute-2, JNK, Dorsal, and Relish. This gene set covers the major known immune pathways: phenoloxidase cascade, siRNA, JNK pathway, Toll pathway, and IMD pathway. Our results indicate H. zea has an extreme immune response to Bacillus thuringiensis bacteria, a mild response to Helicoverpa armigera nucleopolyhedrovirus, and little-to-no detectable response to either the fungus Beauveria bassiana or Steinernema carpocapsae nematodes.	[Black, Joseph L.; Clark, Mason K.; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Black, JL (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	jlb021@tamu.edu		Black, Joseph/0000-0001-5399-0149				Baur ME, 1995, ENTOMOL EXP APPL, V77, P239, DOI 10.1007/BF02383058; Beutler B, 2004, CURR OPIN IMMUNOL, V16, P1, DOI 10.1016/j.coi.2003.11.017; Beutler B, 2003, IMMUNITY, V19, P155, DOI 10.1016/S1074-7613(03)00212-7; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Binda-Rossetti S, 2016, J INVERTEBR PATHOL, V133, P110, DOI 10.1016/j.jip.2015.11.001; Black JL, 2019, J ECON ENTOMOL, V112, P1098, DOI 10.1093/jee/toz012; Brivio MF, 2020, INSECTS, V11, DOI 10.3390/insects11060387; Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010; Bronkhorst AW, 2013, FLY, V7, P216, DOI 10.4161/fly.25708; Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200; Clark KD, 2004, J BIOL CHEM, V279, P33246, DOI 10.1074/jbc.M401157200; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 1998, BIOCHEM BIOPH RES CO, V250, P479, DOI 10.1006/bbrc.1998.9145; Mannino MC, 2019, J FUNGI, V5, DOI 10.3390/jof5020033; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Devi KU, 2008, BIOCONTROL SCI TECHN, V18, P975, DOI 10.1080/09583150802450451; ENGELHARD EK, 1994, P NATL ACAD SCI USA, V91, P3224, DOI 10.1073/pnas.91.8.3224; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garriga A, 2020, INSECTS, V11, DOI 10.3390/insects11040210; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006; Hou CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091189; Hung SY, 1996, J INVERTEBR PATHOL, V67, P35, DOI 10.1006/jipa.1996.0006; HUNG SY, 1992, J INVERTEBR PATHOL, V60, P152, DOI 10.1016/0022-2011(92)90089-M; Ikeda M, 2013, VIROLOGY, V435, P1, DOI 10.1016/j.virol.2012.10.016; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jayachandran B, 2012, J VIROL, V86, P13729, DOI 10.1128/JVI.02041-12; Jiao ZL, 2018, J INVERTEBR PATHOL, V159, P41, DOI 10.1016/j.jip.2018.10.011; Karamipour N, 2018, INSECT BIOCHEM MOLEC, V101, P24, DOI 10.1016/j.ibmb.2018.07.004; Karlikow M, 2014, DEV COMP IMMUNOL, V42, P85, DOI 10.1016/j.dci.2013.05.004; KATO Y, 1994, INSECT BIOCHEM MOLEC, V24, P547, DOI 10.1016/0965-1748(94)90090-6; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kong M, 2018, DEV COMP IMMUNOL, V83, P114, DOI 10.1016/j.dci.2018.01.019; Koppenhofer AM, 2007, J INVERTEBR PATHOL, V94, P184, DOI 10.1016/j.jip.2006.10.005; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Lavine MD, 2001, J INSECT PHYSIOL, V47, P965, DOI 10.1016/S0022-1910(01)00071-3; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lee M, 2005, PHYSIOL ENTOMOL, V30, P287, DOI 10.1111/j.1365-3032.2005.00460.x; Li L, 2014, ARCH INSECT BIOCHEM, V86, P240, DOI 10.1002/arch.21174; Li XY, 2007, INT J PARASITOL, V37, P365, DOI 10.1016/j.ijpara.2006.08.009; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579; McNeil J, 2010, J INSECT PHYSIOL, V56, P1167, DOI 10.1016/j.jinsphys.2010.03.020; McNeil J, 2010, J GEN VIROL, V91, P1590, DOI 10.1099/vir.0.018952-0; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Musser F.R., 2019, ESA NATL M; Musser F.R., 2019, ESA SE BRANCH M; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Palmer WJ, 2015, MOL BIOL EVOL, V32, P2111, DOI 10.1093/molbev/msv093; Pan QJ, 2021, INSECT SCI, V28, P103, DOI 10.1111/1744-7917.12755; Park JW, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P480, DOI 10.1016/B978-0-12-384747-8.10014-5; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; Pertea Geo, 2020, F1000Res, V9, P304, DOI 10.12688/f1000research.23297.1; Popham HJR, 2004, J GEN VIROL, V85, P2255, DOI 10.1099/vir.0.79965-0; RATCLIFFE NA, 1976, J INVERTEBR PATHOL, V28, P373, DOI 10.1016/0022-2011(76)90013-6; Reisig D., 2019, CROPS SOILS, V52, P30, DOI [DOI 10.2134/cs2019.52.0108, 10.2134/cs2019.52.0108, DOI 10.2134/CS2019.52.0108]; Rolff J, 2004, P ROY SOC B-BIOL SCI, V271, P2157, DOI 10.1098/rspb.2004.2859; Rstudio T, 2020, RSTUDIO INT DEV R; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Satyavathi VV, 2014, CELL SIGNAL, V26, P1753, DOI 10.1016/j.cellsig.2014.02.024; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt O, 2008, INSECT IMMUNOLOGY, P1, DOI 10.1016/B978-012373976-6.50003-3; Scholefield JA, 2019, J INVERTEBR PATHOL, V167, DOI 10.1016/j.jip.2019.107232; Shelby KS, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_13.1; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Strand MR, 1999, ARCH INSECT BIOCHEM, V42, P213, DOI 10.1002/(SICI)1520-6327(199911)42:3&lt;213::AID-ARCH5&gt;3.0.CO;2-4; Talbot NJ, 2019, CURR BIOL, V29, pR144, DOI 10.1016/j.cub.2018.12.050; Tessnow AE, 2018, J INSECT PHYSIOL, V106, P88, DOI 10.1016/j.jinsphys.2017.07.004; Trudeau D, 2001, J VIROL, V75, P996, DOI 10.1128/JVI.75.2.996-1003.2001; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang GJ, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5544-1; Wang Q, 2019, MOL IMMUNOL, V106, P69, DOI 10.1016/j.molimm.2018.12.021; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XL, 2019, CURR OPIN INSECT SCI, V33, P105, DOI 10.1016/j.cois.2019.05.004; WIESNER A, 1992, J INSECT PHYSIOL, V38, P533, DOI 10.1016/0022-1910(92)90079-S; Wu QH, 2018, TOXINS, V10, DOI 10.3390/toxins10110461; Xiong GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1509-1; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Zhao ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080146	89	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263620	10.1371/journal.pone.0263620	http://dx.doi.org/10.1371/journal.pone.0263620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134064	gold, Green Published			2022-12-26	WOS:000798968600021
J	Guerra, E; Relli, V; Ceci, M; Tripaldi, R; Simeone, P; Aloisi, AL; Pantalone, L; La Sorda, R; Lattanzio, R; Sacchetti, A; Havas, K; Guarnieri, S; Vergara, D; Fournier, I; Salzet, M; Tinari, N; Piantelli, M; Trerotola, M; Alberti, S				Guerra, Emanuela; Relli, Valeria; Ceci, Martina; Tripaldi, Romina; Simeone, Pasquale; Aloisi, Anna Laura; Pantalone, Ludovica; La Sorda, Rossana; Lattanzio, Rossano; Sacchetti, Andrea; Havas, Kristina; Guarnieri, Simone; Vergara, Daniele; Fournier, Isabelle; Salzet, Michel; Tinari, Nicola; Piantelli, Mauro; Trerotola, Marco; Alberti, Saverio			Trop-2, Na+/K+ ATPase, CD9, PKC alpha, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion	ONCOGENE			English	Article							PROTEIN-KINASE-C; E-CADHERIN; TETRASPANIN CD9; CELL-ADHESION; PH DOMAINS; TUMOR; BINDING; OUABAIN; METASTASIS; CLEAVAGE	Trop-2 is a transmembrane signal transducer that is overexpressed in most human cancers, and drives malignant progression. To gain knowledge on the higher-order molecular mechanisms that drive Trop-2 signaling, we applied next-generation sequencing, proteomics, and high-resolution microscopy to models and primary cases of human colorectal cancer (CRC). We had previously shown that Trop-2 induces a Ca2+ signal. We reveal here that Trop-2 binds the cell membrane Na+/K+-ATPase, and that clustering of Trop-2 induces an intracellular Ca2+ rise followed by membrane translocation of PKC alpha, which in turn phosphorylates the Trop-2 cytoplasmic tail. This feed-forward signaling is promoted by the binding of Trop-2 to the PKC alpha membrane-anchor CD9. CRISPR-based inactivation of CD9 in CRC cells shows that CD9 is required by Trop-2 for recruiting PKC alpha and cofilin-1 to the cell membrane. This induces malignant progression through proteolytic cleavage of E-cadherin, remodeling of the beta-actin cytoskeleton, and activation of Akt and ERK. The interaction between Trop-2 and CD9 was validated in vivo in murine models of CRC growth and invasion. Overexpression of the components of this Trop-2-driven super-complex significantly worsened disease-free and overall survival of CRC patients, supporting a pivotal relevance in CRC malignant progression. Our findings demonstrate a previously unsuspected layer of cancer growth regulation, which is dormant in normal tissues, and is activated by Trop-2 in cancer cells.	[Guerra, Emanuela; Relli, Valeria; Ceci, Martina; Tripaldi, Romina; Simeone, Pasquale; Aloisi, Anna Laura; Pantalone, Ludovica; La Sorda, Rossana; Lattanzio, Rossano; Sacchetti, Andrea; Havas, Kristina; Piantelli, Mauro; Trerotola, Marco; Alberti, Saverio] Univ G DAnnunzio, Ctr Adv Studies & Technol CAST, Lab Canc Pathol, Chieti, Italy; [Guerra, Emanuela; Tinari, Nicola; Piantelli, Mauro; Trerotola, Marco] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Lattanzio, Rossano] Univ G DAnnunzio, Dept Innovat Technol Med & Dent, Chieti, Italy; [Guarnieri, Simone] Univ G DAnnunzio, Ctr Adv Studies & Technol CAST, Lab Cell Physiol, Chieti, Italy; [Guarnieri, Simone] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Vergara, Daniele] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Fournier, Isabelle; Salzet, Michel] Univ Lille 1, INSERM, U1192, Lab Proteom Reponse Inflammatoire Spectrometrie M, Cite Sci, Villeneuve Dascq, France; [Alberti, Saverio] Univ Messina, Dept Biomed Sci, Unit Med Genet, Messina, Italy; [Simeone, Pasquale] Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Simeone, Pasquale] Univ G DAnnunzio, Ctr Adv Studies & Technol CAST, Lab Cytomorphol, Chieti, Italy; [Sacchetti, Andrea] Erasmus MC, Josephine Nefkens Inst, Rotterdam, Netherlands; [Havas, Kristina] FIRC Inst Mol Oncol IFOM, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Salento; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Messina; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Erasmus University Rotterdam; Erasmus MC; IFOM - FIRC Institute of Molecular Oncology	Trerotola, M; Alberti, S (corresponding author), Univ G DAnnunzio, Ctr Adv Studies & Technol CAST, Lab Canc Pathol, Chieti, Italy.; Trerotola, M (corresponding author), Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.; Alberti, S (corresponding author), Univ Messina, Dept Biomed Sci, Unit Med Genet, Messina, Italy.	marco.trerotola@unich.it; salberti@unime.it	Vergara, Daniele/K-3831-2014; Alberti, Saverio/M-4511-2014; Salzet, Michel/A-7675-2011; Simeone, Pasquale/K-7549-2016	Vergara, Daniele/0000-0002-2396-7674; Alberti, Saverio/0000-0002-4647-6042; Salzet, Michel/0000-0003-4318-0817; Simeone, Pasquale/0000-0003-4430-480X; Ceci, Martina/0000-0002-4550-8823; Guerra, Emanuela/0000-0002-7091-8621	Italian Ministry of Health [RicOncol RF-EMR-2006-361866]; Italian Ministry of Development-FESR; Region Abruzzo (POR FESR 2007-2013: Activity 1.1.1 line B) [C78C14000100005]; Oncoxx Biotech, Italy; Marie Curie Transfer of Knowledge Fellowship-EC VI Framework Program [014541]; Programma Per Giovani Ricercatori "Rita Levi Montalcini", Italian Ministry of University and Research [PGR12I7N1Z];  [SSI000651];  [1083/2006];  [1828/2006]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Development-FESR; Region Abruzzo (POR FESR 2007-2013: Activity 1.1.1 line B); Oncoxx Biotech, Italy; Marie Curie Transfer of Knowledge Fellowship-EC VI Framework Program; Programma Per Giovani Ricercatori "Rita Levi Montalcini", Italian Ministry of University and Research; ; ; 	Italian Ministry of Health (RicOncol RF-EMR-2006-361866), Italian Ministry of Development-FESR 2016-2018. SSI000651, art. 69 Reg. (CE) n. 1083/2006 and Reg. (CE) n. 1828/2006, Region Abruzzo (POR FESR 2007-2013: Activity 1.1.1 line B) C78C14000100005, Oncoxx Biotech, Italy and Marie Curie Transfer of Knowledge Fellowship-EC VI Framework Program (Contract 014541) to SA. Programma Per Giovani Ricercatori "Rita Levi Montalcini", Italian Ministry of University and Research (Grant PGR12I7N1Z) to MT. EG is an inventor in patents WO201687651 and WO201784763, and a partner in Mediterranea Theranostic Srl. MT is an inventor in patent WO201784763. SA is an inventor in patents WO201089782, WO201687651, and WO201784763, and is founder and CEO of Oncoxx Biotech Srl and Mediterranea Theranostic Srl. VR was an employee of Oncoxx Biotech Srl. PS is an inventor in a patent application under consideration (EP3546948).	Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Alberti S, 1999, PROTEINS, V35, P360; Alberti S, 1998, PROTEINS, V31, P1, DOI 10.1002/(SICI)1097-0134(19980401)31:1<1::AID-PROT1>3.0.CO;2-R; ALBERTI S, 1992, HYBRIDOMA, V11, P539, DOI 10.1089/hyb.1992.11.539; Ambrogi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096993; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Bahmad HF, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00347; Bardia A, 2019, NEW ENGL J MED, V380, P741, DOI 10.1056/NEJMoa1814213; BASU A, 1995, INT J CANCER, V62, P472, DOI 10.1002/ijc.2910620419; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Chen DD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-716; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Ciccarelli FD, 2000, HUM MOL GENET, V9, P1001, DOI 10.1093/hmg/9.6.1001; Di Baldassarre A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30537-z; El Sewedy T, 1998, INT J CANCER, V75, P324, DOI 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.3.CO;2-5; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; Guerra E, 2021, NEOPLASIA, V23, P898, DOI 10.1016/j.neo.2021.07.002; Guerra E, 2016, CLIN CANCER RES, V22, P4197, DOI 10.1158/1078-0432.CCR-15-1701; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Hoshino A, 2020, CELL, V182, P1044, DOI 10.1016/j.cell.2020.07.009; Jiang XP, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.118574; Krishn SR, 2019, MATRIX BIOL, V77, P41, DOI 10.1016/j.matbio.2018.08.004; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Matchkov VV, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00179; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; Mori Y, 2019, J BIOL CHEM, V294, P11513, DOI 10.1074/jbc.RA119.008084; MORIKAWA K, 1988, CANCER RES, V48, P6863; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Ninsontia C, 2014, ANTICANCER RES, V34, P5495; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Ripani E, 1998, INT J CANCER, V76, P671; Saczko-Brack D, 2016, P NATL ACAD SCI USA, V113, pE8387, DOI 10.1073/pnas.1612719113; Sakuma M, 2012, MOL BIOL CELL, V23, P3707, DOI 10.1091/mbc.E12-01-0053; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shen JJ, 2020, ACTA PHARMACOL SIN, V41, P110, DOI 10.1038/s41401-019-0290-0; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Sveen A, 2011, GENOME MED, V3, DOI 10.1186/gm248; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Thomas A, 2019, CLIN CANCER RES, V25, P6581, DOI 10.1158/1078-0432.CCR-19-1089; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Trerotola M, 2021, NEOPLASIA, V23, P415, DOI 10.1016/j.neo.2021.03.006; Trerotola M, 2015, ONCOTARGET, V6, P14318, DOI 10.18632/oncotarget.3960; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Trerotola M, 2012, J CELL PHYSIOL, V227, P3670, DOI 10.1002/jcp.24074; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wang HX, 2011, J CELL SCI, V124, P2702, DOI 10.1242/jcs.085449; Wanger TM, 2015, CELL SIGNAL, V27, P1325, DOI 10.1016/j.cellsig.2015.03.017; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	66	3	3	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1795	1808		10.1038/s41388-022-02220-1	http://dx.doi.org/10.1038/s41388-022-02220-1		FEB 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35132180	Green Published			2022-12-26	WOS:000752288100002
J	Sadeq, F; Poster, J; Chu, C; Weber, J; Lydon, M; Begis, MD; Sheridan, RL; Uygun, K				Sadeq, Farzin; Poster, Jonah; Chu, Chris; Weber, Joan; Lydon, Martha; Begis, Maggie Dylewski; Sheridan, Robert Leo; Uygun, Korkut			Specific patterns of vital sign fluctuations predict infection and enable sepsis diagnosis in pediatric burn patients	PLOS ONE			English	Article							ORGAN FAILURE; TIME-COURSE; PROCALCITONIN; DEFINITIONS; INDICATOR; CRITERIA; INJURY	Early recognition of the clinical signs of bloodstream infection in pediatric burn patients is key to improving survival rates in the burn unit. The objective of this study was to propose a simple scoring criteria that used readily available temperature, heart rate (HR) and mean arterial pressure (MAP) data to accurately predict bloodstream infection in pediatric burn patients. A retrospective chart review included 100 patients admitted to the pediatric burn unit for >20% total body surface area (TBSA) burn injuries. Each patient had multiple blood culture tests, and each test was treated as a separate and independent "infection event" for analysis. The time at each blood culture draw was time 0 for that event, and temperature, HR and MAP data was collected for 24 hours after the blood culture was drawn. "Infection events" included in this study had at least six complete sets of temperature, HR and MAP data entries. Median temperature, HR and MAP, as well as mean fever spikes, HR spikes and MAP dips, were compared between infection group (positive blood cultures) and control group (negative blood cultures). These vital sign fluctuations were evaluated individually and as a combination of all three as timely predictors of bloodstream infection. In addition, we tested the prediction of Gram-negative bacteria versus Gram-positive or fungi present in blood cultures. Patients in the infection group had significantly higher median temperatures (p<0.001), mean fever spikes (p<0.001) and mean HR spikes (p<0.001), compared to the control group. Using the combination scoring criteria to predict bloodstream infection, the strongest predictive values in the 24-hour timeframe had high sensitivity (93%) and specificity (81%). The predictive test metric based on vital sign spikes predicted Gram-negative bacteria, but with limited sensitivity (57%) and specificity (44%). A simple scoring criteria using a combination of fever spikes, HR spikes and MAP dips predicted bloodstream infection in pediatric burn patients, and can be feasibly implemented in routine clinical care. There is also potential to use the predictive metric to detect a few select organisms based on vital signs, however further work is necessary to enhance accuracy to levels that would allow consideration for clinical use.	[Sadeq, Farzin; Poster, Jonah; Chu, Chris; Weber, Joan; Lydon, Martha; Begis, Maggie Dylewski; Sheridan, Robert Leo; Uygun, Korkut] Shriners Hosp Children Boston, Dept Res, Boston, MA 02114 USA; [Sadeq, Farzin; Chu, Chris; Weber, Joan; Lydon, Martha; Begis, Maggie Dylewski; Sheridan, Robert Leo; Uygun, Korkut] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Sadeq, Farzin; Poster, Jonah; Chu, Chris; Uygun, Korkut] Massachusetts Gen Hosp, Ctr Engn Med & Surg, Boston, MA 02114 USA; [Sadeq, Farzin; Poster, Jonah; Chu, Chris; Weber, Joan; Lydon, Martha; Begis, Maggie Dylewski; Sheridan, Robert Leo; Uygun, Korkut] Harvard Med Sch, Boston, MA 02115 USA; [Poster, Jonah] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Sheridan, RL; Uygun, K (corresponding author), Shriners Hosp Children Boston, Dept Res, Boston, MA 02114 USA.; Sheridan, RL; Uygun, K (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.; Uygun, K (corresponding author), Massachusetts Gen Hosp, Ctr Engn Med & Surg, Boston, MA 02114 USA.; Sheridan, RL; Uygun, K (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	rsheridan@mgh.harvard.edu; kuygun@mgh.harvard.edu			Shriners Hospitals for Children Boston Clinical Research Core, Shriners Hospitals for Children [71004]	Shriners Hospitals for Children Boston Clinical Research Core, Shriners Hospitals for Children	The authors KU and RLS received funding from the Shriners Hospitals for Children Boston Clinical Research Core, Shriners Hospitals for Children (Clinical Research Grant 71004), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafez N M, 2007, Ann Burns Fire Disasters, V20, P89; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bourgi J, 2020, BURNS, V46, P1968, DOI 10.1016/j.burns.2020.05.004; Cabral L, 2017, BURNS, V43, P1427, DOI 10.1016/j.burns.2017.03.026; Dissanaike S., 2016, BURN CARE GEN SURGEO, P85; Erenler AK, 2020, REV MED MICROBIOL, V31, P135, DOI 10.1097/MRM.0000000000000208; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Greenhalgh DG, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-017-0089-5; Hill DM, 2018, J BURN CARE RES, V39, P982, DOI 10.1093/jbcr/iry022; Hogan BK, 2012, J BURN CARE RES, V33, P371, DOI 10.1097/BCR.0b013e3182331e87; Jeschke MG, 2013, INT J BURNS TRAUMA, V3, P137; Lavrentieva A, 2012, BURNS, V38, P356, DOI 10.1016/j.burns.2011.08.021; Lavrentieva A, 2007, BURNS, V33, P189, DOI 10.1016/j.burns.2006.07.001; Li W, 2020, BURNS TRAUMA, V8, DOI 10.1093/burnst/tkz006; Lopez ON, 2017, THER CLIN RISK MANAG, V13, P1107, DOI 10.2147/TCRM.S119938; Mann EA, 2011, BURNS, V37, P549, DOI 10.1016/j.burns.2010.04.013; Mann-Salinas EA, 2013, J BURN CARE RES, V34, P31, DOI 10.1097/BCR.0b013e31826450b5; Neely AN, 2004, J BURN CARE REHABIL, V25, P76, DOI 10.1097/01.BCR.0000105095.94766.89; Nielson CB, 2017, J BURN CARE RES, V38, pE469, DOI 10.1097/BCR.0000000000000355; Poster J, 2019, J BURN CARE RES, V40, P220, DOI 10.1093/jbcr/irz002; Schultz L, 2013, BURNS, V39, P1355, DOI 10.1016/j.burns.2013.04.009; Sheridan Robert L, 2005, Pediatr Crit Care Med, V6, pS112, DOI 10.1097/01.PCC.0000161577.27849.BE; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tan MC, 2019, J CELL BIOCHEM, V120, P5852, DOI 10.1002/jcb.27870; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Yan JH, 2018, SURGERY, V164, P1241, DOI 10.1016/j.surg.2018.05.053; Yan ST, 2017, AM J EMERG MED, V35, P579, DOI 10.1016/j.ajem.2016.12.017; Zhang PJ, 2021, BURNS TRAUMA, V9, DOI 10.1093/burnst/tkaa047	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263421	10.1371/journal.pone.0263421	http://dx.doi.org/10.1371/journal.pone.0263421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130306	Green Published, gold			2022-12-26	WOS:000805530700030
J	Jugwanth, S; Gededzha, MP; Mampeule, N; Zwane, N; David, A; Burgers, WA; Blackburn, JM; Grove, JS; George, JA; Sanne, I; Scott, L; Stevens, W; Mayne, ES				Jugwanth, Sarika; Gededzha, Maemu P.; Mampeule, Nakampe; Zwane, Nontobeko; David, Anura; Burgers, Wendy A.; Blackburn, Jonathan M.; Grove, Jurette S.; George, Jaya A.; Sanne, Ian; Scott, Lesley; Stevens, Wendy; Mayne, Elizabeth S.			Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients	PLOS ONE			English	Article							MULTISYSTEM INFLAMMATORY SYNDROME; COVID-19; IMMUNOASSAY; EUROIMMUN; CHILDREN	In late December 2019, pneumonia cases of unknown origin were reported in Wuhan, China. This virus was named SARS-CoV2 and the clinical syndrome was named coronavirus disease 19 (COVID-19). South Africa, despite strict and early lockdown has the highest infection rate in Africa. A key component of South Africa's response to SARSCoV2 was the rapid scale-up of diagnostic testing. The Abbott SARS-CoV2 assay detects IgG antibodies against the Nucleocapsid (N) protein of the SARS-CoV2 virus. This study undertook to validate and evaluate performance criteria of the Abbott assay and to establish whether this assay would show clinical utility in our population. Positive patients (n = 391) and negative controls (n = 139) were included. The Architect-i and Alinity-i systems were analyzers that were used to perform the SARS-CoV-2 IgG assay. In-house ELISA was incorporated into the study as a confirmatory serology test. A total of number of 530 participants was tested, 87% were symptomatic with infection and 13% were asymptomatic. When compared to RT-qPCR, the sensitivity of Architect and Alinity SARS-CoV2 assays was 69.5% and 64.8%, respectively. Specificity for Architect and Alinity assays was 95% and 90.3%, respectively. The Abbott assay was also compared to in house ELISA assay, with sensitivity for the Architect and Alinity assays of 94.7% and 92.5%, respectively. Specificity for Abbott Alinity assays was 91.7% higher than Abbott Architect 88.1%. Based on the current findings testing of IgG after 14 days is recommended in South Africa and supports other studies performed around the world.	[Jugwanth, Sarika; Gededzha, Maemu P.; Mampeule, Nakampe; Zwane, Nontobeko; Mayne, Elizabeth S.] Univ Witwatersrand, Dept Immunol, Fac Hlth Sci, Johannesburg, South Africa; [Jugwanth, Sarika; Gededzha, Maemu P.; Mampeule, Nakampe; Grove, Jurette S.; George, Jaya A.; Scott, Lesley; Stevens, Wendy; Mayne, Elizabeth S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [David, Anura; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Sch Pathol, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa; [Burgers, Wendy A.] Univ Cape Town, Div Med Virol, Dept Pathol, Fac Hlth Sci, Cape Town, South Africa; [Burgers, Wendy A.] Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Burgers, Wendy A.; Blackburn, Jonathan M.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Blackburn, Jonathan M.] Univ Cape Town, Div Chem & Syst Biol, Dept Integrat Biomed Sci, Fac Hlth Sci, Cape Town, South Africa; [Grove, Jurette S.; George, Jaya A.] Univ Witwatersrand, Dept Chem Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Dept Med, Clin HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; University of Cape Town; University of Cape Town; University of Cape Town; University of Witwatersrand; University of Witwatersrand	Jugwanth, S (corresponding author), Univ Witwatersrand, Dept Immunol, Fac Hlth Sci, Johannesburg, South Africa.; Jugwanth, S (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	Sarika.Jugwanth@nhls.ac.za		Mayne, Elizabeth/0000-0002-6360-3488; Scott, Lesley/0000-0001-6573-9525; Jugwanth, Sarika/0000-0001-5355-2384	Bill Melinda Gates [OPP1171455]	Bill Melinda Gates(Bill & Melinda Gates Foundation)	WS, OPP1171455, Bill & Melinda Gates, https://www.gatesfoundation.org/Foundation, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JMB,64760,NRF,https://www.nrf. ac.za/,The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, SARS COV 2 IGG ARCHI, P16; [Anonymous], 2020, SARS COV 2 IGG ALINI, P16; [Anonymous], 2020, COVID 19 CORONAVIRUS; Ayouba A, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104521; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Clarke C, 2020, J AM SOC NEPHROL, V31, P1969, DOI 10.1681/ASN.2020060827; Grzelak L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3103; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Harritshoj LH, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02596-20; Huang C, 2020, ACS OMEGA, V5, P12550, DOI 10.1021/acsomega.0c01554; Khan S, 2020, J HOSP INFECT, V104, P252, DOI 10.1016/j.jhin.2020.01.019; Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132; M. A. Rodgers, 2021, medRxiv, DOI 10.1101/2021.04.24.21256045; Makatsa MS, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.589940; Manalac J, 2020, CLIN CHIM ACTA, V510, P687, DOI 10.1016/j.cca.2020.09.002; Marklund E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241104; McAndrews KM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142386; Mendelson M, 2021, SAMJ S AFR MED J, V111, P10, DOI [10.7196/SAMJ.2021.v111i1.15433, 10.7196/samj.2021.v111i1.15433, 10.7196/SAMJ.2020.v111i11.15433]; Meschi S, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104539; Mukandavire Z, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236003; Nicol T, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104511; Oliveira SC., 2020, FRONT IMMUNOL, V11, P1, DOI [10.3389/fimmu.2020.00001, DOI 10.3389/FIMMU.2020.00001]; Rafferty MS, 2021, J INFECT PUBLIC HEAL, V14, P484, DOI 10.1016/j.jiph.2021.01.008; Ravi N, 2020, BIOSENS BIOELECTRON, V165, DOI 10.1016/j.bios.2020.112454; Rongqing Z., 2020, EARLY DETECTION SEVE, V71, P2066, DOI [10.1093/cid/ciaa523, DOI 10.1093/CID/CIAA523]; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Stiegler N, 2020, ANN MED-PSYCHOL, V178, P695, DOI 10.1016/j.amp.2020.05.006; Suhandynata RT, 2021, CLIN CHEM, V67, P404, DOI 10.1093/clinchem/hvaa262; Tan S, 2021, ARCH PATHOL LAB MED, V145, P32, DOI 10.5858/arpa.2020-0499-SA; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01243-20; Van Elslande J, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.07.038; Webb Kate, 2020, Lancet Child Adolesc Health, V4, pe38, DOI 10.1016/S2352-4642(20)30272-8; WHO, 2020, RESP COMM SPREAD COV, P1, DOI DOI 10.1017/DMP.2020.166; worldometers, US; Yuan X, 2020, ACS INFECT DIS, V6, P1998, DOI 10.1021/acsinfecdis.0c00365; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262442	10.1371/journal.pone.0262442	http://dx.doi.org/10.1371/journal.pone.0262442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120133	Green Published, gold			2022-12-26	WOS:000789273600008
J	Lee, HW; Huang, D; Shin, WK; de la Torre, K; Yang, JJ; Song, M; Shin, A; Lee, JK; Kang, D				Lee, Hwi-Won; Huang, Dan; Shin, Woo-Kyoung; de la Torre, Katherine; Yang, Jae Jeong; Song, Minkyo; Shin, Aesun; Lee, Jong-koo; Kang, Daehee			Obesity at early adulthood increases risk of gastric cancer from the Health Examinees-Gem (HEXA-G) study	PLOS ONE			English	Article							BODY-MASS INDEX; HELICOBACTER-PYLORI INFECTION; REFLUX SYMPTOMS; ADENOCARCINOMA; ADOLESCENCE; ESOPHAGUS; COHORT; ASSOCIATION; CARDIA; STOMACH	Emerging evidence has indicated a possible link between obesity in early life with subsequent cancer risks, but its association with gastric cancer remains unknown. This study aimed to investigate the association of obesity at ages 18-20 and 35 with the later risk of gastric cancer among the Korean population. Included were 122,724 individuals who participated in the large-scale prospective cohort study, the Health Examinees-Gem (HEXA-G) study, during 2004-2017. Multivariable Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for gastric cancer risk associated with body mass index (BMI) at ages 18-20 and 35 years. During a mean follow-up period of 8.6 +/- 2.1 years, a total 927 gastric cancer cases (531 men and 396 women) were identified. When compared to normal BMI (18.5-23.0 kg/m(2)), obesity (BMI >= 30 kg/m(2)) at age 35 was significantly associated with increased risk of gastric cancer later in life among total participants (HR 1.94, 95% CI 1.26-2.97, p 0.01). When analyzed separately by sex, obesity at 35 years of age was significantly associated with increased risk of gastric cancer among both men (HR 1.79, 95% CI 1.02-3.13, p 0.05) and women (HR 2.35, 95% CI 1.21-4.60, p 0.02). No significant associations were found for obesity at late adolescence in both men and women. Our findings suggest that obesity in early adulthood may be associated with an increased risk of gastric cancer. The results may aid in understanding the etiology of GC in a population with a divergent trend of gastric cancer.	[Lee, Hwi-Won; de la Torre, Katherine] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Lee, Hwi-Won; Huang, Dan; Shin, Woo-Kyoung; de la Torre, Katherine; Yang, Jae Jeong; Song, Minkyo; Shin, Aesun; Kang, Daehee] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Huang, Dan; Shin, Woo-Kyoung; Kang, Daehee] Seoul Natl Univ, Integrated Major Innovat Med Sci, Grad Sch, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kang, D (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Kang, D (corresponding author), Seoul Natl Univ, Integrated Major Innovat Med Sci, Grad Sch, Seoul, South Korea.	dhkang@snu.ac.kr	Song, Minkyo/AAE-9095-2020	Song, Minkyo/0000-0002-9412-2871	Korea Disease Control and Prevention Agency [2004-E71004-00, 2005-E71011-00, 2005-E7100900, 2006-E71001-00, 2006-E71004-00, 2006E71010-00, 2006E71003-00, 2007-E71004-00, 2007-E71006-00, 2008-E7100600, 2008-E7100800, 2009-E71009-00, 2010-E71006-00, 2011E71006-00, 2012-E71001-00, 2013-E7100900]	Korea Disease Control and Prevention Agency	This work was supported by the Research Program funded by the Korea Disease Control and Prevention Agency [grant number 2004-E71004-00; 2005-E71011-00; 2005-E7100900; 2006-E71001-00; 2006-E71004-00; 2006E71010-00; 2006E71003-00; 2007-E71004-00; 2007-E71006-00; 2008-E7100600; 2008-E7100800; 2009-E71009-00; 2010-E71006-00; 2011E71006-00; 2012-E71001-00; 2013-E7100900] This funding source had roles in study design and data collection.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cavaleiro-Pinto M, 2011, CANCER CAUSE CONTROL, V22, P375, DOI 10.1007/s10552-010-9707-2; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Colditz GA, 2018, CLIN CHEM, V64, P154, DOI 10.1373/clinchem.2017.277376; Corder K, 2019, BRIT J SPORT MED, V53, P496, DOI 10.1136/bjsports-2016-097330; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Gonzalez CA, 2006, INT J CANCER, V118, P2559, DOI 10.1002/ijc.21678; HANSSON LE, 1994, INT J CANCER, V57, P32, DOI 10.1002/ijc.2910570107; Health Examinees Study Group, 2015, Asian Pac J Cancer Prev, V16, P1591; Inoue M, 2002, INT J CANCER, V97, P833, DOI 10.1002/ijc.10149; Jang J, 2019, CANCER RES TREAT, V51, P1107, DOI 10.4143/crt.2018.182; Katz LH, 2018, INT J CANCER, V143, P1876, DOI 10.1002/ijc.31589; Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105; Kjollesdal MKR, 2020, INT J OBESITY, V44, P399, DOI 10.1038/s41366-019-0467-0; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Levi Z, 2018, CANCER-AM CANCER SOC, V124, P356, DOI 10.1002/cncr.31049; Levi Z, 2013, CANCER-AM CANCER SOC, V119, P4086, DOI 10.1002/cncr.28241; Levi Z, 2012, CANCER CAUSE CONTROL, V23, P371, DOI 10.1007/s10552-011-9886-5; Li D, 2020, J DIGEST DIS, V21, P222, DOI 10.1111/1751-2980.12858; Lim SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204762; Lubin F, 2003, AM J EPIDEMIOL, V157, P113, DOI 10.1093/aje/kwf184; Machida-Montani Ai, 2004, Gastric Cancer, V7, P46, DOI 10.1007/s10120-004-0268-5; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; Murray L, 2003, INT J EPIDEMIOL, V32, P645, DOI 10.1093/ije/dyg108; Olefson S, 2015, GASTRIC CANCER, V18, P23, DOI 10.1007/s10120-014-0425-4; Park M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058874, 10.1371/journal.pone.0070684]; Peleteiro B, 2014, DIGEST DIS SCI, V59, P1698, DOI 10.1007/s10620-014-3063-0; Petrick JL, 2019, OBESITY, V27, P1520, DOI 10.1002/oby.22570; Petrick JL, 2017, BRIT J CANCER, V116, P951, DOI 10.1038/bjc.2017.29; Robinson OC, 2017, INT J BEHAV DEV, V41, P426, DOI 10.1177/0165025416645201; Shin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467; Shin S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070687; Shin WK, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010032; Singh S, 2014, CANCER PREV RES, V7, P12, DOI 10.1158/1940-6207.CAPR-13-0282; Song M, 2015, J KOREAN MED ASSOC, V58, P183, DOI 10.5124/jkma.2015.58.3.183; Song M, 2015, GASTRIC CANCER, V18, P580, DOI 10.1007/s10120-014-0411-x; Song M, 2015, CANCER CAUSE CONTROL, V26, P247, DOI 10.1007/s10552-014-0506-z; Tanaka T, 2007, CANCER SCI, V98, P1785, DOI 10.1111/j.1349-7006.2007.00583.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; World Health Organization, 2018, TAKING ACTION CHILDH; Wu AH, 2003, CANCER, V98, P940, DOI 10.1002/cncr.11568; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	47	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0260826	10.1371/journal.pone.0260826	http://dx.doi.org/10.1371/journal.pone.0260826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120118	Green Published, gold			2022-12-26	WOS:000789273600003
J	Nakamori, M; Matsushima, H; Tachiyama, K; Hayashi, Y; Imamura, E; Mizoue, T; Wakabayashi, S				Nakamori, Masahiro; Matsushima, Hayato; Tachiyama, Keisuke; Hayashi, Yuki; Imamura, Eiji; Mizoue, Tatsuya; Wakabayashi, Shinichi			Association of ankle-brachial index with cognitive decline in patients with lacunar infarction	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; PRESSURE INDEX; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; IMPAIRMENT; DEMENTIA; STROKE; REPRODUCIBILITY; RELIABILITY	Atherosclerosis is an important risk factor for cognitive decline. This study aimed to investigate the relationship of ankle-brachial pressure index (ABI) and brachial-ankle pulse wave velocity (baPWV) with cognitive function in patients with lacunar infarction. We included records of consecutive patients with their first-ever acute stroke and a diagnosis of lacunar infarction through magnetic resonance imaging (MRI) from July 1, 2011 to December 31, 2018. We excluded patients diagnosed with dementia, including strategic single-infarct dementia, before or after stroke onset. Moreover, we excluded patients with one or more microbleeds, severe white matter lesions, or severe medial temporal atrophy on MRI. For ABI, we used the lower ankle side and divided the results into ABI < 1.0 and ABI >= 1.0. For baPWV, we used the higher ankle side and divided the results into two groups based on the median value of the participants. We analyzed 176 patients with stroke (age 72.5 +/- 11.4 years, 67 females). The median score on the Mini-Mental State Examination (MMSE) was 27. The number of patients with ABI < 1.0 was 19 (10.8%). Univariate analysis revealed that the MMSE score was associated with age, body mass index, education, chronic kidney disease, periventricular hyperintensity, and ABI < 1.0 (p < 0.10), but not baPWV. Multivariate analysis revealed that body mass index (p = 0.039) and ABI < 1.0 (p = 0.015) were independently associated with the MMSE score. For patients with lacunar infarction, a lower ABI, but not a higher PWV, was associated with cognitive decline.	[Nakamori, Masahiro; Tachiyama, Keisuke; Hayashi, Yuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Nakamori, Masahiro; Matsushima, Hayato; Tachiyama, Keisuke; Hayashi, Yuki; Imamura, Eiji] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Mizoue, Tatsuya; Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University	Nakamori, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.; Nakamori, M (corresponding author), Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan.	mnakamori1@gmail.com		Nakamori, Masahiro/0000-0002-0944-5538				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; Caruana MF, 2005, EUR J VASC ENDOVASC, V29, P443, DOI 10.1016/j.ejvs.2005.01.015; de Groot JC, 2000, ANN NEUROL, V47, P145; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Drouet L, 2002, CEREBROVASC DIS, V13, P1, DOI 10.1159/000047782; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2002, J NEUROL, V249, P1423, DOI 10.1007/s00415-002-0861-7; Fujiwara Y, 2005, J GERONTOL A-BIOL, V60, P607, DOI 10.1093/gerona/60.5.607; Fukuhara M, 2006, CIRC J, V70, P756, DOI 10.1253/circj.70.756; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hosomi N, 2012, CEREBROVASC DIS, V34, P385, DOI 10.1159/000343659; Hughes TM, 2014, JAMA NEUROL, V71, P562, DOI 10.1001/jamaneurol.2014.186; Hughes TM, 2013, NEUROLOGY, V81, P1711, DOI 10.1212/01.wnl.0000435301.64776.37; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Laurin D, 2007, CIRCULATION, V116, P2269, DOI 10.1161/CIRCULATIONAHA.106.686477; LIU IY, 1990, AM J EPIDEMIOL, V132, P136, DOI 10.1093/oxfordjournals.aje.a115625; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Matsushima H, 2017, J ATHEROSCLER THROMB, V24, P1167, DOI 10.5551/jat.38901; Mizushima Y, 2003, J AM GERIATR SOC, V51, P1329; Montine TJ, 2014, NEUROLOGY, V83, P851, DOI 10.1212/WNL.0000000000000733; Nakamori M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73404-6; Price JF, 2006, J AM GERIATR SOC, V54, P763, DOI 10.1111/j.1532-5415.2006.00702.x; Scuteri A, 2005, J HYPERTENS, V23, P1211, DOI 10.1097/01.hjh.0000170384.38708.b7; Sugawara N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-46; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; WEILER PG, 1991, AM J PUBLIC HEALTH, V81, P1153, DOI 10.2105/AJPH.81.9.1153; Yamamoto Y, 2002, STROKE, V33, P297, DOI 10.1161/str.33.1.297; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	34	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263525	10.1371/journal.pone.0263525	http://dx.doi.org/10.1371/journal.pone.0263525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120183	gold, Green Published			2022-12-26	WOS:000789273600051
J	Tlale, LB; Gabaitiri, L; Totolo, LK; Smith, G; Puswane-Katse, O; Ramonna, E; Mothowaeng, B; Tlhakanelo, J; Masupe, T; Rankgoane-Pono, G; Irige, J; Mafa, F; Kolane, S				Tlale, Lebapotswe B.; Gabaitiri, Lesego; Totolo, Lorato K.; Smith, Gomolemo; Puswane-Katse, Orapeleng; Ramonna, Eunice; Mothowaeng, Basego; Tlhakanelo, John; Masupe, Tiny; Rankgoane-Pono, Goabaone; Irige, John; Mafa, Faith; Kolane, Samuel			Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana	PLOS ONE			English	Article								Background The COVID-19 disease burden continues to be high worldwide and vaccines continue to be developed to help combat the pandemic. Acceptance and risk perception for COVID-19 vaccines is unknown in Botswana despite the government's decision to roll out the vaccine nationally. Objectives This study aims to assess the acceptance rate and risk perception of COVID-19 vaccines amongst the general population in Botswana. Methods We interviewed 5300 adults in Botswana from 1-28 February 2021 using self-administered questionnaires. The main outcomes of the study were vaccine acceptance and hesitancy rates. Demographic, experiential and socio-cultural factors were explored for their association with outcome variables. Results Two-thirds of the participants were females (3199), with those aged 24-54 making the highest proportion (61%). The acceptance rate of COVID-19 vaccine was 73.4% (95% CI: 72.2%-74.6%) with vaccine hesitancy at 31.3% (95% CI: 30.0%-32.6%). When the dependent variable was vaccine acceptance, males had higher odds of accepting the vaccine compared to females (OR = 1.2, 95% CI: 1.0, 1.4). Individuals aged 55-64 had high odds of accepting the vaccine compared to those aged 65 and above (OR = 1.2, 95% CI: 0.6, 2.5). The odds of accepting the vaccine for someone with primary school education were about 2.5 times that of an individual with post graduate level of education. Finally, individuals with comorbidities had higher odds (OR = 1.2, 95% CI: 1.0, 1.5) of accepting the vaccine compared to those without any underlying conditions. Conclusion This study demonstrated a high acceptance rate for the COVID-19 vaccine and a low risk perception in Botswana. In order to achieve a high vaccine coverage and ensure a successful vaccination process, there is need to target populations with high vaccine hesitancy rates. A qualitative study to assess the factors associated with vaccine acceptance and hesitancy is recommended to provide an in-depth analysis of the findings.	[Tlale, Lebapotswe B.; Totolo, Lorato K.; Smith, Gomolemo; Puswane-Katse, Orapeleng; Ramonna, Eunice; Mothowaeng, Basego; Rankgoane-Pono, Goabaone; Mafa, Faith; Kolane, Samuel] Minist Hlth & Wellness, Gaborone, Botswana; [Gabaitiri, Lesego; Tlhakanelo, John; Masupe, Tiny] Botswana Int Univ Sci & Technol, Palapye, Botswana; [Irige, John] FHI 360, Gaborone, Botswana		Tlale, LB (corresponding author), Minist Hlth & Wellness, Gaborone, Botswana.	cypro330@yahoo.com		Tlale, Lebapotswe/0000-0001-5689-2755; Tlhakanelo, John Thato/0000-0001-7365-1603; Rankgoane-Pono, Goabaone/0000-0001-7233-8412				Al-Mohathithef M., DETERMINANTS VACCINE; [Anonymous], 2021, CANCER-AM CANCER SOC, V127, P497, DOI 10.1002/cncr.33441; Tran BX, 2018, PATIENT PREFER ADHER, V12, P1717, DOI 10.2147/PPA.S171362; Bertin P, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565128; Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736; Chadwick A, 2021, SOC MEDIA SOC, V7, DOI 10.1177/20563051211008817; Chakraborty C, 2020, ARCH MED RES, V51, P728, DOI 10.1016/j.arcmed.2020.05.021; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Echoru I., REASEACRH SQUARE, DOI [10.1186/s12889-021-11197-7, DOI 10.1186/S12889-021-11197-7]; Edwards B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248892; Gan L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041993; Garcia LY, 2020, VACCINE, V38, P5424, DOI 10.1016/j.vaccine.2020.06.068; Habersaat KB, 2020, BUNDESGESUNDHEITSBLA, V63, P32, DOI 10.1007/s00103-019-03063-0; Helgeson J, 2012, LEARNING FOR SUSTAINABILITY IN TIMES OF ACCELERATING CHANGE, P329; Karlsson LC., 2020, FEARING DIS VACCINE, DOI [10.31234/osf.io/7n3gt, DOI 10.31234/OSF.IO/7N3GT]; Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Mogobe KD., 2006, NEONATAL PAEDIAT CHI, V9, P22; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Salali Gul Deniz, 2020, Psychol Med, P1, DOI 10.1017/S0033291720004067; Seale H, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05833-1; Singh MK., 2020, FRONT PHARMACOL, V11, DOI [10.3389/fphar.2020.00011, DOI 10.3389/FPHAR.2020.00011]; Statistics Botswana, 2013, POPULATION HOUSING C; Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482; World Health Organisation, 2021, COVID 19 WEEKL EP UP; Wu SS, 2018, VACCINE, V36, P491, DOI 10.1016/j.vaccine.2017.12.008; Yoda T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010048	31	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263375	10.1371/journal.pone.0263375	http://dx.doi.org/10.1371/journal.pone.0263375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120163	Green Published, gold			2022-12-26	WOS:000789273600034
J	Essien, JP; Ikpe, DI; Inam, ED; Okon, AO; Ebong, GA; Benson, NU				Essien, Joseph P.; Ikpe, Donald I.; Inam, Edu D.; Okon, Aniefiokmkpong O.; Ebong, Godwin A.; Benson, Nsikak U.			Occurrence and spatial distribution of heavy metals in landfill leachates and impacted freshwater ecosystem: An environmental and human health threat	PLOS ONE			English	Article							SEQUENCING BATCH REACTOR; SURFACE SEDIMENTS; RISK-ASSESSMENT; CHEMICAL-COMPOSITION; MUNICIPAL LANDFILL; CO-TREATMENT; LAIZHOU BAY; CONTAMINATION; POLLUTION; ESTUARY	Municipal landfill leachates are a source of toxic heavy metals that have been shown to have a detrimental effect on human health and the environment. This study aimed to assess heavy metal contamination in leachates, surface water, and sediments from non-sanitary landfills in Uyo, Nigeria, and to identify potential health and environmental effects of leachate contamination. Over the wet and dry seasons, surface water and sediment samples were collected from an impacted freshwater ecosystem, and leachates samples from six monitoring wells. Elemental analyses of samples were conducted following standard analytical procedures and methods. The results indicated that leachate, surface water, and sediment samples all had elevated levels of heavy metals, implying a significant impact from landfills. Pollution indices such as the potential ecological risk index (PERI), pollution load index (PLI), degree of contamination (Cd), modified degree of contamination (mCd), enrichment factor (EF), geoaccumulation index (Igeo), and Nemerov pollution index (NPI) were used to assess the ecological impacts of landfill leachates. The following values were derived: PERI (29.09), PLI (1.96E-07), Cd (0.13), mCd (0.16), EF (0.97-1.79E-03), Igeo (0), and NPI (0.74). Pollution indicators suggested that the sediment samples were low to moderately polluted by chemical contaminants from the non-sanitary landfills, and may pose negative risks due to bioaccumulation. Human health risks were also assessed using standard risk models. For adults, children, and kids, the incremental lifetime cancer rate (ILCR) values were within the acceptable range of 1.00E-06-1.00E-04. The lifetime carcinogenicity risks associated with oral ingestion exposure to heavy metals were 9.09E-05, 1.21E-05, and 3.60 E-05 for kids, adults, and children, respectively. The mean cumulative risk values for dermal exposures were 3.24E-07, 1.89E-06, and 1.17E-05 for adults, children, and kids, respectively. These findings emphasized the risks of human and biota exposure to contaminants from landfills.	[Essien, Joseph P.] Univ Uyo, Dept Microbiol, Uyo, Nigeria; [Ikpe, Donald I.] Akwa Ibom State Polytech, Dept Sci Technol, Ikot Ekpene, Nigeria; [Inam, Edu D.; Ebong, Godwin A.] Univ Uyo, Dept Chem, Uyo, Nigeria; [Okon, Aniefiokmkpong O.] Univ Uyo, Dept Anim & Environm Biol, Uyo, Nigeria; [Benson, Nsikak U.] Covenant Univ, Dept Chem, Ota, Nigeria	University of Uyo; University of Uyo; University of Uyo; Covenant University	Essien, JP (corresponding author), Univ Uyo, Dept Microbiol, Uyo, Nigeria.; Benson, NU (corresponding author), Covenant Univ, Dept Chem, Ota, Nigeria.	jomato652011@yahoo.com; nbenson@covenantuniversity.edu.ng	Benson, Nsikak/F-6522-2011; Ebong, Godwin/FOI-0791-2022	Benson, Nsikak/0000-0002-1285-579X; 				Abrahim GMS, 2008, ENVIRON MONIT ASSESS, V136, P227, DOI 10.1007/s10661-007-9678-2; Abrahim G.M.S., 2005, THESIS U AUCKLAND AU, P361; Adamcova D, 2017, CHEMOSPHERE, V185, P1011, DOI 10.1016/j.chemosphere.2017.07.060; Agamuthu P., 2010, ICBBE, P1, DOI DOI 10.1109/ICBBE.2010.5516886; Ali Mir Mohammad, 2016, Environmental Nanotechnology, Monitoring and Management, V5, P27, DOI 10.1016/j.enmm.2016.01.002; Atta M, 2015, ENVIRON EARTH SCI, V73, P3913, DOI 10.1007/s12665-014-3675-x; Benson NU, 2018, REG STUD MAR SCI, V18, P44, DOI 10.1016/j.rsma.2018.01.004; Benson NU, 2017, INT J SEDIMENT RES, V32, P410, DOI 10.1016/j.ijsrc.2017.07.007; Benson NU, 2017, J TAIBAH UNIV SCI, V11, P434, DOI 10.1016/j.jtusci.2016.08.004; Benson NU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156485; Binning K, 2001, WATER SA, V27, P461; Buaisha M, 2020, CIV ENG J-TEHRAN, V6, P470, DOI 10.28991/cej-2020-03091484; Budi S, 2016, WASTE MANAGE, V55, P231, DOI 10.1016/j.wasman.2015.09.022; Chen CW, 2007, CHEMOSPHERE, V66, P1431, DOI 10.1016/j.chemosphere.2006.09.030; Cheng Z, 2013, CHEMOSPHERE, V90, P2142, DOI 10.1016/j.chemosphere.2012.11.017; Chinade A.U., 2017, INT RES J ENG TECHNO, V4, P3248; Cilinskis E, 1996, AMBIO, V25, P103; Deng MJ, 2018, ENVIRON POLLUT, V236, P137, DOI 10.1016/j.envpol.2018.01.042; Donnelly J.A., 1988, HAZARDOUS WASTE DETE, P1073; Ekett SI, 2019, J PHYS CONF SER, V1299, DOI 10.1088/1742-6596/1299/1/012078; Emenike C. U., 2011, Malaysian Journal of Science, V30, P99; EPA U., 1989, HUMAN HLTH EVALUATIO; Essien J.P., 2019, ENV NANOTECHNOL MONI, V11, DOI [10.1016/j.enmm.2019.100215, DOI 10.1016/J.ENMM.2019.100215]; Essien J.P., 2011, WORLD J APPL SCI TEC, V3, P162; Essien Joseph P., 2008, Toxicological and Environmental Chemistry, V90, P259, DOI 10.1080/02772240701550497; Fonge B. A., 2017, African Journal of Biotechnology, V16, P1391, DOI 10.5897/AJB2016.15777; Fu J, 2014, J HAZARD MATER, V270, P102, DOI 10.1016/j.jhazmat.2014.01.044; Fudala-Ksiazek S, 2014, ENVIRON SCI POLLUT R, V21, P7307, DOI 10.1007/s11356-014-2641-1; Gajski G, 2012, ECOTOX ENVIRON SAFE, V78, P253, DOI 10.1016/j.ecoenv.2011.11.032; Ganjian E, 2018, ENVIRON TECHNOL, V39, P2321, DOI 10.1080/09593330.2017.1354923; Gujre N, 2021, CHEMOSPHERE, V271, DOI 10.1016/j.chemosphere.2021.129573; Gujre N, 2021, CHEMOSPHERE, V262, DOI 10.1016/j.chemosphere.2020.128013; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hicham K, 2007, WATER AIR SOIL POLL, V185, P63, DOI 10.1007/s11270-007-9426-9; Hopenhayn C, 2006, J OCCUP ENVIRON MED, V48, P635, DOI 10.1097/01.jom.0000205457.44750.9f; Hou DK, 2013, ECOTOX ENVIRON SAFE, V93, P135, DOI 10.1016/j.ecoenv.2013.03.012; Hu BQ, 2013, ENVIRON MONIT ASSESS, V185, P5071, DOI 10.1007/s10661-012-2926-0; Hussein M, 2021, CHEMOSPHERE, V267, DOI 10.1016/j.chemosphere.2020.128874; Jagaba AH, 2021, J ENVIRON MANAGE, V282, DOI 10.1016/j.jenvman.2021.111946; Kaschl A, 2002, SCI TOTAL ENVIRON, V291, P45, DOI 10.1016/S0048-9697(01)01091-9; Lemieux PM, 2004, PROG ENERG COMBUST, V30, P1, DOI 10.1016/j.pecs.2003.08.001; Li GL, 2012, ENVIRON MONIT ASSESS, V184, P2763, DOI 10.1007/s10661-011-2149-9; Luo HW, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.135468; Michalska J, 2019, WATER-SUI, V11, DOI 10.3390/w11081539; Milton A, 2003, ARCH ENVIRON CON TOX, V44, P405, DOI 10.1007/s00244-002-2014-5; Mohiuddin KM, 2012, ENVIRON MONIT ASSESS, V184, P265, DOI 10.1007/s10661-011-1966-1; Mojiri A, 2017, PROCESS SAF ENVIRON, V111, P253, DOI 10.1016/j.psep.2017.07.013; MULLER G, 1979, UMSCHAU, V79, P778; MULLER G, 1981, CHEM ZTG, V105, P157; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Nartey V. K., 2012, Journal of Water Resource and Protection, V4, P605, DOI 10.4236/jwarp.2012.48070; Nemerow NL., 1985, STREAM LAKE ESTUARY; Nyika JM, 2019, ORIENT J CHEM, V35, P1286, DOI 10.13005/ojc/350406; Oman CB, 2008, WASTE MANAGE, V28, P1876, DOI 10.1016/j.wasman.2007.06.018; Pan H., 2015, ENV SCI MANAG, V40, P57; Popek E. M., 2003, SAMPLING ANAL ENV PO; Robinson H.D., 1983, ANN P, P20; Robinson T, 2017, WASTE MANAGE, V63, P299, DOI 10.1016/j.wasman.2016.12.032; Sheijany MSP, 2020, ENVIRON MONIT ASSESS, V192, DOI 10.1007/s10661-020-08716-1; Salem Z, 2008, DESALINATION, V220, P108, DOI 10.1016/j.desal.2007.01.026; Sanchez-Chardi A, 2007, CHEMOSPHERE, V68, P703, DOI 10.1016/j.chemosphere.2007.01.042; Singare P., 2012, AM J CHEM; Soleimannejad Z, 2016, J MAZANDARAN U MED S, V26, P196; Stefanakis A., 2014, VERTICAL FLOW CONSTR, V392, DOI 10.1016/C2012-0-01288-4; Talang RPN, 2021, J CLEAN PROD, V312, DOI 10.1016/j.jclepro.2021.127761; Tchobanoglous G., 1993, INTEGRATED SOLID WAS; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; Toufexi E, 2013, J HAZARD MATER, V260, P593, DOI 10.1016/j.jhazmat.2013.05.054; Trabelsi I, 2013, ARAB J GEOSCI, V6, P2071, DOI 10.1007/s12517-011-0464-7; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; United States Environmental Protection Agency (USEPA), 2001, 9335424 USEPA OSWER; USEPA, 2000, 3620C USEPA; Vaverkova MD, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114531; Vaverkova MD, 2018, ENVIRON ENG MANAG J, V17, P641, DOI 10.30638/eemj.2018.065; Wachirawongsakorn P., 2013, UTTARADIT NU SCI J, V10, P18; Wang Q, 2021, J HAZARD MATER, V416, DOI 10.1016/j.jhazmat.2021.126042; Wittsiepe J, 2017, ENVIRON SCI POLLUT R, V24, P3097, DOI 10.1007/s11356-016-8002-5; Wu QH, 2015, SCI TOTAL ENVIRON, V506, P217, DOI 10.1016/j.scitotenv.2014.10.121; Xu G, 2015, ENVIRON SCI POLLUT R, V22, P11634, DOI 10.1007/s11356-015-4393-y; Yang XL, 2015, MAR POLLUT BULL, V95, P503, DOI 10.1016/j.marpolbul.2015.02.042; Zhang P, 2017, MAR POLLUT BULL, V119, P429, DOI 10.1016/j.marpolbul.2017.03.046	81	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263279	10.1371/journal.pone.0263279	http://dx.doi.org/10.1371/journal.pone.0263279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113945	Green Published, gold			2022-12-26	WOS:000823694700072
J	O'Regan, A; O'Doherty, J; O'Connor, R; Cullen, W; Niranjan, V; Glynn, L; Hannigan, A				O'Regan, Andrew; O'Doherty, Jane; O'Connor, Ray; Cullen, Walter; Niranjan, Vikram; Glynn, Liam; Hannigan, Ailish			How do multi-morbidity and polypharmacy affect general practice attendance and referral rates? A retrospective analysis of consultations	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; MULTIMORBIDITY; PREVALENCE; WORKLOAD; PRACTITIONERS; ENGLAND; WORKING; BURNOUT	Background As prevalence of multimorbidity and polypharmacy rise, health care systems must respond to these challenges. Data is needed from general practice regarding the impact of age, number of chronic illnesses and medications on specific metrics of healthcare utilisation. Methods This was a retrospective study of general practices in a university-affiliated education and research network, consisting of 72 practices. Records from a random sample of 100 patients aged 50 years and over who attended each participating practice in the previous two years were analysed. Through manual record searching, data were collected on patient demographics, number of chronic illnesses and medications, numbers of attendances to the general practitioner (GP), practice nurse, home visits and referrals to a hospital doctor. Attendance and referral rates were expressed per person-years for each demographic variable and the ratio of attendance to referral rate was also calculated. Results Of the 72 practices invited to participate, 68 (94%) accepted, providing complete data on a total of 6603 patients' records and 89,667 consultations with the GP or practice nurse; 50.1% of patients had been referred to hospital in the previous two years. The attendance rate to general practice was 4.94 per person per year and the referral rate to the hospital was 0.6 per person per year, giving a ratio of over eight attendances for every referral. Increasing age, number of chronic illnesses and number of medications were associated with increased attendance rates to the GP and practice nurse and home visits but did not significantly increase the ratio of attendance to referral rate. Discussion As age, morbidity and number of medications rise, so too do all types of consultations in general practice. However, the rate of referral remains relatively stable. General practice must be supported to provide person centred care to an ageing population with rising rates of multi-morbidity and polypharmacy.	[O'Regan, Andrew; O'Doherty, Jane; O'Connor, Ray; Glynn, Liam; Hannigan, Ailish] Univ Limerick, Fac Educ & Hlth Sci, Sch Med, Hlth Res Inst, Limerick, Ireland; [Cullen, Walter] Univ Coll Dublin, Hlth Sci Ctr, Sch Med, Dublin, Ireland; [Niranjan, Vikram] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Glynn, Liam] Hlth Res Board Primary Care Clin Trial Network, Galway, Ireland	University of Limerick; University College Dublin; University College Dublin	O'Regan, A (corresponding author), Univ Limerick, Fac Educ & Hlth Sci, Sch Med, Hlth Res Inst, Limerick, Ireland.	andrew.oregan@ul.ie		Glynn, Liam/0000-0002-6153-9363; Cullen, Walter/0000-0003-1838-5052; O'Regan, Andrew/0000-0001-8470-2736; Niranjan, Vikram/0000-0003-2202-8250				Avery AJ, 2017, BRIT J GEN PRACT, V67, P390, DOI 10.3399/bjgp17X692201; Baird B, 2016, UNDERSTANDING PRESSU; Cassell A, 2018, BRIT J GEN PRACT, V68, pE245, DOI 10.3399/bjgp18X695465; Cohen J.E., 1988, STAT POWER ANAL BEHA; Croxson CHD, 2017, BRIT J GEN PRACT, V67, pE138, DOI 10.3399/bjgp17X688849; Curry N, 2016, FACT FICTION DEMAND; Dinsdale E, 2020, FAM PRACT, V37, P63, DOI 10.1093/fampra/cmz037; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Hopman P, 2015, EUR J INTERN MED, V26, P190, DOI 10.1016/j.ejim.2015.02.006; Iacobucci G, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l531; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Loeb DF, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0433-z; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McInnes S, 2015, J ADV NURS, V71, P1973, DOI 10.1111/jan.12647; National Collaborating Centre for Mental Health (UK), 2010, DEPR AD CHRON PHYS H; O'Dea B, 2017, IRISH J MED SCI, V186, P447, DOI 10.1007/s11845-016-1407-9; O'Dowd T T, 2016, STRUCTURE GEN PRACTI; O'Regan A, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-1100-y; O'Regan A, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3800-8; Palladino R, 2016, AGE AGEING, V45, P431, DOI 10.1093/ageing/afw044; Pedersen AF, 2020, BRIT J GEN PRACT, V70, pE95, DOI 10.3399/bjgp20X707837; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Ramage-Morin Pamela L, 2009, Health Rep, V20, P37; Reason B, 2012, FAM PRACT, V29, P427, DOI 10.1093/fampra/cmr124; Roland M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i942; Roland M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2510; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Sinnott C, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0322-1; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Smith SM, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514756; Svedahl ER, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0952-5; Sweeney AM, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0523-x; Theile G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-24; TILDA, DESIGN IRISH LONGITU, P53; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Vyas Ami, 2012, Int J Family Med, V2012, P193168, DOI 10.1155/2012/193168; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176	39	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263258	10.1371/journal.pone.0263258	http://dx.doi.org/10.1371/journal.pone.0263258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113926	Green Published, gold			2022-12-26	WOS:000823694700069
J	Okazaki, S; Kimura, R; Otsuka, I; Funabiki, Y; Murai, T; Hishimoto, A				Okazaki, Satoshi; Kimura, Ryo; Otsuka, Ikuo; Funabiki, Yasuko; Murai, Toshiya; Hishimoto, Akitoyo			Epigenetic clock analysis and increased plasminogen activator inhibitor-1 in high-functioning autism spectrum disorder	PLOS ONE			English	Article							AGE; ASSOCIATION; MORTALITY	Background Autism spectrum disorder (ASD) is characterized by impaired social communication and behavioral problems. An increased risk of premature mortality has been observed in individuals with ASD. Therefore, we hypothesized that biological aging is accelerated in individuals with ASD. Recently, several studies have established genome-wide DNA methylation (DNAm) profiles as 'epigenetic clocks' that can estimate biological aging. In addition, ASD has been associated with differential DNAm patterns. Methods We used two independent datasets from blood samples consisting of adult patients with high-functioning ASD and controls: the 1st cohort (38 ASD cases and 31 controls) and the 2nd cohort (6 ASD cases and 10 controls). We explored well-studied epigenetic clocks such as HorvathAge, HannumAge, SkinBloodAge, PhenoAge, GrimAge, and DNAm-based telomere length (DNAmTL). In addition, we investigated seven DNAm-based age-related plasma proteins, including plasminogen activator inhibitor-1 (PAI-1), and smoking status, which are the components of GrimAge. Results Compared to controls, individuals with ASD in the 1st cohort, but not in the 2nd cohort, exhibited a trend for increased GrimAge acceleration and a significant increase of PAI-1 levels. A meta-analysis showed significantly increased PAI-1 levels in individuals with ASD compared to controls. Conclusion Our findings suggest there is no epigenetic age acceleration in the blood of individuals with ASD. However, this study provides novel evidence regarding increased plasma PAI-1 levels in individuals with high-functioning ASD. These findings suggest PAI-1 may be a biomarker for high-functioning ASD, however, larger studies based on epigenetic clocks and PAI-1 will be necessary to confirm these findings.	[Okazaki, Satoshi; Otsuka, Ikuo; Hishimoto, Akitoyo] Kobe Univ, Dept Psychiat, Grad Sch Med, Kobe, Hyogo, Japan; [Kimura, Ryo] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto, Japan; [Funabiki, Yasuko] Kyoto Univ, Grad Sch Human & Environm Studies, Dept Cognit & Behav Sci, Kyoto, Japan; [Funabiki, Yasuko; Murai, Toshiya] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Hishimoto, Akitoyo] Yokohama City Univ, Dept Psychiat, Grad Sch Med, Yokohama, Kanagawa, Japan	Kobe University; Kyoto University; Kyoto University; Kyoto University; Yokohama City University	Hishimoto, A (corresponding author), Kobe Univ, Dept Psychiat, Grad Sch Med, Kobe, Hyogo, Japan.; Hishimoto, A (corresponding author), Yokohama City Univ, Dept Psychiat, Grad Sch Med, Yokohama, Kanagawa, Japan.	hishipon@yokohama-cu.ac.jp	Kimura, Ryo/GSD-9117-2022; Kimura, Ryo/AAY-3037-2021	Kimura, Ryo/0000-0003-3220-991X; Kimura, Ryo/0000-0003-3220-991X; Okazaki, Satoshi/0000-0001-5953-5526	JSPS (Japan Society for the Promotion of Science) KAKENHI [18K15483, 21K07520, 17H04249, 21H02852]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partly supported by grants from JSPS (Japan Society for the Promotion of Science) KAKENHI grant numbers 18K15483 and 21K07520 (S.O.) as well as 17H04249 and 21H02852 (A.H.). https://www.jsps.go.jp/j-grantsinaid/	Andrews SV, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0224-6; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384; Fries GR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0048-8; Goldani AAS, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00100; Han LKM, 2018, AM J PSYCHIAT, V175, P774, DOI 10.1176/appi.ajp.2018.17060595; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Higgins-Chen AT, 2020, BIOL PSYCHIAT, V88, P224, DOI 10.1016/j.biopsych.2020.01.025; Hirvikoski T, 2016, BRIT J PSYCHIAT, V208, P232, DOI 10.1192/bjp.bp.114.160192; Hoirisch-Clapauch S, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0370-4; Horvath S, 2018, AGING-US, V10, P1758, DOI 10.18632/aging.101508; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Horvath S, 2015, AGING CELL, V14, P491, DOI 10.1111/acel.12325; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jag UR, 2009, MOL ENDOCRINOL, V23, P1587, DOI 10.1210/me.2008-0421; Jokiranta-Olkoniemi E, 2021, J AUTISM DEV DISORD, V51, P3098, DOI 10.1007/s10803-020-04768-x; Jylhava J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Katrinli S, 2020, NEUROPSYCHOPHARMACOL, V45, P1609, DOI 10.1038/s41386-020-0700-5; Kimura R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50250-9; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414; Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Lu AT, 2019, AGING-US, V11, P5895, DOI 10.18632/aging.102173; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Maierhofer A, 2017, AGING-US, V9, P1143, DOI 10.18632/aging.101217; McCrory C, 2021, J GERONTOL A-BIOL, V76, P741, DOI 10.1093/gerona/glaa286; McEwen LM, 2020, P NATL ACAD SCI USA, V117, P23329, DOI 10.1073/pnas.1820843116; Okazaki S, 2021, ALCOHOL CLIN EXP RES, V45, P329, DOI 10.1111/acer.14532; Okazaki S, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0813-y; Okazaki S, 2020, PROG NEURO-PSYCHOPH, V98, DOI 10.1016/j.pnpbp.2019.109805; Okazaki S, 2019, NPJ SCHIZOPHR, V5, DOI 10.1038/s41537-019-0072-1; Persico AM, 2001, PSYCHIATR GENET, V11, P99, DOI 10.1097/00041444-200106000-00008; Prosperi M, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120366; Rosen AD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0233-4; Schendel DE, 2016, JAMA PEDIATR, V170, P243, DOI 10.1001/jamapediatrics.2015.3935; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451; Whalley HC., 2017, GENOMICS, DOI [10.1101/210666, DOI 10.1101/210666]; Xiang AH, 2018, JAMA-J AM MED ASSOC, V320, P89, DOI 10.1001/jama.2018.7614; Xiang AH, 2015, JAMA-J AM MED ASSOC, V313, P1425, DOI 10.1001/jama.2015.2707; Yang RT, 2021, MOL PSYCHIATR, V26, P4999, DOI 10.1038/s41380-020-0755-z	44	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263478	10.1371/journal.pone.0263478	http://dx.doi.org/10.1371/journal.pone.0263478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113965	Green Published, gold			2022-12-26	WOS:000823694700100
J	Biondini, M; Kiepas, A; El-Houjeiri, L; Nis, MGA; Hsu, BE; Fortier, AM; Morin, G; Martina, JA; Sirois, I; Aguilar-Mahecha, A; Gruosso, T; McGuirk, S; Rose, AAN; Tokat, UM; Johnson, RM; Sahin, O; Bareke, E; St-Pierre, J; Park, M; Basik, M; Majewski, J; Puertollano, R; Pause, A; Huang, SD; Keler, T; Siegel, PM				Biondini, Marco; Kiepas, Alex; El-Houjeiri, Leeanna; Nis, Matthew G. An; Hsu, Brian E.; Fortier, Anne-Marie; Morin, Genevieve; Martina, Jose A.; Sirois, Isabelle; Aguilar-Mahecha, Adriana; Gruosso, Tina; McGuirk, Shawn; Rose, April A. N.; Tokat, Unal M.; Johnson, Radia M.; Sahin, Ozgur; Bareke, Eric; St-Pierre, Julie; Park, Morag; Basik, Mark; Majewski, Jacek; Puertollano, Rosa; Pause, Arnim; Huang, Sidong; Keler, Tibor; Siegel, Peter M.			HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin	ONCOGENE			English	Article							ANTIBODY-DRUG CONJUGATE; GLYCOPROTEIN NONMETASTATIC B; PHASE-II; TFEB; AUTOPHAGY; MELANOMA; PATHWAY; FLCN; RECRUITMENT; MECHANISMS	Transmembrane glycoprotein NMB (GPNMB) is a prognostic marker of poor outcome in patients with triple-negative breast cancer (TNBC). Glembatumumab Vedotin, an antibody drug conjugate targeting GPNMB, exhibits variable efficacy against GPNMB-positive metastatic TNBC as a single agent. We show that GPNMB levels increase in response to standard-of-care and experimental therapies for multiple breast cancer subtypes. While these therapeutic stressors induce GPNMB expression through differential engagement of the MiTF family of transcription factors, not all are capable of increasing GPNMB cell-surface localization required for Glembatumumab Vedotin inhibition. Using a FACS-based genetic screen, we discovered that suppression of heat shock protein 90 (HSP90) concomitantly increases GPNMB expression and cell-surface localization. Mechanistically, HSP90 inhibition resulted in lysosomal dispersion towards the cell periphery and fusion with the plasma membrane, which delivers GPNMB to the cell surface. Finally, treatment with HSP90 inhibitors sensitizes breast cancers to Glembatumumab Vedotin in vivo, suggesting that combination of HSP90 inhibitors and Glembatumumab Vedotin may be a viable treatment strategy for patients with metastatic TNBC.	[Biondini, Marco; Kiepas, Alex; El-Houjeiri, Leeanna; Nis, Matthew G. An; Hsu, Brian E.; Fortier, Anne-Marie; Morin, Genevieve; Gruosso, Tina; McGuirk, Shawn; Park, Morag; Pause, Arnim; Huang, Sidong; Siegel, Peter M.] McGill Univ, Goodman Canc Res Inst, Montreal, PQ, Canada; [Biondini, Marco; Nis, Matthew G. An; Hsu, Brian E.; Park, Morag; Pause, Arnim; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Kiepas, Alex; McGuirk, Shawn] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [El-Houjeiri, Leeanna; Fortier, Anne-Marie; Morin, Genevieve; Gruosso, Tina; Park, Morag; Huang, Sidong; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Martina, Jose A.; Puertollano, Rosa] NHLBI, Cell & Dev Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sirois, Isabelle; Aguilar-Mahecha, Adriana; Basik, Mark] Sir Mortimer B Davis Jewish Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Rose, April A. N.; Basik, Mark] McGill Univ, Dept Oncol & Surg, Montreal, PQ, Canada; [Tokat, Unal M.] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Johnson, Radia M.] Genentech Inc, 1 DNA Way South, San Francisco, CA USA; [Sahin, Ozgur] Univ South Carolina, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA; [Bareke, Eric; Majewski, Jacek] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Bareke, Eric; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [St-Pierre, Julie] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [St-Pierre, Julie] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Keler, Tibor] Celldex Therapeut, Hampton, NJ USA	McGill University; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Lady Davis Institute; McGill University; McGill University; Ihsan Dogramaci Bilkent University; Roche Holding; Genentech; University of South Carolina System; University of South Carolina Columbia; McGill University; McGill University; University of Ottawa; University of Ottawa	Siegel, PM (corresponding author), McGill Univ, Goodman Canc Res Inst, Montreal, PQ, Canada.; Siegel, PM (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Siegel, PM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	peter.siegel@mcgill.ca	Johnson, Radia/GYV-4663-2022; St-Pierre, Julie/AGB-3651-2022; Aguilar, Adriana/GRF-2369-2022; Kiepas, Alex/GVS-8491-2022; Tokat, Ünal Metin/ABA-6061-2020	Johnson, Radia/0000-0002-9755-9307; St-Pierre, Julie/0000-0002-2815-7099; Tokat, Ünal Metin/0000-0003-0026-368X; Kiepas, Alexander/0000-0001-8169-3897	Fonds de recherche du Quebec-Sante (FRQS) post-doctoral fellowship; Canadian Institutes of Health Research [PJT-153327]	Fonds de recherche du Quebec-Sante (FRQS) post-doctoral fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We acknowledge technical assistance from the McGill GCRC Histology core facility for routine histological services. We acknowledge McGill Life Science Complex Advanced BioImaging Facility (ABIF) for technical assistance in acquisition/analysis of images. We acknowledge McGill Platform for Cellular Perturbation (MPCP) for providing the shRNAs libraries and technical assistance with screnning process and analysis. We acknowledge McGill Life Science Complex Cell Vision Core for technical assistance in acquisition/analysis of flow cytometry data. We acknowledge Genome Quebec and McGill University for support of the Q-CROC-03 trial. We acknowledge Dr. Alana Welm for providing us with HCI-010 PDX tumor model. We thank members of the Siegel laboratory, all collaborators and Dr. Ursini-Siegel for thoughtful discussions and critical reading of the paper. MB was the recipient of a Fonds de recherche du Quebec-Sante (FRQS) post-doctoral fellowship. PMS is a William Dawson Scholar of McGill University. This work was supported by an operating grant from the Canadian Institutes of Health Research to PMS (PJT-153327).	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bekki H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1830-8; Bendell J, 2014, J CLIN ONCOL, V32, P3619, DOI 10.1200/JCO.2013.52.5683; Bergin Alice R T, 2019, F1000Res, V8, DOI 10.12688/f1000research.18888.1; Boshuizen J, 2020, MOL CELL, V78, P1002, DOI 10.1016/j.molcel.2020.05.031; Butler LM, 2015, MOL CANCER RES, V13, P1445, DOI 10.1158/1541-7786.MCR-15-0234; Chen C, 2018, CANCER RES, V78, P6424, DOI 10.1158/0008-5472.CAN-18-0599; Cheng Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22101551; Dai CK, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0525; Damaskos C, 2019, ANTICANCER RES, V39, P5285, DOI 10.21873/anticanres.13722; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; El-Houjeiri L, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144871; Giulino-Roth L, 2017, MOL CANCER THER, V16, P1779, DOI 10.1158/1535-7163.MCT-16-0848; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hoffmann RM, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1395127; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Jansson KH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35417-0; Jing JP, 2012, MOL CANCER THER, V11, P720, DOI 10.1158/1535-7163.MCT-11-0505; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Jongsma MLM, 2016, CELL, V166, P152, DOI 10.1016/j.cell.2016.05.078; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Kong T, 2020, CANCER RES, V80, P444, DOI 10.1158/0008-5472.CAN-19-1108; Kopp LM, 2019, EUR J CANCER, V121, P177, DOI 10.1016/j.ejca.2019.08.015; Lauwers E, 2018, MOL CELL, V71, P689, DOI 10.1016/j.molcel.2018.07.016; Le Borgne R, 2001, J CELL SCI, V114, P2831; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liu H, 2018, CANCER DISCOV, V8, P354, DOI 10.1158/2159-8290.CD-17-0679; Martina JA, 2017, TRANSCR-AUSTIN, V8, P48, DOI 10.1080/21541264.2016.1264353; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; McGuirk Shawn, 2021, Elife, V10, DOI 10.7554/eLife.65150; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noda Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11828-3; Nytko KJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69619-2; Ott PA, 2019, CANCER-AM CANCER SOC, V125, P1113, DOI 10.1002/cncr.31892; Park S, 2019, BIOMOL THER, V27, P423, DOI 10.4062/biomolther.2019.051; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Pogenberg V, 2012, GENE DEV, V26, P2647, DOI 10.1101/gad.198192.112; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Puertollano R, 2018, EMBO J, V37, DOI 10.15252/embj.201798804; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rose AAN, 2017, PHARMACOL THERAPEUT, V179, P127, DOI 10.1016/j.pharmthera.2017.05.010; Rose AAN, 2016, CLIN CANCER RES, V22, P6088, DOI 10.1158/1078-0432.CCR-16-1192; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Schmidt LS, 2018, GENE, V640, P28, DOI 10.1016/j.gene.2017.09.044; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sirois I, 2019, MOL CANCER RES, V17, P2492, DOI 10.1158/1541-7786.MCR-19-0264; Slade L, 2017, MOL CANCER RES, V15, P1637, DOI 10.1158/1541-7786.MCR-17-0320; Starling GP, 2016, EMBO REP, V17, P823, DOI 10.15252/embr.201541382; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tanaka M, 2017, CANCER RES, V77, P897, DOI 10.1158/0008-5472.CAN-16-2486; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Vahdat LT, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.SABCS18-P6-20-01; van der Lienden MJC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010066; Vega-Rubin-de-Celis S, 2017, AUTOPHAGY, V13, P464, DOI 10.1080/15548627.2016.1271514; Wada S, 2016, GENE DEV, V30, P2551, DOI 10.1101/gad.287953.116; Wang H, 2016, MOL CLIN ONCOL, V5, P326, DOI 10.3892/mco.2016.963; Wang Y, 2015, CHEM COMMUN, V51, P1410, DOI 10.1039/c4cc07284g; Woodford MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12037; Yang ZJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09181-2; Yardley DA, 2015, J CLIN ONCOL, V33, P1609, DOI 10.1200/JCO.2014.56.2959; Zhitomirsky B, 2015, ONCOTARGET, V6, P1143, DOI 10.18632/oncotarget.2732	76	2	2	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1701	1717		10.1038/s41388-022-02206-z	http://dx.doi.org/10.1038/s41388-022-02206-z		FEB 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35110681				2022-12-26	WOS:000749991500001
J	Hendrix, RHJ; Kurniawati, ER; Schins, SFC; Maessen, JG; Weerwind, PW				Hendrix, Rik H. J.; Kurniawati, Eva R.; Schins, Sanne F. C.; Maessen, Jos G.; Weerwind, Patrick W.			Dynamic oxygenator blood volume during prolonged extracorporeal life support	PLOS ONE			English	Article							INSENSIBLE WATER-LOSS; HEMOLYSIS; DEPOSITS	Current methods for identification of oxygenator clotting during prolonged extracorporeal life support include visual inspection, evaluation of oxygenator resistance and oxygen exchange performance, and assessment of clotting-related laboratory parameters. However, these observations do not provide a quantitative assessment of oxygenator clot formation. By measuring changes in the dynamic oxygenator blood volume this study aimed to evaluate the relation to oxygenator resistance and oxygen transfer performance. Sixty-seven oxygenators were studied during adult extracorporeal life support. Oxygenator blood volume, oxygenator resistance, and oxygen transfer efficiency were monitored. Oxygenator blood volume decreased with increasing runtime (r = -0.462; p < 0.001). There was a statistically significant, fair negative correlation between oxygenator blood volume and oxygenator resistance (r = -0.476; p< 0.001) in all oxygenators, which became stronger analyzing only exchanged oxygenators (r = -0.680; p< 0.001) and oxygenators with an oxygenator blood volume < 187 mL (r = 0.831; p< 0.001). No relevant correlation between oxygenator blood volume and O-2 transfer was found. Oxygenator blood volume declined over time and was clearly associated with an increasing oxygenator resistance during prolonged extracorporeal life support, though O-2 transfer was less affected.	[Hendrix, Rik H. J.; Kurniawati, Eva R.; Schins, Sanne F. C.; Maessen, Jos G.; Weerwind, Patrick W.] Maastricht Univ, Med Ctr, Dept Cardiothorac Surg, Maastricht, Netherlands	Maastricht University	Hendrix, RHJ (corresponding author), Maastricht Univ, Med Ctr, Dept Cardiothorac Surg, Maastricht, Netherlands.	rik.hendrix@mumc.nl		Kurniawati, Eva/0000-0002-8637-530X; Maessen, Jos G/0000-0003-3230-7712				Annich GM, 2015, J THROMB HAEMOST, V13, pS336, DOI 10.1111/jth.12963; Condello Ignazio, 2020, J Extra Corpor Technol, V52, P43, DOI 10.1182/ject-1900028; Dornia C, 2014, ASAIO J, V60, P652, DOI 10.1097/MAT.0000000000000133; Gill MC, 2013, PERFUSION-UK, V28, P70, DOI 10.1177/0267659112464097; Kaesler A, 2019, ARTIF ORGANS, V43, P159, DOI 10.1111/aor.13343; Krivitski N, 2018, PERFUSION-UK, V33, P51, DOI 10.1177/0267659118765883; Lawson DS, 2007, PERFUSION-UK, V22, P407, DOI 10.1177/0267659108091337; Lawson D Scott, 2005, Pediatr Crit Care Med, V6, P573, DOI 10.1097/01.PCC.0000163282.63992.13; Lehle K, 2008, ASAIO J, V54, P612, DOI 10.1097/MAT.0b013e318186a807; Lubnow M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112316; Lubnow M, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.12.008; Mulder MMG, 2018, NETH J CRIT CARE, V26, P6; Murphy DA, 2015, TRANSFUS MED REV, V29, P90, DOI 10.1016/j.tmrv.2014.12.001; Oliver WC, 2009, SEMIN CARDIOTHORAC V, V13, P154, DOI 10.1177/1089253209347384; Philipp A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198392; Sowemimo-Coker SO, 2002, TRANSFUS MED REV, V16, P46, DOI 10.1053/tmrv.2002.29404; Toomasian JM, 2011, PERFUSION-UK, V26, P5, DOI 10.1177/0267659110396015; Zakhary B, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03388-2	18	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263360	10.1371/journal.pone.0263360	http://dx.doi.org/10.1371/journal.pone.0263360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108345	Green Published, gold			2022-12-26	WOS:000775890100061
J	Ichami, SM; Karuku, GN; Sila, AM; Ayuke, FO; Shepherd, KD				Ichami, Stephen M.; Karuku, George N.; Sila, Andrew M.; Ayuke, Fredrick O.; Shepherd, Keith D.			Spatial approach for diagnosis of yield-limiting nutrients in smallholder agroecosystem landscape using population-based farm survey data	PLOS ONE			English	Article							RECOMMENDATION INTEGRATED-SYSTEM; SOIL FERTILITY GRADIENTS; ORGANIC-CARBON; INFRARED-SPECTROSCOPY; NITROGEN; MAIZE; MANAGEMENT; PHOSPHORUS; GEOSTATISTICS; SURVEILLANCE	Adept use of fertilizers is critical if sustainable development goal two of zero hunger and agroecosystem resilience are to be achieved for African smallholder agroecosystems. These heterogeneous systems are characterized by poor soil health mainly attributed to soil nutrient depletion. However, conventional methods do not take into account spatial patterns across geographies within agroecosystems, which poses great challenges for targeted interventions of nutrient management. This study aimed to develop a novel population-based farm survey approach for diagnosing soil nutrient deficiencies. The approach embraces principles of land health surveillance of problem definition and rigorous sampling scheme. The advent of rapid soil testing techniques, like infrared spectroscopy, offers opportune avenues for high-density soil and plant characterization. A farm survey was conducted on 64 maize fields, to collect data on soil and plant tissue nutrient concentration and grain yield (GY) for maize crops, using hierarchical and purposive sampling. Correlations between soil test values with GY and biomass were established. The relationship between GY, soil NPK, and the tissue nutrient concentrations was evaluated to guide the setting up of localized critical soil test values. Diagnosis Recommendation Integrated System (DRIS) indices for total nitrogen (N), total phosphorus (P), and total potassium (K) were used to rank and map the prevalence of nutrient limitations. A positive correlation existed between plant tissue nutrient concentration with GY with R-2 values of 0.089, 0.033, and 0.001 for NPK, respectively. Soil test cut-off values were 0.01%, 12 mg kg(-1), 4.5 cmol(c) kg(-1) for NPK, respectively, which varied slightly from established soil critical values for soil nutrient diagnostics. N and K were the most limiting nutrients for maize production in 67% of sampled fields. The study demonstrates that a population-based farm survey of crop fields can be a useful tool in nutrient diagnostics and setting priorities for site-specific fertilizer recommendations. A larger-scale application of the approach is warranted.	[Ichami, Stephen M.; Karuku, George N.; Ayuke, Fredrick O.] Univ Nairobi, Fac Agr, Dept Land Resource Management & Agr Technol, Nairobi, Kenya; [Ichami, Stephen M.; Sila, Andrew M.; Shepherd, Keith D.] World Agroforestry Ctr ICRAF, Nairobi, Kenya; [Ichami, Stephen M.] Int Ctr Trop Agr CIAT Kenya, Nairobi, Kenya; [Ichami, Stephen M.] Wageningen Univ, Soil Biol Grp, Wageningen, Netherlands; [Ichami, Stephen M.] Wageningen Univ, Soil Geog & Landscape Grp, Wageningen, Netherlands	University of Nairobi; CGIAR; World Agroforestry (ICRAF); Wageningen University & Research; Wageningen University & Research	Ichami, SM (corresponding author), Univ Nairobi, Fac Agr, Dept Land Resource Management & Agr Technol, Nairobi, Kenya.; Ichami, SM (corresponding author), World Agroforestry Ctr ICRAF, Nairobi, Kenya.; Ichami, SM (corresponding author), Int Ctr Trop Agr CIAT Kenya, Nairobi, Kenya.; Ichami, SM (corresponding author), Wageningen Univ, Soil Biol Grp, Wageningen, Netherlands.; Ichami, SM (corresponding author), Wageningen Univ, Soil Geog & Landscape Grp, Wageningen, Netherlands.	stephen.ichami@gmail.com			Wageningen University; CIAT-Kenya; World Agroforestry Centre (ICRAF); University of Nairobi; CGIAR research program on 'Water, Land and Ecosystems'	Wageningen University(European Commission); CIAT-Kenya; World Agroforestry Centre (ICRAF); University of Nairobi; CGIAR research program on 'Water, Land and Ecosystems'(CGIAR)	This study was funded by Wageningen University as a sandwich PhD, CIAT-Kenya and World Agroforestry Centre (ICRAF) fellowship programs in collaboration with the University of Nairobi. We acknowledge initial comments on the concept of this paper by Prof. Ellis Hoffland and Dr. Jetse Stoorvogel of Wageningen University.The unlimited cooperation and support extended by International Plant Nutrition Institute (IPNI) through Dr. Shamie Zingore in carrying out the field research work in western Kenya are gratefully appreciated. We also acknowledge the support of the CGIAR research program on 'Water, Land and Ecosystems'.	ADEOYE GO, 1985, FERT RES, V6, P65, DOI 10.1007/BF01058165; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Alder J., 2015, MEAWIP ANTIGUA BARBU; [Anonymous], 1957, SOIL SCI; Arnhold S, 2015, SOIL TILL RES, V154, P75, DOI 10.1016/j.still.2015.06.021; Baker RHA, 2000, AGR ECOSYST ENVIRON, V82, P57, DOI 10.1016/S0167-8809(00)00216-4; Bationo A., 2012, IMPROVING SOIL FERTI, P169, DOI [10.1007/978-94-007-2960-5_11, DOI 10.1007/978-94-007-2960-5_11]; Beaufils E., 1973, DIAGNOSIS RECOMMENDA, V1st; Bekunda M, 2010, RESTORING SOIL FERTI, P183, DOI [10.1007/s11111-010-0104-2, DOI 10.1007/S11111-010-0104-2]; Bivand R, 2019, PACKAG SPDEPCRAN, DOI [10.1016/j.csda.2008.07.021, DOI 10.1016/J.CSDA.2008.07.021]; BROUWER J, 1993, AGR ECOSYST ENVIRON, V45, P229, DOI 10.1016/0167-8809(93)90073-X; Campbell CR, 2000, SO COOPERATIVE SERIE, V394, P1; CATE RB, 1971, SOIL SCI SOC AM PRO, V35, P658, DOI 10.2136/sssaj1971.03615995003500040048x; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; Cobo JG, 2010, AGR ECOSYST ENVIRON, V136, P1, DOI 10.1016/j.agee.2009.11.006; Coe R, 2015, ICRAF WORKING PAPER; Cozzolino D, 2006, SOIL TILL RES, V85, P78, DOI 10.1016/j.still.2004.12.006; Das D, 2009, NUTR CYCL AGROECOSYS, V83, P85, DOI 10.1007/s10705-008-9202-2; de Barros I, 2007, FIELD CROP RES, V101, P26, DOI 10.1016/j.fcr.2006.09.005; Diarisso T, 2016, NUTR CYCL AGROECOSYS, V105, P199, DOI 10.1007/s10705-015-9705-6; Foster EF, 2001, CROP SCI, V41, P917, DOI 10.2135/cropsci2001.413917x; Frederiksen ME, 2019, EUR J CANCER PREV, V28, P124, DOI 10.1097/CEJ.0000000000000418; Fu WJ, 2011, J PLANT NUTR SOIL SC, V174, P785, DOI 10.1002/jpln.201000422; Goswami R, 2017, AGROECOL SUST FOOD, V41, P546, DOI 10.1080/21683565.2017.1290730; Havlin JL, 1994, SOIL TESTING PROSPEC, V40; Huising E.J., 2011, DIAGNOSTIC TRIALS FI; Ichami SM, 2020, GEODERMA REG, V22, DOI 10.1016/j.geodrs.2020.e00300; Ichami SM, 2019, NUTR CYCL AGROECOSYS, V113, P1, DOI 10.1007/s10705-018-9958-y; Janik LJ, 2009, CHEMOMETR INTELL LAB, V97, P179, DOI 10.1016/j.chemolab.2009.04.005; Karltun E, 2013, LAND DEGRAD DEV, V24, P228, DOI 10.1002/ldr.1118; Kihara J, 2016, NUTR CYCL AGROECOSYS, V105, P171, DOI 10.1007/s10705-015-9717-2; Kihara J, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0431-0; Kihara J, 2016, AGR ECOSYST ENVIRON, V229, P1, DOI 10.1016/j.agee.2016.05.012; Kuper H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029700; Lafitte HR, 1994, IDENTIFYING PRODUCTI; Landon J. R., 2014, ROUTLEDGE; Lipscomb LL, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3148-0; Lu GY, 2008, COMPUT GEOSCI-UK, V34, P1044, DOI 10.1016/j.cageo.2007.07.010; Mairura FS, 2007, GEODERMA, V139, P134, DOI 10.1016/j.geoderma.2007.01.019; Maleki MR, 2006, BIOSYST ENG, V95, P425, DOI 10.1016/j.biosystemseng.2006.07.015; Mangiafico SS, 2013, J EXT, P51; Mango NAR, 1999, INTEGRATED SOIL FERT; MAYNARD DN, 1979, J PLANT NUTR, V1, P1, DOI 10.1080/01904167909362696; McBratney AB, 2006, GEODERMA, V136, P272, DOI 10.1016/j.geoderma.2006.03.051; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Muhati SI, 2011, J AGR SCI TECH-IRAN; Ngome AF, 2013, INT J PLANT PROD, V7, P517; Njoroge R, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8040049; Njoroge S, 2017, FIELD CROP RES, V214, P321, DOI 10.1016/j.fcr.2017.09.026; Nyamangara J., 2014, 4R PLANT NUTRIENT MA; Nziguheba G, 2009, PLANT SOIL, V314, P143, DOI 10.1007/s11104-008-9714-1; Okalebo R. J., 2002, LAB METHODS SOIL PLA, V2; OVERMAN AR, 1992, AGRON J, V84, P998, DOI 10.2134/agronj1992.00021962008400060018x; Paavola J, 2008, ENVIRON SCI POLICY, V11, P642, DOI 10.1016/j.envsci.2008.06.002; Panday D, 2019, COGENT FOOD AGR, V5, DOI 10.1080/23311932.2019.1600460; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Petersen J, 2012, NUTR CYCL AGROECOSYS, V93, P1, DOI 10.1007/s10705-012-9482-4; Raghupathi HB, 1998, COMMUN SOIL SCI PLAN, V29, P2881, DOI 10.1080/00103629809370162; Ramakrishna A, 2009, PLANT SOIL, V316, P107, DOI 10.1007/s11104-008-9763-5; Raynaud X, 2004, ECOLOGY, V85, P2200, DOI 10.1890/03-0817; Reuter D.J., 1997, PLANT ANAL INTERPRET, P83; Rivera-Andrade A, 2019, NUTR METAB CARDIOVAS, V29, P191, DOI 10.1016/j.numecd.2018.10.008; Romheld V, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P299, DOI 10.1016/B978-0-12-384905-2.00011-X; Ronner E, 2016, FIELD CROP RES, V186, P133, DOI 10.1016/j.fcr.2015.10.023; ROTH GW, 1989, AGRON J, V81, P502, DOI 10.2134/agronj1989.00021962008100030022x; Samberg LH, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124010; Setiyono TD, 2010, FIELD CROP RES, V118, P158, DOI 10.1016/j.fcr.2010.05.006; Shepherd DN, 2010, MOL PLANT PATHOL, V11, P1, DOI [10.1111/j.1364-3703.2009.00568.x, 10.1111/j.1364-3703.2009.00568.X]; Shepherd K. D., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Congress Symposium 1 The GlobalSoilmap.net project, P24; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Shepherd KD, 2007, J NEAR INFRARED SPEC, V15, P1, DOI 10.1255/jnirs.716; Shepherd KD, 2015, AGR SYST, V132, P93, DOI 10.1016/j.agsy.2014.09.002; Sikora FJ, 2005, COMMUN SOIL SCI PLAN, V36, P875, DOI 10.1081/CSS-200049468; Sila A, 2014, R PACKAG VERSION, P2; Sila A, 2017, GEODERMA REG, V10, P39, DOI 10.1016/j.geodrs.2017.04.003; Sileshi G, 2008, PLANT SOIL, V307, P1, DOI 10.1007/s11104-008-9547-y; Snoeck D., 2010, West African Journal of Applied Ecology, V17, P97; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Testen AL, 2018, PLANT HLTH PROG, V19, P56, DOI 10.1094/PHP-08-17-0044-RS; Tittonell P, 2013, SOIL SCI SOC AM J, V77, P525, DOI 10.2136/sssaj2012.0250; Tittonell P, 2015, MANAGING SOIL HETERO; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; Trivedi P, 2018, SOIL CARBON STORAGE: MODULATORS, MECHANISMS AND MODELING, P1, DOI 10.1016/B978-0-12-812766-7.00001-9; Vagen T.-G., 2012, AGROFORESTRY FUTURE, P455, DOI DOI 10.1007/978-94-007-4676-3_22; Valkama E, 2011, NUTR CYCL AGROECOSYS, V91, P1, DOI 10.1007/s10705-011-9434-4; Van Biljon J. J., 2008, South African Journal of Plant and Soil, V25, P8; Vanlauwe B, 2010, OUTLOOK AGR, V39, P17, DOI 10.5367/000000010791169998; Vanlauwe B., 2014, SOIL DISCUSS, V1, P1239, DOI DOI 10.5194/SOILD-1-1239-2014; WALWORTH JL, 1986, SOIL SCI SOC AM J, V50, P123, DOI 10.2136/sssaj1986.03615995005000010024x; Wang EL, 2014, FIELD CROP RES, V155, P120, DOI 10.1016/j.fcr.2013.09.015; Wangai AW, 2012, PLANT DIS, V96, P1582, DOI 10.1094/PDIS-06-12-0576-PDN; Waswa BS, 2013, GEODERMA, V195, P192, DOI 10.1016/j.geoderma.2012.11.007; Webb MJ, 2011, J PLANT NUTR SOIL SC, V174, P311, DOI 10.1002/jpln.201000178; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wopereis MCS, 2006, FIELD CROP RES, V96, P355, DOI 10.1016/j.fcr.2005.08.004; Wright AF, 2001, COMMUN SOIL SCI PLAN, V32, P3243, DOI 10.1081/CSS-120001118; Yang XM, 2012, EUR J SOIL SCI, V63, P177, DOI 10.1111/j.1365-2389.2011.01421.x; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zingore S, 2007, AGR ECOSYST ENVIRON, V119, P112, DOI 10.1016/j.agee.2006.06.019; Zingore S, 2008, NUTR CYCL AGROECOSYS, V80, P1, DOI 10.1007/s10705-007-9117-3	101	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262754	10.1371/journal.pone.0262754	http://dx.doi.org/10.1371/journal.pone.0262754			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108304	Green Published, gold			2022-12-26	WOS:000775890100035
J	Santamaria, C; Armbrecht, I; Lachaud, JP				Santamaria, Carlos; Armbrecht, Inge; Lachaud, Jean-Paul			Nest architecture and colony composition in two populations of Ectatomma ruidum sp. 2 (E. ruidum species complex) in southwestern Colombia	PLOS ONE			English	Article							PONERINE ANT; ROGER HYMENOPTERA; HARVESTER ANT; FORMICIDAE; DYNAMICS; PARASITISM; THIEVERY; BEHAVIOR; DENSITY; ECOLOGY	Nest architecture plays a fundamental role in the adaptation of ants to their habitat, favoring the action of economically important species. Ectatomma ruidum sp. 2 (ruidum species complex) is a biological control agent in Neotropical agroecosystems, exhibiting high bioturbation impact due to high nest densities. The architecture and composition of 152 nests were studied in two Andean populations of southwestern Colombia, 24 of them being cast using the paraffin wax technique. Nest entrance was a single, circular, 4 mm hole at ground level, without any special external structure, connected to a single vertical tunnel communicating with successive half ellipsoidal chambers. Nests were extremely shallow (depth range: 28.7-35.4 cm), with an average of six chambers and an overall volume of 92.2 cm(3) per nest. The deeper the chamber, the smaller its volume. Nest building was independent of plants or roots, and no surface or underground physical connections were found between neighboring nests. Few nests possessed a queen, and neither ergatoids nor microgynes were recorded. Despite significant interactions between localities and the number of both males and workers, queen presence had an overall highly positive effect on the number of workers and larvae and a negative one on the number of gynes. Overall, the studied Colombian populations of E. ruidum sp. 2 retained the simple nest structure described for other species of this species complex and for colonies of the same species from other geographical areas, though they constrasted in their extreme shallowness. Our data suggest that E. ruidum sp. 2, at the local level, does not follow the usual monodomic pattern of this species with facultative polygyny but, rather, has a polydomic pattern with monogyny, perhaps related to the extreme shallowness of the nests due to soil structure, which could significantly enhance the queen's reproductive inhibition previously reported for this species.	[Santamaria, Carlos; Armbrecht, Inge] Univ Valle, Dept Biol, Cali, Colombia; [Lachaud, Jean-Paul] Colegio Frontera Sur ECOSUR, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Lachaud, Jean-Paul] Univ Toulouse, Ctr Rech Cognit Anim CRCA, Ctr Biol Integrat CBI, UPS, Toulouse, France	Universidad del Valle; El Colegio de la Frontera Sur (ECOSUR); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Santamaria, C (corresponding author), Univ Valle, Dept Biol, Cali, Colombia.; Lachaud, JP (corresponding author), Colegio Frontera Sur ECOSUR, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.; Lachaud, JP (corresponding author), Univ Toulouse, Ctr Rech Cognit Anim CRCA, Ctr Biol Integrat CBI, UPS, Toulouse, France.	csantave@gmail.com; jean-paul.lachaud@univ-tise3.fr			COLCIENCIAS [110656933821, 06482013, 727]; Vicerrectoria de Investigaciones de la Universidad del Valle [CI 71000]; Postgraduate Department of Biological Sciences of the Universidad del Valle	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Vicerrectoria de Investigaciones de la Universidad del Valle; Postgraduate Department of Biological Sciences of the Universidad del Valle	Funds to CS were provided by COLCIENCIAS (National Basic Sciences Program, Code 110656933821, Contract RC. No. 06482013), by the 'Vicerrectoria de Investigaciones de la Universidad del Valle' ('International Visibility' call, code CI 71000), and by the founding of the research projects (2015's call #727) for National PhD students by COLCIENCIAS and the Postgraduate Department of Biological Sciences of the Universidad del Valle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; Antonialli WF, 2001, SOCIOBIOLOGY, V38, P475; Antonialli-Junior WF, 1997, J ADV ZOOL, V18, P64; Antonialli WF, 2007, SOCIOBIOLOGY, V50, P1005; Arias-Penna T.M., 2008, P53; Berrod L, 2017, THESIS U PARIS 13, V13; Bollazzi M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13701; BREED MD, 1990, OECOLOGIA, V84, P117, DOI 10.1007/BF00665604; Bruch C., 1916, Revista del Museo de La Plata, V23; Cadena Alex, 2001, Actes des Colloques Insectes Sociaux, V14, P87; Caldato N, 2016, J NAT HIST, V50, P1561, DOI 10.1080/00222933.2016.1166529; Cammeraat ELH, 2008, J APPL ENTOMOL, V132, P285, DOI 10.1111/j.1439-0418.2008.01281.x; Cassill D, 2002, INSECT SOC, V49, P158, DOI 10.1007/s00040-002-8296-9; Cerda X, 2002, ECOL ENTOMOL, V27, P7, DOI 10.1046/j.0307-6946.2001.00386.x; Ceusters R., 1986, Actes des Colloques Insectes Sociaux, V3, P235; CVC-CIAT-DAGM, 2015, ID ZON FORM PROP TRA, P22; Dattilo W, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2944; De Carli P, 1998, ACT COLLOQ INSECT S, V11, P29; De Carli P, 1997, THESIS U P SABATIER; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; DEBRUYN LAL, 1994, AUST J SOIL RES, V32, P555, DOI 10.1071/SR9940555; DEJEAN A, 1991, SOCIOBIOLOGY, V18, P177; DEJEAN A, 1994, INSECT SOC, V41, P191, DOI 10.1007/BF01240478; DELABIE JC, 1990, WESTV STUD, P555; Elahi R, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.34; Fernandez Fernando, 1991, Caldasia, V16, P551; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Forti LC, 2018, REV BRAS ENTOMOL, V62, P46, DOI 10.1016/j.rbe.2017.10.002; FRESNEAU D, 1989, ACT COLLOQ INSECT S, V5, P83; Aguilar-Velasco RG, 2016, ZOOL J LINN SOC-LOND, V178, P226, DOI 10.1111/zoj.12407; Guenard B, 2013, BIOTROPICA, V45, P497, DOI 10.1111/btp.12031; Halfen AF, 2010, PALAIOS, V25, P703, DOI 10.2110/palo.2010.p10-005r; Ibarra-Nunez G, 2001, SOCIOBIOLOGY, V37, P723; Kadochova Stepanka, 2013, F1000Res, V2, P280, DOI 10.12688/f1000research.2-280.v1; Lachaud J. P., 1984, FOLIA ENTOMOL MEX, V61, P159; Lachaud J.-P., 1990, FOLIA ENTOMOL GICA M, V78, P241; Lachaud J-P., ACTES COLL INSECT SO; Lachaud JP, 2009, BIOL CONTROL, V48, P92, DOI 10.1016/j.biocontrol.2008.09.006; Lachaud JP, 1999, OECOLOGIA, V120, P515, DOI 10.1007/s004420050885; Lachaud JP, 1998, ACT COLLOQ INSECT S, V12, P53; Lapola D. M., 2003, Revista Brasileira de Zoociencias, V5, P177; Le MASNE GEORGES, 1953, ANN SCI NAT ZOOL 11E SER, V15, P1; Lenoir JC, 2011, NATURWISSENSCHAFTEN, V98, P347, DOI 10.1007/s00114-011-0774-3; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Meza-Lazaro RN, 2018, MITOCHONDRIAL DNA A, V29, P1203, DOI 10.1080/24701394.2018.1431228; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; Pardo-Locarno LC, 2005, FLA ENTOMOL, V88, P355, DOI 10.1653/0015-4040(2005)88[355:SACOTW]2.0.CO;2; PASSERA L, 1994, ETHOL ECOL EVOL, V6, P13, DOI 10.1080/08927014.1994.9523004; Carrillo KPI, 2022, BIOACOUSTICS, V31, P332, DOI 10.1080/09524622.2021.1938226; Pena-Carrillo KI, 2021, CHEMOECOLOGY, V31, P125, DOI 10.1007/s00049-020-00334-0; Perez-Lachaud G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44791-2; PERFECTO I, 1990, ECOLOGY, V71, P2125, DOI 10.2307/1938626; Pinter-Wollman N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0695; Poteaux C, 2015, FORMIGAS PONEROMORFA, P127; Quevedo Vega CJ, 2015, INTERACCIONES COMPET; R Core Team, 2021, R LANGUAGE ENV STAT; Rocha FH, 2020, INSECTS, V11, DOI 10.3390/insects11030200; Santamari C., 2017, BOL MUS ENTOMOL UNIV, V18, P12; Santamaria C, 2020, PEDOBIOLOGIA, V79, DOI 10.1016/j.pedobi.2020.150626; Santamaria Carlos, 2009, Boletin del Museo de Entomologia de la Universidad del Valle, V10, P10; Santamaria C, 2009, SOCIOBIOLOGY, V53, P517; Schatz B, 1998, ACT COLLOQ INSECT S, V11, P103; Schatz B, 2008, SOCIOBIOLOGY, V51, P623; Starr C, 2019, ENCY SOCIAL INSECTS, P358, DOI [10.1007/978-3-319-90306-4_41-1, DOI 10.1007/978-3-319-90306-4_41-1]; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; Tschinkel WR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158920; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120407; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; Tschinkel WR, 2010, J INSECT SCI, V10, DOI [10.1673/031.010.8801, 10.1673/031.010.6501]; Tschinkel WR, 2013, MYRMECOL NEWS, V18, P99; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; Tschinkel WR., 2021, ANT ARCHITECTURE WON; Vasquez-Ordonez AA., 2012, PSYCHE; Vieira AS, 2007, REV BRAS ENTOMOL, V51, P489, DOI 10.1590/S0085-56262007000400014; Vieira AS, 2006, SOCIOBIOLOGY, V47, P275; WANG D, 1995, GEODERMA, V66, P259, DOI 10.1016/0016-7061(94)00082-L; Weber Neal A., 1946, PROC ENT SOC WASHINGTON, V48, P1; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; Wheeler WM, 1924, J HERED, V15, P485, DOI 10.1093/oxfordjournals.jhered.a102407	82	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263382	10.1371/journal.pone.0263382	http://dx.doi.org/10.1371/journal.pone.0263382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108326	Green Published, gold			2022-12-26	WOS:000775890100065
J	Wang, S; Wu, T; Hu, CY; Fan, J; Liu, Y; Xu, Y; Zhang, H; Xie, L				Wang Shu; Wu Tao; Hu Chunyan; Fan Jie; Liu Yuan; Xu Yan; Zhang Huan; Xie Liang			Preoperative nutritional evaluation of prostate cancer patients undergoing laparoscopic radical prostatectomy	PLOS ONE			English	Article							GASTRIC-CANCER; RISK INDEX; COMPLICATIONS; INFECTION; COHORT; SCORE	Background and objective Prostate cancer (PCa) is one of the most common malignant tumors in men. Geriatric Nutritional Risk Index (GNRI) is an objective index for evaluating nutritional status of elderly people over 65 years old. The aim of the current study was to explore the correlation and predictive value between GNRI and postoperative recovery and complications in PCa patients undergoing laparoscopic radical prostatectomy (LRP). Methods Taking 98 as the GNRI boundary value, 96 PCa patients (aged >= 65 y) undergoing LRP in the Department of Urology, Affiliated Hospital of North Sichuan Medical College from January 2018 to December 2020 were grouped into malnutrition group (MNg, 34 patients, 35.4%) and normal nutrition group (NNg, 62 patients, 64.6%). Basic information, laboratory examination indexes, operation conditions, postoperative complications and postoperative recovery indexes of patients were recorded and retrospectively analyzed. Clavien-Dindo Classification System (CDCS) was used to assess postoperative complications. T-test was used to analyze differences between the two groups. ROC curve was generated to determine the predictive value of GNRI for postoperative complications. Results Percentage of complications was significantly higher in MNg group compared with that in NNg group (P < 0.01). The average grade based on CDCS was significantly lower in NNg group compared with that in MNg group (P < 0.01). Body weight, Body Mass Index (BMI), preoperative hemoglobin value (HGB), serum albumin (ALB) values of MNg and NNg were significantly positively correlated with GNRI (P<0.01). Incidence and severity of postoperative complications of MNg patients were significantly higher compared with those of NNg patients (P<0.05). Average hospitalization cost of MNg patients was higher in MNg patients compared with that of NNg patients (P<0.05). Duration of post-anesthesia care unit (PACU), duration of antibiotic use and duration of indwelling drainage tube were longer in MNg patients compared with those in NNg patients (P<0.05). Furthermore, volume of indwelling drainage tube was higher in MNg patients compared with that in NNg patients (P<0.05). Conclusion GNRI is an effective and reliable tool for evaluation of preoperative nutritional status of prostate cancer patients. The findings showed that GNRI is correlated with postoperative recovery and complications, and is an effective predictive marker.	[Wang Shu; Wu Tao; Hu Chunyan; Liu Yuan] North Sichuan Med Coll, Affiliated Hosp, Dept Urol Surg, Nanchong, Peoples R China; [Fan Jie; Xu Yan] North Sichuan Med Coll, Affiliated Hosp, Dept Digest Syst, Nanchong, Peoples R China; [Zhang Huan] North Sichuan Med Coll, Affiliated Hosp, Hlth Management Ctr, Nanchong, Peoples R China; [Xie Liang] North Sichuan Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg 2, Nanchong, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; North Sichuan Medical University; North Sichuan Medical University	Xie, L (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg 2, Nanchong, Peoples R China.	scuxl@foxmail.com			project of Sichuan Provincial Health and Family Planning Commission [17PJ106]; project of Sichuan Primary Health Development Center [SWFZ18-Y-14]; project of Affiliated Hospital of North Sichuan Medical College [2021ZD018]; project of school level of North Sichuan Medical College [CBY18-A-YB17]	project of Sichuan Provincial Health and Family Planning Commission; project of Sichuan Primary Health Development Center; project of Affiliated Hospital of North Sichuan Medical College; project of school level of North Sichuan Medical College	This paper is supported by the project of Sichuan Provincial Health and Family Planning Commission (17PJ106), the project of Sichuan Primary Health Development Center (SWFZ18-Y-14), the project of Affiliated Hospital of North Sichuan Medical College (2021ZD018), and the project of school level of North Sichuan Medical College (CBY18-A-YB17).	[Anonymous], 2013, CANC NETWORK, V17; Arshad AR, 2020, CUREUS, V12, DOI 10.7759/cureus.7429; Balzano G, 2017, DIGEST LIVER DIS, V49, P1050, DOI 10.1016/j.dld.2017.06.012; Bansal N, 2020, ENDOTEXT; Perez PB, 2021, NUTR HOSP, V38, P765, DOI 10.20960/nh.03464; Bekelman JE, 2018, J ONCOL PRACT, V14, P618, DOI 10.1200/JOP.18.00434; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Bray F, 2020, CA-CANCER J CLIN, V70, P313, DOI 10.3322/caac.21609; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buitrago G, 2020, CLIN NUTR, V39, P2896, DOI 10.1016/j.clnu.2019.12.025; Dekker MJE, 2018, J RENAL NUTR, V28, P435, DOI 10.1053/j.jrn.2018.06.005; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ding DY, 2015, TURK J GASTROENTEROL, V26, P181, DOI 10.5152/tjg.2015.3993; Feng RM, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0368-6; Gao QQ, 2021, INFECT DRUG RESIST, V14, P3817, DOI 10.2147/IDR.S321385; Garg N, 2018, CLIN CASE REP, V6, P2156, DOI 10.1002/ccr3.1813; Gu WJ, 2015, J CACHEXIA SARCOPENI, V6, P222, DOI 10.1002/jcsm.12025; Guenter P, 2021, NUTR CLIN PRACT, V36, P957, DOI 10.1002/ncp.10771; Gyan E, 2018, JPEN-PARENTER ENTER, V42, P255, DOI 10.1177/0148607116688881; Hamilton-Reeves JM, 2018, J UROLOGY, V200, P292, DOI 10.1016/j.juro.2018.03.001; Hung SC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001918; Ingbar DH, 2019, CURR OPIN CRIT CARE, V25, P371, DOI 10.1097/MCC.0000000000000626; Jayanth KS, 2020, CLIN NUTR ESPEN, V37, P141, DOI 10.1016/j.clnesp.2020.03.004; Jia Lei, 2016, Zhonghua Wei Chang Wai Ke Za Zhi, V19, P409; Kadono Y, 2016, NEUROUROL URODYNAM, V35, P1034, DOI 10.1002/nau.22877; Kang HW, 2020, NUTR CANCER, V72, P88, DOI 10.1080/01635581.2019.1621357; Kretschmer A, 2017, EUR UROL FOCUS, V3, P364, DOI 10.1016/j.euf.2017.11.007; Li B, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06879-1; Lidoriki I, 2021, NUTR CANCER, V73, P391, DOI 10.1080/01635581.2020.1756350; Loncar Y, 2020, J VISC SURG, V157, P107, DOI 10.1016/j.jviscsurg.2019.07.007; Lv GY, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4796598; Matsushita M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041447; McLellan LK, 2016, TRENDS MOL MED, V22, P946, DOI 10.1016/j.molmed.2016.09.003; Michel C, 2020, UROL ONCOL-SEMIN ORI, V38, P719, DOI 10.1016/j.urolonc.2020.02.019; Miyake Hideaki, 2017, Curr Urol, V10, P26, DOI 10.1159/000447147; Niki M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237062; Okamoto T, 2019, WORLD J UROL, V37, P1827, DOI 10.1007/s00345-018-2590-2; Pezzana A, 2015, J NUTR HEALTH AGING, V19, P947, DOI 10.1007/s12603-015-0537-5; Renner R, 2019, EUR J DERMATOL, V29, P619, DOI 10.1684/ejd.2019.3678; Rungsakulkij N, 2019, J HEPATO-BIL-PAN SCI, V26, P479, DOI 10.1002/jhbp.673; Sanda MG, 2018, J UROLOGY, V199, P990, DOI 10.1016/j.juro.2018.01.002; Sandrucci S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040559; Sasaki H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121900; Shoji F, 2017, SURG ONCOL, V26, P483, DOI 10.1016/j.suronc.2017.09.006; Shrestha S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260127; Sondekoppam RV, 2020, CAN J ANESTH, V67, P1595, DOI 10.1007/s12630-020-01791-5; Soto-Gonzalez M, 2020, PROG UROL, V30, P209, DOI 10.1016/j.purol.2019.10.007; Strobel R, 2021, CHIRURG, V92, P385, DOI 10.1007/s00104-020-01330-4; Tang HC, 2021, MICROB PATHOGENESIS, V156, DOI 10.1016/j.micpath.2021.104903; Tripathy S, 2015, INDIAN J CRIT CARE M, V19, P518, DOI 10.4103/0972-5229.164798; Wang Y, 2020, NUTR CANCER, V72, P620, DOI 10.1080/01635581.2019.1650189; Weir CB, 2021, STATPEARLS TREASURE; Wiltz AL, 2009, UROLOGY, V73, P316, DOI 10.1016/j.urology.2008.08.493; Wu Guohao, 2010, CHINESE J GASTROINTE, P170; Zhai Z, 2020, CANCER-AM CANCER SOC, V126, P1969, DOI 10.1002/cncr.32733; Zhou JZ, 2016, SCAND J GASTROENTERO, V51, P8, DOI 10.3109/00365521.2015.1063153	56	1	2	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262630	10.1371/journal.pone.0262630	http://dx.doi.org/10.1371/journal.pone.0262630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108317	gold, Green Published			2022-12-26	WOS:000775890100029
J	Liu, J; Shen, QM; Bao, HG				Liu, Jing; Shen, Qingmiao; Bao, Haigang			Comparison of seven SNP calling pipelines for the next-generation sequencing data of chickens	PLOS ONE			English	Article							TOOLS	Single nucleotide polymorphisms (SNPs) are widely used in genome-wide association studies and population genetics analyses. Next-generation sequencing (NGS) has become convenient, and many SNP-calling pipelines have been developed for human NGS data. We took advantage of a gap knowledge in selecting the appropriated SNP calling pipeline to handle with high-throughput NGS data. To fill this gap, we studied and compared seven SNP calling pipelines, which include 16GT, genome analysis toolkit (GATK), Bcftools-single (Bcftools single sample mode), Bcftools-multiple (Bcftools multiple sample mode), VarScan2-single (VarScan2 single sample mode), VarScan2-multiple (VarScan2 multiple sample mode) and Freebayes pipelines, using 96 NGS data with the different depth gradients of approximately 5X, 10X, 20X, 30X, 40X, and 50X coverage from 16 Rhode Island Red chickens. The sixteen chickens were also genotyped with a 50K SNP array, and the sensitivity and specificity of each pipeline were assessed by comparison to the results of SNP arrays. For each pipeline, except Freebayes, the number of detected SNPs increased as the input read depth increased. In comparison with other pipelines, 16GT, followed by Bcftools-multiple, obtained the most SNPs when the input coverage exceeded 10X, and Bcftools-multiple obtained the most when the input was 5X and 10X. The sensitivity and specificity of each pipeline increased with increasing input. Bcftools-multiple had the highest sensitivity numerically when the input ranged from 5X to 30X, and 16GT showed the highest sensitivity when the input was 40X and 50X. Bcftools-multiple also had the highest specificity, followed by GATK, at almost all input levels. For most calling pipelines, there were no obvious changes in SNP numbers, sensitivities or specificities beyond 20X. In conclusion, (1) if only SNPs were detected, the sequencing depth did not need to exceed 20X; (2) the Bcftools-multiple may be the best choice for detecting SNPs from chicken NGS data, but for a single sample or sequencing depth greater than 20X, 16GT was recommended. Our findings provide a reference for researchers to select suitable pipelines to obtain SNPs from the NGS data of chickens or nonhuman animals.	[Liu, Jing; Shen, Qingmiao; Bao, Haigang] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing Key Lab Anim Genet Improvement, Beijing, Peoples R China	China Agricultural University	Bao, HG (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing Key Lab Anim Genet Improvement, Beijing, Peoples R China.	zjbhg@126.com		Bao, Haigang/0000-0003-4591-3957	Modern Agricultural Industry Technology System of China [CARS-40]	Modern Agricultural Industry Technology System of China	This study was supported by the Modern Agricultural Industry Technology System of China [grant number CARS-40]. The funder did not play any role in the design of the study, collection, analysis, interpretation of data or writing the manuscript.	Bassano I, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5621-5; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brouard JS, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0359-0; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Chiara M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4508-1; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Danecek P, 2017, BIOINFORMATICS, V33, P2037, DOI 10.1093/bioinformatics/btx100; De Summa S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1537-8; do Valle IF, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1190-7; Escalona M, 2016, NAT REV GENET, V17, P459, DOI 10.1038/nrg.2016.57; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gezsi A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2050-y; Gholami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094509; Ghoneim Dalia H, 2014, BMC Res Notes, V7, P864, DOI 10.1186/1756-0500-7-864; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Guo YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14283; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hwang KB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39108-2; Hwang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17875; Koboldt Daniel C, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi1504s44; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawal RA, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00264; Liu L, 2018, THEOR APPL GENET, V131, P1835, DOI 10.1007/s00122-018-3116-4; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; Luo RB, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix045; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ni GY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2059-2; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Phillips C, 2020, FORENSIC SCI INT-GEN, V46, DOI 10.1016/j.fsigen.2020.102232; Pirooznia M, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-14; Qanbari S, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007989; Rochus CM, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4447-x; Saint-Pe K, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5958-9; Sandmann S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43169; Schnepp PM, 2019, HUM MOL GENET, V28, DOI 10.1093/hmg/ddz207; Walker Mark A, 2018, Bioinformatics, V34, P4287, DOI 10.1093/bioinformatics/bty501; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Zhang MJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3131-8; Zhao Y, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5533-4	42	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262574	10.1371/journal.pone.0262574	http://dx.doi.org/10.1371/journal.pone.0262574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100292	Green Published, gold			2022-12-26	WOS:000801937600015
J	Ronchini, C; Gandini, S; Pasqualato, S; Mazzarella, L; Facciotti, F; Mapelli, M; Frige', G; Passerini, R; Pase, L; Capizzi, S; Mastrilli, F; Orecchia, R; Natoli, G; Pelicci, PG				Ronchini, Chiara; Gandini, Sara; Pasqualato, Sebastiano; Mazzarella, Luca; Facciotti, Federica; Mapelli, Marina; Frige', Gianmaria; Passerini, Rita; Pase, Luca; Capizzi, Silvio; Mastrilli, Fabrizio; Orecchia, Roberto; Natoli, Gioacchino; Pelicci, Pier Giuseppe		IEO Covid Team	Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs	PLOS ONE			English	Article							SARS-COV-2	The correlation between immune responses and protection from SARS-CoV-2 infections and its duration remains unclear. We performed a sanitary surveillance at the European Institute of Oncology (IEO) in Milan over a 17 months period. Pre-vaccination, in 1,493 participants, we scored 266 infections (17.8%) and 8 possible reinfections (3%). Post-vaccination, we identified 30 infections in 2,029 vaccinated individuals (1.5%). We report that the probability of infection post-vaccination is i) significantly lower compared to natural infection, ii) associated with a significantly shorter median duration of infection than that of first infection and reinfection, iii) anticorrelated with circulating antibody levels.	[Ronchini, Chiara; Frige', Gianmaria] European Inst Oncol IRCCS, Clin Genom, Milan, Italy; [Gandini, Sara; Pasqualato, Sebastiano; Mazzarella, Luca; Facciotti, Federica; Mapelli, Marina; Natoli, Gioacchino; Pelicci, Pier Giuseppe] European Inst Oncol IRCCS, Dept Expt Oncol, Milan, Italy; [Passerini, Rita] European Inst Oncol IRCCS, Div Lab Med, Milan, Italy; [Pase, Luca] European Inst Oncol IRCCS, Occupat Med, Milan, Italy; [Capizzi, Silvio; Mastrilli, Fabrizio] European Inst Oncol, IRCCS, IEO, CMO,Med Adm, Milan, Italy; [Orecchia, Roberto] European Inst Oncol IRCCS, Sci Directorate, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO)	Ronchini, C (corresponding author), European Inst Oncol IRCCS, Clin Genom, Milan, Italy.; Pelicci, PG (corresponding author), European Inst Oncol IRCCS, Dept Expt Oncol, Milan, Italy.	chiara.ronchini@ieo.it; piergiuseppe.pelicci@ieo.it	Doni, Mirko/ABA-9174-2021; Gandini, Sara/J-4916-2018; Ronchini, Chiara/K-3935-2013; Raimondi, Sara/J-5236-2016	Doni, Mirko/0000-0001-7099-2701; Ciossani, Giuseppe/0000-0001-5293-4292; Pasqualato, Sebastiano/0000-0002-9038-7768; Gandini, Sara/0000-0002-1348-4548; Iodice, Maria Giovanna/0000-0002-6173-1080; Natoli, Gioacchino/0000-0003-0711-2411; Ronchini, Chiara/0000-0003-3908-4021; Raimondi, Sara/0000-0003-4673-9049	Fondazione Europea Guido Venosta; National Instruments Corporation; Ralph Lauren; MFS Investment Management	Fondazione Europea Guido Venosta; National Instruments Corporation; Ralph Lauren; MFS Investment Management	Financial support for our study was provided by Fondazione Europea Guido Venosta, National Instruments Corporation, Ralph Lauren and MFS Investment Management. Additional costs were covered through Institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Bartsch SM, 2021, J INFECT DIS, V224, P938, DOI 10.1093/infdis/jiab233; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Bruni M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103188; Xaquin D, 2022, J INTERN MED, V291, P32, DOI 10.1111/joim.13372; Cento V, 2020, J INFECTION, V81, pE90, DOI 10.1016/j.jinf.2020.06.024; Chu CM, 2005, EUR RESPIR J, V25, P12, DOI 10.1183/09031936.04.00057804; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Deiana M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9081738; Eyre DW, 2020, ELIFE, V9, DOI 10.7554/eLife.60675; G. Shen, 2021, medRxiv, DOI 10.1101/2021.02.23.21252221; Grigoryan L, 2020, SEMIN IMMUNOL, V50, DOI 10.1016/j.smim.2020.101422; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Jordan SC, 2021, CLIN EXP IMMUNOL, V204, P310, DOI 10.1111/cei.13582; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Lee BY, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008470; Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001; Low JS, 2021, SCIENCE, V372, P1336, DOI 10.1126/science.abg8985; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Pasomsub E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.05.001; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rhee C, 2021, CLIN INFECT DIS, V72, P1467, DOI 10.1093/cid/ciaa1249; Strafella C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708820; Williams E, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00776-20; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263014	10.1371/journal.pone.0263014	http://dx.doi.org/10.1371/journal.pone.0263014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100309	Green Published, Green Submitted, gold			2022-12-26	WOS:000801937600027
J	Smet, A; Catani, JPP; Ysenbaert, T; Goncalves, A; Kleanthous, H; Vogel, TU; Saelens, X; Job, ER				Smet, Anouk; Catani, Joao Paulo Portela; Ysenbaert, Tine; Goncalves, Amanda; Kleanthous, Harry; Vogel, Thorsten U.; Saelens, Xavier; Job, Emma R.			Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; HEMAGGLUTININ; INFECTION; TARGET	Influenza neuraminidase (NA) is implicated in various aspects of the virus replication cycle and therefore is an attractive target for vaccination and antiviral strategies. Here we investigated the potential for NA-specific antibodies to interfere with A(H1N1)pdm09 replication in primary human airway epithelial (HAE) cells. Mouse polyclonal anti-NA sera and a monoclonal antibody could block initial viral entry into HAE cells as well as egress from the cell surface. NA-specific polyclonal serum also reduced virus replication across multiple rounds of infection. Restriction of virus entry correlated with the ability of the serum or monoclonal antibody to mediate neuraminidase inhibition (NI). Finally, human sera with NI activity against the N1 of A(H1N1)pdm09 could decrease H6N1 virus infection of HAE cells, highlighting the potential contribution of anti-NA antibodies in the control of influenza virus infection in humans.	[Smet, Anouk; Catani, Joao Paulo Portela; Ysenbaert, Tine; Saelens, Xavier; Job, Emma R.] VIB, VIB UGent Med Biotechnol Ctr, Ghent, Belgium; [Smet, Anouk; Catani, Joao Paulo Portela; Ysenbaert, Tine; Saelens, Xavier; Job, Emma R.] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Smet, Anouk; Catani, Joao Paulo Portela; Ysenbaert, Tine; Saelens, Xavier; Job, Emma R.] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium; [Goncalves, Amanda] VIB BioImaging Core, Ghent, Belgium; [Goncalves, Amanda] VIB UGent Ctr Inflammat Res, Ghent, Belgium; [Kleanthous, Harry; Vogel, Thorsten U.] Sanofi Pasteur, Res North Amer, Cambridge, MA USA; [Job, Emma R.] Janssen Res & Discovery, Janssen Infect Dis & Vaccines, Beerse, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University; Sanofi-Aventis	Saelens, X (corresponding author), VIB, VIB UGent Med Biotechnol Ctr, Ghent, Belgium.; Saelens, X (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Saelens, X (corresponding author), Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium.	Xavier.saelens@vib-ugent.be		Goncalves, Amanda Maffioletti Mac Cord/0000-0003-2748-3033; , Xavier/0000-0002-3861-6965	Sanofi Pasteur	Sanofi Pasteur	This work was supported by Sanofi Pasteur.	Allen JD, 2018, HUM VACC IMMUNOTHER, V14, P1840, DOI 10.1080/21645515.2018.1462639; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; COMPANS RW, 1969, J VIROL, V4, P528, DOI 10.1128/JVI.4.4.528-534.1969; Davis AS, 2015, J HISTOCHEM CYTOCHEM, V63, P312, DOI 10.1369/0022155415570968; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; Doyle TM., 2014, BMC GENOMICS, V15, pP8, DOI [10.1186/1471-2164-15-s2-p8, DOI 10.1186/1471-2164-15-S2-P8]; Dunning AJ, 2016, CLIN VACCINE IMMUNOL, V23, P228, DOI 10.1128/CVI.00604-15; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gao J, 2016, JOVE-J VIS EXP, DOI 10.3791/54573; Gilchuk IM, 2019, CELL HOST MICROBE, V26, P715, DOI 10.1016/j.chom.2019.10.003; Gravel C, 2010, VACCINE, V28, P5774, DOI 10.1016/j.vaccine.2010.06.075; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Guo HB, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007233; Job ER, 2019, MBIO, V10, DOI 10.1128/mBio.01667-19; Job ER, 2018, J VIROL, V92, DOI 10.1128/JVI.01584-17; Job ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059623; Koroleva M, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-019-0153-1; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Memoli MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00417-16; Mori K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09163; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Park JK, 2018, MBIO, V9, DOI [10.1128/mBio.02284-17, 10.1128/mbio.02284-17]; Petrie JG, 2015, J INFECT DIS, V212, P1914, DOI 10.1093/infdis/jiv313; Powell H, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008411; Rajendran M, 2017, MBIO, V8, DOI [10.1128/mBio.02281-16, 10.1128/mbio.02281-16]; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Sakai T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45043; Schotsaert M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24402; SETO JT, 1969, J VIROL, V4, P58, DOI 10.1128/JVI.4.1.58-66.1969; Stadlbauer D, 2019, SCIENCE, V366, P499, DOI 10.1126/science.aay0678; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Wan HQ, 2019, NAT MICROBIOL, V4, P2216, DOI 10.1038/s41564-019-0522-6; Wan HQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7114; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; WHO, 2011, MAN LAB DIAGN VIR SU; Wilson JR, 2016, ANTIVIR RES, V135, P48, DOI 10.1016/j.antiviral.2016.10.001; Wohlbold TJ, 2017, NAT MICROBIOL, V2, P1415, DOI 10.1038/s41564-017-0011-8; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; Yasuhara A, 2019, NAT MICROBIOL, V4, P1024, DOI 10.1038/s41564-019-0401-1	45	1	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262873	10.1371/journal.pone.0262873	http://dx.doi.org/10.1371/journal.pone.0262873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100294	Green Published, gold			2022-12-26	WOS:000801937600022
J	Fidyt, K; Pastorczak, A; Cyran, J; Crump, NT; Goral, A; Madzio, J; Muchowicz, A; Poprzeczko, M; Domka, K; Komorowski, L; Winiarska, M; Harman, JR; Siudakowska, K; Graczyk-Jarzynka, A; Patkowska, E; Lech-Maranda, E; Mlynarski, W; Golab, J; Milne, TA; Firczuk, M				Fidyt, Klaudyna; Pastorczak, Agata; Cyran, Julia; Crump, Nicholas T.; Goral, Agnieszka; Madzio, Joanna; Muchowicz, Angelika; Poprzeczko, Martyna; Domka, Krzysztof; Komorowski, Lukasz; Winiarska, Magdalena; Harman, Joe R.; Siudakowska, Karolina; Graczyk-Jarzynka, Agnieszka; Patkowska, Elzbieta; Lech-Maranda, Ewa; Mlynarski, Wojciech; Golab, Jakub; Milne, Thomas A.; Firczuk, Malgorzata			Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax	ONCOGENE			English	Article							H3K79 METHYLATION; FUSION PROTEINS; BCL-2; INHIBITOR; AURANOFIN; APOPTOSIS; MCL-1; THIOREDOXIN; UBIQUITINATION; TRANSCRIPTION	The prognosis for B-cell precursor acute lymphoblastic leukemia patients with Mixed-Lineage Leukemia (MLL) gene rearrangements (MLLr BCP-ALL) is still extremely poor. Inhibition of anti-apoptotic protein BCL-2 with venetoclax emerged as a promising strategy for this subtype of BCP-ALL, however, lack of sufficient responses in preclinical models and the possibility of developing resistance exclude using venetoclax as monotherapy. Herein, we aimed to uncover potential mechanisms responsible for limited venetoclax activity in MLLr BCP-ALL and to identify drugs that could be used in combination therapy. Using RNA-seq, we observed that long-term exposure to venetoclax in vivo in a patient-derived xenograft model leads to downregulation of several tumor protein 53 (TP53)-related genes. Interestingly, auranofin, a thioredoxin reductase inhibitor, sensitized MLLr BCP-ALL to venetoclax in various in vitro and in vivo models, independently of the p53 pathway functionality. Synergistic activity of these drugs resulted from auranofin-mediated upregulation of NOXA pro-apoptotic protein and potent induction of apoptotic cell death. More specifically, we observed that auranofin orchestrates upregulation of the NOXA-encoding gene Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1) associated with chromatin remodeling and increased transcriptional accessibility. Altogether, these results present an efficacious drug combination that could be considered for the treatment of MLLr BCP-ALL patients, including those with TP53 mutations.	[Fidyt, Klaudyna; Cyran, Julia; Goral, Agnieszka; Muchowicz, Angelika; Poprzeczko, Martyna; Domka, Krzysztof; Komorowski, Lukasz; Winiarska, Magdalena; Siudakowska, Karolina; Graczyk-Jarzynka, Agnieszka; Golab, Jakub; Firczuk, Malgorzata] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Fidyt, Klaudyna; Komorowski, Lukasz] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Pastorczak, Agata; Madzio, Joanna; Mlynarski, Wojciech] Med Univ Lodz, Dept Pediat Oncol & Hematol, Lodz, Poland; [Crump, Nicholas T.; Harman, Joe R.; Milne, Thomas A.] Univ Oxford, Med Res Council Mol Haematol Unit, Oxford, England; [Poprzeczko, Martyna; Domka, Krzysztof; Winiarska, Magdalena; Graczyk-Jarzynka, Agnieszka] Polish Acad Sci, Mossakowski Med Res Inst, Warsaw, Poland; [Patkowska, Elzbieta; Lech-Maranda, Ewa] Inst Hematol & Transfus Med, Dept Hematol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University Lodz; University of Oxford; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Firczuk, M (corresponding author), Med Univ Warsaw, Dept Immunol, Warsaw, Poland.	mfirczuk@wum.edu.pl	Madzio, Joanna/ABC-5122-2020; Patkowska, Elżbieta/AAD-3938-2020; Muchowicz, Angelika/J-7494-2012; Golab, Jakub/K-6974-2013	Madzio, Joanna/0000-0003-0766-0194; Patkowska, Elżbieta/0000-0001-8691-4310; Goral, Agnieszka/0000-0002-7324-9718; Pastorczak, Agata/0000-0003-3089-6947; Fidyt, Klaudyna/0000-0003-0568-4950; Crump, Nicholas/0000-0001-9610-6763; Janowska (Poprzeczko), Martyna/0000-0002-8703-5614; Komorowski, Lukasz Wit/0000-0002-7646-1968; Winiarska, Magdalena/0000-0001-5605-3329; Muchowicz, Angelika/0000-0003-4707-1722; Mlynarski, Wojciech/0000-0003-2714-5851; Golab, Jakub/0000-0002-2830-5100	National Science Centre (Poland) [2015/18/E/NZ5/00723, 2018/31/N/NZ5/01438, 2019/32/T/NZ5/00241]; Ministry of Education and Science (Poland) [013/RID/2018/19]; Medical Research Council (MRC, UK) Molecular Haematology Unit (MHU) grant [MC_UU_00016/6]; Engineering and Physical Sciences Research Council (EPSRC) [2119788, EP/R513295/1]	National Science Centre (Poland)(National Science Centre, Poland); Ministry of Education and Science (Poland)(Ministry of Science and Higher Education, Poland); Medical Research Council (MRC, UK) Molecular Haematology Unit (MHU) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the National Science Centre (Poland) grants: 2015/18/E/NZ5/00723 (MF), 2018/31/N/NZ5/01438 (KF), 2019/32/T/NZ5/00241 (KF), and by the Ministry of Education and Science (Poland) within "Regional Initiative of Excellence" program 013/RID/2018/19 (JG), project budget 12 000 000 PLN. TAM, NTC, and JRH are supported by Medical Research Council (MRC, UK) Molecular Haematology Unit (MHU) grant MC_UU_00016/6 and Engineering and Physical Sciences Research Council (EPSRC) Doctoral Training Program grant project reference 2119788 and EP/R513295/1. We gratefully acknowledge Prof Meinrad Busslinger who kindly provided GFP+ OP9 cells for the co-culture studies. We would also like to acknowledge methodological support in co-culture studies and PDXs generation provided by the researchers from Newcastle University, Prof Olaf Heidenreich (currently Princess Maxima Center, Utrecht, the Netherlands), Dr Deepali Pal, and Dr Helen Blair. We thank for the technical support provided by Elzbieta Gutkowska, Ewa Chmiel, Ewa Pieta, Magdalena Dlugolecka from the Department of Immunology at Medical University of Warsaw. We would also like to thank all patients, their parents and staff from Central Clinical Hospital of the Medical University of Lodz, and from the Institute of Hematology and Transfusion Medicine in Warsaw. We also acknowledge Dr Maksymilian Bielecki from SWPS University of Social Sciences and Humanities for advising in statistical analyses.	Agirre X, 2003, MOL CARCINOGEN, V38, P201, DOI 10.1002/mc.10159; Alford SE, 2015, CANCER RES, V75, P1366, DOI 10.1158/0008-5472.CAN-14-1849; Anderson MA, 2016, BLOOD, V127, P3215, DOI 10.1182/blood-2016-01-688796; Benito JM, 2015, CELL REP, V13, P2715, DOI 10.1016/j.celrep.2015.12.003; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bhatt S, 2020, CANCER CELL, V38, P872, DOI 10.1016/j.ccell.2020.10.010; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bohler S, 2021, HAEMATOLOGICA, V106, P3136, DOI 10.3324/haematol.2020.252130; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Deregowska A, 2020, GENES-BASEL, V11, DOI 10.3390/genes11101145; Diaz-Flores E, 2019, CANCER RES, V79, P2339, DOI 10.1158/0008-5472.CAN-18-0236; Fidyt K, 2019, MOL ONCOL, V13, P1180, DOI 10.1002/1878-0261.12476; Fischer U, 2015, NAT GENET, V47, P1020, DOI 10.1038/ng.3362; Frismantas V, 2017, BLOOD, V129, pE26, DOI 10.1182/blood-2016-09-738070; Gibson CJ, 2015, CLIN CANCER RES, V21, P5021, DOI 10.1158/1078-0432.CCR-15-0364; Gomez-Bougie P, 2011, BIOCHEM BIOPH RES CO, V413, P460, DOI 10.1016/j.bbrc.2011.08.118; Herling CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03170-7; Jain P, 2020, AM J HEMATOL, V95, P623, DOI 10.1002/ajh.25796; Jin S, 2020, CLIN CANCER RES, V26, P3371, DOI 10.1158/1078-0432.CCR-19-1900; Khaw SL, 2016, BLOOD, V128, P1382, DOI 10.1182/blood-2016-03-707414; Leonard JT, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1583.1583; Li BS, 2020, BLOOD, V135, P41, DOI 10.1182/blood.2019002220; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu NN, 2014, ONCOTARGET, V5, P5453, DOI 10.18632/oncotarget.2113; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Maji S, 2018, ADV CANCER RES, V137, P37, DOI 10.1016/bs.acr.2017.11.001; Meyer C, 2018, LEUKEMIA, V32, P273, DOI 10.1038/leu.2017.213; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; MIYASHITA T, 1992, CANCER RES, V52, P5407; Moujalled DM, 2020, BLOOD ADV, V4, P2762, DOI 10.1182/bloodadvances.2019001416; Moujalled DM, 2019, LEUKEMIA, V33, P905, DOI 10.1038/s41375-018-0261-3; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Nechiporuk T, 2019, CANCER DISCOV, V9, P910, DOI 10.1158/2159-8290.CD-19-0125; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pal D, 2016, LEUKEMIA, V30, P1691, DOI 10.1038/leu.2016.79; Pang XM, 2014, J BIOL CHEM, V289, P17802, DOI 10.1074/jbc.M114.548172; Pollyea DA, 2021, AM J HEMATOL, V96, P208, DOI 10.1002/ajh.26039; Radenkovic F, 2017, BIOCHEM PHARMACOL, V146, P42, DOI 10.1016/j.bcp.2017.09.009; Ramsey HE, 2018, CANCER DISCOV, V8, P1566, DOI 10.1158/2159-8290.CD-18-0140; Richmond J, 2015, CLIN CANCER RES, V21, P1395, DOI 10.1158/1078-0432.CCR-14-2300; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Scherr M, 2019, LEUKEMIA, V33, P1313, DOI 10.1038/s41375-018-0315-6; Seyfried F, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1801-0; Seyfried F, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1081.1081; Stengel A, 2014, BLOOD, V124, P251, DOI 10.1182/blood-2014-02-558833; Thijssen R, 2021, BLOOD, V137, P2721, DOI 10.1182/blood.2020010167; Trino S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00491; Wang J, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0259-8; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699	58	2	2	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1600	1609		10.1038/s41388-022-02196-y	http://dx.doi.org/10.1038/s41388-022-02196-y		JAN 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35091682	hybrid, Green Published			2022-12-26	WOS:000749073300001
J	Goljan, E; Abouelhoda, M; ElKalioby, MM; Jabaan, A; Alghithi, N; Meyer, BF; Monies, D				Goljan, Ewa; Abouelhoda, Mohammed; ElKalioby, Mohamed M.; Jabaan, Amjad; Alghithi, Nada; Meyer, Brian F.; Monies, Dorota			Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population	PLOS ONE			English	Article							IMPLEMENTATION CONSORTIUM; GENETIC-VARIATION; GUIDELINES; GENOTYPE; ASSOCIATION; REQUIREMENT; GENOMICS; OUTCOMES; DRUG	It is well documented that drug responses are related to Absorption, Distribution, Metabolism, and Excretion (ADME) characteristics of individual patients. Several studies have identified genetic variability in pharmacogenes, that are either directly responsible for or are associated with ADME, giving rise to individualized treatments. Our objective was to provide a comprehensive overview of pharmacogenetic variation in the Saudi population. We mined next generation sequencing (NGS) data from 11,889 unrelated Saudi nationals, to determine the presence and frequencies of known functional SNP variants in 8 clinically relevant pharmacogenes (CYP2C9, CYP2C19, CYP3A5, CYP4F2, VKORC1, DPYD, TPMT and NUDT15), recommended by the Clinical Pharmacogenetics Implementation Consortium (CPIC), and collectively identified 82 such star alleles. Functionally significant pharmacogenetic variants were prevalent especially in CYP genes (excluding CYP3A5), with 10-44.4% of variants predicted to be inactive or to have decreased activity. In CYP3A5, inactive alleles (87.5%) were the most common. Only 1.8%, 0.7% and 0.7% of NUDT15, TPMT and DPYD variants respectively, were predicted to affect gene activity. In contrast, VKORC1 was found functionally, to be highly polymorphic with 53.7% of Saudi individuals harboring variants predicted to result in decreased activity and 31.3% having variants leading to increased metabolic activity. Furthermore, among the 8 pharmacogenes studied, we detected six rare variants with an aggregated frequency of 1.1%, that among several other ethnicities, were uniquely found in Saudi population. Similarly, within our cohort, the 8 pharmacogenes yielded forty-six novel variants predicted to be deleterious. Based upon our findings, 99.2% of individuals from the Saudi population carry at least one actionable pharmacogenetic variant.	[Goljan, Ewa; Meyer, Brian F.; Monies, Dorota] King Faisal Specialist Hosp & Res Ctr, Ctr Genom Med, Clin Genom, Riyadh, Saudi Arabia; [Goljan, Ewa; ElKalioby, Mohamed M.; Jabaan, Amjad; Alghithi, Nada; Meyer, Brian F.; Monies, Dorota] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh, Saudi Arabia; [Abouelhoda, Mohammed; ElKalioby, Mohamed M.] King Faisal Specialist Hosp & Res Ctr, Ctr Genom Med, Computat Biosci, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Abdulaziz City for Science & Technology; King Faisal Specialist Hospital & Research Center	Monies, D (corresponding author), King Faisal Specialist Hosp & Res Ctr, Ctr Genom Med, Clin Genom, Riyadh, Saudi Arabia.; Monies, D (corresponding author), King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh, Saudi Arabia.	DMonies@kfshrc.edu.sa	Jabaan, Amjad/GVR-7466-2022	Jabaan, Amjad/0000-0002-6352-048X; El-Kalioby, Mohamed/0000-0001-7655-4198				Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Abouelhoda M, 2016, GENET MED, V18, P1244, DOI 10.1038/gim.2016.37; Al-Eitan LN, 2020, GENE, V737, DOI 10.1016/j.gene.2020.144408; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Amstutz U, 2018, CLIN PHARMACOL THER, V103, P210, DOI 10.1002/cpt.911; Bielinski SJ, 2014, MAYO CLIN PROC, V89, P25, DOI 10.1016/j.mayocp.2013.10.021; Birdwell KA, 2015, CLIN PHARMACOL THER, V98, P19, DOI 10.1002/cpt.113; Blagec K, 2018, J AM MED INFORM ASSN, V25, P893, DOI 10.1093/jamia/ocy005; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Caudle KE, 2017, GENET MED, V19, P215, DOI 10.1038/gim.2016.87; Chua EW, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00001; Cohn I, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0021-8; Danese E, 2012, CLIN PHARMACOL THER, V92, P746, DOI 10.1038/clpt.2012.184; Del Re M, 2016, PHARMACOGENOMICS, V17, P5, DOI 10.2217/pgs.15.146; EVANS WE, 1991, J PEDIATR-US, V119, P985, DOI 10.1016/S0022-3476(05)83063-X; Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172; Hoff PM, 2001, J CLIN ONCOL, V19, P2282, DOI 10.1200/JCO.2001.19.8.2282; Howe KL, 2021, NUCLEIC ACIDS RES, V49, pD884, DOI 10.1093/nar/gkaa942; Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3; Ji Y, 2016, J MOL DIAGN, V18, P438, DOI 10.1016/j.jmoldx.2016.01.003; Johnson JA, 2017, CLIN PHARMACOL THER, V102, P397, DOI 10.1002/cpt.668; Johnson JA, 2012, CLIN PHARMACOL THER, V92, P437, DOI 10.1038/clpt.2012.125; Johnson J A, 2001, Am J Pharmacogenomics, V1, P271, DOI 10.2165/00129785-200101040-00004; Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Relling MV, 2019, CLIN PHARMACOL THER, V105, P1095, DOI 10.1002/cpt.1304; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schildcrout JS, 2012, CLIN PHARMACOL THER, V92, P235, DOI 10.1038/clpt.2012.66; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Shehab N, 2010, ARCH INTERN MED, V170, P1926, DOI 10.1001/archinternmed.2010.407; Sivadas A, 2018, PHARMACOGENOMICS J, V18, P590, DOI 10.1038/s41397-018-0022-8; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Van Driest SL, 2014, CLIN PHARMACOL THER, V95, P423, DOI 10.1038/clpt.2013.229; Wright GEB, 2018, PHARMACOGENOMICS J, V18, P187, DOI 10.1038/tpj.2016.77; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Zhang JE, 2009, PHARMACOGENET GENOM, V19, P781, DOI 10.1097/FPC.0b013e3283311347; Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690; Zhou YT, 2019, PHARMACOGENOMICS J, V19, P115, DOI 10.1038/s41397-018-0044-2; Zhou YT, 2018, J MED GENET, V55, P617, DOI 10.1136/jmedgenet-2018-105429	45	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263137	10.1371/journal.pone.0263137	http://dx.doi.org/10.1371/journal.pone.0263137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089958	Green Published, gold			2022-12-26	WOS:000769158400040
J	Moon, S; Zhao, YT				Moon, Sohyun; Zhao, Ying-Tao			Recursive splicing is a rare event in the mouse brain	PLOS ONE			English	Article							ANK3; TRANSCRIPTION; ASSOCIATION; GENERATION; MUTATIONS; INTRON	Recursive splicing (RS) is a splicing mechanism to remove long introns from messenger RNA precursors of long genes. Compared to the hundreds of RS events identified in humans and drosophila, only ten RS events have been reported in mice. To further investigate RS in mice, we analyzed RS in the mouse brain, a tissue that is enriched in the expression of long genes. We found that nuclear total RNA sequencing is an efficient approach to investigate RS events. We analyzed 1.15 billion uniquely mapped reads from the nuclear total RNA sequencing data in the mouse cerebral cortex. Unexpectedly, we only identified 20 RS sites, suggesting that RS is a rare event in the mouse brain. We also identified that RS is constitutive between excitatory and inhibitory neurons and between sexes in the mouse cerebral cortex. In addition, we found that the primary sequence context is associated with RS splicing intermediates and distinguishes RS AGGT site from non-RS AGGT sites, indicating the importance of the primary sequence context in RS sites. Moreover, we discovered that cryptic exons may use an RS-like mechanism for splicing. Overall, we provide novel findings about RS in long genes in the mouse brain.	[Moon, Sohyun; Zhao, Ying-Tao] New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY USA	New York Institute Technology	Zhao, YT (corresponding author), New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY USA.	yzhao47@nyit.edu		Zhao, Yingtao/0000-0003-3748-8428				Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Amid C, 2020, NUCLEIC ACIDS RES, V48, pD70, DOI 10.1093/nar/gkz1063; Blazquez L, 2018, MOL CELL, V72, P496, DOI 10.1016/j.molcel.2018.09.033; Brevik EJ, 2016, AM J MED GENET B, V171, P733, DOI 10.1002/ajmg.b.32434; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gurney ME, 2019, J MED CHEM, V62, P4884, DOI 10.1021/acs.jmedchem.9b00193; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Hayashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02866-0; Iqbal Z, 2013, HUM MOL GENET, V22, P1960, DOI 10.1093/hmg/ddt043; Johnson BS, 2017, NAT MED, V23, P1203, DOI 10.1038/nm.4406; Joseph B, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009563; Joseph B, 2018, NAT STRUCT MOL BIOL, V25, P365, DOI 10.1038/s41594-018-0052-6; Kelly S, 2015, NUCLEIC ACIDS RES, V43, P4721, DOI 10.1093/nar/gkv386; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maruani A, 2015, AM J MED GENET A, V167, P3019, DOI 10.1002/ajmg.a.37345; Moon S., 2021, GLYCOBIOLOGY; Pai AA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007588; Pan TT, 2019, BIOORG MED CHEM LETT, V29, P2150, DOI 10.1016/j.bmcl.2019.06.056; Pervouchine DD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6903; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy M, 2008, RNA, V14, P2261, DOI 10.1261/rna.1024908; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; Sibley CR, 2015, NATURE, V521, P371, DOI 10.1038/nature14466; Sinha V, 2021, MOL PSYCHIATR, V26, P816, DOI 10.1038/s41380-019-0429-x; Wan YH, 2021, CELL, V184, P2878, DOI 10.1016/j.cell.2021.04.012; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang XO, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007579; Zhao YT, 2018, GENOME RES, V28, P933, DOI 10.1101/gr.233775.117; Zhao Ying-Tao, 2016, Front Biol (Beijing), V11, P311, DOI 10.1007/s11515-016-1411-5	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263082	10.1371/journal.pone.0263082	http://dx.doi.org/10.1371/journal.pone.0263082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089962	gold, Green Published			2022-12-26	WOS:000769158400038
J	de Miranda, JT; Bringel, FD; Velosa, APP; Protocevich, V; Fernezlian, SD; Silva, PL; Capelozzi, VL; Mathor, MB; Teodoro, WR				de Miranda, Jurandir Tomaz; Bringel, Fabiana de Andrade; Velosa, Ana Paula Pereira; Protocevich, Veronica; Fernezlian, Sandra de Morais; Silva, Pedro Leme; Capelozzi, Vera Luiza; Mathor, Monica Beatriz; Teodoro, Walcy Rosolia			Sterilized human skin graft with a dose of 25 kGy provides a privileged immune and collagen microenvironment in the adhesion of Nude mice wounds	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASES; B-CELLS; ALLOGRAFT; TRANSPLANTATION	This study aimed to report the effects of different doses of ionizing radiation on inflammatory and repair stage of human skin graft adherence in Nude mice wounds. Animals were divided into transplanted with irradiated human skin grafts (IHSG) at 25 and 50 kGy (IHSG 25 kGy; IHSG 50 kGy) and non-IHSG and euthanized on the 3rd, 7th and 21st days after the surgery, by gross and microscopic changes, immunostaining for human type I collagen (Col I) and mouse Col I and Col III and inflammatory cells. We found an effectiveness of human split-thickness graft adherence in mice transplanted with IHSG 25 kGy, as well decrease in dermo-epidermal necrosis and neutrophils, lower loss of skin thickness, epithelization and neo-vascularization. Day 21 post-transplantation with IHSG 25 kGy was observed a well-preserved human skin in the border of the graft, a prominent granulation tissue in an organization by proliferated fibroblasts, Col III deposition and increased B-cells and macrophages. A complete adherence of human skin graft occurred with IHSG 25 kGy. We suggest that the ionizing radiation at 25 kGy mediates inflammation and the repair stage of human skin graft adherence in murine model, thus emerging as a potential tool in healing cutaneous wounds.	[de Miranda, Jurandir Tomaz; Velosa, Ana Paula Pereira; Protocevich, Veronica; Teodoro, Walcy Rosolia] Univ Sao Paulo, FMUSP, Rheumatol Div, Hosp Clin,Fac Med, Sao Paulo, SP, Brazil; [Bringel, Fabiana de Andrade; Mathor, Monica Beatriz] IPEN CNEN SP, Ctr Radiat Technol CTR Inst Energy & Nucl Res, Sao Paulo, Brazil; [Fernezlian, Sandra de Morais; Capelozzi, Vera Luiza] HCFMUSP, Dept Pathol, Hosp Clin, Sao Paulo, Brazil; [Silva, Pedro Leme] Univ Fed Rio de Janeiro, Hlth Sci Ctr, Inst Biophys Carlos Chagas Filho, Lab Pulm Invest, Rio De Janeiro, Brazil; [Silva, Pedro Leme] Natl Inst Sci & Technol Regenerat Med, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Teodoro, WR (corresponding author), Univ Sao Paulo, FMUSP, Rheumatol Div, Hosp Clin,Fac Med, Sao Paulo, SP, Brazil.	walcy.teodoro@fm.usp.br	Teodoro, Walcy/H-5133-2017; Silva, Pedro Leme/AAD-8236-2019	Teodoro, Walcy/0000-0001-7559-4542; Silva, Pedro Leme/0000-0001-5838-4949; Pereira Velosa, Ana Paula/0000-0002-6465-0796	National Nuclear Energy Commission (CNEN, BMT), Sao Paulo; Sao Paulo State Research Support Foundation (FAPESP) [483005/2012-6]	National Nuclear Energy Commission (CNEN, BMT), Sao Paulo; Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	National Nuclear Energy Commission (CNEN, BMT), Sao Paulo https://www.gov.br/cnen/pt-br Sao Paulo State Research Support Foundation (FAPESP; 2018/20403-6) https://fapesp.br/National Council for Scientific and Technological Development (CNPq; 483005/2012-6). https://www.gov.br/cnpq/pt-br The funding agencies of this study did not participate in the design, collection and analysis of data, nor in the decisions of publications or preparation of the manuscript. The financing agencies, assisted only with material expenses and with laboratory supplies and services.	Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Baltzis D, 2014, ADV THER, V31, P817, DOI 10.1007/s12325-014-0140-x; Bourroul SC, 2002, CELL MOL BIOL, V48, P803; Chaganti P, 2019, AM J EMERG MED, V37, P1184, DOI 10.1016/j.ajem.2019.04.014; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; Finnerty CC, 2016, LANCET, V388, P1427, DOI 10.1016/S0140-6736(16)31406-4; Franchini M, 2009, BLOOD TRANSFUS-ITALY, V7, P100, DOI 10.2450/2008.0014-08; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Guillon C, 2021, BMJ OPEN DIAB RES CA, V9, DOI 10.1136/bmjdrc-2020-002091; Herson MR, 2007, BURNS, V33, pS150, DOI [10.1007/s10561-018-9694-1, DOI 10.1007/S10561-018-9694-1]; Kellar Robert S, 2020, J Diabetes Clin Res, V2, P86, DOI 10.33696/diabetes.1.024; Krejner A, 2016, CHRONIC WOUND CARE M, V3, P29, DOI 10.2147/CWCMR.S73819; Langier S, 2012, BRAZ J MED BIOL RES, V45, P942, DOI 10.1590/S0100-879X2012007500089; Leon-Villapalos J, 2010, CELL TISSUE BANK, V11, P99, DOI 10.1007/s10561-009-9152-1; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Mahdavi-Mazdeh M, 2013, INT J TRANSPLANT MED, V4, P96; McQuestion Maurene, 2011, Semin Oncol Nurs, V27, pe1, DOI 10.1016/j.soncn.2011.02.009; Mohd Yussof SJ., 2011, ISRN MAT SCI, V2011, P1, DOI [10.5402/2011/857483, DOI 10.5402/2011/857483]; Mrazova H, 2014, CELL TISSUE BANK, V15, P429, DOI 10.1007/s10561-013-9407-8; Nita M, 2020, TRANSPL P, V52, P2204, DOI 10.1016/j.transproceed.2020.02.115; Obeng MK, 2001, BURNS, V27, P267, DOI 10.1016/S0305-4179(00)00116-9; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Robb EC, 2001, J BURN CARE REHABIL, V22, P393, DOI 10.1097/00004630-200111000-00008; Rooney P, 2008, BURNS, V34, P664, DOI 10.1016/j.burns.2007.08.021; Shi CY, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00182; Singh R, 2016, WORLD J RADIOL, V8, P355, DOI 10.4329/wjr.v8.i4.355; Souto EB, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020393; Tardaguila-Garcia A, 2019, WOUND REPAIR REGEN, V27, P415, DOI 10.1111/wrr.12717; Tugcu H, 2015, ULUS TRAVMA ACIL CER, V21, P491, DOI 10.5505/tjtes.2015.36604; Tzaphlidou M, 1997, INT J RADIAT BIOL, V71, P109, DOI 10.1080/095530097144481; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262532	10.1371/journal.pone.0262532	http://dx.doi.org/10.1371/journal.pone.0262532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085314	Green Published, gold			2022-12-26	WOS:000779379600061
J	Kebede, T; Taddese, Z; Girma, A				Kebede, Taye; Taddese, Zaid; Girma, Abiot			Knowledge, attitude and practices of lifestyle modification and associated factors among hypertensive patients on-treatment follow up at Yekatit 12 General Hospital in the largest city of East Africa: A prospective cross-sectional study	PLOS ONE			English	Article							PREVALENCE; SOCIETY; DISEASE	Background Hypertension is a devastating global public health challenge; studies indicated that Ethiopia has been affected by the burden of hypertension especially in urban areas. The overall prevalence of hypertension in Ethiopia was estimated to be 19.6% (23.5% in urban and 14.7% in rural population). Along with medical management of hypertension, appropriate lifestyle modification is a crucial and inexpensive means of hypertension control. The main purpose of the study was therefore to assess knowledge, attitude and practice of lifestyle modification among patients on follow up for hypertension treatment at Yekatit 12 General Hospital. Methods A prospective cross-sectional study design was applied in Yekatit 12 General Hospital from October 28, 2018, to February 28, 2019, by allotting proportionate samples from the two chronic outpatients departments (OPD). Using single proportion sampling techniques, the study participants were selected and the total sample size calculated was 405. Primarily, clinical measurements were made according to the international standard set to verify true hypertensive patient's inclusions. Then, data about socio-demographic characteristics, lifestyle modification related to knowledge, attitude and practices were comprehensively collected using an interviewer-administered structured questionnaire. The collected data was entered into Epi-data exported to SPSS Window version of 22 for analysis. All variables with rho-value less than 0.05 in the final model were considered as independently associated with knowledge, attitude and practices of patients' lifestyle modification. The strength of association was described by Odds Ratio (OR) at the corresponding CI of 95%. Results The overall sampled hypertensive patients as compared to the planned sample size was 95.5% (n = 387), out of which 53.5% (n = 207) was male patients. The mean age was 50 years with a standard deviation of 14.4. The study revealed that 67.7% [95% CI (65.32%, 70.08%)] were knowledgeable; and 54.0% [95% CI (51.34%, 56.6%)] were reported to have favorable attitude towards lifestyle modification. Regarding their practices, 38% [95% CI (19.91%, 57.49%] of the respondents had good practices. Their monthly income [AOR = 2.39, 95% CI (1.12, 5.11)] and duration on-treatment follow up since diagnosed with hypertension [AOR = 4.39, 95% CI (1.20, 16.03)] were independently associated with knowledge. Concerning their damned practices, age [AOR = 7.71, 95% CI (2.4, 24.8)] and knowledge [AOR = 3.94, 95% CI (2.01, 7.72)] were independently associated with the practices. Conclusion Though the encouraging high knowledge status and favourable attitudes towards lifestyle modification among hypertensive patients, the practices are among the lowest findings report in all standards. Hence, older patients, jobless patients, and low-income patients and patients on long-term treatment follow up who were diagnosed with hypertension before 10 years needs special attention and interventions by the country NCDs policy formulators to rise their non-pharmacological practices to control high blood pressure and its consequences.	[Kebede, Taye] Madda Walabu Univ, Nat Sci Coll, Dept Biomed Sci & Immunol, Bale Robe, Ethiopia; [Taddese, Zaid] ICAP Ethiopia Int Ctr AIDS Care & Treatment Progr, Nongovt & Dev Org Home Based Ethiopia, Addis Ababa, Ethiopia; [Girma, Abiot] Jimma Univ, Coll Hlth Sci & Med, Dept Publ Hlth, Jimma, Ethiopia	Jimma University	Kebede, T (corresponding author), Madda Walabu Univ, Nat Sci Coll, Dept Biomed Sci & Immunol, Bale Robe, Ethiopia.	tayekebede2012@gmail.com		Kebede, Taye/0000-0001-8611-4946				Abdulsalam S, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/842028; Akbarpour S., 2018, SCI REP-UK, V8, P1; Amini M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10429-0; Asemu MM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248934; Bashaar M., 2019, ATTITUDES PRACTICES, V7, P106, DOI [10.15406/ppij.2019.07.00239,3, DOI 10.15406/PPIJ.2019.07.00239,3, 10.15406/ppij.2019.07.00239, DOI 10.15406/PPIJ.2019.07.00239]; Bell K., 2015, HYPERTENSION SILENT; Bente Mikkelsen., 2020, HEARTS, VFirst; Bogale S, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120953291; Bundy JD, 2016, ANN GLOB HEALTH, V82, P227, DOI 10.1016/j.aogh.2016.02.002; Carey RM, 2018, J AM COLL CARDIOL, V72, P1278, DOI 10.1016/j.jacc.2018.07.008; Cashin K., 2018, 360 FANTA FHI; Castro I, 2015, CURR HYPERTENS REV, V11, P91, DOI 10.2174/1573402111666150429170302; Chimberengwa PT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215500; de Vijver SV, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.38.3100; Durai V, 2015, INDAN J COMMUNITY HE, V27, P143; Flack JM, 2020, TRENDS CARDIOVAS MED, V30, P160, DOI 10.1016/j.tcm.2019.05.003; Gaye B, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017458; Gebre NuhaminTekle., 2018, EPIDEMIOLOGY, V8; Ghaddar F, 2021, INT J HYPERTENS, V2021, DOI 10.1155/2021/8858194; Guda Tadesse., 2015, AAU REPOSITORY; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Ha Sung Kyu, 2014, Electrolyte Blood Press, V12, P7, DOI 10.5049/EBP.2014.12.1.7; Hadiza S., 2017, J MED RES, V3, P74, DOI [10.31254/jmr.2017.3210, DOI 10.31254/JMR.2017.3210]; Hagins M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/649836; Hammer JH, 2018, GLOB STAT REP ALC HL; Isiozor NM, 2019, ANN MED, V51, P306, DOI 10.1080/07853890.2019.1639808; Jafari Fahimeh, 2016, Int J Community Based Nurs Midwifery, V4, P286; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Landi F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191820; Landi F, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.10.007; Legese N, 2020, INTEGR BLOOD PRESS C, V13, P135, DOI 10.2147/IBPC.S276089; Mahmood S, 2019, IRISH J MED SCI, V188, P437, DOI 10.1007/s11845-018-1889-8; Meresa A., 2017, CLIN EXP PHARM INTER, V7, P1, DOI [DOI 10.4172/2161-1459.1000228, 10.4172/2161-1459.1000228]; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1; Amoah EM, 2020, INT J HYPERTENS, V2020, DOI 10.1155/2020/9379128; Nawi AM, 2021, INT J HYPERTENS, V2021, DOI 10.1155/2021/6657003; Mounica B, 2015, ASIAN J PHARM CLIN R, P74; Okwuonu C. G., 2014, International Journal of Medicine and Biomedical Research, V3, P121; Oliveira GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086278; Onwukwe SC, 2012, S AFR FAM PRACT, V54, P156, DOI 10.1080/20786204.2012.10874196; Oparil Suzanne., 2019, NAT REV DIS PRIM, V4, P1; Osafo C, 2011, RENAL FAILURE, V33, P388, DOI 10.3109/0886022X.2011.565140; Osuala E. O., 2014, Journal of Public Health and Epidemiology, V6, P48; Parmar P., 2014, INT J CURR MICROBIOL, V3, P680; Ryan RM, 2011, COUNS PSYCHOL, V39, P193, DOI 10.1177/0011000009359313; Schneider DA, 2019, ENDOCR PRACT, V25, P1184, DOI 10.4158/EP-2019-0144; Silveira LCJ., 2019, TRIALS, V20, P1; Soubeiga JK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3926-8; Stergiou GS, 2018, HYPERTENSION, V71, P368, DOI 10.1161/HYPERTENSIONAHA.117.10237; Sun ZQ, 2010, ANN FAM MED, V8, P19, DOI 10.1370/afm.1018; Tesema S., 2016, PRIM HEALTHC OPEN AC, P1, DOI [10.4172/2167-1079.1000218,06(01), DOI 10.4172/2167-1079.1000218,06(01), 10.4172/2167-1079.1000218, DOI 10.4172/2167-1079.1000218]; Tibebu A, 2017, INT J HEALTH SCI-IJH, V11; Twum-Asante M, 2015, AM J HYPERTENS RES, V3, P1; Unger T, 2020, HYPERTENSION, V75, P1334, DOI 10.1161/HYPERTENSIONAHA.120.15026; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; World Health Organization (WHO), 2016, REP STAT MAJ HLTH RI; Zungu L.I., 2013, AFRICAN J PHYS HEAL, P1	61	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262780	10.1371/journal.pone.0262780	http://dx.doi.org/10.1371/journal.pone.0262780			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085323	gold, Green Published			2022-12-26	WOS:000779379600082
J	Lin, YF; Shen, XM; Ke, YZ; Lan, C; Chen, XY; Liang, B; Zhang, YZ; Yan, SJ				Lin, Youfen; Shen, Ximei; Ke, Yuzhen; Lan, Chao; Chen, Xiaoyuan; Liang, Bo; Zhang, Yongze; Yan, Sunjie			Activation of osteoblast ferroptosis via the METTL3/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss	FASEB JOURNAL			English	Article						diabetes mellitus; ferroptosis; glycolipid toxicity; m(6)A modifications; osteoporosis	IRON; MICROSTRUCTURE; OSTEOPOROSIS; APOPTOSIS; MELLITUS; RECEPTOR; OBESITY; STRESS; METTL3; MODEL	Diabetes mellitus (DM) and osteoporosis are two common diseases that may develop as a cause-and-effect relationship since the incidence of osteoporotic fractures is significantly increased in DM patients. However, the pathophysiology of diabetic osteoporosis is yet to be clearly understood. Iron overload has been reported to lead to bone loss and closely related to osteoporosis. In this study, we hypothesized that high glucose and high fat (HGHF) may induce osteoblastic ferroptosis for the pathogenesis of diabetic osteoporosis and explored the possible molecular mechanisms behind. Using the diabetic rat model established by HGHF feeding with a subsequent intraperitoneal injection of a single low dose of streptozocin, we found that the serum ferritin level (a biomarker for body iron store) was significantly elevated in HGHF-fed rats and the expression of SLC7A11 and GPX4 (inhibitory marker proteins for ferroptosis) was markedly attenuated in the bone tissue of the rats with diabetic bone loss as compared to the normal rats. In an osteoblast cell model, treatment of pre-osteoblastic MC3T3-E1 cells with high glucose and palmitic acid (HGPA) not only suppressed osteoblast differentiation and mineralization but also triggered ferroptosis-related osteoblastic cell death. m(6)A-seq revealed that m(6)A methylation on ASK1 was 80.9-fold higher in HGPA-treated cells. The expression of p-ASK1 and p-p38 was also significantly elevated in the HGPA-treated cells. Knockout of METTL3 (methyltransferase-like 3), one of the major m(6)A methyltransferases, in MC3T3-E1 cells not only abrogated HGPA-induced activation of ASK1-p38 signaling pathway but also attenuated the level of ferroptosis. Therefore, HGHF-induced ferroptosis in osteoblasts may be the main cause of osteoporosis in DM via activation of METTL3/ASK1-p38 signaling pathway, and inhibition of ferroptosis in osteoblasts may provide a potential therapeutic strategy for diabetic osteoporosis.	[Lin, Youfen; Shen, Ximei; Ke, Yuzhen; Lan, Chao; Chen, Xiaoyuan; Liang, Bo; Zhang, Yongze; Yan, Sunjie] Fujian Med Univ, Dept Endocrinol, Affiliated Hosp 1, 20 Cha Zhong Rd, Fuzhou 350005, Fujian, Peoples R China; [Shen, Ximei; Yan, Sunjie] Fujian Med Univ, Clin Res Ctr Metab Dis Fujian Prov, Affiliated Hosp 1, Fuzhou, Peoples R China; [Shen, Ximei; Yan, Sunjie] Fujian Med Univ, Diabet Res Inst Fujian Prov, Affiliated Hosp 1, Fuzhou, Peoples R China; [Shen, Ximei; Yan, Sunjie] Fujian Med Univ, Metab Dis Res Inst, Affiliated Hosp 1, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Yan, SJ (corresponding author), Fujian Med Univ, Dept Endocrinol, Affiliated Hosp 1, 20 Cha Zhong Rd, Fuzhou 350005, Fujian, Peoples R China.	fjyansunjie@163.com	Chen, Xiao/GQA-8928-2022	Chen, Xiao/0000-0002-9797-8384	Fujian Province Finance Project [2019B033]; Nature Science Foundation of Fujian Province [2020J02052]; Joint Funds for the Innovation of Science and Technology, Fujian Province [2019Y9110]; Startup Fund for Scientific Research of Fujian Medical University [2019QH2036]	Fujian Province Finance Project; Nature Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Joint Funds for the Innovation of Science and Technology, Fujian Province; Startup Fund for Scientific Research of Fujian Medical University	Fujian Province Finance Project, Grant/Award Number: 2019B033; Nature Science Foundation of Fujian Province, Grant/Award Number: 2020J02052; Joint Funds for the Innovation of Science and Technology, Fujian Province, Grant/Award Number: 2019Y9110; Startup Fund for Scientific Research of Fujian Medical University, Grant/Award Number: 2019QH2036	Al Saedi A, 2020, J GERONTOL A-BIOL, V75, P58, DOI 10.1093/gerona/glz149; Allen CS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001347.pub2; Altamura S, 2017, J MOL MED, V95, P1387, DOI 10.1007/s00109-017-1596-3; Asadipooya K, 2019, J ENDOCR SOC, V3, P1799, DOI 10.1210/js.2019-00160; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canecki-Varzic S, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0094-x; Che JM, 2020, BIOL TRACE ELEM RES, V195, P353, DOI 10.1007/s12011-019-01867-4; Chen HL, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010432, 10.1097/md.0000000000010432]; Chen XJ, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00911; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Darjani Abbas, 2017, Acta Med Iran, V55, P375; DeGregorio-Rocasolano N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00085; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; Hattori K, 2018, CELL CYCLE, V17, P5, DOI 10.1080/15384101.2017.1397330; Hattori K, 2017, EMBO REP, V18, P2067, DOI 10.15252/embr.201744228; Hu YB, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10358; Huang LL, 2019, J CELL MOL MED, V23, P4153, DOI 10.1111/jcmm.14302; Kechin A, 2017, J COMPUT BIOL, V24, P1138, DOI 10.1089/cmb.2017.0096; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kolluru GK, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/918267; Lei PX, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00139; Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759; Li GF, 2012, BIOCHEM BIOPH RES CO, V423, P684, DOI 10.1016/j.bbrc.2012.06.015; Li YQ, 2018, BIOMETALS, V31, P749, DOI 10.1007/s10534-018-0133-3; Liang B, 2021, INT IMMUNOPHARMACOL, V97, DOI 10.1016/j.intimp.2021.107792; Liang C, 2019, ADV MATER, V31, DOI 10.1002/adma.201904197; Liang YW, 2020, J CHIN MED ASSOC, V83, P221, DOI 10.1097/JCMA.0000000000000251; Liu F, 2017, INT J MED SCI, V14, P275, DOI 10.7150/ijms.17860; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Mohsin S, 2019, EXPERT OPIN BIOL TH, V19, P937, DOI 10.1080/14712598.2019.1618266; Mou YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0720-y; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Saito M, 2006, OSTEOPOROSIS INT, V17, P986, DOI 10.1007/s00198-006-0087-0; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sealand R, 2013, CURR DIABETES REP, V13, P411, DOI 10.1007/s11892-013-0376-x; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang XD, 2022, BIOL TRACE ELEM RES, V200, P298, DOI 10.1007/s12011-021-02627-z; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Yao WF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2686-7; Yu JJ, 2020, MOL CELL BIOCHEM, V463, P203, DOI 10.1007/s11010-019-03641-5; Zhang HY, 2021, J HAZARD MATER, V411, DOI 10.1016/j.jhazmat.2021.125179; Zhang WL, 2015, INT J MED SCI, V12, P441, DOI 10.7150/ijms.11986; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhou RP, 2020, THERANOSTICS, V10, P11976, DOI 10.7150/thno.50663	56	14	14	21	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22147	10.1096/fj.202101610R	http://dx.doi.org/10.1096/fj.202101610R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35104016				2022-12-26	WOS:000761250800023
J	Tsutsumi, R; Chaya, T; Tsujii, T; Furukawa, T				Tsutsumi, Ryotaro; Chaya, Taro; Tsujii, Toshinori; Furukawa, Takahisa			The carboxyl-terminal region of SDCCAG8 comprises a functional module essential for cilia formation as well as organ development and homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL-CELL KINASE; NEURONAL MIGRATION; VESICLE DOCKING; PRC1 COMPONENT; GENE; PROTEIN; MAK; ICK; NEPHRONOPHTHISIS; MUTATION	In humans, ciliary dysfunction causes ciliopathies, which present as multiple organ defects, including developmental and sensory abnormalities. Sdccag8 is a centrosomal/basal body protein essential for proper cilia formation. Gene mutations in SDCCAG8 have been found in patients with ciliopathies manifesting a broad spectrum of symptoms, including hypogonadism. Among these mutations, several that are predicted to truncate the SDCCAG8 carboxyl (C) terminus are also associated with such symptoms; however, the underlying mechanisms are poorly understood. In the present study, we identified the Sdccag8 C-terminal region (Sdccag8-C) as a module that interacts with the ciliopathy proteins, Ick/Cilk1 and Mak, which were shown to be essential for the regulation of ciliary protein trafficking and cilia length in mammals in our previous studies. We found that Sdccag8-C is essential for Sdccag8 localization to centrosomes and cilia formation in cultured cells. We then generated a mouse mutant in which Sdccag8-C was truncated (Sdccag8(Delta C/Delta C) mice) using a CRISPR-mediated stop codon knock-in strategy. In Sdccag8(Delta C/Delta C) mice, we observed abnormalities in cilia formation and ciliopathy-like organ phenotypes, including cleft palate, polydactyly, retinal degeneration, and cystic kidney, which partially overlapped with those previously observed in Ick- and Mak-deficient mice. Furthermore, Sdccag8(Delta C/Delta C) mice exhibited a defect in spermatogenesis, which was a previously uncharacterized phenotype of Sdccag8 dysfunction. Together, these results shed light on the molecular and pathological mechanisms underlying ciliopathies observed in patients with SDCCAG8 mutations and may advance our understanding of protein-protein interaction networks involved in cilia development.	[Tsutsumi, Ryotaro; Chaya, Taro; Tsujii, Toshinori; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka, Japan	Osaka University	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science [20J12966]; Takeda Science Foundation; Uehara Memorial Foundation; Cell Science Research Foundation; Suzuken Memorial Foundation;  [21H02657];  [20K07326]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Suzuken Memorial Foundation; ; 	We thank M. Kadowaki, A. Tani, T. Kon, M. Wakabayashi, S. Gion, T. Nakayama, M. Nakamura, K. Yoshida, and M. Nishi for technical assistance. This work was supported by Grant-in-Aid for Scientific Research (B) (21H02657), (C) (20K07326), and JSPS Fellows (20J12966) from the Japan Society for the Promotion of Science, The Takeda Science Foundation, The Uehara Memorial Foundation, The Cell Science Research Foundation, and Suzuken Memorial Foundation.	Airik R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156081; Airik R, 2014, J AM SOC NEPHROL, V25, P2573, DOI 10.1681/ASN.2013050565; Bahmanpour Z, 2021, INT OPHTHALMOL, V41, P389, DOI 10.1007/s10792-020-01588-x; Bailey JN, 2018, NEW ENGL J MED, V378, P1018, DOI 10.1056/NEJMoa1700175; Billingsley G, 2012, OPHTHALMIC GENET, V33, P150, DOI 10.3109/13816810.2012.689411; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chaya T, 2021, J BIOCHEM, V169, P633, DOI 10.1093/jb/mvab024; Chaya T, 2019, EMBO J, V38, DOI 10.15252/embj.2018101409; Chaya T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05543-2; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Flynn M, 2020, HUM MOL GENET, V29, P407, DOI 10.1093/hmg/ddz292; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Insolera R, 2014, NEURON, V83, P805, DOI 10.1016/j.neuron.2014.06.029; Irie S, 2015, MOL CELL BIOL, V35, P2583, DOI 10.1128/MCB.00048-15; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kamio T, 2010, BIOSCI BIOTECH BIOCH, V74, P1466, DOI 10.1271/bbb.100044; Kenedy AA, 2003, GENE, V303, P35, DOI 10.1016/S0378-1119(02)01141-1; Kozuka T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38910-2; Kubo S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83781-1; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Lovera M, 2021, TRENDS CELL BIOL, V31, P876, DOI 10.1016/j.tcb.2021.06.001; Luo FL, 2018, NEPHROLOGY, V23, P904, DOI 10.1111/nep.13393; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Maurya AK, 2019, CURR BIOL, V29, P1286, DOI 10.1016/j.cub.2019.02.062; McConnachie DJ, 2021, AM J KIDNEY DIS, V77, P410, DOI 10.1053/j.ajkd.2020.08.012; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okamoto S, 2017, J NEUROSCI, V37, P2073, DOI 10.1523/JNEUROSCI.3067-16.2017; Omori Y, 2017, P NATL ACAD SCI USA, V114, pE8264, DOI 10.1073/pnas.1707021114; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Oud Machteld M, 2016, Cilia, V5, P8, DOI 10.1186/s13630-016-0029-1; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; Sugiyama T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78452-6; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Taylor SP, 2016, HUM MOL GENET, V25, P3998, DOI 10.1093/hmg/ddw240; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Tsutsumi R, 2018, GENE EXPR PATTERNS, V29, P18, DOI 10.1016/j.gep.2018.04.005; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Ueno A, 2018, CELL REP, V22, P3548, DOI 10.1016/j.celrep.2018.03.007; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054146; Watanabe Y, 2019, TOHOKU J EXP MED, V249, P29, DOI 10.1620/tjem.249.29; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Yamamura T, 2017, CLIN EXP NEPHROL, V21, P136, DOI 10.1007/s10157-016-1256-x; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111	60	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101686	10.1016/j.jbc.2022.101686	http://dx.doi.org/10.1016/j.jbc.2022.101686			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35131266	gold, Green Published			2022-12-26	WOS:000789400700015
J	Zhang, SH; Wang, RR; Wang, XY; Guo, XL; Du, YY; Guo, X; Zong, XL; Zhu, CH; Zhou, XL				Zhang, Shenghong; Wang, Ranran; Wang, Xinyue; Guo, Xueling; Du, Yanyan; Guo, Xin; Zong, Xinlan; Zhu, Changhui; Zhou, Xiaolei			HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER plus breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; REDOX; IRE1; ENVIRONMENT; PROTECTION; APOPTOSIS; CELLS; UPR; BAX	Endocrine-therapy-resistant estrogen receptor-positive (ER+) breast cancer cells often exhibit an augmented capacity to maintain endoplasmic reticulum (EnR) homeostasis under adverse conditions. Oncoprotein hepatitis B X-interacting protein (HBXIP) is a known transcriptional coactivator that promotes cancer development. However, it is unclear whether HBXIP participates in maintaining EnR homeostasis and promoting drug resistance in ER+ breast cancer. Here, we report that tamoxifen-resistant (TmaR) breast cancer cells exhibit increased expression of HBXIP, which acts as an inactivator of the unfolded protein response (UPR) to diminish tamoxifeninduced EnR stress. We show that HBXIP deficiency promotes EnR-associated degradation, enhances UPR-element reporter activity and cellular oxidative stress, and ultimately attenuates the growth of TmaR cells in vitro and in vivo. Mechanistically, we demonstrate that HBXIP acts as a chaperone of UPR transducer inositol-requiring enzyme 1a and diminishes production of reactive oxygen species (ROS) in TamR breast cancer cells. Upon loss of HBXIP expression, tamoxifen treatment hyperactivates IRE1 alpha and its downstream proapoptotic pathways and simultaneously induces accumulation of intracellular ROS. This elevated ROS programmatically activates the other two branches of the UPR, mediated by PKR-like ER kinase and activating transcription factor 6 alpha. Clinical investigations and Kaplan-Meier plotter analysis revealed that HBXIP is highly expressed in TamR breast cancer tissues. Furthermore, reinforced HBXIP expression is associated with a high recurrence and poor relapse-free survival rates in tamoxifen monotherapy ER+ breast cancer patients. These findings indicate that HBXIP is a regulator of EnR homeostasis and a potential target for TamR breast cancer therapy.	[Zhang, Shenghong; Wang, Ranran; Wang, Xinyue; Guo, Xueling; Zong, Xinlan; Zhu, Changhui; Zhou, Xiaolei] Hebei Univ Sci & Technol, Coll Food Sci & Biol, Shijiazhuang, Peoples R China; [Du, Yanyan] Hebei Med Univ, Hosp 4, Dept Clin Lab, Shijiazhuang, Peoples R China; [Guo, Xin] Kanazawa Med Univ, Dept Pathol, Uchinada, Ishikawa, Japan; [Guo, Xin] Kanazawa Med Univ Hosp, Dept Pathol, Uchinada, Ishikawa, Japan; [Guo, Xin] Kanazawa Med Univ, Lab Med, Uchinada, Ishikawa, Japan	Hebei University of Science & Technology; Hebei Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University	Zhou, XL (corresponding author), Hebei Univ Sci & Technol, Coll Food Sci & Biol, Shijiazhuang, Peoples R China.	foxlei@live.cn			Na-tional Natural Scientific Foundation [81602428]; Natural Sci-ence Foundation of Hebei Province of China [H2019208221, H2020208018]; Colleges and Universities in Hebei Province Science and Technology Research Project [QN2019169]	Na-tional Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Natural Sci-ence Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Colleges and Universities in Hebei Province Science and Technology Research Project	The authors thank professor Lihong Ye and Weiying Zhang for excellent technical support and contribution to experiments. This project was supported by grants from the Na-tional Natural Scientific Foundation (No. 81602428) , Natural Sci-ence Foundation of Hebei Province of China (No. H2019208221 and No. H2020208018) , Colleges and Universities in Hebei Province Science and Technology Research Project (No. QN2019169) .	Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Andersson H, 2010, DRUG METAB DISPOS, V38, P200, DOI 10.1124/dmd.109.029488; Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Cao SL, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.620514; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Clarke Robert, 2011, Horm Mol Biol Clin Investig, V5, P35, DOI 10.1515/HMBCI.2010.073; Delaunay-Moisan A, 2015, FREE RADICAL BIO MED, V83, P341, DOI 10.1016/j.freeradbiomed.2015.02.019; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Fang RP, 2020, ONCOGENE, V39, P2290, DOI 10.1038/s41388-019-1146-2; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; He Y, 2012, DEV CELL, V23, P1141, DOI 10.1016/j.devcel.2012.11.006; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Li YH, 2016, CANCER RES, V76, P293, DOI 10.1158/0008-5472.CAN-14-3607; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu BW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0577-5; Liu YF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14190-2; Luo DH, 2008, J BIOL CHEM, V283, P11905, DOI 10.1074/jbc.M710557200; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Margittai E, 2015, FREE RADICAL BIO MED, V83, P331, DOI 10.1016/j.freeradbiomed.2015.01.032; McCloy RA, 2013, BRIT J CANCER, V109, P3034, DOI 10.1038/bjc.2013.693; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mishra RR, 2018, CLIN CANCER RES, V24, P1987, DOI 10.1158/1078-0432.CCR-17-2776; Nagy A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84787-5; Park JS, 2016, FREE RADICAL RES, V50, P1408, DOI 10.1080/10715762.2016.1253073; Phillips AM, 2018, ELIFE, V7, DOI 10.7554/eLife.38795; Pinkaew D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00029-1; Riaz TA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051160; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salaroglio IC, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0657-0; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Sundaram A, 2017, ELIFE, V6, DOI 10.7554/eLife.27187; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang Y, 2014, CANCER LETT, V352, P169, DOI 10.1016/j.canlet.2014.05.007; Xiu MX, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111045; Yoneda A, 2020, MOL CANCER RES, V18, P847, DOI 10.1158/1541-7786.MCR-19-0673; Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005; Zhao Y, 2016, CANCER RES, V76, P4696, DOI 10.1158/0008-5472.CAN-15-1734; Zhou XL, 2019, ONCOGENE, V38, P4028, DOI 10.1038/s41388-019-0698-5; Zhou XL, 2018, ACTA PHARMACOL SIN, V39, P459, DOI 10.1038/aps.2017.157; Zhu YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03951-0	57	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101644	10.1016/j.jbc.2022.101644	http://dx.doi.org/10.1016/j.jbc.2022.101644			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093383	gold, Green Published			2022-12-26	WOS:000789261900012
J	Bromme, R; Mede, NG; Thomm, E; Kremer, B; Ziegler, R				Bromme, Rainer; Mede, Niels G.; Thomm, Eva; Kremer, Bastian; Ziegler, Ricarda			An anchor in troubled times: Trust in science before and within the COVID-19 pandemic	PLOS ONE			English	Article								Researchers, policy makers and science communicators have become increasingly been interested in factors that affect public's trust in science. Recently, one such potentially important driving factor has emerged, the COVID-19 pandemic. Have trust in science and other science-related beliefs changed in Germany from before to during the pandemic? To investigate this, we re-analyzed data from a set of representative surveys conducted in April, May, and November 2020, which were obtained as part of the German survey Science Barometer, and compared it to data from the last annual Science Barometer survey that took place before the pandemic, (in September 2019). Results indicate that German's trust in science increased substantially after the pandemic began and slightly declined in the months thereafter, still being higher in November 2020 than in September 2019. Moreover, trust was closely related to expectations about how politics should handle the pandemic. We also find that increases of trust were most pronounced among the higher-educated. But as the pandemic unfolded, decreases of trust were more likely among supporters of the populist right-wing party AfD. We discuss the sustainability of these dynamics as well as implications for science communication.	[Bromme, Rainer] Univ Munster, Dept Psychol, Munster, Germany; [Mede, Niels G.] Univ Zurich, Dept Commun & Media Res IKMZ, Zurich, Switzerland; [Thomm, Eva] Univ Erfurt, Fac Educ, Erfurt, Germany; [Kremer, Bastian; Ziegler, Ricarda] Wissensch Dial WiD, Berlin, Germany	University of Munster; University of Zurich; University of Erfurt	Bromme, R (corresponding author), Univ Munster, Dept Psychol, Munster, Germany.	bromme@uni-muenster.de	Mede, Niels G./AAF-2614-2021; Ziegler, Ricarda/GXG-6599-2022; Bromme, Rainer/K-2400-2012	Mede, Niels G./0000-0001-5707-7568; Ziegler, Ricarda/0000-0002-8439-4726; Bromme, Rainer/0000-0002-6123-7269	Robert Bosch Stiftung [00906101-0030]; Fraunhofer-Gesellschaft	Robert Bosch Stiftung; Fraunhofer-Gesellschaft	This paper makes use of the he annual German Science Barometer as well as its Corona Special edition survey which was done by Wissenschaft im Dialog (WiD). The Science Barometer project is funded and supported by the Robert Bosch Stiftung (00906101-0030) and the Fraunhofer-Gesellschaft. The funders of the survey data collection had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	3M, 2020, SOSI 2020 PAND PULS; Algan Y, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2108576118|1of8, 10.1073/pnas.2108576118]; [Anonymous], 2020, LANCET, V396, P799, DOI [10.1016/S0140-6736(20)31958-9, 10.1016/S0140-6736(20)31954-1]; Askvall C., 2021, PCST NOTES; Ballew M, 2020, AM PUBLIC RESPONSES, DOI 10.31234/osf.io/qud5t; Battiston Pietro, 2021, SSM Popul Health, V13, P100721, DOI 10.1016/j.ssmph.2020.100721; Besley JC, 2013, B SCI TECHNOL SOC, V33, P12, DOI [10.1177/0270467613496723, DOI 10.1177/0270467613496723]; Besley JC, 2021, SCI COMMUN, V43, P3, DOI 10.1177/1075547020949547; Betsch C., 2020, PSYCHARCHIVES, DOI [10.23668/psycharchives.2776, DOI 10.23668/PSYCHARCHIVES.2776, 10.23668]; BFR Bundesinstitut fur Risikobewertung, BFR COR MONITOR 2020; Bicchieri C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252892; Bostrom A, 2020, J RISK RES, V23, P902, DOI 10.1080/13669877.2020.1756384; Bromme R., 2020, WISSENSCHAFTSREFLEXI, P105, DOI DOI 10.30965/9783957437372_006; Brown MB, 2008, MINERVA, V46, P485, DOI 10.1007/s11024-008-9106-y; Bucchi M, 2021, PUBLIC UNDERST SCI, V30, P807, DOI 10.1177/09636625211023297; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Daniele G., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3671674, DOI 10.2139/SSRN.3671674]; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dohle S., 2020, PSYCHARCHIVES, V15, P1, DOI [10.32872/spb.4315, DOI 10.32872/SPB.4315, DOI 10.31219/OSF.IO/W52NV]; Edelman Trust, ED TRUST BAR 2020; Edwards B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248892; Eichengreen B, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104343; Eitze S, 2021, BUNDESGESUNDHEITSBLA, V64, P268, DOI 10.1007/s00103-021-03279-z; Evans John, 2020, SOCIUS SOCIOLOGICAL, V6, DOI [10.1177/2378023120947337, DOI 10.1177/2378023120947337]; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Heinzel M, 2021, WEST EUR POLIT, V44, P1258, DOI 10.1080/01402382.2021.1873630; Hendriks F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139309; im Dialog Wissenschaftsbarometer-Wissenschaft, 2017, SCI BAR 2017 BROCH; Jensen EA, 2021, NATURE, V591, P34, DOI 10.1038/d41586-021-00542-w; Johnson BB, 2018, PUBLIC UNDERST SCI, V27, P824, DOI 10.1177/0963662517738408; Kienhues D, 2020, EDUC PSYCHOL-US, V55, P144, DOI 10.1080/00461520.2020.1784012; Koch T, 2021, ADV EXP MED BIOL, V1318, P549, DOI 10.1007/978-3-030-63761-3_31; Kohler S., 2020, EUROPEAN JOURNALISM; Kupferschmidt K., 2020, SCIENCE, DOI [10.1126/science.abc5095, DOI 10.1126/SCIENCE.ABC5095]; Lever J, 2016, NAT METHODS, V13, P703, DOI 10.1038/nmeth.3968; Lewandowsky S, 2021, EUR REV SOC PSYCHOL, V32, P348, DOI 10.1080/10463283.2021.1876983; Lumley T., 2020, SURVEY ANAL COMPLEX; Luna Daniel Silva, 2021, Public Health Pract (Oxf), V2, P100103, DOI 10.1016/j.puhip.2021.100103; Mede NG, 2022, PUBLIC UNDERST SCI, V31, P211, DOI 10.1177/09636625211056871; Mede NG, 2021, PUBLIC UNDERST SCI, V30, P91, DOI 10.1177/0963662520954370; Mede NG, 2020, PUBLIC UNDERST SCI, V29, P473, DOI 10.1177/0963662520924259; Merkley E, 2021, NAT HUM BEHAV, V5, P706, DOI 10.1038/s41562-021-01112-w; Moon WK, 2022, HEALTH COMMUN, V37, DOI 10.1080/10410236.2021.1912948; Pagliaro S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248334; Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988; Post S, 2021, PUBLIC UNDERST SCI, V30, P496, DOI 10.1177/09636625211005334; Reeskens T, 2021, EUR SOC, V23, pS153, DOI 10.1080/14616696.2020.1821075; Reinemann C., 2020, IMPACT INFORM SOURCE, DOI 10.13140/RG.2.2.14563.99360; Rieger M.O., 2020, TRUST GOVT ACTIONS C; Ripley B, BOOT BOOTSTRAP FUNCT; RKI Robert Koch Institute, COR DIS 2019 COVID 1; Rothmund T., 2020, PREPRINT; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Rudert S., 2021, EUROPEAN PSYCHOL INT; Rutjens BT, 2021, GROUP PROCESS INTERG, V24, P276, DOI 10.1177/1368430220981415; Sailer M, 2022, EUR J PSYCHOL EDUC, V37, P279, DOI 10.1007/s10212-021-00529-1; Scharrer L, 2017, PUBLIC UNDERST SCI, V26, P1003, DOI 10.1177/0963662516680311; Scharrer L, 2014, APPL COGNITIVE PSYCH, V28, P465, DOI 10.1002/acp.3018; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169; Sokolovska N, 2019, PUBLICATIONS, V7, DOI 10.3390/publications7040064; Thomm E, 2015, LEARN INDIVID DIFFER, V37, P139, DOI 10.1016/j.lindif.2014.12.001; Travis J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256178; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Vraga EK, 2020, WORLD MED HEALTH POL, V12, P233, DOI 10.1002/wmh3.359; Wellcome Trust, 2020, WELLCOME GLOBAL MONI; WID Wissenschaft im Dialog, 2018, SCI BAR 2018 BROCH; WID Wissenschaft im Dialog, 2019, SCI BAR 2019 BROCH; Wieler L.H., 2021, OUR WORLD DATA; Wierda J, BLOG; WissenschaftsbarometerSchweiz, COVID 19 ED 2021	71	4	4	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262823	10.1371/journal.pone.0262823	http://dx.doi.org/10.1371/journal.pone.0262823			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139103	Green Accepted, gold, Green Published			2022-12-26	WOS:000821499100011
J	Liu, C; Fan, FF; Zhong, L; Su, JS; Zhang, Y; Tu, Y				Liu, Chuan; Fan, Fangfang; Zhong, Lu; Su, Jinsong; Zhang, Yi; Tu, Ya			Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ELLAGIC ACID; INHIBITION; GENE; METABOLISM; EXPRESSION; APOPTOSIS; AUTOPHAGY; PATHWAYS; DOCKING	Ershiwuwei Lvxue Pill (ELP,), a traditional Tibetan medicine preparation, has been used hundreds of years for the clinical treatment of rheumatoid arthritis (RA) in the highland region of Tibet, China. Nevertheless, its chemical composition and therapeutic mechanism are unclear. This study aimed to uncover the potentially effective components of ELP and the pharmacological mechanisms against RA by combing UPLC-Q-TOF/MS and network pharmacology. In this study, 96 compounds of ELP were identified or tentatively characterized based on UPLC-Q-TOF/MS analysis. Then, a total of 22 potential bioactive compounds were screened by TCMSP with oral bioavailability and drug-likeness. Preliminarily, 10 crucial targets may be associated with RA through protein-protein interaction network analysis. The functional enrichment analysis indicated that ELP exerted anti-RA effects probably by synergistically regulating many biological pathways, such as PI3K-Akt, Cytokine-cytokine receptor interaction, JAK-STAT, MAPK, TNF, and Toll-like receptor signaling pathway. In addition, good molecular docking scores were highlighted between five promising bioactive compounds (ellagic acid, quercetin, kaempferol, galangin, coptisine) and five core targets (PTGS2, STAT3, VEGFA, MAPK3, TNF). Overall, ELP can exert its anti-RA activity via multicomponent, multitarget, and multichannel mechanisms of action. However, further studies are needed to validate the biological processes and effect pathways of ELP.	[Liu, Chuan] Xihua Univ, Sch Food & Bioengn, Chengdu, Peoples R China; [Fan, Fangfang; Zhong, Lu; Su, Jinsong; Zhang, Yi] Chengdu Univ Tradit Chinese Med, Ethn Med Acad Heritage Innovat Res Ctr, Chengdu, Peoples R China; [Tu, Ya] China Acad Tradit Chinese Med, Dev Res Ctr Tradit Chinese Med, Beijing, Peoples R China	Xihua University; Chengdu University of Traditional Chinese Medicine	Liu, C (corresponding author), Xihua Univ, Sch Food & Bioengn, Chengdu, Peoples R China.	1220210030@mail.xhu.edu.cn	Fan, Fang/GRO-2696-2022	Liu, Chuan/0000-0002-4652-8949	National Key R&D Program of China [2017YFC1703904]; Talent Introduction Project of Xihua University [Z211066]	National Key R&D Program of China; Talent Introduction Project of Xihua University	This study was supported by National Key R&D Program of China (2017YFC1703904), Yi Zhang is the funder. Professor Zhang has made irreplaceable contributions in research design and manuscript review. This study was also supported by the Talent Introduction Project of Xihua University (Z211066), Chuan Liu, the first author, is the funder. I assume full responsibility for the research design, data collection and analysis, publication decisions and manuscript preparation of the paper.	Aihaiti Y, 2020, MOL MED REP, V22, P3513, DOI 10.3892/mmr.2020.11406; Akhtar N, 2016, J IMMUNOL, V197, P2219, DOI 10.4049/jimmunol.1600360; Aletaha D, 2018, JAMA-J AM MED ASSOC, V320, P1360, DOI 10.1001/jama.2018.13103; Allam G, 2016, CENT EUR J IMMUNOL, V41, P339, DOI 10.5114/ceji.2016.65132; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; An QY, 2018, INT IMMUNOPHARMACOL, V65, P119, DOI 10.1016/j.intimp.2018.09.011; Anderson AE, 2019, RHEUMATOLOGY, V58, P1250, DOI 10.1093/rheumatology/kez003; [Anonymous], 1995, MED PUBL HOUS; Arab HH, 2017, CELL PHYSIOL BIOCHEM, V43, P540, DOI 10.1159/000480527; Banerjee S, 2019, PHYTOMEDICINE, V60, DOI 10.1016/j.phymed.2019.152944; Burmester GR, 2017, LANCET, V389, P2338, DOI 10.1016/S0140-6736(17)31491-5; [陈文静 Chen Wenjing], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P1210; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; Fleischmann R, 2017, LANCET, V389, P1168, DOI 10.1016/S0140-6736(17)30405-1; Fougere L, 2019, PHYTOCHEM ANALYSIS, V30, P218, DOI 10.1002/pca.2807; Fu Q, 2018, MOL MED REP, V18, P3619, DOI 10.3892/mmr.2018.9422; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Guo JY, 2019, J FOOD DRUG ANAL, V27, P793, DOI 10.1016/j.jfda.2019.05.007; Haleagrahara N, 2017, BIOMED PHARMACOTHER, V90, P38, DOI 10.1016/j.biopha.2017.03.026; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hostetler GL, 2017, ADV NUTR, V8, P423, DOI 10.3945/an.116.012948; [胡华刚 Hu Huagang], 2016, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V22, P1053; Hu XM, 2019, J CELL PHYSIOL, V234, P20432, DOI 10.1002/jcp.28645; Hughes SD, 2017, CRIT REV FOOD SCI, V57, P3601, DOI 10.1080/10408398.2016.1246413; Ismail BB, 2019, SCI TOTAL ENVIRON, V694, DOI 10.1016/j.scitotenv.2019.07.193; Jin JY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252508; King JD, 2020, CARTILAGE, V11, P329, DOI 10.1177/1947603518790009; Kontoyianni M, 2017, METHODS MOL BIOL, V1647, P255, DOI 10.1007/978-1-4939-7201-2_18; Kuensaen C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218736; Lahoti TS, 2013, ANN RHEUM DIS, V72, P1708, DOI 10.1136/annrheumdis-2012-202639; Lan YY, 2019, J CELL PHYSIOL, V234, P18748, DOI 10.1002/jcp.28514; Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027; Lee YH, 2018, Z RHEUMATOL, V77, P240, DOI 10.1007/s00393-016-0229-5; Li H, 2017, MOLECULES, V22, DOI 10.3390/molecules22050689; Li Q, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00932; Li SC, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/1303524; Li XH, 2020, BIOL PHARM BULL, V43, P296, DOI 10.1248/bpb.b19-00627; Liang YJ, 2020, INFLAMMATION, V43, P1044, DOI 10.1007/s10753-020-01189-x; Liu C, 2021, J ETHNOPHARMACOL, V270, DOI 10.1016/j.jep.2021.113820; Liu C, 2020, TROP J PHARM RES, V19, P1449, DOI 10.4314/tjpr.v19i7.17; Liu F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02847; Liu Y, 2018, CELL MOL IMMUNOL, V15, P171, DOI 10.1038/cmi.2016.60; Loupasakis K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179762; Ma JC., 2019, WORLD LATEST MED INF, V19, P145; Malemud CJ, 2018, THER ADV MUSCULOSKEL, V10, P117, DOI 10.1177/1759720X18776224; Monaco C, 2011, ARTHRIT CARE RES, V63, P500, DOI 10.1002/acr.20382; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; Ni RR, 2020, BIOMATERIALS, V232, DOI 10.1016/j.biomaterials.2019.119730; Ni S, 2019, J CELL PHYSIOL, V234, P454, DOI 10.1002/jcp.26580; Noack M, 2017, SEMIN IMMUNOPATHOL, V39, P365, DOI 10.1007/s00281-017-0619-z; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oliviero F, 2018, J SCI FOOD AGR, V98, P1653, DOI 10.1002/jsfa.8664; Otasek D, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1758-4; Pan DM, 2018, INT IMMUNOPHARMACOL, V55, P174, DOI 10.1016/j.intimp.2017.12.011; Qing ZX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57406-7; Ramirez-Bello J, 2018, J GENE MED, V20, DOI 10.1002/jgm.3024; Rashid M., 2020, POLYMORPHISM, V4, P21; Rose K, 2018, NAT PROD COMMUN, V13, P1309; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Saikia S, 2019, CURR DRUG TARGETS, V20, P501, DOI 10.2174/1389450119666181022153016; Sheng ZL, 2016, PHARM BIOL, V54, P1847, DOI 10.3109/13880209.2015.1131993; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Song B, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105685; Sparks JA, 2019, ANN INTERN MED, V170, pITC1, DOI 10.7326/AITC201901010; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tiberti LA, 2007, J BRAZIL CHEM SOC, V18, P100, DOI 10.1590/S0103-50532007000100011; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang WX, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/5872980; Wu JS, 2019, J CELL MOL MED, V23, P7946, DOI 10.1111/jcmm.14725; Ye CY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1904-7; Yoon CH, 2013, JOINT BONE SPINE, V80, P274, DOI 10.1016/j.jbspin.2012.08.010; Zhai KF, 2019, J AGR FOOD CHEM, V67, P2856, DOI 10.1021/acs.jafc.9b00185; Zhang Q, 2019, COMB CHEM HIGH T SCR, V22, P584, DOI 10.2174/1386207322666191022101613; Zhang Y, 2013, SCAND J RHEUMATOL, V42, P344, DOI 10.3109/03009742.2013.787454; Zhong L., 2021, CHINA PHARM, V32, P7; Zhou K, 2016, INFLAMMATION, V39, P1558, DOI 10.1007/s10753-016-0391-6	78	1	1	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262469	10.1371/journal.pone.0262469	http://dx.doi.org/10.1371/journal.pone.0262469			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130279	Green Published, gold			2022-12-26	WOS:000805530700009
J	Chin, LF; Rosbergen, ICM; Hayward, KS; Brauer, SG				Chin, Lay Fong; Rosbergen, Ingrid C. M.; Hayward, Kathryn S.; Brauer, Sandra G.			A self-directed upper limb program during early post-stroke rehabilitation: A qualitative study of the perspective of nurses, therapists and stroke survivors	PLOS ONE			English	Article								Introduction This study aimed to explore the perspective of nurses, therapists and stroke survivors on the performance of upper limb self-exercise and use outside therapy during early inpatient stroke rehabilitation. Methods A descriptive qualitative approach was used in focus groups with nurses (n = 21) and therapists (n = 8), as well as in-depth semi-structured interviews with stroke survivors (n = 8) who were undergoing subacute inpatient stroke rehabilitation. Inductive thematic analysis of data was performed according to participant group. Results Nurses and therapists perceived that stroke survivors played a central role in determining the success of a self-directed upper limb program. Nurses perceived that stroke survivors needed a lot of prompting to be motivated to perform self-directed upper limb therapy outside therapy. Therapists perceived that not all stroke survivors would be able to perform self-directed upper limb therapy and deemed it important to consider stroke survivor factors before commencing a program. Although some stroke survivors expressed initial reservations with performing self-practice, many indicated that they would participate in the selfdirected upper limb program because they wanted to recover faster. Conclusion A difference between the perspective of nurses/therapists and stroke survivors towards self-directed upper limb performance outside therapy was found. Deeper stroke survivor engagement and a shift in rehabilitation culture to encourage stroke survivor autonomy are important considerations for a self-directed upper limb program. Teamwork amongst healthcare professionals and families is essential to support stroke survivors to participate in a self-directed upper limb program during early inpatient stroke rehabilitation.	[Chin, Lay Fong] Tan Tock Seng Hosp, Rehabil Ctr, Singapore, Singapore; [Chin, Lay Fong; Rosbergen, Ingrid C. M.; Hayward, Kathryn S.; Brauer, Sandra G.] Univ Queensland, Sch Hlth & Rehabil Sci, Physiotherapy, Brisbane, Qld, Australia; [Rosbergen, Ingrid C. M.] Univ Queensland, STARS Surg Treatment & Rehabil Serv, Brisbane, Qld, Australia; [Rosbergen, Ingrid C. M.] Metro North Hlth, STARS Surg Treatment & Rehabil Serv, Brisbane, Qld, Australia; [Hayward, Kathryn S.] Univ Melbourne, Melbourne Sch Hlth Sci, Physiotherapy, Parkville, Vic, Australia; [Hayward, Kathryn S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Stroke Theme, Melbourne, Vic, Australia; [Hayward, Kathryn S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, NHMRC Ctr Res Excellence Stroke Rehabil & Brain R, Melbourne, Australia	Tan Tock Seng Hospital; University of Queensland; University of Queensland; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Chin, LF (corresponding author), Tan Tock Seng Hosp, Rehabil Ctr, Singapore, Singapore.; Chin, LF (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Physiotherapy, Brisbane, Qld, Australia.	Lay_Fong_CHIN@ttsh.com.sg		Chin, Lay Fong/0000-0002-5795-7554				Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Bernhardt J, 2007, J REHABIL MED, V39, P43, DOI 10.2340/16501977-0013; Bleijenberg N, 2018, INT J NURS STUD, V79, P86, DOI 10.1016/j.ijnurstu.2017.12.001; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chin LF, 2021, NEUROREHAB NEURAL RE, V35, P836, DOI 10.1177/15459683211032967; Chin LF, 2021, AM J PHYS MED REHAB, V100, P153, DOI 10.1097/PHM.0000000000001539; Eng XW, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/626538; Galvin R, 2009, DISABIL REHABIL, V31, P898, DOI 10.1080/09638280802356369; Harris JE, 2010, PHYS THER, V90, P1302, DOI 10.2522/ptj.20090349; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Hayward KS, 2015, CLIN REHABIL, V29, P1234, DOI 10.1177/0269215514565395; Janssen J, 2020, PHYS THER, V100, P307, DOI 10.1093/ptj/pzz159; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; Luker JA, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0156-9; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; O'Cathain A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029954; Rosbergen ICM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018226; Schneider EJ, 2016, J PHYSIOTHER, V62, P182, DOI 10.1016/j.jphys.2016.08.006; Scrivener K, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/4574385; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Taub E, 2006, Eura Medicophys, V42, P241; Tinson D J, 1989, Int Disabil Stud, V11, P45; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turakhia Puja, 2017, AMA J Ethics, V19, P1125, DOI 10.1001/journalofethics.2017.19.11.pfor1-1711; Vloothuis J, 2020, DISABIL REHABIL, V42, P698, DOI 10.1080/09638288.2018.1507048; West T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/438679; Woodbury ML, 2013, ARCH PHYS MED REHAB, V94, P1527, DOI 10.1016/j.apmr.2013.03.007	32	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263413	10.1371/journal.pone.0263413	http://dx.doi.org/10.1371/journal.pone.0263413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120167	gold, Green Published			2022-12-26	WOS:000789273600041
J	Guitart, M; Casals, M; Casamichana, D; Cortes, J; Valle, FX; McCall, A; Cos, F; Rodas, G				Guitart, Marc; Casals, Marti; Casamichana, David; Cortes, Jordi; Xavier Valle, Francesc; McCall, Alan; Cos, Francesc; Rodas, Gil			Use of GPS to measure external load and estimate the incidence of muscle injuries in men's football: A novel descriptive study	PLOS ONE			English	Article							PROFESSIONAL SOCCER PLAYERS; PERFORMANCE; UNDER-19; PROFILE; GAMES	Measurement of external load in players provides objective information to optimise the weekly balance between training and recovery to improve performance and prevent injuries. Our aim was to evaluate the incidence of sports-related muscle injuries of the lower limb in relation to external load, measured by global positioning system (GPS), in football players. A descriptive study was carried out. Data were collected from 71 professional male football players (30 professionals and 41 youth players) from an elite football club competing in the Spanish and European League in the 2017-2018 season. As external load variables, we measured High Metabolic Load Distance (HMLD), High Speed Running (HSR), Player Load (PL), and Total Distance (TD) through GPS. Injury rate (IR) was calculated both in relation to such GPS load metrics and to load exposure time. We considered categories (youth and professional), playing positions (centre back, full back, midfielder, and forward), and training day with respect to match-day (-4MD, -3MD, -2MD, -1MD, MD, +1MD, +2MD). The GPS load metrics HMLD, HSR, PL, and TD showed very similar patterns across categories and positions, but varied according to training session or MD. The highest loads were observed on MD and three days prior to the match (-3MD). Similarly, the overall IR, both calculated per load exposure time and per GPS load metrics, was highest on MD and -3MD. Again, no differences were observed between youth and professional players. Midfielders demonstrated the highest IR in all metrics, followed by the forwards. In conclusion, this study suggests that external load and incidence of muscle injuries are directly proportional. Therefore, the measurement of more external load variables other than load exposure time, such as the GPS metrics HMLD, HSR, PL, and TD may help to describe the pattern and magnitude of injuries. Future studies based on ours may help to further improve the understanding of the incidence of muscle injuries on the basis of external loads measurements in different football teams.	[Guitart, Marc; Casals, Marti; Xavier Valle, Francesc; Rodas, Gil] FC Barcelona, Performance & Med Dept, Barcelona, Spain; [Casals, Marti] Univ Vic Cent Univ Catalonia UVic UCC, Sport & Phys Act Studies Ctr CEEAF, Fac Med, Catalonia, Spain; [Casals, Marti; Cos, Francesc] Univ Barcelona, Natl Inst Phys Educ Catalonia INEFC, Barcelona, Spain; [Casamichana, David] Real Soc Futbol, Donostia San Sebastian, Spain; [Cortes, Jordi] Univ Politecn Catalunya BarcelonaTech, Dept Stat & Operat Res, Barcelona, Spain; [McCall, Alan] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Rodas, Gil] Clin St Joan de Deu Hosp, Sports Med Dept, Barcelona, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Barcelona; Universitat Politecnica de Catalunya; Edinburgh Napier University	Casals, M (corresponding author), FC Barcelona, Performance & Med Dept, Barcelona, Spain.; Casals, M (corresponding author), Univ Vic Cent Univ Catalonia UVic UCC, Sport & Phys Act Studies Ctr CEEAF, Fac Med, Catalonia, Spain.; Casals, M (corresponding author), Univ Barcelona, Natl Inst Phys Educ Catalonia INEFC, Barcelona, Spain.	marticasals@gmail.com	Cortés, Jordi/P-6563-2017; Rodas, Gil/B-7235-2019	Cortés, Jordi/0000-0002-3764-0795; Casals, Marti/0000-0002-1775-8331; GUITART TRENCH, MARC/0000-0002-7548-8229; Rodas, Gil/0000-0002-8060-3914	Ministerio de Ciencia e Innovacion y Ministerio de Universidades [PID2019-104830RB-I00]	Ministerio de Ciencia e Innovacion y Ministerio de Universidades	JC and MC acknowledge the financial support from Ministerio de Ciencia e Innovacion y Ministerio de Universidades (Ref: PID2019-104830RB-I00 / AEI DOI: 10.13039/501100011033).	Abade EA, 2014, INT J SPORT PHYSIOL, V9, P463, DOI [10.1123/ijspp.2013-0120, 10.1123/IJSPP.2013-0120]; Anderson L, 2016, J SPORT SCI, V34, P1250, DOI 10.1080/02640414.2015.1106574; Bacon CS, 2017, J STRENGTH COND RES, V31, P3067, DOI 10.1519/JSC.0000000000001744; Bahr R, 2018, BRIT J SPORT MED, V52, P1018, DOI 10.1136/bjsports-2017-098160; Bastida-Castillo A, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9050939; Bianco Antonino, 2016, Asian J Sports Med, V7, pe28425, DOI 10.5812/asjsm.28425; Casamichana D., 2021, BIOL SPORT, P115; Coppalle S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020558; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Dick R., 2009, J ATHL TRAINING, V44, P173; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Ergun M, 2013, ACTA ORTHOP TRAUMATO, V47, P339, DOI 10.3944/AOTT.2013.3177; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gaudino P, 2014, HUM MOVEMENT SCI, V36, P123, DOI 10.1016/j.humov.2014.05.006; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Lacome M, 2018, INT J SPORT PHYSIOL, V13, P568, DOI 10.1123/ijspp.2017-0214; Mechelen W, 1992, INCIDENCE SEVERITY A; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; Reche-Soto P, 2019, J HUM KINET, V69, P259, DOI 10.2478/hukin-2018-0072; Stovitz S., 2012, INJURY RATES TEAM SP; Suarez-Arrones L, 2015, J SPORT MED PHYS FIT, V55, P1417	24	4	4	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263494	10.1371/journal.pone.0263494	http://dx.doi.org/10.1371/journal.pone.0263494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120156	gold, Green Published			2022-12-26	WOS:000789273600045
J	Budziar, W; Gembara, K; Harhala, M; Szymczak, A; Jedruchniewicz, N; Baniecki, K; Pikies, A; Nahorecki, A; Hoffmann, A; Kardas, A; Szewczyk-Dabrowska, A; Klimek, T; Kazmierczak, Z; Witkiewicz, W; Barczyk, K; Dabrowska, K				Budziar, Wiktoria; Gembara, Katarzyna; Harhala, Marek; Szymczak, Aleksander; Jedruchniewicz, Natalia; Baniecki, Krzysztof; Pikies, Aleksandra; Nahorecki, Artur; Hoffmann, Agnieszka; Kardas, Amelia; Szewczyk-Dabrowska, Alina; Klimek, Tomasz; Kazmierczak, Zuzanna; Witkiewicz, Wojciech; Barczyk, Kamil; Dabrowska, Krystyna			Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021	PLOS ONE			English	Article								Population immunity (herd immunity) to SARS-CoV-2 derives from two sources: vaccinations or cases of infection with the virus. Infections can be diagnosed as COVID-19 and registered, or they can be asymptomatic, oligosymptomatic, or even full-blown but undiagnosed and unregistered when patients recovered at home. Estimation of population immunity to SARS-CoV-2 is difficult and remains a subject of speculations. Here we present a population screening for SARS-CoV-2 specific IgG and IgA antibodies in Polish citizens (N = 501) who had never been positively diagnosed with or vaccinated against SARS-CoV-2. Serum samples were collected in Wroctaw (Lower Silesia) on 15th and 22nd May 2021. Sera from hospitalized COVID-19 patients (N = 22) or from vaccinated citizens (N = 14) served as positive controls. Sera were tested with Microblot-Array COVID-19 IgG and IgA (quantitative) that contain specific SARS-CoV-2 antigens: NCP, RBD, Spike S2, E, ACE2, PLPro protein, and antigens for exclusion cross-reactivity with other coronaviruses: MERS-CoV, SARS-CoV, HCoV 229E Np, HCoV NL63 Np. Within the investigated population of healthy individuals who had never been positively diagnosed with or vaccinated against SARS-CoV-2, we found that 35.5% (178 out of 501) were positive for SARS-CoV-2-specific IgG and 52.3% (262 out of 501) were positive for SARS-CoV-2-specific IgA; 21.2% of the investigated population developed virus-specific IgG or IgA while being asymptomatic. Anti-RBD IgG, which represents virus-neutralizing potential, was found in 25.6% of individuals (128 out of 501). These patients, though positive for anti-SARS-CoV-2 antibodies, cannot be identified in the public health system as convalescents due to undiagnosed infections, and they are considered unaffected by SARS-CoV-2. Their contribution to population immunity against COVID-19 should however be considered in predictions and modeling of the COVID-19 pandemic. Of note, the majority of the investigated population still lacked anti-RBD IgG protection (74.4%); thus vaccination against COVID-19 is still of the most importance for controlling the pandemic.	[Budziar, Wiktoria; Gembara, Katarzyna; Harhala, Marek; Szymczak, Aleksander; Jedruchniewicz, Natalia; Hoffmann, Agnieszka; Kardas, Amelia; Szewczyk-Dabrowska, Alina; Klimek, Tomasz; Kazmierczak, Zuzanna; Witkiewicz, Wojciech; Dabrowska, Krystyna] Reg Specialist Hosp Wroclaw, Res & Dev Ctr, Wroclaw, Poland; [Gembara, Katarzyna; Harhala, Marek; Szymczak, Aleksander; Kazmierczak, Zuzanna; Dabrowska, Krystyna] Hirszfeld Inst Immunol & Expt Therapy, Lab Phage Mol Biol, Wroclaw, Poland; [Baniecki, Krzysztof; Pikies, Aleksandra; Nahorecki, Artur; Barczyk, Kamil] Healthcare Ctr Boleslawiec, Boleslawiec, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Dabrowska, K (corresponding author), Reg Specialist Hosp Wroclaw, Res & Dev Ctr, Wroclaw, Poland.; Dabrowska, K (corresponding author), Hirszfeld Inst Immunol & Expt Therapy, Lab Phage Mol Biol, Wroclaw, Poland.	dabrowska@wssk.wroc.pl	Harhala, Marek Adam/AAR-5437-2020; Szewczyk-Dabrowska, Alina/T-7751-2018	Harhala, Marek Adam/0000-0001-7018-6873; Szewczyk-Dabrowska, Alina/0000-0001-7629-4912; Gembara, Katarzyna/0000-0001-9233-7345; Jedruchniewicz, Natalia/0000-0002-6515-5762	National Research and Development Center in Poland [SZPITALE-JEDNOIMIENNE/48/2020]	National Research and Development Center in Poland	This work was supported by the National Research and Development Center in Poland, grant no. SZPITALE-JEDNOIMIENNE/48/2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Finkel Yaara, 2021, Nature, V589, P125, DOI 10.1038/s41586-020-2739-1; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; ICU University of Warsaw, 2021, ICM EPIDEMIOLOGICAL; Kashte S, 2021, HUM CELL, V34, P711, DOI 10.1007/s13577-021-00512-4; Li YD, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00695-2; Meyerowitz EA, 2021, LANCET INFECT DIS, V21, pE163, DOI 10.1016/S1473-3099(20)30837-9; Park SW, 2020, EPIDEMICS-NETH, V31, DOI 10.1016/j.epidem.2020.100392; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]	8	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0253638	10.1371/journal.pone.0253638	http://dx.doi.org/10.1371/journal.pone.0253638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113873	Green Submitted, gold, Green Published			2022-12-26	WOS:000823694700001
J	Tsogli, V; Jentschke, S; Koelsch, S				Tsogli, Vera; Jentschke, Sebastian; Koelsch, Stefan			Unpredictability of the "when" influences prediction error processing of the "what" and "where"	PLOS ONE			English	Article							FORMAL LANGUAGE THEORY; NEURAL REPRESENTATION; RESPONSES; DYNAMICS; MODELS; BRAIN; UNCERTAINTY; PERCEPTION; ATTENTION; CORTEX	The capability to establish accurate predictions is an integral part of learning. Whether predictions about different dimensions of a stimulus interact with each other, and whether such an interaction affects learning, has remained elusive. We conducted a statistical learning study with EEG (electroencephalography), where a stream of consecutive sound triplets was presented with deviants that were either: (a) statistical, depending on the triplet ending probability, (b) physical, due to a change in sound location or (c) double deviants, i.e. a combination of the two. We manipulated the predictability of stimulus-onset by using random stimulus-onset asynchronies. Temporal unpredictability due to random onsets reduced the neurophysiological responses to statistical and location deviants, as indexed by the statistical mismatch negativity (sMMN) and the location MMN. Our results demonstrate that the predictability of one stimulus attribute influences the processing of prediction error signals of other stimulus attributes, and thus also learning of those attributes.	[Tsogli, Vera; Koelsch, Stefan] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Jentschke, Sebastian] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Koelsch, Stefan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Bergen; University of Bergen; Max Planck Society	Koelsch, S (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.; Koelsch, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	Stefan.Koelsch@uib.no	Jentschke, Sebastian/C-1618-2008	Jentschke, Sebastian/0000-0003-2576-5432; Tsogli, Vera/0000-0001-7288-7120				Auksztulewicz R, 2018, J NEUROSCI, V38, P8680, DOI 10.1523/JNEUROSCI.0369-18.2018; Bouwer FL, 2016, NEUROPSYCHOLOGIA, V85, P80, DOI 10.1016/j.neuropsychologia.2016.02.018; Bregman A.S., 1990, AUDITORY SCENE ANAL; CHOMSKY N, 1956, IRE T INFORM THEOR, V2, P113; Clark A., 2015, SURFING UNCERTAINTY, VReprint; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cleeremans A, 2008, CAMB HANDB PSYCHOL, P396; COHEN JE, 1962, BEHAV SCI, V7, P137; Conway CM, 2020, NEUROSCI BIOBEHAV R, V112, P279, DOI 10.1016/j.neubiorev.2020.01.032; Costa-Faidella J, 2011, J NEUROSCI, V31, P18590, DOI 10.1523/JNEUROSCI.2599-11.2011; Daikoku T, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060114; Dehaene S, 2015, NEURON, V88, P2, DOI 10.1016/j.neuron.2015.09.019; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Drake C, 2001, ANN NY ACAD SCI, V930, P17, DOI 10.1111/j.1749-6632.2001.tb05722.x; Dzafic I, 2020, J NEUROSCI, V40, P6759, DOI 10.1523/JNEUROSCI.0315-20.2020; Fitch WT, 2012, PHILOS T R SOC B, V367, P1933, DOI 10.1098/rstb.2012.0103; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Garrido MI, 2009, J NEUROPHYSIOL, V101, P2620, DOI 10.1152/jn.90291.2008; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Hasson U, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0048; Huron D.B., 2006, SWEET ANTICIPATION M; Jager G, 2012, PHILOS T R SOC B, V367, P1956, DOI 10.1098/rstb.2012.0077; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2019, TRENDS COGN SCI, V23, P63, DOI 10.1016/j.tics.2018.10.006; Koelsch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19741; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lumaca M, 2019, EUR J NEUROSCI, V49, P1597, DOI 10.1111/ejn.14329; Lumaca M, 2018, SOC COGN AFFECT NEUR, V13, P877, DOI 10.1093/scan/nsy054; MacKay D. J. C., 2003, INFORM THEORY INFERE; Pearce MT, 2012, TOP COGN SCI, V4, P625, DOI 10.1111/j.1756-8765.2012.01214.x; Pearce MT, 2010, NEUROIMAGE, V50, P302, DOI 10.1016/j.neuroimage.2009.12.019; Pickering MJ, 2014, TRENDS COGN SCI, V18, P451, DOI 10.1016/j.tics.2014.05.006; Quiroga-Martinez DR, 2019, CORTEX, V120, P181, DOI 10.1016/j.cortex.2019.06.010; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ravignani A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01820; Roeber U, 2003, CLIN NEUROPHYSIOL, V114, P341, DOI 10.1016/S1388-2457(02)00377-2; Rohrmeier M, 2015, PHILOS T R SOC B, V370, P107, DOI 10.1098/rstb.2014.0097; Rohrmeier M, 2012, TOP COGN SCI, V4, P525, DOI 10.1111/j.1756-8765.2012.01223.x; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Saffran JR, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9252-y; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Selchenkova T, 2014, Q J EXP PSYCHOL, V67, P2360, DOI 10.1080/17470218.2014.929155; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHEPARD RN, 1964, J MATH PSYCHOL, V1, P54, DOI 10.1016/0022-2496(64)90017-3; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Takegata R, 1999, NEUROSCI LETT, V274, P207, DOI 10.1016/S0304-3940(99)00711-9; Tavano A, 2014, EUR J NEUROSCI, V39, P308, DOI 10.1111/ejn.12404; Tsogli V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42066-4; van den Bergh D, 2020, ANN PSYCHOL, V120, P73	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263373	10.1371/journal.pone.0263373	http://dx.doi.org/10.1371/journal.pone.0263373			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113946	Green Published, gold			2022-12-26	WOS:000823694700086
J	Guo, CJ; Li, SD				Guo, Chuijiang; Li, Shengdong			Optimizing operation of delivering and fetching wagons at a railway station with mixed-shaped goods operation sites	PLOS ONE			English	Article								The problem of delivering and fetching wagons at a railway station with mixed-shaped goods operation sites is considered, with a view to minimizing the running time between goods operation sites and waiting time of the locomotive in the planning period as the optimization objective. A general mathematical model for delivering and fetching wagons at a railway station with mixed-shaped goods operation sites has been formulated. The methods of judging and processing reverse of delivering and fetching wagons, dividing batches, and judging number of wagons for batch operation are provided to determine the feasibility of the solution, and an improved simulated annealing algorithm is introduced as our algorithm to the model. Finally, an experimental station is taken as an example to verify the model and algorithm. The results show that simulated annealing algorithm is relatively superior in computational efficiency and result compared with genetic algorithm and tabu search algorithm, the computing time of the algorithm provided can meet the requirements of planning shunting operations in railway station, and the model proposed is universal for other layout forms of GOSs and different operation forms.	[Guo, Chuijiang; Li, Shengdong] Chengdu Univ Informat Technol, Sch Logist, Chengdu, Peoples R China	Chengdu University of Information Technology	Li, SD (corresponding author), Chengdu Univ Informat Technol, Sch Logist, Chengdu, Peoples R China.	lsdong@cuit.edu.cn			Initiation Project of Introducing Talents for Scientific Research of CUIT [KYTZ 201910]	Initiation Project of Introducing Talents for Scientific Research of CUIT	The study was supported by the Initiation Project of Introducing Talents for Scientific Research of CUIT [Grant no. KYTZ 201910]. The funders played role in role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Ziyang, 2016, INTELLIGENT OPTIMIZA; Carlo SS., 2020, COMPUT OPER RES, V124, P1; Chen JX, 2019, DISSERTATION, P3348; Du W., 1995, J SW JIAOTONG U, V30, P503; Guo C., 2014, MATH PROBL ENG, V2014, P1; [郭垂江 Guo Chuijiang], 2019, [铁道学报, Journal of the China Railway Society], V41, P10; Guo Chuijiang, 2017, China Railway Science, V38, P138, DOI 10.3969/j.issn.1001-4632.2017.01.19; Guo CJ., 2020, INT J RAIL TRANSP, V9, P1; Jaehn F, 2018, OR SPECTRUM, V40, P367, DOI 10.1007/s00291-017-0495-x; Lei You-cheng, 2011, Journal of Central South University (Science and Technology), V42, P2356; Li Bin, 2014, Journal of Zhengzhou University Engineering Science, V35, P20, DOI 10.3969/j.issn.1671-6833.2014.01.005; Li WQ., 1997, J HENAN U NATURAL SC, V27, P1; Mitrovic M., 2001, SNEZANA DYNAMIC PICK; Mu F., 2009, J CHINA RAILWAY SOC, V31, P1; Mu F., 2010, J SW JIAOTONG U, V45, P123; Mu Feng, 2011, China Railway Science, V32, P114; [牟峰 MU Feng], 2010, [西南交通大学学报, Journal of Southwest Jiaotong University], V45, P104; [石红国 Shi Hongguo], 2005, [中国铁道科学, China Railway Science], V26, P132; Sohaib AS, 2013, INT C LEARN INT OPT; Suman B, 2006, J OPER RES SOC, V57, P1143, DOI 10.1057/palgrave.jors.2602068; Zachariadis EE, 2015, TRANSPORT RES B-METH, V71, P158, DOI 10.1016/j.trb.2014.11.004; [张文晰 Zhang Wenxi], 2014, [铁道学报, Journal of the China Railway Society], V36, P1	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263029	10.1371/journal.pone.0263029	http://dx.doi.org/10.1371/journal.pone.0263029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100317	Green Published, gold			2022-12-26	WOS:000801937600030
J	Aptekmann, AA; Bulavka, D; Nadra, AD; Sanchez, IE				Aptekmann, Ariel A.; Bulavka, Denys; Nadra, Alejandro D.; Sanchez, Ignacio E.			Transcription factor specificity limits the number of DNA-binding motifs	PLOS ONE			English	Article							GENOME-WIDE ANNOTATIONS; SEQUENCE LOGOS; BASE; SWISSREGULON; DATABASE; SITES	We study the limits imposed by transcription factor specificity on the maximum number of binding motifs that can coexist in a gene regulatory network, using the SwissRegulon Fantom5 collection of 684 human transcription factor binding sites as a model. We describe transcription factor specificity using regular expressions and find that most human transcription factor binding site motifs are separated in sequence space by one to three motif-discriminating positions. We apply theorems based on the pigeonhole principle to calculate the maximum number of transcription factors that can coexist given this degree of specificity, which is in the order of ten thousand and would fully utilize the space of DNA subsequences. Taking into account an expanded DNA alphabet with modified bases can further raise this limit by several orders of magnitude, at a lower level of sequence space usage. Our results may guide the design of transcription factors at both the molecular and system scale.	[Aptekmann, Ariel A.; Bulavka, Denys; Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Natur, Lab Fisiol Proteinas, Consejo Nacl lnvest Cient & Tecn,Inst Quim Biol F, Buenos Aires, DF, Argentina; [Aptekmann, Ariel A.] Rutgers State Univ, Marine & Coastal Sci Dept, New Brunswick, NJ USA; [Bulavka, Denys] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Matemat, Buenos Aires, DF, Argentina; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Natur, Dept Fisiol Biol Mol & Celular, IB3, Buenos Aires, DF, Argentina	University of Buenos Aires; Rutgers State University New Brunswick; University of Buenos Aires; University of Buenos Aires	Sanchez, IE (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Natur, Lab Fisiol Proteinas, Consejo Nacl lnvest Cient & Tecn,Inst Quim Biol F, Buenos Aires, DF, Argentina.	isanchez@qb.fcen.uba.ar	; Nadra, Alejandro/A-5668-2009	Sanchez, Ignacio Enrique/0000-0003-4284-9013; Aptekmann, Ariel Alejandro/0000-0001-8822-4372; Nadra, Alejandro/0000-0002-7860-3245				Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bulavka D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248841; EHRLICH M, 1987, J BACTERIOL, V169, P939, DOI 10.1128/jb.169.3.939-943.1987; Fleming AM, 2017, P NATL ACAD SCI USA, V114, P2604, DOI 10.1073/pnas.1619809114; Friedlander T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12307; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Marathe A, 2001, J COMPUT BIOL, V8, P201, DOI 10.1089/10665270152530818; Neri F, 2015, CELL REP, V10, P674, DOI 10.1016/j.celrep.2015.01.008; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider TD, 2001, NUCLEIC ACIDS RES, V29, P4881, DOI 10.1093/nar/29.23.4881; Sengupta AM, 2002, P NATL ACAD SCI USA, V99, P2072, DOI 10.1073/pnas.022388499; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sood AJ, 2019, J CHEMINFORMATICS, V11, DOI 10.1186/s13321-019-0349-4; Szoniec G, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-200; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Verbic A, 2021, FEBS J, V288, P5265, DOI 10.1111/febs.15652; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263307	10.1371/journal.pone.0263307	http://dx.doi.org/10.1371/journal.pone.0263307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089985	gold, Green Published			2022-12-26	WOS:000769158400054
J	Hou, Q; Zhao, YQ; Su, XG; Rong, R; Situ, SJ; Cui, Y				Hou, Qian; Zhao, Yueqiao; Su, Xiaoge; Rong, Rong; Situ, Sujian; Cui, Ying			Using Sina-Weibo microblogs to inform the development and dissemination of health awareness material about Zika virus transmission, China, 2016-17	PLOS ONE			English	Article							INFECTION	Background On 1 February 2016, the World Health Organization declared Zika transmission a public health emergency of international concern. Monitoring and responding to community awareness, concern, and possible knowledge gaps are critical during public health emergencies. Here, we describe the review and analysis of micro-blogs posted on Sina-Weibo, China's largest social media platform, to develop and disseminate a Zika virus education campaign. Methods We used CYYUN Voice Express' Weibo Spider tool and the search terms of "Zhaika" OR "Zika" OR "Zikv" to capture microblogs about Zika virus retrospectively from February 1 to December 31, 2016 and prospectively from June 1 to November 15, 2017. We described microblogs meeting our inclusion criteria by month and Zika virus outbreaks in Asia and by source (e.g., government agency, individual, or other). We identified common misleading or inaccurate content authored by individual micro-bloggers (i.e., not supported by available scientific evidence) through a qualitative review. We used this information to develop and disseminate health awareness material about the Zika virus through China CDC's 12320 Health Hotline Weibo account. An online survey was conducted to obtain feedback on the material. Results We captured 15,888 microblogs meeting our inclusion criteria. Zika-related microblogs peaked in September 2016, corresponding to news reports about the Zika outbreak in Singapore (August to November 2016). Most microblogs (12,994 [82%]) were authored by individual users, followed by media agencies (842 [5%]), businesses (829 [5%]), international organizations (370 [2%]), and Chinese government agencies (235 [1%]). Relevant microblogs primarily focused on clinical symptoms and health risks, modes of transmission, and actions taken by individuals to prevent infection and seek health care. Incorrect and/or mis-leading information from individual users concentrated on modes of transmission and possible treatments. The microblog "#Zika is that far and this close" health campaign was posted on Sina-Weibo and Baidu (Internet search engine in China) on September 18, 2016. Younger respondents (p-value = 0.01), and those with at least a college education (p-value = 0.03), were more likely than other respondents to consider the online campaign reliable and trustworthy. Conclusion Routine review of Sina-Weibo and other social media platforms could enhance the ability of public health staff to effectively respond to community concerns and awareness during public health emergencies. Advancements of social media monitoring tools and staff training could help to promote health awareness during emergencies by directly addressing public perceptions and concerns. Various approaches may be needed to reach different at-risk populations, particularly older and less educated populations who may prefer more traditional modes of communication.	[Hou, Qian; Zhao, Yueqiao; Su, Xiaoge; Rong, Rong; Cui, Ying] China Ctr Dis Control & Prevent, Hlth Commun Ctr, Hlth Hotline Management Off, Beijing, Peoples R China; [Situ, Sujian] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Beijing, Peoples R China		Cui, Y (corresponding author), China Ctr Dis Control & Prevent, Hlth Commun Ctr, Hlth Hotline Management Off, Beijing, Peoples R China.	ch20200907@163.com			China-U.S. Collaborative Program on Emerging and Reemerging Infectious Diseases [5 NU2GGH000961-05-00, 717126]	China-U.S. Collaborative Program on Emerging and Reemerging Infectious Diseases	This project was funded by the China-U.S. Collaborative Program on Emerging and Reemerging Infectious Diseases Cooperative Agreement through a grant awarded to YC (#5 NU2GGH000961-05-00; 717126 Using new media to assess public cognitive of Zika). US CDC staff responsible for oversight of this cooperative agreement did not participate in the design, implementation, or interpretation of the survey results.	[Anonymous], 2018, SINA USER DEV REPORT; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1792; Chen CY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032462; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chou WYS, 2018, JAMA-J AM MED ASSOC, V320, P2417, DOI 10.1001/jama.2018.16865; Fu KW, 2014, J INF TECHNOL POLITI, V11, P309, DOI 10.1080/19331681.2014.909344; Fu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058356; Fu KW, 2012, HEALTH RISK SOC, V14, P71, DOI 10.1080/13698575.2011.641521; Fung ICH, 2016, PUBLIC HEALTH REP, V131, P461, DOI 10.1177/003335491613100312; Fung ICH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126092; Fung ICH, 2013, WEST PAC SURVEILL RE, V4, P1, DOI [10.5365/wpsar.2013.4.3.005, 10.5365/WPSAR.2013.4.3.005]; Fung ICH, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-31; Health Hotline Management Office, CHIN CDC; Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mheidly N, 2020, J PUBLIC HEALTH POL, V41, P410, DOI 10.1057/s41271-020-00247-w; Odlum Michelle, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.fa814fb2bec36e29b718ab6af66124fa; Rainey JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163207; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Shang L L, 2008, UNDERSTANDING OLDER, DOI [10.1108/INTR-12-2019-0512/full/html, DOI 10.1108/INTR-12-2019-0512/FULL/HTML]; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; SteelFisher GK, 2015, INFLUENZA OTHER RESP, V9, P131, DOI 10.1111/irv.12306; Umapathi T, 2018, J PERIPHER NERV SYST, V23, P197, DOI 10.1111/jns.12284; Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015; Wang S., AAAI WORKSH WORLD WI; World Health Organization (WHO), 2016, WHO STAT 1 M INT HLT	28	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261602	10.1371/journal.pone.0261602	http://dx.doi.org/10.1371/journal.pone.0261602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085257	gold, Green Published			2022-12-26	WOS:000779379600026
J	Hamasha, M; Hamasha, S; Aqlan, F; Almeanazel, O				Hamasha, Mohammad; Hamasha, Sa'd; Aqlan, Faisal; Almeanazel, Osama			Markovian analysis of unreliable multi-machine flexible manufacturing cell	PLOS ONE			English	Article							STOCHASTIC-MODEL; SYSTEM	In this paper, a Markovian model is constructed to test a flexible manufacturing cell's (FMC) performance. The considered FMC includes a conveyer belt, robot, and n machines. The conveyer belt delivers the working part to the robot, and the robot picks it up and loads it onto the machines. The movement of a working part from one step to the next depends on the availability of the tool in the next step (i.e., conveyer belt, robot, and machine). Any machine is assumed to potentially fail during the processing time as a result of high loading stresses. First, a Markovian model is constructed for single-machine and double-machine FMCs. Then, a generalized FMC with an n-machine is constructed. The introduced model is illustrated with two numerical examples for both the single- and triple-machine. The Markov chain model can be used to estimate the FMC performance measures (i.e., overall utilization of machines and production rate). It is used to analyze the response of these measures under varying parameters (i.e., conveyor belt delivery rate, robot loading rate, processing rate of a machine, failure rate of a machine, and down machines' repairing rate). Moreover, an economic model based on the Markov chain model is introduced to analyze the FMC's net profit under these varying parameters.	[Hamasha, Mohammad; Almeanazel, Osama] Hashemite Univ, Dept Ind Engn, Zarqa, Jordan; [Hamasha, Sa'd] Auburn Univ, Dept Ind Engn, Auburn, AL 36849 USA; [Aqlan, Faisal] Univ Louisville, JB Speed Sch Engn, Louisville, KY 40292 USA	Hashemite University; Auburn University System; Auburn University; University of Louisville	Hamasha, S (corresponding author), Auburn Univ, Dept Ind Engn, Auburn, AL 36849 USA.	smh0083@auburn.edu	Hamasha, Mohammad/N-8159-2016; Al Meanazel, Osama/R-9906-2016	Hamasha, Mohammad/0000-0002-2956-5430; Al Meanazel, Osama/0000-0003-3002-3513				Aldaihani Majid M., 2008, International Journal of Industrial and Systems Engineering, V3, P610, DOI 10.1504/IJISE.2008.018235; Aldaihani MM, 2005, COMPUT IND ENG, V49, P600, DOI 10.1016/j.cie.2005.09.002; Azadeh Ali, 2011, International Journal of Operational Research, V10, P333, DOI 10.1504/IJOR.2011.038905; Batieha FA, 2020, THESIS BINGHAMTON U; Bronnikov A., 2019, ESKISEH TECH U J SCI, V20, P77; CHAN DY, 1990, INT J PROD RES, V28, P2037, DOI 10.1080/00207549008942851; Fahmy Sherif A., 2010, International Journal of Operational Research, V7, P463, DOI 10.1504/IJOR.2010.032422; Gultekin H, 2007, COMPUT OPER RES, V34, P2463, DOI 10.1016/j.cor.2005.09.015; Hamasha MM, 2015, IEEE T COMP PACK MAN, V5, P439, DOI 10.1109/TCPMT.2015.2394232; Hitomi K., 1986, Material Flow, V3, P131; HUTCHISON J, 1991, INT J PROD RES, V29, P1053, DOI 10.1080/00207549108930119; Joseph O. A., 2011, International Journal of Operational Research, V12, P333, DOI 10.1504/IJOR.2011.042920; KOULAMAS CP, 1992, COMPUT OPER RES, V19, P717, DOI 10.1016/0305-0548(92)90011-S; Lee DH, 1999, J MANUF SYST, V18, P301, DOI 10.1016/S0278-6125(00)86632-7; Mansfield E., 1992, JPN WORLD ECON, V4, P1; Pezzella F, 2008, COMPUT OPER RES, V35, P3202, DOI 10.1016/j.cor.2007.02.014; Reddy NS, 2018, ADV INTELL SYST, V632, P421, DOI 10.1007/978-981-10-5520-1_39; Russo D, 2021, P 4 INT C INT HUM SY; Sabri-Laghaiea K., 2019, INT J IND ENG SUPPLY, V6, P62; Sana S. S., 2007, International Journal of Operational Research, V2, P64, DOI 10.1504/IJOR.2007.011444; Sawik T, 2007, EUR J OPER RES, V180, P1060, DOI 10.1016/j.ejor.2006.05.023; Sellitto MA, 2020, INGENIARE, V28, P115; Sharma RK., 2020, OPERATIONS MANAGEMEN, P311; SINHA D, 1992, EUR J OPER RES, V60, P183, DOI 10.1016/0377-2217(92)90092-N; Smith ML, 1986, P 2 ORSA TIMS C FLEX, P478; TU YL, 1991, COMPUT IND, V16, P315, DOI 10.1016/0166-3615(91)90072-H; VINEYARD ML, 1992, INT J PROD RES, V30, P2647, DOI 10.1080/00207549208948182; VISWANADHAM N, 1992, MATH COMPUT MODEL, V16, P15, DOI 10.1016/0895-7177(92)90043-K; Yadav A, 2018, INT J PROD RES, V56, P2464, DOI 10.1080/00207543.2017.1387302; Yadav AV., 2020, J ENG SCI, V11, P970; Yan HS, 2000, COMPUT IND ENG, V38, P435, DOI 10.1016/S0360-8352(00)00056-5; Zhang XG, 2020, J MANUF SYST, V55, P94, DOI 10.1016/j.jmsy.2020.02.013	32	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0259247	10.1371/journal.pone.0259247	http://dx.doi.org/10.1371/journal.pone.0259247			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104294	gold, Green Published			2022-12-26	WOS:000749789300009
J	Yan, QN; Gao, HQ; Yao, Q; Ling, K; Xiao, GZ				Yan, Qinnan; Gao, Huanqing; Yao, Qing; Ling, Kun; Xiao, Guozhi			Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTDINS(4,5)P-2 SYNTHESIS; DIFFERENTIATION; HOMEOSTASIS; EXPRESSION; ISOFORMS	Phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) is a lipid kinase that plays a pivotal role in the regulation of receptor-mediated calcium signaling in multiple tissues; however, its role in the skeleton is not clear. Here, we show that while deleting Pip5k1c expression in the mesenchymal stem cells using Prx1-Cre transgenic mice does not impair the intramembranous and endochondral ossification during skeletal development, it does cause osteopenia in adult mice, but not rapidly growing young mice. We found Pip5k1c loss dramatically decreases osteoblast formation and osteoid and mineral deposition, leading to reduced bone formation. Furthermore, Pip5k1c loss inhibits osteoblastic, but promotes adipogenic, differentiation of bone marrow stromal cells. Pip5k1c deficiency also impairs cytoplasmic calcium influx and inactivates the calcium/calmodulin-dependent protein kinase, which regulates levels of transcription factor Runx2 by modulating its stability and subsequent osteoblast and bone formation. In addition, Pip5k1c loss reduces levels of the receptor activator of nuclear factor -KB ligand, but not that of osteoprotegerin, its decoy receptor, in osteoblasts in bone and in sera. Finally, we found Pip5k1c loss impairs the ability of bone marrow stromal cells to support osteoclast formation of bone marrow monocytes and reduces the osteoclast precursor population in bone marrow, resulting in reduced osteoclast formation and bone resorption. We conclude Pip5k1c deficiency causes a low-turnover osteopenia in mice, with impairment of bone formation being greater than that of bone resorption. Collectively, we uncover a novel function and mechanism of Pip5k1c in the control of bone mass and identify a potential therapeutic target for osteoporosis.	[Yan, Qinnan; Gao, Huanqing; Yao, Qing; Xiao, Guozhi] Southern Univ Sci & Technol, Sch Med, Dept Biochem, Guangdong Prov Key Lab Cell Microenvironm & Dis Re, Shenzhen, Peoples R China; [Ling, Kun] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Southern University of Science & Technology; Mayo Clinic	Xiao, GZ (corresponding author), Southern Univ Sci & Technol, Sch Med, Dept Biochem, Guangdong Prov Key Lab Cell Microenvironm & Dis Re, Shenzhen, Peoples R China.	xiaogz@sustech.edu.cn			National Key Research and Development Program of China [2019YFA0906004]; National Natural Science Foundation of China [81991513, 81870532, 81630066]; Guangdong Provincial Science and Technology Innovation Council [2017B030301018, 20180302174246105]; Shenzhen Municipal Science and Technology Innovation Council [20200925150409001]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Innovation Council; Shenzhen Municipal Science and Technology Innovation Council	We thank Dr Huiling Cao of Southern University of Science and Technology (SUSTech) for critical reading of this article. We acknowledge the assistance of Core Research Facilities of SUSTech. This work was supported, in part, by the National Key Research and Development Program of China Grants (2019YFA0906004) , the National Natural Science Foundation of China Grants (81991513, 81870532, 81630066) , the Guangdong Provincial Science and Technology Innovation Council Grant (2017B030301018, 20180302174246105) , and the Shenzhen Municipal Science and Technology Innovation Council Grant (20200925150409001) .	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao HL, 2020, BONE RES, V8, DOI 10.1038/s41413-019-0073-8; Cao HL, 2013, J BIOL CHEM, V288, P30399, DOI 10.1074/jbc.M113.469973; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Fu XK, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00328-y; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Huang J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10753-5; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Legate KR, 2012, J CELL SCI, V125, P5636, DOI 10.1242/jcs.102145; Lei YM, 2020, BONE RES, V8, DOI 10.1038/s41413-020-00108-y; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Unoki T, 2012, NEURON, V73, P135, DOI 10.1016/j.neuron.2011.09.034; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Vimalraj S, 2015, INT J BIOL MACROMOL, V78, P202, DOI 10.1016/j.ijbiomac.2015.04.008; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131692; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531; Yu SB, 2013, INT J BIOL SCI, V9, P256, DOI 10.7150/ijbs.5898; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14186-y; Zhu K, 2015, J BIOL CHEM, V290, P8081, DOI 10.1074/jbc.M114.603985; Zhu TT, 2013, J BIOL CHEM, V288, P5268, DOI 10.1074/jbc.M112.446054	32	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101639	10.1016/j.jbc.2022.101639	http://dx.doi.org/10.1016/j.jbc.2022.101639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090892	gold, Green Published			2022-12-26	WOS:000789261900006
J	Beverly, E; Hommema, L; Coates, K; Duncan, G; Gable, B; Gutman, T; Love, M; Love, C; Pershing, M; Stevens, N				Beverly, Elizabeth; Hommema, Laurie; Coates, Kara; Duncan, Gary; Gable, Brad; Gutman, Thomas; Love, Matthew; Love, Carrie; Pershing, Michelle; Stevens, Nancy			A tranquil virtual reality experience to reduce subjective stress among COVID-19 frontline healthcare workers	PLOS ONE			English	Article							FOREST THERAPY PROGRAM; PHYSICIANS; DISORDERS; LIFE	Objective The novel coronavirus-19 (COVID-19) has taken an immense physical, social, and emotional toll on frontline healthcare workers. Research has documented higher levels of anxiety, depression, and burnout among healthcare workers during the pandemic. Thus, creative interventions are needed now more than ever to provide brief, accessible support to frontline workers. Virtual reality is a rapidly growing technology with potential psychological applications. In this study, we piloted a three-minute Tranquil Cinematic-VR simulation of a nature scene to lower subjective stress among frontline healthcare workers in COVID-19 treatment units. We chose to film a nature scene because of the extensive empirical literature documenting the benefits of nature exposure and health. Methods A convenience sample of frontline healthcare workers, including direct care providers, indirect care providers, and support or administrative services, were recruited from three COVID-19 units located in the United States. Inclusion criteria for participation included adults aged 18 years and older who could read and speak in English and were currently employed by the healthcare system. Participants viewed a 360-degree video capture of a lush, green nature preserve in an Oculus Go or Pico G2 4K head-mounted display. Prior to viewing the simulation, participants completed a brief demographic questionnaire and the visual analogue scale to rate their subjective stress on a 10-point scale, with 1 = 'Not at all stressed' to 10 = 'Extremely stressed.' We conducted paired t-tests to examine pre- and post-simulation changes in subjective stress as well as Kruskal-Wallis tests and Mann-Whitney U tests to examine differences by demographic variables. All analyses were conducted in SPSS statistical software version 28.0. We defined statistical significance as a p-value less than .05. Results A total of 102 individuals consented to participate in the study. Eighty-four (82.4%) participants reported providing direct patient care, 73 (71.6%) identified as women, 49 (48.0%) were between the ages of 25-34 years old, and 35 (34.3%) had prior experience with VR. The pre-simulation mean stress score was 5.5 +/- 2.2, with a range of 1 to 10. Thirty-three (32.4%) participants met the 6.8 cutoff for high stress pre-simulation. Pre-simulation stress scores did not differ by any demographic variables. Post-simulation, we observed a significant reduction in subjective stress scores from pre- to post-simulation (mean change = -2.2 +/- 1.7, t = 12.749, p <.001), with a Cohen's d of 1.08, indicating a very large effect. Further, only four (3.9%) participants met the cutoff for high stress after the simulation. Post-simulations scores did not differ by provider type, age range, gender, or prior experience with virtual reality. Conclusions Findings from this pilot study suggest that the application of this Tranquil Cinematic-VR simulation was effective in reducing subjective stress among frontline healthcare workers in the short-term. More research is needed to compare the Tranquil Cinematic-VR simulation to a control condition and assess subjective and objective measures of stress over time.	[Beverly, Elizabeth; Hommema, Laurie; Gable, Brad; Stevens, Nancy] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Beverly, Elizabeth] Ohio Univ, Diabet Inst, Athens, OH 45701 USA; [Hommema, Laurie; Duncan, Gary] OhioHlth Riverside Methodist Hosp, Columbus, OH USA; [Coates, Kara; Duncan, Gary; Gable, Brad; Gutman, Thomas] OhioHlth Healthcare Org, Columbus, OH USA; [Duncan, Gary; Gable, Brad; Gutman, Thomas] OhioHlth Ctr Med Educ & Innovat, Columbus, OH USA; [Love, Matthew] Ohio Univ, J Warren McClure Sch Emerging Commun Technol, Athens, OH 45701 USA; [Love, Matthew; Love, Carrie] Ohio Univ, Game Res & Immers Design GRID Lab, Athens, OH 45701 USA; [Love, Carrie] Hocking Coll, Nelsonville, OH USA; [Pershing, Michelle] OhioHlth Res Inst, Columbus, OH USA; [Stevens, Nancy] Ohio Univ, Museum Complex, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; Hocking College; University System of Ohio; Ohio University	Beverly, E (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA.; Beverly, E (corresponding author), Ohio Univ, Diabet Inst, Athens, OH 45701 USA.	beverle1@ohio.edu		Beverly, Elizabeth/0000-0002-6486-8234; Gable, Brad/0000-0001-8015-7785; Love, Carrie/0000-0002-9483-7375				Annerstedt M, 2013, PHYSIOL BEHAV, V118, P240, DOI 10.1016/j.physbeh.2013.05.023; Artiga S, KEY CHARACTERISTICS; Bahadirli S, 2021, AM J EMERG MED, V50, P251, DOI 10.1016/j.ajem.2021.08.027; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Carl E, 2019, J ANXIETY DISORD, V61, P27, DOI 10.1016/j.janxdis.2018.08.003; COHEN S, 1988, CLAR SYMP, P31; Colomb-Cotinat M, 2021, INFECT DIS NOW, V51, P560, DOI 10.1016/j.idnow.2021.06.308; Dhand NK, 2020, STATULATOR ONLINE ST; Antonio-Villa NE, 2021, CLIN INFECT DIS, V73, pE191, DOI 10.1093/cid/ciaa1487; Ferrer-Garcia M, 2019, CYBERPSYCH BEH SOC N, V22, P60, DOI 10.1089/cyber.2017.0675; Forrest CB, 2021, J GEN INTERN MED, V36, P1319, DOI 10.1007/s11606-020-06529-z; Fusaroli P, 2020, INFECTION, V48, P803, DOI 10.1007/s15010-020-01436-1; Gaggioli A., 2009, ADV TECHNOLOGY REHAB; Gibson DM, 2020, J GEN INTERN MED, V35, P2804, DOI 10.1007/s11606-020-05992-y; Hansen MM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080851; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ideno Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1912-z; Jimenez MP, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094790; Kyaw BM, 2019, J MED INTERNET RES, V21, DOI 10.2196/12959; Lee I, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030321; Lesage FX, 2011, OCCUP MED-OXFORD, V61, P434, DOI 10.1093/occmed/kqr037; Lesage FX, 2012, OCCUP MED-OXFORD, V62, P600, DOI 10.1093/occmed/kqs140; Li Q, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2587381; Li Qing, 2010, Environmental Health and Preventive Medicine, V15, P9, DOI 10.1007/s12199-008-0068-3; Marco JH, 2013, PSYCHIAT RES, V209, P619, DOI 10.1016/j.psychres.2013.02.023; Medscape, 2021, 2020 MEDSC; Morita E, 2007, PUBLIC HEALTH, V121, P54, DOI 10.1016/j.puhe.2006.05.024; Nesenbergs K, 2021, EDUC SCI, V11, DOI 10.3390/educsci11010008; Northwood K, 2021, AUSTRALAS PSYCHIATRY, V29, P628, DOI 10.1177/10398562211038906; Ochiai H, 2015, INT J ENV RES PUB HE, V12, P15222, DOI 10.3390/ijerph121214984; Ochiai H, 2015, INT J ENV RES PUB HE, V12, P2532, DOI 10.3390/ijerph120302532; Oh B, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0677-9; Ohue T, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000026828; Olaya B, 2021, J CLIN MED, V10, DOI 10.3390/jcm10153406; Oreskovich MR, 2015, AM J ADDICTION, V24, P30, DOI 10.1111/ajad.12173; Pallavicini F, 2016, AEROSP MED HUM PERF, V87, P1021, DOI 10.3357/AMHP.4596.2016; Papoutsi E, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00195-2020; Repetto C, 2013, PERS UBIQUIT COMPUT, V17, P253, DOI 10.1007/s00779-011-0467-0; Riches S, 2021, SOC PSYCH PSYCH EPID, V56, P1707, DOI [10.1007/s00127-021-02110-z, 10.5117/9789463727709]; Riva G, 2019, CYBERPSYCH BEH SOC N, V22, P82, DOI 10.1089/cyber.2017.29099.gri; Riva G, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00164; Sanchez-Sanchez E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18168310; Segawa T, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01409; Shanafelt TD, 2021, MAYO CLIN PROC, V96, P2067, DOI 10.1016/j.mayocp.2021.01.033; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Song CR, 2017, URBAN FOR URBAN GREE, V21, P247, DOI 10.1016/j.ufug.2016.12.010; Sung J, 2012, CLIN EXP HYPERTENS, V34, P1, DOI 10.3109/10641963.2011.618195; Tsao Tsung-Ming, 2018, Oncotarget, V9, P16501, DOI 10.18632/oncotarget.24741; Valtchanov D, 2010, CYBERPSYCH BEH SOC N, V13, P503, DOI 10.1089/cyber.2009.0308; Wang XB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183263; Williams E., 2021, VIRTUAL REALITY CINE; World Health Organization, 2020, DIR GEN OP REM MED B; Yau KKY, 2020, ENVIRON HEALTH PREV, V25, DOI 10.1186/s12199-020-00856-7; Zeng N, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030042; Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696	56	7	7	10	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262703	10.1371/journal.pone.0262703	http://dx.doi.org/10.1371/journal.pone.0262703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139092	gold, Green Published			2022-12-26	WOS:000821499100010
J	Jung, BK; An, YH; Jang, JJ; Jeon, JH; Jang, SH; Jang, H				Jung, Bo-Kyoung; An, Yong Hee; Jang, Jin-Ju; Jeon, Joo Hee; Jang, Sung Hoon; Jang, Hyun			The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate	PLOS ONE			English	Article							PROTEINS	Since the SARS-CoV-2 infection was identified in December 2019, SARS-CoV-2 infection has rapidly spread worldwide and has become a significant pandemic disease. In addition, human death and serious health problem caused by SARS-CoV-2 infection, the socioeconomic impact has been very serious. Here, we describe the development of the viral vector vaccine, which is the receptor-binding domain (RBD) of SARS-CoV-2 expressed on the surface of Newcastle disease virus (LVP-K1-RBD19). The RBD protein concentrations on the viral surface were measured by the sandwich ELISA method. 10(6.7) TCID50/ml of LVP-K1-RBD19 has a 0.17 mu g of RBD protein. Optical density (OD) values of mouse sera inoculated with 10 mu g of RBD protein expressed on the surface of LVP-K1-RBD19 generated 1.78-fold higher RBD-specific antibody titers than mice inoculated with 10 mu g RBD protein with alum at 28 dpi. Moreover, mice inoculated with 10 mu g of RBD protein expressed on the surface of LVP-K1-RBD19 virus showed more than 80% neutralization at 1:256 against the SARS-CoV-2 pseudovirus. These results demonstrated that inactivated LVP-K1-RBD19 virus produces neutralizing antibodies against SARS-CoV-2 in a short period and could be elect protective immunity in humans and LVP-K1-RBD19 will be a good candidate for the COVID-19 vaccine.	[Jung, Bo-Kyoung; An, Yong Hee; Jang, Jin-Ju; Jeon, Joo Hee; Jang, Hyun] Libentech Co LTD, Daejeon, South Korea; [Jang, Sung Hoon] Inha Univ, Coll Nat Sci, Dept Biol Sci, Incheon, South Korea	Inha University	Jang, H (corresponding author), Libentech Co LTD, Daejeon, South Korea.	vacchyun@naver.com			Libentech	Libentech	This work was funded by Libentech.	A.Garcia-Sastre, 2020, bioRxiv, DOI 10.1101/2020.07.30.229120; [Anonymous], US; Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; Dutch RE, 1998, J VIROL, V72, P7745, DOI 10.1128/JVI.72.10.7745-7753.1998; Ferreira L, 2004, J GEN VIROL, V85, P1981, DOI 10.1099/vir.0.79877-0; Gainey MD, 2008, J VIROL, V82, P9369, DOI 10.1128/JVI.01054-08; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Guler G, 2021, PROG BIOPHYS MOL BIO, V164, P3, DOI 10.1016/j.pbiomolbio.2021.05.007; Harper H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243185; Lara-Puente JH, 2021, MBIO, V12, DOI 10.1128/mBio.01908-21; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Jantzen R, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06002-0; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li HO, 2020, ANTIMICROB AGENTS CH, V64, DOI [10.1128/AAC.00483-20, 10.1128/AAC.00483-20.]; Loo KY, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9030605; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McGinnes Lori W, 2006, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15f02s01; Morais IJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74050-8; Nan FL, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.619829; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Noton SL, 2015, VIROLOGY, V479, P545, DOI 10.1016/j.virol.2015.01.014; Pitisuttithum P, 2021, medRxiv, DOI 10.1101/2021.09.17.21263758; Rangan R, 2020, RNA, V26, P937, DOI 10.1261/rna.076141.120; Riad A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071428; Rodriguez-Rey R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01540; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Salamanna F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.594495; Santry LA, 2018, MOL THER-METH CLIN D, V9, P181, DOI 10.1016/j.omtm.2017.10.004; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Sun WN, 2020, EBIOMEDICINE, V62, DOI 10.1016/j.ebiom.2020.103132; Tabibzadeh A, 2021, VET MED SCI, V7, P559, DOI 10.1002/vms3.394; Sun W, 2021, bioRxiv, DOI 10.1101/2021.07.06.451301; Wang Y, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01311-z; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wong NA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031308; Yang JY, 2020, NATURE, V586, P572, DOI 10.1038/s41586-020-2599-8; Yang YP, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020073; Yin CC, 2020, GENOMICS, V112, P3588, DOI 10.1016/j.ygeno.2020.04.016; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	46	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263684	10.1371/journal.pone.0263684	http://dx.doi.org/10.1371/journal.pone.0263684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134091	gold, Green Published			2022-12-26	WOS:000798968600025
J	Al-Kafaji, G; Bakheit, HF; AlAli, F; Fattah, M; Alhajeri, S; Alharbi, MA; Daif, A; Alsabbagh, MM; Alwehaidah, MS; Bakhiet, M				Al-Kafaji, Ghada; Bakheit, Halla F.; AlAli, Faisal; Fattah, Mina; Alhajeri, Saad; Alharbi, Maram A.; Daif, Abdulqader; Alsabbagh, Manahel Mahmood; Alwehaidah, Materah Salem; Bakhiet, Moiz			Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis	PLOS ONE			English	Article							DNA VARIANTS; OXIDATIVE STRESS; EVOLUTION; DISEASE; RISK; POLYMORPHISMS; PATHOGENESIS; SILENCE; T4216C; DAMAGE	Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system with genetics and environmental determinants. Studies focused on the neurogenetics of MS showed that mitochondrial DNA (mtDNA) mutations that can ultimately lead to mitochondrial dysfunction, alter brain energy metabolism and cause neurodegeneration. We analyzed the whole mitochondrial genome using next-generation sequencing (NGS) from 47 Saudi individuals, 23 patients with relapsing-remitting MS and 24 healthy controls to identify mtDNA disease-related mutations/variants. A large number of variants were detected in the D-loop and coding genes of mtDNA. While distinct unique variants were only present in patients or only occur in controls, a number of common variants were shared among the two groups. The prevalence of some common variants differed significantly between patients and controls, thus could be implicated in susceptibility to MS. Of the unique variants only present in the patients, 34 were missense mutations, located in different mtDNA-encoded genes. Seven of these mutations were not previously reported in MS, and predicted to be deleterious with considerable impacts on the functions and structures of encoded-proteins and may play a role in the pathogenesis of MS. These include two heteroplasmic mutations namely 10237T>C in MT-ND3 gene and 15884G>C in MT-CYB gene; and three homoplasmic mutations namely 9288A>G in MT-0O3 gene, 14484T>C in MT-ND6 gene, 15431G>A in MT-CYB gene, 8490T>C in MT-ATP8 gene and 5437C>T in MT-ND2 gene. Notably some patients harboured multiple mutations while other patients carried the same mutations. This study is the first to sequence the entire mitochondrial genome in MS patients in an Arab population. Our results expanded the mutational spectrum of mtDNA variants in MS and highlighted the efficiency of NGS in population-specific mtDNA variant discovery. Further investigations in a larger cohort are warranted to confirm the role of mtDNA MS.	[Al-Kafaji, Ghada; Bakheit, Halla F.; AlAli, Faisal; Fattah, Mina; Alsabbagh, Manahel Mahmood; Bakhiet, Moiz] Arabian Gulf Univ, Coll Med & Med Sci, Dept Mol Med, Manama, Bahrain; [Al-Kafaji, Ghada; Bakheit, Halla F.; AlAli, Faisal; Fattah, Mina; Alsabbagh, Manahel Mahmood; Bakhiet, Moiz] Arabian Gulf Univ, Coll Med & Med Sci, Al Jawhara Ctr Mol Med Genet & Inherited Disorder, Manama, Bahrain; [Alhajeri, Saad] Minist Hlth, Kuwait, State Of Kuwait, Kuwait; [Alharbi, Maram A.] Naif Arab Univ Secur Sci, Coll Forens Sci, Riyadh, Saudi Arabia; [Daif, Abdulqader] King Saud Univ Med City, Riyadh, Saudi Arabia; [Alwehaidah, Materah Salem] Kuwait Univ, Fac Allied Hlth, Dept Med Lab, Kuwait, State Of Kuwait, Kuwait	Arabian Gulf University; Arabian Gulf University; Naif Arab University for Security Sciences; King Saud University; Kuwait University	Al-Kafaji, G (corresponding author), Arabian Gulf Univ, Coll Med & Med Sci, Dept Mol Med, Manama, Bahrain.; Al-Kafaji, G (corresponding author), Arabian Gulf Univ, Coll Med & Med Sci, Al Jawhara Ctr Mol Med Genet & Inherited Disorder, Manama, Bahrain.	ghadaa@agu.edu.bh	Al-Kafaji, Ghada/GLU-4045-2022; Alsabbagh, Manahel Mahmood/AAH-3149-2021	Alsabbagh, Manahel Mahmood/0000-0002-8013-760X	College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain [37-PI-01/15]	College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain	This study was funded by a research Grant (No: 37-PI-01/15) from the College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharbi MA, 2019, BIOMED REP, V11, P257, DOI 10.3892/br.2019.1250; AlJumah M, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1629-3; Andalib S, 2016, ACTA NEUROL BELG, V116, P439, DOI 10.1007/s13760-016-0675-5; Andalib S, 2015, J NEUROL SCI, V356, P55, DOI 10.1016/j.jns.2015.04.050; Ban M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002891; Bargiela D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.051; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Bohlega S, 2013, J NEUROL, V260, P2959, DOI 10.1007/s00415-013-6876-4; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Calyseva J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1947-7; Campbell GR, 2014, MULT SCLER J, V20, P1806, DOI 10.1177/1352458514544537; Cha MY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.122; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Harbo HF, 2013, THER ADV NEUROL DISO, V6, P237, DOI 10.1177/1756285613488434; HARDING AE, 1995, MUSCLE NERVE, pS82; Hernansanz-Agustin P, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030415; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; Kozin MS, 2018, ACTA NATURAE, V10, P79, DOI 10.32607/20758251-2018-10-4-79-86; Kumleh HH, 2006, J NEUROL SCI, V243, P65, DOI 10.1016/j.jns.2005.11.030; Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058; Liou CW, 2016, EUR J NEUROL, V23, P1289, DOI 10.1111/ene.13020; Loma I, 2011, CURR NEUROPHARMACOL, V9, P409, DOI 10.2174/157015911796557911; Luo ZC, 2019, MITOCHONDRIAL DNA B, V4, P2078, DOI 10.1080/23802359.2019.1619492; Mahad D, 2008, NEUROPATH APPL NEURO, V34, P577, DOI 10.1111/j.1365-2990.2008.00987.x; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; Mihailova SM, 2007, EUR J NEUROL, V14, P44, DOI 10.1111/j.1468-1331.2006.01541.x; Mishmar D, 2010, BBA-BIOENERGETICS, V1797, P1099, DOI 10.1016/j.bbabio.2010.01.003; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Mousavizadeh K, 2015, MITOCHONDR DNA, V26, P579, DOI 10.3109/19401736.2013.878902; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ohl K, 2016, EXP NEUROL, V277, P58, DOI 10.1016/j.expneurol.2015.11.010; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Rudenko G, 1998, P NATL ACAD SCI USA, V95, P621, DOI 10.1073/pnas.95.2.621; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tranah GJ, 2015, NEUROLOGY, V85, P325, DOI 10.1212/WNL.0000000000001744; Umbria M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59631-x; Vyshkina T, 2008, CLIN IMMUNOL, V129, P31, DOI 10.1016/j.clim.2008.07.011; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Waubant E, 2019, ANN CLIN TRANSL NEUR, V6, P1905, DOI 10.1002/acn3.50862; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Yu XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001530; Zonouzi AP, 2014, J NEUROL SCI, V345, P220, DOI 10.1016/j.jns.2014.07.051	62	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263606	10.1371/journal.pone.0263606	http://dx.doi.org/10.1371/journal.pone.0263606			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130313	Green Published, gold			2022-12-26	WOS:000805530700040
J	Baker, KA; Miller, TD; Marino, FE; Hartmann, TE				Baker, Kelly A.; Miller, Timothy D.; Marino, Frank E.; Hartmann, Tegan E.			The exercise-induced inflammatory response in inflammatory bowel disease: A systematic review and meta-analysis	PLOS ONE			English	Review							QUALITY-OF-LIFE; INTENSITY INTERVAL EXERCISE; TUMOR-NECROSIS-FACTOR; PEDRO SCALE; METHODOLOGICAL QUALITY; PSYCHOLOGICAL STRESS; CROHNS-DISEASE; CYTOKINES; IL-6; INTERLEUKIN-10	Background This study investigated selected inflammatory responses to acute and chronic exercise in individuals with inflammatory bowel disease (IBD). Methods A systematic review and meta-analysis was conducted on all relevant exercise-based intervention publications with IBD participants. The study included articles that utilised a broad range of acute and chronic exercise interventions, with inflammatory biomarkers measured and symptoms documented, both pre- and post-exercise for those with IBD. The search was limited to studies published in English, the use of human participants, and primary studies, with no restrictions on date of publication or participant's age. Articles were retrieved through the electronic databases: PubMed, SPORTDiscus, and Scopus. This study adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Results Six inflammatory markers were included in the meta-analysis which consisted of five studies. Exercise interventions resulted in no significant difference in IL-6 (SMD = -0.09; 95% CI = -0.49, 0.30; P = 0.64), TNF-alpha (SMD = 0.08; 95% CI = -0.31, 0.48; P = 0.68), CRP (SMD = -0.04; 95% CI = -0.58, 0.50; P = 0.89), IL-17 (SMD = 0.15; 95% CI = -0.45, 0.76; P = 0.62), leukocytes (SMD = 0.40; 95% CI = -0.53, 1.33; P = 0.40) or lymphocytes (SMD = 0.32; 95% CI = -0.33, 0.97; P = 0.33), thus, indicating exercise may have no effect on inflammatory markers in IBD. Bowel symptoms improved following regular moderate exercise that incorporated stress management. Conclusion Heterogeneity among the identified literature may have led to exercise interventions being ineffective in reducing inflammation. Although the limited number of eligible studies may reduce the reliability of results, it emphasises the need for additional research in this domain. Importantly, no adverse symptomatic responses to exercise indicate that exercise is safe for IBD patients.	[Baker, Kelly A.; Miller, Timothy D.; Marino, Frank E.; Hartmann, Tegan E.] Charles Sturt Univ, Sch Allied Hlth Exercise & Sport Sci, Bathurst, NSW, Australia	Charles Sturt University	Baker, KA (corresponding author), Charles Sturt Univ, Sch Allied Hlth Exercise & Sport Sci, Bathurst, NSW, Australia.	kbaker@csu.edu.au		Marino, Frank/0000-0001-8352-6208; Hartmann, Tegan/0000-0002-9160-1420; Baker, Kelly/0000-0003-3599-0262; Miller, Timothy/0000-0003-3409-0828	Charles Sturt University	Charles Sturt University	The authors would like to acknowledge the Charles Sturt University open access publishing grant.	Allen J, 2015, PROG MOL BIOL TRANSL, V135, P337, DOI 10.1016/bs.pmbts.2015.07.003; Allen NG, 2017, EUR J APPL PHYSIOL, V117, P1249, DOI 10.1007/s00421-017-3613-1; Perez CA, 2009, J CROHNS COLITIS, V3, P225, DOI 10.1016/j.crohns.2009.08.006; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Berger S, 1996, EUR J IMMUNOL, V26, P1297, DOI 10.1002/eji.1830260618; Bernstein CN, 2010, INFLAMM BOWEL DIS, V16, P112, DOI 10.1002/ibd.21048; Bertin B, 2010, CURR OPIN CLIN NUTR, V13, P574, DOI 10.1097/MCO.0b013e32833cf0f4; Bhogal SK, 2005, J CLIN EPIDEMIOL, V58, P668, DOI 10.1016/j.jclinepi.2005.01.002; Bilski J, 2016, PHARMACOL REP, V68, P827, DOI 10.1016/j.pharep.2016.04.009; Bonaz B, 2013, Minerva Gastroenterol Dietol, V59, P241; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Borenstein M., 2009, INTRO METAANALYSIS; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Brzozowski B, 2016, CURR NEUROPHARMACOL, V14, P892, DOI 10.2174/1570159X14666160404124127; Campbell PT, 2009, MED SCI SPORT EXER, V41, P1533, DOI 10.1249/MSS.0b013e31819c7feb; CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434; Collins SM, 2020, INFLAMM BOWEL DIS, V26, P493, DOI 10.1093/ibd/izaa004; Cronin O, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0952-x; Cruz-Topete D, 2015, NEUROIMMUNOMODULAT, V22, P20, DOI 10.1159/000362724; Cullen T, 2016, APPL PHYSIOL NUTR ME, V41, P803, DOI 10.1139/apnm-2015-0640; Davies JM, 2015, SCAND J GASTROENTERO, V50, P24, DOI 10.3109/00365521.2014.966321; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorneles GP, 2016, CYTOKINE, V77, P1, DOI 10.1016/j.cyto.2015.10.003; Dossett Michelle L, 2016, Glob Adv Health Med, V5, P122, DOI 10.7453/gahmj.2015.118; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elsenbruch S, 2005, PSYCHOTHER PSYCHOSOM, V74, P277, DOI 10.1159/000086318; Engler H, 2018, PSYCHONEUROENDOCRINO, V98, P101, DOI 10.1016/j.psyneuen.2018.08.009; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Gerbarg PL, 2015, INFLAMM BOWEL DIS, V21, P2886, DOI 10.1097/MIB.0000000000000568; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goldhammer E, 2005, INT J CARDIOL, V100, P93, DOI 10.1016/j.ijcard.2004.08.073; Gray SR, 2009, PREV MED, V48, P39, DOI 10.1016/j.ypmed.2008.10.013; Gu P, 2020, INFLAMM BOWEL DIS, V26, P181, DOI 10.1093/ibd/izz268; Heck AL, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12599; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Im JP, 2018, KOREAN J INTERN MED, V33, P28, DOI 10.3904/kjim.2017.400; Ishizuka K, 2001, DIGESTION, V63, P22, DOI 10.1159/000051906; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kaistha A, 2014, CURR PROB PEDIATR AD, V44, P328, DOI 10.1016/j.cppeds.2014.10.003; Kamm MA, 2017, LANCET, V390, P2741, DOI 10.1016/S0140-6736(17)32669-7; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Klare P, 2015, DIGESTION, V91, P239, DOI 10.1159/000371795; Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Li MC, 2004, WORLD J GASTROENTERO, V10, P620, DOI 10.3748/wjg.v10.i5.620; Libardi CA, 2012, MED SCI SPORT EXER, V44, P50, DOI 10.1249/MSS.0b013e318229d2e9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mathur Neha, 2008, Mediators Inflamm, V2008, P109502, DOI 10.1155/2008/109502; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Mendham AE, 2014, EUR J APPL PHYSIOL, V114, P2289, DOI 10.1007/s00421-014-2953-3; Mendham AE, 2011, EUR J APPL PHYSIOL, V111, P1035, DOI 10.1007/s00421-010-1724-z; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Miller Ian, 2018, Microbial Ecology in Health and Disease, V29, P1542921, DOI 10.1080/16512235.2018.1542921; Mogilevski T, 2019, ALIMENT PHARM THER, V50, P720, DOI 10.1111/apt.15433; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ortega E, 2016, J PHYSIOL BIOCHEM, V72, P361, DOI 10.1007/s13105-016-0478-4; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Physiotherapy Evidene Database, PEDRO SCAL 1999; Ploeger H, 2012, INT J SPORTS MED, V33, P671, DOI 10.1055/s-0032-1304323; Qazi T, 2017, GUT MICROBES, V8, P574, DOI 10.1080/19490976.2017.1353848; Rogler Gerhard, 2015, Curr Gastroenterol Rep, V17, P26, DOI 10.1007/s11894-015-0449-x; Sajadinejad MS, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/106502; Roman ALS, 2011, WORLD J GASTROENTERO, V17, P2723, DOI 10.3748/wjg.v17.i22.2723; Sandborn WJ, 2002, AM J GASTROENTEROL, V97, P2962; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sharma Purnima, 2015, Int J Yoga Therap, V25, P101, DOI 10.17761/1531-2054-25.1.101; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Sugama K, 2012, EXERC IMMUNOL REV, V18, P116; Sun Y, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00432; Taylor K, 2018, EUR J APPL PHYSIOL, V118, P829, DOI 10.1007/s00421-018-3817-z; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wen Zhonghui, 2004, Clin Dev Immunol, V11, P195, DOI 10.1080/17402520400004201; Wilson D. B., PRACTICAL META ANAL	87	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262534	10.1371/journal.pone.0262534	http://dx.doi.org/10.1371/journal.pone.0262534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120159	gold, Green Published			2022-12-26	WOS:000789273600010
J	Guntur, RD; Kingsley, J; Islam, FMA				Guntur, Robertus Dole; Kingsley, Jonathan; Islam, Fakir M. Amirul			Malaria treatment-seeking behaviour and its associated factors: A cross-sectional study in rural East Nusa Tenggara Province, Indonesia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; HEALTH-SEEKING; CARE-SEEKING; WEST TIMOR; DETERMINANTS; DELAY; CHILDREN; PEOPLE; ELIMINATION; KNOWLEDGE	Introduction The World Health Organization recommends seeking medical treatment within 24 hours after transmission of malaria to reduce the risk of severe complications and its onwards spread. However, in some parts of Indonesia, including East Nusa Tenggara Province (ENTP), this adherence is not achieved for a range of reasons including delays in visiting health centres. This study aims to determine factors related to the poor understanding of appropriate malaria treatment-seeking behaviour (AMTSB) of rural adults in ENTP. AMTSB was defined as seeking treatment at professional health facilities within 24 hours of the onset of malaria symptoms. Methods A cross-sectional study was conducted in the East Sumba, Belu, and East Manggarai district of ENTP between October and December 2019. A multi-stage cluster sampling procedure was applied to enrol 1503 participants aged between 18 and 89 years of age. Data were collected through face-to-face interviews. Multivariable logistic regression analyses were used to assess significant factors associated with the poor understanding of AMTSB. Results Eighty-six percent of participants were found to be familiar with the term malaria. However, poor understanding level of AMTSB in rural adults of ENTP achieved 60.4% with a 95% confidence interval (CI): 56.9-63.8. Poor understanding of AMTSB was significantly higher for adults with no education (adjusted odds ratio (AOR) 3.42, 95% CI: 1.81, 6.48) compared to those with a diploma or above education level; having low SES (AOR: 1.87, 95% CI: 1.19, 2.96) compared to those having high SES; residing at least three kilometres (km) away from the nearest health facilities (AOR: 1.73, 95% CI: 1.2, 2.5) compared to those living within one km from the nearest health service; and working as farmer (AOR: 1.63, 95% CI: 1.012.63) compared to those working at government or non-government sector. Whilst, other factors such as ethnicity and family size were not associated with the poor understanding of AMTSB. Conclusion The proportion of rural adults having a poor understanding of AMTSB was high leading to ineffective implementation of artemisinin- based combination therapies as the method to treat malaria in ENTP. Improving awareness of AMTSB for rural adults having low level education, low SES, working as a farmer, and living at least three km from the nearest health facilities is critical to support the efficacy of malaria treatment in ENTP. This method will support the Indonesian government's objective to achieve malaria elimination by 2030.	[Guntur, Robertus Dole; Kingsley, Jonathan; Islam, Fakir M. Amirul] Swinburne Univ Technol, Dept Hlth Sci & Biostat, Hawthorn, Vic, Australia; [Guntur, Robertus Dole] Nusa Cendana Univ, Dept Math, Fac Sci & Engn, Kupang, Ntt, Indonesia; [Kingsley, Jonathan] Swinburne Univ Technol, Ctr Urban Transit, Hawthorn, Vic, Australia	Swinburne University of Technology; Nippon Telegraph & Telephone Corporation; Universitas Nusa Cendana; Swinburne University of Technology	Guntur, RD (corresponding author), Swinburne Univ Technol, Dept Hlth Sci & Biostat, Hawthorn, Vic, Australia.; Guntur, RD (corresponding author), Nusa Cendana Univ, Dept Math, Fac Sci & Engn, Kupang, Ntt, Indonesia.	rguntur@swin.edu.au	Guntur, Robertus Dole/AAQ-6765-2021	Guntur, Robertus Dole/0000-0002-1597-3644	Australia Awards Scholarship [ST000TBK6]	Australia Awards Scholarship	PhD scholarship for RDG was supported by the Australia Awards Scholarship (ST000TBK6). The Faculty of Health, Arts and Design (FHAD) of the Swinburne University Technology supported for the primary data collection. The funders had no role in study design, data collection and analysis, or interpretation of data or writing the manuscripts.	Abuduxike G, 2020, INT J HEALTH POLICY, V9, P240, DOI 10.15171/ijhpm.2019.106; Adedire Elizabeth B., 2014, SCIENCE, V2, P636, DOI [10.11648/j.sjph.20140206.32, DOI 10.11648/J.SJPH.20140206.32]; Adhikari B, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4070-9; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Al Saffer Q, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06355-x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; Aris A., 2015, DEMOGRAPHY INDONESIA; Babalola OJ, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03371-w; Battle KE, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1048-x; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bjorkman A, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1243-z; Blanch-Hartigan D, 2015, J HEALTH COMMUN, V20, P204, DOI 10.1080/10810730.2014.921742; Bonlay M., 2019, J COMMUN HEALTH, V1; Challenger JD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001856; Chaturvedi HK, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08660-2; Chaturvedi HK, 2014, INT HEALTH, V6, P144, DOI 10.1093/inthealth/ihu020; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chu CS, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003561; Chukwuocha UM, 2014, J COMMUN HEALTH, V39, P1171, DOI 10.1007/s10900-014-9872-4; Coman MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17031114; Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122; Das A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-377; DePina AJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7130-5; Giao PT, 2005, TROP MED INT HEALTH, V10, P919, DOI 10.1111/j.1365-3156.2005.01472.x; Goldlust SM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2372-8; Guntur RD, 2017, J PHYS CONF SER, V812, DOI 10.1088/1742-6596/812/1/012073; Guntur RD., 2015, ASIA PACIFIC COLLABO, V11, P23; Guntur RD., 2021, KOREAN J PREV MED, DOI [10.3961/jpmph.21.367, DOI 10.3961/JPMPH.21.367]; Guntur RD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259950; Guntur RD, 2021, JMIR RES PROTOC, V10, DOI 10.2196/23545; Health Department of the ENTP, 2019, E NUS TENGG PROV ENT; Hutagalung J., 2016, OUTBREAK SURVEILL IN, V9, P1; Ipa M., 2015, J ASPIRATOR J VECTOR, V7, P13; Jullen PC., 2017, REPOS U HASANUDIN, V2, P155; Karolina ME., 2018, JMJ, V6, P20, DOI [10.22437/jmj.v6i1.4818, DOI 10.22437/JMJ.V6I1.4818]; Karolus N., 2013, NATL PUBLIC HLTH J, V7, P271; Karyana M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1588-8; Kassile T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-348; Khaerunnissya RL., 2021, EUR J MOLEC CLIN MED, V7, P2405; Khairy S, 2017, J INFECT PUBLIC HEAL, V10, P499, DOI 10.1016/j.jiph.2016.09.021; Kosasih A, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03709-y; Kusriastuti Rita, 2012, Acta Med Indones, V44, P265; Lidia K., 2020, CENDANA MED J, V8, P411, DOI [10.35508/cmj.v8i1.2644, DOI 10.35508/CMJ.V8I1.2644]; Lidia K., 2021, AUSTR J SCI TECHNOLO, V5, P443; Littrell M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-371; Liu LF, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08804-4; Mahmudi M., 2015, J EPIDEMIOL, V3, P230, DOI [10.20473/JBE.V3I22015.230-241, DOI 10.20473/JBE.V3I22015.230]; Manana PN, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4583-2; Mbanefo A., 2020, EVALUATION MALARIA D, V5, P102, DOI [10.3390/tropicalmed5020102, DOI 10.3390/TROPICALMED5020102]; McMaughan DJ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00231; Ministry of Health Republic of Indonesia, 2013, BAS HLTH RES RISK 20; Ministry of Health Republic of Indonesia, 2019, HLTH PROF IND 2018; Ministry of Health Republic of Indonesia, 2019, NAT REP BAS HLTH RES; Ministry of Health Republic of Indonesia, 2019, BAS DAT PUBL HLTH CT; Ministry of Health Republic of Indonesia, 2020, CURR DEV SIT MAL CON; Ministry of Health Republic of Indonesia, 2021, IND HLTH PROF 2020; Mousa A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003359; Naing PA, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0070-9; Omale UI, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06865-8; Paraiso MN., 2019, DETERMINANTS DELAYS, V7, P9; Peto TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158656; Rajendran J., 2013, AM J MED MED SCI, V3, P81, DOI [10.5923/j.ajmms.20130304.05, DOI 10.5923/J.AJMMS.20130304.05]; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Romay-Barja M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1239-0; Sanjana P, 2006, AM J TROP MED HYG, V75, P783, DOI 10.4269/ajtmh.2006.75.783; Shaikh Babar T, 2008, J Pak Med Assoc, V58, P33; Singh MP, 2017, TROP MED INT HEALTH, V22, P1377, DOI 10.1111/tmi.12973; Singh MP, 2020, J BIOSOC SCI, V52, P317, DOI 10.1017/S0021932019000440; Sitohang V, 2018, LANCET GLOB HEALTH, V6, pE604, DOI 10.1016/S2214-109X(18)30198-0; Sonkong K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-3; Suswardany DL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0593-7; Taek MM, 2019, INTEGR MED RES, V8, P139, DOI 10.1016/j.imr.2019.05.005; Tesfahunegn A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2992-7; Thandar MM, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-1; The Central Bureau of Statistics East Nusa Tenggara Province, 2020, NUS TENGG TIM PROV F; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2015, GLOB TECHN STRAT MAL; Widayanti AW, 2020, J EPIDEMIOL GLOB HEA, V10, P6, DOI 10.2991/jegh.k.200102.001; World Health Organization, 2015, GUID TREATM MAL, Vthird; Xu JW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-417; Yendris KS, 2018, 50 APACPH C KOT KIN	84	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263178	10.1371/journal.pone.0263178	http://dx.doi.org/10.1371/journal.pone.0263178			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120136	Green Submitted, gold, Green Published			2022-12-26	WOS:000789273600026
J	Zhang, YH; Mohibi, S; Vasilatis, DM; Chen, MY; Zhang, J; Chen, XB				Zhang, Yanhong; Mohibi, Shakur; Vasilatis, Demitria M.; Chen, Mingyi; Zhang, Jin; Chen, Xinbin			Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1-SREBP pathway	ONCOGENE			English	Article							LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL-METABOLISM; ADRENODOXIN REDUCTASE; STEROID HYDROXYLASE; ELECTRON-TRANSFER; PROSTATE-CANCER; TRANSGENIC MICE; NILE RED; GENE; BINDING	p53 is known to modulate metabolism and FDXR is required for steroidogenesis. Given that FDXR is a target/regulator of p53, the FDXR-p53 axis may play a unique role in lipid metabolism. Here, we found that expression of ABCA1, a cholesterol-efflux pump, was suppressed by loss of FDXR and/or p53, leading to activation of master lipogenic regulators SREBP1/2. Accordingly, lipid droplets, cholesterol, and triglycerides were increased by loss of FDXR or p53, which were further increased by loss of both FDXR and p53. To explore the biological significance of the FDXR-p53 axis, we generated a cohort of mice deficient in Fdxr and/or Trp53. We found that Fdxr(+/-), Trp53(+/-), and Fdxr(+/-);Trp53(+/-) mice had a short life span and were prone to spontaneous tumors and liver steatosis. Moreover, the levels of serum cholesterol and triglycerides were significantly increased in Fdxr(+/-) and Trp53(+/-) mice, which were further increased in Fdxr(+/-);Trp53(+/-) mice. Interestingly, loss of Fdxr but not p53 led to accumulation of serum low-density lipoprotein. Together, our findings reveal that the FDXR-p53 axis plays a critical role in lipid homeostasis and tumor suppression.	[Zhang, Yanhong; Mohibi, Shakur; Vasilatis, Demitria M.; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Zhang, Yanhong; Mohibi, Shakur; Vasilatis, Demitria M.; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Chen, Mingyi] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA.; Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu		zhang, jin/0000-0002-6835-920X; chen, xinbin/0000-0002-4582-6506; Mohibi, Shakur/0000-0001-5539-0841	NIH [CA224433, CA250338]; UCD Cancer Center Core Support Grant [CA093373]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCD Cancer Center Core Support Grant	This work is supported in part by NIH grant CA224433 and CA250338 and by UCD Cancer Center Core Support Grant CA093373.	Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; DESSI S, 1992, BRIT J CANCER, V66, P787, DOI 10.1038/bjc.1992.361; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Funauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16497; Genicot G, 2005, THERIOGENOLOGY, V63, P1181, DOI 10.1016/j.theriogenology.2004.06.006; Graziani SR, 2002, GYNECOL ONCOL, V85, P493, DOI 10.1006/gyno.2002.6654; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; Hinson DD, 1997, J LIPID RES, V38, P2216; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; KIMURA T, 1967, J BIOL CHEM, V242, P485; Kolanjiappan K, 2003, CLIN BIOCHEM, V36, P61, DOI 10.1016/S0009-9120(02)00421-6; Kubicka S, 1997, HEPATOLOGY, V25, P867, DOI 10.1002/hep.510250414; Lacroix M, 2020, MOL METAB, V33, P2, DOI 10.1016/j.molmet.2019.10.002; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Lochner M, 2015, TRENDS IMMUNOL, V36, P81, DOI 10.1016/j.it.2014.12.005; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Michihara A, 2001, BIOL PHARM BULL, V24, P1231, DOI 10.1248/bpb.24.1231; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Moon SH, 2019, CELL, V176, P564, DOI 10.1016/j.cell.2018.11.011; Moustafa MA, 2004, CANCER SCI, V95, P530, DOI 10.1111/j.1349-7006.2004.tb03244.x; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; OKAMURA T, 1985, P NATL ACAD SCI USA, V82, P5705, DOI 10.1073/pnas.82.17.5705; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parrales A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122074; Paul A, 2017, AM J HUM GENET, V101, P630, DOI 10.1016/j.ajhg.2017.09.007; Peng YY, 2017, HUM MOL GENET, V26, P4937, DOI 10.1093/hmg/ddx377; Rudling M, 1996, BBA-LIPID LIPID MET, V1299, P75, DOI 10.1016/0005-2760(95)00195-6; Sanchez-Macedo N, 2013, CELL DEATH DIFFER, V20, P659, DOI 10.1038/cdd.2012.168; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Schimanski S, 2010, HORM METAB RES, V42, P102, DOI 10.1055/s-0029-1241859; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Simabuco Fernando M, 2018, Oncotarget, V9, P23780, DOI 10.18632/oncotarget.25267; Stenton SL, 2021, HUM MUTAT, V42, P310, DOI 10.1002/humu.24160; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tatidis L, 2002, BIOCHEM PHARMACOL, V63, P2169, DOI 10.1016/S0006-2952(02)01018-3; Veldurthy V, 2016, VITAM HORM, V100, P137, DOI 10.1016/bs.vh.2015.10.005; Vickery LE, 1997, STEROIDS, V62, P124, DOI 10.1016/S0039-128X(96)00170-5; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang XW, 2013, J MOL CELL BIOL, V5, P147, DOI 10.1093/jmcb/mjs064; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Yamauchi Y, 2015, J BIOL CHEM, V290, P23464, DOI 10.1074/jbc.M115.662668; Yang HJ, 2017, P NATL ACAD SCI USA, V114, P11500, DOI 10.1073/pnas.1711814114; Yoshioka Y, 2000, NMR BIOMED, V13, P377, DOI 10.1002/1099-1492(200011)13:7<377::AID-NBM658>3.0.CO;2-E; Zhang J, 2020, J PATHOL, V251, P284, DOI 10.1002/path.5451; Zhang J, 2018, CANCER RES, V78, P1511, DOI 10.1158/0008-5472.CAN-17-2457; Zhang J, 2014, P NATL ACAD SCI USA, V111, P18637, DOI 10.1073/pnas.1415607112; Zhang YH, 2017, GENE DEV, V31, P1243, DOI 10.1101/gad.299388.117; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287; Zollner A, 2008, FEBS J, V275, P799, DOI 10.1111/j.1742-4658.2008.06253.x	68	3	3	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1718	1726		10.1038/s41388-021-02100-0	http://dx.doi.org/10.1038/s41388-021-02100-0		FEB 2022	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35121827	Green Published, hybrid			2022-12-26	WOS:000751251500001
J	Blankson, ER; Tetteh, PN; Oppong, P; Gbogbo, F				Blankson, Emmanuel R.; Tetteh, Patricia Nakie; Oppong, Prince; Gbogbo, Francis			Microplastics prevalence in water, sediment and two economically important species of fish in an urban riverine system in Ghana	PLOS ONE			English	Article							CONTAMINANTS	Urban riverine systems serve as conduits for the transport of plastic waste from the terrestrial dumpsites to marine repositories. This study presented data on the occurrence of microplastics in water, sediment, Bagrid Catfish (Chrysichthys nigrodigitatus) and Black-chinned Tilapia (Sarotherodon melanotheron) from the Densu River, an urban riverine system in Ghana. Microplastics were extracted from the samples collected from both the lentic and lotic sections of the river. The results indicated widespread pollution of the Densu River with microplastics in all the compartments studied. The average numbers of microplastic particles deposited in the Dam (2.0 +/- 0.58) and Delta (2.50 +/- 0.48) sections of the river were not affected by the differences in their hydrology. However, the stagnant water system of the Dam promoted the floating of larger-sized microplastics while the flowing waters of the Delta did not show any selectivity in the deposition of microplastics between sediment and the water column. The number of microplastics ingestions by the Bagrid Catfish (2.88 +/- 2.11) was similar to the Black-chinned Tilapia (2.38 +/- 1.66) but both species ingested lower numbers of microplastics than reported for marine fish species in coastal Ghana.	[Blankson, Emmanuel R.; Tetteh, Patricia Nakie; Oppong, Prince; Gbogbo, Francis] Univ Ghana, Dept Anim Biol & Conservat Sci, Accra, Ghana		Gbogbo, F (corresponding author), Univ Ghana, Dept Anim Biol & Conservat Sci, Accra, Ghana.	fgbogbo@ug.edu.gh		Gbogbo, Francis/0000-0003-0821-1120				Abobi S M, 2015, ELIXIR APPL ZOOL, V79, P30427; Ackah R., 2012, ELIXIR MNGT ARTS, V49, P9879; Adika SA, 2020, MAR POLLUT BULL, V153, DOI 10.1016/j.marpolbul.2020.110998; Alimi OS, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142422; Anani FA., 2016, INT J FISH AQUAT STU, V4, P647; ATLAFCO, 2012, REV FISH AQUAC IND, V1, P1; Bessa F, 2018, MAR POLLUT BULL, V128, P575, DOI 10.1016/j.marpolbul.2018.01.044; Chico-Ortiz N, 2020, REG STUD MAR SCI, V40, DOI 10.1016/j.rsma.2020.101509; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Cozar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121762; Effah K., 2019, US EMBASSY LAMENTS G; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Fadare OO, 2019, ENVIRON SCI-NANO, V6, P1466, DOI 10.1039/c8en01457d; Foekema EM, 2013, ENVIRON SCI TECHNOL, V47, P8818, DOI 10.1021/es400931b; Galloway TS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0116; Gbogbo F, 2008, AFR J AQUAT SCI, V33, P211, DOI 10.2989/AJAS.2008.33.3.3.615; Gbogbo F, 2020, ENVIRON MONIT ASSESS, V192, DOI 10.1007/s10661-020-8175-8; Gordon C, 1998, STATE COASTAL MARINE, P158; HOLMSTROM A, 1975, NATURE, V255, P622, DOI 10.1038/255622a0; Jambeck J, 2018, MAR POLICY, V96, P256, DOI 10.1016/j.marpol.2017.10.041; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Karkanorachaki K, 2021, SCI TOTAL ENVIRON, V793, DOI 10.1016/j.scitotenv.2021.148526; Karlsson TM, 2017, MAR POLLUT BULL, V122, P403, DOI 10.1016/j.marpolbul.2017.06.081; Kooi M, 2017, ENVIRON SCI TECHNOL, V51, P7963, DOI 10.1021/acs.est.6b04702; Kostic S, 2019, J MAR SCI ENG, V7, DOI 10.3390/jmse7010005; Kowalski N, 2016, MAR POLLUT BULL, V109, P310, DOI 10.1016/j.marpolbul.2016.05.064; Liboiron M., 2017, INVESTIGATE FISH GUT; Lourenco PM, 2017, ENVIRON POLLUT, V231, P123, DOI 10.1016/j.envpol.2017.07.103; Lusher A, 2015, MARINE ANTHROPOGENIC LITTER, P245, DOI 10.1007/978-3-319-16510-3_10; Nakki P, 2017, MAR POLLUT BULL, V119, P255, DOI 10.1016/j.marpolbul.2017.03.065; Owusu PA, 2016, COGENT ENG, V3, DOI 10.1080/23311916.2016.1164275; Pauly D., 1983, FAO FISHERIES TECHNI, P52; Plastics Europe, PLAST FACTS 2018; Quarcoopome T., 2010, JAST, V15, P126; Ramsar Information Sheet, 2015, GHAN DENS DELT RAMS; Ribeiro F, 2019, TRAC-TREND ANAL CHEM, V111, P139, DOI 10.1016/j.trac.2018.12.010; Su L, 2016, ENVIRON POLLUT, V216, P711, DOI 10.1016/j.envpol.2016.06.036; Tesfahun A., 2018, INT J FISH AQUAT STU, V6, P43; Wagner Martin, 2014, Environmental Sciences Europe, V26, DOI 10.1186/s12302-014-0012-7	39	6	6	12	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263196	10.1371/journal.pone.0263196	http://dx.doi.org/10.1371/journal.pone.0263196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113953	gold, Green Published			2022-12-26	WOS:000823694700060
J	Dror, AA; Morozov, N; Daoud, A; Namir, Y; Yakir, O; Shachar, Y; Lifshitz, M; Segal, E; Fisher, L; Mizrachi, M; Eisenbach, N; Rayan, D; Gruber, M; Bashkin, A; Kaykov, E; Barhoum, M; Edelstein, M; Sela, E				Dror, Amiel A.; Morozov, Nicole; Daoud, Amani; Namir, Yoav; Yakir, Orly; Shachar, Yair; Lifshitz, Mark; Segal, Ella; Fisher, Lior; Mizrachi, Matti; Eisenbach, Netanel; Rayan, Doaa; Gruber, Maayan; Bashkin, Amir; Kaykov, Edward; Barhoum, Masad; Edelstein, Michael; Sela, Eyal			Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; SEASONAL-VARIATION; VARIABILITY	Objective Studies have demonstrated a potential correlation between low vitamin D status and both an increased risk of infection with SARS-CoV-2 and poorer clinical outcomes. This retrospective study examines if, and to what degree, a relationship exists between pre-infection serum 25-hydroxyvitamin D (25(OH)D) level and disease severity and mortality due to SARS-CoV-2. Participants The records of individuals admitted between April 7th , 2020 and February 4th , 2021 to the Galilee Medical Center (GMC) in Nahariya, Israel, with positive polymerase chain reaction (PCR) tests for SARS-CoV-2 (COVID-19) were searched for historical 25(OH)D levels measured 14 to 730 days prior to the positive PCR test. Design Patients admitted to GMC with COVID-19 were categorized according to disease severity and level of 25(OH)D. An association between pre-infection 25(OH)D levels, divided between four categories (deficient, insufficient, adequate, and high-normal), and COVID-19 severity was ascertained utilizing a multivariable regression analysis. To isolate the possible influence of the sinusoidal pattern of seasonal 25(OH)D changes throughout the year, a cosinor model was used. Results Of 1176 patients admitted, 253 had records of a 25(OH)D level prior to COVID-19 infection. A lower vitamin D status was more common in patients with the severe or critical disease (<20 ng/mL [87.4%]) than in individuals with mild or moderate disease (<20 ng/mL [34.3%] p < 0.001). Patients with vitamin D deficiency (<20 ng/mL) were 14 times more likely to have severe or critical disease than patients with 25(OH)D >= 40 ng/mL (odds ratio [OR], 14; 95% confidence interval [CI], 4 to 51; p< 0.001). Conclusions Among hospitalized COVID-19 patients, pre-infection deficiency of vitamin D was associated with increased disease severity and mortality.	[Dror, Amiel A.; Daoud, Amani; Shachar, Yair; Segal, Ella; Fisher, Lior; Mizrachi, Matti; Eisenbach, Netanel; Rayan, Doaa; Gruber, Maayan; Sela, Eyal] Galilee Med Ctr, Dept Otolaryngol Head & Neck Surg, Nahariyya, Israel; [Dror, Amiel A.; Daoud, Amani; Namir, Yoav; Segal, Ella; Fisher, Lior; Mizrachi, Matti; Eisenbach, Netanel; Rayan, Doaa; Gruber, Maayan; Bashkin, Amir; Kaykov, Edward; Edelstein, Michael; Sela, Eyal] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Morozov, Nicole] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Yakir, Orly] Galilee Med Ctr, Stat Anal Div, Nahariyya, Israel; [Lifshitz, Mark] Galilee Med Ctr, Comp Data Div, Nahariyya, Israel; [Bashkin, Amir] Galilee Med Ctr, Endocrinol Unit, Nahariyya, Israel; [Kaykov, Edward] Galilee Med Ctr, Geriatr Med Dept, Nahariyya, Israel; [Barhoum, Masad] Galilee Med Ctr, Nahariyya, Israel	Western Galilee Hospital; Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Western Galilee Hospital; Western Galilee Hospital; Western Galilee Hospital; Western Galilee Hospital; Western Galilee Hospital	Dror, AA (corresponding author), Galilee Med Ctr, Dept Otolaryngol Head & Neck Surg, Nahariyya, Israel.; Dror, AA (corresponding author), Bar Ilan Univ, Azrieli Fac Med, Safed, Israel.	amieldror@gmail.com	Dror, Amiel/AAD-3348-2022; Edelstein, Michael/GQY-7219-2022	Dror, Amiel/0000-0002-7178-6771; Edelstein, Michael/0000-0002-7323-0806; Morozov, Nicole/0000-0001-6869-8626; FISHER, LIOR/0000-0002-5285-6244				Abu-Saad K, 2012, J NUTR, V142, P2175, DOI 10.3945/jn.112.166611; Al Attia Haider M, 2012, Arch Osteoporos, V7, P307; Al-Anouti F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113680; Bassil D, 2013, DERM-ENDOCRINOL, V5, P274, DOI 10.4161/derm.25111; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Bolland MJ, 2008, NEW ZEAL MED J, V121, P63; Bouillon R, 2010, LANCET, V376, P148, DOI 10.1016/S0140-6736(10)60635-6; Chakhtoura Marlene, 2018, Bone Rep, V8, P135, DOI 10.1016/j.bonr.2018.03.004; Charoenngam N, 2021, ENDOCR PRACT, V27, P271, DOI 10.1016/j.eprac.2021.02.013; Charoenngam N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072097; de Lucena TMC, 2020, DIABETES METAB SYND, V14, P597, DOI 10.1016/j.dsx.2020.05.025; Cozier YC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255132; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Degerud E, 2016, EUR J CLIN NUTR, V70, P517, DOI 10.1038/ejcn.2015.200; Degerud E, OBSERVATIONAL STUDIE; Elkum N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113102; Evans RM, 2020, CELL METAB, V32, P704, DOI 10.1016/j.cmet.2020.09.007; Grant WB, 2021, ENDOCR PRACT, V27, P1266, DOI 10.1016/j.eprac.2021.10.001; Hobbs RD, 2009, ENDOCR PRACT, V15, P35, DOI 10.4158/EP.15.1.35; Jain A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77093-z; Jolliffe DA, 2021, THORAX, V76, pA60, DOI [10.1016/S2213-8587(21)00051-6, 10.1136/thorax-2020-BTSabstracts.105]; Kara M, 2020, BRIT J NUTR, V124, P736, DOI 10.1017/S0007114520001749; Kaufman HW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239252; Levis S, 2005, J CLIN ENDOCR METAB, V90, P1557, DOI 10.1210/jc.2004-0746; Loucera C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02701-5; Ma W, 2021, AM J CLIN NUTR, DOI [10.1093/AJCN/NQAB389, DOI 10.1093/AJCN/NQAB389, 10.1093/ajcn/nqab389]; Maghbooli Z, 2021, ENDOCR PRACT, V27, P1242, DOI 10.1016/j.eprac.2021.09.016; Major JM, 2013, J CLIN ENDOCR METAB, V98, P97, DOI 10.1210/jc.2012-2643; Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722; Merzon E, 2020, FEBS J, V287, P3693, DOI 10.1111/febs.15495; Mishal AA, 2001, OSTEOPOROSIS INT, V12, P931, DOI 10.1007/s001980170021; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Muhsen K, 2017, LANCET, V389, P2531, DOI 10.1016/S0140-6736(17)30574-3; Oren Y, 2010, ISR MED ASSOC J, V12, P751; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Rawat D, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102189; Rhodes JM, 2021, J INTERN MED, V289, P97, DOI 10.1111/joim.13149; Rubin R, 2021, JAMA-J AM MED ASSOC, V325, P329, DOI 10.1001/jama.2020.24127; Sachs MC, 2013, AM J CLIN NUTR, V97, P1243, DOI 10.3945/ajcn.112.054502; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; Smolders J, 2021, METABOLISM, V115, DOI 10.1016/j.metabol.2020.154434; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; Woitge HW, 2000, J BONE MINER RES, V15, P2443, DOI 10.1359/jbmr.2000.15.12.2443; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhao QW, 2020, J MED VIROL, V92, P1915, DOI 10.1002/jmv.25889	46	25	25	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263069	10.1371/journal.pone.0263069	http://dx.doi.org/10.1371/journal.pone.0263069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113901	Green Published, gold, Green Submitted			2022-12-26	WOS:000823694700052
J	Petit, S; Scanlon, AT; Naikatini, A; Pukala, T; Schumann, R				Petit, Sophie; Scanlon, Annette T.; Naikatini, Alivereti; Pukala, Tara; Schumann, Russell			A novel bat pollination system involving obligate flower corolla removal has implications for global Dillenia conservation	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; NECTAR PRODUCTION; BEHAVIOR; ISLAND	The Dilleniaceae is known to produce nectarless flowers pollinated by bees, but the fact that bats ingest Dillenia biflora pollen led us to question pollination assumptions for these trees. We aimed to identify the pollinators of D. biflora, check for nectar presence, and investigate potential for cleistogamy and global prevalence of this pollination system. We examined aspects of the pollination of D. biflora on two Fijian islands using video recordings, direct observations, hand pollination, measurements (flowers, bite marks, nectar), and monitoring. The flowers, receptive for one night, contained copious nectar and had permanently closed globose corollas that required removal by bats for pollination. All the 101 flowers that retained their corolla died and did not produce seeds by cleistogamy. The bat Notopteris macdonaldi was well adapted to corolla removal. Keeping corollas closed until bats manipulate the nectar-rich flowers is a beneficial strategy in high-rainfall environments with many flower parasites. We propose to name a pollination system reliant exclusively on bats "chiropteropisteusis." From clues in the literature, other species in the geographical range of Dillenia are probably chiropteropisunous. Chiropteropisteusis should be investigated in the Old-World range of Dillenia, many species of which are threatened. The remarkable "fall" of the entire corolla observed by an earlier botanist for several species in the genus is most likely attributable to bats. This discovery has important implications for the conservation of bat-dependent trees and their associated fauna, particularly considering the high level of threat faced by flying-foxes globally.	[Petit, Sophie; Scanlon, Annette T.] Univ South Australia, UniSA Stem, Mawson Lakes, SA, Australia; [Petit, Sophie] NatureFiji MareqetiViti, Suva, Fiji; [Petit, Sophie; Schumann, Russell] Kangaroo Isl Res Stn, Dudley West, SA, Australia; [Naikatini, Alivereti] Univ South Pacific, South Pacific Reg Herbarium & Biodivers Ctr, Inst Appl Sci, Private Bag,Laucala Campus, Suva, Fiji; [Pukala, Tara] Univ Adelaide, Sch Phys Sci, Adelaide, SA, Australia	University of South Australia; University of the South Pacific; University of Adelaide	Petit, S (corresponding author), Univ South Australia, UniSA Stem, Mawson Lakes, SA, Australia.; Petit, S (corresponding author), NatureFiji MareqetiViti, Suva, Fiji.; Petit, S (corresponding author), Kangaroo Isl Res Stn, Dudley West, SA, Australia.	sophie.petit@unisa.edu.au	Petit, Sophie/D-1459-2010	Petit, Sophie/0000-0002-7984-5123	Australia and Pacific Science Foundation [APSF_16_01]	Australia and Pacific Science Foundation	The project was funded by the Australia and Pacific Science Foundation (APSF_16_01 to SP, ATS, AN, TP, RS), http://www.apscience.org.au/.	Ali SA., 1931, J BOMBAY NAT HIST SO, V35, P144; Amorim MD, 2021, PLANT BIOLOGY, V23, P728, DOI 10.1111/plb.13283; Andersen K, 1912, CATALOGUE CHIROPTERA, V1; [Anonymous], 2013, PLANT LIST VERSION 1; Aslan CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066993; Baker H. G., 1970, REV BIOL TROP, V17, P187, DOI https://doi.org/10.15517/rbt.v17i2; CCBA, 2008, CLIM COMM BIOD PROJ; Costa VBS, 2017, PLANT BIOLOGY, V19, P115, DOI 10.1111/plb.12523; DOBSON G. E., 1876, MONOGRAPH ASIATIC CH; Endress PK, 1997, PLANT SYST EVOL, V206, P99, DOI 10.1007/BF00987943; Evans MS., 1895, NATURE, V51, P235; FAEGRI K, 1979, P244; Fiji Meteorological Service, 2012, RSMC NAD TROP CYCL C; Fijian Ministry of Forestry, COL SUV FOR PARK; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Freeman PW, 1995, BIOL J LINN SOC, V56, P439; Gottlinger T, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00205; Goldingay Ross L., 2005, Cunninghamia, V9, P324; Gonzalez-Terrazas TP, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160199; GOULD E, 1978, BIOTROPICA, V10, P184, DOI 10.2307/2387904; HOOGLAND R. D., 1959, BLUMEA, V9, P577; HOOGLAND R. D., 1952, BLUMEA, V7, P1; Hopkins H. C. F., 1993, Kew Bulletin, V48, P297, DOI 10.2307/4117936; Horn JW, 2009, INT J PLANT SCI, V170, P794, DOI 10.1086/599239; Horn JW, 2007, FAMILIES GENERA VASC, V9, P132; IUCN, 2008, 2008 IUCN RED LIST T; Johnson KA, 2011, INT J PLANT SCI, V172, P173, DOI 10.1086/657280; Keppel Gunnar, 2005, Pacific Science, V59, P175, DOI 10.1353/psc.2005.0021; Kobayashi S, 2021, PLANT SPEC BIOL, V36, P84, DOI 10.1111/1442-1984.12298; Kobayashi S, 2020, J FOREST RES-JPN, V25, P315, DOI 10.1080/13416979.2020.1762308; Koopman Karl F., 1995, American Museum Novitates, V3125, P1; LADLEY JJ, 1995, NATURE, V378, P766, DOI 10.1038/378766a0; Ladley JJ, 1997, NEW ZEAL J BOT, V35, P345; Lavery TH, 2021, PAC CONSERV BIOL, V27, P27, DOI 10.1071/PC20035; Nassar JM, 1997, AM J BOT, V84, P918, DOI 10.2307/2446282; Ng W., 2020, BIODIVERSITAS, V21, P5579, DOI https://doi.org/10.13057/biodiv/d211203; Olson D, 2010, ORYX, V44, P57, DOI 10.1017/S0030605309990688; Palmeirim J, 2008, NOTOPTERIS MACDONALD, DOI [10.2305/IUCN.UK.2008.RLTS.T14876A4467479.en, DOI 10.2305/IUCN.UK.2008.RLTS.T14876A4467479.EN]; Pestell AJL, 2007, AUST J ZOOL, V55, P275, DOI 10.1071/ZO07037; Petit S, 1997, BIOTROPICA, V29, P175, DOI 10.1111/j.1744-7429.1997.tb00022.x; Petit S., 2021, KANGAROO ISLAND RES; Petit S, 2011, AUST J BOT, V59, P593, DOI 10.1071/BT11226; Petit S, 2011, ECOL RES, V26, P461, DOI 10.1007/s11284-010-0799-7; Raju Aluri J. S., 2005, Ornithological Science, V4, P81, DOI 10.2326/osj.4.81; Ratto F, 2018, FRONT ECOL ENVIRON, V16, P82, DOI 10.1002/fee.1763; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Scanlon A, 2014, ORYX, V48, P451, DOI 10.1017/S0030605312001664; Scanlon AT, 2018, GLOBAL CHANGE BIOL, V24, P3820, DOI 10.1111/gcb.14103; Scanlon Annette Therese, 2015, Pacific Conservation Biology, V21, P315, DOI 10.1071/PC15019; Scanlon AT, 2014, BIOL CONSERV, V174, P111, DOI 10.1016/j.biocon.2014.03.023; Singaravelan N, 2004, J MAMMAL, V85, P1, DOI 10.1644/1545-1542(2004)085<0001:NFAPCF>2.0.CO;2; Sirikolo M., 2020, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2020-1.RLTS.T61995534A61995542.en, DOI 10.2305/IUCN.UK.2020-1.RLTS.T61995534A61995542.EN]; Smith AC, 1981, FLORA VITIENSIS NOVA, V2; Soltis D., 2018, PHYLOGENY EVOLUTION, P590, DOI DOI 10.7208/CHICAGO/9780226441757.001.0001; Sritongchuay T, 2016, J TROP ECOL, V32, P269, DOI 10.1017/S0266467416000353; Tokumoto Y, 2016, J TROP ECOL, V32, P50, DOI 10.1017/S0266467415000632; Toyama C, 2012, MAMM STUDY, V37, P205, DOI 10.3106/041.037.0304; Vincenot CE, 2017, SCIENCE, V355, P1368, DOI 10.1126/science.aam7582; Vogel S, 2004, TAXON, V53, P55, DOI 10.2307/4135488; Von Helversen D, 2003, J EXP BIOL, V206, P1025, DOI 10.1242/jeb.00203; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; Willmer P., 2011, POLLINATION FLORAL E; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Winter Y, 2003, J MAMMAL, V84, P886, DOI 10.1644/BWG-032; Yu YM, 2021, PLANT BIOLOGY, V23, P156, DOI 10.1111/plb.13197	65	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262985	10.1371/journal.pone.0262985	http://dx.doi.org/10.1371/journal.pone.0262985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113889	Green Accepted, gold, Green Published			2022-12-26	WOS:000823694700046
J	Vowels, LM; Francois-Walcott, RRR; Carnelley, KB; Checksfield, EL				Vowels, Laura M.; Francois-Walcott, Rachel R. R.; Carnelley, Katherine B.; Checksfield, Emily L.			Adapting to change: How has COVID-19 affected people's work and personal goals?	PLOS ONE			English	Article							ADAPTATION; PERSPECTIVE	COVID-19 has had a devastating impact on the global economy and affected millions of people's work and personal lives across the world. The purpose of the present study was to better understand how individuals' work and personal goals have been affected by the pandemic and how they have adapted to these changes. We conducted qualitative semi-structured interviews (n = 48) and surveyed participants (n = 200) weekly for 5 weeks. Both methods revealed similar themes regarding the adaptation and pursuit of goals (social support, handling unpredictable situations, logistics, solving problems creatively, goal postponement, and no changes). Survey responses also showed that most individuals experienced their goals as more difficult (79%; 13% easier; 9% no change) and found that many had had to adapt or postpone their work and personal goals, often due to logistical difficulties. Businesses and governments should do more to help individuals adapt their goals to the new circumstances.	[Vowels, Laura M.; Francois-Walcott, Rachel R. R.; Carnelley, Katherine B.; Checksfield, Emily L.] Univ Southampton, Sch Psychol Life & Environm Sci, Southampton, Hants, England	University of Southampton	Carnelley, KB (corresponding author), Univ Southampton, Sch Psychol Life & Environm Sci, Southampton, Hants, England.	k.carnelley@soton.ac.uk		Carnelley, Katherine/0000-0003-4064-8576; Francois-Walcott, Rachel/0000-0001-7628-305X; Vowels, Laura/0000-0001-5594-2095	University of Southampton	University of Southampton	M.V. Jubilee Scholarship, University of Southampton, https://www.southampton.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for L. M. V., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akkermans J, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103434; Alharbi NK, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1917; [Anonymous], 2020, INEWS; Ashforth BE, 2000, ACAD MANAGE REV, V25, P472, DOI 10.2307/259305; Baard SK, 2014, J MANAGE, V40, P48, DOI 10.1177/0149206313488210; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Burke CS, 2006, J APPL PSYCHOL, V91, P1189, DOI 10.1037/0021-9010.91.6.1189; Capitano J, 2018, J VOCAT BEHAV, V109, P87, DOI 10.1016/j.jvb.2018.10.002; Carlson DL., 2020, PREPRINT; Chartered Institute of Personnel and Development, 2020, HOM WORK SET MOR DOU; Consultancy UK, 2020, WORKING HOME HAS LIF, DOI [10.1016/j.amp.2020.06.001, DOI 10.1016/J.AMP.2020.06.001]; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Fitzsimons GM, 2016, RES ORGAN BEHAV, V36, P135, DOI 10.1016/j.riob.2016.11.006; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; ILO, 2021, ILO MONITOR COVID 19, V7th; KANFER R, 1989, J APPL PSYCHOL, V74, P657, DOI 10.1037/0021-9010.74.4.657; Konig CJ, 2010, J PERS PSYCHOL, V9, P50, DOI 10.1027/1866-5888/a000002; Kozlowski SWJ., 2008, TEAM EFFECTIVENESS C, P147; Little B.R., 2007, PERSONAL PROJECT PUR, P3; Little B.R., 1993, PSYCHOL PERSPECTIVES, P157; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Restubog SLD, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103440; Ritchie L, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.559114; Sonnentag S, 2010, J VOCAT BEHAV, V76, P355, DOI 10.1016/j.jvb.2009.06.005; TOSI HL, 1991, ACAD MANAGE REV, V16, P480, DOI 10.2307/258875; Vohs K., 2016, HDB SELF REGULATION; World Bank, 2020, COVID 19 PLUNG GLOB	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262195	10.1371/journal.pone.0262195	http://dx.doi.org/10.1371/journal.pone.0262195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113868	Green Published, Green Accepted, gold			2022-12-26	WOS:000823694700021
J	Kindie, Z; Mulu, A				Kindie, Zerihun; Mulu, Abay			Prevalence of neural tube defects at Debre Berhan Referral Hospital, North Shewa, Ethiopia. A hospital based retrospective cross-section study	PLOS ONE			English	Article							AFFECTED PREGNANCIES; RISK-FACTORS	Background Neural tube defect (NTD) is a structural defect of the central nervous system of the developing embryo during the first month of developmental process. Most congenital malformations are potentially preventable cause of perinatal morbidity and mortality. Worldwide, around 10% of infant mortalities are due to nervous system defects. In Ethiopia there are limited published data regarding the prevalence and established preventive strategy of NTDs. The purpose of this study was to assess the prevalence of NTDs among pregnancy outcomes in Debre Berhan Referral Hospital (DBRH), Ethiopia. Methods Hospital based retrospective cross sectional, descriptive study was conducted on registration of all pregnancy outcomes from August 30, 2017 to August 30, 2019 at DBRH, Ethiopia. The collected data were checked for completeness and consistencies, and cleaned, coded and entered using Epi data version 4.2 and exported to Statistical Package for Social Sciences (SPSS) software version 20 for analysis. Variables were interpreted per 1000 pregnancies and those variables having p<0.05 was considered as statistically significant. Results The total prevalence of NTDs was 10.9 (95% CI 8.9 to 13.3) per 1000 pregnancies and the prevalence of each NTD type was anencephaly 5.6 (95% CI 4.2 to 7.4) per 1000 pregnancies, spina bifida 3.5 (95% CI 2.4 to 4.9) per 1000 pregnancies, encephalocele 1.1 (95% CI 0.6 to 2.0) per 1000 pregnancies, and both spina bifida and anencephaly 0.7(95% CI 0.3 to 1.4) per 1000 pregnancies. Among livebirths, aborted, stillbirths and medically terminated pregnancies (n = 8862), there were 50 anencephaly cases, 31 spina bifida cases, 10 encephalocele cases, and 6 cases affected by both spina bifida and anencephaly. Conclusion The prevalence of NTDs in this study was among the highest globally reported. The total prevalence was 10.9 per 1000 pregnancies. Increased periconceptional folic acid use, counseling for women with certain medical illnesses at higher risk for NTDs, and early maternal screening for genetic factors are possible approaches to reduce in NTDs in the population.	[Kindie, Zerihun] Assosa Univ, Coll Hlth Sci, Sch Med, Dept Anat, Assosa, Ethiopia; [Mulu, Abay] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Anat, Addis Ababa, Ethiopia	Addis Ababa University	Mulu, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Anat, Addis Ababa, Ethiopia.	abaymulu@gmail.com		Mulu, Abay/0000-0002-6396-2181				Berihu BA, 2019, BRAIN DEV-JPN, V41, P11, DOI 10.1016/j.braindev.2018.07.013; Bourouba R., 2018, EGYPT J MED HUM GENE, V19, P225; De Marco P, 2011, CHILD NERV SYST, V27, P1073, DOI 10.1007/s00381-010-1372-y; Flores AL, 2014, INDAN J COMMUNITY HE, V26, P3; Gedefaw A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4829023; Golalipour MJ, 2010, IRAN J PUBLIC HEALTH, V39, P116; Henson G, 2000, J OBSTET GYNAECOL, V20, P651; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P849, DOI 10.1002/bdra.23036; Kumari D., 2014, IOSR J DENT MED SCI, V13, P01; Makelarski JA, 2010, THESIS U IOWA, DOI [10.17077/etd.5dw3uq1h, DOI 10.17077/ETD.5DW3UQ1H]; Muller P, 2006, AM J OBSTET GYNECOL, V195, pS194, DOI 10.1016/j.ajog.2006.10.698; Omer Ilham M, 2016, BMC Res Notes, V9, P495; Poletta FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193127; Rajab A, 1998, J TROP PEDIATRICS, V44, P300, DOI 10.1093/tropej/44.5.300; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Shaw GM, 1998, TERATOLOGY, V57, P1; Taye M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161998; Welderufael AL, 2019, BRAIN DEV-JPN, V41, P406, DOI 10.1016/j.braindev.2018.12.005; Whiteman D, 2000, AM J EPIDEMIOL, V152, P823, DOI 10.1093/aje/152.9.823; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0261177	10.1371/journal.pone.0261177	http://dx.doi.org/10.1371/journal.pone.0261177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108260	Green Published, gold			2022-12-26	WOS:000775890100007
J	Varoni, EM; Cinquanta, L; Rigoni, M; Di Valentin, G; Lodi, G; Muti, P; Sardella, A; Carrassi, A				Varoni, Elena M.; Cinquanta, Lucrezia; Rigoni, Marta; Di Valentin, Giulia; Lodi, Giovanni; Muti, Paola; Sardella, Andrea; Carrassi, Antonio			The impact of COVID-19 on the dental hygienists: A cross-sectional study in the Lombardy first-wave outbreak	PLOS ONE			English	Article							TRANSMISSION; KNOWLEDGE	The impact of COVID-19 on socio-economical activities has changed everyday life. Dental hygienists, who perform aerosol generating procedures, have been strongly affected by changes in routine procedures. This cross-sectional study aimed at carrying out an online survey among dental hygienists in Lombardy. The survey was implemented after the first-wave lockdown focusing on the level of knowledge on COVID-19 and Sars-CoV-2, the virus-related changes in their attitude and working routine, and the socio-economic effects. In this report, we included 313 questionnaires of respondents (259 Females, and 54 Males; age = 33 +/- 9 years). A significant percentage of respondents acknowledged the use of "word of mouth" among colleagues (n = 114, 36%) and social networks (n = 113, 36%) to be up to date on COVID-19. About half of respondents correctly identified the main COVID-19 symptoms/signs, just 13% (n = 41) identified the routes of transmission. Three quarters of respondents (n = 234, 75%) were afraid of being infected during the clinical practice, and about half of them would be afraid to treat patients having symptoms attributable to COVID-19. Twenty-one percent (n = 67) of participants also thought about changing job. Air-polishing was identified as the highest risk procedure, and 82% (n = 256) reported that they eliminated its use. Most claimed they never had a swab or a serological test, with two respondents positive to molecular test (0.6%), and 12 positives to serological test (3.8%). More than half of the participants (65%; n = 202) complained the dental hygienist is not protected, despite a loss of earnings due to lockdown between 2,000 and 10,000 euros. This study demonstrated that dental hygienists were emotionally and economically affected by the pandemic, significantly changing their work routine. Anti-epidemic protocols are pivotal to react promptly and to contain the virus in the dental setting.	[Varoni, Elena M.; Cinquanta, Lucrezia; Rigoni, Marta; Di Valentin, Giulia; Lodi, Giovanni; Muti, Paola; Sardella, Andrea; Carrassi, Antonio] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy	University of Milan	Varoni, EM (corresponding author), Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy.	elena.varoni@unimi.it		Varoni, Elena Maria/0000-0002-7287-2188; SARDELLA, ANDREA/0000-0003-4491-4640				Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821; [Anonymous], 2020, AN RIESG PREV COV; Bakaeen LG, 2021, J AM DENT ASSOC, V152, P16, DOI 10.1016/j.adaj.2020.09.022; Bastani P, 2021, SYST REV-LONDON, V10, DOI 10.1186/s13643-020-01574-5; Bellini P, 2020, MINERBA DENT ORAL SC, DOI [10.23736/S0026-4970.20.04475-1, DOI 10.23736/S0026-4970.20.04475-1]; Bonta G, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05842-x; Brondani M, 2021, JDR CLIN TRANSL RES, V6, P40, DOI 10.1177/2380084420961089; Brondani M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249186; Broussard IM., 2021, STATPEARLS; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Cagetti MG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113835; CDC, 2020, COR DIS 2019 COVID 1; Dziedzic A, 2022, ORAL DIS, V28, P904, DOI 10.1111/odi.13520; Estrich CG, 2020, J AM DENT ASSOC, V151, P815, DOI 10.1016/j.adaj.2020.09.005; Ghalavand H, 2022, BEHAV INFORM TECHNOL, V41, P1544, DOI 10.1080/0144929X.2021.1886326; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gurenlian JoAnn R, 2021, J Dent Hyg, V95, P17; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Johnson IG, 2021, DENT PERIODONTAL PRO; Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798; Klompas M, 2020, JAMA-J AM MED ASSOC, V324, P441, DOI 10.1001/jama.2020.12458; Lamont T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub5; Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; Mustafa RM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239016; Nassar AH, 2020, JAMA SURG, V155, P624, DOI 10.1001/jamasurg.2020.1219; Nasser Z, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01273-6; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Polizzi E, 2020, ORAL HLTH PREV DENT, V18, P1031, DOI 10.3290/j.ohpd.b871059; Salute M della, IND OP ATT OD DUR FA; Sedrak Mina S, 2018, Am Soc Clin Oncol Educ Book, V38, P894, DOI 10.1200/EDBK_204453; Sezgin GP, 2021, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0112; Shacham M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082900; Srivastava KC, 2020, J INT MED RES, V48, DOI 10.1177/0300060520977593; Stehr-Green P., 2003, FOCUS FIELD EPIDEMIO	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262747	10.1371/journal.pone.0262747	http://dx.doi.org/10.1371/journal.pone.0262747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108297	Green Published, gold			2022-12-26	WOS:000775890100034
J	Voigt, A; Omholt, S; Almaas, E				Voigt, Andre; Omholt, Stig; Almaas, Eivind			Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy	PLOS ONE			English	Article							PRACTICES INTERIM RECOMMENDATION; ADVISORY-COMMITTEE; UNITED-STATES; IMMUNIZATION; AGE; 1ST	With limited availability of vaccines, an efficient use of the limited supply of vaccines in order to achieve herd immunity will be an important tool to combat the wide-spread prevalence of COVID-19. Here, we compare a selection of strategies for vaccine distribution, including a novel targeted vaccination approach (EHR) that provides a noticeable increase in vaccine impact on disease spread compared to age-prioritized and random selection vaccination schemes. Using high-fidelity individual-based computer simulations with Oslo, Norway as an example, we find that for a community reproductive number in a setting where the base pre-vaccination reproduction number R = 2.1 without population immunity, the EHR method reaches herd immunity at 48% of the population vaccinated with 90% efficiency, whereas the common age-prioritized approach needs 89%, and a population-wide random selection approach requires 61%. We find that age-based strategies have a substantially weaker impact on epidemic spread and struggle to achieve herd immunity under the majority of conditions. Furthermore, the vaccination of minors is essential to achieving herd immunity, even for ideal vaccines providing 100% protection.	[Voigt, Andre; Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway; [Omholt, Stig] NTNU Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Voigt, A (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway.	andre.viogt@ntnu.no			Norwegian Research Council [270068]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	AV, EA -Norwegian Research Council Grant 270068: ELIXIR Norway - a distributed infrastructure for the next generation of life science Norwegian Research Council: https://prosjektbanken.forskningsradet.no/en/explore/projects The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avadhanula V, 2021, J INFECT DIS, V223, P1528, DOI 10.1093/infdis/jiab097; Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959; Buckner JH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025786118; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Dooling K, 2020, MMWR-MORBID MORTAL W, V69, P1857, DOI [10.15585/mmwr.mm6949e1, 10.15585/mmwr.mm695152e2]; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Fitzpatrick MC, 2021, SCIENCE, V371, P890, DOI 10.1126/science.abg2334; for Disease Prevention EC, 2020, CONTR COVID 19 VACC; Fort H, 2021, VIRUS RES, V304, DOI 10.1016/j.virusres.2021.198531; French National Institute of Statistics and Economic Studies, 2017, HOUS ACC SIZ 2017; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Gomez-Gardenes J, 2006, EUR PHYS J B, V49, P259, DOI 10.1140/epjb/e2006-00041-1; Goyal A, 2021, ELIFE, V10, DOI 10.7554/eLife.63537; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Oliver SE, 2021, MMWR-MORBID MORTAL W, V70, P329, DOI 10.15585/mmwr.mm7009e4; Oliver SE, 2021, MMWR-MORBID MORTAL W, V69, P1653, DOI 10.15585/mmwr.mm695152e1; Oliver SE, 2020, MMWR-MORBID MORTAL W, V69, P1922, DOI 10.15585/mmwr.mm6950e2; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Scientific Advisory Group for Emergencies (SAGE), 2020, SAGE 70 M HOUS HOUS; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Voigt A, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06319-w	26	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263155	10.1371/journal.pone.0263155	http://dx.doi.org/10.1371/journal.pone.0263155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108311	Green Published, gold			2022-12-26	WOS:000775890100050
J	Fernandez, OE; Beltran-Sanchez, H				Fernandez, Oscar E.; Beltran-Sanchez, Hiram			Life span inequality as a function of the moments of the deaths distribution: Connections and insights	PLOS ONE			English	Article							AGE; EXPECTANCY; ENTROPY; SURVIVORSHIP	Recent work has unearthed many empirical regularities in mortality trends, including the inverse correlation between life expectancy and life span inequality, and the compression of mortality into older age ranges. These regularities have furnished important insights into the dynamics of mortality by describing, in demographic terms, how different attributes of the life table deaths distribution interrelate and change over time. However, though empirical evidence suggests that the demographically-meaningful metrics these regularities involve (e.g., life span disparity and life table entropy) are correlated to the moments of the deaths distribution (e.g., variance), the broader theoretical connections between life span inequality and the moments of the deaths distribution have yet to be elucidated. In this article we establish such connections and leverage them to furnish new insights into mortality dynamics. We prove theoretical results linking life span disparity and life table entropy to the central moments of the deaths distribution, and use these results to empirically link statistical measures of variation of the deaths distribution (e.g., variance, index of dispersion) to life span disparity and life table entropy. We validate these results via empirical analyses using data from the Human Mortality Database and extract from them several new insights into mortality shifting and compression in human populations.	[Fernandez, Oscar E.] Wellesley Coll, Dept Math, Wellesley, MA 02181 USA; [Beltran-Sanchez, Hiram] UCLA Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90095 USA; [Beltran-Sanchez, Hiram] Calif Ctr Populat Res, Los Angeles, CA 90095 USA	Wellesley College; University of California System; University of California Los Angeles	Fernandez, OE (corresponding author), Wellesley Coll, Dept Math, Wellesley, MA 02181 USA.; Beltran-Sanchez, H (corresponding author), UCLA Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90095 USA.; Beltran-Sanchez, H (corresponding author), Calif Ctr Populat Res, Los Angeles, CA 90095 USA.	ofernand@wellesley.edu; beltrans@ucla.edu	Fernandez, Oscar/ABC-8697-2021	Fernandez, Oscar/0000-0001-8306-1404	John Simon Guggenheim Memorial Foundation via the Guggenheim Fellowship; National Institute on Aging [R01AG052030]; National Institute of Child Health and Human Development [P2CHD041022]	John Simon Guggenheim Memorial Foundation via the Guggenheim Fellowship; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	O.E.F. is grateful to the John Simon Guggenheim Memorial Foundation for their generous support of this work via the Guggenheim Fellowship O.E.F. received. H.B.S. acknowledges support from grants by the National Institute on Aging (R01AG052030) and the National Institute of Child Health and Human Development (P2CHD041022) to the California Center for Population Research at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto JM, 2020, P NATL ACAD SCI USA, V117, P5250, DOI 10.1073/pnas.1915884117; Aburto JM, 2019, DEMOGR RES, V41, P83, DOI 10.4054/DemRes.2019.41.4; Aburto JM, 2019, AM J PUBLIC HEALTH, V109, P483, DOI 10.2105/AJPH.2018.304878; Aburto JM, 2018, DEMOGRAPHY, V55, P2071, DOI 10.1007/s13524-018-0729-9; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Colchero F, 2016, P NATL ACAD SCI USA, V113, pE7681, DOI 10.1073/pnas.1612191113; DEMETRIUS L, 1978, NATURE, V275, P213, DOI 10.1038/275213a0; Engelman M, 2010, POPUL DEV REV, V36, P511, DOI 10.1111/j.1728-4457.2010.00344.x; Fernandez OE, 2015, THEOR POPUL BIOL, V104, P26, DOI 10.1016/j.tpb.2015.07.001; Glei DA, 2007, POP STUD-J DEMOG, V61, P141, DOI 10.1080/00324720701331433; GOLDMAN N, 1986, DEMOGRAPHY, V23, P275, DOI 10.2307/2061621; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Institute of Medicine, 2013, US HLTH INT PERSP SH, P1; Kannisto V., 2000, DEMOGR RES, V3, P6, DOI [10.4054/demres.2000.3.6, DOI 10.4054/DEMRES.2000.3.6]; KEYFITZ N, 1977, DEMOGRAPHY, V14, P411, DOI 10.2307/2060587; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Luy M, 2014, GERONTOLOGY, V60, P143, DOI 10.1159/000355310; Marmot M.G., 2005, STATUS SYNDROME SOCI; Muszynska Magdalena, 2016, Genus, V72, P6, DOI 10.1186/s41118-016-0011-1; R Core Team, 2020, R LANG ENV STAT COMP; Rudin W, 1953, PRINCIPLES MATH ANAL; Shkolnikov VM, 2011, DEMOGRAPHY, V48, P211, DOI 10.1007/s13524-011-0015-6; Smits J, 2009, SOC SCI MED, V68, P1114, DOI 10.1016/j.socscimed.2008.12.034; Thorslund M, 2013, EUR J AGEING, V10, P271, DOI 10.1007/s10433-013-0274-8; University of California BU and Max Planck Institute for Demographic Research (Germany), 2019, HUM MORT DAT; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Vaupel JW, 2003, DEMOGRAPHY, V40, P201, DOI 10.1353/dem.2003.0018; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wrycza TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119163; Zanotto L, 2021, EUR J POPUL, V37, P1, DOI 10.1007/s10680-019-09552-x; Zhang Z, 2009, DEMOGR RES, V20, P721, DOI 10.4054/DemRes.2009.20.29	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262869	10.1371/journal.pone.0262869	http://dx.doi.org/10.1371/journal.pone.0262869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100280	gold, Green Published			2022-12-26	WOS:000801937600021
J	Li, H; Ren, H; Zhou, YZ; Zhang, Y; Cao, L; Xu, WB				Li, Hai; Ren, Hu; Zhou, Yangzi; Zhang, Yan; Cao, Lei; Xu, Wenbo			HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice	PLOS ONE			English	Article							FUSION-GLYCOPROTEIN VACCINE; SYNCYTIAL VIRUS-DISEASE; RSV; INFANTS; COMBINATION; PROTECTION; POSTFUSION; RESPONSES; EPITOPE; UPDATE	The development of human respiratory syncytial virus (hRSV) vaccine has been hampered by the risk of enhanced respiratory disease (ERD) which was induced by highly skewed toward Th2 immune response. In our previous study, we expressed the recombinant pre-F protein using Escherichia coli BL21, called RBF. To verify if the RBF protein could cause ERD, we tested the immunogenicity and safety of RBF with a commercial alum adjuvant (GMP-grade Adju-Phos). RBF alone and RBF/Adju-Phos elicited long-lasting protective antibodies and a cellular immune response in mice after three immunizations. Unfortunately, compared with the mice in RBF group, mice in RBF/Adju-Phos generated a serious Th2 humoral immune response that elicited Th2-mediated lung pathology. From the IL-4+:IFN gamma+ ratio, there was also a robust Th2 cellullar immunologic response in the RBF/Adju-Phos group. This study demonstrates that it may not be enough for RBF to increase the titer of neutralizing antibodies. A balanced immune response must be induced for hRSV vaccine safety.	[Li, Hai; Ren, Hu; Zhou, Yangzi; Zhang, Yan; Cao, Lei; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Med Virol & Viral Dis, Beijing, Peoples R China; [Zhang, Yan; Xu, Wenbo] Chinese Acad Sci, Ctr Biosafety Megasci, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences	Cao, L; Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.; Xu, WB (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Beijing, Peoples R China.	clsunrise@126.com; wenbo_xu1@aliyun.com			Key Technologies R&D Program of the National Ministry of Science [2018ZX10713002, 2018ZX10713001-003]	Key Technologies R&D Program of the National Ministry of Science	This work was supported by the Key Technologies R&D Program of the National Ministry of Science(2018ZX10713002 and 2018ZX10713001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe GK, 2018, ARCH VIROL, V163, P2283, DOI 10.1007/s00705-018-3814-x; Beran J, 2018, J INFECT DIS, V217, P1616, DOI 10.1093/infdis/jiy065; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; Chen XP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22826-4; Cimica V, 2016, CLIN VACCINE IMMUNOL, V23, P451, DOI 10.1128/CVI.00720-15; Clark CM, 2017, CURR CLIN MICROBIOL, V4, P202, DOI 10.1007/s40588-017-0074-6; Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1; Crunkhorn S, 2014, NAT REV DRUG DISCOV, V13, P17, DOI 10.1038/nrd4207; Cullen LM, 2015, J VIROL, V89, P6835, DOI 10.1128/JVI.00384-15; Esposito S, 2016, FUTURE MICROBIOL, V11, P1479, DOI 10.2217/fmb-2016-0106; Garg R, 2016, VACCINE, V34, P261, DOI 10.1016/j.vaccine.2015.11.029; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Griffin MP, 2020, NEW ENGL J MED, V383, P415, DOI 10.1056/NEJMoa1913556; Heidema J, 2007, J IMMUNOL, V179, P8410, DOI 10.4049/jimmunol.179.12.8410; Hem SL, 2007, VACCINE, V25, P4985, DOI 10.1016/j.vaccine.2007.04.078; Joyce MG, 2016, NAT STRUCT MOL BIOL, V23, P811, DOI 10.1038/nsmb.3267; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; Karron RA, 2017, LANCET, V390, P917, DOI 10.1016/S0140-6736(17)31476-9; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Koivisto K, 2022, J INFECT DIS, V225, P1189, DOI 10.1093/infdis/jiab315; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Lambert SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119509; Langley JM, 2017, J INFECT DIS, V215, P24, DOI 10.1093/infdis/jiw453; Li H, 2020, ARCH VIROL, V165, P1057, DOI 10.1007/s00705-020-04578-7; Madhi SA, 2020, NEW ENGL J MED, V383, P426, DOI 10.1056/NEJMoa1908380; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Openshaw PJM, 2017, ANNU REV IMMUNOL, V35, P501, DOI 10.1146/annurev-immunol-051116-052206; Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4; Roberts JN, 2016, VACCINE, V34, P4843, DOI 10.1016/j.vaccine.2016.07.057; Sastry M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186854; Schickli JH, 2015, J CLIN INVEST, V125, P1637, DOI 10.1172/JCI78450; Schmidt ME, 2020, MUCOSAL IMMUNOL, V13, P507, DOI 10.1038/s41385-019-0243-4; Schneider-Ohrum K, 2019, J VIROL, V93, DOI 10.1128/JVI.00695-19; Staadegaard L, 2021, INFLUENZA OTHER RESP, V15, P732, DOI 10.1111/irv.12885; Swanson KA, 2014, J VIROL, V88, P11802, DOI 10.1128/JVI.01225-14; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Zhan Luting, 2016, Bing Du Xue Bao, V32, P411; Zhang Y, 2016, VACCINE, V34, P252, DOI 10.1016/j.vaccine.2015.11.027; Zheng Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.526965	43	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262231	10.1371/journal.pone.026223	http://dx.doi.org/10.1371/journal.pone.026223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100303				2022-12-26	WOS:000801937600010
J	Torres-Prunonosa, J; Raya, JM; Crespo-Sogas, P; Mur-Gimeno, E				Torres-Prunonosa, Jose; Maria Raya, Josep; Crespo-Sogas, Patricia; Mur-Gimeno, Esther			The economic and social value of spa tourism: The case of balneotherapy in Maresme, Spain	PLOS ONE			English	Article							LOW-BACK-PAIN; COST-EFFECTIVENESS; HOT-SPRINGS; THERAPY; IMPACT; EFFICIENCY; OSTEOARTHRITIS; SEGMENTATION; EVENTS; BANKS	The aim of this article is to assess both the economic and social value of balneotherapy and spa tourism, being the first paper in carrying out this analysis. The study has been conducted in Maresme, a region of Catalonia, Spain. On the one hand, an Input-Output (IO) model with a Social Accounting Matrix (SAM) has been carried out to assess the economic value. On the other hand, a Cost-Benefit Analysis (CBA) has been used to monetise the social value in this region, taking into account, among other concepts, direct and indirect health profits, given that balneotherapy helps to alleviate various diseases. The results show that whereas the economic multiplier is 1.529 considering the direct and indirect effects and 1.712 taking into account also the induced effects, which are similar to health and medical tourism multipliers, social value generates additional positive value, given that the cost-benefit ratio is 1.858. The theoretical implications of the paper as well as the findings' implications for policy so as to encourage investments in spa tourism are discussed.	[Torres-Prunonosa, Jose] Univ Int La Rioja UNIR, Logrono, La Rioja, Spain; [Maria Raya, Josep; Crespo-Sogas, Patricia] Univ Pompeu Fabra, Escola Super Ciencies Socials & Empresa Tecnocamp, Mataro, Spain; [Mur-Gimeno, Esther] Univ Pompeu Fabra, Res Grp Attent Chronic & Innovat Hlth GRACIS, Escola Super Ciencies Salut Tecnocampus, Mataro, Spain	Universidad Internacional de La Rioja (UNIR); Pompeu Fabra University; Pompeu Fabra University	Torres-Prunonosa, J (corresponding author), Univ Int La Rioja UNIR, Logrono, La Rioja, Spain.	jose.torresprunonosa@unir.net	Torres-Pruñonosa, Jose/P-8785-2015	Torres-Pruñonosa, Jose/0000-0003-2276-1655; Mur, Esther/0000-0001-7742-1880	Universidad Internacional de la Rioja; Fundacio Tecnocampus Mataro -Maresme	Universidad Internacional de la Rioja; Fundacio Tecnocampus Mataro -Maresme	JTP. Universidad Internacional de la Rioja. www.unir.net JMR, PCS & EMG. Fundacio Tecnocampus Mataro -Maresme. www.tecnocampus.cat The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkemik KA, 2012, TOURISM MANAGE, V33, P790, DOI 10.1016/j.tourman.2011.09.002; Allard P, 1998, REV RHUM, V65, P173; Alonso-Alvarez L, 2012, J TOUR HIST, V4, P15, DOI 10.1080/1755182X.2012.671373; [Anonymous], 2009, REV SOC ESPA OLA DOL, V16, P417; [Anonymous], SPRING CALDES DESTRA; Argandoa A, 2011, BEIM COMN DOCUMENTO; Aza Conejo R., 2007, International Journal of Sport Management and Marketing, V2, P459, DOI 10.1504/IJSMM.2007.013961; Bai RX, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017092; Balogh Z, 2005, FORSCH KOMP KLAS NAT, V12, P196, DOI 10.1159/000086305; Barajas A, 2014, TOURISM ECON, V20, P279, DOI 10.5367/te.2013.0270; Batlle E., 2005, REV ESPA OLA REUMATO, V32, P22; Butler RW, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11236711; Carneiro MJ., 2013, SOCIOECONOMIC IMPACT, P46; Carrera Percivil M, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P447, DOI 10.1586/14737167.6.4.447; Cheleschi S, 2020, INT J BIOMETEOROL, V64, P1247, DOI 10.1007/s00484-020-01890-4; Chen KH, 2013, INT J HOSP MANAG, V35, P122, DOI 10.1016/j.ijhm.2013.05.013; Cheung H., 2012, STUDIES UNDERGRADUAT, V6, DOI [10.21083/surg.v6i1.2019, DOI 10.21083/SURG.V6I1.2019]; Ciani O, 2017, ARTHRIT CARE RES, V69, P966, DOI 10.1002/acr.23116; Crompton J. L., 2006, Journal of Travel Research, V45, P67, DOI 10.1177/0047287506288870; Daniels M. J., 2003, Journal of Sport Tourism, V8, P214, DOI 10.1080/1477508032000161528; Demsetz Harold, 1993, NATURE FIRM ORIGINS; Dimitrovski D, 2015, TOUR MANAG PERSPECT, V16, P259, DOI 10.1016/j.tmp.2015.09.004; Drakakis P, 2021, TOURISM ECON, V27, P527, DOI 10.1177/1354816620902328; Dryglas D., 2020, International Journal of Spa and Wellness, V3, P69, DOI 10.1080/24721735.2020.1857207; Dunets AN, 2020, ENTREP SUSTAIN ISS, V7, P2213, DOI 10.9770/jesi.2020.7.3(50); Eusebio C., 2012, QUANTITATIVE METHODS, P153, DOI [10.1007/978-3-7908-2879-5_9, DOI 10.1007/978-3-7908-2879-5_9]; Fernandez-de-las-Penas C, 2011, SPINE, V36, pE213, DOI 10.1097/BRS.0b013e3181d952c2; Fioravanti A, 2003, PANMINERVA MED, V45, P211; Fioravanti A, 2017, EUR J INTEGR MED, V9, P148, DOI 10.1016/j.eujim.2017.01.001; FLETCHER JE, 1989, ANN TOURISM RES, V16, P514, DOI 10.1016/0160-7383(89)90006-6; Florio M., 2014, APPL WELFARE EC COST; Freeman R. E., 1984, STRATEGIC MANAGEMENT; Freeman RE, 2004, ORGAN SCI, V15, P364, DOI 10.1287/orsc.1040.0066; Gassenheimer JB, 1998, J ACAD MARKET SCI, V26, P322, DOI 10.1177/0092070398264005; Gati T, 2018, INT J BIOMETEOROL, V62, P897, DOI 10.1007/s00484-017-1491-1; Gomez Rodriguez N, 2003, An Med Interna, V20, P111; Gonzalez-Escalada Castellon JR, 2006, C TEDRA EXTRAORDINAR, P111; Goodrich J. N., 1993, Journal of Travel Research, V32, P36, DOI 10.1177/004728759303200106; Goodrich J.N., 1987, TOURISM MANAGE, V8, P217, DOI [10.1016/0261-5177(87)90053-7, DOI 10.1016/0261-5177(87)90053-7]; Gratton C, 2006, SOCIOL REV, V54, P41, DOI 10.1111/j.1467-954X.2006.00652.x; Guo YY, 2016, ASIA PAC J TOUR RES, V21, P118, DOI 10.1080/10941665.2015.1025085; Gutenbrunner C, 2010, INT J BIOMETEOROL, V54, P495, DOI 10.1007/s00484-010-0321-5; Haji Y, 2021, J PAIN RES, V14, P2491, DOI 10.2147/JPR.S322603; Hernandez-Torres A., 2016, B SOC ESPA OLA HIDRO, V31, P157; INE, 2015, DECIL SAL EMPL PRINC; Jensen MC, 2000, BREAKING THE CODE OF CHANGE, P37; Jeong JY, 2016, J TRAVEL RES, V55, P874, DOI 10.1177/0047287515605932; Jimenez-Naranjo HV, 2016, EUR RES MANAG BUS EC, V22, P131, DOI 10.1016/j.iedee.2015.04.001; Kim H, 2015, TOUR REV, V70, P132, DOI 10.1108/TR-11-2014-0056; Kirkby CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013015; Klijs J, 2015, TOURISM ECON, V21, P931, DOI 10.5367/te.2014.0398; Kroeger A, 2014, ACAD MANAGE REV, V39, P513, DOI 10.5465/amr.2012.0344; Kronenberg K, 2018, TOUR REV, V73, P94, DOI [10.1108/tr-03-2017-0044, 10.1108/TR-03-2017-0044]; Kucukusta D, 2016, ASIA PAC J TOUR RES, V21, P239, DOI 10.1080/10941665.2015.1025087; Laws E., 1996, HLTH INT TOURIST, P199; Lazcano L., 2019, SOCIAL ACCOUNTING SO, P132, DOI [10.4018/978-1-5225-8482-7, DOI 10.4018/978-1-5225-8482-7]; Ledesma R, 2005, MORBILIDAD DISCAPACI; Lee CK, 2017, LEISURE STUD, V36, P138, DOI 10.1080/02614367.2015.1040828; Lingane A, 2004, CALIF MANAGE REV, V46, P116, DOI 10.2307/41166224; Llop M, 2012, ANN REGIONAL SCI, V48, P339, DOI 10.1007/s00168-010-0403-7; Llor JL., 2008, MED NATURISTA, V3, P76; Retolaza JL, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00077; Carbajo JM, 2018, INT J BIOMETEOROL, V62, P1345, DOI 10.1007/s00484-018-1545-z; Maraver F, 2010, VADEMECUM 2 AGUAS MI; Raya JM, 2018, J TRAVEL TOUR MARK, V35, P148, DOI 10.1080/10548408.2017.1350252; Matsumoto S, 2018, J NIPPON MED SCH, V85, P196, DOI 10.1272/jnms.JNMS.2018_85-30; Mayer M, 2014, J SUSTAIN TOUR, V22, P561, DOI 10.1080/09669582.2013.871020; Mennuni G, 2021, Clin Ter, V172, P372, DOI 10.7417/CT.2021.2343; Morer C., 2016, TALASOTERAPIA B SOC, V31, DOI [10.23853/bsehm.2017.0209, DOI 10.23853/BSEHM.2017.0209]; Morer C, 2017, INT J BIOMETEOROL, V61, P2159, DOI 10.1007/s00484-017-1421-2; Mourgues C, 2014, EUR J ONCOL NURS, V18, P505, DOI 10.1016/j.ejon.2014.04.008; Mueller H., 2001, Journal of Vacation Marketing, V7, P5, DOI 10.1177/135676670100700101; Mulgan G., 2010, STANFORD SOCIAL INNO, V8, P38, DOI DOI 10.1257/AER.97.2.433; Nelson R., 1982, EVOL THEOR; Olabe-Sanchez PJ, 2004, REV FISIOTERAPIA, V5; Olsen S., 2008, CATALOG APPROACHES I; Oosterhaven J., 2006, International Journal of Tourism Research, V8, P347, DOI 10.1002/jtr.582; Pittler MH, 2006, RHEUMATOLOGY, V45, P880, DOI 10.1093/rheumatology/kel018; Polo C, 2008, TOURISM ECON, V14, P615, DOI 10.5367/000000008785633604; Novo JP, 2015, REV CUBA REUMATOL, V17, P147; PYATT G, 1979, ECON J, V89, P850, DOI 10.2307/2231503; Retolaza J. L., 2015, NEW CHALLENGES ENTRE, P259, DOI [10.1007/978-3-319-08888, DOI 10.1007/978-3-319-08888, 10.1007/978-3-319-08888-4_19]; Retolaza J.L., 2016, SOCIAL ACCOUNTING SU, DOI [10.1016/j.aprim.2015.06.013, DOI 10.1016/J.APRIM.2015.06.013, 10.1007/978-3-319-13377-5.pdf, DOI 10.1007/978-3-319-13377-5.PDF]; Retolaza JL., 2018, LEGITIMIZING DELEGIT, P159, DOI [10.1007/978-3-319-75990-6_10, DOI 10.1007/978-3-319-75990-6_10]; Salgado-Barandela J, 2021, TOURISM ECON, V27, P436, DOI 10.1177/1354816619884448; San-Jose L., 2012, SOFT COMPUTING MANAG, P153, DOI [10.1007/978-3-642-30451-4_11, DOI 10.1007/978-3-642-30451-4_11]; San-Jose L, 2020, TRIMEST ECON, V87, P759, DOI 10.20430/ete.v87i347.882; San-Jose L, 2014, J INT FINANC MARK I, V32, P240, DOI 10.1016/j.intfin.2014.06.005; Schumpeter J, 1909, Q J ECON, V23, P213, DOI 10.2307/1882798; Silovska HC, 2019, ECON RES-EKON ISTRAZ, V32, P2063, DOI 10.1080/1331677X.2019.1642777; Smith C., 2000, Travel & Tourism Analyst, P41; Smith M.K, 2014, HLTH TOURISM HOSPITA, DOI 10.4324/9780203083772; Snyder J, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-2; Speier Amy R, 2011, Anthropol Med, V18, P55, DOI 10.1080/13648470.2010.525879; Szromek A.R., 2021, J OPEN INNOV-TECHNOL, V7, P73, DOI [10.3390/joitmc7010073, DOI 10.3390/JOITMC7010073, https://doi.org/10.3390/joitmc7010073]; Szromek AR, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11133598; Szromek AR, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102880; Szymanska E, 2017, MODERN TENDENCIES SP; Thorbecke E., 1998, SOCIAL ACCOUNTING MA; Prunonosa JT, 2012, REVESCO-REV ESTUD CO, P152, DOI 10.5209/rev_REVE.2012.v18.39591; Torres-Prunonosa J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.629951; Torres-Prunonosa J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.632600; Van Tubergen A, 2002, ARTHRIT RHEUM-ARTHR, V47, P459, DOI 10.1002/art.10658; Vanhove N, 2013, HANDBOOK OF TOURISM ECONOMICS: ANALYSIS, NEW APPLICATIONS AND CASE STUDIES, P393; Verhagen AP, 2005, BALNEOTERAPIA ARTRIT; Weaver D, 2006, TOURISM MANAGE; West S, 2002, Evid Rep Technol Assess (Summ), P1; Wood J, 2021, TOURISM ECON, V27, P1303, DOI 10.1177/1354816620921577; Zhu Y, 2011, J TOURISM MANAG RES, V15; Zijlstra TR, 2007, RHEUMATOLOGY, V46, P1454, DOI 10.1093/rheumatology/kem157	110	1	1	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262428	10.1371/journal.pone.0262428	http://dx.doi.org/10.1371/journal.pone.0262428			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100293	gold, Green Published			2022-12-26	WOS:000801937600013
J	Belle, SL; Riotte, J; Backhaus, N; Sekhar, M; Jouquet, P; Abiven, S				Belle, Severin-Luca; Riotte, Jean; Backhaus, Norman; Sekhar, Muddu; Jouquet, Pascal; Abiven, Samuel			Tailor-made biochar systems: Interdisciplinary evaluations of ecosystem services and farmer livelihoods in tropical agro-ecosystems	PLOS ONE			English	Article							AGRICULTURE BIOMASS; SOIL PROPERTIES; PLANT-GROWTH; SOLID-WASTE; COMPOST; CARBON; VERMICOMPOST; KNOWLEDGE; EROSION; INDIA	Organic matter management is key to sustain ecosystem services provided by soils. However, it is rarely considered in a holistic view, considering local resources, agro-environmental effects and harmonization with farmers' needs. Organic inputs, like compost and biochar, could represent a sustainable solution to massive current challenges associated to the intensification of agriculture, in particular for tropical regions. Here we assess the potential of agricultural residues as a resource for farmer communities in southwestern India to reduce their dependency on external inputs and sustain ecosystem services. We propose a novel joint evaluation of farmers' aspirations together with agro-environmental effects of organic inputs on soils. Our soil quality evaluation showed that biochar alone or with compost did not improve unilaterally soils in the tropics (Anthroposol, Ferralsol and Vertisol). Many organic inputs led to an initial decrease in water-holding capacities of control soils (-27.3%: coconut shell biochar with compost on Anthroposol). Responses to organic matter inputs for carbon were strongest for Ferralsols (+33.4% with rice husk biochar), and mostly positive for Anthroposols and Vertisols (+12.5% to +13.8% respectively). Soil pH responses were surprisingly negative for Ferralsols and only positive if biochar was applied alone (between -5.6% to +1.9%). For Anthroposols and Vertisols, highest increases were achieved with rice husk biochar + vermicomposts (+7.2% and +5.2% respectively). Our socio-economic evaluation showed that farmers with a stronger economical position showed greater interest towards technology like biochar (factor 1.3 to 1.6 higher for farmers cultivating Anthroposols and/or Vertisols compared to Ferralsols), while poorer farmers more skepticism, which may lead to an increased economical gap within rural communities if technologies are not implemented with long-term guidance. These results advocate for an interdisciplinary evaluation of agricultural technology prior to its implementation as a development tool in the field.	[Belle, Severin-Luca; Backhaus, Norman] Univ Zurich, Dept Geog, Zurich, Switzerland; [Riotte, Jean] Univ Paul Sabatier, Geosci Environm Toulouse, CNRS, IRD, Toulouse, France; [Riotte, Jean; Sekhar, Muddu; Jouquet, Pascal] Indian Inst Sci, Indo French Cell Water Sci, Bangalore, Karnataka, India; [Backhaus, Norman] Univ Zurich, Univ Res Prior Programme URPP Global Change & Bio, Zurich, Switzerland; [Sekhar, Muddu] Indian Inst Sci, Dept Civil Engn, Bangalore, Karnataka, India; [Jouquet, Pascal] Sorbonne Univ, CNRS, Inst Ecol Sci Eenvironm, UPEC,IESS Paris,UMR,IRD,INRAe,FEST Team, Bondy, France; [Abiven, Samuel] PSL Univ, CNRS, Ecole Normale Super, Dept Geosci,Lab Geol, Paris, France; [Abiven, Samuel] PSL Univ, CEREEP Ecotron France, CNRS, ENS, St Pierre Les Nemours, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Indian Institute of Science (IISC) - Bangalore; University of Zurich; Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Abiven, S (corresponding author), PSL Univ, CNRS, Ecole Normale Super, Dept Geosci,Lab Geol, Paris, France.; Abiven, S (corresponding author), PSL Univ, CEREEP Ecotron France, CNRS, ENS, St Pierre Les Nemours, France.	abiven@biotite.ens.fr	Riotte, Jean/K-7185-2017; Bellè, Severin-Luca/AAL-5516-2021	Riotte, Jean/0000-0002-5563-1913; Bellè, Severin-Luca/0000-0002-9881-930X; Backhaus, Norman/0000-0002-9911-4272				Abdulai A, 2006, ENVIRON DEV ECON, V11, P201, DOI 10.1017/S1355770X05002779; Abiven S, 2005, BIOL FERT SOILS, V42, P119, DOI 10.1007/s00374-005-0006-0; Abiven S, 2014, NAT GEOSCI, V7, P326, DOI 10.1038/ngeo2154; Abiven S, 2017, CURR OPIN ENV SUST, V29, P215, DOI 10.1016/j.cosust.2018.04.016; Abiven S, 2011, BIOL FERT SOILS, V47, P111, DOI 10.1007/s00374-010-0489-1; Adhikari K, 2016, GEODERMA, V262, P101, DOI 10.1016/j.geoderma.2015.08.009; Agegnehu G, 2015, AGR ECOSYST ENVIRON, V213, P72, DOI 10.1016/j.agee.2015.07.027; Agegnehu G, 2015, SOIL RES, V53, P1, DOI 10.1071/SR14118; [Anonymous], 2015, BIOCHAR ENV MANAGEME; Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Barbiero L, 2007, CATENA, V70, P313, DOI 10.1016/j.catena.2006.10.013; Barnes RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108340; Barrow CJ, 2012, APPL GEOGR, V34, P21, DOI 10.1016/j.apgeog.2011.09.008; Basso Andres S., 2013, GCB Bioenergy, V5, P132, DOI 10.1111/gcbb.12026; Baur N., 2014, HDB METHODEN EMPIRIS; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Bogner A, 2009, RES METHODS SER, P43; Bunemann EK, 2018, SOIL BIOL BIOCHEM, V120, P105, DOI 10.1016/j.soilbio.2018.01.030; Buvaneshwari S, 2017, SCI TOTAL ENVIRON, V579, P838, DOI 10.1016/j.scitotenv.2016.11.017; Cardoen D, 2015, RESOUR CONSERV RECY, V102, P39, DOI 10.1016/j.resconrec.2015.06.003; Cardoen D, 2015, RESOUR CONSERV RECY, V101, P143, DOI 10.1016/j.resconrec.2015.06.002; Carter S, 2013, AGRONOMY-BASEL, V3, P404, DOI 10.3390/agronomy3020404; Chang YT, 2014, SCI WORLD J, DOI 10.1155/2014/309396; Chen LY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13119-z; Chintala R, 2014, ARCH AGRON SOIL SCI, V60, P393, DOI 10.1080/03650340.2013.789870; Clough TJ, 2013, AGRONOMY-BASEL, V3, P275, DOI 10.3390/agronomy3020275; Crane-Droesch A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044049; Damerau K, 2020, NAT FOOD, V1, P631, DOI 10.1038/s43016-020-00157-w; Das O, 2015, SCI TOTAL ENVIRON, V512, P682, DOI 10.1016/j.scitotenv.2015.01.061; De Schutter O., 2011, SOLUTIONS, V2, P33; Draucker CB, 2007, QUAL HEALTH RES, V17, P1137, DOI 10.1177/1049732307308450; Eden M, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0419-9; FAO, 2011, TEACHING 21 CENTURY; Ghosh N, 2004, ECOL ECON, V49, P149, DOI 10.1016/j.ecolecon.2004.03.016; Giovannucci D., 2012, STRATEGIC INPUT SUST; Gomez C, 2021, GEODERMA REG, V25, DOI 10.1016/j.geodrs.2021.e00389; Grace J, 2014, GLOBAL CHANGE BIOL, V20, P3238, DOI 10.1111/gcb.12600; Hargreaves JC, 2008, AGR ECOSYST ENVIRON, V123, P1, DOI 10.1016/j.agee.2007.07.004; Indian Institute of Science, 2014, TRANS CLIM RES DEV K; IUSS Working Group WRB, 2014, WORLD REFERENCE BASE, DOI [10.1017/S0014479706394902, DOI 10.1017/S0014479706394902]; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Jeffery S, 2015, GCB BIOENERGY, V7, P1, DOI 10.1111/gcbb.12132; Jien SH, 2013, CATENA, V110, P225, DOI 10.1016/j.catena.2013.06.021; Jones DL, 2003, PLANT SOIL, V248, P31, DOI 10.1023/A:1022304332313; Joseph S, 2021, GCB BIOENERGY, V13, P1731, DOI 10.1111/gcbb.12885; Jouquet EP, 2011, COMPOST SCI UTIL, V19, P15; Jouquet P, 2010, APPL SOIL ECOL, V46, P125, DOI 10.1016/j.apsoil.2010.07.002; Kammann CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11080; Kaspar H., 2006, GESELLSCHAFT RAUM KO, V1st ed; KLEINMAN PJA, 1995, AGR ECOSYST ENVIRON, V52, P235, DOI 10.1016/0167-8809(94)00531-I; Kukla J, 2019, LAND DEGRAD DEV, V30, P166, DOI 10.1002/ldr.3203; Kumar M, 2021, J CLEAN PROD, V305, DOI 10.1016/j.jclepro.2021.127143; Kumar P., 2006, AGR EC RES REV, V19, P1; Lehmann J., 2015, BIOCHAR ENV MANAGEME, DOI DOI 10.4324/9780203762264; Lehmann J, 2006, BOOK SOIL P, V113, P517, DOI 10.1201/9781420017113.ch36; Lerche J, 2011, J AGRAR CHANGE, V11, P104, DOI 10.1111/j.1471-0366.2010.00295.x; Lewis J., 2003, QUALITATIVE RES PRAC, P263, DOI DOI 10.4135/9781483348858.N7; Lim SL, 2016, J CLEAN PROD, V111, P262, DOI 10.1016/j.jclepro.2015.08.083; Lim SL, 2015, J SCI FOOD AGR, V95, P1143, DOI 10.1002/jsfa.6849; Liu J, 2012, J PLANT NUTR SOIL SC, V175, P698, DOI 10.1002/jpln.201100172; Mankasingh U, 2011, APPL GEOCHEM, V26, pS218, DOI 10.1016/j.apgeochem.2011.03.108; Martinez-Blanco J, 2013, SUSTAINABLE AGR REV, P255, DOI DOI 10.1007/978-94-007-5961-9_9; Martinsen V, 2015, SOIL SCI PLANT NUTR, V61, P821, DOI 10.1080/00380768.2015.1052985; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; Mehmood K, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0430-1; Meuser M., 2008, HDB FRAUENUND GESCHL, P376; Meuser M., 2009, METHODEN VERGLEICHEN, V1st edn, P465, DOI DOI 10.1007/978-3-531-91826-6_23; Mey Gunter, 2011, GROUNDED THEORY READ, V2nd, P11, DOI DOI 10.1007/978-3-531-93318-4_1; Misra R.V., 2003, LAND WATER DISCUSSIO, VVolume 2, P51; Muller S, 2019, AGRON SUSTAIN DEV, V39, DOI 10.1007/s13593-019-0586-y; National Research Council, 2010, SUSTAINABLE AGR SYST; Patil S, 2014, LAND USE POLICY, V37, P40, DOI 10.1016/j.landusepol.2012.01.006; Ngo PT, 2016, ECOL ENG, V91, P378, DOI 10.1016/j.ecoleng.2016.01.011; Ngo PT, 2011, ECOL ENG, V37, P269, DOI 10.1016/j.ecoleng.2010.11.011; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Purushothaman S, 2013, SUSTAIN SCI, V8, P173, DOI 10.1007/s11625-012-0188-y; Ravindranath NH, 2005, BIOMASS BIOENERG, V29, P178, DOI 10.1016/j.biombioe.2005.03.005; Reddy S. B. N., 2014, BIOCHARCULTURE BIOCH; Richardson AE, 2014, CARBON MANAG, V5, P265, DOI 10.1080/17583004.2014.923226; Robert M, 2017, WATER-SUI, V9, DOI 10.3390/w9010051; Rogers Alisdair, 2013, DICT HUMAN GEOGRAPHY; Saldana J, 2021, CODING MANUAL QUALIT; Schmidt HP, 2017, LAND DEGRAD DEV, V28, P2324, DOI 10.1002/ldr.2761; Scholz SM, 2014, WOR BANK STUD, P1, DOI 10.1596/978-0-8213-9525-7; Sekhar M., 2016, Proceedings of the Indian National Science Academy, V82, P833, DOI 10.16943/ptinsa/2016/48488; Srinivasarao C, 2013, USE BIOCHAR SOIL HLT; Srinivasarao C, 2014, SCI TOTAL ENVIRON, V487, P587, DOI 10.1016/j.scitotenv.2013.10.006; Stavi I, 2013, AGRON SUSTAIN DEV, V33, P81, DOI 10.1007/s13593-012-0081-1; Doan TT, 2015, SCI TOTAL ENVIRON, V514, P147, DOI 10.1016/j.scitotenv.2015.02.005; Trupiano D, 2017, INT J AGRON, V2017, DOI 10.1155/2017/3158207; van Groenigen JW, 2017, ENVIRON SCI TECHNOL, V51, P4738, DOI 10.1021/acs.est.7b01427; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Veeresh S. J., 2011, Bioremediation, Biodiversity and Bioavailability, V5, P77; Wani S. P., 2011, SOIL FERTILITY ATLAS	95	0	0	10	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263302	10.1371/journal.pone.0263302	http://dx.doi.org/10.1371/journal.pone.0263302			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089983	Green Published, gold			2022-12-26	WOS:000769158400051
J	Karal, MA; Mokta, NA; Levadny, V; Belaya, M; Ahmed, M; Ahamed, MK; Ahammed, S				Karal, Mohammad Abu Sayem; Mokta, Nadia Akter; Levadny, Victor; Belaya, Marina; Ahmed, Marzuk; Ahamed, Md. Kabir; Ahammed, Shareef			Effects of cholesterol on the size distribution and bending modulus of lipid vesicles	PLOS ONE			English	Article							WATER PERMEABILITY; GIANT VESICLES; MEMBRANES; CURVATURE; ELASTICITY; BILAYERS; RIGIDITY; STIFFNESS; DELIVERY; PEPTIDE	The influence of cholesterol fraction in the membranes of giant unilamellar vesicles (GUVs) on their size distributions and bending moduli has been investigated. The membranes of GUVs were synthesized by a mixture of two elements: electrically neutral lipid 1, 2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and cholesterol and also a mixture of three elements: electrically charged lipid 1,2-dioleoyl-sn-glycero-3-phospho-(1 ' -rac-glycerol) (DOPG), DOPC and cholesterol. The size distributions of GUVs have been presented by a set of histograms. The classical lognormal distribution is well fitted to the histograms, from where the average size of vesicle is obtained. The increase of cholesterol content in the membranes of GUVs increases the average size of vesicles in the population. Using the framework of Helmholtz free energy of the system, the theory developed by us is extended to explain the experimental results. The theory determines the influence of cholesterol on the bending modulus of membranes from the fitting of the proper histograms. The increase of cholesterol in GUVs increases both the average size of vesicles in population and the bending modulus of membranes.	[Karal, Mohammad Abu Sayem; Mokta, Nadia Akter; Ahmed, Marzuk; Ahamed, Md. Kabir; Ahammed, Shareef] Bangladesh Univ Engn & Technol, Dept Phys, Dhaka, Bangladesh; [Levadny, Victor] Russian Acad Sci, Theoret Problem Ctr Physicochem Pharmacol, Moscow, Russia; [Belaya, Marina] Russian State Univ Humanities, Dept Math, Moscow, Russia	Bangladesh University of Engineering & Technology (BUET); Russian Academy of Sciences; Russian State University for the Humanities	Karal, MA (corresponding author), Bangladesh Univ Engn & Technol, Dept Phys, Dhaka, Bangladesh.	asayem221@phy.buet.ac.bd		Sayem Karal, Mohammad Abu/0000-0001-5288-2357; Ahamed, Md. Kabir/0000-0001-8245-8397; Ahmed, Marzuk/0000-0003-2322-7657				Ahamed MK, 2020, EUR BIOPHYS J BIOPHY, V49, P371, DOI 10.1007/s00249-020-01440-1; Ahmed M, 2021, EUR PHYS J E, V44, DOI 10.1140/epje/s10189-021-00071-4; Alam JM, 2012, BIOCHEMISTRY-US, V51, P5160, DOI 10.1021/bi300448g; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Alwarawrah M, 2010, J PHYS CHEM B, V114, P7516, DOI 10.1021/jp101415g; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Armstrong CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066162; Arriaga LR, 2009, BIOPHYS J, V96, P3629, DOI 10.1016/j.bpj.2009.01.045; Ashkar R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102845118; Ashkar R, 2019, BIOPHYS J, V116, p328A, DOI 10.1016/j.bpj.2018.11.1780; Bardania H, 2017, ARTIF CELL NANOMED B, V45, P1478, DOI 10.1080/21691401.2017.1290647; Bassereau P, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aacb98; Blosser MC, 2016, SOFT MATTER, V12, P7364, DOI 10.1039/c6sm00868b; Boal D. H., 2002, MECH CELL; Chakraborty S, 2020, P NATL ACAD SCI USA, V117, P21896, DOI 10.1073/pnas.2004807117; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Claessens MMAE, 2004, BIOPHYS J, V87, P3882, DOI 10.1529/biophysj.103.036772; Crafford G., 2007, STAT ANAL GROUPED DA; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; DEPIERRE JW, 1973, J CELL BIOL, V56, P275, DOI 10.1083/jcb.56.2.275; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; Dimova R, 2014, ADV COLLOID INTERFAC, V208, P225, DOI 10.1016/j.cis.2014.03.003; Doktorova M, 2017, BIOPHYS J, V113, P2004, DOI 10.1016/j.bpj.2017.08.055; DUWE HP, 1990, J PHYS-PARIS, V51, P945, DOI 10.1051/jphys:019900051010094500; Eid J, 2020, J PHYS CHEM B, V124, P6299, DOI 10.1021/acs.jpcb.0c04253; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Evans E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095010; Faizi HA, 2020, SOFT MATTER, V16, P8996, DOI 10.1039/d0sm00943a; Faizi HA, 2019, SOFT MATTER, V15, P6006, DOI 10.1039/c9sm00772e; Falck E, 2004, BIOPHYS J, V87, P1076, DOI 10.1529/biophysj.104.041368; Finegold L.X., 1992, CHOLESTEROL MEMBRANE; FISCHER TM, 1992, J PHYS II, V2, P327, DOI 10.1051/jp2:1992129; FISCHER TM, 1993, J PHYS II, V3, P1795, DOI 10.1051/jp2:1993230; Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221; Gracia RS, 2010, SOFT MATTER, V6, P1472, DOI 10.1039/b920629a; Gupta S, 2019, CURR OPIN COLLOID IN, V42, P121, DOI 10.1016/j.cocis.2019.05.003; Henriksen J, 2006, BIOPHYS J, V90, P1639, DOI 10.1529/biophysj.105.067652; Henriksen J, 2004, EUR BIOPHYS J BIOPHY, V33, P732, DOI 10.1007/s00249-004-0420-5; Holmberg K., 2002, SURFACTANTS POLYM AQ, Vsecond, DOI [10.1002/0470856424, DOI 10.1002/0470856424]; Huang CJ, 2017, P NATL ACAD SCI USA, V114, P2910, DOI 10.1073/pnas.1702065114; Iqbal U, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/19/195102; Johnson N., 1994, CONTINUOUS UNIVARIAT, V2; JOHNSON SM, 1973, BIOCHIM BIOPHYS ACTA, V307, P27, DOI 10.1016/0005-2736(73)90022-9; Karal MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254930; Karal MA, 2020, CHEM PHYS LIPIDS, V231, DOI 10.1016/j.chemphyslip.2020.104935; Karal MA, 2020, EUR BIOPHYS J BIOPHY, V49, P361, DOI 10.1007/s00249-020-01443-y; Karal MA, 2020, J FLUORESC, V30, P735, DOI 10.1007/s10895-020-02560-9; Karal MA, 2020, CHEM PHYS LIPIDS, V230, DOI 10.1016/j.chemphyslip.2020.104916; Karal MA, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.012404; Karal MA, 2020, EUR BIOPHYS J BIOPHY, V49, P59, DOI 10.1007/s00249-019-01412-0; Karal MA, 2019, EUR BIOPHYS J BIOPHY, V48, P731, DOI 10.1007/s00249-019-01398-9; Karal MA, 2019, EUR BIOPHYS J BIOPHY, V48, P349, DOI 10.1007/s00249-019-01363-6; Karal MA, 2015, LANGMUIR, V31, P3391, DOI 10.1021/la503318z; Kheyfets B., 2015, AREA LIPID DPPC CHOL; Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023; Magarkar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05005; Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Marsh D, 1997, BIOPHYS J, V73, P865, DOI 10.1016/S0006-3495(97)78119-0; Marsh D, 2006, CHEM PHYS LIPIDS, V144, P146, DOI 10.1016/j.chemphyslip.2006.08.004; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Meleard P, 1997, BIOPHYS J, V72, P2616, DOI 10.1016/S0006-3495(97)78905-7; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nagle JF, 2021, PHYS REV E, V104, DOI 10.1103/PhysRevE.104.044405; Nagle JF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025011118; Nagle JF, 2015, CHEM PHYS LIPIDS, V185, P3, DOI 10.1016/j.chemphyslip.2014.04.003; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Neter J., 1996, APPL LINEAR STAT MOD; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Rawicz W, 2008, BIOPHYS J, V94, P4725, DOI 10.1529/biophysj.107.121731; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Sackmann E., 1995, HDB BIOL PHYS A&B, V1A, P213, DOI [10.1016/S1383-8121(06)80022-9, DOI 10.1016/S1383-8121(06)80022-9]; Segota S, 2006, ADV COLLOID INTERFAC, V121, P51, DOI 10.1016/j.cis.2006.01.002; Sharmin S, 2016, BIOCHEMISTRY-US, V55, P4154, DOI 10.1021/acs.biochem.6b00189; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Tamba Y, 2011, CHEM PHYS LIPIDS, V164, P351, DOI 10.1016/j.chemphyslip.2011.04.003; Tian AW, 2009, BIOPHYS J, V97, P1636, DOI 10.1016/j.bpj.2009.07.012; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Yamashita Y, 2002, BBA-BIOMEMBRANES, V1561, P129, DOI 10.1016/S0005-2736(02)00338-3; Zilman AG, 1996, PHYS REV LETT, V77, P4788, DOI 10.1103/PhysRevLett.77.4788; Zupanc J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113405	87	2	2	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263119	10.1371/journal.pone.0263119	http://dx.doi.org/10.1371/journal.pone.0263119			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089965	Green Published, gold			2022-12-26	WOS:000769158400039
J	Suzuki, S; Toyoma, S; Kawasaki, Y; Yamada, T				Suzuki, Shinsuke; Toyoma, Satoshi; Kawasaki, Yohei; Yamada, Takechiyo			Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma	PLOS ONE			English	Article							RADIATION; CANCER; INVASIVENESS; CHEMOTHERAPY; RADIOTHERAPY; METASTASIS; MECHANISMS; RECURRENT	Background Cytotoxic effects of radiation play an important role in the treatment of head and neck cancer. However, irradiation is known to lead to the migration of various cancer cells, including those of head and neck cancer. Recently, fibroblasts in the cancer microenvironment have been reported to be involved in this mechanism. Nevertheless, the mechanism underlying migration of head and neck cancer cells remains unclear. Herein, we aimed to elucidate this migration mechanism induced by irradiation in terms of the interaction of head and neck cancer cells with fibroblasts. Methods We used the head and neck squamous cell carcinoma (HNSCC) cell lines SAS and FaDu as well as fibroblast cell lines. These cells were irradiated and their viability was compared. In fibroblasts, changes in interleukin-6 (IL-6) secretion caused by irradiation were measured by enzyme-linked immunosorbent assay (ELISA). The cell migration ability of cancer cells was evaluated via a migration assay using a semipermeable membrane. HNSCC cells were cocultured with irradiated and nonirradiated fibroblasts, and their migration ability under each condition was compared. We also examined the effect of IL-6 on the migration of HNSCC cells. Furthermore, to investigate the effect of fibroblast-derived IL-6 on the migration ability of HNSCC cells, we conducted a coculture study using IL-6 neutralizing antibody. Results Irradiation reduced the survival of HNSCC cells, whereas fibroblasts were resistant to irradiation. Irradiation also increased IL-6 secretion by fibroblasts. Migration of HNSCC cells was enhanced by coculture with fibroblasts and further enhanced by coculture with irradiated fibroblasts. We also confirmed that the migration of HNSCC cells was induced by IL-6. The enhanced migration of cancer cells caused by coculturing with fibroblasts was canceled by the IL-6 neutralizing antibody. Conclusion These results show that fibroblasts survive irradiation and induce the migration ability of HNSCC cells through increased secretion of IL-6.	[Suzuki, Shinsuke; Toyoma, Satoshi; Kawasaki, Yohei; Yamada, Takechiyo] Akita Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Akita, Japan	Akita University	Suzuki, S (corresponding author), Akita Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Akita, Japan.	suzukis@med.akita-u.ac.jp		Suzuki, Shinsuke/0000-0001-8555-1722				ANDERSON P, 1981, INT J RADIAT ONCOL, V7, P1645, DOI 10.1016/0360-3016(81)90186-3; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Baskar Rajamanickam, 2014, Front Mol Biosci, V1, P24, DOI 10.3389/fmolb.2014.00024; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Bouchard G, 2013, BRIT J CANCER, V109, P1829, DOI 10.1038/bjc.2013.502; Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7; Choy EH, 2020, NAT REV RHEUMATOL, V16, P335, DOI 10.1038/s41584-020-0419-z; Ebbing EA, 2019, P NATL ACAD SCI USA, V116, P2237, DOI 10.1073/pnas.1820459116; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; FAGUNDES H, 1992, INT J RADIAT ONCOL, V24, P197, DOI 10.1016/0360-3016(92)90671-4; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Ho JC, 2018, HEAD NECK-J SCI SPEC, V40, P2078, DOI 10.1002/hed.25180; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Johnson DE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00224-3; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kamochi N, 2008, CANCER SCI, V99, P2417, DOI 10.1111/j.1349-7006.2008.00978.x; Knops AM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.565306; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; Liao ZH, 2019, CELL IMMUNOL, V343, DOI 10.1016/j.cellimm.2017.12.003; Long KB, 2017, MOL CANCER THER, V16, P1898, DOI 10.1158/1535-7163.MCT-16-0899; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Moncharmont C, 2014, CRIT REV ONCOL HEMAT, V92, P133, DOI 10.1016/j.critrevonc.2014.05.006; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Rossi JF, 2015, CLIN CANCER RES, V21, P1248, DOI 10.1158/1078-0432.CCR-14-2291; Siddiqui F, 2017, SEMIN RADIAT ONCOL, V27, P340, DOI 10.1016/j.semradonc.2017.04.008; Straub JM, 2015, J CANCER RES CLIN, V141, P1985, DOI 10.1007/s00432-015-1974-6; STRONG MS, 1978, AM J SURG, V136, P494, DOI 10.1016/0002-9610(78)90268-4; Vilalta M, 2016, CELL MOL LIFE SCI, V73, P2999, DOI 10.1007/s00018-016-2210-5; Wang ZH, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0362-2; Zhou LY, 2012, INT J RADIAT ONCOL, V84, P822, DOI 10.1016/j.ijrobp.2012.01.011	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262549	10.1371/journal.pone.0262549	http://dx.doi.org/10.1371/journal.pone.0262549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089951	Green Submitted, gold, Green Published			2022-12-26	WOS:000769158400016
J	Fidalgo, F; Torrezan, GT; de Sa, BCS; Barros, BDD; Moredo, LF; Valieris, R; de Souza, SJ; Duprat, JP; Krepischi, ACV; Carraro, DM				Fidalgo, Felipe; Torrezan, Giovana Tardin; Soares de Sa, Bianca Costa; de Figueiredo Barros, Bruna Duraes; Moredo, Luciana Facure; Valieris, Renan; de Souza, Sandro J.; Duprat, Joao Pereira; Victorino Krepischi, Ana Cristina; Carraro, Dirce Maria			Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families	PLOS ONE			English	Article							MALIGNANT-MELANOMA; RISK; GENES; SUSCEPTIBILITY; MUTATIONS; ASSOCIATION; EXPRESSION; HORNERIN	Genetic predisposition accounts for nearly 10% of all melanoma cases and has been associated with a dozen moderate- to high-penetrance genes, including CDKN2A, CDK4, POT1 and BAP1. However, in most melanoma-prone families, the genetic etiology of cancer predisposition remains undetermined. The goal of this study was to identify rare genomic variants associated with cutaneous melanoma susceptibility in melanoma-prone families. Whole-exome sequencing was performed in 2 affected individuals of 5 melanoma-prone families negative for mutations in CDKN2A and CDK4, the major cutaneous melanoma risk genes. A total of 288 rare coding variants shared by the affected relatives of each family were identified, including 7 loss-of-function variants. By performing in silico analyses of gene function, biological pathways, and variant pathogenicity prediction, we underscored the putative role of several genes for melanoma risk, including previously described genes such as MYO7A and WRN, as well as new putative candidates, such as SERPINB4, HRNR, and NOP10. In conclusion, our data revealed rare germline variants in melanoma-prone families contributing with a novel set of potential candidate genes to be further investigated in future studies.	[Fidalgo, Felipe; Torrezan, Giovana Tardin; de Figueiredo Barros, Bruna Duraes; Carraro, Dirce Maria] AC Camargo Canc Ctr, CIPE, Int Res Ctr, Genom & Mol Biol Grp, Sao Paulo, Brazil; [Torrezan, Giovana Tardin; de Souza, Sandro J.; Carraro, Dirce Maria] Natl Inst Sci & Technol Oncogen & Therapeut Innov, Sao Paulo, Brazil; [Soares de Sa, Bianca Costa; Moredo, Luciana Facure; Duprat, Joao Pereira] AC Camargo Canc Ctr, Skin Canc Dept, Sao Paulo, Brazil; [Valieris, Renan] AC Camargo Canc Ctr, CIPE, Int Res Ctr, Lab Bioinformat & Computat Biol, Sao Paulo, Brazil; [de Souza, Sandro J.] Univ Fed Rio Grande do Norte, Bioinformat Multidisciplinary Environm, Natal, RN, Brazil; [de Souza, Sandro J.] Univ Fed Rio Grande do Norte, Brain Inst, Natal, RN, Brazil; [Victorino Krepischi, Ana Cristina] Univ Sao Paulo, Inst Biosci, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo	Carraro, DM (corresponding author), AC Camargo Canc Ctr, CIPE, Int Res Ctr, Genom & Mol Biol Grp, Sao Paulo, Brazil.; Carraro, DM (corresponding author), Natl Inst Sci & Technol Oncogen & Therapeut Innov, Sao Paulo, Brazil.	dirce.carraro@accamargo.org.br	Krepischi, Ana C V/E-4976-2012; carraro, dirce/C-9179-2009; torrezan, giovana T/F-6126-2012; Barros, Bruna/K-9131-2016	Krepischi, Ana C V/0000-0003-2931-8605; carraro, dirce/0000-0001-5667-1418; torrezan, giovana T/0000-0002-8659-5329; Barros, Bruna/0000-0001-6734-7285	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/50943-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [465682/2014-6]; CAPES [88887.136405/2017-00]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES-Cancer System Biology) [88887.136405/2017-00]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES-Cancer System Biology)	GTT, SJS and DMC were funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant number 2014/50943-1, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant number 465682/2014-6 and CAPES - 88887.136405/2017-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the patients who participated in the study, and the A.C. Camargo biobank for sample processing. The authors thank the CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES-Cancer System Biology_88887.136405/2017-00).	Aoude LG, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju408; Artomov M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx083; Ashton-Prolla P, 2008, J INVEST DERMATOL, V128, P421, DOI 10.1038/sj.jid.5701030; Campos C, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040403; Carr S, 2020, SURG CLIN N AM, V100, P1, DOI 10.1016/j.suc.2019.09.005; Debniak T, 2019, CANCER RES TREAT, V51, P337, DOI 10.4143/crt.2018.157; del Valle J, 2020, CANCERS, V12, DOI 10.3390/cancers12040829; Fernandez LP, 2009, EXP DERMATOL, V18, P634, DOI 10.1111/j.1600-0625.2009.00846.x; Fidalgo F, 2016, FUTURE ONCOL, V12, P1345, DOI 10.2217/fon.16.22; Fu SJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4719-5; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Goldstein AM, 2017, HUM MOL GENET, V26, P4886, DOI 10.1093/hmg/ddx368; Gutknecht MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00488-6; Hansen CB, 2004, LANCET ONCOL, V5, P314, DOI 10.1016/S1470-2045(04)01469-X; Hayano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164233; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu HH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925716; Huber J, 2006, BRAZ J MED BIOL RES, V39, P237, DOI 10.1590/S0100-879X2006000200010; Izuhara K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041102; Lauper JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059709; Makino T, 2014, ACTA HISTOCHEM, V116, P20, DOI 10.1016/j.acthis.2013.05.001; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Potjer TP, 2019, INT J CANCER, V144, P2453, DOI 10.1002/ijc.31984; Potrony M, 2018, EUR J HUM GENET, V26, P1188, DOI 10.1038/s41431-018-0149-8; Potrony M, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.08.11; Pramio D, 2014, HERED GENET, V03, P1, DOI [10. 4172/2161-1041.1000135, DOI 10.4172/2161-1041.1000135]; Pritchard AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194098; Puig S, 2016, GENET MED, V18, P727, DOI 10.1038/gim.2015.160; Riaz N, 2016, NAT GENET, V48, P1327, DOI 10.1038/ng.3677; de Avila ALR, 2014, FAM CANCER, V13, P645, DOI 10.1007/s10689-014-9736-1; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Sun LX, 2017, NUCLEIC ACIDS RES, V45, P3844, DOI 10.1093/nar/gkx065; Tagliabue E, 2018, CANCER MANAG RES, V10, P1143, DOI 10.2147/CMAR.S155283; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Teerlink CC, 2018, JNCI-J NATL CANCER I, V110, P1380, DOI 10.1093/jnci/djy058; Visser M, 2019, FAM CANCER, V18, P267, DOI 10.1007/s10689-018-00115-3; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Ward KA, 2012, J AM ACAD DERMATOL, V67, P1055, DOI 10.1016/j.jaad.2012.02.042; Wendt J, 2016, JAMA DERMATOL, V152, P776, DOI 10.1001/jamadermatol.2016.0050; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Yang XR, 2009, INT J CANCER, V125, P2912, DOI 10.1002/ijc.24622; Yepes S, 2020, SCI REP, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Yu Y, 2018, BBA-MOL BASIS DIS, V1864, P2247, DOI 10.1016/j.bbadis.2018.01.007	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262419	10.1371/journal.pone.0262419	http://dx.doi.org/10.1371/journal.pone.0262419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085295	Green Published, gold			2022-12-26	WOS:000779379600054
J	Leulseged, TW; Abebe, KG; Hassen, IS; Maru, EH; Zewde, WC; Chamiso, NW; Yegele, KT; Bayisa, AB; Siyoum, DF; Edo, MG; Mesfin, EG; Derejie, MN; Shiferaw, HK				Leulseged, Tigist W.; Abebe, Kindalem G.; Hassen, Ishmael S.; Maru, Endalkachew H.; Zewde, Wuletaw C.; Chamiso, Negat W.; Yegele, Kalkidan T.; Bayisa, Abdi B.; Siyoum, Dagne F.; Edo, Mesay G.; Mesfin, Edmialem G.; Derejie, Meskerem N.; Shiferaw, Helina K.			COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center	PLOS ONE			English	Article							DEATH	Background The COVID-19 pandemic started a little later in Ethiopia than the rest of the world and most of the initial cases were reported to have a milder disease course and a favorable outcome. This changed as the disease spread into the population and the more vulnerable began to develop severe disease. Understanding the risk factors for severe disease in Ethiopia was needed to provide optimal health care services in a resource limited setting. Objective The study assessed COVID-19 patients admitted to Millennium COVID-19 Care Center in Ethiopia for characteristics associated with COVID-19 disease severity. Methods A cross-sectional study was conducted from June to August 2020 among 686 randomly selected patients. Chi-square test was used to detect the presence of a statistically significant difference in the characteristics of the patients based on disease severity (Mild vs Moderate vs Severe). A multinomial logistic regression model was used to identify factors associated with COVID-19 disease severity where Adjusted Odds ratio (AOR), 95% CIs for AOR and P-values were used for significance testing. Results Having moderate as compared with mild disease was significantly associated with having hypertension (AOR = 2.30, 95%CI = 1.27,4.18), diabetes mellitus (AOR = 2.61, 95%CI = 1.31,5.19for diabetes mellitus), fever (AOR = 6.12, 95%CI = 2.94,12.72) and headache (AOR = 2.69, 95%CI = 1.39,5.22). Similarly, having severe disease as compared with mild disease was associated with age group (AOR = 4.43, 95%CI = 2.49,7.85 for 40-59 years and AOR = 18.07, 95%CI = 9.29,35.14for >= 60 years), sex (AOR = 1.84, 95%CI = 1.12,3.03), hypertension (AOR = 1.97, 95%CI = 1.08,3.59), diabetes mellitus (AOR = 3.93, 95%CI = 1.96,7.85), fever (AOR = 13.22, 95%CI = 6.11, 28.60) and headache (AOR = 4.82, 95%CI = 2.32, 9.98). In addition, risk factors of severe disease as compared with moderate disease were found to be significantly associated with age group (AOR = 4.87, 95%CI = 2.85, 8.32 for 40-59 years and AOR = 18.91, 95%CI = 9.84,36.331 for >= 60 years), fever (AOR = 2.16, 95%CI = 1.29,3.63) and headache (AOR = 1.79, 95%CI = 1.03, 3.11). Conclusions Significant factors associated with severe COVID-19 in Ethiopia are being older than 60 years old, male, a diagnosis of hypertension, diabetes mellitus, and the presence of fever and headache. This is consistent with severity indicators identified by WHO and suggests the initial finding of milder disease in Ethiopia may have been because the first people to get COVID-19 in the country were the relatively younger with fewer health problems.	[Leulseged, Tigist W.; Abebe, Kindalem G.; Hassen, Ishmael S.; Maru, Endalkachew H.; Zewde, Wuletaw C.; Chamiso, Negat W.; Yegele, Kalkidan T.; Bayisa, Abdi B.; Siyoum, Dagne F.; Edo, Mesay G.; Mesfin, Edmialem G.; Derejie, Meskerem N.; Shiferaw, Helina K.] St Pauls Hosp, Millennium COVID 19 Care Ctr, Millennium Med Coll, Addis Ababa, Ethiopia		Leulseged, TW (corresponding author), St Pauls Hosp, Millennium COVID 19 Care Ctr, Millennium Med Coll, Addis Ababa, Ethiopia.	tigdolly@gmail.com	Leulseged, Tigist/DQR-5143-2022	Leulseged, Tigist/0000-0002-5767-1417; Getahun, Edmialem/0000-0002-4340-7244				Abdelsalam M, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.670195; Alimohamadi Yousef, 2020, J Prev Med Hyg, V61, pE304, DOI 10.15167/2421-4248/jpmh2020.61.3.1530; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Ethiopian Federal Ministry of Health, 2021, NAT COVID 19 DAIL RE; Fadavi Pedram, 2021, Asian Pac J Cancer Prev, V22, P19, DOI 10.31557/APJCP.2021.22.1.19; Falzone L, 2021, INT J MOL MED, V47, DOI 10.3892/ijmm.2021.4933; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Leulseged TW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259454; Leulseged TW, 2021, ETHIOP J HEALTH SCI, V31, P699, DOI 10.4314/ejhs.v31i4.3; Leulseged TW, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06465-1; Leulseged TW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246087; Leulseged TW, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.351.28831; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8; Meng YF, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008520; Mi BB, 2020, J BONE JOINT SURG AM, V102, P750, DOI 10.2106/JBJS.20.00390; Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x; Oudit GY, 2020, EUR HEART J, V41, P1818, DOI 10.1093/eurheartj/ehaa414; Pan F, 2020, INT J MED SCI, V17, P1281, DOI 10.7150/ijms.46614; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Pennisi M., 2020, SARS COV 2 NERVOUS S, V21; Rakhsha A, 2020, REP PRACT ONCOL RADI, V25, P765, DOI 10.1016/j.rpor.2020.07.001; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Siavashpour Z, 2020, J GASTROINTEST CANC, V51, P800, DOI 10.1007/s12029-020-00454-4; Sun LJ, 2020, J MED VIROL, V92, P2055, DOI 10.1002/jmv.25966; Taghizadeh-Hesary F, 2021, INT J CANCER MANAG, V14, DOI 10.5812/ijcm.110907; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; van Marcke C, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08349-8; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wang F., 2020, ENDOCR PRACT; Wang KM, 2020, CIRCULATION, V142, P426, DOI 10.1161/CIRCULATIONAHA.120.047049; WHO, 2020, WHO AFR NEWS 2 COVID; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Xu SX, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07577-8; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Yang F, 2020, J MED VIROL, V92, P2511, DOI 10.1002/jmv.25891; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262896	10.1371/journal.pone.0262896	http://dx.doi.org/10.1371/journal.pone.0262896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085338	gold, Green Published			2022-12-26	WOS:000779379600094
J	Lunsmann, BJ; Polotzek, K; Kleber, C; Gebler, R; Bierbaum, V; Walther, F; Baum, F; Juncken, K; Forkert, C; Lange, T; Held, HC; Mogwitz, A; Weidemann, RR; Sedlmayr, M; Lakowa, N; Stehr, SN; Albrecht, M; Karschau, J; Schmitt, J				Luensmann, Benedict J.; Polotzek, Katja; Kleber, Christian; Gebler, Richard; Bierbaum, Veronika; Walther, Felix; Baum, Fabian; Juncken, Kathleen; Forkert, Christoph; Lange, Toni; Held, Hanns-Christoph; Mogwitz, Andreas; Weidemann, Robin R.; Sedlmayr, Martin; Lakowa, Nicole; Stehr, Sebastian N.; Albrecht, Michael; Karschau, Jens; Schmitt, Jochen			Regional responsibility and coordination of appropriate inpatient care capacities for patients with COVID-19-the German DISPENSE model	PLOS ONE			English	Article								As of late 2019, the COVID-19 pandemic has been a challenge to health care systems worldwide. Rapidly rising local COVID-19 incidence rates, result in demand for high hospital and intensive care bed capacities on short notice. A detailed up-to-date regional surveillance of the dynamics of the pandemic, precise prediction of required inpatient capacities of care as well as a centralized coordination of the distribution of regional patient fluxes is needed to ensure optimal patient care. In March 2020, the German federal state of Saxony established three COVID-19 coordination centers located at each of its maximum care hospitals, namely the University Hospitals Dresden and Leipzig and the hospital Chemnitz. Each center has coordinated inpatient care facilities for the three regions East, Northwest and Southwest Saxony with 36, 18 and 29 hospital sites, respectively. Fed by daily data flows from local public health authorities capturing the dynamics of the pandemic as well as daily reports on regional inpatient care capacities, we established the information and prognosis tool DISPENSE. It provides a regional overview of the current pandemic situation combined with daily prognoses for up to seven days as well as outlooks for up to 14 days of bed requirements. The prognosis precision varies from 21% and 38% to 12% and 15% relative errors in normal ward and ICU bed demand, respectively, depending on the considered time period. The deployment of DISPENSE has had a major positive impact to stay alert for the second wave of the COVID-19 pandemic and to allocate resources as needed. The application of a mathematical model to forecast required bed capacities enabled concerted actions for patient allocation and strategic planning. The ad-hoc implementation of these tools substantiates the need of a detailed data basis that enables appropriate responses, both on regional scales in terms of clinic resource planning and on larger scales concerning political reactions to pandemic situations.	[Luensmann, Benedict J.; Polotzek, Katja; Bierbaum, Veronika; Walther, Felix; Baum, Fabian; Forkert, Christoph; Lange, Toni; Karschau, Jens; Schmitt, Jochen] Tech Univ Dresden, Ctr Evidence Based Healthcare, Univ Hosp Dresden, Dresden, Germany; [Luensmann, Benedict J.; Polotzek, Katja; Gebler, Richard; Bierbaum, Veronika; Walther, Felix; Baum, Fabian; Forkert, Christoph; Lange, Toni; Sedlmayr, Martin; Karschau, Jens; Schmitt, Jochen] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Kleber, Christian] Univ Hosp Carl Gustav Carus, Univ Ctr Orthopaed Trauma & Plast Surg, Dresden, Germany; [Gebler, Richard; Sedlmayr, Martin] Tech Univ Dresden, Inst Med Informat & Biometry, Univ Hosp Dresden, Dresden, Germany; [Walther, Felix] Univ Hosp Carl Gustav Carus Dresden, Qual & Med Risk Management, Dresden, Germany; [Juncken, Kathleen; Lakowa, Nicole] Klinikum Chemnitz, Clin Infect Dis & Trop Med, Chemnitz, Germany; [Held, Hanns-Christoph; Stehr, Sebastian N.] Leipzig Univ Hosp, Dept Anesthesia & Crit Care Med, Leipzig, Germany; [Mogwitz, Andreas; Weidemann, Robin R.; Albrecht, Michael] Univ Hosp Carl Gustav Carus Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Chemnitz Clinic; Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Lunsmann, BJ (corresponding author), Tech Univ Dresden, Ctr Evidence Based Healthcare, Univ Hosp Dresden, Dresden, Germany.; Lunsmann, BJ (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany.	benedict.luensmann@tu-dresden.de	Walther, Felix/AAZ-8545-2020	Walther, Felix/0000-0002-5259-124X; Polotzek, Katja/0000-0002-4023-6654	Saxon Ministry for Social Affairs; TU Dresden	Saxon Ministry for Social Affairs; TU Dresden(European Commission)	The study was funded by the Saxon Ministry for Social Affairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Open Access Funding by the Publication Fund of the TU Dresden.	Bandyopadhyay A., 2020, COVID 19 ITALY TARGE, DOI [10.1101/2020.10.12.20211169, DOI 10.1101/2020.10.12.20211169]; Barabasi A-L., 2016, NETW SCI, DOI [10.1017/nws.2016.2, DOI 10.1017/NWS.2016.2]; Bicher M., 2021, EVALUATION CONTACT T, DOI [10.1101/2020.05.12.20098970, DOI 10.1101/2020.05.12.20098970]; Dichter JR, 2014, CHEST, V146, pE87S, DOI 10.1378/chest.14-0738; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dreher M, 2020, DTSCH ARZTEBL INT, V117, P271, DOI 10.3238/arztebl.2020.0271; Duncan A., 2020, GEOTEMPORAL SURVEY H, DOI [10.1101/2020.06.24.20139048, DOI 10.1101/2020.06.24.20139048]; Grasner J-T., 2020, DEUT ARZTEBLATT, V117; Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8; Kontis V, 2021, NAT MED, V27, P562, DOI 10.1038/s41591-021-01254-4; Kontopantelis E, 2021, J EPIDEMIOL COMMUN H, V75, P213, DOI 10.1136/jech-2020-214764; Kuhlen R, 2020, DTSCH ARZTEBL INT, V117, P488, DOI [10.3238/arztebl.2020.0489, 10.3238/arztebl.2020.0488]; Kuhn M.J., 2020, ASSESSMENT EFFECTIVE, DOI [10.1101/2020.12.18.20248509, DOI 10.1101/2020.12.18.20248509]; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Neher, 2020, COVID 19 SCENARIOS I, DOI [https://doi.org/10.1101/2020.05.05.20091363, 10.1101/2020.05.05.20091363]; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Qin J, 2020, SCI ADV, V6, DOI [10.1126/sciadv.abc1202, 10.1101/2020.03.06.20032417]; Robert Koch Institute,, 2020, MOD BEISP SARS COV 2; Rommele C, 2020, ANAESTHESIST, V69, P717, DOI 10.1007/s00101-020-00830-6; Rommel A, 2021, DTSCH ARZTEBL INT, V118, P145, DOI 10.3238/arztebl.m2021.0147; Rudan I, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010335; Wei Y, 2020, SYSTEMATIC REV METAA; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang L, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001338; Zangrillo A, 2020, INTENS CARE MED, V46, P1622, DOI 10.1007/s00134-020-06137-9	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262491	10.1371/journal.pone.0262491	http://dx.doi.org/10.1371/journal.pone.0262491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085297	gold, Green Published			2022-12-26	WOS:000779379600060
J	Mahmood, T; Li, JQ; Pei, Y; Akhtar, F; Rehman, MU; Wasti, SH				Mahmood, Tariq; Li, Jianqiang; Pei, Yan; Akhtar, Faheem; Rehman, Mujeeb Ur; Wasti, Shahbaz Hassan			Breast lesions classifications of mammographic images using a deep convolutional neural network-based approach	PLOS ONE			English	Article							SCREENING MAMMOGRAPHY; CANCER; SEGMENTATION	Breast cancer is one of the worst illnesses, with a higher fatality rate among women globally. Breast cancer detection needs accurate mammography interpretation and analysis, which is challenging for radiologists owing to the intricate anatomy of the breast and low image quality. Advances in deep learning-based models have significantly improved breast lesions' detection, localization, risk assessment, and categorization. This study proposes a novel deep learning-based convolutional neural network (ConvNet) that significantly reduces human error in diagnosing breast malignancy tissues. Our methodology is most effective in eliciting task-specific features, as feature learning is coupled with classification tasks to achieve higher performance in automatically classifying the suspicious regions in mammograms as benign and malignant. To evaluate the model's validity, 322 raw mammogram images from Mammographic Image Analysis Society (MIAS) and 580 from Private datasets were obtained to extract in-depth features, the intensity of information, and the high likelihood of malignancy. Both datasets are magnificently improved through preprocessing, synthetic data augmentation, and transfer learning techniques to attain the distinctive combination of breast tumors. The experimental findings indicate that the proposed approach achieved remarkable training accuracy of 0.98, test accuracy of 0.97, high sensitivity of 0.99, and an AUC of 0.99 in classifying breast masses on mammograms. The developed model achieved promising performance that helps the clinician in the speedy computation of mammography, breast masses diagnosis, treatment planning, and follow-up of disease progression. Moreover, it has the immense potential over retrospective approaches in consistency feature extraction and precise lesions classification.	[Mahmood, Tariq; Li, Jianqiang] Beijing Univ Technol, Fac Informat Technol, Beijing, Peoples R China; [Mahmood, Tariq; Wasti, Shahbaz Hassan] Univ Educ, Dept Informat Sci, Div Sci & Technol, Lahore, Pakistan; [Li, Jianqiang] Beijing Engn Res Ctr IoT Software & Syst, Beijing, Peoples R China; [Pei, Yan] Univ Aizu, Comp Sci Div, Aizu Wakamatsu, Fukushima, Japan; [Akhtar, Faheem] Sukkur IBA Univ, Dept Comp Sci, Sukkur, Pakistan; [Rehman, Mujeeb Ur] Continental Med Coll, Radiol Dept, Lahore, Pakistan; [Rehman, Mujeeb Ur] Hayat Mem Teaching Hosp, Lahore, Pakistan	Beijing University of Technology; University of Aizu; Sukkur IBA University	Pei, Y (corresponding author), Univ Aizu, Comp Sci Div, Aizu Wakamatsu, Fukushima, Japan.	peiyan@u-aizu.ac.jp	li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022; Mahmood, Tariq/AAQ-6709-2020; LI, JIAN/GRY-2197-2022; Pei, Yan/B-1356-2010	Mahmood, Tariq/0000-0002-4299-7756; Pei, Yan/0000-0003-1545-9204	National Key R&D Program of China [2017YFB1400803]	National Key R&D Program of China	This study is supported by the National Key R&D Program of China with the project no. 2017YFB1400803. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Rahman Anas S., 2020, 2020 IEEE International Conference on Informatics, IoT, and Enabling Technologies (ICIoT), P271, DOI 10.1109/ICIoT48696.2020.9089535; Agnes SA, 2020, J MED SYST, V44, DOI 10.1007/s10916-019-1494-z; Ahmed L, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-01680-1; Albalawi U., 2020, CONCURR COMP-PRACT E, P1; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Anitha J, 2015, MED BIOL ENG COMPUT, V53, P737, DOI 10.1007/s11517-015-1280-0; Arefan D, 2020, MED PHYS, V47, P110, DOI 10.1002/mp.13886; Benzebouchi NE, 2019, ADV INTELL SYST, V711, P583, DOI 10.1007/978-981-10-8055-5_52; Chakravarthy SRS, 2020, INT J IMAG SYST TECH, V30, P126, DOI 10.1002/ima.22364; Chougrad H, 2018, COMPUT METH PROG BIO, V157, P19, DOI 10.1016/j.cmpb.2018.01.011; Choukroun Y., 2017, MAMMOGRAM CLASSIFICA, P11, DOI DOI 10.2312/VCBM.20171232; Dauphin Y., 2015, ADV NEURAL INFORM PR, V1, P1504; Duraisamy S, 2017, IET COMPUT VIS, V11, P656, DOI 10.1049/iet-cvi.2016.0425; Ferreira CA, 2018, LECT NOTES COMPUT SC, V10882, P763, DOI 10.1007/978-3-319-93000-8_86; Gibson E, 2018, COMPUT METH PROG BIO, V158, P113, DOI 10.1016/j.cmpb.2018.01.025; Guan YF, 2020, PATTERNS, V1, DOI 10.1016/j.patter.2020.100106; Hadush S., COMPUTER VISION PATT, P1; Hayward JH, 2016, AM J ROENTGENOL, V207, P918, DOI 10.2214/AJR.15.15917; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Jiao ZC, 2016, NEUROCOMPUTING, V197, P221, DOI 10.1016/j.neucom.2016.02.060; Karar ME, 2021, COMPLEX INTELL SYST, V7, P235, DOI 10.1007/s40747-020-00199-4; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Khan HN, 2019, IEEE ACCESS, V7, P165724, DOI 10.1109/ACCESS.2019.2953318; Khan S, 2019, PATTERN RECOGN LETT, V125, P1, DOI 10.1016/j.patrec.2019.03.022; Lee J, 2018, MED PHYS, V45, P1178, DOI 10.1002/mp.12763; Lehman CD, 2019, RADIOLOGY, V290, P52, DOI 10.1148/radiol.2018180694; Lehman CD, 2015, JAMA INTERN MED, V175, P1828, DOI 10.1001/jamainternmed.2015.5231; Levy Daniel, 2016, 30 C NEUR INF PROC S, P1; Li SY, 2019, IEEE ACCESS, V7, P59037, DOI 10.1109/ACCESS.2019.2914873; Mahmood T, 2021, P INT COMP SOFTW APP, P1918, DOI 10.1109/COMPSAC51774.2021.00291; Mahmood T, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090859; Mahmood T, 2020, IEEE ACCESS, V8, P165779, DOI 10.1109/ACCESS.2020.3021343; Mendel K, 2019, ACAD RADIOL, V26, P735, DOI 10.1016/j.acra.2018.06.019; Milroy MJ, 2018, QUALITY CANC CARE, P29; Omonigho E.L., 2020, 2020 INT C MATH COMP, P1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ragab DA, 2021, COMPUT BIOL MED, V131, DOI 10.1016/j.compbiomed.2021.104245; Rehman KU, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21144854; Samala RK, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/ab82e8; Schreer I, 2009, BREAST CARE, V4, P89, DOI 10.1159/000211954; Sha ZJ, 2020, INT J IMAG SYST TECH, V30, P495, DOI 10.1002/ima.22400; Shu X, 2020, IEEE T MED IMAGING, V39, P2246, DOI 10.1109/TMI.2020.2968397; Simi V., 2020, APPL SOFT COMPUT, V1, P1; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; SUCKLING J, 1994, INT CONGR SER, V1069, P375; Suh YJ, 2020, J PERS MED, V10, DOI 10.3390/jpm10040211; Takahashi R, 2020, IEEE T CIRC SYST VID, V30, P2917, DOI 10.1109/TCSVT.2019.2935128; Tan YJ, 2017, 2017 INTERNATIONAL CONFERENCE ON ROBOTICS, AUTOMATION AND SCIENCES (ICORAS); Teare P, 2017, J DIGIT IMAGING, V30, P499, DOI 10.1007/s10278-017-9993-2; Ting FF, 2019, EXPERT SYST APPL, V120, P103, DOI 10.1016/j.eswa.2018.11.008; Vesal S, 2018, LECT NOTES COMPUT SC, V10882, P812, DOI 10.1007/978-3-319-93000-8_92; Weiss Karl, 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0043-6; WHO, 2019, FACT SHEET WHO; Yu XC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71431-x; Zhang XF, 2018, IEEE T NANOBIOSCI, V17, P237, DOI 10.1109/TNB.2018.2845103	55	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263126	10.1371/journal.pone.0263126	http://dx.doi.org/10.1371/journal.pone.0263126			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085352	Green Published, gold			2022-12-26	WOS:000779379600115
J	Sasaki, S; Nishihira, K; Yamashita, A; Fujii, T; Onoue, K; Saito, Y; Hatakeyama, K; Shibata, Y; Asada, Y; Ohbayashi, C				Sasaki, Shoh; Nishihira, Kensaku; Yamashita, Atsushi; Fujii, Tomomi; Onoue, Kenji; Saito, Yoshihiko; Hatakeyama, Kinta; Shibata, Yoshisato; Asada, Yujiro; Ohbayashi, Chiho			Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LOW-DENSITY-LIPOPROTEIN; MACROPHAGE APOPTOSIS; UNSTABLE ANGINA; IN-VIVO; LESIONS; CELLS; MAFB; LOCALIZATION; IMMUNOLOGY	Activation of the classical complement pathway plays a major role in regulating atherosclerosis progression, and it is believed to have both proatherogenic and atheroprotective effects. This study focused on C1q, the first protein in the classical pathway, and examined its potentialities of plaque progression and instability and its relationship with clinical outcomes. To assess the localization and quantity of C1q expression in various stages of atherosclerosis, immunohistochemistry, western blotting, and real-time polymerase chain reaction (PCR) were performed using abdominal aortas from eight autopsy cases. C1q immunoreactivity in relation to plaque instability and clinical outcomes was also examined using directional coronary atherectomy (DCA) samples from 19 patients with acute coronary syndromes (ACS) and 18 patients with stable angina pectoris (SAP) and coronary aspirated specimens from 38 patients with acute myocardial infarction. C1q immunoreactivity was localized in the extracellular matrix, necrotic cores, macrophages and smooth muscle cells in atherosclerotic lesions. Western blotting and real-time PCR illustrated that C1q protein and mRNA expression was significantly higher in advanced lesions than in early lesions. Immunohistochemical analysis using DCA specimens revealed that C1q expression was significantly higher in ACS plaques than in SAP plaques. Finally, immunohistochemical analysis using thrombus aspiration specimens demonstrated that histopathological C1q in aspirated coronary materials could be an indicator of poor medical condition. Our results indicated that C1q is significantly involved in atherosclerosis progression and plaque instability, and it could be considered as one of the indicators of cardiovascular outcomes.	[Sasaki, Shoh; Fujii, Tomomi; Hatakeyama, Kinta; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara, Japan; [Nishihira, Kensaku; Shibata, Yoshisato] Miyazaki Med Assoc Hosp, Miyazaki, Japan; [Yamashita, Atsushi; Asada, Yujiro] Univ Miyazaki, Fac Med, Dept Pathol, Kiyotake, Miyazaki, Japan; [Onoue, Kenji; Saito, Yoshihiko] Nara Med Univ, Cardiovasc Med, Kashihara, Nara, Japan; [Hatakeyama, Kinta] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan	Nara Medical University; University of Miyazaki; Nara Medical University; National Cerebral & Cardiovascular Center - Japan	Hatakeyama, K (corresponding author), Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara, Japan.; Hatakeyama, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan.	kpathol@naramed-u.ac.jp	Onoue, Kenji/GRJ-6704-2022					Anselmi M, 2006, ATHEROSCLEROSIS, V185, P114, DOI 10.1016/j.atherosclerosis.2005.05.020; Auer J, 2002, JPN HEART J, V43, P607, DOI 10.1536/jhj.43.607; BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Calabro P, 2003, CIRCULATION, V108, P1930, DOI 10.1161/01.CIR.0000096055.62724.C5; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Cortes-Hernandez J, 2004, EUR J IMMUNOL, V34, P3713, DOI 10.1002/eji.200425616; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Faviou E, 2005, FREE RADICAL RES, V39, P419, DOI 10.1080/10715760500072156; Hamada M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4147; Hasegawa H, 2016, ATHEROSCLEROSIS, V250, P133, DOI 10.1016/j.atherosclerosis.2016.05.021; Hatakeyama K, 1997, ATHEROSCLEROSIS, V133, P213, DOI 10.1016/S0021-9150(97)00132-9; Hatakeyama K, 2012, THROMB RES, V129, pE70, DOI 10.1016/j.thromres.2012.01.003; Ishikawa T, 2003, AM J CARDIOL, V91, P287, DOI 10.1016/S0002-9149(02)03156-9; Machiya J, 2007, AM J RESP CELL MOL, V36, P418, DOI 10.1165/rcmb.2006-0248OC; Tran MTN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01711-0; Niccoli G, 2007, J CARDIOVASC MED, V8, P387, DOI 10.2459/01.JCM.0000268127.36295.04; Nishihira K, 2006, EUR HEART J, V27, P1685, DOI 10.1093/eurheartj/ehl058; Nishihira K, 2008, ATHEROSCLEROSIS, V201, P360, DOI 10.1016/j.atherosclerosis.2008.03.005; Obradovic MM, 2015, CLIN CHEM LAB MED, V53, P29, DOI 10.1515/cclm-2014-0590; PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579; REYNOLDS GD, 1987, ARCH PATHOL LAB MED, V111, P265; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; Santos-Gallego CG, 2016, ATHEROSCLEROSIS, V252, P194, DOI 10.1016/j.atherosclerosis.2016.06.026; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037; Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x; Speidl WS, 2011, FASEB J, V25, P35, DOI 10.1096/fj.10-156083; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; Tsuruda T, 2012, ARTERIOSCL THROM VAS, V32, P1410, DOI 10.1161/ATVBAHA.111.237065; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Xu QB, 1999, CIRCULATION, V100, P1169, DOI 10.1161/01.CIR.100.11.1169	36	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262413	10.1371/journal.pone.0262413	http://dx.doi.org/10.1371/journal.pone.0262413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085285	Green Published, gold			2022-12-26	WOS:000779379600053
J	Simensen, V; Schulz, C; Karlsen, E; Bratelund, S; Burgos, I; Thorfinnsdottir, LB; Garcia-Calvo, L; Bruheim, P; Almaas, E				Simensen, Vetle; Schulz, Christian; Karlsen, Emil; Bratelund, Signe; Burgos, Idun; Thorfinnsdottir, Lilja Brekke; Garcia-Calvo, Laura; Bruheim, Per; Almaas, Eivind			Experimental determination of Escherichia coli biomass composition for constraint-based metabolic modeling	PLOS ONE			English	Article							GROWTH; HMDB; KNOWLEDGEBASE; DATABASE; BALANCE; CHITIN; RNA	Genome-scale metabolic models (GEMs) are mathematical representations of metabolism that allow for in silico simulation of metabolic phenotypes and capabilities. A prerequisite for these predictions is an accurate representation of the biomolecular composition of the cell necessary for replication and growth, implemented in GEMs as the so-called biomass objective function (BOF). The BOF contains the metabolic precursors required for synthesis of the cellular macro- and micromolecular constituents (e.g. protein, RNA, DNA), and its composition is highly dependent on the particular organism, strain, and growth condition. Despite its critical role, the BOF is rarely constructed using specific measurements of the modeled organism, drawing the validity of this approach into question. Thus, there is a need to establish robust and reliable protocols for experimental condition-specific biomass determination. Here, we address this challenge by presenting a general pipeline for biomass quantification, evaluating its performance on Escherichia coli K-12 MG1655 sampled during balanced exponential growth under controlled conditions in a batch-fermentor set-up. We significantly improve both the coverage and molecular resolution compared to previously published workflows, quantifying 91.6% of the biomass. Our measurements display great correspondence with previously reported measurements, and we were also able to detect subtle characteristics specific to the particular E. coli strain. Using the modified E. coli GEM iML1515a, we compare the feasible flux ranges of our experimentally determined BOF with the original BOF, finding that the changes in BOF coefficients considerably affect the attainable fluxes at the genome-scale.	[Simensen, Vetle; Schulz, Christian; Karlsen, Emil; Bratelund, Signe; Burgos, Idun; Thorfinnsdottir, Lilja Brekke; Garcia-Calvo, Laura; Bruheim, Per; Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Gen Practice, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway.; Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	eivind.almaas@ntnu.no	Brekke Thorfinnsdott, Lilja/HHM-9912-2022	Garcia-Calvo, Laura/0000-0002-9885-9854; Simensen, Vetle/0000-0002-2511-1052	European Research Area in Industrial Biotechnology 2, ERA-IB-2 [271585]; Research Council of Norway [294605, 269084, 269432]; NTNU	European Research Area in Industrial Biotechnology 2, ERA-IB-2; Research Council of Norway(Research Council of Norway); NTNU	This work was funded by the following grants: European Research Area in Industrial Biotechnology 2 (https://era-learn.eu/networkinformation/networks/era-ib-2), ERA-IB-2, grant number 271585 (CS); The Research Council of Norway (https://prosjektbanken.forskningsradet.no/en/project/FORISS/294605), grant number 294605 (CS); The Research Council of Norway (https://prosjektbanken.forskningsradet.no/en/project/FORISS/269084), grant number 269084 (EK); The Research Council of Norway (https://prosjektbanken.forskningsradet.no/en/project/FORISS/269432), grant number 269432 (VS); VS, LBT, and LGC were also supported by NTNU internal grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert C., 2006, Acta Agraria Kaposvariensis, V10, P349; Bartosova Z, 2021, J CHROMATOGR SCI, V59, P670, DOI 10.1093/chromsci/bmaa121; Beck AE, 2018, PROCESSES, V6, DOI 10.3390/pr6050038; BENTHIN S, 1991, BIOTECHNOL TECH, V5, P39, DOI 10.1007/BF00152753; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bremer Hans, 2008, EcoSal Plus, V3, DOI 10.1128/ecosal.5.2.3; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Chan SHJ, 2017, BIOINFORMATICS, V33, P3603, DOI 10.1093/bioinformatics/btx453; Chenomx INC, 2021, CHEN NMR MIXT AN; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Cplex I.I., 2009, IBM ILOG CPLEX V12 1, V46, P157; Desjardins Philippe, 2010, J Vis Exp, DOI 10.3791/2565; Dikicioglu D, 2015, METABOLOMICS, V11, P1690, DOI 10.1007/s11306-015-0819-2; Ebbensgaard A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02153; Einbu A, 2008, BIOMACROMOLECULES, V9, P1870, DOI 10.1021/bm8001123; Einbu A, 2007, BIOMACROMOLECULES, V8, P309, DOI 10.1021/bm0608535; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Folsom JP, 2015, MICROBIOL-SGM, V161, P1659, DOI 10.1099/mic.0.000118; Folsom JP, 2014, J BACTERIOL, V196, P2748, DOI 10.1128/JB.01606-14; Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2; HOLT LA, 1971, AUST J BIOL SCI, V24, P509, DOI 10.1071/BI9710509; Hong RS, 2013, J KOREAN MAGN RESON, V17, P98, DOI 10.6564/JKMRS.2013.17.2.098; Huang QH, 2012, LIMNOL OCEANOGR-METH, V10, P608, DOI 10.4319/lom.2012.10.608; Isbell HS, 1932, BUR STAND J RES, V8, P327; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lachance JC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006971; Lakshmanan M, 2019, IMPACT BIOMASS COMPO, DOI [10.1101/652040, DOI 10.1101/652040]; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; Long CP, 2014, ANAL CHEM, V86, P9423, DOI 10.1021/ac502734e; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MathWorks, 2020, MATL 2020A; Monk JM, 2017, NAT BIOTECHNOL, V35, P904, DOI 10.1038/nbt.3956; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Noble JE, 2007, MOL BIOTECHNOL, V37, P99, DOI 10.1007/s12033-007-0038-9; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruhmann B, 2016, JOVE-J VIS EXP, DOI 10.3791/53249; Ruhmann B, 2014, J CHROMATOGR A, V1350, P44, DOI 10.1016/j.chroma.2014.05.014; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schulz C, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008528; Shih FF, 1985, AMSTERDAM PRINTED NE; Simensen V, 2021, BIOTECHNOL BIOENG, V118, P2105, DOI 10.1002/bit.27726; Skedsmo FS, 2020, FASEB J, V34, P2359, DOI 10.1096/fj.201902588R; Sogaard Caroline Krogh, 2018, Oncotarget, V9, P32448, DOI 10.18632/oncotarget.25963; Szeliova D, 2020, METAB ENG, V61, P288, DOI 10.1016/j.ymben.2020.06.002; Szeliova D, 2020, METHODS MOL BIOL, V2088, P119, DOI 10.1007/978-1-0716-0159-4_7; Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Washizaki A, 2016, MICROBIOLOGYOPEN, V5, P1003, DOI 10.1002/mbo3.384; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wright MH, 2017, J MICROBIOL BIOL EDU, V18, DOI 10.1128/jmbe.v18i2.1348	61	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262450	10.1371/journal.pone.0262450	http://dx.doi.org/10.1371/journal.pone.0262450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085271	gold, Green Published			2022-12-26	WOS:000779379600057
J	Tagawa, N; Fujinami, A; Natsume, S; Mizuno, S; Kato, I				Tagawa, Noriko; Fujinami, Aya; Natsume, Shigeatsu; Mizuno, Shigeto; Kato, Ikuo			Relationship between adiponectin multimer levels and subtypes of cerebral infarction	PLOS ONE			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; COMPLEX DISTRIBUTION; PROTEIN; RISK; STROKE; SUPPRESSION; TRENDS; WOMEN	Aim Serum adiponectin levels are decreased in patients with cerebral infarction. Adiponectin in circulation exists in three isoforms: high molecular weight (HMW), medium molecular weight (MMW), and low molecular weight (LMW) adiponectin. We measured serum levels of total adiponectin and adiponectin multimers (HMW, MMW, and LMW) in patients with cerebral infarction and compared the serum levels of the three adiponectin multimers in stroke subtypes. We also evaluated the clinical value of adiponectin multimer levels as a biomarker for cerebral infarction. Methods We assessed a total of 132 patients with cerebral infarctions. The serum levels of total and adiponectin multimers were measured using enzyme-linked immunosorbent assay (ELISA). Results The total and HMW adiponectin levels were significantly lower in atherothrombotic infarction (AI) than in cerebral embolism (CE) (total, p < 0.05; HMW, p < 0.05). In male patients, the MMW adiponectin level was significantly lower in the lacunar infarction (LI) group than in the AI group (p < 0.05). The LMW adiponectin level was significantly lower in the AI group than in the LI and CE groups (LI, p < 0.001; CE, p = 0.001). However, there were no significant differences in adiponectin multimer levels among the stroke subtypes in female subjects. Additionally, in female patients with AI and LI, the LMW adiponectin levels were negatively associated with C-reactive protein (CRP; AI, p < 0.05; LI, p < 0.05). Conclusion These findings suggest that a decrease in adiponectin is associated with AI and that serum LMW adiponectin level represents a potential biomarker for AI.	[Tagawa, Noriko; Kato, Ikuo] Kobe Pharmaceut Univ, Lab Med Biochem, Kobe, Hyogo, Japan; [Fujinami, Aya] Kobe Pharmaceut Univ, Comprehens Educ & Res Ctr, Kobe, Hyogo, Japan; [Natsume, Shigeatsu] Eishokai Yoshida Hosp, Rehabil Dept, Kobe, Hyogo, Japan; [Mizuno, Shigeto] Kindai Univ Nara Hosp, Endoscopy Dept, Ikoma, Japan	Kobe Pharmaceutical University; Kobe Pharmaceutical University	Kato, I (corresponding author), Kobe Pharmaceut Univ, Lab Med Biochem, Kobe, Hyogo, Japan.	i-kato@kobepharma-u.ac.jp			Ministry of Education, Culture, Sports, and Technology of Japan [25460233]; Association of Private Universities of Japan	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Association of Private Universities of Japan	Shigeto Mizuno (SM) received Grants-inAid for Scientific Research (25460233) from the Ministry of Education, Culture, Sports, and Technology of Japan (https://www.mext.go.jp/english/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. "IK (Ikuo Kato) received Center for the Advanced Research and Technology of Kobe Pharmaceutical University (award number: none) from the Association of Private Universities of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	Adamczak M, 2005, CLIN ENDOCRINOL, V62, P114, DOI 10.1111/j.1365-2265.2004.02182.x; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baessler A, 2011, J ATHEROSCLER THROMB, V18, P616, DOI 10.5551/jat.8359; Baranowska B, 2011, NEUROENDOCRINOL LETT, V32, P711; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Bisoendial RJ, 2007, J LIPID RES, V48, P952, DOI 10.1194/jlr.P600014-JLR200; Ciancarelli I, 2020, CURR NEUROVASC RES, V17, P437, DOI 10.2174/1567202617666200603150901; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Goto M, 2014, OBESITY, V22, P401, DOI 10.1002/oby.20553; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kitamura A, 2002, AM J MED, V112, P104, DOI 10.1016/S0002-9343(01)01053-1; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Krysiak R, 2012, EUR J NUTR, V51, P513, DOI 10.1007/s00394-012-0370-0; Krzyzanowska K, 2009, TRANSL RES, V153, P199, DOI 10.1016/j.trsl.2009.01.009; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kusminski CM, 2007, DIABETOLOGIA, V50, P634, DOI 10.1007/s00125-006-0577-9; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lelubre C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/124021; Nakamura Y, 2004, HEART, V90, P528, DOI 10.1136/hrt.2003.011114; Ogorodnikova AD, 2010, STROKE, V41, P1376, DOI 10.1161/STROKEAHA.109.576546; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pasceri V, 2000, CIRCULATION, V102, P2165; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Sasaki M, 2007, AM J MED SCI, V333, P140, DOI 10.1097/MAJ.0b013e318031b7af; Sasaki M, 2010, METABOLISM, V59, P527, DOI 10.1016/j.metabol.2009.08.015; Shibata R, 2008, AM J CARDIOL, V101, P1712, DOI 10.1016/j.amjcard.2008.02.057; Szmitko PE, 2007, AM J PHYSIOL-HEART C, V292, pH1655, DOI 10.1152/ajpheart.01072.2006; The Japan Stroke Society, 2009, JAP GUID MAN STR 200; Wang ZL, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0908-z	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262542	10.1371/journal.pone.0262542	http://dx.doi.org/10.1371/journal.pone.0262542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085298	Green Published, gold			2022-12-26	WOS:000779379600063
J	Wang, GH; Lin, JH; Cheng, L; Dai, YY; Zhang, TL				Wang Gaihua; Lin Jinheng; Cheng Lei; Dai Yingying; Zhang Tianlun			Instance segmentation convolutional neural network based on multi-scale attention mechanism	PLOS ONE			English	Article								Instance segmentation is more challenging and difficult than object detection and semantic segmentation. It paves the way for the realization of a complete scene understanding, and has been widely used in robotics, automatic driving, medical care, and other aspects. However, there are some problems in instance segmentation methods, such as the low detection efficiency for low-resolution objects and the slow detection speed of images with complex backgrounds. To solve these problems, this paper proposes an instance segmentation method with multi-scale attention, which is called a Hybrid Kernel Mask R-CNN. Firstly, the hybrid convolution kernel is constructed by combining different kernels and groups, which can complement each other to extract rich information. Secondly, a multi-scale attention mechanism is designed by assign weights to different convolution kernels, which can retain more important information. After the introduction of our strategy, the network is more inclined to focus on the low-resolution objects in the image. The proposed method achieves the best accuracy over the anchor-based method. To verify the universality of the model, we test Hybrid Kernel Mask R-CNN on Balloon, xBD and COCO datasets. The test results exceed the state of art methods. And the visualization results show our method can extract low-resolution objects effectively.	[Wang Gaihua; Lin Jinheng; Cheng Lei; Dai Yingying; Zhang Tianlun] Hubei Univ Technol, Sch Elect & Elect Engn, Wuhan, Peoples R China; [Wang Gaihua] Hubei Univ Technol, Hubei Key Lab High Efficiency Utilizat Solar Ener, Wuhan, Peoples R China	Hubei University of Technology; Hubei University of Technology	Lin, JH (corresponding author), Hubei Univ Technol, Sch Elect & Elect Engn, Wuhan, Peoples R China.	linjh0@qq.com		Jinheng, Lin/0000-0002-9934-6444	National Key R&D Program of China [2017YFB1302400]	National Key R&D Program of China	Financial funder:The National Key R&D Program of China under Grant 2017YFB1302400. NO -The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Farhadi, 2018, Arxiv, DOI arXiv:1804.02767; Bai M, 2017, PROC CVPR IEEE, P2858, DOI 10.1109/CVPR.2017.305; Bell S, 2016, PROC CVPR IEEE, P2874, DOI 10.1109/CVPR.2016.314; Bolya D, 2019, IEEE I CONF COMP VIS, P9156, DOI 10.1109/ICCV.2019.00925; Cai H., 2018, PROXYLESSNAS DIRECT, P1; Cai ZW, 2021, IEEE T PATTERN ANAL, V43, P1483, DOI 10.1109/TPAMI.2019.2956516; Chen HT, 2020, PROC CVPR IEEE, P1465, DOI 10.1109/CVPR42600.2020.00154; Chen XL, 2019, IEEE I CONF COMP VIS, P2061, DOI 10.1109/ICCV.2019.00215; Dai J., 2016, NIPS, P379; Dai JF, 2016, LECT NOTES COMPUT SC, V9910, P534, DOI 10.1007/978-3-319-46466-4_32; Ding F, 2012, P I MECH ENG I-J SYS, V226, P43, DOI 10.1177/0959651811409491; Ding F, 2010, IEEE T AUTOMAT CONTR, V55, P1976, DOI 10.1109/TAC.2010.2050713; Wang GH, 2021, IEEE ACCESS, V9, P71909, DOI 10.1109/ACCESS.2021.3079243; He KM, 2020, IEEE T PATTERN ANAL, V42, P386, DOI 10.1109/TPAMI.2018.2844175; Howard A.G., 2017, ARXIV; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Kirillov A, 2017, PROC CVPR IEEE, P7322, DOI 10.1109/CVPR.2017.774; Lee Y., 2019, CENTERMASK REAL TIME; Li YH, 2019, IEEE I CONF COMP VIS, P6053, DOI 10.1109/ICCV.2019.00615; Li Y, 2017, PROC CVPR IEEE, P4438, DOI 10.1109/CVPR.2017.472; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Liu S, 2018, PROC CVPR IEEE, P8759, DOI 10.1109/CVPR.2018.00913; Nguyen ND, 2020, J ELECTR COMPUT ENG, V2020, DOI 10.1155/2020/3189691; PinheiroR P.O, 2015, COLLOBERT P DOLLAR; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tan M., 2020, MIXCONV MIXED DEPTHW; Tan MX, 2019, PROC CVPR IEEE, P2815, DOI 10.1109/CVPR.2019.00293; Wang GH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254054; Wu BC, 2019, PROC CVPR IEEE, P10726, DOI 10.1109/CVPR.2019.01099; Zhi Tian, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12346), P282, DOI 10.1007/978-3-030-58452-8_17	34	3	3	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263134	10.1371/journal.pone.0263134	http://dx.doi.org/10.1371/journal.pone.0263134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085359	Green Published, gold			2022-12-26	WOS:000779379600118
J	Kar, S; Sen, S; Maji, S; Saraf, D; Ruturaj; Paul, R; Dutt, S; Mondal, B; Rodriguez-Boulan, E; Schreiner, R; Sengupta, D; Gupta, A				Kar, Sumanta; Sen, Samarpita; Maji, Saptarshi; Saraf, Deepashri; Ruturaj; Paul, Rupam; Dutt, Sohini; Mondal, Basudeb; Rodriguez-Boulan, Enrique; Schreiner, Ryan; Sengupta, Durba; Gupta, Arnab			Copper(II) import and reduction are dependent on His-Met clusters in the extracellular amino terminus of human copper transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED ENDOCYTOSIS; MOLECULAR-DYNAMICS; CU-BINDING; N-TERMINUS; HUMAN CTR1; MODEL; PROTEIN; CELLS; HCTR1; IDENTIFICATION	Copper(I) is an essential metal for all life forms. Though Cu(II) is the most abundant and stable state, its reduction to Cu(I) via an unclear mechanism is prerequisite for its bioutilization. In eukaryotes, the copper transporter-1(CTR1) is the primary high-affinity copper importer, although its mechanism and role in Cu(II) reduction remain uncharacterized. Here we show that extracellular amino-terminus of human CTR1 contains two methionine-histidine clusters and neighboring aspartates that distinctly bind Cu(I) and Cu(II) preceding its import. We determined that hCTR1 localizes at the basolateral membrane of polarized MDCK-II cells and that its endocytosis to Common-Recycling-Endosomes is regulated by reduction of Cu(II) to Cu(I) and subsequent Cu(I) coordination by the methionine cluster. We demonstrate the transient binding of both Cu(II) and Cu(I) during the reduction process is facilitated by aspartates that also act as another crucial determinant of hCTR1 endocytosis. Mutating the first Methionine cluster ((7)Met-Gly-Met(9)) and Asp(13)( )abrogated copper uptake and endocytosis upon copper treatment. This phenotype could be reverted by treating the cells with reduced and nonreoxidizable Cu(I). We show that histidine clusters, on other hand, bind Cu(II) and are crucial for hCTR1 functioning at limiting copper. Finally, we show that two N-terminal His-Met-Asp clusters exhibit functional complementarity, as the second cluster is sufficient to preserve copper-induced CTR1 endocytosis upon complete deletion of the first cluster. We propose a novel and detailed mechanism by which the two His-Met-Asp residues of hCTR1 amino-terminus not only bind copper, but also maintain its reduced state, crucial for intracellular uptake.	[Kar, Sumanta; Sen, Samarpita; Maji, Saptarshi; Ruturaj; Paul, Rupam; Dutt, Sohini; Gupta, Arnab] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, W Bengal, India; [Saraf, Deepashri; Sengupta, Durba] CSIR, Natl Chem Lab, Phys & Mat Chem Div, Pune, Maharashtra, India; [Mondal, Basudeb] Indian Inst Sci Educ & Res Kolkata, Dept Chem Sci, Mohanpur, W Bengal, India; [Rodriguez-Boulan, Enrique; Schreiner, Ryan] Weill Cornell Med, Margaret Dyson Vis Res Inst, Dept Ophthalmol, New York, NY USA; [Dutt, Sohini] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Indian Institute of Science Education & Research (IISER) - Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Indian Institute of Science Education & Research (IISER) - Kolkata; Cornell University; University System of Maryland; University of Maryland College Park	Gupta, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, W Bengal, India.; Sengupta, D (corresponding author), CSIR, Natl Chem Lab, Phys & Mat Chem Div, Pune, Maharashtra, India.	d.sengupta@ncl.res.in; arnab.gupta@iiserkol.ac.in	Saraf, Deepashri/GYR-3455-2022; Mondal, Basudeb/GLN-3201-2022	Mondal, Basudeb/0000-0002-6676-9846; Paul, Rupam/0000-0001-5859-7952; Kar, Sumanta/0000-0002-3368-8986; MAJI, SAPTARSHI/0000-0002-8198-2426; Schreiner, Ryan/0000-0002-7457-6606	DBT-Wellcome Trust India Alliance Fellowship [IA/I/16/1/502369]; Early Career Research Award from SERB, Department of Science and Technology (DST), Government of India [ECR/2015/000220]; IISER-K; Council of Scientific and Industrial Research (CSIR), India; Intramural Institute funding (IISER-K); KVPY fellowships from the Government of India	DBT-Wellcome Trust India Alliance Fellowship; Early Career Research Award from SERB, Department of Science and Technology (DST), Government of India; IISER-K; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Intramural Institute funding (IISER-K); KVPY fellowships from the Government of India	This work is supported by DBT-Wellcome Trust India Alliance Fellowship (IA/I/16/1/502369), Early Career Research Award (ECR/2015/000220) from SERB, Department of Science and Technology (DST), Government of India, and IISER-K intramural funding to A. G. S. K., R. P., S. M., B. M. are supported by a predoctoral fellowship from Council of Scientific and Industrial Research (CSIR), India. The predoctoral fellowship for Ruturaj is supported by Intramural Institute funding (IISER-K). S. S. is supported by KVPY fellowships from the Government of India.	Abada Paolo, 2010, Metal-Based Drugs, P317581, DOI 10.1155/2010/317581; Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Arredondo M, 2003, AM J PHYSIOL-CELL PH, V284, pC1525, DOI 10.1152/ajpcell.00480.2002; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bay AEP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11550; Bay AEP, 2013, EMBO J, V32, P2125, DOI 10.1038/emboj.2013.130; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertinato J, 2015, ENCY FOOD HLTH, P321; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Broyden C. G., 1973, Journal of the Institute of Mathematics and Its Applications, V12, P223; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Chowdhury R, 2021, CHEM-ASIAN J, V16, P1634, DOI 10.1002/asia.202100268; Clifford RJ, 2016, J CELL SCI, V129, P1711, DOI 10.1242/jcs.173351; Curnock R, 2020, J CELL SCI, V133, DOI 10.1242/jcs.249201; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Du XB, 2013, CHEM COMMUN, V49, P9134, DOI 10.1039/c3cc45360j; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Galler T, 2020, CHEM COMMUN, V56, P12194, DOI 10.1039/d0cc04693k; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; Gonzalez P, 2018, CHEM-EUR J, V24, P8029, DOI 10.1002/chem.201705398; Gravotta D, 2019, MOL BIOL CELL, V30, P1716, DOI 10.1091/mbc.E18-12-0811; GUNDERSEN D, 1993, J CELL BIOL, V121, P335, DOI 10.1083/jcb.121.2.335; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kirsipuu T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62560-4; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Larson CA, 2010, BIOCHEM PHARMACOL, V80, P448, DOI 10.1016/j.bcp.2010.04.030; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Liang ZD, 2014, J BIOL INORG CHEM, V19, P17, DOI 10.1007/s00775-013-1051-z; Liao QH, 2015, J PHYS CHEM LETT, V6, P2657, DOI 10.1021/acs.jpclett.5b01122; LINDER MC, 1991, BIOCH COPPER, P1; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Magistrato A, 2019, CURR OPIN STRUC BIOL, V58, P26, DOI 10.1016/j.sbi.2019.05.002; Mandal T, 2020, J MEMBRANE BIOL, V253, P459, DOI 10.1007/s00232-020-00139-w; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Perdew JP, 1999, PHYS REV LETT, V82, P2544, DOI 10.1103/PhysRevLett.82.2544; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Pushie MJ, 2015, INORG CHEM, V54, P8544, DOI 10.1021/acs.inorgchem.5b01162; Ren F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09376-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Schwab S, 2016, J INORG BIOCHEM, V158, P70, DOI 10.1016/j.jinorgbio.2015.12.021; Shenberger Y, 2015, J PHYS CHEM B, V119, P4824, DOI 10.1021/acs.jpcb.5b00091; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soll SJ, 2010, P NATL ACAD SCI USA, V107, P19496, DOI 10.1073/pnas.1012344107; Song IS, 2004, MOL CANCER THER, V3, P1543; Stefaniak E, 2018, METALLOMICS, V10, P1723, DOI 10.1039/c8mt00274f; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Vetterling W.T., 1988, NUMERICAL RECIPES C; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wezynfeld NE, 2019, INORG CHEM, V58, P7488, DOI 10.1021/acs.inorgchem.9b00711; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-38798141-3, DOI 10.1007/978-0-38798141-3]; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Yang Y, 2019, CHEM COMMUN, V55, P11107, DOI 10.1039/c9cc04859f; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	90	1	1	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101631	10.1016/j.jbc.2022.101631	http://dx.doi.org/10.1016/j.jbc.2022.101631			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35090891	Green Published, gold			2022-12-26	WOS:000821051800013
J	Ma, LL; Lu, HY; Tian, ZZ; Yang, MT; Ma, J; Shang, GH; Liu, YL; Xie, MJ; Wang, GG; Wu, W; Zhang, ZD; Dai, SD; Chen, ZZ				Ma, Lulu; Lu, Hongyun; Tian, Zizi; Yang, Meiting; Ma, Jun; Shang, Guohui; Liu, Yunlong; Xie, Mengjia; Wang, Guoguo; Wu, Wei; Zhang, Ziding; Dai, Shaodong; Chen, Zhongzhou			Structural insights into the interactions and epigenetic functions of human nucleic acid repair protein ALKBH6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; RNA DEMETHYLASE; MUTATIONAL LANDSCAPE; CANCER PROGRESSION; DNA; METHYLATION; DAMAGE; EXPRESSION; SUBSTRATE; BACTERIAL	Human AlkB homolog 6, ALKBH6, plays key roles in nucleic acid damage repair and tumor therapy. However, no precise structural and functional information are available for this protein. In this study, we determined atomic resolution crystal structures of human holo-ALKBH6 and its complex with ligands. AlkB members bind nucleic acids by NRLs (nucleotide recognition lids, also called Flips), which can recognize DNA/ RNA and flip methylated lesions. We found that ALKBH6 has unusual Flip1 and Flip2 domains, distinct from other AlkB family members both in sequence and conformation. Moreover, we show that its unique Flip3 domain has multiple unreported functions, such as discriminating against double stranded nucleic acids, blocking the active center, binding other proteins, and in suppressing tumor growth. Structural analyses and substrate screening reveal how ALKBH6 discriminates between different types of nucleic acids and may also function as a nucleic acid demethylase. Structure-based interacting partner screening not only uncovered an unidentified interaction of transcription repressor ZMYND11 and ALKBH6 in tumor suppression but also revealed cross talk between histone modification and nucleic acid modification in epigenetic regulation. Taken together, these results shed light on the molecular mechanism underlying ALKBH6-associated nucleic acid damage repair and tumor therapy.	[Ma, Lulu; Tian, Zizi; Yang, Meiting; Ma, Jun; Shang, Guohui; Liu, Yunlong; Xie, Mengjia; Wang, Guoguo; Wu, Wei; Zhang, Ziding; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Ma, Lulu; Tian, Zizi; Yang, Meiting; Ma, Jun; Shang, Guohui; Liu, Yunlong; Xie, Mengjia; Wang, Guoguo; Wu, Wei; Zhang, Ziding; Chen, Zhongzhou] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Biol Sci, Beijing, Peoples R China; [Lu, Hongyun] Beijing Technol & Business Univ, Sch Food & Hlth, Beijing, Peoples R China; [Dai, Shaodong] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA	China Agricultural University; China Agricultural University; Beijing Technology & Business University; University of Colorado System; University of Colorado Anschutz Medical Campus	Chen, ZZ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Chen, ZZ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Biol Sci, Beijing, Peoples R China.	chenzhongzhou@cau.edu.cn			National Key Research and Development Program of China [2018YFE0113100]; National Natural Science Foundation of China [31872713, 32071210]; Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant [2022SKLAB6-1]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant	We would like to thank the staff of beamlines BL17U1, BL19U1, and BL19U2 at the Shanghai Synchrotron Radiation Facility for the excellent technical assistance. This work was supported by National Key Research and Development Program of China (2018YFE0113100) , National Natural Science Foundation of China (31872713 and 32071210) , and Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant (2022SKLAB6-1) . Funding for open access charge: National Key Research and Development Program of China (2018YFE0113100) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cha S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2209-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZJ, 2019, NUCLEIC ACIDS RES, V47, P2533, DOI 10.1093/nar/gky1250; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Hayward N. K., 2017, NATURE; Herceg Z., 2018, ROADMAP INVESTIGATIN; Hu JZ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00500; Huong TT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186707; Janin M, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01192-8; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin TC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40991; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Lee JK, 2017, NAT GENET, V49, P594, DOI 10.1038/ng.3806; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Liu CX, 2014, INT J CLIN EXP PATHO, V7, P690; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu Zhe, 2018, Oncotarget, V9, P27412, DOI 10.18632/oncotarget.25287; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; McMillan EA, 2018, CELL, V173, P864, DOI 10.1016/j.cell.2018.03.028; Mimaki S., 2016, IN PRESS; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Mishina Y, 2004, NUCLEIC ACIDS RES, V32, P1548, DOI 10.1093/nar/gkh319; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nayar U, 2019, NAT GENET, V51, P207, DOI 10.1038/s41588-018-0287-5; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Perry GS, 2021, J MED CHEM, V64, P16974, DOI 10.1021/acs.jmedchem.1c01694; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Pilzys T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49550-x; Rabbie R, 2021, BRIT J CANCER, V124, P156, DOI 10.1038/s41416-020-01090-2; Ruan DY, 2021, ONCOGENE, V40, P5168, DOI 10.1038/s41388-021-01916-0; Seidlitz T, 2019, GUT, V68, P207, DOI 10.1136/gutjnl-2017-314549; South A. P., 2014, NOTCH1; Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Tian LF, 2020, CELL RES, V30, P272, DOI 10.1038/s41422-019-0233-9; Tian ZZ, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0150-6; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Vinayanuwattikun C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31628; Voegele N., [No title captured]; Wang GQ, 2014, J BIOL CHEM, V289, P27924, DOI 10.1074/jbc.M114.590505; Wang JY, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01450-1; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xiao MZ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110645; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Xu BF, 2021, CELL MOL LIFE SCI, V78, P129, DOI 10.1007/s00018-020-03594-9; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yoshikawa Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.554570; Zhang LS, 2021, NAT CELL BIOL, V23, P684, DOI 10.1038/s41556-021-00709-7; Zhang M, 2020, CELL RES, V30, P197, DOI 10.1038/s41422-019-0237-5; Zhao SY, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.635808; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zou SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6696	76	0	0	10	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101671	10.1016/j.jbc.2022.101671	http://dx.doi.org/10.1016/j.jbc.2022.101671			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120926	gold, Green Published			2022-12-26	WOS:000791230900009
J	Minogue, PJ; Tong, JJ; Wichmann, K; Mysliwiec, H; Ebihara, L; Beyer, EC; Berthoud, VM				Minogue, Peter J.; Tong, Jun-Jie; Wichmann, Kelly; Mysliwiec, Hubert; Ebihara, Lisa; Beyer, Eric C.; Berthoud, Viviana M.			Cataract-linked serine mutations in the gap junction protein connexin50 expose a sorting signal that promotes its lysosomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT; PHOSPHORYLATION; MICROPHTHALMIA; MEMBRANE; CHANNELS; GROWTH; LEADS	Many human connexin50 (Cx50) mutants have been linked to cataracts including two carboxyl terminus serine mutants that are known phosphorylation sites in the lens (Cx50S258F and Cx50S259Y). To examine the behavior of these mutants and the role of phosphorylation at these positions, we stably transfected HeLa cells with cataract-linked and phosphorylation-mimicking (Cx50S258D and Cx50S259D) Cx50 mutants. We observed that gap junctional plaques were rarely detected in Cx50S258Fexpressing and Cx50S259Y-expressing cells compared with wild-type cells. In contrast, gap junction abundance and size were greatly increased for Cx50S258D and Cx50S259D mutants. Cx50S258F and Cx50S259Y supported very low levels of gap junctional coupling, whereas Cx50S258D and Cx50S259D supported extensive intercellular communication. Furthermore, Cx50 levels as detected by immunoblotting were lower in Cx50S258F and Cx50S259Y mutants than in the wild-type or the aspartate substitution mutants, and chloroquine or ammonium chloride treatment significantly increased Cx50S258F and Cx50S259Y protein levels, implying participation of the lysosome in their increased degradation. Alanine substitution of amino acids within a predicted tyrosine-based sorting signal in Cx50S258F and Cx50S259Y increased levels of gap junctional plaques and intercellular transfer of neurobiotin. These results suggest that the absence of phosphorylatable serines at these positions exposes a sorting signal leading to lysosomal degradation of Cx50, whereas phosphorylation at these sites conceals this signal and allows targeting of Cx50 to the plasma membrane and stabilization of gap junction plaques. We propose that in the lens, degradation of Cx50S258F and Cx50S259Y decreases Cx50 levels at the plasma membrane and consequently Cx50 function, leading to cataracts.	[Minogue, Peter J.; Wichmann, Kelly; Mysliwiec, Hubert; Beyer, Eric C.; Berthoud, Viviana M.] Univ Chicago, Dept Pediat, Chicago, IL USA; [Tong, Jun-Jie; Ebihara, Lisa] Rosalind Franklin Univ Med & Sci, Ctr Prote & Mol Therapeut, N Chicago, IL USA; [Ebihara, Lisa] Rosalind Franklin Univ Med & Sci, Discipline Physiol & Biophys, N Chicago, IL USA	University of Chicago; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Berthoud, VM (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL USA.	vberthou@peds.bsd.uchicago.edu		Beyer, Eric/0000-0001-8044-1356; Mysliwiec, Hubert/0000-0002-1294-1014; Ebihara, Lisa/0000-0002-1989-0686	National Institutes of Health [R01-EY030914, R01-EY026902]; Ted Mullins Fund for Cancer Research; University of Chicago	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Mullins Fund for Cancer Research; University of Chicago(University of Chicago)	This work was supported by the National Institutes of Health grants (R01-EY030914 [to E. C. B. and V. M. B.] and R01-EY026902 [to L. E.] ) . K. W. was supported by the Ted Mullins Fund for Cancer Research. H. M. was supported by a Jeff Metcalf Fellowship from the University of Chicago. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldo GJ, 2001, J GEN PHYSIOL, V118, P447, DOI 10.1085/jgp.118.5.447; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Berthoud VM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165822; Berthoud VM, 2019, INVEST OPHTH VIS SCI, V60, P2336, DOI 10.1167/iovs.18-26459; Berthoud VM, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-016-0116-6; Berthoud VM, 2016, J BIOL CHEM, V291, P17569, DOI 10.1074/jbc.M115.707950; Berthoud VM, 2013, INVEST OPHTH VIS SCI, V54, P7614, DOI 10.1167/iovs.13-13188; Berthoud VM, 2003, EUR J CELL BIOL, V82, P209, DOI 10.1078/0171-9335-00316; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen JH, 2014, EYE, V28, P1511, DOI 10.1038/eye.2014.158; Delmar M, 2012, CURR OPIN CARDIOL, V27, P236, DOI 10.1097/HCO.0b013e328352220e; EBIHARA L, 1992, METHOD ENZYMOL, V207, P376; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; Ehrlich A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115734; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Fong JT, 2013, MOL BIOL CELL, V24, P2834, DOI 10.1091/mbc.E13-02-0111; Gao XB, 2010, CURR EYE RES, V35, P597, DOI 10.3109/02713681003725831; Gu SM, 2019, INVEST OPHTH VIS SCI, V60, P4021, DOI 10.1167/iovs.18-26270; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Liu YY, 2015, J GENET, V94, P221; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; Minogue PJ, 2019, MOL VIS, V25, P535; Minogue PJ, 2013, J BIOL CHEM, V288, P20427, DOI 10.1074/jbc.M113.452847; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Minogue PJ, 2005, J BIOL CHEM, V280, P40788, DOI 10.1074/jbc.M504765200; Myers JB, 2018, NATURE, V564, P372, DOI 10.1038/s41586-018-0786-7; Rong P, 2002, DEVELOPMENT, V129, P167; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shearer D, 2008, INVEST OPHTH VIS SCI, V49, P1553, DOI 10.1167/iovs.07-1193; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; Srinivas M, 2018, BBA-BIOMEMBRANES, V1860, P192, DOI 10.1016/j.bbamem.2017.04.024; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; Wang Z, 2013, INVEST OPHTH VIS SCI, V54, P1135, DOI 10.1167/iovs.12-11168; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Xu XR, 1999, INVEST OPHTH VIS SCI, V40, P1844	42	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101673	10.1016/j.jbc.2022.101673	http://dx.doi.org/10.1016/j.jbc.2022.101673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120923	gold, Green Published			2022-12-26	WOS:000791230900007
J	Shimizu, T; Saito, T; Aoki-Saito, H; Okada, S; Ikeda, H; Nakakura, T; Fukuda, H; Arai, S; Fujiwara, K; Nakajima, Y; Horiguchi, K; Yamada, S; Ishida, E; Hisada, T; Shuto, S; Yamada, M				Shimizu, Tomohiko; Saito, Tsugumichi; Aoki-Saito, Haruka; Okada, Shuichi; Ikeda, Hiroyuki; Nakakura, Takashi; Fukuda, Hayato; Arai, Syota; Fujiwara, Kouichi; Nakajima, Yasuyo; Horiguchi, Kazuhiro; Yamada, Sayaka; Ishida, Emi; Hisada, Takeshi; Shuto, Satoshi; Yamada, Masanobu			Resolvin E3 ameliorates high-fat diet-induced insulin resistance via the phosphatidylinositol-3-kinase/Akt signaling pathway in adipocytes	FASEB JOURNAL			English	Article						eicosapentaenoic acid; insulin resistance; omega-3 fatty acids; PI3K; Akt pathway; Resolvin E3	DIABETES-MELLITUS; LIPID MEDIATOR; INFLAMMATION; E1; OMEGA-3-FATTY-ACIDS; EXPRESSION; OBESITY; IDENTIFICATION; ABSORPTION; RESOLUTION	Obesity-associated type 2 diabetes mellitus is associated with the development of insulin resistance. Among several metabolites, resolvins that are metabolites of eicosapentaenoic acid have been shown to exert insulin-sensitizing effects; however, the role of resolvin E3 (RvE3) in glucose metabolism has not been studied. In this study, the effect of RvE3 on glucose metabolism in mice with high-fat diet-induced obesity and 3T3L1 adipocytes was studied. C57BL/6 mice fed a high-fat diet were administered RvE3, for which insulin tolerance, oral glucose tolerance tests, and the homeostasis model assessment of insulin resistance, were performed. RvE3 treatment significantly improved insulin sensitivity and glucose tolerance and regulated protein kinase B (Akt) phosphorylation in the adipose tissue. Moreover, RvE3 treatment enhanced the insulin-stimulated glucose transporter 4 (Glut4) translocation, glucose uptake, phosphatidylinositol-3-kinase (PI3K) activity, and Akt phosphorylation in 3T3L1 adipocytes, whereas a PI3K inhibitor inhibited the enhanced insulin-stimulated glucose uptake induced by RvE3. These findings indicate that RvE3 likely improves insulin sensitivity, resulting in the upregulation of glucose uptake in adipocytes by activating the PI3K/Akt signaling pathways. Collectively, the findings of this study show that RvE3 may play a role in glucose homeostasis and could be used as a potential therapeutic target for developing treatments for obesity-associated diabetes.	[Shimizu, Tomohiko; Saito, Tsugumichi; Okada, Shuichi; Nakajima, Yasuyo; Horiguchi, Kazuhiro; Yamada, Sayaka; Ishida, Emi; Yamada, Masanobu] Gunma Univ, Dept Internal Med, Div Endocrinol & Metab, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Saito, Tsugumichi] Gunma Univ, Ctr Med Educ, Grad Sch Med, Maebashi, Gumma, Japan; [Aoki-Saito, Haruka] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan; [Aoki-Saito, Haruka] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma, Japan; [Ikeda, Hiroyuki; Arai, Syota; Fujiwara, Kouichi; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Nakakura, Takashi] Teikyo Univ, Dept Anat, Tokyo, Japan; [Fukuda, Hayato] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan; [Hisada, Takeshi] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gumma, Japan	Gunma University; Gunma University; Gunma University; Gunma University; Hokkaido University; Teikyo University; Nagasaki University; Gunma University	Saito, T (corresponding author), Gunma Univ, Dept Internal Med, Div Endocrinol & Metab, Grad Sch Med, Maebashi, Gumma 3718511, Japan.	saitotsu@gunma-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25860087, 16K01812, 19K08993, 18K08404, 17K08360, 15H02495, 19H0101409]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 25860087, 16K01812, 19K08993, 18K08404, 17K08360, 15H02495 and 19H0101409	Altaf QA, 2015, DIABETES OBES METAB, V17, P319, DOI 10.1111/dom.12400; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409; Ezaki O, 1997, BIOCHEM BIOPH RES CO, V241, P1, DOI 10.1006/bbrc.1997.7587; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Fukuda H, 2020, J ORG CHEM, V85, P14190, DOI 10.1021/acs.joc.0c01701; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hameed I, 2015, WORLD J DIABETES, V6, P598, DOI 10.4239/wjd.v6.i4.598; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Ishimura K, 2021, ACS MED CHEM LETT, V12, P256, DOI 10.1021/acsmedchemlett.0c00639; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Martinez-Fernandez L, 2015, PROSTAG OTH LIPID M, V121, P24, DOI 10.1016/j.prostaglandins.2015.07.003; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nagy C, 2018, JOVE-J VIS EXP, DOI 10.3791/56672; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal A, 2020, FASEB J, V34, P10640, DOI 10.1096/fj.202000830R; Perez-Matute P, 2005, AM J PHYSIOL-REG I, V288, pR1682, DOI 10.1152/ajpregu.00727.2004; Remesar X, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207729; Sato M, 2019, FASEB J, V33, P12750, DOI 10.1096/fj.201900283R; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Sima C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13185-7; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; SUN XJ, 1992, J BIOL CHEM, V267, P22662; THOMSON ABR, 1989, CAN J PHYSIOL PHARM, V67, P179, DOI 10.1139/y89-031; THOMSON ABR, 1989, LIPIDS, V24, P494, DOI 10.1007/BF02535128; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; WHITE MF, 1994, J BIOL CHEM, V269, P1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	39	6	5	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22188	10.1096/fj.202100053R	http://dx.doi.org/10.1096/fj.202100053R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129868				2022-12-26	WOS:000761250800026
J	Yakobov, N; Mahmoudi, N; Grob, G; Yokokawa, D; Saga, Y; Kushiro, T; Worrell, D; Roy, H; Schaller, H; Senger, B; Huck, L; Gascon, GR; Becker, HD; Fischer, F				Yakobov, Nathaniel; Mahmoudi, Nassira; Grob, Guillaume; Yokokawa, Daisuke; Saga, Yusuke; Kushiro, Tetsuo; Worrell, Danielle; Roy, Herve; Schaller, Hubert; Senger, Bruno; Huck, Laurence; Gascon, Gisela Riera; Becker, Hubert D.; Fischer, Frederic			RNA-dependent synthesis of ergosteryl-3 beta-O-glycine in Ascomycota expands the diversity of steryl-amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE FUSION; FUNCTIONAL-ANALYSIS; PEPTIDE RESISTANCE; CHOLESTEROL; SYNTHETASES; PHOSPHATIDYLGLYCEROL; BIOSYNTHESIS; GLYCOSIDES; ERGOSTEROL; GLUCOSIDE	A wide range of bacteria possess virulence factors such as aminoacyl-tRNA transferases (ATTs) that are capable of rerouting aminoacyl-transfer RNAs away from protein synthesis to conjugate amino acids onto glycerolipids. We recently showed that, although these pathways were thought to be restricted to bacteria, higher fungi also possess ergosteryl-3 beta-O-L-aspartate synthases (ErdSs), which transfer the L-Asp moiety of aspartyl-tRNA(Asp) onto the 3 beta-OH group of ergosterol (Erg), yielding ergosteryl-3 beta-O-L-aspartate (Erg-Asp). Here, we report the discovery, in fungi, of a second type of fungal sterol-specific ATTs, namely, ergosteryl-3 beta-O-glycine (Erg-Gly) synthase (ErgS). ErgS consists of a freestanding DUF2156 domain encoded by a gene distinct from and paralogous to that of ErdS. We show that the enzyme only uses GlytRNA(Gly) produced by an independent glycyl-tRNA synthetase (GlyRS) to transfer glycine onto the 3 beta-OH of Erg, producing Erg-Gly. Phylogenomics analysis also show that the Erg-Gly synthesis pathway exists only in Ascomycota, including species of biotechnological interest, and more importantly, in human pathogens, such as Aspergillus fumigatus. The discovery of a second type of Erg-aa not only expands the repertoire of this particular class of fungal lipids but suggests that Erg-aa synthases might constitute a genuine subfamily of lipid modifying ATTs.	[Yakobov, Nathaniel; Mahmoudi, Nassira; Grob, Guillaume; Senger, Bruno; Huck, Laurence; Gascon, Gisela Riera; Becker, Hubert D.; Fischer, Frederic] Univ Strasbourg, UMR 7156, CNRS, Genet Mol Genom Microbiol, Strasbourg, France; [Yokokawa, Daisuke; Saga, Yusuke; Kushiro, Tetsuo] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan; [Worrell, Danielle; Roy, Herve] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Schaller, Hubert] Univ Strasbourg, Plant Isoprenoid Biol PIB Team, Inst Biol Mol Plantes, CNRS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Meiji University; State University System of Florida; University of Central Florida; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mahmoudi, N; Becker, HD; Fischer, F (corresponding author), Univ Strasbourg, UMR 7156, CNRS, Genet Mol Genom Microbiol, Strasbourg, France.	nmahmoudikaidi@unistra.fr; h.becker@unistra.fr; frfischer@unistra.fr		Yakobov, Nathaniel/0000-0001-9074-1651; Senger, Bruno/0000-0002-5157-7307	Agence Nationale de la Recherche [ANR-20-CE44-0002]; Fondation pour la Recherche Medicale (FRM) [DBF20160635713]; "MitoCross'' Laboratory of Excellence [ANR-10-IDEX-0002-02]; University of Strasbourg; CNRS; French Ministere de l'Enseignement Superieur et de la Recherche; FRM [DBF20160635713]; ANR [ANR-20-CE44-0002]; Meiji University; Japan Society for the Promotion of Science [21K05406]; National Institutes of Health [1R21AI144481-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); "MitoCross'' Laboratory of Excellence; University of Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Enseignement Superieur et de la Recherche; FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); Meiji University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported as the "N-FLAMS" project by the Agence Nationale de la Recherche (ANR-20-CE44-0002), by the Fondation pour la Recherche Medicale (FRM, DBF20160635713), by the "MitoCross'' Laboratory of Excellence funding (Labex, ANR-10-IDEX-0002-02), by the University of Strasbourg and by the CNRS (H. D. B., F. F., N. M., N. Y., G. G., B. S., L. H., H. S.). N. Y. was supported by a fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche, N. M. by a postdoctoral fellowship from the FRM (DBF20160635713) and ANR (ANR-20-CE44-0002). Funding was also provided by Meiji University, as well as Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (Grant Number 21K05406 to T. K.). H. R. and D. W. were supported by a National Institutes of Health Grant: 1R21AI144481-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Alcazar-Fuoli L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00439; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Arendt W, 2013, J BIOL CHEM, V288, P24717, DOI 10.1074/jbc.M113.482935; Bailly M, 2008, METHODS, V44, P146, DOI 10.1016/j.ymeth.2007.11.012; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Choudhary V, 2014, J LIPID RES, V55, P883, DOI 10.1194/jlr.M047126; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Czolkoss S., 2019, MOL MICROBIOL; De Craene JO, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030634; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Dubchak I., 2014, NUCL ACIDS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; ERIANI G, 1995, J MOL EVOL, V40, P499; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Farnoud AM, 2015, CURR TOP MEMBR, V75, P233, DOI 10.1016/bs.ctm.2015.03.005; Favrot L, 2016, BIOCHEMISTRY-US, V55, P989, DOI 10.1021/acs.biochem.5b01269; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fields RN, 2018, RNA BIOL, V15, P480, DOI 10.1080/15476286.2017.1356980; Fischer F, 2012, NUCLEIC ACIDS RES, V40, P4965, DOI 10.1093/nar/gks167; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goswami S K, 1970, J Chromatogr, V53, P389, DOI 10.1016/S0021-9673(01)98486-9; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; Hebecker S, 2015, P NATL ACAD SCI USA, V112, P10691, DOI 10.1073/pnas.1511167112; Hemmerle Marine, 2020, Enzymes, V48, P117, DOI 10.1016/bs.enz.2020.04.003; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Jorda T, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070795; Kaminski DM, 2014, EUR BIOPHYS J BIOPHY, V43, P453, DOI 10.1007/s00249-014-0983-8; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KERN D, 1979, BIOCHIMIE, V61, P1257; Kikuma T, 2017, BIOSCI BIOTECH BIOCH, V81, P384, DOI 10.1080/09168451.2016.1240603; Korber M, 2017, BBA-MOL CELL BIOL L, V1862, P1534, DOI 10.1016/j.bbalip.2017.09.002; Kuroki Y, 2002, FEMS MICROBIOL LETT, V209, P277, DOI 10.1016/S0378-1097(02)00551-7; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; Morioka S, 2013, APPL MICROBIOL BIOT, V97, P4013, DOI 10.1007/s00253-012-4470-9; Moutiez M, 2017, CHEM REV, V117, P5578, DOI 10.1021/acs.chemrev.6b00523; Mueller JW, 2015, ENDOCR REV, V36, P526, DOI 10.1210/er.2015-1036; Nazarko TY, 2007, AUTOPHAGY, V3, P263, DOI 10.4161/auto.3907; Nes WD, 2011, CHEM REV, V111, P6423, DOI 10.1021/cr200021m; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Normile TG, 2020, J FUNGI, V6, DOI 10.3390/jof6010025; Panwar SL, 2008, BIOSCIENCE REP, V28, P217, DOI 10.1042/BSR20080071; Rella A, 2016, PROG LIPID RES, V61, P63, DOI 10.1016/j.plipres.2015.11.003; Rodrigues ML, 2018, MBIO, V9, DOI 10.1128/mBio.01755-18; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Shimamura M, 2020, BIOCHEM J, V477, P4243, DOI 10.1042/BCJ20200532; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Slavetinsky C, 2017, BBA-MOL CELL BIOL L, V1862, P1310, DOI 10.1016/j.bbalip.2016.11.013; Smith AM, 2015, MOL MICROBIOL, V98, P681, DOI 10.1111/mmi.13150; Smith AM, 2013, J BIOL CHEM, V288, P22768, DOI 10.1074/jbc.M113.484402; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Tsakos M, 2015, NAT PROD REP, V32, P605, DOI 10.1039/c4np00106k; Weichert M., 2016, P NATL ACAD SCI USA; Weichert M, 2020, GENETICS, V216, P1103, DOI 10.1534/genetics.120.303623; Yakobov N, 2020, P NATL ACAD SCI USA, V117, P14948, DOI 10.1073/pnas.2003266117; Yamashita SI, 2007, AUTOPHAGY, V3, P35, DOI 10.4161/auto.3311; Yokokawa D, 2021, STEROIDS, V169, DOI 10.1016/j.steroids.2021.108823; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	71	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101657	10.1016/j.jbc.2022.101657	http://dx.doi.org/10.1016/j.jbc.2022.101657			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35131263	gold, Green Published			2022-12-26	WOS:000794865600012
J	Sudo, M; Fujimoto, K				Sudo, Maki; Fujimoto, Koichi			Traveling wave of inflammatory response to regulate the expansion or shrinkage of skin erythema	PLOS ONE			English	Article							CYTOKINES; BARRIER; INNATE	Many skin diseases show circular red lesions on the skin, called erythema. Erythema is characterized by the expansion of its circular area solely from local stimulation. A pathological inflammatory response caused by the stimulation persistently increases inflammatory mediators in the dermis, whereas a normal inflammatory response transiently increases mediators, resulting in the shrinkage of the erythema. Although the diffusion of mediators theoretically reproduces the expansion, how the inflammatory response expands or shrinks the erythema remains unknown. A possibility is positive feedback, which affects mediator production and can generate two distinct stable states (i.e., inflamed and noninflamed), referred to as bistability. Bistability causes a state transition either from the noninflamed to inflamed state or the reverse direction by suprathreshold stimulation. Additionally, the diffusion selectively causes state transition in either direction, resulting in spatial spread of the transited state, known as the traveling wave. Therefore, we hypothesize that the traveling wave of the inflammatory response can account for both the expansion and shrinkage. Using a reaction-diffusion model with bistability, we theoretically show a possible mechanism in which the circular inflamed area expands via the traveling wave from the noninflamed to the inflamed state. During the expansion, the boundary between the inflamed and noninflamed areas moves at a constant velocity while maintaining its concentration gradient. Moreover, when the positive feedback is weak, the traveling wave selectively occurs from the inflamed to noninflamed state, shrinking the inflamed area. Whether the inflamed area expands or shrinks is mainly controlled by the balance of mediator concentration between the noninflamed and inflamed states, relative to the threshold. The traveling wave of the inflammatory response provides an experimentally testable framework for erythema expansion and shrinkage, thereby contributing to the development of effective treatments, including probiotics.	[Sudo, Maki; Fujimoto, Koichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Machikaneyama Cho, Toyonaka, Osaka, Japan	Osaka University	Fujimoto, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Machikaneyama Cho, Toyonaka, Osaka, Japan.	fujimoto@bio.sci.osaka-u.ac.jp		Sudo, Maki/0000-0002-0323-0712; Fujimoto, Koichi/0000-0001-6473-7990	Ministry of Culture, Sports, Science and Technology of Japan [17H06386]	Ministry of Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	work was supported by Grants-inAid for Scientific Research from the Ministry of Culture, Sports, Science and Technology of Japan to KF (17H06386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SHIMIZUS TXB DERMATO; Basler K, 2017, PFLUG ARCH EUR J PHY, V469, P3, DOI 10.1007/s00424-016-1903-9; Barzilai A, 2017, AM J DERMATOPATH, V39, P753, DOI 10.1097/DAD.0000000000000786; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.589726; Cornelissen LH, 2009, ANN BIOMED ENG, V37, P1007, DOI 10.1007/s10439-009-9652-y; Dainichi T, 2014, J DERMATOL SCI, V76, P81, DOI 10.1016/j.jdermsci.2014.08.010; Denda M, 2014, EXP DERMATOL, V23, P79, DOI 10.1111/exd.12302; Dominguez-Huttinger E, 2017, J ALLERGY CLIN IMMUN, V139, P1861, DOI 10.1016/j.jaci.2016.10.026; Fernandez TD, 2009, CURR OPIN INFECT DIS, V22, P272, DOI 10.1097/QCO.0b013e3283298e62; Gilmore S., 2005, J THEOR MED, V6; Kabashima K, 2019, NAT REV IMMUNOL, V19, P19, DOI 10.1038/s41577-018-0084-5; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Meisel JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0404-9; Murphy K, 2017, JANEWAYS IMMUNOBIOLO; Murray, 2002, MATH BIOL I INTRO IN; Nakaoka S, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6090252; Nast A, 2016, BRIT J DERMATOL, V174, P1351, DOI 10.1111/bjd.14419; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ringham L, 2019, ISCIENCE, V20, P546, DOI 10.1016/j.isci.2019.10.008; Segel LA, 1992, THEORETICAL EXPT MEN, P333; Seirin-Lee S, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007590; Valeyev NV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001024; Vig DK, 2014, BIOPHYS J, V106, P763, DOI 10.1016/j.bpj.2013.12.017; Volpert V, 2009, PHYS LIFE REV, V6, P267, DOI 10.1016/j.plrev.2009.10.002; Yeo SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05274-6; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635; Zucchi E, 2018, J CLIN NEUROSCI, V56, P175, DOI 10.1016/j.jocn.2018.06.056	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263049	10.1371/journal.pone.0263049	http://dx.doi.org/10.1371/journal.pone.0263049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139094	Green Published, gold			2022-12-26	WOS:000821499100023
J	Yang, SH; Meng, QX; Zhao, WZ; Wang, JM; Liu, YQ; Gong, XY; Dong, K				Yang, Shunhua; Meng, Qingxin; Zhao, Wenzheng; Wang, Jianming; Liu, Yiqiu; Gong, Xueyang; Dong, Kun			Cell orientation characteristics of the natural combs of honey bee colonies	PLOS ONE			English	Article							PATTERN-FORMATION; APIS-MELLIFERA; CONSTRUCTION; BEHAVIOR; NEST	The cell orientation characteristics of the natural combs of honey bees have received much research attention. Although natural combs have been shown to be composed of cells with three orientations-vertical, intermediate (oblique), and horizontal-the proportion of comb cells in these three orientations varies. Knowledge of the comb-building preferences of honey bees is essential for the installation of wax comb foundations, and clarification of the cell orientation characteristics of natural honey bee combs is important for beekeeping. The purpose of this study was to determine the cell orientation characteristics of natural combs of Eastern honey bees (Apis cerana cerana) and Western honey bees (Apis mellifera ligustica). Newly built combs were used to measure the orientation of hexagonal cells and calculate the proportion of cells in different orientations relative to the total number of cells. The number of eggs laid by queens in the cells of different orientations was also determined. The orientation of cells in the natural combs of Eastern and Western honey bees was determined based on the value of the minimum included angle between the pair of parallel cell walls and a vertical line connecting the top and bottom bars of the movable frame in the geometric plane of the comb: 0 degrees <=theta <= 10 degrees, 10 degrees<theta <= 20 degrees, and 20 degrees<0 <= 30 degrees for vertical, intermediate, and horizontal orientations, respectively. Natural combs were composed of cells with at least one orientation (vertical or horizontal), two orientations (vertical + intermediate (oblique) or vertical + horizontal), or three orientations (vertical + intermediate + horizontal), and the proportions of combs with the three aforementioned configurations differed. Both Eastern honey bees and Western honey bees preferred building combs with cells in a vertical orientation. Queens showed no clear preference for laying eggs in cells of specific orientations. The results of this study provide new insight that could aid the production and cutting of wax comb foundations of Eastern and Western honey bees. Our study highlights the importance of installing wax comb foundations compatible with the comb-building preferences of bees.	[Yang, Shunhua; Meng, Qingxin; Zhao, Wenzheng; Wang, Jianming; Liu, Yiqiu; Gong, Xueyang; Dong, Kun] Yunnan Agr Univ, Coll Anim Sci & Technol, Yunnan Prov Engn & Res Ctr Sustainable Utilizat H, Eastern Bee Res Inst, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University	Gong, XY; Dong, K (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Yunnan Prov Engn & Res Ctr Sustainable Utilizat H, Eastern Bee Res Inst, Kunming, Yunnan, Peoples R China.	xueyangg11@126.com; dongkun19722004@aliyun.com		Yang, Shunhua/0000-0003-4782-8617; Dong, Kun/0000-0001-9370-6966	National Natural Science Foundation of China [32060241, 31572339]; China Agriculture Research System of the Ministry of Finance; Reserve Talents Training Program for Young and Middle-aged Academic and Technical Leaders in Yunnan [2018HB041]; Ministry of Agriculture and Rural Affairs [CARS-44-KXJ13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System of the Ministry of Finance; Reserve Talents Training Program for Young and Middle-aged Academic and Technical Leaders in Yunnan; Ministry of Agriculture and Rural Affairs(Gida Tarim Ve Hayvancilik Bakanligi)	This study was supported by grants from the National Natural Science Foundation of China (Nos. 32060241 and 31572339), the China Agriculture Research System of the Ministry of Finance and the Ministry of Agriculture and Rural Affairs (CARS-44-KXJ13), and the Reserve Talents Training Program for Young and Middle-aged Academic and Technical Leaders in Yunnan (No. 2018HB041).	Allen RMY, 1928, BEE WORLD, V9, P196, DOI [10.1080/0005772X.1928.11096288, DOI 10.1080/0005772X.1928.11096288]; Betts AD, 1929, BEE WORLD, V10, P95, DOI [10.1080/0005772X.1929.11092829, DOI 10.1080/0005772X.1929.11092829]; Betts AD., 1929, BEE WORLD, V10, P87, DOI [10.1080/0005772X.1929.11092821, DOI 10.1080/0005772X.1929.11092821]; Briuchanenko AN, 1931, BEE WORLD, V12, P86, DOI [10.1080/0005772x.1931.11093039, DOI 10.1080/0005772X.1931.11093039]; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; CAMAZINE S, 1990, J THEOR BIOL, V147, P553, DOI 10.1016/S0022-5193(05)80264-4; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; DALY HV, 1990, PAN-PAC ENTOMOL, V66, P208; Darchen R., 1962, Insectes Sociaux Paris, V9, P23, DOI 10.1007/BF02224579; DARCHEN ROGER, 1956, INSECTES SOCIAUX, V3, P293, DOI 10.1007/BF02224312; Dervishian MG., 1919, BEE WORLD, V1, P197, DOI [10.1080/0005772x.1919.11093822, DOI 10.1080/0005772X.1919.11093822]; Digges JG., 1921, PRACTICAL BEE GUIDE, DOI [10.5962/bhl.title.53890, DOI 10.5962/BHL.TITLE.53890]; Gadge SW, 1934, BEE WORLD, V15, P17, DOI [10.1080/0005772X.1934.11093296, DOI 10.1080/0005772X.1934.11093296]; Gallo V, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2111310118; Gillette CP., 1900, APIARY EXPT FDN COMB; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Hepburn H. R, 1986, HONEYBEES WAX EXPT N, DOI [10.1007/978-3-642-71458-0, DOI 10.1007/978-3-642-71458-0]; HEPBURN HR, 1991, APIDOLOGIE, V22, P381, DOI 10.1051/apido:19910403; HEPBURN HR, 1981, J APICULT RES, V20, P234, DOI 10.1080/00218839.1981.11100502; HEPBURN HR, 1983, J ENTOMOL SOC S AFR, V46, P87; Hu LL, 2013, MATER DESIGN, V46, P511, DOI 10.1016/j.matdes.2012.10.050; Johnson BR, 2009, P ROY SOC B-BIOL SCI, V276, P255, DOI 10.1098/rspb.2008.0793; Lau D., 1959, Zoologische Beitraege Berlin (NS), V4, P233; Morse R. A., 1983, Gleanings in Bee Culture, V111, P18; Narumi T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205353; NAULLEAU G., 1961, INSECTES SOCIAUX, V8, P203, DOI 10.1007/BF02224009; Nazzi F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28341; Oldroyd BP, 2015, ADV INSECT PHYSIOL, V49, P101, DOI 10.1016/bs.aiip.2015.06.001; Pratt SC, 2000, NATURWISSENSCHAFTEN, V87, P33, DOI 10.1007/s001140050005; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Shumakova I., 2006, J APIC SCI, V50, P33; Smith ML, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103605118; Thompson F, 1930, BEE WORLD, V11, P105, DOI [10.1080/0005772X.1930.11092949, DOI 10.1080/0005772X.1930.11092949]; VANDENBERG JD, 1985, APIDOLOGIE, V16, P369, DOI 10.1051/apido:19850402; von Oelsen G., 1979, Apidologie, V10, P175, DOI 10.1051/apido:19790208; Wedmore EB., 1929, BEE WORLD, V10, P52, DOI [10.1080/0005772x.1929.11092791, DOI 10.1080/0005772X.1929.11092791]; Yang MX, 2010, J EXP BIOL, V213, P1659, DOI 10.1242/jeb.035626	37	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263249	10.1371/journal.pone.0263249	http://dx.doi.org/10.1371/journal.pone.0263249			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130275	gold, Green Published			2022-12-26	WOS:000805530700023
J	Awad, M; Ibrahim, EDS; Osman, EI; Elmenofy, WH; Mahmoud, AWM; Atia, MAM; Moustafa, MAM				Awad, Mona; Ibrahim, El-Desoky S.; Osman, Engy, I; Elmenofy, Wael H.; Mahmoud, Abdel Wahab M.; Atia, Mohamed A. M.; Moustafa, Moataz A. M.			Nano-insecticides against the black cutworm Agrotis ipsilon (Lepidoptera: Noctuidae): Toxicity, development, enzyme activity, and DNA mutagenicity	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; OXIDATIVE STRESS; ANTIOXIDANT ACTIVITY; IDENTIFICATION; NANOPARTICLES; CHLORINE; SPINOSAD; MARKERS; SYSTEM; ASSAY	Frequent applications of synthetic insecticides might cause environmental pollution due to the high residue. In addition, increasing insecticide resistance in many insect pests requires novel pest control methods. Nanotechnology could be a promising field of modern agriculture, and is receiving considerable attention in the development of novel nano-agrochemicals, such as nanoinsectticides and nanofertilizers. This study assessed the effects of the lethal and sublethal concentrations of chlorantraniliprole, thiocyclam, and their nano-forms on the development, reproductive activity, oxidative stress enzyme activity, and DNA changes in the black cutworm, Agrotis ipsilon, at the molecular level. The results revealed that A. ipsilon larvae were more susceptible to the nano-forms than the regular forms of both nano chlorine and sulfur within the chlorantraniliprole and thiocyclam insecticides, respectively, with higher toxicities than the regular forms (ca. 3.86, and ca.2.06-fold, respectively). Significant differences in biological parameters, including developmental time and reproductive activity (fecundity and hatchability percent) were also observed. Correspondingly, increases in oxidative stress enzyme activities were observed, as were mutagenic effects on the genomic DNA of A. ipsilon after application of the LC50 of the nano-forms of both insecticides compared to the control. These promising results could represent a crucial step toward developing efficient nanoinsecticides for sustainable control of A. ipsilon.	[Awad, Mona; Ibrahim, El-Desoky S.; Moustafa, Moataz A. M.] Cairo Univ, Fac Agr, Dept Econ Entomol & Pesticides, Giza, Egypt; [Osman, Engy, I] Cairo Univ, Fac Agr, Dept Genet, Giza, Egypt; [Elmenofy, Wael H.] ARC, Agr Genet Engn Res Inst, Giza, Egypt; [Mahmoud, Abdel Wahab M.] Cairo Univ, Fac Agr, Bot Dept, Plant Physiol Sect, Giza, Egypt; [Atia, Mohamed A. M.] Agr Res Ctr ARC, Agr Genet Engn Res Inst AGERI, Genome Mapping Dept, Mol Genet & Genome Mapping Lab, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Moustafa, MAM (corresponding author), Cairo Univ, Fac Agr, Dept Econ Entomol & Pesticides, Giza, Egypt.; Atia, MAM (corresponding author), Agr Res Ctr ARC, Agr Genet Engn Res Inst AGERI, Genome Mapping Dept, Mol Genet & Genome Mapping Lab, Giza, Egypt.	matia@ageri.sci.eg; moataz.moustafa79@gmail.com	Awad, Mona/AAG-5870-2021	Awad, Mona/0000-0002-4665-593X; Omar, Prof. Mohamed Atia/0000-0003-2462-1269				Abouseadaa HH, 2020, SAUDI J BIOL SCI, V27, P1649, DOI 10.1016/j.sjbs.2020.03.007; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Afiyanti M, 2014, J PLANT PHYSIOL, V171, P35, DOI 10.1016/j.jplph.2013.10.003; Afolabi OK, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02274; Amin A.R.H., 2019, J NAT RESOUR ECOL MA, V4, P102, DOI [10.11648/j.ijnrem.20190405.11, DOI 10.11648/J.IJNREM.20190405.11]; Atia MAM, 2017, METHODS MOL BIOL, V1638, P227, DOI 10.1007/978-1-4939-7159-6_19; Atia MAM, 2017, METHODS MOL BIOL, V1638, P125, DOI 10.1007/978-1-4939-7159-6_12; Atia MAM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33741; Banerjee B D, 2001, Rev Environ Health, V16, P1; Bednarova A, 2013, COMP BIOCHEM PHYS C, V158, P142, DOI 10.1016/j.cbpc.2013.07.002; Binning RR, 2015, PEST MANAG SCI, V71, P601, DOI 10.1002/ps.3901; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAMARGO JA, 1991, B ENVIRON CONTAM TOX, V47, P261, DOI 10.1007/BF01688649; Cao GC, 2010, PESTIC BIOCHEM PHYS, V98, P99, DOI 10.1016/j.pestbp.2010.05.006; Chaturvedi M, 2014, INT J NANOMED, V9, P575, DOI 10.2147/IJN.S54750; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cota-Arriola O, 2013, J SCI FOOD AGR, V93, P1525, DOI 10.1002/jsfa.6060; Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028; de Castro AP, 2007, EUR J PLANT PATHOL, V117, P347, DOI 10.1007/s10658-007-9103-2; de Oliveira JL, 2015, J AGR FOOD CHEM, V63, P422, DOI 10.1021/jf5059045; DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S; El-Dewy MEH., 2017, ALEX SCI EXCHANGE J, V38, P250; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Goldberg DM., 1983, METHODS ENZYM ANAL, V3, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4; Guedes R. N. C., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127055; Hamada HM, 2018, AFR ENTOMOL, V26, P84, DOI 10.4001/003.026.0084; Han WS, 2012, PEST MANAG SCI, V68, P1184, DOI 10.1002/ps.3282; He F., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Hosseinzadeh A., 2019, Agricultural Engineering International: CIGR Journal, V21, P164; Hundsdoerfer AK, 2005, Z NATURFORSCH C, V60, P618; Institute of Medicine of the National Academies, 2005, CHAPTER 7 DIETARY RE; IRAC-Insecticide Resistance Action Committee, 2020, IRAC MOD ACT CLASS V; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Joshi P, 2007, BIOL PLANTARUM, V51, P22, DOI 10.1007/s10535-007-0005-0; Kah M, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00064; Kah M, 2014, ENVIRON INT, V63, P224, DOI 10.1016/j.envint.2013.11.015; Kandil MA, 2020, EGYPT J BIOL PEST CO, V30, DOI 10.1186/s41938-020-00278-1; Kodrik D, 2015, INT J MOL SCI, V16, P25788, DOI 10.3390/ijms161025788; Lai TC, 2011, J PEST SCI, V84, P381, DOI 10.1007/s10340-011-0366-1; Lihl C, 2020, ENVIRON SCI-PROC IMP, V22, P792, DOI 10.1039/c9em00503j; Lindroth EJ., 2011, ANN ENTOMOL SOC AM, V105, P685; Liu B.-H., 1998, STAT GENOMICS LINKAG; Loewe L, 2010, PHILOS T R SOC B, V365, P1153, DOI 10.1098/rstb.2009.0317; Lutz AL, 2018, PEST MANAG SCI, V74, P2817, DOI 10.1002/ps.5070; Madhuban Gopal, 2012, The Journal of Plant Protection Sciences, V4, P1; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Michod RE., 1995, EROS EVOLUTION NATUR; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moustafa MAM, 2021, APPL ENTOMOL ZOOL, V56, P115, DOI 10.1007/s13355-020-00721-7; Moustafa MAM, 2016, CROP PROT, V90, P197, DOI 10.1016/j.cropro.2016.09.004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parsons BJ, 1997, MOL BREEDING, V3, P115, DOI 10.1023/A:1009635721319; Perez-de-Luque A, 2009, PEST MANAG SCI, V65, P540, DOI 10.1002/ps.1732; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Radwan EM., 2017, EGYPT ACAD J BOIL SC, V9, P81; Rodriguez-Saona LE, 2016, WOODHEAD PUBL FOOD S, P71, DOI 10.1016/B978-0-08-100220-9.00004-7; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rudneva II, 1999, COMP BIOCHEM PHYS C, V122, P265, DOI 10.1016/S0742-8413(98)10121-4; Shadia E., 2007, Research Journal of Agriculture and Biological Sciences, V3, P740; Sharma K, 2008, PLANT BIOTECHNOL REP, V2, P239, DOI 10.1007/s11816-008-0070-7; Tessier C, 1999, THEOR APPL GENET, V98, P171, DOI 10.1007/s001220051054; UConn Home and Garden Education Center, 2017, US; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Van Droogenbroeck B, 2004, THEOR APPL GENET, V108, P1473, DOI 10.1007/s00122-003-1575-7; Wang P, 2017, J ECON ENTOMOL, V110, P1750, DOI 10.1093/jee/tox112; Weirich GF, 2002, APIDOLOGIE, V33, P3, DOI 10.1051/apido:2001001; Wickelmaier F., 2003, INTRO MDS, V1st ed.; Worrall EA, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8120285; Wu GC, 2017, J CEREAL SCI, V77, P17, DOI 10.1016/j.jcs.2017.07.014; Xu ZP, 2006, J AM CHEM SOC, V128, P36, DOI 10.1021/ja056652a; Yan S, 2021, PEST MANAG SCI, V77, P1954, DOI 10.1002/ps.6223; Yin XH, 2008, CROP PROT, V27, P1385, DOI 10.1016/j.cropro.2008.05.008; Yoshida K, 2003, APPL MICROBIOL BIOT, V60, P665, DOI 10.1007/s00253-002-1157-7; Zhang QM, 2013, ENVIRON SCI POLLUT R, V20, P201, DOI 10.1007/s11356-012-0962-5	76	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0254285	10.1371/journal.pone.0254285	http://dx.doi.org/10.1371/journal.pone.0254285			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113879	Green Published, gold, Green Submitted			2022-12-26	WOS:000823694700002
J	Brito, PL; Dos Santos, AF; Chweih, H; Favero, ME; Gotardo, EMF; Silva, JAF; Leonardo, FC; Franco-Penteado, CF; de Oliveira, MG; Ferreira, WA; Zaidan, BC; Billis, A; Baldanzi, G; Mashima, DA; Antunes, E; Saad, STO; Costa, FF; Conran, N				Brito, Pamela L.; Dos Santos, Alisson F.; Chweih, Hanan; Favero, Maria E.; Gotardo, Erica M. F.; Silva, Juliete A. F.; Leonardo, Flavia C.; Franco-Penteado, Carla F.; de Oliveira, Mariana G.; Ferreira Jr, Wilson A.; Zaidan, Bruna C.; Billis, Athanase; Baldanzi, Giorgio; Mashima, Denise A.; Antunes, Edson; Saad, Sara T. Olalla; Costa, Fernando F.; Conran, Nicola			Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition	PLOS ONE			English	Article							SEX-DIFFERENCES; SYSTEM; TISSUE; HYPERTENSION; CHYMASE; PLASMA; KIDNEY; ADULTS; MICE; PATHOGENESIS	Background Sickle cell disease (SCD) incurs vaso-occlusive episodes and organ damage, including nephropathy. Despite displaying characteristics of vascular dysfunction, SCD patients tend to present relatively lower systemic blood pressure (BP), via an unknown mechanism. We investigated associations between BP and renin-angiotensin-system (RAS) components in SCD and determined whether an inhibitor of angiotensin converting enzyme (ACE; often used to slow SCD glomerulopathy) further modulates BP and RAS components in a murine model of SCD. Methods BP was compared in human subjects and mice with/without SCD. Plasma angiotensin II, ACE and renin were measured by immunoassay. BP was reevaluated after treating mice with enalapril (25 mg/kg, 5x/week) for 5 weeks; plasma and organs were stored for angiotensin II and ACE activity measurement, and quantitative real-time PCR. Results Diastolic BP and systolic BP were significantly lower in patients and mice with SCD, respectively, compared to controls. Reduced BP was associated with increased plasma renin and markers of kidney damage (mice) in SCD, as well as significantly decreased plasma ACE concentrations and ACE enzyme activity. As expected, enalapril administration lowered BP, plasma angiotensin II and organ ACE activity in control mice. In contrast, enalapril did not further reduce BP or organ ACE activity in SCD mice; however, plasma angiotensin II and renin levels were found to be significantly higher in enalapril-treated SCD mice than those of treated control mice. Conclusion Relative hypotension was confirmed in a murine model of SCD, in association with decreased ACE concentrations in both human and murine disease. Given that ACE inhibition has an accepted role in decreasing BP, further studies should investigate mechanisms by which ACE depletion, via both Ang II-dependent and alternative pathways, could contribute to reduce BP in SCD and understand how ACE inhibition confers Ang II-independent benefits on kidney function in SCD.	[Brito, Pamela L.; Chweih, Hanan; Gotardo, Erica M. F.; Silva, Juliete A. F.; Leonardo, Flavia C.; Franco-Penteado, Carla F.; Ferreira Jr, Wilson A.; Saad, Sara T. Olalla; Costa, Fernando F.; Conran, Nicola] Univ Estadual Campinas, UNICAMP, Hematol & Transfus Ctr, Campinas, SP, Brazil; [Dos Santos, Alisson F.; Baldanzi, Giorgio] Ctr Hematol & Hemoterapia Parana, Curitiba, Parana, Brazil; [Favero, Maria E.; Mashima, Denise A.] Univ Estadual Londrina, Univ Hosp, Londrina, Parana, Brazil; [de Oliveira, Mariana G.; Antunes, Edson] Univ Estadual Campinas, UNICAMP, Dept Pharmacol, Campinas, SP, Brazil; [Zaidan, Bruna C.; Billis, Athanase] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Pathol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Londrina; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Conran, N (corresponding author), Univ Estadual Campinas, UNICAMP, Hematol & Transfus Ctr, Campinas, SP, Brazil.	conran@unicamp.br	da Silva, Juliete Aparecida Francisco/P-3314-2014	da Silva, Juliete Aparecida Francisco/0000-0002-4543-5169; Chweih, Hanan/0000-0002-6358-3579	Sao Paulo Research Foundation (FAPESP) [2014/00984-3]; Sao Paulo Research Foundation (FAPESP), Brazil [2014/00984-3, 2015/04485-4, 2017/03954-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by: Grant #2014/00984-3, awarded by Sao Paulo Research Foundation (FAPESP; https://fapesp.br/), Brazil to NC and FFC. Grants #2015/04485-4 and #2017/03954-6 awarded by Sao Paulo Research Foundation (FAPESP), Brazil to PLB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airy M, 2017, CLIN NEPHROL, V87, P55, DOI 10.5414/CN108991; Aloni MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096561; AOKI RY, 1995, AM J MED, V98, P432, DOI 10.1016/S0002-9343(99)80341-6; Audard V, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-67; Aurelie NDC, 2011, PEPTIDES, V32, P2141, DOI 10.1016/j.peptides.2011.09.010; Berkenboom G, 1998, AM J CARDIOL, V82, p11S, DOI 10.1016/S0002-9149(98)90423-4; BOCK HA, 1992, KIDNEY INT, V41, P275, DOI 10.1038/ki.1992.39; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cazenave M, 2020, CLIN J AM SOC NEPHRO, V15, P16, DOI 10.2215/CJN.07830719; Chen LM, 2010, J AM SOC NEPHROL, V21, P986, DOI 10.1681/ASN.2009030307; Chirico EN, 2012, IUBMB LIFE, V64, P72, DOI 10.1002/iub.584; Conran N, 2018, CLIN HEMORHEOL MICRO, V68, P263, DOI 10.3233/CH-189012; DEJONG PE, 1982, ARCH INTERN MED, V142, P1239, DOI 10.1001/archinte.142.6.1239; Dell'Italia LJ, 2018, CIRC RES, V122, P319, DOI 10.1161/CIRCRESAHA.117.310978; Desai PC, 2012, AM J HEMATOL, V87, pE65, DOI 10.1002/ajh.23278; Doggrell SA, 2004, CARDIOVASC RES, V61, P653, DOI 10.1016/j.cardiores.2003.11.029; dos Santos AF, 2014, LIFE SCI, V117, P7, DOI 10.1016/j.lfs.2014.08.021; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Ferreira RB, 2016, EUR J PHARMACOL, V791, P803, DOI 10.1016/j.ejphar.2016.10.009; Giani JF, 2021, MOL CELL ENDOCRINOL, V529, DOI 10.1016/j.mce.2021.111257; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; GRELL GAC, 1981, LANCET, V2, P1166; Hariri E, 2018, INT UROL NEPHROL, V50, P1075, DOI 10.1007/s11255-018-1803-3; HATCH FE, 1989, AM J HYPERTENS, V2, P2, DOI 10.1093/ajh/2.1.2; Haymann JP, 2017, BRIT J HAEMATOL, V179, P820, DOI 10.1111/bjh.14969; Heerspink HJL, 2013, BRIT J CLIN PHARMACO, V76, P536, DOI 10.1111/bcp.12195; Ito K, 1997, JPN J PHARMACOL, V75, P311, DOI 10.1254/jjp.75.311; JACOBSON HR, 1991, LANCET, V338, P419, DOI 10.1016/0140-6736(91)91042-S; JOHNSON CS, 1981, ARCH INTERN MED, V141, P891, DOI 10.1001/archinte.141.7.891; Kasztan M, 2019, BLOOD ADV, V3, P1460, DOI 10.1182/bloodadvances.2018028878; Li XC, 2018, CLIN SCI, V132, P1383, DOI 10.1042/CS20180121; Lima CSP, 2008, ACTA CARDIOL, V63, P599, DOI 10.2143/AC.63.5.2033227; Maric-Bilkan C, 2012, GENDER MED, V9, P287, DOI 10.1016/j.genm.2012.06.005; Martins WD, 2012, AUTON NEUROSCI-BASIC, V166, P54, DOI 10.1016/j.autneu.2011.07.011; MATUSTIK MC, 1979, J PEDIATR-US, V95, P206; MURRAY JF, 1969, AM J PHYSIOL, V216, P638, DOI 10.1152/ajplegacy.1969.216.3.638; Muskiet MHA, 2019, LANCET DIABETES ENDO, V7, P397, DOI 10.1016/S2213-8587(18)30263-8; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Olaniran KO, 2019, BLOOD PURIFICAT, V47, P205, DOI 10.1159/000494581; Park F, 2019, BIOCHEM BIOPH RES CO, V515, P72, DOI 10.1016/j.bbrc.2019.05.116; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pegelow CH, 1997, AM J MED, V102, P171; Reckelhoff JF, 2018, ADV EXP MED BIOL, V1065, P139, DOI 10.1007/978-3-319-77932-4_9; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; Reyes-Pardo H, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1490-z; Roy NBA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012380.pub2; Roy S, 2018, AM J HEMATOL, V93, pE177, DOI 10.1002/ajh.25118; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Saijonmaa O, 2001, J VASC RES, V38, P370, DOI 10.1159/000051068; Sasongko TH, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009191.pub3; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Sesso R, 1998, BRAZ J MED BIOL RES, V31, P1257, DOI 10.1590/S0100-879X1998001000004; Sharma N, 2019, BIOMED PHARMACOTHER, V110, P764, DOI 10.1016/j.biopha.2018.12.018; Sharpe CC, 2011, BRIT J HAEMATOL, V155, P287, DOI 10.1111/j.1365-2141.2011.08853.x; Santos RAS, 2018, PHYSIOL REV, V98, P505, DOI 10.1152/physrev.00023.2016; Spence JD, 2018, HYPERTENSION, V72, P263, DOI 10.1161/HYPERTENSIONAHA.118.11064; Steinberg MH., 2016, SICKLE CELL ANEMIA B, P49; Thrower A, 2019, BRIT J HAEMATOL, V184, P246, DOI 10.1111/bjh.15651; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VENER KJ, 1977, J THEOR BIOL, V66, P457, DOI 10.1016/0022-5193(77)90295-8; Wei CC, 2002, AM J PHYSIOL-HEART C, V282, pH2254, DOI 10.1152/ajpheart.00191.2001; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Xiao HD, 2004, CRIT REV EUKAR GENE, V14, P137, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i12.70; Zakiyanov O, 2019, KIDNEY BLOOD PRESS R, V44, P298, DOI 10.1159/000499876	67	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263424	10.1371/journal.pone.0263424	http://dx.doi.org/10.1371/journal.pone.0263424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113975	gold, Green Published			2022-12-26	WOS:000823694700093
J	Leach, JM; Edwards, LJ; Kana, R; Visscher, K; Yi, NJ; Aban, I				Leach, Justin M.; Edwards, Lloyd J.; Kana, Rajesh; Visscher, Kristina; Yi, Nengjun; Aban, Inmaculada		Alzheimer's Dis Neuroimaging Intia	The spike-and-slab elastic net as a classification tool in Alzheimer's disease	PLOS ONE			English	Article							BAYESIAN VARIABLE SELECTION; GENERALIZED LINEAR-MODELS; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; HYPOTHETICAL MODEL; MILD; PART; MRI	Alzheimer's disease (AD) is the leading cause of dementia and has received considerable research attention, including using neuroimaging biomarkers to classify patients and/or predict disease progression. Generalized linear models, e.g., logistic regression, can be used as classifiers, but since the spatial measurements are correlated and often outnumber subjects, penalized and/or Bayesian models will be identifiable, while classical models often will not. Many useful models, e.g., the elastic net and spike-and-slab lasso, perform automatic variable selection, which removes extraneous predictors and reduces model variance, but neither model exploits spatial information in selecting variables. Spatial information can be incorporated into variable selection by placing intrinsic autoregressive priors on the logit probabilities of inclusion within a spike-and-slab elastic net framework. We demonstrate the ability of this framework to improve classification performance by using cortical thickness and tau-PET images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to classify subjects as cognitively normal or having dementia, and by using a simulation study to examine model performance using finer resolution images.	[Leach, Justin M.; Edwards, Lloyd J.; Yi, Nengjun; Aban, Inmaculada] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Kana, Rajesh] Univ Alabama, Dept Psychol, Box 870348, Tuscaloosa, AL 35487 USA; [Visscher, Kristina] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham	Leach, JM (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	jleach@uab.edu	Leach, Justin/AAD-6073-2022	Leach, Justin/0000-0003-0167-9097	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Fujirebio; Johnson & Johnson Pharmaceutical Research & Development LLC.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Takeda Pharmaceutical Company; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; BioClinica, Inc.; Eisai Inc.; Genentech, Inc.; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Lumosity; Lundbeck; Neurotrack Technologies; Servier; Transition Therapeutics	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie, Alzheimer's Association(AbbVie); Alzheimer's Drug Discovery Foundation; Araclon Biotech; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Fujirebio; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioClinica, Inc.; Eisai Inc.(Eisai Co Ltd); Genentech, Inc.(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Lumosity; Lundbeck(Lundbeck Corporation); Neurotrack Technologies; Servier(Servier); Transition Therapeutics	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.;Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.;Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education (NCIRE), and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. This research was also supported by NIH grants P30 AG010129 and K01 AG030514.	Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Bai R, 2020, ARXIV201006451; Banerjee S., 2015, HIERARCHICAL MODELIN; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Bondi MW, 2017, J INT NEUROPSYCH SOC, V23, P818, DOI 10.1017/S135561771700100X; Braak H, 2014, ACTA NEUROPATHOL, V128, P767, DOI 10.1007/s00401-014-1356-1; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brosch JR, 2017, NEUROTHERAPEUTICS, V14, P62, DOI 10.1007/s13311-016-0490-y; Carvalho CM, 2010, BIOMETRIKA, V97, P465, DOI 10.1093/biomet/asq017; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Vos F, 2018, NEUROIMAGE, V167, P62, DOI 10.1016/j.neuroimage.2017.11.025; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Leach JM, 2022, J STAT PLAN INFER, V217, P141, DOI 10.1016/j.jspi.2021.07.010; Lindquist MA, 2015, PSYCHOSOM MED, V77, P114, DOI 10.1097/PSY.0000000000000148; Morris M, 2019, SPAT SPATIO-TEMPORAL, V31, DOI 10.1016/j.sste.2019.100301; Park H, 2012, NEUROSCI LETT, V529, P123, DOI 10.1016/j.neulet.2012.09.011; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; Rockova V, 2018, J AM STAT ASSOC, V113, P431, DOI 10.1080/01621459.2016.1260469; Rockova V, 2014, J AM STAT ASSOC, V109, P828, DOI 10.1080/01621459.2013.869223; RUE H., 2005, GAUSSIAN MARKOV RAND; Schouten TM, 2016, NEUROIMAGE-CLIN, V11, P46, DOI 10.1016/j.nicl.2016.01.002; Tang ZX, 2017, GENETICS, V205, P77, DOI 10.1534/genetics.116.192195; Teipel SJ, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00318; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trzepacz PT, 2016, DEMENT GERIATR COGN, V41, P68, DOI 10.1159/000441351; Vemuri Prashanthi, 2017, Alzheimers Dement (Amst), V6, P21, DOI 10.1016/j.dadm.2016.12.010; Weiner MW, 2017, ALZHEIMERS DIS NEURO; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	42	3	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262367	10.1371/journal.pone.0262367	http://dx.doi.org/10.1371/journal.pone.0262367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113902	gold, Green Published			2022-12-26	WOS:000823694700023
J	Muhammadzai, J; Haider, K; Moser, M; Chalchal, H; Shaw, J; Gardiner, D; Dueck, DA; Ahmed, O; Brunet, B; Iqbal, M; Luo, YG; Beck, G; Zaidi, A; Ahmed, S				Muhammadzai, Javeria; Haider, Kamal; Moser, Michael; Chalchal, Haji; Shaw, John; Gardiner, Donald; Dueck, Dorie-Anna; Ahmed, Osama; Brunet, Bryan; Iqbal, Mussawar; Luo, Yigang; Beck, Gavin; Zaidi, Adnan; Ahmed, Shahid			Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study	PLOS ONE			English	Article							DEFINITIVE SURGERY; FOLINIC ACID; GEMCITABINE; RESECTION; INITIATION; IMPACT; CHEMORADIOTHERAPY; DIAGNOSIS; OUTCOMES; TIME	Background The current study aimed to determine the association between timing and completion of adjuvant chemotherapy and outcomes in real-world patients with early-stage pancreatic cancer. Methods In this multi-center cohort study patients with early-stage pancreatic cancer who were diagnosed from 2007-2017 and underwent complete resection in the province of Saskatchewan were examined. Cox proportional multivariate analyses were performed for correlation with recurrence and survival. Results Of 168 patients, 71 eligible patients with median age of 69 years and M:F of 37:34 were identified. Median time to the start of adjuvant therapy from surgery was 73 days. Of all patients, 49 (69%) patients completed adjuvant chemotherapy and 22 (31%) required early treatment discontinuation. Median recurrence-free survival of patients who completed treatment was 22 months (95%CI:15.8-28.2) vs. 9 months (3.3-14.7) if treatment was discontinued early (P<0.001). Median overall survival of those who completed treatment was 33 (17.5-48.5) vs. 16 months (17.5-48.5) with early treatment discontinuation (P<0.001). In the multivariate analysis, treatment discontinuation was significantly correlated with recurrent disease, hazard ratio (HR), 2.57 (1.41-4.68), P = 0.002 and inferior survival, HR, 2.55 (1.39-4.68), P = 0.003. No correlation between treatment timing and survival was noted. Conclusions Early discontinuation but not the timing of adjuvant chemotherapy correlates with inferior outcomes.	[Muhammadzai, Javeria; Haider, Kamal; Moser, Michael; Chalchal, Haji; Shaw, John; Gardiner, Donald; Dueck, Dorie-Anna; Ahmed, Osama; Brunet, Bryan; Iqbal, Mussawar; Luo, Yigang; Beck, Gavin; Zaidi, Adnan; Ahmed, Shahid] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada; [Haider, Kamal; Dueck, Dorie-Anna; Ahmed, Osama; Zaidi, Adnan; Ahmed, Shahid] Univ Saskatchewan, Saskatoon Canc Ctr, Med Oncol, Saskatoon, SK, Canada; [Moser, Michael; Shaw, John; Luo, Yigang; Beck, Gavin] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Chalchal, Haji; Iqbal, Mussawar] Allan Blair Canc Ctr, Med Oncol, Regina, SK, Canada; [Gardiner, Donald; Brunet, Bryan] Univ Saskatchewan, Saskatoon Canc Ctr, Radiat Oncol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Ahmed, S (corresponding author), Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada.; Ahmed, S (corresponding author), Univ Saskatchewan, Saskatoon Canc Ctr, Med Oncol, Saskatoon, SK, Canada.	shahid.ahmed@saskcancer.ca	Ahmed, Shahid/GPK-2366-2022	Ahmed, Osama/0000-0001-9241-7695	Mach-Gaensslen Foundation of Canada; University of Saskatchewan College of Medicine	Mach-Gaensslen Foundation of Canada; University of Saskatchewan College of Medicine	JM, SA. 2019-DPCOM The MachGaensslen Foundation of Canada and the University of Saskatchewan College of Medicine http://machgaensslen.ca/https://medicine.usask.ca/index.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chu CK, 2010, J AM COLL SURGEONS, V210, P463, DOI 10.1016/j.jamcollsurg.2009.12.029; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; Ducreux M, 2015, ANN ONCOL, V26, pV56, DOI 10.1093/annonc/mdv295; Khorana AA, 2019, J CLIN ONCOL, V37, P2082, DOI 10.1200/JCO.19.00946; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; McGuigan A, 2018, WORLD J GASTROENTERO, V24, P4846, DOI 10.3748/wjg.v24.i43.4846; Mirkin KA, 2016, CANCER-AM CANCER SOC, V122, P2979, DOI 10.1002/cncr.30163; Neoptolemos JP, 2009, BRIT J CANCER, V100, P246, DOI 10.1038/sj.bjc.6604838; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Petrelli F, 2019, CANCERS, V11, DOI 10.3390/cancers11040550; Sanchez CJ, 2007, BREAST CANCER RES TR, V101, P215, DOI 10.1007/s10549-006-9282-0; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; World Cancer Research Fund International, CANC FACTS FIG PANCR	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263250	10.1371/journal.pone.0263250	http://dx.doi.org/10.1371/journal.pone.0263250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108323	gold, Green Published			2022-12-26	WOS:000775890100054
J	Shahi, A; Kahle, J; Hopkins, C; Diakonova, M				Shahi, Aashirwad; Kahle, Jacob; Hopkins, Chandler; Diakonova, Maria			The SH2 domain and kinase activity of JAK2 target JAK2 to centrosome and regulate cell growth and centrosome amplification	PLOS ONE			English	Article							TYROSINE KINASE; NUCLEAR JAK2; MYELOPROLIFERATIVE DISORDERS; CONSTITUTIVE ACTIVATION; DEPENDENT ACTIVATION; RECEPTOR INTERACTION; SIGNAL-TRANSDUCTION; BINDING DOMAIN; JANUS KINASE; PROLACTIN	JAK2 is cytokine-activated non-receptor tyrosine kinase. Although JAK2 is mainly localized at the plasma membrane, it is also present on the centrosome. In this study, we demonstrated that JAK2 localization to the centrosome depends on the SH2 domain and intact kinase activity. We created JAK2 mutants deficient in centrosomal localization Delta SH2, K882E and (Delta SH2, K882E). We showed that JAK2 WT clone strongly enhances cell proliferation as compared to control cells while JAK2 clones Delta SH2, K882E and (Delta SH2, K882E) proliferate slower than JAK2 WT cells. These mutant clones also progress much slower through the cell cycle as compared to JAK2 WT clone and the enhanced proliferation of JAK2 WT cells is accompanied by increased S -> G2 progression. Both the SH2 domain and the kinase activity of JAK2 play a role in prolactin-dependent activation of JAK2 substrate STAT5. We showed that JAK2 is an important regulator of centrosome function as the SH2 domain of JAK2 regulates centrosome amplification. The cells overexpressing Delta SH2 and (Delta SH2, K-E) JAK2 have almost three-fold the amplified centrosomes of WT cells. In contrast, the kinase activity of JAK2 is dispensable for centrosome amplification. Our observations provide novel insight into the role of SH2 domain and kinase activity of JAK2 in centrosome localization of JAK2 and in the regulation of cell growth and centrosome biogenesis.	[Shahi, Aashirwad; Kahle, Jacob; Hopkins, Chandler; Diakonova, Maria] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Diakonova, M (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	maria.diakonova@utoledo.edu		Diakonova, Maria/0000-0002-4554-2730				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Arquint C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0464; Arslanhan MD, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061390; Asteriti IA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00283; Baskin R, 2010, CURR MED CHEM, V17, P4551, DOI 10.2174/092986710794182953; Bauer M, 2016, EMBO J, V35, P2152, DOI 10.15252/embj.201694462; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Breslow DK, 2019, ANNU REV BIOCHEM, V88, P691, DOI 10.1146/annurev-biochem-013118-111153; Brophy VA, 2002, ARCH BIOCHEM BIOPHYS, V397, P199, DOI 10.1006/abbi.2001.2679; Coaxum SD, 2009, BBA-MOL CELL RES, V1793, P1174, DOI 10.1016/j.bbamcr.2009.03.006; Colomiere M, 2009, INT J BIOCHEM CELL B, V41, P1034, DOI 10.1016/j.biocel.2008.09.018; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Alves-Cruzeiro JMD, 2014, NUCLEIC ACIDS RES, V42, pD430, DOI 10.1093/nar/gkt1126; Das R, 1996, BREAST CANCER RES TR, V40, P141, DOI 10.1007/BF01806209; Das R, 1996, ONCOGENE, V13, P1139; Das R, 1997, J MAMMARY GLAND BIOL, V2, P29, DOI 10.1023/A:1026369412612; Delaval B, 2005, LEUKEMIA, V19, P1739, DOI 10.1038/sj.leu.2403926; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Faruki S, 2000, J CELL SCI, V113, P2557; Ferrao R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00071; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Girodon F, 2011, BLOOD, V118, P2633, DOI 10.1182/blood-2011-02-336479; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Gorantla SP, 2010, BLOOD, V116, P4600, DOI 10.1182/blood-2009-07-236133; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Habermann K, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-17; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hammer A, 2013, MOL ENDOCRINOL, V27, P455, DOI 10.1210/me.2012-1291; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; Herrmann L, 2003, MOL BIOL CELL, V14, P230, DOI 10.1091/mbc.E02-04-0191; Hochegger H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120185; Hoeller S, 2011, EXPERT OPIN THER TAR, V15, P53, DOI 10.1517/14728222.2011.538683; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Hubbard SR, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00361; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jay J, 2015, MOL CELL BIOL, V35, P111, DOI 10.1128/MCB.01138-14; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; Katsha A, 2014, MOL ONCOL, V8, P1419, DOI 10.1016/j.molonc.2014.05.012; Keil E, 2014, BLOOD, V123, P520, DOI 10.1182/blood-2013-03-492157; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Klebanovych A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040345; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Lee JE, 2012, AM J PHYSIOL-CELL PH, V302, pC804, DOI 10.1152/ajpcell.00379.2011; Lee S, 2006, J BIOMED SCI, V13, P773, DOI 10.1007/s11373-006-9111-9; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lu YC, 2019, J CELL PHYSIOL, V234, P11511, DOI 10.1002/jcp.27813; Ma XY, 2007, BIOCHEMISTRY-US, V46, P7153, DOI 10.1021/bi700101n; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; McNally R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156218; Metge B, 2004, J BIOL CHEM, V279, P41801, DOI 10.1074/jbc.M407094200; Morris EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15289; Moulin S, 2003, HORM METAB RES, V35, P396; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127; Nilsson J, 2006, MOL CELL BIOL, V26, P5663, DOI 10.1128/MCB.02095-05; Nishijima Y, 2017, MOL BIOL CELL, V28, P1652, DOI 10.1091/mbc.E17-01-0017; Oladimeji P, 2016, CANCER RES, V76, P2600, DOI 10.1158/0008-5472.CAN-15-1758; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Peng B, 2002, MOL ENDOCRINOL, V16, P2019, DOI 10.1210/me.2002-0108; Perner F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080854; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Qian CJ, 2011, ANAT REC, V294, P1446, DOI 10.1002/ar.21443; Quarantotti V, 2019, EMBO J, V38, DOI 10.15252/embj.2018101082; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; Sayeski PP, 1999, J BIOL CHEM, V274, P33131, DOI 10.1074/jbc.274.46.33131; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Steindler C, 2004, J BIOL CHEM, V279, P43168, DOI 10.1074/jbc.M401915200; Stoica B, 1998, J IMMUNOL, V160, P1059; Takahashi S, 2003, J BIOL CHEM, V278, P49129, DOI 10.1074/jbc.C300289200; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tefferi A, 2005, CELL CYCLE, V4, P1053; Thomas SJ, 2015, BRIT J CANCER, V113, P365, DOI 10.1038/bjc.2015.233; Uzbekov RE, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102156; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yokoyama N, 2003, ARCH BIOCHEM BIOPHYS, V417, P87, DOI 10.1016/S0003-9861(03)00333-3; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	99	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0261098	10.1371/journal.pone.0261098	http://dx.doi.org/10.1371/journal.pone.0261098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089929	Green Published, gold			2022-12-26	WOS:000769158400005
J	Hsu, CW; Sowers, ML; Baljinnyam, T; Herring, JL; Hackfeld, LC; Tang, H; Zhang, KL; Sowers, LC				Hsu, Chia Wei; Sowers, Mark L.; Baljinnyam, Tuvshintugs; Herring, Jason L.; Hackfeld, Linda C.; Tang, Hui; Zhang, Kangling; Sowers, Lawrence C.			Measurement of deaminated cytosine adducts in DNA using a novel hybrid thymine DNA glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; P53 GENE; HYDROLYTIC DEAMINATION; SUBSTRATE RECOGNITION; N-GLYCOSYLASE; URACIL; 5-METHYLCYTOSINE; MUTATIONS; RESIDUES; METHYLATION	The hydrolytic deamination of cytosine and 5-methylcytosine drives many of the transition mutations observed in human cancer. The deamination-induced mutagenic intermediates include either uracil or thymine adducts mispaired with guanine. While a substantial array of methods exist to measure other types of DNA adducts, the cytosine deamination adducts pose unusual analytical problems, and adequate methods to measure them have not yet been developed. We describe here a novel hybrid thymine DNA glycosylase (TDG) that is comprised of a 29-amino acid sequence from human TDG linked to the catalytic domain of a thymine glycosylase found in an archaeal thermophilic bacterium. Using defined-sequence oligonucleotides, we show that hybrid TDG has robust mispair-selective activity against deaminated U:G and T:G mispairs. We have further developed a method for separating glycosylase-released free bases from oligonucleotides and DNA followed by GC-MS/MS quantification. Using this approach, we have measured for the first time the levels of total uracil, U:G, and T:G pairs in calf thymus DNA. The method presented here will allow the measurement of the formation, persistence, and repair of a biologically important class of deaminated cytosine adducts.	[Hsu, Chia Wei; Sowers, Mark L.; Baljinnyam, Tuvshintugs; Herring, Jason L.; Hackfeld, Linda C.; Tang, Hui; Zhang, Kangling; Sowers, Lawrence C.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Hsu, Chia Wei; Sowers, Mark L.] Univ Texas Med Branch, MD PhD Combined Degree Program, Galveston, TX USA; [Sowers, Lawrence C.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sowers, LC (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Sowers, LC (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	lasowers@UTMB.edu		Sowers, Mark/0000-0001-6474-017X; Hsu, Chia Wei/0000-0001-8863-462X	University of Texas Medical Branch; National Institutes of Health [SF30 CA225116]	University of Texas Medical Branch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C. W. H. and M. L. S. were supported in part by the University of Texas Medical Branch physician-scientist training program. C. W. H. was supported in part by the National Institutes of Health (grant no.: SF30 CA225116) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbeithuber B, 2016, DNA RES, V23, P547, DOI 10.1093/dnares/dsw038; Beckman KB, 2000, FREE RADICAL BIO MED, V29, P357, DOI 10.1016/S0891-5849(00)00316-6; Begley TJ, 1999, PROTEIN ENG, V12, P333, DOI 10.1093/protein/12.4.333; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; BLOUNT BC, 1994, ANAL BIOCHEM, V219, P195, DOI 10.1006/abio.1994.1257; Briggs AW, 2012, METHODS MOL BIOL, V840, P143, DOI 10.1007/978-1-61779-516-9_18; Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Coey CT, 2016, NUCLEIC ACIDS RES, V44, P10248, DOI 10.1093/nar/gkw768; Cooper David N, 2010, Hum Genomics, V4, P406; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P11595, DOI 10.1021/bi00113a015; DUBE DK, 1979, BIOCHIM BIOPHYS ACTA, V561, P369, DOI 10.1016/0005-2787(79)90145-X; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Galashevskaya A, 2013, DNA REPAIR, V12, P699, DOI 10.1016/j.dnarep.2013.05.002; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Horst JP, 1996, EMBO J, V15, P5459, DOI 10.1002/j.1460-2075.1996.tb00929.x; Iengar P, 2012, NUCLEIC ACIDS RES, V40, P6401, DOI 10.1093/nar/gks290; IVARIE R, 1987, NUCLEIC ACIDS RES, V15, P9975, DOI 10.1093/nar/15.23.9975; Jang HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060148; Jaruga P, 2008, FREE RADICAL BIO MED, V45, P1601, DOI 10.1016/j.freeradbiomed.2008.09.019; Jumpathong W, 2015, P NATL ACAD SCI USA, V112, pE4845, DOI 10.1073/pnas.1503945112; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kim S, 2017, J MOL DIAGN, V19, P137, DOI 10.1016/j.jmoldx.2016.09.006; KIRK JTO, 1967, BIOCHEM J, V105, P673, DOI 10.1042/bj1050673; Kladova OA, 2020, BIOCHEMISTRY-MOSCOW+, V85, P480, DOI 10.1134/S0006297920040082; Lewis CA, 2016, P NATL ACAD SCI USA, V113, P8194, DOI 10.1073/pnas.1607580113; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu PF, 2002, CHEM RES TOXICOL, V15, P1001, DOI 10.1021/tx020030a; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Mashiyama ST, 2008, ANAL BIOCHEM, V372, P21, DOI 10.1016/j.ab.2007.08.034; MCHUGH PJ, 1995, NUCLEIC ACIDS RES, V23, P1664, DOI 10.1093/nar/23.10.1664; Mechetin GV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093118; Minko IG, 2020, DNA REPAIR, V85, DOI 10.1016/j.dnarep.2019.102741; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Mullins EA, 2013, METHODS, V64, P59, DOI 10.1016/j.ymeth.2013.07.020; Olinski R, 2010, MUTAT RES-REV MUTAT, V705, P239, DOI 10.1016/j.mrrev.2010.08.001; PHILIPPSEN P, 1975, EUR J BIOCHEM, V57, P55, DOI 10.1111/j.1432-1033.1975.tb02276.x; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; Ren J, 2002, ANAL CHEM, V74, P295, DOI 10.1021/ac010556k; RICHARDS RG, 1984, ADV ENZYME REGUL, V22, P157, DOI 10.1016/0065-2571(84)90013-X; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Rogstad DK, 2002, BIOCHEMISTRY-US, V41, P8093, DOI 10.1021/bi012180a; Sangaraju D, 2014, J AM SOC MASS SPECTR, V25, P1124, DOI 10.1007/s13361-014-0916-x; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Schuermann D, 2016, NUCLEIC ACIDS RES, V44, P2187, DOI 10.1093/nar/gkv1520; SHEN JC, 1992, NUCLEIC ACIDS RES, V20, P5119, DOI 10.1093/nar/20.19.5119; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SOWERS LC, 1989, MUTAT RES, V215, P131, DOI 10.1016/0027-5107(89)90225-X; STURM KS, 1981, NUCLEIC ACIDS RES, V9, P4537, DOI 10.1093/nar/9.18.4537; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Totsuka Y, 2021, CANCER SCI, V112, P7, DOI 10.1111/cas.14666; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WANG RYH, 1982, BIOCHIM BIOPHYS ACTA, V697, P371, DOI 10.1016/0167-4781(82)90101-4; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730; You CJ, 2016, ACCOUNTS CHEM RES, V49, P205, DOI 10.1021/acs.accounts.5b00437	65	1	1	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101638	10.1016/j.jbc.2022.101638	http://dx.doi.org/10.1016/j.jbc.2022.101638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085553	gold, Green Published			2022-12-26	WOS:000789261900015
J	Mbah, CE; Jasani, A; Aaron, KJ; Akoachere, JF; Tita, ATN; Geisler, WM; Van der Pol, B; Dionne-Odom, J; Ngeudia, JCA				Mbah, Clarisse Engowei; Jasani, Amy; Aaron, Kristal J.; Akoachere, Jane-Francis; Tita, Alan T. N.; Geisler, William M.; Van der Pol, Barbara; Dionne-Odom, Jodie; Ngeudia, Jules Clement Assob			Association between Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis and Secondary Infertility in Cameroon: A case-control study	PLOS ONE			English	Article							PREVALENCE; WOMEN; INFECTIONS	Objective Data on the prevalence and etiology of infertility in Africa are limited. Secondary infertility is particularly common, defined as the inability of a woman to conceive for at least one year following a full-term pregnancy. We describe a prospective study conducted in Cameroon designed to test the hypothesis of an association between common treatable sexually transmitted infections (STI): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) and secondary infertility in women. Methods In this case-control study, we enrolled women in Fako Division, Cameroon between November 2017 and December 2018 with secondary infertility (cases) or current pregnancy (controls). We conducted a baseline survey to collect sociodemographic, and sexual and medical history information. Nucleic acid amplification testing using Aptima (Hologic, San Diego, CA, US) was performed on endocervical swabs for CT, NG, MG, and TV. Multivariable logistic regression was used to assess the relationship between active STI and secondary infertility. Results A total of 416 women were enrolled: 151 cases and 265 controls. Compared to controls, cases were older (median age 32 vs 27 years) and had more lifetime sexual partners (median 4 vs 3) (p<0.001). Cases were more likely to report dyspareunia, abnormal menses, prior miscarriage, and ectopic pregnancy (all p< 0.05). STI positivity was not significantly different among cases and controls (2.7% vs 5.4% for CT, 1.3% vs 2.9% for NG, 6.0% vs 7.0% for MG, respectively), with the exception of TV which was more common in pregnant controls (0.7% vs 5%; p = 0.02). Conclusion Study findings did not support an association between active STI and secondary infertility in Cameroon. Given high rates of pre-existing tubal damage, routine STI screening and treatment in younger women may be more impactful than costly STI testing during infertility assessments.	[Mbah, Clarisse Engowei; Akoachere, Jane-Francis] Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon; [Mbah, Clarisse Engowei; Akoachere, Jane-Francis] Ctr Res Hlth & Prior Pathol, Inst Med Res & Med Plants Studies, Yaounde, Cameroon; [Jasani, Amy; Aaron, Kristal J.; Geisler, William M.; Van der Pol, Barbara; Dionne-Odom, Jodie] Univ Alabama Birmingham, Div Infect Dis, Dept Med, Birmingham, AL USA; [Tita, Alan T. N.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Maternal Fetal Med, Birmingham, AL USA; [Ngeudia, Jules Clement Assob] Univ Douala, Fac Med & Pharmaceut Sci, Dept Lab Med, Douala, Cameroon	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Mbah, CE (corresponding author), Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon.; Mbah, CE (corresponding author), Ctr Res Hlth & Prior Pathol, Inst Med Res & Med Plants Studies, Yaounde, Cameroon.	engoweiclarise@gmail.com		Mbah, Clarisse Engowei/0000-0001-8759-1234	Cameroon Health Initiative at the University of Alabama at Birmingham (CHI UAB)	Cameroon Health Initiative at the University of Alabama at Birmingham (CHI UAB)	We are thankful to the women who agreed to be enrolled in our study. We are equally grateful to the Cameroon Health Initiative at the University of Alabama at Birmingham (CHI UAB) for supporting this pilot research project.	Andrea SB, 2011, J CLIN MICROBIOL, V49, P866, DOI 10.1128/JCM.02367-10; [Anonymous], 2018, GLOBAL REPROD HLTH J, P16, DOI [10.1097/grh.0000000000000016, DOI 10.1097/GRH.0000000000000016]; [Anonymous], 2013, STDS INF; Chemaitelly H, 2021, SEX TRANSM INFECT, V97, P157, DOI 10.1136/sextrans-2020-054515; Chernesky MA, 2006, EXPERT REV MOL DIAGN, V6, P519, DOI 10.1586/14737159.6.4.519; Dhont N, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-32; Egbe TO, 2020, AFR HEALTH SCI, V20, P1985, DOI 10.4314/ahs.v20i4.57; Egbe Thomas Obinchemti, 2020, Fertil Res Pract, V6, P3, DOI 10.1186/s40738-020-00073-4; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Gaydos CA, 2003, J CLIN MICROBIOL, V41, P304, DOI 10.1128/JCM.41.1.304-309.2003; Gaydos CA, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01125-19; Gupta K, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00275-18, 10.1128/jcm.00275-18]; Hay B, 2015, SEX TRANSM DIS, V42, P140, DOI 10.1097/OLQ.0000000000000246; Hussen S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3477-y; Kasia Jean Marie, 2016, J Reprod Infertil, V17, P104; Kassa ZY, 2020, EUR J CONTRACEP REPR, V25, P365, DOI 10.1080/13625187.2020.1779688; Larsen U, 2003, TROP MED INT HEALTH, V8, P354, DOI 10.1046/j.1365-3156.2003.01039.x; Lenz JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02710; Lis R, 2015, CLIN INFECT DIS, V61, P418, DOI 10.1093/cid/civ312; Low N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010866.pub2; Luke B, 2017, AM J OBSTET GYNECOL, V217, P270, DOI 10.1016/j.ajog.2017.03.012; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Naidoo S, 2013, SEX TRANSM INFECT, V89, P519, DOI 10.1136/sextrans-2012-050984; Nodjikouambaye Zita Aleyo, 2019, Infect Dis Obstet Gynecol, V2019, P8639510, DOI 10.1155/2019/8639510; Ombelet V, 2019, FACTS VIEWS VIS OBGY, V11, P65; Organization WH, 1999, GUID SEX TRANSM INF; Otieno FO, 2014, INT J STD AIDS, V25, P851, DOI 10.1177/0956462414523260; Panti AA, 2014, SAHEL MED J, V17, P7; Peipert JF, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.03.011; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; Weinger S., 2009, QUAL SOC WORK, V8, P45, DOI [https://doi.org/10.1177/1473325008100425, DOI 10.1177/1473325008100425]	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263186	10.1371/journal.pone.0263186	http://dx.doi.org/10.1371/journal.pone.0263186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120153	gold, Green Published			2022-12-26	WOS:000789273600027
J	Enriquez, NJ; Campione, NE; White, MA; Fanti, F; Sissons, RL; Sullivan, C; Vavrek, MJ; Bell, PR				Enriquez, Nathan J.; Campione, Nicolas E.; White, Matt A.; Fanti, Federico; Sissons, Robin L.; Sullivan, Corwin; Vavrek, Matthew J.; Bell, Phil R.			The dinosaur tracks of Tyrants Aisle: An Upper Cretaceous ichnofauna from Unit 4 of the Wapiti Formation (upper Campanian), Alberta, Canada	PLOS ONE			English	Article							2 MEDICINE FORMATION; PRINCE CREEK FORMATION; PTEROSAUR MANUS TRACK; DENALI-NATIONAL-PARK; WEST-CENTRAL ALBERTA; GREGARIOUS BEHAVIOR; SOUTHERN ALBERTA; OLDMAN FORMATION; TAPHONOMY; STRATIGRAPHY	The Wapiti Formation of northwest Alberta and northeast British Columbia, Canada, preserves an Upper Cretaceous terrestrial vertebrate fauna that is latitudinally situated between those documented further north in Alaska and those from southern Alberta and the contiguous U.S.A. Therefore, the Wapiti Formation is important for identifying broad patterns in vertebrate ecology, diversity, and distribution across Laramidia during the latest Cretaceous. Tracksites are especially useful as they provide a range of palaeoecological, palaeoenvironmental, and behavioural data that are complementary to the skeletal record. Here, we describe the Tyrants Aisle locality, the largest in-situ tracksite known from the Wapiti Formation. The site occurs in the lower part of Unit 4 of the formation (similar to 72.5 Ma, upper Campanian), exposed along the southern bank of the Redwillow River. More than 100 tracks are documented across at least three distinct track-bearing layers, which were deposited on an alluvial floodplain. Hadrosaurid tracks are most abundant, and are referable to Hadrosauropodus based on track width exceeding track length, broad digits, and rounded or bilobed heel margins. We suggest the hadrosaurid trackmaker was Edmontosaurus regalis based on stratigraphic context. Tyrannosaurids, probable troodontids, possible ornithomimids, and possible azhdarchid pterosaurs represent minor but notable elements of the ichnofauna, as the latter is unknown from skeletal remains within the Wapiti Formation, and all others are poorly represented. Possible social behaviour is inferred for some of the hadrosaurid and small theropod-like trackmakers based on trackway alignment, suitable spacing and consistent preservation. On a broad taxonomic level (i.e., family or above), ichnofaunal compositions indicate that hadrosaurids were palaeoecologically dominant across Laramidia during the late Campanian within both high-and low-latitude deposits, although the role of depositional environment requires further testing.	[Enriquez, Nathan J.; Campione, Nicolas E.; White, Matt A.; Bell, Phil R.] Univ New England, Palaeosci Res Ctr, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Fanti, Federico] Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Terra & Geol Ambientali, Bologna, Italy; [Sissons, Robin L.; Sullivan, Corwin] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Sullivan, Corwin] Philip J Currie Dinosaur Museum, Wembley, AB, Canada; [Vavrek, Matthew J.] Cutbank Palaeontol Consulting, Grande Prairie, AB, Canada; [Vavrek, Matthew J.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada	University of New England; University of Bologna; University of Alberta; Royal Ontario Museum	Enriquez, NJ (corresponding author), Univ New England, Palaeosci Res Ctr, Sch Environm & Rural Sci, Armidale, NSW, Australia.	nenrique@myune.edu.au	; Campione, Nicolas/R-6862-2018	Fanti, Federico/0000-0002-2961-8301; Enriquez, Nathan/0000-0002-3497-4159; Campione, Nicolas/0000-0002-4205-9794	University of New England; Australian Government; River of Death and Discovery Dinosaur Museum Society; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-06246]; Dinosaur Research Institute Fieldwork in Alberta Grants	University of New England; Australian Government(Australian GovernmentCGIAR); River of Death and Discovery Dinosaur Museum Society; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Dinosaur Research Institute Fieldwork in Alberta Grants	Funding for this research was provided by the University of New England and a Research Training Program scholarship from the Australian Government to N.J.E.; the River of Death and Discovery Dinosaur Museum Society in support of the Philip J. Currie Professorship in Vertebrate Palaeontology at the University of Alberta, Canada, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (RGPIN-2017-06246) and start-up funding to C.S.; and the Dinosaur Research Institute Fieldwork in Alberta Grants to N.E.C. and M.J.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens J., 2005, VISUALIZATION HDB, P717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; Albritton CC, 1942, FIELD LAB, V10, P160; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; [Anonymous], 2019, CLOUDCOMPARE VERSION; Avanzini M, 2012, LETHAIA, V45, P238, DOI 10.1111/j.1502-3931.2011.00276.x; Averianov A, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.432.7913; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bell Phil R., 2014, P174; Bell PR, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0050; Bell PR, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0062; Bell PR, 2014, CURR BIOL, V24, P70, DOI 10.1016/j.cub.2013.11.008; Bell PR, 2013, LETHAIA, V46, P274, DOI 10.1111/let.12006; Benson RBJ, 2018, PALAEONTOLOGY, V61, P13, DOI 10.1111/pala.12329; Bravo-Cuevas VM, 2014, DINOSAURS OTHER REPT, P181; Brown CM, ALL ANIMALS ARE INTE; Campione Nicolas E., 2014, P208; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carpenter Kenneth, 1992, Contributions to Geology University of Wyoming, V29, P81; Cignoni P, 2008, EUR IT CHAPT C EUR A, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Clark N.D.L., 2005, ICHNOS, V12, P93, DOI DOI 10.1080/10420940590914516; Coria RA, 2006, GEODIVERSITAS, V28, P71; Corsi DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057646; Cotillon P, 2010, B SOC GEOL FR, V181, P3, DOI 10.2113/gssgfbull.181.1.3; Cotton William D., 1998, Ichnos, V6, P141; Cullen TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058853; Currie P.J., 1989, P293; CURRIE P J, 1983, Acta Palaeontologica Polonica, V28, P63; Currie P.J., 2008, NEW HORNED DINOSAUR; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Currie PJ, 2005, LIFE O PAST, P537; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; CURRIE PJ, 1979, PALAEOGEOGR PALAEOCL, V28, P103, DOI 10.1016/0031-0182(79)90114-7; CURRIE PJ, 1982, CAN J EARTH SCI, V19, P894, DOI 10.1139/e82-074; Davies TG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0194; Diaz-Martinez I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115477; Eberth DA, 2020, CAN J EARTH SCI, V57, P1220, DOI 10.1139/cjes-2019-0019; Eberth DA, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0069; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Enriquez NJ, 2021, GEOL MAG, V158, P1115, DOI 10.1017/S0016756820001247; Enriquez NJ, 2020, J VERTEBR PALEONTOL, V40, DOI 10.1080/02724634.2021.1878201; Enriquez NJ., 2020, TYRANTS AISLE DINOSA; Evans DC, 2015, CAN J EARTH SCI, V52, P642, DOI 10.1139/cjes-2014-0184; Evans DC., 2007, THESIS U TORONTO; Falkingham PL, 2020, PALAEONTOLOGY, V63, P865, DOI 10.1111/pala.12502; Falkingham PL, 2018, PALAEONTOLOGY, V61, P469, DOI 10.1111/pala.12373; Fanti F, 2015, CAN J EARTH SCI, V52, P250, DOI 10.1139/cjes-2014-0197; Fanti F, 2013, CRETACEOUS RES, V41, P256, DOI 10.1016/j.cretres.2012.12.010; Fanti F, 2010, J SEDIMENT RES, V80, P320, DOI 10.2110/jsr.2010.033; Fanti F, 2009, CAN J EARTH SCI, V46, P263, DOI 10.1139/E09-020; Fanti F, 2009, PALAEOGEOGR PALAEOCL, V275, P37, DOI 10.1016/j.palaeo.2009.02.007; Farlow J.O., 2013, TYRANNOSAURID PALEOB, P88; Farlow JO, 2012, COMPLETE DINOSAUR, V2nd, P713; Farrow G. E., 1966, Palaeogeography Palaeoclimatology Palaeoecology, V2, P103, DOI 10.1016/0031-0182(66)90011-3; Fiorillo AR, 2015, HIST BIOL, V27, P671, DOI 10.1080/08912963.2014.933213; Fiorillo A.R., 1989, Mosasaur, V4, P127; Fiorillo AR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223471; Fiorillo AR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30110-8; Fiorillo Anthony R., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P429; Fiorillo AR, 2014, GEOLOGY, V42, P719, DOI 10.1130/G35740.1; Fiorillo AR, 2009, PALAIOS, V24, P466, DOI 10.2110/palo.2008.p08-129r; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Fondevilla V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206287; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Furukawa Y, 2010, PROC CVPR IEEE, P1434, DOI 10.1109/CVPR.2010.5539802; Gangloff RA, 2010, PALAIOS, V25, P299, DOI 10.2110/palo.2009.p09-103r; Gangloff Roland A., 2004, Ichnos, V11, P299, DOI 10.1080/10420940490442269; Garcia-Ortiz E, 2014, J IBER GEOL, V40, P113, DOI 10.5209/rev_JIGE.2014.v40.n1.44091; Gates Terry A., 2013, P463; Gatesy Stephen M., 2001, Bulletin of the Museum of Comparative Zoology, V156, P137; Getty PR, 2012, GUIDEBOOK FIELDTRIPS, V9, pA1; Gierlinski Gerard, 2013, P526; Godfrey SJ, 2005, LIFE O PAST, P292; Henderson DM, 2006, CAN J EARTH SCI, V43, P691, DOI 10.1139/E06-024; Henderson Donald M., 2003, Ichnos, V10, P99, DOI 10.1080/10420940390257914; Holland B, 2021, PEERJ, V9, DOI 10.7717/peerj.11290; Hone DWE, 2019, J VERTEBR PALEONTOL, V39, DOI 10.1080/02724634.2019.1649681; Hone David W.E., 2014, P524; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; Hunt Adrian P., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P379; Hwang KG, 2002, GEOL MAG, V139, P421, DOI 10.1017/S0016756802006647; Kazhdan M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487237; Knaust D, 2013, EARTH-SCI REV, V126, P1, DOI 10.1016/j.earscirev.2013.04.007; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Kuban G.J., 1989, P57; Lallensack JN, 2016, PEERJ, V4, DOI 10.7717/peerj.2059; Li DQ, 2015, SCI BULL, V60, P264, DOI 10.1007/s11434-014-0681-z; Lockley M., 1989, P121; Lockley M., 1991, P1; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley M.G., 1983, Mountain Geologist, V20, P5; LOCKLEY M G, 1986, Palaios, V1, P37, DOI 10.2307/3514457; Lockley M.G., 2011, NEW MEXICO MUSEUM NA, V53, P321; Lockley MG, 2007, NATURWISSENSCHAFTEN, V94, P657, DOI 10.1007/s00114-007-0239-x; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Lockley MG, 2014, BIOL J LINN SOC, V113, P721, DOI 10.1111/bij.12294; Lockley MG, 2012, ICHNOS, V19, P105, DOI 10.1080/10420940.2011.625793; Lockley MG, 1995, J VERTEBR PALEONTOL, V15, P592, DOI 10.1080/02724634.1995.10011251; Lockley MG, 1999, PALAEOGEOGR PALAEOCL, V150, P25, DOI 10.1016/S0031-0182(99)00005-X; Lockley MG, 2016, DINOSAUR TRACKS NEXT, P182; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Lucas SG., 2011, NEW MEXICO MUSEUM NA, V53, P357; Maidment SCR, 2014, NATURWISSENSCHAFTEN, V101, P989, DOI 10.1007/s00114-014-1239-2; Martin-Silverstone E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160333; McAllister J.A., 1989, P343; McCrea Richard T., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P5; McCrea RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103613; McCrea RT, 2005, LIFE O PAST, P405; McCrea RT, ARMORED DINOSAURS; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Milan J, 2008, ICHNOS, V15, P19, DOI 10.1080/10420940600864712; Milner ARC, 2016, DINOSAUR TRACKS NEXT, P152; Moreno K, 2012, ACTA PALAEONTOL POL, V57, P73, DOI 10.4202/app.2010.0119; Morris W.J., 1976, ATHLON ESSAYS PALAEO, P93; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; OSTROM JH, 1972, PALAEOGEOGR PALAEOCL, V11, P287, DOI 10.1016/0031-0182(72)90049-1; Parker L.R., 1989, P361; PARRISH J M, 1987, Palaios, V2, P377, DOI 10.2307/3514763; Pittman J.G., 1989, P135; Ramirez-Velasco Angel A., 2014, P340; Razzolini NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093708; Rivera-Sylva Hector E., 2019, PALAEOVERTEBRATA, V42, pe1, DOI 10.18563/pv.42.2.e1; Rodriguez-de la Rosa RA., 4 EUR M PAL STRAT LA; Rodriguez-de la Rosa Ruben A., 2004, Ichnos, V11, P27, DOI 10.1080/10420940490428841; RUSSELL DA, 1972, CAN J EARTH SCI, V9, P1338, DOI 10.1139/e72-119; Ryan Michael J., 2001, P279; Ryan MJ, DINOSAUR PROVINCIAL; Sahni A., 1972, Bulletin Am Mus nat Hist, V147, P321; Salisbury SW, 2017, J VERTEBR PALEONTOL, V36, P1, DOI 10.1080/02724634.2016.1269539; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Scherzer BA, 2010, PALAIOS, V25, P780, DOI 10.2110/palo.2009.p09-143r; SCHWARTZ HL, 1994, J PALEONTOL, V68, P1118, DOI 10.1017/S0022336000026718; Scotese C.R., 2016, PALEOMAP PALEOATLAS; STERNBERG C. M., 1932, ANN REPT NATION MUS CANADA 1930, P59; Sternberg CM, 1926, Bulletin Geol Surv Ottawa, V44, P85; Tanke Darren H., 2004, Alberta Paleontological Society Bulletin, V19, P3; Therrien Francois, 2014, P532; Therrien F, 2015, CAN J EARTH SCI, V52, P630, DOI 10.1139/cjes-2014-0168; THULBORN RA, 1984, ALCHERINGA, V8, P243, DOI 10.1080/03115518408618947; Thulborn T., 1990, DINOSAUR TRACKS; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Trexler David, 2001, P298; Ullmann PV, 2017, PALAIOS, V32, P779, DOI 10.2110/palo.2017.060; van der Lubbe T, 2011, DINOSAUR TRACKS 2011, P35; van Hinsbergen DJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126946; VARRICCHIO DJ, 1993, CAN J EARTH SCI, V30, P997, DOI 10.1139/e93-083; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; Wolberg DL., 1988, B NEW MEX BUR MIN MI, V122, P33; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zubalich R, 2021, MAR PETROL GEOL, V124, DOI 10.1016/j.marpetgeo.2020.104779	159	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262824	10.1371/journal.pone.0262824	http://dx.doi.org/10.1371/journal.pone.0262824			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108301	gold, Green Published			2022-12-26	WOS:000775890100038
J	de Carvalho, RRB; Cortes, DFM; Sousa, MBE; de Oliveira, LA; de Oliveira, EJ				Bessa de Carvalho, Ravena Rocha; Marmolejo Cortes, Diego Fernando; Bandeira e Sousa, Massaine; de Oliveira, Luciana Alves; de Oliveira, Eder Jorge			Image-based phenotyping of cassava roots for diversity studies and carotenoids prediction	PLOS ONE			English	Article							COMPUTER VISION; ANTIOXIDANT ACTIVITY; DRY-MATTER; FRESH; CROPS; PERFORMANCE; TOOL	Phenotyping to quantify the total carotenoids content (TCC) is sensitive, time-consuming, tedious, and costly. The development of high-throughput phenotyping tools is essential for screening hundreds of cassava genotypes in a short period of time in the biofortification program. This study aimed to (i) use digital images to extract information on the pulp color of cassava roots and estimate correlations with TCC, and (ii) select predictive models for TCC using colorimetric indices. Red, green and blue images were captured in root samples from 228 biofortified genotypes and the difference in color was analyzed using L*, a*, b*, hue and chroma indices from the International Commission on Illumination (CIELAB) color system and lightness. Colorimetric data were used for principal component analysis (PCA), correlation and for developing prediction models for TCC based on regression and machine learning. A high positive correlation between TCC and the variables b* (r = 0.90) and chroma (r = 0.89) was identified, while the other correlations were median and negative, and the L* parameter did not present a significant correlation with TCC. In general, the accuracy of most prediction models (with all variables and only the most important ones) was high (R-2 ranging from 0.81 to 0.94). However, the artificial neural network prediction model presented the best predictive ability (R-2 = 0.94), associated with the smallest error in the TCC estimates (root-mean-square error of 0.24). The structure of the studied population revealed five groups and high genetic variability based on PCA regarding colorimetric indices and TCC. Our results demonstrated that the use of data obtained from digital image analysis is an economical, fast, and effective alternative for the development of TCC phenotyping tools in cassava roots with high predictive ability.	[Bessa de Carvalho, Ravena Rocha] Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Rua Rui Barbosa, Cruz Das Almas, BA, Brazil; [Marmolejo Cortes, Diego Fernando; Bandeira e Sousa, Massaine; de Oliveira, Luciana Alves; de Oliveira, Eder Jorge] Embrapa Mandioca & Fruticultura, Rua Embrapa, Cruz Das Almas, BA, Brazil	Universidade Federal do Reconcavo da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	de Oliveira, EJ (corresponding author), Embrapa Mandioca & Fruticultura, Rua Embrapa, Cruz Das Almas, BA, Brazil.	eder.oliveira@embrapa.br	Cortes, Diego Marmolejo/W-9068-2018; Oliveira, Eder/N-2216-2017	Cortes, Diego Marmolejo/0000-0003-1250-9376; Oliveira, Eder/0000-0001-8992-7459	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [88882.424436/2019-01]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [409229/2018-0, 442050/2019-4, 303912/2018-9]; FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia) [15/2014]; UK's Foreign, Commonwealth & Development Office (FCDO); Bill & Melinda Gates Foundation [INV-007637]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia); UK's Foreign, Commonwealth & Development Office (FCDO); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Ravena Rocha Bessa de Carvalho: CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). Grant number:88882.424436/2019-01. Eder Jorge de Oliveira: CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). Grant number:409229/2018-0, 442050/2019-4 and 303912/2018-9. Eder Jorge de Oliveira: FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia). Grant number: Pronem 15/2014. Eder Jorge de Oliveira and Massaine Bandeira e Sousa: UK's Foreign, Commonwealth & Development Office (FCDO) and the Bill & Melinda Gates Foundation. Grant number: INV-007637. The funder provided support in the form of fellowship and funds for the research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso T, 2017, J INTEGR BIOINFORMAT, V14, DOI 10.1515/jib-2017-0056; Alamu EO, 2019, P 18 INT C NEAR INFR, V1, P91, DOI [10.1255/nir2017.091, DOI 10.1255/NIR2017.091]; Bai G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01002; Belalcazar J, 2016, CROP SCI, V56, P2916, DOI 10.2135/cropsci2015.11.0701; Peprah BB, 2020, FOODS, V9, DOI 10.3390/foods9121800; Burns Anna, 2010, Sustainability, V2, P3572, DOI 10.3390/su2113572; Busener N, 2020, PLANTS PEOPLE PLANET, V2, P678, DOI 10.1002/ppp3.10130; Ceballos H, 2013, CROP SCI, V53, P2342, DOI 10.2135/cropsci2013.02.0123; Ceballos H, 2012, FOOD RES INT, V45, P52, DOI 10.1016/j.foodres.2011.10.001; Ceballos H., 2017, CAROTENOIDS, P189, DOI DOI 10.1371/JOURNAL.PONE.0188918; Chavez AL, 2005, EUPHYTICA, V143, P125, DOI 10.1007/s10681-005-3057-2; CIE (Commission Internationale de L'Eclairage (International Commission on Illumination), 1978, REC UN COL SPAC COL; Darrigues A, 2008, J AM SOC HORTIC SCI, V133, P579, DOI 10.21273/JASHS.133.4.579; do Carmo CD, 2020, CROP SCI, V60, P883, DOI 10.1002/csc2.20102; Dodig D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00814; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Ferraro V, 2016, CRIT REV FOOD SCI, V56, P2714, DOI 10.1080/10408398.2014.922045; Figas MR, 2015, GENET RESOUR CROP EV, V62, P189, DOI 10.1007/s10722-014-0142-1; Food and Agriculture Organization of the United Nations, 2021, FAOSTAT DAT GAT; Fuhrmann Elisiane, 2019, Cientifica (Jaboticabal), V47, P77, DOI 10.15361/1984-5529.2019v47n1p77-82; Gonzalez CS., 2020, COMPUT ELECTRON AGR, V175; Hadimani L, 2019, J FOOD SCI TECH MYS, V56, P2305, DOI 10.1007/s13197-019-03641-9; Ikeogu UN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01570; Ikeogu UN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188918; Itle RA, 2009, HORTSCIENCE, V44, P633, DOI 10.21273/HORTSCI.44.3.633; Jarvis A, 2012, TROP PLANT BIOL, V5, P9, DOI 10.1007/s12042-012-9096-7; Kassambara A., 2017, EXTRACT VISUALIZE RE; Kljak K, 2014, J CEREAL SCI, V59, P109, DOI 10.1016/j.jcs.2013.12.004; Li M., 2019, ARXIV; Liakos KG, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082674; Mario C, 2017, FOOD CHEM, V229, P640, DOI 10.1016/j.foodchem.2017.02.138; Cortes DFM, 2017, SCI AGR, V74, P294, DOI [10.1590/1678-992x-2016-0134, 10.1590/1678-992X-2016-0134]; Moresco R, 2017, ADV INTELL SYST, V616, P280, DOI 10.1007/978-3-319-60816-7_34; Nankar AN, 2020, SCI HORTIC-AMSTERDAM, V260, DOI 10.1016/j.scienta.2019.108862; Pace B, 2013, J FOOD ENG, V117, P74, DOI 10.1016/j.jfoodeng.2013.02.005; Parmar A, 2017, FOOD SECUR, V9, P907, DOI 10.1007/s12571-017-0717-8; Pathare PB, 2013, FOOD BIOPROCESS TECH, V6, P36, DOI 10.1007/s11947-012-0867-9; R Core Team, 2020, R LANG ENV STAT COMP; Rodriguez-Amaya DB., 2004, HARVEST PLUS HDB CAR; Saltzman A, 2017, ANN NY ACAD SCI, V1390, P104, DOI 10.1111/nyas.13314; Sanaeifar A, 2018, COMPUT ELECTRON AGR, V145, P142, DOI 10.1016/j.compag.2017.12.035; Sanchez T, 2014, FOOD CHEM, V151, P444, DOI 10.1016/j.foodchem.2013.11.081; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Selvaraj MG, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00625-1; Singh Y, 2007, INT J COMPUTER SCI S, V1, P70; Souza LS, 2006, ASPECTOS SOCIOECON M; Stinco CM, 2013, FOOD RES INT, V50, P111, DOI 10.1016/j.foodres.2012.10.011; Walter J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00449; Wan P, 2018, COMPUT ELECTRON AGR, V146, P43, DOI 10.1016/j.compag.2018.01.011; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Wasonga DO, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13040598; Ye XJ, 2018, COGENT ENG, V5, DOI 10.1080/23311916.2018.1504499; Zaouay F, 2012, IND CROP PROD, V40, P81, DOI 10.1016/j.indcrop.2012.02.045	53	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263326	10.1371/journal.pone.0263326	http://dx.doi.org/10.1371/journal.pone.0263326			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100324	Green Published, gold			2022-12-26	WOS:000801937600045
J	Hidayat-ur-Rehman, I; Alzahrani, S; Rehman, MZ; Akhter, F				Hidayat-ur-Rehman, Imdadullah; Alzahrani, Saeed; Rehman, Mohd Ziaur; Akhter, Fahim			Determining the factors of m-wallets adoption. A twofold SEM-ANN approach	PLOS ONE			English	Article							MOBILE PAYMENT ACCEPTANCE; CONSUMER ADOPTION; CONTINUANCE INTENTION; INNOVATION THEORY; DIFFUSION; PURCHASE; SERVICES; MODEL; RISK; SECURITY	M-wallets are comparatively more advantageous and convenient than conventional payment systems as m-wallets allow users to avoid cash. The present research uses the diffusion of innovation theory as the base theory to propose a research model by incorporating constructs like convenience, perceived security, personal innovativeness, and perceived trust to investigate the determinants of consumers' intention-to-use m-wallets. A twofold approach comprising of Structural Equation Modelling-Artificial Neural Network (SEM-ANN) was used: First, partial least squares structural equation modelling (PLS-SEM) was employed to determine the significant determinants of intention-to-use. Second, the ANN approach was applied as robustness to corroborate the outcomes of PLS-SEM and to estimate the relative importance of the SEM-based significant determinants. Our findings confirmed that compatibility, ease of use, observability, convenience, relative advantage, personal innovativeness, perceived trust, and perceived security are the key elements that influence the intention-to-use m-wallets. Moreover, we ascertained that perceived security is the most influential predictor of intention-to-use. The outcomes of ANN have complemented the findings of PLS-SEM, but some differences were also exhibited in the order of influential factors. The study brings to fore significant insights and a set of suggestions for the companies carrying out the development, execution, and marketing of M-wallet services.	[Hidayat-ur-Rehman, Imdadullah; Alzahrani, Saeed; Akhter, Fahim] King Saud Univ, Dept MIS, Coll Business Adm, Riyadh, Saudi Arabia; [Rehman, Mohd Ziaur] King Saud Univ, Dept Finance, Coll Business Adm, Riyadh, Saudi Arabia	King Saud University; King Saud University	Hidayat-ur-Rehman, I (corresponding author), King Saud Univ, Dept MIS, Coll Business Adm, Riyadh, Saudi Arabia.	ihidayaturrehman@ksu.edu.sa	REHMAN, MOHD ZIAUR/GYU-8492-2022; Rehman, Imdadullah Hidayat ur/AAS-4754-2020; REHMAN, MOHD/GYU-2820-2022	REHMAN, MOHD ZIAUR/0000-0002-9045-617X; Rehman, Imdadullah Hidayat ur/0000-0001-7763-6566; 				Abraham Samuel, 2019, FINTECH STARTUPS PLA; Agarwal R, 1998, INFORM SYST RES, V9, P204, DOI 10.1287/isre.9.2.204; Alalwan AA, 2017, INT J INFORM MANAGE, V37, P99, DOI 10.1016/j.ijinfomgt.2017.01.002; Alkhowaiter WA, 2020, INT J INFORM MANAGE, V53, DOI 10.1016/j.ijinfomgt.2020.102102; Arvidsson N, 2014, INT J BANK MARK, V32, P150, DOI 10.1108/IJBM-05-2013-0048; Aydin G., 2016, J BUSINESS EC FINANC, V5, P73, DOI [https://doi.org/10.17261/Pressacademia.2016116555, DOI 10.17261/PRESSACADEMIA.2016116555]; Bigne-Alcaniz E, 2008, ONLINE INFORM REV, V32, P648, DOI 10.1108/14684520810914025; Boden J, 2020, J RETAIL CONSUM SERV, V52, DOI 10.1016/j.jretconser.2019.101910; Chen WC, 2019, INFORMATION, V10, DOI 10.3390/info10120384; Chong AYL, 2013, EXPERT SYST APPL, V40, P523, DOI 10.1016/j.eswa.2012.07.068; Cocosila M, 2016, ELECTRON COMMER R A, V20, P159, DOI 10.1016/j.elerap.2016.10.006; Dabholkar PA, 2002, J ACAD MARKET SCI, V30, P184, DOI 10.1177/0092070302303001; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Di Pietro L, 2015, TRANSPORT RES C-EMER, V56, P463, DOI 10.1016/j.trc.2015.05.001; Duane A, 2014, BEHAV INFORM TECHNOL, V33, P318, DOI 10.1080/0144929X.2012.745608; Gao LL, 2017, INFORM SYST FRONT, V19, P525, DOI 10.1007/s10796-015-9611-0; Gao LL, 2015, COMPUT HUM BEHAV, V53, P249, DOI 10.1016/j.chb.2015.07.014; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Hew JJ, 2019, TECHNOL FORECAST SOC, V144, P311, DOI 10.1016/j.techfore.2017.10.007; Hew JJ, 2018, TOURISM MANAGE, V66, P121, DOI 10.1016/j.tourman.2017.10.005; Hew JJ, 2017, TELEMAT INFORM, V34, P914, DOI 10.1016/j.tele.2017.04.001; Ho JC, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101360; Johnson VL, 2018, COMPUT HUM BEHAV, V79, P111, DOI 10.1016/j.chb.2017.10.035; Kalinic Z, 2019, J RETAIL CONSUM SERV, V49, P143, DOI 10.1016/j.jretconser.2019.03.016; Kapoor KK, 2015, INFORM SYST FRONT, V17, P1039, DOI 10.1007/s10796-014-9484-7; Kaur P, 2020, J RETAIL CONSUM SERV, V56, DOI 10.1016/j.jretconser.2020.102091; Khalilzadeh J, 2017, COMPUT HUM BEHAV, V70, P460, DOI 10.1016/j.chb.2017.01.001; Kim M, 2019, TELEMAT INFORM, V38, P46, DOI 10.1016/j.tele.2019.02.003; Kock N, 2015, INT J E-COLLAB, V11, P1, DOI 10.4018/ijec.2015100101; Kumar A, 2018, INT J BANK MARK, V36, P1170, DOI 10.1108/IJBM-04-2017-0077; Lee VH, 2020, EXPERT SYST APPL, V157, DOI 10.1016/j.eswa.2020.113477; Lee VH, 2016, EXPERT SYST APPL, V65, P136, DOI 10.1016/j.eswa.2016.08.042; Leong LY, 2020, INT J INFORM MANAGE, V51, DOI 10.1016/j.ijinfomgt.2019.102047; Leong LY, 2019, EXPERT SYST APPL, V133, P296, DOI 10.1016/j.eswa.2019.05.024; Leong LY, 2018, J ELECTRON COMMER RE, V19, P75; Leong LY, 2018, COMPUT HUM BEHAV, V78, P160, DOI 10.1016/j.chb.2017.09.033; Leong LY, 2013, EXPERT SYST APPL, V40, P5604, DOI 10.1016/j.eswa.2013.04.018; Lew SS, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101430; Lian JW, 2015, INT J INFORM MANAGE, V35, P98, DOI 10.1016/j.ijinfomgt.2014.10.005; Liang CJ, 2008, SERV IND J, V28, P193, DOI 10.1080/02642060701842258; Liebana-Cabanillas F, 2018, TECHNOL FORECAST SOC, V129, P117, DOI 10.1016/j.techfore.2017.12.015; Longyara T., 2015, INT J MANAG STUD RES, V3, P36; Mallat N, 2007, J STRATEGIC INF SYST, V16, P413, DOI 10.1016/j.jsis.2007.08.001; Matemba ED, 2018, TECHNOL SOC, V53, P55, DOI 10.1016/j.techsoc.2017.12.001; Min S, 2019, J TRAVEL TOUR MARK, V36, P770, DOI 10.1080/10548408.2018.1507866; Mohammadi MM, 2018, HEALTH PROMOT PERSPE, V8, P25, DOI 10.15171/hpp.2018.03; Mombeuil C, 2020, J RETAIL CONSUM SERV, V55, DOI 10.1016/j.jretconser.2020.102127; Morosan C, 2016, INT J HOSP MANAG, V53, P17, DOI 10.1016/j.ijhm.2015.11.003; Negnevitsky M, 2011, ARTIF INTELL, V73; Oliveira T, 2016, COMPUT HUM BEHAV, V61, P404, DOI 10.1016/j.chb.2016.03.030; Ooi KB, 2018, EXPERT SYST APPL, V93, P376, DOI 10.1016/j.eswa.2017.10.009; Ooi KB, 2016, EXPERT SYST APPL, V59, P33, DOI 10.1016/j.eswa.2016.04.015; Park J, 2019, J RETAIL CONSUM SERV, V47, P140, DOI 10.1016/j.jretconser.2018.11.015; Pham TTT, 2015, TECHNOL SOC, V43, P159, DOI 10.1016/j.techsoc.2015.05.004; de Luna IR, 2019, TECHNOL FORECAST SOC, V146, P931, DOI 10.1016/j.techfore.2018.09.018; Ramos-de-Luna I, 2016, INF SYST E-BUS MANAG, V14, P293, DOI 10.1007/s10257-015-0284-5; Rogers E.M., 1995, DIFFUSION INNOVATION, V4th ed.; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th; Martin HS, 2012, TOURISM MANAGE, V33, P341, DOI 10.1016/j.tourman.2011.04.003; Schmidthuber L, 2020, TECHNOL FORECAST SOC, V155, DOI 10.1016/j.techfore.2018.06.017; Sharma SK., 2019, INT J INF MANAGE, DOI [10.1016/j.ijinfomgt.2018.10.021, DOI 10.1016/J.IJINFOMGT.2018.10.021]; Sharma SK, 2018, J RETAIL CONSUM SERV, V45, P52, DOI 10.1016/j.jretconser.2018.08.008; Shin DH, 2009, COMPUT HUM BEHAV, V25, P1343, DOI 10.1016/j.chb.2009.06.001; Sim JJ, 2014, TELEMAT INFORM, V31, P569, DOI 10.1016/j.tele.2013.11.005; Singh N, 2020, J RETAIL CONSUM SERV, V52, DOI 10.1016/j.jretconser.2019.101894; Singh N, 2020, INT J INFORM MANAGE, V50, P191, DOI 10.1016/j.ijinfomgt.2019.05.022; Slade EL, 2015, PSYCHOL MARKET, V32, P860, DOI 10.1002/mar.20823; Susanto A, 2012, IEEE SYS MAN CYBERN, P2133, DOI 10.1109/ICSMC.2012.6378055; Talukder MS., 2020, TECHNOL FORECAST SOC, V150, P1; Tan GWH, 2014, COMPUT HUM BEHAV, V36, P198, DOI 10.1016/j.chb.2014.03.052; Urbach N., 2010, J INFORM TECHNOLOGY, V11, P5, DOI DOI 10.1037/0021-9010.90.4.710; van der Boor P, 2014, RES POLICY, V43, P1594, DOI 10.1016/j.respol.2014.05.003; Van Slyke C, 2007, EUR J INFORM SYST, V16, P270, DOI 10.1057/palgrave.ejis.3000680; Wadhera T., 2017, INT J ENG MANAG RES, V7, P1; Wang YC, 2021, TRANSPORT RES A-POL, V143, P1, DOI 10.1016/j.tra.2020.11.002; Williams MD, 2017, AMCIS 2017 AM C INF, P1; Wirth J., 2017, 23 AM C INF SYST BOS, P1; Worldbank, 2020, SAUD AR INV DIG INFR; Wu JN, 2017, IND MANAGE DATA SYST, V117, P1761, DOI 10.1108/IMDS-08-2016-0312; Yates BL., 2001, INT COMMUNICATION AS; Yuen KF, 2020, J CLEAN PROD, V270, DOI 10.1016/j.jclepro.2020.121904	81	0	0	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262954	10.1371/journal.pone.0262954	http://dx.doi.org/10.1371/journal.pone.0262954			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089968	gold, Green Published			2022-12-26	WOS:000769158400029
J	Indra, J; Khoirunurrofik, K				Indra, Jul; Khoirunurrofik, Khoirunurrofik			Understanding the role of village fund and administrative capacity in stunting reduction: Empirical evidence from Indonesia	PLOS ONE			English	Article							IMPACT; RISK	The Indonesian government launched various programs to handle stunting cases, including village funds. This paper examined the effects of village fund programs and village apparatuses' capacities to combat stunting based on aggregate data at the district level in Indonesia. Using descriptive data analysis and fixed effect panel regression, we observed that village fund programs could significantly reduce Indonesia's stunting prevalence, especially outside Java. It also revealed that the increasing education of regional leaders does not necessarily positively impact leaders' skills in handling stunting. At the same time, the number of village officials has a statistically significant influence on reducing stunting prevalence. It advised that the village budget fund can support national priorities in tackling the prevalence of stunting. Furthermore, it is essential to build the capacity of the village head for increasing awareness of health activities, especially early prevention of stunting, in addition to an adequate number of officials.	[Indra, Jul; Khoirunurrofik, Khoirunurrofik] Univ Indonesia, Fac Econ & Business, Grad Programme Econ, Depok, Indonesia; [Khoirunurrofik, Khoirunurrofik] Univ Indonesia, Fac Econ & Business, Res Cluster Energy Modeling & Reg Econ Anal RCEMR, Depok, Indonesia	University of Indonesia; University of Indonesia	Khoirunurrofik, K (corresponding author), Univ Indonesia, Fac Econ & Business, Grad Programme Econ, Depok, Indonesia.; Khoirunurrofik, K (corresponding author), Univ Indonesia, Fac Econ & Business, Res Cluster Energy Modeling & Reg Econ Anal RCEMR, Depok, Indonesia.	Khoirunurrofik@ui.ac.id	Khoirunurrofik, Khoirunurrofik/ABC-9514-2020	Khoirunurrofik, Khoirunurrofik/0000-0002-9345-0400				Bappenas, 2018, PED PEL INT PEN STUN; Bappenas, 2020, REV PEL DAK STUNT 20; Beal T, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12617; Berman P., 2008, Economic and Political Weekly, V43, P209; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Boonperm J, 2013, J ASIAN ECON, V25, P3, DOI 10.1016/j.asieco.2013.01.001; Cahyadi N, 2020, AM ECON J-ECON POLIC, V12, P88, DOI 10.1257/pol.20190245; Center, 2007, TRACKING PROGR COMMU; Chandoevwit Worawan., 2008, TDRI Q REV, V23, P9; De Silva I, 2018, J INT DEV, V30, P837, DOI 10.1002/jid.3365; Dios-Palomares R, 2015, REV CIENT-FAC CIEN V, V25, P43; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; GUPTA S, 2002, EUROPEAN J POLITICAL, V0018; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; Lewis BD, 2017, J URBAN AFF, V39, P1047, DOI 10.1080/07352166.2017.1323544; Lewis BD, 2015, PUBLIC ADMIN DEVELOP, V35, P347, DOI 10.1002/pad.1741; Marini A, 2017, STANDING TALL PERUS; Martinez-Bravo M, 2017, AM ECON J-APPL ECON, V9, P256, DOI 10.1257/app.20150447; Martinez-Bravo M, 2014, AM ECON REV, V104, P1244, DOI 10.1257/aer.104.4.1244; Moreno-Macias L, 2013, GLOB HEALTH PROMOT, V20, P25, DOI 10.1177/1757975913499035; Rachmi CN, 2016, PUBLIC HEALTH NUTR, V19, P2698, DOI 10.1017/S1368980016000926; Ramli, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-64; RISKESDAS, 2018, IND BAS HLTH RES; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Shekar M, 2017, HEALTH POLICY PLANN, V32, P657, DOI 10.1093/heapol/czw184; UNICEF, 2018, NUTR CAP ASS IND; Wirth JP, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12310; World Bank, 2020, FIND PUBL EXP REV, DOI [10.1596/34196, DOI 10.1596/34196]; Yapo YV, 2020, J HEALTH POPUL NUTR, V39, DOI 10.1186/s41043-020-0210-4; Gonzalez CAZ, 2020, REICE-REV ELECTRON I, V8, P68, DOI 10.5377/reice.v8i16.10661	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262743	10.1371/journal.pone.0262743	http://dx.doi.org/10.1371/journal.pone.0262743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089957	Green Published, gold			2022-12-26	WOS:000769158400022
J	Shiba, M; Kato, T; Morimoto, T; Yaku, H; Inuzuka, Y; Tamaki, Y; Ozasa, N; Seko, Y; Yamamoto, E; Yoshikawa, Y; Kitai, T; Yamashita, Y; Iguchi, M; Nagao, K; Kawase, Y; Morinaga, T; Toyofuku, M; Furukawa, Y; Ando, K; Kadota, K; Sato, Y; Nakagawa, Y; Kuwahara, K; Kimura, T				Shiba, Masayuki; Kato, Takao; Morimoto, Takeshi; Yaku, Hidenori; Inuzuka, Yasutaka; Tamaki, Yodo; Ozasa, Neiko; Seko, Yuta; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Yamashita, Yugo; Iguchi, Moritake; Nagao, Kazuya; Kawase, Yuichi; Morinaga, Takashi; Toyofuku, Mamoru; Furukawa, Yutaka; Ando, Kenji; Kadota, Kazushige; Sato, Yukihito; Nakagawa, Yasuaki; Kuwahara, Koichiro; Kimura, Takeshi			Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; STATE	Background This study aimed to investigate the association between changes in brain natriuretic peptide (BNP) from discharge to 6-month visit and subsequent clinical outcomes in patients with acute heart failure (AHF). Methods Among 1246 patients enrolled in the prospective longitudinal follow-up study nested from the Kyoto Congestive Heart Failure registry, this study population included 446 patients with available paired BNP data at discharge and 6-month index visit. This study population was classified into 3 groups by percent change in BNP from discharge to 6-month visit; the low tertile (<= -44%, N = 149), the middle tertile (>-44% and <= 22%, N = 149) and the high tertile (>22%, N = 148). Findings The cumulative 180-day incidence after the index visit of the primary outcome measure (a composite endpoint of all-cause death or hospitalization for HF) was significantly higher in the high and middle tertiles than in the low tertile (26.8% and 14.4% versus 6.9%, log-rank P<0.0001). The adjusted excess risk of the high tertile relative to the low tertile remained significant for the primary outcome measure (hazard ratio: 3.43, 95% confidence interval: 1.51-8.46, P = 0.003). Conclusions Percent change in BNP was associated with a subsequent risk for a composite of all-cause death and hospitalization for HF after adjustment of the absolute BNP values, suggesting that observing the change in BNP levels, in addition to absolute BNP levels themselves, helps us to manage patient with HF.	[Shiba, Masayuki; Kato, Takao; Ozasa, Neiko; Seko, Yuta; Yamamoto, Erika; Yoshikawa, Yusuke; Yamashita, Yugo; Nakagawa, Yasuaki; Kimura, Takeshi] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Yaku, Hidenori] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan; [Inuzuka, Yasutaka] Shiga Gen Hosp, Cardiovasc Med, Moriyama, Japan; [Tamaki, Yodo] Tenri Hosp, Div Cardiol, Tenri, Nara, Japan; [Kitai, Takeshi] Natl Cerebral & Cardiovasc Ctr, Div Heart Failure, Suita, Osaka, Japan; [Iguchi, Moritake] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Nagao, Kazuya] Osaka Red Cross Hosp, Dept Cardiol, Osaka, Japan; [Kawase, Yuichi; Kadota, Kazushige] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan; [Morinaga, Takashi; Ando, Kenji] Kokura Mem Hosp, Dept Cardiol, Kokura, Japan; [Toyofuku, Mamoru] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan; [Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Sato, Yukihito] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan; [Kuwahara, Koichiro] Shinshu Univ, Dept Cardiovasc Med, Grad Sch Med, Nagano, Japan	Kyoto University; Hyogo College of Medicine; Tenri Hospital; National Cerebral & Cardiovascular Center - Japan; Osaka Red Cross Hospital; Kurashiki Central Hospital; Kokura Memorial Hospital; Kobe City Medical Center General Hospital; Shinshu University	Kato, T (corresponding author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan.	tkato75@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170; Kato, Takao/0000-0001-8213-7999; Yoshikawa, Yusuke/0000-0001-8082-2036				Bettencourt P, 2021, JACEP OPEN, V2, DOI 10.1002/emp2.12448; Cioffi G, 2005, EUR J HEART FAIL, V7, P1040, DOI 10.1016/j.ejheart.2004.11.003; Clerico A, 2015, CLIN CHIM ACTA, V443, P17, DOI 10.1016/j.cca.2014.06.003; Farmakis D, 2020, EUR HEART J, V41, P4050, DOI 10.1093/eurheartj/ehaa083; Franzini M, 2013, CLIN CHIM ACTA, V424, P287, DOI 10.1016/j.cca.2013.07.001; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Grodin JL, 2019, J CARD FAIL, V25, P703, DOI 10.1016/j.cardfail.2019.04.002; Hamatani Y, 2018, AM J CARDIOL, V121, P731, DOI 10.1016/j.amjcard.2017.12.012; Kagiyama N, 2019, J CARD FAIL, V25, P712, DOI 10.1016/j.cardfail.2019.04.004; Khanam SS, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0632-0; Madamanchi C, 2014, INT J CARDIOL, V176, P611, DOI 10.1016/j.ijcard.2014.08.007; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Perez-Rodon J, 2018, J CARDIOL, V71, P505, DOI 10.1016/j.jjcc.2017.10.019; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Pugliese NR, 2017, AM J CARDIOL, V119, P71, DOI 10.1016/j.amjcard.2016.09.018; Roberts E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h910; Salah K, 2019, HEART, V105, P1182, DOI 10.1136/heartjnl-2018-314173; Seko Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24875-1; Tsutsui H, 2019, CIRC J, V83, P2084, DOI 10.1253/circj.CJ-19-0342; Yaku H, 2018, CIRC J, V82, P2811, DOI 10.1253/circj.CJ-17-1386; Yamamoto E, 2017, ESC HEART FAIL, V4, P216, DOI 10.1002/ehf2.12138; Zhang J, 2018, INT J CARDIOL, V269, P196, DOI 10.1016/j.ijcard.2018.06.070; Zile MR, 2016, J AM COLL CARDIOL, V68, P2425, DOI 10.1016/j.jacc.2016.09.931	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263165	10.1371/journal.pone.0263165	http://dx.doi.org/10.1371/journal.pone.0263165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089974	Green Published, gold			2022-12-26	WOS:000769158400042
J	Bahl, A; Hijazi, M; Chen, NW				Bahl, Amit; Hijazi, Mahmoud; Chen, Nai-Wei			Vesicant infusates are not associated with ultrasound-guided peripheral intravenous catheter failure: A secondary analysis of existing data	PLOS ONE			English	Article							COMPLICATIONS	Background Intravenous vesicants are commonly infused via peripheral intravenous catheters (PIVC) despite guidelines recommending administration via central route. The impact of these medications on PIVC failure is unclear. We aimed to assess dose-related impact of these caustic medications on ultrasound-guided (US) PIVC survivorship. Methods We performed a secondary analysis of a randomized control trial that compared survival of two catheters: a standard long (SL) and an ultra-long (UL) US PIVC. This study involved reviewing and recording all vesicants infusions through the PIVCs. Type and number of vesicants doses were extracted and characterized as one, two or multiple. The most commonly used vesicants were individually categorized for further analysis. The primary outcome was PIVC failure accounting for use and timing of vesicant infusates. Results Between October 2018 and March 2019, 257 subjects were randomized with 131 in the UL group and 126 in the SL group. Vesicants were infused in 96 (37.4%) out of 257 study participants. In multivariable time-dependent extended Cox regression analysis, there was no significant increased risk of failure due to vesicant use [adjusted hazard ratio, aHR 1.71 (95% CI 0.76-1.81) p = 0.477]. The number of vesicant doses was not significantly associated with the increased risk of PIVC failure [(1 vs 0) aHR 1.20 (95% CI 0.71-2.02) p = 0.500], [(2 vs 0) aHR 1.51 (95% CI 0.67-3.43) p = 0.320] and [(>= 3 vs 0) aHR 0.98 (95% CI 0.50-1.92) p = 0.952]. Conclusion Vesicant usage did not significantly increase the risk of PIVC failure even when multiple doses were needed in this investigation. Ultrasound-guided PIVCs represent a pragmatic option when vesicant therapy is anticipated. Nevertheless, it is notable that overall PIVC failure rates remain high and other safety events related to vesicant use should be considered when clinicians make vascular access decisions for patients.	[Bahl, Amit] Beaumont Hosp, Dept Emergency Med, Royal Oak, MI 48073 USA; [Hijazi, Mahmoud] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Chen, Nai-Wei] Beaumont Hosp, Dept Biostat, Royal Oak, MI USA	Beaumont Health; Oakland University; Beaumont Health	Bahl, A (corresponding author), Beaumont Hosp, Dept Emergency Med, Royal Oak, MI 48073 USA.	Amit.bahl@beaumont.edu	Bahl, Amit/I-8144-2019	Bahl, Amit/0000-0001-9495-1293				Alexandrou E., 2018, J HOSP MED, V13, DOI 10.12788/jhm.3039; Bahl A, 2020, ANN EMERG MED, V76, P134, DOI 10.1016/j.annemergmed.2019.11.013; Caparas JV, 2014, J VASC ACCESS, V15, P251, DOI 10.5301/jva.5000220; Cardenas-Garcia J, 2015, J HOSP MED, V10, P581, DOI 10.1002/jhm.2394; Costantino TG, 2005, ANN EMERG MED, V46, P456, DOI 10.1016/j.annemergmed.2004.12.026; Dick-Perez R, AM COLL EMERGENCY PH; Doellman D, 2009, J INFUS MURS, V32, P203, DOI 10.1097/NAN.0b013e3181aac042; Doyle GR., 2015, INTRAVENOUS FLUID TH; Gorski Lisa A, 2021, J Infus Nurs, V44, pS1, DOI 10.1097/NAN.0000000000000396; Greig JM, 2002, QJM-INT J MED, V95, P412, DOI 10.1093/qjmed/95.6.412; Hadaway L, 2012, J INFUS MURS, V35, P230, DOI 10.1097/NAN.0b013e31825af099; Hawes ML, 2007, J INFUS MURS, V30, P33, DOI 10.1097/00129804-200701000-00006; Helm RE, 2019, J INFUS MURS, V42, P149, DOI 10.1097/NAN.0000000000000324; Jones RK, 2018, J INFUS MURS, V41, P365, DOI 10.1097/NAN.0000000000000303; Kache S, 2022, J VASC ACCESS, V23, P50, DOI 10.1177/1129729820974259; Keleekai NL, 2016, SIMUL HEALTHC, V11, P376, DOI 10.1097/SIH.0000000000000186; Lewis T, 2019, J INTENSIVE CARE MED, V34, P26, DOI 10.1177/0885066616686035; Lim S, 2019, INQUIRY-J HEALTH CAR, V56, DOI 10.1177/0046958019875562; Loubani OM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.01.014; Medlej K, 2018, J EMERG MED, V54, P47, DOI 10.1016/j.jemermed.2017.09.007; Moureau N., 2016, J ASS VASCULAR ACCES, V21, P140; Mowry JL, 2011, WESTERN J NURS RES, V33, P457, DOI 10.1177/0193945910380212; Rupp ME., 2017, OPEN FORUM INFECT DI, V4; Spiegel RJ, 2020, ANN EMERG MED, V75, P538, DOI 10.1016/j.annemergmed.2019.09.018; Tian DH, 2020, EMERG MED AUSTRALAS, V32, P220, DOI 10.1111/1742-6723.13406; Wallis MC, 2014, INFECT CONT HOSP EP, V35, P63, DOI 10.1086/674398	26	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262793	10.1371/journal.pone.0262793	http://dx.doi.org/10.1371/journal.pone.0262793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085318	gold, Green Published			2022-12-26	WOS:000779379600083
J	Obara, K; Shirai, K; Hamada, Y; Arakawa, N; Yamane, M; Takaoka, N; Aki, R; Hoffman, RM; Amoh, Y				Obara, Koya; Shirai, Kyoumi; Hamada, Yuko; Arakawa, Nobuko; Yamane, Michiko; Takaoka, Nanako; Aki, Ryoichi; Hoffman, Robert M.; Amoh, Yasuyuki			Chronic spinal cord injury functionally repaired by direct implantation of encapsulated hair-follicle-associated pluripotent (HAP) stem cells in a mouse model: Potential for clinical regenerative medicine	PLOS ONE			English	Article							BULGE AREA; EXPRESSION; RECOVERY; TRANSPLANTATION; DIFFERENTIATE; GENERATION	Chronic spinal cord injury (SCI) is a highly debilitating and recalcitrant disease with limited treatment options. Although various stem cell types have shown some clinical efficacy for injury repair they have not for SCI. Hair-follicle-associated pluripotent (HAP) stem cells have been shown to differentiate into neurons, Schwan cells, beating cardiomyocytes and many other type of cells, and have effectively regenerated acute spinal cord injury in mouse models. In the present report, HAP stem cells from C57BL/6J mice, encapsulated in polyvinylidene fluoride membranes (PFM), were implanted into the severed thoracic spinal cord of C57BL/6J or athymic nude mice in the early chronic phase. After implantation, HAP stem cells differentiated to neurons, astrocytes and oligodendrocytes in the regenerated thoracic spinal cord of C57BL/6J and nude mice. Quantitative motor function analysis, with the Basso Mouse Scale for Locomotion (BMS) score, demonstrated a significant functional improvement in the HAP-stem-cell-implanted mice, compared to non-implanted mice. HAP stem cells have critical advantages over other stem cells: they do not develop teratomas; do not loose differentiation ability when cryopreserved and thus are bankable; are autologous, readily obtained from anyone; and do not require genetic manipulation. HAP stem cells therefore have greater clinical potential for SCI repair than induced pluripotent stem cells (iPSCs), neuronal stem cells (NSCs)/neural progenitor cells (NPCs) or embryonic stem cells (ESCs). The present report demonstrates future clinical potential of HAP-stem-cell repair of chronic spinal cord injury, currently a recalcitrant disease.	[Obara, Koya; Shirai, Kyoumi; Hamada, Yuko; Arakawa, Nobuko; Yamane, Michiko; Takaoka, Nanako; Aki, Ryoichi; Amoh, Yasuyuki] Kitasato Univ, Dept Dermatol, Sch Med, Sagamihara, Kanagawa, Japan; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Kitasato University; Anti Cancer Inc; University of California System; University of California San Diego	Amoh, Y (corresponding author), Kitasato Univ, Dept Dermatol, Sch Med, Sagamihara, Kanagawa, Japan.; Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.; Hoffman, RM (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	all@anticancer.com; yasuyukiamoh@aol.com			JSPS KAKENHI [JP19K17815]; Kitasato University; Parents Association Grant of Kitasato University, School of Medicine	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University; Parents Association Grant of Kitasato University, School of Medicine	The authors disclosed receipt of the following financial support for the research and authorship of this article: This work was partially supported by JSPS KAKENHI Grant Number JP19K17815, Kitasato University Research Grant for Young Researchers and the Parents Association Grant of Kitasato University, School of Medicine (to K. Obara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116933; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2012, CELL CYCLE, V11, P3513, DOI 10.4161/cc.21803; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Curtis E, 2018, CELL STEM CELL, V22, P941, DOI 10.1016/j.stem.2018.05.014; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Holmes D, 2017, NATURE, V552, pS50, DOI 10.1038/d41586-017-07551-8; Iwai H, 2014, CELL TRANSPLANT, V23, P1451, DOI 10.3727/096368913X670967; Kajiura S, 2015, TISSUE ENG PART C-ME, V21, P825, DOI [10.1089/ten.tec.2014.0500, 10.1089/ten.TEC.2014.0500]; Kawabata S, 2016, STEM CELL REP, V6, P1, DOI 10.1016/j.stemcr.2015.11.013; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kuhl E, 2018, BIOPHYS J, V115, P751, DOI 10.1016/j.bpj.2018.04.052; Kumamaru H, 2013, STEM CELLS, V31, P1535, DOI 10.1002/stem.1404; Kusano K, 2010, BIOCHEM BIOPH RES CO, V393, P812, DOI 10.1016/j.bbrc.2010.02.088; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Nishimura S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-3; Obara K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45740-9; Obara K, 2019, STEM CELL REV REP, V15, P59, DOI 10.1007/s12015-018-9856-3; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Strnadel J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6651; Tashiro S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30898; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Wilcox JT, 2014, STEM CELL TRANSL MED, V3, P1148, DOI 10.5966/sctm.2014-0029; Yamane M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040864; Yamazaki A, 2017, CELL CYCLE, V16, P1927, DOI 10.1080/15384101.2017.1363941; Yamazaki A, 2016, CELL CYCLE, V15, P760, DOI 10.1080/15384101.2016.1146837; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yashiro M, 2015, CELL CYCLE, V14, P2362, DOI 10.1080/15384101.2015.1042633; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262755	10.1371/journal.pone.0262755	http://dx.doi.org/10.1371/journal.pone.0262755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085322	Green Published, gold			2022-12-26	WOS:000779379600079
J	Divorty, N; Jenkins, L; Ganguly, A; Butcher, AJ; Hudson, BD; Schulz, S; Tobin, AB; Nicklin, SA; Milligan, G				Divorty, Nina; Jenkins, Laura; Ganguly, Amlan; Butcher, Adrian J.; Hudson, Brian D.; Schulz, Stefan; Tobin, Andrew B.; Nicklin, Stuart A.; Milligan, Graeme			Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ARRESTIN RECRUITMENT; SELECTIVE AGONISTS; IDENTIFICATION; MECHANISM; DETERMINES; BIOSENSOR; BINDING; SITES	G protein-coupled receptor 35 (GPR35) is poorly charac-terized but nevertheless has been revealed to have diverse roles in areas including lower gut inflammation and pain. The development of novel reagents and tools will greatly enhance analysis of GPR35 functions in health and disease. Here, we used mass spectrometry, mutagenesis, and [P-32] orthophosphate labeling to identify that all five hydroxy-amino acids in the C-terminal tail of human GPR35a became phosphorylated in response to agonist occupancy of the receptor and that, apart from Ser(294), each of these contributed to interactions with arretin-3, which inhibits further G protein-coupled receptor signaling. We found that Ser(303) was key to such interactions; the serine corresponding to human GPR35a residue 303 also played a dominant role in arrestin-3 interactions for both mouse and rat GPR35. We also demonstrated that fully phospho-site-deficient mutants of human GPR35a and mouse GPR35 failed to interact effectively with arrestin-3, and the human phospho-deficient variant was not internalized from the surface of cells in response to agonist treatment. Even in cells stably expressing species orthologues of GPR35, a substantial proportion of the expressed protein(s) was determined to be immature. Finally, phospho-site-specific antisera targeting the region encompassing Ser(303) in human (Ser(301) in mouse) GPR35a identified only the mature forms of GPR35 and provided effective sensors of the activation status of the receptors both in immunoblotting and immunocytochemical studies. Such antisera may be useful tools to evaluate target engagement in drug discovery and target validation programs.	[Divorty, Nina; Jenkins, Laura; Ganguly, Amlan; Hudson, Brian D.; Tobin, Andrew B.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow, Lanark, Scotland; [Divorty, Nina; Nicklin, Stuart A.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Butcher, Adrian J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Schulz, Stefan] 7TM Antibodies GmbH, Jena, Germany; [Schulz, Stefan] Univ Hosp Jena, Inst Pharmacol & Toxicol, Jena, Germany	University of Glasgow; University of Glasgow; University of Cambridge; Friedrich Schiller University of Jena	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk		Ganguly, Amlan/0000-0002-2507-022X; Jenkins, Laura/0000-0003-1382-8547	Biotechnology and Biosciences Research Council [BB/P000649/1, BB/P00069X/1]; British Heart Foundation [RE/13/5/30177/]; Wellcome Trust [099787/Z/12/Z/]; Commonwealth Scholarship [BDCA2019-6]	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Commonwealth Scholarship	These studies were supported by Biotechnology and Biosciences Research Council grants BB/P000649/1 (to G. M.) and BB/P00069X/1 (to A. B. T.) and the British Heart Foundation (RE/13/5/30177/) (S. A. N.). N. D. was supported by a Wellcome Trust studentship (099787/Z/12/Z/) and A. G. by a Commonwealth Scholarship (reference number BDCA2019-6).	Alexander S. P. H., 2019, CONCISE GUIDE PHARM; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Aydin Y, 2021, FEBS J, V288, P2529, DOI 10.1111/febs.15811; Bouzo-Lorenzo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22495; Bradley SJ, 2020, NAT CHEM BIOL, V16, P240, DOI 10.1038/s41589-019-0453-9; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Butcher AJ, 2016, J BIOL CHEM, V291, P8862, DOI 10.1074/jbc.M115.681726; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Che T, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.aav0320; Fang Y, 2007, SENSORS-BASEL, V7, P2316, DOI 10.3390/s7102316; Fernandez TJ, 2020, PROTEIN SCI, V29, P1345, DOI 10.1002/pro.3872; Funke M, 2013, J MED CHEM, V56, P5182, DOI 10.1021/jm400587g; Grundmann M, 2017, HANDB EXP PHARMACOL, V238, P339, DOI 10.1007/164_2015_42; Gurevich VV, 2020, PHARMACOL THERAPEUT, V211, DOI 10.1016/j.pharmthera.2020.107540; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Jenkins L, 2012, J PHARMACOL EXP THER, V343, P683, DOI 10.1124/jpet.112.198945; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Latorraca NR, 2020, CELL, V183, P1813, DOI 10.1016/j.cell.2020.11.014; Latorraca NR, 2018, NATURE, V557, P452, DOI 10.1038/s41586-018-0077-3; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lowe JD, 2015, MOL PHARMACOL, V88, P347, DOI 10.1124/mol.115.098293; Mackenzie A. E., 2014, MOL; Mackenzie AE, 2019, FASEB J, V33, P5005, DOI 10.1096/fj.201801956R; Marti-Solano M, 2020, NATURE, V587, P650, DOI 10.1038/s41586-020-2888-2; McCallum JE, 2015, J VASC RES, V52, P383, DOI 10.1159/000444754; Milligan G, 2018, BRIT J PHARMACOL, V175, P2543, DOI 10.1111/bph.14042; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Milligan G, 2011, TRENDS PHARMACOL SCI, V32, P317, DOI 10.1016/j.tips.2011.02.002; Neetoo-Isseljee Z, 2013, J PHARMACOL EXP THER, V344, P568, DOI 10.1124/jpet.112.201798; Park JY, 2016, ARCH PHARM RES, V39, P293, DOI 10.1007/s12272-016-0712-1; Perez-Riverol Y., 2019, PRIDE DATABASE RELAT; Plouffe B., 2016, MAPPING PHYSIOLOGICA; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Quon T, 2020, ACS PHARMACOL TRANSL, V3, P801, DOI 10.1021/acsptsci.0c00079; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Seyedabadi M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020218; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Southern C, 2013, J BIOMOL SCREEN, V18, P599, DOI 10.1177/1087057113475480; Sulon Sarah M, 2021, Curr Opin Endocr Metab Res, V16, P56, DOI 10.1016/j.coemr.2020.09.002; Sun YV, 2008, GENET EPIDEMIOL, V32, P350, DOI 10.1002/gepi.20309; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Wei L, 2018, ACS MED CHEM LETT, V9, P422, DOI 10.1021/acsmedchemlett.7b00510; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Zhao P., 2010, TARGETING ORPHAN REC; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zindel D, 2016, BIOCHEM J, V473, P4173, DOI 10.1042/BCJ20160740	57	5	5	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101655	10.1016/j.jbc.2022.101655	http://dx.doi.org/10.1016/j.jbc.2022.101655			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101446	gold, Green Published, Green Accepted			2022-12-26	WOS:000794865600004
J	Li, FX; Yu, X; Lv, JM; Wu, QX; An, YL				Li, Fanxi; Yu, Xia; Lv, Jiemei; Wu, Qixin; An, Yanling			Assessment of heavy metal pollution in surface sediments of the Chishui River Basin, China	PLOS ONE			English	Article							ECOLOGICAL RISK; CONTAMINATION; WATER	Accumulated heavy metals in surface sediments are released into the aquatic environment, causing secondary contamination of the hydrosphere, and increasing the risks to human health. To evaluate the pollution characteristics of heavy metals in the sediments of the Chishui River Basin, in the present study, the concentrations of five heavy metals in surface sediments of the Chishui River Basin in China were investigated using the geo-accumulation index, pollution load index, and potential ecological risk indexes. These indexes evaluated the degree of contamination and the influence of human activities on heavy metal levels in the basin. Cu, Zn, Cd, Hg, and As were found at concentrations of 5.12-120.40, 36.01-219.31, 0.03-1.28, 0.01-1.18, and 1.56-11.59 mg kg(-1), respectively, with mean values of 37.43, 91.92, 0.25, 0.07, and 5.16 mg kg(-1), respectively, in the order Zn > Cu > As > Cd > Hg. The contamination indices revealed Hg as the principal pollutant based on the spatial distribution, while Pearson's correlation coefficients suggested that Cu, Zn, and As originated from a similar source. Hg had a different source from the other metals, whereas Cd originated from a different source compared with that of Zn, As, and Hg. This paper showed a Hg and Cd contamination in the Chishui River Basin.	[Li, Fanxi] Guizhou Univ, Key Lab Karst Environm & Geohazard Prevent, Guiyang, Guizhou, Peoples R China; [Yu, Xia; Lv, Jiemei; An, Yanling] Guizhou Inst Technol, Coll Resources & Environm Engn, Guiyang, Guizhou, Peoples R China; [Yu, Xia; Wu, Qixin; An, Yanling] Guizhou Univ, Coll Resources & Environm Engn, Guiyang, Guizhou, Peoples R China; [Yu, Xia] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Shaanxi, Peoples R China	Guizhou University; Guizhou Institute of Technology; Guizhou University; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Yu, X; An, YL (corresponding author), Guizhou Inst Technol, Coll Resources & Environm Engn, Guiyang, Guizhou, Peoples R China.; Yu, X; An, YL (corresponding author), Guizhou Univ, Coll Resources & Environm Engn, Guiyang, Guizhou, Peoples R China.; Yu, X (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Shaanxi, Peoples R China.	yuxia@git.edu.cn; anyanling@git.edu.cn			Open Fund of the State Key Laboratory of Loess and Quaternary Geology [SKLLQG2036]; Chinese Academy of Sciences Strategic Leading Science and Technology Project (Category B) [XDB40000000]; Guizhou Institute of Technology High-level Talent Research Startup Funding Project [2019, 45]; Science and Technology Program of Guizhou Province (Guizhou Science and Technology Cooperation Support) [2018, 20101]; Science and Technology Foundation of Water Resources Department of Guizhou Province [KT201508]	Open Fund of the State Key Laboratory of Loess and Quaternary Geology; Chinese Academy of Sciences Strategic Leading Science and Technology Project (Category B); Guizhou Institute of Technology High-level Talent Research Startup Funding Project; Science and Technology Program of Guizhou Province (Guizhou Science and Technology Cooperation Support); Science and Technology Foundation of Water Resources Department of Guizhou Province	This study was funded by the Open Fund of the State Key Laboratory of Loess and Quaternary Geology [grant number SKLLQG2036], the Chinese Academy of Sciences Strategic Leading Science and Technology Project (Category B) [grant number XDB40000000], the Guizhou Institute of Technology High-level Talent Research Startup Funding Project [grant number 2019, 45], the Science and Technology Program of Guizhou Province (Guizhou Science and Technology Cooperation Support [grant number 2018, 20101]), and the Science and Technology Foundation of Water Resources Department of Guizhou Province [grant number KT201508]. The funder 1(Yanling An) provided financial assistance in our study design, data collection and analysis, funder 2(Peng Cheng) helped us analyze the articles and play a significant role in the polishing of this paper.	Al-Mutairi KA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062798; Alan T, 1993, ELSEV, V271; Arisekar U, 2020, MAR POLLUT BULL, V159, DOI 10.1016/j.marpolbul.2020.111496; Bartoli G, 2012, J ENVIRON MANAGE, V95, pS9, DOI 10.1016/j.jenvman.2011.02.013; Bhuyan MS, 2017, ENVIRON SCI POLLUT R, V24, P27587, DOI 10.1007/s11356-017-0204-y; Cai SW, 2017, INT J ENVIRON RES, V11, P125, DOI 10.1007/s41742-017-0013-7; Cao W. X., 2000, RESOUR ENV YANGTZE B, V9, P131; Dai Jing, 2021, Huanjing Huaxue-Environmental Chemistry, V40, P1795, DOI 10.7524/j.issn.0254-6108.2020020403; [方明 Fang Ming], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P563; Fuentes-Gandara F, 2021, MAR POLLUT BULL, V167, DOI 10.1016/j.marpolbul.2021.112271; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Herath D, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-7016-5; [黄真理 Huang Zhenli], 2003, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V12, P332; Islam MS, 2015, ENVIRON TOXICOL PHAR, V39, P347, DOI 10.1016/j.etap.2014.12.009; Ji Y., 2012, GZ CHEM INDU, P5; Jiang H, 2013, 14 ANN C CHINESE SOC; Kashif A., 2020, ENVIRON TECHNOL INNO; Kukrer S, 2014, ENVIRON MONIT ASSESS, V186, P3847, DOI 10.1007/s10661-014-3662-4; [李佳宣 Li Jiaxuan], 2010, [地球与环境, Earth and Environment], V38, P481; [罗进 Luo Jin], 2014, [地球与环境, Earth and Environment], V42, P297; Lv J, 2013, 14 ANN C CHINESE SOC; Malvandi H, 2017, MAR POLLUT BULL, V117, P547, DOI 10.1016/j.marpolbul.2017.02.035; Merian E, 1991, METALS THEIR COMPOUN, DOI DOI 10.1002/9783527619634; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Patel P, 2018, ENVIRON GEOCHEM HLTH, V40, P609, DOI 10.1007/s10653-017-0006-7; Qiu L., 2013, PEOPLES RIVER, V44, P94; [任杰 Ren Jie], 2021, [地球与环境, Earth and Environment], V49, P416; [任晓冬 REN Xiao-dong], 2009, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V18, P97; San J., 2021, YANGTZ RIVER, P1; Song YX, 2011, CATENA, V85, P73, DOI 10.1016/j.catena.2010.12.009; Suresh G, 2012, ECOTOX ENVIRON SAFE, V84, P117, DOI 10.1016/j.ecoenv.2012.06.027; Wang A, 2011, J ANH AGR SCI, P31; [王方园 Wang Fangyuan], 2012, [环境化学, Environmental Chemistry], V31, P1328; Wu Jinming, 2010, Shengwu Duoyangxing, V18, P162, DOI 10.3724/SP.J.1003.2010.168; Wu Z., 2001, GUIZ ENV PROT TECH, P25; Xu S, 2020, J HYDROL, V591, DOI 10.1016/j.jhydrol.2020.125328; Yan M., 1995, GEOPHY GEOCHEM EXPLO, P468; Yu X.X., 2021, ENVIRONL SCI TECH, P1, DOI 10.11930/j.issn.1004-9649.202010049; Zou F, 2010, CHIN POP RES ENV, pS1; Zoumis T, 2001, SCI TOTAL ENVIRON, V266, P195, DOI 10.1016/S0048-9697(00)00740-3	40	3	3	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0260901	10.1371/journal.pone.0260901	http://dx.doi.org/10.1371/journal.pone.0260901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139087	Green Published, gold			2022-12-26	WOS:000821499100002
J	Yin, SS; Liu, JT; Han, ZL				Yin, Shusheng; Liu, Jiatong; Han, Zenglin			Relationship between urban morphology and land surface temperature-A case study of Nanjing City	PLOS ONE			English	Article							HEAT-ISLAND; VIEW	This study investigated the relationship between urban form and land surface temperature (LST) using the Multi-access Geographically Weighted Regression (MGWR) model. A case study on Nanjing City was conducted using building data, point-of-interest (POI) data, land use data, remote sensing data, and elevation data. The results show that the MGWR model can reveal the influence of altitude, urban green space, road, building height (BH), building density (BD) and POI on LST, with a superior fitting effect over the geographically weighted regression model. LST in Nanjing exhibits a significant spatial differentiation, and the distribution of LST hotspots is spatially consistent with the level of urban construction. In terms of the two-dimensional landscape pattern, LST decreases with altitude and increases with POI. In terms of the three-dimensional structure, building height has a positive correlation with LST. POI, urban roads, and urban buildings positively affect LST, while urban green space and altitude negatively affect LST. The results of this study were verified against existing findings. The LST of areas with high-rise and super high-rise buildings is lower than that of areas with mid-rise building, which can be attributed to the large number of shadow areas formed by high-rise and super high-rise buildings. A similar phenomenon was also observed between areas with medium- and high-density buildings. These findings provide a reference for urban architecture planning and can help to develop urban heat island adaptation strategies based on local conditions.	[Yin, Shusheng; Liu, Jiatong; Han, Zenglin] Liaoning Normal Univ, Sch Geog, Dalian, Liaoning, Peoples R China; [Yin, Shusheng; Han, Zenglin] Liaoning Normal Univ, Ctr Studies Marine Econ & Sustainable Dev, Dalian, Liaoning, Peoples R China	Liaoning Normal University; Liaoning Normal University	Yin, SS (corresponding author), Liaoning Normal Univ, Sch Geog, Dalian, Liaoning, Peoples R China.; Yin, SS (corresponding author), Liaoning Normal Univ, Ctr Studies Marine Econ & Sustainable Dev, Dalian, Liaoning, Peoples R China.	yinshusheng01@gmail.com			National Science Foundation [41976206]	National Science Foundation(National Science Foundation (NSF))	This material is partially based upon work supported by the National Science Foundation under Grant NO. 41976206. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the National Science Foundation.	Cao J, 2021, LANDSCAPE URBAN PLAN, V206, DOI 10.1016/j.landurbplan.2020.103979; Chao LY, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL089152; Chen DC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010309; Chen MX, 2020, J CLEAN PROD, V265, DOI 10.1016/j.jclepro.2020.121708; Fabeku B. B., 2018, Atmospheric and Climate Sciences, V8, P318, DOI 10.4236/acs.2018.83021; [古恒宇 Gu Hengyu], 2019, [地理研究, Geographical Research], V38, P1877; Guanghua Yan, 2019, SCI GEOGRAPHICA SINI, V39, P125, DOI [10.13249/j.cnki.sgs.2019.01.014, DOI 10.13249/J.CNKI.SGS.2019.01.014]; Guo AD, 2020, SUSTAIN CITIES SOC, V63, DOI 10.1016/j.scs.2020.102443; [韩贵锋 Han Guifeng], 2014, [生态学报, Acta Ecologica Sinica], V34, P4017; He BJ, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110584; He BJ, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101472; He BJ, 2019, SUSTAIN CITIES SOC, V44, P416, DOI 10.1016/j.scs.2018.10.049; He C, 2019, ENVIRON INT, V127, P573, DOI 10.1016/j.envint.2019.01.057; Hooker J, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.246; [胡召玲 Hu Zhaoling], 2020, [生态学报, Acta Ecologica Sinica], V40, P4137; Hui Wang, 2011, CHINESE J POPULATION; [李斌 Li Bin], 2017, [地理科学进展, Progress in Geography], V36, P585; Li D, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140570; Li YY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15095-1; Liu YX, 2018, LANDSCAPE URBAN PLAN, V180, P36, DOI 10.1016/j.landurbplan.2018.08.006; Lu Liu, 2019, B SOIL WATER CONSERV, V39, P260, DOI [10.13961/j.cnki.stbctb.2019.06.038, DOI 10.13961/J.CNKI.STBCTB.2019.06.038]; Luo X, 2021, J CLEAN PROD, V310, DOI 10.1016/j.jclepro.2021.127467; Mashhoodi B, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105118; OKE TR, 1981, J CLIMATOL, V1, P237, DOI 10.1002/joc.3370010304; Peng J, 2021, REMOTE SENS ENVIRON, V252, DOI 10.1016/j.rse.2020.112135; Qin Z., 2001, ACTA GEOGR SIN, V56, P456, DOI DOI 10.11821/XB200104009; Qingyan Meng., 2018, REMOTE SENSING TECHN, V33, P370, DOI [10.11873/J.ISSN.1004-0323.2018.2.0370, DOI 10.11873/J.ISSN.1004-0323.2018.2.0370]; Qiong Wu, 2020, CHANG LIUYU ZIYUAN Y, V29, P200, DOI [10.11870/cjlyzyyhj202001018, DOI 10.11870/CJLYZYYHJ202001018]; Scarano M, 2017, INT J REMOTE SENS, V38, P6910, DOI 10.1080/01431161.2017.1368099; [史新 Shi Xin], 2018, [遥感技术与应用, Remote Sensing Technology and Application], V33, P465; [宋挺 Song Ting], 2015, [遥感学报, Journal of Remote Sensing], V19, P451; Stewart ID, 2012, B AM METEOROL SOC, V93, P1879, DOI 10.1175/BAMS-D-11-00019.1; Stewart ID, 2011, INT J CLIMATOL, V31, P200, DOI 10.1002/joc.2141; [唐承丽 Tang Chengli], 2020, [地理科学, Scientia Geographica Sinica], V40, P657; Wan KKW, 2010, PROCEED, V43, P58, DOI [10.3182/20100329-3-PT-3006.00013, DOI 10.3182/20100329-3-PT-3006.00013, 10.3182/20100329-3-PT-2006.00013, DOI 10.3182/20100329-3-PT-2006.00013]; Weiqi Zhou, 2020, ACTA ECOL SIN, V40, P416, DOI [10.5846/stxb201902250353, DOI 10.5846/STXB201902250353]; [薛亚永 Xue Yayong], 2017, [地球与环境, Earth and Environment], V45, P500; Yang C, 2020, GEO-SPAT INF SCI, V23, P327, DOI 10.1080/10095020.2020.1834882; Yang J, 2021, SCI TOTAL ENVIRON, V795, DOI 10.1016/j.scitotenv.2021.148791; Yang J, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101487; Yang J, 2017, URBAN FOR URBAN GREE, V22, P1, DOI 10.1016/j.ufug.2017.01.002; Yaobin Liu., 2020, ECOLOGICAL EC, V36, P92; Zhang Yuan, 2020, Yingyong Shengtai Xuebao, V31, P1213, DOI 10.13287/j.1001-9332.202004.020; Zhang YJ, 2019, LANDSCAPE ECOL, V34, P681, DOI 10.1007/s10980-019-00794-y; Zhao JY, 2020, INT J REMOTE SENS, V41, P8963, DOI 10.1080/01431161.2020.1797216; Zhao Z.Q., 2016, J METEOROL ENV, V32, P102, DOI [10.3969/j.issn.1673-503X.2016.06.013, DOI 10.3969/J.ISSN.1673-503X.2016.06.013]; Zhao ZQ, 2017, ENERG BUILDINGS, V155, P282, DOI 10.1016/j.enbuild.2017.09.046; Zheng Z, 2019, PHYS CHEM EARTH, V110, P149, DOI 10.1016/j.pce.2019.01.008; Zhou B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04242-2; Zhou DC, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11010048	51	2	2	20	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0260205	10.1371/journal.pone.0260205	http://dx.doi.org/10.1371/journal.pone.0260205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139084	gold, Green Published			2022-12-26	WOS:000821499100001
J	Zhou, QH; Zhou, CJ; Wang, X				Zhou, Qihang; Zhou, Changjun; Wang, Xiao			Stock prediction based on bidirectional gated recurrent unit with convolutional neural network and feature selection	PLOS ONE			English	Article							ALGORITHM; MODEL; RNN	With the development of recent years, the field of deep learning has made great progress. Compared with the traditional machine learning algorithm, deep learning can better find the rules in the data and achieve better fitting effect. In this paper, we propose a hybrid stock forecasting model based on Feature Selection, Convolutional Neural Network and Bidirectional Gated Recurrent Unit (FS-CNN-BGRU). Feature Selection (FS) can select the data with better performance for the results as the input data after data normalization. Convolutional Neural Network (CNN) is responsible for feature extraction. It can extract the local features of the data, pay attention to more local information, and reduce the amount of calculation. The Bidirectional Gated Recurrent Unit (BGRU) can process the data with time series, so that it can have better performance for the data with time series attributes. In the experiment, we used single CNN, LSTM and GRU models and mixed models CNN-LSTM, CNN-GRU and FS-CNN-BGRU (the model used in this manuscript). The results show that the performance of the hybrid model (FS-CNN-BGRU) is better than other single models, which has a certain reference value.	[Zhou, Qihang; Zhou, Changjun] Zhejiang Normal Univ, Coll Math & Comp Sci, Jinhua, Zhejiang, Peoples R China; [Wang, Xiao] Zhejiang Normal Univ, Xingzhi Coll, Jinhua, Zhejiang, Peoples R China	Zhejiang Normal University; Zhejiang Normal University	Zhou, CJ (corresponding author), Zhejiang Normal Univ, Coll Math & Comp Sci, Jinhua, Zhejiang, Peoples R China.	zhou-chang231@163.com			National Natural Science Foundation of China [61672121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Nos.61672121).	Adeel A, 2017, COMPUT ELECTR ENG, V57, P336, DOI 10.1016/j.compeleceng.2016.11.005; Barak S, 2015, EXPERT SYST APPL, V42, P9221, DOI 10.1016/j.eswa.2015.08.010; Boer D, 2021, VISION RES, V180, P51, DOI [10.1016/j.visres.2020.12.002, DOI 10.1016/J.VISRES.2020.12.002]; Cao J., 2019, INT J COMMUN SYST INT J COMMUN SYST, V32, P1, DOI [10.1002/dac.3987, DOI 10.1002/DAC.3987]; Chen DQ, 2021, IEEE ACCESS, V9, P1321, DOI 10.1109/ACCESS.2020.3034551; Chen JX, 2019, IEEE ACCESS, V7, P118530, DOI 10.1109/ACCESS.2019.2936817; Chen SL, 2021, IEEE ACCESS, V9, P9066, DOI 10.1109/ACCESS.2020.3047109; Chen WL, 2018, DATA KNOWL ENG, V118, P14, DOI 10.1016/j.datak.2018.08.003; Chong E, 2017, EXPERT SYST APPL, V83, P187, DOI 10.1016/j.eswa.2017.04.030; Hajiabotorabi Z, 2019, EXPERT SYST APPL, V138, DOI 10.1016/j.eswa.2019.112842; Hoseinzade E, 2019, EXPERT SYST APPL, V129, P273, DOI 10.1016/j.eswa.2019.03.029; Huang GY, 2021, SCI TOTAL ENVIRON, V768, DOI 10.1016/j.scitotenv.2020.144516; Konecny J, 2016, IEEE J-STSP, V10, P242, DOI 10.1109/JSTSP.2015.2505682; Lee J, 2017, KSII T INTERNET INF, V11, P6038, DOI 10.3837/tiis.2017.12.019; Liang ZY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260014; Liu DR, 2020, EXPERT SYST, V37, DOI 10.1111/exsy.12511; Lu WJ, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/6622927; Lv YF, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11243006; Markovic I, 2017, SOFT COMPUT, V21, P5387, DOI 10.1007/s00500-016-2123-0; Meng F, 2021, OCEAN ENG, V234, DOI 10.1016/j.oceaneng.2021.108795; Minami S., 2018, J MATH FINANCE, V8, P58, DOI [10.4236/jmf.2018.81005, DOI 10.4236/JMF.2018.81005]; Pang SC, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13091860; Qiu JY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227222; Shi JH, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3054-4; Singh R, 2017, MULTIMED TOOLS APPL, V76, P18569, DOI 10.1007/s11042-016-4159-7; Song T, 2020, IEEE J-STARS, V13, P2853, DOI 10.1109/JSTARS.2020.2998461; Song T, 2020, J ATMOS OCEAN TECH, V37, P317, DOI 10.1175/JTECH-D-19-0168.1; Vidal A, 2020, EXPERT SYST APPL, V157, DOI 10.1016/j.eswa.2020.113481; Wang SH, 2020, NEURAL COMPUT APPL, V32, P665, DOI 10.1007/s00521-018-3924-0; Wu F, 2021, PATTERN RECOGN, V111, DOI 10.1016/j.patcog.2020.107632; Wu SL, 2019, IET IMAGE PROCESS, V13, P2744, DOI 10.1049/iet-ipr.2018.6588; Wu YX, 2019, PHYSICA A, V516, P114, DOI 10.1016/j.physa.2018.09.120; Xiao CL, 2020, NEURAL COMPUT APPL, V32, P5379, DOI 10.1007/s00521-019-04698-5; Yang YJ., 2020, COMPLEXITY; Yuan Y, 2018, IEEE ACCESS, V6, P5573, DOI 10.1109/ACCESS.2018.2796118; Zhang DH, 2021, FUTURE GENER COMP SY, V115, P872, DOI 10.1016/j.future.2020.10.009; Zhang W, 2020, WIREL COMMUN MOB COM, V2020, DOI 10.1155/2020/6686181; Zhao X, 2021, APPL ACOUST, V174, DOI 10.1016/j.apacoust.2020.107794; Zhou XZ, 2017, J AMB INTEL HUM COMP, V8, P861, DOI 10.1007/s12652-017-0514-4	39	1	1	10	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262501	10.1371/journal.pone.0262501	http://dx.doi.org/10.1371/journal.pone.0262501			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120138	Green Published, gold			2022-12-26	WOS:000789273600009
J	Jackson, KC; Short, CT; Toman, KR; Mietchen, MS; Lofgren, E				Jackson, Katelin C.; Short, Christopher T.; Toman, Kellan R.; Mietchen, Matthew S.; Lofgren, Eric		CDC MInD-Healthcare Program	Transient dynamics of infection transmission in a simulated intensive care unit	PLOS ONE			English	Article							REDUCTION; BACTERIA; MODELS	Healthcare-associated infections (HAIs) remain a serious public health problem. In previous work, two models of an intensive care unit (ICU) showed that differing population structures had markedly different rates of Staphylococcus aureus (MRSA) transmission. One explanation for this difference is the models having differing long-term equilbrium dynamics, resulting from different basic reproductive numbers, R-0. We find in this system however that this is not the case, and that both models had the same value for R-0. Instead, short-term, transient dynamics, characterizing a series of small, self-limiting outbreaks caused by pathogen reintroduction were responsible for the differences. These results show the importance of these short-term factors for disease systems where reintroduction events are frequent, even if they are below the epidemic threshold. Further, we examine how subtle changes in how a hospital is organized-or how a model assumes a hospital is organized-in terms of the admission of new patients may impact transmission rates. This has implications for both novel pathogens introduced into ICUs, such as Ebola, MERS or COVID-19, as well as existing healthcare-associated infections such as carbapenem-resistant Enterobacteriaceae.	[Jackson, Katelin C.; Short, Christopher T.; Mietchen, Matthew S.; Lofgren, Eric] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Toman, Kellan R.] Washington State Univ, Dept Math, Pullman, WA 99164 USA	Washington State University; Washington State University	Lofgren, E (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	Eric.Lofgren@wsu.edu		Mietchen, Matthew/0000-0002-1979-6374; Lofgren, Eric/0000-0003-2052-7240	Centers of Disease Control and Prevention [RFACK-17-001]	Centers of Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	CTS, MSM, ETL were funded by the Centers of Disease Control and Prevention RFACK-17-001-Modeling Infectious Diseases in Healthcare Program 191 (MInD-Healthcare).	Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Ballermann MA, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-32; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2010, J ROYAL SOC BIOL INT, V7, P875; Fuller RL, 2017, AM J MED QUAL, V32, P254, DOI 10.1177/1062860616640883; Goel MK., 2010, INT J AYURVEDA RES; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Khader K, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw247; Kim JJ, 2019, AM J INFECT CONTROL, V47, P661, DOI 10.1016/j.ajic.2018.11.016; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Kullar R, 2016, J ANTIMICROB CHEMOTH, V71, P576, DOI 10.1093/jac/dkv368; Lofgren ET, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2632-1; Lofgren ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130574; Lofgren ET, 2014, INFECT CONT HOSP EP, V35, P18, DOI 10.1086/674394; Maarleveld TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079345; Mietchen MS., 2019, MEDRXIV; Sickbert-Bennett EE, 2005, AM J INFECT CONTROL, V33, P67, DOI 10.1016/j.ajic.2004.08.005; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; van den Driessche P, 2008, LECT NOTES MATH, V1945, P159; van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002; Waite H., 1910, BIOMETRIKA, V7, P421; Westbrook JI, 2007, WORK OBSERVATION MET; Yang HM, 2014, BIOSYSTEMS, V126, P52, DOI 10.1016/j.biosystems.2014.10.002	25	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0260580	10.1371/journal.pone.0260580	http://dx.doi.org/10.1371/journal.pone.0260580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113884	gold, Green Published			2022-12-26	WOS:000823694700012
J	Bogdanic, N; Mocibob, L; Vidovic, T; Soldo, A; Begovac, J				Bogdanic, Nikolina; Mocibob, Loris; Vidovic, Toni; Soldo, Ana; Begovac, Josip			Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020	PLOS ONE			English	Article								Background During the initial phase of the COVID-19 pandemic, there was great enthusiasm for the use of azithromycin with or without hydroxychloroquine. Objectives We analyzed azithromycin consumption in Croatia in 2020 and compared this to the period 2017-2019. Methods Azithromycin consumption was evaluated using the IQVIA Adriatic d.o.o. database which collects data on azithromycin distribution from wholesale pharmacies to hospital and non-hospital pharmacies in Croatia. We analyzed data for the period from January 2017 to December 2020. Azithromycin distribution was measured as days of therapy (DOT) and reported as per 1000 inhabitants or per 1000 inhabitant-days. Results In the period 2017-2020, total azithromycin DOT in Croatia increased in 2017, 2018, 2019, and 2020 (1.76, 1.91, 1.91 and 2.01/1000 inhabitant-days, respectively). Non-hospital pharmacies received 2.18 times and hospital pharmacies 4.39 times more DOT units/1000 inhabitants of azithromycin in March 2020 compared to the average distribution rate in March 2017-2019. During the peak of the COVID-19 epidemic (November and December 2020) azithromycin distribution increased considerably in hospital (3.62 and 3.19 times, respectively) and non-hospital pharmacies (1.93 and 1.84 times, respectively) compared to the average consumption in the same months in 2017-2019. Conclusions Our data showed increased azithromycin distribution in the period 2017-2020 which indicates azithromycin overuse. Preliminary information on COVID-19 treatments with a desire to offer and try what is available even in the absence of strong scientific evidence may have influenced practices of antimicrobial prescriptions.	[Bogdanic, Nikolina; Mocibob, Loris; Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Vidovic, Toni; Soldo, Ana] Zagreb City Pharm, Zagreb, Croatia; [Begovac, Josip] Univ Zagreb, Sch Med, Zagreb, Croatia	University of Zagreb	Bogdanic, N (corresponding author), Univ Hosp Infect Dis, Zagreb, Croatia.	nikolinabogdanic@gmail.com						Alsan M, 2015, MED CARE, V53, P1066, DOI 10.1097/MLR.0000000000000440; Andreani J, 2020, MICROB PATHOGENESIS, V145, DOI 10.1016/j.micpath.2020.104228; Beovic B, 2020, J ANTIMICROB CHEMOTH, V75, P3386, DOI 10.1093/jac/dkaa326; De Francesco MA, 2021, J INFECTION, V82, pE4, DOI 10.1016/j.jinf.2021.01.009; European Centre for Disease Prevention and Control, 2019, SURV ANT RES EUR 201; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Gallotti R, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00994-6; Gautret P, MEDRXIV2020031620037; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Joint ECDC/WHO, EUR WEEKL INFL UPD; Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266; King LM, 2021, CLIN INFECT DIS, V73, pE652, DOI 10.1093/cid/ciaa1896; Langford BJ, 2021, CLIN MICROBIOL INFEC, V27, P520, DOI 10.1016/j.cmi.2020.12.018; Niburski K, 2020, J MED INTERNET RES, V22, DOI 10.2196/20044; Rawson TM, 2020, NAT REV MICROBIOL, V18, P409, DOI 10.1038/s41579-020-0395-y; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Sluggett JK, 2021, CLIN INFECT DIS, DOI [10.1093/cid/ciab241, DOI 10.1093/CID/CIAB241]; Sultana J, 2020, DRUG SAFETY, V43, P691, DOI 10.1007/s40264-020-00976-7; Tambic Andrasevic A, 2020, ANTIBIOTIC RESISTANC, V1st; The Agency for Medicinal Products and Medical Devices (HALMED), ANN REP DRUG UT 2019; The Agency for Medicinal Products and Medical Devices (HALMED), MED PROD UT CROAT 20	23	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263437	10.1371/journal.pone.0263437	http://dx.doi.org/10.1371/journal.pone.0263437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108332	Green Published, Green Submitted, gold			2022-12-26	WOS:000775890100070
J	Meyer, N; Niemand, T; Davila, A; Kraus, S				Meyer, Natanya; Niemand, Thomas; Davila, Andres; Kraus, Sascha			Biting the bullet: When self-efficacy mediates the stressful effects of COVID-19 beliefs	PLOS ONE			English	Article							INFORMATION-SEEKING; HEALTH; EMPOWERMENT; SEX	The impact that COVID-19 had on individuals globally has been immense. Our study aims to determine if the various COVID-19 related beliefs (information seeking; invulnerability; disruption; health importance and response effectiveness) are predictors of perceived stress and if self-efficacy acts as a mediator in reducing perceived COVID-19 related stress. From a large sample of 23,629, data were assessed using validated multi-item measures for seven COVID-19 related beliefs, self-efficacy and perceived stress. After conducting a series of tests and checks via Confirmatory Factor Analyses, linear modelling and mediation analyses with bootstrapping were applied to test direct and mediation hypotheses. It is found that stress perception is most strongly affected by self-efficacy and perceived disruption. Except for information seeking, which positively affected perceived stress, self-efficacy partially mediates all other COVID-19 related beliefs (perceptions of disruption, health importance and response effectiveness) in conjunction with their direct effects. Only perceived invulnerability elicited opposite effects on stress, increasing stress directly but decreasing stress indirectly by increasing self-efficacy. This finding gives reason to believe that individuals may disclose that they are less vulnerable to COVID-19, fostering their self-efficacy, but still accept that stressing factors such as economic and social consequences apply. Overall, reinforcing self-efficacy was carved out as the most important resilience factor against perceiving high levels of stress. On this basis, implications for research and practice are provided.	[Meyer, Natanya; Kraus, Sascha] Univ Johannesburg, Dept Business Management, DHET NRF SARChI Entrepreneurship Educ, Auckland Pk, South Africa; [Niemand, Thomas] Tech Univ Clausthal, Inst Management & Econ, Dept Market Res, Clausthal Zellerfeld, Germany; [Davila, Andres] Ecole Supr Commerce Exterieur & Praditus SAS, ESCE Int Business Sch, Paris, France; [Kraus, Sascha] Free Univ Bozen Bolzano, Fac Econ & Management, Bolzano, Italy	University of Johannesburg; TU Clausthal; Free University of Bozen-Bolzano	Kraus, S (corresponding author), Univ Johannesburg, Dept Business Management, DHET NRF SARChI Entrepreneurship Educ, Auckland Pk, South Africa.; Kraus, S (corresponding author), Free Univ Bozen Bolzano, Fac Econ & Management, Bolzano, Italy.	sascha.kraus@zfke.de	; Meyer, Natanya/T-9821-2017	Kraus, Sascha/0000-0003-4886-7482; Meyer, Natanya/0000-0003-3296-7374				Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; ANESHENSEL CS, 1992, ANNU REV SOCIOL, V18, P15, DOI 10.1146/annurev.so.18.080192.000311; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1986, SOCIAL FDN THOUGHT A; Brashers DE, 2002, HUM COMMUN RES, V28, P258, DOI 10.1093/hcr/28.2.258; Brashers DE, 2001, J COMMUN, V51, P477, DOI 10.1111/j.1460-2466.2001.tb02892.x; Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171; Cambridge Dictionary, 2021, MEAN DISR; Carney AK, 2021, GERONTOLOGIST, V61, P30, DOI 10.1093/geront/gnaa106; Case D. O., 2007, LOOKING INFORM SURVE; CDC, 2021, COP STRESS; Chemers MM, 2001, J EDUC PSYCHOL, V93, P55, DOI 10.1037//0022-0663.93.1.55; CHEN PY, 1991, J APPL PSYCHOL, V76, P398, DOI 10.1037/0021-9010.76.3.398; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Cohen S, 1994, PERCEIVED STRESS SCA; Cullen W, 2020, QJM-INT J MED, V113, P311, DOI 10.1093/qjmed/hcaa110; Elliott G., 2021, RES MATTERS; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Gerend MA, 2008, ANN BEHAV MED, V35, P221, DOI 10.1007/s12160-008-9024-0; Gmelch W., 1993, COPING FACUKTY STRES; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Holahan C., 1996, HDB COPING THEORY RE, V1st; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Johnson JD, 1997, CANC RELATED INFORM; JONES AP, 1980, J MARRIAGE FAM, V42, P367, DOI 10.2307/351234; Karademas EC, 2004, PERS INDIV DIFFER, V37, P1033, DOI 10.1016/j.paid.2003.11.012; Keller A, 2012, HEALTH PSYCHOL, V31, P677, DOI 10.1037/a0026743; Kuang JY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197177; Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199; Lathabhavan R, 2021, ASIAN J PSYCHIATR, V64, DOI 10.1016/j.ajp.2021.102774; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus R.S., 1966, PSYCHOL STRESS COPIN; LIVINGSTON IL, 1988, STRESS MEDICINE, V4, P155, DOI 10.1002/smi.2460040308; Menaghan E., 1983, PSYCHOSOCIAL STRESS, P157; Meyer N., 2021, MENDELEY DATA, P1, DOI [10.17632/b8zxmw5z3g.1, DOI 10.17632/B8ZXMW5Z3G.1]; Miller BL, 2020, JAMA-J AM MED ASSOC, V324, P2255, DOI 10.1001/jama.2020.21332; Millstein SG, 2002, J RES ADOLESCENCE, V12, P399, DOI 10.1111/1532-7795.00039; Mo YY, 2021, J CLIN NURS, V30, P397, DOI 10.1111/jocn.15549; Moreno A, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.jul.02; Murthy RS, 2006, WORLD PSYCHIATRY, V5, P25; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Niemand T, 2018, J ACAD MARKET SCI, V46, P1148, DOI 10.1007/s11747-018-0602-9; Oh N, 2017, ASIAN NURS RES, V11, P230, DOI 10.1016/j.anr.2017.08.005; Pearlin L.I., 1983, PSYCHOSOCIAL STRESS, P3, DOI DOI 10.1016/B978-0-12-397560-7.50006-4; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Picou JS, 1992, ORGNA ENV, V6, P235, DOI [10.1177/108602669200600305, DOI 10.1177/108602669200600305]; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Prigge JK, 2015, INT J RES MARK, V32, P375, DOI 10.1016/j.ijresmar.2015.05.009; Rhodes SD, 2004, HEALTH EDUC RES, V19, P272, DOI 10.1093/her/cyg026; Ronkko M, 2022, ORGAN RES METHODS, V25, P6, DOI 10.1177/1094428120968614; Selye H, 1956, J BONE JOINT SURG; Shahrour G, 2020, J NURS MANAGE, V28, P1686, DOI 10.1111/jonm.13124; Spreitzer G. M., 2001, CO LEADERS 5 DISCIPL; SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Torres O., 2020, HLTH PERCEPTION FREN, P18; Vagni M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566912; van Empelen P, 2001, HEALTH EDUC RES, V16, P293, DOI 10.1093/her/16.3.293; Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795; WHO, 2020, WHO COR COVID 19 DAS; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742; World Health Organization (WHO), 2020, WHOEURO2020174441495; Worldometers, 2021, COVID LIV UPD; Yang ZJ, 2013, SCI COMMUN, V35, P189, DOI 10.1177/1075547012441873; Zajacova A, 2005, RES HIGH EDUC, V46, P677, DOI 10.1007/s11162-004-4139-z	67	12	15	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263022	10.1371/journal.pone.0263022	http://dx.doi.org/10.1371/journal.pone.0263022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089967	gold, Green Published			2022-12-26	WOS:000769158400034
J	Bonnet, R; Mariault, L; Peyron, JF				Bonnet, Raphael; Mariault, Lee; Peyron, Jean-Francois			Identification of potentially anti-COVID-19 active drugs using the connectivity MAP	PLOS ONE			English	Article								Drug repurposing can be an interesting strategy for an emergency response to the severe acute respiratory syndrome-coronavirus-2, (SARS-COV-2), the causing agent of the coronavirus disease-19 (COVID-19) pandemic. For this, we applied the Connectivity Map (CMap) bioinformatic resource to identify drugs that generate, in the CMap database, gene expression profiles (GEP) that negatively correlate with a SARS-COV-2 GEP, anticipating that these drugs could antagonize the deleterious effects of the virus at cell, tissue or organism levels. We identified several anti-cancer compounds that target MDM2 in the p53 pathway or signaling proteins: Ras, PKB beta, Nitric Oxide synthase, Rho kinase, all involved in the transmission of proliferative and growth signals. We hypothesized that these drugs could interfere with the high rate of biomass synthesis in infected cells, a feature shared with cancer cells. Other compounds including etomoxir, triacsin-c, PTB1-IN-3, are known to modulate lipid metabolism or to favor catabolic reactions by activating AMPK. Four different anti-inflammatory molecules, including dexamethasone, fluorometholone and cytosporone-b, targeting the glucocorticoid receptor, cyclooxygenase, or NUR77 also came out of the analysis. These results represent a first step in the characterization of potential repositioning strategies to treat SARS-COV-2.	[Bonnet, Raphael; Mariault, Lee; Peyron, Jean-Francois] Univ Cote dAzur, Nice, France; [Bonnet, Raphael; Mariault, Lee; Peyron, Jean-Francois] Ctr Mediterraneen Med Mol C3M, INSERM, U1065, Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Peyron, JF (corresponding author), Univ Cote dAzur, Nice, France.; Peyron, JF (corresponding author), Ctr Mediterraneen Med Mol C3M, INSERM, U1065, Nice, France.	peyron@unice.fr		Mariault, Lee/0000-0001-9836-6630; Bonnet, Raphael/0000-0003-2053-7019	Inserm; Ministere de l'Enseignement Supe'rieur, de la Recherche et de l'Innovation	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Enseignement Supe'rieur, de la Recherche et de l'Innovation	This work is supported by institutional funds from Inserm. RB was recipient of a PhD fellowship from the Ministere de l'Enseignement Supe ' rieur, de la Recherche et de l'Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi F, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104808; [Anonymous], 2021, CONTR ECFDPA; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9; Bonnet R, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.557643; Brunet A, 2016, EUR J IMMUNOL, V46, P2789, DOI 10.1002/eji.201646406; Cardozo CM, 2021, CURR OPIN ONCOL, V33, P149, DOI 10.1097/CCO.0000000000000713; Ciliberto G, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01590-2; Corsini E, 2021, ADV EXP MED BIOL, V1275, P151, DOI 10.1007/978-3-030-49844-3_6; Das S., 2020, RES SQ; Delahaye-Duriez A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1097-7; Dong HR, 2021, AGING-US, V13, P14234, DOI 10.18632/aging.203040; Duarte RRR, 2021, MOL MED, V27, DOI 10.1186/s10020-021-00356-6; Egarnes B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186639; Golob JL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.149187; Guimaraes LMF, 2021, NITRIC OXIDE-BIOL CH, V111, P64, DOI 10.1016/j.niox.2021.04.003; Gupta P, 2014, BBA-REV CANCER, V1846, P405, DOI 10.1016/j.bbcan.2014.08.003; Heimfarth L, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106947; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jang WD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024302118; Josset L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013169; Kamyshnyi O, 2021, BIOMED PHARMACOTHER, V144, DOI 10.1016/j.biopha.2021.112230; Dermani FK, 2021, J CELL PHYSIOL, V236, P7832, DOI 10.1002/jcp.30406; Khosravi M, 2022, PHARMACOPSYCHIATRY, V55, P16, DOI 10.1055/a-1551-3756; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lei YY, 2021, CIRC RES, V128, P1323, DOI 10.1161/CIRCRESAHA.121.318902; Leung SW, 2019, CANCERS, V11, DOI 10.3390/cancers11101482; Lobaina Yadira, 2019, Infectious Disorders - Drug Targets, V19, P2, DOI 10.2174/1871526518666180327124412; Melenotte C, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1807836; Mokou M, 2020, CANCERS, V12, DOI 10.3390/cancers12123519; Qu XYA, 2012, DRUG DISCOV TODAY, V17, P1289, DOI 10.1016/j.drudis.2012.07.017; Rana AK, 2021, CYTOKINE GROWTH F R, V58, P92, DOI 10.1016/j.cytogfr.2020.08.002; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Strauss RA, 2020, JACEP OPEN, V1, P685, DOI 10.1002/emp2.12131; Tang DL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008536; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Uva P, 2021, CANCERS, V13, DOI 10.3390/cancers13112809; Wang AL, 2021, J PERS MED, V11, DOI 10.3390/jpm11030175; Williams CG, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109479; Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7; Zenkova DK., 2019, phantasus: Visual and interactive gene expression analysis, DOI 10.18129/B9.bioc.phantasus; Zerbini LF, 2014, MOL CANCER THER, V13, P1929, DOI 10.1158/1535-7163.MCT-13-0750	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262751	10.1371/journal.pone.0262751	http://dx.doi.org/10.1371/journal.pone.0262751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085325	Green Published, gold			2022-12-26	WOS:000779379600078
J	Ly, HB; Nguyen, TA; Pham, BT				Hai-Bang Ly; Thuy-Anh Nguyen; Binh Thai Pham			Investigation on factors affecting early strength of high-performance concrete by Gaussian Process Regression	PLOS ONE			English	Article							COMPRESSIVE STRENGTH; NEURAL-NETWORKS; SILICA FUME; FLY-ASH; PREDICTION; DESIGN; HPC	This study aims to investigate the influence of all the mixture components of high-performance concrete (HPC) on its early compressive strength, ranging from 1 to 14 days. To this purpose, a Gaussian Process Regression (GPR) algorithm was first constructed using a database gathered from the available literature. The database included the contents of cement, blast furnace slag (BFS), fly ash (FA), water, superplasticizer, coarse, fine aggregates, and testing age as input variables to predict the output of the problem, which was the early compressive strength. Several standard statistical criteria, such as the Pearson correlation coefficient, root mean square error and mean absolute error, were used to quantify the performance of the GPR model. To analyze the sensitivity and influence of the HPC mixture components, partial dependence plots analysis was conducted with both one-dimensional and two-dimensional. Firstly, the results showed that the GPR performed well in predicting the early strength of HPC. Second, it was determined that the cement content and testing age of HPC were the most sensitive and significant elements affecting the early strength of HPC, followed by the BFS, water, superplasticizer, FA, fine aggregate, and coarse aggregate contents. To put it simply, this research might assist engineers select the appropriate amount of mixture components in the HPC production process to obtain the necessary early compressive strength.	[Hai-Bang Ly; Thuy-Anh Nguyen; Binh Thai Pham] Univ Transport Technol, Hanoi, Vietnam		Ly, HB (corresponding author), Univ Transport Technol, Hanoi, Vietnam.	banglh@utt.edu.vn	PHAM, BINH THAI/H-8316-2018	PHAM, BINH THAI/0000-0001-9707-840X				Agha M., 2018, INT J CIVIL ENG TECH, V9; Aitcin P.C., 1993, CONCR INT, V15, P21, DOI 10.1016/c2013-0-11102-6; Aitcin P. C., MODERN CONCRETE TECH; Pham AD, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000506; [Anonymous], 2006, 234R06 ACI, V96, P0; Asteris PG, 2021, SOFT COMPUT, V25, P6347, DOI 10.1007/s00500-021-05626-3; Asteris PG, 2020, NEURAL COMPUT APPL, V32, P11807, DOI 10.1007/s00521-019-04663-2; Chan YN, 2000, CEMENT CONCRETE RES, V30, P247, DOI 10.1016/S0008-8846(99)00240-9; Cheng MY, 2014, ENG APPL ARTIF INTEL, V29, P104, DOI 10.1016/j.engappai.2013.11.014; Chou JS, 2011, J COMPUT CIVIL ENG, V25, P242, DOI 10.1061/(ASCE)CP.1943-5487.0000088; Bui DK, 2018, CONSTR BUILD MATER, V180, P320, DOI 10.1016/j.conbuildmat.2018.05.201; Deepa C., 2010, INT J COMPUT APPL, V6, P18, DOI [10.5120/1076-1406, DOI 10.5120/1076-1406]; Dao DV, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12030830; Dao DV, 2020, CATENA, V188, DOI 10.1016/j.catena.2019.104451; Duce C, 2006, MACROMOL RAPID COMM, V27, P711, DOI 10.1002/marc.200600026; Duval R, 1998, CEMENT CONCRETE RES, V28, P533, DOI 10.1016/S0008-8846(98)00010-6; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; Gupta R, 2006, J MATER CIVIL ENG, V18, P462, DOI 10.1061/(ASCE)0899-1561(2006)18:3(462); Ly HB, 2021, CONSTR BUILD MATER, V301, DOI 10.1016/j.conbuildmat.2021.124081; Ly HB, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072709; KASPERKIEWICZ J, 1995, J COMPUT CIVIL ENG, V9, P279, DOI 10.1061/(ASCE)0887-3801(1995)9:4(279); Khosravi K, 2019, J HYDROL, V573, P311, DOI 10.1016/j.jhydrol.2019.03.073; Kopal I, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11061074; Laskar AI, 2011, MATER RES-IBERO-AM J, V14, P429, DOI [10.1590/S1516-14392011005000088, 10.1590/S1516-14392011000400001]; Ly HB, 2021, NEURAL COMPUT APPL, V33, P17331, DOI 10.1007/s00521-021-06321-y; Mannodi-Kanakkithodi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20952; Melda Yucel E.N., 2020, HIGH PERFORMANCE CON; Mustapha R., 2017, INT J ENG RES AFR, V07, P68, DOI [10.9790/9622-0701016875, DOI 10.9790/9622-0701016875]; Nguyen T.-A, 2021, COMPLEXITY, V2021; Nguyen TA, 2021, COMPLEXITY, V2021, DOI 10.1155/2021/6697923; Hoang ND, 2016, ADV CIV ENG, V2016, DOI 10.1155/2016/2861380; Nickisch H, 2008, J MACH LEARN RES, V9, P2035; Pala M, 2007, CONSTR BUILD MATER, V21, P384, DOI 10.1016/j.conbuildmat.2005.08.009; Paul Z., 1993, MECH BEHAV HIGH PERF, V1; Prasad BKR, 2009, CONSTR BUILD MATER, V23, P117, DOI 10.1016/j.conbuildmat.2008.01.014; Qi CC, 2021, CONSTR BUILD MATER, V284, DOI 10.1016/j.conbuildmat.2021.122857; Qi CC, 2019, MINER ENG, V133, P69, DOI 10.1016/j.mineng.2019.01.004; Rasmussen C.E, 1996, EVALUATION GAUSSIAN; Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4; Williams CKI, 1998, IEEE T PATTERN ANAL, V20, P1342, DOI 10.1109/34.735807; Yasin AK, 2017, IOP CONF SER-MAT SCI, V267, DOI 10.1088/1757-899X/267/1/012004; Yeh IC, 2009, EXPERT SYST APPL, V36, P5807, DOI 10.1016/j.eswa.2008.07.004; Yeh IC, 1999, J COMPUT CIVIL ENG, V13, P36, DOI 10.1061/(ASCE)0887-3801(1999)13:1(36); Yeh IC, 1998, J MATER CIVIL ENG, V10, P263, DOI 10.1061/(ASCE)0899-1561(1998)10:4(263); Yeh IC, 1998, CEMENT CONCRETE RES, V28, P1797, DOI 10.1016/S0008-8846(98)00165-3; Zain M. F. M., 2009, Journal of Applied Sciences, V9, P155, DOI 10.3923/jas.2009.155.160; Zarandi MHF, 2008, APPL SOFT COMPUT, V8, P488, DOI 10.1016/j.asoc.2007.02.010; ZHOU FP, 1995, CEMENT CONCRETE RES, V25, P177, DOI 10.1016/0008-8846(94)00125-I	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262930	10.1371/journal.pone.0262930	http://dx.doi.org/10.1371/journal.pone.0262930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085343	Green Published, gold			2022-12-26	WOS:000779379600098
J	Murayama, MA; Takada, E; Takai, K; Arimitsu, N; Shimizu, J; Suzuki, T; Suzuki, N				Murayama, Masanori A.; Takada, Erika; Takai, Kenji; Arimitsu, Nagisa; Shimizu, Jun; Suzuki, Tomoko; Suzuki, Noboru			Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; ACTIVATION; RESISTANCE; SMOKING; LIGANDS	Y The immune checkpoint molecules such as PD-L1 and PD-L2 have a substantial contribution to cancer immunotherapy including breast cancer. Microarray expression profiling identified several molecular subtypes, namely luminal-type (with a good-prognosis), HER2-type (with an intermediate-prognosis), and triple-negative breast cancer (TNBC)-type (with a poor-prognosis). We found that PD-L1 and PD-L2 mRNA expressions were highly expressed in TNBC-type cell lines (HCC1937, MDA-MB-231), moderately expressed in HER2-type cell line (SK-BR-3), and poorly expressed in luminal-type cell lines (MDA-MB-361, MCF7). The PD-L1 and PD-L2 expression in SK-BR-3 cells, but not those in HCC1937 and MDA-MB-231 cells, decreased by nicotine stimulation in a dose-dependent manner. In addition, nicotine treatment decreased the phosphorylation of Akt in SK-BR-3 cells, but not in other cell lines. These results show that nicotine regulates the expression of immune checkpoint molecules, PD-L1 and PD-L2, via inhibition of Akt phosphorylation. This findings may provide the new therapeutic strategies for the treatment of breast cancer.	[Murayama, Masanori A.; Takada, Erika; Takai, Kenji; Arimitsu, Nagisa; Shimizu, Jun; Suzuki, Tomoko; Suzuki, Noboru] St Marianna Univ, Dept Immunol & Med, Sch Med, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Murayama, Masanori A.] Kansai Med Univ, Inst Biomed Sci, Dept Anim Models Human Dis, Hirakata, Osaka, Japan	Saint Marianna University; Kansai Medical University	Suzuki, N (corresponding author), St Marianna Univ, Dept Immunol & Med, Sch Med, Miyamae Ku, Kawasaki, Kanagawa, Japan.	n3suzuki@marianna-u.ac.jp	Murayama, Masanori A/HHZ-8239-2022	Murayama, Masanori A/0000-0002-0049-0316	SRF (Tokyo, Japan)	SRF (Tokyo, Japan)	This work was supported in part by SRF (Tokyo, Japan, https://www.srf.or.jp/) to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdulkareem H, 2018, BREAST J, V24, P148, DOI 10.1111/tbj.12853; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bae SB, 2016, J BREAST CANCER, V19, P242, DOI 10.4048/jbc.2016.19.3.242; Baptista MZ, 2016, HUM PATHOL, V47, P78, DOI 10.1016/j.humpath.2015.09.006; Bardhan K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00550; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Choi J, 2020, AM J CANCER RES, V10, P2878; Dermani FK, 2019, J CELL PHYSIOL, V234, P1313, DOI 10.1002/jcp.27172; Duan WH, 2017, BREAST, V33, P117, DOI 10.1016/j.breast.2017.03.012; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; Nguyen HD, 2019, CANCERS, V11, DOI 10.3390/cancers11121991; Jabbarzadeh Kaboli Parham, 2020, Pharmacol Res, V156, P104806, DOI 10.1016/j.phrs.2020.104806; Jimenez T, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/5239419; Kim A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11905-7; Kobayashi Yoshie, 2018, Oncotarget, V9, P20979, DOI 10.18632/oncotarget.24761; Koker SC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208982; Lee CH, 2011, BREAST CANCER RES TR, V129, P331, DOI 10.1007/s10549-010-1209-0; Lee CH, 2010, JNCI-J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Liu JJ, 2013, CELL SIGNAL, V25, P447, DOI 10.1016/j.cellsig.2012.10.012; Liu SW, 2017, ONCOTARGET, V8, P99901, DOI 10.18632/oncotarget.21914; Machaalani R, 2014, TOXICOL APPL PHARM, V276, P204, DOI 10.1016/j.taap.2014.02.015; Mei D, 2015, BIOMATERIALS, V42, P52, DOI 10.1016/j.biomaterials.2014.11.044; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Rom-Jurek EM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020563; Spirina LV, 2020, B EXP BIOL MED+, V170, P75, DOI 10.1007/s10517-020-05007-0; Sun ZH, 2020, MAR DRUGS, V18, DOI 10.3390/md18040195; Sun ZH, 2020, MAR DRUGS, V18, DOI 10.3390/md18010061; Wang YT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00536; Xu YP, 2019, CELL REP, V29, P3435, DOI 10.1016/j.celrep.2019.10.093; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang AL, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-15; Zhang NN, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1577-2; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0260838	10.1371/journal.pone.0260838	http://dx.doi.org/10.1371/journal.pone.0260838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085258	Green Published, gold			2022-12-26	WOS:000779379600018
J	Gebreyesus, HA; Abreha, GF; Besherae, SD; Abera, MA; Weldegerima, AH; Gidey, AH; Bezabih, AM; Lemma, TB; Nigatu, TG				Gebreyesus, Hagos Amare; Abreha, Girmatsion Fisseha; Besherae, Sintayehu Degu; Abera, Merhawit Atsbha; Weldegerima, Abraha Hailu; Gidey, Aregawi Haileslassie; Bezabih, Afework Mulugeta; Lemma, Tefera Belachew; Nigatu, Tsinuel Girma			High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia	PLOS ONE			English	Article							GLYCEMIC CONTROL; METABOLIC SYNDROME; DYSLIPIDEMIA; PATHOPHYSIOLOGY; ASSOCIATION; HEMOGLOBIN; PREVALENCE; OUTCOMES; THERAPY; INDEXES	BackgroundType 2 diabetes mellitus (T2DM) is a chronic disease associated with worse clinical presentation. However, the current investigation practices in Ethiopia have limitations to demonstrate the scope of the clinical burden. Hence, this study was aimed at assessing the glycemic status and coronary heart disease (CHD) risk of persons with T2DM using HbA1c and atherogenic index of plasma (AIP). MethodThis institution-based cross-sectional study was conducted among 421 adults with T2DM from September to November 2019. Demographic, socioeconomic, and lifestyle data were collected through a face-to-face interview. Clinical information was retrieved from medical records whereas anthropometric and biochemical measurements were performed using the WHO protocols. Glycemic status was determined using HbA1c and CHD risk assessed using an atherogenic index of plasma (AIP). Gaussian variables were expressed using mean and standard deviation (SD), Log-normal variables using geometric mean and 95% CI and non- Gaussian variables using median and interquartile ranges. Categorical variables were summarized using absolute frequencies and percentages. Multivariable logistic regression was used to identify factors associated with glycemic control with a statistical significance set at 5%. ResultA total of 195 male and 226 female subjects were involved in this study. The results demonstrated that 77% (324) had HbA1c value >= 7% and 87.2% (367) had high atherogenic risk for CHD. Besides, 57% and 67.9% of persons with T2DM had metabolic syndrome according to International Diabetes Federation (IDF) and the National Cholesterol Education Program-Adult treatment panel III (NCEP-ATP III) criteria, respectively. About 36.8% had one or more comorbidities. Having healthy eating behavior [AOR 1.95; CI 1.11-3.43] and taking metformin [AOR 4.88; CI 1.91-12.44] were associated with better glycemic outcomes. ConclusionHigh AIP level concomitant with poor glycemic control indicates increased risk for coronary heart disease among persons with T2DM in Northern Ethiopia.	[Gebreyesus, Hagos Amare; Lemma, Tefera Belachew] Jimma Univ, Dept Nutr & Dietet, Jimma, Ethiopia; [Gebreyesus, Hagos Amare; Abreha, Girmatsion Fisseha; Besherae, Sintayehu Degu; Abera, Merhawit Atsbha; Weldegerima, Abraha Hailu; Gidey, Aregawi Haileslassie; Bezabih, Afework Mulugeta] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Nigatu, Tsinuel Girma] Jimma Univ, Dept Pediat & Child Hlth, Jimma, Ethiopia; [Nigatu, Tsinuel Girma] Jimma Univ, Jimma Univ Clin & Nutr Res Ctr JUCAN, Jimma, Ethiopia	Jimma University; Mekelle University; Jimma University; Jimma University	Gebreyesus, HA (corresponding author), Jimma Univ, Dept Nutr & Dietet, Jimma, Ethiopia.; Gebreyesus, HA (corresponding author), Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.	yom_hag@yahoo.com		Weldegerima, Abraha/0000-0001-9202-3530				Abebe SM, 2015, DIABET METAB SYND OB, V8, P65, DOI 10.2147/DMSO.S75467; Afroz A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46766-9; Agarwal M, 2016, INT J MED SCI PUBLIC, V5, P356, DOI [10.5455/ijmsph.2016.18062015306, DOI 10.5455/IJMSPH.2016.18062015306]; Ahmad NS, 2014, J DIABETES INVEST, V5, P563, DOI 10.1111/jdi.12175; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS111, DOI [10.2337/dc20-s010, 10.2337/dc20-S010]; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anjum M, 2018, INT J RES MED SCI, V6, P776, DOI [10.18203/2320-6012.ijrms20180595, DOI 10.18203/2320-6012.IJRMS20180595]; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bekele S, 2017, DIABETES METAB SYNDR, V10, P265, DOI 10.2147/DMSO.S135064; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Birarra MK, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0880-7; Bruno G, 2004, DIABETES CARE, V27, P2689, DOI 10.2337/diacare.27.11.2689; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cunha-Vaz J, 2010, WORLD SCI, DOI [10.1142/7720, DOI 10.1142/7720]; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Doupa D, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.181.4872; Eticha T., 2016, INT J PHARM PHARM RE, V6, P160; Fiseha Temesgen, 2018, BMC Res Notes, V11, P316, DOI 10.1186/s13104-018-3423-5; Foroozanfar Z, 2015, IRAN J MED SCI, V40, P522; Fseha B, 2017, J DIABETES METAB, V8, DOI 10.4172/2155-6156.1000729; Garber AJ, 2017, ENDOCR PRACT, V23, P207, DOI 10.4158/EP161682.CS; Gaspard U, 2009, MATURITAS, V62, P362, DOI 10.1016/j.maturitas.2008.11.026; Gavin JR, 2010, J AM OSTEOPATH ASSOC, V110, pS2; Gebremeskel GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4609-1; Gebreyesus HA, 2021, BMC ENDOCR DISORD, V21, DOI 10.1186/s12902-021-00750-5; Goff DC, 2003, DIABETES CARE, V26, P805, DOI 10.2337/diacare.26.3.805; Gonna H, 2019, DIABETES OBES METAB, V21, P6, DOI 10.1111/dom.13691; Hailu E, 2012, AFR J PRIM HEALTH CA, V4, DOI 10.4102/phcfm.v4i1.311; Hermans MP, 2010, CLIN LIPIDOL, V5, P811, DOI 10.2217/CLP.10.65; Jelinek HF, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000427; Jisieike-Onuigbo NN, 2011, ANN AFR MED, V10, P285, DOI 10.4103/1596-3519.87045; Jorgensen LGM, 2005, CLIN CHEM LAB MED, V43, P1366, DOI 10.1515/CCLM.2005.233; Kassahun Tefera, 2016, BMC Res Notes, V9, P78, DOI 10.1186/s13104-016-1896-7; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Laissaoui A., 2016, ROMANIAN J DIABETES, V23, P139; Litwak L, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-57; Lobo RA, 2008, MATURITAS, V60, P10, DOI 10.1016/j.maturitas.2008.02.008; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Mideksa S, 2018, ADIPOCYTE, V7, P197, DOI 10.1080/21623945.2018.1467716; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nimmanapalli HD, 2016, INT J RES MED SCI, V4, P2863, DOI DOI 10.18203/2320-6012.IJRMS20161966; Nowlin SY, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/542698; Nsiah Kwabena, 2015, Int J Appl Basic Med Res, V5, P133, DOI 10.4103/2229-516X.157170; Nyunt SW, 2010, SE ASIAN J TROP MED, V41, P943; Omotoye FE., 2017, INDIAN J NUTR, V4, P159; Osuji C, 2010, NIGERIAN MED J, V51, P155; Parhofer KG, 2011, CLIN LIPIDOL, V6, P401, DOI 10.2217/CLP.11.32; Paudel DR, 2019, EMERGING SCI J, DOI [10.28991/esj-2019-01195, DOI 10.28991/ESJ-2019-01195, http%3A//dx.doi.org/10.28991/esj-2019-01195]; Pokharel DR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0104-3; Pozzilli P, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2512; Prevention of Noncommunicable Diseases Department World Health Organization, SURV POP BAS PREV; Puepet F., 2010, AFR J ENDOCRINOL MET, V8, P12, DOI [10.4314/ajem.v8i1.57576, DOI 10.4314/AJEM.V8I1.57576]; Rampal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046365; Sacks DB, 2012, DIABETES CARE, V35, P2674, DOI 10.2337/dc12-1348; Sanal T., 2011, J DIABETOL, V2, P4, DOI DOI 10.1155/2016/2109542; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Serwaa D., 2021, SciMedicine Journal, V3, P23, DOI 10.28991/SciMedJ-2021-0301-4; Sherwani SI, 2016, BIOMARK INSIGHTS, V11, P95, DOI [10.4137/BMIMI.S38440, 10.4137/BMI.S38440]; Shiferaw WS, 2020, DIABETES METAB SYND, V14, P1403, DOI 10.1016/j.dsx.2020.07.013; Sorli C, 2014, J MULTIDISCIP HEALTH, V7, P267, DOI 10.2147/JMDH.S64084; Tadewos A., 2017, HLTH SCI J, V11, P509, DOI [10.21767/1791-809X.1000509, DOI 10.21767/1791-809X.1000509]; Tan MH, 2004, CLIN CHEM, V50, P1184, DOI 10.1373/clinchem.2004.031757; Viana LV, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003336; VinodMahato R, 2011, BIOMED RES-INDIA, V22, P375; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Woldu M, 2014, ENDOCRINOL METAB SYN, V3, DOI DOI 10.4172/2161-1017.1000143; Worku A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0785-1; World Health Organization, 2005, WHO STEPS SURV MAN W; Woyesa SB, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0226-y; Yadav Dhananjay, 2013, Glob J Health Sci, V5, P142, DOI 10.5539/gjhs.v5n6p142; Zerga AA, 2020, DIABET METAB SYND OB, V13, P1297, DOI 10.2147/DMSO.S242792	73	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0262610	10.1371/journal.pone.0262610	http://dx.doi.org/10.1371/journal.pone.0262610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104300	Green Published, gold			2022-12-26	WOS:000749789300007
J	Tooker, BC; Kandel, SE; Work, HM; Lampe, JN				Tooker, Brian C.; Kandel, Sylvie E.; Work, Hannah M.; Lampe, Jed N.			Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CYSTIC-FIBROSIS; HETEROTROPIC COOPERATIVITY; SUBSTRATE-INHIBITION; STRUCTURAL BASIS; HOMOTROPIC COOPERATIVITY; CHOLESTEROL CATABOLISM; MIDAZOLAM METABOLISM; BIOFILM FORMATION; PROVIDES INSIGHT	Pseudomonas aeruginosa is a Gram-negative opportunistic human pathogen that is highly prevalent in individuals with cystic fibrosis (CF). A major problem in treating CF patients infected with P. aeruginosa is the development of antibiotic resistance. Therefore, the identification of novel P. aeruginosa antibiotic drug targets is of the utmost urgency. The genome of P. aeruginosa contains four putative cytochrome P450 enzymes (CYPs) of unknown function that have never before been characterized. Analogous to some of the CYPs from Mycobacterium tuberculosis, these P. aeruginosa CYPs may be important for growth and colonization of CF patients' lungs. In this study, we cloned, expressed, and characterized CYP168A1 from P. aeruginosa and identified it as a subterminal fatty acid hydroxylase. Spectral binding data and computational modeling of substrates and inhibitors suggest that CYP168A1 has a large, expansive active site and preferentially binds long chain fatty acids and large hydrophobic inhibitors. Furthermore, metabolic experiments confirm that the enzyme is capable of hydroxylating arachidonic acid, an important inflammatory signaling molecule present in abundance in the CF lung, to 19-hydroxyeicosatetraenoic acid (19-HETE; K-m = 41 mu M, V-max = 220 pmol/min/nmol P450), a potent vasodilator, which may play a role in the pathogen's ability to colonize the lung. Additionally, we found that the in vitro metabolism of arachidonic acid is subject to substrate inhibition and is also inhibited by the presence of the antifungal agent ketoconazole. This study identifies a new metabolic pathway in this important human pathogen that may be of utility in treating P. aeruginosa infections.	[Tooker, Brian C.; Kandel, Sylvie E.; Work, Hannah M.; Lampe, Jed N.] Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Lampe, JN (corresponding author), Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	jed.lampe@cuanschutz.edu		Tooker, Brian/0000-0002-0018-3658; Kandel, Sylvie/0000-0002-8059-8035; Lampe, Jed/0000-0003-0794-2263	University of Colorado; Skaggs School of Pharmacy; 2021-22 Skaggs Scholar Award	University of Colorado; Skaggs School of Pharmacy; 2021-22 Skaggs Scholar Award	We would like to gratefully acknowledge Michael Armstrong of the CU Skaggs School of Pharmacy and Pharmaceutical Sciences Mass Spectroscopy facility for assistance provided in confirming the CYP168A1 lauric acid metabolites. The research described in this manuscript was generously funded through a University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences Faculty Start-up Package and the 2021-22 Skaggs Scholar Award.	Adris P, 2007, TOXICOL IN VITRO, V21, P1663, DOI 10.1016/j.tiv.2007.07.009; Alvarez-Alvarez R, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0373-7; Auvin S, 2005, PEDIATR RES, V58, P211, DOI 10.1203/01.PDR.0000169979.27641.40; Tooker BC, 2021, bioRxiv, DOI 10.1101/2021.10.19.465045; Baker LY, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1259-8; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Berry SB, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00537; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; Bukhdruker S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207683; BURET A, 1993, AM REV RESPIR DIS, V148, P793, DOI 10.1164/ajrccm/148.3.793; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; CARLSTEDTDUKE J, 1986, P NATL ACAD SCI USA, V83, P9202, DOI 10.1073/pnas.83.23.9202; Carroll MA, 1996, AM J PHYSIOL-REG I, V271, pR863, DOI 10.1152/ajpregu.1996.271.4.R863; Carroll MA, 1997, KIDNEY INT, V51, P1696, DOI 10.1038/ki.1997.234; Child SA, 2020, J INORG BIOCHEM, V209, DOI 10.1016/j.jinorgbio.2020.111116; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; ESCALANTE B, 1988, BIOCHEM BIOPH RES CO, V152, P1269, DOI 10.1016/S0006-291X(88)80422-4; Faure E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02416; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Flitter BA, 2017, P NATL ACAD SCI USA, V114, P136, DOI 10.1073/pnas.1610242114; Follmer AH, 2018, J AM CHEM SOC, V140, P16222, DOI 10.1021/jacs.8b09441; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Ghorbani P, 2015, EUR RESPIR J, V46, P1033, DOI 10.1183/09031936.00143614; GONVINDARAJ S, 1994, BIOCHEM BIOPH RES CO, V203, P1745, DOI 10.1006/bbrc.1994.2388; He YA, 2003, ARCH BIOCHEM BIOPHYS, V409, P92, DOI 10.1016/S0003-9861(02)00484-8; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang L, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.00826-21; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Kandel S, 2005, J BIOL CHEM, V280, P35881, DOI 10.1074/jbc.M500918200; Kelly SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0476; Kim V, 2020, ARCH BIOCHEM BIOPHYS, V692, DOI 10.1016/j.abb.2020.108544; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; LEVISTRE R, 1993, BIOCHIM BIOPHYS ACTA, V1181, P233, DOI 10.1016/0925-4439(93)90026-W; Li JH, 2021, J CHEM INF MODEL, V61, P2418, DOI 10.1021/acs.jcim.1c00266; Li YP, 2020, J APPL MICROBIOL, V128, P151, DOI 10.1111/jam.14470; Liang B, 2014, WATER RES, V54, P137, DOI 10.1016/j.watres.2014.01.052; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Lund-Palau H, 2016, EXPERT REV RESP MED, V10, P685, DOI 10.1080/17476348.2016.1177460; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Malwal SR, 2021, ACS INFECT DIS, V7, P2492, DOI 10.1021/acsinfecdis.1c00259; McDonald MG, 2017, DRUG METAB DISPOS, V45, P1364, DOI 10.1124/dmd.117.078188; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; Montero M, 2010, EUR J CLIN MICROBIOL, V29, P335, DOI 10.1007/s10096-009-0850-1; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Muller CS, 2015, BIOCHEMISTRY-US, V54, P711, DOI 10.1021/bi5011656; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Nelson David R., 2009, Human Genomics, V4, P59; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Patteson JB, 2018, BIOCHEMISTRY-US, V57, P61, DOI 10.1021/acs.biochem.7b00943; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Portet S, 2020, INFECT DIS MODEL, V5, P111, DOI 10.1016/j.idm.2019.12.010; Powell WS, 2015, BBA-MOL CELL BIOL L, V1851, P340, DOI 10.1016/j.bbalip.2014.10.008; Puchkaev AV, 2002, J AM CHEM SOC, V124, P12682, DOI 10.1021/ja0282036; Qhanya LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142100; Qu W, 2001, J BIOL CHEM, V276, P25467, DOI 10.1074/jbc.M100545200; Ranasinghe C, 1998, INSECT BIOCHEM MOLEC, V28, P571, DOI 10.1016/S0965-1748(98)00045-9; Rao J, 2011, CELL IMMUNOL, V270, P95, DOI 10.1016/j.cellimm.2011.04.011; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Roberts AG, 2016, BBA-GEN SUBJECTS, V1860, P669, DOI 10.1016/j.bbagen.2015.12.014; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P10804, DOI 10.1021/bi200924t; Roussel F, 2000, ARCH BIOCHEM BIOPHYS, V374, P269, DOI 10.1006/abbi.1999.1599; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schultz ANO, 2017, PEDIATR PULM, V52, P319, DOI 10.1002/ppul.23638; Scotet V, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060589; Shoieb SM, 2019, CHEM-BIOL INTERACT, V299, P140, DOI 10.1016/j.cbi.2018.12.004; Shoieb SM, 2018, DRUG METAB DISPOS, V46, P1157, DOI 10.1124/dmd.118.082073; SORRELL TC, 1992, INFECT IMMUN, V60, P1779, DOI 10.1128/IAI.60.5.1779-1785.1992; Stein SE., 1990, NATL I STANDARDS TEC; Stockli M, 2019, MOL MICROBIOL, V112, P605, DOI 10.1111/mmi.14277; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strohmaier SJ, 2020, DRUG METAB DISPOS, V48, P432, DOI 10.1124/dmd.120.090555; Sun YX, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.618265; Thornton JM, 2021, PROSTAG OTH LIPID M, V152, DOI 10.1016/j.prostaglandins.2020.106505; Tooker B. C, 2021, FASEB J, V35, P2588; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tunaru S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163633; Ugalde SO, 2019, APPL MICROBIOL BIOT, V103, P3597, DOI 10.1007/s00253-019-09697-z; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; van Vugt-Lussenburg BMA, 2006, BIOCHEM BIOPH RES CO, V346, P810, DOI 10.1016/j.bbrc.2006.05.179; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; White J.R., 2020, MED MICROECOL, V4, P100005, DOI [10.1016/j.medmic.2020.100005, DOI 10.1016/J.MEDMIC.2020.100005]; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wilson M. G, 2021, STATPEARLS, P201; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Winstanley C, 2016, TRENDS MICROBIOL, V24, P327, DOI 10.1016/j.tim.2016.01.008; Wlodarczyk A, 2016, METAB ENG, V33, P1, DOI 10.1016/j.ymben.2015.10.009; Wu BJ, 2011, DRUG METAB REV, V43, P440, DOI 10.3109/03602532.2011.615320; Yaghi A, 2001, J PHARMACOL EXP THER, V297, P479; Yamazaki H, 2013, CHEM RES TOXICOL, V26, P486, DOI 10.1021/tx400008g; Yasutake Y, 2010, J BIOL CHEM, V285, P31193, DOI 10.1074/jbc.M110.147009; Yoshino M, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1082-8; Zhou SS, 2019, ACS CHEM BIOL, V14, P1305, DOI 10.1021/acschembio.9b00270; ZURIER RB, 1993, PROSTAG LEUKOTR ESS, V48, P57, DOI 10.1016/0952-3278(93)90010-T	118	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101629	10.1016/j.jbc.2022.101629	http://dx.doi.org/10.1016/j.jbc.2022.101629			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35085556	gold, Green Published			2022-12-26	WOS:000821051800011
J	Anderson, SR; Jocewicz, R; Kan, A; Zhu, J; Tzeng, SL; Litovsky, RY				Anderson, Sean R.; Jocewicz, Rachael; Kan, Alan; Zhu, Jun; Tzeng, ShengLi; Litovsky, Ruth Y.			Sound source localization patterns and bilateral cochlear implants: Age at onset of deafness effects	PLOS ONE			English	Article							LATERAL SUPERIOR OLIVE; INTERAURAL LEVEL DIFFERENCES; PLACE-OF-STIMULATION; BUSHY CELL AXONS; HORIZONTAL-PLANE; AUDITORY LOCALIZATION; BINAURAL SENSITIVITY; ELECTRIC HEARING; TIME DIFFERENCES; DUPLEX THEORY	The ability to determine a sound's location is critical in everyday life. However, sound source localization is severely compromised for patients with hearing loss who receive bilateral cochlear implants (BiCIs). Several patient factors relate to poorer performance in listeners with BiCIs, associated with auditory deprivation, experience, and age. Critically, characteristic errors are made by patients with BiCIs (e.g., medial responses at lateral target locations), and the relationship between patient factors and the type of errors made by patients has seldom been investigated across individuals. In the present study, several different types of analysis were used to understand localization errors and their relationship with patient-dependent factors (selected based on their robustness of prediction). Binaural hearing experience is required for developing accurate localization skills, auditory deprivation is associated with degradation of the auditory periphery, and aging leads to poorer temporal resolution. Therefore, it was hypothesized that earlier onsets of deafness would be associated with poorer localization acuity and longer periods without BiCI stimulation or older age would lead to greater amounts of variability in localization responses. A novel machine learning approach was introduced to characterize the types of errors made by listeners with BiCIs, making them simple to interpret and generalizable to everyday experience. Sound localization performance was measured in 48 listeners with BiCIs using pink noise trains presented in free-field. Our results suggest that older age at testing and earlier onset of deafness are associated with greater average error, particularly for sound sources near the center of the head, consistent with previous research. The machine learning analysis revealed that variability of localization responses tended to be greater for individuals with earlier compared to later onsets of deafness. These results suggest that early bilateral hearing is essential for best sound source localization outcomes in listeners with BiCIs.	[Anderson, Sean R.; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Jocewicz, Rachael] Stanford Univ, Dept Audiol, Stanford, CA 94305 USA; [Kan, Alan] Macquarie Univ, Sch Engn, Sydney, NSW, Australia; [Zhu, Jun] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Tzeng, ShengLi] Natl Sun Yat Sen Univ, Dept Math, Kaohsiung, Taiwan	University of Wisconsin System; University of Wisconsin Madison; Stanford University; Macquarie University; University of Wisconsin System; University of Wisconsin Madison; National Sun Yat Sen University	Anderson, SR (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	sean.hearing@gmail.com		Kan, Alan/0000-0001-6033-0958; Anderson, Sean/0000-0002-1638-0197	National Institute on Deafness and Other Communication Disorders [R01 DC003083, R03 DC015321]; National Institute on Child Health and Human Development [P30 HD03352]	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants R01 DC003083 (to RYL) and R03 DC015321 (to AK) from National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/), and in part by grant P30 HD03352 (to Waisman Center) from National Institute on Child Health and Human Development (https://www.nichd.nih.gov/).	Abel SM, 2000, J ACOUST SOC AM, V108, P743, DOI 10.1121/1.429607; Anderson SR, 2019, J ACOUST SOC AM, V146, P3232, DOI 10.1121/1.5130384; Anderson SR, 2019, J ACOUST SOC AM, V146, P1189, DOI 10.1121/1.5121423; Archer-Boyd AW, 2019, J ACOUST SOC AM, V145, P1389, DOI 10.1121/1.5093623; Aronoff JM, 2010, J ACOUST SOC AM, V127, pEL87, DOI 10.1121/1.3298451; Asp F, 2015, INT J AUDIOL, V54, P77, DOI 10.3109/14992027.2014.973536; Asp F, 2011, OTOL NEUROTOL, V32, P558, DOI 10.1097/MAO.0b013e318218cfbd; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Babkoff H, 2002, HEARING RES, V165, P117, DOI 10.1016/S0378-5955(02)00292-7; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumgartel RM, 2017, J ACOUST SOC AM, V141, P2338, DOI 10.1121/1.4979114; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brown AD, 2016, J NEUROSCI, V36, P9908, DOI 10.1523/JNEUROSCI.1421-16.2016; Buck AN, 2021, HEARING RES, V408, DOI 10.1016/j.heares.2021.108305; CANT NB, 1986, J COMP NEUROL, V247, P457, DOI 10.1002/cne.902470406; CASEY MA, 1990, NEUROBIOL AGING, V11, P391, DOI 10.1016/0197-4580(90)90004-J; CHANDLER DW, 1992, J ACOUST SOC AM, V91, P1624, DOI 10.1121/1.402443; Chung YJ, 2019, JARO-J ASSOC RES OTO, V20, P37, DOI 10.1007/s10162-018-00708-w; Doucet JR, 2003, J COMP NEUROL, V461, P452, DOI 10.1002/cne.10722; Dunn CC, 2008, EAR HEARING, V29, P352, DOI 10.1097/AUD.0b013e318167b870; Ehlers E, 2017, J ACOUST SOC AM, V141, P4264, DOI 10.1121/1.4983824; FEDDERSEN WE, 1957, J ACOUST SOC AM, V29, P988, DOI 10.1121/1.1909356; Firszt JB, 2015, HEARING RES, V319, P48, DOI 10.1016/j.heares.2014.11.005; Freigang C, 2014, EXP BRAIN RES, V232, P1157, DOI 10.1007/s00221-014-3825-0; Frisina RD, 2006, HEARING RES, V216, P216, DOI 10.1016/j.heares.2006.02.003; Golding NL, 2012, J PHYSIOL-LONDON, V590, P5563, DOI 10.1113/jphysiol.2012.229328; Gordon-Salant S., 2010, AGING AUDITORY SYSTE, DOI [10.1073/pnas.0703993104, DOI 10.1073/PNAS.0703993104]; Goupell MJ, 2013, J ACOUST SOC AM, V133, P2272, DOI 10.1121/1.4792936; Grantham DW, 2008, EAR HEARING, V29, P33; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Gray WO, 2021, TRENDS HEAR, V25, DOI 10.1177/23312165211030411; Green DM, 1966, SIGNAL DETECTION THE; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Grose JH, 2010, EAR HEARING, V31, P755, DOI 10.1097/AUD.0b013e3181e627e7; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hancock KE, 2013, JARO-J ASSOC RES OTO, V14, P393, DOI 10.1007/s10162-013-0380-5; Hartmann WM, 2016, J ACOUST SOC AM, V139, P968, DOI 10.1121/1.4941915; HARTMANN WM, 1983, J ACOUST SOC AM, V74, P1380, DOI 10.1121/1.390163; Heeringa AN, 2020, J NEUROSCI, V40, P343, DOI 10.1523/JNEUROSCI.2784-18.2019; Hughes Kathryn C, 2013, Cochlear Implants Int, V14, P121, DOI 10.1179/1754762812Y.0000000009; Ihlefeld A, 2015, JARO-J ASSOC RES OTO, V16, P641, DOI 10.1007/s10162-015-0527-7; Isaiah A, 2014, J NEUROSCI, V34, P11119, DOI 10.1523/JNEUROSCI.4767-13.2014; Jones H, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514554574; Jones HG, 2016, EAR HEARING, V37, pE341, DOI 10.1097/AUD.0000000000000297; Joris PX, 2008, NEUROSCIENCE, V154, P65, DOI 10.1016/j.neuroscience.2008.03.002; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; Kan A, 2015, HEARING RES, V322, P127, DOI 10.1016/j.heares.2014.08.005; Kan A, 2013, J ACOUST SOC AM, V134, P2923, DOI 10.1121/1.4820889; KATHLEEN M, 1991, J SPEECH HEAR RES, V34, P1410, DOI 10.1044/jshr.3406.1410; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Keine C, 2015, J NEUROSCI, V35, P8579, DOI 10.1523/JNEUROSCI.0133-15.2015; Killan C, 2019, EAR HEARING, V40, P870, DOI 10.1097/AUD.0000000000000666; Konrad-Martin D, 2012, J AM ACAD AUDIOL, V23, P18, DOI 10.3766/jaaa.23.1.3; Laback B, 2015, HEARING RES, V322, P138, DOI 10.1016/j.heares.2014.10.004; Li KY, 2019, J ACOUST SOC AM, V145, pEL341, DOI 10.1121/1.5099164; Litovsky R, 2006, EAR HEARING, V27, P714, DOI 10.1097/01.aud.0000246816.50820.42; Litovsky RY, 2016, HEARING RES, V338, P76, DOI 10.1016/j.heares.2016.01.003; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2012, SPRINGER HANDB AUDIT, V42, P163, DOI 10.1007/978-1-4614-1421-6_6; Litovsky RY, 2010, J ACOUST SOC AM, V127, P400, DOI 10.1121/1.3257546; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Rayleigh,, 1907, PHILOS MAG, V13, P214, DOI 10.1080/14786440709463595; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; Majdak P, 2011, EAR HEARING, V32, P198, DOI 10.1097/AUD.0b013e3181f4dfe9; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Mayo PG, 2020, J ACOUST SOC AM, V147, pEL357, DOI 10.1121/10.0001088; Nawaz S, 2014, OTOL NEUROTOL, V35, P271, DOI 10.1097/MAO.0000000000000257; Neuman AC, 2007, EAR HEARING, V28, P73, DOI 10.1097/01.aud.0000249910.80803.b9; Nopp P, 2004, EAR HEARING, V25, P205, DOI 10.1097/01.AUD.0000130793.20444.50; Pichora-Fuller MK, 1998, PERCEPT PSYCHOPHYS, V60, P1197, DOI 10.3758/BF03206169; Potts WB, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519831492; R Development Core Team, 2019, R LANG ENV STAT COMP; RAKERD B, 1986, J ACOUST SOC AM, V80, P1695, DOI 10.1121/1.394282; Reeder RM, 2014, J SPEECH LANG HEAR R, V57, P1108, DOI 10.1044/2014_JSLHR-H-13-0087; Reiss LAJ, 2016, JARO-J ASSOC RES OTO, V17, P341, DOI 10.1007/s10162-016-0570-z; Roberts MT, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00049; Rosskothen-Kuhl N, 2021, ELIFE, V10, DOI 10.7554/eLife.59300; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Ryugo DK, 2010, J COMP NEUROL, V518, P1046, DOI 10.1002/cne.22262; Ryugo D, 2015, CELL TISSUE RES, V361, P251, DOI 10.1007/s00441-014-2004-8; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schoen F, 2005, OTOL NEUROTOL, V26, P429, DOI 10.1097/01.mao.0000169772.16045.86; Seeber BU, 2008, J ACOUST SOC AM, V123, P1030, DOI 10.1121/1.2821965; Seeber BU, 2004, J ACOUST SOC AM, V116, P1698, DOI 10.1121/1.1776192; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; Shepherd RK, 2001, AUDIOL NEURO-OTOL, V6, P305, DOI 10.1159/000046843; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; Steffens T, 2008, ACTA OTO-LARYNGOL, V128, P164, DOI 10.1080/00016480701411528; Strom-Roum H, 2012, INT J PEDIATR OTORHI, V76, P1245, DOI 10.1016/j.ijporl.2012.05.013; Strouse A, 1998, J ACOUST SOC AM, V104, P2385, DOI 10.1121/1.423748; Sunwoo W, 2021, J NEUROSCI, V41, P3651, DOI 10.1523/JNEUROSCI.1076-20.2021; Takesian AE, 2009, FUTUR NEUROL, V4, P331, DOI 10.2217/FNL.09.5; Thakkar T, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10060406; Tollin DJ, 2002, J NEUROSCI, V22, P1468, DOI 10.1523/JNEUROSCI.22-04-01468.2002; Van den Bogaert T, 2006, J ACOUST SOC AM, V119, P515, DOI 10.1121/1.2139653; Van Deun L, 2010, AUDIOL NEURO-OTOL, V15, P7, DOI 10.1159/000218358; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; Verschuur CA, 2005, OTOL NEUROTOL, V26, P965, DOI 10.1097/01.mao.0000185073.81070.07; Vollmer M, 2018, J NEUROSCI, V38, P6949, DOI 10.1523/JNEUROSCI.3328-17.2018; Whitmer WM, 2014, J ACOUST SOC AM, V135, P3548, DOI 10.1121/1.4875575; Whitton JP, 2011, JARO-J ASSOC RES OTO, V12, P535, DOI 10.1007/s10162-011-0271-6; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; Wightman FL, 1997, J ACOUST SOC AM, V101, P1050, DOI 10.1121/1.418029; Winters BD, 2018, NEURON, V98, P166, DOI 10.1016/j.neuron.2018.03.001; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; Yost WA, 2013, J ACOUST SOC AM, V133, P2876, DOI 10.1121/1.4799803; Zheng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135790	112	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263516	10.1371/journal.pone.0263516	http://dx.doi.org/10.1371/journal.pone.0263516			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134072	Green Published, gold			2022-12-26	WOS:000798968600017
J	Hughes, JP; Efstratiou, A; Komer, SR; Baxter, LA; Vasiljevic, M; Leite, AC				Hughes, Jack P.; Efstratiou, Alexandros; Komer, Sara R.; Baxter, Lilli A.; Vasiljevic, Milica; Leite, Ana C.			The impact of risk perceptions and belief in conspiracy theories on COVID-19 pandemic-related behaviours	PLOS ONE			English	Article							COGNITIVE-DISSONANCE; DRIVING BEHAVIOR; ANTI-VACCINATION; PREDICTORS; ASSOCIATIONS; PERSONALITY; EXPERIENCE; GOVERNMENT; ATTITUDES; EXPOSURE	Throughout the COVID-19 pandemic, conspiracy theories about the virus spread rapidly, and whilst governments across the globe put in place different restrictions and guidelines to contain the pandemic, these were not universally adhered to. This research examined the association between pandemic related risk perceptions, belief in conspiracy theories, and compliance with COVID-19 public guidelines amongst a UK sample (n = 368). Participants rated their level of concern for a series of potential risks during the pandemic (to the economy, personal health, freedom, media integrity and health risk to others). Participants also rated their level of belief in different conspiracy theories and self-reported their behaviour during the first UK lockdown. Mediational analyses showed that stronger belief in conspiracy theories was associated with perceptions of lower risk to health and higher risk to the economy and freedom, which in turn were associated with lower compliance with COVID-19 related governmental guidelines. Perception of information transparency risks did not mediate the association between belief in conspiracy theories and compliant behaviours. These results highlight the key role that risk perception may play in translating belief in conspiracy theories into low compliance with governmental COVID-19 related guidelines. Our findings suggest new patterns with respect to the relationship between conspiracy theory adherence and salience of different risk perceptions amidst the pandemic, which could have implications for the development of public health messaging and communication interventions.	[Hughes, Jack P.; Efstratiou, Alexandros; Komer, Sara R.; Baxter, Lilli A.; Vasiljevic, Milica; Leite, Ana C.] Univ Durham, Dept Psychol, Durham, England; [Efstratiou, Alexandros] UCL, Dept Comp Sci, London, England	Durham University; University of London; University College London	Hughes, JP (corresponding author), Univ Durham, Dept Psychol, Durham, England.	jack.p.hughes@durham.ac.uk		Vasiljevic, Milica/0000-0001-7454-7744; Efstratiou, Alexandros/0000-0003-0590-4204				Abalakina-Paap M, 1999, POLIT PSYCHOL, V20, P637, DOI 10.1111/0162-895X.00160; Abdelrahman M, 2022, INT J MENT HEALTH AD, V20, P237, DOI 10.1007/s11469-020-00352-7; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; Atchinson C. J., 2020, PERCEPTIONS BEHAV RE, DOI [10.1101/2020.04.01.20050039v1, DOI 10.1101/2020.04.01.20050039V1, 10.1101/2020.04.01.20050039v1.full.pdf+html]; Bale JM, 2007, PATTERNS PREJUDICE, V41, P45, DOI 10.1080/00313220601118751; Banai IP., 2020, PSYARXIV; Barron D, 2018, PSYCHIAT RES, V259, P15, DOI 10.1016/j.psychres.2017.10.001; Benjamin DJ., 2020, GRU WORKING PAPER SE; Bhuiya T, 2021, J INVEST MED, V69, P1473, DOI 10.1136/jim-2021-001835; Bierwiaczonek K, 2020, APPL PSYCHOL-HLTH WE, V12, P1270, DOI 10.1111/aphw.12223; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Branstrom R, 2006, EUR J PUBLIC HEALTH, V16, P492, DOI 10.1093/eurpub/cki193; Brinken L, 2020, BRIT J HEALTH PSYCH, V25, P210, DOI 10.1111/bjhp.12402; Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; de Bruin WB, 2020, J RISK UNCERTAINTY, V61, P177, DOI 10.1007/s11166-020-09336-3; Chung JB, 2013, DISASTER PREV MANAG, V22, P148, DOI 10.1108/09653561311325299; Clarke S, 2002, PHILOS SOC SCI, V32, P131, DOI 10.1177/004931032002001; Cori L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093114; de Bruin WB, 2020, AM J PREV MED, V59, P157, DOI 10.1016/j.amepre.2020.05.001; de Bruin WB, 2021, J GERONTOL B-PSYCHOL, V76, pE24, DOI 10.1093/geronb/gbaa074; Desta TT, 2020, INT J PUBLIC HEALTH, V65, P713, DOI 10.1007/s00038-020-01412-4; Douglas KM, 2021, GROUP PROCESS INTERG, V24, P270, DOI 10.1177/1368430220982068; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Earnshaw VA, 2020, TRANSL BEHAV MED, V10, P850, DOI 10.1093/tbm/ibaa090; Edelmann A, 2014, POETICS, V46, P22, DOI 10.1016/j.poetic.2014.08.001; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Ford CL, 2013, GERONTOLOGIST, V53, P973, DOI 10.1093/geront/gns192; Frankovic K., GROWING NUMBER AMERI; Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890; Harmon-Jones E, 2000, PERS SOC PSYCHOL B, V26, P1490, DOI 10.1177/01461672002612004; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Hart J, 2018, J INDIVID DIFFER, V39, P229, DOI 10.1027/1614-0001/a000268; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Im T, 2014, J PUBL ADM RES THEOR, V24, P741, DOI 10.1093/jopart/mus037; Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692; Imhoff R, 2018, EUR J SOC PSYCHOL, V48, P909, DOI 10.1002/ejsp.2494; Johns Hopkins, COVID 19 MAP; Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Kenworthy JB, 2011, EUR REV SOC PSYCHOL, V22, P36, DOI 10.1080/10463283.2011.580155; Krause NM, 2020, J RISK RES, V23, P1052, DOI 10.1080/13669877.2020.1756385; Kummeneje AM, 2020, TRANSPORT RES F-TRAF, V69, P135, DOI 10.1016/j.trf.2020.01.007; Lantian A, 2017, SOC PSYCHOL-GERMANY, V48, P160, DOI 10.1027/1864-9335/a000306; Lantian A, 2016, INT REV SOC PSYCHOL, V29, P1, DOI 10.5334/irsp.8; Larson HJ, 2018, NATURE, V562, P309, DOI 10.1038/d41586-018-07034-4; Leman P. J., 2007, SOC PSYCHOL REV, V9, P18; Leman PJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00378; Loughnan S, 2014, CURR DIR PSYCHOL SCI, V23, P104, DOI 10.1177/0963721414525781; Marinthe G, 2020, BRIT J HEALTH PSYCH, V25, P957, DOI 10.1111/bjhp.12449; MCCAULEY C, 1979, J PERS SOC PSYCHOL, V37, P637, DOI 10.1037/0022-3514.37.5.637; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mendis M., 2020, P INT C IND ENG OPER, P9; Meuer M, 2021, J EXP SOC PSYCHOL, V93, DOI 10.1016/j.jesp.2020.104081; Moser SC, 2011, OXFORD HDB CLIMATE C, P161; Moulding R, 2016, PERS INDIV DIFFER, V98, P345, DOI 10.1016/j.paid.2016.04.060; Murphy Sheila T, 2009, Disaster Med Public Health Prep; Oleksy T, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110289; Pew Research Center, AM NEWS PATHW EXPL D; Pullan S, 2021, VACCINE, V39, P1877, DOI 10.1016/j.vaccine.2021.03.019; Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199; Rundmo T, 2004, SAFETY SCI, V42, P1, DOI 10.1016/S0925-7535(02)00047-4; Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397; Simonov A, 2020, NATL BUREAU EC RES, DOI [10.3386/W27237, DOI 10.3386/W27237]; Smallman S., 2015, J INT GLOB STUD 0401; Smith N, 2019, INFORM COMMUN SOC, V22, P1310, DOI 10.1080/1369118X.2017.1418406; Stewart-Taylor AJ, 1998, ANN OCCUP HYG, V42, P565, DOI 10.1016/S0003-4878(98)00062-3; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Swami V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172617; Swami V, 2016, PERS INDIV DIFFER, V99, P72, DOI 10.1016/j.paid.2016.04.084; Swami V, 2014, COGNITION, V133, P572, DOI 10.1016/j.cognition.2014.08.006; Swami V, 2011, BRIT J PSYCHOL, V102, P443, DOI 10.1111/j.2044-8295.2010.02004.x; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; Thistlethwaite J, 2018, ENVIRON MANAGE, V61, P197, DOI 10.1007/s00267-017-0969-2; Trigg JL, 2016, QUAL REP, V21, P1881; Trueblood JS, 2022, SOC PSYCHOL PERS SCI, V13, P311, DOI 10.1177/1948550621999622; Ulleberg P, 2003, SAFETY SCI, V41, P427, DOI 10.1016/S0925-7535(01)00077-7; Van Rooij B., 2020, COMPLIANCE COVID 19, DOI [110.31234/osf.io/qymu3, DOI 10.31234/OSF.IO/QYMU3]; Weber E.U., 1997, PERCEPTION EXPECTATI, P314; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3; Weber EU, 2015, SOC RES, V82, P561; Winter K, 2022, BRIT J HEALTH PSYCH, V27, P390, DOI 10.1111/bjhp.12550; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742; Wong CML, 2020, J RISK RES, V23, P1021, DOI 10.1080/13669877.2020.1756386	92	3	3	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263716	10.1371/journal.pone.0263716	http://dx.doi.org/10.1371/journal.pone.0263716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134100	Green Published, gold, Green Accepted			2022-12-26	WOS:000798968600029
J	Lawson, MJ; Drawert, B; Petzold, L; Yi, TM				Lawson, Michael J.; Drawert, Brian; Petzold, Linda; Yi, Tau-Mu			A positive feedback loop involving the Spa2 SHD domain contributes to focal polarization	PLOS ONE			English	Article							CELL POLARITY; SECRETORY VESICLES; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; BUD SITE; YEAST; PROTEIN; MECHANISM; PATHWAY; GROWTH	Focal polarization is necessary for finely arranged cell-cell interactions. The yeast mating projection, with its punctate polarisome, is a good model system for this process. We explored the critical role of the polarisome scaffold protein Spa2 during yeast mating with a hypothesis motivated by mathematical modeling and tested by in vivo experiments. Our simulations predicted that two positive feedback loops generate focal polarization, including a novel feedback pathway involving the N-terminal domain of Spa2. We characterized the latter using loss-of-function and gain-of-function mutants. The N-terminal region contains a Spa2 Homology Domain (SHD) which is conserved from yeast to humans, and when mutated largely reproduced the spa2 Delta phenotype. Our work together with published data show that the SHD domain recruits Msb3/4 that stimulates Sec4-mediated transport of Bud6 to the polarisome. There, Bud6 activates Bni1-catalyzed actin cable formation, recruiting more Spa2 and completing the positive feedback loop. We demonstrate that disrupting this loop at any point results in morphological defects. Gain-of-function perturbations partially restored focal polarization in a spa2 loss-of-function mutant without restoring localization of upstream components, thus supporting the pathway order. Thus, we have collected data consistent with a novel positive feedback loop that contributes to focal polarization during pheromone-induced polarization in yeast.	[Lawson, Michael J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Drawert, Brian] Univ North Carolina Asheville, Dept Comp Sci, Asheville, NC USA; [Petzold, Linda] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Yi, Tau-Mu] Univ Calif Santa Barbara, Mol Cellular & Dev Biol, 3131 Biol Sci 2, Santa Barbara, CA 93106 USA	California Institute of Technology; University of North Carolina; University of North Carolina - Asheville; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Yi, TM (corresponding author), Univ Calif Santa Barbara, Mol Cellular & Dev Biol, 3131 Biol Sci 2, Santa Barbara, CA 93106 USA.	tamu.yi@lifesci.ucsb.edu			NSF [DMS-1812843]; NIH [1R01GM113241]; National Institute of Health (NIH) NIGMS [R01-GM113241]; NIBIB [R01EB014877]; Department of Energy (DOE) [DESC0008975]; Institute for Collaborative Biotechnologies (ICB) [W911NF-090001]; U.S. Army Research Office; National Science Foundation (NSF) [DMS1001012]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health (NIH) NIGMS; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Department of Energy (DOE)(United States Department of Energy (DOE)); Institute for Collaborative Biotechnologies (ICB); U.S. Army Research Office; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	T.-M.Y. acknowledges funding from NSF DMS-1001006, NSF DMS-1812843, and NIH 1R01GM113241. L.P. acknowledges funding from National Institute of Health (NIH) NIGMS Award No. R01-GM113241 and NIBIB Award No. R01EB014877, Department of Energy (DOE) Award No. DESC0008975, Institute for Collaborative Biotechnologies (ICB) Award No. W911NF-090001 from the U.S. Army Research Office, and National Science Foundation (NSF) Award No. DMS1001012.	ABADIA J, 1992, J PLANT NUTR, V15, P1699, DOI 10.1080/01904169209364432; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; [Anonymous], 1991, Methods Enzymol, V194, P1; Arkowitz RA, 1997, J CELL BIOL, V138, P17, DOI 10.1083/jcb.138.1.17; Arkowitz RA, 2001, CURR BIOL, V11, pR610, DOI 10.1016/S0960-9822(01)00365-7; Aronov S, 2004, J BIOL CHEM, V279, P36962, DOI 10.1074/jbc.M402068200; Bach S, 2000, YEAST, V16, P1015, DOI 10.1002/1097-0061(200008)16:11<1015::AID-YEA607>3.3.CO;2-F; Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chou CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003103; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Donovan KW, 2015, J CELL BIOL, V210, P181, DOI 10.1083/jcb.201501118; Dorer R, 1997, GENETICS, V146, P39; Dunkler A, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202006193; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; GEHRUNG S, 1990, J CELL BIOL, V111, P1451, DOI 10.1083/jcb.111.4.1451; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Geitmann A, 2000, J MICROSC-OXFORD, V198, P218, DOI 10.1046/j.1365-2818.2000.00702.x; Ghose D, 2020, MOL BIOL CELL, V31, P1085, DOI 10.1091/mbc.E20-01-0040; Glomb O, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237982; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Graziano BR, 2011, MOL BIOL CELL, V22, P4016, DOI 10.1091/mbc.E11-05-0404; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hall AE, 2019, MOL BIOL CELL, V30, P441, DOI 10.1091/mbc.E18-04-0236; Heath IB, 2000, PLANT CELL, V12, P2295, DOI 10.1105/tpc.12.9.1513; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002271; Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Klunder B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003396; Kono K, 2005, YEAST, V22, P129, DOI 10.1002/yea.1205; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Lawson MJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003139; Locke MN, 2019, J CELL BIOL, V218, P961, DOI 10.1083/jcb.201807154; McClure AW, 2015, DEV CELL, V35, P471, DOI 10.1016/j.devcel.2015.10.024; Merlini L, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130008; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; NOVICK P, 1993, CIBA F SYMP, V176, P218; Pruyne D, 2000, J CELL SCI, V113, P365; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Savage NS, 2012, MOL BIOL CELL, V23, P1998, DOI 10.1091/mbc.E11-10-0837; Schekman R, 2010, MOL BIOL CELL, V21, P3781, DOI 10.1091/mbc.E10-05-0416; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Shih JL, 2005, MOL BIOL CELL, V16, P4595, DOI 10.1091/mbc.E05-02-0108; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Sprague GF, 1992, MOL CELLULAR BIOL YE, V2, P657; Tcheperegine SE, 2005, MOL CELL BIOL, V25, P8567, DOI 10.1128/MCB.25.19.8567-8580.2005; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017; Wang SC, 2017, NAT CELL BIOL, V19, P988, DOI 10.1038/ncb3577; Wang X, 2019, J CELL BIOL, V218, P3730, DOI 10.1083/jcb.201901155; Xie Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13125-1; Yuan JH, 2013, J MOL BIOL, V425, P1760, DOI 10.1016/j.jmb.2013.02.016	65	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263347	10.1371/journal.pone.0263347	http://dx.doi.org/10.1371/journal.pone.0263347			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134079	Green Accepted, Green Published, gold			2022-12-26	WOS:000798968600011
J	Jin, Y; Pan, YM; Zheng, S; Liu, Y; Xu, J; Peng, YZ; Zhang, ZM; Wang, YD; Xiong, YL; Xu, L; Mu, KY; Chen, SW; Zheng, F; Yuan, Y; Fu, J				Jin, Ying; Pan, Yamu; Zheng, Shuang; Liu, Yao; Xu, Jie; Peng, Yazhi; Zhang, Zemei; Wang, Yadong; Xiong, Yulian; Xu, Lei; Mu, Kaiyu; Chen, Suwen; Zheng, Fei; Yuan, Ye; Fu, Jian			Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; PROLYL HYDROXYLASE; INDEPENDENT INHIBITION; PYRUVATE-KINASE; PROMOTES; HYPOXIA; PHD3; HIF; DIFFERENTIATION	EGLN3 is critically important for growth of various cancers including lung cancer. However, virtually nothing is known about the role and mechanism for EGLN3 hydroxylase activity in cancers. EGLN3 catalyzes the hydroxylation of extracellular signal-regulated kinase 3 (Erk3), a potent driver of cancers. The role and mechanism for EGLN3-induced stabilization of Erk3 remain to be defined. Here, we show that Erk3 interacts with heat shock cognate protein of 70 kDa (HSC70) and lysosome-associated membrane protein type 2 A (LAMP2A), two core components of chaperone-mediated autophagy (CMA). As a consequence, Erk3 is degraded by the CMA-lysosome pathway. EGLN3-catalyzed hydroxylation antagonizes CMA-dependent destruction of Erk3. Mechanistically, hydroxylation blunts the interaction of Erk3 with LAMP2A, thereby blocking lysosomal decay of Erk3. EGLN3 inactivation inhibits macrophage migration, efferocytosis, and M2 polarization. Studies using EGLN3 catalytically inactive knock-in mice indicate that inactivation of EGLN3 hydroxylase in host cells ameliorates LLC cancer growth through reprogramming the tumor microenvironment (TME). Adoptive transfer of macrophages with inactivated EGLN3 restrains tumor growth by mounting anti-tumor immunity and restricting angiogenesis. Administration of EGLN3 hydroxylase pharmacologic inhibitor to mice bearing LLC carcinoma impedes cancer growth by targeting the TME. LLC cells harboring inactivated EGLN3 exhibit reduced tumor burden via mitigating immunosuppressive milieu and inducing cancer senescence. This study provides novel insights into the role of CMA in regulating Erk3 stability and the mechanism behind EGLN3-enhanced stability of Erk3. This work demonstrates that inactivation of EGLN3 in malignant and stromal cells suppresses tumor by orchestrating reciprocal interplays between cancer cells and the TME. This work sheds new light on the role and mechanism for EGLN3 catalytic activity in regulating cancer growth. Manipulating EGLN3 activity holds promise for cancer treatment.	[Jin, Ying; Pan, Yamu; Zheng, Shuang; Liu, Yao; Xu, Jie; Peng, Yazhi; Zhang, Zemei; Wang, Yadong; Xiong, Yulian; Xu, Lei; Mu, Kaiyu; Chen, Suwen; Zheng, Fei; Yuan, Ye; Fu, Jian] Hubei Univ Med, Lab Inflammat & Vasc Biol, Inst Clin Med, Renmin Hosp, Shiyan, Hubei, Peoples R China; [Jin, Ying; Pan, Yamu; Zheng, Shuang; Liu, Yao; Xu, Jie; Peng, Yazhi; Zhang, Zemei; Wang, Yadong; Xiong, Yulian; Xu, Lei; Mu, Kaiyu; Chen, Suwen; Zheng, Fei; Yuan, Ye; Fu, Jian] Hubei Univ Med, Dept Cardiol, Renmin Hosp, Shiyan, Hubei, Peoples R China; [Jin, Ying; Fu, Jian] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA; [Jin, Ying; Fu, Jian] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14627 USA; [Zheng, Shuang] Hubei Univ Med, Renmin Hosp, Dept Ultrasound, Shiyan, Hubei, Peoples R China; [Zhang, Zemei] Jinzhou Med Univ, Grad Sch, Jinzhou, Liaoning, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; University of Rochester; University of Rochester; Hubei University of Medicine; Jinzhou Medical University	Jin, Y; Fu, J (corresponding author), Hubei Univ Med, Lab Inflammat & Vasc Biol, Inst Clin Med, Renmin Hosp, Shiyan, Hubei, Peoples R China.; Jin, Y; Fu, J (corresponding author), Hubei Univ Med, Dept Cardiol, Renmin Hosp, Shiyan, Hubei, Peoples R China.; Jin, Y; Fu, J (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.; Jin, Y; Fu, J (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14627 USA.	jdyj0001@163.com; jianfu0326@163.com		Jin, Ying/0000-0002-8811-2204	National Natural Science Foundation of China [81872381]; Health Commission of Hubei Province Scientific Research Projects [WJ2019Z003, WJ2019M047]; Hubei University of Medicine; Hubei University of Medicine Renmin Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Commission of Hubei Province Scientific Research Projects; Hubei University of Medicine; Hubei University of Medicine Renmin Hospital	This work was funded by grants from the National Natural Science Foundation of China (81872381) and from the Health Commission of Hubei Province Scientific Research Projects (WJ2019Z003 and WJ2019M047) to Fu and Jin. This work was also supported by startup funds from the Hubei University of Medicine and the Hubei University of Medicine Renmin Hospital to Fu and Jin.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bogucka K, 2021, CANCER GENE THER, V28, P359, DOI 10.1038/s41417-020-00245-w; Carey KL, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108371; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Cerezo-Wallis D, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1073-3; Chen SW, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015513; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Conway EM, 2016, AM J RESP CRIT CARE, V193, P116, DOI 10.1164/rccm.201508-1545CI; Cortes M, 2017, EMBO J, V36, P3336, DOI 10.15252/embj.201797345; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dopeso H, 2018, CANCER RES, V78, P1805, DOI 10.1158/0008-5472.CAN-17-1346; Elkhadragy L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114044; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Franklin RA, 2016, TRENDS CANCER, V2, P20, DOI 10.1016/j.trecan.2015.11.004; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2016, CELL SIGNAL, V28, P72, DOI 10.1016/j.cellsig.2015.11.011; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Gonda TA, 2020, CANCER RES, V80, P4754, DOI 10.1158/0008-5472.CAN-20-0285; Gonzalez-Rodriguez P, 2021, AUTOPHAGY, V17, P1259, DOI 10.1080/15548627.2020.1816664; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Henze AT, 2016, J CLIN INVEST, V126, P3672, DOI 10.1172/JCI84427; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hogel H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0410-5; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Miikkulainen P, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0167-y; Rodriguez J, 2018, CELL REP, V24, P1316, DOI 10.1016/j.celrep.2018.06.108; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Roy S, 2018, CANCER RES, V78, P5600, DOI 10.1158/0008-5472.CAN-18-0562; Schodel J, 2019, NAT REV NEPHROL, V15, P641, DOI 10.1038/s41581-019-0182-z; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Tan BH, 2018, CANCER RES, V78, P4929, DOI 10.1158/0008-5472.CAN-18-0152; Valkenburg KC, 2018, NAT REV CLIN ONCOL, V15, P366, DOI 10.1038/s41571-018-0007-1; Wang Wei, 2018, Cancer Cell, V34, P757, DOI 10.1016/j.ccell.2018.10.006; Wang W, 2014, J CELL PHYSIOL, V229, P1529, DOI 10.1002/jcp.24596; Wang YS, 2020, EMBO REP, V21, DOI 10.15252/embr.201948335; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Xu YM, 2019, J BIOL CHEM, V294, P9949, DOI 10.1074/jbc.RA118.007181; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang M, 2018, CANCER RES, V78, P5492, DOI 10.1158/0008-5472.CAN-18-1367	55	4	4	3	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1752	1766		10.1038/s41388-022-02203-2	http://dx.doi.org/10.1038/s41388-022-02203-2		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35124697	hybrid, Green Published			2022-12-26	WOS:000751597800001
J	Huang, YX; Li, XD; Liu, ZF; Huo, JH; Guo, JW; Chen, YY; Chen, YM; Chen, RL				Huang, Yixiang; Li, Xiande; Liu, Zifeng; Huo, Jinhai; Guo, Jianwei; Chen, Yingying; Chen, Yanmei; Chen, Ruoling			Projections of the economic burden of care for individuals with dementia in mainland China from 2010 to 2050	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DEVELOPING-COUNTRIES; IMPACT; COSTS; LIFE	Background China has stepped into an era of aging society, where the impending considerable economic burden attributed to high prevalence of dementia in the elderly appears to be one of the most important health and social issues to deal with for the country. However, population-based quantification and projections for the economic burden of dementia in China are lacking for further health action and policy making. Objective To estimate and predict the costs of managing dementia in the elderly population aged 60 and above from 2010 to 2050 in China. Methods Data were collected from a six-province study (n = 7072) and other multiple sources for calculation of the economic burden of dementia. With the convincing data from published studies, we quantified and projected the costs attributed to dementia in China from 2010 to 2050. Results The national cost of dementia in 2010 was estimated to be US$22.8 billion by the opportunity cost method and US$26.4 billion by the proxy method. In 2050, the costs would increase to US$372.3 billion by the opportunity cost method and US$430.6 billion by the proxy method, consuming 0.53% and 0.61% of China's total GDP, respectively. A series sensitivity analyses showed that the changes in the proportions of informal caregiving led to the most robust changes in the total burden of care for dementia in China. Conclusion Dementia represents an enormous burden on China's population health and economy. Due to the changes in policies and population structure, policymakers should give priority to dementia care.	[Huang, Yixiang; Li, Xiande; Guo, Jianwei] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China; [Huang, Yixiang] Guangdong Hlth Econ Assoc, Guangzhou, Peoples R China; [Liu, Zifeng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Clin Data Ctr, Guangzhou, Peoples R China; [Huo, Jinhai] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Chen, Yingying] Guangdong Hosp Tradit Chinese Med, Guangzhou, Peoples R China; [Chen, Yanmei] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Chen, Ruoling] Univ Wolverhampton, Fac Educ Hlth & Wellbeing FEHW, Ctr Hlth & Social Care Improvement CHSCI, Millennium City Bldg, Wolverhampton, England; [Huang, Yixiang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Hlth Management, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State University System of Florida; University of Florida; Guangzhou University of Chinese Medicine; Sun Yat Sen University; University of Wolverhampton; Sun Yat Sen University	Huang, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China.; Huang, YX (corresponding author), Guangdong Hlth Econ Assoc, Guangzhou, Peoples R China.; Huang, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Hlth Management, Guangzhou, Peoples R China.	huangyx@mail.sysu.edu.cn	chen, ying/HHS-8254-2022	Huang, Yixiang/0000-0003-3370-148X; Chen, Ruoling/0000-0002-3033-8753	National Social Science Fund of China [18BGL218]; Research and Demonstration of Integrated Medical Care Model for Dementia and Hypertension Treatment and Rehabilitation Based on Artificial Intelligence [202002020047]; BUPA Foundation [45NOV06, TBF-M09-05]; Alzheimer's Research UK [ART/PPG2007B/2]	National Social Science Fund of China; Research and Demonstration of Integrated Medical Care Model for Dementia and Hypertension Treatment and Rehabilitation Based on Artificial Intelligence; BUPA Foundation; Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	This work was supported by the National Social Science Fund of China (grant no. 18BGL218),and Research and Demonstration of Integrated Medical Care Model for Dementia and Hypertension Treatment and Rehabilitation Based on Artificial Intelligence (grant no. 202002020047). The five-province cohort studies of dementia in China were funded by the BUPA Foundation (Grants Nos. 45NOV06, and TBF-M09-05) and Alzheimer's Research UK (Grant No. ART/PPG2007B/2).	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [安翠霞 An Cuixia], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P592; [Anonymous], 2010, CHIN STAT YB 2010; [Anonymous], 2004, MINIMUM WAGE STANDAR; [Anonymous], 2007, N 11 MORE ACRONYM; [Anonymous], 2017, WORLD POPULATION PRO; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen RL, 2013, BRIT J PSYCHIAT, V203, P203, DOI 10.1192/bjp.bp.112.119354; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jia JP, 2018, ALZHEIMERS DEMENT, V14, P483, DOI 10.1016/j.jalz.2017.12.006; Kuo LM, 2014, DEMENT GERIATR COGN, V38, P310, DOI 10.1159/000360414; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079955; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Mould-Quevedo JF, 2013, EXPERT REV PHARM OUT, V13, P663, DOI 10.1586/14737167.2013.838029; Prina AM, 2019, SOC PSYCH PSYCH EPID, V54, P1, DOI 10.1007/s00127-018-1626-7; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2013, POLICY BRIEF HEADS G; Prince M., 2016, WORLD ALZHEIMER REPO; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Stephan A, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0816-1; United Nations Population Information Network, 2015, WORLD POPULATION PRO, DOI [10.1016/j.jceh.2015.09.002, DOI 10.1016/J.JCEH.2015.09.002]; Wang G, 2008, J ALZHEIMERS DIS, V15, P109; Wang HL, 2010, AGEING INT, V35, P153, DOI 10.1007/s12126-010-9056-1; Wang J, 2014, AGING MENT HEALTH, V18, P986, DOI 10.1080/13607863.2014.899976; Wang J, 2014, J ADV NURS, V70, P1369, DOI 10.1111/jan.12299; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Xiao LD, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-6; Xu JF, 2017, B WORLD HEALTH ORGAN, V95, P18, DOI [10.2471/BLT.15.167726, 10.2471/blt.15.167726]	30	0	0	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263077	10.1371/journal.pone.0263077	http://dx.doi.org/10.1371/journal.pone.0263077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113895	Green Published, gold			2022-12-26	WOS:000823694700053
J	Greenwald, SD; Chamoun, NG; Manberg, PJ; Gray, J; Clain, D; Maheshwari, K; Sessler, DI				Greenwald, Scott D.; Chamoun, Nassib G.; Manberg, Paul J.; Gray, Josh; Clain, David; Maheshwari, Kamal; Sessler, Daniel, I			Covid-19 and excess mortality in medicare beneficiaries	PLOS ONE			English	Article								We estimated excess mortality in Medicare recipients in the United States with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29, 2020 through September 30, 2020, with mortality followed through November 30th, 2020. Probable and confirmed Covid-19 diagnoses, presumably mostly symptomatic, were determined from ICD-10 codes. We developed a Risk Stratification Index (RSI) mortality model which was applied prospectively to establish baseline mortality risk. Excess deaths attributable to Covid-19 were estimated by comparing actual-to-expected deaths based on historical (2017-2019) comparisons and in closely matched concurrent (2020) cohorts with and without Covid-19. Overall, 677,100 (2.4%) beneficiaries had confirmed Covid-19 and 2,917,604 (10.3%) had probable Covid-19. A total of 472,329 confirmed cases were community living and 204,771 were in LTC. Mortality following a probable or confirmed diagnosis in the community increased from an expected incidence of about 4.0% to actual incidence of 7.5%. In long-term care facilities, the corresponding increase was from 20.3% to 24.6%. The absolute increase was therefore similar at 3-4% in the community and in LTC residents. The percentage increase was far greater in the community (89.5%) than among patients in chronic care facilities (21.1%) who had higher baseline risk of mortality. The LTC population without probable or confirmed Covid-19 diagnoses experienced 38,932 excess deaths (34.8%) compared to historical estimates. Limitations in access to Covid-19 testing and disease under-reporting in LTC patients probably were important factors, although social isolation and disruption in usual care presumably also contributed. Remarkably, there were 31,360 (5.4%) fewer deaths than expected in community dwellers without probable or confirmed Covid-19 diagnoses. Disruptions to the healthcare system and avoided medical care were thus apparently offset by other factors, representing overall benefit. The Covid-19 pandemic had marked effects on mortality, but the effects were highly context-dependent.	[Greenwald, Scott D.; Chamoun, Nassib G.; Manberg, Paul J.; Gray, Josh; Clain, David] Hlth Data Analyt Inst, Dedham, MA 02026 USA; [Maheshwari, Kamal; Sessler, Daniel, I] Cleveland Clin, Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH 44106 USA; [Maheshwari, Kamal] Cleveland Clin, Anesthesiol Inst, Dept Gen Anesthesiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Greenwald, SD (corresponding author), Hlth Data Analyt Inst, Dedham, MA 02026 USA.	Scott.Greenwald@hda-institute.com		Greenwald, Scott/0000-0001-6067-2907; Chamoun, Nassib/0000-0001-6449-5194	Health Data Analytics Institute (HDAI); Robert Wood Johnson Foundation	Health Data Analytics Institute (HDAI); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was funded by Health Data Analytics Institute (HDAI) (www.hdainstitute.com).The funder provided support in the form of salaries for authors SDG, NCG, PJM, JG and DC, and HDAI consultant DIS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The Robert Wood Johnson Foundation provided support for access to the Covid-19 RSI365 risk prediction models by academic researchers for non-commercial purposes via the HDAI API (https://www.hda-institute.com/application-foruse-of-the-hdai-api/).	AHRQ, 2021, CLIN CLASS SOFTW REF; Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802; CDC, 2020, ICD 10 CM OFF COD RE; CDC, 2021, DIET INT AD AG 20 OV; Chamoun GF, 2017, ANESTHESIOLOGY, V126, P623, DOI 10.1097/ALN.0000000000001560; Chen YH, 2021, JAMA INTERN MED, V181, P705, DOI 10.1001/jamainternmed.2020.7578; CMS, 2021, COND CAT CHRON DAT W; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Dun C, 2020, MACHINE LEARNING STU; Experton B, 2020, PREDICTIVE MODEL SEV; Faust JS, 2021, JAMA-J AM MED ASSOC, V325, P785, DOI 10.1001/jama.2020.24243; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321; Islam N, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1137; Kadri SS, 2020, JAMA-J AM MED ASSOC, V324, P2553, DOI 10.1001/jama.2020.20323; Kowall B, 2021, J INFECTION, V82, pE32, DOI 10.1016/j.jinf.2020.11.028; Lauren M., 2020, EXCESS DEATHS ASS CO; Lopez-Leon S, 2021, SCI REP-UK, DOI DOI 10.1038/S41598-021-95565-8; Nguyen NT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0417; Rosenfeld RL, PANDEMIC SOCIAL UNRE; Stang A, 2020, J INFECTION, V81, P797, DOI 10.1016/j.jinf.2020.09.012; Stokes AC, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003571; Tenforde MW, 2021, JAMA-J AM MED ASSOC, V325, P1464, DOI 10.1001/jama.2021.1995; US Department of Transportation NHSA, 2021, TRAFF SAF FACTS; VanderWeele TJ, 2020, JAMA-J AM MED ASSOC, V324, P445, DOI 10.1001/jama.2020.12187; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang QQ, 2021, ALZHEIMERS DEMENT, V17, P1297, DOI 10.1002/alz.12296; Wang QQ, 2021, JAMA ONCOL, V7, P220, DOI 10.1001/jamaoncol.2020.6178; World Health Organization, 2020, COVID 19 COD ICD 10; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	30	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262264	10.1371/journal.pone.0262264	http://dx.doi.org/10.1371/journal.pone.0262264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108291	Green Submitted, Green Published, gold			2022-12-26	WOS:000775890100020
J	Richardson, KE; Roche, DP; Mugel, SG; Lancaster, ND; Sieving, KE; Freeberg, TM; Lucas, JR				Richardson, Katherine E. (Gentry); Roche, Daniel P.; Mugel, Stephen G.; Lancaster, Nolan D.; Sieving, Kathryn E.; Freeberg, Todd M.; Lucas, Jeffrey R.			Social dynamics of core members in mixed-species bird flocks change across a gradient of foraging habitat quality	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; POECILE-ATRICAPILLUS; COMMUNITY STRUCTURE; CAROLINA-CHICKADEES; INSECTIVOROUS BIRDS; INFORMATION; ASSOCIATION; NETWORKS; PATTERNS; BEHAVIOR	Social associations within mixed-species bird flocks can promote information flow about food availability and provide predator avoidance benefits. The relationship between flocking propensity, foraging habitat quality, and interspecific competition can be altered by human-induced habitat degradation. Here we take a close look at sociality within two ecologically important flock-leader (core) species, the Carolina chickadee (Poecile carolinensis) and tufted titmouse (Baeolophus bicolor), to better understand how degradation of foraging habitat quality affects mixed-species flocking dynamics. We compared interactions of free ranging wild birds across a gradient of foraging habitat quality in three managed forest remnants. Specifically, we examined aspects of the social network at each site, including network density, modularity, and species assortativity. Differences in the social networks between each end of our habitat gradient suggest that elevated levels of interspecific association are more valuable in the habitat with low quality foraging conditions. This conclusion is supported by two additional findings: First, foraging height for the subordinate Carolina chickadee relative to the tufted titmouse decreased with an increase in the number of satellite species in the most disturbed site but not in the other two sites. Second, the chickadee gargle call rate, an acoustic signal emitted during agonistic encounters between conspecifics, was relatively higher at the high-quality site. Collectively, these results suggest an increase in heterospecific associations increases the value of cross-species information flow in degraded habitats.	[Richardson, Katherine E. (Gentry); Roche, Daniel P.; Mugel, Stephen G.; Lancaster, Nolan D.; Lucas, Jeffrey R.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Sieving, Kathryn E.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Freeberg, Todd M.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA; [Freeberg, Todd M.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Richardson, Katherine E. (Gentry)] Florida Fish & Wildlife Conservat Commiss, Div Habitat & Species Conservat, Tallahassee, FL 32399 USA; [Roche, Daniel P.] West Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Mugel, Stephen G.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Lancaster, Nolan D.] Conservat Volunteers Australia, Morningside, Qld, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Florida Fish & Wildlife Conservation Commission; West Virginia University; Colorado State University	Richardson, KE (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.; Richardson, KE (corresponding author), Florida Fish & Wildlife Conservat Commiss, Div Habitat & Species Conservat, Tallahassee, FL 32399 USA.	Katherine.Richardson@MyFWC.com	; Sieving, Kathryn/I-6058-2013	Gentry, Katherine/0000-0002-0006-7403; Sieving, Kathryn/0000-0002-0849-8101; Mugel, Stephen/0000-0003-1078-5078	National Science Foundation, Division of Integrative Organismal Systems [NSF1353326-ios, NSF1353308-ios, NSF1353327-ios]	National Science Foundation, Division of Integrative Organismal Systems(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Division of Integrative Organismal Systems (https://www.nsf.gov/div/index.jsp?div=IOS; [NSF1353326-ios, 2014 awarded to JRL; NSF1353308-ios, 2014 awarded to KES; and NSF1353327-ios, 2014 to TMF]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Aplin LM, 2015, NATURE, V518, P538, DOI 10.1038/nature13998; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baker MC, 2000, ETHOLOGY, V106, P819, DOI 10.1046/j.1439-0310.2000.00602.x; Baker TM, 2012, ANIM BEHAV, V84, P965, DOI 10.1016/j.anbehav.2012.07.022; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Bonamour S, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0178; BREWER RICHARD, 1963, AUK, V80, P9; Bridge ES, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00257; Burger C, 2012, J ANIM ECOL, V81, P926, DOI 10.1111/j.1365-2656.2012.01968.x; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; CIMPRICH DA, 1994, ECOLOGY, V75, P1615, DOI 10.2307/1939622; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dolby AS, 1998, ANIM BEHAV, V56, P501, DOI 10.1006/anbe.1998.0808; Dolby AS, 2000, BEHAV ECOL, V11, P110, DOI 10.1093/beheco/11.1.110; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Farine DR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2804; Farine DR, 2014, ANIM BEHAV, V95, P173, DOI 10.1016/j.anbehav.2014.07.008; Farine DR, 2013, BEHAV ECOL SOCIOBIOL, V67, P321, DOI 10.1007/s00265-012-1452-y; Farine DR, 2012, ANIM BEHAV, V84, P1271, DOI 10.1016/j.anbehav.2012.08.008; Farine DR., 2017, R PACKAGE VERSION, V1; Fernandez-Juricic E, 2002, ECOSCIENCE, V9, P450, DOI 10.1080/11956860.2002.11682733; Firth JA, 2015, CURR BIOL, V25, P3138, DOI 10.1016/j.cub.2015.09.075; Fort KT, 2004, AUK, V121, P1070, DOI 10.1642/0004-8038(2004)121[1070:EOHDOR]2.0.CO;2; Fort KT, 2004, ANIM BEHAV, V68, P407, DOI 10.1016/j.anbehav.2003.08.023; Gentry KE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209680; Gil MA, 2018, TRENDS ECOL EVOL, V33, P535, DOI 10.1016/j.tree.2018.04.010; Gil MA, 2017, AM NAT, V189, P227, DOI 10.1086/690055; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Mangini GG, 2018, BIOTROPICA, V50, P816, DOI 10.1111/btp.12551; Goodale E, 2020, BIOL REV, V95, P889, DOI 10.1111/brv.12591; Goodale E, 2015, AVIAN RES, V6, DOI 10.1186/s40657-015-0023-0; Goodale E, 2010, J AVIAN BIOL, V41, P99, DOI 10.1111/j.1600-048X.2009.04828.x; Greenberg RS., 2001, MOVE WHY ANIMALS TRA; GRUBB TC, 1987, ANIM BEHAV, V35, P794, DOI 10.1016/S0003-3472(87)80116-1; Grubb TC ., 2020, BIRDS OF THE WORLD; Harrap S., 1995, CHICKADEES TITS NUTH; Harrison NM, 2011, ANIM BEHAV, V81, P675, DOI 10.1016/j.anbehav.2011.01.013; He P, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-018-2602-7; Hsieh FS, 2011, J ORNITHOL, V152, P955, DOI 10.1007/s10336-011-0678-1; Jackson JA, 2020, BIRDS OF THE WORLD; Jiang DM, 2020, ECOL EVOL, V10, P5368, DOI 10.1002/ece3.6280; Johnson KVA, 2017, ANIM BEHAV, V128, P21, DOI 10.1016/j.anbehav.2017.04.001; Jones TB, 2017, ANIM BEHAV, V129, P93, DOI 10.1016/j.anbehav.2017.05.011; Kawamori A, 2012, ANIM BEHAV, V84, P1001, DOI 10.1016/j.anbehav.2012.07.026; Krams I, 1998, ORNIS FENNICA, V75, P19; Krams IA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60144-w; Lantz SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183144; Leu ST, 2016, ANIM BEHAV, V111, P23, DOI 10.1016/j.anbehav.2015.10.001; Lucas Jeffrey R., 2007, P199; Lucas JR, 2006, HORM BEHAV, V49, P634, DOI 10.1016/j.yhbeh.2005.12.012; Mammides C, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2324; MANLY BFJ, 1995, ECOLOGY, V76, P1109, DOI 10.2307/1940919; Martinez AE, 2018, ANIM BEHAV, V135, P25, DOI 10.1016/j.anbehav.2017.10.024; Matthysen E, 2008, ORNITOL NEOTROP, V19, P403; Mokross K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2599; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Mostrom AM, 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.carchi.01, DOI 10.2173/BOW.CARCHI.01]; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nolen MT, 2009, ANIM BEHAV, V77, P1137, DOI 10.1016/j.anbehav.2009.01.023; Oh KP, 2010, AM NAT, V176, pE80, DOI 10.1086/655216; PERRET P, 1993, EXPERIENTIA, V49, P94, DOI 10.1007/BF01928800; Pierce AR, 2006, NAT AREA J, V26, P351, DOI 10.3375/0885-8608(2006)26[351:FSIAOD]2.0.CO;2; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R Core Team, 2021, R LANG ENV STAT; Ritchison G., 2015, BIRDS N AM; Rubenstein DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138645; Rutz C, 2012, CURR BIOL, V22, pR669, DOI 10.1016/j.cub.2012.06.037; Ryder TB, 2012, BIOL LETTERS, V8, P917, DOI 10.1098/rsbl.2012.0536; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Shizuka D, 2016, ANIM BEHAV, V112, P237, DOI 10.1016/j.anbehav.2015.12.007; Shizuka D, 2014, ECOL LETT, V17, P998, DOI 10.1111/ele.12304; Silk MJ, 2014, IBIS, V156, P701, DOI 10.1111/ibi.12191; Smith ST., 1972, PUBL NUTTALL ORNITHO, V11, P1; Sridhar H, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0014; Sridhar H, 2012, AM NAT, V180, P777, DOI 10.1086/668012; Stokman FN., NETWORKS SOCIAL; Strandburg-Peshkin A, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0006; Tremblay I, 2005, IBIS, V147, P17, DOI 10.1111/j.1474-919x.2004.00312.x; Veit RR, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00121; WAITE TA, 1988, CONDOR, V90, P132, DOI 10.2307/1368442; Whitehead H., 2005, ANIM BEHAV, V69, pE1, DOI [10.1016/j.anbehav.2004.11.004, DOI 10.1016/J.ANBEHAV.2004.11.004]; Wickham H, INGGPLOT2 2016, P11; Zou FS, 2018, BIOL CONSERV, V224, P267, DOI 10.1016/j.biocon.2018.06.004	87	0	0	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262385	10.1371/journal.pone.0262385	http://dx.doi.org/10.1371/journal.pone.0262385			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108278	Green Published, gold			2022-12-26	WOS:000775890100021
J	Soeroto, AY; Nurhayati, RD; Purwiga, A; Lestari, BW; Pratiwi, C; Santoso, P; Kulsum, ID; Suryadinata, H; Ferdian, F				Soeroto, Arto Yuwono; Nurhayati, Raden Desy; Purwiga, Aga; Lestari, Bony Wiem; Pratiwi, Chica; Santoso, Prayudi; Kulsum, Iceu Dimas; Suryadinata, Hendarsyah; Ferdian, Ferdy			Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; CULTURE CONVERSION; PREDICTORS; DISEASE; MALNUTRITION; MANAGEMENT; ANEMIA; IMPACT	Background and aims Multi drug or rifampicin resistant tuberculosis (MDR/RR-TB) is a major burden to TB prevention and eradication globally. Since 2016, WHO guidelines have included options for treating MDR/RR-TB with a standard regimen of 9 to 11 months duration (the 'shorter regimen') rather than an individual regimen of at least 20 months. This regimen has been introduced in Indonesia since September 2017. Therefore, we aimed to determine the success rate and factors associated with the treatment outcome of shorter injectable based regimen in West Java province, Indonesia. Methods This was a retrospective cohort study of MDR/RR-TB patients aged over 18 years old who received the shorter injectable based regimen between September 2017 and December 2020. We defined successful outcomes as the combined proportion of patients who were cured or had complete treatment. While, unsuccessful outcomes were defined as the combined proportion of patients who died from any causes, failure, and loss to follow-up (LTFU). Results A total of 315 patients were included in this study. The success rate was 64.5%. Multivariate analysis showed male gender (aRR = 1.18, 95% CI 1.04 to 1.34) increased the chance of successful outcome, while malnutrition (aRR = 0.78, 95% CI 0.68 to 0.89), history of previous TB treatment (aRR = 0.80%CI 0.68 to 0.94), and time of culture conversion >2 months (aRR = 0.72 (95% CI 0.59 to 0.87) decreased the chance of successful outcome. Conclusion History of previous TB treatment, time of culture conversion >2 months, and malnutrition were independent factors that decrease the chance for success rate, while male gender increase the likelihood for success rate of patients treated by the shorter injectable based regimen.	[Soeroto, Arto Yuwono; Nurhayati, Raden Desy; Santoso, Prayudi; Kulsum, Iceu Dimas; Suryadinata, Hendarsyah; Ferdian, Ferdy] Univ Padjadjaran, Hasan Sadikin Gen Hosp, Div Respirol & Crit Care Med, Dept Internal Med,Fac Med, Bandung, West Java, Indonesia; [Soeroto, Arto Yuwono; Nurhayati, Raden Desy; Purwiga, Aga; Pratiwi, Chica; Santoso, Prayudi; Kulsum, Iceu Dimas; Suryadinata, Hendarsyah; Ferdian, Ferdy] Univ Padjadjaran, Hasan Sadikin Hosp, Dept Internal Med, Fac Med, Bandung, West Java, Indonesia; [Nurhayati, Raden Desy] Rotinsulu Pulm Hosp, Dept Internal Med, Bandung, West Java, Indonesia; [Lestari, Bony Wiem] Rotinsulu Pulm Hosp, Fac Med, Dept Publ Hlth, Bandung, Indonesia; [Lestari, Bony Wiem] Univ Padjadjaran, TB HIV Res Ctr, Fac Med, Bandung, Indonesia; [Pratiwi, Chica] Cimacan Hosp, Dept Internal Med, Cianjur, West Java, Indonesia	Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Universitas Padjadjaran	Soeroto, AY (corresponding author), Univ Padjadjaran, Hasan Sadikin Gen Hosp, Div Respirol & Crit Care Med, Dept Internal Med,Fac Med, Bandung, West Java, Indonesia.; Soeroto, AY (corresponding author), Univ Padjadjaran, Hasan Sadikin Hosp, Dept Internal Med, Fac Med, Bandung, West Java, Indonesia.	aysoeroto@yahoo.co.id		Soeroto, Arto Yuwono/0000-0001-9027-2453; , Purwiga/0000-0002-3093-8409				Abidi S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01467-2019; Agustina R, 2018, JURNAL EPIDEMIOLOGI; Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Bahi G. A., 2017, International Journal of Biological and Chemical Sciences, V11, P1039, DOI 10.4314/ijbcs.v11i3.9; Basit A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093206; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Colijn C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018327; Das PJ, 2022, EDUC PRIM CARE, DOI 10.1080/14739879.2022.2137856; Das PK, 2020, BIOMED BIOTECH RES J, V4, P143, DOI 10.4103/bbrj.bbrj_131_19; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Eshetie S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2323-y; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2006, GEND PERSP DRUG US R; Falzon D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02308-2016; Gadallah MA, 2016, J FORMOS MED ASSOC, V115, P997, DOI 10.1016/j.jfma.2015.10.002; Girum T, 2017, ANN MED HEALTH SCI R, V7, P331; Hammerly C, 2022, LINGUIST INQ, V53, P823, DOI 10.1162/ling_a_00422; Harries AD, 2016, T ROY SOC TROP MED H, V110, P173, DOI 10.1093/trstmh/trv111; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Irbah SN, 2019, INT J INFECT DIS, V79, P91, DOI 10.1016/j.ijid.2018.11.228; Janmeja A K, 2018, Indian J Tuberc, V65, P135, DOI 10.1016/j.ijtb.2017.12.015; Javaid A, 2018, CLIN MICROBIOL INFEC, V24, P612, DOI 10.1016/j.cmi.2017.09.012; Karo B, 2015, EUROSURVEILLANCE, V20, P18, DOI 10.2807/1560-7917.ES.2015.20.49.30087; Ketema DB, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7838-2; Khan FA, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00061-2017; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Lee HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103768; Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028; Leveri Tamary Henry, 2019, Tuberc Res Treat, V2019, P3569018, DOI 10.1155/2019/3569018; Liu Q, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3021-0; Lv LS, 2018, INFECT DRUG RESIST, V11, P147, DOI 10.2147/IDR.S153499; Maharjan S., 2017, J TUBERCULOSIS RES, V5, P106; Melese Addisu, 2018, BMC Res Notes, V11, P25, DOI 10.1186/s13104-018-3129-8; Nagu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091229; Nair D, 2017, PUBLIC HEALTH ACTION, V7, P32, DOI 10.5588/pha.16.0055; Pefura-Yone EW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-138; Podewils LJ, 2011, EPIDEMIOL INFECT, V139, P113, DOI 10.1017/S0950268810000907; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Reis-Santos B, 2013, J BRAS PNEUMOL, V39, P585, DOI 10.1590/S1806-37132013000500009; Riza AL, 2014, LANCET DIABETES ENDO, V2, P740, DOI 10.1016/S2213-8587(14)70110-X; Sayem MA., 2020, J TUBERCULOSIS RES, V8, P223; Soeroto AY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246284; Soeroto AY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213017; Tamsil TA., 2014, J RESP INDO, V34, P109; Gler MT, 2013, AM J TROP MED HYG, V89, P943, DOI 10.4269/ajtmh.13-0011; Tiwari Simmi, 2012, Indian J Tuberc, V59, P135; Tola H, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-040862; Trubnikov A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084121; Urbanowski ME, 2020, LANCET INFECT DIS, V20, pE117, DOI 10.1016/S1473-3099(20)30148-1; Wahid A, 2021, AM J TROP MED HYG, V104, P1784, DOI 10.4269/ajtmh.20-1134; Wen YF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3019-7; World Health Organization, 2013, GUIDELINES MANAGEMEN	55	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263304	10.1371/journal.pone.0263304	http://dx.doi.org/10.1371/journal.pone.0263304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089981	Green Published, gold			2022-12-26	WOS:000769158400052
J	He, ZR; Zhou, TT				He, Zhuoran; Zhou, Tingtao			A model for cooperative scientific research inspired by the ant colony algorithm	PLOS ONE			English	Article							SCIENCE	Modern scientific research has become largely a cooperative activity in the Internet age. We build a simulation model to understand the population-level creativity based on the heuristic ant colony algorithm. Each researcher has two heuristic parameters characterizing the goodness of his own judgments and his trust on literature. We study how the distributions of contributor heuristic parameters change with the research problem scale, stage of the research problem, and computing power available. We also identify situations where path dependence and hasty research due to the pressure on productivity can significantly impede the long-term advancement of scientific research. Our work provides some preliminary understanding and guidance for the dynamical process of cooperative scientific research in various disciplines.	[He, Zhuoran] Hubei Univ, Sch Phys & Elect Sci, Wuhan, Hubei, Peoples R China; [He, Zhuoran] Huazhong Univ Sci & Technol, Sch Phys, Wuhan, Hubei, Peoples R China; [Zhou, Tingtao] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	Hubei University; Huazhong University of Science & Technology; California Institute of Technology	He, ZR (corresponding author), Hubei Univ, Sch Phys & Elect Sci, Wuhan, Hubei, Peoples R China.; He, ZR (corresponding author), Huazhong Univ Sci & Technol, Sch Phys, Wuhan, Hubei, Peoples R China.; Zhou, TT (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	zhuoranh@hubu.edu.cn; edmondztt@gmail.com			Cecil and Sally Drinkward Fellowship	Cecil and Sally Drinkward Fellowship	We thank the helpful discussions with colleagues in Department of physics at Caltech. T. Z. acknowledges support by the Cecil and Sally Drinkward Fellowship.	ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; [Anonymous], 2021, J ECON DYN CONTROL, V130, DOI [10.1016/j.jedc.2021.104200, DOI 10.1016/J.JEDC.2021.104200]; Applegate D., 2006, CONCORDE TSP SOLVER; Applegate DL, 2009, OPER RES LETT, V37, P11, DOI 10.1016/j.orl.2008.09.006; Axelrod R., 1997, COMPLEXITY COOPERATI, V3; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bazzani A., 2009, TRAFFIC CROWD DYNAMI, P9411, DOI [10.1007/978-0-387-30440-3_561, DOI 10.1007/978-0-387-30440-3_561]; Bloom N, 2020, AM ECON REV, V110, P1104, DOI 10.1257/aer.20180338; Boeing P, 2020, ECON LETT, V197, DOI 10.1016/j.econlet.2020.109646; Chu JSG, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021636118; CROES GA, 1958, OPER RES, V6, P791, DOI 10.1287/opre.6.6.791; DAVID PA, 1985, AM ECON REV, V75, P332; Dorigo M, 1996, IEEE T SYST MAN CY B, V26, P29, DOI 10.1109/3477.484436; Dorigo M., 1991, DISTRIBUTED OPTIMIZA, DOI [10.1111/j.1476-5381.1991.tb12519.x, DOI 10.1111/J.1476-5381.1991.TB12519.X]; Dorigo M, 1992, THESIS; Durve M, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.012402; FLOOD MM, 1956, OPER RES, V4, P61, DOI 10.1287/opre.4.1.61; Fong EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187394; Fortunato S, 2018, SCIENCE, V359, DOI 10.1126/science.aao0185; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Gibbons M, 2018, TECHNICAL OUTREACH C, P37; Ginsparg P, 2011, NATURE, V476, P145, DOI 10.1038/476145a; Gold ER, 2021, RES POLICY, V50, DOI 10.1016/j.respol.2021.104226; GOLDMAN AI, 1991, PHILOS STUD, V63, P31, DOI 10.1007/BF00375996; Goodrum AA, 2001, INFORM PROCESS MANAG, V37, P661, DOI 10.1016/S0306-4573(00)00047-9; Hicks D, 2012, RES POLICY, V41, P251, DOI 10.1016/j.respol.2011.09.007; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Holmberg Kim, 2014, Scientometrics, V101, P1027, DOI 10.1007/s11192-014-1229-3; Hurd JM, 2000, J AM SOC INFORM SCI, V51, P1279, DOI 10.1002/1097-4571(2000)9999:9999<::AID-ASI1044>3.0.CO;2-1; Karamched B, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.218302; Kealey T., 1996, EC LAWS SCIENTIFIC R; Larson RC, 2014, SYST RES BEHAV SCI, V31, P745, DOI 10.1002/sres.2210; Leydesdorff L, 1998, SCIENTOMETRICS, V43, P5, DOI 10.1007/BF02458391; Li ZY, 2020, J COMB THEORY A, V175, DOI 10.1016/j.jcta.2020.105257; Lim IS, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.062113; Massey C., 2006, QUALITATIVE RES, V6, P131, DOI [DOI 10.1177/1468794106062706, 10.1177/1468794106062706]; Milojevic S, 2014, P NATL ACAD SCI USA, V111, P3984, DOI 10.1073/pnas.1309723111; Muscio A, 2013, RES POLICY, V42, P63, DOI 10.1016/j.respol.2012.04.010; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Packalen M, 2020, P NATL ACAD SCI USA, V117, P12011, DOI 10.1073/pnas.1910160117; Slade G., 2019, SELF AVOIDING WALK C; Sonubi A, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.022303; Tang SJ, 2022, SCI CHINA LIFE SCI, V65, P753, DOI 10.1007/s11427-021-1974-7; Tiokhin L, NAT HUM BEHAV, V20; Wakeling J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051920; Wills TJ, 2020, ACS MED CHEM LETT, V11, P2114, DOI 10.1021/acsmedchemlett.0c00319; Wu LF, 2019, NATURE, V566, P378, DOI 10.1038/s41586-019-0941-9; Wu ZX, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012802; Yin GZ, 2017, SCI CHINA CHEM, V60, P338, DOI 10.1007/s11426-016-0436-x	49	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262933	10.1371/journal.pone.0262933	http://dx.doi.org/10.1371/journal.pone.0262933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085346	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000779379600099
J	Rawal, N; Pande, KR; Shrestha, R; Vista, SP				Rawal, Nabin; Pande, Keshab Raj; Shrestha, Renuka; Vista, Shree Prasad			Nutrient use efficiency (NUE) of wheat (Triticum aestivum L.) as affected by NPK fertilization	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; INDO-GANGETIC PLAINS; CROP PRODUCTIVITY; WINTER-WHEAT; YIELD; MANAGEMENT; POTASSIUM; SYSTEM	Nutrient use efficiency is crucial for increasing crop yield and quality while reducing fertilizer inputs and minimizing environmental damage. The experiments were carried out in silty clay loam soil of Lalitpur, Nepal, to examine how different amounts of nitrogen (N), phosphorus (P), and potassium (K) influenced crop performance and nutrient efficiency indices in wheat during 2019/20 and 2020/21. The field experiment comprised three factorial randomized complete block designs that were replicated three times. N levels (100, 125, 150 N kg ha(-1)), P levels (25, 50, 75 P2O5 kg ha(-1)), and K levels (25, 50, 75 K2O kg ha(-1)) were three factors evaluated, with a total of 27 treatment combinations. Grain yields were significantly increased by N and K levels and were optimum @ 125 kg N ha(-1) and @ 50 kg K2O ha(-1) with grain yields of 6.33 t ha(-1) and 6.30 t ha(-1), respectively. Nutrient levels influenced statistically partial factor productivity, internal efficiency, partial nutrient budget, recovery efficiency, agronomic efficiency, and physiological efficiency of NPK for wheat. Nutrient efficiency was found to be higher at lower doses of their respective nutrients. Higher P and K fertilizer rates enhanced wheat N efficiencies, and the case was relevant for P and K efficiencies as well. Wheat was more responsive to N and K fertilizer, and a lower rate of P application reduced N and K fertilizer efficiency. This study recommends to use N @ 125 kg ha(-1), P2O5 @ 25 kg ha(-1) and K2O @ 50 kg ha(-1) as an optimum rate for efficient nutrient management in wheat in mid-hills of Nepal.	[Rawal, Nabin; Pande, Keshab Raj] Agr & Forestry Univ, Dept Soil Sci & Agriengn, Chitwan, Bagmati, Nepal; [Rawal, Nabin; Vista, Shree Prasad] Nepal Agr Res Council, Natl Soil Sci Res Ctr, Lalitpur, Bagmati, Nepal; [Shrestha, Renuka] Nepal Agr Res Council, Natl Agron Res Ctr, Lalitpur, Bagmati, Nepal		Rawal, N (corresponding author), Agr & Forestry Univ, Dept Soil Sci & Agriengn, Chitwan, Bagmati, Nepal.; Rawal, N (corresponding author), Nepal Agr Res Council, Natl Soil Sci Res Ctr, Lalitpur, Bagmati, Nepal.	sargamsagar10@gmail.com		Rawal, Nabin/0000-0001-6231-1232	Nepal Agricultural Study Council; Nepal Seed and Fertilizer Project/CIMMYT; National Soil Science Research Centre; National Agronomy Research Centre in Khumaltar	Nepal Agricultural Study Council; Nepal Seed and Fertilizer Project/CIMMYT; National Soil Science Research Centre; National Agronomy Research Centre in Khumaltar	The financial support for carrying out the research program was provided by Nepal Agricultural Study Council and Nepal Seed and Fertilizer Project/CIMMYT. The funders had no involvement in the study design, data collection and analysis, publication decision, or manuscript preparation.; We would like to express their gratitude to the National Soil Science Research Centre and the National Agronomy Research Centre in Khumaltar for providing the required resources and support for the study's successful completion.	Agriculture Information and Training Center, AGR DIAR; Alok Tiwari, 2002, Journal of the Indian Society of Soil Science, V50, P472; Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Asadi GA., 2014, J AGR SCI SUSTAINABL, V23, P157; Ashutosh Barthwal, 2013, Indian Journal of Agronomy, V58, P208; Brady N. C., 1984, The nature and properties of soils.; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Brhane H, 2017, COGENT FOOD AGR, V3, DOI 10.1080/23311932.2017.1347022; Buah S. S. J., 2009, Journal of Agronomy, V8, P124; Burlacu G., 2007, Analele Institutului National de Cercetare-Dezvoltare Agricola Fundulea, V75, P287; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Dai XQ, 2010, NUTR CYCL AGROECOSYS, V86, P301, DOI 10.1007/s10705-009-9293-4; Dhillon J, 2017, AGRON J, V109, P1670, DOI 10.2134/agronj2016.08.0483; Dobermann A., 2007, Fertilizer best management practices: general principles, strategy for their adoption and voluntary initiatives vs regulations. Papers presented at the IFA International Workshop on Fertilizer Best Management Practices, Brussels, Belgium, 7-9 March, 2007, P1; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Dobermann A., 2005, AGRON FAC PUBL, V316, P1; Fageria NK., 2016, USE NUTR CROP PLANTS; Fixen P, 2015, MANAGING WATER FERTI, V270; Fixen P. E., 2009, Better Crops with Plant Food, V93, P12; Fixen PE., 2010, BOAS PRATICAS USO EF, P01; Fresew Belete, 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0242-9; Fresew Belete, 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0231-z; Ghosh B.N., 2015, NUTR USE EFFICIENCY, P17, DOI [10.1007/978-81-322-2169-2_2, DOI 10.1007/978-81-322-2169-2_2]; Godebo T., 2021, ENV SYSTEMS RES, V10, P1, DOI DOI 10.1186/S40068-020-00210-4; Good AG, 2007, CAN J BOT, V85, P252, DOI 10.1139/B07-019; Gul H., 2011, ARPNJ AGR BIOL SCI, V6; Haile D, 2012, J SOIL SCI PLANT NUT, V12, P389, DOI 10.4067/S0718-95162012005000002; Heinemann AB., 2006, BRAZILIAN J AGR ENV, V10, P352; Hirniak JN, 2018, EVALUATION NITROGEN; Hooper P, 2010, THESIS; Hussain M. I., 2002, International Journal of Agriculture and Biology, V4, P362; International Plant Nutrition Institute (IPNI), 2012, NUTR US INF SYST NUG; Jabbar A., 2009, SOIL ENV PAKISTAN; Jamal Z., 2006, J AGRONOMY; Karki KB., 2000, INT SEM WORKSH FOOD, P28; Khatri-Chhetri TB., 1991, INTRO SOILS SOIL FER, P233; Kidanu S, 2000, CAN J SOIL SCI, V80, P63, DOI 10.4141/S99-008; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Li LI., 2013, CHIN J APPL ECOL, V24; Litke L, 2017, RES RURAL DEV, P54, DOI 10.22616/rrd.23.2017.049; Liu D., 2013, ADV J FOOD SCI TECHN, V5, P646, DOI [10.19026/ajfst.5.3141, DOI 10.19026/AJFST.5.3141]; Liu XY, 2011, AGRON J, V103, P1452, DOI 10.2134/agronj2010.0476; Maiti D, 2006, THESCIENTIFICWORLDJO, V6, P231, DOI 10.1100/tsw.2006.43; Mandic V, 2015, CHIL J AGR RES, V75, P92, DOI 10.4067/S0718-58392015000100013; Melesse Harfe, 2017, African Journal of Agricultural Research, V12, P1646, DOI 10.5897/AJAR2015.10545; Miah MAM., 2008, BANGLADESH J AGR ENV, V4, P51; Mojid MA, 2012, J SOIL SCI PLANT NUT, V12, P655, DOI 10.4067/S0718-95162013005000010; Muhammad Tariq, 2011, Sarhad Journal of Agriculture, V27, P415; Niu JF, 2013, FIELD CROP RES, V140, P69, DOI 10.1016/j.fcr.2012.10.008; Noureldin N. A., 2013, Annals of Agricultural Science (Cairo), V58, P147, DOI 10.1016/j.aoas.2013.07.012; Nyamangara J, 2003, J ENVIRON QUAL, V32, P599, DOI 10.2134/jeq2003.0599; Ojha RB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248837; Pathak H, 2003, NUTR CYCL AGROECOSYS, V65, P105, DOI 10.1023/A:1022177231332; Piper CS., 1966, SOIL PLANTS ANAL; Prasad SK., 2019, GATES OPEN RES, V3, P68; Ramachandran S, 2016, J PLANT NUTR, V39, P1039, DOI 10.1080/01904167.2015.1087028; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Rawal N., 2016, INT J APPL SCI BIOTE, V4, P489, DOI [10.3126/ijasbt.v4i4.16250, DOI 10.3126/IJASBT.V4I4.16250]; Ray K, 2018, EXP AGR, V54, P874, DOI [10.1017/S001447971700045X, 10.1017/s001447971700045x]; Regmi AP, 2002, BIOL FERT SOILS, V36, P240, DOI 10.1007/s00374-002-0525-x; Roberts TL, 2008, TURK J AGRIC FOR, V32, P177; Saha P. K., 2010, Bangladesh Journal of Agricultural Research, V35, P207, DOI 10.3329/bjar.v35i2.5883; Sarkar D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95092-6; Serret MD, 2008, ANN APPL BIOL, V153, P243, DOI 10.1111/j.1744-7348.2008.00259.x; Shao HB, 2007, COLLOID SURFACE B, V54, P143, DOI 10.1016/j.colsurfb.2006.09.004; Singh VK, 2010, FIELD CROP RES, V116, P127, DOI 10.1016/j.fcr.2009.12.002; Snyder C.S., 2007, NUTRIENT USE EFFICIE; SOLOMON W, 2017, INT J SCI RES, V7, P452; STEEL R. G. D., 1960, Principles and procedures of statistics.; Tana T., 2015, E AFRICAN J SCI, V9, P15; Tariq Jan, 2007, Sarhad Journal of Agriculture, V23, P871; Zemichael B, 2017, OPEN AGRIC, V2, P611, DOI 10.1515/opag-2017-0065; Zhang Z, 2021, PEERJ, V9, DOI 10.7717/peerj.11467; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157; Zingore S, 2007, FIELD CROP RES, V101, P296, DOI 10.1016/j.fcr.2006.12.006	75	2	2	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262771	10.1371/journal.pone.0262771	http://dx.doi.org/10.1371/journal.pone.0262771			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085333	gold, Green Published			2022-12-26	WOS:000779379600080
J	Wang, ZY; Xiao, JW; Li, JW; Li, HJ; Wang, LM				Wang, Ziyi; Xiao, Jiewen; Li, Jingwen; Li, Hongjun; Wang, Luman			WBC-AMNet: Automatic classification of WBC images using deep feature fusion network based on focalized attention mechanism	PLOS ONE			English	Article								The recognition and classification of White Blood Cell (WBC) play a remarkable role in blood-related diseases (i.e., leukemia, infections) diagnosis. For the highly similar morphology of different WBC subtypes, it is too confused to classify the WBC effectively and accurately for visual observation of blood cell smears. This paper proposes a Deep Convolutional Neural Network (DCNN) with feature fusion strategies, named WBC-AMNet, for automatically classifying WBC subtypes based on focalized attention mechanism. To obtain more localized attention of CNN, the fusion features of the first and the last convolutional layer are extracted by focalized attention mechanism combining Squeeze-and-Excitation (SE) and Gather-Excite (GE) modules. The new method performs successfully in classifying monocytes, neutrophils, lymphocytes, and eosinophils on the complex background with an overall accuracy of 95.66%, better than that of general CNNs. The multi-classification accuracy of WBC-AMNet with the background segmentation is over 98% in all cases. In addition, Gradient-weighted Class Activation Mapping (Grad-CAM) is employed to visualize the attention heatmaps of different feature maps.	[Wang, Ziyi; Li, Jingwen; Li, Hongjun] Beijing Forestry Univ, Coll Sci, Beijing, Peoples R China; [Xiao, Jiewen] Beijing Forestry Univ, Coll Environm Sci & Engn, Beijing, Peoples R China; [Wang, Luman] Peking Univ, Dept Hlth Informat & Management, Hlth Sci Ctr, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Peking University	Li, HJ (corresponding author), Beijing Forestry Univ, Coll Sci, Beijing, Peoples R China.; Wang, LM (corresponding author), Peking Univ, Dept Hlth Informat & Management, Hlth Sci Ctr, Beijing, Peoples R China.	lihongjun69@bjfu.edu.cn; wangluman@bjmu.edu.cn		Li, Hongjun/0000-0003-1102-6225; Xiao, Jiewen/0000-0001-5189-0443	National Training Programs of Innovation and Entrepreneurship for Undergraduates [X202010022047]; Fundamental Research Funds for the Central Universities [2019SG05]	National Training Programs of Innovation and Entrepreneurship for Undergraduates; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported partly by the National Training Programs of Innovation and Entrepreneurship for Undergraduates (No. X202010022047), partly by the Fundamental Research Funds for the Central Universities, grant number No.2019SG05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2019, COMPUT METH PROG BIO, V180, DOI 10.1016/j.cmpb.2019.105020; Ahmed N, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030104; [Anonymous], 2017, ADV NEURAL INFORM PR; Attar A., 2014, GLOBAL J HEMATOL BLO, V1, P20, DOI [10.15379/2408-9877.2014.01.01.4, DOI 10.15379/2408-9877.2014.01.01.4, 10.15379/2408-9877.2014.01.01.4.]; Baker FJ., 1976, INTRO MED LAB TECHNO, P549; Banik PP, 2020, EXPERT SYST APPL, V149, DOI 10.1016/j.eswa.2020.113211; Baydilli YY, 2020, COMPUT MED IMAG GRAP, V80, DOI 10.1016/j.compmedimag.2020.101699; Colvin Gerald A, 2003, Med Health R I, V86, P243; Fuchs T, 2021, GENOM PROTEOM BIOINF, V19, P926, DOI 10.1016/j.gpb.2019.02.004; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Howard A.G., 2017, ARXIV; Hu J., 2018, 32 C NEURAL INFORM P; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Khan A, 2021, BIOMED SIGNAL PROCES, V69, DOI 10.1016/j.bspc.2021.102932; Khan MM, 2022, J KING SAUD UNIV-COM, V34, P3356, DOI 10.1016/j.jksuci.2021.01.021; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lei X., 2012, 2012 SPRING C ENG TE, P1; Lu Y, 2021, APPL SOFT COMPUT, V101, DOI 10.1016/j.asoc.2020.107006; Ma NN, 2018, LECT NOTES COMPUT SC, V11218, P122, DOI 10.1007/978-3-030-01264-9_8; Matek C, 2019, NAT MACH INTELL, V1, P538, DOI 10.1038/s42256-019-0101-9; Okikiolu J., 2021, MEDICINE, V49, P274, DOI DOI 10.1016/J.MPMED.2021.02.004; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shahin AI, 2019, COMPUT METH PROG BIO, V168, P69, DOI 10.1016/j.cmpb.2017.11.015; SIMONYAN K, 2015, COMPUTER SCI; Supardi N. Z., 2012, 2012 IEEE 8th International Colloquium on Signal Processing & its Applications, P461, DOI 10.1109/CSPA.2012.6194769; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Visser O, 2012, EUR J CANCER, V48, P3257, DOI 10.1016/j.ejca.2012.05.024; Wang HQ, 2009, J BIOMED INFORM, V42, P654, DOI 10.1016/j.jbi.2008.12.010; Wang Q, 2021, OPT LASER TECHNOL, V139, DOI 10.1016/j.optlastec.2021.106931; Wei-Liang Tai, 2011, Proceedings of the 2011 IEEE International Symposium on Multimedia (ISM 2011), P129, DOI 10.1109/ISM.2011.29; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Yang DX, 2021, MEASUREMENT, V173, DOI 10.1016/j.measurement.2020.108643; Yao Nan, 2019, 2019 2nd International Conference on Safety Produce Informatization (IICSPI). Proceedings, P129, DOI 10.1109/IICSPI48186.2019.9096041; Zhao JW, 2017, MED BIOL ENG COMPUT, V55, P1287, DOI 10.1007/s11517-016-1590-x	35	1	1	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261848	10.1371/journal.pone.0261848	http://dx.doi.org/10.1371/journal.pone.0261848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085275	gold, Green Published			2022-12-26	WOS:000779379600033
J	Ng'ambi, WF; Collins, JH; Colbourn, T; Mangal, T; Phillips, A; Kachale, F; Mfutso-Bengo, J; Revill, P; Hallett, TB				Ng'ambi, Wingston Felix; Collins, Joseph H.; Colbourn, Tim; Mangal, Tara; Phillips, Andrew; Kachale, Fannie; Mfutso-Bengo, Joseph; Revill, Paul; Hallett, Timothy B.			Socio-demographic factors associated with early antenatal care visits among pregnant women in Malawi: 2004-2016	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; SERVICES	Introduction In 2016, the WHO published recommendations increasing the number of recommended antenatal care (ANC) visits per pregnancy from four to eight. Prior to the implementation of this policy, coverage of four ANC visits has been suboptimal in many low-income settings. In this study we explore socio-demographic factors associated with early initiation of first ANC contact and attending at least four ANC visits ("ANC4+") in Malawi using the Malawi Demographic and Health Survey (MDHS) data collected between 2004 and 2016, prior to the implementation of new recommendations. Methods We combined data from the 2004-5, 2010 and 2015-16 MDHS using Stata version 16. Participants included all women surveyed between the ages of 15-49 who had given birth in the five years preceding the survey. We conducted weighted univariate, bivariate and multivariable logistic regression analysis of the effects of each of the predictor variables on the binary endpoint of the woman attending at least four ANC visits and having the first ANC attendance within or before the four months of pregnancy (ANC4+). To determine whether a factor was included in the model, the likelihood ratio test was used with a statistical significance of P< 0.05 as the threshold. Results We evaluated data collected in surveys in 2004/5, 2010 and 2015/6 from 26386 women who had given birth in the five years before being surveyed. The median gestational age, in months, at the time of presenting for the first ANC visit was 5 (inter quartile range: 4-6). The proportion of women initiating ANC4+ increased from 21.3% in 2004-5 to 38.8% in 2015-16. From multivariate analysis, there was increasing trend in ANC4+ from women aged 20-24 years (adjusted odds ratio (aOR) = 1.27, 95%CI:1.05-1.53, P = 0.01) to women aged 45-49 years (aOR = 1.91, 95%CI:1.18-3.09, P = 0.008) compared to those aged 15-19 years. Women from richest socio-economic position ((aOR = 1.32, 95%CI:1.12-1.58, P<0.001) were more likely to demonstrate ANC4+ than those from low socio-economic position. Additionally, women who had completed secondary (aOR = 1.24, 95%CI:1.02-1.51, P = 0.03) and tertiary (aOR = 2.64, 95%CI:1.65-4.22, P<0.001) education were more likely to report having ANC4+ than those with no formal education. Conversely increasing parity was associated with a reduction in likelihood of ANC4+ with women who had previously delivered 2-3 (aOR = 0.74, 95%CI:0.63-0.86, P<0.001), 4-5 (aOR = 0.65, 95%CI:0.53-0.80, P<0.001) or greater than 6 (aOR = 0.61, 95%CI: 0.47-0.79, <0.001) children being less likely to demonstrate ANC4+. Conclusion The proportion of women reporting ANC4+ and of key ANC interventions in Malawi have increased significantly since 2004. However, we found that most women did not access the recommended number of ANC visits in Malawi, prior to the 2016 WHO policy change which may mean that women are less likely to undertake the 2016 WHO recommendation of 8 contacts per pregnancy. Additionally, our results highlighted significant variation in coverage according to key socio-demographic variables which should be considered when devising national strategies to ensure that all women access the appropriate frequency of ANC visits during their pregnancy.	[Ng'ambi, Wingston Felix; Mfutso-Bengo, Joseph] Kamuzu Univ Hlth Sci, Hlth Econ & Policy Unit, Lilongwe, Malawi; [Collins, Joseph H.; Colbourn, Tim; Phillips, Andrew] UCL, Inst Global Hlth, London, England; [Mangal, Tara; Hallett, Timothy B.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England; [Kachale, Fannie] Minist Hlth, Reprod Hlth Directorate, Lilongwe, Malawi; [Revill, Paul] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of London; University College London; Imperial College London; University of York - UK	Ng'ambi, WF (corresponding author), Kamuzu Univ Hlth Sci, Hlth Econ & Policy Unit, Lilongwe, Malawi.	wingston.ngambi@gmail.com		Revill, Paul/0000-0001-8632-0600; Hallett, Timothy/0000-0002-9681-0424; Collins, Joseph/0000-0003-4801-7218	UK Research and Innovation (UKRI) through the GCRF Thanzi la Onse (Health of All) research programme [MR/P028004/1]	UK Research and Innovation (UKRI) through the GCRF Thanzi la Onse (Health of All) research programme	Funding for the project was provided by UK Research and Innovation (UKRI) through the GCRF Thanzi la Onse (Health of All) research programme (MR/P028004/1). During the study period, WN, JC, TC, AP, TM, JMB, PR and TBH worked for on the project. The funder had no role in the study design, data collection and analysis, decision to publish, or the presentation of the manuscript.	Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; [Anonymous], 2002, WHO ANTENATAL CARE R; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Colbourn T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004150; Creanga AA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1331-7; Croft TN, 2018, GUIDE DHS STAT; Dunlop CL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020231; Friedman EM., 2002, P AM STAT ASS JOINT, P1064; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jiwani SS, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010502; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Kuuire VZ, 2017, GLOB PUBLIC HEALTH, V12, P711, DOI 10.1080/17441692.2017.1316413; Machira K, 2018, INT J WOMENS HEALTH, V10, P25, DOI 10.2147/IJWH.S144426; Mamba KC, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1631-y; Manthalu G, 2019, HEALTH ECON, V28, P461, DOI 10.1002/hec.3856; Mchenga M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4130-1; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; National Statistical Office (NSO) [Malawi] and ORC Macro, 2005, MAL DEM HLTH SURV 20; National Statistical Office (NSO) [Malawi] & ICF, 2017, MAL DEM HLTH SURV 20; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Rai Rajesh Kumar, 2013, Home Health Care Serv Q, V32, P106, DOI 10.1080/01621424.2013.779354; Rwabilimbo AG, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00226-7; Sonneveldt E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S7; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222566; The World Bank, 2019, TRENDS MATERNAL MORT; Tura G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-60; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; WHO, 2016, WHO TECH REP SER, V997, P1; Yaya S, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000085	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263650	10.1371/journal.pone.0263650	http://dx.doi.org/10.1371/journal.pone.0263650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134088	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000798968600023
J	Han, S; Xu, JL; Yan, MH; Liu, ZX				Han, Shuo; Xu, Jinliang; Yan, Menghua; Liu, Zhaoxin			Using multiple linear regression and BP neural network to predict critical meteorological conditions of expressway bridge pavement icing	PLOS ONE			English	Article							TEMPERATURE; MODEL; DECK; ICE	Icy bridge deck in winter has tremendous consequences for expressway traffic safety, which is closely related to the bridge pavement temperature. In this paper, the critical meteorological conditions of icy bridge deck were predicted by multiple linear regression and BP neural network respectively. Firstly, the main parameters affecting the bridge pavement temperature were determined by Pearson partial correlation analysis based on the three-year winter meteorological data of the traffic meteorological monitoring station on the bridge in Shandong province. Secondly, the bridge pavement temperature is selected as the dependent variable, while air temperature, wind speed, relative humidity, dew point temperature, wet bulb temperature and wind cold temperature were selected as independent variables, and the bridge pavement temperature prediction models of linear regression and 5-layer hidden layer classical BP neural network regression were established respectively based on whether the variables are linear or not. Finally, the prediction accuracy of the above models was compared by using the measured data. The results show that the linear regression model could be established only with air temperature, relative humidity and wind speed, owing to collinearity problem. Compared with multiple linear regression model, the predicted value of the BP neural network has a higher degree of fitting with the measured data, and the coefficient of determination reaches 0.7929. Using multiple linear regression and BP neural network, the critical meteorological conditions of bridge deck icing in winter can be effectively predicted even when the sample size is insufficient.	[Han, Shuo] Changan Univ, Coll Transportat Engn, Xian, Peoples R China; [Xu, Jinliang; Yan, Menghua] Changan Univ, Sch Highway, Xian, Peoples R China; [Liu, Zhaoxin] Shandong Hispeed Infrastruct Construct Co Ltd, Jinan, Peoples R China	Chang'an University; Chang'an University	Xu, JL (corresponding author), Changan Univ, Sch Highway, Xian, Peoples R China.	xujinliang@chd.edu.cn		han, shuo/0000-0002-3817-2487				[Anonymous], 2015, 314432015 PRC GBT; [Anonymous], 1984, J TONGJI U; Bai Y., 2016, METEOROLOGICAL SCI T, V44, P336; Barber ES, 1957, HIGHWAY RES BOARD B, V168; BARKER HW, 1990, J APPL METEOROL, V29, P1180, DOI 10.1175/1520-0450(1990)029<1180:FOIORB>2.0.CO;2; [陈仕周 Chen Shizhou], 2005, [中国公路学报, China Journal of Highway and Transport], V18, P56; Crevier LP, 2001, J APPL METEOROL, V40, P2026, DOI 10.1175/1520-0450(2001)040<2026:MANMFR>2.0.CO;2; Del Vecchio MC, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10144952; [樊健生 Fan Jiansheng], 2020, [中国公路学报, China Journal of Highway and Transport], V33, P1; FHWA, 2021, FHWA ROAD WEATH MAN; Habibzadeh-Bigdarvish O, 2021, APPL THERM ENG, V185, DOI 10.1016/j.applthermaleng.2020.116365; Handler SL., 2020, WEATHER FORECAST, V35, P1520; Highway Statistics Publications, HIGHW FIN TABL SF 4C; Hou Y., 2013, RES J APPL SCI ENG T, V6, P4375; Jian L, 2010, J COMPUT, V5, P1372, DOI 10.4304/jcp.5.9.1372-1379; Jing C, 2018, ADV CIV ENG, V2018, DOI 10.1155/2018/1837952; Korotenko K, 2002, LECT NOTES COMPUT SC, V2331, P1193; Krmanc R, 2013, METEOROL APPL, V20; SASS BH, 1992, J APPL METEOROL, V31, P1499, DOI 10.1175/1520-0450(1992)031<1499:ANMFPO>2.0.CO;2; Shao J, 1998, WEATHER FORECAST, V13, P164, DOI 10.1175/1520-0434(1998)013<0164:INORST>2.0.CO;2; Shao J, 1998, EXPERT SYST APPL, V14, P471, DOI 10.1016/S0957-4174(98)00006-2; Shao J., 1993, TRANSPORT RES REC, V1387, P216; Sherif A, 2004, CAN J CIVIL ENG, V31, P369, DOI 10.1139/L03-107; [王乾 WANG Qian], 2009, [西安建筑科技大学学报, Journal of Xi'an University of Architecture & Technology], V41, P219; Wind Scale, 2012, 285912012 PRC GBT; Xiao SG, 2018, J APPL METEOROL CLIM, V57, P2851, DOI 10.1175/JAMC-D-17-0315.1; Xu B, 2017, APPL THERM ENG, V120, P568, DOI 10.1016/j.applthermaleng.2017.04.024	28	1	1	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263539	10.1371/journal.pone.0263539	http://dx.doi.org/10.1371/journal.pone.0263539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120189	Green Published, gold			2022-12-26	WOS:000789273600052
J	Kaewpan, A; Duangurai, T; Rungruengkitkun, A; Muangkaew, W; Kanjanapruthipong, T; Jitprasutwit, N; Ampawong, S; Sukphopetch, P; Chantratita, N; Pumirat, P				Kaewpan, Anek; Duangurai, Taksaon; Rungruengkitkun, Amporn; Muangkaew, Watcharamat; Kanjanapruthipong, Tapanee; Jitprasutwit, Niramol; Ampawong, Sumate; Sukphopetch, Passanesh; Chantratita, Narisara; Pumirat, Pornpan			Burkholderia pseudomallei pathogenesis in human skin fibroblasts: A Bsa type III secretion system is involved in the invasion, multinucleated giant cell formation, and cellular damage	PLOS ONE			English	Article							EPITHELIAL-CELLS; CUTANEOUS MELIOIDOSIS; EXPRESSION; PROTEIN; PROTECTION; AUSTRALIA; INFECTION; APOPTOSIS; MMP-9	Burkholderia pseudomallei-a causative agent of melioidosis that is endemic in Southeast Asia and Northern Australia-is a Gram-negative bacterium transmitted to humans via inhalation, inoculation through skin abrasions, and ingestion. Melioidosis causes a range of clinical presentations including skin infection, pneumonia, and septicemia. Despite skin infection being one of the clinical symptoms of melioidosis, the pathogenesis of B. pseudomallei in skin fibroblasts has not yet been elucidated. In this study, we investigated B. pseudomallei pathogenesis in the HFF-1 human skin fibroblasts. On the basis of co-culture assays between different B. pseudomallei clinical strains and the HFF-1 human skin fibroblasts, we found that all B. pseudomallei strains have the ability to mediate invasion, intracellular replication, and multinucleated giant cell (MNGC) formation. Furthermore, all strains showed a significant increase in cytotoxicity in human fibroblasts, which coincides with the augmented expression of matrix metalloproteinase-2. Using B. pseudomallei mutants, we showed that the B. pseudomallei Bsa type III secretion system (T3SS) contributes to skin fibroblast pathogenesis, but O-polysaccharide, capsular polysaccharide, and short-chain dehydrogenase metabolism do not play a role in this process. Taken together, our findings reveal a probable connection for the Bsa T3SS in B. pseudomallei infection of skin fibroblasts, and this may be linked to the pathogenesis of cutaneous melioidosis.	[Kaewpan, Anek; Rungruengkitkun, Amporn; Muangkaew, Watcharamat; Sukphopetch, Passanesh; Chantratita, Narisara; Pumirat, Pornpan] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Duangurai, Taksaon] Kasetsart Univ, Fac Vet Med, Dept Compan Anim Clin Sci, Bangkok, Thailand; [Kanjanapruthipong, Tapanee; Ampawong, Sumate] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Jitprasutwit, Niramol] Mahidol Univ, Fac Med, Dept Immunol, Siriraj Hosp, Bangkok, Thailand; [Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	Mahidol University; Kasetsart University; Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Pumirat, P (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	pornpan.pum@mahidol.ac.th			National Research Council of Thailand [NRCT5-RSA63015]; Mahidol University	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Mahidol University	This work was funded by National Research Council of Thailand (NRCT5-RSA63015), and research grant by Mahidol University, Fiscal year 2018, awarded to PP.	Aiastui A, 2010, INFECT IMMUN, V78, P2700, DOI 10.1128/IAI.01389-09; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chiang CY, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0593-3; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dando SJ, 2016, INFECT IMMUN, V84, P1941, DOI 10.1128/IAI.01546-15; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; Duangurai T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3039106; Gibney KB, 2008, CLIN INFECT DIS, V47, P603, DOI 10.1086/590931; Harley VS, 1998, MICROBIOS, V96, P71; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kuhbacher A, 2017, J INFECT DIS, V215, P1742, DOI 10.1093/infdis/jix153; Kumar Priti, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot095505; Kunz P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2266-5; Leisenfelder SA, 2006, J VIROL, V80, P5577, DOI 10.1128/JVI.00163-06; Merritt AJ, 2016, EMERG INFECT DIS, V22, P1420, DOI 10.3201/eid2208.151149; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Panomket Pawana, 2011, Journal of the Medical Association of Thailand, V94, P1410; Phewkliang A, 2010, SE ASIAN J TROP MED, V41, P1164; Pumirat P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096298; Pumirat P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-1; Reamtong O, 2020, PEERJ, V8, DOI 10.7717/peerj.8659; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sarovich DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091682; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Stockton JL, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111637; Stone JK, 2014, EXPERT REV ANTI-INFE, V12, P1487, DOI 10.1586/14787210.2014.970634; Sulik A, 2008, FOLIA HISTOCHEM CYTO, V46, P437, DOI 10.2478/v10042-008-0058-8; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; Suwanmanee S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/138587; Thangapazham RL, 2014, INT J MOL SCI, V15, P8407, DOI 10.3390/ijms15058407; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Utaisincharoen P, 2006, MICROB PATHOGENESIS, V40, P184, DOI 10.1016/j.micpath.2006.01.002; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; Whiteley L, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00468-17, 10.1128/iai.00468-17]; Wikraiphat C, 2015, INFECT IMMUN, V83, P2127, DOI 10.1128/IAI.02785-14; Wright C, 2011, AM J PHYSIOL-LUNG C, V301, pL575, DOI 10.1152/ajplung.00226.2010; Yip CH, 2020, BIOCHEM SOC T, V48, P569, DOI 10.1042/BST20190836; Yokota M, 2021, FASEB J, V35, DOI 10.1096/fj.201902836R	46	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0261961	10.1371/journal.pone.0261961	http://dx.doi.org/10.1371/journal.pone.0261961			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113856	Green Published, gold			2022-12-26	WOS:000823694700019
J	Sinha, DB; Pincus, ZS				Sinha, Drew Benjamin; Pincus, Zachary Scott			High temporal resolution measurements of movement reveal novel early-life physiological decline in C. elegans	PLOS ONE			English	Article							GAIT SPEED; SPAN; SURVIVAL; BEHAVIOR; SYSTEM	Age-related physiological changes are most notable and best-studied late in life, while the nature of aging in early- or middle-aged individuals has not been explored as thoroughly. In C. elegans, many studies of movement vs. age generally focus on three distinct phases: sustained, youthful movement; onset of rapidly progressing impairment; and gross immobility. We investigated whether this first period of early-life adult movement is a sustained "healthy" level of high function followed by a discrete "movement catastrophe"-or whether there are early-life changes in movement that precede future physiological declines. To determine how movement varies during early adult life, we followed isolated individuals throughout life with a previously unachieved combination of duration and temporal resolution. By tracking individuals across the first six days of adulthood, we observed declines in movement starting as early as the first two days of adult life, as well as high interindividual variability in total daily movement. These findings suggest that movement is a highly dynamic behavior early in life, and that factors driving movement decline may begin acting as early as the first day of adulthood. Using simulation studies based on acquired data, we suggest that too-infrequent sampling in common movement assays limits observation of early-adult changes in motility, and we propose feasible strategies and a framework for designing assays with increased sensitivity for early movement declines.	[Sinha, Drew Benjamin; Pincus, Zachary Scott] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Sinha, Drew Benjamin] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO 63110 USA; [Sinha, Drew Benjamin; Pincus, Zachary Scott] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Sinha, Drew Benjamin; Pincus, Zachary Scott] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pincus, ZS (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.; Pincus, ZS (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Pincus, ZS (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	zpincus@gmail.com		Pincus, Zachary/0000-0001-9785-5977	NIH [R01 AG057748]; Arnold and Mabel Beckman Foundation; Washington University Medical Scientist Training Program training grant [NIH T32 GM007200]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Washington University Medical Scientist Training Program training grant	Y This work was supported by NIH R01 AG057748 (ZP), a Beckman Young Investigator award from the Arnold and Mabel Beckman Foundation (ZP), and Washington University Medical Scientist Training Program training grant NIH T32 GM007200 (DS). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Alves LGA, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.022417; Bair WN, 2019, J GERONTOL A-BIOL, V74, P1413, DOI 10.1093/gerona/glz015; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Bolanowski M. A, POPULATION LONGITUDI, P17; BRENNER S, 1974, GENETICS, V77, P71; Buchman AS, 2011, AM J GERIAT PSYCHIAT, V19, P571, DOI 10.1097/JGP.0b013e3181ef7a2e; Chou MY, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1199-7; Churgin MA, 2017, ELIFE, V6, DOI [10.7554/elife.26652, 10.7554/eLife.26652]; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Ghiasi G, 2016, LECT NOTES COMPUT SC, V9907, P519, DOI 10.1007/978-3-319-46487-9_32; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Gomez-Amaro RL, 2015, GENETICS, V200, P443, DOI 10.1534/genetics.115.175851; Hahm JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9919; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; Hardy SE, 2007, J AM GERIATR SOC, V55, P1727, DOI 10.1111/j.1532-5415.2007.01413.x; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HOSONO R, 1980, EXP GERONTOL, V15, P285, DOI 10.1016/0531-5565(80)90032-7; Jushaj A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229583; Kinser HE, 2021, ELIFE, V10, DOI 10.7554/eLife.65026; Kocsisova Z, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.173195; Larson RG, 2017, NATURE, V550, P466, DOI 10.1038/550466a; Le KN, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1013-2; Liu J, 2013, CELL METAB, V18, P392, DOI 10.1016/j.cmet.2013.08.007; Martineau CN, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008002; McCloskey RJ, 2017, J NEUROPHYSIOL, V117, P1911, DOI 10.1152/jn.00555.2016; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Pan CL, 2011, P NATL ACAD SCI USA, V108, P9274, DOI 10.1073/pnas.1011711108; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pitt JN, 2019, GEROSCIENCE, V41, P961, DOI 10.1007/s11357-019-00124-9; Pittman WE, 2017, LAB CHIP, V17, P3909, DOI 10.1039/c7lc00916j; Podshivalova K, 2017, CELL REP, V19, P441, DOI 10.1016/j.celrep.2017.03.062; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rollins JA, 2017, J GERONTOL A-BIOL, V72, P473, DOI 10.1093/gerona/glw248; Saigusa T, 2002, CURR BIOL, V12, pR46, DOI 10.1016/S0960-9822(01)00669-8; Simonetta SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007571; Stamper BLN, 2018, AGING CELL, V17, DOI 10.1111/acel.12704; Stern S, 2017, CELL, V171, P1649, DOI 10.1016/j.cell.2017.10.041; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Xiao R, 2015, CELL REP, V11, P1123, DOI 10.1016/j.celrep.2015.04.024; Yin JA, 2014, J NEUROSCI, V34, P3947, DOI 10.1523/JNEUROSCI.4013-13.2014; Zhang WB, 2016, CELL SYST, V3, P333, DOI 10.1016/j.cels.2016.09.003; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zhao Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15458	45	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0257591	10.1371/journal.pone.0257591	http://dx.doi.org/10.1371/journal.pone.0257591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108272	Green Submitted, gold, Green Published			2022-12-26	WOS:000775890100003
J	Ramos, JB; de Resende, MLV; Botelho, DMD; Pereira, RCM; Reichel, T; Balieiro, AAF; Botega, GP; Abrahao, JCD				Ramos, Juliana Barros; Vilela de Resende, Mario Lucio; Dos Santos Botelho, Deila Magna; Martins Pereira, Renata Cristina; Reichel, Tharyn; Ferreira Balieiro, Andre Augusto; Botega, Gustavo Pucci; de Rezende Abrahao, Juliana Costa			Screening coffee genotypes for brown eye spot resistance in Brazil	PLOS ONE			English	Article							CERCOSPORA-COFFEICOLA; PHENOLIC-COMPOUNDS; FERTILIZATION; VARIABILITY; REML/BLUP; PROGENIES	Several researchers have attempted to develop coffee plants that are resistant to brown eye spot (BES); however, no coffee cultivars are resistant to the disease. In the present study, a blend of strains from Cercospora coffeicola was inoculated into 19 Brazilian commercial cultivars and 41 accessions from the Germplasm Collection of Minas Gerais to evaluate the genetic resistance ability within the population and select superior genotypes for the breeding program. After predicting the genotypic values of the estudied material, the evaluations number necessary for selecting genotypes with accuracy and efficiency was determined based on the data of severity to BES. The action of defense mechanisms plant was also investigated by assessing the levels of total soluble phenolic compounds and soluble lignin in contrasting genotypes for disease susceptibility. Based on the results, the accession MG 1207 Sumatra, had an intrinsic genetic capacity to maintain low levels of severity to BES. The genotype MG 1207 Sumatra can substantially contribute to the development of new cultivars, which may lead to the reduced use of pesticides. According to the accuracy and efficiency results obtained, four evaluations BES severity are sufficient to achieve accuracy, providing expressive genetic gains. Finally, the levels of lignin and phenolic compounds were not found to be associated with the resistance of coffee genotypes to BES.	[Ramos, Juliana Barros; Vilela de Resende, Mario Lucio; Dos Santos Botelho, Deila Magna; Martins Pereira, Renata Cristina; Reichel, Tharyn; Ferreira Balieiro, Andre Augusto] Univ Fed Lavras, Dept Fitopatol, Lavras, MG, Brazil; [Botega, Gustavo Pucci] Univ Fed Lavras, Dept Genet & Melhoramento Plantas, Lavras, MG, Brazil; [de Rezende Abrahao, Juliana Costa] Empresa Pesquisa Agr Minas Gerais, Campus Univ, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras	Abrahao, JCD (corresponding author), Empresa Pesquisa Agr Minas Gerais, Campus Univ, Lavras, MG, Brazil.	julianacosta@epamig.br		Botega, Gustavo/0000-0002-9523-7259; Rezende, Juliana Costa de/0000-0002-6026-7634; Reichel, Tharyn/0000-0003-2754-0245; Pereira, Renata/0000-0002-5606-3823	National Counsel of Technological and Scientific Development-CNPq; Brazilian Consortium Coffee Research and Development; National Institute of Coffee Science and Technology (INCT Cafe/CNPq); Foundation for Research Support of the State of Minas Gerais (FAPEMIG)	National Counsel of Technological and Scientific Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Consortium Coffee Research and Development; National Institute of Coffee Science and Technology (INCT Cafe/CNPq); Foundation for Research Support of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors wish to thank National Counsel of Technological and Scientific Development-CNPq, the Brazilian Consortium Coffee Research and Development, the National Institute of Coffee Science and Technology (INCT Cafe '/CNPq), and the Foundation for Research Support of the State of Minas Gerais (FAPEMIG) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqua RD, 2011, TROP PLANT PATHOL, V36, P313; Patricio Flávia Rodrigues Alves, 2010, Bragantia, V69, P883, DOI 10.1590/S0006-87052010000400014; Andrade VT, 2016, EUPHYTICA, V207, P177, DOI 10.1007/s10681-015-1561-6; Barbosa MP, 2019, AUSTRALAS PLANT PATH, V48, P245, DOI 10.1007/s13313-019-0623-y; Botelho DMD, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1901-9; Cesarino I, 2019, CURR OPIN BIOTECH, V56, P209, DOI 10.1016/j.copbio.2018.12.012; Cotterill PP., 1986, SILVAE GENET, V36; Custodio AADP, 2011, CIENC AGROTEC, V35, P1067, DOI 10.1590/S1413-70542011000600005; Dias MI, 2016, IND CROP PROD, V82, P9, DOI 10.1016/j.indcrop.2015.12.016; dos S., 2009, COFFEE SCI, V4, P93; DOSTER MA, 1988, PHYTOPATHOLOGY, V78, P473, DOI 10.1094/Phyto-78-473; ECHANDI E., 1959, Turrialba, V9, P54; ICO-International Coffee Organization, 2021, STAT DIS CONS SEL IM; ICO-International Coffee Organization, 2021, STAT DOM CONS ALL EX; Luiz de Carvalho Vicente, 1998, INFORME AGROPECURIO, V19, P27; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Marchiosi R, 2020, PHYTOCHEM REV, V19, P865, DOI 10.1007/s11101-020-09689-2; Markakis EA, 2010, PLANT DIS, V94, P1156, DOI 10.1094/PDIS-94-9-1156; Martins RB, 2008, PHYTOPATHOLOGY, V98, P1205, DOI 10.1094/PHYTO-98-11-1205; Matiello JB., 2014, ASABRANCA BEIJA FLOR; Miranda JM, 2005, CIENC AGROTEC, V29, P1195, DOI 10.1590/S1413-70542005000600013; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Noack F, 1901, Z PFLKRANKH PFLSCHUT, V11, P196; Pereira RB, 2008, PESQUI AGROPECU BRAS, V43, P1287, DOI 10.1590/S0100-204X2008001000005; Resende M. D. V. de, 2007, Pesquisa Agropecuaria Tropical, V37, P182; Rhodes JM., 1978, BIOSYNTHESIS PHENOLI, P243, DOI [10.1515/9783111671062-010, DOI 10.1515/9783111671062-010]; Rocha RB, 2009, SCI FOR, V37, P351; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Sharma A, 2019, MOLECULES, V24, DOI 10.3390/molecules24132452; Souza AGC, 2012, J PHYTOPATHOL, V160, P540, DOI 10.1111/j.1439-0434.2012.01947.x; Vale PAS, 2021, EUR J PLANT PATHOL, V159, P399, DOI 10.1007/s10658-020-02170-y; SPANOS GA, 1990, J AGR FOOD CHEM, V38, P1565, DOI 10.1021/jf00097a030; Vanholme R, 2019, CURR OPIN BIOTECH, V56, P230, DOI 10.1016/j.copbio.2019.02.018; de Resende MDV, 2016, CROP BREED APPL BIOT, V16, P330, DOI 10.1590/1984-70332016v16n4a49; Volsi B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219742; Vuolo MM, 2019, BIOACTIVE COMPOUNDS: HEALTH BENEFITS AND POTENTIAL APPLICATIONS, P33, DOI 10.1016/B978-0-12-814774-0.00002-5; Wallis CM, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.580753; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Xie M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01427; Zambolim L., 2016, MANUAL FITOPATOLOGIA, P193	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0258822	10.1371/journal.pone.0258822	http://dx.doi.org/10.1371/journal.pone.0258822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100284	Green Published, Green Submitted, gold			2022-12-26	WOS:000801937600005
J	Bosdriesz, JR; Ritsema, F; Leenstra, T; Petrignani, MWF; Bruisten, SM; Coyer, L; Schreijer, AJM; van Duijnhoven, YTHP; van der Loeff, MFS; Matser, AA				Bosdriesz, Jizzo R.; Ritsema, Feiko; Leenstra, Tjalling; Petrignani, Mariska W. F.; Bruisten, Sylvia M.; Coyer, Liza; Schreijer, Anja J. M.; van Duijnhoven, Yvonne T. H. P.; van der Loeff, Maarten F. Schim; Matser, Amy A.			Self-reported symptoms as predictors of SARS-CoV-2 infection in the general population living in the Amsterdam region, the Netherlands	PLOS ONE			English	Article							COVID-19; SEVERITY	Introduction Most COVID-19 symptoms are non-specific and also common in other respiratory infections. We aimed to assess which symptoms are most predictive of a positive test for SARS-CoV-2 in symptomatic people of the general population who were tested. Methods We used anonymised data of all SARS-CoV-2 test results from the Public Health Service of Amsterdam from June 1,2020 through August 31, 2021. Symptoms were self-reported at time of requesting a test. Multivariable logistic regression models with generalized estimating equations were used to identify predictors of a positive test. Included symptoms were: cough, fever, loss of smell or taste, muscle ache, runny nose, shortness of breath, and throat ache; adjustments were made for age and gender, and stratification by month. Results Overall, 12.0% of 773,680 tests in 432,213 unique individuals were positive. All symptoms were significantly associated with a positive test result, the strongest positive associations were: cough (aOR = 1.78, 95%CI = 1.75-1.80), fever (aOR = 2.11, 95%CI = 2.07-2.14), loss of smell or taste (aOR = 2.55, 95%CI = 2.50-2.61), and muscle ache (aOR = 2.38, 95%CI = 2.34-2.43). The adjusted odds ratios for loss of smell or taste slightly declined over time, while that for cough increased. Conclusion Cough, fever, loss of smell or taste, and muscle ache appear to be most strongly associated with a positive SARS-CoV-2 test in symptomatic people of the general population who were tested.	[Bosdriesz, Jizzo R.; Ritsema, Feiko; Leenstra, Tjalling; Petrignani, Mariska W. F.; Bruisten, Sylvia M.; Coyer, Liza; Schreijer, Anja J. M.; van Duijnhoven, Yvonne T. H. P.; van der Loeff, Maarten F. Schim; Matser, Amy A.] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Bosdriesz, Jizzo R.; Ritsema, Feiko; Coyer, Liza; van der Loeff, Maarten F. Schim; Matser, Amy A.] Univ Amsterdam, Amsterdam UMC, Dept Internal Med, Div Infect Dis, Amsterdam, Netherlands; [Bruisten, Sylvia M.] Amsterdam Univ Med Ctr UMC, Amsterdam Infect Immun Inst AII, Dept Med Microbiol, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam	Bosdriesz, JR (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands.; Bosdriesz, JR (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Internal Med, Div Infect Dis, Amsterdam, Netherlands.	jbosdriesz@ggd.amsterdam.nl	Coyer, Liza/L-9054-2019	Coyer, Liza/0000-0001-5830-2982; Matser, Amy/0000-0003-4291-1905				Ahamad MM, 2020, EXPERT SYST APPL, V160, DOI 10.1016/j.eswa.2020.113661; Alene M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249090; Antonelli M, 2021, J INFECTION, V82, P384, DOI 10.1016/j.jinf.2021.02.015; Boesveldt S, 2017, CHEM SENSES, V42, P513, DOI 10.1093/chemse/bjx025; Bosdriesz JR., 2021, 31 EUROPEAN C CLIN M, DOI [10.2147/IDR.S325770, DOI 10.2147/IDR.S325770]; Coyer L., 2021, SARS COV2 ANTIBODY P; de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773; Donker GA, 2010, CONTINUOUS MORBIDITY; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Elliott J., 2021, SYMPTOM REPORTING 1; Fabella FE., FACTORS AFFECTING WI; Graham MS, 2021, LANCET PUBLIC HEALTH, V6, pE335, DOI 10.1016/S2468-2667(21)00055-4; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; He JJ, 2021, J MED VIROL, V93, P820, DOI 10.1002/jmv.26326; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Karatzas K, 2018, ALLERGY, V73, P1851, DOI 10.1111/all.13487; Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052; Lee K, 2009, GLOB INST, P1; Lee SW, 2021, J ALLER CL IMM-PRACT, V9, P2262, DOI 10.1016/j.jaip.2021.03.044; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n288; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Morris NP, 2020, AM J PUBLIC HEALTH, V110, P1354, DOI 10.2105/AJPH.2020.305810; National Health Service, COVID 19 APP SUPP WH; National Institute for Public Health and the Environment-National Coordination Infectious Disease Prevention (RIVM), GRIEP GRIEPPR FEIT C; National Institute for Public Health and the Environment-National Coordination Infectious Disease Prevention (RIVM), COVID 19 GUID 2020; Nepal G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03121-z; Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0; Rathee M., 2020, AGEUSIA, V2020; Rudberg AS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18848-0; Schroeder A., 2021, SYSTEMATIC REVIEW IM; Shoer S, 2021, MED-CAMBRIDGE, V2, P196, DOI 10.1016/j.medj.2020.10.002; Thunstrom L., 2020, BEHAV PUBLIC POLICY, V5, P135; Tostmann A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.16.2000508; Vandrevala TM A., WILLINGNESS UK PUBLI; Walker S., 2021, CORONAVIRUS COVID 19; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Wynberg E, 2022, CLIN INFECT DIS, V75, pE482, DOI 10.1093/cid/ciab759; Yang JM, 2020, J ALLERGY CLIN IMMUN, V146, P790, DOI 10.1016/j.jaci.2020.08.008	44	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262287	10.1371/journal.pone.0262287	http://dx.doi.org/10.1371/journal.pone.0262287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089936	Green Published, gold			2022-12-26	WOS:000769158400012
J	Fulham, M; McDougall, F; Power, M; McIntosh, RR; Gray, R				Fulham, Mariel; McDougall, Fiona; Power, Michelle; McIntosh, Rebecca R.; Gray, Rachael			Carriage of antibiotic resistant bacteria in endangered and declining Australian pinniped pups	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; STRANDED MARINE MAMMALS; 1 INTEGRON-INTEGRASE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; FORAGING LOCATIONS; WATER; ABUNDANCE; ELEMENTS; PREVALENCE	The rapid emergence of antimicrobial resistance (AMR) is a major concern for wildlife and ecosystem health globally. Genetic determinants of AMR have become indicators of anthropogenic pollution due to their greater association with humans and rarer presence in environments less affected by humans. The objective of this study was to determine the distribution and frequency of the class 1 integron, a genetic determinant of AMR, in both the faecal microbiome and in Escherichia coli isolated from neonates of three pinniped species. Australian sea lion (Neophoca cinerea), Australian fur seal (Arctocephalus pusillus doriferus) and long-nosed fur seal (Arctocephalus forsteri) pups from eight breeding colonies along the Southern Australian coast were sampled between 2016-2019. DNA from faecal samples (n = 309) and from E. coli (n = 795) isolated from 884 faecal samples were analysed for class 1 integrons using PCRs targeting the conserved integrase gene (intI) and the gene cassette array. Class 1 integrons were detected in A. p. doriferus and N. cinerea pups sampled at seven of the eight breeding colonies investigated in 4.85% of faecal samples (n = 15) and 4.52% of E. coli isolates (n = 36). Integrons were not detected in any A. forsteri samples. DNA sequencing of the class 1 integron gene cassette array identified diverse genes conferring resistance to four antibiotic classes. The relationship between class 1 integron carriage and the concentration of five trace elements and heavy metals was also investigated, finding no significant association. The results of this study add to the growing evidence of the extent to which antimicrobial resistant bacteria are polluting the marine environment. As AMR determinants are frequently associated with bacterial pathogens, their occurrence suggests that these pinniped species are vulnerable to potential health risks. The implications for individual and population health as a consequence of AMR carriage is a critical component of ongoing health investigations.	[Fulham, Mariel; Gray, Rachael] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia; [McDougall, Fiona; Power, Michelle] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [McIntosh, Rebecca R.] Res Dept, Cowes, Vic, Australia	University of Sydney; Macquarie University	Gray, R (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia.	rachael.gray@sydney.edu.au		Power, Michelle/0000-0003-3160-4301; McDougall, Fiona/0000-0001-8669-9702				Ali H, 2019, J CHEM-NY, V2019, DOI 10.1155/2019/6730305; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Alonso CA, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix097; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Ashley EA, 2020, J WILDLIFE DIS, V56, P429, DOI 10.7589/2019-04-087; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Bie LY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03172; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Botelho J, 2021, TRENDS MICROBIOL, V29, P8, DOI 10.1016/j.tim.2020.05.011; Bustamante P, 2003, SCI TOTAL ENVIRON, V313, P25, DOI 10.1016/S0048-9697(03)00265-1; DAUM JR, 1993, INT J IMMUNOPHARMACO, V15, P383, DOI 10.1016/0192-0561(93)90049-5; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Delport TC, 2015, J WILDLIFE DIS, V51, P555, DOI 10.7589/2014-08-200; Diaz-Mejia JJ, 2008, MICROBIOL-SGM, V154, P94, DOI 10.1099/mic.0.2007/008649-0; Dickinson AW, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.105117; Dolejska M, 2007, J APPL MICROBIOL, V103, P11, DOI 10.1111/j.1365-2672.2006.03241.x; Dolejska M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01167-19; Domingues Sara, 2012, Mob Genet Elements, V2, P211; Escudero JA, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0019-2014; Fowler SL, 2007, MAR MAMMAL SCI, V23, P598, DOI 10.1111/j.1748-7692.2007.00134.x; Fulham M, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.571171; Fulham M, 2018, INFECT GENET EVOL, V62, P262, DOI 10.1016/j.meegid.2018.05.002; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; Ghaly TM, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9112212; Gillings MR, 2017, CURR OPIN MICROBIOL, V38, P10, DOI 10.1016/j.mib.2017.03.002; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Goulas A, 2018, ENVIRON EVID, V7, DOI 10.1186/s13750-018-0118-2; Gray R, 2008, SCI TOTAL ENVIRON, V399, P202, DOI 10.1016/j.scitotenv.2008.03.039; Grilo ML, 2020, ECOL INDIC, V115, DOI 10.1016/j.ecolind.2020.106396; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Harmer CJ, 2014, MBIO, V5, DOI 10.1128/mBio.01801-14; Hastak P, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000371; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Kirkwood R, 2013, AUSTRAL NAT HIST SER, P1; Koczura R, 2016, MICROB ECOL, V72, P909, DOI 10.1007/s00248-016-0843-4; Koczura R, 2012, SCI TOTAL ENVIRON, V414, P680, DOI 10.1016/j.scitotenv.2011.10.036; Kretzmann M, 2010, AQUAT MAMM, V36, P178, DOI 10.1578/AM.36.2.2010.178; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lundback IC, 2021, INFECT GENET EVOL, V88, DOI 10.1016/j.meegid.2020.104697; McDougall F, 2019, INFECT GENET EVOL, V70, P107, DOI 10.1016/j.meegid.2019.02.022; McDougall Fiona K, 2021, Microb Genom, V7, DOI 10.1099/mgen.0.000571; McIntosh RR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200253; Nguyen CC, 2019, FRONT ENV SCI ENG, V13, DOI 10.1007/s11783-019-1129-0; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; Partridge SR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00088-17; Peters KJ, 2015, MAR ECOL-EVOL PERSP, V36, P347, DOI 10.1111/maec.12145; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Power ML, 2016, ENVIRON POLLUT, V215, P58, DOI 10.1016/j.envpol.2016.04.013; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Ramey AM, 2020, J WILDLIFE DIS, V56, P1, DOI 10.7589/2019-04-099; Reid CJ, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000143; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Schaefer AM, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/597073; Shaughnessy PD, 2015, WILDLIFE RES, V42, P619, DOI 10.1071/WR14209; Souque C, 2021, ELIFE, V10, DOI 10.7554/eLife.62474; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Vittecoq M, 2016, J APPL ECOL, V53, P519, DOI 10.1111/1365-2664.12596; Waldron LS, 2015, JOVE-J VIS EXP, DOI 10.3791/52889; Wallace CC, 2013, ECOHEALTH, V10, P201, DOI 10.1007/s10393-013-0842-6; Wintle NJP, 2011, MAR MAMMAL SCI, V27, pE268, DOI 10.1111/j.1748-7692.2010.00461.x; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Xia WY, 2016, J BIOMED RES, V30, P292, DOI 10.7555/JBR.30.20150153; Yazdankhah Siamak, 2018, Microbial Ecology in Health and Disease, V29, P1548248, DOI 10.1080/16512235.2018.1548248; Yin JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06765-2; Zingali T, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060843	71	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0258978	10.1371/journal.pone.0258978	http://dx.doi.org/10.1371/journal.pone.0258978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089935	Green Submitted, gold, Green Published			2022-12-26	WOS:000769158400002
J	Manoel, FD; Peserico, CS; Machado, FA				Manoel, Francisco de A.; Peserico, Cecilia S.; Machado, Fabiana A.			Novel track field test to determine V-peak, relationship with treadmill test and 10-km running performance in trained endurance runners	PLOS ONE			English	Article							PACING STRATEGY; PHYSIOLOGICAL DETERMINANTS; SPEED; RELIABILITY; TIME; KINEMATICS; VALIDITY; VO2MAX; COST; MAX	Y Objectives The aim of this study was to determine the peak running velocity on the track field (V-peak_TF) based on the laboratory treadmill test (V-peak_T), and relate the V-peak values as well as their correlation with the 10-km running performance in trained endurance runners. Method Twenty male trained endurance runners (age: 29.5 5.3 years; V.O-2max: 67.517.6 ml kg(-1)min(-1)) performed three maximum incremental tests to determine the V-peak: one for V-peak_T determination and two to obtain V-peak_TF on the official track field (400 m), and a 10-km running performance. During the incremental tests, maximum heart rate (HRmax), maximal rating of perceived exertion (RPEmax), and peak lactate concentration (LA(peak)) were determined. Results The results showed significant difference between the V-peak_TF and V-peak_T (18.1 +/- 1.2 vs. 19.2 +/- 1.5 km.h(-1), respectively), as well as the total time of the tests, the distance traveled and the RPEmax determined during the tests. A high correlation was observed between the V-peak values (r = 0.94), and between V-peak_TF and V-peak_T with 10-km running performance (r = -0.95 vs. r = -0.89, respectively). Conclusions The good agreement and association with V-peak_T and high correlation with 10-km running performance demonstrate that the novel track field test is efficient for V-peak_TF determination.	[Manoel, Francisco de A.] Cesumar Univ, Dept Phys Educ, Maringa, Parana, Brazil; [Manoel, Francisco de A.] Univ Fed Lavras, Dept Phys Educ, Lavras, MG, Brazil; [Peserico, Cecilia S.; Machado, Fabiana A.] Univ Estadual Maringa, Dept Phys Educ, Maringa, Parana, Brazil; [Machado, Fabiana A.] Univ Estadual Maringa, Associate Postgrad Program Phys Educ UEM UEL, Maringa, Parana, Brazil; [Machado, Fabiana A.] Univ Estadual Maringa, Postgrad Program Physiol Sci, Dept Physiol Sci, Maringa, Parana, Brazil	Universidade Federal de Lavras; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Machado, FA (corresponding author), Univ Estadual Maringa, Dept Phys Educ, Maringa, Parana, Brazil.; Machado, FA (corresponding author), Univ Estadual Maringa, Associate Postgrad Program Phys Educ UEM UEL, Maringa, Parana, Brazil.; Machado, FA (corresponding author), Univ Estadual Maringa, Postgrad Program Physiol Sci, Dept Physiol Sci, Maringa, Parana, Brazil.	famachado@uem.br		Manoel, Francisco/0000-0003-1841-5637; MACHADO, FABIANA ANDRADE/0000-0003-2235-577X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part (scholarship) by the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001.	Bertuzzi R, 2014, J STRENGTH COND RES, V28, P1688, DOI 10.1519/JSC.0000000000000314; Billat VL, 1999, MED SCI SPORT EXER, V31, P156, DOI 10.1097/00005768-199901000-00024; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buchheit M, 2010, EUR J APPL PHYSIOL, V108, P1153, DOI 10.1007/s00421-009-1317-x; Cappa DF, 2014, J SPORT MED PHYS FIT, V54, P424; Chockalingam N, 2012, ARCH PHYS MED REHAB, V93, P2302, DOI 10.1016/j.apmr.2011.10.022; da Silva DF, 2019, J STRENGTH COND RES, V33, P736, DOI 10.1519/JSC.0000000000002001; Fellin RE, 2010, J APPL BIOMECH, V26, P407, DOI 10.1123/jab.26.4.407; Fernandes RJ, 2006, J SPORT MED PHYS FIT, V46, P373; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Highton JM, 2012, J STRENGTH COND RES, V26, P458, DOI 10.1519/JSC.0b013e318225f384; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Huggett DL, 2005, J GERONTOL A-BIOL, V60, P57, DOI 10.1093/gerona/60.1.57; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kivi DMR, 2002, MED SCI SPORT EXER, V34, P662; Kong PW, 2012, GAIT POSTURE, V36, P46, DOI 10.1016/j.gaitpost.2012.01.001; Kuipers H, 2003, INT J SPORTS MED, V24, P486; Leger L, 1980, Can J Appl Sport Sci, V5, P77; Lima-Silva AE, 2010, EUR J APPL PHYSIOL, V108, P1045, DOI 10.1007/s00421-009-1300-6; Machado FA, 2013, J SCI MED SPORT, V16, P577, DOI 10.1016/j.jsams.2012.12.009; Manoel FD, 2018, INT J PERF ANAL SPOR, V18, P127, DOI 10.1080/24748668.2018.1454744; Manoel Francisco de Assis, 2017, Sports Med Int Open, V1, pE8, DOI 10.1055/s-0042-119951; Massini Danilo Alexandre, 2018, Rev. bras. cineantropom. desempenho hum., V20, P432, DOI 10.5007/1980-0037.2018v20n5p432; Metsios GS, 2008, J SCI MED SPORT, V11, P214, DOI 10.1016/j.jsams.2006.12.120; Midgley AW, 2007, SPORTS MED, V37, P857, DOI 10.2165/00007256-200737100-00003; Milgrom C, 2003, BRIT J SPORT MED, V37, P160, DOI 10.1136/bjsm.37.2.160; Morin JB, 2011, EUR J APPL PHYSIOL, V111, P1695, DOI 10.1007/s00421-010-1804-0; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; Noakes TD, 1990, J SPORT SCI, V8, P35, DOI 10.1080/02640419008732129; Nummela A, 2007, J SPORT SCI, V25, P87, DOI 10.1080/02640410500497717; Pallares JG, 2019, J STRENGTH COND RES, V33, P1216, DOI 10.1519/JSC.0000000000003121; Peserico CS, 2015, INT J SPORTS MED, V36, P729, DOI 10.1055/s-0035-1547225; Peserico CS, 2014, J SPORT SCI, V32, P993, DOI 10.1080/02640414.2013.876087; Schache AG, 2001, CLIN BIOMECH, V16, P667, DOI 10.1016/S0268-0033(01)00061-4; Peserico CS, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00211; Slattery KM, 2006, J STRENGTH COND RES, V20, P47; Smith TP, 2003, EUR J APPL PHYSIOL, V89, P337, DOI 10.1007/s00421-003-0806-6; Smith TP, 1999, MED SCI SPORT EXER, V31, P892, DOI 10.1097/00005768-199906000-00019; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tucker R, 2006, INT J SPORT PHYSIOL, V1, P233, DOI 10.1123/ijspp.1.3.233	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0260338	10.1371/journal.pone.0260338	http://dx.doi.org/10.1371/journal.pone.0260338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085265	Green Published, gold			2022-12-26	WOS:000779379600014
J	Saha, S				Saha, Sumanta			Comparative effectiveness of adjunct non-pharmacological interventions on maternal and neonatal outcomes in gestational diabetes mellitus patients: A systematic review and network meta-analysis protocol of randomized controlled trials	PLOS ONE			English	Review								Background Gestational diabetes mellitus (GDM) in pregnancy leads to a range of perinatal complications. Although several randomized controlled trials (RCT) have tested the effect of non-pharmacological standard GDM care adjuncts on these outcomes, there is no agglomerated statistical evidence on how their occurrence risk varies across interventions and with placebo. Therefore, a systematic review and network meta-analysis (NMA) protocol is proposed here to address this evidence gap. Materials and methods A search for above RCTs published in the English language will transpire in PubMed, Embase, and Scopus databases irrespective of date and geographic boundary. The RCTs must test nutritional supplementation, digital intervention, structured exercise program, educational program, counseling service, or a combination of these prenatally in GDM patients. These should report >= 1 of the following outcomes- cesarean section, pre-eclampsia, polyhydramnios, preterm birth, macrosomia, prolonged labor, gestational hypertension, premature rupture of membranes, congenital anomaly, Apgar scores, birth weight, birth length, gestational age at birth, neonatal hypoglycemia, neonatal hyperbilirubinemia, and neonatal Corpulence Index. The risk of bias assessment of the recruited trials will transpire using the Revised Cochrane risk-of-bias tool. Determination of the comparative effectiveness between interventions will occur by the frequentist method NMA for respective outcomes. The categorical and continuous outcomes effect size will get calculated in risk ratio and weighted or standardized mean difference, respectively. For each NMA model, network maps and league tables will show the connections between interventions and effect sizes with their 95% confidence intervals for each intervention pair compared, respectively. The publication bias assessment will occur using comparison-adjusted funnel plots. Best intervention prediction for NMA models with statistically significant intervention effect will happen by determining the surface under the cumulative ranking curve values. Statistical analysis will ensue using Stata software (v16). The statistical significance estimation will happen at p<0.05 and 95% confidence interval.	[Saha, Sumanta] RG Kar Med Coll, Dept Community Med, Kolkata, W Bengal, India	RG Kar Medical College & Hospital	Saha, S (corresponding author), RG Kar Med Coll, Dept Community Med, Kolkata, W Bengal, India.	sumanta.saha@uq.net.au	Saha, Sumanta/L-8885-2018	Saha, Sumanta/0000-0003-0996-8846				[Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], MEDRXIV ORG THE PREP; Borgen I, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030884; Bramer WM, 2018, J MED LIBR ASSOC, V106, P531, DOI 10.5195/jmla.2018.283; Cundy T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1567; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Higgins JP., 2019, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jamilian M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2258-y; Kokic IS, 2018, WOMEN BIRTH, V31, pE232, DOI 10.1016/j.wombi.2017.10.004; Kolivand M, 2019, J DIABETES, V11, P139, DOI 10.1111/1753-0407.12827; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Quintanilla Rodriguez BS., 2021, STATPEARLS; Rouse B, 2017, INTERN EMERG MED, V12, P103, DOI 10.1007/s11739-016-1583-7; Saha S, HLTH OUTCOMES NEWBOR; Saha S, 2020, AIMS MED SCI, V7, P298, DOI 10.3934/medsci.2020019; Saha S, 2020, INT J HEALTH SCI-IJH, V14, P3; Saha S, 2020, J TURK-GER GYNECOL A, V21, P201, DOI 10.4274/jtgga.galenos.2020.2019.0164; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; White IR, 2015, STATA J, V15, P951, DOI 10.1177/1536867X1501500403; Yang XL, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0290-2; Zhong NE, 2019, GYNECOL ENDOCRINOL, V35, P4, DOI 10.1080/09513590.2018.1480716	26	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263336	10.1371/journal.pone.0263336	http://dx.doi.org/10.1371/journal.pone.0263336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085374	gold, Green Published			2022-12-26	WOS:000779379600130
J	Yamashita, D; Matsumoto, Y; Tamaoki, Y; Ueda, Y; Okada, H; Kawashima, T; Yamashita, Y; Nakayama, T; Umemura, K				Yamashita, Daisuke; Matsumoto, Yuji; Tamaoki, Yoshinori; Ueda, Yukio; Okada, Hiroyuki; Kawashima, Toshiyuki; Yamashita, Yutaka; Nakayama, Teiji; Umemura, Kazuo			In vitro analysis of mechanism of pulsed-laser thrombolysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ABLATION; GELATIN; LIQUIDS; TPA	Y Thrombolytic therapy in the treatment of cardiogenic acute cerebral embolism caused by coagulated blood carries the risk of hemorrhagic complications, and there is a need to develop safer and more reliable treatment methods. Laser thrombolysis therapy, which utilizes the difference in energy absorption between the thrombus and the arterial wall, has shown promise as a new treatment method because it can selectively act only on the thrombus. It has not been applied clinically, however, and one of the main reasons for this is that its underlying mechanism has not been elucidated. We developed a pulse laser thrombolysis system for treating cerebral blood vessels that consists of a diode-pumped solid-state neodymium-yttrium aluminum garnet laser, which has excellent stability and maintainability and is suitable for clinical applications coupled to a small-diameter optical fiber. Moreover, we analyzed the mechanisms that occur during pulsed laser irradiation of transparent glass tubes and gelatin phantoms. We found that bubbles form as a thermal effect in addition to ablation of the pulsed laser irradiation. Furthermore, we detected no shock waves or water jets associated with the bubbles. We analyzed the bubbles' dynamics and growth rate, and their effect on a rabbit blood clot phantom. We concluded that the bubbles generated by the laser irradiation physically cut the thrombus and thereby had a thrombectomy effect. We believe that this study will clarify the mechanism of laser thrombolysis therapy and contribute greatly to the realization of its clinical application.	[Yamashita, Daisuke; Tamaoki, Yoshinori; Ueda, Yukio; Kawashima, Toshiyuki; Yamashita, Yutaka] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Matsumoto, Yuji; Umemura, Kazuo] Hamamatsu Univ, Dept Pharmacol, Sch Med, Hamamatsu, Shizuoka, Japan; [Okada, Hiroyuki] Hamamatsu Photon KK, Global Strateg Challenge Ctr, Hamamatsu, Shizuoka, Japan; [Nakayama, Teiji] Hamamatsu Med Ctr, Dept Neurosurg, Hamamatsu, Shizuoka, Japan; [Yamashita, Yutaka] Res Fdn Optosci & Technol, Hamamatsu, Shizuoka, Japan	Hamamatsu Photonics; Hamamatsu University School of Medicine; Hamamatsu Photonics; Hamamatsu University School of Medicine	Yamashita, D (corresponding author), Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan.	daisuke@crl.hpk.co.jp			Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)	The author(s) received the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) for partly of this work. The funder provided support in the form of salaries for authors DY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Godwin RP., 1998, P LASERS SURG ADV CH; Hacke W, 1999, NEUROLOGY, V53, pS3; Hirano T, 2008, MINIM INVAS NEUROSUR, V51, P324, DOI 10.1055/s-0028-1085429; Janis AD, 2002, J THROMB THROMBOLYS, V13, P167, DOI 10.1023/A:1020431007864; Janis AD., 2000, P LASERS SURG ADV CH; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Manning NW, 2014, STROKE, V45, P640, DOI 10.1161/STROKEAHA.113.003798; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Naganuma M, 2020, GEN THORAC CARDIOVAS, V68, P18, DOI 10.1007/s11748-019-01155-x; Nakagawa A, 2002, LASER SURG MED, V31, P129, DOI 10.1002/lsm.10055; Sathyam US, 1996, LASER SURG MED, V19, P397, DOI 10.1002/(SICI)1096-9101(1996)19:4<397::AID-LSM3>3.0.CO;2-N; Sathyam US., 1996, P LASERS SURG ADV CH, DOI [10.1002/(SICI)1096-9101(1996)19:43.0.CO;2-N, DOI 10.1002/(SICI)1096-9101(1996)19:43.0.CO;2-N]; Shangguan H., 1997, P LASERS SURG ADV CH, DOI [10.1364/ao.36.009034, DOI 10.1364/AO.36.009034]; Shangguan HQ, 1998, OPT ENG, V37, P2217, DOI 10.1117/1.601738; Shangguan HQ, 1996, IEEE J SEL TOP QUANT, V2, P818, DOI 10.1109/2944.577304; Suckow MA, 2012, AM COLL LAB, P1; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Viator JA, 1999, LASER SURG MED, V25, P379, DOI 10.1002/(SICI)1096-9101(1999)25:5<379::AID-LSM3>3.0.CO;2-B; Viator JA., 1998, P LASER TISSUE INTER; Wardlaw JM, 2003, STROKE, V34, P1437, DOI 10.1161/01.STR.0000072513.72262.7E; Wolberg AS, 2012, ANESTH ANALG, V114, P275, DOI 10.1213/ANE.0b013e31823a088c	24	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262991	10.1371/journal.pone.0262991	http://dx.doi.org/10.1371/journal.pone.0262991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085324	Green Published, gold			2022-12-26	WOS:000779379600102
J	Linsdell, P; Irving, CL; Cowley, EA				Linsdell, Paul; Irving, Christina L.; Cowley, Elizabeth A.			Functionally additive fixed positive and negative charges in the CFTR channel pore control anion binding and conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE REGIONS; OUTER MOUTH; SITE; IDENTIFICATION; ARCHITECTURE; SELECTIVITY; VESTIBULE; PERMEANT; LOCATION; ROLES	Ion channels use charged amino-acid residues to attract oppositely charged permeant ions into the channel pore. In the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel, a number of arginine and lysine residues have been shown to be important for Cl- permeation. Among these, two in close proximity in the pore-Lys(95) and Arg(134)-are indispensable for anion binding and high Cl- conductance, suggesting that high positive charge density is required for pore function. Here we used mutagenesis and functional characterization to show that a nearby pore-lining negatively charged residue (Glu(92)) plays a functionally additive role with these two positive charges. While neutralization of this negative charge had little effect on anion binding or Cl- conductance, such neutralization was able to reverse the detrimental effects of removing the positive charge at either Lys(95) or Arg(134), as well as the similar effects of introducing a negative charge at a neighboring residue (Ser(1141)). Furthermore, neutralization of Glu(92) greatly increased the susceptibility of the channel to blockage by divalent S2O32- anions, mimicking the effect of introducing additional positive charge in this region; this effect was reversed by concurrent neutralization of either Lys(95) or Arg(134). Across a panel of mutant channels that introduced or removed fixed charges at these four positions, we found that many pore properties are dependent on the overall charge or charge density. We propose that the CFTR pore uses a com-bination of positively and negatively charged residues to optimize the anion binding and Cl- conductance properties of the channel.	[Linsdell, Paul; Irving, Christina L.; Cowley, Elizabeth A.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	paul.linsdell@dal.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN/05124-2017]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN/05124-2017) to P. L.	Accardi A, 2015, J PHYSIOL-LONDON, V593, P4129, DOI 10.1113/JP270575; Boiteux C, 2019, NEUROSCI LETT, V700, P3, DOI 10.1016/j.neulet.2018.05.036; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2012, BIOPHYS J, V103, P1719, DOI 10.1016/j.bpj.2012.09.020; Farkas B, 2020, CELL MOL LIFE SCI, V77, P765, DOI 10.1007/s00018-019-03211-4; Fatehi M, 2007, BIOPHYS J, V92, P1241, DOI 10.1529/biophysj.106.095349; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Li MS, 2018, J BIOL CHEM, V293, P5649, DOI 10.1074/jbc.RA117.001373; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162413; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 2021, CELL BIOCHEM BIOPHYS, V79, P863, DOI 10.1007/s12013-021-00998-7; Linsdell P, 2021, CELL MOL LIFE SCI, V78, P5213, DOI 10.1007/s00018-021-03859-x; Linsdell P, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2021.183558; Linsdell P, 2018, CHANNELS, V12, P284, DOI 10.1080/19336950.2018.1502585; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; Linsdell P, 2016, BBA-BIOMEMBRANES, V1858, P740, DOI 10.1016/j.bbamem.2016.01.009; Linsdell P, 2015, BBA-BIOMEMBRANES, V1848, P1573, DOI 10.1016/j.bbamem.2015.04.004; Linsdell P, 2014, PFLUG ARCH EUR J PHY, V466, P2243, DOI 10.1007/s00424-014-1501-7; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Prins S, 2020, J BIOL CHEM, V295, P16529, DOI 10.1074/jbc.RA120.014061; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Wang G, 2016, FEBS J, V283, P2458, DOI 10.1111/febs.13752; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	34	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101659	10.1016/j.jbc.2022.101659	http://dx.doi.org/10.1016/j.jbc.2022.101659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101441	gold, Green Published			2022-12-26	WOS:000794865600011
J	Shao, YA; Wang, ZH; Chen, KY; Li, DD; Lv, ZM; Zhang, CD; Zhang, WW; Li, CH				Shao, Yina; Wang, Zhenhui; Chen, Kaiyu; Li, Dongdong; Lv, Zhimeng; Zhang, Chundan; Zhang, Weiwei; Li, Chenghua			Xenophagy of invasive bacteria is differentially activated and modulated via a TLR-TRAF6-Beclin1 axis in echinoderms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSE; UBIQUITIN-PROTEASOME; LIPID-A; AUTOPHAGY; RECOGNITION; TRAF6; LIPOPOLYSACCHARIDE; TLR; MECHANISMS; EXPRESSION	In marine environments, organisms are confronted with numerous microbial challenges, although the differential regulation of xenophagy in response to different pathogenic bacte-rial species remains relatively unknown. Here, we addressed this issue using Apostichopus japonicus as a model. We identified 39 conserved autophagy-related genes by genome-wide screening, which provided a molecular basis for autophagy regulation in sea cucumbers. Furthermore, xenophagy of two Gram-negative bacteria, Vibrio splendidus and Escherichia coli, but not a Gram-positive bacteria, Micrococcus luteus, was observed in different autophagy assays. Surprisingly, a significantly higher autophagy capacity was found in the E. coli-challenged group than in the V. splendidus-challenged group. To confirm these findings, two different lipopolysaccharides, LPSV. splendidus and LPSE. coli, were isolated; we found that these LPS species differentially activated coelomocyte xenophagy. To explore the molecular mechanism mediating differential levels of xenophagy, we used an siRNA knockdown assay and confirmed that LPSV. splendidus-mediated xenophagy was dependent on an AjTLR3-mediated pathway, whereas LPSE. coli-mediated xenophagy was dependent on AjToll. Moreover, the activation of different AjTLRs resulted in AjTRAF6 ubiquitination and sub-sequent activation of K63-linked ubiquitination of AjBeclin1. Inversely, the LPSV. splendidus-induced AjTLR3 pathway simultaneously activated the expression of AjA20, which reduced the extent of K63-linked ubiquitination of AjBeclin1 and impaired the induction of autophagy; however, this finding was no t evident with LPSE. coli. Our present results provide the first evidence showing that xenophagy could be differentially induced by different bacterial species to yield differential autophagy levels in echinoderms.	[Shao, Yina; Wang, Zhenhui; Chen, Kaiyu; Li, Dongdong; Lv, Zhimeng; Zhang, Chundan; Zhang, Weiwei; Li, Chenghua] Ningbo Univ, State Key Lab Qual & Safety Agroprod, Ningbo, Peoples R China; [Li, Chenghua] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Li, Chenghua] Ningbo Univ, State Prov Joint Lab Marine Biotechnol & Engn, Ningbo, Peoples R China	Ningbo University; Qingdao National Laboratory for Marine Science & Technology; Ningbo University	Li, CH (corresponding author), Ningbo Univ, State Key Lab Qual & Safety Agroprod, Ningbo, Peoples R China.; Li, CH (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.; Li, CH (corresponding author), Ningbo Univ, State Prov Joint Lab Marine Biotechnol & Engn, Ningbo, Peoples R China.	lichenghua@nbu.edu.cn			National Nat-ural Science Foundation of China [32073003]; Natural Science Foundation of Zhejiang Province [LZ19C190001]; K. C. Wong Magna Fund in Ningbo University; Bio-ultrastructure Analysis Laboratory of the Key Laboratory of Applied Marine Biotechnology of the Ministry of Education, Ningbo University	National Nat-ural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); K. C. Wong Magna Fund in Ningbo University; Bio-ultrastructure Analysis Laboratory of the Key Laboratory of Applied Marine Biotechnology of the Ministry of Education, Ningbo University	This work was supported by the National Natural Science Foundation of China (32073003) , Natural Science Foundation of Zhejiang Province (LZ19C190001) , K. C. Wong Magna Fund in Ningbo University and the Bio-ultrastructure Analysis Laboratory of the Key Laboratory of Applied Marine Biotechnology of the Ministry of Education, Ningbo University.	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Chan ST, 2016, J VIROL, V90, P10928, DOI 10.1128/JVI.01365-16; Che ZJ, 2019, DEV COMP IMMUNOL, V99, DOI 10.1016/j.dci.2019.103404; Chen KY, 2021, AQUACULTURE, V532, DOI 10.1016/j.aquaculture.2020.736022; Chen KY, 2020, DEV COMP IMMUNOL, V104, DOI 10.1016/j.dci.2019.103541; Chen M, 2017, AUTOPHAGY, V13, P1813, DOI 10.1080/15548627.2017.1356550; Cong YY, 2020, J CELL SCI, V133, DOI 10.1242/jcs.240440; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dinkins C, 2015, IMMUNOL CELL BIOL, V93, P11, DOI 10.1038/icb.2014.88; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fusco C., 2018, TRIM50 REGULATES BEC; Gibson JF, 2021, AUTOPHAGY, V17, P1448, DOI 10.1080/15548627.2020.1765521; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Greenfield LK, 2013, TRENDS MICROBIOL, V21, P602, DOI 10.1016/j.tim.2013.09.004; Grumati P, 2018, J BIOL CHEM, V293, P5404, DOI 10.1074/jbc.TM117.000117; Han QX, 2016, REV FISH SCI AQUAC, V24, P326, DOI 10.1080/23308249.2016.1193472; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hu ZG, 2020, FISH SHELLFISH IMMUN, V99, P257, DOI 10.1016/j.fsi.2020.02.013; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Juarez E, 2012, EUR J IMMUNOL, V42, P880, DOI 10.1002/eji.201142105; Juretschke T, 2019, METHODS MOL BIOL, V1880, P691, DOI 10.1007/978-1-4939-8873-0_46; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15290-z; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Li XZ, 2016, PARASITOLOGY, V143, P639, DOI 10.1017/S0031182015001985; Li YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0030-5; Liu W, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13095; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Maruyama T, 2018, J ANTIBIOT, V71, P72, DOI 10.1038/ja.2017.104; Mizushima N, 2020, CURR OPIN CELL BIOL, V63, P1, DOI 10.1016/j.ceb.2019.12.001; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Norris MH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005571; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Paul PK, 2011, AUTOPHAGY, V7, P555, DOI 10.4161/auto.7.5.15102; Puri C, 2018, AUTOPHAGY, V14, P1475, DOI 10.1080/15548627.2018.1482148; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reggiori F, 2017, J MOL BIOL, V429, P486, DOI 10.1016/j.jmb.2017.01.002; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sharma V, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00056; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; Verstak B, 2014, J LEUKOCYTE BIOL, V96, P427, DOI 10.1189/jlb.2A0913-487R; Wang J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-255; Wang ZH, 2018, INT J BIOL MACROMOL, V113, P1167, DOI 10.1016/j.ijbiomac.2018.03.033; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yan K, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12778; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004; Zhan ZZ, 2014, AUTOPHAGY, V10, P257, DOI 10.4161/auto.27162; Zhang PJ, 2015, GENETICS, V201, P1397, DOI 10.1534/genetics.115.178871; Zhang PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073506; Zhang XJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003790; Zhang YF, 2019, NAT IMMUNOL, V20, P433, DOI 10.1038/s41590-019-0324-2; Zhao Y, 2014, CHIN J OCEANOL LIMN, V32, P1248, DOI 10.1007/s00343-015-4004-2	76	4	4	8	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101667	10.1016/j.jbc.2022.101667	http://dx.doi.org/10.1016/j.jbc.2022.101667			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120925	Green Published, gold			2022-12-26	WOS:000791230900014
J	Wada, J; Rathnayake, U; Jenkins, LM; Singh, A; Mohammadi, M; Appella, E; Randazzo, PA; Samelson, LE				Wada, Junya; Rathnayake, Udumbara; Jenkins, Lisa M.; Singh, Avinash; Mohammadi, Moosa; Appella, Ettore; Randazzo, Paul A.; Samelson, Lawrence E.			In vitro reconstitution reveals cooperative mechanisms of adapter protein-mediated activation of phospholipase C-gamma 1 in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; SIGNALING COMPLEXES; MULTIPOINT BINDING; SH3 DOMAIN; SLP-76; RECEPTOR; LAT; GADS; ITK; OLIGOMERIZATION	Activation of T cells upon engagement of the T cell antigen receptor rapidly leads to a number of phosphorylation and plasma membrane recruitment events. For example, trans location of phospholipase-C gamma 1 (PLC-gamma 1) to the plasma membrane and its association with the transmembrane adapter protein LAT and two other adapter proteins, Gads and SLP-76, are critical events in the early T cell activation process. We have previously characterized the formation of a tetrameric LAT-Gads-SLP-76-PLC-gamma 1 complex by reconstitution in vitro and have also characterized the thermodynamics of tetramer formation. In the current study, we define how PLC-gamma 1 recruitment to liposomes, which serve as a plasma membrane surrogate, and PLC-gamma 1 activation are regulated both independently and additively by recruitment of PLC-gamma 1 to phosphorylated LAT, by formation of the LATGads-SLP-76-PLC-gamma 1 tetramer, and by tyrosine phosphorylation of PLC-gamma 1. The recently solved structure of PLC-gamma 1 indicates that, in the resting state, several PLC-gamma 1 domains inhibit its enzymatic activity and contact with the plasma membrane. We propose the multiple cooperative steps that we observed likely lead to conformational alterations in the regulatory domains of PLC-gamma 1, enabling contact with its membrane substrate, disinhibition of PLC-gamma 1 enzymatic activity, and production of the phosphoinositide cleavage products necessary for T cell activation.	[Wada, Junya; Rathnayake, Udumbara; Randazzo, Paul A.; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, Bethesda, MD USA; [Jenkins, Lisa M.; Appella, Ettore] NCI, Ctr Canc Res, Lab Cell Biol, Bethesda, MD USA; [Singh, Avinash; Mohammadi, Moosa] New York Univ, Langone Med Ctr, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; NYU Langone Medical Center	Samelson, LE (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD USA.	samelsonl@helix.nih.gov	Mohammadi, Moosa/ABA-6745-2020	Mohammadi, Moosa/0000-0003-2434-9437	NIH [NIH RO1 DE013686]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M. M. was supported by an NIH grant, NIH RO1 DE013686.	Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Beach D, 2007, J BIOL CHEM, V282, P2937, DOI 10.1074/jbc.M606697200; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Coussens NP, 2013, MOL CELL BIOL, V33, P4140, DOI 10.1128/MCB.00410-13; Francois P, 2016, J STAT PHYS, V162, P1130, DOI 10.1007/s10955-015-1444-1; Ganti RS, 2020, P NATL ACAD SCI USA, V117, P26020, DOI 10.1073/pnas.2008303117; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Hajicek N, 2019, ELIFE, V8, DOI 10.7554/eLife.51700; Hallumi E, 2021, J IMMUNOL, V206, P2322, DOI 10.4049/jimmunol.2001053; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huang ZF, 2016, MOL CELL, V61, P98, DOI 10.1016/j.molcel.2015.11.010; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Katan M, 2020, PROG LIPID RES, V80, DOI 10.1016/j.plipres.2020.101065; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Liu HB, 2013, J BIOL CHEM, V288, P29539, DOI 10.1074/jbc.M112.424846; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Liu Y, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.102607; Manna A, 2018, P NATL ACAD SCI USA, V115, pE11914, DOI 10.1073/pnas.1817142115; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; N Peterson Scott, 2012, Curr Chem Genomics, V6, P8, DOI 10.2174/1875397301206010008; Prole DL, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a035063; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Sauer K., 2009, CURR PROTOC IMMUNOL; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yi J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08064-2; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	46	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101680	10.1016/j.jbc.2022.101680	http://dx.doi.org/10.1016/j.jbc.2022.101680			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124007	gold, Green Published			2022-12-26	WOS:000789400700013
J	Wu, YZ; Chen, YH; Cheng, CT; Ann, DK; Kuo, CY				Wu, Yi-Zhen; Chen, Yi-Hsuan; Cheng, Chun-Ting; Ann, David K.; Kuo, Ching-Ying			Amino acid restriction induces a long non-coding RNA UBA6-AS1 to regulate GCN2-mediated integrated stress response in breast cancer	FASEB JOURNAL			English	Article						amino acid restriction; integrated stress response; long non-coding RNA; PARP1; UBA6-AS1; UBA6-DT	METABOLIC STRESS; DNA-DAMAGE; CELLS; PARP-1; INHIBITION; EXPRESSION; AUTOPHAGY; INDUCTION; APOPTOSIS; LNCRNAS	Oncogene activation, massive proliferation, and increased nutrient demands often result in nutrient and oxygen deprivation in solid tumors including breast cancer (BC), leading to the induction of oxidative stress and endoplasmic reticulum (ER) stress, and subsequently triggering integrated stress response (ISR). To elucidate the role of long non-coding RNAs (lncRNAs) in the ISR of BC, we performed transcriptome analyses and identified a lncRNA, UBA6-AS1, which was upregulated upon amino acid deprivation and ER stress. UBA6-AS1 was preferentially induced in triple-negative BC (TNBC) cells deprived of arginine or glutamine, two critical amino acids required for cancer cell growth, or treated with ER stress inducers. Mechanistically, UBA6-AS1 was regulated through the GCN2/eIF2 alpha/ATF4 pathway, one of the major routes mediating ISR in amino acid sensing. In addition, both in vitro and in vivo assays indicated that UBA6-AS1 promoted TNBC cell survival when cells encountered metabolic stress, implicating a regulatory role of UBA6-AS1 in response to intratumoral metabolic stress during tumor progression. Moreover, PARP1 expression and activity were positively regulated by the GCN2/UBA6-AS1 axis upon amino acid deprivation. In conclusion, our data suggest that UBA6-AS1 is a novel lncRNA regulating ISR upon metabolic stress induction to promote TNBC cell survival. Furthermore, the GCN2-ATF4 axis is important for UBA6-AS1 induction to enhance PARP1 activity and could serve as a marker for the susceptibility of PARP inhibitors in TNBC.	[Wu, Yi-Zhen; Chen, Yi-Hsuan; Kuo, Ching-Ying] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Chen, Yi-Hsuan; Ann, David K.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Cheng, Chun-Ting; Ann, David K.] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Duarte, CA USA; [Kuo, Ching-Ying] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; City of Hope; City of Hope; National Taiwan University; National Taiwan University Hospital	Kuo, CY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan.	cykuo27@ntu.edu.tw		KUO, CHING-YING/0000-0003-1555-3057	Ministry of Science and Technology [MOST107-2320-B-002-037-MY2, MOST109-2320-B-002-022, MOST110-2320-B-002-061]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Ministry of Science and Technology, Grant/Award Number: MOST107-2320-B-002-037-MY2, MOST109-2320-B-002-022 and MOST110-2320-B-002-061	Agliarulo I, 2015, BBA-MOL CELL RES, V1853, P2570, DOI 10.1016/j.bbamcr.2015.05.034; Ahmadiankia N, 2020, CELL BIOL INT, V44, P1588, DOI 10.1002/cbin.11368; Anda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182143; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bi FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/946268; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chang H, 2022, CANCER BIOTHER RADIO, V37, P824, DOI 10.1089/cbr.2020.4394; Chen JX, 2021, AM J CANCER RES, V11, P624; Connerty P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00285; Darini C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10138-8; Deng SJ, 2019, CANCER RES, V79, P1398, DOI 10.1158/0008-5472.CAN-18-0419; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Domagala P, 2011, BREAST CANCER RES TR, V127, P861, DOI 10.1007/s10549-011-1441-2; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dutta P, 2020, CANCERS, V12, DOI 10.3390/cancers12051317; Endo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28074-w; Ewelina W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10307-z; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gallaher JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39636-x; Gandhi M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17007-9; Garcia-Jimenez C, 2019, CELL METAB, V29, P254, DOI 10.1016/j.cmet.2018.11.018; Gibbons HR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02512; Gwangwa MV, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0224-9; Han J, 2021, ONCOGENE, V40, P833, DOI 10.1038/s41388-020-01574-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hocsak E, 2017, FREE RADICAL BIO MED, V108, P770, DOI 10.1016/j.freeradbiomed.2017.04.018; Hou WH, 2019, MUTAT RES-REV MUTAT, V780, P82, DOI 10.1016/j.mrrev.2017.09.004; Hu F, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3405695; Iurlaro R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00479-16; Jeon H, 2016, ONCOTARGET, V7, P67223, DOI 10.18632/oncotarget.11615; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kan ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04129-4; Karlsson Oskar, 2016, Curr Environ Health Rep, V3, P178, DOI 10.1007/s40572-016-0092-1; Khan MR, 2021, TRENDS GENET, V37, P695, DOI 10.1016/j.tig.2021.03.010; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Lai JZ, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5798-7; Lieu EL, 2020, EXP MOL MED, V52, P15, DOI 10.1038/s12276-020-0375-3; Liu DX, 2010, CANCER LETT, V296, P194, DOI 10.1016/j.canlet.2010.04.017; Liu Y, 2017, CANCER GENE THER, V24, P208, DOI 10.1038/cgt.2017.6; Long Y, 2017, CANCER LETT, V388, P54, DOI 10.1016/j.canlet.2016.11.028; Luhr M, 2019, J BIOL CHEM, V294, P8197, DOI 10.1074/jbc.RA118.002829; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Martinet W, 2005, BIOTECHNOL LETT, V27, P1157, DOI 10.1007/s10529-005-0007-y; Martinez-Romero R, 2008, J CELL BIOCHEM, V104, P2248, DOI 10.1002/jcb.21781; McCann Kelly E, 2018, Drugs Context, V7, P212540, DOI 10.7573/dic.212540; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nyunt T, 2019, FREE RADICAL BIO MED, V143, P25, DOI 10.1016/j.freeradbiomed.2019.07.024; Okazaki A, 2017, J CLIN INVEST, V127, P1631, DOI 10.1172/JCI87800; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pan M, 2016, NAT CELL BIOL, V18, P1090, DOI 10.1038/ncb3410; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Peeters JGC, 2019, AUTOPHAGY, V15, P98, DOI 10.1080/15548627.2018.1509608; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Rodriguez-Vargas JM, 2016, CELL DEATH DIFFER, V23, P2007, DOI 10.1038/cdd.2016.80; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Sang LJ, 2021, NAT METAB, V3, P90, DOI 10.1038/s42255-020-00325-z; Sant Shilpa, 2017, Drug Discov Today Technol, V23, P27, DOI 10.1016/j.ddtec.2017.03.002; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajan M, 2018, CELL METAB, V28, P721, DOI 10.1016/j.cmet.2018.07.005; Teng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.24; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wagle N, 2016, J CLIN ONCOL, V34; Wei HT, 2016, GENOM PROTEOM BIOINF, V14, P131, DOI 10.1016/j.gpb.2016.05.001; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Wu T, 2014, FREE RADICAL BIO MED, V67, P69, DOI 10.1016/j.freeradbiomed.2013.10.806; Zhu CG, 2021, CELL CYCLE, V20, P575, DOI 10.1080/15384101.2021.1885236	84	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22201	10.1096/fj.202101466R	http://dx.doi.org/10.1096/fj.202101466R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35137449				2022-12-26	WOS:000761250800051
J	Becker, L; Kaltenegger, HC; Nowak, D; Weigl, M; Rohleder, N				Becker, Linda; Kaltenegger, Helena C.; Nowak, Dennis; Weigl, Matthias; Rohleder, Nicolas			Physiological stress in response to multitasking and work interruptions: Study protocol	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE TASK; SALIVARY ALPHA-AMYLASE; LOW-GRADE INFLAMMATION; EMOTION REGULATION; OXIDATIVE STRESS; ENZYME-IMMUNOASSAY; ALLOSTATIC LOAD; GERMAN VERSION; NORMATIVE DATA; SOCIAL SELF	Background The biopsychological response patterns to digital stress have been sparsely investigated so far. Important potential stressors in modern working environments due to increased digitalization are multitasking and work interruptions. In this study protocol, we present a protocol for a laboratory experiment, in which we will investigate the biopsychological stress response patterns to multitasking and work interruptions. Methods In total, N= 192 healthy, adult participants will be assigned to six experimental conditions in a randomized order (one single-task, three dual-task (two in parallel and one as interruption), one multitasking, and one passive control condition). Salivary alpha-amylase as well as heart rate as markers for Sympathetic Nervous System Activity, heart rate variability as measure for Parasympathetic Nervous System (PNS) activity, and cortisol as measure for activity of the hypothalamic-pituitary adrenal (HPA) axis will be assessed at six time points throughout the experimental session. Furthermore, inflammatory markers (i.e., IL-6, C-reactive protein (CRP), and secretory immunoglobulin-A) will be assessed before and after the task as well as 24 hours after it (IL-6 and CRP only). Main outcomes will be the time course of these physiological stress markers. Reactivity of these measures will be compared between the experimental conditions (dual-tasking, work interruptions, and multitasking) with the control conditions (single-tasking and passive control). Discussion With this study protocol, we present a comprehensive experiment, which will enable an extensive investigation of physiological stress-responses to multitasking and work interruptions. Our planned study will contribute to a better understanding of physiological response patterns to modern (digital) stressors. Potential risks and limitations are discussed. The findings will have important implications, especially in the context of digital health in modern working and living environments.	[Becker, Linda; Rohleder, Nicolas] Friedrich Alexander Univ Erlangen Nurnberg, Dept Psychol, Chair Hlth Psychol, Erlangen, Germany; [Kaltenegger, Helena C.; Nowak, Dennis; Weigl, Matthias] LMU Univ Hosp Munich, Inst & Clin Occupat Social & Environm Med, Munich, Germany; [Weigl, Matthias] Univ Hosp, Inst Patient Safety, Bonn, Germany	University of Erlangen Nuremberg; University of Munich; University of Bonn	Becker, L (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Psychol, Chair Hlth Psychol, Erlangen, Germany.	linda.becker@fau.de	; Rohleder, Nicolas/N-7598-2013	Becker, Linda/0000-0002-9950-6882; Rohleder, Nicolas/0000-0003-2602-517X	Bavarian Ministry of Science and Arts - Emerging Talents Initiative of the FriedrichAlexander University Erlangen-Nu<spacing diaeresis>rnberg; Munich Centre for Health Sciences (MCHealth); Deutsche Forschungsgemeinschaft; Friedrich-AlexanderUniversita<spacing diaeresis> t Erlangen-Nu<spacing diaeresis>rnberg (FAU)	Bavarian Ministry of Science and Arts - Emerging Talents Initiative of the FriedrichAlexander University Erlangen-Nu<spacing diaeresis>rnberg; Munich Centre for Health Sciences (MCHealth); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-AlexanderUniversita<spacing diaeresis> t Erlangen-Nu<spacing diaeresis>rnberg (FAU)	This study is part of the research project "Identifikation biomedizinischer und gesundheitlicher Wirkweisen von positiven und negativen Auswirkungen von digitalem Stress und dessen Bewa<spacing diaeresis>ltigung" [Identification of biomedical and health effects of positive and negative effects of digital stress and coping with it] which is part of the Bavarian Research Association on Healthy Use of Digital Technologies and Media (ForDigitHealth), funded by the Bavarian Ministry of Science and Arts. Linda Becker has been partly funded by the Emerging Talents Initiative of the FriedrichAlexander University Erlangen-Nurnberg. Matthias Weigl and Dennis Nowak have been partly funded by the Munich Centre for Health Sciences (MCHealth). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-AlexanderUniversitat Erlangen-Nurnberg (FAU) within the funding program Open Access Publishing. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2009, DIAGNOSTICA, V55, P144, DOI 10.1026/0012-1924.55.3.144; Amthauer R., 2001, 1 2000 R INTELLIGENZ; Barley SR, 2011, ORGAN SCI, V22, P887, DOI 10.1287/orsc.1100.0573; Becker L., DIFFERENCES ST UNPUB; Becker L., IN PRESS; Becker L, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.615715; Becker L, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10080544; Becker L, 2021, STRESS, V24, P318, DOI 10.1080/10253890.2020.1799193; Becker L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227721; Becker L, 2019, PEERJ, V7, DOI 10.7717/peerj.7521; Becker L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213883; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Borgaro S, 2003, J CLIN EXP NEUROPSYC, V25, P283, DOI 10.1076/jcen.25.2.283.13646; Britting S, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05481-5; BROD C, 1982, PERS J, V61, P753; BURKE PJ, 1991, AM SOCIOL REV, V56, P836, DOI 10.2307/2096259; Buzug TM, 2013, AKTUEL FORSCH MEDIZ, P1; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Chen Ying, 2014, Inflammation & Allergy Drug Targets, V13, P177; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Clark Michael S, 2007, Psychol Health Med, V12, P18, DOI 10.1080/13548500500429338; Cohen BE, 2015, AM J HYPERTENS, V28, P1295, DOI 10.1093/ajh/hpv047; Cohen S., 1994, MEASURING STRESS GUI, V47, P235; Couzin-Frankel J, 2010, SCIENCE; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Danese A, 2011, MOL PSYCHIATR, V16, P244, DOI 10.1038/mp.2010.5; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Dickerson SS, 2004, J PERS, V72, P1191, DOI 10.1111/j.1467-6494.2004.00295.x; Endler N., 2008, COPING INVENTORY STR; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fydrich T, 2007, FRAGEBOGEN SOZIALEN; Gaab J, 2009, VERHALTENSTHERAPIE, V19, P114, DOI 10.1159/000223610; Gieler U, 2015, CURR DERMATOL REP, V4, P77, DOI 10.1007/s13671-015-0105-6; Goldman N, 2005, STRESS, V8, P95, DOI 10.1080/10253890500141905; Grimm E, 2021, NEUROSCI BIOBEHAV R, V131, P1096, DOI 10.1016/j.neubiorev.2021.09.037; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gruenewald T.L., 2007, SELF CONSCIOUS EMOTI, P68, DOI 10.1007/s10985-004-0385-9; Gruenewald TL, 2004, PSYCHOSOM MED, V66, P915, DOI 10.1097/01.psy.0000143639.61693.ef; Gupta A, 2013, DECIS SUPPORT SYST, V55, P135, DOI 10.1016/j.dss.2012.12.035; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hautzinger M., 2012, ADS ALLGEMEINE DEPRE; Hefner D., 2016, ROUTLEDGE HDB MEDIA, P255; HEIMBERG RG, 1992, BEHAV THER, V23, P53, DOI 10.1016/S0005-7894(05)80308-9; Jerusalem M., 2003, SWE SKALA ALLGEMEINE; Juster RP, 2011, PSYCHONEUROENDOCRINO, V36, P797, DOI 10.1016/j.psyneuen.2010.11.001; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kalin W., 2020, COPING INVENTAR ZUM; Kaltenegger Helena C, 2021, Scand J Work Environ Health, V47, P565, DOI 10.5271/sjweh.3982; Kemeny ME, 2003, CURR DIR PSYCHOL SCI, V12, P124, DOI 10.1111/1467-8721.01246; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim J, 2013, J APPL GERONTOL, V32, P347, DOI 10.1177/0733464811423647; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KLEE SH, 1983, J ABNORM CHILD PSYCH, V11, P487, DOI 10.1007/BF00917077; Klein EM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0875-9; Koch T., 2010, MACHT GEWOHNHEIT EIN; Kopp MS, 2004, BRAIN RES BULL, V62, P351, DOI 10.1016/j.brainresbull.2003.12.001; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Langer K, 2022, EUR J NEUROSCI, V55, P2684, DOI 10.1111/ejn.15182; Langer K, 2021, PSYCHONEUROENDOCRINO, V125, DOI 10.1016/j.psyneuen.2020.105101; Laux L., 2013, STATE TRAIT ANGST DE; Lazarus R. S., 1990, PSYCHOL INQ, V1, P3, DOI DOI 10.1207/S15327965PLI0101_1; Lazarus R.S., 1984, EMOTION ADAPTATION; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Lindstrom J, 2020, UNDERSTANDING DIGITA; Malik M., 1996, ANN NONINVAS ELECTRO, V1, P151, DOI DOI 10.1111/J.1542-474X.1996.TB00275.X; Mark G, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P41, DOI 10.1145/2556288.2557361; Marsland AL, 2017, BRAIN BEHAV IMMUN, V64, P208, DOI 10.1016/j.bbi.2017.01.011; Maslach C., 1981, MASLACH BURNOUT INVE; Matthews G, 2006, J EXP PSYCHOL-APPL, V12, P96, DOI 10.1037/1076-898X.12.2.96; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; McDade TW, 2004, CLIN CHEM, V50, P652, DOI 10.1373/clinchem.2003.029488; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McInnis CM, 2014, BRAIN BEHAV IMMUN, V42, P33, DOI 10.1016/j.bbi.2014.07.018; Morey JN, 2015, CURR OPIN PSYCHOL, V5, P13, DOI 10.1016/j.copsyc.2015.03.007; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Oldehinkel AJ, 2011, PSYCHOPHYSIOLOGY, V48, P441, DOI 10.1111/j.1469-8986.2010.01118.x; Petermann F, 2014, Z PSYCHIATR PSYCH PS, V62, P225, DOI 10.1024/1661-4747/a000199; Peters EMJ, 2016, J DTSCH DERMATOL GES, V14, P233, DOI 10.1111/ddg.12957; Poposki EM, 2010, HUM PERFORM, V23, P247, DOI 10.1080/08959285.2010.487843; Pretscher A, 2021, EUR J AGEING, V18, P575, DOI 10.1007/s10433-021-00616-8; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ragu-Nathan TS, 2008, INFORM SYST RES, V19, P417, DOI 10.1287/isre.1070.0165; Rammstedt B, 2005, DIAGNOSTICA, V51, P195, DOI 10.1026/0012-1924.51.4.195; Reinecke L., 2017, MEDIA PSYCHOL, V20, P90, DOI DOI 10.1080/15213269.2015.1121832; Richardson CME, 2014, J COUNS PSYCHOL, V61, P110, DOI 10.1037/a0034446; Riedl R, 2013, DATA BASE ADV INF SY, V44, P18, DOI 10.1145/2436239.2436242; Rohleder N, 2014, PSYCHOSOM MED, V76, P181, DOI 10.1097/PSY.0000000000000049; Rohleder N, 2009, J CLIN ONCOL, V27, P2909, DOI 10.1200/JCO.2008.18.7435; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Rosen LD, 2013, COMPUT HUM BEHAV, V29, P2501, DOI 10.1016/j.chb.2013.06.006; Russell G, 2019, NAT REV ENDOCRINOL, V15, P525, DOI 10.1038/s41574-019-0228-0; Salanova M, 2013, INT J PSYCHOL, V48, P422, DOI 10.1080/00207594.2012.680460; Sammito S., 2018, AWMF REGISTERNUMMER; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Schut C, 2020, ALLERGY, V75, P224, DOI 10.1111/all.14015; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Smid HGOM, 2006, J CLIN EXP NEUROPSYC, V28, P859, DOI 10.1080/13803390591001025; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; vandenBosch RJ, 1996, SCHIZOPHRENIA BULL, V22, P643, DOI 10.1093/schbul/22.4.643; Wadsworth ME, 2015, CHILD DEV PERSPECT, V9, P96, DOI 10.1111/cdep.12112; Weigl M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019074; Wetherell MA, 2017, NEUROBIOL STRESS, V7, P68, DOI 10.1016/j.ynstr.2017.05.002	113	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263785	10.1371/journal.pone.0263785	http://dx.doi.org/10.1371/journal.pone.0263785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134093	Green Published, gold			2022-12-26	WOS:000798968600036
J	Karimi, H; Khamforoosh, K; Maihami, V				Karimi, Hamed; Khamforoosh, Keyhan; Maihami, Vafa			Improvement of DBR routing protocol in underwater wireless sensor networks using fuzzy logic and bloom filter	PLOS ONE			English	Article							PACKET-SIZE OPTIMIZATION; CHALLENGES	Routing protocols for underwater wireless sensor networks (UWSN) and underwater Internet of Things (IoT_UWSN) networks have expanded significantly. DBR routing protocol is one of the most critical routing protocols in UWSNs. In this routing protocol, the energy consumption of the nodes, the rate of loss of sent packets, and the rate of drop of routing packets due to node shutdown have created significant challenges. For this purpose, in a new scenario called FB-DBR, clustering is performed, and fuzzy logic and bloom filter are used in each cluster's new routing protocol in underwater wireless sensor networks. Due to the fuzzy nature of the parameters used in DBR, better results are obtained and bloom filters are used in routing tables to compensate for the deceleration. as the average number of accesses to routing table entries, dead nodes, Number of Packets Sent to Base Station (BS), Number of Packets Received at BS, Packet Dropped, and Remaining Energy has improved significantly.	[Karimi, Hamed; Khamforoosh, Keyhan; Maihami, Vafa] Islamic Azad Univ, Dept Comp Engn, Sanandaj Branch, Sanandaj, Iran	Islamic Azad University	Khamforoosh, K (corresponding author), Islamic Azad Univ, Dept Comp Engn, Sanandaj Branch, Sanandaj, Iran.	k.khamforoosh@iausdj.ac.ir		Khamforoosh, Keyhan/0000-0003-0792-0523				Al Salti F, 2017, WIREL NETW, V23, P1301, DOI 10.1007/s11276-016-1224-0; Awais M, 2019, LECT NOTE DATA ENG, V29, P528, DOI 10.1007/978-3-030-12839-5_49; Bahrambeigy Bahram., 2017, J INFORM SYSTEMS TEL, V5, P25; BARANIDHARAN V, 2020, J APPL RES TECHNOL O, V18; Bayrakdar Yonca., 2011, OCEANS 2011 IEEE SPA, P1, DOI [10.1016/j.regpep.2010.10.007, DOI 10.1016/J.REGPEP.2010.10.007]; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Bockris J.O.M., 2012, METHODS APPL INTELLI; Broder A., 2004, INTERNET MATH, V1, P485, DOI [DOI 10.1080/15427951.2004.10129096, 10.1080/15427951.2004.10129096]; Cai HL, 2008, PROCEEDINGS OF THE 2008 IEEE INTERNATIONAL CONFERENCE ON NETWORKING, ARCHITECTURE, AND STORAGE, P97, DOI 10.1109/NAS.2008.52; Cao JB, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/429340; Cui JH, 2006, IEEE NETWORK, V20, P12; Faheem M, 2017, INT J COMMUN SYST, V30, DOI 10.1002/dac.3257; Fawzy AbdElwahab., 2016, INT J COMPUTING DIGI, V5; Feng P, 2019, EURASIP J WIREL COMM, V2019, DOI 10.1186/s13638-019-1533-y; Filip Ondrej., 2011, INTERNET WWW BIRD NE; Gaddour O, 2012, COMPUT NETW, V56, P3163, DOI 10.1016/j.comnet.2012.06.016; Gambhir Ankit, 2020, Soft Computing: Theories and Applications. Proceedings of SoCTA 2018. Advances in Intelligent Systems and Computing (AISC 1053), P609, DOI 10.1007/978-981-15-0751-9_57; Geetha N, 2018, INTELL AUTOM SOFT CO, V24, P711, DOI 10.1080/10798587.2017.1309003; Guo DK, 2010, IEEE T KNOWL DATA EN, V22, P120, DOI 10.1109/TKDE.2009.57; Haider T, 2009, INT ARAB J INF TECHN, V6, P179; Han S, 2010, ACM SIGCOMM COMP COM, V40, P195, DOI 10.1145/1851275.1851207; Handley M, 2003, ACM SIGCOMM COMP COM, V33, P53, DOI 10.1145/774763.774771; Heidemann J, 2006, IEEE WCNC, P228; Hwang Daeyoup, 2008, OCEANS 2008, P1; Jafri MR, 2014, 2014 28TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P479, DOI 10.1109/WAINA.2014.149; Jakma Paul., 2015, INTERNET WWW NONGNU; Jan S, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21093000; Javidan Reza., 2013, BRIT J SCI, V8; Karpilovsky E, 2009, LECT NOTES COMPUT SC, V5448, P13, DOI 10.1007/978-3-642-00975-4_2; Keshtgary Manijeh., 2012, MODERN APPL SCI, V6, P65; Khamforoosh K., 2011, 2011 Proceedings of IEEE Symposium on Wireless Technology & Applications (ISWTA 2011), P56, DOI 10.1109/ISWTA.2011.6089553; Khamforoosh K, 2009, 2009 2ND IEEE INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION TECHNOLOGY, VOL 3, P500; Kheirabadi MT, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/701834; Kurt S, 2017, IEEE T IND ELECTRON, V64, P2392, DOI 10.1109/TIE.2016.2619319; Liu Yuanyuan, 2019, INT C SMART COMPUTIN, P93104; Majumdar C, 2017, IEEE ACCESS, V5, P14419, DOI 10.1109/ACCESS.2017.2687083; Mandeh Awat, 2015, INT J COMPUTER APPL, V125; Mandi OA, 2021, J INTELL SYST, V30, P564, DOI 10.1515/jisys-2020-0137; Mohammadi R., 2015, J TELECOMMUN ELECT C, V7, P81; Poncela J, 2012, WIRELESS PERS COMMUN, V64, P547, DOI 10.1007/s11277-012-0600-z; Prasan U.Devee., 2012, INT JOUNAL ENG SCI A, V2, P951; Reinhardt Andreas, 2012, 2012 IEEE INT S WORL, P19; Sarela M, 2011, IEEE INFOCOM SER, P2399, DOI 10.1109/INFCOM.2011.5935060; Salami A.F., 2020, DRONES SMART CITIES, P143; Saxena Sharad, 2013, International Journal of Information Technology and Computer Science, V5, P49, DOI 10.5815/ijitcs.2013.07.06; Sharma A., 2016, J NETWORK SECUR COMP, V2, P228; Tarkoma S, 2012, IEEE COMMUN SURV TUT, V14, P131, DOI 10.1109/SURV.2011.031611.00024; Wahid A, 2011, COMM COM INF SC, V195, P223; Wahid A, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/307246; Watt A. J., 2016, J COMPUTER COMMUNICA, V4, P41, DOI DOI 10.4236/JCC.2016.45006; Xie P, 2006, LECT NOTES COMPUT SC, V3976, P1216; Xu M, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/481570; Yan H, 2008, LECT NOTES COMPUT SC, V4982, P72; Yoon S, 2012, SENSORS-BASEL, V12, P1827, DOI 10.3390/s120201827; Zhang MY, 2020, IEEE SENSOR LETT, V4, DOI 10.1109/LSENS.2020.2995236; Zheng K, 2006, 20TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 1, PROCEEDINGS, P147; Zhu YH, 2011, DES AUT CON, P1044	57	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263418	10.1371/journal.pone.0263418	http://dx.doi.org/10.1371/journal.pone.0263418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130300	gold, Green Published			2022-12-26	WOS:000805530700028
J	Kim, MH; Kim, SG; Kim, DW				Kim, Myoung Hyoun; Kim, Seul-Gi; Kim, Dae-Weung			A novel dual-labeled small peptide as a multimodal imaging agent for targeting wild-type EGFR in tumors	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MESSENGER-RNA; EXPRESSION; PROTEIN; IDENTIFICATION; ACID; PET	The epidermal growth factor receptor (EGFR) is over-expressed in various human cancer. The over-expression of EGFR in tumors is an excellent target for the development of cancer imaging agents. In the present study, we developed Tc-99m SYPIPDT-GHEG-ECG-K-tetramethylrhodamine (SYPIPDT-ECG-TAMRA) as a molecular imaging agent targeting wild-type EFGR (wtEGFR)-positive tumor cells, and verified its feasibility as molecular imaging agent. SYPIPDT-ECG-TAMRA was synthesized using Fmoc solid-phase peptide synthesis. The radiolabeling of SYPIPDT-ECG-TAMRA with Tc-99m was accomplished using ligand exchange via tartrate. Cellular uptake and binding affinity studies were performed. In vivo gamma camera imaging, ex vivo imaging and biodistribution studies were performed using NCI-H460 and SW620 tumor-bearing murine models. After radiolabeling procedures with Tc-99m, Tc-99m SYPIPDT-ECG-TAMRA complexes were prepared at high yield (> 95%). The binding affinity value (K-d) of Tc-99m SYPIPDT-ECG-TAMRA for NCI-H460 cells was estimated to be 76.5 +/- 15.8 nM. In gamma camera imaging, the tumor to normal muscle uptake ratios of Tc-99m SYPIPDT-ECG-TAMRA increased with time (2.7 +/- 0.6, 4.0 +/- 0.9, and 6.2 +/- 1.0 at 1, 2, and 3 h, respectively). The percentage injected dose per gram of wet tissue for the NCI-H460 tumor was 1.91 +/- 0.11 and 1.70 +/- 0.22 at 1 and 3 h, respectively. We developed Tc-99m SYPIPDT-ECG-TAMRA, which is dual-labeled with both radioisotope and fluorescence. In vivo and in vitro studies demonstrated specific uptake of Tc-99m SYPIPDT-ECG-TAMRA into wtEGFR-positive NCI-H460 cells and tumors. Thus, the results of the present study suggest that Tc-99m SYPIPDT-ECG-TAMRA is a potential dual-modality imaging agent targeting wtEGFR.	[Kim, Myoung Hyoun; Kim, Dae-Weung] Wonkwang Univ, Dept Nucl Med, Sch Med, Iksan, Jeollabuk Do, South Korea; [Kim, Myoung Hyoun; Kim, Dae-Weung] Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Jeollabuk Do, South Korea; [Kim, Seul-Gi; Kim, Dae-Weung] Wonkwang Univ, Res Unit Mol Imaging Agent RUMIA, Sch Med, Iksan, Jeollabuk Do, South Korea	Wonkwang University; Wonkwang University; Wonkwang University	Kim, DW (corresponding author), Wonkwang Univ, Dept Nucl Med, Sch Med, Iksan, Jeollabuk Do, South Korea.; Kim, DW (corresponding author), Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Jeollabuk Do, South Korea.; Kim, DW (corresponding author), Wonkwang Univ, Res Unit Mol Imaging Agent RUMIA, Sch Med, Iksan, Jeollabuk Do, South Korea.	akaxan@nate.com			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019M2D2A1A01032296, 2020R1A2C4001475]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	DW Kim; National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019M2D2A1A01032296 and 2020R1A2C4001475). https://www.nrf.re.kr/index The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Du BL, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044313; Guo LH, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5555-y; Hamzeh-Mivehroud M, 2012, CHEM BIOL DRUG DES, V79, P246, DOI 10.1111/j.1747-0285.2011.01282.x; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Huang L, 2008, MOL IMAGING BIOL, V10, P167, DOI 10.1007/s11307-008-0133-8; Kim MH, 2021, J LABELLED COMPD RAD, V64, P4, DOI 10.1002/jlcr.3884; Kim MH, 2019, ANN NUCL MED, V33, P606, DOI 10.1007/s12149-019-01369-2; King R, 2009, J NUCL MED, V50, P591, DOI 10.2967/jnumed.108.058289; Memon AA, 2009, CANCER RES, V69, P873, DOI 10.1158/0008-5472.CAN-08-3118; Miao Z, 2012, J NUCL MED, V53, P1110, DOI 10.2967/jnumed.111.100842; Passaro A, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000919; Saw PE, 2019, PROTEIN CELL, V10, P787, DOI 10.1007/s13238-019-0639-7; Shazeeb MS, 2011, CANCER RES, V71, P2230, DOI 10.1158/0008-5472.CAN-10-1139; Sun XL, 2017, ADV DRUG DELIVER REV, V110, P38, DOI 10.1016/j.addr.2016.06.007; Sundberg AL, 2004, CANCER BIOTHER RADIO, V19, P195; Tolmachev V, 2004, CANCER BIOTHER RADIO, V19, P491, DOI 10.1089/1084978041979616; Van de Wiele C, 2004, Q J NUCL MED MOL IM, V48, P317; Vera DRB, 2012, NUCL MED BIOL, V39, P3, DOI 10.1016/j.nucmedbio.2011.07.001; Walker RA, 1999, BREAST CANCER RES TR, V53, P167, DOI 10.1023/A:1006194700667; Wu CY, 2007, BIOORGAN MED CHEM, V15, P2789, DOI 10.1016/j.bmc.2006.11.022; Yang SL, 2014, VET IMMUNOL IMMUNOP, V160, P12, DOI 10.1016/j.vetimm.2014.03.004; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhao XM, 2014, J NUCL MED, V55, P1008, DOI 10.2967/jnumed.113.136101	25	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263474	10.1371/journal.pone.0263474	http://dx.doi.org/10.1371/journal.pone.0263474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120180	Green Published, gold			2022-12-26	WOS:000789273600043
J	Paramasivam, P; Meugnier, E; Gokulakrishnan, K; Ranjini, H; Staimez, LR; Weber, MB; Narayan, KMV; Vidal, H; Tandon, N; Prabhakaran, D; Mohan, AR; Mohan, V; Rome, S; Balasubramanyam, M				Paramasivam, Prabu; Meugnier, Emmanuelle; Gokulakrishnan, Kuppan; Ranjini, Harish; Staimez, Lisa R.; Weber, Mary Beth; Narayan, K. M. Venkat; Vidal, Hubert; Tandon, Nikhil; Prabhakaran, Dorairaj; Mohan, Anjana Ranjit; Mohan, Viswanathan; Rome, Sophie; Balasubramanyam, Muthuswamy			Blood-derived miRNA levels are not correlated with metabolic or anthropometric parameters in obese pre-diabetic subjects but with systemic inflammation	PLOS ONE			English	Article							DIABETES PREVENTION; MICRORNAS; EXERCISE; CELLS	As blood-derived miRNAs (c-miRNAs) are modulated by exercise and nutrition, we postulated that they might be used to monitor the effects of a lifestyle intervention (LI) to prevent diabetes development. To challenge this hypothesis, obese Asian Indian pre-diabetic patients were submitted to diet modifications and physical activity for 4 months (LI group) and compared to a control group which was given recommendations only. We have considered 2 periods of time to analyze the data, i.e.; a first one to study the response to the intervention (4 months), and a second one post-intervention (8 months). At basal, 4 months and 8 months post-intervention the levels of 17 c-miRNAs were quantified, selected either for their relevance to the pathology or because they are known to be modulated by physical activity or diet. Their variations were correlated with variations of 25 metabolic and anthropometric parameters and cytokines. As expected, fasting-glycaemia, insulin-sensitivity, levels of exercise- and obesity-induced cytokines were ameliorated after 4 months. In addition, the levels of 4 miRNAs (i.e.; miR-128-3p, miR-374a-5p, miR-221-3p, and miR-133a-3p) were changed only in the LI group and were correlated with metabolic improvement (insulin sensitivity, cytokine levels, waist circumference and systolic blood pressure). However, 8 months post-intervention almost all ameliorated metabolic parameters declined indicating that the volunteers did not continue the protocol on their own. Surprisingly, the LI positive effects on c-miRNA levels were still detected, and were even more pronounced 8 months post-intervention. In parallel, MCP-1, involved in tissue infiltration by immune cells, and Il-6, adiponectin and irisin, which have anti-inflammatory effects, continued to be significantly and positively modified, 8 months post-intervention. These data demonstrated for the first time, that c-miRNA correlations with metabolic parameters and insulin sensitivity are in fact only indirect and likely associated with the level systemic inflammation. More generally speaking, this important result explains the high variability between the previous studies designed to identify specific c-miRNAs associated with the severity of insulin-resistance. The results of all these studies should take into account the level of inflammation of the patients. In addition, this finding could also explain why, whatever the pathology considered (i.e.; cancers, diabetes, neurodegenerative disorders, inflammatory diseases) the same subset of miRNAs is always found altered in the blood of patients vs healthy subjects, as these pathologies are all associated with the development of inflammation.	[Paramasivam, Prabu; Ranjini, Harish; Mohan, Anjana Ranjit; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] WHO Collaborating Ctr Noncommunicable Dis Prevent, Madras Diabet Res Fdn & Dr Mohans Diabet Special, Chennai, Tamil Nadu, India; [Paramasivam, Prabu] Univ New Mexico, Sch Med, Dept Neurol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Meugnier, Emmanuelle; Vidal, Hubert; Rome, Sophie] Claude Bernard Univ Lyon 1, CarMeN Lab, French Natl Inst Hlth & Med Res INSERM U1060, Univ Lyon,Natl Res Inst Agr Food & Environm INRAE, Oullins, France; [Gokulakrishnan, Kuppan] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Bengaluru, India; [Staimez, Lisa R.; Weber, Mary Beth] Emory Univ, Atlanta, GA 30322 USA; [Narayan, K. M. Venkat] All India Inst Med Sci, Dept Endocrinol, New Delhi, India; [Tandon, Nikhil; Prabhakaran, Dorairaj] Ctr Chron Dis Control & Publ Hlth Fdn India, New Delhi, India; [Balasubramanyam, Muthuswamy] SRM Inst Sci & Technol SRMIST, Med & Hlth Sci MHS, Chennai, Tamil Nadu, India	Madras Diabetes Research Foundation; University of New Mexico; University of New Mexico's Health Sciences Center; INRAE; National Institute of Mental Health & Neurosciences - India; Emory University; All India Institute of Medical Sciences (AIIMS) New Delhi; Public Health Foundation of India; SRM Institute of Science & Technology Chennai	Balasubramanyam, M (corresponding author), WHO Collaborating Ctr Noncommunicable Dis Prevent, Madras Diabet Res Fdn & Dr Mohans Diabet Special, Chennai, Tamil Nadu, India.; Rome, S (corresponding author), Claude Bernard Univ Lyon 1, CarMeN Lab, French Natl Inst Hlth & Med Res INSERM U1060, Univ Lyon,Natl Res Inst Agr Food & Environm INRAE, Oullins, France.; Balasubramanyam, M (corresponding author), SRM Inst Sci & Technol SRMIST, Med & Hlth Sci MHS, Chennai, Tamil Nadu, India.	srome@univ-lyon1.fr; balumentor@gmail.com	Carmen, Team2/Y-7383-2019; Prabu, Paramasivam/V-8323-2018; Vidal, Hubert/M-6674-2017; Carmen, Team1/Y-7382-2019	Carmen, Team2/0000-0001-9867-5724; Prabu, Paramasivam/0000-0002-8626-1601; Vidal, Hubert/0000-0002-9467-0317; Carmen, Team1/0000-0003-4234-1746; GOKULAKRISHNAN, KUPPAN/0000-0003-3167-8239; meugnier, emmanuelle/0000-0002-2291-7691; Lab, Carmen/0000-0002-5935-3236	FRENCH - INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR) COOPERATION (INSERM - ICMR PROGRAM, 2014-2017); Department of Biotechnology (DBT), Government of INDIA	FRENCH - INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR) COOPERATION (INSERM - ICMR PROGRAM, 2014-2017); Department of Biotechnology (DBT), Government of INDIA(Department of Biotechnology (DBT) India)	This work was supported by the FRENCH - INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR) COOPERATION (INSERM - ICMR PROGRAM, 2014-2017) as well as grant support from the Department of Biotechnology (DBT), Government of INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganzo M, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800619; Ahmed FW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103242; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Demirsoy IH, 2018, J MED BIOCHEM, V37, P499, DOI 10.2478/jomb-2018-0009; Flowers E, 2015, PHYSIOL GENOMICS, V47, P1, DOI 10.1152/physiolgenomics.00095.2014; Ford CN, 2019, ACTA DIABETOL, V56, P197, DOI 10.1007/s00592-018-1249-1; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gokulakrishnan K, 2017, ACTA DIABETOL, V54, P843, DOI 10.1007/s00592-017-1015-9; Guay C, 2019, CELL METAB, V29, P348, DOI 10.1016/j.cmet.2018.09.011; Guzik TJ, 2017, CARDIOVASC RES, V113, P1009, DOI 10.1093/cvr/cvx108; Kolandouzi S, 2019, PHYSIOL BEHAV, V205, P15, DOI 10.1016/j.physbeh.2018.11.033; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Liang YZ, 2020, J DIABETES, V12, P633, DOI 10.1111/1753-0407.12643; Lopez YON, 2017, INT J OBESITY, V41, P1121, DOI 10.1038/ijo.2017.84; Lopez YON, 2019, MOL METAB, V20, P63, DOI 10.1016/j.molmet.2018.11.003; Mahdavi R, 2018, CLIN LAB, V64, P77, DOI 10.7754/Clin.Lab.2017.170618; Mazur-Bialy AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040701; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Niimoto T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-209; Olioso D., 2018, J CLIN ENDOCR METAB; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Prabu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128372; Rome S, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0483-1; Russo A, 2018, IUBMB LIFE, V70, P1012, DOI 10.1002/iub.1926; Scheller J., 2011, Biochim Biophys Act, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schmitz B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00395; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Tang DH, 2019, MICROVASC RES, V123, P86, DOI 10.1016/j.mvr.2018.10.009; Vatansever-Ozen S, 2011, J SPORT SCI MED, V10, P283; Villard Audrey, 2015, J Mol Biomark Diagn, V6; Weber MB, 2016, DIABETES CARE, V39, P1760, DOI 10.2337/dc16-1241; Yao Y, 2018, ANATOL J CARDIOL, V20, P100, DOI 10.14744/AnatolJCardiol.2018.43255; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang Y, 2017, ENDOCR REV, V38, P145, DOI 10.1210/er.2016-1122	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263479	10.1371/journal.pone.0263479	http://dx.doi.org/10.1371/journal.pone.0263479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120179	Green Published, gold			2022-12-26	WOS:000789273600044
J	Qian, J; Xiao, LJ; Feng, K; Li, W; Liao, CS; Zhang, TL; Liu, JS				Qian, Jing; Xiao, Lingjun; Feng, Kai; Li, Wei; Liao, Chuansong; Zhang, Tanglin; Liu, Jiashou			Effect of dietary protein levels on the growth, enzyme activity, and immunological status of Culter mongolicus fingerlings	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; TROUT ONCORHYNCHUS-MYKISS; BREAM SPARUS-AURATA; DIGESTIVE ENZYME; NILE TILAPIA; INTESTINAL MORPHOLOGY; NONSPECIFIC IMMUNITY; METABOLIC PROFILE; FEED-UTILIZATION; BODY-COMPOSITION	A 65-day growth trial was conducted to investigate the dietary protein requirements for Culter mongolicus fingerlings. Isolipidic and isoenergetic diets were formulated with five dietary protein levels (32%, 37%, 42%, 47%, and 52%). Each diet was assigned to triplicate groups of 70 C. mongolicus fingerlings (0.99 +/- 0.08 g). The results indicated that weight gain and specific growth rate (SGR) increased with increasing dietary protein levels up to 47%. The activities of intestinal trypsin and lipase were the lowest in the 32% protein and 52% protein groups, while amylase activity reduced markedly in the 47% protein group. These results suggest that different dietary protein levels may cause different transformations of nutrients. The activities of superoxide dismutase (SOD) and lysozyme were not affected by varying dietary protein levels, except for those in the 32% protein group. In contrast, the content of malondialdehyde (MDA) increased with increasing dietary protein levels and reaching a maximum in the 52% protein group, suggesting that MDA accumulation depends on the protein concentration and the potential oxidative stress. Taken together, based on the broken-line analysis of SGR, we recommended the optimum dietary protein for C. mongolicus fingerlings to be 48.97%similar to 49.31%.	[Qian, Jing; Xiao, Lingjun; Feng, Kai; Li, Wei; Liao, Chuansong; Zhang, Tanglin; Liu, Jiashou] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China; [Qian, Jing; Xiao, Lingjun; Feng, Kai; Zhang, Tanglin; Liu, Jiashou] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Wei; Liao, Chuansong; Zhang, Tanglin; Liu, Jiashou] Natl Res Ctr Freshwater Fisheries Engn, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JS (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China.; Liu, JS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Liu, JS (corresponding author), Natl Res Ctr Freshwater Fisheries Engn, Wuhan, Peoples R China.	jsliu@ihb.ac.cn			National R & D Supporting Program [2015BAD25B01]; Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology; earmarked fund for China Agriculture Research System [CARS-45]; Shandong Provincial Agricultural Seed Engineering Project [2017LZN003]; earmarked fund for China Agriculture Research System (CARS-45)	National R & D Supporting Program; Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology; earmarked fund for China Agriculture Research System; Shandong Provincial Agricultural Seed Engineering Project; earmarked fund for China Agriculture Research System (CARS-45)	This work was financially supported by the National R & D Supporting Program (2015BAD25B01), Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology and the earmarked fund for China Agriculture Research System (CARS-45), and the Shandong Provincial Agricultural Seed Engineering Project (No. 2017LZN003). The contribution of programs are as follows: The National R & D Supporting Program (2015BAD25B01) played a role in study design, the Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology and the earmarked fund for China Agriculture Research System (CARS-45) played a role in data collection and analysis, and the Shandong Provincial Agricultural Seed Engineering Project (No. 2017LZN003) played a role in experiment conduction and data analysis.	Abdel-Tawwab M, 2010, AQUACULTURE, V298, P267, DOI 10.1016/j.aquaculture.2009.10.027; [Anonymous], 358922018 GBT; Arnason J, 2010, AQUAC RES, V41, P385, DOI 10.1111/j.1365-2109.2009.02439.x; Bibiano Melo JF, 2006, COMP BIOCHEM PHYS A, V145, P181, DOI 10.1016/j.cbpa.2006.06.007; Buddington RK, 2004, COMP BIOCHEM PHYS A, V139, P261, DOI 10.1016/j.cbpb.2004.09.007; CAHU CL, 1994, COMP BIOCHEM PHYS A, V109, P213, DOI 10.1016/0300-9629(94)90123-6; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CAS (Chinese Academy of Sciences), 1976, FISH YANGTZ RIV; Chen Y.Y., 1998, FAUNA SINICA OSTEICH; Chiang I-Kuei., 1959, ACTA HYDROBIOLOGY SI, V0, P375; Chong ASC, 2004, AQUACULTURE, V234, P381, DOI 10.1016/j.aquaculture.2003.12.003; Cordova AI, 2002, FISH SHELLFISH IMMUN, V12, P353, DOI 10.1006/fsim.2001.0377; Coutinho F, 2016, AQUACULT NUTR, V22, P465, DOI 10.1111/anu.12269; Coutinho F, 2012, AQUACULTURE, V356, P391, DOI 10.1016/j.aquaculture.2012.04.037; De Almeida LC, 2006, AQUACULT NUTR, V12, P443, DOI 10.1111/j.1365-2095.2006.00446.x; de Carvalho CVA, 2010, AQUAC RES, V41, P511, DOI 10.1111/j.1365-2109.2009.02340.x; Debnath D, 2007, COMP BIOCHEM PHYS B, V146, P107, DOI 10.1016/j.cbpb.2006.09.008; Ding ZL, 2015, FISH SHELLFISH IMMUN, V44, P295, DOI 10.1016/j.fsi.2015.02.024; El-Dakar AY, 2011, AQUAC RES, V42, P1050, DOI 10.1111/j.1365-2109.2010.02694.x; El-Sayed AFM, 2003, AQUACULTURE, V220, P619, DOI 10.1016/S0044-8486(02)00221-1; Eliss A. E., 1990, TECHNIQUES FISH IMMU, P101, DOI DOI 10.1016/S0145-305X(01)00038-6; Garcia-Meilan I, 2016, AQUACULTURE, V459, P54, DOI 10.1016/j.aquaculture.2016.03.021; Garcia-Meilan I, 2013, AQUACULTURE, V412, P1, DOI 10.1016/j.aquaculture.2013.06.031; Giri SS, 2011, AQUACULT NUTR, V17, P332, DOI 10.1111/j.1365-2095.2010.00787.x; Cornelio FHG, 2014, J WORLD AQUACULT SOC, V45, P45, DOI 10.1111/jwas.12090; Gunasekera RM, 1997, AQUACULTURE, V149, P57, DOI 10.1016/S0044-8486(96)01441-X; GUNASEKERA RM, 1995, AQUACULTURE, V134, P169, DOI 10.1016/0044-8486(95)00028-Z; Han B, 2015, FISH SHELLFISH IMMUN, V46, P225, DOI 10.1016/j.fsi.2015.06.018; Hanif A, 2005, FISH SHELLFISH IMMUN, V19, P345, DOI 10.1016/j.fsi.2004.12.009; Hermes-Lima M, 1998, COMP BIOCHEM PHYS B, V120, P437, DOI 10.1016/S0305-0491(98)10053-6; Jiang HaiFeng, 2016, Fisheries Science (Dalian), V35, P130; Jiang WD, 2017, FISH SHELLFISH IMMUN, V68, P154, DOI 10.1016/j.fsi.2017.07.019; Keshavanath P, 2002, AQUACULT NUTR, V8, P169, DOI 10.1046/j.1365-2095.2002.00202.x; Kim DH, 2006, FISH SHELLFISH IMMUN, V21, P513, DOI 10.1016/j.fsi.2006.02.007; Kim SS, 2009, AQUACULTURE, V287, P219, DOI 10.1016/j.aquaculture.2008.10.021; Krogdahl A, 2004, AQUACULTURE, V229, P335, DOI 10.1016/S0044-8486(03)00396-X; Lall Santosh P., 2009, Veterinary Clinics of North America Exotic Animal Practice, V12, P361, DOI 10.1016/j.cvex.2009.01.005; Li JL., 2011, CULTURE FISH POND, P116; Li QF, 2018, AQUAC RES, V49, P2099, DOI 10.1111/are.13656; Li W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29758-z; Li WJ, 2016, FISHERIES SCI, V82, P137, DOI 10.1007/s12562-015-0945-9; Liang P., 2018, CHINESE AGR SCI B, V34, P136; Lin ML, 2021, FISH RES, V234, DOI 10.1016/j.fishres.2020.105809; Lin ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120298; Lin ML, 2012, N AM J FISH MANAGE, V32, P968, DOI 10.1080/02755947.2012.711271; Ling J, 2010, AQUACULT NUTR, V16, P616, DOI 10.1111/j.1365-2095.2009.00699.x; Liu F, 2016, FISH SHELLFISH IMMUN, V51, P125, DOI 10.1016/j.fsi.2016.02.020; Lopez-Lopez S, 2005, AQUACULT NUTR, V11, P79, DOI 10.1111/j.1365-2095.2004.00305.x; Lundstedt LM, 2004, COMP BIOCHEM PHYS B, V137, P331, DOI 10.1016/j.cbpc.2003.12.003; McGoogan BB, 1999, AQUACULTURE, V178, P333, DOI 10.1016/S0044-8486(99)00137-4; Mohanta KN, 2008, AQUACULT NUTR, V14, P350, DOI 10.1111/j.1365-2095.2007.00542.x; Mohanta KN, 2008, AQUACULT NUTR, V14, P143, DOI 10.1111/j.1365-2095.2007.00514.x; Montero D, 2010, FISH SHELLFISH IMMUN, V29, P1073, DOI 10.1016/j.fsi.2010.08.024; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Papoutsoglou ES, 2006, J FISH BIOL, V69, P446, DOI 10.1111/j.1095-8649.2006.01108.x; PARRY RM, 1965, P SOC EXP BIOL MED, V119, P384; Perez-Jimenez A, 2009, COMP BIOCHEM PHYS A, V154, P157, DOI 10.1016/j.cbpa.2009.05.126; Sa R, 2014, AQUACULTURE, V428, P125, DOI 10.1016/j.aquaculture.2014.02.017; SIWICKI AK, 1994, VET IMMUNOL IMMUNOP, V41, P125, DOI 10.1016/0165-2427(94)90062-0; Skov C, 2002, FRESHWATER BIOL, V47, P2388, DOI 10.1046/j.1365-2427.2002.01012.x; Sondergaard M, 1997, HYDROBIOLOGIA, V342, P319, DOI 10.1023/A:1017084600712; Sterzelecki FC, 2018, AQUACULT NUTR, V24, P366, DOI 10.1111/anu.12567; Suzer C, 2008, AQUACULTURE, V280, P140, DOI 10.1016/j.aquaculture.2008.04.020; Tu YQ, 2015, AQUACULTURE, V446, P290, DOI 10.1016/j.aquaculture.2015.05.003; Velazco-Vargas J, 2014, AQUACULT NUTR, V20, P520, DOI 10.1111/anu.12105; Wang JT, 2016, AQUACULTURE, V450, P289, DOI 10.1016/j.aquaculture.2015.08.007; Wilson RP., 2002, AMINO ACIDS PROTEIN, V3nd, P144; Xie CX., 2009, ICHTHYOLOGY, P331; Yang M, 2016, AQUACULTURE, V459, P191, DOI 10.1016/j.aquaculture.2016.03.044; Yang YZ, 2018, COMP BIOCHEM PHYS B, V217, P60, DOI 10.1016/j.cbpb.2017.12.012; Ye S, 2007, THESIS CHINESE ACAD; Zahran E, 2014, FISH SHELLFISH IMMUN, V38, P149, DOI 10.1016/j.fsi.2014.03.002; Zhang TL, 2005, LIFE HIST STRATEGIES; Zhu JH., 1962, ACTA HYDROBIOLOGY SI, V0, P14	75	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263507	10.1371/journal.pone.0263507	http://dx.doi.org/10.1371/journal.pone.0263507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120192	Green Published, gold			2022-12-26	WOS:000789273600047
J	Gebreayohanes, M; Dessie, A				Gebreayohanes, Mulugeta; Dessie, Awrajaw			Prevalence of stunting and its associated factors among children 6-59 months of age in pastoralist community, Northeast Ethiopia: A community-based cross-sectional study	PLOS ONE			English	Article							NUTRITIONAL-STATUS; UNDER-5 CHILDREN; UNDERNUTRITION; MALNUTRITION	Introduction Globally, stunting is a significant public health concern and it is very critical in Ethiopia. This research aims to determine the prevalence of stunting and its correlates among children in the pastoral community. Methods A community-based cross-sectional study was conducted in Dubti District, Afar Region, North East Ethiopia from 2-31 January 2018. A total of 554 children were recruited using a multi-stage sampling technique and participated in this study. A binary logistic regression analysis was performed to determine factors linked to stunting. The significance of the associations was determined at a p-value < 0.05 and the adjusted odds ratio at 95% CI was calculated to evaluate the strength of the associations. Results The prevalence of stunting was 39.5% (95% CI: 35.4-43.5%). The odds of stunting were increased, so does the age of the child increased as compared to 6-11 months of children. Initiating breastfeeding after 1 hour after birth (AOR = 1.99; 95% CI: 1.22, 3.23), not exclusively breastfeeding for at least 6 months (AOR = 2.57; 95% CI: 1.49, 4.42), poor dietary diversity (AOR = 1.93; 95% CI: 1.03, 3.62), and using unprotected water for drinking (AOR = 1.68; 95% CI: 1.21, 2.94) were significant factors. Conclusion Among children aged 6-59 months, the level of stunting in the pastoral community was significantly high. The study found that stunting was associated with multiple nutritional and non-nutritional factors. To tackle stunting, inter-sectoral cooperation is needed by enhancing the clean water supply of the community, optimal breastfeeding practice, food diversity, and economic status.	[Gebreayohanes, Mulugeta] Univ Gondar, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia; [Dessie, Awrajaw] Univ Gondar, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia	University of Gondar; University of Gondar	Dessie, A (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia.	awrajawdss@gmail.com						Alam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227839; Alemayehu M., 2014, INT J NUTR FOOD SCI, V3, P579; Alemayehu M, 2015, NUTRITION, V31, P964, DOI 10.1016/j.nut.2015.01.013; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Burney T., 2014, FINDINGS CARE LEARNI, P3; Center DWH, 2016, DUBT WOR HLTH CTR 20; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Central Statistical Agency [Ethiopia], 2014, ETH MIN DEM HLTH SUR; Central Statistical Agency [Ethiopia] ORC Macro., 2006, CENTR STAT AG ETH DE; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; CSA [Ethiopia] and ICF, 2012, 2011 ETH DEM HLTH SU; CSA [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; De Onis M., 2003, WHO GLOBAL DATABASE; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Ethiopian MOH, 2015, HLTH SECT TRANSF PLA; FAO Tropical Livestock Units (TLU), AGAINFOPROGRAMMESENL; Fentaw R, 2013, NUTR RES PRACT, V7, P122, DOI 10.4162/nrp.2013.7.2.122; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fikadu T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-800; Geberselassie SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195361; Gebre A, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9187609; Giashuddin M. S., 2003, Indian Journal of Pediatrics, V70, P471, DOI 10.1007/BF02723136; Government of Ethiopia & Ethiopia Humanitarian Country Team, 2015, ETH HUM OV 2016; Huriah T., PREVALENCE ASS FACTO; IFPRI, 2016, GLOBAL NUTR REPORT 2; Kandala NB, 2001, RES OFFICIAL STAT, V1, P81; Khamis AG, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1897-5; Kinyoki DK, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0449-9; Liben M. L., 2016, HLTH SCI J, V10, P15; Lind J., 2018, INT FOOD POLICY RES; Mengistu K, 2013, J NUTR DISORDERS THE, VT1, DOI DOI 10.4172/2161-0509.T1-001; Mihret J TA, 2014, DISASTER RISK MANAGE; Motbainor A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133542; Muldiasman, 2018, J HEALTH RES, V32, P334, DOI 10.1108/JHR-08-2018-038; Olack B, 2011, J HEALTH POPUL NUTR, V29, P357, DOI 10.3329/jhpn.v29i4.8451; Sanghvi T, 2013, FOOD NUTR BULL, V34, pS156, DOI 10.1177/15648265130343S203; Sarson M., 2013, ECHO SUPPORT COMMUNI, P1; Tadesse SE, 2020, NUTR DIET SUPPL, V12, P41, DOI 10.2147/NDS.S237407; Takele K., 2014, FAR E J THEOR STAT, V48, P87; Takele K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6984-x; Tenaw Gualu, 2017, Advances in Public Health, V2017, P5352847, DOI 10.1155/2017/5352847; Udoh EE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3751-7; UNICEF WHO The World Bank Group, 2016, LEV TRENDS CHILD MAL; United Nations, 2017, SUSTAINABLE DEV GOAL; WHO, 2014, GLOB NUTR TARG 2025, V4; WHO, 2009, INF YOUNG CHILD FEED; Yisak H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0535-0; Zewdu S., 2012, HARAR B HLTH SCI, V4, P221	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0256722	10.1371/journal.pone.0256722	http://dx.doi.org/10.1371/journal.pone.0256722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113874	Green Published, Green Submitted, gold			2022-12-26	WOS:000823694700006
J	Komatsu, M; Yamamoto, H; Ichiyama, T; Kawakami, S; Uehara, T; Yoshikawa, Y; Kitaguchi, Y; Ushiki, A; Yasuo, M; Hanaoka, M				Komatsu, Masamichi; Yamamoto, Hiroshi; Ichiyama, Takashi; Kawakami, Satoshi; Uehara, Takeshi; Yoshikawa, Yumi; Kitaguchi, Yoshiaki; Ushiki, Atsuhito; Yasuo, Masanori; Hanaoka, Masayuki			Tolerability of nintedanib in the elderly with idiopathic pulmonary fibrosis: A single-center retrospective study	PLOS ONE			English	Article							DIAGNOSIS; EFFICACY; UPDATE	Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial lung disease, predominantly affects the elderly and is associated with a high mortality risk. Nintedanib, a tyrosine kinase inhibitor, significantly reduces IPF progression. However, data on the tolerability and efficacy of nintedanib in the elderly with IPF are limited. Therefore, this study aimed to examine the tolerability and efficacy of nintedanib in the elderly with IPF in a real-world setting. Medical records of 19 elderly IPF patients (>= 75 years) and 46 non-elderly IPF patients (< 75 years) newly administered nintedanib were retrospectively analyzed. We compared the forced vital capacity (FVC) level, incidence and severity of adverse events, and continuation rates of nintedanib between the two groups. FVC and percent predicted diffusing capacity of the lung for carbon monoxide (DLco) were lower in the elderly IPF group at baseline. Although the elderly IPF patients had a significantly higher incidence of adverse events, such as diarrhea, nausea, and elevation of hepatic enzymes, the rate of discontinuation of nintedanib owing to adverse events was not different between the groups. The continuation rates of nintedanib treatment at 6 months and 1 year in the elderly IPF group were equivalent. Furthermore, there was a similar trend in the reduction of the annual FVC decline after nintedanib initiation between the groups. Our study demonstrated that nintedanib was tolerable in both the IPF patient groups in a real-world setting. Proper management of adverse events in the elderly with IPF would lead to a better clinical outcome.	[Komatsu, Masamichi; Yamamoto, Hiroshi; Ichiyama, Takashi; Kitaguchi, Yoshiaki; Ushiki, Atsuhito; Yasuo, Masanori; Hanaoka, Masayuki] Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano, Japan; [Kawakami, Satoshi] Shinshu Univ, Sch Med, Dept Radiol, Matsumoto, Nagano, Japan; [Uehara, Takeshi] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano, Japan; [Yoshikawa, Yumi] Shinshu Univ, Sch Med, Dept Pharm, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University	Yamamoto, H (corresponding author), Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano, Japan.	yama5252@shinshu-u.ac.jp			Aiba Works Research Scholarship for Young Physicians	Aiba Works Research Scholarship for Young Physicians	We thank Editage for editing of the manuscript. This study was supported by the Aiba Works Research Scholarship for Young Physicians.	Abe M, 2018, DRUG DES DEV THER, V12, P3369, DOI 10.2147/DDDT.S179427; Antoniou K, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00172-2019; Costabel U, 2016, AM J RESP CRIT CARE, V193, P178, DOI 10.1164/rccm.201503-0562OC; Crestani B, 2019, LANCET RESP MED, V7, P60, DOI 10.1016/S2213-2600(18)30339-4; Distler O, 2019, NEW ENGL J MED, V380, P2518, DOI 10.1056/NEJMoa1903076; du Bois RM, 2012, EUR RESPIR REV, V21, P141, DOI 10.1183/09059180.00000812; Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681; Galli JA, 2017, RESPIROLOGY, V22, P1171, DOI 10.1111/resp.13024; Guenther A, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0845-5; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Jo HE, 2016, DRUG AGING, V33, P321, DOI 10.1007/s40266-016-0366-1; Kato M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48593-4; Kolb M, 2017, THORAX, V72, P340, DOI 10.1136/thoraxjnl-2016-208710; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Maher TM, 2018, RESPIRATION, V96, P514, DOI 10.1159/000490667; Mura M, 2012, EUR RESPIR J, V40, P101, DOI 10.1183/09031936.00106011; Nakamura M, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.33; Nathan SD, 2011, CHEST, V140, P221, DOI 10.1378/chest.10-2572; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Proesmans VLJ, 2019, LUNG, V197, P551, DOI 10.1007/s00408-019-00260-1; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sakayori M, 2019, DRUG DES DEV THER, V13, P2295, DOI 10.2147/DDDT.S208733; Takeda T, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030755; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309	29	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262795	10.1371/journal.pone.0262795	http://dx.doi.org/10.1371/journal.pone.0262795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113907	Green Published, gold			2022-12-26	WOS:000823694700036
J	Pina, JM; Hernandez, LA; Keppetipola, NM				Pina, Jeffrey M.; Hernandez, Luis A.; Keppetipola, Niroshika M.			Polypyrimidine tract binding proteins PTBP1 and PTBP2 interact with distinct proteins under splicing conditions	PLOS ONE			English	Article							RNA INTERACTIONS; REPRESSOR; IDENTIFICATION; REVEALS; SWITCH; ROLES	RNA binding proteins play an important role in regulating alternative pre-mRNA splicing and in turn cellular gene expression. Polypyrimidine tract binding proteins, PTBP1 and PTBP2, are paralogous RNA binding proteins that play a critical role in the process of neuronal differentiation and maturation; changes in the concentration of PTBP proteins during neuronal development direct splicing changes in many transcripts that code for proteins critical for neuronal differentiation. How the two related proteins regulate different sets of neuronal exons is unclear. The distinct splicing activities of PTBP1 and PTBP2 can be recapitulated in an in vitro splicing system with the differentially regulated N1 exon of the c-src pre-mRNA. Here, we conducted experiments under these in vitro splicing conditions to identify PTBP1 and PTBP2 interacting partner proteins. Our results highlight that both PTBPs interact with proteins that participate in chromatin remodeling and transcription regulation. Our data reveal that PTBP1 interacts with many proteins involved in mRNA processing including splicing regulation while PTBP2 does not. Our results also highlight enzymes that can serve as potential "writers" and "erasers" in adding chemical modifications to the PTB proteins. Overall, our study highlights important differences in protein-protein interactions between the PTBP proteins under splicing conditions and supports a role for post-translational modifications in dictating their distinct splicing activities.	[Pina, Jeffrey M.; Keppetipola, Niroshika M.] Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92634 USA; [Hernandez, Luis A.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA	California State University System; California State University Fullerton; California State University System; California State University Fullerton	Keppetipola, NM (corresponding author), Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92634 USA.	nkeppetipola@fullerton.edu			National Institutes of Health [1SC3GM132036]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant 1SC3GM132036 to N.M.K	Ashiya M, 1997, RNA, V3, P996; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; Guo R, 2009, METHODS, V48, P72, DOI 10.1016/j.ymeth.2009.02.011; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hodge K, 2013, J PROTEOMICS, V88, P92, DOI 10.1016/j.jprot.2013.02.023; Hu Jing, 2018, Biophys Rep, V4, P204, DOI 10.1007/s41048-018-0066-y; Joshi A, 2014, PEERJ, V2, DOI 10.7717/peerj.305; Kafasla P, 2012, BIOCHEM SOC T, V40, P815, DOI 10.1042/BST20120044; Keppetipola N, 2012, CRIT REV BIOCHEM MOL, V47, P360, DOI 10.3109/10409238.2012.691456; Keppetipola NM, 2016, RNA, V22, P1172, DOI 10.1261/rna.057505.116; Li Q, 2014, ELIFE, V3, DOI 10.7554/eLife.01201; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Linares AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09268; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Pellacani C, 2018, ELIFE, V7, DOI 10.7554/eLife.40325; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petoukhov MV, 2006, STRUCTURE, V14, P1021, DOI 10.1016/j.str.2006.04.005; Pina JM, 2018, BIOCHEMISTRY-US, V57, P3873, DOI 10.1021/acs.biochem.8b00256; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Romanelli MG, 2013, INT J MOL SCI, V14, P22906, DOI 10.3390/ijms141122906; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Vuong JK, 2016, CELL REP, V17, P2766, DOI 10.1016/j.celrep.2016.11.034; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263287	10.1371/journal.pone.0263287	http://dx.doi.org/10.1371/journal.pone.0263287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113929	Green Published, gold			2022-12-26	WOS:000823694700073
J	Mazzuco, S; Campostrini, S				Mazzuco, Stefano; Campostrini, Stefano			Life expectancy drop in 2020. Estimates based on Human Mortality Database	PLOS ONE			English	Article								In many countries of the world, COVID-19 pandemic has led to exceptional changes in mortality trends. Some studies have tried to quantify the effects of Covid-19 in terms of a reduction in life expectancy at birth in 2020. However, these estimates might need to be updated now that, in most countries, the mortality data for the whole year are available. We used data from the Human Mortality Database (HMD) Short-Term Mortality Fluctuations (STMF) data series to estimate life expectancy in 2020 for several countries. The changes estimated using these data and the appropriate methodology seem to be more pessimistic than those that have been proposed so far: life expectancy dropped in the Russia by 2.16 years, 1.85 in USA, and 1.27 in England and Wales. The differences among countries are substantial: many countries (e.g. Denmark, Island, Norway, New Zealand, South Korea) saw a rather limited drop in life expectancy or have even seen an increase in life expectancy.	[Mazzuco, Stefano] Univ Padua, Dept Stat Sci, Padua, Italy; [Campostrini, Stefano] Univ Ca Foscari Venice, Dept Econ, Venice, Italy	University of Padua; Universita Ca Foscari Venezia	Mazzuco, S (corresponding author), Univ Padua, Dept Stat Sci, Padua, Italy.	stefano.mazzuco@unipd.it	MAZZUCO, STEFANO/AAH-6412-2021	MAZZUCO, STEFANO/0000-0002-1686-5477	Ministero dell'Istruzione, dell'Universita e della Ricerca [20177BR-JXS]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	SM and SC acknowledge support from grant miur-prin 2017 project 20177BR-JXS from Ministero dell'Istruzione, dell'Universita e della Ricerca.	Aburto JM, 2021, J EPIDEMIOL COMMUN H, V75, P735, DOI 10.1136/jech-2020-215505; Andrasfay T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014746118; [Anonymous], 2021, HUM MORT DAT; Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802; C. J.Murray, 2020, medRxiv, DOI 10.1101/2020.04.21.20074732; Eker S, 2020, HUM SOC SCI COMMUN, V7, DOI 10.1057/s41599-020-00553-4; Goldstein JR, 2006, POP STUD-J DEMOG, V60, P257, DOI 10.1080/00324720600895876; Ho JY, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2562; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n230; Aburto JM, 2021, medRxiv, DOI 10.1101/2021.03.02.21252772; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Nemeth L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246663; Nepomuceno MR, PREPRINT, DOI [10.1101/2021.07.20.21260869, DOI 10.1101/2021.07.20.21260869]; Preston S, 2000, DEMOGRAPHY MEASURING; Rizzi S, 2022, SCAND J PUBLIC HEALT, V50, P33, DOI 10.1177/14034948211027818; Scholey J., 2021, MEDRXIV, DOI [10.1101/2021.06.04.21258353, DOI 10.1101/2021.06.04.21258353, 10.1101/2021.06.04.21258353v1]; Trias-Llimos S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241952; Weinberger DM, 2020, JAMA INTERN MED, V180, P1336, DOI 10.1001/jamainternmed.2020.3391; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787	19	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262846	10.1371/journal.pone.0262846	http://dx.doi.org/10.1371/journal.pone.0262846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100285	gold, Green Published			2022-12-26	WOS:000801937600020
J	Oiki, S; Yaguchi, T; Urayama, SI; Hagiwara, D				Oiki, Sayoko; Yaguchi, Takashi; Urayama, Syun-ichi; Hagiwara, Daisuke			Wide distribution of resistance to the fungicides fludioxonil and iprodione in Penicillium species	PLOS ONE			English	Article							2-COMPONENT HISTIDINE KINASE; ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; DICARBOXIMIDE-RESISTANCE; OSMOTIC SENSITIVITY; BOTRYTIS-CINEREA; STRESS-RESPONSE; PYRROLNITRIN; GENE; OSMOREGULATION	Fludioxonil and iprodione are effective fungicides widely used for crop protection and are essential for controlling plant pathogenic fungi. The emergence of fungicide-resistant strains of targeted pathogens is regularly monitored, and several cases have been reported. Non-targeted fungi may also be exposed to the fungicide residues in agricultural fields. However, there are no comprehensive reports on fungicide-resistant strains of non-targeted fungi. Here, we surveyed 99 strains, representing 12 Penicillium species, that were isolated from a variety of environments, including foods, dead bodies, and clinical samples. Among the Penicillium strains, including non-pathogenic P. chrysogenum and P. camembertii, as well as postharvest pathogens P. expansum and P. digitatum, 14 and 20 showed resistance to fludioxonil and iprodione, respectively, and 6 showed multi-drug resistance to the fungicides. Sequence analyses revealed that some strains of P. chrysogenum and Penicillium oxalicum had mutations in NikA, a group III histidine kinase of the high-osmolarity glycerol pathway, which is the mode of action for fludioxonil and iprodione. The single nucleotide polymorphisms of G693D and T1318P in P. chrysogenum and T960S in P. oxalicum were only present in the fludioxonil- or iprodione-resistant strains. These strains also exhibited resistance to pyrrolnitrin, which is the lead compound in fludioxonil and is naturally produced by some Pseudomonas species. This study demonstrated that non-targeted Penicillium strains distributed throughout the environment possess fungicide resistance.	[Oiki, Sayoko; Urayama, Syun-ichi; Hagiwara, Daisuke] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Yaguchi, Takashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Urayama, Syun-ichi; Hagiwara, Daisuke] Univ Tsukuba, Microbiol Res Ctr Sustainabil, Tsukuba, Ibaraki, Japan	University of Tsukuba; Chiba University; University of Tsukuba	Hagiwara, D (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Hagiwara, D (corresponding author), Univ Tsukuba, Microbiol Res Ctr Sustainabil, Tsukuba, Ibaraki, Japan.	hagiwara.daisuke.gb@u.tsukuba.ac.jp			Institute for Fermentation, Osaka; National Bioresource Project	Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); National Bioresource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a grant from the Institute for Fermentation, Osaka and partly by the National Bioresource Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz S, 2010, PLANT PATHOL, V59, P556, DOI 10.1111/j.1365-3059.2009.02230.x; Alberoni G, 2010, EUR J PLANT PATHOL, V128, P171, DOI 10.1007/s10658-010-9642-9; ARIMA K, 1964, AGR BIOL CHEM TOKYO, V28, P575, DOI 10.1080/00021369.1964.10858275; Avenot HF, 2015, CROP PROT, V78, P214, DOI 10.1016/j.cropro.2015.09.012; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; BEEVER RE, 1983, NEW ZEAL J AGR RES, V26, P391, DOI 10.1080/00288233.1983.10427048; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; CHANG CJ, 1981, J ANTIBIOT, V34, P555, DOI 10.7164/antibiotics.34.555; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Duan YB, 2013, MOL PLANT PATHOL, V14, P708, DOI 10.1111/mpp.12041; Duan YB, 2013, PESTIC BIOCHEM PHYS, V106, P61, DOI 10.1016/j.pestbp.2013.04.004; Fillinger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042520; Fujimura M, 2003, BIOSCI BIOTECH BIOCH, V67, P186, DOI 10.1271/bbb.67.186; Fujimura M., 2010, Journal of Pesticide Science, V35, P351, DOI 10.1584/jpestics.J10-02; GEHMANN K, 1990, BRIGHTON CROP PROTECTION CONFERENCE - PESTS AND DISEASES, 1990 : PROCEEDINGS, VOLS 1-3, P399; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P844, DOI 10.1271/bbb.70051; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hagiwara D, 2009, FUNGAL GENET BIOL, V46, P868, DOI 10.1016/j.fgb.2009.07.003; Han X, 2017, PESTIC BIOCHEM PHYS, V139, P32, DOI 10.1016/j.pestbp.2017.04.006; Iacomi-Vasilescu B, 2004, CROP PROT, V23, P481, DOI 10.1016/j.cropro.2003.10.003; Jacob S, 2015, FUNGAL BIOL-UK, V119, P580, DOI 10.1016/j.funbio.2015.03.003; Kanetis L, 2008, PHYTOPATHOLOGY, V98, P205, DOI 10.1094/PHYTO-98-2-0205; Kilani J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02014; Li HX, 2008, PHYTOPATHOLOGY, V98, P427, DOI 10.1094/PHYTO-98-4-0427; Liu WW, 2008, FUNGAL GENET BIOL, V45, P1062, DOI 10.1016/j.fgb.2008.04.003; Motoyama T, 2005, CURR GENET, V47, P298, DOI 10.1007/s00294-005-0572-6; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Okada A, 2005, J PESTIC SCI, V30, P378, DOI 10.1584/jpestics.30.378; Oshima Michiyo, 2006, Journal of General Plant Pathology, V72, P65, DOI 10.1007/s10327-005-0247-7; Pawar S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090443; Ren WC, 2016, PLANT DIS, V100, P1414, DOI 10.1094/PDIS-11-15-1290-RE; Sang H, 2017, PHYTOPATHOLOGY, V107, P198, DOI 10.1094/PHYTO-05-16-0211-R; Schumacher MM, 1997, CURR MICROBIOL, V34, P340, DOI 10.1007/s002849900193; Takahashi H, 2021, ENVIRON MICROBIOL, V23, P5621, DOI 10.1111/1462-2920.15724; Wang MS, 2014, MICROBIOL RES, V169, P511, DOI 10.1016/j.micres.2013.12.004; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	39	0	0	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262521	10.1371/journal.pone.0262521	http://dx.doi.org/10.1371/journal.pone.0262521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100282	Green Published, gold			2022-12-26	WOS:000801937600014
J	Bharathy, N; Cleary, MM; Kim, JA; Nagamori, K; Crawford, KA; Wang, E; Saha, D; Settelmeyer, TP; Purohit, R; Skopelitis, D; Chang, K; Doran, JA; Kirschbaum, CW; Bharathy, S; Crews, DW; Randolph, ME; Karnezis, AN; Hudson-Price, L; Dhawan, J; Michalek, JE; Ciulli, A; Vakoc, CR; Keller, C				Bharathy, Narendra; Cleary, Megan M.; Kim, Jin-Ah; Nagamori, Kiyo; Crawford, Kenneth A.; Wang, Eric; Saha, Debarya; Settelmeyer, Teagan P.; Purohit, Reshma; Skopelitis, Damianos; Chang, Kenneth; Doran, Jessica A.; Kirschbaum, C. Ward; Bharathy, Suriya; Crews, Davis W.; Randolph, Matthew E.; Karnezis, Anthony N.; Hudson-Price, Lisa; Dhawan, Jyotsna; Michalek, Joel E.; Ciulli, Alessio; Vakoc, Christopher R.; Keller, Charles			SMARCA4 biology in alveolar rhabdomyosarcoma	ONCOGENE			English	Article							SMALL-CELL CARCINOMA; METASTATIC RHABDOMYOSARCOMA; SWI/SNF COMPLEXES; GENETIC LANDSCAPE; MUTATIONS; OVARY; BROMODOMAIN; CHILDREN; OUTCOMES; SARCOMA	Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and phenocopies a muscle precursor that fails to undergo terminal differentiation. The alveolar subtype (ARMS) has the poorest prognosis and represents the greatest unmet medical need for RMS. Emerging evidence supports the role of epigenetic dysregulation in RMS. Here we show that SMARCA4/BRG1, an ATP-dependent chromatin remodeling enzyme of the SWI/SNF complex, is prominently expressed in primary tumors from ARMS patients and cell cultures. Our validation studies for a CRISPR screen of 400 epigenetic targets identified SMARCA4 as a unique factor for long-term (but not short-term) tumor cell survival in ARMS. A SMARCA4/SMARCA2 protein degrader (ACBI-1) demonstrated similar long-term tumor cell dependence in vitro and in vivo. These results credential SMARCA4 as a tumor cell dependency factor and a therapeutic target in ARMS.	[Bharathy, Narendra; Cleary, Megan M.; Kim, Jin-Ah; Nagamori, Kiyo; Crawford, Kenneth A.; Saha, Debarya; Settelmeyer, Teagan P.; Purohit, Reshma; Doran, Jessica A.; Kirschbaum, C. Ward; Bharathy, Suriya; Crews, Davis W.; Randolph, Matthew E.; Hudson-Price, Lisa; Keller, Charles] Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA; [Wang, Eric; Skopelitis, Damianos; Chang, Kenneth; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Saha, Debarya; Dhawan, Jyotsna] CSIR CCMB, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Karnezis, Anthony N.] Univ Calif C Davis Med Ctr, Sacramento, CA 95817 USA; [Karnezis, Anthony N.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Michalek, Joel E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Ciulli, Alessio] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Bharathy, Narendra] Univ Penn, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA	Cold Spring Harbor Laboratory; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); British Columbia Cancer Agency; University of Texas System; University of Texas Health San Antonio; University of Dundee; University of Pennsylvania; Pennsylvania Medicine	Keller, C (corresponding author), Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA.; Ciulli, A (corresponding author), Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	a.ciulli@dundee.ac.uk; charles@cc-tdi.org		Nagamori, Kiyo/0000-0002-7891-3534; Keller, Charles/0000-0003-2505-7487	Braver Stronger Smarter Foundation; Maddie's Promise Foundation; NIH [R01CA189299, R01CA258720]; Boehringer Ingelheim; Pershing Square Sohn Cancer Research Alliance, Northwell Health Translational Research Award; Christina Renna Foundation; Clark Gillies Foundation; Friends of T.J. Foundation; Michelle Paternoster Foundation; National Cancer Institute [CA2455859]; Department of Biotechnology (DBT), Govt. of India; Indo-U.S. Science and Technology Forum (IUSSTF)	Braver Stronger Smarter Foundation; Maddie's Promise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); Pershing Square Sohn Cancer Research Alliance, Northwell Health Translational Research Award(Pershing Square Sohn Cancer Research Alliance); Christina Renna Foundation; Clark Gillies Foundation; Friends of T.J. Foundation; Michelle Paternoster Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Indo-U.S. Science and Technology Forum (IUSSTF)	We thank Dr. Manfred Kogl for generously providing vectors LMH-SMARCA2 and LMH-PBRM1. This study was funded by Braver Stronger Smarter Foundation, Maddie's Promise Foundation and by NIH grants R01CA189299 & R01CA258720. The ACBI-1 PROTAC degrader was developed with funding support to the Ciulli Laboratory by Boehringer Ingelheim. CRV was supported by the Pershing Square Sohn Cancer Research Alliance, Northwell Health Translational Research Award, The Christina Renna Foundation, The Clark Gillies Foundation, The Friends of T.J. Foundation, The Michelle Paternoster Foundation, and a grant from National Cancer Institute (CA2455859). DS was supported by the Indo-U.S. GETin program from Department of Biotechnology (DBT), Govt. of India and Indo-U.S. Science and Technology Forum (IUSSTF).	Abraham J, 2014, GENE DEV, V28, P1578, DOI 10.1101/gad.238733.114; Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Bell EH, 2016, CLIN CANCER RES, V22, P2396, DOI 10.1158/1078-0432.CCR-15-1468; Bharathy N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau7632; Bharathy N, 2016, J PATHOL, V240, P269, DOI 10.1002/path.4773; Blandford MC, 2006, PEDIATR BLOOD CANCER, V46, P329, DOI 10.1002/pbc.20466; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Chan-Penebre E, 2017, MOL CANCER THER, V16, P850, DOI 10.1158/1535-7163.MCT-16-0678; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dagher R, 1999, Oncologist, V4, P34; Farnaby W, 2019, NAT CHEM BIOL, V15, P672, DOI 10.1038/s41589-019-0294-6; Gryder BE, 2017, CANCER DISCOV, V7, P884, DOI 10.1158/2159-8290.CD-16-1297; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Karnezis AN, 2016, J PATHOL, V238, P389, DOI 10.1002/path.4633; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Malempati S, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.10556; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; McBride MJ, 2018, J PATHOL, V244, P638, DOI 10.1002/path.5042; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Michel BC, 2018, NAT CELL BIOL, V20, P1410, DOI 10.1038/s41556-018-0221-1; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Rudzinski ER, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26645; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Vangamudi B, 2015, CANCER RES, V75, P3865, DOI 10.1158/0008-5472.CAN-14-3798; Wexler LH, 1997, J PEDIATR-US, V131, P508; Williams BA, 2004, J PEDIAT HEMATOL ONC, V26, P243, DOI 10.1097/00043426-200404000-00006; Willis MS, 2012, CIRC RES, V111, pE111, DOI 10.1161/CIRCRESAHA.112.265587; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931	36	0	0	6	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1647	1656		10.1038/s41388-022-02205-0	http://dx.doi.org/10.1038/s41388-022-02205-0		JAN 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35094009	Green Submitted			2022-12-26	WOS:000750486500002
J	Al-Mulki, JM; Hassoun, MH; Adib, SM				Al-Mulki, Jida M.; Hassoun, Mahmoud H.; Adib, Salim M.			Epidemics and local governments in struggling nations: COVID-19 in Lebanon	PLOS ONE			English	Article							PREPAREDNESS; LESSONS; MODEL	Municipalities in Lebanon represent local governments at the basic community level. The proximity of the municipality to the local community and its knowledge of available resources, can be crucial in easing the impact of any disaster. This study aimed to document the range of preparedness/reactivity of municipalities as COVID-19 swept through Lebanon. A qualitative case study was implemented to explore municipal response to control the epidemic, using in-depth semi-structured interviews with twenty-seven stakeholders from nine municipalities across all governorates in Lebanon. In each municipality, participants included mayors/deputy mayors, available members of municipal councils, prominent community leaders, health care professionals, and managers of local NGOs. The collected data were analyzed using the comparative thematic analysis. The socioecological model was adopted to illustrate the dynamic interplay between the barriers and facilitators at all ecological levels. The response to the pandemic differed significantly in volume and nature among different municipalities across regions, with rural areas clearly disadvantaged in terms of adequacy and completeness of response. Barriers consistently mentioned by most municipalities included economic collapse and poverty, shortage in resources, lack of support from the central government, stigma, lack of awareness, underreporting, flaws in the MOPH surveillance system, impeded accessibility to healthcare services, limited number and weak role of municipal police, increased mental illnesses, and political patronage, favoritism, and interference. On the other hand, increased donations, community engagement, social support and empathy, sufficient human resources, the effective role of healthcare systems, and good governance were identified as key facilitators. The socioecological model identified several multi-level facilitators and loopholes which can be addressed through a suggested strategic "roadmap" providing evidence-based interventions for future epidemics. It is crucial meanwhile that the central government strengthens the administrative and financial resources of municipalities in preparing and rapidly deploying the expected optimal response.	[Al-Mulki, Jida M.; Adib, Salim M.] Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Beirut, Lebanon; [Hassoun, Mahmoud H.] Rafik Hariri Univ Hosp, Dept Crit Care, Beirut, Lebanon	American University of Beirut	Al-Mulki, JM (corresponding author), Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Beirut, Lebanon.	jma54@mail.aub.edu		mulki, jida/0000-0003-4369-7795				Abdelhafiz AS, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00429; Abou Samra C, 2020, K2P COVID 19 SERIES; Al-Awsat A., 2020, LEBANONS MUNICIPALIT; Atallah S., 2002, EMP LOC GOV I MENA R; Beerman A., 2020, SUPPORT CITY LOCAL G; Bizri AR, 2021, J COMMUN HEALTH, V46, P487, DOI 10.1007/s10900-020-00884-y; CDC, 2020, INT GUID GET YOUR CO; Dureab F, 2020, LANCET PUBLIC HEALTH, V5, pE311, DOI 10.1016/S2468-2667(20)30101-8; El Othman R, 2021, INT J PSYCHIAT CLIN, V25, P152, DOI 10.1080/13651501.2021.1879159; El-Jardali F, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-49; El-Zoghby SM, 2020, J COMMUN HEALTH, V45, P689, DOI 10.1007/s10900-020-00853-5; Figueroa ME, 2017, J HEALTH COMMUN, V22, P5, DOI 10.1080/10810730.2016.1231725; Gourinchas P-O., 2020, MITIGATING COVID EC, P31; Hassan I, 2021, NAT MED, V27, P396, DOI 10.1038/s41591-021-01272-2; Isiko A.P., 2020, J AFRICAN STUD DEV, V12, P77, DOI [DOI 10.5897/JASD2020.0573, 10.5897/JASD2020.0573]; Jaspal R, 2020, MENT HEALTH REV J, V25, P215, DOI 10.1108/MHRJ-05-2020-0027; Lau H, 2021, PULMONOLOGY, V27, P110, DOI 10.1016/j.pulmoe.2020.05.015; Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Logie CH, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25504; Lu HY, 2021, APPL RES QUAL LIFE, V16, P1925, DOI 10.1007/s11482-020-09851-0; Makhoul J, 2021, GLOB HEALTH PROMOT, V28, P33, DOI 10.1177/1757975920984178; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Mourad L., 2016, REFUGEE RES POLICY A; Overholt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206595; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; RONDINELLI DA, 1982, WORLD POLIT, V35, P43, DOI 10.2307/2010279; Sahal N, 2009, SCAND J PUBLIC HEALT, V37, P187, DOI 10.1177/1403494808101179; Sarti TD, WHAT IS ROLE PRIMARY; Schwartz J, 2017, J MICROBIOL IMMUNOL, V50, P125, DOI 10.1016/j.jmii.2016.08.010; Scottish Government, 2020, TERR IMP COVID 19 MA; Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022; The World Bank, UNDERSTANDING POVERT; Tubadji A., 2020, CTR EC POLICY RES, V20, P109; Turner-Musa J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020168; Vokshi J., 2020, LESSONS FRONTLINE LO; World Health Organization, 2020, DAIL BRIEFS COR DIS	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262048	10.1371/journal.pone.0262048	http://dx.doi.org/10.1371/journal.pone.0262048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085281	Green Published, gold			2022-12-26	WOS:000779379600036
J	Kim, KE; Sinn, DH; Choi, MS; Kim, H				Kim, Ka Eun; Sinn, Dong Hyun; Choi, Moon Seok; Kim, Honsoul			Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment	PLOS ONE			English	Article							TRANSPLANTATION; SURVEILLANCE; HCC; RECURRENCE; CT	Purpose Hepatocellular carcinoma (HCC) patients usually achieve a complete response after treatment. This study was aimed to assess the clinical outcome of HCC patients who had achieved a complete response but later presented with elevated tumor marker levels without an identifiable recurrent tumor on gadoxetic acid-enhanced magnetic resonance imaging (MRI). Methods We retrospectively reviewed the clinical outcome of 58 HCC treated patients who had achieved a complete response but later was referred to our institution's multidisciplinary tumor board for a clinically suspected hidden HCC recurrence based on elevated tumor marker levels but negative gadoxetic acid-enhanced MRI. The imaging studies, tumor markers, and clinical information were reviewed. The total follow-up period was at least 15 months after the initial negative gadoxetic acid-enhanced MRI. Results Follow-up imaging studies detected an HCC lesion in 89.7% (n = 52/58) of the patients within the study period, and approximately half of the tumors (46.2%, n = 24/52) developed within 3 months. The most frequent site of recurrence was the liver (86.5%; n = 45/52), but extra-hepatic metastasis was also common (19.2%; n = 10/52). In 5.8% (n = 3/52), HCC reoccurred in the combined form of intra-hepatic and extra-hepatic recurrence. Extra-hepatic metastasis alone occurred in 13.5% (n = 7/52) of patients. Conclusions HCC frequently recurred within a short interval in patients who achieved a complete response to treatment in the presence of increased tumor marker levels, even if gadoxetic acid-enhanced MRI was negative. Under such circumstances, we suggest a short-term follow-up including, but not limited to, gadoxetic acid-enhanced MRI along with systemic evaluation.	[Kim, Ka Eun; Kim, Honsoul] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Sinn, Dong Hyun; Choi, Moon Seok] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea; [Kim, Honsoul] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Kim, H (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea.; Kim, H (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.	pine0205@hanmail.net		Kim, Ka Eun/0000-0002-8916-1761				Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burgio MD, 2015, TRANSPLANTATION, V99, P1613, DOI 10.1097/TP.0000000000000659; Choi JY, 2014, RADIOLOGY, V273, P30, DOI 10.1148/radiol.14132362; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Gordic S, 2017, J HEPATOL, V67, P1213, DOI 10.1016/j.jhep.2017.07.030; Gosalia Ashil J, 2017, Gastroenterol Hepatol (N Y), V13, P398; Hyder O, 2013, J GASTROINTEST SURG, V17, P1774, DOI 10.1007/s11605-013-2302-6; Imai Y, 2017, LIVER CANCER, V6, P349, DOI 10.1159/000481416; Kim BS, 2013, RADIOLOGY, V268, P109, DOI 10.1148/radiol.13121314; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Kim JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005666; Kim SK, 2003, RADIOGRAPHICS, V23, P107, DOI 10.1148/rg.231025055; Lee CH, 2011, J MAGN RESON IMAGING, V33, P1399, DOI 10.1002/jmri.22326; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Liu D, 2017, TRANSPLANTATION, V101, P107, DOI 10.1097/TP.0000000000001513; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Medavaram S, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0109-6; Mendiratta-Lala M, 2018, INT J RADIAT ONCOL, V102, P1063, DOI 10.1016/j.ijrobp.2017.08.022; Mendiratta-Lala M, 2019, INT J RADIAT ONCOL, V103, P169, DOI 10.1016/j.ijrobp.2018.09.004; Park JW, 2019, GUT LIVER, V13, P227, DOI 10.5009/gnl19024; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Sinn DH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210730; Song SH, 2019, ACTA RADIOL, V60, P826, DOI 10.1177/0284185118805253; Toyoda H, 2015, LIVER CANCER, V4, P126, DOI 10.1159/000367735; Yamamoto K, 2009, ANN SURG ONCOL, V16, P2795, DOI 10.1245/s10434-009-0618-y	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262750	10.1371/journal.pone.0262750	http://dx.doi.org/10.1371/journal.pone.0262750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085305	Green Published, gold			2022-12-26	WOS:000779379600077
J	Narvaez-Bandera, I; Suarez-Gomez, D; Isaza, CE; Cabrera-Rios, M				Narvaez-Bandera, Isis; Suarez-Gomez, Deiver; Isaza, Clara E.; Cabrera-Rios, Mauricio			Multiple Criteria Optimization (MCO): A gene selection deterministic tool in RStudio	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXPRESSION; NEURONS; CANCER	Identifying genes with the largest expression changes (gene selection) to characterize a given condition is a popular first step to drive exploration into molecular mechanisms and is, therefore, paramount for therapeutic development. Reproducibility in the sciences makes it necessary to emphasize objectivity and systematic repeatability in biological and informatics analyses, including gene selection. With these two characteristics in mind, in previous works our research team has proposed using multiple criteria optimization (MCO) in gene selection to analyze microarray datasets. The result of this effort is the MCO algorithm, which selects genes with the largest expression changes without user manipulation of neither informatics nor statistical parameters. Furthermore, the user is not required to choose either a preference structure among multiple measures or a predetermined quantity of genes to be deemed significant a priori. This implies that using the same datasets and performance measures (PMs), the method will converge to the same set of selected differentially expressed genes (repeatability) despite who carries out the analysis (objectivity). The present work describes the development of an open-source tool in RStudio to enable both: (1) individual analysis of single datasets with two or three PMs and (2) meta-analysis with up to five microarray datasets, using one PM from each dataset. The capabilities afforded by the code include license-free portability and the possibility to carry out analyses via modest computer hardware, such as personal laptops. The code provides affordable, repeatable, and objective detection of differentially expressed genes from microarrays. It can be used to analyze other experiments with similar experimental comparative layouts, such as microRNA arrays and protein arrays, among others. As a demonstration of the capabilities of the code, the analysis of four publicly-available microarray datasets related to Parkinson ' s Disease (PD) is presented here, treating each dataset individually or as a four-way meta-analysis. These MCO-supported analyses made it possible to identify MMP9 and TUBB2A as potential PD genetic biomarkers based on their persistent appearance across each of the case studies. A literature search confirmed the importance of these genes in PD and indeed as PD biomarkers, which evidences the code ' s potential.	[Narvaez-Bandera, Isis; Suarez-Gomez, Deiver; Isaza, Clara E.; Cabrera-Rios, Mauricio] Univ Puerto Rico, Appl Optimizat Grp, Bioengn Grad Program, Mayaguez, PR 00682 USA; [Isaza, Clara E.] Ponce Hlth Sci Univ, Publ Hlth Program, Ponce, PR USA; [Isaza, Clara E.] Ponce Hlth Sci Univ, Basic Sci Dept, Ponce, PR USA; [Isaza, Clara E.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Cabrera-Rios, Mauricio] Univ Puerto Rico, Ind Engn Dept, Appl Optimizat Grp, Mayaguez, PR 00682 USA	University of Puerto Rico; University of Puerto Rico Mayaguez; Ponce Health Sciences University; Ponce Health Sciences University; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico Mayaguez	Cabrera-Rios, M (corresponding author), Univ Puerto Rico, Appl Optimizat Grp, Bioengn Grad Program, Mayaguez, PR 00682 USA.; Cabrera-Rios, M (corresponding author), Univ Puerto Rico, Ind Engn Dept, Appl Optimizat Grp, Mayaguez, PR 00682 USA.	mauricio.cabrera1@upr.edu			National Institute on Minority Health and Health Disparities [U54MD007579]	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project described was supported by Award Number U54MD007579 from the National Institute on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal M, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00054; Camacho-Caceres KI, 2015, CANCER MED-US, V4, P1884, DOI 10.1002/cam4.540; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Cruz-Rivera YE, 2018, J ALZHEIMERS DIS, V65, P193, DOI 10.3233/JAD-170799; Fernandes HJR, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108263; Garcia-Esparcia P, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0257-4; George G, 2019, GENOMICS, V111, P819, DOI 10.1016/j.ygeno.2018.05.005; Goldman SM, 2014, MOVEMENT DISORD, V29, P1171, DOI 10.1002/mds.25895; Gordon R, 2016, NEUROBIOL DIS, V93, P96, DOI 10.1016/j.nbd.2016.04.008; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073777; Isaza C, 2018, CANCER MED-US, V7, P1875, DOI 10.1002/cam4.1301; Jan A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0554-9; Jiang FH, 2019, FEBS OPEN BIO, V9, P1460, DOI 10.1002/2211-5463.12687; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Kapur M, 2017, NEURON, V96, P616, DOI 10.1016/j.neuron.2017.09.057; Khwanraj K, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/8716016; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Kim JE, 2008, MOL CELL BIOL, V28, P803, DOI 10.1128/MCB.01226-07; Lee M, 2015, NEUROBIOL AGING, V36, P2748, DOI 10.1016/j.neurobiolaging.2015.06.018; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Locascio JJ, 2015, BRAIN, V138, P2659, DOI 10.1093/brain/awv202; Lorenzl S, 2004, NEUROMOL MED, V5, P119, DOI 10.1385/NMM:5:2:119; Lorenzo Enery, 2015, Microarrays (Basel), V4, P287, DOI 10.3390/microarrays4020287; Lyttleton Oliver, 2011, J Pathol Inform, V2, P17, DOI 10.4103/2153-3539.78263; Maetzler W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149349; Mastrokolias A, 2015, EUR J HUM GENET, V23, P1349, DOI 10.1038/ejhg.2014.281; Moran LB, 2008, NEUROGENETICS, V9, P1, DOI 10.1007/s10048-007-0116-y; Natarajan R, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/371734; Picillo M, 2017, J NEUROL, V264, P1583, DOI 10.1007/s00415-016-8384-9; Rocha S, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010001; Russo Isabella, 2012, Am J Neurodegener Dis, V1, P217; Santiago JA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00073; Santiago JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083940; Sferra A, 2018, HUM MOL GENET, V27, P1892, DOI 10.1093/hmg/ddy096; Shamir R, 2017, NEUROLOGY, V89, P1676, DOI 10.1212/WNL.0000000000004516; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Shukla AK, 2020, J INTELL FUZZY SYST, V38, P6637, DOI 10.3233/JIFS-179743; Shukla AK, 2020, GENES GENOM, V42, P449, DOI 10.1007/s13258-020-00916-w; Shukla AK, 2019, ADV INTELL SYST, V711, P783, DOI 10.1007/978-981-10-8055-5_69; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; Singh P, 2017, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON INVENTIVE COMPUTING AND INFORMATICS (ICICI 2017), P832; Su LN, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0357-7; Tyagi V., 2013, INT J COMPUT APPL, V67, P36, DOI [10.5120/11482-7181, DOI 10.5120/11482-7181]; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zhang X, 2019, SUBSTANTIA NIGRA DYS	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262890	10.1371/journal.pone.0262890	http://dx.doi.org/10.1371/journal.pone.0262890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085348	gold, Green Published			2022-12-26	WOS:000779379600093
J	Miranda, GHN; Lima, LAD; Bittencourt, LO; dos Santos, SM; de Souza, MPC; Nogueira, LS; de Oliveira, EHC; Monteiro, MC; Dionizio, A; Leite, AL; Pessan, JP; Buzalaf, MAR; Lima, RR				Nonato Miranda, Giza Hellen; de Oliveira Lima, Leidiane Alencar; Bittencourt, Leonardo Oliveira; dos Santos, Savio Monteiro; Caldas de Souza, Michel Platini; Nogueira, Lygia Sega; Correa de Oliveira, Edivaldo Herculano; Monteiro, Marta Chagas; Dionizio, Aline; Leite, Aline Lima; Pessan, Juliano Pelim; Rabelo Buzalaf, Marilia Afonso; Lima, Rafael Rodrigues			Effects of long-term fluoride exposure are associated with oxidative biochemistry impairment and global proteomic modulation, but not genotoxicity, in parotid glands of mice	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; DNA-DAMAGE; STRESS; ASSAY; MECHANISMS; EXPRESSION; APOPTOSIS; NAF	Background Fluoride has become widely used in dentistry because of its effectiveness in caries control. However, evidence indicates that excessive intake interferes with the metabolic processes of different tissues. Thus, this study aimed to investigate the effects of long-term exposure to F on the parotid salivary gland of mice, from the analysis of oxidative, proteomic and genotoxic parameters. Materials and methods The animals received deionized water containing 0, 10 or 50 mg/L of F, as sodium fluoride, for 60 days. After, parotid glands were collected for analysis of oxidative biochemistry, global proteomic profile, genotoxicity assessment and histopathological analyses. Results The results revealed that exposure to fluoride interfered in the biochemical homeostasis of the parotid gland, with increased levels of thiobarbituric acid reactive species and reduced glutathione in the exposed groups; as well as promoted alteration of the glandular proteomic profile in these groups, especially in structural proteins and proteins related to oxidative stress. However, genotoxic assessment demonstrated that exposure to fluoride did not interfere with DNA integrity in these concentrations and durations of exposure. Also, it was not observed histopathological alterations in parotid gland. Conclusions Thus, our results suggest that long-term exposure to fluoride promoted modulation of the proteomic and biochemical profile in the parotid glands, without inducing damage to the genetic component. These findings reinforce the importance of rationalizing the use of fluorides to maximize their preventative effects while minimizing the environmental risks.	[Nonato Miranda, Giza Hellen; de Oliveira Lima, Leidiane Alencar; Bittencourt, Leonardo Oliveira; Lima, Rafael Rodrigues] Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil; [dos Santos, Savio Monteiro; Monteiro, Marta Chagas] Fed Univ Para, Pharm Fac, Inst Hlth Sci, Lab Clin Immunol & Oxidat Stress, Belem, Para, Brazil; [Caldas de Souza, Michel Platini; Nogueira, Lygia Sega; Correa de Oliveira, Edivaldo Herculano] Evandro Chagas Inst, Ananindeua, PA, Brazil; [Dionizio, Aline; Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, Bauru, SP, Brazil; [Leite, Aline Lima] Univ Nebraska Lincoln, Dept Chem, Lincoln, NE USA; [Pessan, Juliano Pelim] Sao Paulo State Univ, Sch Dent, Dept Prevent & Restorat Dent, UNESP, Aracatuba, SP, Brazil	Universidade Federal do Para; Universidade Federal do Para; Instituto Evandro Chagas; Universidade de Sao Paulo; University of Nebraska System; University of Nebraska Lincoln; Universidade Estadual Paulista	Lima, RR (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil.	rafalima@ufpa.br	Lima, Rafael Rodrigues/M-7726-2019; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Bittencourt, Leonardo O/N-4526-2017; Monteiro, Marta C./F-6575-2010; Dionizio, Aline/N-6464-2016; de Oliveira, Edivaldo H. C./C-3368-2013	Lima, Rafael Rodrigues/0000-0003-1486-4013; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Bittencourt, Leonardo O/0000-0002-9525-2723; Monteiro, Marta C./0000-0002-3328-5650; Dionizio, Aline/0000-0002-8687-0124; de Oliveira, Edivaldo H. C./0000-0001-6315-3352	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) [435093/2018-5]; Coordination of Personal Improvement of Higher Education - (CAPES) [001]; Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESP-UFPA)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Personal Improvement of Higher Education - (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESP-UFPA)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) (grant no. 435093/2018-5) and the Coordination of Personal Improvement of Higher Education - (CAPES - Finance Code 001). The APC was funded by Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESP-UFPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdoosh M, 2017, BIOINFORMATICS, V33, P414, DOI 10.1093/bioinformatics/btw623; ANGMARMANSSON B, 1984, CARIES RES, V18, P25, DOI 10.1159/000260743; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; BANCI L, 1989, INORG CHEM, V28, P2377, DOI 10.1021/ic00311a024; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castagnola M, 2017, ACTA OTORHINOLARYNGO, V37, P94, DOI 10.14639/0392-100X-1598; Chen Q, 2009, J TOXICOL SCI, V34, P399, DOI 10.2131/jts.34.399; Chouhan S, 2008, TOXICOLOGY, V254, P61, DOI 10.1016/j.tox.2008.09.008; de Paula F, 2017, ANAT REC, V300, P1180, DOI 10.1002/ar.23569; Dionizio AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21533-4; Dong XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24711; DUNIPACE AJ, 1995, J DENT RES, V74, P358, DOI 10.1177/00220345950740011201; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Barbosa KBF, 2010, REV NUTR, V23, P629, DOI 10.1590/S1415-52732010000400013; Hodge HC., 1965, FLOURINE CHEM, V4, P1; Iano FG, 2014, J FLUORINE CHEM, V168, P212, DOI 10.1016/j.jfluchem.2014.09.029; Karube H, 2009, J DENT RES, V88, P461, DOI 10.1177/0022034509334771; KLEINER HS, 1979, J DENT RES, V58, P1920, DOI 10.1177/00220345790580091801; Kovacs P, 2008, CELL BIOCHEM FUNCT, V26, P591, DOI 10.1002/cbf.1482; Lawson PB, 2003, FLUORIDE, V36, P143; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; Lopes GO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197297; Ferreira MKM, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111437; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mohammed AT, 2017, ACTA HISTOCHEM, V119, P357, DOI 10.1016/j.acthis.2017.03.004; Nicolau J., 1992, ALTERATION NAF J BIO, V20, P97; Niu RY, 2015, CHEMOSPHERE, V139, P422, DOI 10.1016/j.chemosphere.2015.07.011; Miranda GHN, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8379123; Pereira HABS, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06028; Podder S, 2008, FLUORIDE, V41, P301; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reichmann D, 2018, MOL CELL, V69, P203, DOI 10.1016/j.molcel.2017.12.021; Reyes-Caudillo E, 2008, FOOD CHEM, V107, P656, DOI 10.1016/j.foodchem.2007.08.062; Ribeiro DA, 2004, CARIES RES, V38, P576, DOI 10.1159/000080590; Ribeiro DA, 2017, ENVIRON SCI POLLUT R, V24, P15254, DOI 10.1007/s11356-017-9105-3; Speit G, 1999, METH MOL B, V113, P203; TAVES DR, 1968, TALANTA, V15, P969, DOI 10.1016/0039-9140(68)80097-9; ten Cate JM, 2019, J DENT RES, V98, P725, DOI 10.1177/0022034519831604; Tian Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171003; Vasconcelos SML, 2007, QUIM NOVA, V30, P1323, DOI 10.1590/S0100-40422007000500046; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; WHITFORD GM, 1996, METABOLISM TOXICITY; Xu H, 2007, BIOL TRACE ELEM RES, V116, P279, DOI 10.1007/BF02698012; Yamaguti PM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/674593; Zhang LJ, 2011, MUTAT RES-GEN TOX EN, V721, P153, DOI 10.1016/j.mrgentox.2011.01.006; Zuo H, 2018, LIFE SCI, V198, P18, DOI 10.1016/j.lfs.2018.02.001	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261252	10.1371/journal.pone.0261252	http://dx.doi.org/10.1371/journal.pone.0261252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085268	gold, Green Published			2022-12-26	WOS:000779379600024
J	Roessink, I; van der Zon, KAE; de Reus, SRMM; Peeters, ETHM				Roessink, Ivo; van der Zon, Karina A. E.; de Reus, Sophie R. M. M.; Peeters, Edwin T. H. M.			Native European crayfish Astacus astacus competitive in staged confrontation with the invasive crayfish Faxonius limosus and Procambarus acutus	PLOS ONE			English	Article							PACIFASTACUS-LENIUSCULUS; APHANOMYCES-ASTACI; AGGRESSIVE INTERACTIONS; SHELTER COMPETITION; COMMUNICATION; POPULATIONS; INFECTION; DYNAMICS; DECAPODA; GIRARD	The European native, noble crayfish (Astacus astacus) has suffered from a serious and long term population decline due to habitat destruction, water pollution and the impact of the invasive North American crayfish that are carriers of the crayfish plague (Aphanomyces astaci). The latter being the major factor currently confining noble crayfish to uninvaded (parts of) waterbodies. However, recently wild populations of apparently healthy noble crayfish carrying the crayfish plague have been found. As crayfish are known for their inter- and intraspecific agonistic behaviour which may be key for their competitive success, this raised the interesting question what would happen if the crayfish plague would not be a dominant factor anymore in the interaction between native and invasive species. Since the outcome of those encounters is still unclear, this study explores whether the noble crayfish can stand its ground towards invasive species in such agonistic interactions. Furthermore, the ability of the noble crayfish and invasive crayfish to acquire shelter through agonistic interaction is also assessed. Through pairwise staged interactions, agonistic behaviour and shelter competition between the native A. astacus and the invasive Faxonius limosus and Procambarus acutus were examined. The results showed that A. astacus triumphs over F. limosus and P. acutus in agonistic encounters and in competition for shelter. In turn, P. acutus dominates F. limosus in staged encounters and shelter. In possible future situations were crayfish plague does no longer eradicate noble crayfish populations, our results show that the native noble crayfish might still have a promising future when confronted with invasive species.	[Roessink, Ivo] Wageningen Environm Res, Environm Risk Assessment, Wageningen, Netherlands; [van der Zon, Karina A. E.; de Reus, Sophie R. M. M.; Peeters, Edwin T. H. M.] Wageningen Univ & Res, Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [van der Zon, Karina A. E.] Univ Otago, Dept Zool, Dunedin, New Zealand; [de Reus, Sophie R. M. M.] Royal HaskoningDHV, Advisory Grp Ecol, Amersfoort, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Otago	Roessink, I (corresponding author), Wageningen Environm Res, Environm Risk Assessment, Wageningen, Netherlands.	ivo.roessink@wur.nl		Peeters, Edwin T.H.M./0000-0003-2541-1829				Bergman DA, 2003, BEHAVIOUR, V140, P805, DOI 10.1163/156853903322370689; Blank GS, 1996, J CRUSTACEAN BIOL, V16, P300, DOI 10.2307/1548887; BOVBJERG RV, 1970, ECOLOGY, V51, P225, DOI 10.2307/1933658; BRUSKI CA, 1987, BEHAVIOUR, V103, P83, DOI 10.1163/156853987X00288; Cerenius L, 2009, OOMYCETE GENETICS GE, P425, DOI DOI 10.1002/9780470475898.CH21; Clout MN., 2009, INVASIVE SPECIES MAN, P153, DOI 10.1177/0309133309357023; Gherardi F, 2004, CAN J ZOOL, V82, P1923, DOI 10.1139/Z04-185; Gross R, 2013, CONSERV GENET, V14, P809, DOI 10.1007/s10592-013-0476-9; Guiasu RC, 1997, CRUSTACEANA, V70, P480; Guiasu RC, 1999, J CRUSTACEAN BIOL, V19, P131, DOI 10.2307/1549555; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich D. M., 2002, Biology of freshwater crayfish; Hudina S, 2016, MAR FRESHW BEHAV PHY, V49, P147, DOI 10.1080/10236244.2016.1146448; Hudina S, 2011, BIOL INVASIONS, V13, P1791, DOI 10.1007/s10530-010-9933-2; Jussila J, 2011, AQUACULTURE, V321, P17, DOI 10.1016/j.aquaculture.2011.08.026; Kokko H, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012006; Kouba A, 2014, KNOWL MANAG AQUAT EC, p05P1, DOI 10.1051/kmae/2014007; Kozak P, 2007, HYDROBIOLOGIA, V590, P85, DOI 10.1007/s10750-007-0760-0; Kusar D, 2013, DIS AQUAT ORGAN, V103, P157, DOI 10.3354/dao02567; Lele SF, 2017, BIOLOGIA, V72, P877, DOI 10.1515/biolog-2017-0094; Makkonen J, 2012, DIS AQUAT ORGAN, V102, P129, DOI 10.3354/dao02547; Makkonen J, 2014, J INVERTEBR PATHOL, V115, P86, DOI 10.1016/j.jip.2013.10.009; Martin-Torrijos L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88704-8; Martin-Torrijos L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181226; R Core Team, 2021, R LANGUAGE ENV STAT; Savvides P, 2015, AQUAT ECOL, V49, P273, DOI 10.1007/s10452-015-9522-7; Schulz HK, 2002, B FR PECHE PISCIC, P861, DOI 10.1051/kmae:2002073; SODERBACK B, 1995, FRESHWATER BIOL, V33, P291; SODERBACK B, 1991, CAN J ZOOL, V69, P1321, DOI 10.1139/z91-186; Soderhall Kenneth, 1999, Freshwater Crayfish, V12, P11; Team Rs, 2020, RSTUDIO INT DEV ENV; Tierney AJ, 2000, J CRUSTACEAN BIOL, V20, P54, DOI 10.1651/0278-0372(2000)020[0054:CAOABI]2.0.CO;2; Unestam T., 1969, Report Institute of Freshwater Research Drottningholm, VNo. 49, P202; Unestam T., 1972, Report lnst Freshwat Res Drottningholm, VNo. 52, P192; van Kuijk T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82302-4; VANNINI M, 1971, Monitore Zoologico Italiano, V5, P173; Vey A., 1983, Freshwater Crayfish, V5, P284; Westman K, 2002, ECOGRAPHY, V25, P53, DOI 10.1034/j.1600-0587.2002.250107.x	38	1	1	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263133	10.1371/journal.pone.0263133	http://dx.doi.org/10.1371/journal.pone.0263133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085350	Green Published, gold			2022-12-26	WOS:000779379600117
J	Khan, N; Halcrow, PW; Afghah, Z; Baral, A; Geiger, JD; Chen, XS				Khan, Nabab; Halcrow, Peter W.; Afghah, Zahra; Baral, Aparajita; Geiger, Jonathan D.; Chen, Xuesong			HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes	FASEB JOURNAL			English	Article						astrocytes; endolysosomes; HIV-1 latency; HIV-1 LTR transactivation; HIV-1 Tat	IMMUNODEFICIENCY-VIRUS TYPE-1; LYSOSOMAL MEMBRANE PERMEABILIZATION; ARGININE-RICH PEPTIDES; CENTRAL-NERVOUS-SYSTEM; CELLULAR UPTAKE; ANTIRETROVIRAL THERAPY; NEURONAL DYSFUNCTION; LATE ENDOSOMES; PROTEIN; INFECTION	The presence of latent HIV-1 reservoirs in the periphery and brain represents a major obstacle to curing HIV-1 infection. As an essential protein for HIV-1 viral replication, HIV-1 Tat, mostly intracellular, has been implicated in latent HIV-1 infection. From HIV-1 infected cells, HIV-1 Tat is actively secreted and bystander cells uptake the released Tat whereupon it is endocytosed and internalized into endolysosomes. However, to activate the HIV-1 LTR promoter and increase HIV-1 replication, HIV-1 Tat must first escape from the endolysosomes and then enter the nucleus. Here, we tested the hypothesis that HIV-1 Tat can accumulate in endolysosomes and contribute to the activation of latent HIV-1 in astrocytes. Using U87MG astrocytoma cells expressing HIV-1 LTR-driven luciferase and primary human astrocytes we found that exogenous HIV-1 Tat enters endolysosomes, resides in endolysosomes for extended periods of time, and induces endolysosome de-acidification as well as enlargement. The weak base chloroquine promoted the release of HIV-1 Tat from endolysosomes and induced HIV-1 LTR transactivation. Similar results were observed by activating endolysosome Toll-like receptor 3 (TLR3) and TLR7/8. Conversely, pharmacological block of TLRs and knocking down expression levels of TLR3 and TLR7, but not TLR8, prevented endolysosome leakage and attenuated HIV-1 Tat-mediated HIV-1 LTR transactivation. Our findings suggest that HIV-1 Tat accumulation in endolysosomes may play an important role in controlling HIV-1 transactivation.	[Khan, Nabab; Halcrow, Peter W.; Afghah, Zahra; Baral, Aparajita; Geiger, Jonathan D.; Chen, Xuesong] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA	University of North Dakota Grand Forks	Geiger, JD; Chen, XS (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA.	jonathan.geiger@und.edu; xuesong.chen@und.edu		Chen, Xuesong/0000-0003-0714-1378	HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS065957]; HHS \ NIH \ National Institute on Drug Abuse (NIDA) [R01DA032444]; National Institute of General Medical Sciences [P30GM100329, U54GM115458]; National Institute of Mental Health [R01MH100972, R01MH105329, R01MH119000]	HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ National Institute on Drug Abuse (NIDA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS065957; HHS vertical bar NIH vertical bar National Institute on Drug Abuse (NIDA), Grant/Award Number: R01DA032444; National Institute of General Medical Sciences, Grant/Award Number: P30GM100329 and U54GM115458; National Institute of Mental Health, Grant/Award Number: R01MH100972, R01MH105329 and R01MH119000	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Afghah Z, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104670; Agostini S, 2017, EBIOMEDICINE, V21, P170, DOI 10.1016/j.ebiom.2017.06.011; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Ajasin D, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00061; Alirezaei M, 2008, AUTOPHAGY, V4, P963, DOI 10.4161/auto.6805; Andres-Alonso M, 2021, CELL MOL LIFE SCI, V78, P2621, DOI 10.1007/s00018-020-03722-5; Badadani M, 2012, ISRN CELL BIOL, V2012, DOI DOI 10.5402/2012/927064; Beckel JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23877-3; Bender Andrew T, 2020, Immunohorizons, V4, P93, DOI 10.4049/immunohorizons.2000002; Boliar S, 2021, MOL THER-NUCL ACIDS, V23, P1272, DOI 10.1016/j.omtn.2021.02.004; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Brencicova E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00037; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 2016, CURR BIOL, V26, P2233, DOI 10.1016/j.cub.2016.06.046; Browne EP, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111787; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chauhan A, 2015, MICROB PATHOGENESIS, V78, P1, DOI 10.1016/j.micpath.2014.11.003; Chauhan A, 2014, VIROLOGY, V456, P1, DOI 10.1016/j.virol.2014.03.002; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Chen XS, 2013, NEUROBIOL AGING, V34, P2370, DOI 10.1016/j.neurobiolaging.2013.04.015; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; de Marcken M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw1347; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dominguez-Villar M, 2015, NAT IMMUNOL, V16, P118, DOI 10.1038/ni.3036; Dossou AS, 2019, CANCERS, V11, DOI 10.3390/cancers11101422; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Elsheikh MM, 2019, EBIOMEDICINE, V45, P624, DOI 10.1016/j.ebiom.2019.06.020; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fields J, 2015, J NEUROSCI, V35, P1921, DOI 10.1523/JNEUROSCI.3207-14.2015; Fitting S, 2010, AM J PATHOL, V177, P1397, DOI 10.2353/ajpath.2010.090945; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gaskill PJ, 2017, NEUROBIOL DIS, V105, P51, DOI 10.1016/j.nbd.2017.04.015; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Giovedi S, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.602116; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Henderson LJ, 2019, AIDS, V33, pS145, DOI 10.1097/QAD.0000000000002268; Herbein G, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102906; Hu XT, 2016, CURR DRUG TARGETS, V17, P4, DOI 10.2174/1389450116666150531162212; Hu ZY, 2018, CELL CHEM BIOL, V25, P1286, DOI 10.1016/j.chembiol.2018.07.004; Hui L, 2012, ASN NEURO, V4, P243, DOI 10.1042/AN20120017; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Kamori D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00080; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khan N, 2020, J ALLERGY INFECT DIS, V1, P38; Khan N, 2021, J NEUROVIROL, V27, P755, DOI 10.1007/s13365-021-01016-5; Khan N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.595888; Khan N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040471; Khan N, 2020, FASEB J, V34, P4147, DOI 10.1096/fj.201902534R; Khan N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48777-y; Khan N, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146389; Khan N, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1129-1; Khanal S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020475; Khoury G, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0421-6; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968; Lederman MM, 2015, NAT IMMUNOL, V16, P8, DOI 10.1038/ni.3051; Li C, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0267-8; Li GH, 2020, AIDS, V34, P963, DOI 10.1097/QAD.0000000000002512; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Luo XY, 2015, J NEUROVIROL, V21, P66, DOI 10.1007/s13365-014-0304-0; Lutgen V, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008381; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marban C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00397; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; Meas HZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13837-4; Mediouni S, 2019, FASEB J, V33, P8280, DOI 10.1096/fj.201801165R; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Minton K, 2019, NAT REV IMMUNOL, V19, P660; Moranguinho I, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121443; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; Mousseau G, 2015, MBIO, V6, DOI 10.1128/mBio.00465-15; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pomerantz RJ, 2002, CLIN INFECT DIS, V34, P91, DOI 10.1086/338256; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Rahimian P, 2016, J NEUROVIROL, V22, P774, DOI 10.1007/s13365-016-0451-6; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Razooky BS, 2011, METHODS, V53, P68, DOI 10.1016/j.ymeth.2010.12.006; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Sagnier S, 2015, J VIROL, V89, P615, DOI 10.1128/JVI.02174-14; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Spector SA, 2008, AUTOPHAGY, V4, P704, DOI 10.4161/auto.6105; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Thangaraj A, 2018, AUTOPHAGY, V14, P1596, DOI 10.1080/15548627.2018.1476810; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valdebenito S, 2021, J NEUROCHEM, V158, P429, DOI 10.1111/jnc.15336; Van Grol J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011733; Vasile F, 2017, BRAIN STRUCT FUNCT, V222, P2017, DOI 10.1007/s00429-017-1383-5; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wallet C, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00362; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; Williams ME, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104701; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Zeitler M, 2015, J BIOL CHEM, V290, P21976, DOI 10.1074/jbc.M115.667097; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836; Zhou DJ, 2011, J INFECT DIS, V203, P1647, DOI 10.1093/infdis/jir163; Zucchini S, 2013, NEUROBIOL DIS, V55, P110, DOI 10.1016/j.nbd.2013.02.004	130	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22184	10.1096/fj.202101722R	http://dx.doi.org/10.1096/fj.202101722R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35113458				2022-12-26	WOS:000761250800018
J	Spiegel, M; Tookes, H				Spiegel, Matthew; Tookes, Heather			All or nothing? Partial business shutdowns and COVID-19 fatality growth	PLOS ONE			English	Article								Incomplete vaccine uptake and limited vaccine availability for some segments of the population could lead policymakers to consider re-imposing restrictions to help reduce fatalities. Early in the pandemic, full business shutdowns were commonplace. Given this response, much of the literature on policy effectiveness has focused on full closures and their impact. But were complete closures necessary? Using a hand-collected database of partial business closures for all U.S. counties from March through December 2020, we examine the impact of capacity restrictions on COVID-19 fatality growth. For the restaurant and bar sector, we find that several combinations of partial capacity restrictions are as effective as full shutdowns. For example, point estimates indicate that, for the average county, limiting restaurants and bars to 25% of capacity reduces the fatality growth rate six weeks ahead by approximately 43%, while completely closing them reduces fatality growth by about 16%. The evidence is more mixed for the other sectors that we study. We find that full gym closures reduce the COVID-19 fatality growth rate, while partial closures may be counterproductive relative to leaving capacity unrestricted. Retail closures are ineffective, but 50% capacity limits reduce fatality growth. We find that restricting salons, other personal services and movie theaters is either ineffective or counterproductive.	[Spiegel, Matthew; Tookes, Heather] Yale Univ, Yale Sch Management, New Haven, CT 06520 USA	Yale University	Spiegel, M (corresponding author), Yale Univ, Yale Sch Management, New Haven, CT 06520 USA.	matthew.spiegel@yale.edu			Tobin Center at Yale University	Tobin Center at Yale University	We would like to thank the Tobin Center at Yale University for extensive financial support.	Abouk R, 2021, PUBLIC HEALTH REP, V136, P245, DOI 10.1177/0033354920976575; Askitas N., 2020, LOCKDOWN STRATEGIES; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Banholzer N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252827; Bongaerts D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251373; Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; Carlson CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18150-z; Center for disease control and prevention, 2021, COVID 19 VACC PAT CA; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chapman S., 2020, INDIANA PLAN CATCH S; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; DeGregory P., 2020, UNFAIRINDOOR DINING, DOI [10.1177/1078155219873014, DOI 10.1177/1078155219873014]; Di Domenico L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21249-6; Georghiou T, 2020, STATES OPEN RESTAURA; Goolsbee A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104311; Gozgor G, 2022, APPL RES QUAL LIFE, V17, P559, DOI 10.1007/s11482-020-09902-6; Guo C, 2021, SCI TOTAL ENVIRON, V757, DOI 10.1016/j.scitotenv.2020.143783; Holtz D, 2020, P NATL ACAD SCI USA, V117, P19837, DOI 10.1073/pnas.2009522117; Jones TL, 2000, ITE J, V70, P42; Kissane E., 2020, DAILY COVID 19 DATA; Lewnard JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1923; Ling DC, 2020, REV ASSET PRICING ST, V10, P669, DOI 10.1093/rapstu/raaa014; RISA AE, 1994, SOUTHERN ECON J, V60, P844, DOI 10.2307/1060424; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Spiegel M, 2021, REV FINANC STUD, V34, P5266, DOI 10.1093/rfs/hhab069; Valencia M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240013	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262925	10.1371/journal.pone.0262925	http://dx.doi.org/10.1371/journal.pone.0262925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139100	gold, Green Published			2022-12-26	WOS:000821499100016
J	Wei, YZ; Yao, ZH; Chong, XL; Zhang, JH; Zhang, J				Wei, Ya-zhi; Yao, Zhi-hua; Chong, Xiao-lei; Zhang, Jian-hua; Zhang, Jun			Influence mechanism of structure on shear mechanical deformation characteristics of loess-steel interface	PLOS ONE			English	Article							RESIDUAL STRENGTH; LANDSLIDE; BEHAVIOR; SOILS; MICROSTRUCTURE; TESTS	The mechanical properties of loess-steel interface are of great significance for understanding the residual strength and deformation of loess. However, the undisturbed loess has significant structural properties, while the remolded loess has weak structural properties. There are few reports on the mechanical properties of loess-steel interface from the structural point of view. This paper focused on the ring shear test between undisturbed loess as well as its remolded loess and steel interface under the same physical mechanics and test conditions (water content, shear rate and vertical pressure), and explored the influence mechanism of structure on the mechanical deformation characteristics of steel-loess interface. The results show that the shear rate has little effect on the residual strength of the undisturbed and remolded loess-steel interface. However, the water content has a significant influence on the residual strength of the loess-steel interface, moreover, the residual internal friction angle is the dominant factor supporting the residual strength of the loess-steel interface. In general, the residual strength of the undisturbed loess-steel interface is greater than that of the remolded loess specimen (for example, the maximum percentage of residual strength difference between undisturbed and remolded loess specimens under the same moisture content is 6.8%), which is because that compared with the mosaic arrangement structure of the remolded loess, the overhead arrangement structure of the undisturbed loess skeleton particles makes the loess particles on the loess-steel interface re-adjust the arrangement direction earlier and reach a stable speed relatively faster. The loess particles with angular angles in the undisturbed loess make the residual internal friction between the particles greater than the smoother particles of the remolded loess (for example, the maximum percentage of residual cohesion difference between undisturbed and remolded loess specimens under the same vertical pressure is 4.29%), and the intact cement between undisturbed loess particles brings stronger cohesion than the remolded loess particles with destroyed cement (for example, the maximum difference percentage of residual cohesion between undisturbed and remolded soil specimens under the same vertical pressure is 33.80%). The test results provide experimental basis for further revealing the influence mechanism of structure, and parameter basis for similar engineering construction.	[Wei, Ya-zhi; Yao, Zhi-hua; Chong, Xiao-lei; Zhang, Jun] Air Force Engn Univ, Coll Aeronaut Engn, Xian, Peoples R China; [Zhang, Jian-hua] China Southwest Geotech Invest & Design Inst Co L, Chengdu, Peoples R China	Air Force Engineering University	Yao, ZH (corresponding author), Air Force Engn Univ, Coll Aeronaut Engn, Xian, Peoples R China.	lightbright@163.com			Innovative Research Group Project of the National Natural Science Foundation of China [11972374, 51509257]	Innovative Research Group Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded studies Zhi-hua Yao, 11972374; Zhi-hua Yao, 51509257 by Innovative Research Group Project of the National Natural Science Foundation of China.	[Anonymous], 2006, D248706 ASTM INT; BISHOP AW, 1971, GEOTECHNIQUE, V21, P273, DOI 10.1680/geot.1971.21.4.273; Chen CS, 2013, ADV MATER RES-SWITZ, V639-640, P598, DOI 10.4028/www.scientific.net/AMR.639-640.598; Chen H., 2018, P GEOSHANGHAI 2018 I; Chen XP, 2014, LANDSLIDES, V11, P305, DOI 10.1007/s10346-013-0451-z; Delage P., 1995, P 1 INT C UNSATURATE, V3, P1223; Deng LS, 2020, ADV CIV ENG, V2020, DOI 10.1155/2020/3681382; [丁红丽 Ding Hongli], 2017, [地下空间与工程学报, Chinese Journal of Underground Space and Engineering], V13, P1511; Ge M., 2019, JAPANESE GEOTECHNICA, V7, P209, DOI [10.3208/jgssp.v07.032, DOI 10.3208/JGSSP.V07.032]; GIBO S, 1987, CAN GEOTECH J, V24, P456, DOI 10.1139/t87-057; HadiNikovic Gordana D., 2009, AAALES GEOLOGIOUES P, V2009, P83; Hongchun Xia, 2011, Advanced Materials Research, V243-249, P2332, DOI 10.4028/www.scientific.net/AMR.243-249.2332; Hu W, 2018, ENG GEOL, V237, P1, DOI 10.1016/j.enggeo.2018.02.005; Jia L, 2019, RSC ADV, V9, P19680, DOI 10.1039/c9ra01914f; Jing XY, 2018, INT J NUMER ANAL MET, V42, P339, DOI 10.1002/nag.2745; Jwa B., 2019, J ASIAN EARTH SCI, V169, P298; Kimura S, 2014, LANDSLIDES, V11, P969, DOI 10.1007/s10346-013-0457-6; LEROUEIL S, 1979, J GEOTECH ENG-ASCE, V105, P759; Li Lingyun, 2015, Journal of Xi'an University of Technology, V31, P113; Li P, 2020, J SOIL SEDIMENT, V20, P2855, DOI 10.1007/s11368-020-02621-3; Li XJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78489-7; Li YR, 2018, ENG GEOL, V236, P4, DOI 10.1016/j.enggeo.2017.02.023; Lian BQ, 2020, NAT HAZARD EARTH SYS, V20, P2843, DOI 10.5194/nhess-20-2843-2020; Lian BQ, 2020, B ENG GEOL ENVIRON, V79, P999, DOI 10.1007/s10064-019-01597-w; [刘动 Liu Dong], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P1827; Liu ZC, 2018, GEOPHYS RES LETT, V45, P715, DOI 10.1002/2017GL076374; LUPINI JF, 1981, GEOTECHNIQUE, V31, P181, DOI 10.1680/geot.1981.31.2.181; Matalucci RudolphV., 1969, MICROSTRUCTURE LOESS; MATALUCCI RV, 1970, ENG GEOL, V4, P341, DOI 10.1016/0013-7952(70)90024-4; MATALUCCI RV, 1970, ENG GEOL, V4, P121, DOI 10.1016/0013-7952(70)90008-6; Ministry of Water Resources of the Peoples Republic of China, 1999, GBT501231999; Mitchell J., 2005, FUNDAMENTALS SOIL BE; Moeyersons J, 2008, CATENA, V75, P45, DOI 10.1016/j.catena.2008.04.004; Nan JJ, 2021, ENG GEOL, V280, DOI 10.1016/j.enggeo.2020.105964; Ng CWW, 2020, CAN GEOTECH J, V57, P221, DOI 10.1139/cgj-2018-0592; Ng CWW., 2020, CAN GEOTECH J; Ni WK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62571-1; Samoilych KO, 2016, J GEOL GEOGR GEOECOL, V24, P125, DOI 10.15421/111619; Scaringi G, 2018, GEOPHYS RES LETT, V45, P766, DOI 10.1002/2017GL076214; Seguin A, 2020, GRANUL MATTER, V22, DOI 10.1007/s10035-020-01015-z; Skempton AW., 1964, LONG TERM STABILITY, V14, P77, DOI [10.1680/geot.1964.14.2.77, DOI 10.1680/GEOT.1964.14.2.77]; Summa V, 2010, CATENA, V80, P75, DOI 10.1016/j.catena.2009.09.002; Summa V, 2018, CATENA, V171, P199, DOI 10.1016/j.catena.2018.07.009; Sun JC, 2012, ADV MATER RES-SWITZ, V446-449, P1661, DOI 10.4028/www.scientific.net/AMR.446-449.1661; Tan QW, 2018, LANDSLIDES, V15, P2499, DOI 10.1007/s10346-018-1062-5; Tiwari B, 2005, J GEOTECH GEOENVIRON, V131, P1071, DOI 10.1061/(ASCE)1090-0241(2005)131:9(1071); Wang JD, 2019, J SOIL SEDIMENT, V19, P1226, DOI 10.1007/s11368-018-2136-7; Wang LN, 2020, GEOTECH GEOL ENG, V38, P2773, DOI 10.1007/s10706-020-01186-9; Wang LN, 2020, ARAB J GEOSCI, V13, DOI 10.1007/s12517-020-5237-8; Wang S., 2012, ROCK SOIL MECH, V33, P91; Wang S, 2015, SPRINGER SER GEOMECH, P19, DOI 10.1007/978-3-319-11053-0_3; Wang W, 2009, ROCK SOIL MECH, V30, P1303; Wang XG, 2021, B ENG GEOL ENVIRON, V80, P5021, DOI 10.1007/s10064-021-02243-0; Wang Y, 2021, GEOTECH GEOL ENG, V39, P65, DOI 10.1007/s10706-020-01420-4; Wei YN, 2020, CATENA, V192, DOI 10.1016/j.catena.2020.104585; Wei YZ., 2021, CHINESE J GEOTECHNIC, V43, P1; Wen BP, 2014, ENG GEOL, V168, P46, DOI 10.1016/j.enggeo.2013.10.023; Wu BW., 2021, STUDY THIXOTROPIC ME; Wu ZJ, 2020, SOIL DYN EARTHQ ENG, V132, DOI 10.1016/j.soildyn.2020.106067; Xie QY, 2018, PROCESSES, V6, DOI 10.3390/pr6070092; Xie X, 2020, ADV MATER SCI ENG, V2020, DOI 10.1155/2020/3402607; Xu PP, 2021, ENG GEOL, V282, DOI 10.1016/j.enggeo.2020.105875; Xu Q, 2021, B ENG GEOL ENVIRON, V80, P3733, DOI 10.1007/s10064-021-02171-z; Yuan WN, 2019, ENG GEOL, V250, P11, DOI 10.1016/j.enggeo.2019.01.007; [翟栋梁 Zhai Dongliang], 2019, [中国地质灾害与防治学报, The Chinese Journal of Geological Hazard and Control], V30, P120; Zhang D., 2017, SAFETY ENV ENG, V24, P39; Zhao M, 2020, B ENG GEOL ENVIRON, V79, P4829, DOI 10.1007/s10064-020-01816-9; Zou ZX, 2020, ENG GEOL, V276, DOI 10.1016/j.enggeo.2020.105766	68	1	1	13	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263676	10.1371/journal.pone.0263676	http://dx.doi.org/10.1371/journal.pone.0263676			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130325	Green Published, gold			2022-12-26	WOS:000805530700044
J	Opoku, E; Berisha, S; Brubaker, G; Robinet, P; Smith, JD				Opoku, Emmanuel; Berisha, Stela; Brubaker, Gregory; Robinet, Peggy; Smith, Jonathan D.			Oxidant resistant human apolipoprotein A-I functions similarly to the unmodified human isoform in delaying atherosclerosis progression and promoting atherosclerosis regression in hyperlipidemic mice	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; EXPRESSION	Background Transgenic overexpression of apolipoprotein A-I (apoA1) has been shown to delay atherosclerosis lesion progression and promote lesion regression in mouse models; however, apoA1 is subject to oxidation by myeloperoxidase (MPO) and loss of function. The activity of oxidant resistant human apoA1 was compared to unmodified human apoA1 in mouse models of atherosclerosis progression and regression. Methods and results Human apoA1 and the MPO oxidant resistant 4WF isoform transgenic mice were bred to LDL receptor deficient (LDLr KO) mice and fed a western-type diet. High level expression of these human apoA1 isoforms did not lead to increased HDL-cholesterol levels on the LDLr KO background. In males and females, lesion progression was studied over time, and both apoA1 and 4WF transgenic mice vs. LDLr KO mice had significant and similar delayed lesion progression and reduced non-HDL cholesterol. Using time points with equivalent lesion areas, lesion regression was initiated by feeding the mice a low-fat control diet containing a microsomal triglyceride transfer protein inhibitor for 7 weeks. Lesions regressed more in the male apoA1 and 4WF transgenics vs. the LDLr KO, but the 4WF isoform was not superior to the unmodified isoform in promoting lesion regression. Conclusions Both human apoA1 and the 4WF MPO oxidant resistant apoA1 isoform delayed lesion progression and promoted lesion regression in LDLr KO mice, with more pronounced effects in males than females; moreover, the 4WF isoform functioned similarly to the unmodified human apoA1 isoform.	[Opoku, Emmanuel; Berisha, Stela; Brubaker, Gregory; Robinet, Peggy; Smith, Jonathan D.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA; [Berisha, Stela] Univ Hosp Cleveland, Med Ctr, Ctr Human Genet, Cleveland, OH USA; [Robinet, Peggy] ProEd Commun Inc, Beachwood, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Smith, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA.	smithj4@ccf.org	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Opoku, Emmanuel/0000-0003-2816-7761	National Institutes of Health [R01HL130085]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01HL130085 to J.D.S. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglione Julie, 2006, V129, P83; Berisha SZ, 2015, J LIPID RES, V56, P653, DOI 10.1194/jlr.M056754; Bolli A, 2021, CIRCULATION, V143, P1452, DOI 10.1161/CIRCULATIONAHA.120.051843; CHAJEKSHAUL T, 1991, P NATL ACAD SCI USA, V88, P6731, DOI 10.1073/pnas.88.15.6731; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Hewing B, 2013, ATHEROSCLEROSIS, V227, P125, DOI 10.1016/j.atherosclerosis.2012.12.026; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Kasumov T, 2013, ARTERIOSCL THROM VAS, V33, P1994, DOI 10.1161/ATVBAHA.113.301700; Madsen CM, 2017, EUR HEART J, V38, P2478, DOI 10.1093/eurheartj/ehx163; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Robinet P, 2018, ARTERIOSCL THROM VAS, V38, P292, DOI 10.1161/ATVBAHA.117.309524; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shepherd J, 2007, CHEM BIOL, V14, P1221, DOI 10.1016/j.chembiol.2007.10.005; Smith JD, 2010, ARTERIOSCL THROM VAS, V30, P151, DOI 10.1161/ATVBAHA.108.179226; Valenta DT, 2006, ATHEROSCLEROSIS, V189, P255, DOI 10.1016/j.atherosclerosis.2005.12.019; Voight Benjamin F, 2012, Lancet, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0259751	10.1371/journal.pone.0259751	http://dx.doi.org/10.1371/journal.pone.0259751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120132	gold, Green Published			2022-12-26	WOS:000789273600002
J	Kim, G; Seong, SH; Hong, SS; Choi, E				Kim, Garam; Seong, So Hyun; Hong, Seok-Sung; Choi, Eunsoo			Impact of face masks and sunglasses on emotion recognition in South Koreans	PLOS ONE			English	Article							FACIAL EXPRESSIONS; CULTURAL-DIFFERENCES; PERCEPTION; INFORMATION; COMPETENCE; MOVEMENT; MOUTH; EYES	Due to the prolonged COVID-19 pandemic, wearing masks has become essential for social interaction, disturbing emotion recognition in daily life. In the present study, a total of 39 Korean participants (female = 20, mean age = 24.2 years) inferred seven emotions (happiness, surprise, fear, sadness, disgust, anger, surprise, and neutral) from uncovered, mask-covered, sunglasses-covered faces. The recognition rates were the lowest under mask conditions, followed by the sunglasses and uncovered conditions. In identifying emotions, different emotion types were associated with different areas of the face. Specifically, the mouth was the most critical area for happiness, surprise, sadness, disgust, and anger recognition, but fear was most recognized from the eyes. By simultaneously comparing faces with different parts covered, we were able to more accurately examine the impact of different facial areas on emotion recognition. We discuss the potential cultural differences and the ways in which individuals can cope with communication in which facial expressions are paramount.	[Kim, Garam; Seong, So Hyun; Choi, Eunsoo] Korea Univ, Sch Psychol, Seoul, South Korea; [Hong, Seok-Sung] Ajou Univ, Dept IT Psychol, Suwon, South Korea	Korea University; Ajou University	Choi, E (corresponding author), Korea Univ, Sch Psychol, Seoul, South Korea.	taysoo@korea.ac.kr		Kim, Garam/0000-0003-4237-1929; Choi, Eunsoo/0000-0003-1502-4788; Seong, So Hyun/0000-0003-4261-2446	School of Psychology, Korea University [K2110491]	School of Psychology, Korea University	E.C received the grant from School of Psychology, Korea University (K2110491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, STAT POWER ANAL BEHA; [Anonymous], 2012, CROSS CULTURAL BUSIN; Baehr P., 2008, NETWORKED DIS EMERGI, DOI [10.1002/9781444305012.ch8, DOI 10.1002/9781444305012.CH8]; Beams AB, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050854; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Bombari D, 2013, Q J EXP PSYCHOL, V66, P2426, DOI 10.1080/17470218.2013.789065; Carbon CC, 2021, I-PERCEPTION, V12, DOI 10.1177/20416695211038265; Carbon CC, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566886; 김민우, 2011, [Korean Journal of Psychology: General, 한국심리학회지:일반], V30, P1189; Choliz M, 2012, PSYCHOL REP, V110, P338, DOI 10.2466/07.09.17.PR0.110.1.338-350; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Cunningham DW., 2004, P 1 S APPL PERC GRAP, P143, DOI [10.1145/1012551.1012578, DOI 10.1145/1012551.1012578]; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Denham SA, 2014, INFANT CHILD DEV, V23, P426, DOI 10.1002/icd.1840; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman P., 2003, EMOTIONS REVEALED, V2; Fischer AH, 2012, SOC PSYCHOL PERS SCI, V3, P266, DOI 10.1177/1948550611418534; Folster M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00030; FRASER IH, 1990, PERCEPTION, V19, P661, DOI 10.1068/p190661; Freud E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78986-9; Gori M, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.669432; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Grundmann F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249792; Haensel JX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58802-0; Hofmann SG, 2006, PERS INDIV DIFFER, V40, P1683, DOI 10.1016/j.paid.2005.12.014; Horning SM, 2012, AGING NEUROPSYCHOL C, V19, P657, DOI 10.1080/13825585.2011.645011; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kastendieck T, 2022, COGNITION EMOTION, V36, P59, DOI 10.1080/02699931.2021.1950639; Koc E, 2020, J HOSP MARKET MANAG, V29, P121, DOI 10.1080/19368623.2019.1608885; Kontsevich LL, 2004, VISION RES, V44, P1493, DOI 10.1016/j.visres.2003.11.027; Kotsia I, 2008, IMAGE VISION COMPUT, V26, P1052, DOI 10.1016/j.imavis.2007.11.004; Kret ME, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00110; Lee T., 2006, KOREA U FACIAL EXPRE; MATSUMOTO D, 1989, MOTIV EMOTION, V13, P143, DOI 10.1007/BF00992959; Miyazawa D., 2020, PREPRINT; Nestor MS, 2020, J COSMET DERMATOL-US, V19, P2154, DOI 10.1111/jocd.13569; Noyes E, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.201169; Pavlova MA, 2022, CEREB CORTEX, V32, P249, DOI 10.1093/cercor/bhab311; Roberson D, 2012, COGNITION, V125, P195, DOI 10.1016/j.cognition.2012.06.018; Roy-Charland A, 2014, COGNITION EMOTION, V28, P1214, DOI 10.1080/02699931.2013.878687; Ruba AL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243708; Schmidtmann G, 2020, I-PERCEPTION, V11, DOI 10.1177/2041669520961116; Song I-H., 2008, KOREAN J WOMAN PSYCH, V13, P197; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	49	9	9	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							0263466	10.1371/journal.pone.0263466	http://dx.doi.org/10.1371/journal.pone.0263466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113970	gold, Green Published			2022-12-26	WOS:000823694700098
J	Kodama, T; Taniuchi, Y; Kasai, H; Yamaguchi, T; Nakae, M; Okumura, Y				Kodama, Taketoshi; Taniuchi, Yukiko; Kasai, Hiromi; Yamaguchi, Tamaha; Nakae, Misato; Okumura, Yutaka			Empirical estimation of marine phytoplankton assemblages in coastal and offshore areas using an in situ multi-wavelength excitation fluorometer	PLOS ONE			English	Article							COMMUNITY STRUCTURE; NORTH PACIFIC; CHLOROPHYLLS; CAROTENOIDS; POPULATIONS; SIGNATURES; WATER	Phytoplankton assemblages are essential for understanding the quality of primary production in marine ecosystems. Here, we describe the development of a methodology for monitoring marine phytoplankton assemblages using an in situ multi-wavelength excitation fluorometer (MEX). The MEX recorded the fluorescence excited with nine light-emitting diodes, temperature, and sensor depth. We prepared reference datasets comprising MEX fluorescence and plant pigment-based phytoplankton assemblages of nine chemotaxonomy groups (diatoms, dinoflagellates, cryptophytes, chlorophytes, haptophytes type 3, haptophytes type 4, prasinophytes, cyanophytes, and prochlorophytes). Conversions from the MEX fluorescence to the phytoplankton assemblages were conducted with two processes. First, target MEX fluorescence was decomposed using a linear inverse model for calculating coefficients. Second, pigment-based chemotaxonomy of the target MEX fluorescence was reconstructed using the coefficients and the chemotaxonomy assemblages of the reference data. Cross-validation analyses indicated good estimation of the proportion of diatoms, dinoflagellates, cryptophytes, cyanophytes, and prochlorophytes with MEX, and when chlorophytes, haptophytes and prasinophytes were summarized as other eukaryotes, the positive correlation was seen between proportions estimated with MEX and pigments as same as other five chemotaxonomy groups. Repeated MEX observations were conducted in the Kuroshio, the Sea of Japan, the Oyashio, and the Okhotsk Sea. The water-column integrated biomass indicated that the diatoms were an important primary producer in the Oyashio and the Okhotsk Sea, while eukaryotes were important in the Sea of Japan and prochlorophytes were important in the Kuroshio. Our method with the MEX will be a powerful tool to understand and estimate the chemotaxonomy-level assemblages and biomass in the ocean.	[Kodama, Taketoshi; Taniuchi, Yukiko; Kasai, Hiromi; Yamaguchi, Tamaha; Nakae, Misato; Okumura, Yutaka] Japan Fisheries Res & Educ Agcy, Fisheries Resources Inst, Yokohama, Kanagawa, Japan	Japan Fisheries Research & Education Agency (FRA)	Kodama, T (corresponding author), Japan Fisheries Res & Educ Agcy, Fisheries Resources Inst, Yokohama, Kanagawa, Japan.	blc_kodama@hotmail.com	Kodama, Taketoshi/D-4305-2018	Kodama, Taketoshi/0000-0001-8031-7881	Fisheries Agency of Japan	Fisheries Agency of Japan	All the authors received the funding provided from Fisheries Agency of Japan entitled "Project for establishing a network of environment and fisheries network." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Bracher A, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00235; Cardona L, 2015, MAR ECOL PROG SER, V531, P1, DOI 10.3354/meps11353; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fujiki T, 2016, J OCEANOGR, V72, P343, DOI 10.1007/s10872-015-0346-9; Fujiki T, 2014, LIMNOL OCEANOGR, V59, P887, DOI 10.4319/lo.2014.59.3.0887; Fujiwara A, 2018, POLAR BIOL, V41, P1279, DOI 10.1007/s00300-018-2284-7; Garrido JL., 2011, PHYTOPLANKTON PIGMEN, P165; Hashihama F, 2008, J OCEANOGR, V64, P23, DOI 10.1007/s10872-008-0002-8; Hirata T, 2011, BIOGEOSCIENCES, V8, P311, DOI 10.5194/bg-8-311-2011; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Koike I., 2001, J OCEANOGR, V57, P253, DOI [10.1023/a:1012474327158, DOI 10.1023/A:1012474327158]; Kring SA, 2014, CAN J FISH AQUAT SCI, V71, P1087, DOI 10.1139/cjfas-2013-0599; Kuroda H, 2019, PROG OCEANOGR, V175, P328, DOI 10.1016/j.pocean.2019.05.004; Latasa M, 2017, LIMNOL OCEANOGR, V62, P665, DOI 10.1002/lno.10452; Lorrain A, 2020, GLOBAL CHANGE BIOL, V26, P458, DOI 10.1111/gcb.14858; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Maechler M, PACKAGE ROBUST BASEB; Matsumoto T, 2021, REG STUD MAR SCI, V43, DOI 10.1016/j.rsma.2021.101683; Nishibe Y, 2017, J OCEANOGR, V73, P463, DOI 10.1007/s10872-017-0415-3; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Ornolfsdottir EB, 2003, J PHYCOL, V39, P449; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; R Core Team, 2021, R LANGUAGE ENV STAT; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Soetaert K., 2009, R PACKAGE VERSION, V1; Suzuki K, 2015, MAR CHEM, V176, P96, DOI 10.1016/j.marchem.2015.07.010; Suzuki Reiko, 1993, Journal of Oceanography, V49, P571, DOI 10.1007/BF02237463; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207; Van den Meersche K, 2008, LIMNOL OCEANOGR-METH, V6, P190, DOI 10.4319/lom.2008.6.190; Wang SQ, 2016, OPT EXPRESS, V24, P23635, DOI 10.1364/OE.24.023635; YENTSCH CS, 1979, J MAR RES, V37, P471; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799; Yoshida K, 2018, ESTUAR COAST SHELF S, V212, P80, DOI 10.1016/j.ecss.2018.06.018; Yoshida M., 2011, OCEANS 11 MTSIEEE KO; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029; Zhao Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15284	38	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0257258	10.1371/journal.pone.0257258	http://dx.doi.org/10.1371/journal.pone.0257258			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113867	Green Submitted, gold, Green Published			2022-12-26	WOS:000823694700007
J	Lawrence, A; Green, S; Wang, T; Bachvaroff, T; Chung, JS				Lawrence, Amanda; Green, Shadaesha; Wang, Tao; Bachvaroff, Tsvetan; Chung, J. Sook			Seasonal changes in the expression of insulin-like androgenic hormone (IAG) in the androgenic gland of the Jonah crab, Cancer borealis	PLOS ONE			English	Article							ORIENTAL RIVER PRAWN; CALLINECTES-SAPIDUS; BLUE-CRAB; MOLECULAR CHARACTERIZATION; GENE; EYESTALK; SEQUENCE; STIMPSON; PEPTIDE; BIOLOGY	Harvesting the adult male Jonah crab, Cancer borealis, mainly based on the size, has become an economically significant fishery, particularly in the Southern New England region of the US since 2000. Many decapod crustacean fisheries including C. borealis rely on harvesting adult males. Understanding the size related-sexual maturity and the seasonal changes in male reproductive activity is critical for sustainable management. In other decapods, an insulin-like hormone produced by the male-specific androgenic gland (AG), called insulin-like androgenic gland factor (IAG), plays an essential role in sexual maturity. Specifically IAG is involved in developing male primary and secondary sexual characteristics including spermatogenesis. This study aimed first to identify the IAG, then examine if season influences IAG expression in C. borealis males. Finally, the AG transcriptome was used to test if eyestalk neuropeptides regulate IAG levels via an endocrine axis between the two endocrine tissues as established in other crustaceans. The full-length CablAG sequence is 928 nucleotides long, encoding a 151 amino acid deduced sequence. The CablAG identified from the AG transcriptome after eyestalk ablation was the most highly expressed gene and accounted for up to 25% of transcripts, further confirming the presence of an endocrine axis between the androgenic gland and eyestalk ganglia. This gene expression was exclusive in male C. borealis AG. The transcriptomic analysis also revealed strong upregulation of the PPOAE transcript and downregulation of proteolytic enzymes. The CablAG levels differ by season, increasing AG activity in fall and possibly coinciding with high mating activity. The timing of increased AG activity correlating to mating with females should be considered for better stock management for the C. borealis population.	[Lawrence, Amanda; Green, Shadaesha; Wang, Tao; Bachvaroff, Tsvetan; Chung, J. Sook] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Chung, JS (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	chung@umces.edu		Wang, Tao/0000-0002-2618-3365	National Institute of Standards and Technology (NIST) [70NANB17H341]; National Science Foundation [1146774]; NOAA Educational Partnership Program with Minority-Serving Institutions (EPP/MSI) [NA16SEC4810007]	National Institute of Standards and Technology (NIST)(National Institute of Standards & Technology (NIST) - USA); National Science Foundation(National Science Foundation (NSF)); NOAA Educational Partnership Program with Minority-Serving Institutions (EPP/MSI)(National Oceanic Atmospheric Admin (NOAA) - USA)	JSC received all awards. NOAA Educational Partnership Program with Minority-Serving Institutions (EPP/MSI), FY 2016 Award #NA16SEC4810007 and National Institute of Standards and Technology (NIST) award # 70NANB17H341 and a National Science Foundation program award to J.S.C. (no. 1146774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136916; ASMFC, 2020, ATLANTIC STATES MARI; Atlantic States Marine Fisheries Commission, 2014, JON CRAB FISH; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Bembe S, 2017, AQUAC RES, V48, P5498, DOI 10.1111/are.13366; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Burkenroad M. D., 1963, Tulane Studies in Geology, V2, P1; Chandler JC, 2015, SEX DEV, V9, P338, DOI 10.1159/000443943; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; Chung JS, 2020, GEN COMP ENDOCR, V295, DOI 10.1016/j.ygcen.2020.113522; Chung JS, 2011, GEN COMP ENDOCR, V173, P4, DOI 10.1016/j.ygcen.2011.04.017; Chung J Sook, 2008, Saline Syst, V4, P18, DOI 10.1186/1746-1448-4-18; ELNER RW, 1985, CRUSTACEANA, V48, P34, DOI 10.1163/156854085X00701; FOULKS NB, 1974, GEN COMP ENDOCR, V22, P439, DOI 10.1016/0016-6480(74)90018-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAEFNER PA, 1977, J NAT HIST, V11, P303, DOI 10.1080/00222937700770221; HARTNOLL R G, 1969, Crustaceana (Leiden), V16, P161, DOI 10.1163/156854069X00420; Huang XS, 2017, GEN COMP ENDOCR, V249, P64, DOI 10.1016/j.ygcen.2017.05.001; Huang XS, 2014, GEN COMP ENDOCR, V204, P229, DOI 10.1016/j.ygcen.2014.06.002; Khalaila I, 2002, GEN COMP ENDOCR, V127, P147, DOI 10.1016/S0016-6480(02)00031-X; Lawrence A, 2017, MAR DRUGS, V15, DOI 10.3390/md15080241; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li FJ, 2015, GEN COMP ENDOCR, V216, P152, DOI 10.1016/j.ygcen.2014.12.007; Li SH, 2012, GEN COMP ENDOCR, V177, P246, DOI 10.1016/j.ygcen.2012.04.010; Liu A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00924; Lucu C, 2003, COMP BIOCHEM PHYS A, V135, P195; Lycett KA, 2020, J SHELLFISH RES, V39, P699, DOI 10.2983/035.039.0316; Ma KY, 2013, GEN COMP ENDOCR, V185, P90, DOI 10.1016/j.ygcen.2013.01.018; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Maine Gulf of MRI& U of Maine, 2013, J CRAB MSC PREASSESS; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Mareddy VR, 2011, AQUACULTURE, V318, P364, DOI 10.1016/j.aquaculture.2011.05.027; Martin G, 1999, EUR J BIOCHEM, V262, P727, DOI 10.1046/j.1432-1327.1999.00442.x; Mitchell RT, 2014, BIOL BULL-US, V227, P285, DOI 10.1086/BBLv227n3p285; NICOL DSHW, 1960, NATURE, V187, P483, DOI 10.1038/187483a0; North Pacific Fishery Management Council, 2011, FISHERY MANAGEMENT P; Okuno A, 2001, PEPTIDES, V22, P175, DOI 10.1016/S0196-9781(00)00374-0; Okuno A, 1999, BIOCHEM BIOPH RES CO, V264, P419, DOI 10.1006/bbrc.1999.1522; Phoungpetchara I, 2011, TISSUE CELL, V43, P165, DOI 10.1016/j.tice.2011.02.001; Pinfold G., 2006, OVERVIEW ATLANTIC SN; Rasmuson LK, 2013, ADV MAR BIOL, V65, P95, DOI 10.1016/B978-0-12-410498-3.00003-3; Shi LL, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090645; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sroyraya M, 2010, TISSUE CELL, V42, P293, DOI 10.1016/j.tice.2010.07.003; Thongda W, 2015, COMP BIOCHEM PHYS A, V179, P35, DOI 10.1016/j.cbpa.2014.08.019; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Wolcott DL, 2005, J EXP MAR BIOL ECOL, V319, P43, DOI 10.1016/j.jembe.2005.01.001	48	0	0	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0261206	10.1371/journal.pone.0261206	http://dx.doi.org/10.1371/journal.pone.0261206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113906	Green Published, gold			2022-12-26	WOS:000823694700015
J	Howley, BV; Mohanty, B; Dalton, A; Grelet, S; Karam, J; Dincman, T; Howe, PH				Howley, Breege, V; Mohanty, Bidyut; Dalton, Annamarie; Grelet, Simon; Karam, Joseph; Dincman, Toros; Howe, Philip H.			The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MESSENGER-RNA; TGF-BETA; PCBP 1; TRANSLATION; METASTASIS; EXPRESSION; PARKIN; SWITCH; HHARI	The epithelial to mesenchymal transition (EMT), a process that is aberrantly activated in cancer and facilitates metastasis to distant organs, requires coordinated transcriptional and post-transcriptional control of gene expression. The tumor-suppressive RNA binding protein, hnRNP-E1, regulates splicing and translation of EMT-associated transcripts and it is thought that it plays a major role in the control of epithelial cell plasticity during cancer progression. We have utilized yeast 2 hybrid screening to identify novel hnRNP-E1 interactors that play a role in regulating hnRNP-E1; this approach led to the identification of the E3 ubiquitin ligase ARIH1. Here, we demonstrate that hnRNP-E1 protein stability is increased upon ARIH1 silencing, whereas, overexpression of ARIH1 leads to a reduction in hnRNP-E1. Reduced ubiquitination of hnRNP-E1 detected in ARIH1 knockdown (KD) cells compared to control suggests a role for ARIH1 in hnRNP-E1 degradation. The identification of hnRNP-E1 as a candidate substrate of ARIH1 led to the characterization of a novel function for this ubiquitin ligase in EMT induction and cancer progression. We demonstrate a delayed induction of EMT and reduced invasion in mammary epithelial cells silenced for ARIH1. Conversely, ARIH1 overexpression promoted EMT induction and invasion. ARIH1 silencing in breast cancer cells significantly attenuated cancer cell stemness in vitro and tumor formation in vivo. Finally, we utilized miniTurboID proximity labeling to identify novel ARIH1 interactors that may contribute to ARIH1's function in EMT induction and cancer progression.	[Howley, Breege, V; Mohanty, Bidyut; Dalton, Annamarie; Grelet, Simon; Karam, Joseph; Howe, Philip H.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Grelet, Simon] Univ S Alabama, Mitchell Canc Inst, Dept Biochem & Mol Biol, Mobile, AL USA; [Dincman, Toros] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Howe, Philip H.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; University of South Alabama; Medical University of South Carolina; Medical University of South Carolina	Howe, PH (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Howe, PH (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.	howep@musc.edu		Karam, Joseph/0000-0002-4536-7362; Howe, Philip/0000-0002-1358-1313	National Cancer Institute [CA154663]; DOD BCRP [BC170301, W81XWH-18-1-0003]; NIH [5KL2TR001452]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD BCRP(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by CA154663 from the National Cancer Institute to PHH, DOD BCRP BC170301 under Award No. W81XWH-18-1-0003 to ACD, and NIH 5KL2TR001452 to TD. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. This study used the services of the Cell & Molecular Imaging Shared Resource of MUSC, the Biorepository & Tissue Analysis Shared Resource, and the Gene Targeting and Knockout Shared Resource at MUSC. We would like to thank members of the Howe lab and Dr. Shaun Olsen for providing helpful feedback during the preparation of this manuscript.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Cao L, 2017, CANCER LETT, V403, P246, DOI 10.1016/j.canlet.2017.06.021; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen Q, 2021, CELL MOL LIFE SCI, V78, P949, DOI 10.1007/s00018-020-03544-5; Elmehdawi F, 2013, EXP CELL RES, V319, P161, DOI 10.1016/j.yexcr.2012.10.002; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grelet S, 2017, NAT CELL BIOL, V19, P1105, DOI 10.1038/ncb3595; Harvey SE, 2018, RNA, V24, P1326, DOI 10.1261/rna.066712.118; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Howley BV, 2016, ONCOGENE, V35, P1725, DOI 10.1038/onc.2015.238; Howley BV, 2019, CYTOKINE, V118, P19, DOI 10.1016/j.cyto.2017.12.032; Howley BV, 2018, ONCOGENE, V37, P1308, DOI 10.1038/s41388-017-0023-0; Huang LX, 2017, CANCER SCI, V108, P1985, DOI 10.1111/cas.13338; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; James P, 1996, GENETICS, V144, P1425; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Ko TY, 2019, FASEB J, V33, P7143, DOI 10.1096/fj.201801534RR; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Li F, 2019, EBIOMEDICINE, V45, P208, DOI 10.1016/j.ebiom.2019.06.017; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Schnoor M, 2018, TRENDS CELL BIOL, V28, P79, DOI 10.1016/j.tcb.2017.10.009; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Shinriki S, 2018, J PATHOL, V244, P367, DOI 10.1002/path.5019; Sohn M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32796-2; Tan KL, 2018, DEV CELL, V45, P226, DOI 10.1016/j.devcel.2018.03.020; Tripathi V, 2016, MOL CELL, V64, P549, DOI 10.1016/j.molcel.2016.09.013; Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087; von Stechow L, 2015, MOL CELL BIOL, V35, P1254, DOI 10.1128/MCB.01152-14; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Woosley AN, 2019, ONCOGENE, V38, P3794, DOI 10.1038/s41388-019-0703-z; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zhang MP, 2017, AM J TRANSL RES, V9, P708; Zhang MP, 2016, AM J TRANSL RES, V8, P3567; Zhang ZZ, 2015, MOL CANCER THER, V14, P1162, DOI 10.1158/1535-7163.MCT-14-0695; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	49	6	6	3	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1679	1690		10.1038/s41388-022-02199-9	http://dx.doi.org/10.1038/s41388-022-02199-9		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35102251	hybrid, Green Published			2022-12-26	WOS:000750409400003
J	Meinhardt, AL; Munkhbaatar, E; Hockendorf, U; Dietzen, M; Dechant, M; Anton, M; Jacob, A; Steiger, K; Weichert, W; Brcic, L; McGranahan, N; Branca, C; Kaufmann, T; Dengler, MA; Jost, PJ				Meinhardt, Anna-Lena; Munkhbaatar, Enkhtsetseg; Hockendorf, Ulrike; Dietzen, Michelle; Dechant, Marta; Anton, Martina; Jacob, Anne; Steiger, Katja; Weichert, Wilko; Brcic, Luka; McGranahan, Nicholas; Branca, Caterina; Kaufmann, Thomas; Dengler, Michael A.; Jost, Philipp J.			The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner	ONCOGENE			English	Article							APOPTOSIS; CELLS; PROLIFERATION; EXPRESSION; MUTATIONS; ENABLES; BAX	A variety of cancer entities are driven by KRAS mutations, which remain difficult to target clinically. Survival pathways, such as resistance to cell death, may represent a promising treatment approach in KRAS mutated cancers. Based on the frequently observed genomic deletions of BCL-2-related ovarian killer (BOK) in cancer patients, we explored the function of BOK in a mutant Kras(G12D)-driven murine model of lung cancer. Using Kras(G12D/+)Bok(-/-) mice, we observed an overall tumor-promoting function of BOK in vivo. Specifically, loss of BOK reduced proliferation both in cell lines in vitro as well as in Kras(G12D)-driven tumor lesions in vivo. During tumor development in vivo, loss of BOK resulted in a lower tumor burden, with fewer, smaller, and less advanced tumors. Using Kras(G12D/+)Tp53(Delta/Delta)Bok(-/-) mice, we identified that this phenotype was entirely dependent on the presence of functional p53. Furthermore, analysis of a human dataset of untreated early-stage lung tumors did not identify any common deletion of the BOK locus, independently of the TP53 status or the histopathological classification. Taken together our data indicate that BOK supports tumor progression in Kras-driven lung cancer.	[Meinhardt, Anna-Lena; Munkhbaatar, Enkhtsetseg; Hockendorf, Ulrike; Dechant, Marta; Branca, Caterina; Jost, Philipp J.] Tech Univ Munich, TUM Sch Med, Dept Med 3, Klinikum Rechts Isar, Munich, Germany; [Dietzen, Michelle; McGranahan, Nicholas] UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg, London, England; [Dietzen, Michelle; McGranahan, Nicholas] UCL, Canc Inst, Canc Genome Evolut Res Grp, London, England; [Dietzen, Michelle] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Anton, Martina] Tech Univ Munich, Sch Med, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Jacob, Anne; Steiger, Katja; Weichert, Wilko] Tech Univ Munich, Inst Pathol, Munich, Germany; [Steiger, Katja; Weichert, Wilko; Jost, Philipp J.] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany; [Brcic, Luka] Med Univ Graz, Diagnost & Res Inst Pathol, Diagnost & Res Ctr Mol BioMed, Graz, Austria; [Kaufmann, Thomas] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Dengler, Michael A.; Jost, Philipp J.] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Meinhardt, Anna-Lena] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA; [Munkhbaatar, Enkhtsetseg] Tech Univ Munich, Sch Med, Dept Surg, Munich, Germany	Technical University of Munich; Cancer Research UK; University of London; University College London; University of London; University College London; Francis Crick Institute; Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Graz; University of Bern; Medical University of Graz; Rutgers State University New Brunswick; Rutgers State University Medical Center; Technical University of Munich	Jost, PJ (corresponding author), Tech Univ Munich, TUM Sch Med, Dept Med 3, Klinikum Rechts Isar, Munich, Germany.; Jost, PJ (corresponding author), German Canc Consortium DKTK, Partner Site Munich, Munich, Germany.; Dengler, MA; Jost, PJ (corresponding author), Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria.	michael.dengler@medunigraz.at; philipp.jost@medunigraz.at	Jost, Philipp J./S-4962-2016; Dengler, Michael/AFR-3509-2022	Jost, Philipp J./0000-0003-2454-0362; Dietzen, Michelle/0000-0002-6853-7563; Kaufmann, Thomas/0000-0001-9906-874X; Steiger, Katja/0000-0002-7269-5433; Anton, Martina/0000-0001-5290-5213; Brcic, Luka/0000-0002-9098-8416; Hockendorf, Ulrike/0000-0002-8218-3343; Dengler, Michael/0000-0002-1693-1761	Deutsche Krebshilfe for AM (Doktorandenstipendium) [112066]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [FOR 2036, SFB 1335, 360372040]; German Consortium for Translational Cancer Research (DKTK); Swiss National Science Foundation [31003A_173006]; Wellcome Trust; Royal Society [211179/Z/18/Z]; Cancer Research UK Lung Cancer Center of Excellence; NIHR BRC at University College London Hospitals; Rosetrees	Deutsche Krebshilfe for AM (Doktorandenstipendium)(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); German Consortium for Translational Cancer Research (DKTK); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Cancer Research UK Lung Cancer Center of Excellence; NIHR BRC at University College London Hospitals; Rosetrees(Rosetrees Trust)	We thank the members of the TRACERx consortium for participating in this study. The authors thank Bettina Flasch for excellent technical assistance. Grant support by Deutsche Krebshilfe for AM (Doktorandenstipendium 112066); the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation - FOR 2036, SFB 1335 (Project-ID 360372040)), German Consortium for Translational Cancer Research (DKTK) to KS and PJJ; Support by the Swiss National Science Foundation (project grant #31003A_173006) to TK; NM is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (Grant Number 211179/Z/18/Z), and also receives funding from Cancer Research UK Lung Cancer Center of Excellence, Rosetrees, and the NIHR BRC at University College London Hospitals.	Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brock CK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09010-6; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Carpio MA, 2015, P NATL ACAD SCI USA, V112, P7201, DOI 10.1073/pnas.1421063112; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Janic A, 2018, NAT MED, V24, P947, DOI 10.1038/s41591-018-0043-5; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Ke F, 2012, CELL DEATH DIFFER, V19, P915, DOI 10.1038/cdd.2011.210; Ke FFS, 2018, CELL, V173, P1217, DOI 10.1016/j.cell.2018.04.036; Lieschke E, 2019, J MOL CELL BIOL, V11, P212, DOI 10.1093/jmcb/mjy077; Llambi F, 2016, CELL, V165, P421, DOI 10.1016/j.cell.2016.02.026; Marino S, 2000, GENE DEV, V14, P994; Moravcikova E, 2017, INT J CANCER, V141, P2050, DOI 10.1002/ijc.30906; Munkhbaatar E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18372-1; Naim S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.574338; Rabachini T, 2018, CELL DEATH DIFFER, V25, P706, DOI 10.1038/s41418-017-0008-0; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ray JE, 2010, CELL DEATH DIFFER, V17, P846, DOI 10.1038/cdd.2009.167; Srivastava R, 2019, P NATL ACAD SCI USA, V116, P15469, DOI 10.1073/pnas.1904523116; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang F, 2019, MED SCI MONITOR, V25, P5356, DOI 10.12659/MSM.913706; Zheng JH, 2018, CELL REP, V23, P2083, DOI 10.1016/j.celrep.2018.04.060	33	1	1	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1376	1382		10.1038/s41388-021-02161-1	http://dx.doi.org/10.1038/s41388-021-02161-1		JAN 2022	7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	35091677	Green Published, hybrid			2022-12-26	WOS:000749073200002
J	Paolillo, G; Petrini, A; Casiraghi, E; De Iorio, MG; Biffani, S; Pagnacco, G; Minozzi, G; Valentini, G				Paolillo, Gianluigi; Petrini, Alessandro; Casiraghi, Elena; De Iorio, Maria Grazia; Biffani, Stefano; Pagnacco, Giulio; Minozzi, Giulietta; Valentini, Giorgio			Automated image analysis to assess hygienic behaviour of honeybees	PLOS ONE			English	Article							BEES; RESISTANCE; LINES	Focus of this study is to design an automated image processing pipeline for handling uncontrolled acquisition conditions of images acquired in the field. The pipeline has been tested on the automated identification and count of uncapped brood cells in honeybee (Apis Mellifera) comb images to reduce the workload of beekeepers during the study of the hygienic behavior of honeybee colonies. The images used to develop and test the model were acquired by beekeepers on different days and hours in summer 2020 and under uncontrolled conditions. This resulted in images differing for background noise, illumination, color, comb tilts, scaling, and comb sizes. All the available 127 images were manually cropped to approximately include the comb area. To obtain an unbiased evaluation, the cropped images were randomly split into a training image set (50 images), which was used to develop and tune the proposed model, and a test image set (77 images), which was solely used to test the model. To reduce the effects of varied illuminations or exposures, three image enhancement algorithms were tested and compared followed by the Hough Transform, which allowed identifying individual cells to be automatically counted. All the algorithm parameters were automatically chosen on the training set by grid search. When applied to the 77 test images the model obtained a correlation of 0.819 between the automated counts and the experts' counts. To provide an assessment of our model with publicly available images acquired by a different equipment and under different acquisition conditions, we randomly extracted 100 images from a comb image dataset made available by a recent literature work. Though it has been acquired under controlled exposure, the images in this new set have varied illuminations; anyhow, our pipeline obtains a correlation between automatic and manual counts equal to 0.997. In conclusion, our tests on the automatic count of uncapped honey bee comb cells acquired in the field and on images extracted from a publicly available dataset suggest that the hereby generated pipeline successfully handles varied noise artifacts, illumination, and exposure conditions, therefore allowing to generalize our method to different acquisition settings. Results further improve when the acquisition conditions are controlled.	[Paolillo, Gianluigi; De Iorio, Maria Grazia; Minozzi, Giulietta] Univ Milan, Dipartimento Med Vet, Lodi, Italy; [Petrini, Alessandro; Casiraghi, Elena; Valentini, Giorgio] Univ Milan, AnacletoLab, Comp Sci Dept Giovanni degli Antoni, Milan, Italy; [Casiraghi, Elena; Valentini, Giorgio] CINI Natl Lab Artificial Intelligence & Intellige, Rome, Italy; [Biffani, Stefano; Pagnacco, Giulio] CNR IBBA Milano, Milan, Italy	University of Milan; University of Milan	Casiraghi, E (corresponding author), Univ Milan, AnacletoLab, Comp Sci Dept Giovanni degli Antoni, Milan, Italy.; Casiraghi, E (corresponding author), CINI Natl Lab Artificial Intelligence & Intellige, Rome, Italy.	elena.casiraghi@unimi.it	Pagnacco, Giulio/K-8202-2017; Minozzi, Giulietta/K-8126-2017; Casiraghi, Elena/M-4867-2017	Pagnacco, Giulio/0000-0002-5013-5179; Biffani, Stefano/0000-0001-5559-3630; Minozzi, Giulietta/0000-0002-0020-8798; Valentini, Giorgio/0000-0002-5694-3919; Casiraghi, Elena/0000-0003-2024-7572; De Iorio, Maria Grazia/0000-0001-9150-2388	BEENOMIX project - Lombardy Region (FEASR program); BEENOMIX 2.0 project - Lombardy Region (FEASR program); PSR 2014-2020 [2016/00361532-G42F16000540002]; PSR [201801057971G44I19001910002]	BEENOMIX project - Lombardy Region (FEASR program); BEENOMIX 2.0 project - Lombardy Region (FEASR program); PSR 2014-2020; PSR	Funded study. G.M. received the funding. This work was supported by the BEENOMIX and BEENOMIX 2.0 projects funded by the Lombardy Region (FEASR program), PSR 2014-2020 (grant number 2016/00361532-G42F16000540002) and PSR (grant number 201801057971G44I19001910002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves TS, 2020, COMPUT ELECTRON AGR, V170, DOI 10.1016/j.compag.2020.105244; Avni D, 2015, JULIUS-KUHN-ARCH, V450, P103; Colin T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205816; Cornelissen B., 2009, P 41 INT AP C MONTP, V48; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Emsen B., 2006, Journal of Animal and Veterinary Advances, V5, P1229; Heckbert P., 1994, CONTRAST LTD ADAPTIV, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6; Hoferlin B., 2013, APIDOLOGIE, V44, P19; Jeker L, 2012, J APICULT RES, V51, P63, DOI 10.3896/IBRA.1.51.1.08; Lam HK, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL III, PROCEEDINGS, P493; Liew L.H., 2010, P INT C SCI SOC RES, P191; Macenko M, 2009, I S BIOMED IMAGING, P1107, DOI 10.1109/ISBI.2009.5193250; Momot J. P, 1971, J Apic Res, V10, P11; NEWTON DC, 1986, AM BEE J, V126, P278; Nikitenko D., 2008, J MULTIMEDIA, V3, P921; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rizzi A, 2003, PATTERN RECOGN LETT, V24, P1663, DOI 10.1016/S0167-8655(02)00323-9; Rodrigues PJ., 2016, EURBEE 2016 7 EUROPE; ROTHENBUHLER WC, 1964, ANIM BEHAV, V12, P578, DOI 10.1016/0003-3472(64)90082-X; Spivak M, 1998, AM BEE J, V138, P283; Vahadane A, 2016, IEEE T MED IMAGING, V35, P1962, DOI 10.1109/TMI.2016.2529665; Wang M., 2013, 8 SETAC EUR SPEC SCI; Wang M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229295; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Yoshiyama M, 2011, J APICULT RES, V50, P170, DOI 10.3896/IBRA.1.50.2.10	26	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263183	10.1371/journal.pone.0263183	http://dx.doi.org/10.1371/journal.pone.0263183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085372	gold, Green Published			2022-12-26	WOS:000779379600125
J	Zelinka, SL; Kirker, GT; Sterbinsky, GE; Bourne, KJ				Zelinka, Samuel L.; Kirker, Grant T.; Sterbinsky, George E.; Bourne, Keith J.			Oxidation states of copper in preservative treated wood as studied by X-ray absorption near edge spectroscopy (XANES)	PLOS ONE			English	Article							CORROSION RATES; SOLUBILIZATION; FASTENERS	Y Copper is a common component in wood preservatives and is used to protect the wood against fungal degradation. Previous research has shown that the Cu++ oxidation state provides the best wood protection, and Cu++ is widely believed to be the oxidation state of most copper within treated wood. A recent study using X-ray absorption near edge spectroscopy (XANES) reported high amounts of Cu+ in wood that had been in contact with corroded fasteners. This study uses XANES to examine the copper oxidation states in wood treated with several different wood preservatives as a function of time after treatment. In contrast with previous literature which focused on the fixation reaction in the first few hours after treatment, this paper examines the oxidation state of Cu in treated wood at longer times (up to 1-year) after treatment. The results showed in nearly all cases, Cu was in the Cu++ oxidation state to within the measurement uncertainty. Cu XANES patterns taken approximately 1-year after treatment showed no discernable differences between preservative systems, indicating that regardless of the starting treatment the final Cu speciation is the same within one year. The results confirm previously held beliefs about the Cu oxidation states in wood and give further insights into the corrosion mechanism of metals embedded in treated wood.	[Zelinka, Samuel L.; Bourne, Keith J.] US Forest Serv, Forest Prod Lab, Bldg & Fire Sci, Madison, WI 53726 USA; [Kirker, Grant T.] US Forest Serv, Forest Prod Lab, Durabil & Wood Protect, Madison, WI USA; [Sterbinsky, George E.] Adv Photon Source, Argonne Natl Lab, Lemont, IL USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Energy (DOE); Argonne National Laboratory	Zelinka, SL (corresponding author), US Forest Serv, Forest Prod Lab, Bldg & Fire Sci, Madison, WI 53726 USA.	samuel.l.zelinka@USDA.gov		Zelinka, Samuel/0000-0002-1348-7730	DOE Office of Science [DE-AC0206CH11357]; US Forest Service through the Forest Products Laboratory	DOE Office of Science(United States Department of Energy (DOE)); US Forest Service through the Forest Products Laboratory	This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC0206CH11357. This research was funded by the US Forest Service through the Forest Products Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, P48 AWPA; [Anonymous], 2021, ESR2240 ICCES; [Anonymous], 2020, P29 AWPA; [Anonymous], 2016, P61 AWPA; [Anonymous], 2007, P5 AWPA; [Anonymous], 2014, P23 AWPA; Association AWP, 2019, 2019 AWPA BOOK STAND; Baker AJ., 1988, WOOD PROTECTION TECH, P99; Burkholder M., 2004, FRAME BUILDING NEWS, V16, P6; Civardi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163124; Earle E., 1838, US Patent, Patent No. [#934, 934]; Evans P, 2008, NAT NANOTECHNOL, V3, P577, DOI 10.1038/nnano.2008.286; Evans PD, 2014, ACS SYM SER, V1158, P227; Johnson MG, 2021, ENVIRON POLLUT, V287, DOI 10.1016/j.envpol.2021.117189; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Lankone RS, 2019, SCI TOTAL ENVIRON, V668, P234, DOI 10.1016/j.scitotenv.2019.01.433; Leach R., 2004, World patent, Patent No. 200409187532; Lebow S, 2004, FPLRP618 USDA FOR SE; Matsunaga H, 2008, IAWA J, V29, P387, DOI 10.1163/22941932-90000193; Matsunaga H, 2007, 38 ANN M INT RES GRO; Mazela B, 2005, WOOD RES-SLOVAKIA, V50, P1; MCCALLAN SEA, 1949, BOT REV, V15, P629, DOI 10.1007/BF02861716; Newton MA, 2020, PHYS CHEM CHEM PHYS, V22, P6826, DOI 10.1039/d0cp00402b; Parks AN, 2018, ENVIRON TOXICOL CHEM, V37, P1956, DOI 10.1002/etc.4141; Rasouli D, 2017, DRVNA IND, V68, P211, DOI 10.5552/drind.2017.1701; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Tarmaian A., 2017, FOREST WOOD PRODUCTS, V70, P353; Xue W, 2016, DALTON T, V45, P3679, DOI 10.1039/c5dt03159a; Xue W, 2015, HOLZFORSCHUNG, V69, P509, DOI 10.1515/hf-2014-0128; Xue W, 2013, HOLZFORSCHUNG, V67, P815, DOI 10.1515/hf-2012-0136; Xue W, 2012, HOLZFORSCHUNG, V66, P889, DOI 10.1515/HF.2011.188; Zelinka SL, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0249-2; Zelinka SL, 2010, CORROS SCI, V52, P3943, DOI 10.1016/j.corsci.2010.08.014; Zelinka SL, 2009, J MATER CIVIL ENG, V21, P758, DOI 10.1061/(ASCE)0899-1561(2009)21:12(758); Zelinka SL, 2016, P 112 ANN M AM WOOD	35	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263073	10.1371/journal.pone.0263073	http://dx.doi.org/10.1371/journal.pone.0263073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085335	gold, Green Published			2022-12-26	WOS:000779379600109
J	Bai, N; Riching, KM; Makaju, A; Wu, H; Acker, TM; Ou, SC; Zhang, YR; Shen, XM; Bulloch, DN; Rui, H; Gibson, BW; Daniels, DL; Urh, M; Rock, BM; Humphreys, SC				Bai, Nan; Riching, Kristin M.; Makaju, Aman; Wu, Hao; Acker, Timothy M.; Ou, Shu-Ching; Zhang, Yaru; Shen, Xiaomeng; Bulloch, Daryl N.; Rui, Huan; Gibson, Bradford W.; Daniels, Danette L.; Urh, Marjeta; Rock, Brooke M.; Humphreys, Sara C.			Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; DEGRADATION; ARCHITECTURE; RECOGNITION; ACTIVATION; DESIGN; SCF	PROteolysis TArgeting Chimeras (PROTACs) are heterobifunctional small molecules that can simultaneously recruit target proteins and E3 ligases to form a ternary complex, promoting target protein ubiquitination and degradation via the Ubiquitin-Proteasome System (UPS). PROTACs have gained increasing attention in recent years due to certain advantages over traditional therapeutic modalities and enabling targeting of previously "undruggable " proteins. To better understand the mechanism of PROTAC-induced Target Protein Degradation (TPD), several computational approaches have recently been developed to study and predict ternary complex formation. However, mounting evidence suggests that ubiquitination can also be a rate-limiting step in PROTAC-induced TPD. Here, we propose a structure-based computational approach to predict target protein ubiquitination induced by cereblon (CRBN)-based PROTACs by leveraging available structural information of the CRL4A ligase complex (CRBN/ DDB1/CUL4A/Rbx1/NEDD8/E2/Ub). We generated ternary complex ensembles with Rosetta, modeled multiple CRL4A ligase complex conformations, and predicted ubiquitination efficiency by separating the ternary ensemble into productive and unproductive complexes based on the proximity of the ubiquitin to accessible lysines on the target protein. We validated our CRL4A ligase complex models with published ternary complex structures and additionally employed our modeling workflow to predict ubiquitination efficiencies and sites of a series of cyclin-dependent kinases (CDKs) after treatment with TL12-186, a pan-kinase PROTAC. Our predictions are consistent with CDK ubiquitination and site directed mutagenesis of specific CDK lysine residues as measured using a NanoBRET ubiquitination assay in HEK293 cells. This work structurally links PROTAC-induced ternary formation and ubiquitination, representing an important step toward prediction of target "degradability. "	[Bai, Nan; Wu, Hao; Acker, Timothy M.; Shen, Xiaomeng; Rock, Brooke M.; Humphreys, Sara C.] Amgen Res, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA; [Riching, Kristin M.; Daniels, Danette L.; Urh, Marjeta] Promega Corp, Res & Dev Dept, Madison, WI 53711 USA; [Makaju, Aman; Bulloch, Daryl N.; Gibson, Bradford W.] Amgen Res, Discovery Attribute Sci, San Francisco, CA USA; [Ou, Shu-Ching; Rui, Huan] Amgen Res, Discovery Attribute Sci, Thousand Oaks, CA USA; [Zhang, Yaru] Amgen Res, Oncol, Thousand Oaks, CA USA	Promega Corporation	Bai, N; Humphreys, SC (corresponding author), Amgen Res, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA.; Riching, KM (corresponding author), Promega Corp, Res & Dev Dept, Madison, WI 53711 USA.	nbai@amgen.com; Kristin.Riching@promega.com; shumph01@amgen.com		Riching, Kristin/0000-0003-4646-1067; Bai, Nan/0000-0002-2222-0472; Bulloch, Daryl/0000-0002-3885-2343	Amgen; Promega	Amgen(Amgen); Promega	This study was funded jointly by Amgen and Promega where relevant, according to the author guidelines.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baek K, 2021, CURR OPIN STRUC BIOL, V67, P101, DOI 10.1016/j.sbi.2020.10.007; Baek K, 2020, NATURE, V578, P461, DOI 10.1038/s41586-020-2000-y; Bai N, 2021, J CHEM INF MODEL, V61, P1368, DOI 10.1021/acs.jcim.0c01451; Bondeson DP, 2018, CELL CHEM BIOL, V25, P78, DOI 10.1016/j.chembiol.2017.09.010; Chung CW, 2020, ACS CHEM BIOL, V15, P2316, DOI 10.1021/acschembio.0c00266; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dragovich PS, 2021, J MED CHEM, V64, P2576, DOI 10.1021/acs.jmedchem.0c01846; Drummond ML, 2020, J CHEM INF MODEL, V60, P5234, DOI 10.1021/acs.jcim.0c00897; Drummond ML, 2019, J CHEM INF MODEL, V59, P1634, DOI 10.1021/acs.jcim.8b00872; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eron SJ, 2021, ACS CHEM BIOL, V16, P2228, DOI 10.1021/acschembio.1c00376; Farnaby W, 2019, NAT CHEM BIOL, V15, P672, DOI 10.1038/s41589-019-0294-6; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Gadd MS, 2017, NAT CHEM BIOL, V13, P514, DOI [10.1038/NCHEMBIO.2329, 10.1038/nchembio.2329]; HaileMariam M, 2018, J PROTEOME RES, V17, P2917, DOI 10.1021/acs.jproteome.8b00505; Han BM, 2020, J BIOL CHEM, V295, P15280, DOI 10.1074/jbc.RA120.014715; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Harper JW, 2021, ANNU REV BIOCHEM, V90, P403, DOI 10.1146/annurev-biochem-090120-013613; Henneberg LT, 2021, CELL CHEM BIOL, V28, P889, DOI 10.1016/j.chembiol.2021.03.009; Horn-Ghetko D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03197-9; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Hughes SJ, 2017, ESSAYS BIOCHEM, V61, P505, DOI 10.1042/EBC20170041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kaiho-Soma A, 2021, MOL CELL, V81, P1411, DOI 10.1016/j.molcel.2021.01.023; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Landrum g, 2006, RDKIT OPEN SOURCE CH; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lebraud H, 2016, ACS CENTRAL SCI, V2, P927, DOI 10.1021/acscentsci.6b00280; Lumpkin RJ, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.RA120.002414; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MacPherson T., 2021, BIORXIV, DOI [10.1101/461830, DOI 10.1101/461830]; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Neklesa TK, 2017, PHARMACOL THERAPEUT, V174, P138, DOI 10.1016/j.pharmthera.2017.02.027; New York NY, 2021, MAESTR; Nowak RP, 2018, NAT CHEM BIOL, V14, P706, DOI 10.1038/s41589-018-0055-y; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pettersson Mariell, 2019, Drug Discov Today Technol, V31, P15, DOI 10.1016/j.ddtec.2019.01.002; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Reichermeier K. M., 2020, THESIS CALTECH; Riching KM, 2021, SLAS DISCOV, V26, P560, DOI 10.1177/2472555220973602; Riching KM, 2018, ACS CHEM BIOL, V13, P2758, DOI 10.1021/acschembio.8b00692; Roy MJ, 2019, ACS CHEM BIOL, V14, P361, DOI 10.1021/acschembio.9b00092; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schapira M, 2019, NAT REV DRUG DISCOV, V18, P949, DOI 10.1038/s41573-019-0047-y; Testa A, 2020, ANGEW CHEM INT EDIT, V59, P1727, DOI 10.1002/anie.201914396; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Udeshi ND, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14175-1; Vieux EF, 2021, SLAS DISCOV, V26, P547, DOI 10.1177/24725552211000673; Zaidman D, 2020, J CHEM INF MODEL, V60, P4894, DOI 10.1021/acs.jcim.0c00589; Zhang W., 2021, BIORXIV, DOI [10.1101/462040, DOI 10.1101/462040]; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zorba A, 2018, P NATL ACAD SCI USA, V115, pE7285, DOI 10.1073/pnas.1803662115	57	3	3	11	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101653	10.1016/j.jbc.2022.101653	http://dx.doi.org/10.1016/j.jbc.2022.101653			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35101445	Green Published, gold			2022-12-26	WOS:000793617400012
J	Wirianto, M; Wang, CY; Kim, E; Koike, N; Gomez-Gutierrez, R; Nohara, K; Escobedo, G; Choi, JM; Han, CR; Yagita, K; Jung, SY; Soto, C; Lee, HK; Morales, R; Yoo, SH; Chen, Z				Wirianto, Marvin; Wang, Chih-Yen; Kim, Eunju; Koike, Nobuya; Gomez-Gutierrez, Ruben; Nohara, Kazunari; Escobedo, Gabriel, Jr.; Choi, Jong Min; Han, Chorong; Yagita, Kazuhiro; Jung, Sung Yun; Soto, Claudio; Lee, Hyun Kyoung; Morales, Rodrigo; Yoo, Seung-Hee; Chen, Zheng			The clock modulator Nobiletin mitigates astrogliosis-associated neuroinflammation and disease hallmarks in an Alzheimer's disease model	FASEB JOURNAL			English	Article						Alzheimer's disease; A beta pathology; circadian clock; neuroinflammation; Nobiletin (NOB); ROR nuclear receptors	COGNITIVE IMPAIRMENT; CIRCADIAN-RHYTHMS; GENE-EXPRESSION; MOUSE MODEL; NLRP3 INFLAMMASOME; AMYLOID-BETA; A-BETA; SLEEP; DEMENTIA; DISTURBANCES	Alzheimer's disease (AD) is a devastating neurodegenerative disorder, and there is a pressing need to identify disease-modifying factors and devise interventional strategies. The circadian clock, our intrinsic biological timer, orchestrates various cellular and physiological processes including gene expression, sleep, and neuroinflammation; conversely, circadian dysfunctions are closely associated with and/or contribute to AD hallmarks. We previously reported that the natural compound Nobiletin (NOB) is a clock-enhancing modulator that promotes physiological health and healthy aging. In the current study, we treated the double transgenic AD model mice, APP/PS1, with NOB-containing diets. NOB significantly alleviated beta-amyloid burden in both the hippocampus and the cortex, and exhibited a trend to improve cognitive function in these mice. While several systemic parameters for circadian wheel-running activity, sleep, and metabolism were unchanged, NOB treatment showed a marked effect on the expression of clock and clock-controlled AD gene expression in the cortex. In accordance, cortical proteomic profiling demonstrated circadian time-dependent restoration of the protein landscape in APP/PS1 mice treated with NOB. More importantly, we found a potent efficacy of NOB to inhibit proinflammatory cytokine gene expression and inflammasome formation in the cortex, and immunostaining further revealed a specific effect to diminish astrogliosis, but not microgliosis, by NOB in APP/PS1 mice. Together, these results underscore beneficial effects of a clock modulator to mitigate pathological and cognitive hallmarks of AD, and suggest a possible mechanism via suppressing astrogliosis-associated neuroinflammation.	[Wirianto, Marvin; Kim, Eunju; Nohara, Kazunari; Han, Chorong; Yoo, Seung-Hee; Chen, Zheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biochem & Mol Biol, Houston, TX 70030 USA; [Wang, Chih-Yen; Lee, Hyun Kyoung] Texas Childrens Hosp, Baylor Coll Med, Neurol Res Inst, Dept Pediat, Houston, TX USA; [Koike, Nobuya; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Physiol & Syst Biosci, Kyoto, Japan; [Gomez-Gutierrez, Ruben; Escobedo, Gabriel, Jr.; Soto, Claudio; Morales, Rodrigo] Univ Texas Hlth Sci Ctr UTHlth, Dept Neurol, Houston, TX USA; [Gomez-Gutierrez, Ruben] Univ Malaga, Fac Sci, Dept Cell Biol Genet & Physiol, Malaga, Spain; [Choi, Jong Min; Jung, Sung Yun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX USA; [Morales, Rodrigo] Univ Bernardo OHiggins, Ctr Integrat Biol & Quim Aplicada CIBQA, Santiago, Chile	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Kyoto Prefectural University of Medicine; University of Texas System; University of Texas Health Science Center Houston; Universidad de Malaga; Baylor College of Medicine; Universidad  Bernardo O'Higgins	Chen, Z (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biochem & Mol Biol, UT McGovern Med Sch, 6431 Fannin St,MSB 6-200, Houston, TX 70030 USA.	Zheng.chen.1@uth.tmc.edu	Morales, Rodrigo/K-7173-2015	Yagita, Kazuhiro/0000-0002-1889-7050; Jung, Sung Yun/0000-0003-1521-7977; Gomez-Gutierrez, Ruben/0000-0001-9134-4375	HHS \ NIH \ National Institute on Aging (NIA) [RF1AG061901]	HHS \ NIH \ National Institute on Aging (NIA)	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: RF1AG061901	Aguilar BJ, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0320-4; Ahsan S., 2017, CURR PROTOC BIOINFOR, V57, P11; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bedrosian TA, 2013, EXP NEUROL, V243, P67, DOI 10.1016/j.expneurol.2012.05.005; Burish MJ, 2021, CHRONOBIOL INT, V38, P839, DOI 10.1080/07420528.2021.1892127; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; Cirmi S, 2016, MOLECULES, V21, DOI 10.3390/molecules21101312; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Duncan MJ, 2012, EXP NEUROL, V236, P249, DOI 10.1016/j.expneurol.2012.05.011; Duran-Aniotz C, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01155-0; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Fusilier AR, 2021, NEUROBIOL DIS, V158, DOI 10.1016/j.nbd.2021.105454; Griffin P, 2020, ELIFE, V9, DOI 10.7554/eLife.58765; Griffin P, 2019, P NATL ACAD SCI USA, V116, P5102, DOI 10.1073/pnas.1812405116; Han CR, 2021, CLOCKS SLEEP, V3, P351, DOI 10.3390/clockssleep3030022; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Homolak Jan, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6030052; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Huang H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2918796; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jones CR, 2013, EXP NEUROL, V243, P28, DOI 10.1016/j.expneurol.2012.07.012; Jung SY, 2017, MOL CELL PROTEOMICS, V16, P581, DOI 10.1074/mcp.M116.061440; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kim E, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11071004; Kress GJ, 2018, J EXP MED, V215, P1059, DOI 10.1084/jem.20172347; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lananna BV, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax3519; Lananna BV, 2018, CELL REP, V25, P1, DOI 10.1016/j.celrep.2018.09.015; Lee J, 2020, AGING CELL, V19, DOI 10.1111/acel.13078; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim ASP, 2013, JAMA NEUROL, V70, P1544, DOI 10.1001/jamaneurol.2013.4215; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lonnemann N, 2020, P NATL ACAD SCI USA, V117, P32145, DOI 10.1073/pnas.2009680117; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; Ma ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep36035; Manocha GD, 2016, J NEUROSCI, V36, P8471, DOI 10.1523/JNEUROSCI.4654-15.2016; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Mileykovskaya E, 2020, BIOCHEMISTRY-MOSCOW+, V85, P1554, DOI 10.1134/S000629792012007X; Mogensen FLH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147491; Morales R, 2021, MOL PSYCHIATR, V26, P5690, DOI 10.1038/s41380-021-01150-w; Mulvihill EE, 2016, ANNU REV NUTR, V36, P275, DOI 10.1146/annurev-nutr-071715-050718; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakajima A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143380; Nakajima A, 2015, BEHAV BRAIN RES, V289, P69, DOI 10.1016/j.bbr.2015.04.028; Ni JJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1562-9; Nohara K, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5304768; Nohara K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174281; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; Nohara K, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0020-7; Onyango IG, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050524; Qi GY, 2019, J AGR FOOD CHEM, V67, P5122, DOI 10.1021/acs.jafc.9b00133; Roh JH, 2014, J EXP MED, V211, P2487, DOI 10.1084/jem.20141788; Saltzman AB, 2018, MOL CELL PROTEOMICS, V17, P2270, DOI 10.1074/mcp.TIR118.000850; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Sheehan PW, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00703; Socodato R, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107796; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Van Zeller M, 2021, J ALZHEIMERS DIS, V83, P939, DOI 10.3233/JAD-210268; Vanderheyden WM, 2018, J NEUROSCI, V38, P2901, DOI 10.1523/JNEUROSCI.1135-17.2017; Videnovic A, 2014, NAT REV NEUROL, V10, P683, DOI 10.1038/nrneurol.2014.206; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Walle T, 2007, SEMIN CANCER BIOL, V17, P354, DOI 10.1016/j.semcancer.2007.05.002; Weldemichael Dawit A, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/716453; Wirianto M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108140; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang R, 2012, J ALZHEIMERS DIS, V31, P801, DOI 10.3233/JAD-2012-120151; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	81	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22186	10.1096/fj.202101633R	http://dx.doi.org/10.1096/fj.202101633R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35120261	Green Published			2022-12-26	WOS:000761250800024
J	Akoko, LO; Rutashobya, AK; Lutainulwa, EW; Mwanga, AH; Kivuyo, SL				Akoko, Larry Onyango; Rutashobya, Amonius K.; Lutainulwa, Evelyne W.; Mwanga, Ally H.; Kivuyo, Sokoine L.			The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among black Tanzanian women: A case control study	PLOS ONE			English	Article							RECEPTOR STATUS; EPIDEMIOLOGY; COUNTRIES; PATTERNS; SMOKING	Purpose This study aimed to determine the effect of reproductive, hormonal, lifestyle and nutritional factors on breast cancer development among Tanzanian black women. Methodology We undertook a case-control study age-matched to +/- 5years in 2018 at Muhimbili National Hospital. The study recruited 105 BC patients and 190 controls giving it 80% power to detect an odds ratio of >= 2 at the alpha error of <5% for exposure with a prevalence of 30% in the control group with 95% confidence. Controls were recruited from in patients being treated for non-cancer related conditions. Information regarding hormonal, reproductive, nutritional and lifestyle risk for breast cancer and demography was collected by interviews using a pre-defined data set. Conditional multinomial logistic regression used to determine the adjusted odds ratio for variables that had significant p-value in the binomial logistic regression model with 5% allowed error at 95% confidence interval. Results The study recruited 105 cases and 190 controls. Only old age at menopause had a significant risk, a 2.6 fold increase. Adolescent obesity, family history of breast cancer, cigarette smoking and alcohol intake had increased odds for breast cancer but failed to reach significant levels. The rural residency had 61% reduced odds for developing breast cancer though it failed to reach significant levels. Conclusion Older age at menopause is a significant risk factor for the development of breast cancer among Tanzanian women. This study has shed light on the potential role of modifiable risk factors for breast cancer which need to be studied further for appropriate preventive strategies in similar settings.	[Akoko, Larry Onyango; Rutashobya, Amonius K.; Mwanga, Ally H.] Muhimbili Univ Hlth & Allied Sci, Dept Surg, Dar Es Salaam, Tanzania; [Lutainulwa, Evelyne W.] ICAP MSPH Tanzania, Programs Dept, Dar Es Salaam, Tanzania; [Kivuyo, Sokoine L.] Natl Inst Med Res, Muhimbili Branch, Dar Es Salaam, Tanzania; [Rutashobya, Amonius K.] Benjamin Mkapa Referral Hosp, Dept Surg, Dodoma, Tanzania	Muhimbili University of Health & Allied Sciences; National Institute of Medical Research	Akoko, LO (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Surg, Dar Es Salaam, Tanzania.	akokole12@gmail.com		Kivuyo, Sokoine Lesikari/0000-0003-2257-5254				Ambrosone CB, 2014, CANCER CAUSE CONTROL, V25, P259, DOI 10.1007/s10552-013-0323-9; Anderson BO, 2015, BREAST J, V21, P111, DOI 10.1111/tbj.12357; Barnard ME, 2015, BBA-REV CANCER, V1856, P73, DOI 10.1016/j.bbcan.2015.06.002; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Bosco JLF, 2012, BREAST CANCER RES TR, V134, P1247, DOI 10.1007/s10549-012-2131-4; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burson Ashley M, 2010, Breast Dis, V31, P33, DOI 10.3233/BD-2009-0296; CHU SY, 1991, J CLIN EPIDEMIOL, V44, P1197, DOI 10.1016/0895-4356(91)90152-Y; Cramer DW, 2012, HEMATOL ONCOL CLIN N, V26, P1, DOI 10.1016/j.hoc.2011.10.009; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; Fei XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117572; Galukande M, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.249.330; Global Cancer Observatory, 2020, TANZ UN REP; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; International Agency for Research on Cancer , 2012, IARC MONOGRAPHS EVAL, P92; Islami F, 2015, ANN ONCOL, V26, P2398, DOI 10.1093/annonc/mdv379; Kawai M, 2014, CANCER-AM CANCER SOC, V120, P1026, DOI 10.1002/cncr.28402; Lambertini M, 2016, CANCER TREAT REV, V49, P65, DOI 10.1016/j.ctrv.2016.07.006; LUBIN F, 1985, AM J EPIDEMIOL, V122, P579, DOI 10.1093/oxfordjournals.aje.a114137; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Nagrani R, 2016, CANCER CAUSE CONTROL, V27, P199, DOI 10.1007/s10552-015-0697-y; Nur U, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5985-6; Perrine CG, 2016, ANNU REV NUTR, V36, P627, DOI 10.1146/annurev-nutr-071715-051213; Phipps AI, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju281; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Terry MB, 2006, ANN EPIDEMIOL, V16, P230, DOI 10.1016/j.annepidem.2005.06.048; Wen DG, 2018, THORAC CANCER, V9, P262, DOI 10.1111/1759-7714.12575; Zahnd WE, 2018, CANCER EPIDEM BIOMAR, V27, P1265, DOI 10.1158/1055-9965.EPI-17-0430; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263374	10.1371/journal.pone.0263374	http://dx.doi.org/10.1371/journal.pone.0263374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139096	gold, Green Published			2022-12-26	WOS:000821499100027
J	Singh, S; Shekhar, C; Bankole, A; Acharya, R; Audam, S; Akinade, T				Singh, Susheela; Shekhar, Chander; Bankole, Akinrinola; Acharya, Rajib; Audam, Suzette; Akinade, Temitope			Key drivers of fertility levels and differentials in India, at the national, state and population subgroup levels, 2015-2016: An application of Bongaarts' proximate determinants model	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; INFERTILITY; FRAMEWORK	Objectives The transition to small family size is at an advanced phase in India, with a national TFR of 2.2 in 2015-16. This paper examines the roles of four key determinants of fertility-marriage, contraception, abortion and postpartum infecundability-for India, all 29 states and population subgroups. Methods Data from the most recent available national survey, the National Family Health Survey, conducted in 2015-16, were used. The Bongaarts proximate determinants model was used to quantify the roles of the four key factors that largely determine fertility. Methodological contributions of this analysis are: adaptations of the model to the Indian context; measurement of the role of abortion; and provision of estimates for sub-groups nationally and by state: age, education, residence, wealth status and caste. Results Nationally, marriage is the most important determinant of the reduction in fertility from the biological maximum, contributing 36%, followed by contraception and abortion, contributing 24% and 23% respectively, and post-partum infecundability contributed 16%. This national pattern of contributions characterizes most states and subgroups. Abortion makes a larger contribution than contraception among young women and better educated women. Findings suggest that sterility and infertility play a greater than average role in Southern states; marriage practices in some Northeastern states; and male migration for less-educated women. The absence of stronger relationships between the key proximate fertility determinants and geography or socio-economic status suggests that as family size declined, the role of these determinants is increasingly homogenous. Conclusions Findings argue for improvements across all states and subgroups, in provision of contraceptive care and safe abortion services, given the importance of these mechanisms for implementing fertility preferences. In-depth studies are needed to identify policy and program needs that depend on the barriers and vulnerabilities that exist in specific areas and population groups.	[Singh, Susheela; Bankole, Akinrinola; Audam, Suzette; Akinade, Temitope] Guttmacher Inst, New York, NY 10038 USA; [Shekhar, Chander] Int Inst Populat Sci IIPS, Dept Fertil Studies, Mumbai, Maharashtra, India; [Acharya, Rajib] Populat Council, New Delhi, India	International Institute for Population Sciences	Singh, S (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	ssingh@guttmacher.org		Shekhar, Chander/0000-0002-6090-8470	Bill & Melinda Gates Foundation [INV-002939]; David and Lucile Packard Foundation [2019-69110]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This article is based on research funded by the Bill & Melinda Gates Foundation, grant INV-002939 (https://www.gatesfoundation.org/) and the David and Lucile Packard Foundation, grant 2019-69110 (https://www.packard.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ASIAN POPUL STUD; [Anonymous], 2017, NATL FAMILY HLTH SUR; [Anonymous], 2021, SDG INDIA INDEX DASH; Banerjee SK., 2009, PREVENTION UNSAFE AB, P99; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Bongaarts J, 2015, DEMOGR RES, V33, P535, DOI 10.4054/DemRes.2015.33.19; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Dhillon P, 2021, J BIOSOC SCI, V53, P167, DOI 10.1017/S0021932020000115; Diamond-Smith N, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4318-4; Dowerah S., 2015, FIRSTPOST; Ewerling F, 2021, REPROD HEALTH, V18, DOI 10.1186/s12978-021-01220-w; Ganatra B., 2010, EXPANDING COMMUNITY; Government of India, 2002, MED TERM PREGN AM AC; Government of India, 1971, MED TERM PREGN ACT A; International Institute for Population Sciences (IIPS), 1995, NATL FAMILY HLTH SUR; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International Institute for Population Sciences (IIPS) and Population Council, 2010, YOUTH IND SIT NEEDS; Jayachandran AA., 2018, WHAT FACTORS EXPLAIN; Kalyanwala S., 2010, POPULATION COUNCIL; Keshri K, 2013, ASIAN POPUL STUD, V9, P175, DOI 10.1080/17441730.2013.797294; Kumar A, 2019, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-019-4778-6; Kumar K, 1973, J INDIAN LAW I, V15, P638; LEDBETTER R, 1984, ASIAN SURV, V24, P736, DOI 10.1525/as.1984.24.7.01p0176y; Leridon H., 1977, HUMAN FERTILITY BASI; Majumder N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115441; Ministry of Health and Family Welfare (MoHFW) Government of India & UNICEF, 2019, NAT POP POL 2000; Mozumdar A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4249-0; Muttreja Poonam, 2018, Indian J Med Res, V148, pS1, DOI 10.4103/ijmr.IJMR_2067_17; National Sample Survey Organisation (NSSO), 2000, CONC DEF US NSS; NEFF DL, 1994, SOC SCI MED, V39, P475, DOI 10.1016/0277-9536(94)90091-4; Pachauri S, 2014, INDIAN J MED RES, V140, P137; Paul P., 2020, INDIAN J HUM DEV, V14, P304; Powell-Jackson T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120637; Pradhan MR, 2021, J INFERTIL REPROD BI, V9, P27; Purkayastha N, 2021, CLIN EPIDEMIOL GLOB, V9, P162, DOI 10.1016/j.cegh.2020.08.008; Ram F, 2014, INDIAN J MED RES, V140, P17; Rutstein S.O., 2004, DHS COMP REPORTS; Sanjay Kumar, 2016, Demography India, V45, P59; Saxena BN, 1996, ADV CONTRACEPT, V12, P265, DOI 10.1007/BF01849328; SHOPS Plus, 2019, SOURC FAM PLANN NEP; Singh S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002372; Singh S, 2018, LANCET GLOB HEALTH, V6, pE111, DOI [10.1016/S2214-109X(17)30453-9, 10.1016/s2214-109x(17)30453-9]; Stillman M., 2014, ABORTION INDIA LIT R; Stover J, 1998, STUD FAMILY PLANN, V29, P255, DOI 10.2307/172272; Sully E, 2020, ADDING IT INVESTING; Syamala TS., 2012, WORKING PAPERS I SOC; Tombing T, 2017, MARRIAGE DIVORCE LAW, P38; Trends KumarS, 2020, ECON POLIT WEEKLY, V55, P7; Visaria L, 1999, INT FAM PLAN PERSPEC, V25, pS44, DOI 10.2307/2991871; Wulifan JK, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-015-0281-3; Yokoe R, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001491	53	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263532	10.1371/journal.pone.0263532	http://dx.doi.org/10.1371/journal.pone.0263532			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130319	gold, Green Published			2022-12-26	WOS:000805530700035
J	Gathright, EC; Vickery, KD; Ayenew, W; Whited, MC; Adkins-Hempel, M; Chrastek, M; Carter, JK; Rosen, RK; Wu, WC; Busch, AM				Gathright, Emily C.; Vickery, Katherine Diaz; Ayenew, Woubeshet; Whited, Matthew C.; Adkins-Hempel, Melissa; Chrastek, Michelle; Carter, Jill K.; Rosen, Rochelle K.; Wu, Wen-Chih; Busch, Andrew M.			The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent acute coronary syndrome	PLOS ONE			English	Article							HEART-DISEASE; SECONDARY PREVENTION; SCIENTIFIC STATEMENT; MEDICATION ADHERENCE; RISK; SYMPTOMS; ASSOCIATION; SMOKING; CARE; EXERCISE	Background Patients with acute coronary syndrome (ACS) with depressed mood demonstrate poor cardiovascular behavioral risk profiles and elevated risk for recurrent ACS and mortality. Behavioral Activation (BA) offers an intervention framework for an integrated treatment targeting both depression and critical health behaviors post-ACS. Behavioral Activation for Health and Depression (BA-HD) was developed and pilot tested in a multiphase iterative process. Methods First, an initial treatment manual was conceptualized based on the team's prior work, as well as the extant literature. Second, qualitative interviews were conducted with target patients and target providers on the proposed BA-HD treatment rationale, content, and structure. Framework matrix analyses were used to summarize and aggregate responses. Third, an expert panel was convened to elicit additional manual refinements. Finally, patients with post-ACS depression and health behavior non-adherence were recruited to complete an open pilot trial to evaluate acceptability (Client Satisfaction Questionnaire [CSQ], exit interview) and treatment engagement (number of sessions attended; treatment completion was considered completion of 8 out of 10 possible sessions). Results The initial BA-HD treatment manual expanded an existing treatment manual for post-ACS BA-based mood management and smoking cessation to target four health behaviors relevant to post-ACS patients (e.g., smoking cessation, medication adherence, physical activity, and diet). After the initial conceptualization, ten post-ACS patients and eight cardiac rehabilitation professionals completed qualitative interviews. Patients endorsed bi-directional interactions between mood and health behaviors post-ACS. Both patients and providers expressed general support of the proposed treatment rationale and values-guided, collaborative goal-setting approach. Patients, providers, and experts provided feedback that shaped the iterative manual development. After the BA-HD manual was finalized, eight participants were enrolled in a single-arm pilot trial. The mean CSQ score was 30.57 +/- 2.23, indicating high satisfaction. Seven out of eight (88%) completed treatment. Pre- to post treatment improvements in depressed mood and health behaviors were promising. Conclusions BA-HD treatment is an acceptable approach to target both mood and health behaviors in post-ACS patients with depression. A future larger, controlled trial is needed to evaluate the efficacy of the BA-HD treatment.	[Gathright, Emily C.; Rosen, Rochelle K.] Miriam Hosp, Ctr Behav & Prevent Med, Providence, RI 02906 USA; [Gathright, Emily C.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Vickery, Katherine Diaz] Hennepin Healthcare Res Inst, Hlth Homelessness & Criminal Justice Lab, Minneapolis, MN USA; [Vickery, Katherine Diaz; Ayenew, Woubeshet; Carter, Jill K.; Busch, Andrew M.] Hennepin Healthcare, Dept Med, Minneapolis, MN USA; [Vickery, Katherine Diaz; Ayenew, Woubeshet; Busch, Andrew M.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Whited, Matthew C.] East Carolina Univ, Dept Psychol, Greenville, NC 27858 USA; [Adkins-Hempel, Melissa; Chrastek, Michelle; Busch, Andrew M.] Hennepin Healthcare Res Inst, Behav Hlth Equ Res Grp, Minneapolis, MN USA; [Rosen, Rochelle K.] Brown Univ, Brown Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Wu, Wen-Chih] Providence Vet Affairs Med Ctr, Div Cardiol, Providence, RI USA; [Wu, Wen-Chih] Miriam Hosp, Lifespan Cardiovasc Inst, Providence, RI 02906 USA; [Wu, Wen-Chih] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Miriam Hospital; Brown University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; East Carolina University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Lifespan Health Rhode Island; Miriam Hospital; Brown University	Gathright, EC (corresponding author), Miriam Hosp, Ctr Behav & Prevent Med, Providence, RI 02906 USA.; Gathright, EC (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA.	Emily_gathright@brown.edu		Busch, Andrew/0000-0002-3577-5960; Adkins-Hempel, Melissa/0000-0002-9157-4469; Gathright, Emily/0000-0002-6418-6639; Rosen, Rochelle/0000-0003-1598-667X	National Heart, Lung, and Blood Institute of the National Institutes of Health [1R03HL136540]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [K23DK118117]; National Institute on Aging of the National Institutes of Health [K23AG061214]	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number 1R03HL136540 to AMB (PI). The role of KDV in this research/publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number K23DK118117. The effort of ECG was supported by the National Institute on Aging of the National Institutes of Health under award number K23AG061214. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2020, JAMA-J AM MED ASSOC, V324, P651, DOI 10.1001/jama.2020.11747; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Araya R, 2021, JAMA-J AM MED ASSOC, V325, P1852, DOI 10.1001/jama.2021.4348; Brummett BH, 2003, AM J CARDIOL, V92, P529, DOI 10.1016/S0002-9149(03)00719-7; Busch AM, 2011, CURR CARDIOVASC RISK, V5, P510, DOI 10.1007/s12170-011-0198-9; Busch AM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4250-7; Busch AM, 2015, INT J BEHAV MED, V22, P563, DOI 10.1007/s12529-014-9456-9; Celano CM, 2011, CARDIOL REV, V19, P130, DOI 10.1097/CRD.0b013e31820e8106; Choi NG, 2020, AM J GERIAT PSYCHIAT, V28, P698, DOI 10.1016/j.jagp.2020.02.008; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Chrysohoou C, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/429487; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Ekers DM, 2013, J PSYCHIATR MENT HLT, V20, P186, DOI 10.1111/j.1365-2850.2012.01906.x; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; HAYS RD, 1994, J BEHAV MED, V17, P347, DOI 10.1007/BF01858007; Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951; Kanter J. W., 2009, BEHAV ACTIVATION DIS; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kronish IM, 2012, AM HEART J, V164, P524, DOI 10.1016/j.ahj.2012.07.024; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Martinez-Vispo C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214252; Myers V, 2012, J PSYCHOSOM RES, V72, P5, DOI 10.1016/j.jpsychores.2011.09.009; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; O'Halloran P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234420; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Richards SH, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2576-9; Romanelli J, 2002, J AM GERIATR SOC, V50, P817, DOI 10.1046/j.1532-5415.2002.50205.x; Roy MJ, 2019, J GEN INTERN MED, V34, P1289, DOI 10.1007/s11606-019-04917-8; Schneider KL, 2016, BEHAV THER, V47, P198, DOI 10.1016/j.beth.2015.10.005; Sin NL, 2016, ANN BEHAV MED, V50, P523, DOI 10.1007/s12160-016-9777-9; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Tull MT, 2018, BEHAV MODIF, V42, P196, DOI 10.1177/0145445517723901; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Ye SQ, 2013, J AM COLL CARDIOL, V61, P622, DOI 10.1016/j.jacc.2012.09.058; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0261490	10.1371/journal.pone.0261490	http://dx.doi.org/10.1371/journal.pone.0261490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113860	Green Published, gold			2022-12-26	WOS:000823694700016
J	Lai, HC; Chou, JW; Wu, YH; Huang, PJ; Cheng, KS; Chen, TW				Lai, Hsiang-Chun; Chou, Jen-Wei; Wu, Yi-Hua; Huang, Po-Ju; Cheng, Ken-Sheng; Chen, Tsung-Wei			ABO blood type and clinical characteristics of patients with ulcerative colitis: A hospital-based study in central Taiwan	PLOS ONE			English	Article							SECRETOR STATUS; CROHNS-DISEASE; RISK-FACTORS; EPIDEMIOLOGY; MICROBIOTA	Background The variations in ABO blood groups are reported to be associated with multiple disorders, including ulcerative colitis (UC). We aimed to investigate the distribution of ABO blood groups in UC patients and explore its impact on disease severity. Methods We retrospectively collected 129 UC patients diagnosed at our hospital between January 2000 and November 2019. Clinical characteristics, ABO blood groups, and operation rates were analyzed. Results The mean diagnostic age of patients was 38.97 years. Males accounted for the majority of all patients (62.8%). Of 129 patients, 43 (33.3%) were blood type O, 41 (31.8%) were blood type A, 38 (29.5%) were blood type B, and 7 (5.4%) were blood type AB. Although our patients had higher ratio of blood type A comparing our general population, there was no statistically significant association of ABO blood types distribution between these two groups (p = 0.1906). In the subgroup analysis, there were no significant difference of disease locations and operation rates between different ABO blood groups. Furthermore, blood type A patients had higher serum hemoglobin (Hb) levels compared to blood type O patients (13.31 g/dL vs. 12.30 g/dL, p = 0.0347). Blood type A patients had lower serum erythrocyte sedimentation rate (ESR) levels compared to blood type O patients (12.46 mm/hour vs. 21.5 mm/hour, p = 0.0288). Blood type O had higher serum ESR levels compared to non-O groups (p = 0.0228). In the ABO blood groups and mean diagnostic age (<= 40 years or > 40 years), there were no statistically significant difference between these two age groups, p = 0.5515. Conclusions Our results showed ABO blood groups are not associated with UC in spite of a higher ratio of blood type A in our patients. Blood type O patients had higher serum ESR levels; however, blood type A patients had higher Hb levels.	[Lai, Hsiang-Chun] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Chou, Jen-Wei; Wu, Yi-Hua; Huang, Po-Ju; Cheng, Ken-Sheng] China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, Taichung, Taiwan; [Chou, Jen-Wei] Taiwan Soc Inflammatory Bowel Dis TSIBD, Taipei, Taiwan; [Chou, Jen-Wei] Taiwan Assoc Study Small Intestinal Dis TASSID, Touyuan, Taiwan; [Chen, Tsung-Wei] Asia Univ Hosp, Dept Pathol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chou, JW (corresponding author), China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, Taichung, Taiwan.; Chou, JW (corresponding author), Taiwan Soc Inflammatory Bowel Dis TSIBD, Taipei, Taiwan.; Chou, JW (corresponding author), Taiwan Assoc Study Small Intestinal Dis TASSID, Touyuan, Taiwan.	codecol@yahoo.com.tw						Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; BOYD WC, 1961, NATURE, V190, P1123, DOI 10.1038/1901123a0; BUCKWALTER JA, 1956, JAMA-J AM MED ASSOC, V162, P1210, DOI 10.1001/jama.1956.02970300010005; Chou JW, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/4175923; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; DABELSTEEN E, 1988, CANCER RES, V48, P181; Forni D, 2014, J CROHNS COLITIS, V8, P489, DOI 10.1016/j.crohns.2013.10.014; Ng SC, 2019, AM J GASTROENTEROL, V114, P107, DOI 10.1038/s41395-018-0233-2; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Sicilia B, 2008, J CROHNS COLITIS, V2, P158, DOI 10.1016/j.crohns.2008.01.003; SMITH RS, 1961, BRIT MED J, V1, P870, DOI 10.1136/bmj.1.5229.870; Sun WJ, 2015, CANCER EPIDEMIOL, V39, P150, DOI 10.1016/j.canep.2014.12.006; THAYER WR, 1965, GASTROENTEROLOGY, V48, P326; Vegh Z, 2017, J DIGEST DIS, V18, P92, DOI 10.1111/1751-2980.12449; Vesely K T, 1970, Rev Czech Med, V16, P60; Vesely K T, 1969, Vnitr Lek, V15, P1089; WINSTONE NE, 1960, LANCET, V2, P64; Ye BD, 2020, J GASTROEN HEPATOL, V35, P104, DOI 10.1111/jgh.14766; Yu Q, 2016, BLOOD TRANSFUS-ITALY, V14, P460, DOI 10.2450/2016.0199-15	20	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0260018	10.1371/journal.pone.0260018	http://dx.doi.org/10.1371/journal.pone.0260018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113863	Green Published, gold			2022-12-26	WOS:000823694700009
J	Li, BY; Spronk, D; Luo, YT; Puett, C; Inscoe, CR; Tyndall, DA; Lee, YZ; Lu, JP; Zhou, O				Li, Boyuan; Spronk, Derrek; Luo, Yueting; Puett, Connor; Inscoe, Christina R.; Tyndall, Donald A.; Lee, Yueh Z.; Lu, Jianping; Zhou, Otto			Feasibility of dual-energy CBCT by spectral filtration of a dual-focus CNT x-ray source	PLOS ONE			English	Article							CONE-BEAM CT; MAXILLOFACIAL RADIOLOGY; COMPUTED-TOMOGRAPHY; SYSTEM; NECK; HEAD	Cone beam computed tomography (CBCT) is now widely used in dentistry and growing areas of medical imaging. The presence of strong metal artifacts is however a major concern of using CBCT especially in dentistry due to the presence of highly attenuating dental restorations, fixed appliances, and implants. Virtual monoenergetic images (VMIs) synthesized from dual energy CT (DECT) datasets are known to reduce metal artifacts. Although several techniques exist for DECT imaging, they in general come with significantly increased equipment cost and not available in dental clinics. The objectives of this study were to investigate the feasibility of developing a low-cost dual energy CBCT (DE-CBCT) by retrofitting a regular CBCT scanner with a carbon nanotube (CNT) x-ray source with dual focal spots and corresponding low-energy (LE) and high-energy (HE) spectral filters. A testbed with a CNT field emission x-ray source (NuRay Technology, Chang Zhou, China), a flat panel detector (Teledyne, Waterloo, Canada), and a rotating object stage was used for this feasibility study. Two distinct polychromatic x-ray spectra with the mean photon energies of 66.7keV and 86.3keV were produced at a fixed 120kVp x-ray tube voltage by using Al+Au and Al+Sn foils as the respective LE and HE filters attached to the exist window of the x-ray source. The HE filter attenuated the x-ray photons more than the LE filter. The calculated post-object air kerma rate of the HE beam was 31.7% of the LE beam. An anthropomorphic head phantom (RANDO, Nuclear Associates, Hicksville, NY) with metal beads was imaged using the testbed and the images were reconstructed using an iterative volumetric CT reconstruction algorithm. The VMIs were synthesized using an image-domain basis materials decomposition method with energy ranging from 30 to 150keV. The results were compared to the reconstructed images from a single energy clinical dental CBCT scanner (CS9300, Carestream Dental, Atlanta, GA). A significant reduction of the metal artifacts was observed in the VMI images synthesized at high energies compared to those from the same object imaged by the clinical dental CBCT scanner. The ability of the CNT x-ray source to generate the output needed to compensate the reduction of photon flux due to attenuation from the spectral filters and to maintain the CT imaging time was evaluated. The results demonstrated the feasibility of DE-CBCT imaging using the proposed approach. Metal artifact reduction was achieved in VMIs synthesized. The x-ray output needed for the proposed DE-CBCT can be generated by a fixed-anode CNT x-ray source.	[Li, Boyuan; Inscoe, Christina R.; Lu, Jianping; Zhou, Otto] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27515 USA; [Spronk, Derrek; Luo, Yueting] Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC 27515 USA; [Puett, Connor] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Tyndall, Donald A.] Univ N Carolina, Adams Sch Dent, Chapel Hill, NC 27515 USA; [Lee, Yueh Z.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhou, O (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27515 USA.	zhou@email.unc.edu		Zhou, Otto/0000-0003-1476-5517; Lee, Yueh/0000-0003-1846-7680	U.S. Department of Defense (DOD) [DM180025]; David Godschalk Distinguished Professor fund at the University of North Carolina at Chapel Hill	U.S. Department of Defense (DOD)(United States Department of Defense); David Godschalk Distinguished Professor fund at the University of North Carolina at Chapel Hill	The work was supported by the U.S. Department of Defense (DOD) under Grant DM180025 and the David Godschalk Distinguished Professor fund at the University of North Carolina at Chapel Hill. There was no additional external fund received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Otto Zhou has equity ownership and serves on the board of directors of Xintek, Inc., to which the technologies used or evaluated in this project have been licensed. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Jianping Lu has equity ownership in Xintek, Inc. All activities have been approved by institutional COI committees. We thank Dr. Enrique Platin for helpful discussions.	Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; Cotton TP, 2007, J ENDODONT, V33, P1121, DOI 10.1016/j.joen.2007.06.011; Dawson LA, 2007, J CLIN ONCOL, V25, P938, DOI 10.1200/JCO.2006.09.9515; Euler A, 2016, INVEST RADIOL, V51, P491, DOI 10.1097/RLI.0000000000000257; Fang CYJ, 2020, PRO BIOMED OPT IMAG, V11312, DOI 10.1117/12.2549498; Gaeta-Araujo H, 2020, DENTOMAXILLOFAC RAD, V49, DOI 10.1259/dmfr.20200145; Hansen PC, 2018, NUMER ALGORITHMS, V79, P107, DOI 10.1007/s11075-017-0430-x; Hernandez AM, 2014, MED PHYS, V41, DOI 10.1118/1.4866216; Hokamp NG, 2018, EUR J RADIOL, V104, P136, DOI 10.1016/j.ejrad.2018.04.018; Inscoe C., 2020, NANOSTRUCTURED CARBO; Iramina H, 2018, J RADIAT RES, V59, P511, DOI 10.1093/jrr/rry034; Jacobs R, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0523-5; Jaffray D, 2007, EXPERT REV ANTICANC, V7, P89, DOI 10.1586/14737140.7.1.89; Johnson TRC, 2012, AM J ROENTGENOL, V199, pS3, DOI 10.2214/AJR.12.9116; Kaemmerer N, 2016, INVEST RADIOL, V51, P618, DOI 10.1097/RLI.0000000000000290; Katsura M, 2018, RADIOGRAPHICS, V38, P450, DOI 10.1148/rg.2018170102; Kiljunen T, 2015, PHYS MEDICA, V31, P844, DOI 10.1016/j.ejmp.2015.09.004; King E, 2013, HEAD NECK-J SCI SPEC, V35, P959, DOI 10.1002/hed.23060; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Ludlow JB, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140197; Luo Y., 2020, SPIE MED IMAGING; Mory C, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaeaf2; Niu ZF, 2019, EUR J RADIOL, V121, DOI 10.1016/j.ejrad.2019.108702; Orhan K, 2021, DENTOMAXILLOFAC RAD, V50, DOI 10.1259/dmfr.20200372; Polo A, 2010, RADIOTHER ONCOL, V94, P12, DOI 10.1016/j.radonc.2009.12.012; Schulze R, 2011, DENTOMAXILLOFAC RAD, V40, P265, DOI 10.1259/dmfr/30642039; Siewerdsen JH, 2004, MED PHYS, V31, P3057, DOI 10.1118/1.1758350; Spronk D, 2021, MED PHYS, V48, P1089, DOI 10.1002/mp.14696; Tang XY, 2018, MED PHYS, V45, pE761, DOI 10.1002/mp.13095; Tyndall DA, 2012, OR SURG OR MED OR PA, V113, P817, DOI 10.1016/j.oooo.2012.03.005; Tyndall Donald A, 2008, Dent Clin North Am, V52, P825, DOI 10.1016/j.cden.2008.05.002; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Zhang J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923750; Zhang RQ, 2014, IEEE T MED IMAGING, V33, P117, DOI 10.1109/TMI.2013.2282370; Zhu L, 2019, DENTOMAXILLOFAC RAD, V48, DOI 10.1259/dmfr.20180044	35	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262713	10.1371/journal.pone.0262713	http://dx.doi.org/10.1371/journal.pone.0262713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113908	Green Published, gold			2022-12-26	WOS:000823694700033
J	Morris, MC; Russell, TM; Lyman, CA; Wong, WK; Broderick, G; Ferran, MC				Morris, Matthew C.; Russell, Thomas M.; Lyman, Cole A.; Wong, Wesley K.; Broderick, Gordon; Ferran, Maureen C.			Computational prediction of intracellular targets of wild-type or mutant vesicular stomatitis matrix protein	PLOS ONE			English	Article							TUMOR-SPECIFIC DEFECTS; NF-KAPPA-B; INTERFERON INDUCTION; VIRUS INFECTION; CELL-DIFFERENTIATION; REGULATORY NETWORKS; GENE-EXPRESSION; CANCER CELLS; TRANSCRIPTION; INHIBITION	The matrix (M) protein of vesicular stomatitis virus (VSV) has a complex role in infection and immune evasion, particularly with respect to suppression of Type I interferon (IFN). Viral strains bearing the wild-type (wt) M protein are able to suppress Type I IFN responses. We recently reported that the 22-25 strain of VSV encodes a wt M protein, however its sister plaque isolate, strain 22-20, carries a M[MD52G] mutation that perturbs the ability of the M protein to block NF kappa B, but not M-mediated inhibition of host transcription. Therefore, although NF kappa B is activated in 22-20 infected murine L929 cells infected, no IFN mRNA or protein is produced. To investigate the impact of the M[D52G] mutation on immune evasion by VSV, we used transcriptomic data from L929 cells infected with wt, 22-25, or 22-20 to define parameters in a family of executable logical models with the aim of discovering direct targets of viruses encoding a wt or mutant M protein. After several generations of pruning or fixing hypothetical regulatory interactions, we identified specific predicted targets of each strain. We predict that wt and 22-25 VSV both have direct inhibitory actions on key elements of the NF kappa B signaling pathway, while 22-20 fails to inhibit this pathway.	[Morris, Matthew C.; Lyman, Cole A.; Broderick, Gordon] Rochester Gen Hosp, Ctr Clin Syst Biol, Rochester, NY 14621 USA; [Russell, Thomas M.; Wong, Wesley K.; Ferran, Maureen C.] Rochester Inst Technol, Thomas Gosnell Sch Life Sci, Rochester, NY 14623 USA	Rochester General Hospital; Rochester Institute of Technology	Broderick, G (corresponding author), Rochester Gen Hosp, Ctr Clin Syst Biol, Rochester, NY 14621 USA.; Ferran, MC (corresponding author), Rochester Inst Technol, Thomas Gosnell Sch Life Sci, Rochester, NY 14623 USA.	Gordonbroderick@rochesterregional.org; mcfsbi@rit.edu		Broderick, Gordon/0000-0002-3588-8252	National Cancer Institute (National Institutes of Health) [R15CA246419]	National Cancer Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MCF R15CA246419 National Cancer Institute (National Institutes of Health) https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmageed Alaa A, 2020, Curr Protoc Microbiol, V58, pe110, DOI 10.1002/cpmc.110; Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Ahmed S, 2013, J IMMUNOL, V190, P2217, DOI 10.4049/jimmunol.1201630; Arshad OA, 2016, IEEE J BIOMED HEALTH, V20, P399, DOI 10.1109/JBHI.2014.2368391; Barber GN, 2004, VIRAL IMMUNOL, V17, P516, DOI 10.1089/vim.2004.17.516; BLACK BL, 1992, J VIROL, V66, P4058, DOI 10.1128/JVI.66.7.4058-4064.1992; Carey BL, 2008, J VIROL, V82, P12104, DOI 10.1128/JVI.01508-08; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Dominguez JA, 2013, CRIT CARE MED, V41, pE275, DOI 10.1097/CCM.0b013e31828a44ed; DUNIGAN DD, 1983, J VIROL, V45, P618, DOI 10.1128/JVI.45.2.618-626.1983; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Escobar-Zarate D, 2013, CANCER GENE THER, V20, P582, DOI 10.1038/cgt.2013.55; Felt SA, 2015, VIROLOGY, V474, P163, DOI 10.1016/j.virol.2014.10.026; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298; Hastie E, 2013, VIRUS RES, V176, P16, DOI 10.1016/j.virusres.2013.06.003; Hastie E, 2012, J GEN VIROL, V93, P2529, DOI 10.1099/vir.0.046672-0; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Jensen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023023; Kandasamy RK, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.27; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; MARCUS PI, 1993, J INTERFERON RES, V13, P413, DOI 10.1089/jir.1993.13.413; MARCUS PI, 1980, J GEN VIROL, V47, P89, DOI 10.1099/0022-1317-47-1-89; Marcus PI, 1998, J VIROL, V72, P542, DOI 10.1128/JVI.72.1.542-549.1998; MARCUS PI, 1987, J INTERFERON RES, V7, P269, DOI 10.1089/jir.1987.7.269; MARCUS PI, 1992, J INTERFERON RES, V12, P297, DOI 10.1089/jir.1992.12.297; Marquis KA, 2020, VIROLOGY, V548, P117, DOI 10.1016/j.virol.2020.06.013; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Morris MC, 2014, J BIOL CHEM, V289, P21584, DOI 10.1074/jbc.M114.583518; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; PAIK SY, 1995, J VIROL, V69, P3529, DOI 10.1128/JVI.69.6.3529-3537.1995; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; RCore Team, 2020, R LANG ENV STAT COMP; Russell TM, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.00012-19, 10.1128/mra.00012-19]; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Sedghamiz H, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00048; STANNERS CP, 1977, CELL, V11, P273, DOI 10.1016/0092-8674(77)90044-7; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Varble AJ, 2016, VIROLOGY, V499, P99, DOI 10.1016/j.virol.2016.09.009; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Whitlow ZW, 2008, J VIROL, V82, P2286, DOI 10.1128/JVI.01761-07; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhao X, 2014, INT J CLIN EXP MED, V7, P1204	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263065	10.1371/journal.pone.0263065	http://dx.doi.org/10.1371/journal.pone.0263065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108303	Green Published, gold			2022-12-26	WOS:000775890100048
J	Aellen, M; Siebeck, UE; Bshary, R				Aellen, Melisande; Siebeck, Ulrike E.; Bshary, Redouan			Cleaner wrasse Labroides dimidiatus perform above chance in a "matching-to-sample" experiment	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; FISH; INTELLIGENCE; EVOLUTION; PRIMATES; ODDITY; BRAIN; SIZE; DISCRIMINATION; CATEGORIZATION	Concept learning have been studied widely in non-human animal species within or not an ecological context. Here we tested whether cleaner fish Labroides dimidiatus, which show generalised rule learning in an ecologically relevant context; they generalise that any predator may provide protection from being chased by other fish; can also learn a general concept when presented with abstract cues. We tested for this ability in the matching-to-sample task. In this task, a sample is shown first, and then the subject needs to choose the matching sample over a simultaneously presented different one in order to obtain a food reward. We used the most general form of the task, using each stimulus only once in a total of 200 trials. As a group, the six subjects performed above chance, and four individuals eventually reached learning criteria. However, individual performance was rather unstable, yielding overall only 57% correct choices. These results add to the growing literature that ectotherms show the ability of abstract concept learning, though the lack of stable high performance may indicate quantitative performance differences to endotherms.	[Aellen, Melisande; Bshary, Redouan] Univ Neuchatel, Dept Behav Ecol, Neuchatel, Switzerland; [Siebeck, Ulrike E.] Univ Queensland, Sch Biomed Sci, Brisbane St Lucia, Qld, Australia	University of Neuchatel; University of Queensland	Aellen, M (corresponding author), Univ Neuchatel, Dept Behav Ecol, Neuchatel, Switzerland.	melisande.aellen@outlook.com		Aellen, Melisande/0000-0002-8408-0268	Swiss National Science Foundation [31003A_153067, 310030B_173334/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation (grant numbers 31003A_153067 and 310030B_173334/1) to R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aellen M, 2021, ANIM BEHAV, V176, P125, DOI 10.1016/j.anbehav.2021.04.002; Augier L, 2013, PSYCHON B REV, V20, P1126, DOI 10.3758/s13423-013-0436-x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beran MJ, 1999, DEV PSYCHOBIOL, V34, P119, DOI 10.1002/(SICI)1098-2302(199903)34:2<119::AID-DEV5>3.0.CO;2-P; Bloch S, 2019, BEHAV BRAIN RES, V370, DOI 10.1016/j.bbr.2019.111924; BLOUGH DS, 1959, J EXP ANAL BEHAV, V2, P151, DOI 10.1901/jeab.1959.2-151; Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Burkart JM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16000959; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; Chojnacka D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135373; Chung YJ, 2013, PSYCHOMETRIKA, V78, P685, DOI 10.1007/s11336-013-9328-2; CLARK HB, 1970, J EXP ANAL BEHAV, V13, P375, DOI 10.1901/jeab.1970.13-375; d'Amato M.R., 1984, P149; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; FERSTER CB, 1960, J EXP ANAL BEHAV, V3, P259, DOI 10.1901/jeab.1960.3-259; Fisher R. A., 1946, Statistical methods for research workers.; FOSTER TM, 1995, J EXP ANAL BEHAV, V64, P19, DOI 10.1901/jeab.1995.64-19; French RM., 1995, SUBTLETY SAMENESS TH; Gentner D, 1998, COGNITION, V65, P263, DOI 10.1016/S0010-0277(98)00002-X; Gierszewski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057363; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOLDMAN M, 1979, J EXP ANAL BEHAV, V31, P259, DOI 10.1901/jeab.1979.31-259; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; HERMAN L M, 1974, Journal of the Experimental Analysis of Behavior, V21, P19, DOI 10.1901/jeab.1974.21-19; HERMAN LM, 1989, J EXP PSYCHOL ANIM B, V15, P124, DOI 10.1037/0097-7403.15.2.124; Herrmann E, 2012, PHILOS T R SOC B, V367, P2753, DOI 10.1098/rstb.2012.0191; IVERSEN IH, 1993, J EXP ANAL BEHAV, V59, P471, DOI 10.1901/jeab.1993.59-471; Jenkins HM., 2019, ANIM LEARN BEHAV, P177; Kamil Alan C., 1998, P1, DOI 10.1016/B978-012077030-4/50053-2; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; KONORSKI J., 1959, BULL ACAD POLONAISE SCI SER SCI BIOL, V7, P115; Kotrschal A, 2013, CURR BIOL, V23, P168, DOI 10.1016/j.cub.2012.11.058; Leonardi RJ, 2012, ANIM COGN, V15, P107, DOI 10.1007/s10071-011-0437-y; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Muszynski NM, 2020, J COMP PSYCHOL, V134, P266, DOI 10.1037/com0000228; Nakamura T, 2009, J COMP PSYCHOL, V123, P79, DOI 10.1037/a0013126; Newport C, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00039; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; Ortony A., 1989, SIMILARITY ANALOGICA; OVERMAN WH, 1990, ANN NY ACAD SCI, V608, P365, DOI 10.1111/j.1749-6632.1990.tb48903.x; OVERMAN WH, 1983, ANIM LEARN BEHAV, V11, P483, DOI 10.3758/BF03199805; PACK AA, 1991, ANIM LEARN BEHAV, V19, P37, DOI 10.3758/BF03197858; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Perry CJ, 2013, WIRES COGN SCI, V4, P561, DOI 10.1002/wcs.1248; PREMACK D, 1983, ANNU REV PSYCHOL, V34, P351, DOI 10.1146/annurev.ps.34.020183.002031; PREMACK D, 1983, BEHAV BRAIN SCI, V6, P125, DOI 10.1017/S0140525X00015077; Premack D., 1978, COGNITIVE PROCESS; R Core Team, 2021, R LANG ENV STAT; Salwiczek LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049068; Shettleworth SJ, 2009, BEHAV PROCESS, V80, P210, DOI 10.1016/j.beproc.2008.09.001; SKINNER BF, 1950, PSYCHOL REV, V57, P193, DOI 10.1037/h0054367; Thibaut JP, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00643; Thibaut JP, 2010, PSYCHON B REV, V17, P569, DOI 10.3758/PBR.17.4.569; Thomas RK, 1996, COGNITIVE BRAIN RES, V3, P157, DOI 10.1016/0926-6410(96)00003-1; THOMAS RK, 1980, BRAIN BEHAV EVOLUT, V17, P454, DOI 10.1159/000121814; Thompson RK., 1995, COMP APPROACHES COGN, V175, P224; Thompson RKR, 2000, COGNITIVE SCI, V24, P363; Thorndike EL, 1998, AM PSYCHOL, V53, P1125, DOI 10.1037/0003-066X.53.10.1125; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; Triki Z, 2018, ANIM COGN, V21, P99, DOI 10.1007/s10071-017-1143-1; Truppa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023809; Truppa V, 2010, ANIM COGN, V13, P835, DOI 10.1007/s10071-010-0332-y; van Schaik CP, 2012, TRENDS COGN SCI, V16, P277, DOI 10.1016/j.tics.2012.04.004; Wasserman EA, 2010, J EXP PSYCHOL-ANIM B, V36, P3, DOI 10.1037/a0016327; Wismer S, 2019, ANIM BEHAV, V158, P249, DOI 10.1016/j.anbehav.2019.09.013; Wismer S, 2016, ANIM COGN, V19, P769, DOI 10.1007/s10071-016-0975-4; Wright AA, 2005, J EXP PSYCHOL ANIM B, V31, P425, DOI 10.1037/0097-7403.31.4.425; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; Wynne CD, 2001, ANIMAL COGNITION MEN; Wynne Clive D. L., 2013, ANIMAL COGNITION EVO; Zentall TR, 2014, J EXP ANAL BEHAV, V101, P130, DOI 10.1002/jeab.55; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002; ZERBOLIO DJ, 1983, ANIM LEARN BEHAV, V11, P341, DOI 10.3758/BF03199786	81	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262351	10.1371/journal.pone.0262351	http://dx.doi.org/10.1371/journal.pone.0262351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100297	gold, Green Published			2022-12-26	WOS:000801937600012
J	Brennan, C; Gunasekaran, T; Sanders, RA				Brennan, Christopher; Gunasekaran, Tamilselvam; Sanders, Robert A.			Evaluation of plasma N-terminal pro-B-type natriuretic peptide levels in healthy North American Salukis with normal echocardiographic measurements	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; CARDIAC TROPONIN-I; MITRAL-VALVE DISEASE; DIAGNOSTIC MARKER; DOGS; VALUES; CARDIOMYOPATHY; BIOMARKERS; MANAGEMENT; SEVERITY	Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels has been shown to have clinical significance for diagnosis and management of heart disease in dogs. Evaluation of current reference limits for specific breeds is necessary to ensure the test can accurately distinguish between healthy and diseased animals. The objective of this study is to evaluate the adequacy of currently established NT-proBNP reference limits for clinical use in healthy Salukis. Cardiac health of 33 clinically healthy Salukis was evaluated via echocardiography using available breed standards. Plasma concentrations of NT-proBNP were measured using a commercially available assay. A one-sided 97.5% upper reference limit for the NT-proBNP concentrations was calculated using non-parametric percentile method. The 97.5% upper reference limit was 769 pmol/L (90% CI, 547-1214 pmol/L) for the study dogs. This upper reference limit was within the currently established non-breed specific NT-proBNP upper reference limit of 900 pmol/L. No relationship between sex, age, or body weight on plasma levels of NT-proBNP was noted. Results of this study supports the use of currently available non-breed specific NT-proBNP cut-off values for clinical evaluation of healthy Salukis.	[Brennan, Christopher; Gunasekaran, Tamilselvam; Sanders, Robert A.] Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA		Sanders, RA (corresponding author), Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	ras@msu.edu		Gunasekaran, Tamilselvam/0000-0002-1861-9122				Cahill RJ, 2015, J VET DIAGN INVEST, V27, P61, DOI 10.1177/1040638714562826; Chetboul V, 2009, J VET INTERN MED, V23, P984, DOI 10.1111/j.1939-1676.2009.0347.x; Chow SL, 2017, CIRCULATION, V135, pE1054, DOI 10.1161/CIR.0000000000000490; Couto KM, 2015, VET CLIN PATH, V44, P405, DOI 10.1111/vcp.12266; DeFrancesco TC, 2007, J VET INTERN MED, V21, P243, DOI 10.1892/0891-6640(2007)21[243:PCEOAE]2.0.CO;2; Ebisawa T, 2012, INT J APPL RES VET M, V10, P234; Fine DM, 2008, JAVMA-J AM VET MED A, V232, P1674, DOI 10.2460/javma.232.11.1674; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Giraut S, 2019, J SMALL ANIM PRACT, V60, P374, DOI 10.1111/jsap.12975; Hassdenteufel E, 2012, TIERAERZTL PRAX K H, V40, P171; Hezzell MJ, 2012, J VET INTERN MED, V26, P302, DOI 10.1111/j.1939-1676.2012.00894.x; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Kurosawa TA, 2018, J VET CARDIOL, V20, P301, DOI 10.1016/j.jvc.2018.07.003; LaVecchio D, 2009, J VET INTERN MED, V23, P87, DOI 10.1111/j.1939-1676.2008.0237.x; Maries L, 2013, CARDIOVASC J AFR, V24, P286, DOI 10.5830/CVJA-2013-055; Marin LM, 2007, VET RADIOL ULTRASOUN, V48, P332, DOI 10.1111/j.1740-8261.2007.00252.x; Oyama MA, 2008, JAVMA-J AM VET MED A, V232, P1496, DOI 10.2460/javma.232.10.1496; Oyama MA, 2007, AM J VET RES, V68, P42, DOI 10.2460/ajvr.68.1.42; Oyama MA, 2010, VET CLIN N AM-SMALL, V40, P545, DOI 10.1016/j.cvsm.2010.03.004; Oyama MA, 2009, JAVMA-J AM VET MED A, V235, P1319, DOI 10.2460/javma.235.11.1319; PAGE A, 1993, AUST VET J, V70, P361, DOI 10.1111/j.1751-0813.1993.tb00808.x; Prosek R, 2007, J VET INTERN MED, V21, P238, DOI 10.1892/0891-6640(2007)21[238:DCANDI]2.0.CO;2; Reynolds CA, 2012, J VET CARDIOL, V14, P193, DOI 10.1016/j.jvc.2012.01.008; Serres Francois, 2009, J Vet Cardiol, V11, P103, DOI 10.1016/j.jvc.2009.07.001; Sjostrand K, 2014, J VET INTERN MED, V28, P451, DOI 10.1111/jvim.12310; SNYDER PS, 1995, VET RADIOL ULTRASOUN, V36, P387, DOI 10.1111/j.1740-8261.1995.tb00283.x; Tarnow I, 2009, VET J, V180, P195, DOI 10.1016/j.tvjl.2007.12.026; Wess G, 2011, AM J VET RES, V72, P642, DOI 10.2460/ajvr.72.5.642; Zaldivar-Lopez S, 2011, VET CLIN PATH, V40, P414, DOI 10.1111/j.1939-165X.2011.00360.x	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0260079	10.1371/journal.pone.0260079	http://dx.doi.org/10.1371/journal.pone.0260079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100273	Green Submitted, Green Published, gold			2022-12-26	WOS:000801937600007
J	Zou, HL; Luo, J; Guo, YB; Liu, YH; Wang, Y; Deng, L; Li, P				Zou, Hailin; Luo, Juan; Guo, Yibo; Liu, Yuhong; Wang, Yun; Deng, Liang; Li, Peng			RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7	ONCOGENE			English	Article							BREAST-CANCER; EXPRESSION; PATHWAY; TAZ; MICRORNA; LIN28A; YAP; TRANSFORMATION; PROLIFERATION; PLURIPOTENCY	The RNA binding protein LIN28 directly modulates the stability and translation of target mRNAs independently of Let-7; however, the key downstream targets of LIN28 in this process are largely unknown. Here, we revealed that Hippo signaling effector YAP1 functioned as a key downstream regulator of LIN28 to modulate the cancer stem cell (CSC)-like properties and tumor progressions in triple negative breast cancer (TNBC). LIN28 was overexpressed in BC tissues and cell lines, and significantly correlated with poorer overall survivals in patients. Ectopic LIN28 expression enhanced, while knockdown of LIN28A inhibited the CSC-like properties, cell growth and invasive phenotypes of TNBC cells in vitro and in vivo. Transcriptome analysis demonstrated LIN28 overexpression significantly induced the expressions of YAP1 downstream genes, while reduced the transcripts of YAP1 upstream kinases, such as MST1/2 and LATS1/2, and knockdown of LIN28A exhibited the opposite effects. Furthermore, constitutive activation of YAP1 in LIN28 knockdown TNBC cells could rescue the cell growth and invasive phenotypes in vitro and in vivo. Mechanistically, instead of the dependence of Let-7, LIN28 recruited RNA binding protein MSI2 in a manner dependent on the LIN28 CSD domain and MSI2 RRM domain, to directly induce the mRNA decay of YAP1 upstream kinases, leading to the inhibition of Hippo pathway and activation of YAP1, which eventually gave rise to increased CSC populations, enhanced tumor cell growth and invasive phenotypes. Accordingly, co-upregulations of LIN28 and MSI2 in TNBC tissues were strongly associated with YAP1 protein level and tumor malignance. Taken together, our findings unravel a novel LIN28/MSI2-YAP1 regulatory axis to induce the CSC-like properties, tumor growth and metastasis, independently of Let-7, which may serve as a potential therapeutic strategy for the treatment of a subset of TNBC with LIN28 overexpression.	[Zou, Hailin; Luo, Juan; Guo, Yibo; Wang, Yun; Li, Peng] Sun Yat Sen Univ, Sci Res Ctr, Affiliated Hosp 7, Shenzhen 518107, Guangdong, Peoples R China; [Liu, Yuhong; Deng, Liang] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Gen Surg, Shenzhen 518107, Guangdong, Peoples R China; [Li, Peng] Sun Yat Sen Univ, Affiliated Hosp 7, Guangdong Prov Key Lab Digest Canc Res, 628 Zhenyuan Rd, Shenzhen 518107, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, P (corresponding author), Sun Yat Sen Univ, Sci Res Ctr, Affiliated Hosp 7, Shenzhen 518107, Guangdong, Peoples R China.; Li, P (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 7, Guangdong Prov Key Lab Digest Canc Res, 628 Zhenyuan Rd, Shenzhen 518107, Guangdong, Peoples R China.	lipeng56@mail.sysu.edu.cn	Deng, Liang/GXH-6710-2022	Li, Peng/0000-0001-7226-4214	Shenzhen Science and Technology Innovation Commission [JCYJ20210324120409026]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110285]; National Natural Science Foundation of China [32000679, 82072901]; Fundamental Research Funds for the Central Universities [20ykzd02]; Guangdong Provincial Key Laboratory of Digestive Cancer Research [2021B1212040006]	Shenzhen Science and Technology Innovation Commission; Guangdong Basic and Applied Basic Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Provincial Key Laboratory of Digestive Cancer Research	This work was supported by Shenzhen Science and Technology Innovation Commission (JCYJ20210324120409026 to PL), Guangdong Basic and Applied Basic Research Foundation (Grant No. 2021A1515111052 to JL), National Natural Science Foundation of China (Grant No. 32000679 and 82072901 to PL), the Fundamental Research Funds for the Central Universities (Grant No. 20ykzd02 to PL), Guangdong Basic and Applied Basic Research Foundation (Grant No. 2019A1515110285 to PL), and the Guangdong Provincial Key Laboratory of Digestive Cancer Research (No. 2021B1212040006).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ali MA, 2021, CRIT REV ONCOL HEMAT, V157, DOI 10.1016/j.critrevonc.2020.103197; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Beachy SH, 2012, BLOOD, V120, P1048, DOI 10.1182/blood-2012-01-401760; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Borah A, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.35; Choi YM, 2017, ONCOGENE, V36, P2802, DOI 10.1038/onc.2016.441; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Farzaneh M, 2017, CELL REPROGRAM, V19, P289, DOI 10.1089/cell.2017.0015; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Kang MH, 2017, ONCOGENE, V36, P1745, DOI 10.1038/onc.2016.327; Kim T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10186; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Kudinov AE, 2017, CLIN CANCER RES, V23, P2143, DOI 10.1158/1078-0432.CCR-16-2728; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li MX, 2019, ORAL ONCOL, V98, P92, DOI 10.1016/j.oraloncology.2019.09.024; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Luo J, 2021, STEM CELLS INT, V2021, DOI 10.1155/2021/6674283; Maugeri-Sacca M, 2016, CRIT REV ONCOL HEMAT, V99, P115, DOI 10.1016/j.critrevonc.2015.12.004; Mo HN, 2021, FRONT MED-PRC, V15, P1, DOI 10.1007/s11684-020-0741-5; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Park JH, 2018, MOL CELLS, V41, P83, DOI 10.14348/molcells.2018.2242; Peng F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.438; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Reggiani F, 2021, TRENDS BIOCHEM SCI, V46, P154, DOI 10.1016/j.tibs.2020.08.012; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Thompson BJ, 2020, BIOESSAYS, V42, DOI 10.1002/bies.201900162; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Vadla B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002588; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang LF, 2018, CELL REP, V23, P3091, DOI 10.1016/j.celrep.2018.04.116; Wang LF, 2017, CELL REP, V18, P2664, DOI 10.1016/j.celrep.2017.02.044; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu ZM, 2021, TRENDS BIOCHEM SCI, V46, P51, DOI 10.1016/j.tibs.2020.08.008; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang HY, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-01384-8; Yang J, 2015, MOL CELL BIOL, V35, P3225, DOI 10.1128/MCB.00426-15; Zeng YX, 2016, MOL CELL, V61, P153, DOI 10.1016/j.molcel.2015.11.020; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhang R, 2022, SEMIN CANCER BIOL, V82, P11, DOI 10.1016/j.semcancer.2021.03.008; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	52	5	5	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1657	1672		10.1038/s41388-022-02198-w	http://dx.doi.org/10.1038/s41388-022-02198-w		JAN 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35102250	hybrid, Green Published			2022-12-26	WOS:000750409400001
J	Angarita-Diaz, MD; Bernal-Cepeda, L; Bastidas-Legarda, L; Forero-Escobar, D; Ricaurte-Avendano, A; Mora-Reina, J; Vergara-Mercado, M; Herrera-Herrera, A; Rodriguez-Paz, M; Caceres- Matta, S; Fortich-Mesa, N; Ochoa-Acosta, EM				del Pilar Angarita-Diaz, Maria; Bernal-Cepeda, Lilia; Bastidas-Legarda, Leidy; Forero-Escobar, Diana; Ricaurte-Avendano, Angelica; Mora-Reina, Julian; Vergara-Mercado, Martha; Herrera-Herrera, Alejandra; Rodriguez-Paz, Martha; Caceres- Matta, Sandra; Fortich-Mesa, Natalia; Maria Ochoa-Acosta, Emilia			Impact of a virtual learning environment on the conscious prescription of antibiotics among Colombian dentists	PLOS ONE			English	Article							PRESCRIBING PRACTICES; PROPHYLAXIS; INTENTION; MODEL	Appropriate antibiotic prescription contributes to reducing bacterial resistance; therefore, it is critical to provide training regarding this challenge. The objective of this study was to develop a virtual learning environment for antibiotic prescription and to determine its impact on dentists' awareness, attitudes, and intention to practice. First, the learning content on multimedia resources was developed and distributed into three challenges that participants had to overcome. Then, a quasi-experimental study was performed in which the virtual learning environment was implemented on dentists from seven Colombian cities. The median of correct answers and the levels of awareness, attitudes, and intention to practice were compared before, immediately after, and 6-months post-intervention. Wilcoxon signed-rank and McNemar's tests were used to determine the differences. A total of 206 participants who finished the virtual learning environment activities exhibited a favorable and statistically significant impact on the median of correct answers of awareness (p < 0.001), attitudes (p < 0.001), and intention to practice (p = 0.042). A significant increase occurred in the number of participants with a high level of awareness (p < 0.001) and a non-significant increase in participants with high levels of attitudes (p = 0.230) and intention to practice (p = 0.286). At 6 months, the positive effect on the median of correct answers on awareness and intention to practice persisted (p < 0.001); however, this was not evident for attitudes (p = 0.105). Moreover, there was a significant decrease in the number of participants who showed low levels of awareness (p = 0.019) and a slight increase in those with high levels of the same component (p = 0.161). The use of a virtual learning environment designed for dentists contributed to a rapid improvement in awareness and intention to practice antibiotic prescription; however, their attitudes and information retention need reinforcement.	[del Pilar Angarita-Diaz, Maria; Forero-Escobar, Diana; Mora-Reina, Julian] Univ Cooperat Colombia, Fac Odontol, Villavicencio, Colombia; [Bernal-Cepeda, Lilia] Univ Nacl Colombia, Fac Odontol, Bogota, Colombia; [Bastidas-Legarda, Leidy] Univ Southampton, Sch Clin & Expt Sci, Fac Med, Southampton, Hants, England; [Ricaurte-Avendano, Angelica] Univ Cooperat Colombia, Sub Direct Learning, Medellin, Colombia; [Vergara-Mercado, Martha] Univ Sinu, Fac Odontol, Monteria, Colombia; [Herrera-Herrera, Alejandra] Univ Metropolitana, Fac Odontol, Barranquilla, Colombia; [Rodriguez-Paz, Martha] Univ Valle, Fac Odontol, Cali, Colombia; [Caceres- Matta, Sandra] Univ Sinu, Fac Odontol, Cartagena, Colombia; [Fortich-Mesa, Natalia] Univ Rafael Nunez, Fac Odontol, Cartagena, Colombia; [Maria Ochoa-Acosta, Emilia] Univ Cooperat Colombia, Fac Odontol, Medellin, Colombia	Universidad Cooperativa de Colombia; Universidad Nacional de Colombia; University of Southampton; Universidad Cooperativa de Colombia; Universidad del Valle; Universidad Cooperativa de Colombia	Angarita-Diaz, MD (corresponding author), Univ Cooperat Colombia, Fac Odontol, Villavicencio, Colombia.	maria.angaritad@campusucc.edu.co		Angarita Diaz, Maria del Pilar/0000-0002-5435-3456; Bernal, Lilia Jadith/0000-0002-2889-5497; FORERO ESCOBAR, DIANA/0000-0002-3344-4666				Aboalshamat Khalid T, 2019, Open Access Maced J Med Sci, V7, P2917, DOI 10.3889/oamjms.2019.723; American Association of Endodontists, 2017, ANT PROPH 2017 UPD; American Dental Association, 2021, ANT PROPH PRIOR DENT; Angarita-Diaz MD, 2021, J PUBLIC HEALTH DENT, V81, P100, DOI 10.1111/jphd.12416; Angarita-Díaz María del Pilar, 2019, Rev Fac Odontol Univ Antioq, V31, P112, DOI 10.17533/udea.rfo.v31n1-2a10; Asthana A., 2008, ENCY MULTIMEDIA; Berr L, 2013, Bull Group Int Rech Sci Stomatol Odontol, V51, pe25; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Car LT, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1370-1; Caris MG, 2018, J ANTIMICROB CHEMOTH, V73, P509, DOI 10.1093/jac/dky169; Chen C, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9080492; Daly CG, 2017, AUST PRESCR, V40, P184, DOI 10.18773/austprescr.2017.054; Dar-Odeh NS, 2010, THER CLIN RISK MANAG, V6, P301; Derakhshanrad SA, 2016, OCCUP THER INT, V23, P29, DOI 10.1002/oti.1402; Durkin MJ, 2017, J AM DENT ASSOC, V148, P878, DOI 10.1016/j.adaj.2017.07.019; FDI World Dental Federation, 2019, ANT STEW DENT; Goff DA, 2020, CLIN INFECT DIS, V71, P455, DOI 10.1093/cid/ciz1118; Gross AE, 2021, INFECT CONT HOSP EP, V42, P110, DOI 10.1017/ice.2020.1261; Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P867, DOI 10.2471/BLT.15.153171; Hyde S, 2018, EUR J DENT EDUC, V22, pE687, DOI 10.1111/eje.12380; Kyaw BM, 2019, J MED INTERNET RES, V21, DOI 10.2196/14984; Lozano A., 2018, CPU E REV INVESTIG E, V26, P114; Mayer R. E., 2014, CAMBRIDGE HDB MULTIM, V2nd, DOI [10.1017/CBO9781139547369, DOI 10.1017/CBO9781139547369]; Mueller D, 2011, COMPUT EDUC, V57, P2505, DOI 10.1016/j.compedu.2011.06.017; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; ONeill J., 2014, REV ANTIMICROB RESIS; Raya PR, 2017, ATEN PRIM, V49, P611, DOI 10.1016/j.aprim.2017.05.003; Roque F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1276; Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625; Sikkens JJ, 2018, J ANTIMICROB CHEMOTH, V73, P2243, DOI 10.1093/jac/dky163; Sofhauser C, 2016, NURS SCI QUART, V29, P31, DOI 10.1177/0894318415614629; Soltanimehr E, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1649-0; Stein K, 2018, J AM DENT ASSOC, V149, P869, DOI 10.1016/j.adaj.2018.05.034; Stevens NT, 2019, JAC-ANTIMICROB RESIS, V1, DOI 10.1093/jacamr/dlz081; Suda KJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3909; Teoh L, 2021, BRIT J CLIN PHARMACO, V87, P152, DOI 10.1111/bcp.14373; Thompson W, 2019, J ANTIMICROB CHEMOTH, V74, P2139, DOI 10.1093/jac/dkz152; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00194; WHO, NEW REP CALLS URG AC; World Health Organization, 2015, GLOB ACT PLAN ANT RE; Xu DM, 2005, EXPERT SYST APPL, V29, P525, DOI 10.1016/j.eswa.2005.04.028	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262731	10.1371/journal.pone.0262731	http://dx.doi.org/10.1371/journal.pone.0262731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089952	gold, Green Published			2022-12-26	WOS:000769158400020
J	Gong, YD; Zhao, M; Wang, Q; Lv, ZH				Gong, Yangda; Zhao, Min; Wang, Qin; Lv, Zhihan			Design and interactive performance of human resource management system based on artificial intelligence	PLOS ONE			English	Article							GREEN; EMPLOYEES; BEHAVIOR; NEXUS	The purpose is to strengthen Human Resources Management (HRM) through information management using Artificial Intelligence (AI) technology. First, the selection criteria of the applicant's resume during recruitment and the formulation standards of the contract salary are analyzed. Then, the resume information is extracted and converted into the data-type format. Besides, the salary forecast model in the HRM system (HRMS) is designed based on the Back Propagation Neural Network (BPNN), and network structure, parameter initialization, and activation function of the BPNN are selected and optimized. The experimental results demonstrate that the algorithm optimized by the Nadm has shown improved convergence speed and forecast effect, with 187 iterations. Moreover, compared with other regression algorithms, the designed algorithm achieves the best test scores. The above results can provide references for designing the AI-based HRMS.	[Gong, Yangda; Zhao, Min] Hohai Univ, Sch Business, Nanjing, Peoples R China; [Wang, Qin] Jiangsu Branch China Mobile Grp, Nanjing, Peoples R China; [Lv, Zhihan] Qingdao Univ, Sch Data Sci & Software Engn, Qingdao, Peoples R China	Hohai University; Qingdao University	Gong, YD (corresponding author), Hohai Univ, Sch Business, Nanjing, Peoples R China.	gongyangda@hhu.edu.cn	Lv, Zhihan/GLR-6000-2022; Lv, Zhihan/I-3187-2014	Lv, Zhihan/0000-0003-2525-3074; Lv, Zhihan/0000-0003-2525-3074				Abdullah P.Y., 2020, INT J RES GRANTHAALA, V8, P56, DOI DOI 10.1007/S10257-018-0389-8; Babel'ova ZG, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020574; Bagherinezhad Z., 2020, J EDUC COMPUT RES, V12, P147; Barrena-Martinez J, 2019, INT J HUM RESOUR MAN, V30, P2544, DOI 10.1080/09585192.2017.1332669; Bin Saeed B, 2019, CORP SOC RESP ENV MA, V26, P424, DOI 10.1002/csr.1694; Boon C, 2019, J MANAGE, V45, P2498, DOI 10.1177/0149206318818718; Chae CG, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145700; Chams N, 2019, RESOUR CONSERV RECY, V141, P109, DOI 10.1016/j.resconrec.2018.10.006; Chou YC, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11020251; Cooke FL, 2019, INT J HUM RESOUR MAN, V30, P1239, DOI 10.1080/09585192.2015.1137618; Danylovych-Kropyvnytska, 2019, J ENTREPRENEURSHIP E, V22, P1; Ferraris A, 2019, INT J HUM RESOUR MAN, V30, P680, DOI 10.1080/09585192.2017.1291530; He W, 2016, HUM RESOUR MANAGE-US, V55, P301, DOI 10.1002/hrm.21674; Hong CH, 2019, ACM COMPUT SURV, V52, DOI 10.1145/3326066; Jabbour CJC, 2019, J CLEAN PROD, V222, P793, DOI 10.1016/j.jclepro.2019.03.038; Jawad WK., 2020, INT J FOUND COMPUT S, V3, P1; Kim YJ, 2019, INT J HOSP MANAG, V76, P83, DOI 10.1016/j.ijhm.2018.04.007; Lee HW, 2019, J MANAGE, V45, P819, DOI 10.1177/0149206316680029; Macke J, 2019, J CLEAN PROD, V208, P806, DOI 10.1016/j.jclepro.2018.10.091; Namany S, 2019, J CLEAN PROD, V225, P610, DOI 10.1016/j.jclepro.2019.03.304; Necula SC, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11133520; Pham NT, 2019, TOURISM MANAGE, V72, P386, DOI 10.1016/j.tourman.2018.12.008; Ogbonnaya C, 2019, HUM RESOUR MANAG J, V29, P509, DOI 10.1111/1748-8583.12203; Parry E., 2019, EMERALD OPEN RES, V1, P5, DOI DOI 10.12688/EMERALDOPENRES.12907.1; Peccei R, 2019, J MANAGE, V45, P786, DOI 10.1177/0149206316673720; Purwanto A., 2019, JURNAL INOVASI BISNI, V6, P180; Qin C, 2020, ACM T INFORM SYST, V38, DOI 10.1145/3376927; Raut RD, 2019, J CLEAN PROD, V215, P926, DOI 10.1016/j.jclepro.2019.01.139; Roscoe S, 2019, BUS STRATEG ENVIRON, V28, P737, DOI 10.1002/bse.2277; Santana M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041678; Serje J, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0093-z; Shen CG, 2019, J MANAGE PSYCHOL, V34, P546, DOI 10.1108/JMP-10-2018-0480; Singh SK, 2020, TECHNOL FORECAST SOC, V150, DOI 10.1016/j.techfore.2019.119762; Siriyanun S., 2019, INT J SUPPLY CHAIN M, V8, P685; Sodhro AH, 2019, J CLEAN PROD, V220, P1167, DOI 10.1016/j.jclepro.2019.01.188; Stachova K, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020345; Tambe P, 2019, CALIF MANAGE REV, V61, P15, DOI 10.1177/0008125619867910; Wang T, 2019, J NETW COMPUT APPL, V135, P11, DOI 10.1016/j.jnca.2019.02.021; Yong JY, 2019, J CLEAN PROD, V215, P364, DOI 10.1016/j.jclepro.2018.12.306	39	2	2	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262398	10.1371/journal.pone.0262398	http://dx.doi.org/10.1371/journal.pone.0262398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089946	Green Published, gold			2022-12-26	WOS:000769158400014
J	Zhang, XM; Tang, ZS				Zhang, Xiaomei; Tang, Zhuosi			Construction of computer model for enterprise green innovation by PSO-BPNN algorithm and its impact on economic performance	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; SUSTAINABLE DEVELOPMENT; NEURAL-NETWORK	The present work aims to analyze the elements that affect corporate green technology innovation and investigate a method suitable for predicting and evaluating corporate performance. First, the elements of green technology innovation and their relationships are analyzed and explained. Then, the Complex Adaptive System (CAS) theory is introduced. On this basis, a computer model for the driving mechanism system of corporate green technology innovation is constructed on the Recursive Porus Agent Simulation (Repast) platform. Finally, the Backpropagation Neural Network (BPNN) model is optimized by Particle Swarm Optimization (PSO), constituting the PSO-BPNN algorithm to evaluate corporate performance. The results of network training and simulation demonstrate that compared with traditional BPNN, PSO-BPNN achieve a faster convergence speed and fewer errors. Besides, the actual output value has a tiny difference from the expected value, showing the application potential of this algorithm in corporate performance prediction. Moreover, the driving factors of green technology innovation greatly affect the profitability and performance of enterprises. Given insufficient corporate profit margin, continuous technological innovation activities can ensure the normal operation of enterprises. A smaller corporate tax rate can shorten the time for the system to reach equilibrium. When the corporate tax rate is above 0.2, the system takes longer to reach equilibrium. In addition, the public opinion coefficient directly affects the time needed for the system to attain equilibrium. When the public opinion coefficient is within 50,00 ~ 6,000 interval, the time that the system takes to reach equilibrium changes significantly. Furthermore, corporate internal and external driving factors have a direct effect on corporate green technology innovation and performance. The research findings indicate that the PSO-BPNN algorithm is of vital practical value to corporate performance evaluation.	[Zhang, Xiaomei; Tang, Zhuosi] SouthWestern Univ Finance & Econ, Sch Finance, Chengdu, Peoples R China	Southwestern University of Finance & Economics - China	Tang, ZS (corresponding author), SouthWestern Univ Finance & Econ, Sch Finance, Chengdu, Peoples R China.	zhuositang@smail.swufe.edu.cn						Abbas J, 2019, J CLEAN PROD, V229, P611, DOI 10.1016/j.jclepro.2019.05.024; Chung N, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205744; Dai YZ, 2019, PROCEDIA COMPUT SCI, V147, P519, DOI 10.1016/j.procs.2019.01.235; He F, 2018, INT J ADV MANUF TECH, V95, P4081, DOI 10.1007/s00170-017-1517-1; Jiali Zhao, 2020, IOP Conference Series: Earth and Environmental Science, V512, DOI 10.1088/1755-1315/512/1/012062; Khomri B, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.5.056004; Kruger C, 2018, J CLEAN PROD, V191, P400, DOI 10.1016/j.jclepro.2018.04.180; Li Q, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062209; Mirghasemi S, 2019, EXPERT SYST APPL, V133, P126, DOI 10.1016/j.eswa.2019.04.050; Mona S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138481; Olagunju A., 2019, COMPUTING REV, V60, P217; Palcic I, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083499; Pearce F, 2019, NEW SCI, V242, P42, DOI 10.1016/S0262-4079(19)30651-7; Peng BH, 2020, J CLEAN PROD, V252, DOI 10.1016/j.jclepro.2019.119711; Sebestyen V, 2019, J ENVIRON MANAGE, V238, P126, DOI 10.1016/j.jenvman.2019.02.096; Talebi A, 2019, ECOL ENG, V126, P1, DOI 10.1016/j.ecoleng.2018.10.006; Tamrakar S, 2017, SIMUL-T SOC MOD SIM, V93, P69, DOI 10.1177/0037549716673724; Wang K, 2020, J INTELL FUZZY SYST, V38, P1; Xu Y, 2018, NEURAL NETW WORLD, V28, P345, DOI 10.14311/NNW.2018.28.020; Ye Qiaolin, 2018, Journal of Huazhong University of Science and Technology (Natural Science Edition), V46, P30, DOI 10.13245/j.hust.180306; Yu X, 2019, PATTERN RECOGN, V94, P96, DOI 10.1016/j.patcog.2019.05.030; Zhang Q, 2020, J COASTAL RES, P481, DOI 10.2112/JCR-SI115-133.1; Zhang YZ, 2019, COGN SYST RES, V57, P228, DOI 10.1016/j.cogsys.2018.10.025	23	2	2	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262963	10.1371/journal.pone.0262963	http://dx.doi.org/10.1371/journal.pone.0262963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089955	Green Published, gold			2022-12-26	WOS:000769158400032
J	Jung, NY; Kim, HS; Kim, ES; Jeon, S; Lee, MJ; Pak, K; Lee, JH; Lee, YM; Lee, K; Shin, JH; Ko, JK; Lee, JM; Yoon, JA; Hwang, C; Choi, KU; Huh, GY; Kim, YE; Kim, EJ				Jung, Na-Yeon; Kim, Hyang-Sook; Kim, Eun Soo; Jeon, Sumin; Lee, Myung Jun; Pak, Kyoungjune; Lee, Jae-Hyeok; Lee, Young Min; Lee, Kangyoon; Shin, Jin-Hong; Ko, Jun Kyeung; Lee, Jae Meen; Yoon, Jin A.; Hwang, Chungsu; Choi, Kyung-Un; Huh, Gi Yeong; Kim, Young-Eun; Kim, Eun-Joo			Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; MUTATIONS; DEMENTIA; PLASMA; GRN; CRITERIA; VARIANT	Low serum progranulin (PGRN) is known to be associated with granulin (GRN) gene mutation and T alleles of GRN rs5848 polymorphism. However, there have been only a few Asian studies exploring these. We investigated the serum PGRN levels, rs5848 genotypes, and their relations with cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers in the Korean population. Serum PGRN levels, GRN rs5848 polymorphism, and GRN mutations were evaluated in 239 participants (22 cognitively unimpaired participants and 217 patients with neurodegenerative diseases). CSF AD biomarkers were also evaluated in 214 participants. There was no significant difference in the serum PGRN levels among the diagnostic groups. We could not find any GRN mutation carrier in our sample. The differences in the frequencies of the rs5848 genotypes among the clinical groups or the effects of the rs5848 genotypes on serum PGRN were not observed. There was no correlation between the serum PGRN level or rs5848 genotype and CSF AD biomarkers. Neither the T allele nor the TT genotype had an effect on the development of AD. Our results showed that serum PGRN levels were not associated with rs5848 genotypes, indicating that multiple single nucleotide polymorphisms might affect PGRN concentrations in an ethnicity-specific manner.	[Jung, Na-Yeon; Lee, Jae-Hyeok; Shin, Jin-Hong] Pusan Natl Univ, Sch Med, Dept Neurol, Yangsan Hosp, Yangsan, South Korea; [Jung, Na-Yeon; Kim, Hyang-Sook; Lee, Jae-Hyeok; Shin, Jin-Hong] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea; [Kim, Eun Soo] Pusan Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Busan, South Korea; [Jeon, Sumin; Lee, Myung Jun; Kim, Eun-Joo] Pusan Natl Univ, Sch Med, Dept Neurol, Pusan Natl Univ Hosp, Busan, South Korea; [Jeon, Sumin; Lee, Myung Jun; Kim, Eun-Joo] Med Res Inst, Busan, South Korea; [Pak, Kyoungjune] Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Nucl Med, Sch Med, Busan, South Korea; [Lee, Young Min; Lee, Kangyoon] Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Psychiat, Sch Med, Busan, South Korea; [Ko, Jun Kyeung; Lee, Jae Meen] Pusan Natl Univ Hosp, Med Res Inst, Dept Neurosurg, Busan, South Korea; [Yoon, Jin A.] Pusan Natl Univ, Sch Med, Dept Rehabil Med, Busan, South Korea; [Yoon, Jin A.] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Hwang, Chungsu; Choi, Kyung-Un] Pusan Natl Univ, Dept Pathol, Sch Med, Yangsan, South Korea; [Huh, Gi Yeong] Pusan Natl Univ, Dept Forens Med, Sch Med, Yangsan, South Korea; [Kim, Young-Eun] Hanyang Univ, Dept Lab Med, Coll Med, Seoul, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Hanyang University	Kim, EJ (corresponding author), Pusan Natl Univ, Sch Med, Dept Neurol, Pusan Natl Univ Hosp, Busan, South Korea.; Kim, EJ (corresponding author), Med Res Inst, Busan, South Korea.	eunjookim@pusan.ac.kr	Shin, Jin-Hong/AAZ-8809-2020; Pak, Kyoungjune/CAE-5230-2022	Shin, Jin-Hong/0000-0002-5174-286X; Pak, Kyoungjune/0000-0001-5051-1894	Research of Korea Centers for Disease Control and Prevention [2018ER6204-00, 2019-ER6202-00, 2020-ER6201-00, 2021-ER1004-00]; National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A3B01007733]	Research of Korea Centers for Disease Control and Prevention; National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	E-JK was supported by a fund (2018ER6204-00, 2019-ER6202-00, 2020-ER6201-00, 2021-ER1004-00) by the Research of Korea Centers for Disease Control and Prevention and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A3B01007733). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alrneida MR, 2014, NEURODEGENER DIS, V13, P214, DOI 10.1159/000352022; Antonell A, 2012, J ALZHEIMERS DIS, V31, P581, DOI 10.3233/JAD-2012-112120; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Chang KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054448; Chen YD, 2015, J NEUROL, V262, P814, DOI 10.1007/s00415-014-7630-2; Cooper YA, 2018, ANN CLIN TRANSL NEUR, V5, P616, DOI 10.1002/acn3.560; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Fenoglio C, 2009, J ALZHEIMERS DIS, V18, P603, DOI 10.3233/JAD-2009-1170; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Ghidoni R, 2012, NEURODEGENER DIS, V9, P121, DOI 10.1159/000333132; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Guven G, 2019, J ALZHEIMERS DIS, V67, P159, DOI 10.3233/JAD-180599; Hosokawa M, 2015, J NEUROPATH EXP NEUR, V74, P158, DOI 10.1097/NEN.0000000000000158; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; Jing H, 2016, MOL NEUROBIOL, V53, P4189, DOI 10.1007/s12035-015-9358-0; Jung NY, 2020, J ALZHEIMERS DIS, V74, P473, DOI 10.3233/JAD-191109; Kamalainen A, 2013, J ALZHEIMERS DIS, V33, P23, DOI 10.3233/JAD-2012-120946; Kang Y., 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kim EJ, 2018, NEUROBIOL AGING, V72, DOI 10.1016/j.neurobiolaging.2018.06.031; Kim EJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.11.033; Lee MJ, 2011, NEURODEGENER DIS, V8, P216, DOI 10.1159/000322538; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Morenas-Rodriguez E, 2016, J ALZHEIMERS DIS, V50, P539, DOI 10.3233/JAD-150746; Nicholson AM, 2014, NEUROLOGY, V82, P1871, DOI 10.1212/WNL.0000000000000445; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Piscopo P, 2013, J ALZHEIMERS DIS, V35, P313, DOI 10.3233/JAD-121606; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Pottier C, 2019, ACTA NEUROPATHOL, V137, P879, DOI 10.1007/s00401-019-01962-9; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sheng JH, 2014, GENE, V542, P141, DOI 10.1016/j.gene.2014.03.041; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Takahashi H, 2017, ACTA NEUROPATHOL, V133, P785, DOI 10.1007/s00401-017-1668-z; Tonjes A, 2018, HUM MOL GENET, V27, P546, DOI 10.1093/hmg/ddx413; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Wang XM, 2021, J NEUROCHEM, V158, P119, DOI 10.1111/jnc.15378; Yabe I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19198-0	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261007	10.1371/journal.pone.0261007	http://dx.doi.org/10.1371/journal.pone.0261007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085262	gold, Green Published			2022-12-26	WOS:000779379600022
J	Van Gerwen, OT; Austin, EL; Camino, AF; Odom, LV; Muzny, CA				Van Gerwen, Olivia T.; Austin, Erika L.; Camino, Andres F.; Odom, L. Victoria; Muzny, Christina A.			"It's behaviors, not identity": Attitudes and beliefs related to HIV risk and pre-exposure prophylaxis among transgender women in the Southeastern United States	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; MEN; SEX; INFECTION; PREP; ACCEPTABILITY; EPIDEMIOLOGY; PREVENTION	HIV prevalence is high among transgender women (TGW) in the Southeastern U.S. Uptake of HIV Pre-Exposure Prophylaxis (PrEP) is low among TGW nationwide. We aimed to explore beliefs associated with PrEP among TGW in the Southeastern U.S., framed by the Health Belief Model. HIV-negative TGW >= 18 years old in Alabama participated in virtual focus group discussions. Authors coded and amended transcripts to explore emerging themes. Between July-December 2020, 17 TGW participated in 4 sessions. Mean age was 28.1 +/- 8.5 years. Several themes were identified: frustration with conflation of transgender identity and HIV risk, inappropriate transgender representation in PrEP advertising, concerns for interactions between PrEP and hormone therapy, perception that PrEP is meant for cisgender men who have sex with men and limited trans-affirming healthcare. Nuanced messaging is necessary to properly educate and engage TGW in HIV prevention strategies including PrEP given the diversity of this population.	[Van Gerwen, Olivia T.; Muzny, Christina A.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Austin, Erika L.] Univ Alabama Birmingham, Dept Biostat, Sch Publ Hlth, Birmingham, AL USA; [Camino, Andres F.; Odom, L. Victoria] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Van Gerwen, OT (corresponding author), Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA.	oliviavangerwen@uabmc.edu		Van Gerwen, Olivia/0000-0002-9362-6234	UAB Center for AIDS Research [P30 AI027767-32]; Agency of Healthcare Research and Quality [T32HS013852]	UAB Center for AIDS Research; Agency of Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the UAB Center for AIDS Research [P30 AI027767-32 to OTVG] and the Agency of Healthcare Research and Quality [T32HS013852 to OTVG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2005, HLTH BELIEF MODEL; [Anonymous], 2014, RES DESIGN QUALITATI, V4th; Austin EL, 2014, SEX HEALTH, V11, P24, DOI 10.1071/SH13145; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Becasen JS, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2018.304727; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Carlson JA, 2010, QUAL REP, V15, P1102; Clark H, 2017, AIDS BEHAV, V21, P2774, DOI 10.1007/s10461-016-1656-7; Desai M, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5011; Eaton EF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209666; Eaton LA, 2017, AIDS BEHAV, V21, P1236, DOI 10.1007/s10461-017-1690-0; Eisinger RW, 2018, EMERG INFECT DIS, V24, P413, DOI 10.3201/eid2403.171797; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Fiereck K, 2015, DEV WORLD BIOETH, V15, P27, DOI 10.1111/dewb.12034; Finlayson T, 2019, MMWR-MORBID MORTAL W, V68, P597, DOI 10.15585/mmwr.mm6827a1; Flores A. R., 2016, MANY ADULTS IDENTIFY; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Hiransuthikul A, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25338; Miles MB HA, 2014, QUALITATIVE DATA ANA; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Muzny CA, 2013, SEX TRANSM DIS, V40, P395, DOI 10.1097/OLQ.0b013e31828caf34; Neff J A, 1998, Ethn Health, V3, P283; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Nwogwugwu Charlotte, 2019, J Natl Black Nurses Assoc, V30, P18; Perez-Figueroa RE, 2015, AIDS EDUC PREV, V27, P112, DOI 10.1521/aeap.2015.27.2.112; Poteat T, 2016, JAIDS-J ACQ IMM DEF, V72, pS210, DOI 10.1097/QAI.0000000000001087; Prevention CfDCa, 2021, MON SEL NAT HIV PREV, V26; Prevention CfDCa, 2020, HIV SURV REP; Sevelius JM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21105; Sevelius JM, 2016, GLOB PUBLIC HEALTH, V11, P1060, DOI 10.1080/17441692.2016.1154085; Shieh E, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25405; Sullivan PS, 2018, ANN EPIDEMIOL, V28, P833, DOI 10.1016/j.annepidem.2018.06.009; Wirtz A PT, 10 INT AIDS SOC C HI; Workowski KA, 2021, MMWR RECOMM REP, V70, P1; Zak-Place J, 2004, J AM COLL HEALTH, V52, P229, DOI 10.3200/JACH.52.5.229-236	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262205	10.1371/journal.pone.0262205	http://dx.doi.org/10.1371/journal.pone.0262205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085284	gold, Green Published			2022-12-26	WOS:000779379600042
J	Nazario-Toole, A; Nguyen, HM; Xia, H; Frankel, DN; Kieffer, JW; Gibbons, TF				Nazario-Toole, Ashley; Nguyen, Holly M.; Xia, Hui; Frankel, Dianne N.; Kieffer, John W.; Gibbons, Thomas F.			Sequencing SARS-CoV-2 from antigen tests	PLOS ONE			English	Article							VARIANTS	Genomic surveillance empowers agile responses to SARS-CoV-2 by enabling scientists and public health analysts to issue recommendations aimed at slowing transmission, prioritizing contact tracing, and building a robust genomic sequencing surveillance strategy. Since the start of the pandemic, real time RT-PCR diagnostic testing from upper respiratory specimens, such as nasopharyngeal (NP) swabs, has been the standard. Moreover, respiratory samples in viral transport media are the ideal specimen for SARS-CoV-2 whole-genome sequencing (WGS). In early 2021, many clinicians transitioned to antigen-based SARS-CoV-2 detection tests, which use anterior nasal swabs for SARS-CoV-2 antigen detection. Despite this shift in testing methods, the need for whole-genome sequence surveillance remains. Thus, we developed a workflow for whole-genome sequencing with antigen test-derived swabs as an input rather than nasopharyngeal swabs. In this study, we use excess clinical specimens processed using the BinaxNOW (TM) COVID-19 Ag Card. We demonstrate that whole-genome sequencing from antigen tests is feasible and yields similar results from RT-PCR-based assays utilizing a swab in viral transport media.	[Nazario-Toole, Ashley; Nguyen, Holly M.; Xia, Hui; Gibbons, Thomas F.] 59th Med Wing, Clin Invest & Res Support Lab, San Antonio, TX 78211 USA; [Frankel, Dianne N.; Kieffer, John W.] 59th Med Wing, THLS, Trainee Hlth Surveillance, San Antonio, TX USA		Gibbons, TF (corresponding author), 59th Med Wing, Clin Invest & Res Support Lab, San Antonio, TX 78211 USA.	thomas.f.gibbons6.civ@mail.mil			59th Medical Wing Clinical Investigations Program	59th Medical Wing Clinical Investigations Program	This study was funded 59th Medical Wing Clinical Investigations Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and do not reflect the official views of the Department of Defense or its Components.	Center for Devices and Radiological Health FDA., 2021, IN VITR DIAGN EUASMO; Centers for Disease Control and Prevention, 2021, INT GUID ANT TEST SA; Chiara M, 2021, BRIEF BIOINFORM, V22, P616, DOI 10.1093/bib/bbaa297; Coughlin Steven S, 2021, Public Health Pract (Oxf), V2, P100064, DOI 10.1016/j.puhip.2020.100064; Cyranoski D, 2021, NATURE, V589, P337, DOI 10.1038/d41586-021-00065-4; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Food and Drug Administration, 2020, BIOFIRE COVID 19 TES; Food and Drug Administration, 2020, BINAXNOW COVID 19 AG; Ito Y, 2018, METHODS MOL BIOL, V1836, P23, DOI 10.1007/978-1-4939-8678-1_2; Joint Base San Antonio, 2021, MEDCOE ADDS ANT TEST; Li XG, 2020, J MED VIROL, V92, P501, DOI 10.1002/jmv.25701; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1070, DOI 10.1515/cclm-2020-0285; Long SW, 2021, AM J PATHOL, V191, P983, DOI 10.1016/j.ajpath.2021.03.004; Marcus JE, 2020, MMWR-MORBID MORTAL W, V69, P685, DOI 10.15585/mmwr.mm6922e2; Mutnal MB, 2022, J MED VIROL, V94, P937, DOI 10.1002/jmv.27373; Nazario-Toole AE, 2022, MIL MED, V187, pE130, DOI 10.1093/milmed/usab031; Network of Genomic Surveillance in South Africa (NGS-SA), 2021, NAT SARS COV 2 STRAI, DOI DOI 10.1126/SCISIGNAL.ABH3628; Office of the Commissioner FDA., 2020, COR COVID 19 UPD FDA; Munnink BBO, 2021, NAT MED, V27, P1518, DOI 10.1038/s41591-021-01472-w; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7	21	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263794	10.1371/journal.pone.0263794	http://dx.doi.org/10.1371/journal.pone.0263794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134077	Green Submitted, gold, Green Published			2022-12-26	WOS:000798968600037
J	Li, CC; Chen, DY; Xie, CJ; Tang, Y				Li, Changcheng; Chen, Deyun; Xie, Chengjun; Tang, You			Algorithm for wireless sensor networks in ginseng field in precision agriculture	PLOS ONE			English	Article							ROUTING PROTOCOL; LEACH	In the research on energy-efficient networking methods for precision agriculture, a hot topic is the energy issue of sensing nodes for individual wireless sensor networks. The sensing nodes of the wireless sensor network should be enabled to provide better services with limited energy to support wide-range and multi-scenario acquisition and transmission of three-dimensional crop information. Further, the life cycle of the sensing nodes should be maximized under limited energy. The transmission direction and node power consumption are considered, and the forward and high-energy nodes are selected as the preferred cluster heads or data-forwarding nodes. Taking the cropland cultivation of ginseng as the background, we put forward a particle swarm optimization-based networking algorithm for wireless sensor networks with excellent performance. This algorithm can be used for precision agriculture and achieve optimal equipment configuration in a network under limited energy, while ensuring reliable communication in the network. The node scale is configured as 50 to 300 nodes in the range of 500 x 500 m(2), and simulated testing is conducted with the LEACH, BCDCP, and ECHERP routing protocols. Compared with the existing LEACH, BCDCP, and ECHERP routing protocols, the proposed networking method can achieve the network lifetime prolongation and mitigate the decreased degree and decreasing trend of the distance between the sensing nodes and center nodes of the sensor network, which results in a longer network life cycle and stronger environment suitability. It is an effective method that improves the sensing node lifetime for a wireless sensor network applied to cropland cultivation of ginseng.	[Li, Changcheng; Chen, Deyun] Harbin Univ Sci & Technol, Sch Comp Sci & Technol, Harbin, Peoples R China; [Li, Changcheng; Tang, You] Jilin Agr Sci & Technol Univ, Sch Elect & Informat Engn, Jilin, Jilin, Peoples R China; [Li, Changcheng; Tang, You] Smart Agr Engn Res Ctr Jilin Prov, Jilin, Jilin, Peoples R China; [Xie, Chengjun] Beihua Univ, Sch Comp Sci & Technol, Jilin, Jilin, Peoples R China	Harbin University of Science & Technology; Jilin Agricultural Science & Technology University; Beihua University	Li, CC; Chen, DY (corresponding author), Harbin Univ Sci & Technol, Sch Comp Sci & Technol, Harbin, Peoples R China.; Li, CC (corresponding author), Jilin Agr Sci & Technol Univ, Sch Elect & Informat Engn, Jilin, Jilin, Peoples R China.; Li, CC (corresponding author), Smart Agr Engn Res Ctr Jilin Prov, Jilin, Jilin, Peoples R China.	934853276@qq.com; lichangcheng@jlnku.edu.cn			National Natural Science Foundation of China [60972127, 61072111, 60672156]; Key Scientific Research Project of Jilin Provincial Department of Education [JJKH20220390KJ]; Key Project of Jilin Provincial Science and Technology Department [20100503]; Project for Science and Technology Center and Science and Technology Service Platform [20180623004TC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Project of Jilin Provincial Department of Education; Key Project of Jilin Provincial Science and Technology Department; Project for Science and Technology Center and Science and Technology Service Platform	This work was supported by the National Natural Science Foundation of China (Project No. 60972127, 61072111 and 60672156) and the Key Scientific Research Project of Jilin Provincial Department of Education (Project No. JJKH20220390KJ) and Key Project of Jilin Provincial Science and Technology Department (Project No. 20100503) and the Project for Science and Technology Center and Science and Technology Service Platform (Project No. 20180623004TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azharuddin M, 2015, COMPUT ELECTR ENG, V41, P177, DOI 10.1016/j.compeleceng.2014.07.019; Baek J, 2020, IEEE T VEH TECHNOL, V69, P1741, DOI 10.1109/TVT.2019.2959808; Ban BR, 2021, IEEE T MOBILE COMPUT, V20, P1993, DOI 10.1109/TMC.2020.2974195; Cao B, 2020, IEEE T IND INFORM, V16, P5309, DOI 10.1109/TII.2019.2961340; Cauteruccio F, 2019, INFORM FUSION, V52, P13, DOI 10.1016/j.inffus.2018.11.010; Chatterjee B, 2021, IEEE INTERNET THINGS, V8, P6800, DOI 10.1109/JIOT.2020.3036087; Chen YB, 2015, SENSORS-BASEL, V15, P19507, DOI 10.3390/s150819507; Deng F, 2019, IEEE INTERNET THINGS, V6, P918, DOI 10.1109/JIOT.2018.2865431; Ebrahimi D, 2019, IEEE INTERNET THINGS, V6, P1893, DOI 10.1109/JIOT.2018.2878834; Guo ZJ, 2021, IEEE INTERNET THINGS, V8, P512, DOI 10.1109/JIOT.2020.3004554; Jawad HM, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081781; Kamarudin LM, 2016, INT J SENS NETW, V21, P16, DOI 10.1504/IJSNET.2016.076858; Karimi-Bidhendi S, 2021, IEEE T WIREL COMMUN, V20, P40, DOI 10.1109/TWC.2020.3023065; Kuila P, 2014, APPL SOFT COMPUT, V25, P414, DOI 10.1016/j.asoc.2014.08.064; Kuila P, 2012, PROC TECH, V1, P771, DOI 10.1016/j.protcy.2012.10.093; Kunzel G, 2020, IEEE T IND INFORM, V16, P5617, DOI 10.1109/TII.2019.2941771; Li XG, 2020, IEEE INTERNET THINGS, V7, P9805, DOI 10.1109/JIOT.2020.2989924; Liu L, 2020, IEEE T IND INFORM, V16, P2072, DOI 10.1109/TII.2019.2933238; Liu ZY, 2021, MOL BIOL REP, V48, P2639, DOI 10.1007/s11033-021-06187-2; Lu WD, 2021, IEEE T IND INFORM, V17, P4335, DOI 10.1109/TII.2020.2996672; Maes WH, 2019, TRENDS PLANT SCI, V24, P152, DOI 10.1016/j.tplants.2018.11.007; Mathur P, 2016, IET WIREL SENS SYST, V6, P17, DOI 10.1049/iet-wss.2014.0120; Mostafaei H, 2019, IEEE T IND ELECTRON, V66, P5567, DOI 10.1109/TIE.2018.2869345; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Ndzi DL, 2014, COMPUT ELECTRON AGR, V105, P83, DOI 10.1016/j.compag.2014.04.012; Nikolidakis SA, 2013, ALGORITHMS, V6, DOI 10.3390/a6010029; Rathee M, 2021, IEEE T ENG MANAGE, V68, P170, DOI 10.1109/TEM.2019.2953889; Saeed N, 2019, IEEE T WIREL COMMUN, V18, P2652, DOI 10.1109/TWC.2019.2906309; Sahoo BM, 2021, SWARM EVOL COMPUT, V60, DOI 10.1016/j.swevo.2020.100772; Stergiou A, 2021, NANOSCALE, V13, P8948, DOI 10.1039/d1nr00404b; The State Pharmacopoeia Commission, 2015, CHINESE PHARMACOPOEI, P260; Wang K, 2021, IEEE INTERNET THINGS, V8, P2080, DOI 10.1109/JIOT.2020.3025039; Wen F, 2020, NANO ENERGY, V67, DOI 10.1016/j.nanoen.2019.104266; Yang X, 2021, IEEE-CAA J AUTOMATIC, V8, P273, DOI 10.1109/JAS.2020.1003536; Zhang J, 2020, INFORM FUSION, V56, P103, DOI 10.1016/j.inffus.2019.10.008; Zhang Y, 2021, IEEE WIREL COMMUN LE, V10, P406, DOI 10.1109/LWC.2020.3033039; Zhao DD, 2021, IEEE T POWER ELECTR, V36, P1259, DOI 10.1109/TPEL.2020.3006536	37	0	0	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263401	10.1371/journal.pone.0263401	http://dx.doi.org/10.1371/journal.pone.0263401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130303	Green Published, gold			2022-12-26	WOS:000805530700027
J	Sun, HR				Sun, Haoran			Equilibrium properties of E. coli lactose permease symport-A random-walk model approach	PLOS ONE			English	Article							PERIPLASMIC SPACE; TRANSPORT; MECHANISM	The symport of lactose and H+ is an important physiological process in E. coli, for it is closely related to cellular energy supply. In this paper, we review, extend and analyse a newly proposed cotransport model that takes the "leakage" phenomenon (uncoupled particle translocation) into account and also satisfies the static head equilibrium condition. Then, we use the model to study the equilibrium properties, including equilibrium solution and the time required to reach equilibrium, of the symport process of E. coli LacY protein, when varying the parameters of the initial state of cotransport system. It can be found that in our extended model, H+ and lactose will reach their equilibrium state separately, and when "leakage" exists, it linearly affects the equilibrium solution, which is a useful property that the original model does not have. We later investigated the effect of the volume of periplasm and cytoplasm on the equilibrium properties. For a certain E. coli cell, as it continues to lose water and contract, the time for cytoplasm pH to be stabilized by symport increases monotonically when the cell survives. Finally, we reproduce the experimental data from a literature to verify the validity of the extension in this symport process. The above phenomena and other findings in this paper may help us to not only further validate or improve the model, but also deepen our understanding of the cotransport process of E. coli LacY protein.	[Sun, Haoran] Fudan Univ, Sch Math Sci, Shanghai, Peoples R China	Fudan University	Sun, HR (corresponding author), Fudan Univ, Sch Math Sci, Shanghai, Peoples R China.	18300180051@fudan.edu.cn		Sun, Haoran/0000-0001-6476-2096				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adelman JL, 2016, P NATL ACAD SCI USA, V113, pE3960, DOI 10.1073/pnas.1525378113; Andrini O, 2008, CHANNELS, V2, P346, DOI 10.4161/chan.2.5.6900; Barreto YB, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.022403; Barreto YB, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.052411; Bathe K.-J., 2006, FINITE ELEMENT PROCE; Bazzone A, 2017, BIOPHYS J, V113, P2736, DOI 10.1016/j.bpj.2017.09.038; BROOKER RJ, 1991, J BIOL CHEM, V266, P4131; CENTELLES JJ, 1991, BIOCHIM BIOPHYS ACTA, V1065, P239, DOI 10.1016/0005-2736(91)90236-2; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2019, J GEN PHYSIOL, V151, P878, DOI 10.1085/jgp.201912377; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kramer R., 2014, MEMBRANE TRANSPORT M, V17; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Naftalin RJ, 2010, J MEMBRANE BIOL, V234, P75, DOI 10.1007/s00232-010-9228-7; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; STOCK JB, 1977, J BIOL CHEM, V252, P7850; UJWAL ML, 1994, MOL MEMBR BIOL, V11, P9, DOI 10.3109/09687689409161024; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263286	10.1371/journal.pone.0263286	http://dx.doi.org/10.1371/journal.pone.0263286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120164	Green Published, Green Submitted, gold			2022-12-26	WOS:000789273600030
J	Xu, LM; Zhang, J; Ma, Y; Yuan, YJ; Yu, H; Wang, J; Cao, XC; Zhu, L; Wang, P				Xu, Li-Ming; Zhang, Jiao; Ma, Yue; Yuan, Ya-Jing; Yu, Hao; Wang, Jun; Cao, Xu-Chen; Zhu, Li; Wang, Ping			MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG	ONCOGENE			English	Article							CELL-PROLIFERATION; STEM-CELLS; TRANSCRIPTION; BIOMARKER; ONCOGENE	MicroRNAs play significant roles in various malignancies, with breast cancer (BC) being no exception. Consequently, we explored the functional mechanism of miR-135 in the progression of BC. In total, 55 pairs of BC and matched adjacent normal tissues were clinically collected from patients, followed by quantification of miR-135 and zinc finger protein 217 (ZNF217) expression patterns in BC tissues and cells. Accordingly, high ZNF217 expression and low miR-135 expression levels were identified in BC tissues and cells. Subsequently, the expressions of miR-135 and ZNF217 were altered to evaluate their effects on BC cell migration, invasion and EMT initiation. It was found that when ZNF217 was silenced or miR-135 was elevated, BC cell malignant behaviors were significantly inhibited, which was reproduced in nude mice for in vivo evidence. Furthermore, dual-luciferase reporter gene assay revealed the presence of direct binding between miR-135 and ZNF217. Subsequent co-immunoprecipitation, methylated-RNA binding protein immunoprecipitation and photoactivatable ribonucleoside enhanced-crosslinking and immunoprecipitation assays further revealed that ZNF217 could upregulate NANOG by reducing N6-methyladenosine levels via methyltransferase-like 13 (METTL3). Collectively, our findings highlighted the role of the miR-135/ZNF217/METTL3/NANOG axis in the progression of BC, emphasizing potential therapeutic targets ZNF217 silencing and miR-135 upregulation in preventing or treating BC.	[Xu, Li-Ming; Yu, Hao; Wang, Jun; Zhu, Li; Wang, Ping] Tianjin Med Univ, Minist Educ,Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Key Lab Breast Canc Preven, Dept Radiotherapy,Tianjins Clin Res Ctr Canc,Key, Tianjin 300060, Peoples R China; [Xu, Li-Ming; Wang, Jun] Tianjin Med Univ, Dept Radiotherapy, Canc Hosp, Airport Hosp, Tianjin 300308, Peoples R China; [Zhang, Jiao; Ma, Yue; Cao, Xu-Chen] Tianjin Med Univ, Minist Educ,Tianjins Clin Res Ctr Canc,Key Lab Br, Dept Breast Canc 1,Key Lab Canc Prevent & Therapy, Tianjin Med Univ Canc Inst & Hosp,Natl Clin Res C, Tianjin 300060, Peoples R China; [Zhang, Jiao] Zhengzhou Univ, Henan Breast Canc Ctr, Dept Breast Dis, Affiliated Canc Hosp, Zhengzhou 450008, Peoples R China; [Zhang, Jiao] Henan Canc Hosp, Zhengzhou 450008, Peoples R China; [Yuan, Ya-Jing] Tianjin Med Univ Canc Inst & Hosp, Dept Anesthesia, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Tianjins Clin Res, Tianjin 300060, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Zhengzhou University; Zhengzhou University; Tianjin Medical University	Zhu, L; Wang, P (corresponding author), Tianjin Med Univ, Minist Educ,Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Key Lab Breast Canc Preven, Dept Radiotherapy,Tianjins Clin Res Ctr Canc,Key, Tianjin 300060, Peoples R China.; Cao, XC (corresponding author), Tianjin Med Univ, Minist Educ,Tianjins Clin Res Ctr Canc,Key Lab Br, Dept Breast Canc 1,Key Lab Canc Prevent & Therapy, Tianjin Med Univ Canc Inst & Hosp,Natl Clin Res C, Tianjin 300060, Peoples R China.	xlm19821223@126.com; zhuli@tjmuch.com; wangping@tjmuch.com			National Natural Science Foundation of China [81502656, 81501140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81502656 and No. 81501140).	Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005; Akram M, 2017, BIOL RES, V50, DOI 10.1186/s40659-017-0140-9; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bellanger A, 2017, J PATHOL, V242, P73, DOI 10.1002/path.4882; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cohen PA, 2015, ONCOTARGET, V6, P41566, DOI 10.18632/oncotarget.5893; Gibadulinova A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124299; Goh JN, 2016, BIOL REV, V91, P409, DOI 10.1111/brv.12176; Hamam R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.440; Horne HN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23733-4; Hu C, 2016, J DRUG TARGET, V24, P422, DOI 10.3109/1061186X.2015.1082567; Jiang DQ, 2019, INT J MOL MED, V43, P1623, DOI 10.3892/ijmm.2019.4081; Jiang XK, 2016, ONCOTARGET, V7, P84893, DOI 10.18632/oncotarget.12753; Suarez-Sanchez FJ, 2021, CANCERS, V13, DOI 10.3390/cancers13030395; Kocak A, 2020, AM J PATHOL, V190, P1643, DOI 10.1016/j.ajpath.2020.04.015; Li F, 2020, MOL THER-NUCL ACIDS, V22, P456, DOI 10.1016/j.omtn.2020.09.008; Li ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116170; Lin CH, 2018, ONCOTARGETS THER, V11, P5419, DOI 10.2147/OTT.S164575; Littlepage LE, 2012, CANCER DISCOV, V2, P638, DOI 10.1158/2159-8290.CD-12-0093; McGuire A, 2015, CANCER METAST REV, V34, P145, DOI 10.1007/s10555-015-9551-7; Qin S, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160247; Qiu Y, 2018, ONCOL REP, V39, P138, DOI 10.3892/or.2017.6081; Rezaei M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3367; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Smith BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104987; Sun YS, 2017, INT J BIOL SCI, V13, P1387, DOI 10.7150/ijbs.21635; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Vendrell JA, 2012, CANCER RES, V72, P3593, DOI 10.1158/0008-5472.CAN-11-3095; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang L, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030457; Wang XW, 2020, BREAST CANCER-TOKYO, V27, P765, DOI 10.1007/s12282-020-01075-2; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yang DD, 2018, NUCLEIC ACIDS RES, V46, P3906, DOI 10.1093/nar/gky130; Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08759-0; Yeung KT, 2017, MOL ONCOL, V11, P28, DOI 10.1002/1878-0261.12017; Zhang CZ, 2016, ONCOTARGET, V7, P64527, DOI 10.18632/oncotarget.11743; Zhao M, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691682	40	2	2	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1742	1751		10.1038/s41388-022-02211-2	http://dx.doi.org/10.1038/s41388-022-02211-2		FEB 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35121826				2022-12-26	WOS:000751251500002
J	Gopalan, N; Senthil, S; Prabakar, NL; Senguttuvan, T; Bhaskar, A; Jagannathan, M; Sivaraman, R; Ramasamy, J; Chinnaiyan, P; Arumugam, V; Getrude, B; Sakthivel, G; Srinivasalu, VA; Rajendran, D; Nadukkandiyil, A; Ravi, V; Rahamane, SNH; Paramasivam, NA; Manoharan, T; Theyagarajan, M; Chadha, VK; Natrajan, M; Dhanaraj, B; Murhekar, MV; Ramalingam, SM; Chandrasekaran, P				Gopalan, Narendran; Senthil, Sumathi; Prabakar, Narmadha Lakshmi; Senguttuvan, Thirumaran; Bhaskar, Adhin; Jagannathan, Muthukumaran; Sivaraman, Ravi; Ramasamy, Jayalakshmi; Chinnaiyan, Ponnuraja; Arumugam, Vijayalakshmi; Getrude, Banumathy; Sakthivel, Gautham; Srinivasalu, Vignes Anand; Rajendran, Dhanalakshmi; Nadukkandiyil, Arunjith; Ravi, Vaishnavi; Rahamane, Sadiqa Nasreen Hifzour; Paramasivam, Nirmal Athur; Manoharan, Tamizhselvan; Theyagarajan, Maheshwari; Chadha, Vineet Kumar; Natrajan, Mohan; Dhanaraj, Baskaran; Murhekar, Manoj Vasant; Ramalingam, Shanthi Malar; Chandrasekaran, Padmapriyadarsini			Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care-An experience from South India	PLOS ONE			English	Article							SYSTEM	Background We retrospectively data-mined the case records of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed COVID-19 patients hospitalized to a tertiary care centre to derive mortality predictors and formulate a risk score, for prioritizing admission. Methods and findings Data on clinical manifestations, comorbidities, vital signs, and basic lab investigations collected as part of routine medical management at admission to a COVID-19 tertiary care centre in Chengalpattu, South India between May and November 2020 were retrospectively analysed to ascertain predictors of mortality in the univariate analysis using their relative difference in distribution among 'survivors' and 'non-survivors'. The regression coefficients of those factors remaining significant in the multivariable logistic regression were utilised for risk score formulation and validated in 1000 bootstrap datasets. Among 746 COVID-19 patients hospitalised [487 "survivors" and 259 "non-survivors" (deaths)], there was a slight male predilection [62.5%, (466/746)], with a higher mortality rate observed among 40-70 years age group [59.1%, (441/746)] and highest among diabetic patients with elevated urea levels [65.4% (68/104)]. The adjusted odds ratios of factors [OR (95% CI)] significant in the multivariable logistic regression were SaO(2)<95%; 2.96 (1.71-5.18), Urea >= 50 mg/dl: 4.51 (2.59-7.97), Neutrophil-lymphocytic ratio (NLR) >3; 3.01 (1.61-5.83), Age >= 50 years;2.52 (1.45-4.43), Pulse Rate >= 100/min: 2.02 (1.19-3.47) and coexisting Diabetes Mellitus; 1.73 (1.02-2.95) with hypertension and gender not retaining their significance. The individual risk scores for SaO(2) <95-11, Urea >= 50 mg/dl-15, NLR >3-11, Age >= 50 years-9, Pulse Rate >= 100/min-7 and coexisting diabetes mellitus-6, acronymed collectively as 'OUR-ARDs score' showed that the sum of scores >= 25 predicted mortality with a sensitivity-90%, specificity-64% and AUC of 0.85. Conclusions The 'OUR ARDs' risk score, derived from easily assessable factors predicting mortality, offered a tangible solution for prioritizing admission to COVID-19 tertiary care centre, that enhanced patient care but without unduly straining the health system.	[Gopalan, Narendran; Senguttuvan, Thirumaran; Srinivasalu, Vignes Anand; Rajendran, Dhanalakshmi; Ravi, Vaishnavi; Rahamane, Sadiqa Nasreen Hifzour; Theyagarajan, Maheshwari; Natrajan, Mohan; Dhanaraj, Baskaran] ICMR Natl Inst Res TB, Dept Clin Res, TB Res Ctr, Chennai, Tamil Nadu, India; [Senthil, Sumathi; Prabakar, Narmadha Lakshmi; Ramasamy, Jayalakshmi; Sakthivel, Gautham; Nadukkandiyil, Arunjith; Paramasivam, Nirmal Athur] Govt Chengalpattu Med Coll & Hosp, Dept Gen Med, Chengalpattu, Tamil Nadu, India; [Bhaskar, Adhin; Chinnaiyan, Ponnuraja; Manoharan, Tamizhselvan] ICMR Natl Inst Res TB, Dept Stat, TB Res Ctr, Chennai, Tamil Nadu, India; [Jagannathan, Muthukumaran; Ramalingam, Shanthi Malar] Govt Chengalpattu Med Coll & Hosp, Chengalpattu, Tamil Nadu, India; [Sivaraman, Ravi] Govt Chengalpattu Med Coll & Hosp, MDRU, Chengalpattu, Tamil Nadu, India; [Arumugam, Vijayalakshmi] Govt Chengalpattu Med Coll & Hosp, Dept Microbiol, Chengalpattu, Tamil Nadu, India; [Getrude, Banumathy] Govt Chengalpattu Med Coll & Hosp, Dept Community Med, Chengalpattu, Tamil Nadu, India; [Rajendran, Dhanalakshmi; Rahamane, Sadiqa Nasreen Hifzour] ICM R Vector Control Res Ctr, Div Epidemiol & Operat Res, Pondicherry, India; [Chadha, Vineet Kumar] Cent Leprosy Teaching & Res Inst, Chengalpattu, Tamil Nadu, India; [Murhekar, Manoj Vasant; Chandrasekaran, Padmapriyadarsini] ICMR Natl Inst Res TB, TB Res Ctr, Chennai, Tamil Nadu, India; [Murhekar, Manoj Vasant] ICMR Natl Inst Epidemiol, Chennai, Tamil Nadu, India; [Ramalingam, Shanthi Malar] Govt Kilpauk Med Coll, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Gopalan, N (corresponding author), ICMR Natl Inst Res TB, Dept Clin Res, TB Res Ctr, Chennai, Tamil Nadu, India.	gopalannaren@yahoo.co.in		Gopalan, Narendran/0000-0002-8049-7541; Rajendran, Dr. Dhanalakshmi/0000-0003-3332-8400; Senguttuvan, Thirumaran/0000-0003-1497-8678; Srinivasalu, Vignes Anand/0000-0002-4932-0617				Ahmad S, 2021, J PRIM CARE COMMUNIT, V12, DOI 10.1177/21501327211041486; Ahn JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32750-2; [Anonymous], 2020, MYG IN; [Anonymous], CLIN MANAGEMENT PROT; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Badawi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200200; Bhargava A, 2020, CLIN INFECT DIS, V71, P1962, DOI 10.1093/cid/ciaa674; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Chauhan Nishant Kumar, 2021, Acta Biomed, V92, pe2021024, DOI 10.23750/abm.v92i3.10630; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; Galloway JB, 2020, J INFECTION, V81, P282, DOI 10.1016/j.jinf.2020.05.064; Garcia-Gordillo JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248357; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Huang W, 2020, CYTOM PART A, V97, P772, DOI 10.1002/cyto.a.24172; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Joshi Shashank R, 2020, J Assoc Physicians India, V68, P11; Khan IH, 2020, J VASC SURG, V72, P799, DOI 10.1016/j.jvs.2020.05.015; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Ko JJ, 2021, J INTENSIVE CARE MED, V36, P673, DOI 10.1177/0885066621994057; Li J, 2021, AM J INFECT CONTROL, V49, P82, DOI 10.1016/j.ajic.2020.06.008; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Mehta HB, 2016, J CLIN EPIDEMIOL, V79, P22, DOI 10.1016/j.jclinepi.2016.03.031; Mudatsir Mudatsir, 2020, F1000Res, V9, P1107, DOI 10.12688/f1000research.26186.2; Mullen B, COVID 19 CLIN GUIDAN; Myrstad M, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00764-3; Nakakubo S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05604-4; Pereira MR, 2020, AM J TRANSPLANT, V20, P1800, DOI 10.1111/ajt.15941; Preetam M, 2021, J FAM MED PRIM CARE, V10, P223, DOI 10.4103/jfmpc.jfmpc_1766_20; Rai D, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.17660; Ranjbar K, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06045-3; Rod JE, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002481; Salunke AA, 2020, DIABETES METAB SYND, V14, P1495, DOI 10.1016/j.dsx.2020.07.053; Shang YF, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100426; Steinberg Eric, 2020, Emerg Med Pract, V22, pCD1; Varghese GM, 2020, INDIAN J MED RES, V151, P401, DOI 10.4103/ijmr.IJMR_957_20; Zhou CZ, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01412-1; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	38	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263471	10.1371/journal.pone.0263471	http://dx.doi.org/10.1371/journal.pone.0263471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113971	Green Published, gold			2022-12-26	WOS:000823694700099
J	Kimbowa, IM; Eriksen, J; Nakafeero, M; Obua, C; Lundborg, CS; Kalyango, J; Ocan, M				Kimbowa, Isaac Magulu; Eriksen, Jaran; Nakafeero, Mary; Obua, Celestino; Lundborg, Cecilia Stalsby; Kalyango, Joan; Ocan, Moses			Antimicrobial stewardship: Attitudes and practices of healthcare providers in selected health facilities in Uganda	PLOS ONE			English	Article							KNOWLEDGE; RESISTANCE; COUNTRIES	Though antimicrobial stewardship (AMS) programmes are the cornerstone of Uganda's national action plan (NAP) on antimicrobial resistance, there is limited evidence on AMS attitude and practices among healthcare providers in health facilities in Uganda. We determined healthcare providers' AMS attitudes, practices, and associated factors in selected health facilities in Uganda. We conducted a cross-sectional study among nurses, clinical officers, pharmacy technicians, medical officers, pharmacists, and medical specialists in 32 selected health facilities in Uganda. Data were collected once from each healthcare provider in the period from October 2019 to February 2020. Data were collected using an interviewadministered questionnaire. AMS attitude and practice were analysed using descriptive statistics, where scores of AMS attitude and practices for healthcare providers were classified into high, fair, and low using a modified Blooms categorisation. Associations of AMS attitude and practice scores were determined using ordinal logistic regression. This study reported estimates of AMS attitude and practices, and odds ratios with 95% confidence intervals were reported. We adjusted for clustering at the health facility level using clustered robust standard errors. A total of 582 healthcare providers in 32 healthcare facilities were recruited into the study. More than half of the respondents (58%,340/582) had a high AMS attitude. Being a female (aOR: 0.66, 95% CI: 0.47-0.92, P < 0.016), having a bachelor's degree (aOR: 1.81, 95% CI: 1.24-2.63, P < 0.002) or master's (aOR: 2.06, 95% CI: 1.13-3.75, P < 0.018) were significant predictors of high AMS attitude. Most (46%, 26 1 / 5 82) healthcare providers had fair AMS practices. Healthcare providers in the western region's health facilities were less likely to have a high AMS practice (aOR: 0.52, 95% CI 0.34-0.79, P < 0.002). In this study, most healthcare providers in health facilities had a high AMS attitude and fair AMS practice.	[Kimbowa, Isaac Magulu; Ocan, Moses] Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda; [Eriksen, Jaran] Stockholm South Hosp, Unit Infect Dis Venhalsan, Stockholm, Sweden; [Eriksen, Jaran; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Nakafeero, Mary] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Obua, Celestino] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Kalyango, Joan] Makerere Univ, Dept Pharm, Coll Hlth Sci, Kampala, Uganda	Makerere University; Karolinska Institutet; Makerere University; Mbarara University of Science & Technology; Makerere University	Kimbowa, IM (corresponding author), Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda.	jakemagulu@gmail.com		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Ocan, Moses/0000-0002-8852-820X; Kimbowa, Isaac/0000-0003-2339-4535; Nakafeero, Mary/0000-0003-2943-0744; Eriksen, Jaran/0000-0003-1146-5615	Makerere University-Swedish International Development Agency (SIDA) collaboration [Sida PI0010]	Makerere University-Swedish International Development Agency (SIDA) collaboration	This work was supported by Makerere University-Swedish International Development Agency (SIDA) collaboration (Sida PI0010).	A. C.Zulu, 2020, medRxiv, DOI 10.1101/2020.08.27.20181826; Akpan MR, 2020, J GLOB ANTIMICROB RE, V22, P317, DOI 10.1016/j.jgar.2020.03.009; [Anonymous], 2019, JAC-ANTIMICROB RESIS, V1, DOI 10.1093/jacamr/dlz073; Arifin WN, 2013, ED MED J, V5, P89, DOI [DOI 10.5959/EIMJ.V5I2.130, 10.5959/eimj.v5i2.130]; Atif M, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06043-5; Babatola AO, 2021, EXPERT REV ANTI-INFE, V19, P537, DOI 10.1080/14787210.2021.1829474; Baudet A, 2020, EUR J CLIN MICROBIOL, V39, P1295, DOI 10.1007/s10096-020-03849-0; Bauer KA, 2019, CURR OPIN INFECT DIS, V32, P553, DOI 10.1097/QCO.0000000000000604; Bebell LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175456; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Buckel W.R., 2016, HOSP PHARM, V51, P149, DOI [10.1310/hpj5102-149, DOI 10.1310/hpj5102-149]; Cabana MD, 2000, ARCH PEDIAT ADOL MED, V154, P685, DOI 10.1001/archpedi.154.7.685; Cole KA, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0689-2; Cox JA, 2017, CLIN MICROBIOL INFEC, V23, P812, DOI 10.1016/j.cmi.2017.07.010; Dadgostar P, 2019, INFECT DRUG RESIST, V12, P3903, DOI 10.2147/IDR.S234610; Doron S, 2011, MAYO CLIN PROC, V86, P1113, DOI 10.4065/mcp.2011.0358; Erku D. A., 2016, Interdisciplinary Perspectives on Infectious Diseases, V2016, P5686752, DOI 10.1155/2016/5686752; Evans B, 2019, CUREUS, V11, DOI 10.7759/cureus.6419; Feng ZT, 2021, EXPERT REV ANTI-INFE, V19, P529, DOI 10.1080/14787210.2021.1826307; Garau J, 2018, INT J CLIN PHARM-NET, V40, P948, DOI 10.1007/s11096-018-0675-z; Joshi MP, 2021, J PHARM POLICY PRACT, V14, DOI 10.1186/s40545-021-00309-8; Kalungia AC, 2019, J CHEMOTHERAPY, V31, P378, DOI 10.1080/1120009X.2019.1622293; Majumder MAA, 2020, EXPERT REV ANTI-INFE, V18, P1245, DOI 10.1080/14787210.2020.1796638; Mendelson M, 2015, SAMJ S AFR MED J, V105, P325, DOI [10.7196/SAMJ.9644, 10.7196/samj.9644]; Minister of Health MoA Animal Industry and Fisheries and Minster of Water and the Environment Goverment-of-Uganda, 2018, UGANDA NATL ACTION P, P115; Ministry of Health, 2018, NAT HLTH FAC MAST LI; Ministry of Health, 2018, TUBERCULOSIS LAB NET; Ministry-of-Health Health Mo, 2014, UGANDA HOSP HLTH CTR; Mukundane M., 2016, ASSESSING MANAGEMENT; Musoke D, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9110764; Ogyu A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002427; Palagin I, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10080892; Pereira NR, 2017, INFECT DIS REP, V9, P1, DOI 10.4081/idr.2017.6917; Rehman IU, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6040116; Rizvi T, 2018, INT J CLIN PHARM-NET, V40, P1380, DOI 10.1007/s11096-018-0701-1; Salsgiver E, 2018, INFECT CONT HOSP EP, V39, P316, DOI 10.1017/ice.2017.317; Sartelli M, 2016, SURG INFECT, V17, P625, DOI 10.1089/sur.2016.187; Sayegh N, 2021, PHARM PRACT-GRANADA, V19, DOI [10.18549/pharmpract.2021.1.2192, 10.18549/PharmPract.2021.1.2192]; Ssengooba F., 2018, UNIVERSAL HLTH COVER; Tegagn G., 2017, J BIOANAL BIOMED, V9, P91, DOI [10.4172/1948-593X.1000159, DOI 10.4172/1948-593X.1000159]; Tusubira AK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235696; Wickens HJ, 2013, J ANTIMICROB CHEMOTH, V68, P2675, DOI 10.1093/jac/dkt241; World Health Organisation, 2019, ANT STEW PROGR HLTH; World-Health-Organisation, 2020, CHALL TACKL ANT RES	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262993	10.1371/journal.pone.0262993	http://dx.doi.org/10.1371/journal.pone.0262993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113932	Green Published, gold			2022-12-26	WOS:000823694700047
J	Reukers, DFM; van Jaarsveld, CHM; Akkermans, RP; Keijmel, SP; Morroy, G; van Dam, ASG; Wever, PC; Wielders, CCH; van der Velden, K; van Loenhout, JAF; Hautvast, JLA				Reukers, Daphne F. M.; van Jaarsveld, Cornelia H. M.; Akkermans, Reinier P.; Keijmel, Stephan P.; Morroy, Gabriella; van Dam, Adriana S. G.; Wever, Peter C.; Wielders, Cornelia C. H.; van der Velden, Koos; van Loenhout, Joris A. F.; Hautvast, Jeannine L. A.			Impact of Q-fever on physical and psychosocial functioning until 8 years after Coxiella burnetii infection: An integrative data analysis	PLOS ONE			English	Article							IMPAIRED HEALTH-STATUS; QUALITY-OF-LIFE; FOLLOW-UP; FATIGUE; LONG; OUTBREAK; EPIDEMIC; PROFILE	Background This study aimed to determine short- and long-term physical and psychosocial impact of Coxiella burnetii infection in three distinct entities: Q-fever fatigue syndrome (QFS), chronic Q-fever, and patients with past acute Q-fever without QFS or chronic Q-fever. Methods Integrative data analysis was performed, combining original data from eight studies measuring quality of life (QoL), fatigue, physical and social functioning with identical validated questionnaires, from three months to eight years after onset infection. Linear trends in each outcome were compared between Q-fever groups using multilevel linear regression analyses to account for repeated measures within patients. Results Data included 3947 observations of 2313 individual patients (228 QFS, 135 chronic Q-fever and 1950 patients with past acute Q-fever). In the first years following infection, physical and psychosocial impact was highest among QFS patients, and remained high without significant improvements over time. In chronic Q-fever patients, QoL and physical functioning worsened significantly over time. Levels of fatigue and social participation in patients with past acute Q-fever improved significantly over time. Conclusion The impact differs greatly between the three Q-fever groups. It is important that physicians are aware of these differences, in order to provide relevant care for each patient group.	[Reukers, Daphne F. M.; van Jaarsveld, Cornelia H. M.; Akkermans, Reinier P.; van der Velden, Koos; van Loenhout, Joris A. F.; Hautvast, Jeannine L. A.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [Akkermans, Reinier P.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Sci Inst Qual Care, Nijmegen, Netherlands; [Keijmel, Stephan P.] Radboud Univ Nijmegen, Radboud Expert Ctr Q Fever, Med Ctr, Div Infect Dis,Dept Internal Med, Nijmegen, Netherlands; [Morroy, Gabriella; van Dam, Adriana S. G.] Municipal Hlth Serv Hart Brabant, Dept Infect Dis Control, sHertogenbosch, Netherlands; [Wever, Peter C.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands; [Wielders, Cornelia C. H.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [van Loenhout, Joris A. F.] Catholic Univ Louvain, Ctr Res Epidemiol Disasters CRED, Inst Hlth & Soc, Brussels, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; Universite Catholique Louvain	Reukers, DFM (corresponding author), Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.	Daphne.Reukers@radboudumc.nl	Wielders, Cornelia CH/I-1970-2019; Reukers, Daphne F.M./E-6105-2016; Van Jaarsveld, Cornelia HM/A-4632-2016	Wielders, Cornelia CH/0000-0002-2413-9088; Reukers, Daphne F.M./0000-0002-3324-6993; Van Jaarsveld, Cornelia HM/0000-0002-4269-0041	Q-support [AMPHI150114-00]	Q-support	This work was supported by Q-support [grant number AMPHI150114-00]. Funder had no involvement in study design; data collection, analysis or interpretation; in the writing of the report; or in the decision to submit the article for publication.	Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Cairns R, 2005, OCCUP MED-OXFORD, V55, P20, DOI 10.1093/occmed/kqi013; Cairns V, 2005, INT J EPIDEMIOL, V34, P1340, DOI 10.1093/ije/dyi129; Curran PJ, 2009, PSYCHOL METHODS, V14, P81, DOI 10.1037/a0015914; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Hagenaars JCJP, 2015, EPIDEMIOL INFECT, V143, P2903, DOI 10.1017/S0950268814003951; Hagenaars JCJP, 2014, J INFECTION, V69, P154, DOI 10.1016/j.jinf.2014.03.009; Jacobs HM, 1990, NED TIJDSCHR GENEES, V134; Kampschreur LM, 2014, J CLIN MICROBIOL, V52, P1637, DOI 10.1128/JCM.03221-13; Keijmel SP, 2017, CLIN INFECT DIS, V64, P998, DOI 10.1093/cid/cix013; Keijmel Stephan P, 2012, Ned Tijdschr Geneeskd, V156, pA5258; Lettinga KD, 2002, CLIN INFECT DIS, V35, P11, DOI 10.1086/340738; Limonard GJM, 2016, EPIDEMIOL INFECT, V144, P1142, DOI 10.1017/S0950268815002216; Limonard GJM, 2010, QJM-INT J MED, V103, P953, DOI 10.1093/qjmed/hcq144; Marmion BP, 1996, LANCET, V347, P977, DOI 10.1016/S0140-6736(96)91469-5; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Morroy G, 2016, EPIDEMIOL INFECT, V144, P1153, DOI 10.1017/S0950268815002472; Morroy G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155884; Morroy G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-97; National Institute for Public Health and the Environment, 2019, MULTIDISCIPLINARY GU; National Institute for Public Health and the Environment (RIVM), HOM TOP Q Q FEV HOM; Reukens D, 20200133 RIVM; Reukers DFM, 2019, J PSYCHOSOM RES, V121, P37, DOI 10.1016/j.jpsychores.2019.03.185; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Stormorken E, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0614-4; van Dam ASG, 2015, EPIDEMIOL INFECT, V143, P48, DOI 10.1017/S0950268814000417; Van Loenhout JAF, 2015, EPIDEMIOL INFECT, V143, P2580, DOI 10.1017/S0950268814003689; van Loenhout JAF, 2015, J INFECTION, V70, P237, DOI 10.1016/j.jinf.2014.10.010; van Loenhout JAF, 2014, J INFECTION, V68, P527, DOI 10.1016/j.jinf.2014.01.004; van Roeden SE, 2019, CLIN MICROBIOL INFEC, V25, P1390, DOI 10.1016/j.cmi.2018.11.023; van Roeden SE, 2018, QJM-INT J MED, V111, P791, DOI 10.1093/qjmed/hcy171; Vercoulen J., 1999, GEDRAGSTHERAPIE, V32, P131; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Wielders CCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131848; Wildman MJ, 2002, QJM-INT J MED, V95, P527, DOI 10.1093/qjmed/95.8.527; Wills AB, 2016, CLIN INFECT DIS, V62, P1546, DOI 10.1093/cid/ciw189	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263239	10.1371/journal.pone.0263239	http://dx.doi.org/10.1371/journal.pone.0263239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108330	Green Published, gold			2022-12-26	WOS:000775890100052
J	Niibo, M; Kanasaki, A; Iida, T; Ohnishi, K; Ozaki, T; Akimitsu, K; Minamino, T				Niibo, Misato; Kanasaki, Akane; Iida, Tetsuo; Ohnishi, Keisuke; Ozaki, Taro; Akimitsu, Kazuya; Minamino, Tetsuo			D-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes	PLOS ONE			English	Article							D-PSICOSE; MESSENGER-RNA; RARE SUGAR; METABOLISM; PREVENTION; EXPANSION; TOXICITY; DISEASE; SERICIN	D-allulose is a rare sugar that has been reported to possess anti-hyperglycemic effects. In the present study, we hypothesized that D-allulose is effective in attenuating the progression of diabetic nephropathy in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat model of type 2 diabetes mellitus. Drinking water with or without 3% D-allulose was administered to OLETF rats for 13 weeks. Long-Evans Tokushima Otsuka rats that received drinking water without D-allulose were used as non-diabetic control rats. D-allulose significantly attenuated the increase in blood glucose levels and progressive mesangial expansion in the glomerulus, which is regarded as a characteristic of diabetic nephropathy, in OLETF rats. D-allulose also attenuated the significant increases in renal IL-6 and tumor necrosis factor-alpha mRNA levels in OLETF rats, which is a proinflammatory parameter. Additionally, we showed that D-allulose suppresses mesangial matrix expansion, but its correlation with suppressing renal inflammation in OLETF rats should be investigated further. Collectively, our results support the hypothesis that D-allulose can prevent diabetic nephropathy in rats.	[Niibo, Misato; Kanasaki, Akane; Iida, Tetsuo] Matsutani Chem Ind Co Ltd, Res & Dev, Itami, Hyogo, Japan; [Niibo, Misato; Ohnishi, Keisuke; Ozaki, Taro; Minamino, Tetsuo] Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, Miki, Kagawa, Japan; [Akimitsu, Kazuya] Kagawa Univ, Int Inst Rare Sugar Res, Miki, Kagawa, Japan; [Akimitsu, Kazuya] Kagawa Univ, Fac Agr, Miki, Kagawa, Japan	Kagawa University; Kagawa University; Kagawa University	Kanasaki, A (corresponding author), Matsutani Chem Ind Co Ltd, Res & Dev, Itami, Hyogo, Japan.	akane-kanasaki@matsutani.co.jp		Akimitsu, Kazuya/0000-0003-4374-1426; Kanasaki, Akane/0000-0002-8983-6343	Matsutani Chemical Industry Co. Ltd.	Matsutani Chemical Industry Co. Ltd.	The study was funded by Matsutani Chemical Industry Co. Ltd. The funder provided support in the form of salaries for MN, AK, and TI. The specific roles of these authors are articulated in the `author contributions' section. D-Allulose was supplied by the International Institute of Rare Sugar Research and Education, Kagawa University. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; AYO SH, 1991, AM J PHYSIOL, V260, pF185, DOI 10.1152/ajprenal.1991.260.2.F185; Chung MY, 2012, J AGR FOOD CHEM, V60, P863, DOI 10.1021/jf204050w; Chung S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00271; FLYVBJERG A, 1990, DIABETOLOGIA, V33, P334, DOI 10.1007/BF00404636; Flyvbjerg A, 1998, NEPHROL DIAL TRANSPL, V13, P1104, DOI 10.1093/ndt/13.5.1104; Han YJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072113; Han Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020160; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Hossain A, 2015, DRUG DES DEV THER, V9, P525, DOI 10.2147/DDDT.S71289; Hossain A, 2012, BIOCHEM BIOPH RES CO, V425, P717, DOI 10.1016/j.bbrc.2012.07.135; Hossain MA, 2011, BIOCHEM BIOPH RES CO, V405, P7, DOI 10.1016/j.bbrc.2010.12.091; Iida T., 2007, J ADV FOOD INGREDIEN, V10, P15; Iida T, 2010, METABOLISM, V59, P206, DOI 10.1016/j.metabol.2009.07.018; Iwasaki Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02488-y; Kikkawa R., 1997, CLIN EXP NEPHROL, V1, P3; Kim SE, 2017, J FUNCT FOODS, V28, P265, DOI 10.1016/j.jff.2016.11.029; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Mahadevan P, 1996, DIABETES, V45, P44, DOI 10.2337/diabetes.45.1.44; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77, DOI 10.3177/jnsv.48.77; Matsuo T, 2012, J CLIN BIOCHEM NUTR, V50, P158, DOI 10.3164/jcbn.11-66; MOGENSEN CE, 1975, DIABETOLOGIA, V11, P221, DOI 10.1007/BF00422325; Moran TH, 2006, DEV PSYCHOBIOL, V48, P360, DOI 10.1002/dev.20149; Mori S, 1996, DIABETES RES CLIN PR, V33, P145, DOI 10.1016/0168-8227(96)01290-9; Nagai N, 2013, WORLD J DIABETES, V4, P282, DOI 10.4239/wjd.v4.i6.282; Nagai N, 2009, BIOL PHARM BULL, V32, P1594, DOI 10.1248/bpb.32.1594; Parving HH, 2001, KIDNEY INT, V60, P2041, DOI 10.1046/j.1523-1755.2001.00020.x; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rector RS, 2011, AM J PHYSIOL-GASTR L, V300, pG874, DOI 10.1152/ajpgi.00510.2010; Sindhughosa DA, 2017, BALI MED J, V6, P44, DOI 10.15562/bmj.v6i1.299; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Tanaka M., 2020, FUNDAM TOXICOL SCI, V7, P15; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Yabuki A, 2006, EXP ANIM TOKYO, V55, P17, DOI 10.1538/expanim.55.17; Yagi K, 2009, J CLIN BIOCHEM NUTR, V45, P271, DOI 10.3164/jcbn.08-191	37	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263300	10.1371/journal.pone.0263300	http://dx.doi.org/10.1371/journal.pone.0263300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100325	gold, Green Published			2022-12-26	WOS:000801937600044
J	Ninomiya, K; Arimura, H; Yoshitake, T; Hirose, TA; Shioyama, Y				Ninomiya, Kenta; Arimura, Hidetaka; Yoshitake, Tadamasa; Hirose, Taka-Aki; Shioyama, Yoshiyuki			Synergistic combination of a topologically invariant imaging signature and a biomarker for the accurate prediction of symptomatic radiation pneumonitis before stereotactic ablative radiotherapy for lung cancer: A retrospective analysis	PLOS ONE			English	Article							BODY RADIOTHERAPY; SERUM-LEVELS; THERAPY; CLASSIFICATION; KL-6; FEATURES; DISEASE; IMPACT; RISK	Objectives We aimed to explore the synergistic combination of a topologically invariant Betti number (BN)-based signature and a biomarker for the accurate prediction of symptomatic (grade >= 2) radiation-induced pneumonitis (RP+) before stereotactic ablative radiotherapy (SABR) for lung cancer. Methods A total of 272 SABR cases with early-stage non-small cell lung cancer were chosen for this study. The occurrence of RP+ was predicted using a support vector machine (SVM) model trained with the combined features of the BN-based signature extracted from planning computed tomography (pCT) images and a pretreatment biomarker, serum Krebs von den Lungen-6 (BN+KL-6 model). In all, 242 (20 RP+ and 222 RP-(grade 1)) and 30 cases (8 RP+ and 22 RP-) were used for training and testing the model, respectively. The BN-based features were extracted from BN maps that characterize topologically invariant heterogeneous traits of potential RP+ lung regions on pCT images by applying histogram- and texture-based feature calculations to the maps. The SVM models were built to predict RP+ patients with a BN signature that was constructed based on the least absolute shrinkage and selection operator logistic regression model. The evaluation of the prediction models was performed based on the area under the receiver operating characteristic curves (AUCs) and accuracy in the test. The performance of the BN+KL-6 model was compared to the performance based on the BN, conventional original pCT, and wavelet decomposition (WD) models. Results The test AUCs obtained for the BN+KL-6, BN, pCT, and WD models were 0.825, 0.807, 0.642, and 0.545, respectively. The accuracies of the BN+KL-6, BN, pCT, and WD models were found to be 0.724, 0.708, 0.591, and 0.534, respectively. Conclusion This study demonstrated the comprehensive performance of the BN+KL-6 model for the prediction of potential RP+ patients before SABR for lung cancer.	[Ninomiya, Kenta] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Div Med Quantum Sci,Higashi Ku, Fukuoka, Japan; [Arimura, Hidetaka] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Div Med Quantum Sci,Higashi Ku, Fukuoka, Japan; [Yoshitake, Tadamasa] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka, Japan; [Hirose, Taka-Aki] Kyushu Univ Hosp, Dept Med Technol, Div Radiol, Higashi Ku, Fukuoka, Japan; [Shioyama, Yoshiyuki] SAGA HIMAT Fdn, Ion Beam Therapy Ctr, Tosu, Saga, Japan	Kyushu University; Kyushu University; Kyushu University	Arimura, H (corresponding author), Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Div Med Quantum Sci,Higashi Ku, Fukuoka, Japan.; Yoshitake, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka, Japan.	arimura.hidetaka.616@m.kyushu-u.ac.jp; yoshitake.tadamasa.386@m.kyushu-u.ac.jp		Ninomiya, Kenta/0000-0002-9566-4875	JSPS KAKENHI [JP20K08084, JP21J12635]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers JP20K08084 and JP21J12635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2021, MED PHYS, V48, P1781, DOI 10.1002/mp.14769; Bajraszewski C, 2020, J MED IMAG RADIAT ON, V64, P546, DOI 10.1111/1754-9485.13041; Branco P, 2015, ARXIV CSLG; Brandsma CA, 2020, J PATHOL, V250, P624, DOI 10.1002/path.5364; Cui SN, 2019, MED PHYS, V46, P2497, DOI 10.1002/mp.13497; Cunliffe A, 2015, INT J RADIAT ONCOL, V91, P1048, DOI 10.1016/j.ijrobp.2014.11.030; d'Alessandro M, 2020, BIOMARK MED, V14, P675, DOI 10.2217/bmm-2019-0545; d'Alessandro M, 2020, J MED VIROL, V92, P2216, DOI 10.1002/jmv.26087; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Glick D, 2018, CLIN LUNG CANCER, V19, pE219, DOI 10.1016/j.cllc.2017.06.021; Goto K, 2001, LUNG CANCER, V34, P141, DOI 10.1016/S0169-5002(01)00215-X; Haga A, 2019, J MED INVESTIG, V66, P35, DOI 10.2152/jmi.66.35; Hara R, 2004, CHEST, V125, P340, DOI 10.1378/chest.125.1.340; Hirose T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77552-7; Hobbs Stephen, 2021, Radiol Cardiothorac Imaging, V3, pe200279, DOI 10.1148/ryct.2021200279; Ishihara T, 2018, ACTA ONCOL, V57, P1232, DOI 10.1080/0284186X.2018.1468088; Ishijima M, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140596; Iwata H, 2011, RADIOTHER ONCOL, V101, P267, DOI 10.1016/j.radonc.2011.05.031; Kadoch MA, 2015, CURR PROBL DIAGN RAD, V44, P15, DOI 10.1067/j.cpradiol.2014.07.005; Kimura T, 2012, BRIT J RADIOL, V85, P135, DOI 10.1259/bjr/32629867; Kumar Pradeep, 2021, IOP Conference Series: Materials Science and Engineering, V1099, DOI 10.1088/1757-899X/1099/1/012077; Larsen BT, 2012, ARCH PATHOL LAB MED, V136, P1234, DOI 10.5858/arpa.2012-0225-RA; Li JY, 2016, J SUPERCOMPUT, V72, P3708, DOI 10.1007/s11227-015-1541-6; Li XQ, 2020, J BUON, V25, P1497; Luna JM, 2019, RADIOTHER ONCOL, V133, P106, DOI 10.1016/j.radonc.2019.01.003; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Moran A, 2017, CLIN LUNG CANCER, V18, pE425, DOI 10.1016/j.cllc.2017.05.014; Ninomiya K, 2021, PROC SPIE, V11313, DOI 10.1117/12.2548918; Ninomiya K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244354; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Qin H, 2019, PULMONOLOGY, V25, P143, DOI 10.1016/j.pulmoe.2018.05.008; Ryckman JM, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-1479-6; Schiller TW, 2010, NEUROCOMPUTING, V73, P1861, DOI 10.1016/j.neucom.2009.09.023; Sun YM, 2009, INT J PATTERN RECOGN, V23, P687, DOI 10.1142/S0218001409007326; Tomita N, 2021, CLIN TRANSL ONCOL, V23, P638, DOI 10.1007/s12094-020-02459-8; Yamashita H, 2014, WORLD J RADIOL, V6, P708, DOI 10.4329/wjr.v6.i9.708; Yamashita H, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-32; Yoshimasu T., 2012, J PULMONARY RESP SER, V2, DOI [10.4172/2161-105X.10001, DOI 10.4172/2161-105X.10001]; Yoshitake T, 2015, ANTICANCER RES, V35, P4909	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263292	10.1371/journal.pone.0263292	http://dx.doi.org/10.1371/journal.pone.0263292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100322	Green Published, gold			2022-12-26	WOS:000801937600043
J	Samji, H; Hu, J; Otterstatter, M; Hull, M; Grennan, T; Moore, D; Gilbert, M; Higgins, R; Wong, J				Samji, Hasina; Hu, Jia; Otterstatter, Michael; Hull, Mark; Grennan, Troy; Moore, David; Gilbert, Mark; Higgins, Rob; Wong, Jason			Gay, bisexual, and other men who have sex with men accessing STI clinics: Optimizing HIV PrEP implementation	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PREEXPOSURE PROPHYLAXIS; RECTAL GONORRHEA; DISEASE CLINICS; OPEN-LABEL; RISK; SEROINCIDENCE; DOXYCYCLINE; CHLAMYDIA; VOLUNTARY	Background Gay, bisexual and other men who have sex with men (gbMSM) who attend STI clinics represent an easily accessible population for promoting HIV prevention interventions. We examined characteristics of gbMSM STI clinic attendees to identify those who could most benefit from pre-exposure prophylaxis (PrEP). Setting GbMSM STI clinic attendees in British Columbia (BC), Canada Methods A clinical electronic charting system of STI clinics in BC was used to identify gbMSM from 2004 to 2017. Incident HIV cases were defined as testers who had at least one HIV-negative test and a subsequent HIV-positive test. Seroconversion rates were calculated by risk factor variables and by year. Cox proportional hazards regression was used to identify independent predictors of HIV seroconversion. Results There were 9,038 gbMSM included, of whom 257 HIV seroconverted over the study period and 8,781 remained negative HIV testers, contributing 650.8 and 29,591.0 person-years to the analysis, respectively. The overall rate of seroconversion was 0.85 per 100 person-years (95% CI: 0.75-0.96). Incidence rates were higher among patients reporting >5 partners in the previous six months, inconsistent condom use, or having a partner living with HIV and who had a previous or concurrent diagnosis of rectal gonorrhea or rectal chlamydia. gbMSM presenting with two STIs such as rectal gonorrhea and syphilis (3.59/100 person-years [95%CI: 2.33-5.22]) or rectal chlamydia and syphilis (3.01/100 person-years [95%CI: 2.00-4.29]) had the highest incidence rates. Conclusion gbMSM with preceding or concurrent rectal STI diagnoses or syphilis had higher rates of HIV seroconversion. The data support the inclusion of specific STI diagnoses as an indication for PrEP.	[Samji, Hasina; Otterstatter, Michael; Grennan, Troy; Moore, David; Gilbert, Mark; Wong, Jason] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Samji, Hasina; Higgins, Rob] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Hu, Jia] Univ Toronto, Publ Hlth & Prevent Med, Toronto, ON, Canada; [Otterstatter, Michael; Gilbert, Mark; Wong, Jason] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hull, Mark; Moore, David] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hull, Mark; Grennan, Troy; Moore, David] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Higgins, Rob] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada	Simon Fraser University; University of Toronto; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of Victoria	Samji, H (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.; Samji, H (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	Hasina_Samp@sfu.ca		Samji, Hasina/0000-0002-4555-7609				[Anonymous], 2016, REPORTED STDS US; Barbee LA, 2017, SEX TRANSM DIS, V44, P385, DOI 10.1097/OLQ.0000000000000614; BC Centre for Excellence in HIV/AIDS BC Ministry of Health, 2020, HIV MON SEM REP BRIT; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Bolan RK, 2015, SEX TRANSM DIS, V42, P98, DOI 10.1097/OLQ.0000000000000216; British Columbia Centre for Disease Control, 2016, STI BRIT COL ANN SUR; British Columbia Centre for Disease Control, 2016, HIV BRIT COL ANN SUR; British Columbia Centre for Excellence in HIV/AIDS, 2020, GUID US PREEXP PROPH; British Columbia Ministry of Health, 2012, HOP HLTH AIDS FREE G; Buchbinder SP, 2018, C RETROVIRUSES OPPOR; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Cheung KT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156160; Desai S, 2017, HIV MED, V18, P615, DOI 10.1111/hiv.12498; Ferlatte O., 2017, SEX TRANSM DIS; Ferrer L, 2016, SEX TRANSM INFECT, V92, P70, DOI 10.1136/sextrans-2015-052042; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2018, LANCET HIV, V5, pE629, DOI 10.1016/S2352-3018(18)30215-7; JEWELL NP, 1990, BIOMETRICS, V46, P1133, DOI 10.2307/2532454; Kelley CF, 2015, AIDS RES HUM RETROV, V31, P587, DOI [10.1089/aid.2015.0013, 10.1089/AID.2015.0013]; Kellogg TA, 2005, JAIDS-J ACQ IMM DEF, V39, P112, DOI 10.1097/01.qai.0000144444.44518.a3; Kent CK, 2004, SEX TRANSM DIS, V31, P596, DOI 10.1097/01.olq.0000140011.93104.32; Kitayama K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0595-3; KITAYAPORN D, 1994, AIDS, V8, P1443, DOI 10.1097/00002030-199410000-00011; Lachowsky N, 2016, 25 ANN CANADIAN C HI; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Ling DI, 2015, SEX TRANSM DIS, V42, P153, DOI 10.1097/OLQ.0000000000000250; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Margolis DA, 2017, LANCET, V390, P1499, DOI 10.1016/S0140-6736(17)31917-7; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McFarland W, 1997, AM J EPIDEMIOL, V146, P662, DOI 10.1093/oxfordjournals.aje.a009332; Meireles P, 2015, EUROSURVEILLANCE, V20, P45, DOI 10.2807/1560-7917.ES2015.20.14.21091; Molina JM, 2018, LANCET INFECT DIS, V18, P308, DOI [10.1016/S1473-3099(17)30725-9, 10.1016/s1473-3099(17)30725-9]; Pathela P, 2017, AIDS BEHAV, V21, P1444, DOI 10.1007/s10461-016-1499-2; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Presanis AM, 2011, BIOSTATISTICS, V12, P666, DOI 10.1093/biostatistics/kxr006; Raymond HF, 2013, SEX TRANSM INFECT, V89, P383, DOI 10.1136/sextrans-2012-050675; SAS Institute Inc. 100 SAS Campus Drive Cary NC 27513-2414 USA, 2012, SAS COMP PROGR; Scott HM, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0089-8; Smith DK, 2012, JAIDS-J ACQ IMM DEF, V60, P421, DOI 10.1097/QAI.0b013e318256b2f6; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Stenger MR, 2017, SEX HEALTH, V14, P18, DOI 10.1071/SH16104; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Tan DHS, 2017, CAN MED ASSOC J, V189, pE1448, DOI 10.1503/cmaj.170494; Valdiserri RO, 2019, J COMMUN HEALTH, V44, P423, DOI 10.1007/s10900-018-00616-3; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Weinstock H, 1998, J ACQ IMMUN DEF SYND, V19, P506, DOI 10.1097/00042560-199812150-00010; Wilton J, 2017, JAIDS-J ACQ IMM DEF, V76, pE58, DOI 10.1097/QAI.0000000000001472	47	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261705	10.1371/journal.pone.0261705	http://dx.doi.org/10.1371/journal.pone.0261705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085280	Green Published, gold			2022-12-26	WOS:000779379600029
J	Songserm, N; Woradet, S; Kankarn, W; Pintakham, K; Vanhnivongkham, P; Uyen, NTT; Cuu, NC; Cua, LN; Sripa, B; Ali, A				Songserm, Nopparat; Woradet, Somkiattiyos; Kankarn, Waratip; Pintakham, Kanjanar; Vanhnivongkham, Phouthong; Nguyen Thi To Uyen; Nguyen Cong Cuu; Le Ngoc Cua; Sripa, Banchob; Ali, Akhtar			Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems	PLOS ONE			English	Article							OPISTHORCHIS-VIVERRINI INFECTION; NORTHEAST THAILAND; RISK-FACTORS; EPIDEMIOLOGY; AREA	Although Opisthorchis viverrini (OV), lifestyle, and diet co-factors have a relatively high prevalence in the Greater Mekong Subregion (GMS) population, cumulative (0-74) incidence rates of cholangiocarcinoma (CCA) do not reach 5% in this region. Other co-factors must influence, but in this study, we only highlighted positive factors for guiding joint planning to address public health problems at the regional level. Therefore, we aimed to study prevalence and factors associated with CCA incidence focusing only on protective factors. A cross-sectional analytic study was carried out from June to October 2017. Participants with informed consent completed the questionnaires. Descriptive statistics were used to analyze general information. Primary variables were classified into high and low levels by mean. Logistic regression was employed to investigate the correlation between interesting variables and the overall risk level of CCA. The overall prevalence of CCA protective factors of the whole region was knowledge (61.39%), health beliefs (42.32%), prevention behavior (31.93%), and community participation (14.53%). When considering the proportions at a high level, they were 49.53%, 53.72%, 35.37%, and 49.67%, respectively. Significant factors associated with CCA prevention were females with secondary or vocational education, a high level of perceived seriousness and benefits, and community participation. These findings are likely to be helpful for both the public and administrators. First, it can be information for people to be aware of CCA risk. Second, policy-driven authorities at the local or regional level should apply the critical issues from this study for joint planning to sustainably solve regional public health problems.	[Songserm, Nopparat] Ubon Ratchathani Rajabhat Univ, Fac Publ Hlth, Ubon Ratchathani, Thailand; [Woradet, Somkiattiyos] Thaksin Univ, Fac Hlth & Sports Sci, Phatthalung, Thailand; [Kankarn, Waratip] Ubon Ratchathani Rajabhat Univ, Fac Nursing, Ubon Ratchathani, Thailand; [Pintakham, Kanjanar] Chiang Rai Rajabhat Univ, Fac Hlth Sci, Chiang Rai, Thailand; [Vanhnivongkham, Phouthong] Champasak Hlth Sci Coll, Champasak, Laos; [Nguyen Thi To Uyen; Nguyen Cong Cuu] Dong Thap Med Coll, Dong Thap, Vietnam; [Le Ngoc Cua] Mekong Univ, Fac Allied Hlth Sci, Vinh Long, Vietnam; [Sripa, Banchob] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand; [Sripa, Banchob] Khon Kaen Univ, Fac Med, Trop Dis Res Lab, WHO Collaborating Ctr Res & Control Opisthorchias, Khon Kaen, Thailand; [Ali, Akhtar] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	Ubon Ratchathani Rajabhat University; Ubon Ratchathani University; Thaksin University; Ubon Ratchathani Rajabhat University; Ubon Ratchathani University; Chiang Rai Rajabhat University; Khon Kaen University; Khon Kaen University; University of Tulsa	Songserm, N (corresponding author), Ubon Ratchathani Rajabhat Univ, Fac Publ Hlth, Ubon Ratchathani, Thailand.	nopparat.s@ubru.ac.th			Faculty of Public Health, Ubon Ratchathani Rajabhat University, Thailand [2560-03-20]	Faculty of Public Health, Ubon Ratchathani Rajabhat University, Thailand	This research was supported by the Faculty of Public Health, Ubon Ratchathani Rajabhat University, Thailand (NS was granted the research to build a research network among the educational institutions in the Greater Mekong Subregion; Grant number 2560-03-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Bray F., 2017, CANC INCIDENCE 5 CON; Human Development, 2013, RIS S HUM PROGR DIV; Jongsuksuntigul P., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P327; Jongsuksuntigul P., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P551; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Kaewpitoon Soraya J, 2016, Asian Pac J Cancer Prev, V17, P1111; Khuntikeo N, 2018, ADV PARASIT, V102, P141, DOI 10.1016/bs.apar.2018.06.003; Manwong M, 2013, ASIAN PAC J CANCER P, V14, P5953, DOI 10.7314/APJCP.2013.14.10.5953; Panithanang Benchapan, 2018, Asian Pac J Cancer Prev, V19, P2673, DOI 10.22034/APJCP.2018.19.9.2673; Phatisena Panida, 2016, Asian Pac J Cancer Prev, V17, P2889; Sayasone S, 2007, T ROY SOC TROP MED H, V101, P40, DOI 10.1016/j.trstmh.2006.02.018; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Songserm Nopparat, 2021, Asian Pac J Cancer Prev, V22, P3181, DOI 10.31557/APJCP.2021.22.10.3181; Songserm N, 2022, NUTR CANCER, V74, P1724, DOI 10.1080/01635581.2021.1957949; Songserm N, 2021, TROP MED INT HEALTH, V26, P962, DOI 10.1111/tmi.13598; Songserm N, 2021, J CANCER EDUC, V36, P1306, DOI 10.1007/s13187-020-01768-4; Songserm Nopparat, 2020, Asian Pac J Cancer Prev, V21, P777, DOI 10.31557/APJCP.2020.21.3.777; Songserm N, 2020, ACTA TROP, V201, DOI 10.1016/j.actatropica.2019.105221; Songserm N, 2016, NUTR CANCER, V68, P1289, DOI 10.1080/01635581.2016.1225101; Songserm Nopparat, 2016, Asian Pac J Cancer Prev, V17, P1811; Songserm Nopparat, 2015, Asian Pac J Cancer Prev, V16, P7375; Songserm N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005447; Songserm N, 2012, CANCER EPIDEMIOL, V36, pE89, DOI 10.1016/j.canep.2011.11.007; Songserm N, 2011, ASIAN PAC J CANCER P, V12, P1341; Sriamporn S, 2004, TROP MED INT HEALTH, V9, P588, DOI 10.1111/j.1365-3156.2004.01234.x; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2017, PARASITOL INT, V66, P346, DOI 10.1016/j.parint.2016.11.013; Sripa B, 2010, ADV PARASIT, V72, P305, DOI 10.1016/S0065-308X(10)72011-X; Srithongklang W, 2019, J CANCER EDUC, V34, P1173, DOI 10.1007/s13187-018-1424-7; Steele JA, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0434-3; Suarez-Barraza MF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093297; Tangkawattana S, 2018, ADV PARASIT, V102, P115, DOI 10.1016/bs.apar.2018.07.002; Whitehead PG, 2019, SCI TOTAL ENVIRON, V673, P218, DOI 10.1016/j.scitotenv.2019.03.315	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262589	10.1371/journal.pone.0262589	http://dx.doi.org/10.1371/journal.pone.0262589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085313	gold, Green Published			2022-12-26	WOS:000779379600067
J	Raza, MF; Anwar, M; Husain, A; Rizwan, M; Li, ZG; Nie, HY; Hlavac, P; Ali, MA; Rady, A; Su, S				Fahad Raza, Muhammad; Anwar, Muhammad; Husain, Arif; Rizwan, Muhmmad; Li, Zhiguo; Nie, Hongyi; Hlavac, Pavol; Ali, M. Ajmal; Rady, Ahmed; Su, Songkun			Differential gene expression analysis following olfactory learning in honeybee (Apis mellifera L.)	PLOS ONE			English	Article							PROBOSCIS EXTENSION RESPONSE; ROYAL JELLY PROTEIN; BATTEN-DISEASE; NEURONAL EXCITABILITY; MOLECULAR-MECHANISMS; MEMORY FORMATION; MUSHROOM BODIES; BRAIN; CYTOCHROME-P450; PLASTICITY	Insects change their stimulus-response through the perception of associating these stimuli with important survival events such as rewards, threats, and mates. Insects develop strong associations and relate them to their experiences through several behavioral procedures. Among the insects, Apis species, Apis mellifera ligustica are known for their outstanding ability to learn with tremendous economic importance. Apis mellifera ligustica has a strong cognitive ability and promising model species for investigating the neurobiological basis of remarkable olfactory learning abilities. Here we evaluated the olfactory learning ability of A. mellifera by using the proboscis extension reflex (PER) protocol. The brains of the learner and failed-learner bees were examined for comparative transcriptome analysis by RNA-Seq to explain the difference in the learning capacity. In this study, we used an appetitive olfactory learning paradigm in the same age of A. mellifera bees to examine the differential gene expression in the brain of the learner and failed-learner. Bees that respond in 2(nd) and 3(rd) trials or only responded to 3(rd) trials were defined as learned bees, failed-learner individuals were those bees that did not respond in all learning trials The results indicate that the learning ability of learner bees was significantly higher than failed-learner bees for 12 days. We obtained approximately 46.7 and 46.4 million clean reads from the learner bees failed-learner bees, respectively. Gene expression profile between learners' bees and failed-learners bees identified 74 differentially expressed genes, 57 genes up-regulated in the brains of learners and 17 genes were down-regulated in the brains of the bees that fail to learn. The qRT-PCR validated the differently expressed genes. Transcriptome analyses revealed that specific genes in learner and failed-learner bees either down-regulated or up-regulated play a crucial role in brain development and learning behavior. Our finding suggests that down-regulated genes of the brain involved in the integumentary system, storage proteins, brain development, sensory processing, and neurodegenerative disorder may result in reduced olfactory discrimination and olfactory sensitivity in failed-learner bees. This study aims to contribute to a better understanding of the olfactory learning behavior and gene expression information, which opens the door for understanding of the molecular mechanism of olfactory learning behavior in honeybees.	[Fahad Raza, Muhammad; Rizwan, Muhmmad; Li, Zhiguo; Nie, Hongyi; Su, Songkun] Fujian Agr & Forestry Univ, Coll Anim Sci, Coll Bee Sci, Fuzhou, Peoples R China; [Fahad Raza, Muhammad; Rizwan, Muhmmad] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Anwar, Muhammad] Shenzhen Univ, Coll Life Sci & Oceanog, Guangdong Technol Res Ctr Marine Algal Bioengn, Guangdong Key Lab Plant Epigenet, Shenzhen, Peoples R China; [Husain, Arif] Ghazi Univ Dera Ghazi Khan, Fac Agr Sci, Dept Soil & Environm Sci, Dera Ghazi Khan, Pakistan; [Hlavac, Pavol] Tech Univ Zvolen, Fac Forestry, Dept Integrated Forest & Landscape Protect, Zvolen, Slovakia; [Ali, M. Ajmal] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Rady, Ahmed] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Shenzhen University; Technical University Zvolen; King Saud University; King Saud University	Raza, MF; Su, S (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Coll Bee Sci, Fuzhou, Peoples R China.; Raza, MF (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China.	mfahadrazafafu@gmail.com; susongkun@zju.edu.cn	Hlaváč, Pavol/AGY-2773-2022	Raza, Dr. Muhammad Fahad/0000-0001-6237-7960	"Modern Agro-industry Technology Research System [CARS-44-KXJ4]; National Natural Science Foundation of China [31772684, 31702192, RSP2021/306]	"Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are thankful to "Modern Agro-industry Technology Research System (No. CARS-44-KXJ4), the National Natural Science Foundation of China (31772684; 31702192). The authors also extend their appreciation to the Researchers Supporting Project number (RSP2021/306), King Saud University, Riyadh, Saudi Arabia.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HR, 2010, DEV MED CHILD NEUROL, V52, P637, DOI 10.1111/j.1469-8749.2010.03628.x; Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Buttstedt A, 2014, BIOL REV, V89, P255, DOI 10.1111/brv.12052; Cash AC, 2005, GENES BRAIN BEHAV, V4, P267, DOI 10.1111/j.1601-183X.2005.00131.x; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Dacher M, 2008, PHYSIOL BEHAV, V95, P200, DOI 10.1016/j.physbeh.2008.05.019; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Denton JA, 2021, INSECTS, V12, DOI 10.3390/insects12090842; Dolisca SB, 2013, J CHILD NEUROL, V28, P1074, DOI 10.1177/0883073813493665; Eisenhardt D, 2014, LEARN MEMORY, V21, P534, DOI 10.1101/lm.033118.113; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Ferguson CS, 2011, TRENDS PHARMACOL SCI, V32, P708, DOI 10.1016/j.tips.2011.08.005; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Fiala A, 1999, J NEUROSCI, V19, P10125; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; Garcia L, 2009, J PROTEOME RES, V8, P1464, DOI 10.1021/pr800823r; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Gerber B, 1999, J EXP BIOL, V202, P1839; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2021, CURR OPIN BEHAV SCI, V37, P1, DOI 10.1016/j.cobeha.2020.05.008; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Godinez-Vidal AR, 2020, CIR CIR, V88, P150, DOI [10.24875/CIRU.19000993, 10.24875/ciru.19000993]; Grunewald B, 2017, ELIFE, V6, DOI 10.7554/eLife.28685; Haduch A, 2018, DRUG METAB REV, V50, P415, DOI 10.1080/03602532.2018.1554674; Hojo M, 2010, APIDOLOGIE, V41, P194, DOI 10.1051/apido/2009075; Ichikawa N, 2003, APPL ENTOMOL ZOOL, V38, P203, DOI 10.1303/aez.2003.203; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katz ML, 2008, NEUROBIOL DIS, V29, P242, DOI 10.1016/j.nbd.2007.08.017; Khan KA, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2021.101487; Khan KA, 2021, SAUDI J BIOL SCI, V28, P3362, DOI 10.1016/j.sjbs.2021.02.084; Khan KA, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2021.101393; Khan KA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248593; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Koroglu C, 2013, J MED GENET, V50, P515, DOI 10.1136/jmedgenet-2013-101634; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kucharski R, 1998, NATURWISSENSCHAFTEN, V85, P343, DOI 10.1007/s001140050512; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Kupke J, 2012, INSECT BIOCHEM MOLEC, V42, P647, DOI 10.1016/j.ibmb.2012.05.003; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Lamminranta S, 2001, J INTELL DISABIL RES, V45, P8, DOI 10.1046/j.1365-2788.2001.00288.x; Laska M, 1999, CHEM SENSES, V24, P429, DOI 10.1093/chemse/24.4.429; Lear BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078147; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Li ZG, 2019, PESTIC BIOCHEM PHYS, V156, P36, DOI 10.1016/j.pestbp.2019.02.001; Licchetta L, 2015, EUR J MED GENET, V58, P540, DOI 10.1016/j.ejmg.2015.09.002; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9; Mizunami M, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.661225; Mohammed A, 2017, NEUROBIOL DIS, V103, P123, DOI 10.1016/j.nbd.2017.03.015; Morale MC, 2008, BRAIN RES REV, V57, P431, DOI 10.1016/j.brainresrev.2007.10.011; Mou X., 2016, NEUROL NEUROPHYSIOL, V7, P367; Muniz JP., 2019, FLORAL BIOL, V50, P640; Murakami G, 2006, DRUG METAB REV, V38, P353, DOI 10.1080/03602530600724068; Nunes FMF, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-84; Oetjen S, 2016, J NEUROCHEM, V139, P456, DOI 10.1111/jnc.13744; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Ostergaard JR, 2016, DEGENER NEUROL NEURO, V6, P73, DOI 10.2147/DNND.S111967; Perez Y, 2016, J MED GENET, V53, P397, DOI 10.1136/jmedgenet-2015-103352; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Shamseldin HE, 2016, AM J HUM GENET, V98, P210, DOI 10.1016/j.ajhg.2015.11.013; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Shibuya K, 2003, BBA-GEN SUBJECTS, V1619, P301, DOI 10.1016/S0304-4165(02)00489-0; Simcock NK, 2018, J INSECT PHYSIOL, V106, P71, DOI 10.1016/j.jinsphys.2017.08.009; Smith BH, 2014, JOVE-J VIS EXP, DOI 10.3791/51057; Stollhoff N, 2008, NEUROBIOL LEARN MEM, V89, P419, DOI 10.1016/j.nlm.2007.10.003; Stray-Pedersen A, 2016, AM J HUM GENET, V98, P202, DOI 10.1016/j.ajhg.2015.11.004; Sumner S, 2006, P ROY SOC B-BIOL SCI, V273, P19, DOI 10.1098/rspb.2005.3291; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Takeuchi H, 2004, CELL TISSUE RES, V316, P281, DOI 10.1007/s00441-004-0865-y; Thompson GJ, 2006, INSECT MOL BIOL, V15, P637, DOI 10.1111/j.1365-2583.2006.00678.x; Wang F, 2014, HUM GENET, V133, P331, DOI 10.1007/s00439-013-1381-5; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547; Wilson DA, 2004, NEUROSCIENTIST, V10, P513, DOI 10.1177/1073858404267048; Woltedji D, 2012, J PROTEOME RES, V11, P4526, DOI 10.1021/pr300298w; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; Zhang SW, 2006, J EXP BIOL, V209, P4420, DOI 10.1242/jeb.02522	90	0	0	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262441	10.1371/journal.pone.0262441	http://dx.doi.org/10.1371/journal.pone.0262441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139088	gold, Green Published			2022-12-26	WOS:000821499100007
J	Ballutaud, M; Travers-Trolet, M; Marchal, P; Dubois, SF; Giraldo, C; Parnell, AC; Nuche-Pascual, MT; Lefebvre, S				Ballutaud, Marine; Travers-Trolet, Morgane; Marchal, Paul; Dubois, Stanislas F.; Giraldo, Carolina; Parnell, Andrew C.; Nuche-Pascual, M. Teresa; Lefebvre, Sebastien			Inferences to estimate consumer's diet using stable isotopes: Insights from a dynamic mixing model	PLOS ONE			English	Article							TROPHIC DISCRIMINATION FACTORS; BIOENERGETICS MODELS; FORAGING ECOLOGY; METABOLIC-RATE; NICHE WIDTH; DELTA-C-13; DELTA-N-15; NITROGEN; TURNOVER; CARBON	Stable isotope ratios are used to reconstruct animal diet in trophic ecology via mixing models. Several assumptions of stable isotope mixing models are critical, i.e., constant trophic discrimination factor and isotopic equilibrium between the consumer and its diet. The isotopic turnover rate (lambda and its counterpart the half-life) affects the dynamics of isotopic incorporation for an organism and the isotopic equilibrium assumption: lambda involves a time lag between the real assimilated diet and the diet estimated by mixing models at the individual scale. Current stable isotope mixing model studies consider neither this time lag nor even the dynamics of isotopic ratios in general. We developed a mechanistic framework using a dynamic mixing model (DMM) to assess the contribution of A to the dynamics of isotopic incorporation and to estimate the bias induced by neglecting the time lag in diet reconstruction in conventional static mixing models (SMMs). The DMM includes isotope dynamics of sources (denoted delta(s)), lambda and frequency of diet-switch (omega). The results showed a significant bias generated by the SMM compared to the DMM (up to 50% of differences). This bias can be strongly reduced in SMMs by averaging the isotopic variations of the food sources over a time window equal to twice the isotopic half-life. However, the bias will persist (similar to 15%) for intermediate values of the co/A ratio. The inferences generated using a case study highlighted that DMM enhanced estimates of consumer's diet, and this could avoid misinterpretation in ecosystem functioning, food-web structure analysis and underlying biological processes.	[Ballutaud, Marine; Nuche-Pascual, M. Teresa; Lefebvre, Sebastien] Univ Lille, Univ Littoral Cote Opale, UMR 8187 Lab Oceanol & Geosci, CNRS,IRD, Lille, France; [Travers-Trolet, Morgane] IFREMER, Ctr Atlantique, EMH, Nantes, France; [Marchal, Paul; Giraldo, Carolina] IFREMER, Channel & North Sea Fisheries Res Unit, Boulogne Sur Mer, France; [Dubois, Stanislas F.] IFREMER, Lab Coastal Benth Ecol, DYNECO, Plouzane, France; [Parnell, Andrew C.] Maynooth Univ, Insight Ctr Data Analyt, Hamilton Inst, Maynooth, Kildare, Ireland	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Lille - ISITE; Universite de Lille; Ifremer; Ifremer; Ifremer; Maynooth University	Ballutaud, M (corresponding author), Univ Lille, Univ Littoral Cote Opale, UMR 8187 Lab Oceanol & Geosci, CNRS,IRD, Lille, France.	marine.ballutaud@gmail.com	Lefebvre, Sébastien/G-8562-2011	Lefebvre, Sébastien/0000-0002-7152-5897; Giraldo, Carolina/0000-0003-0278-522X; Marchal, Paul/0000-0003-2047-4599; Ballutaud, Marine/0000-0002-2161-3207; Dubois, Stanislas/0000-0002-3326-4892; Travers-Trolet, Morgane/0000-0003-1493-662X	French government as part of the Programme Investissement d'Avenir [I-SITE ULNE/ANR-16-IDEX-0004 ULNE]; Metropole Europeenne de Lille; Science Foundation Ireland Career Development Award [17/CDA/4695 (T)]	French government as part of the Programme Investissement d'Avenir(French National Research Agency (ANR)); Metropole Europeenne de Lille; Science Foundation Ireland Career Development Award(Science Foundation Ireland)	This study is part of the ISIT-U project funded by the French government as part of the Programme Investissement d'Avenir (I-SITE ULNE/ANR-16-IDEX-0004 ULNE) managed by the Agence Nationale de la Recherche (ANR) and by the Metropole Europeenne de Lille. A.C. Parnell was further supported by Science Foundation Ireland Career Development Award 17/CDA/4695 (T).	Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Bastos RF, 2017, ECOL INDIC, V75, P234, DOI 10.1016/j.ecolind.2016.12.007; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bentzen TW, 2007, CAN J ZOOL, V85, P596, DOI 10.1139/Z07-036; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carter WA, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11050084; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; D'Agostino VC, 2018, CONT SHELF RES, V164, P45, DOI 10.1016/j.csr.2018.06.003; Das S, 2021, PALAEOGEOGR PALAEOCL, V562, DOI 10.1016/j.palaeo.2020.110076; Davis M, 2016, ECOL EVOL, V6, P1883, DOI 10.1002/ece3.2054; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Emmery A, 2011, J SEA RES, V66, P361, DOI 10.1016/j.seares.2011.08.002; Fink P, 2012, OIKOS, V121, P1985, DOI 10.1111/j.1600-0706.2012.20185.x; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Flynn KJ, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3405-0; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Fry B, 2006, STABLE ISOTOPE ECOLO, DOI 10.1007/0-387-33745-8_3; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gaye-Siessegger J, 2004, OECOLOGIA, V138, P175, DOI 10.1007/s00442-003-1429-7; Gelpi CG, 2013, MAR ECOL PROG SER, V494, P205, DOI 10.3354/meps10540; Gorokhova E, 2018, METHODS ECOL EVOL, V9, P269, DOI 10.1111/2041-210X.12887; Gronkjaer P, 2020, J FISH BIOL, V97, P1507, DOI 10.1111/jfb.14520; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Guelinckx J, 2008, OECOLOGIA, V157, P41, DOI 10.1007/s00442-008-1045-7; Guerra M, 2020, MAR ECOL PROG SER, V638, P207, DOI 10.3354/meps13255; Gulka J, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00324; Harvey CJ, 2002, CAN J FISH AQUAT SCI, V59, P115, DOI 10.1139/F01-203; Heady WN, 2013, OECOLOGIA, V172, P21, DOI 10.1007/s00442-012-2483-9; Healy K, 2018, ECOGRAPHY, V41, P1393, DOI 10.1111/ecog.03371; Hertz E, 2016, J ANIM ECOL, V85, P681, DOI 10.1111/1365-2656.12504; Herzka SZ, 2005, ESTUAR COAST SHELF S, V64, P58, DOI 10.1016/j.ecss.2005.02.006; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hette-Tronquart N, 2019, ECOL LETT, V22, P1987, DOI 10.1111/ele.13218; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Kaufman MR, 2008, OECOLOGIA, V158, P11, DOI 10.1007/s00442-008-1122-y; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Lanari M., 2021, Hydrobiologia, V848, P593, DOI 10.1007/s10750-020-04462-0; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Leal JCM, 2008, MAR BIOL, V153, P673, DOI 10.1007/s00227-007-0841-7; Lefebvre S, 2016, VIE MILIEU, V66, P305; Lefebvre S, 2009, MAR ECOL PROG SER, V390, P27, DOI 10.3354/meps08187; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; McCluskey SM, 2021, GLOB ECOL CONSERV, V25, DOI 10.1016/j.gecco.2020.e01396; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMahon KW, 2015, LIMNOL OCEANOGR, V60, P1076, DOI 10.1002/lno.10081; Mille T, 2016, MAR ECOL PROG SER, V555, P167, DOI 10.3354/meps11784; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Nahon S, 2020, FRESHWATER BIOL, V65, P1870, DOI 10.1111/fwb.13578; Oppel S, 2010, J ORNITHOL, V151, P123, DOI 10.1007/s10336-009-0434-y; Orben RA, 2018, MAR ECOL PROG SER, V593, P231, DOI 10.3354/meps12459; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Pecquerie L, 2010, PHILOS T R SOC B, V365, P3455, DOI 10.1098/rstb.2010.0097; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Possamai B, 2021, MAR ECOL PROG SER, V666, P19, DOI 10.3354/meps13682; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Potapov AM, 2019, AM NAT, V194, P823, DOI 10.1086/705811; Rodde C, 2020, J EXP MAR BIOL ECOL, V533, DOI 10.1016/j.jembe.2020.151468; S. Lefebvre, 2021, bioRxiv, DOI 10.1101/2021.05.28.446143; Sanchez-Hernandez J, 2019, BIOL REV, V94, P539, DOI 10.1111/brv.12468; Savoye N, 2003, MAR ECOL PROG SER, V255, P27, DOI 10.3354/meps255027; Shipley ON, 2021, METHODS ECOL EVOL, V12, P897, DOI 10.1111/2041-210X.13567; Shipley ON, 2020, OECOLOGIA, V193, P27, DOI 10.1007/s00442-020-04654-4; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stock BC, 2016, ECOLOGY, V97, P2562, DOI 10.1002/ecy.1517; Swan GJF, 2020, METHODS ECOL EVOL, V11, P139, DOI 10.1111/2041-210X.13311; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Thuss SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090641; Travers-Trolet M, 2019, ECOL MODEL, V410, DOI 10.1016/j.ecolmodel.2019.108800; Trueman CN, 2019, PEERJ, V7, DOI 10.7717/peerj.7912; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Yeakel JD, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00001; Young BG, 2014, MAR MAMMAL SCI, V30, P706, DOI 10.1111/mms.12075	89	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263454	10.1371/journal.pone.0263454	http://dx.doi.org/10.1371/journal.pone.0263454			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130334	Green Submitted, gold, Green Published			2022-12-26	WOS:000805530700031
J	Siddiky, NA; Sarker, S; Khan, SR; Rahman, T; Kafi, A; Samad, MA				Siddiky, Nure Alam; Sarker, Samun; Khan, Shahidur Rahman; Rahman, Tanvir; Kafi, Abdul; Samad, Mohammed A.			Virulence and antimicrobial resistance profile of non-typhoidal Salmonella enterica serovars recovered from poultry processing environments at wet markets in Dhaka, Bangladesh	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHICKEN MEAT; ANTIBIOTIC-RESISTANCE; GENETIC DIVERSITY; BETA-LACTAMASES; RETAIL MEATS; PREVALENCE; ENTERITIDIS; IDENTIFICATION; TYPHIMURIUM	The rapid emergence of virulent and multidrug-resistant (MDR) non-typhoidal Salmonella (NTS) enterica serovars is a growing public health concern globally. The present study focused on the assessment of the pathogenicity and antimicrobial resistance (AMR) profiling of NTS enterica serovars isolated from the chicken processing environments at wet markets in Dhaka, Bangladesh. A total of 870 samples consisting of carcass dressing water (CDW), chopping board swabs (CBS), and knife swabs (KS) were collected from 29 wet markets. The prevalence of Salmonella was found to be 20% in CDW, 19.31% in CBS, and 17.58% in KS, respectively. Meanwhile, the MDR Salmonella was found to be 72.41%, 73.21%, and 68.62% in CDW, CBS, and KS, respectively. All isolates were screened by polymerase chain reaction (PCR) for eight virulence genes, namely invA, agfA, IpfA, hilA, sivH, sefA, sopE, and spvC. The S. Enteritidis and untyped Salmonella isolates harbored all virulence genes while S. Typhimurium isolates carried six virulence genes, except sefA and spvC. Phenotypic resistance revealed decreased susceptibility to ciprofloxacin, streptomycin, ampicillin, tetracycline, gentamicin, sulfamethoxazole-trimethoprim, amoxicillin-clavulanic acid, and azithromycin. Genotypic resistance showed a higher prevalence of plasmid-mediated bIaTEM followed by tetA, sul1, sul2, sul3, and strA/B genes. The phenotypic and genotypic resistance profiles of the isolates showed a harmonic and symmetrical trend. According to the findings, MDR and virulent NTS enterica serovars predominate in wet market conditions and can easily enter the human food chain. The chi-square analysis showed significantly higher associations among the phenotypic resistance, genotypic resistance and virulence genes in CDW, CBS, and KS respectively (p < 0.05).	[Siddiky, Nure Alam; Sarker, Samun; Samad, Mohammed A.] Bangladesh Livestock Res Inst, Antimicrobial Resistance Act Ctr, Dhaka, Bangladesh; [Khan, Shahidur Rahman; Rahman, Tanvir; Kafi, Abdul] Bangladesh Agr Univ, Dept Microbiol & Hyg, Mymensingh, Bangladesh	Bangladesh Livestock Research Institute (BLRI); Bangladesh Agricultural University (BAU)	Samad, MA (corresponding author), Bangladesh Livestock Res Inst, Antimicrobial Resistance Act Ctr, Dhaka, Bangladesh.	msamad@blri.gov.bd	Sarker, Md Samun/GYA-5968-2022; Rahman, Md.Tanvir, PhD (UK)/C-3110-2009	Rahman, Md.Tanvir, PhD (UK)/0000-0001-5432-480X; SAMAD, MOHAMMED/0000-0001-7329-7325; Siddiky, Nure Alam/0000-0002-1705-7885; Sarker, Md Samun/0000-0001-5445-1040				Adzitey F, 2012, FOOD RES INT, V45, P947, DOI 10.1016/j.foodres.2011.02.051; Agron PG, 2001, APPL ENVIRON MICROB, V67, P4984, DOI 10.1128/AEM.67.11.4984-4991.2001; Ahmed Dilruba, 2014, ISRN Microbiol, V2014, P715310, DOI 10.1155/2014/715310; Akond MA., 2012, STAMFORD J MICROBIOL, V2, P15, DOI [10.3329/sjm.v2i1.15207, DOI 10.3329/SJM.V2I1.15207]; Al Masud A, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00078; Al-Mamun M. A., 2017, African Journal of Microbiology Research, V11, P474, DOI 10.5897/ajmr2017-8431; Alam SB, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030201; Alvarez J, 2004, J CLIN MICROBIOL, V42, P1734, DOI 10.1128/JCM.42.4.1734-1738.2004; Amini K, 2010, AFR J MICROBIOL RES, V4, P2202; [Anonymous], 2002, 65792002 ISO; Arkali A, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02425-0; Aslam M, 2012, FOOD MICROBIOL, V32, P110, DOI 10.1016/j.fm.2012.04.017; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; BAUMLER AJ, 1995, J BACTERIOL, V177, P2087; Behravesh CB, 2014, CLIN INFECT DIS, V58, P1432, DOI 10.1093/cid/ciu067; Biswas S, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090298; Borges KA, 2013, PESQUI VET BRASIL, V33, P1416, DOI 10.1590/S0100-736X2013001200004; Borsoi A, 2009, POULTRY SCI, V88, P750, DOI 10.3382/ps.2008-00466; Bupasha Z.B., 2020, WORLDS VET J, V10, P508, DOI [10.54203/scil.2020.wvj61, DOI 10.29252/SCIL.2020.WVJ61, DOI 10.54203/SCIL.2020.WVJ61]; Campioni F, 2012, FOOD MICROBIOL, V32, P254, DOI 10.1016/j.fm.2012.06.008; Cardona-Castro N, 2002, MEM I OSWALDO CRUZ, V97, P1153, DOI 10.1590/S0074-02762002000800016; Castilla KS, 2006, BRAZ J MICROBIOL, V37, P135, DOI 10.1590/S1517-83822006000200007; Cesco MAO, 2008, ANAIS 35 CONGRESSO B; Chitanand MP, 2010, INDIAN J MICROBIOL, V50, P216, DOI 10.1007/s12088-010-0042-9; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Clinical and Laboratory Standards Institute (CLSI), 2016, M100 PERFORMANCE STA, V26th; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Craciunas C, 2012, J ENVIRON MANAGE, V95, pS15, DOI 10.1016/j.jenvman.2010.07.027; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; Darwin KH, 1999, J BACTERIOL, V181, P4949; de Freitas CG, 2010, INT J FOOD MICROBIOL, V139, P15, DOI 10.1016/j.ijfoodmicro.2010.02.007; Doosti A, 2016, THAI J VET MED, V46, P691; Ed-Dra A, 2018, J GLOB ANTIMICROB RE, V14, P297, DOI 10.1016/j.jgar.2018.05.019; El-Sharkawy H, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0157-1; Elbediwi M, 2020, EMERG MICROBES INFEC, V9, P535, DOI 10.1080/22221751.2020.1733439; Elkenany R, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1867-z; Garedew L, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0062-7; Gieraltowski L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162369; Gonzalez Fanny, 2013, Int J Microbiol, V2013, P628185, DOI 10.1155/2013/628185; Guo X, 2000, APPL ENVIRON MICROB, V66, P5248, DOI 10.1128/AEM.66.12.5248-5252.2000; Hawker J., 2018, COMMUNICABLE DIS CON; Heidary M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.12329; Huehn S, 2010, FOODBORNE PATHOG DIS, V7, P523, DOI 10.1089/fpd.2009.0447; IACG, 2019, NO TIM WAIT SEC FUT; Im MC, 2015, POULTRY SCI, V94, P1691, DOI 10.3382/ps/pev137; Isidori M, 2005, SCI TOTAL ENVIRON, V346, P87, DOI 10.1016/j.scitotenv.2004.11.017; Islam Md. Jakirul, 2016, Journal of Applied Biology & Biotechnology, V4, P46, DOI 10.7324/JABB.2016.40308; Issenhuth-Jeanjean S, 2014, RES MICROBIOL, V165, P526, DOI 10.1016/j.resmic.2014.07.004; Jain P, 2020, BRAZ J MICROBIOL, V51, P613, DOI 10.1007/s42770-019-00213-z; Jaja IF, 2019, ACTA TROP, V190, P129, DOI 10.1016/j.actatropica.2018.11.003; Jiang ZH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01513; Karim M.R., 2017, INT J ANIM BIOL, V3, P18; Kaushik P, 2014, VET WORLD, V7, P62, DOI 10.14202/vetworld.2014.62-65; Keerthirathne TP, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030335; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Lin DC, 2014, FOOD MICROBIOL, V43, P1, DOI 10.1016/j.fm.2014.04.010; Long M, 2016, J APPL MICROBIOL, V121, P672, DOI 10.1111/jam.13184; Lu Y, 2011, FOODBORNE PATHOG DIS, V8, P45, DOI 10.1089/fpd.2010.0605; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mahmud MS, 2011, FOODBORNE PATHOG DIS, V8, P1111, DOI 10.1089/fpd.2011.0917; Malorny B, 2003, INT J FOOD MICROBIOL, V89, P241, DOI 10.1016/S0168-1605(03)00154-5; Manyi-Loh C, 2018, MOLECULES, V23, DOI 10.3390/molecules23040795; McCrea BA, 2006, POULTRY SCI, V85, P136, DOI 10.1093/ps/85.1.136; Mishra M., 2013, RES MICROBIOL BIOTEC, V1, P239; Momtaz S., 2018, BIORES COMMUN, V4, P506; Motta R.N., 2003, Braz J Infect Dis, V7, P129, DOI 10.1590/S1413-86702003000200006; Mridha D, 2020, VET WORLD, V13, P275, DOI 10.14202/vetworld.2020.275-283; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Nayak R, 2004, INT J FOOD MICROBIOL, V91, P51, DOI 10.1016/S0168-1605(03)00330-1; Nidaullah H, 2017, VET WORLD, V10, P286, DOI 10.14202/vetworld.2017.286-292; O'Bryan C.A., 2018, FOOD FEED SAFETY SYS, VMA, P99, DOI DOI 10.1016/B978-0-12-811835-1.00006-3; Oliveira SD, 2002, VET MICROBIOL, V87, P25, DOI 10.1016/S0378-1135(02)00028-7; ONeill J., 2014, REV ANTIMICROBIAL RE; Osimani A, 2016, EPIDEMIOL INFECT, V144, P3000, DOI 10.1017/S0950268816001540; Pang L., 2011, CHIN J FOOD HYG, V23, P560; Park HC, 2014, APPL BIOCHEM BIOTECH, V174, P793, DOI 10.1007/s12010-014-1103-z; Parvej MS, 2016, VET WORLD, V9, P65, DOI 10.14202/vetworld.2016.65-70; Parvej S., 2016, TURKISH J AGR FOOD S, V4, P519, DOI [10.24925/turjaf.v4i7.519-523.695, DOI 10.24925/TURJAF.V4I7.519-523.695]; Parvin MS, 2020, J FOOD PROTECT, V83, P2107, DOI 10.4315/JFP-20-172; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paudyal N, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00163-20; Prager R, 2003, J CLIN MICROBIOL, V41, P4270, DOI 10.1128/JCM.41.9.4270-4278.2003; Ramatla T, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040034; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Rusul G, 1996, INT J FOOD MICROBIOL, V33, P183, DOI 10.1016/0168-1605(96)01125-7; Saitanu Kriengsag, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P328; Sallam KI, 2014, FOOD CONTROL, V38, P209, DOI 10.1016/j.foodcont.2013.10.027; Samanta I, 2014, AVIAN DIS, V58, P39, DOI 10.1637/10586-052913-Reg.1; Sarker BR, 2021, VET MED SCI, V7, P820, DOI 10.1002/vms3.440; Sarker MS, 2019, VET WORLD, V12, P1578, DOI 10.14202/vetworld.2019.1578-1583; Shah A. H., 2012, Journal of Veterinary & Animal Sciences (Lahore), V2, P40; Sharma J, 2019, FOOD CONTROL, V102, P104, DOI 10.1016/j.foodcont.2019.01.021; Siddiky NA, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9050952; Silva C, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx070; Sin M, 2020, J APPL POULTRY RES, V29, P502, DOI 10.1016/j.japr.2019.12.010; Sobur A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040191; Spector MP, 2012, FOOD RES INT, V45, P455, DOI 10.1016/j.foodres.2011.06.056; Sripaurya B, 2019, J FOOD SAFETY, V39, DOI 10.1111/jfs.12601; Sultana M, 2014, J POULT SCI, V51, P424, DOI 10.2141/jpsa.0130222; Suresh T, 2006, FOOD MICROBIOL, V23, P294, DOI 10.1016/j.fm.2005.04.001; Suresh Y., 2019, PHARMA INNOVATION J, V8, P277; Swamy SC, 1996, APPL ENVIRON MICROB, V62, P3768, DOI 10.1128/AEM.62.10.3768-3771.1996; Takaya A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03155; Tarabees R, 2017, J INFECT DEV COUNTR, V11, P314, DOI 10.3855/jidc.8043; Thenmozhi S, 2014, INT J PHARM SCI RES, V5, P2908, DOI 10.13040/IJPSR.0975-8232.5(7).2908-18; Thung TY, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02697; Titilawo Y, 2015, ENVIRON SCI POLLUT R, V22, P10969, DOI 10.1007/s11356-014-3887-3; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029; Vuthy Y, 2017, ASIAN PAC J TROP BIO, V7, P670, DOI 10.1016/j.apjtb.2017.07.002; Waghamare RN., 2017, INT J CURR MICROBIOL, V6, P630, DOI [10.20546/ijcmas.2017.605.073, DOI 10.20546/IJCMAS.2017.605.073]; Wang HH, 2013, FOOD CONTROL, V33, P378, DOI 10.1016/j.foodcont.2013.03.030; World Health Organization, 2019, 2019 WHO AW CLASS DA; Xiang Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00801; Xu YH, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00497; Yang BW, 2010, INT J FOOD MICROBIOL, V141, P63, DOI 10.1016/j.ijfoodmicro.2010.04.015; Yoo AY, 2013, BIOCHEM BIOPH RES CO, V430, P131, DOI 10.1016/j.bbrc.2012.11.025; Yu H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083001; Zahraei-Salehi T., 2006, Journal of the Faculty of Veterinary Medicine, University of Tehran, V61, P195; Zeng YB, 2019, FOODBORNE PATHOG DIS, V16, P339, DOI 10.1089/fpd.2018.2510; Zhu YT, 2017, INT J FOOD MICROBIOL, V259, P43, DOI 10.1016/j.ijfoodmicro.2017.07.023	123	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0254465	10.1371/journal.pone.0254465	http://dx.doi.org/10.1371/journal.pone.0254465			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130286	gold, Green Submitted, Green Published			2022-12-26	WOS:000805530700002
J	Teshale, AB; Tesema, GA				Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn			Discriminatory attitude towards people living with HIV/AIDS and its associated factors among adult population in 15 sub-Saharan African nations	PLOS ONE			English	Article							STIGMA; HIV; KNOWLEDGE; WOMEN; PERCEPTIONS; ETHIOPIA; CITY	Background Discrimination of people living with HIV/AIDS is one of the reported obstacles to the achievement of universal access to HIV/AIDS prevention, treatment, care, and support programs. Many international agencies have made combating HIV/AIDS stigma and discrimination a top priority. However, previous evidence in different parts of Africa revealed that the magnitude of HIV/AIDS-related discriminatory attitude is significantly high. Objective To assess discriminatory attitude towards people living with HIV/AIDS and its associated factors among the adult population in 15 sub-Saharan African nations. Methods We have used the 15 Demographic and Health Survey data that were conducted in sub-Saharan Africa (SSA) from 2015 to 2019/20. Each country's data was appended and a total weighted sample of 318,186 (unweighted sample = 315,448) adults who had ever heard of AIDS was used for the final analysis. The two discriminatory attitude questions were used to get the outcome variable and those who answered "Yes" or "don't know" for both questions were counted as if they had no discriminatory attitude towards people living with HIV/AIDS. To assess the factors associated with discriminatory attitude towards people living with HIV/AIDS, we have fitted a multilevel binary logistic regression model. Bivariable analysis was done to select eligible variables for the multivariable analysis. Finally, variables with p<0.05, in the multivariable analysis, were considered as significant predictors of discriminatory attitude towards people living with HIV/AIDS. Results The prevalence of discriminatory attitude towards HIV/AIDS in the 15 sub-Saharan African nations was 47.08% (95% CI: 47.08, 47.42), which ranges from 17.64% (95% CI: 17.22, 18.07) in Malawi to 79.75% (95% CI: 79.02, 80.45) in Guinea. In the multivariable analysis, both individual level and community level variables were significantly associated with discriminatory attitude towards people living with HIV/AIDS. Being younger age, no formal education, never married, low socioeconomic status, male-headed household, non-contraceptive use, no mass media exposure, and incorrect comprehensive knowledge towards HIV/AIDS were among the individual-level factors that were associated with higher odds of discriminatory attitude towards people living with HIV/AIDS. While being from urban residence and the western SSA region were among the community-level factors that were significantly associated with higher odds discriminatory attitude towards people living with HIV/AIDS. Conclusion The prevalence of discriminatory attitude towards people living with HIV/AIDS in 15 sub-Saharan African nations was high. Both individual and community-level factors were associated with discriminatory attitude towards people living with HIV/AIDS. Therefore, special attention should be given to those who are poor, uneducated, and younger adults. In addition, it is better to strengthen the accessibilities of different media for adult populations to create an appropriate attitude towards people with HIV/AIDS.	[Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Teshale, Achamyeleh/0000-0002-7572-9993				Adane B, 2020, HIV AIDS-RES PALLIAT, V12, P551, DOI 10.2147/HIV.S274019; Aggleton P., 2000, HIV AIDS RELATED STI; Andrewin A, 2008, AIDS PATIENT CARE ST, V22, P897, DOI 10.1089/apc.2007.0219; Arefaynie M, 2021, HIV AIDS-RES PALLIAT, V13, P283, DOI 10.2147/HIV.S299812; Arrey AE, 2017, J BIOSOC SCI, V49, P578, DOI 10.1017/S0021932016000468; Asamoah CK, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1331538; Bekker LG, 2018, LANCET, V392, P312, DOI [10.1016/s0140-6736(18)31070-5, 10.1016/S0140-6736(18)31070-5]; Bhagavathula AS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1541-2; Chimoyi L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26950; Coombe C., 2001, PROSPECTS, V31, P435; Croft TN, 2018, GUIDE DHS STAT; Dahlui M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143749; Diress GA, 2020, SAHARA J-J SOC ASP H, V17, P38, DOI 10.1080/17290376.2020.1857300; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Gurmu E, 2015, AJAR-AFR J AIDS RES, V14, P191, DOI 10.2989/16085906.2015.1051066; Herek GM, 1998, AIDS PUBLIC POLICY J, V13, P36; Iqbal S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7124-3; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Joint U. Programme on HIV/AIDS, 2014, GAP REP, V7; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Lau JTF, 2005, SEX TRANSM INFECT, V81, P113, DOI 10.1136/sti.2004.011767; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P347; Lifson AR, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-6; Morrison K., 2006, BREAKING CYCLE STIGM; Nachega Jean B, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P172, DOI 10.1177/1545109712436723; Nattabi B, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17421; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Rukhsana Khan, 2019, Pakistan Journal of Public Health, V9, P37, DOI 10.32413/pjph.v9i1.237; Ulasi CI, 2009, HEALTH PLACE, V15, P255, DOI 10.1016/j.healthplace.2008.05.006; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; Zainiddinov Hakim, 2019, Cent Asian J Glob Health, V8, P349, DOI 10.5195/cajgh.2019.349	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0261978	10.1371/journal.pone.0261978	http://dx.doi.org/10.1371/journal.pone.0261978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120129	Green Published, gold			2022-12-26	WOS:000789273600006
J	Vehlen, A; Standard, W; Domes, G				Vehlen, Antonia; Standard, William; Domes, Gregor			How to choose the size of facial areas of interest in interactive eye tracking	PLOS ONE			English	Article							GAZE; AVOIDANCE; ATTENTION; FACE	Advances in eye tracking technology have enabled the development of interactive experimental setups to study social attention. Since these setups differ substantially from the eye tracker manufacturer's test conditions, validation is essential with regard to the quality of gaze data and other factors potentially threatening the validity of this signal. In this study, we evaluated the impact of accuracy and areas of interest (AOIs) size on the classification of simulated gaze (fixation) data. We defined AOIs of different sizes using the Limited-Radius Voronoi-Tessellation (LRVT) method, and simulated gaze data for facial target points with varying accuracy. As hypothesized, we found that accuracy and AOI size had strong effects on gaze classification. In addition, these effects were not independent and differed in falsely classified gaze inside AOIs (Type I errors; false alarms) and falsely classified gaze outside the predefined AOIs (Type II errors; misses). Our results indicate that smaller AOIs generally minimize false classifications as long as accuracy is good enough. For studies with lower accuracy, Type II errors can still be compensated to some extent by using larger AOIs, but at the cost of more probable Type I errors. Proper estimation of accuracy is therefore essential for making informed decisions regarding the size of AOIs in eye tracking research.	[Vehlen, Antonia; Standard, William; Domes, Gregor] Univ Trier, Dept Psychol Biol & Clin Psychol, Trier, Germany	Universitat Trier	Domes, G (corresponding author), Univ Trier, Dept Psychol Biol & Clin Psychol, Trier, Germany.	domes@uni-trier.de		Vehlen, Antonia/0000-0002-6019-3161	German Research Foundation [DO1312/5-1]; Trier University Research Priority Program "Psychobiology of Stress"; State Rhineland-Palatinate	German Research Foundation(German Research Foundation (DFG)); Trier University Research Priority Program "Psychobiology of Stress"; State Rhineland-Palatinate	The study was in part supported by grants from the German Research Foundation (DO1312/5-1) to GD and the Trier University Research Priority Program "Psychobiology of Stress", funded by the State Rhineland-Palatinate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos B., 2016, CMUCS16118; [Anonymous], 2012, P S EYE TRACKING RES, DOI [DOI 10.1145/2168556.2168563, DOI 10.3758/s13428-012-0234-9]; Canigueral R, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00560; Carter BT, 2020, INT J PSYCHOPHYSIOL, V155, P49, DOI 10.1016/j.ijpsycho.2020.05.010; Castner N, 2020, ETRA'20 FULL PAPERS: ACM SYMPOSIUM ON EYE TRACKING RESEARCH AND APPLICATIONS, DOI 10.1145/3379155.3391320; Chen NTM, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0808-4; Chita-Tegmark M, 2016, REV J AUTISM DEV DIS, V3, P209, DOI 10.1007/s40489-016-0077-x; Dalrymple KA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00803; DeBruine L., 2017, FACE RES LAB LONDON, DOI [10.6084/m9.figshare.5047666.v3, 10.6084/M9.FIGSHARE.5047666.V2, DOI 10.6084/M9.FIGSHARE.5047666.V2]; Domes G, 2013, PSYCHONEUROENDOCRINO, V38, P1198, DOI 10.1016/j.psyneuen.2012.10.002; Fuhl W, 2019, ETRA 2019: 2019 ACM SYMPOSIUM ON EYE TRACKING RESEARCH & APPLICATIONS, DOI 10.1145/3314111.3323074; Grossman RB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49039-7; Hessels RS, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01367; Hessels RS, 2017, CAN J EXP PSYCHOL, V71, P226, DOI 10.1037/cep0000113; Hessels RS, 2016, BEHAV RES METHODS, V48, P1694, DOI 10.3758/s13428-015-0676-y; Hessels RS., 2018, J Exp Psychopathol, P1, DOI 10.5127/jep.062917; Kaiser D, 2019, J PERS DISORD, V33, P671, DOI 10.1521/pedi_2019_33_363; Lischke A, 2012, PSYCHONEUROENDOCRINO, V37, P475, DOI 10.1016/j.psyneuen.2011.07.015; Mojzisch A, 2006, SOC NEUROSCI-UK, V1, P184, DOI 10.1080/17470910600985621; Niehorster DC, 2020, BEHAV RES METHODS, V52, P1140, DOI 10.3758/s13428-019-01307-0; Orquin JL, 2016, J BEHAV DECIS MAKING, V29, P103, DOI 10.1002/bdm.1867; Orquin JL., 2018, Behav Res Methods, V50, P1645, DOI 10.3758/s13428-017-0998-z; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Rim NW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250170; Rubin M, 2020, BEHAV RES THER, V134, DOI 10.1016/j.brat.2020.103706; Vatheuer CC, 2021, J NEURAL TRANSM, V128, P1269, DOI 10.1007/s00702-021-02344-w; Vehlen A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81987-x; Wass SV, 2013, BEHAV RES METHODS, V45, P229, DOI 10.3758/s13428-012-0245-6	28	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263594	10.1371/journal.pone.0263594	http://dx.doi.org/10.1371/journal.pone.0263594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120188	Green Published, gold			2022-12-26	WOS:000789273600056
J	Pfenning-Butterworth, A; Cooper, RO; Cressler, CE				Pfenning-Butterworth, Alaina; Cooper, Reilly O.; Cressler, Clayton E.			Daily feeding rhythm linked to microbiome composition in two zooplankton species	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; GUT MICROBIOTA; PHOTOTACTIC BEHAVIOR; DAPHNIA; DIVERSITY; MODEL	Host-associated microbial communities are impacted by external and within-host factors, i.e., diet and feeding behavior. For organisms known to have a circadian rhythm in feeding behavior, microbiome composition is likely impacted by the different rates of microbe introduction and removal across a daily cycle, in addition to any diet-induced changes in microbial interactions. Here, we measured feeding behavior and used 16S rRNA sequencing to compare the microbial community across a diel cycle in two distantly related species of Daphnia, that differ in their life history traits, to assess how daily feeding patterns impact microbiome composition. We find that Daphnia species reared under similar laboratory conditions have significantly different microbial communities. Additionally, we reveal that Daphnia have daily differences in their microbial composition that correspond with feeding behavior, such that there is greater microbiome diversity at night during the host's active feeding phase. These results highlight that zooplankton microbiomes are relatively distinct and are likely influenced by host phylogeny.	[Pfenning-Butterworth, Alaina; Cooper, Reilly O.; Cressler, Clayton E.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Pfenning-Butterworth, A (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	apfenning@huskers.unl.edu		Pfenning-Butterworth, Alaina/0000-0001-7719-1632				Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Alishum A., 2019, **DATA OBJECT**, DOI 10.5281/zenodo.3266798; Amato KR, 2016, OECOLOGIA, V180, P717, DOI 10.1007/s00442-015-3507-z; Auld SKJR, 2014, OIKOS, V123, P232, DOI 10.1111/j.1600-0706.2013.00720.x; Brooks AW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000225; Buffington SA, 2021, CELL, V184, P1740, DOI 10.1016/j.cell.2021.02.009; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cellier-Michel S, 2003, ANN LIMNOL-INT J LIM, V39, P265, DOI 10.1051/limn/2003021; Cooper RO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57367-x; Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dawidowicz P., 2018, NATURAL HIST CRUSTAC, P231; DEMEESTER L, 1991, HYDROBIOLOGIA, V225, P217, DOI 10.1007/BF00028400; DEMEESTER L, 1993, ECOLOGY, V74, P1467; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Eckert EM, 2021, MOL ECOL, V30, P1545, DOI 10.1111/mec.15815; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Fitzpatrick CR, 2018, P NATL ACAD SCI USA, V115, pE1157, DOI 10.1073/pnas.1717617115; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; GLANDER K E, 1982, Yearbook of Physical Anthropology, V25, P1; HANEY JF, 1975, ARCH HYDROBIOL, V75, P413; Hite JL, 2020, ECOL EVOL, V10, P6239, DOI 10.1002/ece3.6352; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Lahti L, 2017, TOOLS MICROBIOME ANA; Lim SJ, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2900; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; Macke E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00380; Mallott EK, 2018, AM J PHYS ANTHROPOL, V165, P576, DOI 10.1002/ajpa.23395; May CE, 2019, CELL REP, V27, P1675, DOI 10.1016/j.celrep.2019.04.027; Mazel F, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00097-18; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mushegian AA, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01547-18; Najarro MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1173; Oren A., 2013, PROKARYOTES, V4th ed., DOI 10.1007/978-3-642-30123-0; Pfenning-Butterworth AC, 2021, J BIOL RHYTHM, V36, P589, DOI 10.1177/07487304211054404; Provensi G, 2019, P NATL ACAD SCI USA, V116, P9644, DOI 10.1073/pnas.1820832116; R Core Team, 2020, R LANG ENV STAT COMP; Ringelberg J, 1999, BIOL REV, V74, P397, DOI 10.1017/S0006323199005381; RINGELBERG J, 1995, HYDROBIOLOGIA, V307, P161, DOI 10.1007/BF00032008; Rund SSC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2998-2; Sarnelle O, 2005, J PLANKTON RES, V27, P1229, DOI 10.1093/plankt/fbi086; Sarnelle O, 2008, ECOLOGY, V89, P1723, DOI 10.1890/07-0935.1; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schwarzenberger A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77065-3; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Sison-Mangus MP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27681-x; Udayangani RMC, 2017, FISH SHELLFISH IMMUN, V66, P173, DOI 10.1016/j.fsi.2017.05.018; Vernier CL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3431; Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347; Wang J, 2014, P NATL ACAD SCI USA, V111, pE2703, DOI 10.1073/pnas.1402342111; WEIDER LJ, 1992, LIMNOL OCEANOGR, V37, P1327, DOI 10.4319/lo.1992.37.6.1327; Willis AD, 2022, BIOSTATISTICS, V23, P207, DOI 10.1093/biostatistics/kxaa015; Wright ES, 2016, R J, V8, P352; Zheng DP, 2020, TRENDS IMMUNOL, V41, P512, DOI 10.1016/j.it.2020.04.005; Zuykova EI, 2016, RUSS J GENET+, V52, P585, DOI 10.1134/S102279541604013X	58	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263538	10.1371/journal.pone.0263538	http://dx.doi.org/10.1371/journal.pone.0263538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113950	gold, Green Published, Green Submitted			2022-12-26	WOS:000823694700106
J	Qin, GH; He, F; Zhang, HD; Pazo, EE; Dai, GZ; Yao, QC; He, W; Xu, L; Lin, TZ				Qin, Guanghao; He, Fang; Zhang, Hongda; Pazo, Emmanuel Eric; Dai, Guangzheng; Yao, Qingchi; He, Wei; Xu, Ling; Lin, Tiezhu			Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) are more prominent in retinal artery occlusion (RAO) compared to retinal vein occlusion (RVO)	PLOS ONE			English	Article							DEXAMETHASONE INTRAVITREAL IMPLANT; MACULAR EDEMA SECONDARY; NEUTROPHIL/LYMPHOCYTE RATIO; PROGNOSTIC-FACTOR; ASSOCIATION; INFLAMMATION; SURVIVAL; ATHEROSCLEROSIS; MULTICENTER; CHEMOKINES	Aim To evaluate the association between the value of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), monocyte to high-density lipoprotein ratio (MHR) and the development of retinal artery occlusion (RAO) and retinal vein occlusion (RVO). Methods This retrospective study assessed 41 RAO, 50 RVO and 50 control (age and gender matched senile cataract) participants. The NLR, PLR and MHR parameters of patients' peripheral blood were analyzed. A receiver operating characteristics (ROC) curve analysis and the best cutoff value were used to specify the predictive value of NLR, PLR and MHR in RAO and RVO. Results The NLR, PLR and MHR were significantly higher in RAO group compared to the control group (p<0.001, p<0.001 and p = 0.008; respectively). The NLR, PLR and MHR were also significantly higher in the RVO group compared to the control group (p<0.001, p = 0.001 and p = 0.012, respectively). The NLR and PLR were significantly higher in the RAO group compared to the RVO group (p<0.001 and p = 0.022, respectively). The optimal cut-off value of NLR to predict RAO was >2.99, with 90.2% sensitivity and 100% specificity. The PLR to predict RAO was > 145.52, with 75.6% sensitivity and 80.0% specificity. Conclusion Higher NLR, PLR and MHR are related to the occurrence of RAO and RVO. NLR and PLR are more prominent in RAO compared to RVO.	[Qin, Guanghao; Zhang, Hongda; Pazo, Emmanuel Eric; Dai, Guangzheng; Yao, Qingchi; He, Wei; Xu, Ling; Lin, Tiezhu] He Eye Specialist Hosp, Shenyang, Liaoning, Peoples R China; [Qin, Guanghao] Dalian Med Univ, Dalian, Liaoning, Peoples R China; [He, Fang] Peoples Liberat Army Gen Hosp, Med Ctr 8, Beijing, Peoples R China	Dalian Medical University; Chinese People's Liberation Army General Hospital	Xu, L; Lin, TZ (corresponding author), He Eye Specialist Hosp, Shenyang, Liaoning, Peoples R China.	xuling@hsyk.com.cn; 360970814@qq.com		Lin, Tiezhu/0000-0001-6000-8774; GUANGHAO, QIN/0000-0003-1596-7970	National Science Foundation of Liaoning Province, China [2020-MS-360]; Science and Technology Program of Shenyang, China [20-2054-063]	National Science Foundation of Liaoning Province, China; Science and Technology Program of Shenyang, China	This study was supported in part by the National Science Foundation of Liaoning Province, China (2020-MS-360), and Science and Technology Program of Shenyang, China (20-2054-063).	Akboga MK, 2016, ANGIOLOGY, V67, P89, DOI 10.1177/0003319715583186; Angkananard T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2703518; Atum M, 2020, J OPHTHAL VIS RES, V15, P195, DOI 10.18502/jovr.v15i2.6737; Bolayir A, 2018, NEUROL NEUROCHIR POL, V52, P150, DOI 10.1016/j.pjnns.2017.08.011; de Boer OJ, 2013, THROMB HAEMOSTASIS, V109, P290, DOI 10.1160/TH12-06-0425; Dursun A, 2015, EUR J OPHTHALMOL, V25, P343, DOI 10.5301/ejo.5000570; Elbeyli A, 2021, OCUL IMMUNOL INFLAMM, DOI 10.1080/09273948.2021.1986546; Eter N, 2017, GRAEF ARCH CLIN EXP, V255, P77, DOI 10.1007/s00417-016-3431-x; Flaxel CJ, 2020, OPHTHALMOLOGY, V127, pP288, DOI 10.1016/j.ophtha.2019.09.029; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Guven S, 2021, OCUL IMMUNOL INFLAMM, V29, P997, DOI 10.1080/09273948.2020.1712433; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1928, DOI 10.1016/j.ophtha.2009.03.006; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Kim JH, 2015, ANN SURG TREAT RES, V89, P81, DOI 10.4174/astr.2015.89.2.81; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Korobelnik JF, 2016, GRAEF ARCH CLIN EXP, V254, P2307, DOI 10.1007/s00417-016-3394-y; Kumral ET, 2016, SAUDI J OPHTHALMOL, V30, P105, DOI 10.1016/j.sjopt.2016.02.003; Kurtul BE, 2020, THER ADV OPHTHALMOL, V12, DOI 10.1177/2515841420971949; Kurtul BE, 2019, INT J OPHTHALMOL-CHI, V12, P1951, DOI 10.18240/ijo.2019.12.18; Kuyumcu ME, 2012, DEMENT GERIATR COGN, V34, P69, DOI 10.1159/000341583; Laridan E, 2019, SEMIN THROMB HEMOST, V45, P86, DOI 10.1055/s-0038-1677040; Li XX, 2018, GRAEF ARCH CLIN EXP, V256, P59, DOI 10.1007/s00417-017-3831-6; Libby P, 2001, AM J CARDIOL, V88, p3J; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Liu ZY, 2022, ACTA OPHTHALMOL, V100, pE635, DOI 10.1111/aos.14955; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Mirza E, 2020, OCUL IMMUNOL INFLAMM, V28, P142, DOI 10.1080/09273948.2018.1545913; Nakazawa D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00333; Pick J, 2020, ACTA OPHTHALMOL, V98, pE656, DOI 10.1111/aos.14369; Pinna A, 2021, ACTA OPHTHALMOL, V99, P637, DOI 10.1111/aos.14699; Pinna A, 2021, OPHTHAL EPIDEMIOL, V28, P39, DOI 10.1080/09286586.2020.1791349; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Rehak M, 2010, J THROMB HAEMOST, V8, P1886, DOI 10.1111/j.1538-7836.2010.03909.x; Rezar-Dreindl S, 2017, ACTA OPHTHALMOL, V95, pE119, DOI 10.1111/aos.13152; Riegger J, 2016, EUR HEART J, V37, P1538, DOI 10.1093/eurheartj/ehv419; Sahin M, 2020, CLIN EXP OPTOM, V103, P490, DOI 10.1111/cxo.13008; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schmidt-Erfurth U, 2019, OPHTHALMOLOGICA, V242, P123, DOI 10.1159/000502041; Scott IU, 2020, LANCET, V396, P1927, DOI 10.1016/S0140-6736(20)31559-2; Seidman Michael A, 2012, Surg Pathol Clin, V5, P435, DOI 10.1016/j.path.2012.04.006; Shchors K, 2013, ONCOGENE, V32, P502, DOI 10.1038/onc.2012.60; Sonmez O, 2013, ANATOL J CARDIOL, V13, P662, DOI 10.5152/akd.2013.188; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Wallsh J., 2020, CLIN OPHTHALMOL, DOI [10.2147/OPTH.S264559 33116361, DOI 10.2147/OPTH.S26455933116361]; Woo SCY, 2016, EYE, V30, P1031, DOI 10.1038/eye.2016.111; Yayla C, 2017, ANGIOLOGY, V68, P651, DOI 10.1177/0003319716664026; Yi QY, 2020, ACTA OPHTHALMOL, V98, pE309, DOI 10.1111/aos.14248; Zeng YK, 2019, MOL VIS, V25, P756; Zhu DD, 2019, J OPHTHALMOL, V2019, DOI 10.1155/2019/6043612	50	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263587	10.1371/journal.pone.0263587	http://dx.doi.org/10.1371/journal.pone.0263587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113973	gold, Green Published			2022-12-26	WOS:000823694700108
J	Takigami, M; Tsubata, H; Nakanishi, N; Matsubara, Y; Wakana, N; Yanishi, K; Zen, K; Nakamura, T; Matoba, S				Takigami, Masao; Tsubata, Hideo; Nakanishi, Naohiko; Matsubara, Yuki; Wakana, Noriyuki; Yanishi, Kenji; Zen, Kan; Nakamura, Takeshi; Matoba, Satoaki			The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension	PLOS ONE			English	Article							ENDARTERECTOMY; RIOCIGUAT	Background Balloon pulmonary angioplasty (BPA) is an effective treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). The purpose of this study is to evaluate the therapeutic effect and safety of the non-slip element percutaneous transluminal angioplasty (NSE PTA) scoring balloons in BPA. Methods 108 pulmonary artery branches in 14 CTEPH patients who underwent BPA using NSE PTA scoring balloon (the NSE PTA group) or plain balloon (the POBA group) and pressure gradient evaluation were analyzed. We compared the improvement of the pressure ratios after BPA (Delta Pressure ratio) of both groups. Results There was no significant difference in the Delta Pressure ratios of the two groups (0.241 +/- 0.196 POBA, 0.259 +/- 0.177 NSE PTA, p = 0.63). No complications occurred in the NSE PTA group, while 3 episodes of hemoptysis were seen in the POBA group. This, however, was not found to be significant (p = 0.27). In the cases where balloon-to-vessel ratio exceeded 1.0 (n = 35), multivariate analysis showed that the use of NSE PTA scoring balloon and pressure ratio before BPA were significantly correlated with Delta Pressure ratio (beta coefficient: 0.047, 95% CI: 0.0016 to 0.093, p = 0.043 and beta coefficient: -0.60, 95% CI: -0.78 to -0.42, p < 0.01, respectively). Conclusions Although NSE PTA scoring balloon was safe, there was no significant pressure gradient improvement with NSE PTA scoring balloon compared to conventional BPA. Nevertheless, the NSE PTA scoring balloon showed effective blood-flow improvement in the case of large balloon-to-vessel ratio.	[Takigami, Masao; Tsubata, Hideo; Nakanishi, Naohiko; Matsubara, Yuki; Wakana, Noriyuki; Yanishi, Kenji; Zen, Kan; Nakamura, Takeshi; Matoba, Satoaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Kyoto, Japan	Kyoto Prefectural University of Medicine	Nakanishi, N (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Kyoto, Japan.	naka-nao@koto.kpu-m.ac.jp						Aoki J, 2019, J CARDIOL, V74, P436, DOI 10.1016/j.jjcc.2019.04.011; Bonderman D, 2007, CIRCULATION, V115, P2153, DOI 10.1161/CIRCULATIONAHA.106.661041; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Fearon WF, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005905; Feinstein JA, 2001, CIRCULATION, V103, P10; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Fukui S, 2014, EUR RESPIR J, V43, P1394, DOI 10.1183/09031936.00012914; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Hong H, 2021, VASC ENDOVASC SURG, V55, P135, DOI 10.1177/1538574420968977; Horie K, 2020, J ENDOVASC THER, V27, P481, DOI 10.1177/1526602820914618; Inami T, 2014, JACC-CARDIOVASC INTE, V7, P1297, DOI 10.1016/j.jcin.2014.06.010; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Karashima E, 2020, J ENDOVASC THER, V27, P102, DOI 10.1177/1526602819887954; Kim NH, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01915-2018; Kinutani H, 2016, IJC HEART VASC, V11, P1, DOI 10.1016/j.ijcha.2015.11.006; Lang I, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0119-2016; Matsukawa R, 2019, CARDIOVASC INTERV TH, V34, P325, DOI 10.1007/s12928-019-00578-w; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Nakanishi N, 2019, HEART LUNG CIRC, V28, P655, DOI 10.1016/j.hlc.2018.08.008; Ogawa A, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004029; Shimokawahara H, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.006010; Simonneau G, 2015, EUR RESPIR J, V45, P1293, DOI 10.1183/09031936.00087114; Soga Y, 2018, CARDIOVASC INTERV TH, V33, P35, DOI 10.1007/s12928-016-0430-0; Sugawara Y, 2019, CARDIOVASC INTERV TH, V34, P242, DOI 10.1007/s12928-018-0553-6; Sugimura K, 2012, CIRC J, V76, P485, DOI 10.1253/circj.CJ-11-1217; Taniguchi Y, 2021, INT J CARDIOL, V326, P170, DOI 10.1016/j.ijcard.2020.10.026	26	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263244	10.1371/journal.pone.0263244	http://dx.doi.org/10.1371/journal.pone.0263244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113935	gold, Green Published			2022-12-26	WOS:000823694700068
J	Candoni, A; Petruzzellis, G; Sperotto, A; Andreotti, V; Giavarra, M; Corvaja, C; Minisini, A; Comuzzi, C; Tascini, C; Fanin, R; Fasola, G				Candoni, Anna; Petruzzellis, Giuseppe; Sperotto, Alessandra; Andreotti, Victoria; Giavarra, Marco; Corvaja, Carla; Minisini, Alessandro; Comuzzi, Chiara; Tascini, Carlo; Fanin, Renato; Fasola, Gianpiero			Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave	PLOS ONE			English	Article							COVID-19; ONCOLOGY	Introduction Even if now we have available the weapon of vaccination against SARS-CoV-2, the patients with cancer remains a very frail population in which frequently the immunologic response to vaccination may be impaired. In this setting, the SARS-CoV-2 infection screening retains a great value. However, there are still limited data on the feasibility and efficacy of combined screening procedures to assess the prevalence of SARS-CoV-2 infection (including asymptomatic cases) in cancer outpatients undergoing antineoplastic therapy. Patients and results From May 1, 2020, to June 15, 2020, during the first wave of SARS-CoV-2 pandemic, 860 consecutive patients, undergoing active anticancer therapy, were evaluated and tested for SARS-CoV-2 with a combined screening procedure, including a self-report questionnaire, a molecular nasopharyngeal swab (NPS) and a rapid serological immunoassay (for anti-SARS-CoV-2 IgG/IgM antibodies). The primary endpoint of the study was to estimate the prevalence of SARS-CoV-2 infection (including asymptomatic cases) in consecutive and unselected cancer outpatients by a combined screening modality. A total of 2955 SARS-CoV-2 NPS and 860 serological tests, in 475 patients with hematologic cancers and in 386 with solid tumors, were performed. A total of 112 (13%) patients self-reported symptoms potentially COVID-19 related. In 1/860 cases (<1%) SARS-CoV-2 NPS was positive and in 14 cases (1.62%) the specific serological test was positive (overall prevalence of SARS-CoV-2 infection 1.62%). Of the 112 cases who declared symptoms potentially COVID-19-related, only 2.7% (3/112) were found SARS-CoV-2 positive. Conclusions This is the largest study reporting the feasibility of a combined screening procedure (including triage, NPS and serologic test) to evaluate the prevalence of SARS-CoV-2 infection in cancer patients receiving active therapy, during the first epidemic wave and under the restrictive lockdown measures, in one of the active areas of the SARS-CoV-2 circulation. Lacking specific recommendations for the detection of asymptomatic SARS-CoV-2 cases, a combined diagnostic screening might be more effective to detect the exact prevalence of SARS-CoV-2 in neoplastic patient population. The prevalence can obviously change according to the territorial context, the entity of the restrictive measures adopted and the phase of the epidemic curve. However, its exact and real-time knowledge could be important to balance risks/benefits of oncologic treatments, avoiding (if the prevalence is low) the reduction of dose intensity or the selection of less intensive (but also less effective) anti-cancer therapies.	[Candoni, Anna; Petruzzellis, Giuseppe; Sperotto, Alessandra; Comuzzi, Chiara; Fanin, Renato] ASUFC, Dept Hematol & SCT, Santa Maria della Misericordia Hosp, Udine, Italy; [Andreotti, Victoria; Giavarra, Marco; Corvaja, Carla; Minisini, Alessandro; Fasola, Gianpiero] ASUFC, Dept Oncol, Santa Maria della Misericordia Hosp, Udine, Italy; [Tascini, Carlo] ASUFC, Dept Infect Dis, Santa Maria della Misericordia Hosp, Udine, Italy; [Tascini, Carlo; Fanin, Renato] Univ Udine, DAME, Udine, Italy	Hospital Santa Maria della Misericordia; Hospital Santa Maria della Misericordia; Hospital Santa Maria della Misericordia; University of Udine	Candoni, A (corresponding author), ASUFC, Dept Hematol & SCT, Santa Maria della Misericordia Hosp, Udine, Italy.	anna.candoni@asufc.sanita.fvg.it		GIAVARRA, Marco/0000-0002-9345-126X				Brandes AA, 2020, EXPERT REV ANTICANC, V20, P429, DOI 10.1080/14737140.2020.1766355; Cabezon-Gutierrez L, 2020, CANCER TREAT REV, V90, DOI 10.1016/j.ctrv.2020.102102; Cantini L, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071503; Cortiula F, 2020, ANN ONCOL, V31, P553, DOI 10.1016/j.annonc.2020.03.286; Curigliano G, 2020, ANN ONCOL, V31, P1320, DOI 10.1016/j.annonc.2020.07.010; ECDC, RISK ASSESSMENT RISK; Fasola G, 2021, ONCOLOGIST, V26, pE694, DOI 10.1002/onco.13706; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001; Garattini SK, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-01400-x; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Hanna TP, 2020, NAT REV CLIN ONCOL, V17, P268, DOI 10.1038/s41571-020-0362-6; Indini A, 2021, CANCER-AM CANCER SOC, V127, P1091, DOI 10.1002/cncr.33366; Klompas M, 2020, ANN INTERN MED, V172, P619, DOI 10.7326/M20-0751; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Ladoire S, 2021, EUR J CANCER, V148, P359, DOI 10.1016/j.ejca.2021.02.027; Lee LYW., 2020, LANCET, V395, P1919, DOI [10.1016/S0140-6736(20)31173-9, DOI 10.1016/S0140-6736(20)31173-9]; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Maple PAC, 2021, CLIN ONCOL-UK, V33, pE73, DOI 10.1016/j.clon.2020.10.008; Marra A, 2021, ANN ONCOL, V32, P113, DOI 10.1016/j.annonc.2020.10.473; Marron JM, 2020, J CLIN ONCOL, V38, P2201, DOI 10.1200/JCO.20.00960; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Passamonti F, 2020, LANCET HAEMATOL, V7, pE737, DOI 10.1016/S2352-3026(20)30251-9; Passaro A, 2020, ANN ONCOL, V31, P832, DOI 10.1016/j.annonc.2020.04.002; Richards M, 2020, NAT CANCER, V1, P565, DOI 10.1038/s43018-020-0074-y; Saini KS, 2020, EUR J CANCER, V139, P43, DOI 10.1016/j.ejca.2020.08.011; Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124; Tartarone A, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-01406-5; Ternovoi V A, 2020, Klin Lab Diagn, V65, P785, DOI 10.18821/0869-2084-2020-65-12-785-792; Tian JB, 2020, LANCET ONCOL, V21, P893, DOI 10.1016/S1470-2045(20)30309-0; Ueda M, 2020, J NATL COMPR CANC NE, V18, P366, DOI 10.6004/jnccn.2020.7560; van de Haar J, 2020, NAT MED, V26, P665, DOI [10.1038/s41591-020-0874-8, 10.1038/s41591-020-0948-7]; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Wang YS, 2020, J MED VIROL, V92, P1401, DOI 10.1002/jmv.25990; Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461; Zambelli A, 2021, ONCOLOGIST, V26, P341, DOI 10.1002/onco.13654	44	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262784	10.1371/journal.pone.0262784	http://dx.doi.org/10.1371/journal.pone.0262784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108300	Green Published, gold			2022-12-26	WOS:000775890100037
J	Coyle, PV; El Kahlout, RA; Dargham, SR; Chemaitelly, H; Kacem, MAB; Al-Mawlawi, NHA; Gilliani, I; Younes, N; Al Kanaani, Z; Al Khal, A; Al Kuwari, E; Jeremijenko, A; Kaleeckal, AH; Latif, AN; Shaik, RM; Rahim, HFA; Nasrallah, GK; Yassine, HM; Al Kuwari, MG; Al Romaihi, HE; Tang, P; Bertollini, R; Al-Thani, MH; Abu-Raddad, LJ				Coyle, Peter, V; El Kahlout, Reham Awni; Dargham, Soha R.; Chemaitelly, Hiam; Kacem, Mohamed Ali Ben Hadj; Al-Mawlawi, Naema Hassan Abdulla; Gilliani, Imtiaz; Younes, Nourah; Al Kanaani, Zaina; Al Khal, Abdullatif; Al Kuwari, Einas; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Rahim, Hanan F. Abdul; Nasrallah, Gheyath K.; Yassine, Hadi M.; Al Kuwari, Mohamed G.; Al Romaihi, Hamad Eid; Tang, Patrick; Bertollini, Roberto; Al-Thani, Mohamed H.; Abu-Raddad, Laith J.			Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2	PLOS ONE			English	Article							INFECTION	This study investigated the performance of a rapid point-of-care antibody test, the BioMedomics COVID-19 IgM/IgG Rapid Test, in comparison with a high-quality, validated, laboratory-based platform, the Roche Elecsys Anti-SARS-CoV-2 assay. Serological testing was conducted on 709 individuals. Concordance metrics were estimated. Logistic regression was used to assess associations with seropositivity. SARS-CoV-2 seroprevalence was 63.5% (450/709; 95% CI 59.8%-67.0%) using the BioMedomics assay and 71.9% (510/709; 95% CI 68.5%-75.2%) using the Elecsys assay. There were 60 discordant results between the two assays, all of which were seropositive in the Elecsys assay, but seronegative in the BioMedomics assay. Overall, positive, and negative percent agreements between the two assays were 91.5% (95% CI 89.2%-93.5%), 88.2% (95% CI 85.1%-90.9%), and 100% (95% CI 98.2%-100%), respectively, with a Cohen's kappa of 0.81 (95% CI 0.78-0.84). Excluding specimens with lower (Elecsys) antibody titers, the agreement improved with overall, positive, and negative percent concordance of 94.4% (95% CI 92.3%-96.1%), 91.8% (95% CI 88.8%-94.3%), and 100% (95% CI 98.2%-100%), respectively, and a Cohen's kappa of 0.88 (95% CI 0.85-0.90). Logistic regression confirmed better agreement with higher antibody titers. The BioMedomics COVID-19 IgM/IgG Rapid Test demonstrated good performance in measuring detectable antibodies against SARS-CoV-2, supporting the utility of such rapid point-of-care serological testing to guide the public health responses and vaccine prioritization.	[Coyle, Peter, V; El Kahlout, Reham Awni; Kacem, Mohamed Ali Ben Hadj; Al-Mawlawi, Naema Hassan Abdulla; Gilliani, Imtiaz; Younes, Nourah; Al Kanaani, Zaina; Al Khal, Abdullatif; Al Kuwari, Einas; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad] Hamad Med Corp, Doha, Qatar; [Coyle, Peter, V; Nasrallah, Gheyath K.; Yassine, Hadi M.] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Coyle, Peter, V] Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [Dargham, Soha R.; Chemaitelly, Hiam; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Univ Qatar Fdn Educ City, Doha, Qatar; [Dargham, Soha R.; Chemaitelly, Hiam; Abu-Raddad, Laith J.] Cornell Univ, Who Collaborating Ctr Dis Epidemiol Analyt HIV AI, Sexually Transmitted Infect & Viral Hepatitis, Weill Cornell Med Qatar,Qatar Fdn Educ City, Doha, Qatar; [Rahim, Hanan F. Abdul] Qatar Univ, Coll Hlth Sci, QU Hlth, Doha, Qatar; [Nasrallah, Gheyath K.; Yassine, Hadi M.] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar; [Nasrallah, Gheyath K.; Yassine, Hadi M.] Qatar Univ, QU Hlth, Doha, Qatar; [Al Kuwari, Mohamed G.] Primary Hlth Care Corp, Doha, Qatar; [Al Romaihi, Hamad Eid; Bertollini, Roberto; Al-Thani, Mohamed H.] Minist Publ Hlth, Doha, Qatar; [Tang, Patrick] Dept Pathol, Sidra Med, Doha, Qatar; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med, Dept Populat Hlth Sci, New York, NY 10021 USA	Hamad Medical Corporation; Qatar University; Queens University Belfast; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar University; Qatar University; Qatar University; Hamad Medical Corporation; Primary Health Care Corporation (PHCC); Sidra Medical & Research Center; Cornell University	Coyle, PV (corresponding author), Hamad Med Corp, Doha, Qatar.; Coyle, PV (corresponding author), Qatar Univ, Biomed Res Ctr, Doha, Qatar.; Coyle, PV (corresponding author), Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Univ Qatar Fdn Educ City, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Who Collaborating Ctr Dis Epidemiol Analyt HIV AI, Sexually Transmitted Infect & Viral Hepatitis, Weill Cornell Med Qatar,Qatar Fdn Educ City, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med, Dept Populat Hlth Sci, New York, NY 10021 USA.	pcoyle@hamad.qa; lja2002@qatar-med.cornell.edu	Nasrallah, Gheyath K/H-7949-2019; YASSINE, HADI M./AAW-6475-2020	YASSINE, HADI M./0000-0001-7592-2788; Jeremijenko, Andrew Martin/0000-0002-0375-2713; Chemaitelly, Hiam/0000-0002-8756-6968	Hamad Medical Corporation; Ministry of Public Health; Biomedical Research Program at Weill Cornell Medicine-Qatar; Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar	Hamad Medical Corporation; Ministry of Public Health; Biomedical Research Program at Weill Cornell Medicine-Qatar(Qatar National Research Fund (QNRF)); Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar(Qatar National Research Fund (QNRF))	The authors are grateful for support provided by Hamad Medical Corporation, the Ministry of Public Health, and the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine-Qatar. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2021, CLIN INFECT DIS, V73, pE1830, DOI 10.1093/cid/ciaa1846; Abu-Raddad LJ, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab083; Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Abu-Raddad LJ, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100861; Abu-Raddad LJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85428-7; Abu-Raddad LJ, 2021, INFECT GENET EVOL, V88, DOI 10.1016/j.meegid.2020.104684; Al Kuwari HM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040428; Al-Thani MH, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab221; Ayoub HH, 2021, BMJ INNOV, V7, P327, DOI 10.1136/bmjinnov-2021-000677; Ayoub HH, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.05005; Babiker A, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02769-20; Bertollini R, 2021, JAMA-J AM MED ASSOC, V326, P185, DOI 10.1001/jama.2021.9970; BioMedomics I, 2020, COVID 19 IGM IGG RAP; Chemaitelly H., 2021, IN PRESS; Coyle PV, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102646; Ebinger JE, 2021, NAT MED, V27, P981, DOI 10.1038/s41591-021-01325-6; Fleiss JL., 2013, STAT METHODS RATES P, P598; Hamad Medical Corporation, 2020, NAT SARS COV 2 PCR T; Jahrsdorfer B, 2021, J INFECT DIS, V223, P796, DOI 10.1093/infdis/jiaa656; Jeremijenko A, 2021, EMERG INFECT DIS, V27, P1343, DOI [10.3201/eid2705.20.4365, 10.3201/eid2705.204365]; Kalikiri MKR., 2020, MEDRXIV, DOI [10.1101/2020.04.08.20055731, DOI 10.1101/2020.04.08.20055731]; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Kubina R, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060434; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Manisty C, 2021, LANCET, V397, P1057, DOI 10.1016/S0140-6736(21)00501-8; Muench P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01694-20; Nasrallah GK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91235-x; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Oved K, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100651; Seedat S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97606-8; The Roche Group, 2020, ROCH COVID 19 ANT TE; Thermo Fisher Scientific, TAQPATH COVID 19 CE; US Food and Drug Administration, COB SARS COV 2 QUAL; WHO, 2020, CLIN MAN COVID 19	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262897	10.1371/journal.pone.0262897	http://dx.doi.org/10.1371/journal.pone.0262897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100295	Green Published, Green Submitted, gold			2022-12-26	WOS:000801937600023
J	Xu, QC; Tien, YC; Shi, YH; Chen, S; Zhu, YQ; Huang, XT; Huang, CS; Zhao, W; Yin, XY				Xu, Qiong-Cong; Tien, Yi-Chih; Shi, Yin-Hao; Chen, Siyun; Zhu, Ying-Qin; Huang, Xi-Tai; Huang, Chen-Song; Zhao, Wei; Yin, Xiao-Yu			METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner	ONCOGENE			English	Article							CANCER; RNA	N6-methyladenosine (m(6)A) RNA methylation has recently been found involving in regulatory mechanism of the tumor progression. Our aim was to explore the biological function and clinical significance of the m(6)A methyltransferase METTL3 in intrahepatic cholangiocarcinoma (ICC). In this study, we revealed that METTL3 was upregulated and predicted poor prognosis of patients with ICC. Multivariate regression analysis demonstrated that METTL3 expression was an independent predictor for overall survival in patients with ICC. Moreover, METTL3 knockdown inhibited ICC progression, while METTL3 overexpression showed the opposite effect. METTL3 inhibitor STM2457 also showed anti-tumor effect in ICC. Mechanistically, METTL3 transcription was driven by H3K4me3 activation. Upregulation of METTL3 mediated m(6)A modification of IFIT2 mRNA and accelerated IFIT2 mRNA decay in a YTHDF2-dependent manner, which promoted the development of ICC and lead to poorer prognosis. In summary, our findings revealed that H3K4me3 activation-driven METTL3 transcription promotes ICC progression by YTHDF2-mediated IFIT2 mRNA degradation, suggesting that METTL3 may serve as a potential target for human ICC therapy.	[Xu, Qiong-Cong; Tien, Yi-Chih; Shi, Yin-Hao; Zhu, Ying-Qin; Huang, Xi-Tai; Huang, Chen-Song; Yin, Xiao-Yu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, Guangzhou 510080, Peoples R China; [Chen, Siyun; Zhao, Wei] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Peoples R China; [Zhao, Wei] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangzhou 510080, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Yin, XY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, Guangzhou 510080, Peoples R China.; Zhao, W (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Peoples R China.; Zhao, W (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangzhou 510080, Peoples R China.	zhaowei23@mail.sysu.edu.cn; yinxy@mail.sysu.edu.cn			National Natural Science Foundation of China [81772522, 82002501, 82072644, 81972651, 31771630]; Guangdong Basic and Applied Basic Research Foundation [2021A1515010123, 2019A1515010096, 2019A1515010686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation	The authors greatly acknowledge the financial support from National Natural Science Foundation of China (81772522, 82002501, 82072644, 81972651, and 31771630), the Guangdong Basic and Applied Basic Research Foundation (2021A1515010123, 2019A1515010096 and 2019A1515010686).	Cai XL, 2018, CANCER LETT, V415, P11, DOI 10.1016/j.canlet.2017.11.018; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Cheng MS, 2019, ONCOGENE, V38, P3667, DOI 10.1038/s41388-019-0683-z; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; He LE, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1109-9; Huang CS, 2018, CANCER LETT, V421, P63, DOI 10.1016/j.canlet.2018.02.020; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jusakul A, 2017, CANCER DISCOV, V7, P1116, DOI 10.1158/2159-8290.CD-17-0368; Koh SY, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030624; Lai KC, 2013, ONCOGENE, V32, P3686, DOI 10.1038/onc.2012.384; Lai KC, 2016, CANCER LETT, V370, P207, DOI 10.1016/j.canlet.2015.10.016; Li JF, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01267-6; Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Nepal C, 2018, HEPATOLOGY, V68, P949, DOI 10.1002/hep.29764; Pidugu VK, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00148; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157; Shen H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0107-3; Shroff RT, 2019, JAMA ONCOL, V5, P824, DOI 10.1001/jamaoncol.2019.0270; Su WY, 2019, ONCOTARGETS THER, V12, P8139, DOI 10.2147/OTT.S220698; Valle Juan, 2010, N Engl J Med, V362, P1273, DOI 10.1056/NEJMoa0908721; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang HS, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1108-x; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wardell CP, 2018, J HEPATOL, V68, P959, DOI 10.1016/j.jhep.2018.01.009; Yang C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03143-z; Yankova E, 2021, NATURE, V593, P597, DOI 10.1038/s41586-021-03536-w; Zeng CW, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00951-w	31	9	9	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1622	1633		10.1038/s41388-022-02185-1	http://dx.doi.org/10.1038/s41388-022-02185-1		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35094011	hybrid, Green Published			2022-12-26	WOS:000750486500004
J	Adhikari, N; Bhattarai, RB; Basnet, R; Joshi, LR; Tinkari, BS; Thapa, A; Joshi, B				Adhikari, Nilaramba; Bhattarai, Ratna Bahadur; Basnet, Rajendra; Joshi, Lok Raj; Tinkari, Bhim Singh; Thapa, Anil; Joshi, Basant			Prevalence and associated risk factors for tuberculosis among people living with HIV in Nepal	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; POSITIVE PATIENTS; INFECTION; INFANTS; HAART; TERM	Background Worldwide tuberculosis (TB) takes more lives than any other infectious diseases. WHO estimates around 68,000 incident TB cases in Nepal. However, in 2018 only around 27,232 new TB cases were reported in the national system, resulting around 40,768 incident TB cases missing every year in Nepal. National Tuberculosis Control Center carried out this study in anti-retroviral therapy (ART) sites to estimate the prevalence of TB and identify the associated risk factors for TB among the people living with Human Immunodeficiency Virus (PLHIVs) in Nepal. Methods It was a cross-sectional institution-based study conducted between March and August 2018. Six ART sites with high caseloads of PLHIVs were selected. PLHIVs who were equal or above 18 years of age and were in ART program at the selected study sites were considered eligible for the study. Diagnosis of tuberculosis among PLHIVs who agreed to participate in the study was carried out as per the National Tuberculosis Management Guideline of National Tuberculosis Program of Nepal. Results Among 403 PLHIVs, tuberculosis was diagnosed in 40 (9.9%) individuals. Median age of the participants was 36 (30-43) years. Prevalence of TB was significantly higher among male PLHIVs than female PLHIVs (13.6% Vs 5.8%; P = 0.02) and Dalit ethnic group compared to Brahmin/Chettri (22.0%Vs5.9%, P = 0.01). The risk of developing TB was found significant among those with HIV stage progressed to WHO stage 3 and 4 (OR = 4.85, P<0.001) and with the family history of TB (OR = 4.50, P = 0.002). Conclusions Prevalence of TB among PLHIVs in Nepal was found 9.9%. Risk of developing TB was higher among PLHIVs who were male, Dalit, with HIV stage progressed to WHO stage 3 and 4 and with family history of TB. Hence, targeted interventions are needed to prevent the risk of developing TB among PLHIVs. Similarly, integrated, and comprehensive TB and HIV diagnosis and treatment services are needed for the management of TB/HIV co-infection in Nepal.	[Adhikari, Nilaramba] Tribhuvan Univ, Inst Med, Cent Dept Publ Hlth, Kathmandu, Nepal; [Bhattarai, Ratna Bahadur; Basnet, Rajendra; Joshi, Lok Raj] Natl TB Control Ctr, Thimi, Bhaktapur, Nepal; [Tinkari, Bhim Singh; Thapa, Anil] Minist Hlth & Populat, Dept Hlth Serv, Kathmandu, Nepal; [Joshi, Basant] Univ Bordeaux, Inst Rech Dev IRD, UMR 1219, INSERM, Bordeaux, France	Tribhuvan University; Institute of Medicine (IoM) - Nepal; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Adhikari, N (corresponding author), Tribhuvan Univ, Inst Med, Cent Dept Publ Hlth, Kathmandu, Nepal.; Bhattarai, RB (corresponding author), Natl TB Control Ctr, Thimi, Bhaktapur, Nepal.	nilaramba4u@gmail.com; rbhattrai@gmail.com		Adhikari, Nilaramba/0000-0002-5074-1670				Adhikari N., 2019, SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, V17, P34; Assebe LF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1719-0; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bruchfeld J, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017871; Codlin AJ, 2011, AM J TROP MED HYG, V85, P514, DOI 10.4269/ajtmh.2011.10-0701; Cotton MF, 2008, INT J TUBERC LUNG D, V12, P225; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Dhungana G P, 2013, Nepal Med Coll J, V15, P113; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Ghimire U., 2019, DHS FURTH ANAL REP, V117; Gunda DW, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/1346104; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Kruk A, 2011, AIDS, V25, P1505, DOI 10.1097/QAD.0b013e328348fafd; Kyu HH, 2018, LANCET INFECT DIS, V18, P1329, DOI 10.1016/S1473-3099(18)30625-X; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Batista JDL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063916; Martin-Echevarria E, 2014, INT J TUBERC LUNG D, V18, P1080, DOI 10.5588/ijtld.13.0757; Meda ZC, 2013, AIDS RES HUM RETROV, V29, P1045, DOI [10.1089/aid.2012.0239, 10.1089/AID.2012.0239]; Ministry of Health and Population and New Era ICF Inc, 2017, NEP DEM HLTH SURV 20; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; National Center for AIDS and STD Control, 2020, HIV EP UPD NEP; National Tuberculosis Center, 2014, SENTINEL SURVEILLANC; National Tuberculosis Control Center, 2021, NAT TUB PROGR TUB PR; National Tuberculosis Control Center, 2017, TB HIV COINF; Nepal Health Sector Support Program, 2020, IMPR US HLTH MAN INF; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Ngosa K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3547-2; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Pathmanathan I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173309; Peters JS, 2019, LANCET INFECT DIS, V19, pE65, DOI 10.1016/S1473-3099(18)30477-8; Rosenman KD, 1996, AM J IND MED, V30, P148, DOI 10.1002/(SICI)1097-0274(199608)30:2<148::AID-AJIM5>3.0.CO;2-X; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Subedi M., 2016, NEPALI J CONT STUD, V16, P1; Suggaravetsiri P, 2003, INT J TUBERC LUNG D, V7, pS424; Taha M., 2011, ETHIOP J HEAL SCI, V21; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220; Verma S C, 2012, J Nepal Health Res Counc, V10, P32; Walzl G, 2018, LANCET INFECT DIS, V18, pE199, DOI 10.1016/S1473-3099(18)30111-7; World Health Organization, 2004, INT POL COLL TB HIV; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yirdaw KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104557	48	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262720	10.1371/journal.pone.0262720	http://dx.doi.org/10.1371/journal.pone.0262720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089953	gold, Green Published			2022-12-26	WOS:000769158400019
J	Du, RJ; Qu, YJ; Zhao, M; Liu, YH; Qi, PX; Sun, XB				Du, Renjie; Qu, Yuejun; Zhao, Min; Liu, Yanhong; Qi, Phoebe X.; Sun, Xingbin			Logistic modeling to predict the minimum inhibitory concentration (MIC) of olive leaf extract (OLE) against Listeria monocytogenes	PLOS ONE			English	Article							MICROBIAL-GROWTH; CURVES	Olive leaf extract (OLE) has been increasingly recognized as a natural and effective antimicrobial against a host of foodborne pathogens. This study attempts to predict the minimum inhibitory concentration (MIC) of OLE against Listeria monocytogenes F2365 by utilizing the asymptotic deceleration point (PDA) in a logistic model (LM), namely MIC-PDA. The experimental data obtained from the inhibitory rate (IR) versus OLE concentration against L. monocytogenes were sufficiently fitted (R-2 = 0.88957). Five significant critical points were derived by taking the multi-order derivatives of the LM function: the inflection point (PI), the maximum acceleration point (PAM), the maximum deceleration point (PDM), the absolute acceleration point (PAA), and the asymptotic deceleration point (PDA). The PDA ([OLE] = 37.055 mg/mL) was employed to approximate the MIC-PDA. This MIC value was decreased by over 42% compared to the experimental MIC of 64.0 mg/mL, obtained using the conventional 2-fold dilution method (i.e., MIC-2fold). The accuracy of MIC-PDA was evaluated by an in vitro L. monocytogenes growth inhibition assay. Finally, the logistic modeling method was independently validated using our previously published inhibition data of OLE against the growths of Escherichia coli O157:H7 and Salmonella enteritidis. The MIC-PDA (for [OLE]) values were estimated to be 41.083 and 35.313 mg/mL, respectively, compared to the experimental value of 62.5 mg/mL. Taken together, MIC-PDA, as estimated from the logistic modeling, holds the potential to shorten the time and reduce cost when OLE is used as an antimicrobial in the food industry.	[Du, Renjie; Zhao, Min; Sun, Xingbin] Northeast Forestry Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Du, Renjie; Qu, Yuejun] Mudanjiang Branch Heilongjiang Acad Forestry Sci, Mudanjiang, Heilongjiang, Peoples R China; [Liu, Yanhong] USDA, ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA USA; [Qi, Phoebe X.] United States Dept Agr, Agr Res Serv, Dairy & Funct Foods Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA USA	Northeast Forestry University - China; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Zhao, M (corresponding author), Northeast Forestry Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China.; Liu, YH (corresponding author), USDA, ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA USA.; Qi, PX (corresponding author), United States Dept Agr, Agr Res Serv, Dairy & Funct Foods Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA USA.	82191513@163.com; Yanhong.Liu@usda.gov; Phoebe.Qi@usda.gov	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022	Qi, Phoebe/0000-0003-1276-0878				Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Passos JRD, 2012, SCI AGR, V69, P308, DOI 10.1590/S0103-90162012000500004; Difonzo G, 2019, FOODS, V8, DOI 10.3390/foods8040138; Draper NR., 2014, WILEY SERIES PROBABI, V326, P736; Du RJ, 2020, NANOSCALE, V12, P5627, DOI 10.1039/c9nr10095d; Erdohan ZO., 2011, SCI MICROBIAL PATHOG, P1094; Haghighi H, 2020, FOOD HYDROCOLLOID, V100, DOI 10.1016/j.foodhyd.2019.105419; Han J. H., 2003, Novel food packaging techniques, P50, DOI 10.1533/9781855737020.1.50; Kakaei S, 2016, LWT-FOOD SCI TECHNOL, V72, P432, DOI 10.1016/j.lwt.2016.05.021; Korkmaz M., 2018, TURK J MATH COMPUT S, V10, P33; Kranz P, 2010, J FOOD SCI, V75, pS308, DOI 10.1111/j.1750-3841.2010.01698.x; Lagerweij M., 2019, IMPACT NUTR DIET ORA, P68; Liu YH, 2018, ACS SYM SER, V1287, P119; Liu YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00113; Marcos B, 2014, FOOD PACKAGING SHELF, V1, P140, DOI 10.1016/j.fpsl.2014.04.002; Marroki A., 2021, REFERENCE MODULE BIO, DOI [10.1007/s12602-021-09755-x, DOI 10.1007/S12602-021-09755-X]; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Ozcan MM, 2017, EUR FOOD RES TECHNOL, V243, P89, DOI 10.1007/s00217-016-2726-9; Pan YC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0220084; Peleg M, 2011, CRIT REV FOOD SCI, V51, P917, DOI 10.1080/10408398.2011.570463; Rychter AM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030814; Senol H, 2020, BIORESOURCE TECHNOL, V300, DOI 10.1016/j.biortech.2019.122660; SKINNER GE, 1994, J FOOD SAFETY, V14, P175, DOI 10.1111/j.1745-4565.1994.tb00594.x; Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990; Sudjana AN, 2009, INT J ANTIMICROB AG, V33, P461, DOI 10.1016/j.ijantimicag.2008.10.026; Tovissode CF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240578; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zhang FY, 2020, ACS OMEGA, V5, P7537, DOI 10.1021/acsomega.0c00352	29	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263359	10.1371/journal.pone.0263359	http://dx.doi.org/10.1371/journal.pone.0263359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089984	Green Published, gold			2022-12-26	WOS:000769158400059
J	Ings, DP; Hatfield, KM; Fifield, KE; Harnum, DOA; Holder, KA; Russell, RS; Grant, MD				Ings, Danielle P.; Hatfield, Keeley M.; Fifield, Kathleen E.; Harnum, Debbie O. A.; Holder, Kayla A.; Russell, Rodney S.; Grant, Michael D.			Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation	PLOS ONE			English	Article								Objective To assess the incidence of COVID-19 infection in the absence of a confirmatory test in persons suspecting they contracted COVID-19 and elucidate reasons for their belief. Methods We recruited persons with a confirmed COVID-19 diagnosis and persons who believed they may have contracted COVID-19 between December, 2019 and April, 2021 into a study of immunity against SARS-CoV-2. An intake questionnaire captured their perceived risk factors for exposure and symptoms experienced, including symptom duration and severity. ELISA testing against multiple SARS-CoV-2 antigens was done to detect antibodies against SARS-CoV-2. No participant had received COVID-19 vaccination prior to the time of testing. Results The vast majority of study subjects without Public Health confirmation of infection had no detectable antibodies against SARS-CoV-2. Suspected infection with SARS-CoV-2 generally involved experiencing symptoms common to many other respiratory infections. Unusually severe or persistent symptoms often supported suspicion of infection with SARS-CoV-2 as did travel or contact with travelers from outside Newfoundland and Labrador. Rare cases in which antibodies against SARS-CoV-2 were detected despite negative results of Public Health testing for SARS-CoV-2 RNA involved persons in close contact with confirmed cases. Conclusions Broad public awareness and declaration of pandemic status in March, 2020 contributed to the perceived risk of contracting COVID-19 in Newfoundland and Labrador from late 2019 to April 2021 and raised expectation of its severity. Serological testing is useful to diagnose past infection with SARS-CoV-2 to accurately estimate population exposure rates.	[Ings, Danielle P.; Hatfield, Keeley M.; Fifield, Kathleen E.; Holder, Kayla A.; Russell, Rodney S.; Grant, Michael D.] Mem Univ Newfoundland, Div Biomed Sci, Fac Med, St John, NF, Canada; [Harnum, Debbie O. A.] Eastern Hlth Reg Hlth Author, St John, NF, Canada	Memorial University Newfoundland	Grant, MD (corresponding author), Mem Univ Newfoundland, Div Biomed Sci, Fac Med, St John, NF, Canada.	mgrant@mun.ca						Anderson EM, 2021, CELL, V184, P1858, DOI 10.1016/j.cell.2021.02.010; Bagus P, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041376; Bryant JE, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc6347; Chen JZ, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2211; Daniali H, 2022, SCAND J PUBLIC HEALT, V50, P61, DOI 10.1177/14034948211018385; Daniali H, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.667722; Deslandes A, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.106006; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]; Jaiswal A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.590160; Lee SA, 2022, OMEGA-J DEATH DYING, V85, P483, DOI 10.1177/0030222820949350; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Marklund E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241104; Ogbe A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21856-3; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Pappas G, 2003, CLIN INFECT DIS, V37, P939, DOI 10.1086/377740; Pappas G, 2009, CLIN MICROBIOL INFEC, V15, P743, DOI 10.1111/j.1469-0691.2009.02947.x; Patel SKS, 2020, INDIAN J MICROBIOL, V60, P263, DOI 10.1007/s12088-020-00893-4; Pearce N, 2020, AM J PUBLIC HEALTH, V110, P949, DOI 10.2105/AJPH.2020.305708; Piscotta FJ, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00711-21; Rishi P, 2020, INDIAN J MICROBIOL, V60, P420, DOI 10.1007/s12088-020-00908-0; Roltgen K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0240; Rubin R, 2020, JAMA-J AM MED ASSOC, V324, P1381, DOI 10.1001/jama.2020.17709; Tilocca B, 2020, MICROBES INFECT, V22, P188, DOI 10.1016/j.micinf.2020.04.002; Tomes N, 2000, AM J PUBLIC HEALTH, V90, P191, DOI 10.2105/AJPH.90.2.191; Wang ZF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22036-z; Webster P, 2021, LANCET, V397, P183, DOI 10.1016/S0140-6736(21)00083-0; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu HB, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00135-6; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262957	10.1371/journal.pone.0262957	http://dx.doi.org/10.1371/journal.pone.0262957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089949	gold, Green Published			2022-12-26	WOS:000769158400030
J	Mshelia, AB; Osman, M; Misni, NB				Mshelia, Arhyel Buba; Osman, Malina; Misni, Norashiqin Binti			A cross-sectional study design to determine the prevalence of knowledge, attitude, and the preventive practice of food poisoning and its factors among postgraduate students in a public university in Selangor, Malaysia	PLOS ONE			English	Article							SAFETY KNOWLEDGE; HYGIENE PRACTICES; HANDLERS; CONSUMERS; KAP	Objectives This study is designed to determine the knowledge, attitude, and practice of food poisoning and its factors among postgraduate students in Universiti Putra Malaysia. Methods A cross-sectional study was conducted among 212 respondents who were selected through simple random sampling. Data was generated using a validated and reliable self-administered questionnaire. Results The majority of the respondents are male, aged less than 35 years old, non-Malaysian, single, first-degree holders, not working, received a monthly income of less than 3264 Malaysian Ringgit, aware of food poisoning outbreak and the sources of their information of the food poisoning outbreak were television, the internet, newspaper, Online journals, friends, Facebook, community, nurse, drinking raw milk for the second time, information from their parents, relatives, restaurant, and radio. Majority had previous history of food poisoning illness but didn't correctly confirm the causes of their food poisoning illness. Majority had poor knowledge, acceptable attitude, and good practice of food poisoning. A significant association was observed for citizen, marital status, awareness of food poisoning outbreak, and previous history of food poisoning illness with knowledge. Gender and awareness of food poisoning outbreak were significantly associated with attitude. Attitude and practice were significantly associated. Logistic regression revealed that being married, awareness of food poisoning outbreak, and previous history of food poisoning illness are predictors for good knowledge. Female respondents and awareness of food poisoning outbreak are predictors for acceptable attitude. Conclusion Documentation of the identified poor knowledge and factors affecting knowledge, attitude, and practice provides essential information on the baseline indicators towards the risk of food poisoning among the respondents. A relevant interventional program is highly recommended to prevent the potential risks of food poisoning outbreak among them.	[Mshelia, Arhyel Buba] Univ Maiduguri, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Maiduguri, Borno State, Nigeria; [Osman, Malina; Misni, Norashiqin Binti] Univ Putra Malaysia, Dept Med Microbiol, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Mshelia, AB (corresponding author), Univ Maiduguri, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Maiduguri, Borno State, Nigeria.	arhyelbm@gmail.com	MSHELIA, ARHYEL/HGD-7231-2022	MSHELIA, ARHYEL/0000-0001-6106-329X				Abd Patah MOR., 2009, INT ED STUD; Abdul-Mutalib NA, 2012, FOOD CONTROL, V27, P289, DOI 10.1016/j.foodcont.2012.04.001; Abdullahi A, 2016, INT J GEN MED, V9, P79, DOI 10.2147/IJGM.S98436; Abu Bakar NAN., 2021, INT J ACAD RES BUS S, V10; Afifah N., 2020, FOOD RES, V4, P1832; Ali Abdul Nazer, 2018, Journal of Natural Remedies, V18, P113, DOI 10.18311/jnr/2018/22289; Anant JK., 2018, WORLD J PHARM LIFE S, V45, P94; Angelillo IF, 2001, INT J FOOD MICROBIOL, V64, P161, DOI 10.1016/S0168-1605(00)00451-7; Auad LI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081784; Badran IG., 1995, EMHJ E MEDITERRANEAN; Banawas S.S., 2019, MAJMAAH J HLTH SCI, V7, P1; Binti Samsudin S., 2017, KNOWLEDGE ATTITUDE P; Chun BC, 2007, J KOREAN MED ASSOC, V50, P606, DOI 10.5124/jkma.2007.50.7.606; Coorey R, 2018, COMPR REV FOOD SCI F, V17, P827, DOI 10.1111/1541-4337.12357; Fitria L., 2018, KNE LIFE SCI; Food And Agriculture Organization (FAO), 2017, SURV REP FOOD SAF KN; Food Safety, 2019, COLDFOODSTORAGECHART; Hamed A, 2020, E MEDITERR HEALTH J, V26, P374, DOI 10.26719/emhj.19.047; Isara A. R., 2013, Journal of Medicine and Biomedical Research, V12, P69; Ismail RM., 2018, J SOC SCI RES, V2018; Jianu C, 2014, FOOD CONTROL, V42, P214, DOI 10.1016/j.foodcont.2014.02.032; Kaewpitoon S.J., 2016, ASIAN PAC J CANCER P, V17; Kubde S., 2016, INT J COMMUNITY MED; Langiano E, 2012, J PUBLIC HEALTH-HEID, V20, P47, DOI 10.1007/s10389-011-0437-z; Le Nguyen AT., 2018, VIETNAM INT J ENV RE, V15; Lee HK, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010055; Mahmood K., 2018, INT J ADV SCI ENG IN; Marriott NG., 2018, FOOD CONTAMINATION S; Martins RB, 2012, FOOD CONTROL, V23, P184, DOI 10.1016/j.foodcont.2011.07.008; MoH, 2020, HLTH FACTS; MoH, 2013, HLTH FACTS; MoH, 2019, HLTH FACTS; MoH, 2015, HLTH FACTS; MoH, 2016, HLTH FACTS; MoH, 2017, HLTH FACTS; MoH, 2014, HLTH FACTS; MoH, 2018, HLTH FACTS; MZ NA., 2021, FOOD RES, V5; Nee SO, 2011, SAINS MALAYS, V40, P403; Nee SO., 2011, SAINS MALAYS; Nkhebenyane JS, 2020, FOOD SCI NUTR, V8, P2598, DOI 10.1002/fsn3.1499; Odeyemi OA, 2019, FOOD RES INT, V116, P1386, DOI 10.1016/j.foodres.2018.10.030; Ogston SA, 1991, BIOMETRICS, V47, P347, DOI DOI 10.2307/2532527; Protus BM., 2014, J MED LIB ASS, P224; Rosmawati N., 2011, KNOWLEDGE ATTITUDE P; Salleh W., 2017, MALAY APPL BIOL; Sayuti YA., 2020, MANAG SCI LETT; Sharif L, 2010, FOOD CONTROL, V21, P55, DOI 10.1016/j.foodcont.2009.03.015; Siau AMF, 2015, INT FOOD RES J, V22, P1843; Soon JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235870; Statistics D, 2019, BUDGETS TAX; Stratev D, 2017, J INFECT PUBLIC HEAL, V10, P778, DOI 10.1016/j.jiph.2016.12.001; Syahira, 2019, INT J PUBLIC HLTH CL; Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30; World Health Organization (WHO), 2015, FACT SHEETS FOOD SAF; Yusof AMM, 2018, J PHARM BIOALLIED SC, V10, P232, DOI [10.4103/JPBS.JPBS_141_18, 10.4103/jpbs.JPBS_141_18]; Zain MM., 2002, SE ASIAN J TROP MED, V33; Zyoud S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6955-2	58	1	1	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262313	10.1371/journal.pone.0262313	http://dx.doi.org/10.1371/journal.pone.0262313			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089947	Green Published, gold			2022-12-26	WOS:000769158400013
J	Saliba, J; Coutaud, B; Makhani, K; Roth, NE; Jackson, J; Park, JY; Gagnon, N; Costa, P; Jeyakumar, T; Bury, M; Beauchemin, N; Mann, KK; Blank, V				Saliba, James; Coutaud, Baptiste; Makhani, Kiran; Roth, Noam Epstein; Jackson, Jennie; Park, Joo Yeoun; Gagnon, Natascha; Costa, Paolo; Jeyakumar, Thiviya; Bury, Marina; Beauchemin, Nicole; Mann, Koren K.; Blank, Volker			Loss of NFE2L3 protects against inflammation-induced colorectal cancer through modulation of the tumor microenvironment	ONCOGENE			English	Article							ERYTHROID 2-LIKE 3; MAST-CELLS; NUCLEAR FACTOR; COLON-CANCER; METASTASIS; EXPRESSION; CARCINOMA; IL-33; ACTIVATION; CONTRIBUTE	We investigated the role of the NFE2L3 transcription factor in inflammation-induced colorectal cancer. Our studies revealed that Nfe2l3(-/-) mice exhibit significantly less inflammation in the colon, reduced tumor size and numbers, and skewed localization of tumors with a more pronounced decrease of tumors in the distal colon. CIBERSORT analysis of RNA-seq data from normal and tumor tissue predicted a reduction in mast cells in Nfe2l3(-/-) animals, which was confirmed by toluidine blue staining. Concomitantly, the transcript levels of Il33 and Rab27a, both important regulators of mast cells, were reduced and increased, respectively, in the colorectal tumors of Nfe2l3(-/-) mice. Furthermore, we validated NFE2L3 binding to the regulatory sequences of the IL33 and RAB27A loci in human colorectal carcinoma cells. Using digital spatial profiling, we found that Nfe2l3(-/-) mice presented elevated FOXP3 and immune checkpoint markers CTLA4, TIM3, and LAG3, suggesting an increase in Treg counts. Staining for CD3 and FOXP3 confirmed a significant increase in immunosuppressive Tregs in the colon of Nfe2l3(-/-) animals. Also, Human Microbiome Project (HMP2) data showed that NFE2L3 transcript levels are higher in the rectum of ulcerative colitis patients. The observed changes in the tumor microenvironment provide new insights into the molecular differences regarding colon cancer sidedness. This may be exploited for the treatment of early-onset colorectal cancer as this emerging subtype primarily displays distal/left-sided tumors.	[Saliba, James; Coutaud, Baptiste; Makhani, Kiran; Roth, Noam Epstein; Jackson, Jennie; Park, Joo Yeoun; Gagnon, Natascha; Costa, Paolo; Bury, Marina; Mann, Koren K.; Blank, Volker] Lady Davis Inst Med Res, Montreal, PQ, Canada; [Saliba, James; Makhani, Kiran; Roth, Noam Epstein; Jeyakumar, Thiviya; Beauchemin, Nicole; Blank, Volker] McGill Univ, Dept Med, Montreal, PQ, Canada; [Jeyakumar, Thiviya; Beauchemin, Nicole] McGill Univ, Goodman Canc Inst, Montreal, PQ, Canada; [Jeyakumar, Thiviya; Beauchemin, Nicole] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Jeyakumar, Thiviya; Beauchemin, Nicole] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Mann, Koren K.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Blank, Volker] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Jackson, Jennie] Univ British Columbia, Life Sci Inst, Vancouver, BC, Canada; [Jackson, Jennie] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Bury, Marina] UCLouvain, De Duve Inst, Brussels, Belgium	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of British Columbia; University of British Columbia; Universite Catholique Louvain	Blank, V (corresponding author), Lady Davis Inst Med Res, Montreal, PQ, Canada.; Blank, V (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Blank, V (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	volker.blank@mcgill.ca		Jackson, Jennie/0000-0003-2890-4047	SEG (Lebanon) studentship; McGill Integrated Cancer Research Training Program (MICRTP) studentship; LDI/TD bank fellowship; Gordon Phillip Studentship; Division of Experimental Medicine, McGilll University; Lady Davis Institute/TB bank studentship; Biotalent Canada; MICRTP studentship; Donner Canada Foundation; MICRTP; FRQS; Cole Foundation fellowship; Canadian Institutes of Health Research (CIHR) [MOP-97932, PJT-152937]	SEG (Lebanon) studentship; McGill Integrated Cancer Research Training Program (MICRTP) studentship; LDI/TD bank fellowship; Gordon Phillip Studentship; Division of Experimental Medicine, McGilll University; Lady Davis Institute/TB bank studentship; Biotalent Canada; MICRTP studentship; Donner Canada Foundation; MICRTP(Canadian Institutes of Health Research (CIHR)); FRQS; Cole Foundation fellowship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We would like to thank Steven Hebert and Claudia Kleinman for bioinformatics analyses and expertise, and Ulrich Blank for advice on mast cells. JS was supported by SEG (Lebanon) and McGill Integrated Cancer Research Training Program (MICRTP) studentships. KM obtained a studentship from LDI/TD bank fellowship and Gordon Phillip Studentship, NER was supported by a recruitment award (Division of Experimental Medicine, McGilll University) and a Lady Davis Institute/TB bank studentship, JJ received support from Biotalent Canada, JYP was supported by a MICRTP studentship and TJ from Donner Canada Foundation, MB was supported by MICRTP, FRQS and a Cole Foundation fellowship. The study was supported by the Canadian Institutes of Health Research (CIHR) MOP-97932 and PJT-152937 grants to VB.	Akimoto N, 2021, NAT REV CLIN ONCOL, V18, P230, DOI 10.1038/s41571-020-00445-1; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Aono S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133344; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Baran B, 2018, GASTROENTEROL RES, V11, P264, DOI 10.14740/gr1062w; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Bleeker JS, 2020, J CLIN ONCOL, V38; Bury M, 2019, CELL REP, V29, P1469, DOI 10.1016/j.celrep.2019.09.087; Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12; Chen LB, 2019, GENE, V692, P119, DOI 10.1016/j.gene.2019.01.001; Chenais B, 2005, MOL ENDOCRINOL, V19, P125, DOI 10.1210/me.2003-0379; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; Chevillard G, 2011, CELL MOL LIFE SCI, V68, P3337, DOI 10.1007/s00018-011-0747-x; Chevillard G, 2011, BLOOD, V117, P2005, DOI 10.1182/blood-2010-02-271460; Chowdhury A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42725; Cui GL, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00561; Danelli L, 2015, CANCER IMMUNOL RES, V3, P85, DOI 10.1158/2326-6066.CIR-14-0102; De Oliveira T, 2019, ONCOGENE, V38, P1787, DOI 10.1038/s41388-018-0551-2; Dong WW, 2015, DISCOV MED, V20, P357; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fodil N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01381-y; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Gulubova MV, 2012, INT J COLORECTAL DIS, V27, P159, DOI 10.1007/s00384-011-1334-1; Heijmans J, 2012, BBA-MOL BASIS DIS, V1822, P9, DOI 10.1016/j.bbadis.2010.12.001; Hodzic Z, 2017, CYTOKINE, V100, P1, DOI 10.1016/j.cyto.2017.06.017; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Joulia R, 2017, J ALLERGY CLIN IMMUN, V140, P497, DOI 10.1016/j.jaci.2016.09.049; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kannan MB, 2015, J BIOL CHEM, V290, P26292, DOI 10.1074/jbc.M115.666446; Keller DS, 2019, TECH COLOPROCTOL, V23, P3, DOI 10.1007/s10151-019-1926-2; Kitaya K, 2007, INT J MOL MED, V20, P689; Kolde Raivo, 2019, CRAN; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YK, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0839-7; Li ZY, 2015, CELL MOL IMMUNOL, V12, P558, DOI 10.1038/cmi.2015.10; Liu XJ, 2014, BIOCHEM BIOPH RES CO, V453, P486, DOI 10.1016/j.bbrc.2014.09.106; Loomans-Kropp HA, 2019, J CANCER EPIDEMIOL, V2019, DOI 10.1155/2019/9841295; Low EE, 2020, GASTROENTEROLOGY, V159, P492, DOI 10.1053/j.gastro.2020.01.004; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Mauri G, 2019, MOL ONCOL, V13, P109, DOI 10.1002/1878-0261.12417; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Parang B, 2016, METHODS MOL BIOL, V1422, P297, DOI 10.1007/978-1-4939-3603-8_26; Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8; Ren YG, 2020, J CANCER, V11, P6939, DOI 10.7150/jca.48100; Ribatti D, 2018, INT ARCH ALLERGY IMM, V176, P55, DOI 10.1159/000487538; Rigoni A, 2015, CANCER RES, V75, P3760, DOI 10.1158/0008-5472.CAN-14-3767; Saluja R, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0076-5; Shi CB, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0303-3; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Sun JG, 2019, ONCOTARGETS THER, V12, P3019, DOI 10.2147/OTT.S197409; Suzuki R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-84; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thaker Ameet I, 2012, J Vis Exp, DOI 10.3791/4100; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Vuik FER, 2019, GUT, V68, P1820, DOI 10.1136/gutjnl-2018-317592; Vukman KV., 2014, BIOPROTOC, V4, pe1053; Wang CJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90651; Wang H, 2018, CELL CYCLE, V17, P2164, DOI 10.1080/15384101.2018.1520558; Wang J, 2019, J CANCER, V10, P6726, DOI 10.7150/jca.35641; Ward-Hartstonge KA, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.43; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu MM, 2019, WORLD J GASTROENTERO, V25, P1210, DOI 10.3748/wjg.v25.i10.1210; Yu YX, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1504729; Zhang LH, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/2829798; Zhang Z, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00017	78	1	1	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1563	1575		10.1038/s41388-022-02192-2	http://dx.doi.org/10.1038/s41388-022-02192-2		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35091681	hybrid, Green Published			2022-12-26	WOS:000749073300003
J	Bhandari, S; Crego, RD; Stabach, JA				Bhandari, Shivish; Crego, Ramiro D.; Stabach, Jared A.			Spatial segregation between wild ungulates and livestock outside protected areas in the lowlands of Nepal	PLOS ONE			English	Article							BOSELAPHUS-TRAGOCAMELUS; FOREST RESOURCES; NATIONAL-PARK; TIGER; PREY; BIODIVERSITY; EXTINCTION; CONSERVATION; HABITAT; DECLINE	Understanding how wildlife interacts with human activities across non-protected areas are critical for conservation. This is especially true for ungulates that inhabit human-dominated landscapes outside the protected area system in Nepal, where wildlife often coexists with livestock. Here we investigated how elevation, agricultural land, distance from roads, and the relative abundance of livestock (goats, sheep, cow and buffalo) influenced wild ungulate chital (Axis axis), nilgai (Boselaphustrago camelus), wild boar (Sus scrofa) and sambar (Rusa unicolor) abundance and occurrence. We counted all individuals of wild ungulates and livestock along 35 transects conducted between November 2017 and March 2018 in community forests of Bara and Rautahat distracts in the lowlands of Nepal. We assessed abundance and occurrence relation to covariates using Generalized Linear Models. We found that livestock outnumbered wild ungulates 6.6 to 1. Wild boar was the most abundant wild ungulate, followed by nilgai, chital, and sambar. Elevation and livestock abundance were the most important covariates affecting the overall abundance of wild ungulates and the distribution of each individual ungulate species. Our results suggest spatial segregation between wild ungulates, which occur mainly on high grounds (> 300 m.a.s.l.), and livestock that concentrate across low ground habitats (< 300 m.a.s.l.). Our results provide a critical first step to inform conservation in community forest areas of Nepal, where wildlife interacts with people and their livestock. Finding better strategies to allow the coexistence of ungulates with people and their livestock is imperative if they are to persist into the future.	[Bhandari, Shivish] Nat Sci Soc, Kathmandu, Nepal; [Crego, Ramiro D.; Stabach, Jared A.] Smithsonian Natl Zoo & Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Bhandari, S (corresponding author), Nat Sci Soc, Kathmandu, Nepal.	shivish.bhandari@yahoo.com	Stabach, Jared/AEX-9187-2022	Stabach, Jared/0000-0002-7896-1237; Crego, Ramiro/0000-0001-8583-5936				Allendorf TD, 2020, BIODIVERS CONSERV, V29, P933, DOI 10.1007/s10531-019-01919-0; Aryal A, 2007, TIGERPAPER, V32, P4; Atwood TB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb8458; Aziz MA, 2017, GLOB ECOL CONSERV, V9, P70, DOI 10.1016/j.gecco.2016.12.001; Badola R, 1998, BIODIVERS CONSERV, V7, P1245, DOI 10.1023/A:1008845510498; Bagchia S, 2008, MAMMALIA, V72, P44, DOI 10.1515/MAMM.2008.008; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Baral Hem Sagar, 2014, Gnusletter, V32, P6; Baral K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260307; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bhandari S, 2019, RUSS J ECOL+, V50, P590, DOI 10.1134/S1067413619060031; Bhandari S, 2021, GLOB ECOL CONSERV, V27, DOI 10.1016/j.gecco.2021.e01619; Bhandari S, 2020, ECOL EVOL, V10, P7953, DOI 10.1002/ece3.6223; Bhandari Shivish, 2016, Journal of Threatened Taxa, V8, P9125, DOI 10.11609/jott.2518.8.9.9125-9130; Bhattarai BP, 2013, J ENVIRON MANAGE, V131, P343, DOI 10.1016/j.jenvman.2013.10.005; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2020, P NATL ACAD SCI USA, V117, P13596, DOI 10.1073/pnas.1922686117; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chao S, 2012, FOREST PEOPLE PROGRA; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; DFRS [Department of Forest Research and Survey], 2015, STAT NEP FOR FOR RES; Di Marco M, 2014, CONSERV BIOL, V28, P1109, DOI 10.1111/cobi.12249; DNPWC, 2021, DEP NAT PARK WILDL C, P190; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Halladay P, 1995, CONSERVING BIODIVERS; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hempson GP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17348-4; IUCN (Internation Union for Conservation of Nature), 2020, INT UNION CONSERVATI; Kery M., 2010, INTRO WINBUGS ECOLOG; Khanal Srijana, 2018, Proceedings of the Zoological Society (Calcutta), V71, P352, DOI 10.1007/s12595-017-0218-y; Leslie David M. Jr., 2008, Mammalian Species, DOI 10.1644/813.1; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 1997, NATURE, V387, P803, DOI 10.1038/42935; Madhusudan MD, 2004, J APPL ECOL, V41, P858, DOI 10.1111/j.0021-8901.2004.00950.x; McLaren BE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2066; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Pandey P, 2016, EUR J WILDLIFE RES, V62, P103, DOI 10.1007/s10344-015-0978-5; Panta M, 2008, FOREST ECOL MANAG, V256, P1587, DOI 10.1016/j.foreco.2008.07.023; Poffenberger M, 2006, INT J ENVIRON SUSTAI, V5, P57, DOI 10.1504/IJESD.2006.008683; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Ram AK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98327-8; Ramakrishnan U, 1999, BIOL CONSERV, V89, P113, DOI 10.1016/S0006-3207(98)00159-1; RCore Team, 2020, R LANG ENV STAT COMP; Ren Y., 2021, SCI REP-UK, V11, P1, DOI DOI 10.1038/S41598-020-79139-8; Ripple WJ, 2016, BIOSCIENCE, V66, P807, DOI 10.1093/biosci/biw092; Roman-Palacios C, 2020, P NATL ACAD SCI USA, V117, P4211, DOI 10.1073/pnas.1913007117; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Simcharoen A, 2014, RAFFLES B ZOOL, V62, P100; SMITH J L D, 1992, Oryx, V26, P34; Smith JLD, 1998, CONSERV BIOL, V12, P1338, DOI 10.1046/j.1523-1739.1998.97068.x; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Squires D, 2014, ASIA PAC POLICY STUD, V1, P144, DOI 10.1002/app5.13; Stears K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236895; Thapa K, 2017, BIODIVERS CONSERV, V26, P593, DOI 10.1007/s10531-016-1260-1; Veldhuis MP, 2019, SCIENCE, V363, P1424, DOI 10.1126/science.aav0564; Wang SW, 2010, ORYX, V44, P376, DOI 10.1017/S0030605310000487; Wegge P, 2009, BIOL CONSERV, V142, P189, DOI 10.1016/j.biocon.2008.10.020; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Xiao WH, 2018, ECOL EVOL, V8, P11677, DOI 10.1002/ece3.4620; Xu HG, 2009, BIOSCIENCE, V59, P843, DOI 10.1525/bio.2009.59.10.6; Yen SC, 2014, ORYX, V48, P232, DOI 10.1017/S0030605312001378; Yeo-Chang Y, 2009, FOREST ECOL MANAG, V257, P2027, DOI 10.1016/j.foreco.2009.01.054	72	1	1	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263122	10.1371/journal.pone.0263122	http://dx.doi.org/10.1371/journal.pone.0263122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085356	gold, Green Submitted, Green Published			2022-12-26	WOS:000779379600114
J	Destrempes, F; Gesnik, M; Chayer, B; Roy-Cardinal, MH; Olivie, D; Giard, JM; Sebastiani, G; Nguyen, BN; Cloutier, G; Tang, A				Destrempes, Francois; Gesnik, Marc; Chayer, Boris; Roy-Cardinal, Marie-Helene; Olivie, Damien; Giard, Jeanne-Marie; Sebastiani, Giada; Nguyen, Bich N.; Cloutier, Guy; Tang, An			Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; HOMODYNED-K-DISTRIBUTION; HEPATIC STEATOSIS; MR ELASTOGRAPHY; STEATOHEPATITIS; QUANTIFICATION; CLASSIFICATION; CURVES; CAP	Objective To develop a quantitative ultrasound (QUS)- and elastography-based model to improve classification of steatosis grade, inflammation grade, and fibrosis stage in patients with chronic liver disease in comparison with shear wave elastography alone, using histopathology as the reference standard. Methods This ancillary study to a prospective institutional review-board approved study included 82 patients with non-alcoholic fatty liver disease, chronic hepatitis B or C virus, or autoimmune hepatitis. Elastography measurements, homodyned K-distribution parametric maps, and total attenuation coefficient slope were recorded. Random forests classification and bootstrapping were used to identify combinations of parameters that provided the highest diagnostic accuracy. Receiver operating characteristic (ROC) curves were computed. Results For classification of steatosis grade S0 vs. S1-3, S0-1 vs. S2-3, S0-2 vs. S3, area under the receiver operating characteristic curve (AUC) were respectively 0.60, 0.63, and 0.62 with elasticity alone, and 0.90, 0.81, and 0.78 with the best tested model combining QUS and elastography features. For classification of inflammation grade A0 vs. A1-3, A0-1 vs. A2-3, A0-2 vs. A3, AUCs were respectively 0.56, 0.62, and 0.64 with elasticity alone, and 0.75, 0.68, and 0.69 with the best model. For classification of liver fibrosis stage F0 vs. F1-4, F0-1 vs. F2-4, F0-2 vs. F3-4, F0-3 vs. F4, AUCs were respectively 0.66, 0.77, 0.72, and 0.74 with elasticity alone, and 0.72, 0.77, 0.77, and 0.75 with the best model. Conclusion Random forest models incorporating QUS and shear wave elastography increased the classification accuracy of liver steatosis, inflammation, and fibrosis when compared to shear wave elastography alone.	[Destrempes, Francois; Gesnik, Marc; Chayer, Boris; Roy-Cardinal, Marie-Helene; Cloutier, Guy] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Olivie, Damien; Cloutier, Guy; Tang, An] Univ Montreal, Dept Radiol Radiat Oncol & Nucl Med, Montreal, PQ, Canada; [Olivie, Damien; Tang, An] Ctr Hosp Univ Montreal CHUM, Dept Radiol, Montreal, PQ, Canada; [Giard, Jeanne-Marie] Univ Montreal, Dept Med, Div Hepatol & Liver Transplantat, Montreal, PQ, Canada; [Sebastiani, Giada] McGill Univ, Dept Med, Div Gastroenterol & Hepatol, Hlth Ctr MUHC, Montreal, PQ, Canada; [Nguyen, Bich N.] Ctr Hosp Univ Montreal CHUM, Dept Pathol, Montreal, PQ, Canada; [Nguyen, Bich N.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada; [Tang, An] Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Lab Med Image Anal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Cloutier, G (corresponding author), Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.; Cloutier, G; Tang, A (corresponding author), Univ Montreal, Dept Radiol Radiat Oncol & Nucl Med, Montreal, PQ, Canada.; Tang, A (corresponding author), Ctr Hosp Univ Montreal CHUM, Dept Radiol, Montreal, PQ, Canada.; Cloutier, G (corresponding author), Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada.; Tang, A (corresponding author), Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Lab Med Image Anal, Montreal, PQ, Canada.	guy.cloutier@umontreal.ca; an.tang@umontreal.ca	; Tang, An/E-5333-2016	Roy Cardinal, Marie-Helene/0000-0001-9590-1167; Tang, An/0000-0001-8967-5503	Canadian Institutes of Health Research (CIHR)-Institute of Nutrition, Metabolism and Diabetes (INMD) [273738, 301520]; Fonds de recherche du Quebec en Sante (FRQS); Fondation de l'Association des radiologistes du Quebec (FARQ) [26993, 34939]; FRQS [27127]; McGill University	Canadian Institutes of Health Research (CIHR)-Institute of Nutrition, Metabolism and Diabetes (INMD)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec en Sante (FRQS); Fondation de l'Association des radiologistes du Quebec (FARQ); FRQS; McGill University	This work was supported by grants from the Canadian Institutes of Health Research (CIHR)-Institute of Nutrition, Metabolism and Diabetes (INMD) (CIHR-INMD #273738 and #301520, https://cihr-irsc.gc.ca/) to AT. This work was also supported by Junior 1 and Junior 2 Clinical Research Scholarships from the Fonds de recherche du Que ' bec en Sante ' (FRQS, https://frq.gouv.qc.ca/en/) and Fondation de l'Association des radiologistes du Que ' bec (FARQ) (FRQS-FARQ #26993 and #34939 to AT; and by a Junior 1 Clinical Research Scholarships from FRQS (#27127) and research salary from McGill University to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mrs. Assia Belblidia, Mrs. Catherine Huet, and Mr. Walid El Abyad for their assistance in patient enrollment. ACUSON S2000 and S3000 ultrasound systems were lent by Siemens Healthineers.	Bigelow TA., 2013, QUANTITATIVE ULTRASO, P75; Brattain LJ, 2020, ULTRASOUND MED BIOL, V46, P2667, DOI 10.1016/j.ultrasmedbio.2020.05.016; Breiman L, 2002, MANUAL SETTING USING, V1, P58; Breiman L., 2001, MACH LEARN, V45, P5; Breiman M, 2015, PACKAGE RANDOMFOREST; Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942; Davis J., 2006, P 23 INT C MACH LEAR, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Destrempes F, 2016, IEEE T MED IMAGING, V35, P488, DOI 10.1109/TMI.2015.2479455; Destrempes F, 2013, SIAM J IMAGING SCI, V6, P1499, DOI 10.1137/120875727; Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952; Dong DR, 2015, MOL MED REP, V11, P4174, DOI 10.3892/mmr.2015.3299; Durot I, 2020, ULTRASOUND MED BIOL, V46, P26, DOI 10.1016/j.ultrasmedbio.2019.09.004; DUTT V, 1994, ULTRASONIC IMAGING, V16, P265, DOI 10.1006/uimg.1994.1016; Fang J, 2018, ULTRASONICS, V87, P91, DOI 10.1016/j.ultras.2018.02.015; Gatos I, 2020, ULTRASOUND MED BIOL, V46, P959, DOI 10.1016/j.ultrasmedbio.2019.12.016; Gatos I, 2019, MED PHYS, V46, P2298, DOI 10.1002/mp.13521; Gatos I, 2017, ULTRASOUND MED BIOL, V43, P1797, DOI 10.1016/j.ultrasmedbio.2017.05.002; Gatos I, 2016, MED PHYS, V43, P1428, DOI 10.1118/1.4942383; Ghoshal G, 2012, ULTRASOUND MED BIOL, V38, P2238, DOI 10.1016/j.ultrasmedbio.2012.08.010; Han AG, 2020, RADIOLOGY, V295, P106, DOI 10.1148/radiol.2020191152; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; HOLM S, 1979, SCAND J STAT, V6, P65; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kagadis GC, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/abae06; Kazemirad S, 2017, RADIOLOGY, V282, P726, DOI 10.1148/radiol.2016160308; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Labranche R, 2018, RADIOGRAPHICS, V38, P392, DOI 10.1148/rg.2018170079; Lefebvre T, 2019, EUR RADIOL, V29, P6477, DOI 10.1007/s00330-019-06331-4; Lima PH, 2019, AM J ROENTGENOL, V213, P17, DOI 10.2214/AJR.18.20341; Mamou J, 2013, QUANTITATIVE ULTRASO; Meyer D., 2021, PACKAGE E1071 VERSIO; Moret A, 2022, ULTRASCHALL MED, V43, P479, DOI 10.1055/a-1233-2290; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Petitclerc L, 2017, J MAGN RESON IMAGING, V45, P1276, DOI 10.1002/jmri.25550; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Sheet D, 2014, MED IMAGE ANAL, V18, P103, DOI 10.1016/j.media.2013.10.002; Stoean R, 2011, ARTIF INTELL MED, V51, P53, DOI 10.1016/j.artmed.2010.06.002; Tang A, 2019, EUR RADIOL, V29, P2175, DOI 10.1007/s00330-018-5915-z; Tang A, 2015, AM J ROENTGENOL, V205, P33, DOI 10.2214/AJR.15.14553; Tang A, 2015, AM J ROENTGENOL, V205, P22, DOI 10.2214/AJR.15.14552; Trop I, 2015, RADIOLOGY, V275, P666, DOI 10.1148/radiol.14140318; Venables W., 2002, MODERN APPL STAT S, VFourth; Venables W. N., 2013, MODERN APPL STAT S P; Wang K, 2019, GUT, V68, P729, DOI 10.1136/gutjnl-2018-316204; Wilcox R.R., 2011, INTRO ROBUST ESTIMAT, DOI DOI 10.1016/C2010-0-67044-1; Woods K, 1997, IEEE T MED IMAGING, V16, P329, DOI 10.1109/42.585767; Yilmaz Y, 2014, SCAND J GASTROENTERO, V49, P611, DOI 10.3109/00365521.2014.881548; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zeng XH, 2015, ULTRASOUND MED BIOL, V41, P1538, DOI 10.1016/j.ultrasmedbio.2015.01.011; Zhou ZH, 2020, ULTRASONICS, V101, DOI 10.1016/j.ultras.2019.106001	55	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262291	10.1371/journal.pone.0262291	http://dx.doi.org/10.1371/journal.pone.0262291			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085294	Green Published, gold			2022-12-26	WOS:000779379600046
J	El Mesmoudi, N; Al Dhaheri, AS; Feehan, J; Stojanovska, L; Ali, HI				El Mesmoudi, Najoua; Al Dhaheri, Ayesha S.; Feehan, Jack; Stojanovska, Lily; Ali, Habiba, I			Validation of a quantitative web-based food frequency questionnaire to assess dietary intake in the adult Emirati population	PLOS ONE			English	Article							RELATIVE VALIDITY; ENERGY-INTAKE; REPRODUCIBILITY; NUTRITION; CONSUMPTION; AGREEMENT; DESIGN; POLICY	Background and objective A culture-specific web-based food frequency questionnaire (FFQ) to assess dietary intake in the United Arab Emirates (UAE) adult population was developed using data from the 2009-2010 national nutrition survey. The objective of this study was to assess the relative validity of the newly developed FFQ for use in the adult Emirati population (AE-FFQ), which contained a list of 139 food lines. Methods A convenient sample of 60 (36 females and 24 males) adult Emiratis completed 3 non-consecutive 24HRs over a period of one month, followed by the AE-FFQ, which assessed the intake over the previous month. Relative validity was evaluated by comparing nutrient and food group intakes from the AE-FFQ with the average three 24HRs using Wilcoxon signed-rank tests, Spearman's correlation coefficients (CC), Bland-Altman analysis, and cross-classification. Results The AE-FFQ overestimated energy and most nutrients and food groups. Bland-Altman analysis showed significant proportional bias between the 2 methods. Deattenuated energy-adjusted Spearman correlation coefficients were poor to good ranging from 0.06 (iron) to 0.62 (fiber) for nutrients, 0.39 median value, and from -0.01 (cruciferous vegetables) to 0.64 (eggs) for food groups, 0.41 median value. A fairly acceptable agreement was obtained, with correct classification into the same or adjacent quartile ranging from 34% (vitamin B12) to 78% (pyridoxine), median 69% for nutrients and from 55% (diet soft drinks) to 87% (soft drinks), median 67% for food groups. Conclusions The AE-FFQ is an acceptable tool for ranking UAE adults (aged 18 to 50) according to their dietary intake to investigate the role of Emirati dietary patterns on health and disease. Caution is needed for assessing absolute intake, however, given the bias observed in assessing group-level agreement.	[El Mesmoudi, Najoua; Al Dhaheri, Ayesha S.; Stojanovska, Lily; Ali, Habiba, I] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Nutr & Hlth, Al Ain, U Arab Emirates; [Feehan, Jack] Univ Melbourne, Dept Med Western Hlth, Melbourne, Vic, Australia; [Feehan, Jack; Stojanovska, Lily] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia	United Arab Emirates University; University of Melbourne; Victoria University	Ali, HI (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Nutr & Hlth, Al Ain, U Arab Emirates.	habAli@uaeu.ac.ae		Ali, Habiba I./0000-0003-2685-1244				Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Ahuja JKC, 2013, J NUTR, V143, p241S, DOI 10.3945/jn.112.170043; Al-Amiri HA, 2009, INT J FOOD SCI NUTR, V60, P668, DOI 10.3109/09637480802002408; [Anonymous], 2009, SAUDI MED J; Apovian CM, 2010, PUBLIC HEALTH NUTR, V13, P615, DOI 10.1017/S1368980009991996; Axxya Systems, 2016, SEARCH AV FOODS ONL; Beasley JM, 2009, PUBLIC HEALTH NUTR, V12, P651, DOI 10.1017/S1368980008002668; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Bergstrom L., 1994, 3294 NAT FOOD ADM; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bognar A., 2002, TABLES WEIGHT YIELD; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Christensen SE, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2458; da Silva NF, 2013, CAD SAUDE PUBLICA, V29, P1783, DOI 10.1590/0102-311X00120312; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Dehghan NA-HCMPPAM M., 2009, SAUDI MED J, V30; Du SS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002130; El Kinany K, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0368-4; El Mesmoudi N, 2021, J FOOD COMPOS ANAL, V100, DOI 10.1016/j.jfca.2021.103899; Eldridge AL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010055; EuroFIR-European Food Information Resource, 2014, EUROFIR; Fallaize R, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.3355, 10.2196/jmir.3105]; Falomir Z, 2012, COMPUT BIOL MED, V42, P964, DOI 10.1016/j.compbiomed.2012.07.008; FAO/INFOODS. Food and Agriculture organisation/International International Network of Food Data Systems, 2012, GUID CHECK FOOD COMP; FAO/INFOODS-Food and Agriculture organisation/International International Network of Food Data Systems, 2012, GUID FOOD MATCH; Feng RN, 2016, ASIA PAC J CLIN NUTR, V25, P841, DOI 10.6133/apjcn.092015.26; Gibson R. S., 2005, Principles of nutritional assessment; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; Harmouche-Karaki M, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00581-5; IDF-International Diabetes Federation, 2019, DIABETES ATLAS; Kato E, 2017, J EPIDEMIOL, V27, P435, DOI 10.1016/j.je.2016.08.021; Kristal AR, 2014, J ACAD NUTR DIET, V114, P613, DOI 10.1016/j.jand.2013.11.017; Labonte ME, 2012, EUR J CLIN NUTR, V66, P166, DOI 10.1038/ejcn.2011.163; Lombard MJ, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0027-y; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Machin D., 1997, SAMPLE SIZE TABLES C, P315; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; Matthys C, 2007, J AM DIET ASSOC, V107, P605, DOI 10.1016/j.jada.2007.01.005; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Muhamad MN., 2016, GLYCEMIC INDEX FOODS, P548; Mumu SJ, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00563-7; Musaiger AO, 1998, J ROY SOC HEALTH, V118, P146, DOI 10.1177/146642409811800304; Nelson M, 1998, PUBLIC HEALTH NUTR, V1, P219, DOI 10.1079/PHN19980038; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Rhee JJ, 2015, AM J EPIDEMIOL, V181, P225, DOI 10.1093/aje/kwu308; Tayyem RF, 2014, J ACAD NUTR DIET, V114, P1046, DOI 10.1016/j.jand.2013.08.019; THOMPSON FE, 1994, J NUTR, V124, pS2245, DOI 10.1093/jn/124.suppl_11.2245s; Tsubono Y., VALIDITY REPRODUCIBI; Tueni, 2018, UNIVERSAL J PUBLIC H, V6, P262, DOI [10.13189/ujph.2018.060505, DOI 10.13189/UJPH.2018.060505]; USDA-United States Department of Agriculture. Global Agricultural Information Network, 2020, GRAIN FEED ANN UN AR; Verger EO, 2017, J ACAD NUTR DIET, V117, P878, DOI 10.1016/j.jand.2016.10.030; Willett W., 2013, NUTR EPIDEMIOLOGY, P529; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WITS-World Integrated Trade Solution, 2018, UNITED ARAB EMIRATES; World Health Organisation, 2018, GLOB STAT REP ROAD S	59	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262150	10.1371/journal.pone.0262150	http://dx.doi.org/10.1371/journal.pone.0262150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085272	gold, Green Published			2022-12-26	WOS:000779379600039
J	Spirov, AV; Myasnikova, EM				Spirov, Alexander, V; Myasnikova, Ekaterina M.			Heuristic algorithms in evolutionary computation and modular organization of biological macromolecules: Applications to in vitro evolution	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BUILDING-BLOCKS; RNA APTAMERS; ROYAL ROAD; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; SELEX; SELECTION; RECOMBINATION; RIBOZYMES	Y Evolutionary computing (EC) is an area of computer sciences and applied mathematics covering heuristic optimization algorithms inspired by evolution in Nature. EC extensively study all the variety of methods which were originally based on the principles of selectionism. As a result, many new algorithms and approaches, significantly more efficient than classical selectionist schemes, were found. This is especially true for some families of special problems. There are strong arguments to believe that EC approaches are quite suitable for modeling and numerical analysis of those methods of synthetic biology and biotechnology that are known as in vitro evolution. Therefore, it is natural to expect that the new algorithms and approaches developed in EC can be effectively applied in experiments on the directed evolution of biological macromolecules. According to the John Holland's Schema theorem, the effective evolutionary search in genetic algorithms (GA) is provided by identifying short schemata of high fitness which in the further search recombine into the larger building blocks (BBs) with higher and higher fitness. The multimodularity of functional biological macromolecules and the preservation of already found modules in the evolutionary search have a clear analogy with the BBs in EC. It seems reasonable to try to transfer and introduce the methods of EC, preserving BBs and essentially accelerating the search, into experiments on in vitro evolution. We extend the key instrument of the Holland's theory, the Royal Roads fitness function, to problems of the in vitro evolution (Biological Royal Staircase, BioRS, functions). The specific version of BioRS developed in this publication arises from the realities of experimental evolutionary search for (DNA-) RNA-devices (aptazymes). Our numerical tests showed that for problems with the BioRS functions, simple heuristic algorithms, which turned out to be very effective for preserving BBs in GA, can be very effective in in vitro evolution approaches. We are convinced that such algorithms can be implemented in modern methods of in vitro evolution to achieve significant savings in time and resources and a significant increase in the efficiency of evolutionary search.	[Spirov, Alexander, V] Russian Acad Sci, IM Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Spirov, Alexander, V] Inst Sci Informat Social Sci RAS, Moscow, Russia; [Myasnikova, Ekaterina M.] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Peter the Great St. Petersburg Polytechnic University	Spirov, AV (corresponding author), Russian Acad Sci, IM Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia.; Spirov, AV (corresponding author), Inst Sci Informat Social Sci RAS, Moscow, Russia.	alexander.spirov@gmail.com			Russian Science Foundation [17-18-01536]	Russian Science Foundation(Russian Science Foundation (RSF))	The research was supported by the Russian Science Foundation (grant 17-18-01536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2012, NUCLEIC ACIDS RES, V40, P11777, DOI 10.1093/nar/gks899; Arnold FH, 1996, CHEM ENG SCI, V51, P5091, DOI 10.1016/S0009-2509(96)00288-6; Babiskin AH, 2011, NUCLEIC ACIDS RES, V39, P5299, DOI 10.1093/nar/gkr090; BACK T, 1993, PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P2; Back T., 1996, Foundations of Intelligent Systems. 9th International Symposium, ISMIS '96. Proceedings, P158; Baltz RH., 1986, BACTERIA, P61; Banzhaf W, 2003, GENET PROGR SER, V6, P43; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BORK P, 1991, FEBS LETT, V286, P47, DOI 10.1016/0014-5793(91)80937-X; BURGSTALLER P, 1994, ANGEW CHEM INT EDIT, V33, P1084, DOI 10.1002/anie.199410841; Burke DH, 1997, NUCLEIC ACIDS RES, V25, P2020, DOI 10.1093/nar/25.10.2020; Burke DH, 1998, RNA, V4, P1165, DOI 10.1017/S1355838298980542; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005; Carothers JM, 2006, RNA, V12, P567, DOI 10.1261/rna.2251306; Chen CK, 2007, COMPUT METH PROG BIO, V87, P189, DOI 10.1016/j.cmpb.2007.05.008; Chiu FWY, 2019, ELECTROPHORESIS, V40, P2860, DOI 10.1002/elps.201900222; Chongstitvatana Sangkavichitr C, 2010, EXPLOITATION LINKAGE; Corne D., 2003, FDN GENETIC ALGORITH, P347; Corne DW., 2002, PARALLEL PROBLEM SOL, V2439, DOI [10.1007/3-540-45712-7_13, DOI 10.1007/3-540-45712-7_13]; Cubi R, 2021, RNA, V27, P841, DOI 10.1261/rna.077586.120; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Darmostuk M, 2015, BIOTECHNOL ADV, V33, P1141, DOI 10.1016/j.biotechadv.2015.02.008; Dieckmann T, 1996, RNA, V2, P628; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Djordjevic M, 2010, METHODS MOL BIOL, V674, P195, DOI 10.1007/978-1-60761-854-6_12; Doerr B., 2020, PROBABILISTIC TOOLS, P1; Droste S, 2002, THEOR COMPUT SCI, V276, P51, DOI 10.1016/S0304-3975(01)00182-7; Eiben A.E, 2003, ADV EVOLUTIONARY COM; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; El-Mihoub TA, 2006, ENG LET, V13; Eremeev A, 2019, PROCEEDINGS OF THE 2019 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE COMPANION (GECCCO'19 COMPANION), P113, DOI 10.1145/3319619.3321906; Eremeev AV, 2021, BIOSYSTEMS, V200, DOI 10.1016/j.biosystems.2020.104312; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; FORREST S, 1993, FOUNDATIONS OF GENETIC ALGORITHMS 2, P109; Forrest S, 1991, P 4 INT C GEN ALG SA; Fraser LA, 2019, ADV BIOSYST, V3, DOI 10.1002/adbi.201900012; Gebhardt K, 2000, BIOCHEMISTRY-US, V39, P7255, DOI 10.1021/bi000295t; Grabow Wade, 2013, F1000Prime Rep, V5, P46, DOI 10.12703/P5-46; Griffiths AD, 2006, TRENDS BIOTECHNOL, V24, P395, DOI 10.1016/j.tibtech.2006.06.009; Hager AJ, 1997, CHEM BIOL, V4, P607, DOI 10.1016/S1074-5521(97)90246-5; Hendrix DK, 2005, Q REV BIOPHYS, V38, P221, DOI 10.1017/S0033583506004215; Hoinka J, 2018, MOL THER-NUCL ACIDS, V11, P515, DOI 10.1016/j.omtn.2018.04.006; Hoinka J, 2015, NUCLEIC ACIDS RES, V43, P5699, DOI 10.1093/nar/gkv308; Hopgood AA, 2009, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXV, P349, DOI 10.1007/978-1-84882-171-2_26; Hu T, 2014, LECT NOTES COMPUT SC, V8672, P424; IRVINE D, 1991, J MOL BIOL, V222, P739, DOI 10.1016/0022-2836(91)90509-5; Ishida R, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa484; Jansen T, 2005, DISCRETE APPL MATH, V149, P111, DOI 10.1016/j.dam.2004.02.019; Jose AM, 2001, NUCLEIC ACIDS RES, V29, P1631, DOI 10.1093/nar/29.7.1631; Kameya Y, 2011, IEEE C EVOL COMPUTAT, P2578; Kell DB, 2017, GENET PROGRAM EVOL M, V18, P373, DOI 10.1007/s10710-017-9292-1; Knight CG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn899; Koizumi M, 2000, BIOCHEMISTRY-US, V39, P8983, DOI 10.1021/bi000149n; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Komarova N, 2019, MOLECULES, V24, DOI 10.3390/molecules24193598; Koza John R., 2001, P95; Koza JR., 1999, GENETIC PROGRAMMING, DOI [10.1109/tevc.1999.788530, 10.1109/TEVC.1999.788530, DOI 10.1109/TEVC.1999.788530]; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Lee YG, 2011, APPL SOFT COMPUT, V11, P5528, DOI 10.1016/j.asoc.2011.05.006; Leier A, 2006, LECT NOTES COMPUT SC, V3905, P290; Levine HA, 2007, COMPUT BIOL CHEM, V31, P11, DOI 10.1016/j.compbiolchem.2006.10.002; Li F, 2006, LECT NOTES ARTIF INT, V3930, P507; LORSCH JR, 1994, NATURE, V371, P31, DOI 10.1038/371031a0; Mallikaratchy PR, 2011, NUCLEIC ACIDS RES, V39, P2458, DOI 10.1093/nar/gkq996; Manrubia SC, 2007, RNA, V13, P97, DOI 10.1261/rna.203006; MITCHELL M, 1993, PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P647; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Muhlenbein H, 2001, NAT COMP SER, P135; MUHLENBEIN H, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P15; Nordin P., 1997, Proceedings of BCEC97. Biocomputing and Emergent Computation, P22; O'Hagan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048862; Oates M., 2005, OBSERVED DYNAMICS LA, P208, DOI [10.1142/9789812561794_0012, DOI 10.1142/9789812561794_0012]; Oates M. J., 2003, RECENT ADV SIMULATED, P215; Ochoa G, 2008, LECT NOTES COMPUT SC, V4926, P184; Oh IS, 2011, IEEE C EVOL COMPUTAT, P2717; Ouellet E, 2015, BIOTECHNOL BIOENG, V112, P1506, DOI 10.1002/bit.25581; Paegel BM, 2010, CHEM BIOL, V17, P717, DOI 10.1016/j.chembiol.2010.05.021; Pal S, 2019, NUCLEIC ACIDS RES, V47, P6632, DOI 10.1093/nar/gkz540; Payne JL, 2014, ARTIF LIFE, V20, P111, DOI 10.1162/ARTL_a_00099; Pelikan M, 2002, COMPUT OPTIM APPL, V21, P5, DOI 10.1023/A:1013500812258; Platt M, 2009, INTEGR BIOL-UK, V1, P116, DOI 10.1039/b814892a; Platt M, 2009, ANAL BIOCHEM, V390, P203, DOI 10.1016/j.ab.2009.04.013; Price AK, 2016, ANAL CHEM, V88, P339, DOI 10.1021/acs.analchem.5b04139; Pritchard L, 2005, J THEOR BIOL, V234, P497, DOI 10.1016/j.jtbi.2004.12.005; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Riccardi C, 2020, MOLECULES, V25, DOI 10.3390/molecules25225227; Richter JN, 2005, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE, P381; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Roeva O., 2012, REAL WORLD APPL GENE, DOI [10.5772/36817, DOI 10.5772/36817]; Rowe W, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036007; Ryckelynck M, 2015, RNA, V21, P458, DOI 10.1261/rna.048033.114; Sangkavichitr C, 2016, INT J SYST SCI, V47, P691, DOI 10.1080/00207721.2014.901580; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; Sazani PL, 2004, J AM CHEM SOC, V126, P8370, DOI 10.1021/ja049171k; Seo YJ, 2014, B MATH BIOL, V76, P1455, DOI 10.1007/s11538-014-9954-6; Seo YJ, 2010, B MATH BIOL, V72, P1623, DOI 10.1007/s11538-009-9491-x; Shi YH, 1999, IEEE T FUZZY SYST, V7, P109, DOI 10.1109/91.755393; Simon-Loriere E, 2010, J VIROL, V84, P12675, DOI 10.1128/JVI.01302-10; Skinner C, 2004, LECT NOTES COMPUT SC, V3242, P121; Smith J., 1995, Evolutionary Computing. AISB Workshop. Selected Papers, P48; Spirov A, 2016, WILEY SER BIOINFORM, P240, DOI 10.1109/MMET.2016.7544043; Spirov A, 2013, METHODS, V62, P39, DOI 10.1016/j.ymeth.2013.05.013; Stebel S. C., 2008, MOL BIOMETHODS HDB, P631, DOI DOI 10.1007/978-1-60327-375-6_36; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stephens C, 1999, EVOL COMPUT, V7, P109, DOI 10.1162/evco.1999.7.2.109; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; SYSWERDA G, 1993, FOUNDATIONS OF GENETIC ALGORITHMS 2, P239; TANESE R, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P434; Tang J, 1998, NUCLEIC ACIDS RES, V26, P4214, DOI 10.1093/nar/26.18.4214; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Ting CK, 2010, EXPERT SYST APPL, V37, P1879, DOI 10.1016/j.eswa.2009.07.082; Trausch JJ, 2015, METHOD ENZYMOL, V550, P41, DOI 10.1016/bs.mie.2014.10.031; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Umbarkar AJ, 2015, ICTAT J SOFT COMPUT, V6, P1083; van Nimwegen E, 1999, THEOR COMPUT SCI, V229, P41, DOI 10.1016/S0304-3975(99)00119-X; Van Nimwegen E, 2001, MACH LEARN, V45, P77, DOI 10.1023/A:1010928206141; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Vorobyeva MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020470; Vorobyeva M, 2016, MOLECULES, V21, DOI 10.3390/molecules21121613; Wang JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043940; Watson RA, 1998, LECT NOTES COMPUT SC, V1498, P97, DOI 10.1007/BFb0056853; Watson RA., 2001, FDN GENETIC ALGORITH, P69, DOI [10.1016/B978-155860734-7/50087-1, DOI 10.1016/B978-155860734-7/50087-1]; Wedge DC, 2009, J THEOR BIOL, V257, P131, DOI 10.1016/j.jtbi.2008.11.005; WILSON C, 1995, NATURE, V374, P777, DOI 10.1038/374777a0; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wu LH, 1999, NUCLEIC ACIDS RES, V27, P1512, DOI 10.1093/nar/27.6.1512; Zaritsky A, 2004, IEEE T EVOLUT COMPUT, V8, P443, DOI 10.1109/TEVC.2004.831260; Zhang WY, 2012, ANAL CHEM, V84, P350, DOI 10.1021/ac2026942; Zhou QT, 2015, J CHEM THEORY COMPUT, V11, P5939, DOI 10.1021/acs.jctc.5b00707	135	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0260497	10.1371/journal.pone.0260497	http://dx.doi.org/10.1371/journal.pone.0260497			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085255	Green Published, gold			2022-12-26	WOS:000779379600017
J	Bhat, N; Esteghamat, F; Chaube, BK; Gunawardhana, K; Mani, M; Thames, C; Jain, D; Ginsberg, HN; Fernandes-Hernando, C; Mani, A				Bhat, Neha; Esteghamat, Fatemehsadat; Chaube, Bal Krishna; Gunawardhana, Kushan; Mani, Mitra; Thames, Clay; Jain, Dhanpat; Ginsberg, Henry N.; Fernandes-Hernando, Carlos; Mani, Arya			TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk	FASEB JOURNAL			English	Article						Fgf19; lipid absorption; NASH; tcf7l2	FIBROBLAST GROWTH FACTOR-19; HEPATIC RESPONSE; METABOLIC-RATE; DISEASE; PROTEIN; GENE; FXR; WNT; CHOLESTEROL; ABSORPTION	FGF19/FGF15 is an endocrine regulator of hepatic bile salt and lipid metabolism, which has shown promising effects in the treatment of NASH in clinical trials. FGF19/15 is transcribed and released from enterocytes of the small intestine into enterohepatic circulation in response to bile-induced FXR activation. Previously, the TSS of FGF19 was identified to bind Wnt-regulated TCF7L2/encoded transcription factor TCF4 in colorectal cancer cells. Impaired Wnt signaling and specifical loss of function of its coreceptor LRP6 have been associated with NASH. We, therefore, examined if TCF7L2/TCF4 upregulates Fgf19 in the small intestine and restrains NASH through gut-liver crosstalk. We examined the mice globally overexpressing, haploinsufficient, and conditional knockout models of TCF7L2 in the intestinal epithelium. The TCF7L2(+/-) mice exhibited increased plasma bile salts and lipids and developed diet-induced fatty liver disease while mice globally overexpressing TCF7L2 were protected against these traits. Comprehensive in vivo analysis revealed that TCF7L2 transcriptionally upregulates FGF15 in the gut, leading to reduced bile synthesis and diminished intestinal lipid uptake. Accordingly, Vilin(Creert2); Tcf7L2(fl/fl) mice showed reduced Fgf19 in the ileum, and increased plasma bile. The global overexpression of TCF7L2 in mice with metabolic syndrome-linked LRP6(R611C) substitution rescued the fatty liver and fibrosis in the latter. Strikingly, the hepatic levels of TCF4 were reduced and CYP7a1 was increased in human NASH, indicating the relevance of TCF4-dependent regulation of bile synthesis to human disease. These studies identify the critical role of TCF4 as an upstream regulator of the FGF15-mediated gut-liver crosstalk that maintains bile and liver triglyceride homeostasis.	[Bhat, Neha; Esteghamat, Fatemehsadat; Gunawardhana, Kushan; Thames, Clay; Mani, Arya] Yale Univ, Cardiovasc Res Ctr, Dept Internal Med, Sch Med, New Haven, CT 06511 USA; [Chaube, Bal Krishna; Fernandes-Hernando, Carlos] Yale Sch Med, Dept Comparat Med, New Haven, CT USA; [Mani, Mitra] New York Med Coll, Valhalla, NY 10595 USA; [Mani, Mitra; Ginsberg, Henry N.] Columbia Univ, Dept Internal Med, Coll Phys & Surg, New York, NY USA; [Jain, Dhanpat] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Mani, Arya] Yale Sch Med, Dept Genet, New Haven, CT USA	Yale University; Yale University; New York Medical College; Columbia University; Yale University; Yale University	Mani, A (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, 300 George St, New Haven, CT 06511 USA.	arya.mani@yale.edu	Chaube, Balkrishna/F-8879-2012	Chaube, Balkrishna/0000-0003-4378-7416	NHLBI [5R35HL135767, 5R35HL135833]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI, Grant/Award Number: 5R35HL135767 and 5R35HL135833	Alvarez-Sola G, 2017, GUT, V66, P1818, DOI 10.1136/gutjnl-2016-312975; Appleby RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211348; Aryal B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97918; Azzu V, 2021, MOL METAB, V48, DOI 10.1016/j.molmet.2021.101210; Bhat N, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI153724; Bhat N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166703; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Bozadjieva N, 2018, DIABETES, V67, P1720, DOI 10.2337/dbi17-0007; Brighton CA, 2015, ENDOCRINOLOGY, V156, P3961, DOI 10.1210/en.2015-1321; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chen MM, 2018, J ENDOCRINOL, V237, P139, DOI 10.1530/JOE-17-0727; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Geoghegan G, 2019, MOL METAB, V24, P44, DOI 10.1016/j.molmet.2019.03.003; Go GW, 2014, CELL METAB, V19, P209, DOI 10.1016/j.cmet.2013.11.023; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huertas-Vazquez A, 2008, DIABETOLOGIA, V51, P62, DOI 10.1007/s00125-007-0850-6; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kim YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19803-9; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; McCarthy MI, 2013, CELL METAB, V17, P157, DOI 10.1016/j.cmet.2013.01.011; Miyata M, 2012, J STEROID BIOCHEM, V132, P41, DOI 10.1016/j.jsbmb.2012.04.008; MORGAN RGH, 1969, Q J EXP PHYSIOL CMS, V54, P228, DOI 10.1113/expphysiol.1969.sp002021; Nishikawa K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103103; O'Rourke Kevin P, 2016, Bio Protoc, V6; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Shin DJ, 2009, J BIOL CHEM, V284, P11110, DOI 10.1074/jbc.M808747200; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Srivastava R, 2019, ARTERIOSCL THROM VAS, V39, P250, DOI 10.1161/ATVBAHA.118.311830; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Wang JN, 2018, GENE, V674, P57, DOI 10.1016/j.gene.2018.06.053; Wang SX, 2015, FASEB J, V29, P3436, DOI 10.1096/fj.15-271171; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P1089, DOI 10.1515/jpem-2012-0253; Woollett LA, 2006, GUT, V55, P197, DOI 10.1136/gut.2005.069906; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Ye ZJ, 2012, J BIOL CHEM, V287, P1335, DOI 10.1074/jbc.M111.295287; Zhou M, 2017, HEPATOL COMMUN, V1, P1024, DOI 10.1002/hep4.1108	50	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22185	10.1096/fj.202101607R	http://dx.doi.org/10.1096/fj.202101607R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35133032				2022-12-26	WOS:000761250800020
J	Eh, M; Kaczmarek, AT; Schwarz, G; Bender, D				Eh, Malin; Kaczmarek, Alexander Tobias; Schwarz, Guenter; Bender, Daniel			Molecular mechanism of intramolecular electron transfer in dimeric sulfite oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM; NITRITE; MITOCHONDRIA; DEFICIENCY; CATALYSIS; COFACTOR; IMPORT; G473D	Sulfite oxidase (SOX) is a homodimeric molybdoheme enzyme that oxidizes sulfite to sulfate at the molybdenum center. Following substrate oxidation, molybdenum is reduced and subsequently regenerated by two sequential electron transfers (ETs) via heme to cytochrome c. SOX harbors both metals in spatially separated domains within each subunit, suggesting that domain movement is necessary to allow intramolecular ET. To address whether one subunit in a SOX dimer is sufficient for catalysis, we produced heterodimeric SOX variants with abolished sulfite oxidation by replacing the molybdenum-coordinating and essential cysteine in the active site. To further elucidate whether electrons can bifurcate between subunits, we truncated one or both subunits by deleting the heme domain. We generated three SOX heterodimers: (i) SOX/Mo with two active molybdenum centers but one deleted heme domain, (ii) SOX/Mo_C264S with one unmodified and one inactive subunit, and (iii) SOX_C264S/Mo harboring a functional molybdenum center on one subunit and a heme domain on the other subunit. Steady-state kinetics showed 50% SOX activity for the SOX/Mo and SOX/Mo_C264S heterodimers, whereas SOX_C264S/Mo activity was reduced by two orders of magnitude. Rapid reaction kinetics monitoring revealed comparable ET rates in SOX/Mo, SOX/Mo_C264S, and SOX/SOX, whereas in SOX_C264S/Mo, ET was strongly compromised. We also combined a functional SOX Mo domain with an inactive full-length SOX R217W variant and demonstrated interdimer ET that resembled SOX_C264S/Mo activity. Collectively, our results indicate that one functional subunit in SOX is sufficient for catalysis and that electrons derived from either Mo(IV)or Mo(V) follow this path.	[Eh, Malin; Kaczmarek, Alexander Tobias; Schwarz, Guenter; Bender, Daniel] Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany; [Bender, Daniel] Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland	University of Cologne; University Children's Hospital Zurich	Schwarz, G; Bender, D (corresponding author), Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany.; Bender, D (corresponding author), Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland.	gschwarz@uni-koeln.de; daniel.bender@kispi.uzh.ch		Schwarz, Guenter/0000-0002-2118-9338; Kaczmarek, Alexander/0000-0001-5425-0425; Bender, Daniel/0000-0002-2975-4186	Center for Molecular Medicine Cologne, Germany [CMMC2017-C13]	Center for Molecular Medicine Cologne, Germany	Acknowledgments-We thank Monika Laurien, Simona Jansen, Joana Stegemann, and Julia Reich for excellent technical assistance. We thank Laura Vierbaum for initiating the project. This research was funded by grant CMMC2017-C13 from the Center for Molecular Medicine Cologne, Germany.	Bender D, 2020, J INHERIT METAB DIS, V43, P748, DOI 10.1002/jimd.12216; Bender D, 2019, BIOCHEM J, V476, P1805, DOI 10.1042/BCJ20190143; Bender D, 2019, HUM MOL GENET, V28, P2885, DOI 10.1093/hmg/ddz109; Claerhout H, 2018, J INHERIT METAB DIS, V41, P101, DOI 10.1007/s10545-017-0089-4; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; Edwards MC, 1999, OPHTHALMOLOGY, V106, P1957, DOI 10.1016/S0161-6420(99)90408-6; Enemark JH, 2008, BIOCHEM SOC T, V36, P1129, DOI 10.1042/BST0361129; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Feng CJ, 2005, BIOCHEMISTRY-US, V44, P13734, DOI 10.1021/bi050907f; Feng CJ, 2002, BIOCHEMISTRY-US, V41, P5816, DOI 10.1021/bi016059f; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; ITO A, 1971, J BIOCHEM-TOKYO, V70, P1061, DOI 10.1093/oxfordjournals.jbchem.a129716; JOHNSON JL, 1977, J BIOL CHEM, V252, P2017; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Johnson-Winters K, 2010, BIOCHEMISTRY-US, V49, P1290, DOI 10.1021/bi9020296; Kaczmarek AT, 2019, NITRIC OXIDE-BIOL CH, V89, P22, DOI 10.1016/j.niox.2019.04.004; Kaczmarek AT, 2021, MOL GENET METAB, V134, P188, DOI 10.1016/j.ymgme.2021.07.011; Kaczmarek AT, 2022, J INHERIT METAB DIS, V45, P169, DOI 10.1002/jimd.12454; Kappler U, 2015, J BIOL INORG CHEM, V20, P253, DOI 10.1007/s00775-014-1197-3; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Klein JM, 2012, J CELL SCI, V125, P4876, DOI 10.1242/jcs.110114; Kumar A., 2017, S SULFOCYSTEINENMDA; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; ONO H, 1984, J BIOCHEM-TOKYO, V95, P345, DOI 10.1093/oxfordjournals.jbchem.a134614; Pacheco A, 1999, J BIOL INORG CHEM, V4, P390, DOI 10.1007/s007750050325; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Peariso K, 2002, J AM CHEM SOC, V124, P9006, DOI 10.1021/ja017217t; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Tejada-Jimenez M, 2018, MOLECULES, V23, DOI 10.3390/molecules23123287; Wang J, 2015, ANTIOXID REDOX SIGN, V23, P283, DOI 10.1089/ars.2013.5397; Wilson HL, 2006, BIOCHEMISTRY-US, V45, P2149, DOI 10.1021/bi051609l; Wilson HL, 2004, J BIOL CHEM, V279, P15105, DOI 10.1074/jbc.M314288200	35	0	0	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101668	10.1016/j.jbc.2022.101668	http://dx.doi.org/10.1016/j.jbc.2022.101668			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120924	gold, Green Published, Green Accepted			2022-12-26	WOS:000791230900011
J	Kumar, A; Yang, TH; Chakravorty, S; Majumdar, A; Nairn, BL; Six, DA; dos Santos, NM; Price, SL; Lawrenz, MB; Actis, LA; Marques, M; Russo, TA; Newton, SM; Klebba, PE				Kumar, Ashish; Yang, Taihao; Chakravorty, Somnath; Majumdar, Aritri; Nairn, Brittany L.; Six, David A.; dos Santos, Naara Marcondes; Price, Sarah L.; Lawrenz, Matthew B.; Actis, Luis A.; Marques, Marilis; Russo, Thomas A.; Newton, Salete M.; Klebba, Phillip E.			Fluorescent sensors of siderophores produced by bacterial pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SITE-DIRECTED ALKYLATION; UROPATHOGENIC ESCHERICHIA-COLI; FERRIC ENTEROBACTIN RECEPTOR; FLANKING HYDROPHILIC DOMAINS; IRON ACQUISITION-SYSTEMS; LOW-COPY-NUMBER; LACTOSE PERMEASE; OUTER-MEMBRANE; SALMONELLA-ENTERICA	Siderophores are iron-chelating molecules that solubilize Fe3+ for microbial utilization and facilitate colonization or infection of eukaryotes by liberating host iron for bacterial uptake. By fluorescently labeling membrane receptors and binding proteins, we created 20 sensors that detect, discriminate, and quantify apo-and ferric siderophores. The sensor proteins originated from TonB-dependent ligand-gated porins (LGPs) of Escherichia coli (Fiu, FepA, Cir, FhuA, IutA, BtuB), Klebsiella pneumoniae (IroN, FepA, FyuA), Acinetobacter baumannii (PiuA, FepA, PirA, BauA), Pseudomonas aeruginosa (FepA, FpvA), and Caulobacter crescentus (HutA) from a periplasmic E. coli binding protein (FepB) and from a human serum binding protein (siderocalin). They detected ferric catecholates (enterobactin, degraded enterobactin, glucosylated enterobactin, dihydroxybenzoate, dihydroxybenzoyl serine, cefidericol, MB 1), ferric hydroxamates (ferrichromes, aerobactin), mixed iron complexes (yersiniabactin, acinetobactin, pyoverdine), and porphyrins (hemin, vitamin B12). The sensors defined the specificities and corresponding affinities of the LGPs and binding proteins and monitored ferric siderophore and porphyrin transport by microbial pathogens. We also quantified, for the first time, broad recognition of diverse ferric complexes by some LGPs, as well as monospecificity for a single metal chelate by others. In addition to their primary ferric siderophore ligands, most LGPs bound the corresponding aposiderophore with ~& nbsp;100-fold lower affinity. These sensors provide insights into ferric siderophore biosynthesis and uptake pathways in freeliving, commensal, and pathogenic Gram-negative bacteria.	[Kumar, Ashish; Yang, Taihao; Chakravorty, Somnath; Majumdar, Aritri; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Chakravorty, Somnath; Russo, Thomas A.] Univ Buffalo, Sch Med, Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA; [Nairn, Brittany L.] Bethel Univ, Dept Biol Sci, St Paul, MN USA; [Six, David A.] Venatorx Pharmaceut Inc, Dept Biol, Malvern, PA USA; [dos Santos, Naara Marcondes; Marques, Marilis] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, Brazil; [Price, Sarah L.; Lawrenz, Matthew B.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Kansas State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade de Sao Paulo; University of Louisville; University System of Ohio; Miami University	Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	peklebba@ksu.edu	Marques, Marilis V/C-3085-2013; Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711; Marques, Marilis/0000-0003-1542-8221; Santos, Naara Marcondes/0000-0001-7487-952X	Veterans Administration Western New York Healthcare System, Buffalo, New York, USA; Department of Veterans Affairs VA Merit Review [1I01BX004677-01A1]; NIH [1R21AI141826-01A1, R21AI135225, R01AI148241, F31AI147404]; Defense Threat Reduction Agency (DTRA) [HDTRA117C0070]; NIAID, National Institutes of Health [75N93020C00016]; Sao Paulo Research Foundation (FAPESP ) [2019/08514-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil) [307974/2017-0]; FAPESP [2017/021279]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil [CAPES 88887.470428/2019-00]	Veterans Administration Western New York Healthcare System, Buffalo, New York, USA; Department of Veterans Affairs VA Merit Review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sao Paulo Research Foundation (FAPESP )(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	T. A. R. was supported by the Veterans Administration Western New York Healthcare System, Buffalo, New York, USA, the Department of Veterans Affairs VA Merit Review 1I01BX004677-01A1, and NIH 1R21AI141826-01A1. D. A. S. was supported by the Defense Threat Reduction Agency (DTRA) under Contract No. HDTRA117C0070 and NIAID, National Institutes of Health under Contract No. 75N93020C00016. M. B. L. was supported by NIH grants R21AI135225 and R01AI148241 and S. L. P. by NIH F31AI147404. N. M. d. S. was supported by the Sao Paulo Research Foundation (FAPESP 2019/08514-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil 307974/2017-0), FAPESP (2017/021279), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES 88887.470428/2019-00). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelhamed H, 2016, MICROB PATHOGENESIS, V100, P195, DOI 10.1016/j.micpath.2016.09.018; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; ACTIS LA, 1986, J BACTERIOL, V167, P57, DOI 10.1128/jb.167.1.57-65.1986; Allred BE, 2013, ACS CHEM BIOL, V8, P1882, DOI 10.1021/cb4002552; AMES GFL, 1974, J BIOL CHEM, V249, P634; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Bachman MA, 2012, MBIO, V3, DOI 10.1128/mBio.00224-11; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Balhesteros H, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00723-16; Bister B, 2004, BIOMETALS, V17, P471, DOI 10.1023/B:BIOM.0000029432.69418.6a; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; BROCK JH, 1991, INFECT IMMUN, V59, P3185, DOI 10.1128/IAI.59.9.3185-3190.1991; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chakravorty S, 2019, J BIOL CHEM, V294, P4682, DOI 10.1074/jbc.RA118.006921; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; DERVARTANIAN M, 1992, INFECT IMMUN, V60, P2800, DOI 10.1128/IAI.60.7.2800-2807.1992; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; FAUNDEZ G, 1988, J CLIN MICROBIOL, V26, P928, DOI 10.1128/JCM.26.5.928-932.1988; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; Fischbach M. A., 2006, PROC NATL ACAD SCI S; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P3950, DOI 10.1021/bi952601m; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P5333, DOI 10.1021/bi953068d; Frillingos S, 1997, PROTEIN SCI, V6, P438; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P269, DOI 10.1021/bi9618629; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P14284, DOI 10.1021/bi972314d; Ganz T, 2018, INT J HEMATOL, V107, P7, DOI 10.1007/s12185-017-2366-2; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grinter R, 2019, J BIOL CHEM, V294, P19523, DOI 10.1074/jbc.RA119.011018; GROMAN NB, 1965, J BACTERIOL, V90, P1563, DOI 10.1128/JB.90.6.1563-1568.1965; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; HANCOCK REW, 1976, FEBS LETT, V65, P208, DOI 10.1016/0014-5793(76)80481-4; Hanson M, 2016, J BIOMOL SCREEN, V21, P316, DOI 10.1177/1087057115613788; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holden VI, 2016, MBIO, V7, DOI 10.1128/mBio.01397-16; Holden VI, 2015, METALLOMICS, V7, P986, DOI 10.1039/c4mt00333k; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Ito A, 2016, ANTIMICROB AGENTS CH, V60, P7396, DOI 10.1128/AAC.01405-16; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; JUNG K, 1994, BIOCHEMISTRY-US, V33, P3980, DOI 10.1021/bi00179a026; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 2021, CHEM REV, V121, P5193, DOI 10.1021/acs.chemrev.0c01005; KLUG CS, 1995, BIOCHEMISTRY-US, V34, P14230, DOI 10.1021/bi00043a030; Kohira N., 2016, ANTIMICROB AGENTS CH; Kokesov A., 2006, FOLIA MICROBIOL, V51; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee I. R., 2016, SCI REP-UK; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Liu J., 1994, FEPA BIOCH, V33, P13274; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Lukacik P., 2012, P NATL ACAD SCI; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Mabayoje DA, 2021, JAC-ANTIMICROB RESIS, V3, P21, DOI 10.1093/jacamr/dlab055; Majumdar A, 2020, J BIOL CHEM, V295, P4974, DOI 10.1074/jbc.RA119.011850; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; Massip C, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008029; MCLAUCHLIN J, 1990, EPIDEMIOL INFECT, V104, P181, DOI 10.1017/S0950268800059343; MONTGOMERIE JZ, 1984, INFECT IMMUN, V46, P835, DOI 10.1128/IAI.46.3.835-838.1984; Moynie L, 2018, ELIFE, V7, DOI 10.7554/eLife.42270; Moynie L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02531-16; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Nairn BL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00889-16; Nazareth H, 2007, INFECT IMMUN, V75, P2776, DOI 10.1128/IAI.01095-06; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neilands J. B., 1974, MICROBIAL IRON METAB, P434; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Nie Y, 2007, J MOL BIOL, V374, P356, DOI 10.1016/j.jmb.2007.09.006; NIKAIDO H, 1990, J BACTERIOL, V172, P1361, DOI 10.1128/jb.172.3.1361-1367.1990; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Pi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050020; Pradhan S, 2020, MBIO, V11, DOI 10.1128/mBio.01470-20; Ramakrishnan G, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00107; Roberts R. B., 1957, STUDIES BIOSYNTHESIS, V607, P5; ROSENBUSCH JP, 1990, EXPERIENTIA, V46, P167; Russo TA, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00001-19; Russo TA, 2015, INFECT IMMUN, V83, P3325, DOI 10.1128/IAI.00430-15; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; RUTZ JM, 1991, J BACTERIOL, V173, P5964, DOI 10.1128/jb.173.19.5964-5974.1991; Saha P, 2019, GUT MICROBES, V10, P412, DOI 10.1080/19490976.2018.1546519; SAHINTOTH M, 1993, PROTEIN SCI, V2, P1024, DOI 10.1002/pro.5560020615; Saier MH, 2000, J MEMBRANE BIOL, V175, P165, DOI 10.1007/s00232001065; Schalk IJ, 1999, BIOCHEMISTRY-US, V38, P9357, DOI 10.1021/bi990421x; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Schauer K., 2008, TRENDS BIOCHEM SCI, V6, P6; Scott D. C., 2000, THESIS U OKLAHOMA; Scott DC, 2002, J BACTERIOL, V184, P4906, DOI 10.1128/JB.184.17.4906-4911.2002; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Sheldon JR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008995; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Sia AK, 2013, CURR OPIN CHEM BIOL, V17, P150, DOI 10.1016/j.cbpa.2012.11.014; Smallwood CR, 2014, J GEN PHYSIOL, V144, P69, DOI 10.1085/jgp.201311159; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Song WY, 2017, ORG LETT, V19, P500, DOI 10.1021/acs.orglett.6b03671; Sonnenborn U, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw212; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tomaras AP, 2015, ANTIMICROB AGENTS CH, V59, P2439, DOI 10.1128/AAC.04172-14; Tomaras AP, 2013, ANTIMICROB AGENTS CH, V57, P4197, DOI 10.1128/AAC.00629-13; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10641, DOI 10.1021/bi000438b; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10649, DOI 10.1021/bi0004394; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10656, DOI 10.1021/bi0004403; Voss J, 1997, BIOCHEMISTRY-US, V36, P15055, DOI 10.1021/bi971726j; Voss J, 1996, BIOCHEMISTRY-US, V35, P12915, DOI 10.1021/bi9608774; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; WEITZMAN C, 1995, BIOCHEMISTRY-US, V34, P9374, DOI 10.1021/bi00029a013; WILLIAMS P, 1989, J GEN MICROBIOL, V135, P3173; Williams PH, 2006, VACCINE, V24, P3840, DOI 10.1016/j.vaccine.2005.07.020; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506; Wright H, 2017, CLIN MICROBIOL INFEC, V23, P704, DOI 10.1016/j.cmi.2017.09.001; Wu JY, 2020, INFECT DIS THER, V9, P17, DOI 10.1007/s40121-020-00286-6; Wu JH, 1996, P NATL ACAD SCI USA, V93, P10123, DOI 10.1073/pnas.93.19.10123; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Zhang W, 2003, BIOCHEMISTRY-US, V42, P4904, DOI 10.1021/bi034078e	157	3	3	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101651	10.1016/j.jbc.2022.101651	http://dx.doi.org/10.1016/j.jbc.2022.101651			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101443	gold, Green Published			2022-12-26	WOS:000794865600014
J	Tominari, T; Akita, M; Matsumoto, C; Hirata, M; Yoshinouchi, S; Tanaka, Y; Karouji, K; Itoh, Y; Maruyama, T; Miyaura, C; Numabe, Y; Inada, M				Tominari, Tsukasa; Akita, Miyuki; Matsumoto, Chiho; Hirata, Michiko; Yoshinouchi, Shosei; Tanaka, Yuki; Karouji, Kento; Itoh, Yoshifumi; Maruyama, Takayuki; Miyaura, Chisato; Numabe, Yukihiro; Inada, Masaki			Endosomal TLR3 signaling in stromal osteoblasts induces prostaglandin E-2-mediated inflammatory periodontal bone resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; OSTEOCLAST DIFFERENTIATION; PORPHYROMONAS-GINGIVALIS; CYTOKINE PRODUCTION; EXPRESSION; RANKL; E-2; LIPOPOLYSACCHARIDE; STIMULATION	Toll-like receptors (TLRs) are pattern recognition receptors that play a critical role in innate immune diseases. TLR3, which is localized in the endosomal compartments of hematopoietic immune cells, is able to recognize double-stranded RNA (dsRNA) derived from viruses and bacteria and thereby induce innate immune responses. Inflammatory periodontal bone resorption is caused by bacterial infections, which initially is regulated by innate immunity; however, the roles of TLR3 signaling in bone resorption are still not known. We examined the roles of TLR3 signaling in bone resorption using poly(I:C), a synthetic dsRNA analog. In cocultures of mouse bone marrow cells and stromal osteoblasts, poly(I:C) clearly induced osteoclast differentiation. In osteoblasts, poly(I:C) increased PGE(2) production and upregulated the mRNA expression of PGE2- related genes, Ptgs2 and Ptges, as well as that of a gene related to osteoclast differentiation, Tnfsf11. In addition, we found that indomethacin (a COX-2 inhibitor) or an antagonist of the PGE(2)-receptor EP4 attenuated the poly(I:C)-induced PGE(2) production and subsequent Tnfsf11 expression. Poly(I:C) also prolonged the survival of the mature osteoclasts associated with the increased mRNA expression of osteoclast marker genes, Nfatc1 and Ctsk. In ex vivo organ cultures of periodontal alveolar bone, poly(I:C) induced bone-resorbing activity in a dose-dependent manner, which was attenuated by the simultaneous administration of either indomethacin or an EP4 antagonist. These data suggest that TLR3 signaling in osteoblasts controls PGE(2) production and induces the subsequent differentiation and survival of mature osteoclasts. Endogenous TLR3 in stromal osteoblasts and osteoclasts synergistically induces inflammatory alveolar bone resorption in periodontitis.	[Tominari, Tsukasa; Akita, Miyuki; Matsumoto, Chiho; Hirata, Michiko; Tanaka, Yuki; Karouji, Kento; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Yoshinouchi, Shosei; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Adv Hlth Sci, Koganei, Tokyo, Japan; [Itoh, Yoshifumi; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo, Japan; [Itoh, Yoshifumi] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Maruyama, Takayuki] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka, Japan; [Numabe, Yukihiro] Nippon Dent Univ Tokyo, Sch Dent, Dept Periodontol, Chiyoda Ku, Tokyo, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; University of Oxford; Ono Pharmaceutical Co Ltd; Nippon Dental University	Inada, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan.; Inada, M (corresponding author), Tokyo Univ Agr & Technol, Adv Hlth Sci, Koganei, Tokyo, Japan.; Inada, M (corresponding author), Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo, Japan.	m-inada@cc.tuat.ac.jp	Tominari, Tsukasa/B-6054-2015	Tominari, Tsukasa/0000-0001-5683-8951	Japan Society for the Promotion of Science (Kakenhi) [JP18K19730]; Institute of Global Innovation Research in Tokyo University of Agriculture and Technology	Japan Society for the Promotion of Science (Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute of Global Innovation Research in Tokyo University of Agriculture and Technology	We thank Ms Wakana Kaizuka for expert assistance. This work was supported by the Grant-in-aid for Sci-entific Research by the Japan Society for the Promotion of Science (Kakenhi grants JP18K19730) and Institute of Global Innovation Research in Tokyo University of Agriculture and Technology.	Bai WJ, 2014, CELL SIGNAL, V26, P942, DOI 10.1016/j.cellsig.2014.01.015; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Campos PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00028; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Gan TT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03174; Ha H, 2008, J IMMUNOL, V180, P1382, DOI 10.4049/jimmunol.180.3.1382; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kassem A, 2015, FASEB J, V29, P4449, DOI 10.1096/fj.15-272559; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kim K.-W., 2009, IMMUNOL LETT; Kim KW, 2019, J BIOCHEM, V166, P259, DOI 10.1093/jb/mvz033; Kim PD, 2015, INFECT IMMUN, V83, P2992, DOI 10.1128/IAI.00424-15; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lacey D. L., 1998, CELL; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Miyaura C, 2000, J BIOL CHEM, V275, P19819, DOI 10.1074/jbc.M002079200; Mori K, 2015, J DENT RES, V94, P1149, DOI 10.1177/0022034515589289; Myneni SR, 2011, J IMMUNOL, V187, P501, DOI 10.4049/jimmunol.1100683; Noguchi K, 2007, PERIODONTOL 2000, V43, P85, DOI 10.1111/j.1600-0757.2006.00170.x; Park HJ, 2015, J CELL PHYSIOL, V230, P667, DOI 10.1002/jcp.24790; Park KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23103; Pilbeam C, 2019, HANDB EXP PHARM, V262, P157; Raisz LG, 2003, PROSTAG OTH LIPID M, V71, P287, DOI 10.1016/S1098-8823(03)00049-2; Sahingur SE, 2013, J PERIODONTOL, V84, pE48, DOI 10.1902/jop.2013.120739; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanabe N, 2005, LIFE SCI, V77, P615, DOI 10.1016/j.lfs.2004.10.079; Tanaka S, 2018, MOD RHEUMATOL, V28, P9, DOI 10.1080/14397595.2017.1369491; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yu BH, 2019, INT J MOL MED, V43, P2341, DOI 10.3892/ijmm.2019.4165; Zare F, 2004, J IMMUNOL, V172, P5656, DOI 10.4049/jimmunol.172.9.5656; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhou H, 2013, J IMMUNOL, V190, P115, DOI 10.4049/jimmunol.1202136; Zubery Y, 1998, INFECT IMMUN, V66, P4158	50	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101603	10.1016/j.jbc.2022.101603	http://dx.doi.org/10.1016/j.jbc.2022.101603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35101442	Green Published, gold			2022-12-26	WOS:000791267400017
J	Zhang, WY; Rong, G; Gu, JG; Fan, CL; Guo, TT; Jiang, TT; Deng, WQ; Xie, JY; Su, ZH; Yu, QM; Mai, JY; Zheng, RN; Chen, XL; Tang, X; Zhang, J				Zhang, Wenying; Rong, Guang; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Jiang, Tingting; Deng, Weiqian; Xie, Jiayu; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun; Zhang, Jun			Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-beta 1/Smad3 pathway	FASEB JOURNAL			English	Article						1-methylnicotinamide (MNAM); chronic kidney disease (CKD); nicotinamide N-methyltransferase (NNMT); TGF-beta 1/Smad3; tubulointerstitial fibrosis (TIF)	MATRIX GENE-EXPRESSION; TGF-BETA; ANTIBODY THERAPY; CELL-DEATH; NEPHROPATHY; MICRORNA; PROTECTS; INJURY; MICE	Chronic kidney disease (CKD), a disease involving damage to the kidney structure and function, is a global public health problem. Tubulointerstitial fibrosis (TIF) is both an inevitable pathological change in individuals with CKD and a driving force in the progression of renal fibrosis. Nicotinamide N-methyltransferase (NNMT) and its metabolite 1-methylnicotinamide (MNAM) have been shown to protect against lipotoxicity-induced kidney tubular injury. However, the biological roles of NNMT and MNAM in regulating TIF remain elusive. This study aimed to investigate the protective effect of NNMT and MNAM on TIF and the mechanisms involved. We explored the functions and mechanisms of NNMT and MNAM in TIF, as well as the interaction between NNMT and MNAM, using unilateral ureteral obstruction (UUO) mice and cultured mouse tubular epithelial cells (mTECs) stimulated with transforming growth factor-beta 1 (TGF-beta 1). Several important findings were obtained as follows: (1) NNMT expression was upregulated in the kidneys of UUO mice and TGF-beta 1-induced mTECs, and this upregulation was proposed to be a protective compensatory response to TIF. (2) MNAM was a potentially effective antifibrotic and anti-inflammatory medication in UUO mice. (3) The antifibrotic effect of NNMT overexpression was exerted by increasing the concentration of MNAM. (4) The renoprotective role of MNAM depended on the selective blockade of the interaction of Smad3 with TGF beta receptor I. Overall, our study shows that NNMT is involved in the development and progression of CKD and that its metabolite MNAM may be a novel inhibitor of the TGF-beta 1/Smad3 pathway with great therapeutic potential for CKD.	[Zhang, Wenying; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun; Zhang, Jun] Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Ind Rd 253, Guangzhou 510280, Guangdong, Peoples R China; [Zhang, Wenying] Guangzhou Med Univ, Dept Nephrol, Affiliated Hosp 2, Guangzhou, Peoples R China; [Rong, Guang] SSL Cent Hosp Dongguan City, Dept Nephrol, Dongguan, Peoples R China; [Jiang, Tingting] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Nephrol, Nanning, Peoples R China; [Deng, Weiqian] Southern Med Univ, Affiliated Hosp 5, Dept Nephrol, Guangzhou, Peoples R China; [Xie, Jiayu] Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Dept Neurosurg,Engn Technol Res Ctr Educ,Minist C, Zhujiang Hosp,Natl Key Clin Specialty,Neurosurg I, Guangzhou, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Southern Medical University - China	Tang, X; Zhang, J (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Ind Rd 253, Guangzhou 510280, Guangdong, Peoples R China.	1847672118@qq.com; gzh_zj@qq.com	Su, Zhihua/GWN-1858-2022		Guangdong Medical Research Foundation (Guangdong Province Medical Research Foundation) [A2019169]; Natural Science Foundation of Guangdong Province [2018A030313557, 2021A1515012175]	Guangdong Medical Research Foundation (Guangdong Province Medical Research Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	Guangdong Medical Research Foundation (Guangdong Province Medical Research Foundation), Grant/Award Number: A2019169; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2018A030313557 and 2021A1515012175	Ai J, 2015, J AM SOC NEPHROL, V26, P1827, DOI 10.1681/ASN.2014040363; AKSOY S, 1994, J BIOL CHEM, V269, P14835; Bar A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00183; Campagna R, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.119082; Chen HY, 2014, MOL THER, V22, P842, DOI 10.1038/mt.2013.235; CHRIST M, 1994, J IMMUNOL, V153, P1936; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Cui YY, 2020, MOL CARCINOGEN, V59, P940, DOI 10.1002/mc.23209; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Domagala TB, 2012, HYPERTENSION, V59, P825, DOI 10.1161/HYPERTENSIONAHA.111.183210; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Ferenbach D, 2007, SEMIN NEPHROL, V27, P250, DOI 10.1016/j.semnephrol.2007.02.001; Gisewhite S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03544-2; Giusti B, 2008, J MED GENET, V45, P721, DOI 10.1136/jmg.2008.057851; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Harmankaya I, 2021, J OBSTET GYNAECOL, V41, P248, DOI 10.1080/01443615.2020.1732891; Hong SY, 2015, NAT MED, V21, P887, DOI 10.1038/nm.3882; Kannt A, 2015, DIABETOLOGIA, V58, P799, DOI 10.1007/s00125-014-3490-7; Kim HC, 2010, AM J RESP CRIT CARE, V181, P797, DOI 10.1164/rccm.200906-0936OC; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Li R, 2013, KIDNEY INT, V84, P1129, DOI 10.1038/ki.2013.272; Liang XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155534; Liu WT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.335; Liu WT, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104506; Mateuszuk L, 2016, J PHARMACOL EXP THER, V356, P514, DOI 10.1124/jpet.115.228643; Mistry RJ, 2020, J BIOCHEM MOL TOXIC, V34, DOI 10.1002/jbt.22439; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Nath KA, 2011, AM J PHYSIOL-RENAL, V301, pF436, DOI 10.1152/ajprenal.00162.2011; Niewczas MA, 2019, NAT MED, V25, P805, DOI 10.1038/s41591-019-0415-5; Pissios P, 2017, TRENDS ENDOCRIN MET, V28, P340, DOI 10.1016/j.tem.2017.02.004; SANO A, 1989, CHEM PHARM BULL, V37, P3330; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Song MM, 2020, CANCER MED-US, V9, P2030, DOI 10.1002/cam4.2890; Tanaka Y, 2015, FREE RADICAL BIO MED, V89, P831, DOI 10.1016/j.freeradbiomed.2015.10.414; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Tonelli M, 2020, J AM SOC NEPHROL, V31, P1931, DOI 10.1681/ASN.2020030277; Voelker J, 2017, J AM SOC NEPHROL, V28, P953, DOI 10.1681/ASN.2015111230; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Zhang JF, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/1080152; Zhao LJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00187; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	52	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22084	10.1096/fj.202100913RRR	http://dx.doi.org/10.1096/fj.202100913RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35107844				2022-12-26	WOS:000761250800050
J	Miles, LF; Couture, EJ; Potes, C; Makar, T; Fernando, MC; Hungenahally, A; Mathieson, MD; Perlman, H; Perini, MV; Thind, D; Weinberg, L; Denault, AY				Miles, Lachlan F.; Couture, Etienne J.; Potes, Cristhian; Makar, Timothy; Fernando, Malindra C.; Hungenahally, Akshay; Mathieson, Matthew D.; Perlman, Hannah; Perini, Marcos V.; Thind, Dilraj; Weinberg, Laurence; Denault, Andre Y.			Preliminary experience with continuous right ventricular pressure and transesophageal echocardiography monitoring in orthotopic liver transplantation	PLOS ONE			English	Article							CARDIAC-OUTPUT MEASUREMENT; RIGHT HEART-FAILURE; LUNG TRANSPLANTATION; REPERFUSION	Background Despite increasing attention in the cardiac anesthesiology literature, continuous measurement of right ventricular pressure using a pulmonary artery catheter has not been described in orthotopic liver transplantation, despite similarities in the anesthetic approach to the two populations. We describe our preliminary experience with this technique in orthotopic liver transplantation, and by combining various derived measures with trans-esophageal echocardiography, make some early observations regarding the response of these measures of right ventricular function during the procedure. Methods In this case series, ten patients (five men and five women) undergoing orthotopic liver transplantation in our institution had their surgeries performed while monitored with a pulmonary artery catheter with continuous right ventricular port transduction and trans-esophageal echocardiography. We recorded various right ventricular waveform (early-to-end diastolic pressure difference, right ventricular outflow tract gradient, right ventricular dP/dT and right ventricular end-diastolic pressure) and echocardiographic (right ventricular fractional area change, tricuspid annular plane systolic excursion, right ventricular lateral wall strain) and described their change relative to baseline at timepoints five minutes before and after portal vein reperfusion, immediately after hepatic artery reperfusion and on abdominal closure. Results Except for tricuspid annular plane systolic excursion at five minutes prior to reperfusion (mean -0.8 cm; 95% CI-1.4, -0.3; p = 0.007), no echocardiographic metric was statistically significantly different at any timepoint relative to baseline. In contrast, changes in right ventricular outflow tract gradient and right ventricular dP/dt were highly significant at multiple timepoints, generally peaking immediately before or after reperfusion before reducing, but not returning to baseline in the neohepatic phase. Nine of 10 participants in this series demonstrated a degree of dynamic right ventricular outflow tract obstruction, which met criteria for hemodynamic significance (> 25 mmHg) in two participants. These changes were not materially affected by cardiac index. Conclusions Dynamic right ventricular outflow tract obstruction of varying severity appears common in patients undergoing orthotopic liver transplantation. These results are hypothesis generating and will form the basis of future prospective research.	[Miles, Lachlan F.; Weinberg, Laurence] Univ Melbourne, Dept Crit Care, Melbourne, Vic, Australia; [Miles, Lachlan F.; Makar, Timothy; Fernando, Malindra C.; Hungenahally, Akshay; Mathieson, Matthew D.; Perlman, Hannah; Thind, Dilraj; Weinberg, Laurence] Austin Hlth, Dept Anaesthesia, Melbourne, Vic, Australia; [Couture, Etienne J.] Laval Univ, Dept Anesthesiol, Div Intens Care Med, Quebec City, PQ, Canada; [Couture, Etienne J.] Laval Univ, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ, Canada; [Potes, Cristhian] Edwards LifeSci Pty Ltd, Irvine, CA USA; [Perini, Marcos V.; Weinberg, Laurence] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Perini, Marcos V.] Austin Hlth, Victorian Liver & Intestinal Transplant Unit, Melbourne, Vic, Australia; [Denault, Andre Y.] Univ Montreal, Dept Anesthesiol, Montreal, PQ, Canada; [Denault, Andre Y.] Univ Montreal, Montreal Heart Inst, Crit Care Div, Montreal, PQ, Canada	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Laval University; Laval University; Quebec Heart & Lung Institute; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Universite de Montreal; Universite de Montreal	Miles, LF (corresponding author), Univ Melbourne, Dept Crit Care, Melbourne, Vic, Australia.; Miles, LF (corresponding author), Austin Hlth, Dept Anaesthesia, Melbourne, Vic, Australia.	lachlan.miles@unimelb.edu.au	Perini, Marcos/D-4616-2019	Perini, Marcos/0000-0002-0165-1564; Miles, Lachlan/0000-0003-2044-5560; Mathieson, Matthew/0000-0002-4865-659X	Edwards LifeSciences	Edwards LifeSciences	Edwards LifeSciences provided support in the form of salaries for CP. The specific roles of these authors are articulated in the `author contributions' section. Edwards LifeSciences also provided in-kind support for RV waveform analysis.	Acosta F, 1999, TRANSPLANT P, V31, P2384, DOI 10.1016/S0041-1345(99)00392-9; Bottiger BW, 1997, ANAESTHESIA, V52, P207, DOI 10.1111/j.1365-2044.1997.079-az0077.x; Cingolani HE, 2013, AM J PHYSIOL-HEART C, V304, pH175, DOI 10.1152/ajpheart.00508.2012; Denault A, 2014, CAN J CARDIOL, V30, pS459, DOI 10.1016/j.cjca.2014.09.029; Denault AY, 2006, J THORAC CARDIOV SUR, V132, P43, DOI 10.1016/j.jtcvs.2006.03.014; DEWOLF AM, 1993, ANESTH ANALG, V76, P562; Fukazawa K, 2014, J CARDIOTHOR VASC AN, V28, P994, DOI 10.1053/j.jvca.2014.02.017; Gronlykke L, 2020, J CARDIOTHOR VASC AN, V34, P2116, DOI 10.1053/j.jvca.2019.12.042; Haddad F, 2016, CURR OPIN ANESTHESIO, V29, P68, DOI 10.1097/ACO.0000000000000284; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kirshbom PM, 1996, CHEST, V109, P575, DOI 10.1378/chest.109.2.575; KROSHUS TJ, 1995, ANN THORAC SURG, V59, P995, DOI 10.1016/0003-4975(94)00734-O; Lee HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20062-4; Ma Y, 2012, REGION ANESTH PAIN M, V37, P99, DOI 10.1097/AAP.0b013e31823ebc74; Nissen P, 2009, LIVER TRANSPLANT, V15, P287, DOI 10.1002/lt.21689; Raymond M, 2019, J CARDIOTHOR VASC AN, V33, P1090, DOI 10.1053/j.jvca.2018.08.198; RITCHIE ME, 1994, CHEST, V105, P610, DOI 10.1378/chest.105.2.610; Rosendal C, 2012, ANN TRANSPL, V17, P21; Shillcutt SK, 2016, J CARDIOTHOR VASC AN, V30, P107, DOI 10.1053/j.jvca.2015.09.009; Singbal Y, 2015, ECHOCARDIOGR-J CARD, V32, P1347, DOI 10.1111/echo.12877; Siniscalchi A, 2016, WORLD J GASTROENTERO, V22, P1551, DOI 10.3748/wjg.v22.i4.1551; Smith NK, 2021, ANESTH ANALG, V132, P130, DOI 10.1213/ANE.0000000000004734; Steib A, 1997, Liver Transpl Surg, V3, P518, DOI 10.1002/lt.500030507; Xu HT, 2012, CLIN TRANSPLANT, V26, pE485, DOI 10.1111/ctr.12010; Zeng Yu Hao, 2021, CJC Open, V3, P1153, DOI 10.1016/j.cjco.2021.03.011	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263386	10.1371/journal.pone.0263386	http://dx.doi.org/10.1371/journal.pone.0263386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120144	Green Published, gold			2022-12-26	WOS:000789273600035
J	Ganbat, M; Erdenebileg, N; Batbold, C; Nergui, S; Anderson, R; Wigfall, C; Amarsanaa, N; Heikens, A; Sarantuya, M; Warburton, D				Ganbat, Mandukhai; Erdenebileg, Nasantogtokh; Batbold, Chuluunbileg; Nergui, Saruultuya; Anderson, Ron; Wigfall, Clarence; Amarsanaa, Narantsetseg; Heikens, Alex; Sarantuya, Moiltmaa; Warburton, David			Integrating quantitative and qualitative approaches to assess wintertime illness-related absenteeism and its direct and indirect costs among the private sector in Ulaanbaatar	PLOS ONE			English	Article							AIR-POLLUTION; OF-ILLNESS; HEALTH; IMPACT	Causes for employee absenteeism vary. The commonest cause of work absenteeism is "illness-related." Mongolia's capital city, Ulaanbaatar, experiences high employee absenteeism during the winter than during other seasons due to the combination of extreme cold and extreme air pollution. We identified direct and indirect costs of absenteeism attributed to air pollution among private-sector employees in Ulaanbaatar. Using a purposive sampling design, we obtained questionnaire data for 1,330 employees working for private-sector companies spanning six economic sectors. We conducted 26 employee focus groups and 20 individual employer in-depth interviews. We used both quantitative and qualitative instruments to characterize the direct and indirect costs of absence due to illnesses attributed to severe air pollution during wintertime. Female employees and employees with a young child at home were more likely to be absent. Respiratory diseases accounted for the majority of reported air pollution-related illnesses. All participants perceived that air pollution adversely affected their health. Individual employee direct costs related to absence totaled 875,000 MNT ($307.10) for an average of three instances of three-day illness-related absences during the winter. This sum included diagnostic and doctor visit-related, medication costs and hospitalization costs. Non-healthcare-related direct cost (transportation) per absence was 50,000T ($17.60). Individual indirect costs included the value of lost wages for the typical 3-day absence, amounting to 120,000T ($42.10). These total costs to employees, therefore, may amount to as much as 10% of annual income. The majority of sick absences were unpaid. Overall, the cost of wintertime absences is substantial and fell disproportionately on female employees with young children.	[Ganbat, Mandukhai] Mongolian Natl Univ Med Sci, Dept Epidemiol & Biostat, Ulaanbaatar, Mongolia; [Erdenebileg, Nasantogtokh; Batbold, Chuluunbileg; Nergui, Saruultuya; Anderson, Ron] Mongolian Natl Univ Med Sci, Sch Med, Ulaanbaatar, Mongolia; [Wigfall, Clarence] Claremont Grad Univ, Dept Appl Social Psychol, Claremont, CA USA; [Amarsanaa, Narantsetseg] Mandakh Univ, Dept Accounting, Ulaanbaatar, Mongolia; [Heikens, Alex; Sarantuya, Moiltmaa] United Nations Children Fund, Ulaanbaatar, Mongolia; [Warburton, David] Univ Southern Calif, Dept Surg, Childrens Hosp Los Angeles, Los Angeles, CA 90007 USA	Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Claremont Colleges; Claremont Graduate School; Children's Hospital Los Angeles; University of Southern California	Ganbat, M (corresponding author), Mongolian Natl Univ Med Sci, Dept Epidemiol & Biostat, Ulaanbaatar, Mongolia.	mandukhai@mnums.edu.mn	Ganbat, Mandukhai/GQB-2190-2022; Erdenebileg, Nasantogtokh/AAE-7898-2021; Ganbat, Mandukhai/GRJ-0326-2022	Erdenebileg, Nasantogtokh/0000-0002-0573-9424; Ganbat, Mandukhai/0000-0002-9000-0463	United Nations Children's Fund; Swiss Agency for Development and Cooperation;  [43279983]	United Nations Children's Fund; Swiss Agency for Development and Cooperation; 	The research was funded by United Nations Children's Fund and Swiss Agency for Development and Cooperation that is co-financing organization. M received the award. M, N, Ch and S received the salary. Contract number: 43279983 https://www.unicef.org/mongolia/https://www.eda.admin.ch/sdc.	ADLER S, 1981, J APPL PSYCHOL, V66, P544, DOI 10.1037/0021-9010.66.5.544; Air Quality Analysis of Ulaanbaatar Bank W, 2011, IMPROVING AIR QUALIT; Aldana SG, 2001, AM J HEALTH PROMOT, V15, P296, DOI 10.4278/0890-1171-15.5.296; Allen RW, 2013, AIR QUAL ATMOS HLTH, V6, P137, DOI 10.1007/s11869-011-0154-3; [Anonymous], 2017, HOUSEHOLD SOCIAL FIN; Bai RQ, 2018, ENVIRON INT, V120, P279, DOI 10.1016/j.envint.2018.08.001; Balfanz R., 2012, CHRONIC ABSENTEEISM; bank W, 2016, WORLD BANK I HLTH ME; Byford S, 2000, BRIT MED J, V320, P1335, DOI 10.1136/bmj.320.7245.1335; Clabaugh G, 2008, VALUE HEALTH, V11, P13, DOI 10.1111/j.1524-4733.2007.00210.x; Cousins S, 2019, B WORLD HEALTH ORGAN, V97, P79, DOI 10.2471/BLT.19.020219; De Klerk M., 2010, J HUMAN RESOURCE MAN, V8, P1, DOI DOI 10.4102/SAJHRM.V8I1.203; Enkhmaa D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-146; Goetzel RZ, 1998, J OCCUP ENVIRON MED, V40, P843, DOI 10.1097/00043764-199810000-00003; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Hansen AC, 2000, ENVIRON RESOUR ECON, V16, P31, DOI 10.1023/A:1008318004154; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Kocakulah M.C., 2016, INT BUSINESS EC RES, V15, P89, DOI [10.19030/iber.v15i3.9673, DOI 10.19030/IBER.V15I3.9673]; Kocakulah MG., 2011, INT BUSINESS EC RES, V8, P81; LEIGH JP, 1983, IND RELAT, V22, P349, DOI 10.1111/j.1468-232X.1983.tb00940.x; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; Maji KJ, 2017, ENVIRON SCI POLLUT R, V24, P4709, DOI 10.1007/s11356-016-8164-1; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Manning MR, 1996, ACAD MANAGE J, V39, P738, DOI 10.2307/256662; Nagata T, 2018, J OCCUP ENVIRON MED, V60, pE273, DOI 10.1097/JOM.0000000000001291; Nakao M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3481-x; Patel JG, 2014, INT J CHRONIC OBSTR, V9, P289, DOI 10.2147/COPD.S57157; Soliman AM, 2018, ADV THER, V35, P408, DOI 10.1007/s12325-018-0667-3; Trust KffaTHRaE, 2000, EMPLOYER HLTH BENEFI; UNICEF, 2018, MONG AIR POLL CRIS; Warburton D, 2018, ANN AM THORAC SOC, V15, pS86, DOI [10.1513/annalsats.201710-758mg, 10.1513/AnnalsATS.201710-758MG]	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263220	10.1371/journal.pone.0263220	http://dx.doi.org/10.1371/journal.pone.0263220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113912	gold, Green Published			2022-12-26	WOS:000823694700063
J	Idler, E; Bernau, JA; Zaras, D				Idler, Ellen; Bernau, John A.; Zaras, Dimitrios			Narratives and counter-narratives in religious responses to COVID-19: A computational text analysis	PLOS ONE			English	Article								Religious responses to COVID-19 as portrayed in a major news source raise the issue of conflict or cooperation between religious bodies and public health authorities. We compared articles in the New York Times relating to religion and COVID-19 with the COVID-19 statements posted on 63 faith-based organizations' web sites, and with the guidance documents published by the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) specifically for religious bodies. We used computational text analysis to identify and compare sentiments and topics in the three bodies of text. Sentiment analysis showed consistent positive values for faith-based organizations' texts throughout the period. The initial negative sentiment of religion-COVID-19 coverage in the New York Times rose over the period and eventually converged with the consistently positive sentiment of faith-based documents. In our topic modelling analysis, rank order and regression analysis showed that topic prevalence was similar in the faith-based and public health sources, and both showed statistically significant differences from the New York Times. We conclude that there is evidence of both narratives and counter-narratives, and that these showed demonstrable shifts over time. Text analysis of public documents shows alignment of the interests of public health and religious bodies, which can be discerned for the benefit of communities if parties are trusted and religious messages are consistent with public health communications.	[Idler, Ellen; Zaras, Dimitrios] Emory Univ, Dept Sociol, Atlanta, GA 30322 USA; [Bernau, John A.] Emory Univ, Ctr Study Law & Relig, Atlanta, GA 30322 USA	Emory University; Emory University	Idler, E (corresponding author), Emory Univ, Dept Sociol, Atlanta, GA 30322 USA.	eidler@emory.edu		Bernau, John/0000-0001-6482-5368	Department of Sociology, Emory University	Department of Sociology, Emory University	A modest amount of internal funding was provided by the Department of Sociology, Emory University. DZ received the award. The Department of Sociology played no role in study design, data collection and analysis, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, P508; Abdo MS, 2021, DIGIT SCHOLARSH HUM, V36, P509, DOI 10.1093/llc/fqaa037; [Anonymous], EXAMPLES ARE TAKEN S; Associated Press/National Opinion Research Center, RELIG PRACTICE TIME; Baker P, 2008, DISCOURSE SOC, V19, P273, DOI 10.1177/0957926508088962; Baumann S, 2001, AM SOCIOL REV, V66, P404, DOI 10.2307/3088886; Bentzen J., 2020, CRISIS WE PRAY RELIG; Berkley Center for Religion Peace and World Affairs, 2020, TENSIONS UNDERSTANDI; Beyerlein K, 2020, US TODAY 0602; Biologos, CHRISTIAN STATEMENT; Blevins JB, 2019, AM J PUBLIC HEALTH, V109, P379, DOI 10.2105/AJPH.2018.304870; Browne I., SOCIOL QUART; CNN, 2020, US; Earl J, 2004, ANNU REV SOCIOL, V30, P65, DOI 10.1146/annurev.soc.30.012703.110603; Evans JA, 2016, ANNU REV SOCIOL, V42, P21, DOI 10.1146/annurev-soc-081715-074206; Facebook Group, SPIRITUAL COMMUNAL R; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Idler E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189134; Idler EL, 2011, INT HANDB POPUL, V2, P345, DOI 10.1007/978-90-481-9996-9_17; James A, 2020, MMWR-MORBID MORTAL W, V69, P632, DOI 10.15585/mmwr.mm6920e2; Janssen S, 2008, AM SOCIOL REV, V73, P719, DOI 10.1177/000312240807300502; Kaleem J., 2020, LOS ANGELES TIMES; Kiser M, 2019, AM J PUBLIC HEALTH, V109, P371, DOI 10.2105/AJPH.2018.304826; Liptak A, 2020, NEW YORK TIMES 1126; Morabia A, 2019, AM J PUBLIC HEALTH, V109, P341, DOI 10.2105/AJPH.2018.304935; Nelson LK, 2021, SOCIOL METHOD RES, V50, P202, DOI 10.1177/0049124118769114; Ortiz DG, 2005, MOBILIZATION, V10, P397; Park HW, 2020, J MED INTERNET RES, V22, DOI 10.2196/18897; Pew Research Center, 2020, AMERICANS OPPOSE REL; Polanyi L, 2006, INFORM RETRIEVAL SER, V20, P1; Rinker T., PACKAGESENTIMENTR, V8, P31; Roberts ME, 2019, J STAT SOFTW, V91, P1, DOI 10.18637/jss.v091.i02; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Samuel J, 2020, INFORMATION, V11, DOI 10.3390/info11060314; Seeman E., 2020, NATL LAW REV; Sidner S, 2020, CNN 0707; Sonntag E., 2020, RELIG LEADERSPERSPEC; Stack L., 2020, NEW YORK TIMES 0428; Statista, 2020, US; Walter D, 2020, AM J PUBLIC HEALTH, V110, P718, DOI 10.2105/AJPH.2019.305564	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262905	10.1371/journal.pone.0262905	http://dx.doi.org/10.1371/journal.pone.0262905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113914	gold, Green Published			2022-12-26	WOS:000823694700040
J	Morsica, G; Galli, L; Messina, E; Castagna, A; Bagaglio, S; Salpietro, S; Liviana, D; Uberti-Foppa, C; Hasson, H				Morsica, Giulia; Galli, Laura; Messina, Emanuela; Castagna, Antonella; Bagaglio, Sabrina; Salpietro, Stefania; Liviana, Della Torre; Uberti-Foppa, Caterina; Hasson, Hamid			Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV	PLOS ONE			English	Article							HEPATITIS-C VIRUS; LOW-LEVEL VIREMIA; DACLATASVIR PLUS SOFOSBUVIR; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; VIROLOGICAL OUTCOMES; COINFECTED PATIENTS; LIVER FIBROSIS; OPEN-LABEL; RIBAVIRIN	Background The dynamic of HIV-viral load (VL) remains poorly investigated in HIV/HCV patients under direct acting antivirals (DAAs). Methods We retrospectively evaluated HIV-VL at baseline (BL) during and up to 24 weeks post-DAAs in a cohort of 305 HIV-1/HCV patients, on ART and with no HIV virological failure (VF) in the 6 months before treatment with DAAs; during the period of observation VF was defined as confirmed VL >= 50 copies/mL; virological blips (VB, transient, not confirmed, VL >= 50 copies/mL). Stepwise Cox regression models were fitted to estimate adjusted hazard ratios (aHR) of VF. Results Fifteen VF occurred in 13 patients over 187 person-years of follow-up (PYFU): incidence rate (IR) of 8.0 per 100-PYFU (95% CI = 4.0-12.1); 29 VBs were detected in 26 patients over 184 PYFU: IR = 15.8 per 100-PYFU (95% CI = 10.0-21.5). The most prominent factor associated with VF was the presence of BL HIV residual viremia (RV = HIV-RNA detectable but not precisely quantifiable) [aHR = 12.26 (95% CI = 3.74-40.17), P<0.0001]. Other factors were >= 1 VBs in the 6 months before DAAs [aHR = 6.95 (95% CI = 1.77-27.37) P = 0.006] number of ART regimens failed before DAAs initiation [aHR (per more regimen) = 1.22 (95% CI = 1.04-1.42), P = 0.012] and age [aHR (per year older) = 1.16 (95% CI = 1.04-1.29), P = 0.010]. Conclusions Our findings underline the importance for close monitoring HIV-VL in selected patients. Whether this phenomenon is triggered by the rapid clearance of HCV remains to be established.	[Morsica, Giulia; Galli, Laura; Messina, Emanuela; Castagna, Antonella; Bagaglio, Sabrina; Salpietro, Stefania; Liviana, Della Torre; Uberti-Foppa, Caterina; Hasson, Hamid] IRCCS San Raffaele Sci Inst, Div Infect Dis, Milan, Italy; [Castagna, Antonella; Uberti-Foppa, Caterina] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Morsica, G (corresponding author), IRCCS San Raffaele Sci Inst, Div Infect Dis, Milan, Italy.	morsica.giulia@hsr.it		BAGAGLIO, Sabrina/0000-0002-3671-6022				Auma AWN, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab079; Baroncelli S, 2015, AIDS RES HUM RETROV, V31, P71, DOI [10.1089/AID.2014.0060, 10.1089/aid.2014.0060]; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; Bezabhe WM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003361; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Chew KW, 2016, AIDS, V30, P2395, DOI 10.1097/QAD.0000000000001203; Clutter DS, 2016, JAIDS-J ACQ IMM DEF, V72, P171, DOI 10.1097/QAI.0000000000000942; Cooper C, 2015, HIV MED, V16, P24, DOI 10.1111/hiv.12168; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Di Biagio A, 2014, J MED VIROL, V86, P1648, DOI 10.1002/jmv.24017; Doyle MA, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz318; Falade-Nwulia O, 2017, HEPATOLOGY, V66, P1402, DOI 10.1002/hep.29308; Gianotti N, 2018, INT J ANTIMICROB AG, V52, P492, DOI 10.1016/j.ijantimicag.2018.07.001; Gordon LL, 2015, AIDS PATIENT CARE ST, V29, P384, DOI 10.1089/apc.2014.0165; Kovari H, 2010, CLIN INFECT DIS, V50, P502, DOI 10.1086/649922; Kumar S, 2015, EXPERT OPIN DRUG MET, V11, P343, DOI 10.1517/17425255.2015.996546; Lacombe K, 2017, JAIDS-J ACQ IMM DEF, V75, P97, DOI 10.1097/qai.0000000000001342; Li JZ, 2012, ANTIMICROB AGENTS CH, V56, P5998, DOI 10.1128/AAC.01217-12; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Medrano LM, 2018, AIDS, V32, P1095, DOI 10.1097/QAD.0000000000001787; Milazzo L, 2017, HIV MED, V18, P284, DOI 10.1111/hiv.12429; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Mucke MM, 2018, LANCET GASTROENTEROL, V3, P172, DOI 10.1016/S2468-1253(18)30002-5; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Parisi SG, 2017, MED MICROBIOL IMMUN, V206, P419, DOI 10.1007/s00430-017-0518-x; Patel M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx062; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Pugliese P, 2013, HIV MED, V14, P509, DOI 10.1111/hiv.12041; Rockstroh JK, 2017, ANTIVIR THER, V22, P225, DOI 10.3851/IMP3108; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Rodriguez-Luna H, 2005, LIVER TRANSPLANT, V11, P479, DOI 10.1002/lt.20424; Rozera G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187095; Rusconi S, 2019, J CLIN VIROL, V116, P23, DOI 10.1016/j.jcv.2019.04.009; Shmagel KV, 2016, HIV MED, V17, P581, DOI 10.1111/hiv.12357; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; Teira R, 2017, HIV MED, V18, P196, DOI 10.1111/hiv.12413; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thorpe J, 2011, AIDS, V25, P967, DOI 10.1097/QAD.0b013e3283455e4b; Townsend K, 2016, AIDS, V30, P261, DOI 10.1097/QAD.0000000000000903; Vandenhende MA, 2015, AIDS, V29, P373, DOI 10.1097/QAD.0000000000000544; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Wyles D, 2017, CLIN INFECT DIS, V65, P6, DOI 10.1093/cid/cix260	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262917	10.1371/journal.pone.0262917	http://dx.doi.org/10.1371/journal.pone.0262917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113890	Green Published, gold			2022-12-26	WOS:000823694700042
J	Grzegorczyn, S; Slezak, A				Grzegorczyn, Slawomir; Slezak, Andrzej			Study of thin layer film evolution near bacterial cellulose membrane by Ag vertical bar AgCl electrodes in chamber with lower concentration	PLOS ONE			English	Article							CONCENTRATION BOUNDARY-LAYERS; CONCENTRATION POLARIZATION PHENOMENON; MICROBIAL CELLULOSE; CONVECTION	We used the method of measuring potential difference between two Ag vertical bar AgCl electrodes immersed directly into electrolyte solution with lower concentration and at different distances from membrane. The bacterial cellulose membrane was placed in horizontal plane in the membrane system with configurations with higher NaCl concentration and density under (A) and over the membrane (B). In both configurations at the initial moment the voltage between electrodes amounted to zero. After turning off mechanical stirring of solutions, in configuration A we observed the monotonic increase and next stabilization of voltage while in configuration B after short time dependent on the initial quotient of NaCl concentrations on the membrane we observed appearance of pulsations of measured voltage and gradual decrease of mean voltage over time. Smooth changes of voltage are connected with diffusional reconstruction of Concentration Boundary Layers (CBLs) while fast increase and subsequent pulsations of voltage are connected with the appearance of hydrodynamic instabilities (gravitational convection) near membrane imposed on diffusive reconstruction of thin layer. The time needed for the appearance of hydrodynamic instabilities in CBL depended nonlinearly on the initial ratio of electrolyte concentrations on the membrane.	[Grzegorczyn, Slawomir] Med Univ Silesia, Sch Med, Dept Biophys, Div Dent Zabrze, Zabrze, Poland; [Slezak, Andrzej] Jan Dlugosz Univ, Dept Hlth Sci, Czestochowa, Poland	Medical University Silesia; Jan Dlugosz University	Grzegorczyn, S (corresponding author), Med Univ Silesia, Sch Med, Dept Biophys, Div Dent Zabrze, Zabrze, Poland.	grzegorczyn@sum.edu.pl		Grzegorczyn, Slawomir/0000-0002-5248-3505	Medical University of Silesia [KNW-1-044/N/8/I]	Medical University of Silesia	Slawomir Grzegorczyn KNW-1-044/N/8/I This work was supported by Medical University of Silesia No.	Abeer MM, 2014, J PHARM PHARMACOL, V66, P1047, DOI 10.1111/jphp.12234; Baranowski B, 1970, ANN SOC CHIM POL, V44, P2447; BEHRENS HM, 1985, PLANTA, V163, P463, DOI 10.1007/BF00392703; Casas-Vazquez J., 2008, UNDERSTANDING NONEQU; Curvello R, 2019, ADV COLLOID INTERFAC, V267, P47, DOI 10.1016/j.cis.2019.03.002; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Deon S, 2013, WATER RES, V47, P2260, DOI 10.1016/j.watres.2013.01.044; Dworecki K, 2003, PHYSICA A, V326, P360, DOI 10.1016/S0378-4371(03)00266-8; DWORECKI K, 1995, J BIOL PHYS, V21, P37, DOI 10.1007/BF00701008; Fernandez-Sempere J, 2004, J MEMBRANE SCI, V229, P187, DOI 10.1016/j.memsci.2003.10.029; Fu LN, 2013, CARBOHYD POLYM, V92, P1432, DOI 10.1016/j.carbpol.2012.10.071; Grzegorczyn S., 2006, J MEMB SCI, V280; Grzegorczyn S, 2007, J MEMBRANE SCI, V304, P148, DOI 10.1016/j.memsci.2007.07.027; Grzegorczyn S, 2020, J POROUS MEDIA, V23, P425, DOI 10.1615/JPorMedia.2020030939; Grzegorczyn S, 2017, J BIOL PHYS, V43, P225, DOI 10.1007/s10867-017-9448-5; Grzegorczyn S, 2016, J BIOL PHYS, V42, P383, DOI 10.1007/s10867-016-9413-8; Grzegorczyn S, 2012, J NON-EQUIL THERMODY, V37, P77, DOI 10.1515/JNETDY.2011.027; ISHIKAWA H, 1990, PLANT CELL PHYSIOL, V31, P457; Jamaly S, 2014, DESALINATION, V354, P30, DOI 10.1016/j.desal.2014.09.017; Jorfi M, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41719; Katchalsky A., 1965, NONEQUILIBRIUM THERM; Kucharzewski M, 2003, PHLEBOLOGIE, V32, P147; Lakshminarayanaiah N., 1969, TRANSPORT PHENOMENA; LERCHE D, 1976, J MEMBRANE BIOL, V27, P193, DOI 10.1007/BF01869136; Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025; Mishchuk NA, 2010, ADV COLLOID INTERFAC, V160, P16, DOI 10.1016/j.cis.2010.07.001; MULLER SC, 1984, NATURWISSENSCHAFTEN, V71, P637, DOI 10.1007/BF00377902; NORMAND C, 1977, REV MOD PHYS, V49, P581, DOI 10.1103/RevModPhys.49.581; Novev JK, 2018, CURR OPIN ELECTROCHE, V7, P118, DOI 10.1016/j.coelec.2017.09.010; Pismensky AV, 2012, RUSS J ELECTROCHEM+, V48, P756, DOI 10.1134/S1023193512070075; REJOUMICHEL A, 1979, BIOELECTROCH BIOENER, V6, P289, DOI 10.1016/0302-4598(79)87014-2; Schlichting H., 2017, BOUNDARY LAYER THEOR, VNinth, DOI DOI 10.1007/978-3-642-85829-1; Sheldrake R, 2012, PRESENCE MORFIC RESO; SLEZAK A, 1985, J MEMBRANE SCI, V23, P71, DOI 10.1016/S0376-7388(00)83135-X; TOKO K, 1990, BIOPHYS J, V57, P269, DOI 10.1016/S0006-3495(90)82529-7; Uragami T., 2017, SCI TECHNOLOGY SEPAR, P587; Wang JW, 2014, J MEMBRANE SCI, V454, P516, DOI 10.1016/j.memsci.2013.12.034	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263059	10.1371/journal.pone.0263059	http://dx.doi.org/10.1371/journal.pone.0263059			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108308	gold, Green Published			2022-12-26	WOS:000775890100047
J	Jones, N; Baird, S; Abu Hamad, B; Bhutta, ZA; Oakley, E; Shah, M; Sajdi, J; Yount, KM				Jones, Nicola; Baird, Sarah; Abu Hamad, Bassam; Bhutta, Zulfiqar A.; Oakley, Erin; Shah, Manisha; Sajdi, Jude; Yount, Kathryn M.			Compounding inequalities: Adolescent psychosocial wellbeing and resilience among refugee and host communities in Jordan during the COVID-19 pandemic	PLOS ONE			English	Article							HEALTH	Purpose The COVID-19 pandemic and associated risk-mitigation strategies have altered the social contexts in which adolescents in low- and middle-income countries live. Little is known, however, about the impacts of the pandemic on displaced populations, and how those impacts differ by gender and life stage. We investigate the extent to which the pandemic has compounded pre-existing social inequalities among adolescents in Jordan, and the role support structures play in promoting resilience. Methods Our analysis leverages longitudinal quantitative survey data and in-depth qualitative interviews, collected before and after the onset of COVID-19, with over 3,000 Syrian refugees, stateless Palestinians and vulnerable Jordanians, living in camps, host communities and informal tented settlements. We utilize mixed-methods analysis combining multivariate regression with deductive qualitative tools to evaluate pandemic impacts and associated policy responses on adolescent wellbeing and mental health, at three and nine months after the pandemic onset. We also explore the role of support systems at individual, household, community, and policy levels. Findings We find the pandemic has resulted in severe economic and service disruptions with far-reaching and heterogenous effects on adolescent wellbeing. Nine months into the pandemic, 19.3% of adolescents in the sample presented with symptoms of moderate-to severe depression, with small signs of improvement (3.2 percentage points [pp], p<0.001). Two thirds of adolescents reported household stress had increased during the pandemic, especially for Syrian adolescents in host communities (10.7pp higher than any other group, p<0.001). Social connectedness was particularly low for girls, who were 13.4 percentage points (p<0.001) more likely than boys to have had no interaction with friends in the past 7 days. Adolescent programming shows signs of being protective, particularly for girls, who were 8.8 percentage points (p<0.01) more likely to have a trusted friend than their peers who were not participating in programming. Conclusions Pre-existing social inequalities among refugee adolescents affected by forced displacement have been compounded during the COVID-19 pandemic, with related disruptions to services and social networks. To achieve Sustainable Development Goal targets to support healthy and empowered development in adolescence and early adulthood requires interventions that target the urgent needs of the most vulnerable adolescents while addressing population-level root causes and determinants of psychosocial wellbeing and resilience for all adolescent girls and boys.	[Jones, Nicola] ODI, Gender & Adolescence Global Evidence GAGE, London, England; [Baird, Sarah; Oakley, Erin] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Abu Hamad, Bassam] Al Quds Univ, Dept Publ Hlth, Gaza, State Of Palest, Palestine; [Bhutta, Zulfiqar A.] Hosp Sick Children, Dept Nutr Sci, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Shah, Manisha] Univ Calif Los Angeles, Luskin Sch Publ Affairs, Los Angeles, CA USA; [Sajdi, Jude] King Hussein Fdn, Informat & Res Ctr, Amman, Jordan; [Yount, Kathryn M.] Emory Univ, Dept Global Hlth, Atlanta, GA 30322 USA	George Washington University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; University of California System; University of California Los Angeles; Emory University	Jones, N (corresponding author), ODI, Gender & Adolescence Global Evidence GAGE, London, England.	n.jones@odi.org.uk	Abu Hamad, Bassam A/GYR-3662-2022; Bhutta, Zulfiqar/L-7822-2015	Yount, Kathryn/0000-0003-1917-1574; Baird, Sarah/0000-0001-5363-8559; Oakley, Erin/0000-0002-6339-4823; Bhutta, Zulfiqar/0000-0003-0637-599X; Jones, Nicola/0000-0002-9164-7947	Research and Evaluation Division of the UK Foreign Commonwealth and Development Office (FCDO); BMGF [OPP1163682, INV018007]; Research Grants on Women, Victimization, and COVID-19 [INV-003527]	Research and Evaluation Division of the UK Foreign Commonwealth and Development Office (FCDO); BMGF; Research Grants on Women, Victimization, and COVID-19	Funding was received from the Research and Evaluation Division of the UK Foreign Commonwealth and Development Office (FCDO) for the Gender and Adolescence: Global Evidence (GAGE) longitudinal study. In addition, supplementary funding was provided by BMGF through the EMERGE PROJECT: OPP1163682 and INV018007 and Research Grants on Women, Victimization, and COVID-19 (#INV-003527). Dr Sarah Baird is the recipient of the latter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2016, ECONOMETRICA, V84, P781, DOI 10.3982/ECTA11293; Addae EA, 2021, INT J HEALTH PLAN M, V36, P219, DOI 10.1002/hpm.3059; Al-Hourani MAK, 2019, INT J CHILD YOUTH FA, V10, P24, DOI 10.18357/ijcyfs104.1201919285; Alemi Q, 2020, B WORLD HEALTH ORGAN, V98, P510, DOI 10.2471/BLT.20.271080; [Anonymous], 2020, UNDP SOC EC FRAM COV; Asanov I, 2021, WORLD DEV, V138, DOI 10.1016/j.worlddev.2020.105225; Ataullahjan A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m2876; Baird S., 2020, COVID 19 PHONE SURVE; Baird S, INT J DEV RES; Baird S, 2020, GIRLHOOD STUD, V13, P98, DOI 10.3167/ghs.2020.130308; Baloch Z, 2020, J INFECT PUBLIC HEAL, V13, P1247, DOI 10.1016/j.jiph.2020.06.034; Banati P, 2020, EUR J DEV RES, V32, P1613, DOI 10.1057/s41287-020-00325-5; Barca V.., 2020, SOCIAL PROTECTION AP; Barendse M, 2021, PSYARXIV, V2021, DOI [10.31234/osf.io/hn7us, DOI 10.31234/OSF.IO/HN7US]; Bellerose M, 2020, GIRLHOOD STUD, V13, P133, DOI 10.3167/ghs.2020.130310; Bhutta ZA, 2021, LANCET, V397, P448, DOI 10.1016/S0140-6736(21)00127-6; Bhutta ZA, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003449; Breen R, 2018, ANNU REV SOCIOL, V44, P39, DOI 10.1146/annurev-soc-073117-041429; Briggs H, 2020, IMPACT COVID 19 OPPO; Brown H., 2019, VULNERABILITY ASSESS; CARE, 2020, GIRL DRIV CHANG M NE; Chanchlani N, 2020, CAN MED ASSOC J, V192, pE921, DOI 10.1503/cmaj.201008; Cluver L, 2020, LANCET, V395, pE64, DOI 10.1016/S0140-6736(20)30736-4; Coates J, 2007, HOUSEHOLD FOOD INSEC, V3; de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845; Dempster H., 2020, 179 CTR GLOB DEV REF; Donker MH, 2020, DEV PARENT ADOLESCEN; Edstrom J, 2015, ENGENDERING MEN COOL; Egger D, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe0997; Ezpeleta L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197327; Facundo Cuevas P., WORLD BANK BLOG 1121; Favara M, 2021, COVID EC VETTED REAL; Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fioretti C, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.599531; Gaffey MF, 2021, LANCET, V397, P543, DOI 10.1016/S0140-6736(21)00133-1; GAGE consortium, 2019, GEND ADOL UND ADOL C, V2nd; Ghatak N, 2020, CTR BUDGET POLICY ST; Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2; Gomila R., 2019, PSYARXIV, DOI [10.1002/ijop.12500, DOI 10.1002/IJOP.12500]; Guessoum SB, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113264; Guglielmi S, 2021, REIMAGINING GIRLS ED; Guglielmi Silvia, 2020, J Migr Health, V1-2, P100031, DOI 10.1016/j.jmh.2020.100031; Habib RR, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003283; Haddad N, 2020, SILENT PANDEMIC IMPA; Hale T., 2020, OXFORD COVID 19 GOVT; Hidrobo M, GENDER SENSITIVE SOC; Himelein K, 2020, MOBILE PHONE SURVEYS, DOI [10.1186/s12942-020-00205-5, DOI 10.1186/S12942-020-00205-5]; Hussong AM, COPING MENTAL HLTH E, DOI [10.1007/ s10802-021-00821-0, DOI 10.1007/S10802-021-00821-0]; Jones N., 2018, GAGE RES DESIGN SAMP; Jones N, ADOLESCENTS HUMANITA, P2021; Jones N., 2019, ADOLESCENT WELL BEIN; Kabunga A, 2020, PREVALENCE DEPRESSIV, DOI [10.1101/2020.10.21.20216754, DOI 10.1101/2020.10.21.20216754]; Kamali M, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002014; Karajerjian S., 2021, GENDER DEV, V29, P95, DOI [10.1080/13552074.2021.1885216, DOI 10.1080/13552074.2021.1885216]; Keats EC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121978; Kebede TA, 2020, FACING DOUBLE CRISES; Kilincel S, 2021, ASIA-PAC PSYCHIAT, V13, DOI 10.1111/appy.12406; Kira IA, 2021, J LOSS TRAUMA, V26, P666, DOI 10.1080/15325024.2020.1869444; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Labrague LJ, 2021, J NURS MANAGE, V29, P395, DOI 10.1111/jonm.13168; Lakner C, 2020, WORLD BANK BLOG 0608, DOI [10.1016/j. amp.2020.06.001, DOI 10.1016/J.AMP.2020.06.001]; Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7; Lee K, 2009, GLOB INST, P1; Li W., 2010, NEW ENGL J MED, V18, P121, DOI [10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042]; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Mahamid FA, 2021, J RELIG HEALTH, V60, P34, DOI 10.1007/s10943-020-01121-5; Majeed S, 2020, ANN KING EDWARD MED, V26, P165; Malachowska A, 2021, ADOLESCENTS HUMANITA; Malachowska A., 2020, GAGE VIRTUAL RES TOO; Malaeb B, 2020, COMPOUNDING MISFORTU; Marchini S, 2021, J COMMUNITY PSYCHOL, V49, P468, DOI 10.1002/jcop.22473; Marcus R, 2018, PROGRAMMING ADOLESCE; Marques ES, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00074420; Mlambo-Ngcuka P., 2020, VIOLENCE WOMEN GIRLS; Monash Health, 2021, OUR COV 19 VACC CTR; Mukumbang FC, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01259-4; Nussbaum Martha, 1995, WOMEN CULTURE DEV ST, DOI DOI 10.1093/0198289642.001.0001; OCHA, 2016, WORLD HUM DATA TREND; Orben A, 2020, LANCET CHILD ADOLESC, V4, P634, DOI 10.1016/S2352-4642(20)30186-3; Orgiles M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.579038; Patel K, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102273; Patra S, 2020, LANCET PSYCHIAT, V7, P1015, DOI 10.1016/S2215-0366(20)30461-2; Peterman A., 2020, CTR GLOBAL DEV WORKI; Pinchoff J, HAS COVID 19 RELATED, DOI [10. 1016/j.jadohealth.2021.07.023, DOI 10.1016/J.JADOHEALTH.2021.07.023]; Pinchoff J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244053; Porter C, BMJ OPEN, V11, DOI [10.1136/bmjopen-2021-049653, DOI 10.1136/BMJOPEN-2021-049653]; Qi M, 2020, J ADOLESCENT HEALTH, V67, P514, DOI 10.1016/j.jadohealth.2020.07.001; Racine N, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113307; Ross DA, 2020, J ADOLESCENT HEALTH, V67, P472, DOI 10.1016/j.jadohealth.2020.06.042; Sen A.K., 1985, COMMODITIES CAPABILI; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stefanini P, 2018, DECADES RESILIENCE S; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Teras M., 2020, POSTDIGIT SCI ED, V2, DOI [10.1007/s42438-020-00164-x, DOI 10.1007/S42438-020-00164-X]; UNESCO, 2020, ED DISR REC; UNHCR, 2020, WORLD BANK UNHCR MEN; UNHCR, 2020, COV 19 CAS CONF ZAAT; UNHCR, 2021, SYR REG REF RESP; UNHCR, 2021, JORD COVID 19 DASHB; UNHCR, 2019, PREV RESP SEX GEND B; UNHCR Jordan, 2021, 3 REF ELIG COVID 19; Veronese G, 2021, HEALTH PSYCHOL REP, V9, P398, DOI 10.5114/hpr.2021.104490; Wickramanayake J., 2020, MEET 10 YOUNG PEOPLE; Wiguna T, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.598756; World Bank, MACR POV OUTL JORD; World Food Programme, 2020, OVERV REF FOOD SEC J; Ye Z, 2020, APPL PSYCHOL-HLTH WE, V12, P1074, DOI 10.1111/aphw.12211; Zhou SJ, 2020, EUR CHILD ADOLES PSY, V29, P749, DOI 10.1007/s00787-020-01541-4; Zhu N, 2020, CHILD ADOL MENT H-UK, V25, P173, DOI 10.1111/camh.12408	113	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0261773	10.1371/journal.pone.0261773	http://dx.doi.org/10.1371/journal.pone.0261773			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108293	Green Published, gold			2022-12-26	WOS:000775890100013
J	Grieshaber, NA; Chiarelli, TJ; Appa, CR; Neiswanger, G; Peretti, K; Grieshaber, SS				Grieshaber, Nicole A.; Chiarelli, Travis J.; Appa, Cody R.; Neiswanger, Grace; Peretti, Kristina; Grieshaber, Scott S.			Translational gene expression control in Chlamydia trachomatis	PLOS ONE			English	Article							ESCHERICHIA-COLI; UNITED-STATES; INFECTIONS; RIBOSWITCH; PROMOTERS	The human pathogen Chlamydia trachomatis proceeds through a multi phenotypic developmental cycle with each cell form specialized for different roles in pathogenesis. Understanding the mechanisms regulating this complex cycle has historically been hampered by limited genetic tools. In an effort to address this issue, we developed a translational control system to regulate gene expression in Chlamydia using a synthetic riboswitch. Here we demonstrate that translational control via a riboswitch can be used in combination with a wide range of promoters in C. trachomatis. The synthetic riboswitch E, inducible with theophylline, was used to replace the ribosome binding site of the synthetic promoter T5-lac, the native chlamydial promoter of the pgp4 plasmid gene and an anhydrotetracycline responsive promoter. In all cases the riboswitch inhibited translation, and high levels of protein expression was induced with theophylline. Combining the Tet transcriptional inducible promoter with the translational control of the riboswitch resulted in strong repression and allowed for the cloning and expression of the potent chlamydial regulatory protein, HctB. The ability to control the timing and strength of gene expression independently from promoter specificity is a new and important tool for studying chlamydial regulatory and virulence genes.	[Grieshaber, Nicole A.; Chiarelli, Travis J.; Appa, Cody R.; Neiswanger, Grace; Peretti, Kristina; Grieshaber, Scott S.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Grieshaber, SS (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	scottg@uidaho.edu		Grieshaber, Scott/0000-0002-6570-8291	National Institutes of Health [R01AI130072, R21AI135691, R21AI113617]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Granst R01AI130072, R21AI135691 and R21AI113617 (NG, SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Brothwell JA, 2018, CURR TOP MICROBIOL, V412, P133, DOI 10.1007/82_2017_76; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; Chiarelli TJ, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00689-20; Chiarelli TJ, 2020, JOVE-J VIS EXP, DOI 10.3791/61365; Clifton KP, 2018, J BIOL ENG, V12, DOI 10.1186/s13036-018-0115-6; Cui WJ, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0599-z; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; GENTZ R, 1985, J BACTERIOL, V164, P70, DOI 10.1128/JB.164.1.70-77.1985; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Grieshaber NA, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.692224; Grieshaber NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116593; Haslwanter T., 2013, INTRO STAT PYTHON AP, DOI [10.1002/eji.201343681, DOI 10.1002/EJI.201343681]; HOWARD L, 1974, APPL MICROBIOL, V27, P102, DOI 10.1128/AEM.27.1.102-106.1974; Langdon WB, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-014-0034-0; Larson CL, 2016, FUTURE MICROBIOL, V11, P919, DOI 10.2217/fmb-2016-0044; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch SA, 2009, NUCLEIC ACIDS RES, V37, P184, DOI 10.1093/nar/gkn924; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Nakahira Y, 2013, PLANT CELL PHYSIOL, V54, P1724, DOI 10.1093/pcp/pct115; Nelson JA, 2005, BIOCHEMISTRY-US, V44, P14577, DOI 10.1021/bi051130t; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; Owusu-Edusei K, 2013, SEX HEALTH, V10, P434, DOI 10.1071/SH13021; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Rahnama M, 2018, MICROBES INFECT, V20, P445, DOI 10.1016/j.micinf.2018.01.002; Reynoso CMK, 2012, MBIO, V3, DOI 10.1128/mBio.00253-12; Richardson MW., 2004, METHODS MOL BIOL CLI, P33958, DOI [10.1385/1-59259-746-7:339, DOI 10.1385/1-59259-746-7:339]; Rudolph MM, 2015, METHOD ENZYMOL, V550, P283, DOI 10.1016/bs.mie.2014.10.036; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Thomson NR, 2010, FUTURE MICROBIOL, V5, P555, DOI 10.2217/FMB.10.31; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; Torrone EA., 2014, CONCEPTS METHODS INF, DOI [10.1002/9781118928646.ch12, DOI 10.1002/9781118928646.CH12]; Van Vlack ER, 2015, METHOD ENZYMOL, V550, P251, DOI 10.1016/bs.mie.2014.10.034; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Zhang Q, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00793-19	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0257259	10.1371/journal.pone.0257259	http://dx.doi.org/10.1371/journal.pone.0257259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085261	Green Published, Green Submitted, gold			2022-12-26	WOS:000779379600005
J	Rozzi, CA; Frigerio, F; Balletti, L; Mattoni, S; Grasso, D; Fogola, J				Rozzi, Carlo Andrea; Frigerio, Francesco; Balletti, Luca; Mattoni, Silvia; Grasso, Daniele; Fogola, Jacopo			Indoor noise level measurements and subjective comfort: Feasibility of smartphone-based participatory experiments	PLOS ONE			English	Article							SOUND; MICROPHONES	We designed and performed a participatory sensing initiative to explore the reliability and effectiveness of a distributed network of citizen-operated smartphones in evaluating the impact of environmental noise in residential areas. We asked participants to evaluate the comfort of their home environment in different situations and at different times, to select the most and least comfortable states and to measure noise levels with their smartphones. We then correlated comfort ratings with noise measurements and additional contextual information provided by participants. We discuss how to strengthen methods and procedures, particularly regarding the calibration of the devices, in order to make similar citizen-science efforts effective at monitoring environmental noise and planning long-term solutions to human well-being.	[Rozzi, Carlo Andrea] CNR, Ist Nanosci, Modena, Italy; [Frigerio, Francesco] ICS Maugeri Spa, Ctr Ric Ambientali, Pavia, Italy; [Balletti, Luca; Mattoni, Silvia] CNR, Unita Comunicaz & Relaz Con Pubbl, Rome, Italy; [Grasso, Daniele; Fogola, Jacopo] ARPA Piemonte, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituti Clinici Scientifici Maugeri IRCCS; Consiglio Nazionale delle Ricerche (CNR); Regional Environmental Protection Agency - Italy	Rozzi, CA (corresponding author), CNR, Ist Nanosci, Modena, Italy.	carloandrea.rozzi@nano.cnr.it	; /D-4390-2013	Frigerio, Francesco/0000-0003-3164-3933; /0000-0001-6429-4835; BALLETTI, LUCA/0000-0003-1362-0324				Aletta F, 2020, NOISE MAPP, V7, P123, DOI 10.1515/noise-2020-0011; Asensio C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124205; Aspuru I, 2016, NOISE MAPP, V3, P37, DOI 10.1515/noise-2016-0003; Bartalucci C, 2020, NOISE MAPP, V7, P199, DOI 10.1515/noise-2020-0017; Becker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081638; Bocher E, 2017, DATA BRIEF, V14, P498, DOI 10.1016/j.dib.2017.07.039; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Brambilla G, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12197899; Celestina M, 2018, APPL ACOUST, V139, P119, DOI 10.1016/j.apacoust.2018.04.011; Fiebig A., 2009, NAG DAGA INT C AC, P984; Frigerio F, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON ENVIRONMENT AND ELECTRICAL ENGINEERING AND 2019 IEEE INDUSTRIAL AND COMMERCIAL POWER SYSTEMS EUROPE (EEEIC / I&CPS EUROPE); Garg S, 2019, APPL ACOUST, V143, P222, DOI 10.1016/j.apacoust.2018.08.013; Italiano Governo., 1997, GAZZETTA UFFICIALE 2; Italiano Governo., 1998, GAZZETTA UFFICIALE, V76; Kanjo E, 2010, MOBILE NETW APPL, V15, P562, DOI 10.1007/s11036-009-0217-y; Kardous CA, 2016, J ACOUST SOC AM, V140, pEL327, DOI 10.1121/1.4964639; Kardous CA, 2014, J ACOUST SOC AM, V135, pEL186, DOI 10.1121/1.4865269; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Maisonneuve N., 2014, P 10 INT DIG GOV RES, P96; Masera S., 2016, RIV ITALIANA ACUSTIC, V40, P48; Murphy E, 2016, APPL ACOUST, V106, P16, DOI 10.1016/j.apacoust.2015.12.012; Nast DR, 2014, NOISE HEALTH, V16, P251, DOI 10.4103/1463-1741.140495; OpeNoise, ARPA PIEMONTE; Picaut J, 2019, BUILD ENVIRON, V148, P20, DOI 10.1016/j.buildenv.2018.10.049; Podor A., 2021, URBAN ANAL CITY SCI, V0; Radicchi A., 2017, J ACOUST SOC AM, V141, P3622; Rusconi G., 2021, IL SOLE 24 ORE; #scienzasulbalcone [Internet], CONSIGLIO NAZL RICER; Ventura R, 2017, J ACOUST SOC AM, V142, P3084, DOI 10.1121/1.5009448; Zamora W, 2016, MOB INF SYST, V2016, DOI 10.1155/2016/9681842	30	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262835	10.1371/journal.pone.0262835	http://dx.doi.org/10.1371/journal.pone.0262835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085311	gold, Green Published, Green Submitted			2022-12-26	WOS:000779379600087
J	Mori, K; Imaki, S; Ohyama, Y; Satoh, KK; Abe, TK; Takeuchi, IK				Mori, Kosuke; Imaki, Shohei; Ohyama, Yutaro; Satoh, Kosuke K.; Abe, Takeru K.; Takeuchi, Ichiro K.			Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test	PLOS ONE			English	Article								Rapid screening and diagnosis of coronavirus disease 2019 in the emergency department is important for controlling infections. When polymerase chain reaction tests cannot be rapidly performed, rapid antigen testing is often used, albeit with insufficient sensitivity. Therefore, we evaluated the diagnostic accuracy of combining rapid antigen and antibody test results. This was a retrospective review of patients who visited our emergency department between February and May 2021 and underwent rapid antigen, immunoglobulin G antibody, and reverse transcription-polymerase chain reaction tests. The study included 1,070 patients, of whom 56 (5.2%) tested positive on reverse transcription-polymerase chain reaction. The sensitivity, specificity, and area under the curve of rapid antigen testing were 73.7%, 100.0%, and 0.87, respectively. The combined rapid antigen and antibody test result had improved diagnostic accuracy, with 91.2% sensitivity, 97.9% specificity, and an area under the curve of 0.95. The results of the rapid antigen and antibody tests could be combined as a reliable alternative to reverse transcription-polymerase chain reaction.	[Mori, Kosuke; Imaki, Shohei; Ohyama, Yutaro; Satoh, Kosuke K.] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan; [Abe, Takeru K.; Takeuchi, Ichiro K.] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan	Yokohama City University	Mori, K (corresponding author), Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan.	morimati81@yahoo.co.jp	Abe, Takeru/GQP-5825-2022	Abe, Takeru/0000-0003-3496-1953; Mori, Kosuke/0000-0002-2992-056X				Barycka K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242901; Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516; Caliendo AAM, 2021, COVID 19 DIAGNOSIS U; Centers for Disease Control And Prevention, SCI BRIEF SARS COV 2; Centers for Disease Control and Prevention, NUCL ACID AMPLIFICAT; Cheng MP, 2020, ANN INTERN MED, V173, P450, DOI 10.7326/M20-2854; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]; Echternach M, 2020, AM J RESP CRIT CARE, V202, P1584, DOI 10.1164/rccm.202009-3438LE; Infectious Diseases Society of America, COVID 19 DIAGN ANT T; Klompas M, 2021, ANN INTERN MED, V174, P794, DOI 10.7326/M20-7567; Long DR, 2021, CLIN INFECT DIS, V72, P323, DOI [10.1093/cid/ciaa722, 10.1101/2020.05.03.20089151]; Rhee C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20498; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Tabatabaeizadeh SA, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-020-00475-6; World Health Organization, COR DIS COVID 19 PAN	16	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263327	10.1371/journal.pone.0263327	http://dx.doi.org/10.1371/journal.pone.0263327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104281	Green Published, gold			2022-12-26	WOS:000749789300008
J	Nishimura, T; Okamura, T; Fujimura, T; Miyazaki, Y; Takenaka, H; Akase, H; Tateishi, H; Mochizuki, M; Uchinoumi, H; Oda, T; Yano, M				Nishimura, Takashi; Okamura, Takayuki; Fujimura, Tatsuhiro; Miyazaki, Yosuke; Takenaka, Hitoshi; Akase, Hideaki; Tateishi, Hiroki; Mochizuki, Mamoru; Uchinoumi, Hitoshi; Oda, Tetsuro; Yano, Masafumi			Feasibility, reproducibility and characteristics of coronary bifurcation type assessment by three-dimensional optical coherence tomography	PLOS ONE			English	Article							SIDE-BRANCH; LESIONS; ANGLE; PREDICTORS; CRUSH; INTERVENTION; ANGIOGRAPHY; CONSENSUS; COVERAGE; DISEASE	AimTo investigate the characteristics of coronary artery bifurcation type (parallel or perpendicular type) using three-dimensional (3D) optical coherence tomography (OCT), and determine the feasibility, reproducibility, assessment time and correlation with bifurcation angles measured by 3D quantitative coronary angiography (QCA). Methods and resultsWe evaluated 60 lesions at the coronary bifurcation that were treated by main vessel (MV) stenting with kissing balloon inflation (KBI) under OCT/optical frequency domain imaging (OFDI) guidance. Inter- and intra-observer agreement regarding the assessment of 3D bifurcation types were 0.88 and 0.94, respectively. The assessment times of 3D-OCT bifurcation type with OCT and OFDI were within about 30 seconds. 3D-OCT bifurcation types showed the greatest correlation with the distal bifurcation angle assessed by 3D-QCA among the three bifurcation angles (distal bifurcation angle, proximal bifurcation angle and main vessel angle), and the optimal cut-off distal bifurcation angle to predict a perpendicular type bifurcation, as determined by ROC analysis, was 51.0 degrees (AUC 0.773, sensitivity 0.80, specificity 0.67). Based on this cut-off value for the distal bifurcation angle (51 degrees), the diagnostic accuracy for perpendicular type bifurcation in cases with a BA >= 51 degrees (n = 34) was 70.6% (24/34) and that of the parallel type bifurcation in cases of BA < 51 degrees (n = 26) was 76.9% (20/26). ConclusionPerforming 3D-OCT for assessment of coronary artery bifurcation type is feasible and simple, and can be done in a short time with high reproducibility.	[Nishimura, Takashi; Okamura, Takayuki; Fujimura, Tatsuhiro; Miyazaki, Yosuke; Takenaka, Hitoshi; Akase, Hideaki; Tateishi, Hiroki; Mochizuki, Mamoru; Uchinoumi, Hitoshi; Oda, Tetsuro; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi, Japan	Yamaguchi University	Okamura, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi, Japan.	t-okamu@yamaguchi-u.ac.jp						Ali ZA, 2016, LANCET, V388, P2618, DOI 10.1016/S0140-6736(16)31922-5; Amemiya K, 2014, AM J CARDIOVASC DIS, V4, P168; Burzotta F, 2021, EUROINTERVENTION, V16, P1307, DOI 10.4244/EIJ-D-20-00169; Chen SL, 2013, J AM COLL CARDIOL, V61, P1482, DOI 10.1016/j.jacc.2013.01.023; Collet C, 2017, EUROINTERVENTION, V13, P634, DOI 10.4244/EIJ-D-17-00465; Dzavik V, 2006, AM HEART J, V152, P762, DOI 10.1016/j.ahj.2006.04.033; Elbasan Z, 2013, J INVASIVE CARDIOL, V25, P118; Farooq V, 2011, JACC-CARDIOVASC INTE, V4, P921, DOI 10.1016/j.jcin.2011.06.004; Gil RJ, 2009, J INTERV CARDIOL, V22, pE1, DOI 10.1111/j.1540-8183.2009.00492.x; Girasis C, 2010, JACC-CARDIOVASC INTE, V3, P41, DOI 10.1016/j.jcin.2009.10.019; Givehchi S, 2018, PHYS MEDICA, V45, P198, DOI 10.1016/j.ejmp.2017.09.137; Gutierrez-Chico JL, 2011, CIRCULATION, V124, P612, DOI 10.1161/CIRCULATIONAHA.110.014514; Konishi T, 2016, CORONARY ARTERY DIS, V27, P449, DOI 10.1097/MCA.0000000000000381; Lansky A, 2009, CATHETER CARDIO INTE, V73, P258, DOI 10.1002/ccd.21814; Lassen JF, 2014, EUROINTERVENTION, V10, P545, DOI 10.4244/EIJV10I5A97; Okamura T, 2018, EUROINTERVENTION, V13, P1785, DOI 10.4244/EIJ-D-17-00591; Okamura T, 2010, JACC-CARDIOVASC INTE, V3, P836, DOI 10.1016/j.jcin.2010.05.011; Onuma Y, 2020, CIRC-CARDIOVASC INTE, V13, P355, DOI 10.1161/CIRCINTERVENTIONS.120.009183; Onuma Y, 2019, EUROINTERVENTION, V14, pE1568, DOI 10.4244/EIJ-D-18-00391; Onuma Y, 2011, EUROINTERVENTION, V7, P629, DOI 10.4244/EIJV7I5A100; Pflederer T, 2006, INVEST RADIOL, V41, P793, DOI 10.1097/01.rli.0000239318.88270.9f; Raber L, 2018, EUR HEART J, V39, P3281, DOI 10.1093/eurheartj/ehy285; de Lezo JS, 2012, EUROINTERVENTION, V7, P1147, DOI 10.4244/EIJV7I10A185; Takagi K, 2021, CARDIOVASC INTERV TH, V36, P54, DOI 10.1007/s12928-020-00701-2; Tyczynski P, 2010, REV ESP CARDIOL, V63, P904, DOI 10.1016/S0300-8932(10)70202-5; Watanabe M, 2016, CORONARY ARTERY DIS, V27, P682, DOI 10.1097/MCA.0000000000000422; Watanabe M, 2014, CORONARY ARTERY DIS, V25, P321, DOI 10.1097/MCA.0000000000000091; Zhang D, 2015, CATHETER CARDIO INTE, V85, P706, DOI 10.1002/ccd.25858	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263246	10.1371/journal.pone.0263246	http://dx.doi.org/10.1371/journal.pone.0263246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104282	gold, Green Published			2022-12-26	WOS:000749789300012
J	Medeiros, PJJ; Pascetta, SAA; Kirsh, SMM; Al-Khazraji, BKK; Uniacke, J				Medeiros, Philip J. J.; Pascetta, Sydney A. A.; Kirsh, Sarah M. M.; Al-Khazraji, Baraa K. K.; Uniacke, James			Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; BINDING SITES; TARGET GENES; GROWTH; HIF; ACTIVATION; PROMOTES; SIGNAL; IDENTIFICATION	Neuropeptide Y (NPY) is an abundant neurohormone in the central and peripheral nervous system involved in feeding behavior, energy balance, nociception, and anxiety. Several NPY receptor (NPYR) subtypes display elevated expression in many cancers including in breast tumors where it is exploited for imaging and diagnosis. Here, we address how hypoxia, a common feature of the tumor microenvironment, influences the expression of the NPYRs. We show that NPY1R and NPY5R mRNA abundance is induced by hypoxia in a hypoxia inducible factor (HIF)-dependent manner in breast cancer cell lines MCF7 and MDA-MB-231. We demonstrate that HIFs bind to several genomic regions upstream of the NPY1R and NPY5R transcription start sites. In addition, the MAPK/ERK pathway is activated more rapidly upon NPY5R stimulation in hypoxic cells compared with normoxic cells. This pathway requires insulin-like growth factor 1 receptor (IGF1R) activity in normoxia, but not in hypoxic cells, which display resistance to the radiosensitizer and IGF1R inhibitor AG1024. Furthermore, hypoxic cells proliferate and migrate more when stimulated with NPY relative to normoxic cells and exhibit a more robust response to a Y5-specific agonist. Our data suggest that hypoxia-induced NPYRs render hypoxic cells more sensitive to NPY stimulation. Considering that breast tissue receives a constant supply of NPY, hypoxic breast tumors are the perfect storm for hyperactive NPYR. This study not only highlights a new relationship between the HIFs and NPYR expression and activity but may inform the use of chemotherapeutics targeting NPYRs and hypoxic cells.	[Medeiros, Philip J. J.; Pascetta, Sydney A. A.; Kirsh, Sarah M. M.; Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Al-Khazraji, Baraa K. K.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Medeiros, Philip J. J.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON, Canada	University of Guelph; McMaster University; Wilfrid Laurier University	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	juniacke@uoguelph.ca		Kirsh, Sarah/0000-0002-5261-2100	Natural Sciences and Engineering Council of Canada [04807]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding and additional information-This work was funded by the Natural Sciences and Engineering Council of Canada grant number 04807 to J. U.	Ahrens VM, 2015, CHEMMEDCHEM, V10, P164, DOI 10.1002/cmdc.201402368; Al-Khazraji BK, 2011, BIOL PROCED ONLINE, V13, P1, DOI 10.1186/1480-9222-13-9; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Czarnecka M, 2019, NEUROPEPTIDES, V73, P11, DOI 10.1016/j.npep.2018.11.008; Daimiel I, 2019, J BREAST CANCER, V22, P155, DOI 10.4048/jbc.2019.22.e26; Dimitrijevic M, 2013, AMINO ACIDS, V45, P41, DOI 10.1007/s00726-011-1185-7; Fradette C, 2004, CURR DRUG METAB, V5, P257, DOI 10.2174/1389200043335577; Hofmann S, 2015, MOL PHARMACEUT, V12, P1121, DOI 10.1021/mp500601z; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Khan IU, 2010, ANGEW CHEM INT EDIT, V49, P1155, DOI 10.1002/anie.200905008; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korner M, 2008, J NEUROPATH EXP NEUR, V67, P741, DOI 10.1097/NEN.0b013e318180e618; Korner M, 2007, PEPTIDES, V28, P419, DOI 10.1016/j.peptides.2006.08.037; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Korner M, 2004, CLIN CANCER RES, V10, P8426, DOI 10.1158/1078-0432.CCR-04-0821; Korner M, 2004, LAB INVEST, V84, P71, DOI 10.1038/labinvest.3700009; Lecat S, 2015, CELL SIGNAL, V27, P1297, DOI 10.1016/j.cellsig.2015.03.016; Li J, 2015, ACS APPL MATER INTER, V7, P5574, DOI 10.1021/acsami.5b00270; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Magni P, 2001, ANN ONCOL, V12, pS27, DOI 10.1093/annonc/12.suppl_2.S27; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Medeiros PJ, 2013, PEPTIDES, V48, P106, DOI 10.1016/j.peptides.2013.07.029; Medeiros PJ, 2012, INT J CANCER, V131, P276, DOI 10.1002/ijc.26350; Michel MC, 1998, PHARMACOL REV, V50, P143; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nie M, 1998, REGUL PEPTIDES, V75-6, P207, DOI 10.1016/S0167-0115(98)00070-6; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pressley M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85184-8; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reubi JC, 2001, CANCER RES, V61, P4636; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2007, CANCER METAST REV, V26, P223, DOI 10.1007/s10555-007-9058-y; Sheriff S, 2010, MOL CANCER RES, V8, P604, DOI 10.1158/1541-7786.MCR-09-0301; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Tilan JU, 2013, ONCOTARGET, V4, P2487, DOI 10.18632/oncotarget.1604; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Zagorac I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05742-z; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhdanov AV, 2015, BBA-BIOENERGETICS, V1847, P1254, DOI 10.1016/j.bbabio.2015.06.016	52	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101645	10.1016/j.jbc.2022.101645	http://dx.doi.org/10.1016/j.jbc.2022.101645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093384	gold, Green Published			2022-12-26	WOS:000789261900008
J	Mohamed, T; Adolph, MB; Cortez, D				Mohamed, Taha; Adolph, Madison B.; Cortez, David			Oligomerization of DNA replication regulatory protein RADX is essential to maintain replication fork stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GENOME STABILITY; REGRESSION; SMARCAL1; REVERSAL	Genome integrity requires complete and accurate DNA replication once per cell division cycle. Replication stress poses obstacles to this process that must be overcome to prevent replication fork collapse. An important regulator of replication fork stability is the RAD51 protein, which promotes replication fork reversal and protects nascent DNA strands from nuclease mediated degradation. Many regulatory proteins control these RAD51 activities, including RADX, which binds both ssDNA and RAD51 at replication forks to ensure that fork reversal is confined to stalled forks. Many ssDNA-binding proteins function as hetero-or homo-oligomers. In this study, we addressed whether this is also the case for RADX. Using biochemical and genetic approaches, we found that RADX acts as a homooligomer to control replication fork stability. RADX oligomerizes using at least two different interaction surfaces, including one mapped to a C-terminal region. We demonstrate that mutations in this region prevent oligomerization and prevent RADX function in cells, and that addition of a heterologous dimerization domain to the oligomerization mutants restored their ability to regulate replication. Taken together, our results demonstrate that like many ssDNA-binding proteins, oligomerization is essential for RADX-mediated regulation of genome stability.	[Mohamed, Taha; Adolph, Madison B.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA.	david.cortez@vanderbilt.edu	Mohamed, Taha M./GQH-0736-2022	Mohamed, Taha M./0000-0002-2752-9663	National Institutes of Health [R01GM116616]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-Funding for this work was provided by National Institutes of Health grant R01GM116616 to D. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adolph MB, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.036; Bai GS, 2020, MOL CELL, V78, P1237, DOI 10.1016/j.molcel.2020.04.031; Berti M, 2020, NAT REV MOL CELL BIO, V21, P633, DOI 10.1038/s41580-020-0257-5; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhat KP, 2018, CELL REP, V24, P538, DOI 10.1016/j.celrep.2018.06.061; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cortez D, 2019, MOL CELL, V74, P866, DOI 10.1016/j.molcel.2019.04.027; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Dungrawala H, 2017, MOL CELL, V67, P374, DOI 10.1016/j.molcel.2017.06.023; Fugger K, 2015, CELL REP, V10, P1749, DOI 10.1016/j.celrep.2015.02.028; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Krishnamoorthy A, 2021, MOL CELL, V81, P3007, DOI 10.1016/j.molcel.2021.05.014; Liu W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc3598; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schubert L, 2017, EMBO REP, V18, P1991, DOI 10.15252/embr.201744877; Vujanovic M, 2017, MOL CELL, V67, P882, DOI 10.1016/j.molcel.2017.08.010; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang HS, 2020, NUCLEIC ACIDS RES, V48, P7834, DOI 10.1093/nar/gkaa559	22	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101672	10.1016/j.jbc.2022.101672	http://dx.doi.org/10.1016/j.jbc.2022.101672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120927	gold, Green Published			2022-12-26	WOS:000791230900008
J	Wall, CTJ; Lefebvre, G; Metairon, S; Descombes, P; Wiederkehr, A; Santo-Domingo, J				Wall, Christopher Tadhg James; Lefebvre, Gregory; Metairon, Sylviane; Descombes, Patrick; Wiederkehr, Andreas; Santo-Domingo, Jaime			Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-SYNTHESIS; GENE-EXPRESSION; CELL BIOLOGY; DEGRADATION; BINDING; PHOSPHORYLATION; INHIBITION; METABOLISM; ATF4	Mitochondrial dysfunction induces a strong adaptive retrograde signaling response; however, many of the downstream effectors of this response remain to be discovered. Here, we studied the shared transcriptional responses to three different mitochondrial respiratory chain inhibitors in human primary skin fibroblasts using QuantSeq 3 '-RNA-sequencing. We found that genes involved in the mevalonate pathway were concurrently downregulated, irrespective of the respiratory chain complex affected. Targeted metabolomics demonstrated that impaired mitochondrial respiration at any of the three affected complexes also had functional consequences on the mevalonate pathway, reducing levels of cholesterol precursor metabolites. A deeper study of complex I inhibition showed a reduced activity of endoplasmic reticulum-bound sterol-sensing enzymes through impaired processing of the transcription factor Sterol Regulatory Element-Binding Protein 2 and accelerated degradation of the endoplasmic reticulum cholesterol-sensors squalene epoxidase and HMG-CoA reductase. These adaptations of mevalonate pathway activity affected neither total intracellular cholesterol levels nor the cellular free (nonesterified) cholesterol pool. Finally, measurement of intracellular cholesterol using the fluorescent cholesterol binding dye filipin revealed that complex I inhibition elevated cholesterol on intracellular compartments. Taken together, our study shows that mitochondrial respiratory chain dysfunction elevates intracellular free cholesterol levels and therefore attenuates the expression of mevalonate pathway enzymes, which lowers endogenous cholesterol biosynthesis, disrupting the metabolic output of the mevalonate pathway. We conclude that intracellular disturbances in cholesterol homeostasis may alter systemic cholesterol management in diseases associated with declining mitochondrial function.	[Wall, Christopher Tadhg James; Wiederkehr, Andreas; Santo-Domingo, Jaime] Soc Produits Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland; [Wall, Christopher Tadhg James; Wiederkehr, Andreas] Ecole Polytech Fed Lausanne, Inst Bioengn, Life Sci Fac, Lausanne, Switzerland; [Lefebvre, Gregory; Metairon, Sylviane; Descombes, Patrick] Soc Prod Nestle SA, Nestle Inst Food Safety & Analyt Sci, Nestle Res, Lausanne, Switzerland; [Santo-Domingo, Jaime] Univ Valladolid, Fac Med, Unidad Excelencia Inst Biol & Genet Mol IBGM, Dept Biochem & Mol Biol, Valladolid, Spain; [Santo-Domingo, Jaime] CSIC, Valladolid, Spain	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nestle SA; Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Wiederkehr, A; Santo-Domingo, J (corresponding author), Soc Produits Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland.; Wiederkehr, A (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Life Sci Fac, Lausanne, Switzerland.; Santo-Domingo, J (corresponding author), Univ Valladolid, Fac Med, Unidad Excelencia Inst Biol & Genet Mol IBGM, Dept Biochem & Mol Biol, Valladolid, Spain.; Santo-Domingo, J (corresponding author), CSIC, Valladolid, Spain.	andreas.wiederkehr@epfl.ch; jaime.santo-domingo@uva.es		Lefebvre, Greg/0000-0001-7519-2316; Wall, Christopher/0000-0001-7807-4534; Santo Domingo, Jaime/0000-0001-5501-0482				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Distelmaier F, 2015, BBA-MOL BASIS DIS, V1852, P529, DOI 10.1016/j.bbadis.2014.12.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Garcia-Bartolome A, 2017, HUM MOL GENET, V26, P2493, DOI 10.1093/hmg/ddx144; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2; Howe V, 2017, BBA-MOL CELL BIOL L, V1862, P647, DOI 10.1016/j.bbalip.2017.03.009; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kuhl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7; Luo J, 2019, TRENDS BIOCHEM SCI, V44, P273, DOI 10.1016/j.tibs.2018.10.001; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Ribatti D, 2017, EXP CELL RES, V359, P17, DOI 10.1016/j.yexcr.2017.06.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Sprouffske K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1016-7; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilhelm LP, 2019, METHODS MOL BIOL, V1949, P137, DOI 10.1007/978-1-4939-9136-5_11; Zheng B., 2011, AMPK PHOSPHORYLATES; Zorova L. D., 2018, ANAL BIOCHEM	50	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101652	10.1016/j.jbc.2022.101652	http://dx.doi.org/10.1016/j.jbc.2022.101652			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101444	Green Published, gold			2022-12-26	WOS:000794865600001
J	Wang, YQ; Zhang, X; Yao, HY; Chen, XC; Shang, L; Li, P; Cui, XJ; Zeng, J				Wang, Yaoqing; Zhang, Xiao; Yao, Haoya; Chen, Xiaocui; Shang, Lin; Li, Ping; Cui, Xiaojuan; Zeng, Jia			Peroxisome-generated succinate induces lipid accumulation and oxidative stress in the kidneys of diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ALBUMIN PERMEABILITY; ISOLATED RAT GLOMERULI; FATTY-ACID OXIDATION; BETA-OXIDATION; DICARBOXYLIC-ACIDS; OMEGA-OXIDATION; COA THIOESTERASE; RECEPTOR GPR91; ANGIOTENSIN-II; LIVER	Diabetes normally causes lipid accumulation and oxidative stress in the kidneys, which plays a critical role in the onset of diabetic nephropathy; however, the mechanism by which dysregulated fatty acid metabolism increases lipid and reactive oxygen species (ROS) formation in the diabetic kidney is not clear. As succinate is remarkably increased in the diabetic kidney, and accumulation of succinate suppresses mitochondrial fatty acid oxidation and increases ROS formation, we hypothesized that succinate might play a role in inducing lipid and ROS accumulation in the diabetic kidney. Here we demonstrate a novel mechanism by which diabetes induces lipid and ROS accumulation in the kidney of diabetic animals. We show that enhanced oxidation of dicarboxylic acids by peroxisomes leads to lipid and ROS accumulation in the kidney of diabetic mice via the metabolite succinate. Furthermore, specific suppression of peroxisomal beta-oxidation improved diabetes-induced nephropathy by reducing succinate generation and attenuating lipid and ROS accumulation in the kidneys of the diabetic mice. We suggest that peroxisome-generated succinate acts as a pathological molecule inducing lipid and ROS accumulation in kidney, and that specifically targeting peroxisomal beta-oxidation might be an effective strategy in treating diabetic nephropathy and related metabolic disorders.	[Wang, Yaoqing; Zhang, Xiao; Yao, Haoya; Chen, Xiaocui; Shang, Lin; Li, Ping; Cui, Xiaojuan; Zeng, Jia] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China.	zengj@hnu.edu.cn			Distinguished Professor Funds from Hunan University of Science and Technology	Distinguished Professor Funds from Hunan University of Science and Technology	Supported by Distinguished Professor Funds from Hunan University of Science and Technology.	Ackrell B A, 1978, Methods Enzymol, V53, P466; Antonenkov E. D., 2004, AM J PHYSIOL-CELL PH, V287, pC1623; BERGSETH S, 1988, BIOCHIM BIOPHYS ACTA, V961, P103, DOI 10.1016/0005-2760(88)90135-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnet F, 2000, DIABETES METAB, V26, P254; BREMER J, 1966, BIOCHIM BIOPHYS ACTA, V116, P1, DOI 10.1016/0005-2760(66)90087-7; BREMER J, 1972, BIOCHIM BIOPHYS ACTA, V280, P515, DOI 10.1016/0005-2760(72)90131-2; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; Chen XC, 2020, J BIOL CHEM, V295, P10168, DOI 10.1074/jbc.RA120.013583; De Vries A. P. J., 2014, FATTY KIDNEY EMERGIN; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; EATON S, 1994, EUR J BIOCHEM, V220, P671, DOI 10.1111/j.1432-1033.1994.tb18668.x; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; He AY, 2020, MOL CELL, V79, P30, DOI 10.1016/j.molcel.2020.05.007; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; HORIE S, 1981, J BIOCHEM, V90, P1691, DOI 10.1093/oxfordjournals.jbchem.a133645; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Inouye M, 2000, ATHEROSCLEROSIS, V148, P197, DOI 10.1016/S0021-9150(99)00263-4; Jha JC, 2016, ANTIOXID REDOX SIGN, V25, P657, DOI 10.1089/ars.2016.6664; Kakizawa H, 2004, HORM METAB RES, V36, P458, DOI 10.1055/s-2004-825725; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; KING MT, 1988, METHOD ENZYMOL, V166, P70; KREBS HA, 1961, BIOCHEM J, V80, P225, DOI 10.1042/bj0800225; KREBS HA, 1961, BIOCHEM J, V79, P537, DOI 10.1042/bj0790537; LATIPAA PM, 1988, ANAL BIOCHEM, V171, P67, DOI 10.1016/0003-2697(88)90125-X; LATIPAA PM, 1986, BIOCHIM BIOPHYS ACTA, V875, P293, DOI 10.1016/0005-2760(86)90179-7; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1987, J INHERIT METAB DIS, V10, P11, DOI 10.1007/BF01812843; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LIEBICH HM, 1986, J CHROMATOGR, V379, P347, DOI 10.1016/S0378-4347(00)80689-1; MARKWELL MA, 1973, J BIOL CHEM, V248, P3426; McCarthy ET, 1998, J AM SOC NEPHROL, V9, P433; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; MORTENSEN PB, 1980, BIOCHIM BIOPHYS ACTA, V620, P177, DOI 10.1016/0005-2760(80)90199-X; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; Okada M, 2002, KIDNEY INT, V61, P113, DOI 10.1046/j.1523-1755.2002.00107.x; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Peti-Peterdi J, 2013, PFLUG ARCH EUR J PHY, V465, P53, DOI 10.1007/s00424-012-1130-y; POWELL PJ, 1987, BIOCHEMISTRY-US, V26, P3704, DOI 10.1021/bi00386a066; PREISS B, 1964, J BIOL CHEM, V239, P85; QUANT PA, 1989, BIOCHEM J, V262, P159, DOI 10.1042/bj2620159; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; SCHIFFERDECKER J, 1974, LIFE SCI, V14, P1487, DOI 10.1016/0024-3205(74)90159-3; Sharma R, 2000, KIDNEY INT, V58, P131, DOI 10.1046/j.1523-1755.2000.00148.x; SINGH B, 1982, H-S Z PHYSIOL CHEM, V363, P920; SMITH CM, 1974, J BIOL CHEM, V249, P1497; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; TSERNG KY, 1991, J BIOL CHEM, V266, P2924; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; Veeger C., 1969, METHODS ENZYMOL, V13, P524; Verkade PE, 1934, BIOCHEM J, V28, P31, DOI 10.1042/bj0280031; WADA F, 1977, BIOCHIM BIOPHYS ACTA, V487, P261, DOI 10.1016/0005-2760(77)90002-9; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; Zeng J, 2017, J BIOL CHEM, V292, P3800, DOI 10.1074/jbc.M116.763532; Zhang X, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100622	66	1	1	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101660	10.1016/j.jbc.2022.101660	http://dx.doi.org/10.1016/j.jbc.2022.101660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35124006	gold, Green Published			2022-12-26	WOS:000794865600008
J	Xiao, MM; Zhang, SY; Liu, Z; Mo, YQ; Wang, H; Zhao, X; Yang, X; Boohaker, RJ; Chen, Y; Han, YM; Liu, H; Xu, B				Xiao, Mingming; Zhang, Siyue; Liu, Zhuang; Mo, Yaqi; Wang, Han; Zhao, Xu; Yang, Xue; Boohaker, Rebecca J.; Chen, Yang; Han, Yamei; Liu, Hong; Xu, Bo			Dual-functional significance of ATM-mediated phosphorylation of spindle assembly checkpoint component Bub3 in mitosis and the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BREAKS; INSTABILITY; INHIBITION; ACTIVATION; STABILITY; REVEALS; BIOLOGY; CANCER; CELLS	Both the DNA damage response (DDR) and the mitotic checkpoint are critical for the maintenance of genomic stability. Among proteins involved in these processes, the ataxia-telangiectasia mutated (ATM) kinase is required for both activation of the DDR and the spindle assembly checkpoint (SAC). In mitosis without DNA damage, the enzymatic activity of ATM is enhanced; however, substrates of ATM in mitosis are unknown. Using stable isotope labeling of amino acids in cell culture mass spectrometry analysis, we identified a number of proteins that can potentially be phosphorylated by ATM during mitosis. This list is highly enriched in proteins involved in cell cycle regulation and the DDR. Among them, we further validated that ATM phosphorylated budding uninhibited by benzimidazoles 3 (Bub3), a major component of the SAC, on serine 135 (Ser135) both in vitro and in vivo. During mitosis, this phosphorylation promoted activation of another SAC component, benzimidazoles 1. Mutation of Bub3 Ser135 to alanine led to a defect in SAC activation. Furthermore, we found that ATM-mediated phosphorylation of Bub3 on Ser135 was also induced by ionizing radiation-induced DNA damage. However, this event resulted in independent signaling involving interaction with the Ku70-Ku80-DNA-PKcs sensor/kinase complex, leading to efficient nonhomologous end-joining repair. Taken together, we highlight the functional significance of the crosstalk between the kinetochore-oriented signal and double-strand break repair pathways via ATM phosphorylation of Bub3 on Ser135.	[Xiao, Mingming; Xu, Bo] Chongqing Univ Canc Hosp, Chongqing Key Lab Intelligent Oncol Breast Canc, Chongqing, Peoples R China; [Xiao, Mingming; Xu, Bo] Chongqing Univ, Sch Med, Chongqing, Peoples R China; [Xiao, Mingming; Zhang, Siyue; Liu, Zhuang; Mo, Yaqi; Wang, Han; Zhao, Xu; Yang, Xue; Chen, Yang; Han, Yamei; Liu, Hong; Xu, Bo] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Tianjins Clin Res Ctr Ca, Dept Biochem & Mol Biol,Key Lab Canc Prevent &, Key Lab Breast Canc Prevent & Therapy,Minist Educ, Tianjin, Peoples R China; [Xiao, Mingming] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China; [Boohaker, Rebecca J.; Xu, Bo] Southern Res Inst, Dept Oncol, Birmingham, AL 35205 USA	Chongqing University; Tianjin Medical University; Fudan University	Xu, B (corresponding author), Chongqing Univ Canc Hosp, Chongqing Key Lab Intelligent Oncol Breast Canc, Chongqing, Peoples R China.; Xu, B (corresponding author), Chongqing Univ, Sch Med, Chongqing, Peoples R China.; Xu, B (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Tianjins Clin Res Ctr Ca, Dept Biochem & Mol Biol,Key Lab Canc Prevent &, Key Lab Breast Canc Prevent & Therapy,Minist Educ, Tianjin, Peoples R China.; Xu, B (corresponding author), Southern Res Inst, Dept Oncol, Birmingham, AL 35205 USA.	xubo731@cqu.edu.cn			National Natural Science Foundation of China [81974464, 81672743, 82003237]; Beijing Tianjin Hebei basic research cooperation project [19JCZDJC64500]; Shenzhen Basic Research Project [JCYJ20160331114230843]; US National Institutes of Health [R01CA133093]; Tianjin Medical University Cancer Institute and Hospital Innovation Fund [:1803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Tianjin Hebei basic research cooperation project; Shenzhen Basic Research Project; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Medical University Cancer Institute and Hospital Innovation Fund	This work was supported by the National Natural Science Foundation of China (grant nos.: 81974464 and 81672743; to B. X.), Beijing Tianjin Hebei basic research cooperation project (grant no.: 19JCZDJC64500(Z); to B. X.), the National Natural Science Foundation of China (grant no.: 82003237; to Y. H.), Shenzhen Basic Research Project (grant no.: JCYJ20160331114230843; to B. X.), the US National Institutes of Health grant (grant no.:R01CA133093; to B. X.), and the Tianjin Medical University Cancer Institute and Hospital Innovation Fund (grant no.:1803; to M. X.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfieri C, 2016, NATURE, V536, P431, DOI 10.1038/nature19083; Blackford AN, 2020, TRENDS BIOCHEM SCI, V45, P321, DOI 10.1016/j.tibs.2019.12.010; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; de Voer RM, 2013, GASTROENTEROLOGY, V145, P544, DOI 10.1053/j.gastro.2013.06.001; Derive N, 2015, J CELL BIOL, V211, P517, DOI 10.1083/jcb.201504059; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Guleria A, 2016, DNA REPAIR, V39, P1, DOI 10.1016/j.dnarep.2015.12.009; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Landmann C, 2020, J CELL SCI, V133, DOI 10.1242/jcs.244442; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Levy A, 2018, MOVEMENT DISORD, V33, P1238, DOI 10.1002/mds.27319; Li YM, 2018, MOL CELL PROTEOMICS, V17, P607, DOI 10.1074/mcp.RA118.000586; Liu CL, 2019, CANCER RES, V79, P2392, DOI 10.1158/0008-5472.CAN-18-3024; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morales AG, 2013, CHILD NERV SYST, V29, P2241, DOI 10.1007/s00381-013-2175-8; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Pilie PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z; Rigbolt KTG, 2012, SEMIN CELL DEV BIOL, V23, P863, DOI 10.1016/j.semcdb.2012.05.006; Shindo K, 2017, J CLIN ONCOL, V35, P3382, DOI 10.1200/JCO.2017.72.3502; Siemeister G, 2019, CLIN CANCER RES, V25, P1404, DOI 10.1158/1078-0432.CCR-18-0628; Silva PMA, 2019, ORAL DIS, V25, P1291, DOI 10.1111/odi.13089; Subramanian C, 2019, SURGERY, V165, P202, DOI 10.1016/j.surg.2018.04.080; Tarrant MK, 2009, ANNU REV BIOCHEM, V78, P797, DOI 10.1146/annurev.biochem.78.070907.103047; Terradas M, 2016, ARCH TOXICOL, V90, P2657, DOI 10.1007/s00204-016-1818-4; Tomimatsu N, 2007, J BIOL CHEM, V282, P10138, DOI 10.1074/jbc.M611880200; Toulany M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010025; Yang CY, 2014, CARCINOGENESIS, V35, P2007, DOI 10.1093/carcin/bgu087; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yu HT, 2005, CELL CYCLE, V4, P262	38	0	0	7	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101632	10.1016/j.jbc.2022.101632	http://dx.doi.org/10.1016/j.jbc.2022.101632			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35085551	Green Published, gold			2022-12-26	WOS:000821051800014
J	Nieto, K; Ang, D; Liu, HZ				Nieto, Kenny; Ang, Darwin; Liu, Huazhi			Dysphagia among geriatric trauma patients: A population-based study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; NECK-CANCER; INJURY; ASPIRATION; MORTALITY; OUTCOMES; PLACEMENT; HEAD	Objective To determine the significance of dysphagia on clinical outcomes of geriatric trauma patients. Methods This is a retrospective population-based study of geriatric trauma patients 65 years and older utilizing the Florida Agency for Health Care Administration dataset from 2010 to 2019. Patients with pre-admission dysphagia were excluded. Multivariable regression was used to create statistical adjustments. Primary outcomes included mortality and the development of dysphagia. Secondary outcomes included length of stay and complications. Subgroup analyses included patients with dementia, patients who received transgastric feeding tubes (GFTs) or tracheostomies, and speech language therapy consultation. Results A total of 52,946 geriatric patients developed dysphagia after admission during a 9-year period out of 1,150,438 geriatric trauma admissions. In general, patients who developed dysphagia had increased mortality, length of stay, and complications. When adjusted for traumatic brain and cervical spine injuries, the addition of mechanical ventilation decreased the mortality odds. This was also observed in the subset of patients with dysphagia who had GFTs placed. Of the three primary risk factors for dysphagia investigated, mechanical ventilation was the most strongly associated with later development of dysphagia and mortality. Conclusion The geriatric trauma population is vulnerable to dysphagia with a large number associated with traumatic brain injury, cervical spine injury, and polytraumatic injuries that lead to mechanical ventilation. Earlier intubation/mechanical ventilation in association with GFTs was found to be associated with decreased inpatient hospital mortality. Tracheostomy placement was shown to be an independent risk factor for the development of dysphagia. The utilization of speech language therapy was found to be inconsistently utilized.	[Nieto, Kenny; Ang, Darwin] Univ Cent Florida, Dept Surg, HCA Healthcare GME Consortium, Ocala, FL 34474 USA; [Ang, Darwin] Univ S Florida, Dept Surg, Tampa, FL 33620 USA; [Ang, Darwin; Liu, Huazhi] Ocala Reg Med Ctr, Dept Surg, Div Trauma, Ocala, FL 34471 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of South Florida	Nieto, K; Ang, D (corresponding author), Univ Cent Florida, Dept Surg, HCA Healthcare GME Consortium, Ocala, FL 34474 USA.; Ang, D (corresponding author), Univ S Florida, Dept Surg, Tampa, FL 33620 USA.; Ang, D (corresponding author), Ocala Reg Med Ctr, Dept Surg, Div Trauma, Ocala, FL 34471 USA.	Kenny.Nieto@hcahealthcare.com; Darwin.Ang@hcahealthcare.com		Nieto, Kenny/0000-0002-8885-9033	State of Florida; University of Central Florida; University of South Florida; HCA Healthcare	State of Florida; University of Central Florida; University of South Florida; HCA Healthcare	The authors would like to acknowledge the State of Florida for the custodianship of The Agency for Health Care Administration dataset used here. In addition, acknowledgement to the University of Central Florida, the University of South Florida, and HCA Healthcare for their direct support in graduate medical education programs.	Adams SD, 2013, J TRAUMA ACUTE CARE, V74, P1327, DOI 10.1097/TA.0b013e31828c4698; American College of Surgeons CoT, 2020, NATL TRAUMA DATA STA, piv; Angela L, 2004, CENTRAL NERVOUS SYST; Arnold M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148424; Bailey RL., 2005, PERSPECTIVES SWALLOW, V14, P3; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dimick JB, 2012, ANN SURG, V255, P703, DOI 10.1097/SLA.0b013e31824b46ff; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Givens JL, 2013, J AM GERIATR SOC, V61, P1645, DOI 10.1111/jgs.12476; Goldberg LS, 2014, CLIN INTERV AGING, V9, P1733, DOI 10.2147/CIA.S53153; Gonzalez-Fernandez M, 2009, DYSPHAGIA, V24, P398, DOI 10.1007/s00455-009-9216-1; Han TR, 2008, DYSPHAGIA, V23, P59, DOI 10.1007/s00455-007-9097-0; Howle A., 2014, CURR PHYS MED REHABI, V2, P219, DOI [10.1007/s40141-014-0064-z, DOI 10.1007/S40141-014-0064-Z]; Jr WJP, 2005, PRACT GASTROENTEROL; Julie Louise Gerberding IA, 2005, TRAUMATIC BRAIN INJU; Karla Grimwood M, 2019, DEMENTIA CODING REQU; Karthikumar B, 2018, INDIAN J RADIOL IMAG, V28, P225, DOI 10.4103/ijri.IJRI_393_17; Keller JM, 2012, J ORTHOP TRAUMA, V26, pE161, DOI 10.1097/BOT.0b013e3182324460; Kim J, 2014, DYSPHAGIA, V29, P438, DOI 10.1007/s00455-014-9524-y; Kim YK, 2015, ANN REHABIL MED-ARM, V39, P778, DOI 10.5535/arm.2015.39.5.778; Kirshblum S, 1999, ARCH PHYS MED REHAB, V80, P1101, DOI 10.1016/S0003-9993(99)90068-0; Kuo S, 2009, J AM MED DIR ASSOC, V10, P264, DOI 10.1016/j.jamda.2008.10.010; Leder SB, 1998, DYSPHAGIA, V13, P167, DOI 10.1007/PL00009568; Lynch CR, 2004, NUTR ISSUES GASTROEN; Mandaville A, 2014, DYSPHAGIA, V29, P310, DOI 10.1007/s00455-013-9509-2; Martin-Harris B, 2008, PHYS MED REH CLIN N, V19, P769, DOI 10.1016/j.pmr.2008.06.004; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Michael C., 2016, NTDB ANN PEDIAT REPO; MUZ J, 1987, LARYNGOSCOPE, V97, P1180; MUZ J, 1989, AM J OTOLARYNG, V10, P282, DOI 10.1016/0196-0709(89)90009-4; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Palecek EJ, 2010, J AM GERIATR SOC, V58, P580, DOI 10.1111/j.1532-5415.2010.02740.x; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Richard DP, 2018, DEMENTIA; Santry HP, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.01.003; Schrag SP, 2007, J GASTROINTEST LIVER, V16, P407; Skoretz SA, 2010, CHEST, V137, P665, DOI 10.1378/chest.09-1823; Speed L, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.05.005; Tokunaga T, 2008, GERIATR GERONTOL INT, V8, P19, DOI 10.1111/j.1447-0594.2008.00442.x; Trapl M, 2007, STROKE, V38, P2948, DOI 10.1161/STROKEAHA.107.483933; Trauma Co, 2018, ADV TRAUMA LIFE SUPP, VTenth; Tsai MH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003871; Vudayagiri L, 2020, PERCUTANEOUS ENDOSCO	45	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0262623	10.1371/journal.pone.0262623	http://dx.doi.org/10.1371/journal.pone.0262623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134076	Green Published, gold			2022-12-26	WOS:000798968600006
J	Adeke, AS; Umeokonkwo, CD; Balogun, MS; Odili, AN				Adeke, Azuka Stephen; Umeokonkwo, Chukwuma David; Balogun, Muhammad Shakir; Odili, Augustine Nonso			Essential medicines and technology for hypertension in primary healthcare facilities in Ebonyi State, Nigeria	PLOS ONE			English	Article								Introduction Cardiovascular diseases (CVDs) now constitute major cause of morbidity and mortality in middle and low income countries including Nigeria. One of the major efforts at controlling CVDs in Nigeria includes expanding universal access to care through the primary healthcare (PHC) system. The study was to assess essential medicines and technology for control of hypertension in PHC facilities in Ebonyi Nigeria. Methods The study used mixed method cross-sectional survey to assess availability, affordability and accessibility of essential medicines and technology in 45 facilities and among their patients with hypertension (145). Results Most of the PHC facilities (71.1%) assessed were rural. The heads of facilities were mainly community health extension workers (86.7%). One (2.2%) facility had a pharmacy technician. All facilities had been supervised by the regulatory authority in the last one year. Out of 15 anti-hypertensive drugs assessed, 10 were available in some facilities (2.2%-44.4%) but essential drug availability was low (<80%). Only mercury sphygmomanometers were available in all facilities with 82.2% functioning. Stethoscopes were available in all facilities and 95.6% were functional. Glucometers were present in 20.0% of facilities and were all functional. All the respondents (100.0%) reported they could not afford their anti-hypertensive drugs. Median monthly income was 8,000 Nigerian Naira (range = 2,000-52,000). Median monthly cost of anti-hypertensive drugs was 3,500 Naira (range = 1,500-10,000). For 99 (68.3%) of the respondents, the facilities were accessible. Median cost of transportation for care was 400 Naira (range = 100-2,000). Conclusion Gaps still exist in the provision of hypertension control services in PHC facilities in Ebonyi State, Nigeria. The essential drugs were not always available, and cost of the drugs were still a challenge to the patients. There is urgent need to expand health insurance coverage to rural communities to ameliorate the catastrophic out-of-pocket health expenditures and improve control of CVDs.	[Adeke, Azuka Stephen; Umeokonkwo, Chukwuma David; Balogun, Muhammad Shakir] Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria; [Adeke, Azuka Stephen; Umeokonkwo, Chukwuma David] Alex Ekwueme Fed Univ Teaching Hosp, Dept Community Med, Abakaliki, Ebonyi State, Nigeria; [Balogun, Muhammad Shakir] African Field Epidemiol Network, Abuja, Nigeria; [Odili, Augustine Nonso] Univ Abuja, Coll Hlth Sci, Circulatory Hlth Res Lab, Abuja, Nigeria		Adeke, AS (corresponding author), Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria.; Adeke, AS (corresponding author), Alex Ekwueme Fed Univ Teaching Hosp, Dept Community Med, Abakaliki, Ebonyi State, Nigeria.	azukaadeke@gmail.com	Umeokonkwo, Chukwuma David/U-7112-2019	Umeokonkwo, Chukwuma David/0000-0002-0050-2874; Adeke, Azuka/0000-0002-6737-0378; Odili, Augustine/0000-0002-4564-1587	Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET)	Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET)	ASA received funding from the Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET, https://www.tephinet.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulraheem I. S., 2012, Journal of Public Health and Epidemiology, V4, P5; Adeloye D, 2015, J HYPERTENS, V33, P230, DOI 10.1097/HJH.0000000000000413; Akinlua JT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209334; Akinlua JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140021; Australian Government Department of Health, 2019, NAT STRAT ACT PLAN O; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Ebonyi State Ministry of Health, 2010, EB STAT GOV STRAT HL; Federal Ministry of Health, 2016, NIG ESS MED LIST; Federal Ministry of Health (FMOH) National Health Insurance Scheme (NHIS) National Primary Care Development Agency (NPHCDA), 2016, GUID ADM DISB MON FD; Frieden TR, 2019, J CLIN HYPERTENS, V21, P1442, DOI 10.1111/jch.13655; Mukundiyukuri JP, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2729; Muntner P, 2019, HYPERTENSION, V73, pE35, DOI 10.1161/HYP.0000000000000087; National Primary Health Care Development Agency, 2015, NAT STAND ORD COMM H; Nelissen HE, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3740-3; Odili AN, 2020, GLOB HEART, V15, DOI 10.5334/gh.848; Okubadejo NU, 2019, CLIN HYPERTENS, V25, DOI 10.1186/s40885-019-0112-1; Owoseye A., 2019, PREMIUM TIMES; Oyekale AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2112-8; The Nigerian Hypertension Society, 2020, GUIDELINES MANAGEMEN; Unger T, 2020, HYPERTENSION, V75, P1334, DOI 10.1161/HYPERTENSIONAHA.120.15026; Uzochukwu B, 2015, IMPLEMENTING BASIC H; WHO, RAIS BLOOD PRESS; WHO African Region, 2019, NIG FULF COMM LAUNCH; World Health Organization, 2018, HEARTS TECHN PACK CA	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263394	10.1371/journal.pone.0263394	http://dx.doi.org/10.1371/journal.pone.0263394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113947	gold, Green Published			2022-12-26	WOS:000823694700090
J	Kilercik, M; Ucal, Y; Serdar, M; Serteser, M; Ozpinar, A; Schweigert, FJ				Kilercik, Meltem; Ucal, Yasemin; Serdar, Muhittin; Serteser, Mustafa; Ozpinar, Aysel; Schweigert, Florian J.			Zinc protoporphyrin levels in COVID-19 are indicative of iron deficiency and potential predictor of disease severity	PLOS ONE			English	Article							ANEMIA; DIAGNOSIS; FERRITIN; INFLAMMATION; INFECTION	Background Coronavirus disease (COVID-19) has a severe impact on all aspects of patient care. Among the numerous biomarkers of potential validity for diagnostic and clinical management of COVID-19 are biomarkers at the interface of iron metabolism and inflammation. Methods The follow-up study included 54 hospitalized patients with laboratory-confirmed COVID-19 with a moderate and severe/critical form of the disease. Iron deficiency specific biomarkers such as iron, ferritin, transferrin receptor, hepcidin, and zinc protoporphyrin (ZnPP) as well as relevant markers of inflammation were evaluated twice: in the first five days when the patient was admitted to the hospital and during five to 15 days; and their validity to diagnose iron deficiency was further assessed. The regression and Receiver Operating Characteristics (ROC) analyses were performed to evaluate the prognosis and determine the probability for predicting the severity of the disease in the first five days of COVID-19. Results Based on hemoglobin values, anemia was observed in 21 of 54 patients. Of all iron deficiency anemia-related markers, only ZnPP was significantly elevated (P<0.001) in the anemic group. When patients were grouped according to the severity of disease, slight differences in hemoglobin or other anemia-related parameters could be observed. However, the levels of ZnPP were significantly increased in the severely ill group of patients. The ratio of ZnPP to lymphocyte count (ZnPP/L) had a discrimination power stronger than the neutrophil to lymphocyte count ratio (N/L) to determine disease severity. Additionally, only two markers were independently associated with the severity of COVID-19 in logistic regression analysis; D-dimer (OR (5.606)(95% CI 1.019-30.867)) and ZnPP/L ratio (OR (74.313) (95% CI 1.081-5108.103)). Conclusions For the first time ZnPP in COVID-19 patients were reported in this study. Among all iron-related markers tested, ZnPP was the only one that was associated with anemia as based on hemoglobin. The increase in ZnPP might indicate that the underlying cause of anemia in COVID-19 patients is not only due to the inflammation but also of nutritional origin. Additionally, the ZnPP/L ratio might be a valid prognostic marker for the severity of COVID-19.	[Kilercik, Meltem; Ucal, Yasemin; Serdar, Muhittin; Serteser, Mustafa; Ozpinar, Aysel] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey; [Kilercik, Meltem; Serteser, Mustafa] Acibadem Labmed Clin Labs, Dept Med Biochem, Istanbul, Turkey; [Schweigert, Florian J.] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol, Potsdam, Germany	Acibadem University; Acibadem Hospitals Group; University of Potsdam	Ozpinar, A (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey.; Schweigert, FJ (corresponding author), Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol, Potsdam, Germany.	florian.schweigert@uni-potsdam.de; Aysel.ozpinar@acibadem.edu.tr			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [491466077]; Acibadem Labmed Clinical Laboratories	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Acibadem Labmed Clinical Laboratories	This work is supported by Acibadem Labmed Clinical Laboratories and funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -project number 491466077.	Algassim AA, 2021, ANN HEMATOL, V100, P37, DOI 10.1007/s00277-020-04256-3; Archer NM, 2015, CRIT REV CL LAB SCI, V52, P256, DOI 10.3109/10408363.2015.1038744; Asare K, 2008, PHARMACOTHERAPY, V28, P1267, DOI 10.1592/phco.28.10.1267; Bellamy MC, 1998, LANCET, V352, P1903, DOI 10.1016/S0140-6736(98)00088-9; Bellmann-Weiler R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082429; Bergamaschi G, 2021, CLIN EXP MED, V21, P239, DOI 10.1007/s10238-020-00679-4; BLUMBERG WE, 1980, CLIN CHEM, V26, P409; Boshuizen M, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0261-2; Dinevari MF, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05868-4; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gomez-Pastora J, 2020, CLIN CHIM ACTA, V509, P249, DOI 10.1016/j.cca.2020.06.033; Hadadi A, 2020, J MED VIROL, V92, P915, DOI 10.1002/jmv.25839; Handelman GJ, 2008, HEART FAIL REV, V13, P393, DOI 10.1007/s10741-008-9086-x; HART D, 1981, CLIN CHEM, V27, P220; HASTKA J, 1993, BLOOD, V81, P1200; HASTKA J, 1994, CLIN CHEM, V40, P768; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Labbe RF, 2004, CLIN BIOCHEM, V37, P165, DOI 10.1016/j.clinbiochem.2003.10.006; Langer AL, 2017, HEMODIAL INT, V21, pS37, DOI 10.1111/hdi.12543; Lasocki S, 2011, ANESTHESIOLOGY, V114, P688, DOI 10.1097/ALN.0b013e3182065c57; Lawaczeck R, 2020, ACS CHEM NEUROSCI, V11, P3996, DOI 10.1021/acschemneuro.0c00572; Leventi E, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020366; Lippi G, 2020, HEMATOL TRANSF CELL, V42, P116, DOI 10.1016/j.htct.2020.03.001; Liu W, 2020, CURR CLIN MICROBIOL, V7, P13, DOI 10.1007/s40588-020-00140-w; Loftus TJ, 2019, J TRAUMA ACUTE CARE, V86, P260, DOI 10.1097/TA.0000000000002147; Lv YL, 2021, CLIN NUTR, V40, P3462, DOI 10.1016/j.clnu.2020.11.033; Maiti BK, 2020, ACS PHARMACOL TRANSL, V3, P1032, DOI 10.1021/acsptsci.0c00136; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4617, DOI 10.3748/wjg.15.4617; Myers B, 2002, Hematol J, V3, P116, DOI 10.1038/sj.thj.6200156; Nai A, 2021, AM J HEMATOL, V96, pE32, DOI 10.1002/ajh.26027; Patteril MV, 2001, ANAESTH INTENS CARE, V29, P473, DOI 10.1177/0310057X0102900504; Peng YY, 2017, ANN CLIN BIOCHEM, V54, P43, DOI 10.1177/0004563216675185; Prakash D, 2012, CRIT CARE CLIN, V28, P333, DOI 10.1016/j.ccc.2012.04.012; Sayad B, 2020, HEALTH SCI REP-US, V3, DOI 10.1002/hsr2.194; Su WL, 2021, J MICROBIOL IMMUNOL, V54, P113, DOI [10.1016/j.jmii.2020.10.001, 10.1016/jmii.2020.10.001]; Taneri PE, 2020, EUR J EPIDEMIOL, V35, P763, DOI 10.1007/s10654-020-00678-5; Tao ZY, 2021, J MED VIROL, V93, P1478, DOI 10.1002/jmv.26444; Thomas Christian, 2005, Lab Hematol, V11, P14, DOI 10.1532/LH96.04049; Thomas DW, 2013, BRIT J HAEMATOL, V161, P639, DOI 10.1111/bjh.12311; Tolich Deborah, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc053; Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061; WHO, 2011, WHO TECH REP SER, V959, P1; Wong SS, 1996, CLIN CHIM ACTA, V244, P91; Zhou CX, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.926178	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262487	10.1371/journal.pone.0262487	http://dx.doi.org/10.1371/journal.pone.0262487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113876	Green Published, gold			2022-12-26	WOS:000823694700024
J	Wajnsztajn, D; Shmueli, O; Zur, K; Frucht-Pery, J; Solomon, A				Wajnsztajn, Denise; Shmueli, Or; Zur, Ken; Frucht-Pery, Joseph; Solomon, Abraham			Predicting factors for the efficacy of cross-linking for keratoconus	PLOS ONE			English	Article							PROGRESSIVE KERATOCONUS; OUTCOMES; ULTRAVIOLET; RIBOFLAVIN; TRIAL	Purpose To evaluate predictors for success in corneal crosslinking (CXL) for keratoconus in a large cohort and extended follow-up. Design A retrospective study based on a prospectively built database. Methods Participants underwent CXL for keratoconus from 2007 to 2018. Statistical analysis was performed for patients with at least 1-year follow-up. We analyzed effects of CXL type (Epithelium-on or Epithelium-off and Accelerated (9mW/cm2@10min) or Standard (3mW/ cm2@30min)) and pre-operative factors including age, gender, baseline LogMAR visual acuity (LogMAR(pre)), maximal corneal power (Kmax(pre)), pachymetry, refractive and topographic cylinders, spherical equivalent (SEpre), mean corneal power (MeanK) and follow-up time on outcome measures. The outcome measures were the final change of Kmax (Delta Kmax) and the final change in LogMAR visual acuity (Delta LogMAR). A more negative Delta Kmax or Delta LogMAR represents a favorable effect of crosslinking. Results 517 eyes had Kmax results, and 385 eyes had LogMAR results with more than one year follow-up. These eyes were included in the study. The mean follow-up time was 2.29 years. Mean Kmax decreased from 54.07 +/- 5.99 diopters to 52.84 +/- 5.66 diopters (p<0.001), and Mean LogMAR decreased from 0.28 +/- 0.20 to 0.25 +/- 0.21 (p<0.001). Non-accelerated epithelium-off CXL resulted in greater flattening of Kmax when compared with other protocols. Visual acuity improvement was similar when comparing different CXL protocols. Multivariate analysis showed four factors associated with negative Delta Kmax: high Kmax(pre), high SEpre, high MeanK(pre), and non-accelerated procedure. Multivariate analysis showed three factors associated with negative Delta LogMAR: high LogMAR(pre), high SEpre, and Low MeanK(pre). After excluding corneas with Kmax(pre) >65 D or Pachymetry<400 microns, multivariate analysis showed that high Kmax(pre), high SEpre, and non-accelerated CXL were associated with negative Delta Kmax while high LogMAR(pre) and high SEpre were associated with negative Delta LogMAR. Conclusion CXL for keratoconus is a highly effective treatment, as evident by its effects on the outcome measures: Delta Kmax and Delta LogMAR. CXL was more successful in eyes with high Kmax(pre), high SEpre, and high LogMAR(pre), hich express disease severity. The non-accelerated epithelium-off protocol was associated with greater flattening of corneal curvature but did not show a better effect on visual acuity as compared to the other CXL protocols.	[Wajnsztajn, Denise; Shmueli, Or; Zur, Ken; Frucht-Pery, Joseph; Solomon, Abraham] Hadassah Hebrew Univ, Dept Ophthalmol, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Solomon, A (corresponding author), Hadassah Hebrew Univ, Dept Ophthalmol, Med Ctr, Jerusalem, Israel.	dr.avi.solomon@gmail.com	Shmueli, Or/AHD-0983-2022	Shmueli, Or/0000-0003-3718-2664; Solomon, Abraham/0000-0003-3222-9507				Caporossi A, 2010, AM J OPHTHALMOL, V149, P585, DOI 10.1016/j.ajo.2009.10.021; Craig JA, 2014, OCUL SURF, V12, P202, DOI 10.1016/j.jtos.2014.05.002; Ferdi AC, 2019, OPHTHALMOLOGY, V126, P935, DOI 10.1016/j.ophtha.2019.02.029; Godefrooij DA, 2017, INT OPHTHALMOL, V37, P341, DOI 10.1007/s10792-016-0262-z; Greenstein SA, 2013, J CATARACT REFR SURG, V39, P1133, DOI 10.1016/j.jcrs.2013.06.007; Hersh PS, 2017, OPHTHALMOLOGY, V124, P1259, DOI [10.1016/j.ophtha.2017.03.052, 10.1016/j.ophtha.2017.05.036]; Kimura K, 2010, EXP EYE RES, V90, P337, DOI 10.1016/j.exer.2009.11.012; Koller T, 2011, J CATARACT REFR SURG, V37, P1488, DOI 10.1016/j.jcrs.2011.03.041; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Kymionis GD, 2015, CORNEA, V34, P704, DOI 10.1097/ICO.0000000000000424; MAEDA N, 1995, ARCH OPHTHALMOL-CHIC, V113, P870, DOI 10.1001/archopht.1995.01100070044023; Meiri Z, 2016, CORNEA, V35, P417, DOI 10.1097/ICO.0000000000000723; Noor IH, 2018, J REFRACT SURG, V34, P567, DOI 10.3928/1081597X-20180607-01; O'Brart DPS, 2015, AM J OPHTHALMOL, V160, P1154, DOI 10.1016/j.ajo.2015.08.023; O'Brart David P S, 2014, J Optom, V7, P113, DOI 10.1016/j.optom.2013.12.001; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raiskup F, 2015, J CATARACT REFR SURG, V41, P41, DOI 10.1016/j.jcrs.2014.09.033; Randleman JB, 2015, SURV OPHTHALMOL, V60, P509, DOI 10.1016/j.survophthal.2015.04.002; Sadoughi MM, 2018, INT OPHTHALMOL, V38, P67, DOI 10.1007/s10792-016-0423-0; Shajari M, 2019, ACTA OPHTHALMOL, V97, pE22, DOI 10.1111/aos.13814; Sloot F, 2013, J CATARACT REFR SURG, V39, P1141, DOI 10.1016/j.jcrs.2013.01.045; Soeters N, 2015, AM J OPHTHALMOL, V159, P821, DOI 10.1016/j.ajo.2015.02.005; Subasinghe SK, 2018, GRAEF ARCH CLIN EXP, V256, P1363, DOI 10.1007/s00417-018-3966-0; Tian CY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05652; Toprak I, 2014, EYE, V28, P41, DOI 10.1038/eye.2013.224; Wen DZ, 2018, INVEST OPHTH VIS SCI, V59, P3920, DOI 10.1167/iovs.18-24656; Wen DZ, 2018, CORNEA, V37, P1018, DOI 10.1097/ICO.0000000000001632; Wisse RPL, 2014, AM J OPHTHALMOL, V157, P519, DOI 10.1016/j.ajo.2013.11.001; Wittig-Silva C, 2014, OPHTHALMOLOGY, V121, P812, DOI 10.1016/j.ophtha.2013.10.028; Yam JCS, 2013, EUR J OPHTHALMOL, V23, P799, DOI 10.5301/ejo.5000321	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263528	10.1371/journal.pone.0263528	http://dx.doi.org/10.1371/journal.pone.0263528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113959	Green Published, gold			2022-12-26	WOS:000823694700105
J	O'Kelly, E; Arora, A; Pirog, S; Pearson, C; Ward, J; Clarkson, PJ				O'Kelly, Eugenia; Arora, Anmol; Pirog, Sophia; Pearson, Charlotte; Ward, James; Clarkson, P. John			Face mask fit hacks: Improving the fit of KN95 masks and surgical masks with fit alteration techniques	PLOS ONE			English	Article							EFFICIENCY	Introduction During the course of the COVID-19 pandemic, there have been suggestions that various techniques could be employed to improve the fit and, therefore, the effectiveness of face masks. It is well recognized that improving fit tends to improve mask effectiveness, but whether these fit modifiers are reliable remains unexplored. In this study, we assess a range of common "fit hacks" to determine their ability to improve mask performance. Methods Between July and September 2020, qualitative fit testing was performed in an indoor living space. We used quantitative fit testing to assess the fit of both surgical masks and KN95 masks, with and without 'fit hacks', on four participants. Seven fit hacks were evaluated to assess impact on fit. Additionally, one participant applied each fit hack multiple times to assess how reliable hacks were when reapplied. A convenience of four participants took part in the study, three females and one male with a head circumference range of 54 to 60 centimetres. Results and discussion The use of pantyhose, tape, and rubber bands were effective for most participants. A pantyhose overlayer was observed to be the most effective hack. High degrees of variation were noted between participants. However, little variation was noted within participants, with hacks generally showing similar benefit each time they were applied on a single participant. An inspection of the fit hacks once applied showed that individual facial features may have a significant impact on fit, especially the nose bridge. Conclusions Fit hacks can be used to effectively improve the fit of surgical and KN95 masks, enhancing the protection provided to the wearer. However, many of the most effective hacks are very uncomfortable and unlikely to be tolerated for extended periods of time. The development of effective fit-improvement solutions remains a critical issue in need of further development.	[O'Kelly, Eugenia; Ward, James; Clarkson, P. John] Univ Cambridge, Dept Engn, Cambridge, England; [Arora, Anmol] Univ Cambridge, Sch Clin Med, Cambridge, England; [Pirog, Sophia] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Pearson, Charlotte] Univ Oregon, Lundquist Coll Business, Eugene, OR 97403 USA	University of Cambridge; University of Cambridge; Northwestern University; Feinberg School of Medicine; University of Oregon	O'Kelly, E (corresponding author), Univ Cambridge, Dept Engn, Cambridge, England.	eo339@cam.ac.uk	Arora, Anmol/AAP-7498-2020	Arora, Anmol/0000-0003-4881-8293; Clarkson, P. John/0000-0001-8018-7706				[Anonymous], 2015, PORTACOUNT PRO 8030; [Anonymous], 1910.134-Respiratory Protection; [Anonymous], 2019, 3M TECHNICAL B; Clapp PW, 2021, JAMA INTERN MED, V181, P463, DOI 10.1001/jamainternmed.2020.8168; Gandhi M, 2020, J GEN INTERN MED, V35, P3063, DOI 10.1007/s11606-020-06067-8; Gardner A., GLAMOUR; Kahler CJ, 2020, J AEROSOL SCI, V148, DOI 10.1016/j.jaerosci.2020.105617; Larson EL, 2011, PREVENTING TRANSMISSION OF PANDEMIC INFLUENZA AND OTHER VIRAL RESPIRATORY DISEASES: PERSONAL PROTECTIVE EQUIPMENT FOR HEALTHCARE PERSONNEL: UPDATE 2010, P71; Mueller AV, 2020, MATTER-US, V3, P950, DOI 10.1016/j.matt.2020.07.006; O'Kelly E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245688; O'Kelly E, 2022, DISASTER MED PUBLIC, V16, P60, DOI 10.1017/dmp.2020.352; Occupational Safety and Health Administration, 2009, ASS PROT FACT REV RE, DOI [10.1016/j.jchas.2006.01.007, DOI 10.1016/J.JCHAS.2006.01.007]; OKelly E, 2021, IMPROVING FABRIC FAC; Wen ZB, 2010, AEROBIOLOGIA, V26, P245, DOI 10.1007/s10453-010-9160-4	14	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262830	10.1371/journal.pone.0262830	http://dx.doi.org/10.1371/journal.pone.0262830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108287	gold, Green Published, Green Submitted			2022-12-26	WOS:000775890100039
J	Siew, SKH; Chia, JL; Mahendran, R; Yu, JH				Siew, Savannah Kiah Hui; Chia, Jonathan Louis; Mahendran, Rathi; Yu, Junhong			Older adults' perceptions of government handling of COVID-19: Predictors of protective behaviors from lockdown to post-lockdown	PLOS ONE			English	Article								Background Distrust, and more broadly, public perception of government's handling of a crisis, has been a widely studied topic within health crisis research and suggests that these perceptions are significantly associated with the behavior of its citizens. Purpose To understand which aspects of the public's perception of government handling of the COVID-19 pandemic predicted engagement of protective behaviors among older adults, who are the most vulnerable to COVID-19. Methods Participants were recruited from an ongoing biopsychosocial study on aging amongst community-dwelling older adults. There were two rounds of data collection, during the national lockdown and post-lockdown. The average length of follow-up was 5.88 months. N = 421 completed the first round of data collection and N = 318 subsequently completed the second round of questionnaires. Results During the lockdown, perceptions that pandemic-related measures in place were sufficient, effective, timely, provided a sense of safety, important information was easily accessible, and government handling of the pandemic could be trusted, were found to significantly predict engagement in protective behaviors. During post-lockdown, only perceptions that measures in place were sufficient, provided a sense of safety, and important information was easily accessible, remained significant predictors. The perception that COVID-19 measures were clear and easy to understand now became a significant predictor. Conclusions Public perceptions of government handling of the pandemic predicted engagement in protective behaviors but were less important during post-lockdown. To effectively engage older adults in protective behavior, our findings suggest for pandemic-related information to be accessible, introducing timely safety measures, and having easy-to-understand instructions for nuanced measures.	[Siew, Savannah Kiah Hui; Chia, Jonathan Louis; Mahendran, Rathi; Yu, Junhong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Siew, Savannah Kiah Hui; Yu, Junhong] Nanyang Technol Univ, Sch Social Sci, Psychol, Singapore, Singapore; [Chia, Jonathan Louis] Singapore Management Univ, Sch Social Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore Management University	Siew, SKH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore.; Siew, SKH (corresponding author), Nanyang Technol Univ, Sch Social Sci, Psychol, Singapore, Singapore.	savannahsiew@gmail.com	Yu, Junhong/AFL-7994-2022	Yu, Junhong/0000-0002-2563-9658; Chia, Jonathan/0000-0002-1055-5056; Siew, Savannah/0000-0003-1927-3845	Kwan Im Thong Hood Cho Temple; Lee Kim Tah Holdings Pte Ltd, under the MindScience Center at National University of Singapore	Kwan Im Thong Hood Cho Temple; Lee Kim Tah Holdings Pte Ltd, under the MindScience Center at National University of Singapore	This work was supported by Research Donations from Kwan Im Thong Hood Cho Temple and Lee Kim Tah Holdings Pte Ltd, under the MindScience Center at National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah WJ, 2020, AM REV PUBLIC ADM, V50, P770, DOI 10.1177/0275074020942454; Al-Rasheed M, 2020, SOC WORK PUBLIC HLTH, V35, P546, DOI 10.1080/19371918.2020.1806171; Banerjee D, 2020, INT J GERIATR PSYCH, V35, P1466, DOI 10.1002/gps.5320; Bearman G, 2020, INT J INFECT DIS, V96, P610, DOI 10.1016/j.ijid.2020.05.059; Biddlestone M, 2020, BRIT J SOC PSYCHOL, V59, P663, DOI 10.1111/bjso.12397; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Cava MA, 2005, J NURS SCHOLARSHIP, V37, P343, DOI 10.1111/j.1547-5069.2005.00059.x; Chuang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122970; Claeson M, 2021, LANCET, V397, P259, DOI 10.1016/S0140-6736(20)32750-1; Dighe A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01791-8; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Gros D., 2020, CEPS POLICY INSIGHTS, VVolume 11; Hatcher W, 2020, AM REV PUBLIC ADM, V50, P614, DOI 10.1177/0275074020941734; Kaiser Family Foundation, 2020, STAT DAT POL ACT ADD; Kuguyo O, 2020, OMICS, V24, P470, DOI 10.1089/omi.2020.0077; Lee K, 2009, GLOB INST, P1; Lee RZY, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035003; Lim VW, 2021, B WORLD HEALTH ORGAN, V99, P92, DOI 10.2471/BLT.20.269142; Navarro JA, 2021, AM J PUBLIC HEALTH, V111, P416, DOI 10.2105/AJPH.2020.305958; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Ozdemir S, 2022, INT J HEALTH POLICY, V11, P579, DOI 10.34172/ijhpm.2020.199; Quah SR, 2004, EMERG INFECT DIS, V10, P364, DOI 10.3201/eid1002.030418; Scandurra C, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-02059-x; Shi GQ, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-021-01015-2; Shimizu K, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040426; Sun YM, 2021, J SURG ONCOL, V123, pS30, DOI 10.1002/jso.26388; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4; Wright JH, 2020, PSYCHOTHER PSYCHOSOM, V89, P130, DOI 10.1159/000507376; Yan Y, 2020, INT J MATH IND, V12, DOI 10.1142/S266133522050001X	31	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263039	10.1371/journal.pone.0263039	http://dx.doi.org/10.1371/journal.pone.0263039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108322	Green Published, gold			2022-12-26	WOS:000775890100045
J	Hettich, N; Beutel, ME; Ernst, M; Schliessler, C; Kampling, H; Kruse, J; Braehler, E				Hettich, Nora; Beutel, Manfred E.; Ernst, Mareike; Schliessler, Clara; Kampling, Hanna; Kruse, Johannes; Braehler, Elmar			Conspiracy endorsement and its associations with personality functioning, anxiety, loneliness, and sociodemographic characteristics during the COVID-19 pandemic in a representative sample of the German population	PLOS ONE			English	Article							HOSPITAL ANXIETY; RELIABILITY; VALIDITY; BELIEFS; VERSION; SCALE	Background In the context of the COVID-19 pandemic, many individuals have been found to endorse conspiracy beliefs. Socio-demographic variables, personality functioning, anxiety, and loneliness could be risk factors for this endorsement. Methods In a representative sample of the German population (N = 2,503) measures of conspiracy mentality, conspiracy-related beliefs toward COVID-19, personality functioning (OPD-SQS), anxiety (HADS), and loneliness (UCLA) were assessed. Pearson product-moment correlations and multiple linear regression analyses were conducted. Results Conspiracy mentality and conspiracy-related beliefs toward COVID-19 were strongly correlated. Regression analyses found younger age, male gender, lower education, and lower income to be associated with conspiracy mentality. The subscales relationship model and self-perception of the OPD-SQS were positively related to conspiracy mentality whereas interpersonal contact was negatively associated. Higher levels of anxiety were statistically predictive for conspiracy mentality. Conclusion Our findings indicate a contribution of personality functioning to the understanding of conspiracy mentality and thus to the advancement of interventions during the pandemic.	[Hettich, Nora; Beutel, Manfred E.; Ernst, Mareike; Braehler, Elmar] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Schliessler, Clara; Braehler, Elmar] Univ Leipzig, Else Frenkel Brunswik Inst Democracy Res, Leipzig, Germany; [Kampling, Hanna; Kruse, Johannes] Justus Liebig Univ Giessen, Dept Psychosomat Med & Psychotherapy, Med Ctr, Giessen, Germany; [Kruse, Johannes] Philipps Univ Marburg, Dept Psychosomat Med & Psychotherapy, Med Ctr, Marburg, Germany	Johannes Gutenberg University of Mainz; Leipzig University; Justus Liebig University Giessen; Philipps University Marburg	Hettich, N (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	nora.hettich@unimedizin-mainz.de	Ernst, Mareike/AIC-0514-2022; Kampling, Hanna/GXZ-9506-2022	Ernst, Mareike/0000-0003-4952-9717; Kampling, Hanna/0000-0002-5213-0179; Hettich, Nora/0000-0003-0422-7037				Aberglaube SchliesslerC., 2020, AUTORIT RE DYNAMIKEN, P283; Barron D, 2018, PSYCHIAT RES, V259, P15, DOI 10.1016/j.psychres.2017.10.001; Barron D, 2014, PERS INDIV DIFFER, V70, P156, DOI 10.1016/j.paid.2014.06.040; Bender DS, 2011, J PERS ASSESS, V93, P332, DOI 10.1080/00223891.2011.583808; Benecke C, 2009, Z PSYCHOSOM MED PSYC, V55, P84, DOI 10.13109/zptm.2009.55.1.84; Bertin P, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565128; Bierwiaczonek K, 2020, APPL PSYCHOL-HLTH WE, V12, P1270, DOI 10.1111/aphw.12223; Bowlby J, 1978, Adolesc Psychiatry, V6, P5; Brahler E., 2015, PSYCHOL SOZIALWISSEN; Bruder M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00225; Chen X, 2020, JMIR PUBLIC HLTH SUR, V6, P275, DOI 10.2196/20737; Cichocka A, 2016, SOC PSYCHOL PERS SCI, V7, P157, DOI 10.1177/1948550615616170; Cierpka M, 2007, PSYCHOPATHOLOGY, V40, P209, DOI 10.1159/000101363; Cohen J, 2003, POWER PRIMER, P436; Decker O., 2020, PSYCHOSOZIAL VERLAG; Dinger U, 2014, J PERS ASSESS, V96, P220, DOI 10.1080/00223891.2013.828065; Doering S, 2014, PSYCHOPATHOLOGY, V47, P185, DOI 10.1159/000355062; Douglas KM, 2019, POLIT PSYCHOL, V40, P3, DOI 10.1111/pops.12568; Douglas KM, 2017, CURR DIR PSYCHOL SCI, V26, P538, DOI 10.1177/0963721417718261; Ehrenthal J. C., MEASURING PERSONALIT; Ehrenthal J. C., 2019, CASE FORMULATION PER, P291, DOI [10.1016/B978-0-12-813521-1.00015-1, DOI 10.1016/B978-0-12-813521-1.00015-1]; Ehrenthal JC, 2015, Z PSYCHOSOM MED PSYC, V61, P262, DOI 10.13109/zptm.2015.61.3.262; Ehrenthal JC, 2012, PSYCHOTHER PSYCH MED, V62, P25, DOI 10.1055/s-0031-1295481; Entringer TM, PSYCHISCHE KRISE DUR; Force OT., 2008, OPERATIONALIZED PSYC; Franks B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00861; Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890; Galliford N, 2017, SCAND J PSYCHOL, V58, P422, DOI 10.1111/sjop.12382; Georgiou N, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110201; Goreis A, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00205; Gottlieb M, 2020, ACAD EMERG MED, V27, P640, DOI 10.1111/acem.14036; Graeupner D, 2017, J EXP SOC PSYCHOL, V69, P218, DOI 10.1016/j.jesp.2016.10.003; Green R, 2018, PERS INDIV DIFFER, V125, P30, DOI 10.1016/j.paid.2017.12.023; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; Hollander BA, 2018, J MASS COMMUN Q, V95, P691, DOI 10.1177/1077699017728919; Horz S., 2011, PSYCHOTHER PSYCHIATR, V16, P41; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Imhoff R., 2013, RECHTSEXTREMISMUS MI, P146; Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692; Imhoff R, 2014, EUR J PERSONALITY, V28, P25, DOI 10.1002/per.1930; Jauk E, 2021, J PERS ASSESS, V103, P365, DOI 10.1080/00223891.2020.1775089; Kraus B, 2021, PSYCHOTHER RES, V31, P117, DOI 10.1080/10503307.2020.1763493; Lantian A, 2020, CONSPIR THEOR, P155; Leibovitz T, 2021, PERS INDIV DIFFER, V175, DOI 10.1016/j.paid.2021.110704; Marinthe G, 2020, BRIT J HEALTH PSYCH, V25, P957, DOI 10.1111/bjhp.12449; Miller JM, 2020, CAN J POLIT SCI, V53, P327, DOI 10.1017/S000842392000058X; Moscovici S., 1987, CHANGING CONCEPTIONS, P151, DOI 10.1007/978-1-4612-4618-3_9; Obbarius A, 2019, PSYCHOTHER PSYCH MED, V69, P38, DOI 10.1055/s-0043-125394; Radicalisation LeeB., 2020, ROUTLEDGE HDB CONSPI, P344; RUDOLF G, 1995, Z PSYCHOSOM MED PSYC, V41, P197; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Sallam M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144915; Santabarbara J, 2021, PROG NEURO-PSYCHOPH, V109, DOI 10.1016/j.pnpbp.2020.110207; Schmalbach B, ULTRASHORT VERSION H; Stand DW, 2011, DIV WE STAND WHY IN; Sutton RM, 2022, PSYCHOL MED, V52, P791, DOI 10.1017/S0033291720002780; Swami V, 2016, PSYCHIAT RES, V236, P86, DOI 10.1016/j.psychres.2015.12.027; Swami V, 2012, J GEN PSYCHOL, V139, P244, DOI 10.1080/00221309.2012.697932; Tyrer P, 2019, ANNU REV CLIN PSYCHO, V15, P481, DOI 10.1146/annurev-clinpsy-050718-095736; Tyrer P, 2011, PERSONAL MENT HEALTH, V5, P246, DOI 10.1002/pmh.190; Walter AS, 2022, POLIT STUD-LONDON, V70, P483, DOI 10.1177/0032321720972616; Will AK, 2019, ETHNICITIES, V19, P535, DOI 10.1177/1468796819833437; Yousuf H, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14323; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263301	10.1371/journal.pone.0263301	http://dx.doi.org/10.1371/journal.pone.0263301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089987	Green Published, gold			2022-12-26	WOS:000769158400050
J	Zhang, WY; Chen, SY; Du, Q; Bian, PP; Chen, YT; Liu, ZX; Zheng, J; Sai, K; Mou, YG; Chen, ZP; Fan, X; Jiang, XB				Zhang, Weiyu; Chen, Siyu; Du, Qiu; Bian, Piaopiao; Chen, Yutong; Liu, Zexian; Zheng, Jian; Sai, Ke; Mou, Yonggao; Chen, Zhongping; Fan, Xiang; Jiang, Xiaobing			CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1	ONCOGENE			English	Article							RIBOSOME-BINDING PROTEIN-1; CIRCULAR RNA; COLORECTAL-CANCER; TRANSLOCATION; EPIDEMIOLOGY; EXPRESSION; INDUCTION; APOPTOSIS; PATHWAY	CircRNAs play important roles in a variety of biological processes by acting as microRNA sponges and protein scaffolds or by encoding functional proteins. However, their functions and underlying mechanisms remain largely unknown. Distinctive circRNA patterns were explored by comparing nonfunctioning pituitary adenomas (NFPAs) and normal pituitary tissues with a circRNA array. The biological functions of selected circRNAs were determined in vitro and in vivo. RNA-seq and circRNA pulldown assays were applied to investigate the underlying mechanisms. The circRNA profile of NFPAs is tremendously different from that of normal pituitary tissues. CircVPS13C is significantly upregulated in NFPA samples and cell lines. Gain- and loss-of-function experiments demonstrate that silencing circVPS13C inhibits the proliferation of pituitary tumor cells in vitro and in vivo. Mechanistically, circVPS13C silencing increases the expression of IFITM1 and subsequently activates its downstream genes involved in MAPK- and apoptosis-associated signaling pathways. Rescue experiments show that IFITM1 overexpression partly reverses the biological effects of circVPS13C. Further studies reveal that circVPS13C inhibits IFITM1 expression through a novel mechanism mainly by competitively interacting with RRBP1, a ribosome-binding protein of the endoplasmic reticulum membrane, and thereby alleviating the stability of IFITM1 mRNA. Clinically, circVPS13C expression is markedly higher in high-risk NFPA samples and is downregulated in patient serum 7 days post-transsphenoidal adenoma resection. Our findings suggest that circVPS13C is a critical regulator in the proliferation and development of NFPAs through a novel mechanism, whereby regulating mRNA stability via interacting with ribosome-binding proteins on the endoplasmic reticulum membrane.	[Zhang, Weiyu; Chen, Siyu; Du, Qiu; Bian, Piaopiao; Sai, Ke; Mou, Yonggao; Chen, Zhongping; Jiang, Xiaobing] Sun Yat Sen Univ, Dept Neurosurg Neurooncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China; [Zhang, Weiyu; Fan, Xiang] Sun Yat Sen Univ, Dept Neurosurg, Affiliated Hosp 5, Zhuhai, Peoples R China; [Du, Qiu] Yangzhou Univ, Dept Neurosurg, Affiliated Hosp, Yangzhou, Jiangsu, Peoples R China; [Bian, Piaopiao] Guangzhou Med Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Chen, Yutong] Sun Yat Sen Univ, Affiliated Hosp 5, Canc Ctr, Dept Abdominal Oncol, Zhuhai, Peoples R China; [Liu, Zexian; Zheng, Jian] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Jiang, Xiaobing] Jiangmen Cent Hosp, Dept Neurosurg, Jiangmen, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Yangzhou University; Guangzhou Medical University; Sun Yat Sen University; State Key Lab Oncology South China	Jiang, XB (corresponding author), Sun Yat Sen Univ, Dept Neurosurg Neurooncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China.; Fan, X (corresponding author), Sun Yat Sen Univ, Dept Neurosurg, Affiliated Hosp 5, Zhuhai, Peoples R China.; Jiang, XB (corresponding author), Jiangmen Cent Hosp, Dept Neurosurg, Jiangmen, Peoples R China.	xiangfan@msn.com; jiangxiaob1@sysucc.org.cn	CHEN, SI/GZL-4800-2022	Liu, Ze-Xian/0000-0001-9698-0610; zhang, weiyu/0000-0002-8928-6636; Zheng, Jian/0000-0001-9831-7038; chen, zhongping/0000-0002-6226-5771	National Natural Science Foundation of China for Young Scholars [81702479]; Guangdong Basic and Applied Basic Research Foundation [2020A151501281]; Science and Technology Program of Jiangmen, China [2018630100110019805]; Natural Science Foundation of Jiangsu Province [BK20200936]	National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation; Science and Technology Program of Jiangmen, China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the National Natural Science Foundation of China for Young Scholars (grant number 81702479 to XJ), Guangdong Basic and Applied Basic Research Foundation (grant number 2020A151501281 to XJ), Science and Technology Program of Jiangmen, China (grant number 2018630100110019805 to YM), and the Natural Science Foundation of Jiangsu Province (grant number BK20200936 to QD).	Abdelmohsen K, 2017, RNA BIOL, V14, P361, DOI 10.1080/15476286.2017.1279788; Abe N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16435; Aflorei ED, 2014, J NEURO-ONCOL, V117, P379, DOI 10.1007/s11060-013-1354-5; Agustsson TT, 2015, EUR J ENDOCRINOL, V173, P655, DOI 10.1530/EJE-15-0189; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen NF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1594-y; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Danila DC, 2000, J CLIN ENDOCR METAB, V85, P1180, DOI 10.1210/jc.85.3.1180; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Du Q, 2019, J CLIN ENDOCR METAB, V104, P2419, DOI 10.1210/jc.2018-01851; Du WW, 2017, CELL DEATH DIFFER, V24, P357, DOI 10.1038/cdd.2016.133; Escher TE, 2019, MOL CANCER RES, V17, P1180, DOI 10.1158/1541-7786.MCR-18-0916; Esposito D, 2019, PITUITARY, V22, P422, DOI 10.1007/s11102-019-00960-0; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Huang AQ, 2020, THERANOSTICS, V10, P3503, DOI 10.7150/thno.42174; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Jagannathan S, 2014, J BIOL CHEM, V289, P25907, DOI 10.1074/jbc.M114.580688; Jasim S, 2017, ENDOCRINE, V56, P33, DOI 10.1007/s12020-016-1159-3; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Lei M, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1135-7; Liang XS, 2015, CANCER SCI, V106, P740, DOI 10.1111/cas.12666; Melmed S, 2020, NEW ENGL J MED, V382, P937, DOI 10.1056/NEJMra1810772; Mete O, 2017, ENDOCR PATHOL, V28, P228, DOI 10.1007/s12022-017-9498-z; Ng WL, 2018, RNA BIOL, V15, P995, DOI 10.1080/15476286.2018.1486659; Pan Y, 2015, BRIT J CANCER, V113, P763, DOI 10.1038/bjc.2015.260; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; SAVITZ AJ, 1993, J CELL BIOL, V120, P853, DOI 10.1083/jcb.120.4.853; Song ZJ, 2016, CELL RES, V26, P1255, DOI 10.1038/cr.2016.114; Tsai HY, 2013, ONCOGENE, V32, P4921, DOI 10.1038/onc.2012.514; Yacqub-Usman K, 2012, NAT REV ENDOCRINOL, V8, P486, DOI 10.1038/nrendo.2012.54; Yanez DC, 2020, IMMUNOLOGY, V159, P365, DOI 10.1111/imm.13163; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yang J, 2018, CANCER SCI, V109, P3115, DOI 10.1111/cas.13640; Yang Yibing, 2018, J Natl Cancer Inst, V110, DOI 10.1093/jnci/djx166; Yang ZG, 2017, MOL THER, V25, P2062, DOI 10.1016/j.ymthe.2017.05.022; Yu F, 2015, CANCER LETT, V368, P135, DOI 10.1016/j.canlet.2015.07.034; Zhang LL, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01224-3; Zhang SJ, 2012, EUR J CANCER, V48, P389, DOI 10.1016/j.ejca.2011.11.002	43	3	3	10	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1550	1562		10.1038/s41388-022-02186-0	http://dx.doi.org/10.1038/s41388-022-02186-0		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35091683				2022-12-26	WOS:000749073300005
J	Igata, T; Tanaka, H; Etoh, K; Hong, S; Tani, N; Koga, T; Nakao, M				Igata, Tomoka; Tanaka, Hiroshi; Etoh, Kan; Hong, Seonghyeon; Tani, Naoki; Koga, Tomoaki; Nakao, Mitsuyoshi			Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation	PLOS ONE			English	Article							ZINC-FINGERS; CELLULAR SENESCENCE; OXIDATIVE-PHOSPHORYLATION; PROTEIN; FAMILY; METABOLISM; LOCUS; FORMS	Cellular senescence is accompanied by metabolic and epigenomic remodeling, but the transcriptional mechanism of this process is unclear. Our previous RNA interference-based screen of chromatin factors found that lysine methyltransferases including SETD8 and NSD2 inhibited the senescence program in cultured fibroblasts. Here, we report that loss of the zinc finger and homeobox protein 3 (ZHX3), a ubiquitously expressed transcription repressor, induced senescence-associated gene expression and mitochondrial-nucleolar activation. Chromatin immunoprecipitation-sequencing analyses of growing cells revealed that ZHX3 was enriched at the transcription start sites of senescence-associated genes such as the cyclin-dependent kinase inhibitor (ARF-p16(INK4a)) gene and ribosomal RNA (rRNA) coding genes. ZHX3 expression was consistently downregulated in cells with replicative or oncogene-induced senescence. Mass spectrometry-based proteomics identified 28 proteins that interacted with ZHX3, including ATP citrate lyase and RNA metabolism proteins. Loss of ZHX3 or ZHX3-interaction partners by knockdown similarly induced the expression of p16(INK4a) and rRNA genes. Zhx3-knockout mice showed upregulation of p16(INK4a) in the testes, thymus and skeletal muscle tissues, together with relatively short survival periods in males. These data suggested that ZHX3 plays an essential role in transcriptional control to prevent cellular senescence.	[Igata, Tomoka; Tanaka, Hiroshi; Etoh, Kan; Hong, Seonghyeon; Tani, Naoki; Koga, Tomoaki; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan	Kumamoto University	Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan.	mnakao@gpo.kumamoto-u.ac.jp		Nakao, Mitsuyoshi/0000-0002-2196-8673	JSPS KAKENHI [18H02618, 21H02686, 20KK0185, 15H06507, 17J40011, 18K15048]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants (18H02618, 21H02686, and 20KK0185 to M.N., and 15H06507, 17J40011, and 18K15048 to T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy I, 1996, BIOCHEM BIOPH RES CO, V224, P870, DOI 10.1006/bbrc.1996.1114; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Bouska M, 2019, J GENET GENOMICS, V46, P171, DOI 10.1016/j.jgg.2019.03.011; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Deng MH, 2021, CANCER SCI, V112, P1758, DOI 10.1111/cas.14810; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Hirano S, 2002, GENE, V290, P107, DOI 10.1016/S0378-1119(02)00553-X; Hirosue A, 2012, AGING CELL, V11, P553, DOI 10.1111/j.1474-9726.2012.00809.x; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kawata H, 2003, GENE, V323, P133, DOI 10.1016/j.gene.2003.09.013; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kwon RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171036; Liu Y, 2015, CANCER GENE THER, V22, P223, DOI 10.1038/cgt.2015.16; Nakao M, 2020, TRENDS CELL BIOL, V30, P919, DOI 10.1016/j.tcb.2020.08.009; Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Suehiro F, 2011, STEM CELLS DEV, V20, P1540, DOI 10.1089/scd.2010.0279; Takebayashi S, 2015, AGING CELL, V14, P689, DOI 10.1111/acel.12351; Tanaka H, 2020, AGING CELL, V19, DOI 10.1111/acel.13173; Tanaka H, 2017, CELL REP, V18, P2148, DOI 10.1016/j.celrep.2017.02.021; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010; Yamada K, 2003, BIOCHEM J, V373, P167, DOI 10.1042/BJ20021866; You YJ, 2019, CANCER MANAG RES, V11, P1199, DOI 10.2147/CMAR.S184340; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262488	10.1371/journal.pone.0262488	http://dx.doi.org/10.1371/journal.pone.0262488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085309	Green Published, gold			2022-12-26	WOS:000779379600059
J	Rajaraman, S; Ganesan, P; Antani, S				Rajaraman, Sivaramakrishnan; Ganesan, Prasanth; Antani, Sameer			Deep learning model calibration for improving performance in class-imbalanced medical image classification tasks	PLOS ONE			English	Article								In medical image classification tasks, it is common to find that the number of normal samples far exceeds the number of abnormal samples. In such class-imbalanced situations, reliable training of deep neural networks continues to be a major challenge, therefore biasing the predicted class probabilities toward the majority class. Calibration has been proposed to alleviate some of these effects. However, there is insufficient analysis explaining whether and when calibrating a model would be beneficial. In this study, we perform a systematic analysis of the effect of model calibration on its performance on two medical image modalities, namely, chest X-rays and fundus images, using various deep learning classifier backbones. For this, we study the following variations: (i) the degree of imbalances in the dataset used for training; (ii) calibration methods; and (iii) two classification thresholds, namely, default threshold of 0.5, and optimal threshold from precision-recall (PR) curves. Our results indicate that at the default classification threshold of 0.5, the performance achieved through calibration is significantly superior (p < 0.05) to using uncalibrated probabilities. However, at the PR-guided threshold, these gains are not significantly different (p > 0.05). This observation holds for both image modalities and at varying degrees of imbalance. The code is available at https://github.com/sivaramakrishnan-rajaraman/Model_calibration.	[Rajaraman, Sivaramakrishnan; Antani, Sameer] NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Ganesan, Prasanth] Stanford Univ, Dept Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Stanford University	Rajaraman, S (corresponding author), NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	sivaramakrishnan.rajaraman@nih.gov	Antani, Sameer/GVS-8371-2022	Antani, Sameer/0000-0002-0040-1387; Ganesan, Prasanth/0000-0002-1885-0690	Intramural Research Program (IRP) of the National Library of Medicine (NLM); National Institutes of Health (NIH)	Intramural Research Program (IRP) of the National Library of Medicine (NLM); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is supported by the Intramural Research Program (IRP) of the National Library of Medicine (NLM) and the National Institutes of Health (NIH). The intramural research scientists (authors) at the NIH dictated study design, data collection, data analysis, decision to publish and preparation of the manuscript.	Bohning D, 2008, STAT METHODS MED RES, V17, P543, DOI 10.1177/0962280207081867; Carneiro G, 2020, MED IMAGE ANAL, V62, DOI 10.1016/j.media.2020.101653; Cohen I., KNOWLEDGE DISCOVERY, V3202, DOI [10.1007/978-3-540-30116-5_14, DOI 10.1007/978-3-540-30116-5_14]; Esposito C, 2021, J CHEM INF MODEL, V61, P2623, DOI 10.1021/acs.jcim.1c00160; Flach P., 2015, ADV NEURAL INFORM PR, V28, P838, DOI DOI 10.5555/2969239.2969333; Fujiwara K, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00178; Ganesan P, 2019, IEEE ENG MED BIO, P841, DOI 10.1109/EMBC.2019.8857516; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Guo CA, 2017, PR MACH LEARN RES, V70; Guo P, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10070451; He H., IMBALANCED LEARNING; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang GL, 2017, IEEE ICC; Iandola F. N., 2016, CORR ABS160207360, DOI DOI 10.48550/ARXIV.1602.07360; Jaeger S, 2014, QUANT IMAGING MED SU, V4, P475, DOI 10.3978/j.issn.2223-4292.2014.11.20; Jiang XQ, 2012, J AM MED INFORM ASSN, V19, P263, DOI 10.1136/amiajnl-2011-000291; Jiang Xiaoqian, 2011, AMIA Jt Summits Transl Sci Proc, V2011, P16; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kull M, 2017, PR MACH LEARN RES, V54, P623; Liang G., 2020, BRIT MACHINE VISION; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Lucena B., 2018, ABS180907751 CORR; Niculescu-Mizil A., 2005, MACH LEARN P 22 INT, P625, DOI 10.1145/1102351.1102430; Nixon J., 2020, MEASURING CALIBRATIO; Pollastri Federico, 2020, 2020 25th International Conference on Pattern Recognition (ICPR), P1298, DOI 10.1109/ICPR48806.2021.9412685; Qu WD, 2020, INT J COMPUT ASS RAD, V15, P2041, DOI 10.1007/s11548-020-02260-6; Rajaraman S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242301; Sahiner B, 2019, MED PHYS, V46, pe1, DOI 10.1002/mp.13264; Simonyan K., 2015, ICLR; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tan MX, 2019, PR MACH LEARN RES, V97; Wang D, 2019, J BIOPHARM STAT, V29, P98, DOI 10.1080/10543406.2018.1489410; Zamzmi G, 2021, IEEE REV BIOMED ENG, V14, P181, DOI 10.1109/RBME.2020.2988295	33	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262838	10.1371/journal.pone.0262838	http://dx.doi.org/10.1371/journal.pone.0262838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085334	gold, Green Submitted, Green Published			2022-12-26	WOS:000779379600088
J	Di, J; Li, Q				Di, Jie; Li, Qing			A method of detecting apple leaf diseases based on improved convolutional neural network	PLOS ONE			English	Article							IDENTIFICATION; SELECTION	Apple tree diseases have perplexed orchard farmers for several years. At present, numerous studies have investigated deep learning for fruit and vegetable crop disease detection. Because of the complexity and variety of apple leaf veins and the difficulty in judging similar diseases, a new target detection model of apple leaf diseases DF-Tiny-YOLO, based on deep learning, is proposed to realize faster and more effective automatic detection of apple leaf diseases. Four common apple leaf diseases, including 1,404 images, were selected for data modeling and method evaluation, and made three main improvements. Feature reuse was combined with the DenseNet densely connected network and further realized to reduce the disappearance of the deep gradient, thus strengthening feature propagation and improving detection accuracy. We introduced Resize and Re-organization (Reorg) and conducted convolution kernel compression to reduce the calculation parameters of the model, improve the operating detection speed, and allow feature stacking to achieve feature fusion. The network terminal uses convolution kernels of 1 x 1, 1 x 1, and 3 x 3, in turn, to realize the dimensionality reduction of features and increase network depth without increasing computational complexity, thus further improving the detection accuracy. The results showed that the mean average precision (mAP) and average intersection over union (IoU) of the DF-Tiny-YOLO model were 99.99% and 90.88%, respectively, and the detection speed reached 280 FPS. Compared with the Tiny-YOLO and YOLOv2 network models, the new method proposed in this paper significantly improves the detection performance. It can also detect apple leaf diseases quickly and effectively.	[Di, Jie; Li, Qing] Xinjiang Univ, Ctr Innovat Management Res Xinjiang, Sch Econ & Management, Urumqi, Xinjiang, Peoples R China	Xinjiang University	Li, Q (corresponding author), Xinjiang Univ, Ctr Innovat Management Res Xinjiang, Sch Econ & Management, Urumqi, Xinjiang, Peoples R China.	Qing.Li@USherbrooke.ca			National Natural Science Foundation of China [82060265]; Department of Human Resources and Social Security of Xinjiang Uygur Autonomous Region [042419001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Human Resources and Social Security of Xinjiang Uygur Autonomous Region	National Natural Science Foundation of China (82060265)"and "the Department of Human Resources and Social Security of Xinjiang Uygur Autonomous Region (042419001).	Al Bashish Dheeb, 2011, Information Technology Journal, V10, P267, DOI 10.3923/itj.2011.267.275; Babu DRK., 2020, INT J RECENT TECHNOL, V9; Baranwal S, 2019, P INT C SUST COMP SC, P260, DOI DOI 10.2139/SSRN.3351641; Brahimi M, 2017, APPL ARTIF INTELL, V31, P299, DOI 10.1080/08839514.2017.1315516; Di J., 2020, J SHANDONG NORMAL U, V35, P78; Dubey SR, 2016, SIGNAL IMAGE VIDEO P, V10, P819, DOI 10.1007/s11760-015-0821-1; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Gu JX, 2018, PATTERN RECOGN, V77, P354, DOI 10.1016/j.patcog.2017.10.013; Huang GL, 2017, IEEE ICC; Jan M., 2020, International Journal of Agricultural and Environmental Information Systems (IJAEIS), V11, P31, DOI 10.4018/IJAEIS.2020070103; Jiang P, 2019, IEEE ACCESS, V7, P59069, DOI 10.1109/ACCESS.2019.2914929; Khan A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243243; Khan MA, 2018, COMPUT ELECTRON AGR, V155, P220, DOI 10.1016/j.compag.2018.10.013; Kogilavani SV., 2019, INT J INNOVATIVE TEC, V8; Krizhevsky A., 2012, ADV NEURAL INF PROCE; [李宗儒 Li Zongru], 2010, [计算机工程与设计, Computer Engineering and Design], V31, P3051; Liu B, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10010011; Liu W, 2016, LECT NOTES COMPUT SC, V9905, P21, DOI 10.1007/978-3-319-46448-0_2; Mehta R., 2018, 2018 3 INT C CONV TE, P1; Omrani E, 2014, MEASUREMENT, V55, P512, DOI 10.1016/j.measurement.2014.05.033; Priyadharshini RA, 2019, NEURAL COMPUT APPL, V31, P8887, DOI 10.1007/s00521-019-04228-3; Redmon J, 2017, PROC CVPR IEEE, P6517, DOI 10.1109/CVPR.2017.690; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Rong-Ming HU., 2012, J NW F U NATURAL SCI; Shuaibu M, 2018, COMPUT ELECTRON AGR, V148, P45, DOI 10.1016/j.compag.2017.09.038; Suganthy KB, 2019, J TREND SCI RES DEV, V3; Sun HN, 2021, COMPUT ELECTRON AGR, V189, DOI 10.1016/j.compag.2021.106379; Voulodimos A, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/7068349; Xu YW, 2013, BIOSYST ENG, V115, P144, DOI 10.1016/j.biosystemseng.2013.03.011; Xue YueJu, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P173, DOI 10.11975/j.issn.1002-6819.2018.07.022; Yu HJ, 2020, J IMAGING SCI TECHN, V64, DOI 10.2352/J.ImagingSci.Technol.2020.64.2.020507; Yu Xiao, 2020, Journal of Northeast Agricultural University (English Edition), V27, P9; Zhang CL, 2017, INT J AGR BIOL ENG, V10, P74, DOI 10.3965/j.ijabe.20171002.2166; Zhang QR, 2019, NEUROCOMPUTING, V323, P37, DOI 10.1016/j.neucom.2018.09.038; Zhang SW, 2019, COMPUT ELECTRON AGR, V162, P422, DOI 10.1016/j.compag.2019.03.012; Zhao CQ, 2020, SCI CHINA TECHNOL SC, V63, P1612, DOI 10.1007/s11431-020-1582-8; Zhong Y, 2020, COMPUT ELECTRON AGR, V168, DOI 10.1016/j.compag.2019.105146; Zhu JJ, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.695749	40	1	1	17	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0262629	10.1371/journal.pone.0262629	http://dx.doi.org/10.1371/journal.pone.0262629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104299	gold, Green Published			2022-12-26	WOS:000749789300001
J	Chen, GX; Li, Q; Yan, JS				Chen, Guanxing; Li, Qin; Yan, Jiusheng			The leucine-rich repeat domains of BK channel auxiliary ? subunits regulate their expression, trafficking, and channel-modulation functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; BETA-SUBUNITS; POTASSIUM CHANNELS; MOLECULAR-BASIS; VOLTAGE; STOICHIOMETRY; CURRENTS; PROTEIN; ALPHA	As high-conductance calcium-and voltage-dependent potassium channels, BK channels consist of pore-forming, voltage-, and Ca2+-sensing alpha and auxiliary subunits. The leucine-rich repeat (LRR) domain-containing auxiliary gamma subunits potently modulate the voltage dependence of BK channel activation. Despite their dominant size in whole protein masses, the function of the LRR domain in BK channel gamma subunits is unknown. We here investigated the function of these LRR domains in BK channel modulation by the auxiliary gamma 1-3 (LRRC26, LRRC52, and LRRC55) subunits. Using cell surface protein immunoprecipitation, we validated the predicted extracellular localization of the LRR domains. We then refined the structural models of mature proteins on the membrane via molecular dynamic simulations. By replacement of the LRR domain with extracellular regions or domains of non-LRR proteins, we found that the LRR domain is nonessential for the maximal channel-gating modulatory effect but is necessary for the all-or-none phenomenon of BK channel modulation by the gamma 1 subunit. Mutational and enzymatic blockade of N-glycosylation in the gamma 1-3 subunits resulted in a reduction or loss of BK channel modulation by gamma subunits. Finally, by analyzing their expression in whole cells and on the plasma membrane, we found that blockade of N-glycosylation drastically reduced total expression of the gamma 2 subunit and the cell surface expression of the gamma 1 and gamma 3 subunits. We conclude that the LRR domains play key roles in the regulation of the expression, cell surface trafficking, and channel-modulation functions of the BK channel gamma subunits.	[Chen, Guanxing; Li, Qin; Yan, Jiusheng] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Yan, Jiusheng] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Grad Programs Neurosci & Biochem & Cell Biol, Houston, TX 77030 USA; [Li, Qin] Penn State Univ, Coll Med, Heart & Vasc Inst, Hershey, PA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yan, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA.; Yan, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Grad Programs Neurosci & Biochem & Cell Biol, Houston, TX 77030 USA.	jyan1@mdanderson.org			National Institutes of Health [NS078152]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by National Institutes of Health grants NS078152 (J. Y.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedford C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00035; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brody MJ, 2016, AM J PHYSIOL-HEART C, V310, pH269, DOI 10.1152/ajpheart.00717.2014; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Carrasquel-Ursulaez W, 2018, BIOPHYS J, V114, P2493, DOI 10.1016/j.bpj.2018.04.008; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Dudem S, 2020, P NATL ACAD SCI USA, V117, P2194, DOI 10.1073/pnas.1916715117; Gonzalez-Perez V., 2021, PROC NATL; Gonzalez-Perez V, 2019, ANNU REV PHYSIOL, V81, P113, DOI 10.1146/annurev-physiol-022516-034038; Gonzalez-Perez V, 2018, P NATL ACAD SCI USA, V115, P9923, DOI 10.1073/pnas.1804560115; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Guan X, 2017, SCI REP-UK, V7, DOI 10.1038/srep42240; Hagen BM, 2006, AM J PHYSIOL-CELL PH, V291, pC750, DOI 10.1152/ajpcell.00116.2006; Huang ZG, 2017, CHANNELS, V11, P156, DOI 10.1080/19336950.2016.1243631; Khan HM, 2019, J CHEM THEORY COMPUT, V15, P7, DOI 10.1021/acs.jctc.8b00839; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Lee J., 2016; Li Q, 2016, INT REV NEUROBIOL, V128, P51, DOI 10.1016/bs.irn.2016.03.015; Li Q, 2016, J GEN PHYSIOL, V147, P337, DOI 10.1085/jgp.201511551; Li Q, 2015, J GEN PHYSIOL, V145, P543, DOI 10.1085/jgp.201511356; Lingle CJ, 2019, P NATL ACAD SCI USA, V116, P18397, DOI 10.1073/pnas.1907065116; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Murray CI, 2016, ELIFE, V5, DOI 10.7554/eLife.11815; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Noda S, 2020, BIOL PHARM BULL, V43, P1118, DOI 10.1248/bpb.b20-00125; Peltola MA, 2011, EMBO REP, V12, P1293, DOI 10.1038/embor.2011.204; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; Sausbier M., 2004, CEREBELLAR ATAXIA PU; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Szent-Gyorgyi C, 2013, J MOL BIOL, V425, P4595, DOI 10.1016/j.jmb.2013.08.014; Tao X, 2019, ELIFE, V8, DOI 10.7554/eLife.51409; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Typlt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081270; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wang XL, 2021, J VENOM ANIM TOXINS, V27, DOI [10.1590/1678-9199-jvatitd-2020-0182, 10.1590/1678-9199-JVATITD-2020-0182]; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Xia XM, 2000, J NEUROSCI, V20, P4890; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang CT, 2017, P NATL ACAD SCI USA, V114, pE3739, DOI 10.1073/pnas.1703081114; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2015, P NATL ACAD SCI USA, V112, P2599, DOI 10.1073/pnas.1423869112; Zhang JY, 2018, P NATL ACAD SCI USA, V115, pE9006, DOI 10.1073/pnas.1802567115	57	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101664	10.1016/j.jbc.2022.101664	http://dx.doi.org/10.1016/j.jbc.2022.101664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35104503	gold, Green Published			2022-12-26	WOS:000791230900002
J	Malik, M; Fang, YY; Wakle-Prabagaran, M; Roh, M; Prifti, K; Frolova, AI; Imoukhuede, PI; England, SK				Malik, Manasi; Fang, Yingye; Wakle-Prabagaran, Monali; Roh, Michelle; Prifti, Kevin; Frolova, Antonina, I; Imoukhuede, Princess I.; England, Sarah K.			Pharmacological chaperones for the oxytocin receptor increase oxytocin responsiveness in myometrial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL-FETAL MEDICINE; MEMBRANE-PERMEABILITY; SURFACE EXPRESSION; FUNCTIONAL RESCUE; CESAREAN DELIVERY; IN-VITRO; VASOPRESSIN; PHARMACOCHAPERONES; SELECTIVITY; POTENT	Oxytocin is a potent uterotonic agent administered to nearly all patients during childbirth in the United States. Inadequate oxytocin response can necessitate Cesarean delivery or lead to uterine atony and postpartum hemorrhage. Thus, it may be clinically useful to identify patients at risk for poor oxytocin response and develop strategies to sensitize the uterus to oxytocin. Previously, we showed that the V281M variant in the oxytocin receptor (OXTR) gene impairs OXTR trafficking to the cell surface, leading to a decreased oxytocin response in cells. Here, we sought to identify pharmacological chaperones that increased oxytocin response in cells expressing WT or V281M OXTR. We screened nine small-molecule agonists and antagonists of the oxytocin/vasopressin receptor family and identified two, SR49059 and L371,257, that restored both OXTR trafficking and oxytocin response in HEK293T cells transfected with V281M OXTR. In hTERT-immortalized human myometrial cells, which endogenously express WT OXTR, treatment with SR49059 and L371,257 increased the amount of OXTR on the cell surface by two-to fourfold. Furthermore, SR49059 and L371,257 increased the endogenous oxytocin response in hTERT-immortalized human myometrial cells by 35% and induced robust oxytocin responses in primary myometrial cells obtained from patients at the time of Cesarean section. If future studies demonstrate that these pharmacological chaperones or related compounds function similarly in vivo, we propose that they could potentially be used to enhance clinical response to oxytocin.	[Malik, Manasi; Wakle-Prabagaran, Monali; Roh, Michelle; Prifti, Kevin; Frolova, Antonina, I; England, Sarah K.] Washington Univ, Ctr Reprod Hlth Sci, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Fang, Yingye; Imoukhuede, Princess I.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	England, SK (corresponding author), Washington Univ, Ctr Reprod Hlth Sci, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	englands@wustl.edu		Fang, Yingye/0000-0003-4137-866X; England, Sarah/0000-0003-4247-0281; Malik, Manasi/0000-0002-4203-962X	National Institute of Child Health and Human Development [R01 HD096737, F30 HD097925]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the National Institute of Child Health and Human Development (R01 HD096737 to S. K. E. and P. I. I., and F30 HD097925 to M. M.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130; Bennion BJ, 2017, J PHYS CHEM B, V121, P5228, DOI 10.1021/acs.jpcb.7b02914; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen S, 2017, METHODS MOL BIOL, V1570, P117, DOI 10.1007/978-1-4939-6840-4_8; Committee on Practice Bulletins-Obstetrics, 2017, Obstet Gynecol, V130, pe168, DOI 10.1097/AOG.0000000000002351; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Frantz MC, 2010, J MED CHEM, V53, P1546, DOI 10.1021/jm901084f; Frey HA, 2015, J MATERN-FETAL NEO M, V28, P1614, DOI 10.3109/14767058.2014.963046; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Griffante C, 2005, BRIT J PHARMACOL, V146, P744, DOI 10.1038/sj.bjp.0706383; Hall DA, 2010, BRIT J PHARMACOL, V161, P1276, DOI 10.1111/j.1476-5381.2010.00879.x; Hammad IA, 2014, J MATERN-FETAL NEO M, V27, P463, DOI 10.3109/14767058.2013.818970; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Iijima M, 2014, BRIT J PHARMACOL, V171, P3511, DOI 10.1111/bph.12699; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kondo K, 1999, BIOORGAN MED CHEM, V7, P1743, DOI 10.1016/S0968-0896(99)00101-7; Malik M, 2021, ACS PHARMACOL TRANSL, V4, P1543, DOI 10.1021/acsptsci.1c00095; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; MEDDINGS JB, 1989, AM J PHYSIOL, V257, pG982, DOI 10.1152/ajpgi.1989.257.6.G982; MILLER RR, 1975, NEW ENGL J MED, V293, P416, DOI 10.1056/NEJM197508282930902; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mouillac B, 2018, HANDB EXP PHARMACOL, V245, P63, DOI 10.1007/164_2017_50; Nasrollahi-Shirazi S, 2016, J PHARMACOL EXP THER, V359, P73, DOI 10.1124/jpet.116.232884; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Pergialiotis V, 2020, EUR J OBSTET GYN R B, V252, P62, DOI 10.1016/j.ejogrb.2020.06.018; Refsgaard HHF, 2005, J MED CHEM, V48, P805, DOI 10.1021/jm049661n; Ring RH, 2010, NEUROPHARMACOLOGY, V58, P69, DOI [10.1016/j.neuropharm.2009.07.016, 10.1016/j.neuropharm.2009.08.015]; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Spong CY, 2013, OBSTET GYNECOL, V121, P687, DOI 10.1097/AOG.0b013e3182854b36; Tahara A, 2000, BRIT J PHARMACOL, V129, P131, DOI 10.1038/sj.bjp.0702996; Tahara A, 1997, J PHARMACOL EXP THER, V282, P301; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; WILLIAMS PD, 1995, J MED CHEM, V38, P4634, DOI 10.1021/jm00023a002; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	38	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101646	10.1016/j.jbc.2022.101646	http://dx.doi.org/10.1016/j.jbc.2022.101646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093385	gold, Green Published			2022-12-26	WOS:000789261900014
J	Raeeszadeh-Sarmazdeh, M; Coban, M; Mahajan, S; Hockla, A; Sankaran, B; Downey, GP; Radisky, DC; Radisky, ES				Raeeszadeh-Sarmazdeh, Maryam; Coban, Mathew; Mahajan, Shivansh; Hockla, Alexandra; Sankaran, Banumathi; Downey, Gregory P.; Radisky, Derek C.; Radisky, Evette S.			Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; MODERATES INFLAMMATION; MOLECULAR REPLACEMENT; THERAPEUTIC TARGETS; PROTECTIVE ROLES; TERMINAL DOMAIN; GELATINASE-B; MATRIX-METALLOPROTEINASE-9; CANCER; DEFICIENCY	Matrix metalloproteinases (MMPs) have long been known as key drivers in the development and progression of diseases, including cancer and neurodegenerative, cardiovascular, and many other inflammatory and degenerative diseases, making them attractive potential drug targets. Engineering selective inhibitors based upon tissue inhibitors of metalloproteinases (TIMPs), endogenous human proteins that tightly yet nonspecifically bind to the family of MMPs, represents a promising new avenue for therapeutic development. Here, we used a counter-selective screening strategy for directed evolution of yeast-displayed human TIMP-1 to obtain TIMP-1 variants highly selective for the inhibition of MMP-3 in preference over MMP-10. As MMP-3 and MMP-10 are the most similar MMPs in sequence, structure, and function, our results thus clearly demonstrate the capability for engineering full-length TIMP proteins to be highly selective MMP inhibitors. We show using protein crystal structures and models of MMP-3-selective TIMP-1 variants bound to MMP-3 and counter-target MMP10 how structural alterations within the N-terminal and C-terminal TIMP-1 domains create new favorable and selective interactions with MMP-3 and disrupt unique interactions with MMP-10. While our MMP-3-selective inhibitors may be of interest for future investigation in diseases where this enzyme drives pathology, our platform and screening strategy can be employed for developing selective inhibitors of additional MMPs implicated as therapeutic targets in disease.	[Raeeszadeh-Sarmazdeh, Maryam; Coban, Mathew; Mahajan, Shivansh; Hockla, Alexandra; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Div Mol Biophys & Integrated Bioimaging, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO USA; [Downey, Gregory P.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Downey, Gregory P.] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Raeeszadeh-Sarmazdeh, Maryam] Univ Nevada, Dept Chem & Mat Engn, Reno, NV 89557 USA; [Mahajan, Shivansh] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Nevada System of Higher Education (NSHE); University of Nevada Reno; California Institute of Technology	Radisky, ES (corresponding author), Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu		Radisky, Evette/0000-0003-3121-109X	US National Institutes of Health [R01 GM132100, R01 CA258274, R01 HL157424]; US Department of Defense [W81XWH-16-2-0030]; National Institutes of Health [P20 GM103650]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grants (R01 GM132100 and R01 CA258274 [to E. S. R.], R01 HL157424 [to G. P. D., D. C. R., and E. S. R.]) and US Department of Defense grant (grant no.: W81XWH-16-2-0030 [to G. P. D. and D. C. R.]). M. R.-S. is supported in part by National Institutes of Health grant (grant no.: P20 GM103650). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine P. V., 2005, CCP4 NEWSL, V42, P42; Albaiceta GM, 2008, AM J PHYSIOL-LUNG C, V294, pL535, DOI 10.1152/ajplung.00334.2007; Arkadash Valeria, 2018, Oncotarget, V9, P32036, DOI 10.18632/oncotarget.25885; Arkadash V, 2017, J BIOL CHEM, V292, P3481, DOI 10.1074/jbc.M116.756718; Artham S, 2020, CYTOKINE, V131, DOI 10.1016/j.cyto.2020.155086; Artham S, 2019, PHARMACOL RES, V141, P249, DOI 10.1016/j.phrs.2019.01.006; Batra J., 2014, ENCY INORGANIC BIOIN, P1; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Cabrera S, 2019, AM J PHYSIOL-LUNG C, V316, pL961, DOI 10.1152/ajplung.00455.2017; Coban M. A., 2021, BIOMOLECULES, V11, P787; Cohen I, 2019, J BIOL CHEM, V294, P5105, DOI 10.1074/jbc.RA118.007292; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Craig VJ, 2015, AM J RESP CELL MOL, V53, P585, DOI 10.1165/rcmb.2015-0020TR; Crombez L, 2005, BIOCHEM BIOPH RES CO, V337, P908, DOI 10.1016/j.bbrc.2005.09.136; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Fingleton B, 2017, BBA-MOL CELL RES, V1864, P2036, DOI 10.1016/j.bbamcr.2017.05.010; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Green MJ, 2003, RHEUMATOLOGY, V42, P83, DOI 10.1093/rheumatology/keg037; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Kassim SY, 2007, INFECT IMMUN, V75, P5640, DOI 10.1128/IAI.00799-07; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Konning D, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0881-3; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuhlman B, 2019, NAT REV MOL CELL BIO, V20, P681, DOI 10.1038/s41580-019-0163-x; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McMahan RS, 2016, J IMMUNOL, V197, P899, DOI 10.4049/jimmunol.1600502; McPherson A, 2014, ACTA CRYSTALLOGR F, V70, P1445, DOI 10.1107/S2053230X14019670; Mehner C, 2014, MOL CANCER RES, V12, P1430, DOI 10.1158/1541-7786.MCR-13-0557-T; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nerusu KC, 2007, EXP MOL PATHOL, V83, P169, DOI 10.1016/j.yexmp.2007.04.003; Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Puntorieri V, 2016, EXP LUNG RES, V42, P365, DOI 10.1080/01902148.2016.1231243; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Radisky ES, 2017, J CELL BIOCHEM, V118, P3531, DOI 10.1002/jcb.26185; Radisky ES, 2015, FRONT BIOSCI-LANDMRK, V20, P1144, DOI 10.2741/4364; Raeeszadeh-Sarmazdeh M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051313; Raeeszadeh-Sarmazdeh M, 2019, J BIOL CHEM, V294, P9476, DOI 10.1074/jbc.RA119.008321; Razai AS, 2020, J BIOL CHEM, V295, P2464, DOI 10.1074/jbc.RA119.011712; Sen AI, 2010, EXP LUNG RES, V36, P615, DOI 10.3109/01902148.2010.497201; Shirian J, 2018, FEBS LETT, V592, P1122, DOI 10.1002/1873-3468.13016; Stallings-Mann ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004062; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandivort TC, 2017, INT J NANOMED, V12, P1019, DOI 10.2147/IJN.S123484; Wang YJ, 2021, CHEM REV, V121, P12384, DOI 10.1021/acs.chemrev.1c00260; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Yamashita CM, 2016, CAN J PHYSIOL PHARM, V94, P682, DOI 10.1139/cjpp-2015-0377; Yamashita CM, 2014, EXPERT REV RESP MED, V8, P411, DOI 10.1586/17476348.2014.909288; Yamashita CM, 2011, AM J PATHOL, V179, P1733, DOI 10.1016/j.ajpath.2011.06.041; Yoon HK, 2007, ENVIRON HEALTH PERSP, V115, P1557, DOI 10.1289/ehp.10289; Yosef G, 2018, J BIOL CHEM, V293, P13310, DOI 10.1074/jbc.RA118.004406; Yu GY, 2012, AM J RESP CRIT CARE, V186, P752, DOI 10.1164/rccm.201202-0302OC	80	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101654	10.1016/j.jbc.2022.101654	http://dx.doi.org/10.1016/j.jbc.2022.101654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101440	gold, Green Accepted, Green Published			2022-12-26	WOS:000794865600006
J	Uppala, JK; Sathe, L; Chakraborty, A; Bhattacharjee, S; Pulvino, AT; Dey, M				Uppala, Jagadeesh Kumar; Sathe, Leena; Chakraborty, Abhijit; Bhattacharjee, Sankhajit; Pulvino, Anthony Thomas; Dey, Madhusudan			The cap-proximal RNA secondary structure inhibits preinitiation complex formation on HAC1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; GENOME-WIDE ANALYSIS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; TRANSLATION INITIATION; MECHANISM; HAC1; REVEALS	Translation of HAC1 mRNA in the budding yeast Saccharomyces cerevisiae is derepressed when RNase Ire1 removes its intron via nonconventional cytosolic splicing in response to accumulation of unfolded proteins inside the endoplasmic reticulum. The spliced HAC1 mRNA is translated into a transcription factor that changes the cellular gene expression patterns to increase the protein folding capacity of cells. Previously, we showed that a segment of the intronic sequence interacts with the 5'-UTR of the unspliced mRNA, resulting in repression of HAC1 translation at the initiation stage. However, the exact mechanism of translational derepression is not clear. Here, we show that at least 11-base-pairing interactions between the 5'-UTR and intron (UI) are sufficient to repress HAC1 translation. We also show that overexpression of the helicase eukaryotic initiation factor 4A derepressed translation of an unspliced HAC1 mRNA containing only 11-bp interactions between the 5'-UTR and intronic sequences. In addition, our genetic screen identifies that single mutations in the UI interaction site could derepress translation of the unspliced HAC1 mRNA. Furthermore, we show that the addition of 24 RNA bases between the mRNA 5'-cap and the UI interaction site derepressed translation of the unspliced HAC1 mRNA. Together, our data provide a mechanistic explanation for why the cap-proximal UI-RNA duplex inhibits the recruitment of translating ribosomes to HAC1 mRNA, thus keeping mRNA translationally repressed.	[Uppala, Jagadeesh Kumar; Sathe, Leena; Bhattacharjee, Sankhajit; Pulvino, Anthony Thomas; Dey, Madhusudan] Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI USA; [Chakraborty, Abhijit] La Jolla Inst Immunol, Ctr Autoimmun & Inflammat, Ctr Canc Immunotherapy, La Jolla, CA USA	University of Wisconsin System; University of Wisconsin Milwaukee; La Jolla Institute for Immunology	Dey, M (corresponding author), Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI USA.	deym@uwm.edu	Uppala, Jagadeesh/AAY-7265-2021	Uppala, Jagadeesh/0000-0002-3653-0316	National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA [1R01GM124183]	National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA	This work was supported partly by grant from the National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA (grant no.: 1R01GM124183; to M. D.) . The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2018, ELIFE, V7, DOI 10.7554/eLife.43036; Amin-ul Mannan M, 2013, J MOL BIOL, V425, P2083, DOI 10.1016/j.jmb.2013.02.036; Andreev DE, 2017, NUCLEIC ACIDS RES, V45, P513, DOI 10.1093/nar/gkw1190; Bevilacqua PC, 2016, ANNU REV GENET, V50, P235, DOI 10.1146/annurev-genet-120215-035034; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dever TE, 2016, GENETICS, V203, P65, DOI 10.1534/genetics.115.186221; Di Santo R, 2016, ELIFE, V5, DOI 10.7554/eLife.20069; Elfakess R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003094; Gao ZF, 2016, ELIFE, V5, DOI 10.7554/eLife.16408; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Haimov O, 2015, BBA-GENE REGUL MECH, V1849, P1313, DOI 10.1016/j.bbagrm.2015.09.006; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hooks KB, 2011, RNA BIOL, V8, P552, DOI 10.4161/rna.8.4.15396; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iracane E, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00532-18; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sathe L, 2015, J BIOL CHEM, V290, P21821, DOI 10.1074/jbc.M115.649335; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Uppala JK, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00662-20; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Weenink T, 2018, SYN BIOL, V3, DOI 10.1093/synbio/ysy019; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001	45	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101648	10.1016/j.jbc.2022.101648	http://dx.doi.org/10.1016/j.jbc.2022.101648			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35101452	Green Published, gold			2022-12-26	WOS:000789261900016
J	Arroyo, J; Marini, TJ; Saavedra, AC; Toscano, M; Baran, TM; Drennan, K; Dozier, A; Zhao, YT; Egoavil, M; Tamayo, L; Ramos, B; Castaneda, B				Arroyo, Junior; Marini, Thomas J.; Saavedra, Ana C.; Toscano, Marika; Baran, Timothy M.; Drennan, Kathryn; Dozier, Ann; Zhao, Yu Tina; Egoavil, Miguel; Tamayo, Lorena; Ramos, Berta; Castaneda, Benjamin			No sonographer, no radiologist: New system for automatic prenatal detection of fetal biometry, fetal presentation, and placental location	PLOS ONE			English	Article							COUNTRIES	Ultrasound imaging is a vital component of high-quality Obstetric care. In rural and under-resourced communities, the scarcity of ultrasound imaging results in a considerable gap in the healthcare of pregnant mothers. To increase access to ultrasound in these communities, we developed a new automated diagnostic framework operated without an experienced sonographer or interpreting provider for assessment of fetal biometric measurements, fetal presentation, and placental position. This approach involves the use of a standardized volume sweep imaging (VSI) protocol based solely on external body landmarks to obtain imaging without an experienced sonographer and application of a deep learning algorithm (U-Net) for diagnostic assessment without a radiologist. Obstetric VSI ultrasound examinations were performed in Peru by an ultrasound operator with no previous ultrasound experience who underwent 8 hours of training on a standard protocol. The U-Net was trained to automatically segment the fetal head and placental location from the VSI ultrasound acquisitions to subsequently evaluate fetal biometry, fetal presentation, and placental position. In comparison to diagnostic interpretation of VSI acquisitions by a specialist, the U-Net model showed 100% agreement for fetal presentation (Cohen's kappa 1 (p<0.0001)) and 76.7% agreement for placental location (Cohen's kappa 0.59 (p<0.0001)). This corresponded to 100% sensitivity and specificity for fetal presentation and 87.5% sensitivity and 85.7% specificity for anterior placental location. The method also achieved a low relative error of 5.6% for biparietal diameter and 7.9% for head circumference. Biometry measurements corresponded to estimated gestational age within 2 weeks of those assigned by standard of care examination with up to 89% accuracy. This system could be deployed in rural and underserved areas to provide vital information about a pregnancy without a trained sonographer or interpreting provider. The resulting increased access to ultrasound imaging and diagnosis could improve disparities in healthcare delivery in under-resourced areas.	[Arroyo, Junior; Saavedra, Ana C.; Castaneda, Benjamin] Pontificia Univ Catolica Peru, Dept Ingn, Lab Imagenes Med, Lima, Peru; [Marini, Thomas J.; Baran, Timothy M.; Zhao, Yu Tina; Ramos, Berta] Univ Rochester, Med Ctr, Dept Imaging Sci, Rochester, NY 14642 USA; [Toscano, Marika; Drennan, Kathryn] Univ Rochester, Med Ctr, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Dozier, Ann] Univ Rochester, Med Ctr, Dept Publ Hlth, Rochester, NY 14642 USA; [Egoavil, Miguel; Tamayo, Lorena] Med Innovat & Technol, Res & Dev, Lima, Peru	Pontificia Universidad Catolica del Peru; University of Rochester; University of Rochester; University of Rochester	Castaneda, B (corresponding author), Pontificia Univ Catolica Peru, Dept Ingn, Lab Imagenes Med, Lima, Peru.	castaneda.b@pucp.edu.pe		Saavedra Bazan, Ana Cecilia/0000-0002-3960-3314; Castaneda, Benjamin/0000-0002-1913-0636	Innovate Peru [409-FIDECOM INNOVATEPERU-PVE-2017]; Pontifical Catholic University of Peru (Periodos de Investigacion 2020) from Benjamin Castaneda	Innovate Peru; Pontifical Catholic University of Peru (Periodos de Investigacion 2020) from Benjamin Castaneda	The authors acknowledge the following funding sources: Innovate Peru (409-FIDECOM INNOVATEPERU-PVE-2017) and Pontifical Catholic University of Peru (Periodos de Investigacio ' n 2020) from Benjamin Castaneda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At the time of the study, Miguel Egoavil, Lorena Tamayo, and Benjamin Castaneda were employed by the company Medical Innovation and Technology which seeks to bring ultrasound to rural areas. The funder provided support in the form of salaries for authors ME, LT, and BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. They only provided support in the form of author salaries and access to the ultrasound imaging used in the study.	Arnaout R, 2021, NAT MED, V27, P882, DOI 10.1038/s41591-021-01342-5; Baumgartner CF, 2017, IEEE T MED IMAGING, V36, P2204, DOI 10.1109/TMI.2017.2712367; Chen H, 2017, IEEE T CYBERNETICS, V47, P1576, DOI 10.1109/TCYB.2017.2685080; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Clinical Stand Comm, 2019, ULTRASOUND OBST GYN, V53, P715, DOI 10.1002/uog.20272; Cresswell JA, 2013, TROP MED INT HEALTH, V18, P712, DOI 10.1111/tmi.12100; de Sanjose S, 2019, INT J WOMENS HEALTH, V11, P381, DOI 10.2147/IJWH.S197115; Girum Tadele, 2017, Matern Health Neonatol Perinatol, V3, P19, DOI 10.1186/s40748-017-0059-8; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Ioffe S., 2015, P INT C MACH LEARN L, P448; Kingma D.P., 2015, C PAP ICLR 2015; Lan L, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00164; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lindfors KK, 2010, RADIOL CLIN N AM, V48, P1043, DOI 10.1016/j.rcl.2010.06.001; Liu SF, 2019, ENGINEERING-PRC, V5, P261, DOI 10.1016/j.eng.2018.11.020; Marini TJ, 2021, J ENDOCRINOL INVEST, V44, P2699, DOI 10.1007/s40618-021-01584-7; Marini TJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255919; Marini TJ, 2021, J ULTRAS MED, V40, P583, DOI 10.1002/jum.15420; Marini TJ, 2019, J CLIN IMAG SCI, V9, DOI 10.25259/JCIS_29_2019; McCannon CJ, 2007, JAMA-J AM MED ASSOC, V298, P1937, DOI 10.1001/jama.298.16.1937; Mollura DJ, 2013, J AM COLL RADIOL, V10, P618, DOI 10.1016/j.jacr.2013.01.019; Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736; Pellerito J, 2018, J ULTRAS MED, V37, pE13, DOI 10.1002/jum.14831; Perrin D., 2017, APPL CONVOLUTIONAL A; Roberts M, 2006, JAMA-J AM MED ASSOC, V295, P1491, DOI 10.1001/jama.295.13.1491; Ronneberger O., 2015, MED IMAGE COMPUTING, DOI [DOI 10.48550/ARXIV.1505.04597, DOI 10.1007/978-3-319-24574-4_28], Patent No. [ArXiv150504597Cs, 150504597]; Rueda S, 2014, IEEE T MED IMAGING, V33, P797, DOI 10.1109/TMI.2013.2276943; Saavedra AC., 2020, 2020 IEEE INT ULTRAS; Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831; Small MJ, 2017, SEMIN PERINATOL, V41, P318, DOI 10.1053/j.semperi.2017.04.009; Toscano Marika, 2021, BMC Pregnancy Childbirth, V21, P328, DOI 10.1186/s12884-021-03720-w; van den Heuvel TLA, 2019, ULTRASOUND MED BIOL, V45, P773, DOI 10.1016/j.ultrasmedbio.2018.09.015; van den Heuvel TLA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200412; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Xie HN, 2020, ULTRASOUND OBST GYN, V56, P579, DOI 10.1002/uog.21967	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262107	10.1371/journal.pone.0262107	http://dx.doi.org/10.1371/journal.pone.0262107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139093	gold, Green Published			2022-12-26	WOS:000821499100004
J	Hamzeh, H; Spencer, S; Kelly, C				Hamzeh, Hayat; Spencer, Sally; Kelly, Carol			Development of a core outcome set and outcome measurement set for physiotherapy trials in adults with Bronchiectasis (COS-PHyBE study): A protocol	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; MORTALITY; UK	Background Bronchiectasis is a chronic respiratory disease characterised by airways widening and recurrent infections, resulting in episodes of chronic cough, sputum expectoration, and dyspnoea. This leads to deterioration in daily function, repeated hospital admissions and poor quality of life. The prevalence and mortality related to bronchiectasis is increasing worldwide with growing economic burden on healthcare systems. Physiotherapy for bronchiectasis aims to decrease accumulation of sputum, dyspnoea, and improve exercise capacity and daily function. A robust evidence base to support physiotherapy in bronchiectasis is currently lacking. This is partly because of inconsistency and poor reporting of outcomes in available studies. A core outcome set is the minimum acceptable group of outcomes that should be used in clinical trials for a specific condition. This decreases research waste by improving consistency and reporting of key outcomes and facilitates the synthesis of study outcomes in systematic reviews and guidelines. The aim of the study is therefore to develop a core outcome set and outcome measurement set for physiotherapy research in adults with bronchiectasis. This will ensure outcomes important to key stakeholders are consistently used and reported in future research. Methods and analysis This project will use the COMET Initiative and COSMIN guidelines of core outcome set development and will include three phases. In the first phase, a comprehensive list of outcomes will be developed using systematic review of reported outcomes and qualitative interviews with patients and physiotherapists. Then consensus on key outcomes will be established in phase two using a Delphi survey and a consensus meeting. Finally, in phase three, we will identify appropriate instruments to measure the core outcomes by evaluating the psychometric properties of available instruments and a stakeholders' meeting to establish consensus.	[Hamzeh, Hayat; Spencer, Sally; Kelly, Carol] Edge Hill Univ, Fac Hlth Social Care & Med, Ormskirk, England; [Spencer, Sally; Kelly, Carol] Edge Hill Univ, Resp Res Ctr, Ormskirk, Lancs, England; [Spencer, Sally] Edge Hill Univ, Hlth Res Inst, Ormskirk, Lancs, England	Edge Hill University; Edge Hill University; Edge Hill University	Hamzeh, H (corresponding author), Edge Hill Univ, Fac Hlth Social Care & Med, Ormskirk, England.	hamzehh@edgehill.ac.uk	Hamzeh, Hayat/U-3249-2019	Hamzeh, Hayat/0000-0002-1074-2599; Kelly, Carol/0000-0002-9927-1382	Edge Hill University	Edge Hill University	HH has a Graduate Teaching Assistant studentship from Edge Hill University for this doctoral research. https://www.edgehill.ac.uk/The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti S, 2016, EUR RESPIR J, V48, P632, DOI 10.1183/13993003.01888-2015; Aliberti S, 2016, EUR RESPIR J, V47, P1113, DOI 10.1183/13993003.01899-2015; Blanchette Christopher M, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040020; Bott J, 2009, THORAX, V64, P1, DOI 10.1136/thx.2008.110726; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chandrasekaran R, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0638-0; Diel R, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02033-2018; Dodd S, 2018, J CLIN EPIDEMIOL, V96, P84, DOI 10.1016/j.jclinepi.2017.12.020; Dudgeon EK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0631-7; Gargon E, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0209869, 10.1371/journal.pone.0225980]; Goeminne PC, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0818-6; Hill AT, 2019, THORAX, V74, P1, DOI 10.1136/thoraxjnl-2018-212463; Hill AT., 2018, BRIT THORACIC SOC RE, V9; Hsu C.C, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [DOI 10.7275/PDZ9-TH90, 10.7275/pdz9-th90]; Kelly C, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012528.pub2; Kirkham JJ, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3230-x; Kirkham JJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002447; Lee AL, 2017, ARCH PHYS MED REHAB, V98, P774, DOI 10.1016/j.apmr.2016.05.017; Lee AL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008351.pub3; Lee AL, 2015, CHRON RESP DIS, V12, P36, DOI 10.1177/1479972314562407; McDonnell MJ, 2016, LANCET RESP MED, V4, P969, DOI 10.1016/S2213-2600(16)30320-4; O'Neill B, 2002, INT J CLIN PRACT, V56, P34; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Phillips Jennifer, 2021, Arch Physiother, V11, P3, DOI 10.1186/s40945-020-00097-5; Phillips J, 2020, PHYSIOTHER THEOR PR, V36, P1300, DOI 10.1080/09593985.2019.1579286; Prinsen CAC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1555-2; QSR International Pty L, 2020, NVIVO RELEASED MARCH; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Spargo M, 2018, CHRON RESP DIS, V16, DOI 10.1177/1479972318804167; Spinou A, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01610-2019; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; Welsh EJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010337.pub2; Williamson PR, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1978-4; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263695	10.1371/journal.pone.0263695	http://dx.doi.org/10.1371/journal.pone.0263695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134099	Green Published, gold			2022-12-26	WOS:000798968600026
J	Johnson, FA				Johnson, Fiifi Amoako			Spatiotemporal clustering and correlates of childhood stunting in Ghana: Analysis of the fixed and nonlinear associative effects of socio-demographic and socio-ecological factors	PLOS ONE			English	Article							MODEL SELECTION	Childhood stunting remains a major public health issue in many low- and middle-income countries. In Ghana, the progress made is insufficient to reach the targets set by the 2025 World Health Assembly and the 2030 United Nations Sustainable Development Goals. Although studies have examined the socio-demographic determinants of childhood stunting, there has not been any systematic study to examine the spatial associative effects of the socio-demographic and socio-ecological factors at the district level, where health programmes are implemented and monitored. Bayesian geo-additive semiparametric regression technique was used to analyse five conservative rounds of Demographic and Health Surveys in Ghana, with socio-ecological covariates derived from the Demographic and Health Survey Program Geospatial Covariate datasets to examine the temporal trends in childhood stunting, the extent of geospatial clustering at the district level and their associative relationships with socio-demographic and socio-ecological factors. The findings show that childhood stunting in Ghana is not spatially randomly distributed but clustered. Clustering of high childhood stunting was observed amongst districts in the Upper West, Upper East, Northern, North East, Savannah, and Western North regions, whilst clustering of low childhood stunting was observed in districts in the Greater Accra, Volta, Bono and the Eastern regions. Whist socio-demographic factors were predominantly associated with clustering of districts with high childhood stunting, the socio-ecological factors were mainly associated with clustering of districts with low childhood stunting. The socio-ecological factors identified to have a nonlinear associative effect with childhood stunting were Insecticide Treated Net (ITN) coverage, nightlight composite, travel time to a main settlement and population density. The findings suggest that targeted interventions at the district level are essential to reducing childhood stunting in Ghana.	[Johnson, Fiifi Amoako] Univ Cape Coast, Coll Humanities & Legal Studies, Fac Social Sci, Dept Populat & Hlth, Cape Coast, Ghana	University of Cape Coast	Johnson, FA (corresponding author), Univ Cape Coast, Coll Humanities & Legal Studies, Fac Social Sci, Dept Populat & Hlth, Cape Coast, Ghana.	famoakojohnson@ucc.edu.gh	Amoako Johnson, Fiifi/GWC-1466-2022	Amoako Johnson, Fiifi/0000-0003-0896-937X				Agyepong IA, 1999, HEALTH POLICY PLANN, V14, P59, DOI 10.1093/heapol/14.1.59; Aheto JMK, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08782-7; Allen C. K, 2020, DATA QUALITY DEMOGRA; Amare M, 2020, WORLD BANK ECON REV, V34, P63, DOI 10.1093/wber/lhy015; Boah M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219665; Christian AK, 2020, SSM-POPUL HLTH, V12, DOI 10.1016/j.ssmph.2020.100683; Couttolenc B.F., 2012, DECENTRALIZATION GOV, DOI [10.1016/j.rbp.2012.05.009, DOI 10.1016/J.RBP.2012.05.009]; Darteh EKM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-504; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Ewusie JE, 2017, MATERN CHILD HLTH J, V21, P797, DOI 10.1007/s10995-016-2173-z; Frempong RB, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00298; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; GSS GHS and ICFInternational, GHAN DEM HLTH SURV 1; GSS) GSS GHS (GHS) and ICF, 2018, GHAN MAT HLTH SURV; Hoeting JA, 2006, ECOL APPL, V16, P87, DOI 10.1890/04-0576; Hong R, 2007, PUBLIC HEALTH NUTR, V10, P371, DOI 10.1017/S1368980007226035; Johnson FA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223296; Jonah CMP, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0320-2; Kneib T, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P133, DOI 10.1007/978-3-7908-2413-1_8; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lee H, 2009, J STAT COMPUT SIM, V79, P93, DOI 10.1080/00949650701611143; Li ZH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3386; Mayala B., 2018, DHS PROGRAM GEOSPATI; Nikoi E, 2013, PUBLIC HEALTH NUTR, V16, P46, DOI 10.1017/S1368980012001346; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Tette EMA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2853-z; The World Bank, 2020, GHAN POV ASS POV EQ; Umlauf N, 2015, J STAT SOFTW, V63, P1; UNICEF WHO WorldBank, 2020, UNICEF WHO WORLD BAN; Van de Poel Ellen, 2007, Int J Equity Health, V6, P21, DOI 10.1186/1475-9276-6-21; van Doorn J, 2007, J CONSUM POLICY, V30, P75, DOI 10.1007/s10603-007-9028-3; Vilcins D, 2018, ANN GLOB HEALTH, V84, P551, DOI 10.29024/aogh.2361; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WHO-WORLD HEALTH ORGANIZATION, 2014, GLOB NUTR TARG 2025; Wirth JP, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12310; World Health Organization, 2006, WHO CHILD GROWTH STA; Yaya S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002042	39	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263726	10.1371/journal.pone.0263726	http://dx.doi.org/10.1371/journal.pone.0263726			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134090	Green Published, gold			2022-12-26	WOS:000798968600030
J	Lv, DM; Ding, SR; Zhong, L; Tu, J; Li, HB; Yao, H; Zou, YT; Zeng, ZL; Liao, Y; Wan, XS; Wen, LL; Xie, XB				Lv, Dongming; Ding, Shirong; Zhong, Li; Tu, Jian; Li, Hongbo; Yao, Hao; Zou, Yutong; Zeng, Ziliang; Liao, Yan; Wan, Xuesi; Wen, Lili; Xie, Xianbiao			M(6)A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression	ONCOGENE			English	Article							GENE; SUPPRESSES; PROTEIN	Despite advances in clinical diagnosis and treatment, the prognosis of patients with osteosarcoma (OS) remains poor, and the treatment efficacy has plateaued. Therefore, it is important to identify new therapeutic targets for OS. N-6-methyladenosine (m(6)A) modification has been reported to participate in tumor malignancy. In this study, functional screening showed that the m(6)A demethylase FTO could be a candidate therapeutic target for OS. Upregulated FTO in OS could predict a poorer prognosis. FTO promoted the growth and metastasis of OS in vitro and in vivo. Methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) were performed to identify DACT1 as a potential target of FTO. In vitro assays demonstrated that FTO could reduce the mRNA stability of DACT1 via m(6)A demethylation, which decreased DACT1 expression and further activated the Wnt signaling pathway. The oncogenic effect of FTO on OS was dependent on DACT1. In addition, the m(6)A reader IGF2BP1 was validated to participate in the regulation of DACT1. Entacapone, a conventional drug for Parkinson's disease, was confirmed to suppress OS via m(6)A-mediated regulation through the FTO/DACT1 axis. Our findings demonstrate that FTO may be a novel therapeutic target and that entacapone has preclinical value to be repurposed for OS.	[Lv, Dongming; Tu, Jian; Li, Hongbo; Yao, Hao; Zou, Yutong; Zeng, Ziliang; Liao, Yan; Xie, Xianbiao] Sun Yat Sen Univ, Dept Musculoskeletal Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Lv, Dongming; Tu, Jian; Li, Hongbo; Yao, Hao; Zou, Yutong; Zeng, Ziliang; Liao, Yan; Xie, Xianbiao] Guangdong Prov Key Lab Orthoped & Traumatol, Guangzhou, Peoples R China; [Ding, Shirong] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Guangzhou, Peoples R China; [Zhong, Li] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China; [Zhong, Li] Sun Yat Sen Univ, Affiliated Hosp 7, Sci Res Ctr, Shenzhen, Peoples R China; [Wan, Xuesi] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Wan, Xuesi] Sun Yat Sen Univ, Diabet Ctr, Affiliated Hosp 1, Guangzhou, Peoples R China; [Wen, Lili] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, XB (corresponding author), Sun Yat Sen Univ, Dept Musculoskeletal Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China.; Xie, XB (corresponding author), Guangdong Prov Key Lab Orthoped & Traumatol, Guangzhou, Peoples R China.; Wen, LL (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.	wenll@sysucc.org.cn; xiexbiao@mail.sysu.edu.cn		Zeng, Ziliang/0000-0002-0095-8396; DONGMING, LV/0000-0001-9642-0410	National Natural Science Foundation of China [81972510, 81772864, 81572638]; Natural Science Foundation of Guangdong Province [2016A030313239]; Medical Scientific Research Foundation of Guangdong Province [A2020483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province	This study was supported by National Natural Science Foundation of China (Grants 81972510, 81772864 and 81572638), Natural Science Foundation of Guangdong Province (No.2016A030313239), and Medical Scientific Research Foundation of Guangdong Province (A2020483).	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Barbieri I, 2020, NAT REV CANCER, V20, P303, DOI 10.1038/s41568-020-0253-2; Berulava T, 2020, EUR J HEART FAIL, V22, P54, DOI 10.1002/ejhf.1672; Cacabelos R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030551; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Chen HR, 2021, GASTROENTEROLOGY, V160, P1284, DOI 10.1053/j.gastro.2020.11.013; Chen SJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02847-6; Chen XX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01220-7; Chen YB, 2021, AUTOPHAGY, V17, P457, DOI 10.1080/15548627.2020.1720431; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Eaton BR, 2021, PEDIATR BLOOD CANCER, V68, DOI 10.1002/pbc.28352; Esposito M, 2021, NAT CELL BIOL, V23, P257, DOI 10.1038/s41556-021-00641-w; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Gordin A, 2004, J NEURAL TRANSM, V111, P1343, DOI 10.1007/s00702-004-0190-3; Harrison DJ, 2018, EXPERT REV ANTICANC, V18, P39, DOI 10.1080/14737140.2018.1413939; Huang HL, 2020, CANCER CELL, V37, P270, DOI 10.1016/j.ccell.2020.02.004; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Li HY, 2020, THERANOSTICS, V10, P9477, DOI 10.7150/thno.45763; Li JH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00769; Li Zejuan, 2017, Cancer Cell, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Liao D, 2015, CLIN CANCER RES, V21, P5349, DOI 10.1158/1078-0432.CCR-15-0198; Lin ZY, 2020, EMBO J, V39, DOI 10.15252/embj.2019103181; Liu H, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02422-5; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Lv DM, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-01745-4; Matsuoka K, 2020, CELL RES, V30, P885, DOI 10.1038/s41422-020-0370-1; Niu Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1004-4; Okerlund ND, 2010, J NEUROSCI, V30, P4362, DOI 10.1523/JNEUROSCI.0354-10.2010; Peng SM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau7116; Simpson E, 2018, JAAPA-J AM ACAD PHYS, V31, P15, DOI 10.1097/01.JAA.0000541477.24116.8d; Stojic L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14978-7; Su R, 2020, CANCER CELL, V38, P79, DOI 10.1016/j.ccell.2020.04.017; Sun T, 2020, ONCOGENE, V39, P5358, DOI 10.1038/s41388-020-1338-9; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang XR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15304-x; Wang YJ, 2019, EPIGENOMICS-UK, V11, P1693, DOI 10.2217/epi-2019-0262; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xiao YR, 2020, P NATL ACAD SCI USA, V117, P21441, DOI 10.1073/pnas.2000516117; Yang CF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21196985; Yang JH, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0238-3; Yang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10669-0; Yin XD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3399; Zhang CZ, 2020, ONCOGENE, V39, P4507, DOI 10.1038/s41388-020-1303-7; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhong L, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00414-1; Zhong L, 2019, CANCER LETT, V442, P252, DOI 10.1016/j.canlet.2018.11.006; Zhou B, 2021, HEPATOLOGY, V73, P91, DOI 10.1002/hep.31220; Zhou L, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109964; Zhou ZJ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01216-3; Zhu ST, 2020, MOL THER-NUCL ACIDS, V22, P957, DOI 10.1016/j.omtn.2020.10.010; Zhuang CS, 2019, J CELL MOL MED, V23, P2163, DOI 10.1111/jcmm.14128	58	7	7	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1727	1741		10.1038/s41388-022-02214-z	http://dx.doi.org/10.1038/s41388-022-02214-z		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35121825				2022-12-26	WOS:000751251500003
J	Terray, L; Denys, C; Goodman, SM; Soarimalala, V; Lalis, A; Cornette, R				Terray, Lea; Denys, Christiane; Goodman, Steven M.; Soarimalala, Voahangy; Lalis, Aude; Cornette, Raphael			Skull morphological evolution in Malagasy endemic Nesomyinae rodents	PLOS ONE			English	Article							BODY-SIZE; R PACKAGE; GEOGRAPHIC-VARIATION; PHYLOGENETIC SIGNAL; SHAPE; PRIMATES; MADAGASCAR; DIVERSIFICATION; SUPERIMPOSITION; PATTERNS	Madagascar is a large island to the south-east of Africa and in many ways continental in size and ecological complexity. Here we aim to define how skull morphology of an endemic and monophyletic clade of rodents (sub-family Nesomyinae), that show considerable morphological variation, have evolved and how their disparity is characterized in context of the geographical and ecological complexity of the island. We performed a two-dimensional geometric morphometric analysis on 370 dorsal and 399 ventral skull images of 19 species (comprising all nine extant endemic genera) and tested the influence of three ecological parameters (climate, locomotor habitat and nychthemeral cycle) in a phylogenetic context on size and shape. The results indicate that skull shape appears to importantly reflect phylogeny, whereas skull size does not carry a significant phylogenetic signal. Skull shape is significantly influenced by climate while, skull size is not impacted by any of the ecological factors tested, which is controversial to expectations in an insular context. In conclusion, Nesomyinae must have evolved under unusual types of local constraints, preventing this radiation from demonstrating strong ecological release.	[Terray, Lea; Denys, Christiane; Lalis, Aude; Cornette, Raphael] SU, Inst Systemat Evolut Biodivers ISYEB, Museum Natl Hist Nat, CNRS,EPHE,UA,CP 51, Paris, France; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.; Soarimalala, Voahangy] Assoc Vahatra, Antananarivo, Madagascar; [Soarimalala, Voahangy] Univ Fianarantsoa, Inst Sci & Tech Environm, Fianarantsoa, Madagascar	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Field Museum of Natural History (Chicago)	Denys, C (corresponding author), SU, Inst Systemat Evolut Biodivers ISYEB, Museum Natl Hist Nat, CNRS,EPHE,UA,CP 51, Paris, France.	christiane.denys@mnhn.fr		Christiane, Denys/0000-0002-1519-1546	ATM Rodeo; Labex BCDIV	ATM Rodeo; Labex BCDIV	We received funding from our institution (internal projects funded ATM Rodeo and Labex BCDIV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alhajeri BH, 2015, J ZOOL SYST EVOL RES, V53, P312, DOI 10.1111/jzs.12102; BATTISTINI R, 1972, BIOGEOGRAPHY ECOLOGY; Baylac M, 2005, DEV PRIMATOL-PROG PR, P145, DOI 10.1007/0-387-27614-9_6; Bertrand OC, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1014905; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blondel J, 2000, VIE MILIEU, V50, P205; Camargo NF, 2019, J ZOOL, V308, P128, DOI 10.1111/jzo.12659; Carleton MD, 1996, FLORAL FAUNAL INVENT; Caumul R, 2005, EVOLUTION, V59, P2460; Christidis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092440; Clavel J, 2019, SYST BIOL, V68, P93, DOI 10.1093/sysbio/syy045; Clavel J, 2015, METHODS ECOL EVOL, V6, P1311, DOI 10.1111/2041-210X.12420; Crowley BE, 2010, QUATERNARY SCI REV, V29, P2591, DOI 10.1016/j.quascirev.2010.06.030; Darvish Jamshid, 2009, Iranian Journal of Animal Biosystematics, V5, P59; Dumont M, 2016, BIOL J LINN SOC, V117, P858, DOI 10.1111/bij.12719; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Giacomini G, 2022, INTEGR ZOOL, V17, P430, DOI 10.1111/1749-4877.12564; Gommery D., 2011, PRIMATOL ADRSC MARSE, DOI [10.4000/primatologie.670, DOI 10.4000/PRIMATOLOGIE.670]; Goodman S.M., 2018, AIRES PROTEGEES TERR; Goodman S.M., 2014, EXTINCT MADAGASCAR P; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM., 2018, LES AIRES PROTEGEES, P373; Hautier L, 2012, J MORPHOL, V273, P1319, DOI 10.1002/jmor.20061; Heesy CP, 2008, BRAIN BEHAV EVOLUT, V71, P54, DOI 10.1159/000108621; Heesy CP, 2001, J HUM EVOL, V40, P111, DOI 10.1006/jhev.2000.0447; Huang GT, 2002, J COMP PHYSIOL A, V188, P663, DOI 10.1007/s00359-002-0332-8; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Jedrusik M., 2018, MISC GEOGR, V13, P251, DOI [10.2478/mgrsd-2008-0025, DOI 10.2478/MGRSD-2008-0025]; Kappeler PL., 2019, SCI REP-UK, V9, P14, DOI [10.1038/s41598-018-36846-7, DOI 10.1038/S41598-018-36846-7]; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kraatz B, 2016, PEERJ, V4, DOI 10.7717/peerj.2453; Lavocat R., 1973, ECOLE PRATIQUE HAUTE; Ledevin R, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2820; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; LOFTUS GR, 1978, MEM COGNITION, V6, P312, DOI 10.3758/BF03197461; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Maestri R, 2016, J EVOLUTION BIOL, V29, P2191, DOI 10.1111/jeb.12937; Meador LR, 2019, J MAMM EVOL, V26, P237, DOI 10.1007/s10914-017-9391-z; Mein P, 2010, CR PALEVOL, V9, P101, DOI 10.1016/j.crpv.2010.03.002; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Mullin SK, 2002, COMPUT BIOL MED, V32, P455, DOI 10.1016/S0010-4825(02)00037-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson LE, 2004, BIOL J LINN SOC, V83, P1, DOI 10.1111/j.1095-8312.2004.00366.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez VR, 2005, J HUM EVOL, V49, P722, DOI 10.1016/j.jhevol.2005.08.004; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Renaud S, 1999, J BIOGEOGR, V26, P857, DOI 10.1046/j.1365-2699.1999.00327.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306; Ruth AA, 2016, J HUM EVOL, V94, P45, DOI 10.1016/j.jhevol.2016.01.003; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Sassi PL, 2017, ETHOL ECOL EVOL, V29, P351, DOI 10.1080/03949370.2016.1188158; Schenk JJ, 2018, AM NAT, V192, P415, DOI 10.1086/699221; Schenk JJ, 2013, SYST BIOL, V62, P837, DOI 10.1093/sysbio/syt050; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Soarimalala V., 2011, PETITS MAMMIFERES MA; Steppan SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183070; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; Tabatabaei Yazdi F., 2011, Iranian Journal of Animal Biosystematics, V7, P129; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Wittaker RJ, 1998, ISLAND BIOGEOGRAPHY; Yom-Tov Y, 2004, BIOL J LINN SOC, V82, P263, DOI 10.1111/j.1095-8312.2004.00357.x; Yom-Tov Y, 2006, OECOLOGIA, V148, P213, DOI 10.1007/s00442-006-0364-9; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	70	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263045	10.1371/journal.pone.0263045	http://dx.doi.org/10.1371/journal.pone.0263045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120158	Green Published, gold			2022-12-26	WOS:000789273600019
J	Gabaldon, J; Zhang, D; Lauderdale, L; Miller, L; Johnson-Roberson, M; Barton, K; Shorter, KA				Gabaldon, Joaquin; Zhang, Ding; Lauderdale, Lisa; Miller, Lance; Johnson-Roberson, Matthew; Barton, Kira; Shorter, K. Alex			Computer-vision object tracking for monitoring bottlenose dolphin habitat use and kinematics	PLOS ONE			English	Article							WELFARE; BEHAVIORS; STRESS	This research presents a framework to enable computer-automated observation and monitoring of bottlenose dolphins (Tursiops truncatus) in a zoo environment. The resulting approach enables detailed persistent monitoring of the animals that is not possible using manual annotation methods. Fixed overhead cameras were used to opportunistically collect similar to 100 hours of observations, recorded over multiple days, including time both during and outside of formal training sessions, to demonstrate the viability of the framework. Animal locations were estimated using convolutional neural network (CNN) object detectors and Kalman filter post-processing. The resulting animal tracks were used to quantify habitat use and animal kinematics. Additionally, Kolmogorov-Smirnov analyses of the swimming kinematics were used in high-level behavioral mode classification. The object detectors achieved a minimum Average Precision of 0.76, and the post-processed results yielded 1.24 x 10(7) estimated dolphin locations. Animal kinematic diversity was found to be lowest in the morning and peaked immediately before noon. Regions of the zoo habitat displaying the highest activity levels correlated to locations associated with animal care specialists, conspecifics, or enrichment. The work presented here demonstrates that CNN object detection is viable for large-scale marine mammal tracking, and results from the proposed framework will enable future research that will offer new insights into dolphin behavior, biomechanics, and how environmental context affects movement and activity.	[Gabaldon, Joaquin; Johnson-Roberson, Matthew; Barton, Kira] Univ Michigan, Robot Inst, Ann Arbor, MI 48109 USA; [Zhang, Ding; Barton, Kira; Shorter, K. Alex] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Lauderdale, Lisa; Miller, Lance] Brookfield Zoo, Chicago Zool Soc, Brookfield, IL USA; [Johnson-Roberson, Matthew] Univ Michigan, Naval Architecture & Marine Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gabaldon, J (corresponding author), Univ Michigan, Robot Inst, Ann Arbor, MI 48109 USA.	gabaldon@umich.edu		Gabaldon, Joaquin/0000-0003-3775-6154; Lauderdale, Lisa/0000-0003-1008-7886; Zhang, Ding/0000-0002-3501-5486	Granger Foundation; Chicago Zoological Society (CZS)	Granger Foundation; Chicago Zoological Society (CZS)	This study was funded by the Granger Foundation and the Chicago Zoological Society (CZS). Authors L. Lauderdale and L. Miller are members of CZS and contributed to the study design, data collection and analysis, and manuscript revision.	Ames AE., 2019, INT J COMP PSYCHOL, V32, P1, DOI [10.46867/ijcp.2019.32.02.02, DOI 10.46867/IJCP.2019.32.02.02]; Brunetti A, 2018, NEUROCOMPUTING, V300, P17, DOI 10.1016/j.neucom.2018.01.092; Clegg ILK, 2015, ANIM WELFARE, V24, P267, DOI 10.7120/09627286.24.3.267; Clegg ILK, 2017, J COMP PSYCHOL, V131, P214, DOI 10.1037/com0000059; Gabaldon J, 2017, IEEE INT C INT ROBOT, P2505; Guirado E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50795-9; Harvey BS, 2017, BEHAV PROCESS, V135, P145, DOI 10.1016/j.beproc.2016.12.013; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hwang JN, 2021, LECT NOTES COMPUTER, V12662, P434, DOI [10.1007/978-3-030-68790-8_34, DOI 10.1007/978-3-030-68790-8_34]; Kagan R, 2015, J APPL ANIM WELF SCI, V18, pS1, DOI 10.1080/10888705.2015.1075830; Karnowski J, 2015, 2015 IEEE WINTER APPLICATIONS AND COMPUTER VISION WORKSHOPS (WACVW), P51, DOI 10.1109/WACVW.2015.10; Manning T, 2019, IEEE INT C BIOINFORM, P1876, DOI 10.1109/BIBM47256.2019.8983195; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Miller LJ, 2011, ANIM WELFARE, V20, P159; Moore TY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00373-2; Porter F. C., 2008, ARXIV08040380, Patent No. [0804.0380, 08040380]; Rachinas-Lopes P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201614; REDMON J, 2017, PROC CVPR IEEE, DOI [DOI 10.1109/CVPR.2017.690, 10.1109/CVPR.2017.690]; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Sekiguchi Y, 2003, PHYSIOL BEHAV, V79, P643, DOI 10.1016/S0031-9384(03)00119-7; Sharma N, 2018, LECT NOTES ARTIF INT, V11320, P224, DOI 10.1007/978-3-030-03991-2_23; Shorter KA, 2017, MAR MAMMAL SCI, V33, P785, DOI 10.1111/mms.12408; The MathWorks I, 2019, DEEP LEARNING TOOLBO; Ugaz C, 2013, J VET BEHAV, V8, P285, DOI 10.1016/j.jveb.2012.10.006; Walker RT, 2017, INT J COMP PSYCHOL, V30, DOI DOI 10.46867/IJCP.2017.30.00.05; Wang SH, 2017, MULTIMED TOOLS APPL, V76, P23679, DOI 10.1007/s11042-016-4045-3; Waples KA, 2002, ZOO BIOL, V21, P5, DOI 10.1002/zoo.10004; Whitham JC, 2013, APPL ANIM BEHAV SCI, V147, P247, DOI 10.1016/j.applanim.2013.02.004; Zhang D, 2019, IEEE INT CONF ROBOT, P6575, DOI 10.1109/ICRA.2019.8794141	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0254323	10.1371/journal.pone.0254323	http://dx.doi.org/10.1371/journal.pone.0254323			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113869	gold, Green Published			2022-12-26	WOS:000823694700003
J	Wartelle, A; Mourad-Chehade, F; Yalaoui, F; Questiaux, H; Monneret, T; Soliveau, G; Chrusciel, J; Duclos, A; Laplanche, D; Sanchez, S				Wartelle, Adrien; Mourad-Chehade, Farah; Yalaoui, Farouk; Questiaux, Helene; Monneret, Thomas; Soliveau, Ghislain; Chrusciel, Jan; Duclos, Antoine; Laplanche, David; Sanchez, Stephane			Multimorbidity clustering of the emergency department patient flow: Impact analysis of new unscheduled care clinics	PLOS ONE			English	Article							MEDICAID ENROLLEES; CONVENIENT CARE; ACCESS; CLASSIFICATION; VISITS; USERS	Background In France, the number of emergency department (ED) admissions doubled between 1996 and 2016. To cope with the resulting crowding situation, redirecting patients to new healthcare services was considered a viable solution which would spread demand more evenly across available healthcare delivery points and render care more efficient. The objective of this study was to analyze the impact of opening new on-demand care services based on variations in patient flow at a large hospital emergency department. Methods We performed a before-and-after study investigating the use of unscheduled care services in the Aube region in eastern France, that focused on ED attendance at Troyes Hospital. A hierarchical clustering based on co-occurrence of diagnoses was applied which divided the population into different multimorbidity profiles. Temporal trends of the resultant clusters were also studied empirically and using regression models. A multivariate logistic regression model was constructed to adjust the periodic effect for appropriate confounders and therefore confirm its presence. Results In total, 120,722 visits to the ED were recorded over a 24-month period (2018-2019) and 16 clusters were identified, accounting for 94.76% of all visits. There was a decrease of 56.77 visits per week in seven specific clusters and an increase of use of unscheduled health care services by 328.12 visits per week. Conclusions Using an innovative and reliable methodology to evaluate changes in patient flow through the ED, these findings may help inform public health policy experts on the implementation of unscheduled care services to ease pressure on hospital EDs.	[Wartelle, Adrien; Mourad-Chehade, Farah; Yalaoui, Farouk] Univ Technol Troyes, Comp Sci & Digital Soc Lab LIST3N, Troyes, France; [Wartelle, Adrien; Chrusciel, Jan; Laplanche, David; Sanchez, Stephane] Ctr Hosp Troyes, Publ Hlth & Performance Dept, Troyes, France; [Questiaux, Helene] Ctr Hosp Troyes, Emergency Dept, Troyes, France; [Monneret, Thomas; Soliveau, Ghislain] Etab Aubois Soins Immediats, Troyes, France; [Duclos, Antoine] Univ Claude Bernard Lyon 1, Res Healthcare Performance Lab, INSERM U1290 RESHAPE, Villeurbanne, France; [Duclos, Antoine] Hosp Civils Lyon, Hlth Data Dept, Lyon, France; [Sanchez, Stephane] Univ Reims, Res Hlth Univ Dept, Reims, France	Universite de Technologie de Troyes; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Reims Champagne-Ardenne	Wartelle, A (corresponding author), Univ Technol Troyes, Comp Sci & Digital Soc Lab LIST3N, Troyes, France.; Wartelle, A; Sanchez, S (corresponding author), Ctr Hosp Troyes, Publ Hlth & Performance Dept, Troyes, France.; Sanchez, S (corresponding author), Univ Reims, Res Hlth Univ Dept, Reims, France.	adrien.wartelle@ch-troyes.fr; stephane.sanchez@hcs-sante.fr	Sanchez, Stephane/ABD-3014-2020	Sanchez, Stephane/0000-0002-0925-6948; Wartelle, Adrien/0000-0003-1471-0866	French Regional Health Agency	French Regional Health Agency	Our institution received an exceptional funding of 3000 euros for this study from the French Regional Health Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received salaries from the French Regional Health Agency.	Ablard S, 2017, EMERG MED J, V34, P672, DOI 10.1136/emermed-2016-206539; Afilal M, 2016, IFAC PAPERSONLINE, V49, P721, DOI 10.1016/j.ifacol.2016.07.859; Afilal M, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0527-0; Ahmadi-Javid A, 2020, OPER RES HEALTH CARE, V24, DOI 10.1016/j.orhc.2019.100226; [Anonymous], 2015, CHIFFR CLS; Baum Z, 2016, PEERJ, V4, DOI 10.7717/peerj.1544; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bozdogan H, 2000, J MATH PSYCHOL, V44, P62, DOI 10.1006/jmps.1999.1277; Capp R, 2016, ACAD EMERG MED, V23, P476, DOI 10.1111/acem.12952; Capp R, 2015, MED CARE, V53, P530, DOI 10.1097/MLR.0000000000000364; Chauvin A., 2016, MEDITERRANEAN J EMER, P5; Chrusciel J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026200; de la Fuente DO, 2007, EUR J PUBLIC HEALTH, V17, P186, DOI 10.1093/eurpub/ckl085; DeVries A, 2013, MED CARE, V51, P224, DOI 10.1097/MLR.0b013e3182726b83; DREES. France. Ministre du travail de lemploi et de la sant., 2017, DIR RECH TUD LVAL ST, V2017; Durand Anne-Claire, 2012, BMC Res Notes, V5, P525, DOI 10.1186/1756-0500-5-525; EVERITT B, 1980, QUAL QUANT, V14, P75, DOI 10.1007/BF00154794; Gandhi SO, 2014, AM J MANAG CARE, V20, P315; Gay B., 2019, M DECINE, V15, P34, DOI [10.1684/med.2019.401, DOI 10.1684/MED.2019.401]; Globerson A, 2007, J MACH LEARN RES, V8, P2265; Granger B., 2019, DEBAT, DOI [10.3917/deba.203.0098, DOI 10.3917/DEBA.203.0098]; Han JH, 2007, ACAD EMERG MED, V14, P338, DOI 10.1197/j.aem.2006.12.005; Hansen-Turton T, 2007, DIS MANAGE, V10, P61, DOI 10.1089/dis.2006.636; Hefner JL, 2015, AM J MED QUAL, V30, P135, DOI 10.1177/1062860614521278; Hsia RY, 2017, INT J QUAL HEALTH C, V29, P642, DOI 10.1093/intqhc/mzx081; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Jarvis PRE, 2016, CLIN EXP EMERG MED, V3, P63, DOI 10.15441/ceem.16.127; Jones D, 2011, J PRIM CARE COMMUNIT, V2, P250, DOI 10.1177/2150131911408431; Khanolkar AR, 2019, EUR J PUBLIC HEALTH, V29; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Leporatti L, 2016, HEALTH POLICY, V120, P462, DOI 10.1016/j.healthpol.2016.03.005; Moe Jessica, 2019, Healthc Q, V22, P42, DOI 10.12927/hcq.2019.25837; Morley C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203316; Naouri D, 2020, BMJ QUAL SAF, V29, P449, DOI 10.1136/bmjqs-2019-009396; Naouri D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198474; Parchman ML., 2007, APPL MULTIVAR RES, V12, P163, DOI [DOI 10.22329/AMR.V12I3.658, 10.22329/amr.v12i3.658]; Patel PB., 2018, AM J MANAG CARE; Patwardhan A, 2012, J PRIM CARE COMMUNIT, V3, P243, DOI 10.1177/2150131911436251; Petrou P, 2019, PUBLIC HEALTH, V169, P50, DOI 10.1016/j.puhe.2018.12.014; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Raven MC, 2016, ANN EMERG MED, V68, P467, DOI 10.1016/j.annemergmed.2016.04.015; Salway R, 2017, REV MED CLIN CONDES, V28, P213, DOI [10.1016/j.rmclc.2017.04.008, DOI 10.1016/J.RMCLC.2017.04.008, 10.1016/J.RMCLC.2017.04.008]; Scailteux LM, 2019, THERAPIE, V74, P215, DOI 10.1016/j.therap.2018.09.072; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Soler G, 2018, IEEE INT CON AUTO SC, P365, DOI 10.1109/COASE.2018.8560585; Tangianu F, 2018, ITAL J MED, V12, P137, DOI 10.4081/itjm.2018.940; Thakkar AB, 2019, FAM MED, V51, P420, DOI 10.22454/FamMed.2019.477798; Travers DA, 2003, ACAD EMERG MED, V10, P1337, DOI 10.1197/S1069-6563(03)00536-0; Vetrano DL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16780-x; Violan C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029594; Violan C, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0790-x; Wartelle A, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11052373; Whitt W, 2017, OPER RES HEALTH CARE, V12, P1, DOI 10.1016/j.orhc.2016.11.001	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262914	10.1371/journal.pone.0262914	http://dx.doi.org/10.1371/journal.pone.0262914			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100301	Green Published, Green Submitted, gold			2022-12-26	WOS:000801937600025
J	Esteves, E; Mendes, AK; Barros, M; Figueiredo, C; Andrade, J; Capelo, J; Novais, A; Rebelo, C; Soares, R; Nunes, A; Ferreira, A; Lemos, J; Duarte, AS; Silva, RM; Inacio Bernardino, L; Correia, MJ; Esteves, AC; Rosa, N				Esteves, Eduardo; Mendes, Ana Karina; Barros, Marlene; Figueiredo, Catia; Andrade, Joana; Capelo, Joana; Novais, Antonio; Rebelo, Carla; Soares, Rita; Nunes, Ana; Ferreira, Andre; Lemos, Joana; Duarte, Ana Sofia; Silva, Raquel M.; Inacio Bernardino, Liliana; Correia, Maria Jose; Esteves, Ana Cristina; Rosa, Nuno			Population wide testing pooling strategy for SARS-CoV-2 detection using saliva	PLOS ONE			English	Article								SARS-CoV-2 pandemic has forced frequent testing of populations. It is necessary to identify the most cost-effective strategies for the detection of COVID-19 outbreaks. Nasopharyngeal samples have been used for SARS-CoV-2 detection but require a healthcare professional to collect the sample and cause discomfort and pain to the individual. Saliva has been suggested as an appropriate fluid for the diagnosis of COVID-19. We have investigated the possibility of using pools of saliva samples to detect SARS-CoV-2 in symptomatic and asymptomatic patients. Two hundred and seventy-nine saliva samples were analyzed through RT-PCR of Envelope, Nucleocapsid and Open Reading Frame 1ab genes. Reproducibility assays showed an almost perfect agreement as well as high sensitivity (96.6%), specificity (96.8%), positive predicted value (96.6%), and negative predicted value (96.8%). The average Cycle Threshold of the genes detected was 29.7. No significant differences (p > 0.05) were detected when comparing the cycle threshold average of two consecutive reactions on the same positive saliva samples. Saliva samples have a higher median viral load (32.6) than in nasopharyngeal samples (28.9), although no significant differences were detected (p > 0.05). Saliva-pool samples allowed effective SARS-CoV-2 screening, with a higher sensibility (96.9%) on 10-sample pools than in 20-sample pools (87.5%). Regardless of pools size specificity was high (99.9%) and an almost perfect agreement was observed. Our strategy was successfully applied in population wide testing of more than 2000 individuals, showing that it is possible to use pooled saliva as diagnostic fluid for SARS-CoV-2 infection.	[Esteves, Eduardo; Mendes, Ana Karina; Barros, Marlene; Duarte, Ana Sofia; Silva, Raquel M.; Correia, Maria Jose; Rosa, Nuno] Univ Catolica Portuguesa, Fac Dent Med FMD, Ctr Interdisciplinary Res Hlth CIIS, Viseu, Portugal; [Esteves, Eduardo; Inacio Bernardino, Liliana] Univ Beira Interior, Fac Hlth Sci, Covilha, Portugal; [Figueiredo, Catia; Andrade, Joana; Capelo, Joana; Novais, Antonio; Rebelo, Carla; Soares, Rita; Nunes, Ana; Ferreira, Andre; Lemos, Joana] Ctr Hosp Tondela Viseu, Viseu, Portugal; [Esteves, Ana Cristina] Univ Aveiro, Dept Biol, CESAM, Aveiro, Portugal	Universidade Catolica Portuguesa; Universidade da Beira Interior; Universidade de Aveiro	Rosa, N (corresponding author), Univ Catolica Portuguesa, Fac Dent Med FMD, Ctr Interdisciplinary Res Hlth CIIS, Viseu, Portugal.	nrosa@ucp.pt	Correia, Maria/ABE-2500-2021; Soares, Rita/GVT-2865-2022; Duarte, Ana Sofia/A-5212-2009; Esteves, Ana Cristina/B-2939-2008; Barros, Marlene/AAG-6405-2021; Rosa, Nuno/A-5627-2013; Silva, Raquel/B-8337-2008	Correia, Maria/0000-0002-6141-9089; Duarte, Ana Sofia/0000-0001-6849-6004; Esteves, Ana Cristina/0000-0003-2239-2976; Barros, Marlene/0000-0003-0631-4062; Bernardino, Liliana/0000-0003-3395-5973; Rosa, Nuno/0000-0003-4604-0780; Silva Mendes, Ana Karina/0000-0002-9413-2367; Silva, Raquel/0000-0001-5926-8042				Asai T, 2021, J ANESTH, V35, P328, DOI 10.1007/s00540-020-02875-8; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Babady NE, 2021, J MOL DIAGN, V23, P3, DOI 10.1016/j.jmoldx.2020.10.018; Barat B, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02486-20; Borghi E, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.721635; Byrne RL, 2020, EMERG INFECT DIS, V26, P2769, DOI 10.3201/eid2611.203283; Callahan C, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00162-21; Control ECfDPa, 2020, POP WID TEST SARS CO; Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112; Darab MG, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06126-8; de Wolff T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243692; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Fernandes LL, 2020, J DENT RES, V99, P1435, DOI 10.1177/0022034520960070; Fini MB, 2020, ORAL ONCOL, V108, DOI 10.1016/j.oraloncology.2020.104821; Hashmi HAS, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00311; Herrera LA, 2021, INT J INFECT DIS, V105, DOI 10.1016/j.ijid.2021.02.009; Hiebert Nole M, 2021, J Otolaryngol Head Neck Surg, V50, P5, DOI 10.1186/s40463-020-00490-x; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Iwasaki S, 2020, J INFECTION, V81, pE145, DOI 10.1016/j.jinf.2020.05.071; Jamal AJ, 2021, CLIN INFECT DIS, V72, P1064, DOI 10.1093/cid/ciaa848; Jamshaid H, 2020, AAPS PHARMSCITECH, V21, DOI 10.1208/s12249-020-01756-3; Kinloch NN, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa488; Klemes JJ, 2020, ENERGY, V211, DOI 10.1016/j.energy.2020.118701; Landry ML, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104567; Nacher M, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.621160; Nagura-Ikeda M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01438-20; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Niedrig M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3611-x; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Pasomsub E, 2021, J MED VIROL, V93, P1506, DOI 10.1002/jmv.26460; Rosa N, 2016, BIOPRESERV BIOBANK, V14, P289, DOI 10.1089/bio.2015.0054; Silva Julio, 2021, medRxiv, DOI 10.1101/2021.01.04.21249236; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624; Vanapalli KR, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141514; Watkins Anne E, 2020, medRxiv, DOI 10.1101/2020.09.02.20183830; Williams E, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00776-20; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531; Yokota I, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84059-2	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263033	10.1371/journal.pone.0263033	http://dx.doi.org/10.1371/journal.pone.0263033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089942	Green Published, gold			2022-12-26	WOS:000769158400035
J	Niederstrasser, NG; Attridge, N				Niederstrasser, Nils Georg; Attridge, Nina			Associations between pain and physical activity among older adults	PLOS ONE			English	Article							GENERAL-POPULATION; LEISURE-TIME; HEALTH; AGE; COMORBIDITY; DEPRESSION; EXERCISE; OBESITY; RISK; LIFE	Objectives Chronic pain is a significant societal problem and pain complaints are one of the main causes of work absenteeism and emergency room visits. Physical activity has been associated with reduced risk of suffering from musculoskeletal pain complaints, but the exact relationship in an older adult sample is not known. Methods Participants self-reported their physical activity level and whether they were often troubled by bone, joint, or muscle pain. Logistic regression analyses revealed the nature of the relationship between musculoskeletal pain and physical activity cross-sectionally and longitudinally over the course of 10 years. Data were taken from the English Longitudinal Study of Ageing, comprising of 5802 individuals residing in England aged 50 or older. Results Only high levels of physical activity were associated with a reduced risk of suffering from musculoskeletal pain compared to a sedentary lifestyle longitudinally. In addition, having low wealth, being female, and being overweight or obese were found to be risk factors for suffering from musculoskeletal pain. Conclusions The development of interventions aimed at alleviating and preventing musculoskeletal pain complaints might benefit from incorporating physical activity programs, weight loss, and aspects addressing wealth inequality to maximise their efficacy.	[Niederstrasser, Nils Georg; Attridge, Nina] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	University of Portsmouth	Niederstrasser, NG (corresponding author), Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England.	nils.niederstrasser@port.ac.uk		Niederstrasser, Nils/0000-0002-6605-2896; Attridge, Nina/0000-0001-9586-372X				ADLER G, 1993, BIOL PSYCHIAT, V34, P687, DOI 10.1016/0006-3223(93)90041-B; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Becker N, 1997, PAIN, V73, P393, DOI 10.1016/S0304-3959(97)00126-7; Bergman S, 2007, BEST PRACT RES CL RH, V21, P191, DOI 10.1016/j.berh.2006.08.012; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Cairns BE, 2009, MATURITAS, V63, P292, DOI 10.1016/j.maturitas.2009.06.004; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Dorner TE, 2011, EUR J PAIN, V15, P103, DOI 10.1016/j.ejpain.2010.05.013; Fayaz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010364; Forsythe LP, 2011, J PAIN, V12, P563, DOI 10.1016/j.jpain.2010.11.003; Gordon AL, 2014, AGE AGEING, V43, P97, DOI 10.1093/ageing/aft077; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hildebrandt VH, 2000, INT ARCH OCC ENV HEA, V73, P507, DOI 10.1007/s004200000167; Hitt HC, 2007, J PAIN, V8, P430, DOI 10.1016/j.jpain.2006.12.003; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Joint Health Surveys Unit, 2007, HLTH SURVEY ENGLAND; Jones H., 2011, ADULT PARTICIPATION; Kee WG, 1998, CLIN J PAIN, V14, P121, DOI 10.1097/00002508-199806000-00006; Klauenberg S, 2008, PAIN, V140, P332, DOI 10.1016/j.pain.2008.09.003; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; Law LF, 2017, PAIN, V158, P369, DOI 10.1097/j.pain.0000000000000792; Leblanc A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1357-0; Lenert ME, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab109; Makris UE, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0042-z; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; McVinnie DS, 2013, BRIT J PAIN, V7, P163, DOI 10.1177/2049463713484296; Mucci N, 2016, NEUROPSYCH DIS TREAT, V12, P983, DOI 10.2147/NDT.S98525; Mucke M, 2018, SPORTS MED, V48, P2607, DOI 10.1007/s40279-018-0979-0; Naugle KM, 2014, MED SCI SPORT EXER, V46, P622, DOI 10.1249/MSS.0b013e3182a69cf1; Palmlof L, 2012, J EPIDEMIOL COMMUN H, V66, P1063, DOI 10.1136/jech-2011-200783; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Peng P, 2008, PAIN RES MANAG, V13, P484, DOI 10.1155/2008/726804; Reid MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h532; Santavicca N., 2016, GERIATR EMERGENCIES, V41, P110, DOI [10.1002/9781118753262.ch9, DOI 10.1002/9781118753262.CH9]; Santos MCS, 2018, BEHAV MED, V44, P335, DOI 10.1080/08964289.2017.1384358; Schofield Pat, 2007, Rev Pain, V1, P12, DOI 10.1177/204946370700100104; Smith TO, 2019, BRIT J PAIN, V13, P82, DOI 10.1177/2049463718802868; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Vincent K, 2013, PAIN, V154, P515, DOI 10.1016/j.pain.2012.11.016; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7	43	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263356	10.1371/journal.pone.0263356	http://dx.doi.org/10.1371/journal.pone.0263356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089966	Green Published, gold			2022-12-26	WOS:000769158400058
J	Rodriguez-Hernandez, AJ; Sevcik, C				Javier Rodriguez-Hernandez, Antonio; Sevcik, Carlos			Hidden chaos factors inducing random walks which reduce hospital operative efficiency	PLOS ONE			English	Article							VENOM COMPLEXITY; SCORPION-VENOM; DIMENSION; ALGORITHM; ENTROPY; STORM	Operative parameters of La Fuenfria Hospital such as: hospitalized patients; daily admissions and discharges were studies for the hospital as a whole, and for each hospital's service unit (henceforth called 'services'). Conventional statistical analyzes and fractal dimension analyzes were performed on daily In-Patient series. The sequence of daily admissions and patients staying on each service were found to be a kind of random series known as random walks (Rw), sequences where what happens next, depends on what happens now plus a random variable. Rw analyzed with parametric or nonparametric statistics may simulate cycles and drifts which resemble seasonal variations or fake trends which reduce the Hospital's efficiency. Globally, inpatients Rw s in LFH, were found to be determined by the time elapsed between daily discharges and admissions. The factors determining LFH R were found to be the difference between daily admissions and discharges. The discharges are replaced by admissions with some random delay and the random difference determines LFH Rw s. These findings show that if the daily difference between admissions and discharges is minimized, the number of inpatients would fluctuate less and the number of unoccupied beds would be reduced, thus optimizing the Hospital service.	[Javier Rodriguez-Hernandez, Antonio] Hosp Fuenfria, Madrid, Spain; [Sevcik, Carlos] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Caracas, Venezuela; [Sevcik, Carlos] SciMeDAn, Barcelona, Spain	Venezuelan Institute Science Research	Sevcik, C (corresponding author), Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Caracas, Venezuela.; Sevcik, C (corresponding author), SciMeDAn, Barcelona, Spain.	carlos.sevcik.s@gmail.com		Sevcik, Carlos/0000-0003-3783-6541	Hospital La Fuenfria, Servicio Madrileno de Salud (SERMAS), Comunidad Autonoma de Madrid, Madrid, Spain	Hospital La Fuenfria, Servicio Madrileno de Salud (SERMAS), Comunidad Autonoma de Madrid, Madrid, Spain	All funds were provided by Hospital La Fuenfria, Servicio Madrileno de Salud (SERMAS), Comunidad Autonoma de Madrid, Madrid, Spain.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; [Anonymous], HDB EUR DAT PROT LAW, V20108th, P218; Bak P, 1995, FRACTAL DYNAMICS EAR; BARNETT VD, 1966, J AM STAT ASSOC, V61, P1205, DOI 10.2307/2283210; Barnsley MF., 1993, FRACTALS EVERYWHERE; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bera AK, 1981, EFFICIENT LARGE SAMP; Besicovitch AS, 1929, MATH ANN, V101, P161, DOI 10.1007/BF01454831; Bharucha-Reid A. T, 1960, ELEMENTS THEORY MARK; Bhattacharya P, 2009, FRACTAL MODELS EARTH; BLACKMAN RB, 1958, AT&T TECH J, V37, P185, DOI 10.1002/j.1538-7305.1958.tb03874.x; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Brown R., 1829, PHILOS MAG, V6, P161, DOI [DOI 10.1080/14786442908675115, 10.1080/14786442908675115]; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; BURT Stephen D., 1988, WEATHER, V43, P90, DOI [10.1002/j.1477-8696.1988.tb03885.x, DOI 10.1002/J.1477-8696.1988.TB03885.X]; Chebyshev P.L., 1867, J MATH PURE APPL, V12, P177; COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Cramer H., 1991, MATH METHODS STAT, V18th; D'Suze G, 2015, TOXICON, V108, P62, DOI 10.1016/j.toxicon.2015.09.034; D'Suze G, 2010, J THEOR BIOL, V267, P405, DOI 10.1016/j.jtbi.2010.09.009; Dahlquist G., 1974, NUMERICAL METHODS; Deming E., 1986, OUT CRISIS QUALITY P; Diao XY, 2017, ALGORITHMS, V10, DOI 10.3390/a10030096; Dunne J, 2013, STORM HITS HOME 1987; FAMA EF, 1968, J AM STAT ASSOC, V63, P817, DOI 10.2307/2283875; Fisher RA., 1954, STAT METHODS RES WOR, V12th ed; Gel YR, 2008, ECON LETT, V99, P30, DOI 10.1016/j.econlet.2007.05.022; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Guttman I., 1971, INTRO ENG STAT; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Hasselman F, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00075; Hastings HH., 1993, USERS GUIDE NATURAL; Hausdorff F, 1919, MATH ANN, V79, P157; Hojat M, 2004, ADV HEALTH SCI EDUC, V9, P241, DOI 10.1023/B:AHSE.0000038173.00909.f6; Hollander M., 1973, NONPARAMETRIC STAT M, V1st; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; JARRAUD M, 1989, WEATHER FORECAST, V4, P517, DOI 10.1175/1520-0434(1989)004<0517:POAESO>2.0.CO;2; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kolodziej M, 2020, 21 INT C COMP PROBL, P1; Lohninger H, 2012, FUNDAMENTALS STAT; LORENC AC, 1988, METEOROL MAG, V117, P118; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Macrotrends, 2019, CRUD OIL PRIC 70 YEA; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mandelbrot B.B., 1983, AM J PHYS, DOI 10.1119/1.13295; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Matsumoto M, 2000, MONTE CARLO AND QUASI-MONTE CARLO METHODS 1998, P56; MELTZER MI, 1991, PREV VET MED, V11, P255, DOI 10.1016/S0167-5877(05)80011-X; Metropolis N, 1987, LOS ALARNOS SCI SPEC, P125; Mitchel C., 2020, INVESTORPEDIA; Mood AM, 1940, ANN MATH STAT, V11, P367, DOI 10.1214/aoms/1177731825; Nepiklonov VB., 2020, GEODES PHOTO SYS, V64, P380, DOI [10.30533/0536-101X-2020-64-4-380-390, DOI 10.30533/0536-101X-2020-64-4-380-390]; Norman GR., 1989, PDQ STAT, V1; Petunin DFVYI, 1980, THEOR PROBAB MATH ST, V21, P25; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Pitman J., 1993, SPRINGER TEXTS STAT, V1st; Rodriguez-Hernandez J, 2017, THESIS U POMPEU FABR; Rosenblatt M, 1974, GRADUATE TEXT MATH; Ross SM, 1983, STOCHASTIC PROCESSES; ROTHENBERG TJ, 1964, J AM STAT ASSOC, V59, P460, DOI 10.2307/2282999; Sevcik C., 1998, COMPLEX INT, V5, P1; Sevcik C, 2018, EXP MATH, V27, P331, DOI 10.1080/10586458.2017.1279092; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharma N., 2013, INT J COMP SCI TECH, V4, P52; Shi CT, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8081327; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smirnov N., 1939, B MOSCOW U, V2, P3; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Streiner DL, 2012, CHEST, V141, P595, DOI 10.1378/chest.11-2473; Telesca L, 2005, PHYSICA A, V354, P629, DOI 10.1016/j.physa.2005.02.053; Theil H., 1950, RANK INVARIANT METHO, V53, P386, DOI DOI 10.1007/978-94-011-2546-8_20; Theil H., 1992, HENRI THEILS CONTRIB, P345, DOI [DOI 10.1007/978-94-011-2546-8_20, DOI 10.1007/978-94-011-2546-820]; Theil H, 1950, P KON NED AKDA WETEN, V53, P1897; Vysochansky DF., 1979, THEOR PROBAB MATH ST, V21, P23; Vysochansky DF, 1983, THEOR PROBAB MATH ST, V27, P27; Walck C., 1996, SUFPFY9601 U STOCKH; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wilks SS., 1962, MATH STAT; Wolfram S., 2003, MATH BOOK, V5th ed; World population review, 2019, HAW POP 2019 DEM MAP; Xue R, 2020, INFORMATION, V11, DOI 10.3390/info11110520	89	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262815	10.1371/journal.pone.0262815	http://dx.doi.org/10.1371/journal.pone.0262815			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085317	gold, Green Submitted, Green Published			2022-12-26	WOS:000779379600085
J	Barczyk, M; Chydzinski, A				Barczyk, Marek; Chydzinski, Andrzej			AQM based on the queue length: A real-network study	PLOS ONE			English	Article							DROPPING FUNCTION	Active Queue Management (AQM) is recommended by Internet Engineering Task Force to mitigate the bufferbloat phenomenon in the Internet. In this paper, we show the results of comprehensive measurements carried out in our university network, in which a device with an AQM algorithm, designed and programmed for this purpose, was running. The implemented AQM algorithm was based on the dropping function, i.e. arriving packets were dropped randomly, with the probability being a function of the queue length. Several different dropping function forms, proposed in the networking literature, were used, in addition to the classic FIFO queue (no AQM). The experiment lasted over a month, during which the state of the network was measured and recorded several thousand times. This made the results independent of the natural fluctuations of the users' behavior and the network load. Conclusions on the general performance improvement offered by the implemented AQM, as well as the differences in the performance between particular forms of the dropping function, were reached. Some of these conclusions differ from those drawn previously from simulations. This underlines the need for carrying measurements of new AQMs in real, operating networks, with complex, natural traffic.	[Barczyk, Marek; Chydzinski, Andrzej] Silesian Tech Univ, Dept Comp Networks & Syst, Gliwice, Poland	Silesian University of Technology	Chydzinski, A (corresponding author), Silesian Tech Univ, Dept Comp Networks & Syst, Gliwice, Poland.	andrzej.chydzinski@polsl.pl		Barczyk, Marek/0000-0002-9106-8355; Chydzinski, Andrzej/0000-0002-0168-6919	National Science Centre, Poland [2020/39/B/ST6/00224]	National Science Centre, Poland(National Science Centre, Poland)	This work was conducted within project 2020/39/B/ST6/00224, founded by National Science Centre, Poland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas G, 2018, TELECOMMUN SYST, V67, P3, DOI 10.1007/s11235-017-0306-3; Al-Faiz M. Z., 2012, 2012 International Conference on Future Communication Networks (ICFCN), P78, DOI 10.1109/ICFCN.2012.6206877; Athuraliya S, 2001, IEEE NETWORK, V15, P48, DOI 10.1109/65.923940; Augustyn DR, 2010, COMM COM INF SC, V79, P199, DOI 10.1007/978-3-642-13861-4_20; Baker F., 2015, 7567 INT ENG TASK FO; Barczyk M, 2020, IEEE SYMP COMP COMMU, P52; Bisoy SK, 2021, IEEE ACCESS, V9, P27723, DOI 10.1109/ACCESS.2021.3056885; Bratiychuk M, 2009, APPL MATH MODEL, V33, P3565, DOI 10.1016/j.apm.2008.11.015; Cerf VG, 2014, IEEE INTERNET COMPUT, V18, P80, DOI 10.1109/MIC.2014.89; Chen JCV, 2012, COMPUT STAND INTER, V34, P426, DOI 10.1016/j.csi.2012.02.002; Chrost L, 2016, TELECOMMUN SYST, V63, P27, DOI 10.1007/s11235-015-9969-9; Chrost L, 2009, COMM COM INF SC, V39, P168, DOI 10.1007/978-3-642-02671-3_20; Chydzinski A., 2010, Proceedings of the 2010 Second International Conference on Advances in Future Internet (AFIN 2010), P88, DOI 10.1109/AFIN.2010.22; Chydzinski A, 2022, APPL MATH COMPUT, V415, DOI 10.1016/j.amc.2021.126724; Chydzinski A, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/3260428; Chydzinski A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150702; CIDON I, 1993, IEEE T INFORM THEORY, V39, P98, DOI 10.1109/18.179347; Feng CW, 2017, IEEE SYST J, V11, P2247, DOI 10.1109/JSYST.2014.2375314; Floyd S, 1993, IEEE ACM T NETWORK, V1, P397, DOI 10.1109/90.251892; Gettys J, 2011, IEEE INTERNET COMPUT, V15, P95, DOI 10.1109/MIC.2011.56; ITU-T Recommendation G.107, 2014, G107 ITUT; Kahe G, 2019, TELECOMMUN SYST, V71, P215, DOI 10.1007/s11235-018-0526-1; Khoshnevisan L, 2016, INT J SYST SCI, V47, P1586, DOI 10.1080/00207721.2014.941959; Li F, 2014, J NETW COMPUT APPL, V41, P274, DOI 10.1016/j.jnca.2014.01.005; McGowan J.W, 2005, US Patent, Patent No. [6,931,017, 6931017]; Menacer O, 2021, J ELECTR ENG TECHNOL, V16, P2235, DOI 10.1007/s42835-021-00737-1; Mrozowski P, 2018, METHODOL COMPUT APPL, V20, P97, DOI 10.1007/s11009-016-9534-3; Nichols K, 2012, COMMUN ACM, V55, P42, DOI 10.1145/2209249.2209264; Patel S, 2019, WIRELESS PERS COMMUN, V104, P37, DOI 10.1007/s11277-018-6007-8; Ren FY, 2005, IEEE COMMUN LETT, V9, P471, DOI [10.1109/LCOMM.2005.1431175, 10.1109/TCOMM.2005.05030]; Rosolen V., 1999, Computer Communication Review, V29, P23, DOI 10.1145/505724.505728; Samociuk D, 2018, 2018 41ST INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P426; Smolka B, 2004, MATH PROBL ENG, P77, DOI 10.1155/S1024123X04110016; Wang CM, 2021, IEEE T CIRCUITS-I, V68, P387, DOI 10.1109/TCSI.2020.3031663; Weijie Chen, 2010, Proceedings of the 2010 International Conference on Computational Aspects of Social Networks (CASoN 2010), P315, DOI 10.1109/CASoN.2010.77; Zhou KY, 2006, COMPUT NETW, V50, P3784, DOI 10.1016/j.comnet.2006.04.007	36	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263407	10.1371/journal.pone.0263407	http://dx.doi.org/10.1371/journal.pone.0263407			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104284	Green Published, gold			2022-12-26	WOS:000749789300004
J	Chen, Y; Yang, WH; Chen, HF; Huang, LM; Gao, JY; Lin, CW; Wang, YC; Yang, CS; Liu, YL; Hou, MH; Tsai, CL; Chou, YZ; Huang, BY; Hung, CF; Hung, YL; Wang, WJ; Su, WC; Kumar, V; Wu, YC; Chao, SW; Chang, CS; Chen, JS; Chiang, YP; Cho, DY; Jeng, LB; Tsai, CH; Hung, MC				Chen, Yeh; Yang, Wen-Hao; Chen, Hsiao-Fan; Huang, Li-Min; Gao, Jing-Yan; Lin, Cheng-Wen; Wang, Yu-Chuan; Yang, Chia-Shin; Liu, Yi-Liang; Hou, Mei-Hui; Tsai, Chia-Ling; Chou, Yi-Zhen; Huang, Bao-Yue; Hung, Chian-Fang; Hung, Yu-Lin; Wang, Wei-Jan; Su, Wen-Chi; Kumar, Vathan; Wu, Yu-Chieh; Chao, Shih-Wei; Chang, Chih-Shiang; Chen, Jin-Shing; Chiang, Yu-Ping; Cho, Der-Yang; Jeng, Long-Bin; Tsai, Chang-Hai; Hung, Mien-Chie			Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-VIVAX MALARIA; THERMAL SHIFT ASSAYS; MAIN PROTEINASE; PREVENTION; RELAPSE; COVID-19; ENTRY	The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has severely affected human lives around the world as well as the global economy. Therefore, effective treatments against COVID-19 are urgently needed. Here, we screened a library containing Food and Drug Administration (FDA)-approved compounds to identify drugs that could target the SARS-CoV-2 main protease (M-pro), which is indispensable for viral protein maturation and regard as an important therapeutic target. We identified antimalarial drug tafenoquine (TFQ), which is approved for radical cure of Plasmodium vivax and malaria prophylaxis, as a top candidate to inhibit Mpro protease activity. The crystal structure of SARS-CoV-2 M-pro in complex with TFQ revealed that TFQ non-covalently bound to and reshaped the substrate-binding pocket of Mpro by altering the loop region (residues 139-144) near the catalytic Cys145, which could block the catalysis of its peptide substrates. We also found that TFQ inhibited human trans-membrane protease serine 2 (TMPRSS2). Furthermore, one TFQ derivative, compound 7, showed a better therapeutic in-dex than TFQ on TMPRSS2 and may therefore inhibit the infectibility of SARS-CoV-2, including that of several mutant variants. These results suggest new potential strategies to block infection of SARS-CoV-2 and rising variants.	[Chen, Yeh; Wang, Yu-Chuan; Yang, Chia-Shin; Hou, Mei-Hui; Tsai, Chia-Ling; Chou, Yi-Zhen] China Med Univ, Inst New Drug Dev, Taichung, Taiwan; [Chen, Yeh; Yang, Wen-Hao; Gao, Jing-Yan; Kumar, Vathan; Chao, Shih-Wei; Chang, Chih-Shiang; Hung, Mien-Chie] China Med Univ, Drug Dev Ctr, Taichung, Taiwan; [Chen, Yeh; Yang, Wen-Hao; Wang, Wei-Jan; Hung, Mien-Chie] China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan; [Yang, Wen-Hao; Chen, Hsiao-Fan; Huang, Bao-Yue; Hung, Chian-Fang; Su, Wen-Chi; Cho, Der-Yang; Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Yang, Wen-Hao; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Huang, Li-Min; Chiang, Yu-Ping] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Gao, Jing-Yan; Wu, Yu-Chieh; Chang, Chih-Shiang] China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan; [Lin, Cheng-Wen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lin, Cheng-Wen] Asia Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Liu, Yi-Liang] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Hung, Yu-Lin] China Med Univ, Program Digital Hlth Innovat, Taichung, Taiwan; [Wang, Wei-Jan] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Chen, Jin-Shing] Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei, Taiwan; [Chen, Jin-Shing] Natl Taiwan Univ, Taipei, Taiwan; [Cho, Der-Yang] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan; [Jeng, Long-Bin; Tsai, Chang-Hai] China Med Univ, China Med Univ Hosp, Sch Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, China Med Univ Childrens Hosp, Taichung, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Chen, Y (corresponding author), China Med Univ, Inst New Drug Dev, Taichung, Taiwan.; Chen, Y; Hung, MC (corresponding author), China Med Univ, Drug Dev Ctr, Taichung, Taiwan.; Chen, Y; Hung, MC (corresponding author), China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	bluecrystalprotein@gmail.com; mhung@cmu.edu.tw	Yang, wenhao/GXG-5965-2022	Yang, Wen-Hao/0000-0002-6292-9048; Wang, Wei-Jan/0000-0002-0811-8199; Hung, Mien-Chie/0000-0003-4317-4740; Hung, Yu-Lin/0000-0002-6394-9753; CHEN, JIN-SHING/0000-0001-5077-4483; Jeng, Long-Bin/0000-0002-2928-4698	Ministry of Science and Technology, Taiwan [MOST108-2311-B-241-001, MOST109-2327-B039-003, MOST110-2923-B-039-001-MY3]; Yingtsai Young Scholar Award [CMU108-YTY-04]; "Drug Development Center, China Medical University" from the Featured Areas Research Center Program by the Ministry of Education (MOE), Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Yingtsai Young Scholar Award; "Drug Development Center, China Medical University" from the Featured Areas Research Center Program by the Ministry of Education (MOE), Taiwan	This research was supported in part by the following: The Ministry of Science and Technology, Taiwan (MOST108-2311-B-241-001; to Y. C., MOST109-2327-B039-003; to M.-C. H. and MOST110-2923-B-039-001-MY3; to C.-W. L.); Yingtsai Young Scholar Award (CMU108-YTY-04; to W.-H. Y.); the "Drug Development Center, China Medical University" from the Featured Areas Research Center Program within the Framework of the Higher Education Sprout Project by the Ministry of Education (MOE), Taiwan.	Aljoundi A, 2020, PROTEIN J, V39, P97, DOI 10.1007/s10930-020-09884-2; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Ayerbe L, 2021, LANCET RHEUMATOL, V3, pE172, DOI [10.1016/S2665-9913(21)00030-8, 10.1016/S2665-9913(21)00031-X]; Bansal P., 2021, ANN MED; Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943; Campo B, 2015, PATHOG GLOB HEALTH, V109, P107, DOI 10.1179/2047773215Y.0000000013; Cherian S., 2021, BIORXIV, DOI [10.1101/2021. 04.22.440932, DOI 10.1101/2021.04.22.440932, 10.1101/2021.04.22.440932]; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ebstie YA, 2016, DRUG DES DEV THER, V10, P2387, DOI 10.2147/DDDT.S61443; Fornasier E., 2021, BIORXIV, DOI [10.1101/2021.03.04.433882, DOI 10.1101/2021.03.04.433882]; Frampton JE, 2018, DRUGS, V78, P1517, DOI 10.1007/s40265-018-0979-2; Gordon D. E., 2020, SARS; Gunther S, 2021, SCIENCE, V372, P642, DOI 10.1126/science.abf7945; Harcourt J., 2020, EMERG INFECT DIS, DOI 10.3201/; Haston JC, 2019, MMWR-MORBID MORTAL W, V68, P1062, DOI 10.15585/mmwr.mm6846a4; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Hoffmann M., 2021, SARS COV 2; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hossain MK, 2021, EXPERT REV VACCINES, V20, P635, DOI 10.1080/14760584.2021.1915140; Hounkpatin AB, 2019, INFECT DRUG RESIST, V12, P553, DOI 10.2147/IDR.S151031; Zahradník J, 2021, bioRxiv, DOI 10.1101/2021.01.06.425392; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jirjees F, 2021, INFECT DIS REP, V13, P259, DOI 10.3390/idr13020029; Katz IT, 2021, NEW ENGL J MED, V384, P1281, DOI 10.1056/NEJMp2103614; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kumar V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179131; Lee TC, 2021, INT J INFECT DIS, V104, P671, DOI 10.1016/j.ijid.2021.01.065; Levine-Tiefenbrun M., 2021, INITIAL REPORT DECRE; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lockbaum GJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020174; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Mahmoud IS, 2020, BIOCHIMIE, V175, P93, DOI 10.1016/j.biochi.2020.05.012; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Mitja O, 2021, NEW ENGL J MED, V384, P417, DOI 10.1056/NEJMoa2021801; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Naqvi A. A. T., 2020, BIOCH BIOPHYS ACTA M; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park WB, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e84; Pawlowski C, 2021, MED-CAMBRIDGE, V2, P979, DOI 10.1016/j.medj.2021.06.007; Pillaiyar T, 2016, J MED CHEM, V59, P6595, DOI 10.1021/acs.jmedchem.5b01461; Ragia G, 2020, EUR J CLIN PHARMACOL, V76, P1623, DOI 10.1007/s00228-020-02963-4; Reynolds C. J., UK COVIDSOR TIUM IMM, P2021; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Seetoh WG, 2016, J AM CHEM SOC, V138, P14303, DOI 10.1021/jacs.6b07440; Singh J, 2021, NAT MED, V27, P1131, DOI 10.1038/s41591-021-01397-4; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; Su H, 2020, BIORXIV, DOI [10.1101/2020.04.13.038687v1, DOI 10.1101/2020.04.13.038687, 10.1101/2020.04.13.038687]; Tada T., 2021, BIORXIV2021051444407, DOI [10.1101/2021.05.14.444076, DOI 10.1101/2021.05.14.444076]; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; Vaidyanathan G, 2021, NATURE, V593, P321, DOI 10.1038/d41586-021-01274-7; Verschueren KHG, 2008, CHEM BIOL, V15, P597, DOI 10.1016/j.chembiol.2008.04.011; Vicenzi E, 2004, EMERG INFECT DIS, V10, P413, DOI 10.3201/eid1003.030683; Wang P., 2021, RESEARCHSQUARE, V593, P130, DOI [11.17.516888, DOI 10.21203/RS.3.RS-1708394/V1]; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wang YC, 2020, AM J CANCER RES, V10, P2535; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Woolger N, 2017, J BIOL CHEM, V292, P18577, DOI 10.1074/jbc.M117.790014; World Health Organization, 2021, NOV COR 2019 NCOV SI; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xiu SY, 2020, J MED CHEM, V63, P12256, DOI 10.1021/acs.jmedchem.0c00502; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; Yang H., 2003, P NATL ACAD SCI USA; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	70	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101658	10.1016/j.jbc.2022.101658	http://dx.doi.org/10.1016/j.jbc.2022.101658			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101449	gold, Green Published			2022-12-26	WOS:000794865600003
J	Morrison, JJ; Conti, J; Camberg, JL				Morrison, Josiah J.; Conti, Joseph; Camberg, Jodi L.			Assembly and architecture of Escherichia coli divisome proteins FtsA and FtsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION GENE; Z-RING; SELF-INTERACTION; ATP HYDROLYSIS; SWISS-MODEL; COLI FTSA; ACTIN; ZIPA; RECRUITMENT; ACTIVATION	During Escherichia coli cell division, an intracellular complex of cell division proteins known as the Z-ring assembles at midcell during early division and serves as the site of constriction. While the predominant protein in the Z-ring is the widely conserved tubulin homolog FtsZ, the actin homolog FtsA tethers the Z-ring scaffold to the cytoplasmic membrane by binding to FtsZ. While FtsZ is known to function as a dynamic, polymerized GTPase, the assembly state of its partner, FtsA, and the role of ATP are still unclear. We report that a substitution mutation in the FtsA ATP-binding site impairs ATP hydrolysis, phospholipid vesicle remodeling in vitro, and Z-ring assembly in vivo. We demonstrate by transmission electron microscopy and Forster Resonance Energy Transfer that a truncated FtsA variant, FtsA(& UDelta;MTS) lacking a C -terminal membrane targeting sequence, self assembles into ATP dependent filaments. These filaments coassemble with FtsZ polymers but are destabilized by unassembled FtsZ. These findings suggest a model wherein ATP binding drives FtsA polymerization and membrane remodeling at the lipid surface, and FtsA polymerization is coregulated with FtsZ polymerization. We conclude that the coordinated assembly of FtsZ and FtsA polymers may serve as a key checkpoint in division that triggers cell wall synthesis and division progression.	[Morrison, Josiah J.; Conti, Joseph; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Rhode Island	Camberg, JL (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	cambergj@uri.edu			National Institute of General Medical Sciences of the National Institutes of Health [R01GM118927]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM118927 to J. L. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the authors' respective institutions.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Caldas P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13702-4; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chou SZ, 2019, P NATL ACAD SCI USA, V116, P4265, DOI 10.1073/pnas.1807028115; Conti J, 2018, MOL MICROBIOL, V107, P558, DOI 10.1111/mmi.13902; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Du SS, 2020, MBIO, V11, DOI 10.1128/mBio.01247-20; Du SS, 2019, TRENDS MICROBIOL, V27, P781, DOI 10.1016/j.tim.2019.04.011; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Du SS, 2016, P NATL ACAD SCI USA, V113, pE5052, DOI 10.1073/pnas.1606656113; FOWLER WE, 1983, J CELL BIOL, V97, P264, DOI 10.1083/jcb.97.1.264; GAYDA RC, 1992, J BACTERIOL, V174, P5362, DOI 10.1128/JB.174.16.5362-5370.1992; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; GERSHMAN LC, 1984, BIOCHEMISTRY-US, V23, P2199, DOI 10.1021/bi00305a015; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Gurung R, 2016, BIOCHEM J, V473, P383, DOI 10.1042/BJ20151050; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; HANSON J, 1965, BRIT MED BULL, V21, P264, DOI 10.1093/oxfordjournals.bmb.a070407; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Krupka M, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15957; Krupka M, 2014, MBIO, V5, DOI 10.1128/mBio.02221-14; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; McCullagh M, 2014, J AM CHEM SOC, V136, P13053, DOI 10.1021/ja507169f; Merino F, 2018, NAT STRUCT MOL BIOL, V25, P531, DOI 10.1038/s41594-018-0074-0; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Nag D, 2020, INT J BIOL MACROMOL, V142, P18, DOI 10.1016/j.ijbiomac.2019.11.217; Ostrowska Z, 2017, POSTEP HIG MED DOSW, V71, P339; Park KT, 2020, MBIO, V11, DOI 10.1128/mBio.03012-20; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Pichoff S, 2018, P NATL ACAD SCI USA, V115, pE6855, DOI 10.1073/pnas.1806450115; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Shaevitz JW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000364; Soderstrom B, 2016, MOL MICROBIOL, V101, P425, DOI 10.1111/mmi.13400; Stoddard PR, 2017, MOL BIOL CELL, V28, P2461, DOI 10.1091/mbc.E15-11-0778; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tsang MJ, 2015, CURR OPIN MICROBIOL, V24, P60, DOI 10.1016/j.mib.2015.01.002; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Vega DE, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00579-18; Viola MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170505; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yan K, 2000, BIOCHEM BIOPH RES CO, V270, P387, DOI 10.1006/bbrc.2000.2439; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	65	1	1	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101663	10.1016/j.jbc.2022.101663	http://dx.doi.org/10.1016/j.jbc.2022.101663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35104502	gold, Green Published			2022-12-26	WOS:000794865600009
J	Xin, Y; Shen, C; Tang, MW; Guo, ZT; Shi, Y; Gu, ZH; Shao, J; Zhang, L				Xin, Yu; Shen, Chen; Tang, Mengwei; Guo, Zitao; Shi, Yi; Gu, Zhenghua; Shao, Jun; Zhang, Liang			Recreating the natural evolutionary trend in key microdomains provides an effective strategy for engineering of a thermomicrobial N-demethylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOSINE OXIDASE; METHYLATION; AMINES; EXPRESSION; MECHANISM; PEPTIDES; REVEALS; IMPACT; BASES; SITE	N-demethylases have been reported to remove the methyl groups on primary or secondary amines, which could further affect the properties and functions of biomacromolecules or chemical compounds; however, the substrate scope and the robustness of N-demethylases have not been systematically investigated. Here we report the recreation of natural evolution in key microdomains of the Thermomicrobium roseum sarcosine oxidase (TrSOX), an N-demethylase with marked stability (melting temperature over 100(degrees)C) and enantioselectivity, for enhanced substrate scope and catalytic efficiency on -C-Nbonds. We obtained the structure of TrSOX by crystallization and X-ray diffraction (XRD) for the initial framework. The natural evolution in the nonconserved residues of key microdomains-including the catalytic loop, coenzyme pocket, substrate pocket, and entrance site-was then identified using ancestral sequence reconstruction (ASR), and the substitutions that accrued during natural evolution were recreated by site directed mutagenesis. The single and double substitution variants catalyzed the N-demethylation of N-methyl-L-amino acids up to 1800- and 6000-fold faster than the wild type, respectively. Additionally, these single substitution variants catalyzed the terminal N-demethylation of non-amino-acid compounds and the oxidation of the main chain -C-N- bond to a -C=N- bond in the nitrogen-containing heterocycle. Notably, these variants retained the enantioselectivity and stability of the initial framework. We conclude that the variants of TrSOX are of great potential use in N-methyl enantiomer resolution, main-chain Schiff base synthesis, and alkaloid modification or degradation.	[Xin, Yu; Shen, Chen; Tang, Mengwei; Guo, Zitao; Shi, Yi; Gu, Zhenghua; Zhang, Liang] Jiangnan Univ, Key Lab Ind Biotechnol, Natl Engn Lab Cereal Fermentat Technol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Shao, Jun] Nanjing Med Univ, Dept Ophthalmol, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Nanjing Medical University	Xin, Y; Zhang, L (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Natl Engn Lab Cereal Fermentat Technol, Minist Educ, Wuxi, Jiangsu, Peoples R China.; Shao, J (corresponding author), Nanjing Med Univ, Dept Ophthalmol, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China.	yuxin@jiangnan.edu.cn; shaojun@njmu.edu.cn; zhangl@jiangnan.edu.cn	Xin, Yu/AAG-8968-2021; Shao, Jun/AAX-5904-2021	Xin, Yu/0000-0002-5396-4319; Shao, Jun/0000-0003-3477-4568	National Key Research and Development Program of China [2021YFC2100303]; National Natural Science Foundation of China [81970819]; Natural Science Foundation of Jiangsu Province [BK20160053, BE2018055]; Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee [2020012]; Priority Academic Program Development of Jiangsu Higher Education Institutions, 111 Project [111-2-06]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee; Priority Academic Program Development of Jiangsu Higher Education Institutions, 111 Project	This work was supported by National Key Research and Development Program of China (2021YFC2100303); National Natural Science Foundation of China (Grant No. 81970819); Natural Science Foundation of Jiangsu Province (BK20160053 and BE2018055); Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee (2020012); Priority Academic Program Development of Jiangsu Higher Education Institutions, 111 Project (No. 111-2-06). The authors are grateful to Shanghai Medicilon Inc for technological support. We thank the staff at the Beamline 17U, Shanghai Synchrotron Radiation Facility (SSRF).	Abe Y, 2017, PHYS CHEM CHEM PHYS, V19, P9811, DOI 10.1039/c6cp08172j; Augustin MM, 2019, NAT SUSTAIN, V2, P465, DOI 10.1038/s41893-019-0302-6; Ayuso-Fernandez I, 2019, P NATL ACAD SCI USA, V116, P17900, DOI 10.1073/pnas.1905040116; Bobbink FD, 2017, NAT PROTOC, V12, P417, DOI 10.1038/nprot.2016.175; Cappelletti P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196283; Chatterjee J, 2013, ANGEW CHEM INT EDIT, V52, P254, DOI 10.1002/anie.201205674; Chen YS, 2020, CHEM-EUR J, V26, P2973, DOI 10.1002/chem.201905505; Clifton BE, 2018, NAT CHEM BIOL, V14, P542, DOI 10.1038/s41589-018-0043-2; Farber Nuri B, 2019, Handb Exp Pharmacol, V250, P287, DOI 10.1007/164_2018_165; Gao QY, 2021, INT J BIOL MACROMOL, V178, P434, DOI 10.1016/j.ijbiomac.2021.02.176; Ghislandi AB, 2020, J MOL NEUROSCI, V70, P590, DOI 10.1007/s12031-019-01463-0; Glotz G, 2020, ORG LETT, V22, P6891, DOI 10.1021/acs.orglett.0c02424; Hameed A, 2017, EXPERT OPIN THER PAT, V27, P63, DOI 10.1080/13543776.2017.1252752; Han HaoLei, 2021, Shipin Kexue / Food Science, V42, P255, DOI 10.7506/spkx1002-6630-20200708-106; Hassan-Abdalla A, 2008, BIOCHEMISTRY-US, V47, P2913, DOI 10.1021/bi702351v; Hsu A, 2018, METHODS, V138, P76, DOI 10.1016/j.ymeth.2017.12.020; Ilari A, 2008, PROTEINS, V71, P2065, DOI 10.1002/prot.21898; Janik E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051181; Johnson RC, 2009, J ANAL TOXICOL, V33, P77, DOI 10.1093/jat/33.2.77; Jorns MS, 2010, BIOCHEMISTRY-US, V49, P3631, DOI 10.1021/bi100160j; Kazlauskas R, 2018, CHEM SOC REV, V47, P9026, DOI 10.1039/c8cs00014j; KEDDERIS GL, 1983, J BIOL CHEM, V258, P8129; Kok GB, 2010, J ORG CHEM, V75, P4806, DOI 10.1021/jo1008492; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lauterbach E. H, 2009, Deme-thylation of 14-hydroxy substituted alkaloid derivatives, Patent No. [US2009/0163717A1, 20090163717]; Li WJ, 2018, CHEM COMMUN, V54, P1865, DOI 10.1039/c7cc09201f; Liu Q, 2019, BIOTECHNOL ADV, V37, P530, DOI 10.1016/j.biotechadv.2018.10.011; Mathis D, 2020, J INHERIT METAB DIS, V43, P1102, DOI 10.1002/jimd.12244; McBrayer DN, 2019, ACS INFECT DIS, V5, P1035, DOI 10.1021/acsinfecdis.9b00097; Mori S, 2018, NAT CHEM BIOL, V14, P428, DOI 10.1038/s41589-018-0014-7; Nagata K, 2005, P JPN ACAD B-PHYS, V81, P220, DOI 10.2183/pjab.81.220; Negreira N, 2014, SCI TOTAL ENVIRON, V497, P68, DOI 10.1016/j.scitotenv.2014.07.101; Ongpipattanakul C, 2018, ACS CHEM BIOL, V13, P2989, DOI 10.1021/acschembio.8b00668; Peat AJ, 1996, J AM CHEM SOC, V118, P1028, DOI 10.1021/ja953080t; Qin J, 2021, NAT PROD RES, V35, P3254, DOI 10.1080/14786419.2019.1696334; Rader AFB, 2018, BIOORGAN MED CHEM, V26, P2766, DOI 10.1016/j.bmc.2017.08.031; Rosenau T, 2004, ORG LETT, V6, P541, DOI 10.1021/ol036319g; Schriever K, 2021, J AM CHEM SOC, V143, P3794, DOI 10.1021/jacs.0c10214; Sciabola S, 2016, BIOORGAN MED CHEM, V24, P3513, DOI 10.1016/j.bmc.2016.05.062; Selfridge BR, 2015, J MED CHEM, V58, P5038, DOI 10.1021/acs.jmedchem.5b00426; Sun ZT, 2019, CHEM REV, V119, P1626, DOI 10.1021/acs.chemrev.8b00290; Dang TT, 2015, ACS CATAL, V5, P4082, DOI 10.1021/acscatal.5b00606; Vallejo-Lopez M, 2017, CHEM-EUR J, V23, P16491, DOI 10.1002/chem.201702232; van der Velden NS, 2017, NAT CHEM BIOL, V13, P833, DOI 10.1038/nchembio.2393; von Braun J, 1909, BER DTSCH CHEM GES, V42, P2035; Nguyen V, 2017, SCIENCE, V355, P289, DOI 10.1126/science.aah3717; Wicks Christopher, 2021, Alkaloids Chem Biol, V86, P145, DOI 10.1016/bs.alkal.2021.04.001; Xin Y, 2021, FRONT CHEM SCI ENG, V15, P615, DOI 10.1007/s11705-020-1989-7; Xin Y, 2019, MOL CATAL, V464, P48, DOI 10.1016/j.mcat.2018.12.021; Yi XW, 2020, ORG LETT, V22, P4583, DOI 10.1021/acs.orglett.0c00863; Yu HR, 2015, BBA-PROTEINS PROTEOM, V1854, P65, DOI 10.1016/j.bbapap.2014.10.017; Zamanian G, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107343; Zhao Senzhi, 2021, Alkaloids Chem Biol, V86, P1, DOI 10.1016/bs.alkal.2021.05.001	53	1	1	6	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101656	10.1016/j.jbc.2022.101656	http://dx.doi.org/10.1016/j.jbc.2022.101656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35124004	gold, Green Published			2022-12-26	WOS:000794865600010
J	Hong, S; Park, KH; Lee, YE; Lee, JE; Kim, YM; Joo, E; Cho, I				Hong, Subeen; Park, Kyo Hoon; Lee, Young Eun; Lee, Ji Eun; Kim, Yu Mi; Joo, Eunwook; Cho, Iseop			Antibody microarray analysis of amniotic fluid proteomes in women with cervical insufficiency and short cervix, and their association with pregnancy latency length	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; NECROSIS-FACTOR-ALPHA; PRETERM BIRTH; PREDICTION; INFECTION; CERCLAGE; RECEPTOR; INFLAMMATION; INTERLEUKIN-6; INCOMPETENCE	Introduction This study aimed to investigate amniotic fluid (AF) proteins that were differentially expressed between patients with cervical insufficiency (CI) and asymptomatic short cervix (SCX, <= 25 mm), and whether these proteins could be predictive of spontaneous preterm birth (SPTB) in these patients. Method This was a retrospective cohort study of 129 singleton pregnant women with CI (n = 80) or SCX (n = 49) at 17 to 26 weeks who underwent amniocentesis. An antibody microarray was used to perform comparative proteomic profiling of AF from matched CI (n = 20) and SCX (n = 20) pregnancies. In the total cohort, an ELISA validation study was performed for 15 candidate proteins of interest. Subgroup analyses of patients with CI and SCX were conducted to evaluate the association between the 15 proteins and SPTB at < 32 weeks of gestation. Results Eighty-six proteins showed intergroup differences. ELISA validation confirmed significantly higher levels of AF EN-RAGE, IL-8, lipocalin-2, MMP-9, S100A8/A9, thrombospondin-2, and TNFR2 in patients with CI than in those with SCX. Multivariable analysis showed that increased AF levels of EN-RAGE, S100A8/A9, and uPA were independently associated with SPTB at < 32 weeks in patients with CI; whereas in patients with SCX, high AF levels of APRIL, EN-RAGE, LBP, and TNFR2 were independently associated with SPTB at < 32 weeks. Conclusions Multiple AF proteins show altered expression in patients with CI compared with SCX controls. Moreover, several novel mediators involved in inflammation were identified as potential biomarkers for predicting SPTB after the diagnosis of CI and SCX. These results provide new insights into target-specific molecules for targeted therapies to prevent SPTB in patients with CI/SCX.	[Hong, Subeen] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Kyo Hoon; Lee, Young Eun; Kim, Yu Mi; Joo, Eunwook; Cho, Iseop] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Coll Med, Seongnam, South Korea; [Lee, Ji Eun] Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Div, Seoul, South Korea	Catholic University of Korea; Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Coll Med, Seongnam, South Korea.	pkh0419@snubh.org			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1F1A1048362]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1F1A1048362). The sponsor or funding organization had no role in the design or conduct of this research. The author who received grant is KH Park. URL of the funder: https://www.nrf.re.kr/eng/index.	Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; [Anonymous], 2014, Obstet Gynecol, V123, P372, DOI 10.1097/01.AOG.0000443276.68274.cc; Braekke K, 2005, AM J OBSTET GYNECOL, V193, P227, DOI 10.1016/j.ajog.2004.11.055; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi IA, 2008, OBSTET GYNECOL, V111, P403, DOI 10.1097/AOG.0b013e31816102aa; Buhimschi IA, 2007, AM J OBSTET GYNECOL, V197, pS11, DOI 10.1016/j.ajog.2007.10.026; Chen ZQ, 2018, CLIN PROTEOM, V15, DOI 10.1186/s12014-018-9184-2; Dashe J. S., 2014, WILLAMS OBSTET EDITO; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Espinoza J, 2002, J Matern Fetal Neonatal Med, V12, P313; Gardella C, 2001, AM J OBSTET GYNECOL, V184, P1241, DOI 10.1067/mob.2001.113908; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Govia RNM, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13030; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; HALLMANN R, 1993, BEHR INST MITT, V92, P138; HARGER JH, 1983, CLIN PERINATOL, V10, P321, DOI 10.1016/S0095-5108(18)30969-2; Hassan S, 2006, J PERINAT MED, V34, P13, DOI 10.1515/JPM.2006.002; Hong S, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13371; HOOVER RL, 1980, J CELL SCI, V45, P73; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Jung EY, 2016, INT J GYNECOL OBSTET, V132, P165, DOI 10.1016/j.ijgo.2015.07.011; Jung EY, 2015, ARCH GYNECOL OBSTET, V292, P579, DOI 10.1007/s00404-015-3684-3; Kalan AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.013; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Keeler SM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.045; Kiefer DG, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.002; Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047; Kim YM, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e220; Kokenyesi R, 2004, BIOL REPROD, V70, P385, DOI 10.1095/biolreprod.102.014704; Kostakis ID, 2010, EUR J OBSTET GYN R B, V151, P3, DOI 10.1016/j.ejogrb.2010.03.006; Kusonmano K, 2012, SCI WORLD J, DOI 10.1100/2012/278352; Kuusela P, 2015, ACTA OBSTET GYN SCAN, V94, P598, DOI 10.1111/aogs.12622; Langat DL, 2008, AM J PATHOL, V172, P1303, DOI 10.2353/ajpath.2008.071139; Lee SM, 2016, J OBSTET GYNAECOL RE, V42, P776, DOI 10.1111/jog.12976; Lee SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.047; Lee SY, 2013, J KOREAN MED SCI, V28, P1226, DOI 10.3346/jkms.2013.28.8.1226; Li D, 1999, J GASTROEN HEPATOL, V14, P618, DOI 10.1046/j.1440-1746.1999.01928.x; LIDEGAARD O, 1994, ACTA OBSTET GYN SCAN, V73, P35, DOI 10.3109/00016349409013390; Lui S, 2018, BIOL REPROD, V98, P422, DOI 10.1093/biolre/iox186; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Mahmood N, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00024; Maymon E, 1999, AM J OBSTET GYNECOL, V181, P1142, DOI 10.1016/S0002-9378(99)70097-9; Medler J, 2019, EXPERT OPIN THER TAR, V23, P295, DOI 10.1080/14728222.2019.1586886; Meijer B, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/907078; Park H, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e26; Park JW, 2019, REPROD SCI, V26, P1476, DOI 10.1177/1933719119828043; ROMERO R, 1992, AM J OBSTET GYNECOL, V167, P1086, DOI 10.1016/S0002-9378(12)80043-3; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2006, AM J OBSTET GYNECOL, V194, P1, DOI 10.1016/j.ajog.2005.12.002; SO T, 1992, BIOL REPROD, V46, P772, DOI 10.1095/biolreprod46.5.772; Son GH, 2016, AM J REPROD IMMUNOL, V75, P155, DOI 10.1111/aji.12451; Spong CY, 1998, AM J OBSTET GYNECOL, V178, P783, DOI 10.1016/S0002-9378(98)70492-2; Suh YH, 2007, J KOREAN MED SCI, V22, P89, DOI 10.3346/jkms.2007.22.1.89; Tarca AL, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12686; Telaar Anna, 2010, Advances in Bioinformatics, V2010, P318573, DOI 10.1155/2010/318573; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Vaisbuch E, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.007; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; WATANABE T, 1993, AM J OBSTET GYNECOL, V168, P1283, DOI 10.1016/0002-9378(93)90381-R; Weiner CP, 2005, AM J OBSTET GYNECOL, V192, P710, DOI 10.1016/j.ajog.2004.10.588; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xiao Z, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.579036; Yang SJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00784; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yoo HN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180878; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	69	4	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263586	10.1371/journal.pone.0263586	http://dx.doi.org/10.1371/journal.pone.0263586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130326	Green Published, gold			2022-12-26	WOS:000805530700037
J	Khanam, R; Applegate, J; Nisar, I; Dutta, A; Rahman, S; Nizar, A; Ali, SM; Chowdhury, NH; Begum, F; Dhingra, U; Tofail, F; Mehmood, U; Deb, S; Ahmed, S; Muhammad, S; Das, S; Ahmed, S; Mittal, H; Minckas, N; Yoshida, S; Bahl, R; Jehan, F; Sazawal, S; Baqui, AH				Khanam, Rasheda; Applegate, Jennifer; Nisar, Imran; Dutta, Arup; Rahman, Sayedur; Nizar, Ambreen; Ali, Said Mohammed; Chowdhury, Nabidul Haque; Begum, Farzana; Dhingra, Usha; Tofail, Fahmida; Mehmood, Usma; Deb, Saikat; Ahmed, Salahuddin; Muhammad, Sajid; Das, Sayan; Ahmed, Saifuddin; Mittal, Harshita; Minckas, Nicole; Yoshida, Sachiyo; Bahl, Rajiv; Jehan, Fyezah; Sazawal, Sunil; Baqui, Abdullah H.			Burden and risk factors for antenatal depression and its effect on preterm birth in South Asia: A population-based cohort study	PLOS ONE			English	Article							NEONATAL OUTCOMES; PREGNANCY; ANXIETY; WOMEN; EPIDEMIOLOGY; DISORDERS; COUNTRIES; DELIVERY; VALIDITY; PHQ-9	Introduction Women experience high rates of depression, particularly during pregnancy and the postpartum periods. Using population-based data from Bangladesh and Pakistan, we estimated the burden of antenatal depression, its risk factors, and its effect on preterm birth. Methods The study uses the following data: maternal depression measured between 24 and 28 weeks of gestation using the 9-question Patient Health Questionnaire (PHQ-9); data on pregnancy including an ultrasound before 19 weeks of gestation; data on pregnancy outcomes; and data on woman's age, education, parity, weight, height, history of previous illness, prior miscarriage, stillbirth, husband's education, and household socioeconomic data collected during early pregnancy. Using PHQ-9 cutoff score of >= 12, women were categorized into none to mild depression or moderate to moderately severe depression. Using ultrasound data, preterm birth was defined as babies born <37 weeks of gestation. To identify risk ratios (RR) for antenatal depression, unadjusted and adjusted RR and 95% confidence intervals (CI) were calculated using log- binomial model. Log-binomial models were also used for determining the effect of antenatal depression on preterm birth adjusting for potential confounders. Data were analyzed using Stata version 16 (Stata-Corp LP). Results About 6% of the women reported moderate to moderately severe depressive symptoms during the antenatal period. A parity of >= 2 and the highest household wealth status were associated with an increased risk of depression. The overall incidence of preterm birth was 13.4%. Maternal antenatal depression was significantly associated with the risk of preterm birth (ARR, 95% CI: 1.34, 1.02-1.74). Conclusion The increased risk of preterm birth in women with antenatal depression in conjunction with other significant risk factors suggests that depression likely occurs within a constellation of other risk factors. Thus, to effectively address the burden of preterm birth, programs require developing and providing integrated care addressing multiple risk factors.	[Khanam, Rasheda; Applegate, Jennifer; Baqui, Abdullah H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Nisar, Imran; Nizar, Ambreen; Begum, Farzana; Mehmood, Usma; Muhammad, Sajid; Jehan, Fyezah] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Sindh, Pakistan; [Dutta, Arup; Dhingra, Usha; Deb, Saikat; Das, Sayan; Mittal, Harshita; Sazawal, Sunil] Ctr Publ Hlth Kinet, Global Div, New Delhi, India; [Rahman, Sayedur; Chowdhury, Nabidul Haque; Ahmed, Salahuddin] Projahnmo Res Fdn, Dhaka, Bangladesh; [Ali, Said Mohammed; Deb, Saikat; Sazawal, Sunil] Publ Hlth Lab IDC, Chake Chake, Pemba, Tanzania; [Tofail, Fahmida] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Ahmed, Saifuddin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Minckas, Nicole; Yoshida, Sachiyo; Bahl, Rajiv] WHO MCA MRD, Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khanam, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Bahl, R (corresponding author), WHO MCA MRD, Geneva, Switzerland.	Rkhanam1@jhu.edu; bahlr@who.int	Rahman, Sayedur/R-2843-2018	Rahman, Sayedur/0000-0002-4445-3699; CHOWDHURY, MD NABIDUL HAQUE/0000-0002-6149-1152	Bill & Melinda Gates Foundation [OPP1054163]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The AMANHI study was funded by the Bill & Melinda Gates Foundation (Award No: OPP1054163). The funders had no role in study design, data collection and data analysis, decision to publish, or preparation of the manuscript.	Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Andersson L, 2004, OBSTET GYNECOL, V104, P467, DOI 10.1097/01.AOG.0000135277.04565.e9; Azami M, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0732-3; Baqui AH, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.021202; Baron EC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1291-z; Becker M, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0664-7; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Biaggi A, 2016, J AFFECT DISORDERS, V191, P62, DOI 10.1016/j.jad.2015.11.014; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; Chaplin AB, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03207-0; Dadi AF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227323; Falah-Hassani K, 2017, PSYCHOL MED, V47, P2041, DOI 10.1017/S0033291717000617; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Gilbody S, 2007, BRIT J GEN PRACT, V57, P650; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jarde A, 2016, JAMA PSYCHIAT, V73, P826, DOI 10.1001/jamapsychiatry.2016.0934; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessous R, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.041; Khanam R, 2019, EUR J CLIN NUTR, V73, P733, DOI 10.1038/s41430-018-0237-4; Knight AK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7040015; Kozhimannil KB, 2009, JAMA-J AM MED ASSOC, V301, P842, DOI 10.1001/jama.2009.201; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li D, 2009, HUM REPROD, V24, P146, DOI 10.1093/humrep/den342; Lopez-de-Andres A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020582; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Maynard M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071424; Melbye M, 1999, BRIT J CANCER, V80, P609, DOI 10.1038/sj.bjc.6690399; Menard C, 2016, NEUROSCIENCE, V321, P138, DOI 10.1016/j.neuroscience.2015.05.053; Okagbue Hilary I, 2019, Open Access Maced J Med Sci, V7, P1555, DOI 10.3889/oamjms.2019.270; Park GY, 2019, J MATERN-FETAL NEO M, V32, P1938, DOI 10.1080/14767058.2017.1421934; Pearlstein T, 2015, BEST PRACT RES CL OB, V29, P754, DOI 10.1016/j.bpobgyn.2015.04.004; Pearson RM, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0725; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Razieh C, 2019, DIABETIC MED, V36, P1158, DOI 10.1111/dme.13986; Read JR, 2017, J AFFECT DISORDERS, V221, P36, DOI 10.1016/j.jad.2017.06.009; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Shah R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-112; Staneva A, 2015, WOMEN BIRTH, V28, P179, DOI 10.1016/j.wombi.2015.02.003; Stein A, 2012, J ABNORM PSYCHOL, V121, P795, DOI 10.1037/a0026847; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157; Tang J, 2021, BMJ OPEN DIAB RES CA, V9, DOI 10.1136/bmjdrc-2020-001641; Ververs T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-119; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2015, MENT HLTH ATL 2014, V2015; World Health Organization, 2017, US; World Health Organization, 2016, WHO GUID APPR GUID R, V2016	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263091	10.1371/journal.pone.0263091	http://dx.doi.org/10.1371/journal.pone.0263091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130270	Green Published, gold			2022-12-26	WOS:000805530700017
J	Lin, LF; Shi, KX; Zhou, SQ; Cai, MC; Zhang, CY; Sun, YH; Zang, JY; Cheng, L; Ye, KY; Ma, PF; Shen, PY; Zhang, MY; Cheng, Y; Qi, CT; Li, Y; Yin, X; Zheng, YY; Tan, L; Zhuang, GL; Zang, RY				Lin, Lifeng; Shi, Kaixuan; Zhou, Shaoqing; Mei-Chun Cai; Zhang, Caiyan; Sun, Yunheng; Zang, Jingyu; Cheng, Lin; Ye, Kaiyan; Ma, Pengfei; Shen, Peiye; Zhang, Meiying; Cheng, Yan; Qi, Chunting; Li, Ying; Yin, Xia; Zheng, Yiyan; Tan, Li; Zhuang, Guanglei; Zang, Rongyu			SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer	ONCOGENE			English	Article							CELL; REGULATORS; ADDICTION; SPECIFICATION; DEPENDENCIES; BINDING	Mu''llerian tissue-specific oncogenes, prototyped by PAX8, underlie ovarian tumorigenesis and represent unique molecular vulnerabilities. Further delineating such lineage-dependency factors and associated therapeutic implications would provide valuable insights into ovarian cancer biology and treatment. In this study, we identified SOX17 as a new lineage-survival master transcription factor, which shared co-expression pattern with PAX8 in epithelial ovarian carcinoma. Genetic disruption of SOX17 or PAX8 analogously inhibited neoplastic cell viability and downregulated a spectrum of lineage-related transcripts. Mechanistically, we showed that SOX17 physically interacted with PAX8 in cultured cell lines and clinical tumor specimens. The two nuclear proteins bound to overlapping genomic regions and regulated a common set of downstream genes, including those involved in cell cycle and tissue morphogenesis. In addition, we revealed that small-molecule inhibitors of transcriptional cyclin-dependent kinases (CDKs) effectively reduced SOX17 and PAX8 expression. ZSQ1722, a novel orally bioavailable CDK12/13 covalent antagonist, exerted potent anti-tumor activity in xenograft models. These findings shed light on an actionable lineage-survival transcriptional complex in ovarian cancer, and facilitated drug discovery by generating a serial of candidate compounds to pharmacologically target this difficult-to-treat malignancy.	[Lin, Lifeng; Zheng, Yiyan; Zang, Rongyu] Fudan Univ, Zhongshan Hosp, Dept Gynecol Oncol, Ovarian Canc Program, Shanghai, Peoples R China; [Shi, Kaixuan; Sun, Yunheng; Zang, Jingyu; Cheng, Lin; Ye, Kaiyan; Ma, Pengfei; Shen, Peiye; Zhang, Meiying; Yin, Xia; Zhuang, Guanglei] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Dept Obstet & Gynecol,Ren Ji Hosp, Shanghai, Peoples R China; [Shi, Kaixuan; Sun, Yunheng; Zang, Jingyu; Cheng, Lin; Ye, Kaiyan; Ma, Pengfei; Shen, Peiye; Zhang, Meiying; Yin, Xia; Zhuang, Guanglei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Shanghai Key Lab Gynecol Oncol, Sch Med, Shanghai, Peoples R China; [Zhou, Shaoqing; Cheng, Yan; Qi, Chunting; Li, Ying; Tan, Li] Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China; [Zhou, Shaoqing; Tan, Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mei-Chun Cai; Zhang, Caiyan] Shanghai Jiao Tong Univ, Ren Ji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Zang, RY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gynecol Oncol, Ovarian Canc Program, Shanghai, Peoples R China.; Zhuang, GL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Dept Obstet & Gynecol,Ren Ji Hosp, Shanghai, Peoples R China.; Zhuang, GL (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Shanghai Key Lab Gynecol Oncol, Sch Med, Shanghai, Peoples R China.; Tan, L (corresponding author), Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China.; Tan, L (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	tanli@sioc.ac.cn; zhuangguanglei@gmail.com; zang.rongyu@zs-hospital.sh.cn	张, 梅莹/GPC-5265-2022	lin, lifeng/0000-0002-5160-9145	National Natural Science Foundation of China [81972429, 81922047, 82172596, 82173077, 82173111]; Science and Technology Commission of Shanghai Municipality [18140902300, 18JC1420500]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20161313]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; Shanghai Natural Science Foundation [20ZR1433100]; Shanghai Shenkang Hospital Development Center [SHDC2020CR3057B]; Shanghai Collaborative Innovation Center for Translational Medicine [TM202004]; Beijing Kuanghua foundation for the development of Chinese and Western Medicine (BKF) [KH-2021-LLZX-018]; Shanghai Jiao Tong University School of Medicine [YG2021GD02, TMSK-2021-207]; Shanghai Key Laboratory of Gynecologic Oncology [FKZL-2018-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Shanghai Municipal Science and Technology Major Project; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Shenkang Hospital Development Center; Shanghai Collaborative Innovation Center for Translational Medicine; Beijing Kuanghua foundation for the development of Chinese and Western Medicine (BKF); Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Gynecologic Oncology	This work was supported by the National Natural Science Foundation of China (81972429 to RZ; 81922047 and 82172596 to GZ; 82173077 to XY; 82173111 to MZ), the Science and Technology Commission of Shanghai Municipality (18140902300 to RZ; 18JC1420500 to LT), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20161313 to GZ), Shanghai Municipal Science and Technology Major Project (Grant No. 2019SHZDZX02 to LT), Shanghai Natural Science Foundation (20ZR1433100 to XY), Shanghai Shenkang Hospital Development Center (SHDC2020CR3057B to XY), Shanghai Collaborative Innovation Center for Translational Medicine (TM202004 to XY), Beijing Kuanghua foundation for the development of Chinese and Western Medicine (BKF) (KH-2021-LLZX-018 to XY), Shanghai Jiao Tong University School of Medicine (YG2021GD02 and TMSK-2021-207 to XY), the grants from Shanghai Key Laboratory of Gynecologic Oncology (FKZL-2018-02 to PM).	Ashrafizadeh M, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105159; Augert A, 2014, CANCER CELL, V26, P783, DOI 10.1016/j.ccell.2014.11.012; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Bleu M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22708-w; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Brien GL, 2016, CANCER CELL, V29, P464, DOI 10.1016/j.ccell.2016.03.007; Cai MC, 2020, J PATHOL, V251, P147, DOI 10.1002/path.5435; Cai MC, 2019, INT J CANCER, V144, P788, DOI 10.1002/ijc.31975; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chaves-Moreira D, 2020, BIORXIV, DOI [10.1101/2020.09.09.290387, DOI 10.1101/2020.09.09.290387]; Chaves-Moreira D, 2021, CANCER RES, V81, P806, DOI 10.1158/0008-5472.CAN-20-3173; Chen Y, 2020, ONCOGENE, V39, P6633, DOI 10.1038/s41388-020-01459-w; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Dinh HQ, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108978; Durbin AD, 2018, NAT GENET, V50, P1240, DOI 10.1038/s41588-018-0191-z; Elias KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87988; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Ghannam-Shahbari D, 2018, ONCOGENE, V37, P2213, DOI 10.1038/s41388-017-0040-z; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Gryder BE, 2019, NAT GENET, V51, P1714, DOI 10.1038/s41588-019-0534-4; Gryder BE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11046-7; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kaya-Okur HS, 2020, NAT PROTOC, V15, P3264, DOI 10.1038/s41596-020-0373-x; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kuroki L, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3773; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lheureux S, 2019, LANCET, V393, P1240, DOI 10.1016/S0140-6736(18)32552-2; Lv L, 2020, ELIFE, V9, DOI 10.7554/eLife.59994; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Mills Kathryn, 2017, F1000Res, V6, P84, DOI 10.12688/f1000research.9977.1; Parua PK, 2020, NAT CHEM BIOL, V16, P716, DOI 10.1038/s41589-020-0563-4; Quereda V, 2019, CANCER CELL, V36, P545, DOI 10.1016/j.ccell.2019.09.004; Reddy J, 2019, PREDICTING MASTER TR, DOI [10.1101/839142, DOI 10.1101/839142]; Richters A, 2021, CELL CHEM BIOL, V28, P134, DOI 10.1016/j.chembiol.2020.10.001; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sharifnia T, 2019, NAT MED, V25, P292, DOI 10.1038/s41591-018-0312-3; Shi KX, 2019, ELIFE, V8, DOI 10.7554/eLife.44306; Slabicki M, 2020, NATURE, V585, P293, DOI 10.1038/s41586-020-2374-x; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tan DS, 2020, SEMIN CANCER BIOL, V67, P65, DOI 10.1016/j.semcancer.2019.08.008; Wei W, 2013, J CLIN INVEST, V123, P4435, DOI 10.1172/JCI70625; Zaret KS, 2020, ANNU REV GENET, V54, P367, DOI 10.1146/annurev-genet-030220-015007; Zhang TH, 2016, NAT CHEM BIOL, V12, P876, DOI 10.1038/nchembio.2166; Zhang ZF, 2017, MOL CANCER THER, V16, P1739, DOI 10.1158/1535-7163.MCT-17-0078	49	3	3	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1767	1779		10.1038/s41388-022-02210-3	http://dx.doi.org/10.1038/s41388-022-02210-3		FEB 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35124696				2022-12-26	WOS:000751581600001
J	Adugna, T; Getu, E; Yewhelew, D				Adugna, Tilahun; Getu, Emana; Yewhelew, Delenasaw			Parous rate and longevity of anophelines mosquitoes in bure district, northwestern Ethiopia	PLOS ONE			English	Article							HUMAN BLOOD INDEX; DAILY SURVIVAL; MALARIA; ARABIENSIS	The intensity of malaria transmission is measured by parous rate, daily survival rate, human blood meal frequency, sporozoite rate, and entomological inoculation rates. Female parous status is a key index of vector competence, adult vector longevity, recruitment rate of adult, and the length of a gonotrophic cycle. Hence, the present study was aimed to investigate the parous rate and the longevity of Anopheles mosquitoes in Bure District, Northwestern Ethiopia. Parous rate was estimated as the number of mosquitoes with parous ovaries divided by the number of females dissected multiplied by 100. Mosquito life expectancy (longevity as d) was estimated by. One way- ANOVA was applied to confirm the presence of parous rate difference in the villages (p < 0.05). A total of 952 unfed hosts-seeking Anopheles mosquitoes was dissected for parous rate determination. The overall parous rate of An. arabiensis in the district was 52.0%, and the highest parous rate was recorded in Shnebekuma than other villages (F 2, 33 = 6.974; p = 0.003). Similarly, the parous rate of An. cinereus showed significant variation among villages (F 2, 33 = 5.044, p = 0.012) and the highest rate (63.0%) was recorded in Bukta. The mean longevity of An. funestus, An. arabiensis, An. coustani, An. squamosus, An. pharoensis, and An. cinereus was 6.5 days, 4.6 days, 3.5 days, 3.7 days, 2.7 days, and 2.2 days, respectively. The longevity of each species was not sufficient to complete the life cycle of malaria parasite for malaria transmission throughout the year because P. falciparum requires from 12-14 day.	[Adugna, Tilahun] Fac Nat & Computat Sci, Dept Biol, Debre Tabor, Amhara, Ethiopia; [Getu, Emana] Addis Ababa Univ, Dept Zool Sci, Addis Ababa, Ethiopia; [Yewhelew, Delenasaw] Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Oromia, Ethiopia; [Adugna, Tilahun] Debre Tabor Univ, Dept Biol, Debre Tabor, Ethiopia	Addis Ababa University	Adugna, T (corresponding author), Fac Nat & Computat Sci, Dept Biol, Debre Tabor, Amhara, Ethiopia.; Adugna, T (corresponding author), Debre Tabor Univ, Dept Biol, Debre Tabor, Ethiopia.	tilahun46@yahoo.com						Adugna T., 2021, MALARIA J, DOI [10.21203/rs.3.rs-103609/v1, DOI 10.21203/RS.3.RS-103609/V1]; Adugna T, 2021, INT J TROP INSECT SC, V41, P2385, DOI 10.1007/s42690-020-00412-4; Adugna T, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04669-7; Adugna T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05063; Adugna Woyessa, 2004, Ethiopian Journal of Health Development, V18, P2; Alelign A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5913-8; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; Animut A., 2013, MALARIA J, V12, P123, DOI [10.1186/1475-2875-12-123, DOI 10.1186/1475-2875-12-123]; Arum SO, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0907-1; Aschale Y, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05068-6; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Blood DNeasy., 2011, DNEASY BLOOD TISSUE; Carter Center, 2013, SUMM P 4 ANN MAL CON; Charlwood JD, 2012, MED VET ENTOMOL, V26, P263, DOI 10.1111/j.1365-2915.2011.00987.x; DAVIDSON G, 1954, NATURE, V174, P792, DOI 10.1038/174792a0; Fisiha MY, 2002, THESIS DURHAM U; Gaffigan TV., 2013, SYSTEMATIC CATALOG C; Gari T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1199-4; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Gillies M. T., 1968, ANOPHELINE AFRICA S; Glick Jayson I., 1992, Mosquito Systematics, V24, P125; Hay SI, 2003, MALARIA EPIDEMICS ET; Jaleta KT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-350; Jawara Musa, 2008, Malaria Journal, V7, P1; Kaindoa EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177807; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; KRAFSUR E S, 1982, Parassitologia (Rome), V24, P105; KRAFSUR ES, 1978, T ROY SOC TROP MED H, V72, P348, DOI 10.1016/0035-9203(78)90125-6; Lyimo Issa N, 2012, J Parasitol Res, V2012, P280583, DOI 10.1155/2012/280583; Mbogo CM., 2012, VECTOR CONTROL ENTOM; Midekisa A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0954-7; MILBY M M, 1989, Bulletin of the Society for Vector Ecology, V14, P47; Ministry of Health of Ethiopia (MOH), 2012, NAT MAL GUID; MoH, 2010, NAT STRAT PLAN MAL P; Molla E., 2015, J BACTERIOL PARASITO, V6, P1; Ndoen E., 2012, INT SCHOLARLY RES NE, P1; Njila HL., 2019, INT ARCH MULTIDIS ST, V1, P1; O'CONNOR CHARLES T., 1967, MOSQUITO NEWS, V27, P42; Obala AA, 2012, J INFECT DEV COUNTR, V6, P637, DOI 10.3855/jidc.1979; Pennas T., 2012, USAID PRESIDENT MALA; Pinto J., 2012, TRAINING MANUAL MALA; PMI, 2014, ETH MAL OP PLAN FY 2; PMI, 2015, PRES MAL IN 9 ANN RE; Poncon N., 2008, THESIS; Ree HI, 2001, J AM MOSQUITO CONTR, V17, P67; Snow RW, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P195; Tanga MC, 2011, TROP MED INT HEALTH, V16, P447, DOI 10.1111/j.1365-3156.2011.02726.x; Taye A, 2006, ACTA TROP, V97, P50, DOI 10.1016/j.actatropica.2005.08.002; Taye B., 2017, J PARASITOL VECTOR B, V9, P137; Taye B, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iev150; Tefera G., 2014, IMMUNOL INFECT DIS, V2, P25; Tesfaye S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-153; Toyama Y, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1133-9; TSUDA Y, 1991, Tropical Medicine, V33, P47; Uttah EC., 2013, INT J SCI RES, V3, P1; VERRONE GESWALDO A., 1962, MOSQUITO NEWS, V22, P37; White GB., 1980, T R SOC TROP MED HYG, V74, P683; WHO, 2016, CCBY NC SA 30 IGO; WHO, 2013, MAL ENT VECT CONTR G; Wilkins Elien E., 2006, Malaria Journal, V5, P1; World Health Organization, 1975, WHO MAN PRACT ENT 2; Yoshio T., TROP MED, V33, P41	62	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263295	10.1371/journal.pone.0263295	http://dx.doi.org/10.1371/journal.pone.0263295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120146	gold, Green Published			2022-12-26	WOS:000789273600031
J	Zhao, LH; Jing, LL; Li, J; Du, XL				Zhao, Lianghui; Jing, Lili; Li, Jie; Du, Xianli			Changes in corneal densitometry after long-term orthokeratology for myopia and short-term discontinuation	PLOS ONE			English	Article							LENS WEAR; KERATOCONUS; REVERSIBILITY	Purpose To quantify changes in corneal densitometry after long-term orthokeratology treatment in myopic children and to analyze the reversibility one month after discontinuation. Methods Seventy-four myopic subjects aged 8-16 years, who wore orthokeratology lenses for two years, were divided into relatively steep-(lens movement within 1.0-1.5 mm, thirty-six participants) and flat-fitting groups (lens movement within 1.5-2.0 mm, thirty-eight participants). Based on refractive errors, they were divided into low and moderate myopia groups (thirty-seven participants in each group). Corneal densitometry was performed using Pentacam (Oculus Optikgerate GmbH, Wetzlar, Germany) at each follow-up timepoint. Repeated-measures analysis of variance was used to compare the parameters before and after orthokeratology. Results The corneal densitometry values over the 0-10 mm diameter area increased from 12.84 +/- 1.38 grayscale units (GSU) at baseline to 13.59 +/- 1.42 GSU after three-month orthokeratology (P =.001) and reached 14.92 +/- 1.45 GSU at two years (P <.001). An increase in densitometry began at one month (P =.001) over the 0-2 mm annulus compared with that at three months over the 2-6 mm and 6-10 mm zones (P =.002,.014). The densitometry values significantly increased at three months in the relatively steep-fitting group (P =.003) and at one year in the relatively flat-fitting group (P =.001). After discontinuation of orthokeratology for one month, the values showed no significant decrease. Conclusions Long-term orthokeratology treatment causes a small but statistically significant increase in corneal densitometry values. During the first year, the onset of these changes was related to the fitting mode. Corneal densitometry values showed no significant reduction after onemonth discontinuation.	[Zhao, Lianghui; Jing, Lili; Li, Jie; Du, Xianli] Shandong First Med Univ, Qingdao Eye Hosp, Qingdao, Peoples R China; [Zhao, Lianghui; Jing, Lili; Li, Jie; Du, Xianli] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China; [Zhao, Lianghui] Weifang Med Univ, Weifang, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Weifang Medical University	Du, XL (corresponding author), Shandong First Med Univ, Qingdao Eye Hosp, Qingdao, Peoples R China.; Du, XL (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China.	lilibestever@126.com			Academic Promotion Program of Shandong First Medical University [2019ZL001]; Qingdao Science and Technology Project [19-6-1-24-nsh]	Academic Promotion Program of Shandong First Medical University; Qingdao Science and Technology Project	This work was supported by the Academic Promotion Program of Shandong First Medical University (2019ZL001) and Qingdao Science and Technology Project (19-6-1-24-nsh). And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullimore Mark A, 2020, Cont Lens Anterior Eye, V43, P322, DOI 10.1016/j.clae.2020.03.018; Cheah PS, 2008, CORNEA, V27, P461, DOI 10.1097/ICO.0b013e318165642c; Chen D, 2010, OPHTHAL PHYSL OPT, V30, P274, DOI 10.1111/j.1475-1313.2010.00710.x; Cheung SW, 2005, OPHTHAL PHYSL OPT, V25, P264, DOI 10.1111/j.1475-1313.2005.00283.x; Cho P, 2003, OPTOMETRY VISION SCI, V80, P791, DOI 10.1097/00006324-200312000-00008; Cho P, 2002, OPTOMETRY VISION SCI, V79, P565, DOI 10.1097/00006324-200209000-00007; Choo Jennifer D, 2008, Cont Lens Anterior Eye, V31, P29, DOI 10.1016/j.clae.2007.07.002; Dhubhghaill SN, 2014, INVEST OPHTH VIS SCI, V55, P162, DOI 10.1167/iovs.13-13236; Ding W Z, 2019, Zhonghua Yan Ke Za Zhi, V55, P435, DOI 10.3760/cma.j.issn.0412-4081.2019.06.006; Ishikawa S, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0998-5; Kim BZ, 2016, J CATARACT REFR SURG, V42, P1053, DOI 10.1016/j.jcrs.2016.04.019; Kim WK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203652; Kobayashi Y, 2008, EYE CONTACT LENS, V34, P224, DOI 10.1097/ICL.0b013e318165d501; Koc M, 2018, CORNEA, V37, P580, DOI 10.1097/ICO.0000000000001537; Li XT, 2017, J PEDIAT OPHTH STRAB, V54, P142, DOI 10.3928/01913913-20170106-01; Nieto-Bona A, 2011, CURR EYE RES, V36, P895, DOI 10.3109/02713683.2011.593723; Nieto-Bona A, 2011, CORNEA, V30, P646, DOI 10.1097/ICO.0b013e31820009bc; Ozek D, 2021, OPTOMETRY VISION SCI, V98, P592, DOI 10.1097/OPX.0000000000001707; Pahuja N, 2016, CORNEA, V35, P833, DOI 10.1097/ICO.0000000000000800; Rah Marjorie J, 2002, Optometry, V73, P425; Reinstein DZ, 2009, OPTOMETRY VISION SCI, V86, P1006, DOI 10.1097/OPX.0b013e3181b18219; Santodomingo-Rubido J, 2014, EYE CONTACT LENS, V40, P84, DOI 10.1097/ICL.0000000000000014; Schaub F, 2019, AM J OPHTHALMOL, V198, P124, DOI 10.1016/j.ajo.2018.10.002; Shajari M, 2018, CURR EYE RES, V43, P605, DOI 10.1080/02713683.2018.1431288; Tekin K, 2017, CORNEA, V36, P1336, DOI 10.1097/ICO.0000000000001363; van der Meulen IJE, 2010, CORNEA, V29, P516, DOI 10.1097/ICO.0b013e3181c11e29; Wu R, 2009, EYE CONTACT LENS, V35, P333, DOI 10.1097/ICL.0b013e3181bdc41f	27	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263121	10.1371/journal.pone.0263121	http://dx.doi.org/10.1371/journal.pone.0263121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120161	Green Published, gold			2022-12-26	WOS:000789273600021
J	Sakulpaptong, W; Clairmonte, IA; Blackstone, BN; Leblebicioglu, B; Powell, HM				Sakulpaptong, Wichurat; Clairmonte, Isabelle A.; Blackstone, Britani N.; Leblebicioglu, Binnaz; Powell, Heather M.			3D engineered human gingiva fabricated with electrospun collagen scaffolds provides a platform for in vitro analysis of gingival seal to abutment materials	PLOS ONE			English	Article							PERI-IMPLANT; WOUND CONTRACTION; SOFT-TISSUE; JUNCTIONAL EPITHELIUM; KERATINIZED MUCOSA; DENTAL IMPLANT; CELL-ADHESION; ORAL-MUCOSA; PORE-SIZE; FIBROBLASTS	In order to advance models of human oral mucosa towards routine use, these models must faithfully mimic the native tissue structure while also being scalable and cost efficient. The goal of this study was to develop a low-cost, keratinized human gingival model with high fidelity to human attached gingiva and demonstrate its utility for studying the implant-tissue interface. Primary human gingival fibroblasts (HGF) and keratinocytes (HGK) were isolated from clinically healthy gingival biopsies. Four matrices, electrospun collagen (ES), decellularized dermis (DD), type I collagen gels (Gel) and released type I collagen gels (Gel-R)) were tested to engineer lamina propria and gingiva. HGF viability was similar in all matrices except for Gel-R, which was significantly decreased. Cell penetration was largely limited to the top layers of all matrices. Histomorphometrically, engineered human gingiva was found to have similar appearance to the native normal human gingiva except absence of rete pegs. Immunohistochemical staining for cell phenotype, differentiation and extracellular matrix composition and organization within 3D engineered gingiva made with electrospun collagen was mostly in agreement with normal gingival tissue staining. Additionally, five types of dental material posts (5-mm diameter x 3-mm height) with different surface characteristics were used [machined titanium, SLA (sandblasted-acid etched) titanium, TiN-coated (titanium nitride-coated) titanium, ceramic, and PEEK (Polyetheretherketone) to investigate peri-implant soft tissue attachment studied by histology and SEM. Engineered epithelial and stromal tissue migration to the implant-gingival tissue interface was observed in machined, SLA, ceramic, and PEEK groups, while TiN was lacking attachment. Taken together, the results suggest that electrospun collagen scaffolds provide a scalable, reproducible and cost-effective lamina propria and 3D engineered gingival that can be used to explore biomaterial-soft tissue interface.	[Sakulpaptong, Wichurat; Leblebicioglu, Binnaz] Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA; [Sakulpaptong, Wichurat] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok, Thailand; [Clairmonte, Isabelle A.; Blackstone, Britani N.; Powell, Heather M.] Ohio State Univ, Dept Mat Sci & Engn, 116 W 19Th Ave, Columbus, OH 43210 USA; [Powell, Heather M.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Powell, Heather M.] Shriners Childrens Ohio, Res Dept, Dayton, OH 45404 USA	University System of Ohio; Ohio State University; Mahidol University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Powell, HM (corresponding author), Ohio State Univ, Dept Mat Sci & Engn, 116 W 19Th Ave, Columbus, OH 43210 USA.; Powell, HM (corresponding author), Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA.; Powell, HM (corresponding author), Shriners Childrens Ohio, Res Dept, Dayton, OH 45404 USA.	Powell.299@osu.edu		Powell, Heather/0000-0002-6845-8101	Zimmer Biomet	Zimmer Biomet	The study was funded in part by a research grant from Zimmer Biomet(BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibrad M, 2009, J ORAL IMPLANTOL, V35, P232, DOI 10.1563/AAID-JOI-D-09-00035.1; Al Rezk Feras, 2018, General Dentistry, V66, P18; Almela T, 2018, TISSUE ENG PART C-ME, V24, P99, DOI [10.1089/ten.tec.2017.0370, 10.1089/ten.TEC.2017.0370]; AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; Atsuta I, 2019, J BIOMED MATER RES A, V107, P1379, DOI 10.1002/jbm.a.36651; Barbagli G, 2018, J UROLOGY, V200, P448, DOI 10.1016/j.juro.2018.02.3102; Benz K, 2019, MATERIALS, V12, DOI 10.3390/ma12172739; Bhargava S, 2004, BJU INT, V93, P807, DOI 10.1111/j.1464-410X.2003.04723.x; Boyce ST, 2002, J INVEST DERMATOL, V118, P565, DOI 10.1046/j.1523-1747.2002.01717.x; Brunello G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199591; Buskermolen JK, 2018, J DENT RES, V97, P201, DOI 10.1177/0022034517729998; Cao J, 2018, ARCH ORAL BIOL, V87, P204, DOI 10.1016/j.archoralbio.2017.12.013; Carcuac O, 2013, CLIN ORAL IMPLAN RES, V24, P363, DOI 10.1111/clr.12067; Chai WL, 2010, J PERIODONTOL, V81, P1187, DOI 10.1902/jop.2010.090648; Chatterjee S, 2012, ORAL MAXILLOFAC PATH, V3, P198; Costea DE, 2003, J INVEST DERMATOL, V121, P1479, DOI 10.1111/j.1523-1747.2003.12616.x; Damante CA, 2004, LASER SURG MED, V35, P377, DOI 10.1002/lsm.20111; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Ferra-Canellas MD, 2021, J PERIODONTOL, V92, P1448, DOI 10.1002/JPER.20-0552; Furuhashi A, 2012, ODONTOLOGY, V100, P199, DOI 10.1007/s10266-011-0029-y; Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x; Giannasi C, 2018, INT J PERIODONT REST, V38, P127, DOI 10.11607/prd.3304; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Gursoy UK, 2012, J PERIODONTOL, V83, P242, DOI 10.1902/jop.2011.110177; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; HENRICSSON V, 1990, SCAND J DENT RES, V98, P520; Hormia M, 2001, J PERIODONTOL, V72, P788, DOI 10.1902/jop.2001.72.6.788; Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x; Izumi K, 2013, INT J ORAL MAX IMPL, V28, pE295, DOI 10.11607/jomi.te11; Jennings LR, 2016, TISSUE ENG PART C-ME, V22, P1108, DOI 10.1089/ten.tec.2016.0310; Kedjarune U, 2001, J CRANIO MAXILL SURG, V29, P224, DOI 10.1054/jcms.2001.0229; Kim SS, 2015, J CELL MOL MED, V19, P1183, DOI 10.1111/jcmm.12451; Kim YS, 2015, ACTA ODONTOL SCAND, V73, P38, DOI 10.3109/00016357.2014.949845; Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010; Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Bedran TBL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106766; Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929; Moharamzadeh K, 2012, J DENT RES, V91, P642, DOI 10.1177/0022034511435702; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Moulin V, 2002, BRIT J DERMATOL, V147, P886, DOI 10.1046/j.1365-2133.2002.04975.x; Mustafa K, 2008, CLIN ORAL IMPLAN RES, V19, P1178, DOI 10.1111/j.1600-0501.2008.01560.x; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; OUHAYOUN JP, 1990, J PERIODONTAL RES, V25, P283, DOI 10.1111/j.1600-0765.1990.tb00917.x; Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005; Powell HM, 2008, J BIOMED MATER RES A, V84A, P1078, DOI 10.1002/jbm.a.31498; Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036; Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473; Ramenzoni LL, 2019, MATERIALS, V12, DOI 10.3390/ma12091401; RAMFJORD SP, 1966, J PERIODONTOL, V37, P179, DOI 10.1902/jop.1966.37.3.179; Ritz U, 2017, CLIN ORAL INVEST, V21, P255, DOI 10.1007/s00784-016-1784-5; ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F; Rouabhia M, 2010, BIOMATERIALS, V31, P5798, DOI 10.1016/j.biomaterials.2010.04.004; Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195; Schrott AR, 2009, CLIN ORAL IMPLAN RES, V20, P1170, DOI 10.1111/j.1600-0501.2009.01795.x; Vinuela-Prieto JM, 2015, J PERIODONTAL RES, V50, P658, DOI 10.1111/jre.12247; WIKESJO UME, 1992, J PERIODONTOL, V63, P158, DOI 10.1902/jop.1992.63.3.158; Yadev NR, 2011, MICROB PATHOGENESIS, V50, P278, DOI 10.1016/j.micpath.2010.11.009; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933; Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183	62	3	3	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263083	10.1371/journal.pone.0263083	http://dx.doi.org/10.1371/journal.pone.0263083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113915	gold, Green Published			2022-12-26	WOS:000823694700054
J	Kuitunen, I; Jokihaara, J; Ponkilainen, V; Reito, A; Paloneva, J; Mattila, VM; Launonen, AP				Kuitunen, Ilari; Jokihaara, Jarkko; Ponkilainen, Ville; Reito, Aleksi; Paloneva, Juha; Mattila, Ville M.; Launonen, Antti P.			Emergency department visits due to hand trauma and subsequent emergency hand surgery in three Finnish hospitals during the first and second waves of COVID-19 pandemic	PLOS ONE			English	Article							INJURIES; SAW	Introductions The rate of acute hand trauma visits to emergency departments (ED) and surgeries decreased during the COVID-19 lockdown. Our aim was to analyze the influence of national lockdown during the first wave and the regional restrictions during the second wave on the rate of visits to the ED and urgent hand surgeries in Finland. Methods Material for this retrospective study was gathered from three Finnish hospitals All ED visits and urgent or emergency surgeries from January 2017 to December 2020 were included. Incidences per 100 000 persons with 95% confidence intervals (CI) were calculated and compared by incidence rate ratios (IRR). Results The incidence of hand injury was lower after the beginning of the lockdown in March 2020 (IRR 0.70 CI 0.63-0.78). After lockdown ended in May, the monthly incidences of ED visits returned to the reference level. During the lockdown, the incidence of fractures and dislocations was 42% lower in March (IRR 0.58 CI 0.50-0.68) and 33% lower in April 2020 (IRR 0.67 CI 0.57-0.80). The incidence of fracture repair surgeries was 43% lower in March 2020 (IRR 0.57 CI 0.35-0.93) and 41% lower in July 2020 (IRR 0.59 CI 0.36-0.98). Incidence of replantation was 49% higher in March 2020 (IRR 1.49 CI 0.53-4.20) and 200% higher in July 2020 (IRR 3.00 CI 0.68-13.2) but these increases had high uncertainty. Conclusions The rate of ED visits due to hand injuries decreased while the rate of emergency hand operations remained unchanged during the national COVID-19 lockdown in spring. After the lockdown, the incidences returned to reference level and were unaffected by regional restrictions during the second wave of pandemic.	[Kuitunen, Ilari; Paloneva, Juha] Univ Eastern Finland, Sch Med, Kuopio, Finland; [Kuitunen, Ilari] Mikkeli Cent Hosp, Mikkeli, Finland; [Jokihaara, Jarkko] Tampere Univ Hosp, Dept Hand & Microsurg, Tampere, Finland; [Jokihaara, Jarkko; Mattila, Ville M.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Ponkilainen, Ville; Reito, Aleksi; Mattila, Ville M.; Launonen, Antti P.] Tampere Univ Hosp, Dept Orthopaed & Traumatol, Tampere, Finland; [Paloneva, Juha] Cent Finland Hosp, Jyvaskyla, Finland	University of Eastern Finland; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Central Finland Central Hospital	Kuitunen, I (corresponding author), Univ Eastern Finland, Sch Med, Kuopio, Finland.; Kuitunen, I (corresponding author), Mikkeli Cent Hosp, Mikkeli, Finland.	ilari.kuitunen@uef.fi		Launonen, Antti/0000-0002-3125-0171; Paloneva, Juha/0000-0003-3340-9390; Kuitunen, Ilari/0000-0001-8178-9610; Jokihaara, Jarkko/0000-0001-6153-2180				ANGERMANN P, 1993, J HAND SURG-BRIT EUR, V18B, P642, DOI 10.1016/0266-7681(93)90024-A; [Anonymous], 2011, CHANGING SUMMER COTT; [Anonymous], 2020, WHO ANN COVID 19 OUT; [Anonymous], 2020, ROAD ACCIDENTS FINLA; [Anonymous], 2020, PREPAREDNESS NOVEL C; Aulanko M, 2012, SCAND J SURG, V101, P271, DOI 10.1177/145749691210100409; Coccolini F, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00307-2; COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646; Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; Jokihaara J, 2017, J HAND SURG-EUR VOL, V42, P121, DOI 10.1177/1753193416653282; Lepy E, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080822; Lopponen P, 2019, J HAND SURG-EUR VOL, V44, P651, DOI 10.1177/1753193419840587; Nordic Centre for Classifications in Health Care, 2010, NOMESCO CLASS SURG P; Pichard R, 2020, INT ORTHOP, V44, P1497, DOI 10.1007/s00264-020-04654-2; Raitio A, 2021, SCAND J SURG, V110, P254, DOI 10.1177/1457496920968014; Sadr AH, 2020, J PLAST RECONSTR AES, V73, P1367, DOI 10.1016/j.bjps.2020.05.026; Sinikumpu Juha-Jaakko, 2017, Eur J Orthop Surg Traumatol, V27, P243, DOI 10.1007/s00590-016-1890-8; Sinikumpu JJ, 2013, INJURY, V44, P1569, DOI 10.1016/j.injury.2013.04.021; Sritharen Y, 2018, AM J EMERG MED, V36, P846, DOI 10.1016/j.ajem.2018.01.047; Statistics Finland, 2019, FINN INH 2019; Veith NT, 2017, ZBL CHIR, V142, P194, DOI 10.1055/s-0041-107435	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263435	10.1371/journal.pone.0263435	http://dx.doi.org/10.1371/journal.pone.0263435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108329	Green Published, gold			2022-12-26	WOS:000775890100069
J	Saito, Y; Miura, K; Arima, H; Hayakawa, T; Takashima, N; Kita, Y; Okuda, N; Fujiyoshi, A; Iwahori, T; Miyagawa, N; Kondo, K; Torii, S; Kadota, A; Ohkubo, T; Okayama, A; Okamura, T; Ueshima, H				Saito, Yoshino; Miura, Katsuyuki; Arima, Hisatomi; Hayakawa, Takehito; Takashima, Naoyuki; Kita, Yoshikuni; Okuda, Nagako; Fujiyoshi, Akira; Iwahori, Toshiyuki; Miyagawa, Naoko; Kondo, Keiko; Torii, Sayuki; Kadota, Aya; Ohkubo, Takayoshi; Okayama, Akira; Okamura, Tomonori; Ueshima, Hirotsugu		NIPPON DATA90 Res Grp	Predictors of lower limb fractures in general Japanese: NIPPON DATA90	PLOS ONE			English	Article							HIP-FRACTURES; PHYSICAL-ACTIVITY; RISK; WOMEN; MEN; CALCIUM; TRENDS	Objective This study aimed to investigate the incidence rates and predictors of lower limb fractures in a general Japanese population. Methods NIPPON DATA is a nationwide, long-term, prospective cohort study of individuals who participated in the National Cardiovascular Survey Japan and the National Nutrition Survey in 1990. Overall, 3,134 individuals (1,827 women, 1,307 men) who participated in follow-up assessments in 1995, 2000, and/or 2006 were included in the present analysis. The outcomes of this study were lower limb fractures (including proximal femur fractures). Results The mean age at baseline was 63.8 years in women and 63.1 years in men. The average body mass index (BMI) was 23.3 kg/m(2) in women and 22.9 kg/m(2) in men. During a mean follow-up of 12.1 years, 271 total lower limb fractures were observed. In women, older age, lower BMI, and less intake of vegetables were associated with increased risks of proximal femur fractures. With regard to the outcome of total lower limb fractures, less intake of vegetables and regular exercise were significant predictors in women. Calcium intake was not significantly associated with proximal femur or total lower limb fractures. There were no significant predictors of proximal femur or total lower limb fractures in men, except for age. Conclusions Aging was a significant risk factor for proximal femur and total lower limb fractures in both men and women. With regard to modifiable risk factors, low BMI and low intake of vegetables were associated with increased risks of proximal femur and/or total lower limb fractures in the general population of Japanese women.	[Saito, Yoshino] Aino Univ, Dept Nursing, Fac Hlth Sci, Osaka, Japan; [Saito, Yoshino; Miura, Katsuyuki; Takashima, Naoyuki; Iwahori, Toshiyuki; Kondo, Keiko; Torii, Sayuki; Kadota, Aya; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga, Japan; [Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med, Sci, NCD Epidemiol Res Ctr, Otsu, Shiga, Japan; [Arima, Hisatomi] Fukuoka Univ, Dept Prevent Med & Publ Hlth, Fukuoka, Japan; [Hayakawa, Takehito] Ritsumeikan Univ, Res Ctr Social Studies Hlth & Community, Kyoto, Japan; [Takashima, Naoyuki] Kindai Univ, Fac Med, Dept Publ Hlth, Osaka, Japan; [Kita, Yoshikuni] Tsuruga Nursing Univ, Fukui, Japan; [Okuda, Nagako] Kyoto Prefectural Univ, Dept Hlth Sci, Kyoto, Japan; [Fujiyoshi, Akira] Wakayama Med Univ, Wakayama, Japan; [Miyagawa, Naoko; Okamura, Tomonori] Keio Univ, Dept Prevent Med & Publ Hlth, Sch Med, Tokyo, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Fukuoka University; Ritsumeikan University; Kindai University (Kinki University); Kyoto Prefectural University; Wakayama Medical University; Keio University; Teikyo University	Saito, Y (corresponding author), Aino Univ, Dept Nursing, Fac Hlth Sci, Osaka, Japan.; Saito, Y (corresponding author), Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga, Japan.	y-saito@ns-u.aino.ac.jp	Okamura, Tomonori/L-1693-2013; Takashima, Naoyuki/AAG-8978-2021; Iwahori, Toshiyuki/U-9428-2017	Okamura, Tomonori/0000-0003-0488-0351; Iwahori, Toshiyuki/0000-0001-6972-7900; Kondo, Keiko/0000-0002-9709-4474	Ministry of Health, Labour and Welfare of Japan [H22-JunkankitouSeishuu-Sitei-017, H25-Junkankitou-SeishuuSitei-022, H29-Junkankitou-Sitei-002, H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19Chouju-Ippan-014, 7A2]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	Dr Katsuyuki Miura received research grants from Ministry of Health, Labour and Welfare of Japan (Award Number:H22-JunkankitouSeishuu-Sitei-017, H25-Junkankitou-SeishuuSitei-022, H29-Junkankitou-Sitei-002, H11-Chouju-046, H14-Chouju-003, H17-Chouju-012 and H19Chouju-Ippan-014) and Dr Hirotsugu Ueshima received research grants from Ministry of Health, Labour and Welfare of Japan (Award Number: 7A2).	Bolland MJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4580; Fan Y, 2016, OSTEOPOROSIS INT, V27, P219, DOI 10.1007/s00198-015-3279-7; Fujiwara S, 2003, J BONE MINER RES, V18, P1547, DOI 10.1359/jbmr.2003.18.8.1547; Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x; Hamidi M, 2011, OSTEOPOROSIS INT, V22, P1681, DOI 10.1007/s00198-010-1510-0; Harada Atsushi, 2004, Clin Calcium, V14, P424; Huang HL, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6230-y; Huang SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23360; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Koike T, 2009, OSTEOPOROSIS INT, V20, P1613, DOI 10.1007/s00198-008-0824-7; KRIEGER NS, 1992, AM J PHYSIOL, V262, pF442, DOI 10.1152/ajprenal.1992.262.3.F442; Ministry of Health, 1993, KOUSEI NO SHIHYOU, V40, P36; Miyasaka D, 2016, J BONE MINER METAB, V34, P92, DOI 10.1007/s00774-015-0648-4; Moayyeri A, 2008, ANN EPIDEMIOL, V18, P827, DOI 10.1016/j.annepidem.2008.08.007; Nakamura K, 2009, BRIT J NUTR, V101, P285, DOI 10.1017/S0007114508993533; National Institute of Health and Nutrition, REP CURR NUTR STAT J; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; Okuda N, 2010, J EPIDEMIOL, V20, pS506, DOI 10.2188/jea.JE20090218; Orimo H, 2016, OSTEOPOROSIS INT, V27, P1777, DOI 10.1007/s00198-015-3464-8; Orimo H, 2000, J BONE MINER METAB, V18, P126, DOI 10.1007/s007740050102; Orimo Hajime, 2009, Arch Osteoporos, V4, P71; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Resource Research Committee of Science and Technology Agency, 1982, STAND TABL FOOD COMP, V4th; Sakamoto K, 2006, J ORTHOP SCI, V11, P127, DOI 10.1007/s00776-005-0998-1; Shi TT, 2019, OSTEOPOROSIS INT, V30, P1157, DOI 10.1007/s00198-019-04951-6; Suzuki T, 2010, OSTEOPOROSIS INT, V21, P71, DOI 10.1007/s00198-009-0970-6; Tai V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4183; Tsugawa N, 2006, AM J CLIN NUTR, V83, P380; Vestergaard P, 2003, J INTERN MED, V254, P572, DOI 10.1111/j.1365-2796.2003.01232.x; Xie HL, 2013, OSTEOPOROSIS INT, V24, P2827, DOI 10.1007/s00198-013-2383-9; Xu LZ, 2004, BRIT J NUTR, V91, P625, DOI 10.1079/BJN20031085; Yoshiike N, 1996, J Epidemiol, V6, pS189	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0261716	10.1371/journal.pone.0261716	http://dx.doi.org/10.1371/journal.pone.0261716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108263	Green Published, gold			2022-12-26	WOS:000775890100010
J	Baru, A; Sultan, M; Beza, L				Baru, Ararso; Sultan, Menbeu; Beza, Lemlem			The status of prehospital care delivery for COVID-19 patients in Addis Ababa, Ethiopia: The study emphasizing adverse events occurring in prehospital transport and associated factors	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTRAHOSPITAL TRANSPORT; GROUND TRANSPORT; SCIENCE; HEALTH	BackgroundCOVID-19 patients may require emergency medical services for emergent treatment and/or transport to a hospital for further treatment. However, it is common for the patients to experience adverse events during transport, even the shortest transport may cause life-threatening conditions. Most of the studies that have been done on prehospital care of COVID-19 patients were conducted in developed countries. Differences in population demographics and economy may limit the generalizability of available studies. So, this study was aimed at investigating the status of prehospital care delivery for COVID-19 patients in Addis Ababa focusing on adverse events that occurred during transport and associated factors. MethodsA total of 233 patients consecutively transported to Saint Paul's Hospital Millennium Medical College from November 6 to December 31, 2020, were included in the study. A team of physicians and nurses collected the data using a structured questionnaire. Descriptive statistics were used to summarize data, and ordinal logistic regression was carried out to assess the association between explanatory variables and the outcome variable. Results are presented using frequency, percentage, chi-square, crude and adjusted odds ratios (OR) with 95% confidence intervals. ResultsThe overall level of adverse events in prehospital setting was 44.2%. Having history of at least one chronic medical illness, [AOR3.2 (95%; CI; 1.11-9.53)]; distance traveled to reach destination facility, [AOR 0.11(95%; CI; 0.02-0.54)]; failure to recognize and administer oxygen to the patient in need of oxygen, [AOR 15.0(95%; CI; 4.0-55.7)]; absent or malfunctioned suctioning device, [AOR 4.0(95%; CI; 1.2-13.0)]; patients handling mishaps, [AOR 12.7(95%; CI; 2.9-56.8)] were the factors associated with adverse events in prehospital transport of COVID-19 patients. ConclusionsThere were a significant proportion of adverse events in prehospital care among COVID-19 patients. Most of the adverse events were preventable. There is an urgent need to strengthen prehospital emergency care in Ethiopia by equipping the ambulances with essential and properly functioning equipment and trained manpower. Awareness creation and training of transport staff in identifying potential hazards, at-risk patients, adequate documentation, and patient handling during transport could help to prevent or minimize adverse events in prehospital care.	[Baru, Ararso] Arbaminch Univ, Coll Med & Hlth Sci, Arbaminch, Ethiopia; [Baru, Ararso] Slum & Rural Hlth Initiat Ethiopia, Addis Ababa, Ethiopia; [Sultan, Menbeu] St Pauls Hosp, Millennium Med Coll, Dept Emergency Med & Crit Care, Addis Ababa, Ethiopia; [Beza, Lemlem] Addis Ababa Univ, Dept Emergency Med & Crit Care, Addis Ababa, Ethiopia	Arba Minch University; Addis Ababa University	Baru, A (corresponding author), Arbaminch Univ, Coll Med & Hlth Sci, Arbaminch, Ethiopia.; Baru, A (corresponding author), Slum & Rural Hlth Initiat Ethiopia, Addis Ababa, Ethiopia.	ararsob@gmail.com		Baru, Ararso/0000-0003-1646-3571				Allen Rebecca, 2020, Air Med J, V39, P498, DOI 10.1016/j.amj.2020.07.007; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; Beckmann U, 2004, INTENS CARE MED, V30, P1579, DOI 10.1007/s00134-004-2177-9; Bergman LM, 2017, CRIT CARE MED, V45, pE1043, DOI 10.1097/CCM.0000000000002653; Bitely C, 2019, CURR EMERG HOSP ME R, V7, P135, DOI 10.1007/s40138-019-00200-6; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Brown Abigail S, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc045; de Vries J, 2020, SAMJ S AFR MED J, V110, P635, DOI 10.7196/SAMJ.2020.v110i7.14863; Edelson DP, 2020, CIRCULATION, V141, pE933, DOI 10.1161/CIRCULATIONAHA.120.047463; EPHI, 2020, PUBL HLTH EMERG OPER; European Commission  European Medicines Agency  National Head of Medicines Agencies, 2020, COM EUR, V19, P1; Fernandez AR, 2020, PREHOSP EMERG CARE, V25, P16, DOI 10.1080/10903127.2020.1792016; Hagiwara MA, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0228-3; Hayward RA, 2005, J GEN INTERN MED, V20, P686, DOI 10.1111/j.1525-1497.2005.0152.x; Jia L, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1183-y; Kang J, 2018, AM J INFECT CONTROL, V46, P235, DOI 10.1016/j.ajic.2017.08.041; Laeke T, 2019, WORLD NEUROSURG, V127, pE186, DOI 10.1016/j.wneu.2019.03.044; Lancet EA, 2021, JACEP OPEN, V2, DOI 10.1002/emp2.12407; Laudermilch DJ, 2010, J AM COLL SURGEONS, V210, P220, DOI 10.1016/j.jamcollsurg.2009.10.008; Liew MF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2828-4; Ligtenberg JJM, 2005, CRIT CARE, V9, pR446, DOI 10.1186/cc3749; Mazzoli C. A., 2020, AIR MED J, V39, P423; McPherson ML, 2021, PEDIATR EMERG CARE, V37, P175, DOI 10.1097/PEC.0000000000002330; Meisel ZF, 2008, PREHOSP EMERG CARE, V12, P411, DOI 10.1080/10903120802290851; Mosadeghrad Ali Mohammad, 2019, Human Antibodies, V27, pS33, DOI 10.3233/HAB-190368; Nogueira LC, 2016, HEALTH CARE MANAG SC, V19, P31, DOI 10.1007/s10729-014-9280-4; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; Patterson PD, 2014, PREHOSP EMERG CARE, V18, P35, DOI 10.3109/10903127.2013.818179; Patterson PD, 2012, AM J MED QUAL, V27, P139, DOI 10.1177/1062860611415515; Price R, 2013, EMERG MED J, V30, P583, DOI 10.1136/emermed-2011-200971; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Shigute Z, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010369; Siman-Tov M, 2021, AM J EMERG MED, V44, P45, DOI 10.1016/j.ajem.2021.01.051; Sultan M, 2018, ETHIOPIAN MED J, V56, P119; Sultan M, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0242-5; Sultan M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3820-4; Wang HE, 2009, QUAL SAF HEALTH CARE, V18, P213, DOI 10.1136/qshc.2007.024562; Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x; Yirga AA, 2019, AFR HEALTH SCI, V19, P1897, DOI 10.4314/ahs.v19i2.13; Yousuf B, 2020, INTENS CARE MED, V46, P1663, DOI 10.1007/s00134-020-06115-1; Zikargae MH, 2020, RISK MANAG HEALTHC P, V13, P2803, DOI 10.2147/RMHP.S278234	41	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263278	10.1371/journal.pone.0263278	http://dx.doi.org/10.1371/journal.pone.0263278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104287	Green Published, gold			2022-12-26	WOS:000749789300011
J	Delgado-Calle, J; McAndrews, K; Wu, G; Orr, AL; Ferrari, A; Tu, X; Srinivasan, V; Roodman, GD; Ebetino, FH; Boeckman, RK; Bellido, T				Delgado-Calle, Jesus; McAndrews, Kevin; Wu, Gerald; Orr, Ashley L.; Ferrari, Adam; Tu, Xiaolin; Srinivasan, Venkatesan; Roodman, G. David; Ebetino, Frank H.; Boeckman, Robert K.; Bellido, Teresita			The Notch pathway regulates the bone gain induced by PTH anabolic signaling	FASEB JOURNAL			English	Article						bone; Notch; osteoblasts; osteoclasts; osteocytes; PTH; resorption	PARATHYROID-HORMONE; LIGAND JAGGED1; BETA-CATENIN; OSTEOCYTES; RECEPTOR; GENE; OSTEOPOROSIS; OSTEOBLASTS; ACTIVATION; MECHANISMS	Parathyroid hormone (PTH) signaling downstream of the PTH 1 receptor (Pth1r) results in both bone anabolic and catabolic actions by mechanisms not yet fully understood. In this study, we show that Pth1r signaling upregulates the expression of several components of the Notch pathway and that Notch signals contribute to the catabolic actions of PTH in bone. We found that constitutive genetic activation of PTH receptor signaling in osteocytes (caPth1r(Ot)) or treatment with PTH daily increased the expression of several Notch ligands/receptors in bone. In contrast, sustained elevation of endogenous PTH did not change Notch components expression. Deletion of the PTH receptor or sclerostin overexpression in osteocytes abolished Notch increases by PTH. Further, deleting the canonical Notch transcription factor Rbpjk in osteocytes decreased bone mass and increased resorption and Rankl expression in caPth1r(Ot) mice. Moreover, pharmacological bone-targeted Notch inhibition potentiated the bone mass gain induced by intermittent PTH by reducing bone resorption and preserving bone formation. Thus, Notch activation lies downstream of anabolic signaling driven by PTH actions in osteocytes, and Notch pharmacological inhibition maximizes the bone anabolic effects of PTH.	[Delgado-Calle, Jesus; Bellido, Teresita] Univ Arkansas Med Sci, Dept Physiol & Cell Biol, 4301 W Markham St, Little Rock, AR 72205 USA; [Delgado-Calle, Jesus; Bellido, Teresita] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [McAndrews, Kevin; Wu, Gerald; Tu, Xiaolin] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Orr, Ashley L.; Ferrari, Adam; Roodman, G. David] Univ Rochester, Dept Med, Div Hematol Oncol, Rochester, NY USA; [Srinivasan, Venkatesan; Ebetino, Frank H.; Boeckman, Robert K.] Univ Rochester, Dept Chem, Rochester, NY USA; [Ebetino, Frank H.] Biovinc LLC, Pasadena, CA USA; [Bellido, Teresita] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University Bloomington; University of Rochester; University of Rochester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Delgado-Calle, J; Bellido, T (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Cell Biol, 4301 W Markham St, Little Rock, AR 72205 USA.	jdelgadocalle@uams.edu; tmbellido@uams.edu	Delgado-Calle, Jesus/AAG-1417-2020	Delgado-Calle, Jesus/0000-0002-2083-2774	HHS \ National Institutes of Health (NIH) [R37-CA251763, R01-AR059357, P20GM125503]; U.S. Department of Veterans Affairs (VA) [I01 BX002104, IK6BX004596]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R37--CA251763, R01--AR059357 and P20GM125503; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX002104 and IK6BX004596	Armas LAG, 2012, ENDOCRIN METAB CLIN, V41, P475, DOI 10.1016/j.ecl.2012.04.006; Bagheri L, 2018, J TISSUE ENG REGEN M, V12, P304, DOI 10.1002/term.2455; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bivi N, 2012, CALCIFIED TISSUE INT, V91, P215, DOI 10.1007/s00223-012-9628-z; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2016, AM J PHYSIOL-ENDOC M, V310, pE171, DOI 10.1152/ajpendo.00395.2015; Chakravorty N, 2014, CLIN ORAL IMPLAN RES, V25, P475, DOI 10.1111/clr.12178; Chen SX, 2015, J BONE MINER RES, V30, P1184, DOI 10.1002/jbmr.2453; Cosman Felicia, 2005, Curr Osteoporos Rep, V3, P143, DOI 10.1007/BF02686941; Cosman F, 2017, J BONE MINER RES, V32, P198, DOI 10.1002/jbmr.3051; Delgado-Calle J, 2022, PHYSIOL REV, V102, DOI 10.1152/physrev.00043.2020; Delgado-Calle J, 2018, FASEB J, V32, P2878, DOI 10.1096/fj.201700919RRR; Delgado-Calle J, 2017, J BONE MINER RES, V32, P522, DOI 10.1002/jbmr.3011; Eriksen EF, 2016, BONE, V86, P139, DOI 10.1016/j.bone.2016.02.009; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Lawal RA, 2017, J BONE MINER RES, V32, P1320, DOI 10.1002/jbmr.3106; Leder BZ, 2016, BONE, V89, P73, DOI 10.1016/j.bone.2016.04.026; Li JY, 2019, J BONE MINER RES, V34, P349, DOI 10.1002/jbmr.3600; Liu P, 2016, P NATL ACAD SCI USA, V113, pE2152, DOI 10.1073/pnas.1603399113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolagas SC, 2018, J BONE MINER RES, V33, P371, DOI 10.1002/jbmr.3400; Martin TJ, 2021, ENDOCR REV, V42, P383, DOI 10.1210/endrev/bnab005; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; Reid IR, 2015, NAT REV ENDOCRINOL, V11, P418, DOI 10.1038/nrendo.2015.71; Sabol HM, 2021, CANCER RES, V81, P5102, DOI 10.1158/0008-5472.CAN-21-0524; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Tu XL, 2015, P NATL ACAD SCI USA, V112, pE478, DOI 10.1073/pnas.1409857112; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Yu J, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101376; Yu J, 2020, BONE, V138, DOI 10.1016/j.bone.2020.115474; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027	42	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22196	10.1096/fj.202101807R	http://dx.doi.org/10.1096/fj.202101807R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35137455				2022-12-26	WOS:000761250800004
J	Gasparrini, M; Mazzola, F; Cuccioloni, M; Sorci, L; Audrito, V; Zamporlini, F; Fortunato, C; Amici, A; Cianci, M; Deaglio, S; Angeletti, M; Raffaelli, N				Gasparrini, Massimiliano; Mazzola, Francesca; Cuccioloni, Massimiliano; Sorci, Leonardo; Audrito, Valentina; Zamporlini, Federica; Fortunato, Carlo; Amici, Adolfo; Cianci, Michele; Deaglio, Silvia; Angeletti, Mauro; Raffaelli, Nadia			Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; EQUILIBRIUM; RECOGNITION; EXPRESSION; INHIBITOR; MECHANISM; SEQUENCE; COMPLEX; ENZYMES; MODEL	The secreted form of the enzyme nicotinamide phosphoribosyltransferase (NAMPT), which catalyzes a key reaction in intracellular NAD biosynthesis, acts as a damage-associated molecular pattern triggering Toll-like receptor 4 (TLR4)mediated inflammatory responses. However, the precise mechanism of interaction is unclear. Using an integrated approach combining bioinformatics and functional and structural analyses, we investigated the interaction between NAMPT and TLR4 at the molecular level. Starting from previous evidence that the bacterial ortholog of NAMPT cannot elicit the inflammatory response, despite a high degree of structural conservation, two positively charged areas unique to the human enzyme (the alpha 1-alpha 2 and beta 1-beta 2 loops) were identified as likely candidates for TLR4 binding. However, alanine substitution of the positively charged residues within these loops did not affect either the oligomeric state or the catalytic efficiency of the enzyme. The kinetics of the binding of wildtype and mutated NAMPT to biosensor-tethered TLR4 was analyzed. We found that mutations in the alpha 1-alpha 2 loop strongly decreased the association rate, increasing the KD value from 18 nM, as determined for the wildtype, to 1.3 mu M. In addition, mutations in the beta 1-beta 2 loop or its deletion increased the dissociation rate, yielding KD values of 0.63 and 0.22 mu M, respectively. Mutations also impaired the ability of NAMPT to trigger the NF -KB inflammatory signaling pathway in human cultured macrophages. Finally, the involvement of the two loops in receptor binding was supported by NAMPT-TLR4 docking simulations. This study paves the way for future development of compounds that selectively target eNAMPT/TLR4 signaling in inflamma-tory disorders.	[Gasparrini, Massimiliano; Zamporlini, Federica; Fortunato, Carlo; Cianci, Michele; Raffaelli, Nadia] Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Mazzola, Francesca; Amici, Adolfo] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Cuccioloni, Massimiliano; Angeletti, Mauro] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy; [Sorci, Leonardo] Polytech Univ Marche, Dept Mat Environm Sci & Urban Planning, Div Bioinformat & Biochem, Ancona, Italy; [Audrito, Valentina; Deaglio, Silvia] Univ Turin, Dept Med Sci, Turin, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Camerino; Marche Polytechnic University; University of Turin	Raffaelli, N (corresponding author), Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	n.raffaelli@staff.univpm.it	Amici, Adolfo/C-5342-2012; SORCI, LEONARDO/AAD-7395-2019; Mazzola, Francesca/ADC-1197-2022; Cianci, Michele/I-5577-2012	Amici, Adolfo/0000-0002-1081-7749; SORCI, LEONARDO/0000-0002-4356-8873; Cianci, Michele/0000-0001-5607-6061	Ministero dell'Universita e della Ricerca, PRIN Project [2017CBNCYT]; Fondazione Cariverona, Bando Ricerca Scientifica di Eccellenza 2018 [NADBES 2018.0773]	Ministero dell'Universita e della Ricerca, PRIN Project; Fondazione Cariverona, Bando Ricerca Scientifica di Eccellenza 2018	This work was supported by Ministero dell'Universita e della Ricerca, PRIN Project 2017CBNCYT to N. R. and by Fondazione Cariverona, Bando Ricerca Scientifica di Eccellenza 2018, Project NADBES 2018.0773, to N. R.	Akashi S., 2003, J EXP MED; Audrito V, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00358; Audrito V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01720; Berglund NA, 2015, PROG BIOPHYS MOL BIO, V119, P72, DOI 10.1016/j.pbiomolbio.2015.06.021; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bockwoldt M, 2019, P NATL ACAD SCI USA, V116, P15957, DOI 10.1073/pnas.1902346116; Buonvicino D., 2018, IDENTIFICATION NICOT; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Camp SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13135; Carbone F, 2017, COMPR PHYSIOL, V7, P603, DOI 10.1002/cphy.c160029; Chandana T, 2016, CURR PROTEIN PEPT SC, V17, P507, DOI 10.2174/1389203717666151201192348; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Colombo G, 2020, J MOL MED, V98, P595, DOI 10.1007/s00109-020-01892-0; Cuccioloni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13709-1; Cuccioloni M, 2016, FOOD CHEM, V213, P571, DOI 10.1016/j.foodchem.2016.07.020; Garten A., 2010, BIOCHEM BIOPH RES CO; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grolla A. A., 2015, NICOTINAMIDE PHOSPHO; Grolla AA, 2020, J BIOL CHEM, V295, P3635, DOI 10.1074/jbc.RA119.010571; Grolla AA, 2016, BRIT J PHARMACOL, V173, P2182, DOI 10.1111/bph.13505; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; He MZ, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0023-8; Jaffe EK, 2012, METHODS MOL BIOL, V796, P217, DOI 10.1007/978-1-61779-334-9_12; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Kishko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043902; Knoops B, 2018, CELL CHEM BIOL, V25, P550, DOI 10.1016/j.chembiol.2018.02.006; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Lu YB, 2019, J NEUROCHEM, V150, P723, DOI 10.1111/jnc.14811; Manago A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12055-2; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Quijada H, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02536-2020; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ratnayake D., 2021, MACROPHAGES PROVIDE; Romacho T., 2020; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Shazman S, 2007, NUCLEIC ACIDS RES, V35, pW526, DOI 10.1093/nar/gkm401; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Torretta S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020496; Van den Bergh R., 2012, PLOS; Vangone A, 2015, ELIFE, V4, DOI 10.7554/eLife.07454; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yoshida M, 2019, CELL METAB, V30, P329, DOI 10.1016/j.cmet.2019.05.015; Zamporlini F, 2014, FEBS J, V281, P5104, DOI 10.1111/febs.13050; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75	51	2	2	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101669	10.1016/j.jbc.2022.101669	http://dx.doi.org/10.1016/j.jbc.2022.101669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120922	Green Published, gold			2022-12-26	WOS:000791230900013
J	Li, ZF; Kim, KH; Bhatnagar, N; Park, BR; Jeeva, S; Jung, YJ; Raha, J; Kang, SM; Chen, XY				Li, Zhuofan; Kim, Ki-Hye; Bhatnagar, Noopur; Park, Bo Ryoung; Jeeva, Subbiah; Jung, Yu-Jin; Raha, Jannatul; Kang, Sang-Moo; Chen, Xinyuan			Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination	FASEB JOURNAL			English	Article						MF59; physical adjuvant; radiofrequency; RFA	CROSS-PROTECTION	Pre-pandemic influenza H5N1 vaccine has relatively low immunogenicity and often requires high antigen amounts and two immunizations to induce protective immunity. Incorporation of vaccine adjuvants is promising to stretch vaccine doses during pandemic outbreaks. This study presents a physical radiofrequency (RF) adjuvant (RFA) to conveniently and effectively increase the immunogenicity and efficacy of H5N1 vaccine without modification of vaccine preparation. Physical RFA is based on a brief RF treatment of the skin to induce thermal stress to enhance intradermal vaccine-induced immune responses with minimal local or systemic adverse reactions. We found that physical RFA could significantly increase H5N1 vaccine-induced hemagglutination inhibition antibody titers in murine models. Intradermal H5N1 vaccine in the presence of RFA but not vaccine alone significantly lowered lung viral titers, reduced body weight loss, and improved survival rates after lethal viral challenges. The improved protection in the presence of RFA was correlated with enhanced humoral and cellular immune responses to H5N1 vaccination in both male and female mice, indicating no gender difference of RFA effects in murine models. Our data support further development of the physical RFA to conveniently enhance the efficacy of H5N1 vaccine.	[Li, Zhuofan; Chen, Xinyuan] Univ Rhode Isl, Coll Pharm, Biomed & Pharmaceut Sci, 7 Greenhouse Rd,Pharm Bldg,Room 480, Kingston, RI 02881 USA; [Kim, Ki-Hye; Bhatnagar, Noopur; Park, Bo Ryoung; Jeeva, Subbiah; Jung, Yu-Jin; Raha, Jannatul; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30302 USA	University of Rhode Island; University System of Georgia; Georgia State University	Chen, XY (corresponding author), Univ Rhode Isl, Coll Pharm, Biomed & Pharmaceut Sci, 7 Greenhouse Rd,Pharm Bldg,Room 480, Kingston, RI 02881 USA.; Kang, SM (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30302 USA.	skang24@gsu.edu; xchen14@uri.edu	Bhatnagar, Noopur/HGE-6220-2022	chen, xinyuan/0000-0003-4735-3922	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI139473, AI156510, AI093772, AI152800, AI154656]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID)	HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI139473, AI156510, AI093772, AI152800 and AI154656	Bartee E, 2008, CURR OPIN MICROBIOL, V11, P378, DOI 10.1016/j.mib.2008.05.015; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Cao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06151-y; Chen XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013776; Clegg CH, 2013, EXPERT REV VACCINES, V12, P767, DOI 10.1586/14760584.2013.811178; El Sahlyt HM, 2008, EXPERT REV VACCINES, V7, P241, DOI 10.1586/14760584.7.2.241; Fischinger S, 2019, SEMIN IMMUNOPATHOL, V41, P239, DOI 10.1007/s00281-018-0726-5; Gelfand JA, 2019, FASEB J, V33, P3074, DOI 10.1096/fj.201801095R; Godeaux O, 2015, VACCINE, V33, P2189, DOI 10.1016/j.vaccine.2014.07.062; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim KH, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050516; Kim KH, 2020, VIROLOGY, V550, P51, DOI 10.1016/j.virol.2020.08.003; Kim KH, 2019, VIROLOGY, V535, P179, DOI 10.1016/j.virol.2019.07.008; Ko EJ, 2018, ANTIVIR RES, V156, P107, DOI 10.1016/j.antiviral.2018.06.004; Li YB, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9121382; Li ZF, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.nsight.144627; Li ZF, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020075; Long JS, 2019, NAT REV MICROBIOL, V17, P67, DOI 10.1038/s41579-018-0115-z; MacPherson A, 2021, ANN INTERN MED, V174, P326, DOI 10.7326/M20-5350; Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Nickol ME, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3750-8; O'Hagan DT, 2013, HUM VACC IMMUNOTHER, V9, P1698, DOI 10.4161/hv.24829; Peteranderl C, 2016, SEMIN RESP CRIT CARE, V37, P487, DOI 10.1055/s-0036-1584801; Petrova VN, 2018, NAT REV MICROBIOL, V16, P60, DOI [10.1038/nrmicro.2017.146, 10.1038/nrmicro.2017.118]; Poovorawan Y, 2013, PATHOG GLOB HEALTH, V107, P217, DOI 10.1179/2047773213Y.0000000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Taubenberger JK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5485; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; To J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070654; Tokars JI, 2018, CLIN INFECT DIS, V66, P1511, DOI 10.1093/cid/cix1060; Wang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5447; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Yokomizo S, 2021, NANOPHOTONICS-BERLIN, V10, P3187, DOI 10.1515/nanoph-2021-0133	39	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22182	10.1096/fj.202101703R	http://dx.doi.org/10.1096/fj.202101703R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35113455				2022-12-26	WOS:000761250800016
J	Heraganahally, SS; Howarth, T; Sorger, L; Ben Saad, H				Heraganahally, Subash S.; Howarth, Timothy; Sorger, Lisa; Ben Saad, Helmi			Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease	PLOS ONE			English	Article							REFERENCE VALUES; ABORIGINAL PATIENTS; NORTHERN-TERRITORY; GENDER-DIFFERENCES; LUNG-FUNCTION; TOP END; POPULATION; SPIROMETRY	Background Studies assessing normative values and sex differences in pulmonary function test parameters (PFTPs) among Indigenous populations are sparse. Methods PFTPs were compared between male and female Indigenous Australian adults with and without chest radiologically proven chronic airway diseases (CADs). Results 485 adults (56% were female) with no significant difference in age, body mass index or smoking status between sexes were included. Females displayed a higher prevalence of radiology without CADs compared to males (66 vs. 52%, respectively). Among patients without CADs, after adjustment for age, stature and smoking, males displayed significantly higher absolute values of Forced Vital Capacity (FVC) (mean difference, 0.41L (0.21,0.62), p<0.001) and Forced Expiratory Volume in one second (FEV1) (mean difference 0.27L (0.07,0.47), p<0.001), with no significant difference in FEV1/FVC ratio (mean difference -0.02 (-0.06, 0.02), p = 0.174). Male and female patients with radiologically proven CADs demonstrated lower FEV1/FVC values. However, compared to females, males showed significantly greater reductions in pre- [-0.53 (-0.74, -0.32) vs. -0.29 (-0.42, -0.16), p = 0.045] and post- [-0.51 (-0.72, -0.3) vs. -0.27 (-0.39, -0.14), p = 0.049] bronchodilator FEV1. Conclusions There are significant sex differences in the PFTPs among Indigenous Australians. Recognising these differences may be of value in the accurate diagnosis, management, monitoring and prognostication of CADs in this population.	[Heraganahally, Subash S.] Royal Darwin Hosp, Dept Resp & Sleep Med, Darwin, NT, Australia; [Heraganahally, Subash S.] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Heraganahally, Subash S.; Howarth, Timothy] Darwin Private Hosp, Darwin Resp & Sleep Hlth, Darwin, NT, Australia; [Howarth, Timothy] Charles Darwin Univ, Coll Hlth & Human Sci, Darwin, NT, Australia; [Sorger, Lisa] Royal Darwin Hosp, Dept Med Imaging, Darwin, NT, Australia; [Ben Saad, Helmi] Univ Sousse, Fac Med Sousse, Lab Physiol, Sousse, Tunisia; [Ben Saad, Helmi] Univ Sousse, Farhat HACHED Hosp, Res Lab Heart Failure, LR12SP09, Sousse, Tunisia	Flinders University South Australia; Charles Darwin University; Universite de Sousse; Universite de Sousse; Hopital Farhat Hached	Heraganahally, SS (corresponding author), Royal Darwin Hosp, Dept Resp & Sleep Med, Darwin, NT, Australia.; Heraganahally, SS (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.; Heraganahally, SS (corresponding author), Darwin Private Hosp, Darwin Resp & Sleep Hlth, Darwin, NT, Australia.	hssubhashcmc@hotmail.com	Ben Saad, Helmi/C-8263-2018	Ben Saad, Helmi/0000-0002-7477-2965; sorger, lisa/0000-0001-5470-1118; Heraganahally, Subash/0000-0003-0788-7137	Darwin Respiratory and Sleep health; Darwin, Australia; Darwin, Northern Territory, Australia	Darwin Respiratory and Sleep health; Darwin, Australia; Darwin, Northern Territory, Australia	We sincerely thank all the respiratory technologists and Respiratory Clinical Nurse Consultants from Darwin Respiratory and Sleep health and Royal Darwin Hospital, Darwin Private Hospital, Darwin, Australia, for their invaluable contribution towards this study. We thank Mr. Xinlin Jing, Health Information Services, Royal Darwin Hospital, Darwin, Northern Territory, Australia for helping with data collection for this study. We also extend our sincere gratitude to our research assistant, Mrs. Joy J Mingi, Department of Public Health, Charles Darwin University, Darwin, Northern Territory, Australia and special thanks to Ms. Ara Joy Perez from Darwin Respiratory and Sleep health, Darwin Private Hospital, Darwin, Australia for her invaluable contribution towards this study. We also extend our sincere appreciation to our Indigenous health workers, especially to Mr Izaak Thomas (Australian Indigenous Luritja descendent) from the chronic respiratory disease co-ordination division in reviewing and approving this manuscript for the appropriateness of the representation and respect to the Indigenous context represented in this study. Finally we thank Ms Elisha White, senior respiratory scientist for her contribution towards this study.	[Anonymous], 2017, PNEUMOLOGIE, V71, P9; Australian Bureau of Statistics, 2016, EST AB TORR STRAIT I; Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; Ben Saad H, 2006, REV MAL RESPIR, V23, P324, DOI 10.1016/S0761-8425(06)71598-4; Benn E, 2021, NAT SCI SLEEP, V13, P315, DOI 10.2147/NSS.S298409; Blake TL, 2016, MED J AUSTRALIA, V205, P35, DOI 10.5694/mja16.00226; Dales RE, 2006, EUR RESPIR J, V28, P319, DOI 10.1183/09031936.06.00138105; Gao CL, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000011904, 10.1097/md.0000000000011904]; Garg H, 2020, NAT SCI SLEEP, V12, P1123, DOI 10.2147/NSS.S286403; GBD 2016 Healthcare Access and Quality Collaborators, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, DOI 10.1016/S0140-6736(18)30994-2]; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Heraganahally SS, 2020, CLIN PULM MED, V27, P175; Heraganahally SS., 2020, SLEEP VIGIL, V4, P195, DOI 10.1007/s41782-020-00114-4; Heraganahally S, 2019, RESPIR MED CASE REP, V26, P94, DOI 10.1016/j.rmcr.2018.11.015; Heraganahally SS, 2022, BMC EMERG MED, V22, DOI 10.1186/s12873-022-00570-3; Heraganahally SS, 2021, BMJ OPEN RESPIR RES, V8, DOI 10.1136/bmjresp-2021-001135; Heraganahally SS, 2022, INTERN MED J, DOI 10.1111/imj.15633; Heraganahally SS, 2021, INT J CHRONIC OBSTR, V16, P2707, DOI 10.2147/COPD.S328137; Heraganahally SS, 2021, AUST J RURAL HEALTH, V29, P919, DOI 10.1111/ajr.12782; Heraganahally SS, 2021, HEART LUNG CIRC, V30, P1184, DOI 10.1016/j.hlc.2021.01.007; Heraganahally SS, 2021, EXPERT REV RESP MED, V15, P1229, DOI 10.1080/17476348.2021.1928496; Heraganahally SS, 2022, INTERN MED J, V52, P1232, DOI 10.1111/imj.15310; Heraganahally SS, 2021, EXPERT REV RESP MED, V15, P833, DOI 10.1080/17476348.2021.1847649; Heraganahally SS, 2022, INTERN MED J, V52, P440, DOI 10.1111/imj.15076; Heraganahally SS, 2020, INTERN MED J, V50, P1505, DOI 10.1111/imj.14718; Heraganahally SS, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz248; Heraganahally SS, 2019, INT J CHRONIC OBSTR, V14, P2205, DOI 10.2147/COPD.S213947; Heraganahally SS, 2019, AM J TROP MED HYG, V101, P937, DOI 10.4269/ajtmh.19-0434; Heraganahally SS, 2022, J MED IMAG RADIAT ON, V66, P337, DOI 10.1111/1754-9485.13295; Howarth T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248900; Jagia GJ, 2014, INT J BIOMED RES, V5, P379; Ketfi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225067; Kruavit A, 2017, AUST J RURAL HEALTH, V25, P275, DOI 10.1111/ajr.12349; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; LoMauro A, 2018, BREATHE, V14, P131, DOI 10.1183/20734735.000318; MCDONNELL WF, 1991, EUR RESPIR J, V4, P279; Mehra S, 2021, RURAL REMOTE HEALTH, V21, DOI 10.22605/RRH6390; Mehra S, 2020, NAT SCI SLEEP, V12, P593, DOI 10.2147/NSS.S258330; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; NDD Medical Technologies, 2017, EASYONE PRO; Ospina MB, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/8419686; Ospina MB, 2012, CAN RESPIR J, V19, P355, DOI 10.1155/2012/825107; Ostrowski S, 2004, J Physiol Pharmacol, V55 Suppl 3, P95; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raghavan D, 2016, RESPIROLOGY, V21, P449, DOI 10.1111/resp.12702; Ranu Harpreet, 2011, Ulster Med J, V80, P84; Roberts NJ, 2016, RESP MED, V111, P60, DOI 10.1016/j.rmed.2015.12.008; Schubert J, 2019, INTERN MED J, V49, P217, DOI 10.1111/imj.14112; Solanki S., 2016, SCH J APP MED SCI, V4, P3398; State of the Worlds Indigenous Peoples, 2021, INDIGENOUS PEOPLES A; Barroso AT, 2018, ARCH BRONCONEUMOL, V54, P327, DOI 10.1016/j.arbres.2018.01.030; Triki L, 2021, EXPERT REV RESP MED, V15, P1169, DOI 10.1080/17476348.2021.1935246; White E, 2019, AUSTR INDIGENOUS HEA, P19	53	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263744	10.1371/journal.pone.0263744	http://dx.doi.org/10.1371/journal.pone.0263744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134094	gold, Green Published			2022-12-26	WOS:000798968600033
J	Karamagi, HC; Titi-Ofei, R; Kipruto, HK; Seydi, ABW; Droti, B; Talisuna, A; Tsofa, B; Saikat, S; Schmets, G; Barasa, E; Tumusiime, P; Makubalo, L; Cabore, JW; Moeti, M				Karamagi, Humphrey Cyprian; Titi-Ofei, Regina; Kipruto, Hillary Kipchumba; Seydi, Aminata Benitou-Wahebine; Droti, Benson; Talisuna, Ambrose; Tsofa, Benjamin; Saikat, Sohel; Schmets, Gerard; Barasa, Edwine; Tumusiime, Prosper; Makubalo, Lindiwe; Cabore, Joseph Waogodo; Moeti, Matshidiso			On the resilience of health systems: A methodological exploration across countries in the WHO African Region	PLOS ONE			English	Article							SECURITY; EBOLA; CARE	The need for resilient health systems is recognized as important for the attainment of health outcomes, given the current shocks to health services. Resilience has been defined as the capacity to "prepare and effectively respond to crises; maintain core functions; and, informed by lessons learnt, reorganize if conditions require it". There is however a recognized dichotomy between its conceptualization in literature, and its application in practice. We propose two mutually reinforcing categories of resilience, representing resilience targeted at potentially known shocks, and the inherent health system resilience, needed to respond to unpredictable shock events. We determined capacities for each of these categories, and explored this methodological proposition by computing country-specific scores against each capacity, for the 47 Member States of the WHO African Region. We assessed face validity of the computed index, to ensure derived values were representative of the different elements of resilience, and were predictive of health outcomes, and computed biascorrected non-parametric confidence intervals of the emergency preparedness and response (EPR) and inherent system resilience (ISR) sub-indices, as well as the overall resilience index, using 1000 bootstrap replicates. We also explored the internal consistency and scale reliability of the index, by calculating Cronbach alphas for the various proposed capacities and their corresponding attributes. We computed overall resilience to be 48.4 out of a possible 100 in the 47 assessed countries, with generally lower levels of ISR. For ISR, the capacities were weakest for transformation capacity, followed by mobilization of resources, awareness of own capacities, self-regulation and finally diversity of services respectively. This paper aims to contribute to the growing body of empirical evidence on health systems and service resilience, which is of great importance to the functionality and performance of health systems, particularly in the context of COVID-19. It provides a methodological reflection for monitoring health system resilience, revealing areas of improvement in the provision of essential health services during shock events, and builds a case for the need for mechanisms, at country level, that address both specific and non-specific shocks to the health system, ultimately for the attainment of improved health outcomes.	[Karamagi, Humphrey Cyprian; Titi-Ofei, Regina; Seydi, Aminata Benitou-Wahebine] WHO Reg Off Africa, Data Analyt & Knowledge Management, Brazzaville, Rep Congo; [Kipruto, Hillary Kipchumba; Droti, Benson] WHO Reg Off Africa, Hlth Informat Syst Team, Brazzaville, Rep Congo; [Talisuna, Ambrose] WHO Reg Off Africa, Emergency Preparedness & Response Cluster, Brazzaville, Rep Congo; [Tsofa, Benjamin] KEMRI Wellcome Trust Res Programme, Hlth Policy & Syst Res Team, Nairobi, Kenya; [Saikat, Sohel] WHO Headquarters, Hlth Serv Resilience Team, Geneva, Switzerland; [Schmets, Gerard] WHO Headquarters, Primary Hlth Care Special Programme, Geneva, Switzerland; [Barasa, Edwine] KEMRI Wellcome Trust Res Programme, Hlth Econ Res Unit, Nairobi, Kenya; [Tumusiime, Prosper] Hlth Syst Expert, Kampala, Uganda; [Makubalo, Lindiwe; Moeti, Matshidiso] WHO Reg Off Africa, Brazzaville, Rep Congo; [Cabore, Joseph Waogodo] WHO Reg Off Africa, Program Management, Brazzaville, Rep Congo	World Health Organization; World Health Organization; World Health Organization; World Health Organization; World Health Organization; World Health Organization	Karamagi, HC (corresponding author), WHO Reg Off Africa, Data Analyt & Knowledge Management, Brazzaville, Rep Congo.	karamagih@gmail.com	Talisuna, Ambrose/GYU-0950-2022; Karamagi, Humphrey/AAQ-5031-2020	Karamagi, Humphrey/0000-0002-6277-2095; Seydi, Aminata/0000-0001-5582-2579				Abbey EJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239398; Abimbola S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000758; Agyepong Irene Akua, 2021, BMC Health Serv Res, V21, P476, DOI 10.1186/s12913-021-06500-6; Al-Kuwari MG, 2021, J PUBLIC HEALTH RES, V10, DOI 10.4081/jphr.2021.1910; [Anonymous], 2017, FRAMEWORK HLTH SYSTE; [Anonymous], 2021, WHOS WORK HLTH EMERG; [Anonymous], 2020, ALL CAUS EXC MORT CO; Barasa E, 2018, INT J HEALTH POLICY, V7, P491, DOI 10.15171/ijhpm.2018.06; Barasa EW, 2017, HEALTH POLICY PLANN, V32, P91, DOI 10.1093/heapol/czx118; Biddle L, 2020, HEALTH POLICY PLANN, V35, P1084, DOI 10.1093/heapol/czaa032; Blanchet K, 2015, INT J HEALTH POLICY, V4, P307, DOI 10.15171/ijhpm.2015.49; Cabore JW, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002647; Crawford SM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5425; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Dovlo Delanyo., 2017, I HIG MED TROP LISB, V16, P51; Fitter DL, 2017, AM J TROP MED HYG, V97, P4, DOI 10.4269/ajtmh.16-0862; Fridell M, 2020, INT J HEALTH POLICY, V9, P6, DOI 10.15171/ijhpm.2019.71; Fukuma S, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010501; Gilson L, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000224; Glandon DM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07576-200227; Haider N, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820002046; Hanefeld J, 2018, HEALTH POLICY PLANN, V33, P355, DOI 10.1093/heapol/czx183; Hick JL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005118; Hogan DR, 2018, LANCET GLOB HEALTH, V6, pE152, DOI 10.1016/S2214-109X(17)30472-2; Ibeneme S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00372; Kandel N, 2017, LANCET GLOB HEALTH, V5, pE857, DOI 10.1016/S2214-109X(17)30264-4; Karamagi HC, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004618; Katz R., 2010, GLOBAL HLTH GOVERNAN, V3, P18; Kluge H, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000656; Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3; Kutzin J, 2016, B WORLD HEALTH ORGAN, V94, P2, DOI 10.2471/BLT.15.165050; Lal A, 2021, LANCET, V397, P61, DOI 10.1016/S0140-6736(20)32228-5; Lee K, 2009, GLOB INST, P1; Loubet P, 2015, AIDS, V29, P2347, DOI 10.1097/QAD.0000000000000821; Maina J, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0142-2; Mboussou F, 2019, Epidemiol Infect, V147, pe299, DOI 10.1017/S0950268819001912; Nuzzo JB, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7707-z; Nxumalo N, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000842; Okware SI, 2015, AFR HEALTH SCI, V15, P312, DOI 10.4314/ahs.v15i1.45; Olu O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00263; pubmed.ncbi, ADM SURG IND HOSP FU; Ravi SJ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003648; Razavi A, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00720-5; Razavi A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002477; Ribacke KJB, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00222; Schmuck H, EC EARLY RESPONSE RE; sciencedirect, EXC MORT COV 19 PAND; Sochas L, 2017, HEALTH POLICY PLANN, V32, P32, DOI 10.1093/heapol/czx108; Tambo E, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0278-2; Tanner T., 2017, CHALLENGES RESILIENC; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Therrien MC, 2017, J HEALTH ORGAN MANAG, V31, P96, DOI 10.1108/JHOM-04-2016-0067; Titi-Ofei R, 2021, GLOBAL HEALTH ACTION, V14, DOI 10.1080/16549716.2021.1939493; Tsai FJ, 2018, HEALTH SECUR, V16, P304, DOI 10.1089/hs.2018.0019; Tumusiime Prosper, 2020, BMC Proc, V14, P16, DOI 10.1186/s12919-020-00203-2; Tumusiime P, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-002006; Turenne CP, 2019, SOC SCI MED, V232, P168, DOI 10.1016/j.socscimed.2019.04.020; Wenham C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001145; who, COVID 19 SHOWS WHY U; Wilhelm JA, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010406; World Health Organization, IHR COR CAP MON FRAM	61	3	3	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0261904	10.1371/journal.pone.0261904	http://dx.doi.org/10.1371/journal.pone.0261904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130289	Green Published, gold			2022-12-26	WOS:000805530700003
J	Khakpour, S; Esrafilian, A; Tanska, P; Mononen, ME; Korhonen, RK; Jamsa, T				Khakpour, Shahab; Esrafilian, Amir; Tanska, Petri; Mononen, Mika E.; Korhonen, Rami K.; Jamsa, Timo			Effect of osteoporosis-related reduction in the mechanical properties of bone on the acetabular fracture during a sideways fall: A parametric finite element approach	PLOS ONE			English	Article							SOFT-TISSUE THICKNESS; TRABECULAR BONE; HIP FRACTURE; IMPACT VELOCITY; PROXIMAL FEMUR; LOAD-TRANSFER; PELVIS; SIMULATION; NATIONWIDE; DENSITY	Purpose The incidence of acetabular fractures due to low-energy falls is increasing among the geriatric population. Studies have shown that several biomechanical factors such as body configuration, impact velocity, and trochanteric soft-tissue thickness contribute to the severity and type of acetabular fracture. The effect of reduction in apparent density and elastic modulus of bone as well as other bone mechanical properties due to osteoporosis on low-energy acetabular fractures has not been investigated. Methods The current comprehensive finite element study aimed to study the effect of reduction in bone mechanical properties (trabecular, cortical, and trabecular + cortical) on the risk and type of acetabular fracture. Also, the effect of reduction in the mechanical properties of bone on the load-transferring mechanism within the pelvic girdle was examined. Results We observed that while the reduction in the mechanical properties of trabecular bone considerably affects the severity and area of trabecular bone failure, reduction in mechanical properties of cortical bone moderately influences both cortical and trabecular bone failure. The results also indicated that by reducing bone mechanical properties, the type of acetabular fracture turns from elementary to associated, which requires a more extensive intervention and rehabilitation period. Finally, we observed that the cortical bone plays a substantial role in load transfer, and by increasing reduction in the mechanical properties of cortical bone, a greater share of load is transmitted toward the pubic symphysis. Conclusion This study increases our understanding of the effect of osteoporosis progression on the incidence of low-energy acetabular fractures. The osteoporosis-related reduction in the mechanical properties of cortical bone appears to affect both the cortical and trabecular bones. Also, during the extreme reduction in the mechanical properties of bone, the acetabular fracture type will be more complicated. Finally, during the final stages of osteoporosis (high reduction in mechanical properties of bone) a smaller share of impact load is transferred by impact-side hemipelvis to the sacrum, therefore, an osteoporotic pelvis might mitigate the risk of sacral fracture.	[Khakpour, Shahab; Jamsa, Timo] Univ Oulu, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Esrafilian, Amir; Tanska, Petri; Mononen, Mika E.; Korhonen, Rami K.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Jamsa, Timo] Univ Oulu, Med Res Ctr, Oulu, Finland; [Jamsa, Timo] Oulu Univ Hosp, Oulu, Finland; [Jamsa, Timo] Oulu Univ Hosp, Diagnost Radiol, Oulu, Finland	University of Oulu; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu	Khakpour, S (corresponding author), Univ Oulu, Res Unit Med Imaging Phys & Technol, Oulu, Finland.	Shahab.khakpour@oulu.fi	Esrafilian, Amir/ADQ-1897-2022; Tanska, Petri/E-6224-2015	Esrafilian, Amir/0000-0002-8321-8528; Khakpour, Shahab/0000-0002-1795-4404; Tanska, Petri/0000-0002-9684-6902	European Union's Horizon 2020 research and innovation programme under the Marie Skoldowska-Curie [713606]	European Union's Horizon 2020 research and innovation programme under the Marie Skoldowska-Curie	Shahab Khakpour: This project received funding from European Union's Horizon 2020 research and innovation programme under the Marie Skoldowska-Curie grant agreement No 713606. https://www.oulu.fi/i4future/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, LS DYNA KEYWORD USER; Askarinejad S, 2019, J MECH BEHAV BIOMED, V96, P269, DOI 10.1016/j.jmbbm.2019.04.038; Borah B, 2001, ANAT RECORD, V265, P101, DOI 10.1002/ar.1060; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cruz DJ., 2016, J OSTEOPOROS PHYS AC, V04; DALSTRA M, 1993, J BIOMECH, V26, P523, DOI 10.1016/0021-9290(93)90014-6; DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N; Dempster DW., 2011, OSTEOPOROSIS BURDEN; Dequeker J, 1997, BRIT J RHEUMATOL, V36, P5; DICKENSON RP, 1981, J BONE JOINT SURG BR, V63, P233, DOI 10.1302/0301-620X.63B2.7217148; Enns-Bray WS, 2018, J MECH BEHAV BIOMED, V78, P196, DOI 10.1016/j.jmbbm.2017.10.033; Ferguson TA, 2010, J BONE JOINT SURG BR, V92B, P250, DOI 10.1302/0301-620X.92B2.22488; Firoozabadi R, 2017, ARCH BONE JT SURG-AB, V5, P96; Fleps I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200952; Gebre RK, 2019, BONE, V127, P334, DOI 10.1016/j.bone.2019.07.004; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Human Biodigital online platform [Internet], 2020, BIODIGITAL; Kannus P, 2015, CALCIFIED TISSUE INT, V97, P577, DOI 10.1007/s00223-015-0056-8; Khakpour S, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11010365; Khakpour S, 2021, J BIOMECH, V114, DOI 10.1016/j.jbiomech.2020.110156; Lee J, 2013, ENDOCRINOL METAB, V28, P180, DOI 10.3803/EnM.2013.28.3.180; Lee Y, 2019, J MECH BEHAV BIOMED, V97, P312, DOI 10.1016/j.jmbbm.2019.05.018; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; Letournel E JRR., 1993, FRACTURES ACETABULUM, V2nd ed, P733; Li ZP, 2006, ANN BIOMED ENG, V34, P1452, DOI 10.1007/s10439-006-9145-1; LOTZ JC, 1995, OSTEOPOROSIS INT, V5, P252, DOI 10.1007/BF01774015; Lundin N, 2021, INJURY, V52, P1410, DOI 10.1016/j.injury.2021.03.013; Majumder S, 2004, INT J CRASHWORTHINES, V9, P89; Majumder S, 2008, J BIOMECH, V41, P2834, DOI 10.1016/j.jbiomech.2008.07.001; Majumder S, 2008, INT J CRASHWORTHINES, V13, P313, DOI 10.1080/13691450801940309; Majumder S, 2007, MED ENG PHYS, V29, P1167, DOI 10.1016/j.medengphy.2006.11.001; Majumder S, 2013, CLIN BIOMECH, V28, P1034, DOI 10.1016/j.clinbiomech.2013.09.008; Majumder S, 2009, J BIOMECH, V42, P1475, DOI 10.1016/j.jbiomech.2009.03.044; MAZESS RB, 1982, CLIN ORTHOP RELAT R, P239; Mechlenburg I, 2007, OSTEOARTHR CARTILAGE, V15, P366, DOI 10.1016/j.joca.2006.10.005; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Noor V., 2013, SKIN FRICTION NOVEL; Osterhoff G, 2016, INJURY, V47, pS11, DOI 10.1016/S0020-1383(16)47003-8; Ott SM, 2018, AM J NEPHROL, V47, P373, DOI 10.1159/000489672; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Phruetthiphat OA, 2017, J ORTHOP TRAUMA, V31, P31, DOI 10.1097/BOT.0000000000000720; Polikeit A, 2004, J BIOMECH, V37, P1061, DOI 10.1016/j.jbiomech.2003.11.018; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Rinne PP, 2017, INJURY, V48, P2157, DOI 10.1016/j.injury.2017.08.003; Russow G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010083; Seeman E, 2004, MED J AUSTRALIA, V180, P298, DOI 10.5694/j.1326-5377.2004.tb05931.x; Shim V, 2010, J BIOMECH, V43, P1635, DOI 10.1016/j.jbiomech.2010.01.017; Smith MG, 2004, ANN ROY COLL SURG, V86, P344, DOI 10.1308/147870804371; Svedbom A, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0187-y; Tucci JR, 2006, AM J MANAG CARE, V12, pS181; Zaharie DT, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039894; Zheng N, 1997, MED BIOL ENG COMPUT, V35, P77, DOI 10.1007/BF02534134	53	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263458	10.1371/journal.pone.0263458	http://dx.doi.org/10.1371/journal.pone.0263458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130332	Green Published, gold			2022-12-26	WOS:000805530700032
J	Lv, C; Saba, T; Wang, JY; Hui, WK; Liu, WL; Fan, JT; Wu, JH; Liu, XZ; Gong, W				Lv, Chen; Saba, Tahseen; Wang, Jingyan; Hui, Wenkai; Liu, Wanlin; Fan, Jiangtao; Wu, Jiahui; Liu, Xianzhi; Gong, Wei			Conversion effects of farmland to Zanthoxylum bungeanum plantations on soil organic carbon mineralization in the arid valley of the upper reaches of Yangtze River, China	PLOS ONE			English	Article							MICROBIAL BIOMASS; TEMPERATURE SENSITIVITY; STAND AGE; RESPIRATION; NITROGEN; MATTER; DECOMPOSITION; COMMUNITY; FERTILIZATION; RESTORATION	Farmland conversion to forest is considered to be one of the effective measures to mitigate climate change. However, the impact of farmland conversion to forest land or grassland on soil CO2 emission in arid areas is unclear due to the lack of comparative information on soil organic carbon (SOC) mineralization of different conversion types. The SOC mineralization in 0-100 cm soil layer in farmland (FL), abandoned land (AL) and different ages (including 8, 15, 20 and 28 years) of Zanthoxylum bungeanum plantations were measured by laboratory incubation. The size and decomposition rate of fast pool (C-f) and slow pool (C-s) in different land-use types and soil layers were estimated by double exponential model. The results showed that: 1) Farmland conversion increased the cumulative CO2-C release (C-min) and SOC mineralization efficiency, and those indexes in AL were higher than that in Z. bungeanum plantations. The C-min and SOC mineralization efficiency of 0-100 cm soil increased with the ages of Z. bungeanum plantation. Both C-min and SOC mineralization efficiency decreased with the increase of soil depth; 2) Both soil C-f and C-s increased after farmland converted to Z. bungeanum plantations and AL. The C-s in the same soil layer increased with the ages of Z. bungeanum plantation, and the C-f showed a "V" type with the increased ages of Z. bungeanum plantation. The C-f and C-s decreased with the increase of soil depth in all land-use types; 3) Farmland conversion increased the decomposition rate of C-f (k(1)) in all soil layer by 0.008-0.143 d(-1) and 0.082-0.148 d(-1) in Z. bungeanum plantations and AL, respectively. The k(1) was obviously higher in the 0-20 cm soil layer than that in other soil layers, while the decomposition rate of C-s (k(2)) was not affected by FL conversion and soil depth; and 4) The initial soil chemical properties and enzyme activity affected SOC mineralization, especially the concentrations of total organic nitrogen (TON), SOC, easily oxidizable organic carbon (EOC) and microbial biomass carbon (MBC). It indicated that the conversion of farmland to Z. bungeanum plantations and AL increases SOC mineralization, especially in deeper soils, and it increased with the ages. The conversion of farmland to Z. bungeanum plantation is the optimal measure when the potential C sequestration of plant-soil system were taken in consideration.	[Lv, Chen; Saba, Tahseen; Wang, Jingyan; Hui, Wenkai; Liu, Wanlin; Fan, Jiangtao; Wu, Jiahui; Liu, Xianzhi; Gong, Wei] Sichuan Agr Univ, Key Lab Natl Forestry Adm Forest Resources Conser, Coll Forestry, Chengdu, Peoples R China	Sichuan Agricultural University	Wang, JY; Hui, WK; Gong, W (corresponding author), Sichuan Agr Univ, Key Lab Natl Forestry Adm Forest Resources Conser, Coll Forestry, Chengdu, Peoples R China.	wangjingyan@sicau.edu.cn; wkxi@sicau.edu.cn; gongwei@sicau.edu.cn		Saba, Tahseen/0000-0002-2116-8246	National Key Research and Development Program of China [2018YFD1000605, 2020YFD1000700]; Projects of Science and Technology Department of Sichuan Province [2016NYZ0035, 2021YFYZ0032]	National Key Research and Development Program of China; Projects of Science and Technology Department of Sichuan Province	The sources of funding are the National Key Research and Development Program of China - Program No. 2018YFD1000605, 2020YFD1000700 - URL: https://service.most.gov. cn/ (received by WG) and the Projects of Science and Technology Department of Sichuan Province Grant No. 2016NYZ0035, 2021YFYZ0032 - URL: http://kjt.sc.gov.cn/ (received by WG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Birge HE, 2015, SOIL BIOL BIOCHEM, V81, P304, DOI 10.1016/j.soilbio.2014.11.028; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Bolan NS, 2011, ADV AGRON, V110, P1, DOI 10.1016/B978-0-12-385531-2.00001-3; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chen FL, 2013, J SOIL SEDIMENT, V13, P887, DOI 10.1007/s11368-013-0669-3; Creamer CA, 2011, SOIL BIOL BIOCHEM, V43, P1678, DOI 10.1016/j.soilbio.2011.04.013; Crowther TW, 2019, SCIENCE, V365, P772, DOI 10.1126/science.aav0550; Dai XQ, 2017, SCI TOTAL ENVIRON, V580, P556, DOI 10.1016/j.scitotenv.2016.11.212; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DICK RP, 1994, SSSA SPEC PUBL, P107; Dunham-Cheatham SM, 2020, GEODERMA, V376, DOI 10.1016/j.geoderma.2020.114535; Feng J, 2018, SCI TOTAL ENVIRON, V640, P653, DOI 10.1016/j.scitotenv.2018.05.332; Gao XS, 2020, URBAN FOR URBAN GREE, V54, DOI 10.1016/j.ufug.2020.126761; Gong W, 2009, PLANT SOIL, V314, P67, DOI 10.1007/s11104-008-9705-2; Gosling P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11083-6; Gregorich EG, 2006, SOIL SCI SOC AM J, V70, P975, DOI 10.2136/sssaj2005.0116; Hong SB, 2020, NAT SUSTAIN, V3, P694, DOI 10.1038/s41893-020-0557-y; Jiang L, 2017, SOIL BIOL BIOCHEM, V108, P91, DOI 10.1016/j.soilbio.2017.01.028; Jiang R, 2019, CATENA, V177, P49, DOI 10.1016/j.catena.2019.02.002; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Kan ZR, 2020, J CLEAN PROD, V265, DOI 10.1016/j.jclepro.2020.121921; Li BB, 2021, LAND DEGRAD DEV, V32, P505, DOI 10.1002/ldr.3644; Liu ZF, 2010, ANN NY ACAD SCI, V1195, pE82, DOI 10.1111/j.1749-6632.2009.05407.x; Lu XQ, 2014, EUR J SOIL BIOL, V61, P49, DOI 10.1016/j.ejsobi.2013.12.007; Ma YN, 2019, SOIL BIOL BIOCHEM, V134, P90, DOI 10.1016/j.soilbio.2019.03.020; Nazaries L, 2015, SOIL BIOL BIOCHEM, V89, P123, DOI 10.1016/j.soilbio.2015.06.027; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Pang DB, 2019, ECOL ENG, V138, P391, DOI 10.1016/j.ecoleng.2019.08.008; Rey A, 2008, EUR J SOIL SCI, V59, P1049, DOI 10.1111/j.1365-2389.2008.01065.x; Rong GH, 2021, CATENA, V202, DOI 10.1016/j.catena.2021.105226; Sahoo UK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219969; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Sinsabaugh RL, 2016, ECOL MONOGR, V86, P172, DOI 10.1890/15-2110.1; Spohn M, 2015, SOIL BIOL BIOCHEM, V81, P128, DOI 10.1016/j.soilbio.2014.11.008; Spohn M, 2015, BIOGEOSCIENCES, V12, P817, DOI 10.5194/bg-12-817-2015; Taylor PG, 2017, ECOL LETT, V20, P779, DOI 10.1111/ele.12765; Torres IF, 2014, SOIL BIOL BIOCHEM, V75, P152, DOI 10.1016/j.soilbio.2014.04.007; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Turrion MB, 2012, J ENVIRON MANAGE, V95, pS245, DOI 10.1016/j.jenvman.2010.10.020; van Gestel N, 2018, NATURE, V554, pE4, DOI 10.1038/nature25745; Wan QZ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53837-4; Wang JY, 2020, GEODERMA, V374, DOI 10.1016/j.geoderma.2020.114426; Wang MY, 2020, FOREST ECOL MANAG, V462, DOI 10.1016/j.foreco.2020.117991; Wang QK, 2018, GLOBAL CHANGE BIOL, V24, P2841, DOI 10.1111/gcb.14105; Wang QK, 2016, ECOSYSTEMS, V19, P450, DOI 10.1007/s10021-015-9941-2; Wu JQ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90543-6; Wu LW, 2017, ISME J, V11, P2102, DOI 10.1038/ismej.2017.75; Xie JY, 2017, GEODERMA, V296, P1, DOI 10.1016/j.geoderma.2017.02.023; Xu HW, 2020, LAND DEGRAD DEV, V31, P1001, DOI 10.1002/ldr.3513; Xu PD, 2020, SOIL TILL RES, V201, DOI 10.1016/j.still.2020.104594; Yang Li-xia, 2006, Journal of Forestry Research (Harbin), V17, P39, DOI 10.1007/s11676-006-0009-1; Yu KY, 2019, CATENA, V178, P313, DOI 10.1016/j.catena.2019.03.038; Zhang LG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68163-3; Zhang Y, 2019, GEODERMA, V338, P247, DOI 10.1016/j.geoderma.2018.11.050; Zhao FZ, 2019, FOREST ECOL MANAG, V441, P167, DOI 10.1016/j.foreco.2019.03.036; Zhao XX, 2020, SCI TOTAL ENVIRON, V740, DOI 10.1016/j.scitotenv.2020.139634; Zhu RH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185271	59	0	0	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262961	10.1371/journal.pone.0262961	http://dx.doi.org/10.1371/journal.pone.0262961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120155	gold, Green Published			2022-12-26	WOS:000789273600017
J	Menin, D; Aureli, T; Dondi, M				Menin, Damiano; Aureli, Tiziana; Dondi, Marco			Two forms of yawning modulation in three months old infants during the Face to Face Still Face paradigm	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MINI-PUBERTY; BEHAVIOR; DEPRESSION; CONTAGION; AROUSAL; HUMANS; BRAIN	The last decades have seen an increasing interest in the phenomenon of yawning and the dynamics of its modulation, yet no widespread consensus exists on its origins and potential functions. Although most scholars have focused on its potential physiological functions, e.g., related to thermoregulation, arousal modulation or cortisol levels and distress, an emerging line of research has been also investigating the social implications of yawning, including its hypothesized relationship with empathy. In order to explore the dynamics of yawning modulation in infants, we investigated whether a social perturbation-like the one induced by the Face to Face Still Face paradigm, a procedure designed to assess socio-emotional regulation in infants-affects yawning and self-touch hand movements behavior in three-months old infants. As the Still Face episode represents a source of mild distress, we hypothesized that during this phase yawns would be more frequent. Moreover, through the use of path analysis, we investigated potential dynamics of facilitation, inhibition or covariance between the frequencies of these behavioral patterns. Our results showed a sharp increase in self-touch hand movements as well as in the likelihood of yawning during the stressful phase of the procedure (still-face) compared with the two minutes of face-to-face interaction and the reunion episode. Regressions also showed a higher incidence of yawns among girls, consistently with the hypothesis that the analysis of yawning behavior might capture subtle differences in regulatory strategies of infants, possibly related to the transient sex-specific activation of the hypothalamic-pituitary-gonadal axis known as mini-puberty. The path analysis showed a greater consistency between the frequencies of self-touch hand movements during the three episodes of the procedure, compared with yawning. This finding could be a result of distinct yawning-regulating mechanisms being at play in different conditions, e.g., a modulation related to stress and one to social interaction. Taken together, these results suggest that human yawning regulation is an irreducibly complex and multifaceted phenomenon since early age. Moreover, the gender differences highlighted might suggest an early diversification in yawning modulation.	[Menin, Damiano; Dondi, Marco] Univ Ferrara, Dipartimento Studi Umanistici, Ferrara, Italy; [Aureli, Tiziana] Univ Chieti Pescara G DAnnunzio, Dipartimento Neurosci Imaging & Sci Clin, Chieti, Italy	University of Ferrara; G d'Annunzio University of Chieti-Pescara	Dondi, M (corresponding author), Univ Ferrara, Dipartimento Studi Umanistici, Ferrara, Italy.	marco.dondi@unife.it		Dondi, Marco/0000-0003-0745-9589; Menin, Damiano/0000-0002-8034-1512				Adamson LB, 2003, INFANCY, V4, P451, DOI 10.1207/S15327078IN0404_01; Anderson JR, 2010, FRONT NEUROL NEUROSC, V28, P63, DOI 10.1159/000307082; Argiolas A, 1998, EUR J PHARMACOL, V343, P1, DOI 10.1016/S0014-2999(97)01538-0; ASKENASY JJM, 1989, J PSYCHOL, V123, P609, DOI 10.1080/00223980.1989.10543014; Baenninger R, 1997, PSYCHON B REV, V4, P198, DOI 10.3758/BF03209394; Becker M, 2020, HORM RES PAEDIAT, V93, P76, DOI 10.1159/000508329; Braungart-Rieker J, 1998, DEV PSYCHOL, V34, P1428, DOI 10.1037/0012-1649.34.6.1428; Braungart-Rieker J, 1999, J FAM PSYCHOL, V13, P535, DOI 10.1037/0893-3200.13.4.535; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Catli T, 2015, EUR ARCH OTO-RHINO-L, V272, P3611, DOI 10.1007/s00405-014-3302-1; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Collins GT, 2010, FRONT NEUROL NEUROSC, V28, P90, DOI 10.1159/000307085; Daquin G, 2001, SLEEP MED REV, V5, P299, DOI 10.1053/smrv.2001.0175; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; Dondi M, 2015, MONOGRAPH CODING MAN; Filippa M, 2020, J NONVERBAL BEHAV, V44, P453, DOI 10.1007/s10919-020-00336-0; FOGEL A, 1980, INFANT BEHAV DEV, V3, P315, DOI 10.1016/S0163-6383(80)80040-3; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; Gallup AC, 2021, NEUROSCI BIOBEHAV R, V121, P18, DOI 10.1016/j.neubiorev.2020.11.023; Gallup AC, 2021, ANIM COGN, V24, P583, DOI 10.1007/s10071-020-01462-4; Gallup AC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160174; Gallup AC, 2013, MED HYPOTHESES, V81, P1034, DOI 10.1016/j.mehy.2013.09.026; Gallup AC, 2011, NEUROSCI BIOBEHAV R, V35, P765, DOI 10.1016/j.neubiorev.2010.09.009; Gao S, 2016, P NATL ACAD SCI USA, V113, P7650, DOI 10.1073/pnas.1602620113; Ghanizadeh Ahmad, 2012, Gen Hosp Psychiatry, V34, DOI 10.1016/j.genhosppsych.2011.09.021; Gibbins S, 2008, EARLY HUM DEV, V84, P451, DOI 10.1016/j.earlhumdev.2007.12.007; Giganti F, 2010, FRONT NEUROL NEUROSC, V28, P26, DOI 10.1159/000307072; Guggisberg AG, 2010, FRONT NEUROL NEUROSC, V28, P47, DOI 10.1159/000307079; Gunning M, 2013, INFANT BEHAV DEV, V36, P319, DOI 10.1016/j.infbeh.2013.02.003; Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0; Hensch T, 2015, PHARMACOPSYCHIATRY, V48, P118, DOI 10.1055/s-0035-1545332; Kanagasabai P., 2016, J NEPAL PAEDIAT SOC, V36, P110; KOCH P, 1987, CHRONOBIOL INT, V4, P525, DOI 10.3109/07420528709078544; Kurtoglu S, 2014, TURK PEDIATR ARSIVI, V49, P186, DOI 10.5152/tpa.2014.2038; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Massen JJM, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02019-y; Massen JJM, 2017, NEUROSCI BIOBEHAV R, V80, P573, DOI 10.1016/j.neubiorev.2017.07.006; Massen JJM, 2014, PHYSIOL BEHAV, V130, P145, DOI 10.1016/j.physbeh.2014.03.032; Menin D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226921; Montirosso R, 2015, INFANT BEHAV DEV, V38, P67, DOI 10.1016/j.infbeh.2014.12.015; Montirosso R, 2012, INFANT BEHAV DEV, V35, P819, DOI 10.1016/j.infbeh.2012.07.005; Muchnik S, 2003, MEDICINA-BUENOS AIRE, V63, P229; NEUMANN BG, 1990, ARCH INT PHARMACOD T, V308, P32; Norscia I, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00442; Norscia I, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150459; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Oster H, 2015, BABY FACS FACIAL ACT; Palagi E, 2020, NEUROSCI BIOBEHAV R, V111, P149, DOI 10.1016/j.neubiorev.2020.01.020; Palagi E, 2014, PEERJ, V2, DOI 10.7717/peerj.519; PROVINE RR, 1989, B PSYCHONOMIC SOC, V27, P211, DOI 10.3758/BF03334587; R Core Team, 2021, R LANGUAGE ENV STAT; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Seuntjens W, 2010, FRONT NEUROL NEUROSC, V28, P55, DOI 10.1159/000307081; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; SUGANAMI S, 1977, Okayama Igakkai Zasshi, V89, P195; Tarabulsy GM, 2003, INFANT BEHAV DEV, V26, P421, DOI 10.1016/S0163-6383(03)00039-0; Thompson SBN., 2015, J NEUROLOGY NEUROSCI, V06; Thompson SBN, 2011, MED HYPOTHESES, V77, P861, DOI 10.1016/j.mehy.2011.07.056; TODA S, 1993, DEV PSYCHOL, V29, P532, DOI 10.1037/0012-1649.29.3.532; Tomlinson C, 2004, ARCH DIS CHILD-FETAL, V89, pF558, DOI 10.1136/adc.2003.034017; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; van Berlo E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79160-x; Walusinski O, 2004, REV NEUROL-FRANCE, V160, P1011, DOI 10.1016/S0035-3787(04)71138-8; Walusinski Olivier, 2006, Psychol Neuropsychiatr Vieil, V4, P39; Walusinski O, 2006, MED HYPOTHESES, V67, P6, DOI 10.1016/j.mehy.2006.01.020; Weinberg MK, 2008, INFANT MENT HEALTH J, V29, P472, DOI 10.1002/imhj.20193; Yoo K, 2013, INFANT BEHAV DEV, V36, P344, DOI 10.1016/j.infbeh.2013.03.002	68	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263510	10.1371/journal.pone.0263510	http://dx.doi.org/10.1371/journal.pone.0263510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120177	gold, Green Published			2022-12-26	WOS:000789273600048
J	Tsui, TCO; Trudeau, M; Mitsakakis, N; Torres, S; Bremner, KE; Kim, D; Davis, AM; Krahn, MD				Tsui, Teresa C. O.; Trudeau, Maureen; Mitsakakis, Nicholas; Torres, Sofia; Bremner, Karen E.; Kim, Doyoung; Davis, Aileen M.; Krahn, Murray D.			Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions	PLOS ONE			English	Article							STATE CLASSIFICATION-SYSTEM; EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; FIT INDEXES; QUESTIONNAIRE; MODELS; SURVIVAL	Objectives Breast cancer (BrC) and its treatments impair health-related quality of life (HRQoL). Utility is a measure of HRQoL that includes preferences for health outcomes, used in treatment decision-making. Generic preference-based instruments lack BrC-specific concerns, indicating the need for a BrC-specific preference-based instrument. Our objective was to determine dimensions of the European Organisation for Research and Treatment of Cancer (EORTC) general cancer (QLQ-C30) and breast module (BR45) instruments, the first step in our development of the novel Breast Utility Instrument (BUI). Methods Patients (n = 408) attending outpatient BrC clinics at an urban cancer centre, and representing a spectrum of BrC health states, completed the QLQ-C30 and BR45. We performed confirmatory factor analysis of the combined QLQ-C30 and BR45 using mean-and variance-adjusted unweighted least squares estimation. The hypothesized factor model was based on clinical relevance, item distributions, missing data, item-importance, and internal reliability of dimensions. Models were evaluated based on global and item fit, local areas of strain, and likelihood ratio tests of nested models. Results Our final model had 10 dimensions: physical and role functioning, emotional functioning, social functioning, body image, pain, fatigue, systemic therapy side effects, sexual functioning and enjoyment, arm and breast symptoms, and endocrine therapy symptoms. Good overall model fit was achieved: chi(2)/df: 1.45, Tucker-Lewis index: 0.946, comparative fit index: 0.951, standardized root-mean-square residual: 0.069, root-mean-square error of approximation: 0.033 (0.030-0.037). All items had salient factor loadings (lambda>0.4, p<0.001). Conclusions We identified important BrC HRQoL dimensions to develop the BUI, a BrC-specific preference-based instrument.	[Tsui, Teresa C. O.; Bremner, Karen E.; Krahn, Murray D.] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada; [Tsui, Teresa C. O.; Krahn, Murray D.] Univ Toronto, Leslie Dan Fac Pharm, Grad Dept Pharmaceut Sci, Toronto, ON, Canada; [Trudeau, Maureen] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada; [Mitsakakis, Nicholas] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Mitsakakis, Nicholas] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Torres, Sofia; Davis, Aileen M.; Krahn, Murray D.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kim, Doyoung] Univ Toronto, Temerty Fac Med, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University of Toronto; University of Toronto	Tsui, TCO (corresponding author), Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.; Tsui, TCO (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Grad Dept Pharmaceut Sci, Toronto, ON, Canada.	teresa.tsui@utoronto.ca		Cid Torres, Sofia/0000-0001-6108-6918	THETA Fund for Excellence [5790 6839 0706]	THETA Fund for Excellence	The authors received financial support for patient honoraria from the THETA Fund for Excellence (# 5790 6839 0706), and for the Biomatrix data warehouse from Dr. Kathleen Pritchard's direct donation.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], 2006, CONSTITUTION WHO WHO; Bjelic-Radisic V, 2020, ANN ONCOL, V31, P283, DOI 10.1016/j.annonc.2019.10.027; Brazier JE, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16320; Brown TA, 2006, CONFIRMATORY FACTORY; Burstein HJ, 2019, J CLIN ONCOL, V37, P423, DOI 10.1200/JCO.18.01160; Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02; Canadian Cancer Statistics Advisory Committee, 2018, LEEUW; Cangur S, 2015, J MOD APPL STAT METH, V14, P152, DOI 10.22237/jmasm/1430453580; Chlebowski RT, 2015, LANCET ONCOL, V16, P749, DOI 10.1016/S1470-2045(15)00052-2; Costa DSJ, 2014, PATIENT-RELAT OUTCOM, V5, P119, DOI 10.2147/PROM.S68776; Drummond MF, 2015, METHODS EC EVALUATIO; Flora DB, 2017, CAN J BEHAV SCI, V49, P78, DOI 10.1037/cbs0000069; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Gandjour A, 2010, MED DECIS MAKING, V30, pE57, DOI 10.1177/0272989X10370488; GERBING DW, 1984, J CONSUM RES, V11, P572, DOI 10.1086/208993; Goodwin E, 2016, APPL HEALTH ECON HEA, V14, P161, DOI 10.1007/s40258-015-0219-9; Groenvold M, 1997, J CLIN EPIDEMIOL, V50, P441, DOI 10.1016/S0895-4356(96)00428-3; Gundy CM, 2012, QUAL LIFE RES, V21, P1607, DOI 10.1007/s11136-011-0082-6; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; King MT, 2016, QUAL LIFE RES, V25, P625, DOI 10.1007/s11136-015-1217-y; King MT, 2021, VALUE HEALTH, V24, P862, DOI 10.1016/j.jval.2021.01.007; Krahn M, 2000, J CLIN EPIDEMIOL, V53, P920, DOI 10.1016/S0895-4356(00)00211-0; Li CH, 2016, PSYCHOL METHODS, V21, P369, DOI 10.1037/met0000093; Lidgren M, 2007, INT J TECHNOL ASSESS, V23, P223, DOI 10.1017/S0266462307070328; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Longworth L, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18090; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Marschner N, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0643; Matza LS, 2020, MED DECIS MAKING, V40, P897, DOI 10.1177/0272989X20951782; Menzel P, 2002, SOC SCI MED, V55, P2149, DOI 10.1016/S0277-9536(01)00358-6; Michels Fernanda Alessandra Silva, 2013, Rev. bras. epidemiol., V16, P352, DOI 10.1590/S1415-790X2013000200011; Michiels S, 2016, ANN ONCOL, V27, P1029, DOI 10.1093/annonc/mdw132; Mierzynska J, 2020, EUR J CANCER, V125, P69, DOI 10.1016/j.ejca.2019.10.031; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mittmann Nicole, 2020, CMAJ Open, V8, pE191, DOI 10.9778/cmajo.20190114; Norman G., 2008, BIOSTATISTICS BARE E, V3rd, P194; OBRIEN RM, 1994, SOCIOL METHODOL, V24, P137, DOI 10.2307/270981; OSOBA D, 1994, QUAL LIFE RES, V3, P353, DOI 10.1007/BF00451727; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Reilly B., 1990, CLIN METHODS HIST PH, V3rd; Revelle W., PSYCH PROCEDURES PSY; Roelstraete B, 2011, J STAT SOFTW, V44, P1; Rowen D, 2017, PHARMACOECONOMICS, V35, pS33, DOI 10.1007/s40273-017-0546-9; Rowen D, 2011, VALUE HEALTH, V14, P721, DOI 10.1016/j.jval.2011.01.004; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; SEER, 2021, FEMALE BREAST CANC; Seung SJ, 2020, CURR ONCOL, V27, pE191, DOI 10.3747/co.27.5769; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Statistics Canada, 2017, CAT NO 98 316 X20160; Sundaram M, 2009, J CLIN EPIDEMIOL, V62, P845, DOI 10.1016/j.jclinepi.2009.01.020; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; ten Klooster PM, 2008, ARTHRIT RHEUM-ARTHR, V59, P692, DOI 10.1002/art.23569; Tripathy D, 2018, LANCET ONCOL, V19, P904, DOI 10.1016/S1470-2045(18)30292-4; Wei T., 2021, R PACKAGE CORRPLOT V; Whittaker TA, 2012, J EXP EDUC, V80, P26, DOI 10.1080/00220973.2010.531299	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262635	10.1371/journal.pone.0262635	http://dx.doi.org/10.1371/journal.pone.0262635			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120148	Green Published, gold			2022-12-26	WOS:000789273600011
J	Islam, MS; Tarannum, S; Banu, S; Chowdhury, KIA; Nazneen, A; Chughtai, AA; Seale, H				Islam, Md Saiful; Tarannum, Sayeeda; Banu, Sayera; Chowdhury, Kamal Ibne Amin; Nazneen, Arifa; Chughtai, Abrar Ahmad; Seale, Holly			Preparedness of tertiary care hospitals to implement the national TB infection prevention and control guidelines in Bangladesh: A qualitative exploration	PLOS ONE			English	Article								In high tuberculosis (TB) burden countries, health settings, including non-designated TB hospitals, host many patients with pulmonary TB. Bangladesh's National TB Control Program aims to strengthen TB infection prevention and control (IPC) in health settings. However, there has been no published literature to date that assessed the preparedness of hospitals to comply with the recommendations. To address this gap, our study examined healthcare workers knowledge and attitudes towards TB IPC guidelines and their perceptions regarding the hospitals' preparedness in Bangladesh. Between January to December 2019, we conducted 16 key-informant interviews and four focus group discussions with healthcare workers from two public tertiary care hospitals. In addition, we undertook a review of 13 documents [i.e., hospital policy, annual report, staff list, published manuscript]. Our findings showed that healthcare workers acknowledged the TB risk and were willing to implement the TB IPC measures but identified key barriers impacting implementation. Gaps were identified in: policy (no TB policy or guidelines in the hospital), health systems (healthcare workers were unaware of the guidelines, lack of TB IPC program, training and education, absence of healthcare-associated TB infection surveillance, low priority of TB IPC, no TB IPC monitoring and feedback, high patient load and bed occupancy, and limited supply of IPC resources) and behavioural factors (risk perception, compliance, and self and social stigma). The additional service-level gap was the lack of electronic medical record systems. These findings highlighted that while there is a demand amongst healthcare workers to implement TB IPC measures, the public tertiary care hospitals have got key issues to address. Therefore, the National TB Control Program may consider these gaps, provide TB IPC guidelines to these hospitals, assist them in developing hospital-level IPC manual, provide training, and coordinate with the ministry of health to allocate separate budget, staffing, and IPC resources to implement the control measures successfully.	[Islam, Md Saiful; Tarannum, Sayeeda; Banu, Sayera; Chowdhury, Kamal Ibne Amin; Nazneen, Arifa] Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh; [Islam, Md Saiful; Chughtai, Abrar Ahmad; Seale, Holly] Univ New South Wales, Fac Med & Hlth, Sch Populat Hlth, Sydney, NSW, Australia; [Islam, Md Saiful] Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney; University of New South Wales Sydney	Islam, MS (corresponding author), Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh.; Islam, MS (corresponding author), Univ New South Wales, Fac Med & Hlth, Sch Populat Hlth, Sydney, NSW, Australia.; Islam, MS (corresponding author), Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia.	saiful@icddrb.org		Islam, Md Saiful/0000-0002-5690-5971; Chowdhury, Kamal/0000-0001-7125-7071	United States Centre for Disease Control and Prevention (CDC) [5U01GH1207]	United States Centre for Disease Control and Prevention (CDC)	This research protocol was funded by the United States Centre for Disease Control and Prevention (CDC) through the cooperative agreement grant number 5U01GH1207. MSI and SB received this award. None of the authors received any other funding for this research. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2020, DAILY STAR; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Biswas MAAJ., 2021, UNPUB; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Maroldi MAC, 2017, BMC NURS, V16, DOI 10.1186/s12912-017-0245-z; Ching WH, 2008, INDOOR BUILT ENVIRON, V17, P252, DOI 10.1177/1420326X08091957; Engelbrecht M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4115-z; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Escombe AR, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3717-9; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Granich Reuben., 1999, GUIDELINES PREVENTIO; Islam MS, 2021, J INFECT PUBLIC HEAL, V14, P588, DOI 10.1016/j.jiph.2021.01.014; Islam MS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243951; Islam MS., 2021, PLOS GLOBAL PUBLIC H; Nardell EA, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a018192; National Tuberculosis Control Programme, 2011, NAT GUID TUB INF CON; Nazneen A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246923; O'Connor C, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406919899220; Petticrew M, 2011, EUR J PUBLIC HEALTH, V21, P397, DOI 10.1093/eurpub/ckr084; Storr J, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-016-0149-9; Timimi H, 2012, J AM MED INFORM ASSN, V19, P939, DOI 10.1136/amiajnl-2011-000755; Von Delft A, 2015, INT J INFECT DIS, V32, P147, DOI 10.1016/j.ijid.2014.12.003; Weiner BJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-67; WHO, 2022, DIFF SIMPL PREEXP PR; Woith W, 2012, INT J TUBERC LUNG D, V16, P1092, DOI 10.5588/ijtld.10.0779; World Health Organization, 2018, IMPR INF PREV CONTR; World Health Organization, 2012, EL REC REP TUB CAR C; World Health Organization, 2016, GUID COR COMP INF PR; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2010, IMPL WHO POL TB INF; World Health Organization, 2015, DIG HLTH END TB STRA; World Health Organization, 2009, WHOHTMTB2009; Zetola NM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-409; Zwama G, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004735	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263115	10.1371/journal.pone.0263115	http://dx.doi.org/10.1371/journal.pone.0263115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113905	gold, Green Published			2022-12-26	WOS:000823694700056
J	Lafta, A; Ukrainetz, J; Davison, S; Thompson, S; Bello, A; Braam, B				Lafta, Aya; Ukrainetz, Judy; Davison, Sara; Thompson, Stephanie; Bello, Aminu; Braam, Branko			Inter- and intradialytic fluid volume changes and vascular stiffness parameters in patients on hemodialysis	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; BLOOD-PRESSURE; AUGMENTATION INDEX; AORTIC STIFFNESS; HYDRATION; OVERLOAD; SURVIVAL; OVERHYDRATION; REFLECTIONS	Background Whether fluid overload is associated with vascular stiffness parameters in hemodialysis (HD) patients has not been fully elucidated. We hypothesized that interdialytic fluid accumulation increases vascular stiffness parameters, which improves with intradialytic ultrafiltration. Methods Fluid overload and vascular stiffness parameters were assessed in 39 HD patients (20 with and 19 without fluid overload) and compared to 26 healthy controls. Fluid status was assessed 15 minutes before the mid-week HD session by bio-impedance spectroscopy. Following this, ambulatory pulse wave velocity (PWV) and augmentation index (Alx) were measured for 24 hours before another mid-week HD session and then for 5 hours starting 30 minutes before and ending 30 minutes after the session. Results HD patients had significant fluid overload compared to healthy controls (2.0 +/- 2.4 vs. -0.2 +/- 0.6 L; P<0.001) and baseline PWV was higher (10.3 +/- 1.7 vs. 8.8 +/- 1.4 m/s; P<0.001). There was no significant difference between PWV and Alx in fluid overloaded and non-fluid overloaded HD patients prior to, or during the HD session. Alx of non-fluid overloaded HD patients improved after the HD session (P = 0.04). Average 24-hour Alx was higher in fluid overloaded HD patients (P<0.001). Conclusions Inter- and intradialytic changes in fluid volume were only weakly related to vascular stiffness parameters in HD patients. Although there was a modest reduction in Alx in non-fluid overloaded HD patients after the dialysis session, fluid removal did not improve vascular stiffness parameters during the HD session. We speculate that the effect of fluid overload correction on vascular stiffness parameters requires long-term adjustments in the vasculature.	[Lafta, Aya; Ukrainetz, Judy; Davison, Sara; Thompson, Stephanie; Bello, Aminu; Braam, Branko] Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB, Canada; [Ukrainetz, Judy] Univ Alberta Hosp, Alberta Hlth Serv, Alberta Kidney Care North, Edmonton, AB, Canada; [Braam, Branko] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; Alberta Health Services (AHS); University of Alberta; University of Alberta	Braam, B (corresponding author), Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB, Canada.; Braam, B (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	braam@ualberta.ca			Kidney Health Translational Chair of the Faculty of Medicine and Dentistry, Department of Medicine, Division of Nephrology	Kidney Health Translational Chair of the Faculty of Medicine and Dentistry, Department of Medicine, Division of Nephrology	Branko Braam's research is supported by the Kidney Health Translational Chair of the Faculty of Medicine and Dentistry, Department of Medicine, Division of Nephrology. Aya Lafta received her graduate study stipend via this Research Chair award.	Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Banerjee D, 2007, CLIN J AM SOC NEPHRO, V2, P1186, DOI 10.2215/CJN.01110307; Bia D, 2015, INT J NEPHROL, V2015, DOI 10.1155/2015/628654; Bia D, 2017, HIGH BLOOD PRESS CAR, V24, P37, DOI 10.1007/s40292-017-0178-3; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; CHAIGNON M, 1981, HYPERTENSION, V3, P333, DOI 10.1161/01.HYP.3.3.333; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Covic A, 2005, J NEPHROL, V18, P388; Covic A, 2000, KIDNEY INT, V57, P2634, DOI 10.1046/j.1523-1755.2000.00124.x; Di Iorio B, 2010, NEPHROL DIAL TRANSPL, V25, P1579, DOI 10.1093/ndt/gfp662; Dou YN, 2012, SEMIN DIALYSIS, V25, P377, DOI 10.1111/j.1525-139X.2012.01095.x; Dubin R, 2011, HEMODIAL INT, V15, P350, DOI 10.1111/j.1542-4758.2011.00560.x; Garnier AS, 2015, PULSE, V3, P229, DOI 10.1159/000443616; Georgianos PI, 2013, NEPHROL DIAL TRANSPL, V28, P2160, DOI 10.1093/ndt/gft085; Georgianos PI, 2011, AM J NEPHROL, V34, P407, DOI 10.1159/000331700; Guerin AP, 2001, CIRCULATION, V103, P987; Hogas S, 2012, INT UROL NEPHROL, V44, P897, DOI 10.1007/s11255-011-9933-x; Horvath IG, 2010, J HYPERTENS, V28, P2068, DOI 10.1097/HJH.0b013e32833c8a1a; Ie EHY, 2005, J HUM HYPERTENS, V19, P439, DOI 10.1038/sj.jhh.1001813; Kalainy Sylvia, 2015, Can J Kidney Health Dis, V2, P54, DOI 10.1186/s40697-015-0090-5; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Karpetas A, 2015, CLIN J AM SOC NEPHRO, V10, P630, DOI 10.2215/CJN.08180814; Kosch M, 2001, NEPHROL DIAL TRANSPL, V16, P1663, DOI 10.1093/ndt/16.8.1663; Lin YP, 2005, J HUM HYPERTENS, V19, P425, DOI 10.1038/sj.jhh.1001842; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Nongnuch A, 2015, KIDNEY INT, V87, P452, DOI 10.1038/ki.2014.276; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Ogunc H, 2015, HEMODIAL INT, V19, P463, DOI 10.1111/hdi.12277; Tsai YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111000; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Vuurmans JLT, 2002, J AM SOC NEPHROL, V13, P177, DOI 10.1681/ASN.V131177; Wabel P, 2008, NEPHROL DIAL TRANSPL, V23, P2965, DOI 10.1093/ndt/gfn228; Wang ZM, 1999, AM J PHYSIOL-ENDOC M, V276, pE995, DOI 10.1152/ajpendo.1999.276.6.E995; Wever R, 1999, ARTERIOSCL THROM VAS, V19, P1168, DOI 10.1161/01.ATV.19.5.1168; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262519	10.1371/journal.pone.0262519	http://dx.doi.org/10.1371/journal.pone.0262519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113896	gold, Green Published			2022-12-26	WOS:000823694700025
J	Mokria, M; Gebrekirstos, A; Said, H; Hadgu, K; Hagazi, N; Dubale, W; Brauning, A				Mokria, Mulugeta; Gebrekirstos, Aster; Said, Hadia; Hadgu, Kiros; Hagazi, Niguse; Dubale, Workneh; Brauning, Achim			Volume estimation models for avocado fruit	PLOS ONE			English	Article							APPLE-TREES; SIZE; BIOMASS; WEIGHT	Avocado (Persea americana Mill.) is an important horticultural crop and proved to be a very profitable commercial crop for both local consumption and export. The physical characteristics of fruits are an important factor to determine the quality of fruit produced. On the other hand, estimation of fruit volume is time-consuming and impractical under field conditions. Thus, this study was conducted to devise cultivar-specific and generalized allometric models to analytically and non-destructively determine avocado fruit volume of five wildly distributed avocado cultivars. A significant relationship (P <= 0.01) was found between fruit diameter, length, and volume of each cultivar. Our best models (VM2 -for cultivar specific, and VM7-generalized model) has passed all the rigorous cross-validation and performance statistics tests and explained 94%, 92%, 87%, 93%, 94% and 93% of the variations in fruit volume of Ettinger, Fuerte, Hass, Nabal, Reed, and Multiple cultivars, respectively. Our finding revealed that in situations where measurements of volume would be inconvenient, or time-consuming, a reliable volume and yield estimation can be obtained using site- and cultivar-specific allometric equations. Allometric models could also play a significant role in improving data availability on avocado fruit physical appearance which is critical to assess the quality and taste of fresh products influencing the purchase decision of customers. Moreover, such information can also be used as a ripeness index to predict optimum harvest time important for planned marketing. More importantly, the models might assist horticulturists, agronomists, and physiologists to conduct further study on avocado production and productivity through agroforestry landuse system across Ethiopia.	[Mokria, Mulugeta; Said, Hadia; Hadgu, Kiros; Hagazi, Niguse] World Agroforestry ICRAF, C-O ILRI Campus, Addis Ababa, Ethiopia; [Gebrekirstos, Aster] World Agroforestry ICRAF, UN Ave, Nairobi, Kenya; [Dubale, Workneh] Int Livestock Res Inst ILRI, Addis Ababa, Ethiopia; [Brauning, Achim] Friedrich Alexander Univ Erlangen Nuremberg, Inst Geog, Erlangen, Germany	CGIAR; World Agroforestry (ICRAF); CGIAR; International Livestock Research Institute (ILRI); University of Erlangen Nuremberg	Mokria, M (corresponding author), World Agroforestry ICRAF, C-O ILRI Campus, Addis Ababa, Ethiopia.	m.mokria@cgiar.org	MOKRIA, MULUGETA GEMI/I-6415-2019	MOKRIA, MULUGETA GEMI/0000-0002-7812-8296	United States Agency for International Development (USAID) as part of the United States Government's Feed the Future Initiative	United States Agency for International Development (USAID) as part of the United States Government's Feed the Future Initiative(United States Agency for International Development (USAID))	This study was conducted with the financial support of the Africa Rising Project-a program financed by the United States Agency for International Development (USAID) as part of the United States Government's Feed the Future Initiative.	Ali S, 2020, SCI HORTIC-AMSTERDAM, V261, DOI 10.1016/j.scienta.2019.109008; Ammann CM, 2007, CLIMATIC CHANGE, V85, P71, DOI 10.1007/s10584-007-9276-x; Barmore CR., 1976, AVOCADO FRUIT MATURI, P103; Bayram S., 2019, Derim, V36, P1, DOI 10.16882/derim.2019.410329; Bayram S, 2012, J FOOD AGRIC ENVIRON, V10, P588; Berhanu Megerssa, 2013, African Journal of Agricultural Research, V8, P2285; Beyene K., 2017, ADVISOR CHARACTERIZA; Bozokalfa MK, 2010, CHIL J AGR RES, V70, P626, DOI 10.4067/S0718-58392010000400013; Burnham KP, 2003, MODEL SELECTION MULT; Central Statistical Agency, 2007, CENTRAL STAT AGENCY; Dorantes L., 2004, POSTHARVEST OPERATIO; Elias. S., 2016, SUPPLY CHAIN ANAL AV, V6, P46, DOI ISSN 2225-0581 (online); Erickson LC., 1965, DETERMINATION SURFAC, P103; FAO, 2019, MAJ TROP FRUITS MARK, DOI DOI 10.4060/CA5688-N; FAOSTAT, 2020, AGR PROD DAT; Faris A., 2016, IND ENG LETT, V6, P33, DOI [ISSN 2225-0581(online), 2225-0581]; Fulgoni VL, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-1; GILL JL, 1986, J ANIM BREED GENET, V103, P161, DOI 10.1111/j.1439-0388.1986.tb00079.x; Janice DA., 2018, AFRICAN J PLANT SCI, V12, P88, DOI [10.5897/ajps2017.1625, DOI 10.5897/AJPS2017.1625, 10.5897/AJPS2017.1625]; Johnston R, 2018, QUAL QUANT, V52, P1957, DOI 10.1007/s11135-017-0584-6; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; LEE SK, 1983, J AM SOC HORTIC SCI, V108, P390; Mahanti KK., 2016, SUPPL AGRON, V11, P659; Marini RP, 2019, HORTSCIENCE, V54, P1017, DOI 10.21273/HORTSCI13956-19; Marini RP, 2001, J AM SOC HORTIC SCI, V126, P503, DOI 10.21273/JASHS.126.4.503; Mekonnen K, 2019, P WORKSHOP; Mokria M., 2018, ENVIRONMEANTAL RES L, V00, P00; Mokria M, 2017, GLOBAL CHANGE BIOL, V23, P5436, DOI 10.1111/gcb.13809; Moreda GP, 2009, J FOOD ENG, V92, P119, DOI 10.1016/j.jfoodeng.2008.11.004; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Negash M, 2013, AGROFOREST SYST, V87, P953, DOI 10.1007/s10457-013-9611-3; Ngouajio M, 2003, HORTSCIENCE, V38, P509, DOI 10.21273/HORTSCI.38.4.509; Palou A, 2003, EUR J CLIN NUTR, V57, pS12, DOI 10.1038/sj.ejcn.1601822; Rahman S.K., 2012, INT J RES COMPUT SCI, V2, P23, DOI 10.7815/ijorcs.22.2012.018; Riga FT., 2017, BIOMASS YIELD NUTRIT; SCHAFFER B, 1986, J AM SOC HORTIC SCI, V111, P985; Schaffer B., 2003, ACTAS C MUND AGUACAT, P335; Seong C, 2015, WATER-SUI, V7, P503, DOI 10.3390/w7020503; Shumeta Z, 2010, TRENDS AGR EC, V3, P190, DOI [10.3923/tae.2010.190.206, DOI 10.3923/TAE.2010.190.206]; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Tadesse AY, 2011, THESIS; Terheggen A., 2019, ETHIOPIAS POTENTIAL, DOI [10.13140/RG.2.2.31755.23848, DOI 10.13140/RG.2.2.31755.23848]; USDA, 2020, AV RAW ALL COMM VAR, DOI [10.1177/1120700020921110, DOI 10.1177/1120700020921110]; Vanderlei RS., 2019, REV OURICURI, V9, P1, DOI [10.29327/ouricuri.9.2-1, DOI 10.29327/OURICURI.9.2]; Wang ZL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122738; Woolf A., 2003, Orchardist, V76, P40; Ziaratban A, 2017, INT J FOOD PROP, V20, P762, DOI 10.1080/10942912.2016.1180533; ZILKAH S, 1987, SCI HORTIC-AMSTERDAM, V32, P195, DOI 10.1016/0304-4238(87)90086-0	48	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263564	10.1371/journal.pone.0263564	http://dx.doi.org/10.1371/journal.pone.0263564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113958	gold, Green Published			2022-12-26	WOS:000823694700107
J	Scantlebury, S; McCormack, S; Sawczuk, T; Emmonds, S; Collins, N; Beech, J; Ramirez, C; Owen, C; Jones, B				Scantlebury, Sean; McCormack, Sam; Sawczuk, Thomas; Emmonds, Stacey; Collins, Neil; Beech, Jake; Ramirez, Carlos; Owen, Cameron; Jones, Ben			The anthropometric and physical qualities of women's rugby league Super League and international players; identifying differences in playing position and level	PLOS ONE			English	Article							MIDTHIGH-PULL DYNAMOMETER; ELITE; VALIDITY; RELIABILITY; STRENGTH; FITNESS	Participation in women's rugby league has been growing since the foundation of the English women's rugby league Super League in 2017. However, the evidence base to inform women's rugby league remains sparse. This study provides the largest quantification of anthropometric and physical qualities of women's rugby league players to date, identifying differences between positions (forwards & backs) and playing level (Women's Super League [WSL] vs. International). The height, weight, body composition, lower body strength, jump height, speed and aerobic capacity of 207 players were quantified during the pre-season period. Linear mixed models and effects sizes were used to determine differences between positions and levels. Forwards were significantly (p < 0.05) heavier (forwards: 82.5 +/- 14.8kg; backs: 67.7 +/- 9.2kg) and have a greater body fat % (forwards: 37.7 +/- 6.9%; backs: 30.4 +/- 6.3%) than backs. Backs had significantly greater lower body power measured via jump height (forwards: 23.5 +/- 4.4cm; backs: 27.6 +/- 4.9cm), speed over 10m (forwards: 2.12 +/- 0.14s; backs: 1.98 +/- 0.11s), 20m (forwards: 3.71 +/- 0.27s; backs: 3.46 +/- 0.20s), 30m (forwards: 5.29 +/- 0.41s; backs: 4.90 +/- 0.33s), 40m (forwards: 6.91 +/- 0.61s; backs: 6.33 +/- 0.46s) and aerobic capacity (forwards: 453.4 +/- 258.8m; backs: 665.0 +/- 298.2m) than forwards. Additionally, international players were found to have greater anthropometric and physical qualities in comparison to their WSL counterparts. This study adds to the limited evidence base surrounding the anthropometric and physical qualities of elite women's rugby league players. Comparative values for anthropometric and physical qualities are provided which practitioners may use to evaluate the strengths and weaknesses of players, informing training programs to prepare players for the demands of women's rugby league.	[Scantlebury, Sean; McCormack, Sam; Sawczuk, Thomas; Emmonds, Stacey; Collins, Neil; Beech, Jake; Ramirez, Carlos; Owen, Cameron; Jones, Ben] Leeds Beckett Univ, Carnegie Appl Rugby Res CARR Ctr, Carnegie Sch Sport, Leeds, W Yorkshire, England; [Scantlebury, Sean; McCormack, Sam; Sawczuk, Thomas; Emmonds, Stacey; Collins, Neil; Ramirez, Carlos; Jones, Ben] Rugby Football League Ltd, England Performance Unit, Leeds, W Yorkshire, England; [Sawczuk, Thomas] Leeds Beckett Univ, Sch Built Environm Engn & Comp, Leeds, W Yorkshire, England; [Owen, Cameron] Leeds Rhinos Netball, Leeds, W Yorkshire, England; [Jones, Ben] Leeds Rhinos Rugby League Club, Leeds, W Yorkshire, England; [Jones, Ben] Univ Cape Town, Fac Hlth Sci, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Jones, Ben] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia	Leeds Beckett University; Leeds Beckett University; University of Cape Town; University of New England	Scantlebury, S (corresponding author), Leeds Beckett Univ, Carnegie Appl Rugby Res CARR Ctr, Carnegie Sch Sport, Leeds, W Yorkshire, England.; Scantlebury, S (corresponding author), Rugby Football League Ltd, England Performance Unit, Leeds, W Yorkshire, England.	s.scantlebury@leedsbeckett.ac.uk		Ramirez-Lopez, Carlos/0000-0003-1605-3484; McCormack, Sam/0000-0001-6994-178X; Scantlebury, Sean/0000-0001-7065-7057	Rugby Football League	Rugby Football League	The funder (the Rugby Football League) provided support in the form of salaries for authors [SS, SM, CR, BJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Cummins C, 2020, BRIT J SPORT MED, V54, DOI 10.1136/bjsports-2019-101403; Dobbin N, 2021, J STRENGTH COND RES, V35, P176, DOI 10.1519/JSC.0000000000002621; Dobbin N, 2018, INT J SPORT PHYSIOL, V13, P235, DOI 10.1123/ijspp.2017-0166; Emmonds S, 2020, J SPORT SCI, V38, P2454, DOI 10.1080/02640414.2020.1790815; Gabbett T, 2007, J STRENGTH COND RES, V21, P1126; Gabbett T, 2009, J SCI MED SPORT, V12, P215, DOI 10.1016/j.jsams.2007.06.008; Gabbett TJ, 2007, J STRENGTH COND RES, V21, P875; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P3259, DOI 10.1519/JSC.0b013e31828d6219; Gabbett TJ, 2012, J SCI MED SPORT, V15, P496, DOI 10.1016/j.jsams.2012.03.017; Haugen TA, 2012, INT J SPORT PHYSIOL, V7, P340, DOI 10.1123/ijspp.7.4.340; Jones B, 2016, J STRENGTH COND RES, V30, P1333, DOI 10.1519/JSC.0000000000001225; Lloyd RS, 2016, J STRENGTH COND RES, V30, P1491, DOI 10.1519/JSC.0000000000001387; Loenneke JP, 2013, CLIN PHYSIOL FUNCT I, V33, P405, DOI 10.1111/cpf.12045; Lombard WP, 2015, J STRENGTH COND RES, V29, P980, DOI 10.1519/JSC.0000000000000724; McCormack S, 2020, SPORTS, V8, DOI 10.3390/sports8090130; Owen C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233796; Roe G, 2017, INT J SPORT PHYSIOL, V12, P836, DOI 10.1123/ijspp.2016-0256; Rugby Football League, 2019, DISTR PAS NONPL ROL; Sawczuk T, 2018, MEAS PHYS EDUC EXERC, V22, P11, DOI 10.1080/1091367X.2017.1360304; Till K, 2018, J STRENGTH COND RES, V32, P490, DOI 10.1519/JSC.0000000000002324; Till K, 2017, SPORTS MED, V47, P2171, DOI 10.1007/s40279-017-0745-8; Till K, 2011, J SCI MED SPORT, V14, P264, DOI 10.1016/j.jsams.2011.01.006	22	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0249803	10.1371/journal.pone.0249803	http://dx.doi.org/10.1371/journal.pone.0249803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100275	gold, Green Published			2022-12-26	WOS:000801937600002
J	Chandra, R; Jain, A; Chauhan, DS				Chandra, Rohitash; Jain, Ayush; Chauhan, Divyanshu Singh			Deep learning via LSTM models for COVID-19 infection forecasting in India	PLOS ONE			English	Article							RECURRENT NEURAL-NETWORKS; FINITE-STATE AUTOMATA; HEALTH; PREDICTION	The COVID-19 pandemic continues to have major impact to health and medical infrastructure, economy, and agriculture. Prominent computational and mathematical models have been unreliable due to the complexity of the spread of infections. Moreover, lack of data collection and reporting makes modelling attempts difficult and unreliable. Hence, we need to re-look at the situation with reliable data sources and innovative forecasting models. Deep learning models such as recurrent neural networks are well suited for modelling spatiotemporal sequences. In this paper, we apply recurrent neural networks such as long short term memory (LSTM), bidirectional LSTM, and encoder-decoder LSTM models for multi-step (short-term) COVID-19 infection forecasting. We select Indian states with COVID-19 hotpots and capture the first (2020) and second (2021) wave of infections and provide two months ahead forecast. Our model predicts that the likelihood of another wave of infections in October and November 2021 is low; however, the authorities need to be vigilant given emerging variants of the virus. The accuracy of the predictions motivate the application of the method in other countries and regions. Nevertheless, the challenges in modelling remain due to the reliability of data and difficulties in capturing factors such as population density, logistics, and social aspects such as culture and lifestyle.	[Chandra, Rohitash] Univ New South Wales, Sch Math & Stat, Transit Artificial Intelligence Res Grp, Sydney, NSW, Australia; [Jain, Ayush] Indian Inst Technol Guwahati, Dept Elect & Elect Engn, Gauhati, Assam, India; [Chauhan, Divyanshu Singh] Indian Inst Technol Guwahati, Dept Mech Engn, Gauhati, Assam, India	University of New South Wales Sydney; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Chandra, R (corresponding author), Univ New South Wales, Sch Math & Stat, Transit Artificial Intelligence Res Grp, Sydney, NSW, Australia.	rohitash.chandra@unsw.edu.au	Chandra, Rohitash/D-5748-2015	Chandra, Rohitash/0000-0001-6353-1464				Alzahrani SI, 2020, J INFECT PUBLIC HEAL, V13, P914, DOI 10.1016/j.jiph.2020.06.001; Anand A., LETT APPL NANOBIOSCI, V10, P2044; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, LANCET, V395, P1315, DOI 10.1016/S0140-6736(20)30938-7; [Anonymous], 2020, WORLD EC OUTLOOK APR; [Anonymous], 2020, COVID 19 INDIA DATA; Velasquez RMA, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109924; Athreya S, 2020, COVID 19 INDIA TIMEL; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Battineni G., 2020, APPL COMPUTING INFOR, P1; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bhimala K. R., 2020, AUTHOREA PREPRINTS, DOI [10.22541/au.160275979.91541585/v1, DOI 10.22541/AU.160275979.91541585/V1]; Biavardi N.G., 2020, INT J MED STUDENTS, V8, P49, DOI [10.5195/ijms.2020.489, DOI 10.5195/IJMS.2020.489, 10.5195/ijms.0.489]; Bodapati Suraj, 2020, 2020 IEEE 5th International Conference on Computing Communication and Automation (ICCCA), P525, DOI 10.1109/ICCCA49541.2020.9250863; Callard F, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113426; Chakraborty T, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109850; Chandra R, 2020, NEUROCOMPUTING, V378, P54, DOI 10.1016/j.neucom.2019.10.042; Chandra R, 2019, NEUROCOMPUTING, V359, P315, DOI 10.1016/j.neucom.2019.05.082; Chandra R, 2015, IEEE T NEUR NET LEAR, V26, P3123, DOI 10.1109/TNNLS.2015.2404823; Chaurasia Vikas, 2022, Research on Biomedical Engineering, V38, P35, DOI 10.1007/s42600-020-00105-4; Chimmula VKR, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109864; Chin V, 2020, EUR J EPIDEMIOL, V35, P733, DOI 10.1007/s10654-020-00669-6; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; da Silva RG, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110027; Dandekar A., 2020, ECON POLIT WEEKLY, VLV, P28; Debnath R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238972; del Rio C, 2021, JAMA-J AM MED ASSOC, V326, P1001, DOI 10.1001/jama.2021.14811; Dev SM, 2020, MUMBAI WORKING PAPER; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; ELMAN JL, 1988, J ACOUST SOC AM, V83, P1615, DOI 10.1121/1.395916; Fan Y, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2013, VOL 2; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Frazier C, 2004, TRANSPORT RES REC, P9, DOI 10.3141/1897-02; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Giles CL, 1999, P IEEE, V87, P1623, DOI 10.1109/5.784244; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2013, 2013 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P273, DOI 10.1109/ASRU.2013.6707742; Gupta A, 2020, IEEE T INTELL TRANSP, V21, P5316, DOI 10.1109/TITS.2019.2957325; Hart C.E., 2020, IMPACT COVID 19 IOWA; Hochreiter S, 1998, INT J UNCERTAIN FUZZ, V6, P107, DOI 10.1142/S0218488598000094; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Huang YB, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110041; Imber-Black E, 2020, FAM PROCESS, V59, P912, DOI 10.1111/famp.12581; Istaiteh O, 2020, 2020 INT C INT DAT S, P50, DOI DOI 10.1109/IDSTA50958.2020.9264101; Jain VK, 2021, DIABETES METAB SYND, V15, P1047, DOI 10.1016/j.dsx.2021.05.009; Johns Hopkins Coronavirus Resource Center, COVID 19 DASHB; Joshi M., 2021, 1 DETECTION SARS COV, DOI [10.1101/2021.07.07.21260142, DOI 10.1101/2021.07.07.21260142]; Kerimray A, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.139179; Kluge HHP, 2020, LANCET, V395, P1237, DOI 10.1016/S0140-6736(20)30791-1; Kumar A, 2020, ADV INTELL SYST COMP, V1069, P1, DOI [10.1007/978-3-030-32520-6_1, 10.1016/j.puhip.2020.100009]; Lebow JL, 2020, FAM PROCESS, V59, P309, DOI 10.1111/famp.12543; Leite H, 2020, PUBLIC MONEY MANAGE, V40, P483, DOI 10.1080/09540962.2020.1748855; Liem A, 2020, LANCET PSYCHIAT, V7, pE20, DOI 10.1016/S2215-0366(20)30076-6; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2815; Maleki M, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101742; Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Muhammad S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138820; Nadler P., 2020, MACHINE LEARNING HLT, P254; Omlin C. W., 1992, P 9 INT C MACHINE LE, P363; Omlin CW, 1996, J ACM, V43, P937, DOI 10.1145/235809.235811; Omlin CW, 1998, IEEE T FUZZY SYST, V6, P76, DOI 10.1109/91.660809; Owusu-Fordjour C., 2020, EUROPEAN J ED STUDIE, V7, P88, DOI [DOI 10.5281/ZENODO.3753586, 10.5281/zenodo.3753586]; Pall J, 2020, ENVIRON MODELL SOFTW, V125, DOI 10.1016/j.envsoft.2019.104610; Pinter G, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8060890; Rab S, 2020, DIABETES METAB SYND, V14, P1617, DOI 10.1016/j.dsx.2020.08.021; Rai B., 2020, POPULATION MED, V2, DOI [10.18332/popmed/125064, DOI 10.18332/POPMED/125064]; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Ren HY, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138995; Ritchie H., 2020, CO2 GREENHOUSE GAS E; Saba AI, 2020, PROCESS SAF ENVIRON, V141, P1, DOI 10.1016/j.psep.2020.05.029; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Shetty R.P., 2021, J I ENG SER B, V102, P1201, DOI [10.1007/s40031-021-00623-4, DOI 10.1007/S40031-021-00623-4, 10.1007/S40031-021-00623-4]; Shi XJ, 2015, ADV NEUR IN, V28; Siche R, 2020, SCI AGROPEC, V11, P3, DOI 10.17268/sci.agropecu.2020.01.00; Singh S, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109866; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5; Tomar A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138762; Wang HZ, 2017, APPL ENERG, V188, P56, DOI 10.1016/j.apenergy.2016.11.111; WERBOS PJ, 1990, P IEEE, V78, P1550, DOI 10.1109/5.58337; Wikipedia contributors, 2020, LIST CIT PROP POP DE; World Health Organization, 2020, DIG TOOLS COVID 19 C; Yang W., 2021, COVID 19 PANDEMIC DY, DOI [https://doi.org/10.1101/2021.06.21.21259268, DOI 10.1101/2021.06.21.21259268]; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Ye F, 2020, INT J INFECT DIS, V94, P133, DOI 10.1016/j.ijid.2020.03.042; Yousaf M, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109926; Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813; Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005	99	20	20	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262708	10.1371/journal.pone.0262708	http://dx.doi.org/10.1371/journal.pone.0262708			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089976	gold, Green Submitted, Green Published			2022-12-26	WOS:000769158400018
J	Guo, SQ; Chongsuvivatwong, V; Guo, M; Lei, SG; Li, JL; Chen, HJ; Zhang, JP; Wang, W; Cai, C				Guo, Shengqiong; Chongsuvivatwong, Virasakdi; Guo, Min; Lei, Shiguang; Li, Jinlan; Chen, Huijuan; Zhang, Jiangping; Wang, Wen; Cai, Cui			Yield, NNS and prevalence of screening for DM and hypertension among pulmonary tuberculosis index cases and contacts through single time screening: A contact tracing-based study	PLOS ONE			English	Article							RISK; MANAGEMENT; TESTS	Introduction Diabetes mellitus (DM), hypertension and pulmonary tuberculosis (PTB) are catastrophic illnesses that collectively lead to increased mortality and premature death. However, the size of the problem and the appropriate approach to deal with the burden is still unclear. We aimed to evaluate the yield, number needed to screen (NNS) to prevent one death or adverse event for screening DM and hypertension and assess the prevalence and contributors to DM and/or hypertension. Methods Based on PTB contact tracing, a cross-sectional study was conducted among 801 PTB index cases and 972 household contacts from April 2019 to October 2020 in Guizhou, China. All the participants were screened for DM and hypertension. The yield was calculated as the proportion of newly detected cases among the study subjects, excluding known cases. The NNS was computed by dividing the number needed to treat for risk factors by the prevalence of the unrecognized diseases. The univariate and multivariate logistic regression analyses were applied to determine the independent predictors of DM and/or hypertension. Results Of the 1,773 participants, the prevalence of DM and hypertension was 8.7% (70/801) and 15.2% (122/801) in the PTB patients, 3.2% (31/972) and 14.0% (136/972) in the contacts, respectively. The prevalence of DM and/or hypertension was 21.2% (170/801) among the PTB patients and 15.4% (150/972) among their contacts. The screening yields to detect new cases of DM and hypertension among PTB patients were 1.9% and 5.2%, and that in the contacts were 0.8% and 4.8%, respectively. The NNS for DM was 359 for the PTB cases and 977 for the contacts, 299 for PTB cases and 325 for hypertension, respectively. Older age, under or overweight and obesity, family history hypertension and earlier diagnosis of other chronic conditions were the independent predictors for DM and/or hypertension among both PTB cases and their contacts. Conclusion Screening for DM and hypertension should be mandated in PTB patients and their household contacts to disclose undetected cases of these two conditions during TB contact tracing, which might reduce the potential cardiovascular disease deaths.	[Guo, Shengqiong; Lei, Shiguang; Li, Jinlan; Chen, Huijuan] Guizhou Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Guo, Shengqiong; Chongsuvivatwong, Virasakdi] Prince Songkla Univ, Dept Epidemiol, Fac Med, Hat Yai, Thailand; [Guo, Min] Anshun Peoples Hosp, Anshun, Guizhou, Peoples R China; [Zhang, Jiangping; Wang, Wen] Yunyan Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Cai, Cui] Guiyang Publ Hlth Clin Ctr, Guiyang, Guizhou, Peoples R China	Prince of Songkla University	Lei, SG; Li, JL (corresponding author), Guizhou Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China.; Chongsuvivatwong, V (corresponding author), Prince Songkla Univ, Dept Epidemiol, Fac Med, Hat Yai, Thailand.	cvirasak@medicine.psu.ac.th; 948488961@qq.com; 740820442@qq.com	Guo, Shengqiong/AHB-1174-2022	Guo, Shengqiong/0000-0002-8461-6114; Chongsuvivatwong, Virasakdi/0000-0002-9850-4463				Aamir AH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025300; Basit A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020961; Byrne AL, 2018, INT J TUBERC LUNG D, V22, P86, DOI 10.5588/ijtld.17.0381; Chang SY, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/4687380; Codewar, DRAW FOR REGR R; Heianza Y, 2013, J CLIN ENDOCR METAB, V98, P1051, DOI 10.1210/jc.2012-3092; Ho CLB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017723; Kaasenbrood L, 2016, CIRC-CARDIOVASC QUAL, V9, P213, DOI 10.1161/CIRCOUTCOMES.115.001980; Hindi NKK, 2021, REV MED MICROBIOL, V32, P124, DOI 10.1097/MRM.0000000000000240; Kenaope L, 2020, J GLOB ANTIMICROB RE, V21, P434, DOI 10.1016/j.jgar.2019.11.008; Kerner W, 2014, EXP CLIN ENDOCR DIAB, V122, P384, DOI 10.1055/s-0034-1366278; Kubiak RW., 2021, PREVALENCE RISK FACT, V15, P1, DOI [10.1186/s13031-021-00388-z, DOI 10.1186/S13031-021-00388-Z]; Kumpatla S, 2013, DIABETES RES CLIN PR, V102, P60, DOI 10.1016/j.diabres.2013.08.007; Kust SA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.662128; Liu Tao, 2015, STATUS CHRONIC DIS A; Marak Bibha, 2016, Indian J Tuberc, V63, P123, DOI 10.1016/j.ijtb.2015.07.018; Molinaro AM, 2015, NEURO-ONCOL PRACT, V2, P162, DOI 10.1093/nop/npv030; Ogbera Anthonia Okeoghene, 2014, Indian J Endocrinol Metab, V18, P475, DOI 10.4103/2230-8210.137488; Organization WH, 2018, WHO VACC COV CLUST S; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Pastakia SD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-21; Peltzer K, 2018, AFR J PRIM HEALTH CA, V10, DOI 10.4102/phcfm.v10i1.1651; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; Riza AL, 2014, LANCET DIABETES ENDO, V2, P740, DOI 10.1016/S2213-8587(14)70110-X; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sarker M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165396; Segafredo G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218052; Sharma B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7891-x; Shiferaw DA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4695-7; Tripathy JP, 2017, DIABETES METAB SYND, V11, pS459, DOI 10.1016/j.dsx.2017.03.036; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; WHO, IMPL TOOLS; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Workneh MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175925; Zhang CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176581; Zhang N, 2017, EUR J CLIN NUTR, V71, P832, DOI 10.1038/ejcn.2017.41	37	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263308	10.1371/journal.pone.0263308	http://dx.doi.org/10.1371/journal.pone.0263308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089989	gold, Green Published			2022-12-26	WOS:000769158400055
J	Hull, MA; Reynolds, PS; Nunamaker, EA				Hull, Margaret A.; Reynolds, Penny S.; Nunamaker, Elizabeth A.			Effects of non-aversive versus tail-lift handling on breeding productivity in a C57BL/6J mouse colony	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; FEMALE MICE; STRESS; CAGE; BEHAVIOR; SIZE; AGGRESSION; ENRICHMENT; FREQUENCY; ANXIETY	Non-aversive handling is a well-documented refinement measure for improving rodent welfare. Because maternal stress is related to reduced productivity, we hypothesized that welfare benefits associated with non-aversive handling would translate to higher production and fewer litters lost in a laboratory mouse breeding colony. We performed a randomized controlled trial to examine the effects of a standard method of handling (tail-lift with forceps) versus non-aversive handling with transfer tunnels ('tunnel-handled') on breeding performance in 59 C57BL/6J mouse pairs. Intervention assignments could not be concealed from technicians, but were concealed from assessors and data analyst. An operationally significant effect of tunnel-handling (large enough differences to warrant programmatic change) was defined before study initiation as a 5% increase in productivity, or one extra pup over the reproductive lifetime of each pair. Pairs were randomly allocated to handling intervention and cage rack location, and monitored over an entire 6-month breeding cycle. For each group, we measured number of pups born and weaned, and number of entire litters lost prior to weaning. Differences between transfer methods were estimated by two-level hierarchical mixed models adjusted for parental effects and parity. Compared to tail-lift mice, tunnel-handled mice averaged one extra pup per pair born (+1.0; 95% CI 0.9, 1.1; P = 0.41) and weaned (+1.1, 95% CI 0.9, 1.2; P = 0.33). More tunnel-handled pairs successfully weaned all litters produced (13/29 pairs, 45% vs 4/30 pairs, 13%; P = 0.015), averaged fewer litter losses prior to weaning (11/29 pairs [38%] vs 26/30 pairs [87%]; P <0.001), and had a 20% lower risk of recurrent litter loss. The increase in numbers of pups produced and weaned with tunnel handling met threshold requirement for operational significance. These data and projected cost savings persuaded management to incorporate tunnel handling as standard of care across the institution. These data also suggest that overlooked husbandry practices such as cage transfer may be major confounders in studies of mouse models.	[Hull, Margaret A.; Nunamaker, Elizabeth A.] Univ Florida, Anim Care Serv, Gainesville, FL USA; [Reynolds, Penny S.] Univ Florida, Dept Anesthesiol Stat Anesthesiol Res STAR Core, Coll Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hull, MA (corresponding author), Univ Florida, Anim Care Serv, Gainesville, FL USA.	ma.hull@ufl.edu		Hull, Margaret/0000-0002-8397-0744				Amorim LDAF, 2015, INT J EPIDEMIOL, V44, P324, DOI 10.1093/ije/dyu222; Austin PC, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1195; Bell, 2013, MULTILEVEL MODEL PRI; Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; Brajon S, 2019, APPL ANIM BEHAV SCI, V218, DOI 10.1016/j.applanim.2019.06.008; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Burkus J, 2015, J REPROD DEVELOP, V61, P325, DOI 10.1262/jrd.2015-012; Burkus J, 2013, GEN PHYSIOL BIOPHYS, V32, P129, DOI 10.4149/gpb_2013010; Clarkson JM, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1636; Clarkson JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20716-3; Doerning CM, 2019, J AM ASSOC LAB ANIM, V58, P767, DOI 10.30802/AALAS-JAALAS-19-000015; Ene M., PROC GLIMMIX BASICS2; Eskola S, 1999, LAB ANIM-UK, V33, P122, DOI 10.1258/002367799780578354; Gao Y, 2016, REPROD SCI, V23, P1148, DOI 10.1177/1933719116630416; Ghosal S, 2015, PHYSIOL BEHAV, V150, P31, DOI 10.1016/j.physbeh.2015.06.021; Gouveia K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56860-7; Gouveia K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44999; Gouveia K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066401; Henderson LJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71476-y; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; HURST JL, 1993, ANIM BEHAV, V45, P55, DOI 10.1006/anbe.1993.1007; Kiernan K., 2012, SAS GLOBAL FORUM 201; KRACKOW S, 1990, LAB ANIM, V24, P345, DOI 10.1258/002367790780865895; LAGAKOS S, 1981, J NATL CANCER I, V66, P197; Lecker J, 2016, LAB ANIMAL, V45, P406, DOI 10.1038/laban.1114; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Lu J., PHARMASUG 2014 C P; MANN MA, 1983, PHYSIOL BEHAV, V30, P697, DOI 10.1016/0031-9384(83)90165-8; MarchlewskaKoj A, 1997, NEUROSCI BIOBEHAV R, V21, P699, DOI 10.1016/S0149-7634(96)00021-8; Mertens S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215367; Nakamura Y, 2018, J VET MED SCI, V80, P886, DOI 10.1292/jvms.18-0044; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; Ono M, 2016, JPN J VET RES, V64, P265, DOI 10.14943/jjvr.64.4.265; Orso R, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00197; Potgieter FJ, 1997, J S AFR VET ASSOC, V68, P8; Powell CA, 2019, AM J PHYSIOL-ENDOC M, V317, pE261, DOI 10.1152/ajpendo.00024.2019; Rasmussen S, 2011, J AM ASSOC LAB ANIM, V50, P479; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Roughan JV, 2019, J AM ASSOC LAB ANIM, V58, P142, DOI [10.30802/aalas-jaalas-18-000057, 10.30802/AALAS-JAALAS-18-000057]; Sanderson AE, 2010, LAB ANIMAL, V39, P177, DOI 10.1038/laban0610-177; Sensini F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74279-3; Sternberg WF, 2003, PHYSIOL BEHAV, V78, P375, DOI 10.1016/S0031-9384(03)00015-5; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Weber EM, 2013, REPROD DOMEST ANIM, V48, P292, DOI 10.1111/j.1439-0531.2012.02147.x; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Zhang SY, 2011, BIOL REPROD, V84, P672, DOI 10.1095/biolreprod.110.087890	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263192	10.1371/journal.pone.0263192	http://dx.doi.org/10.1371/journal.pone.0263192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089969	Green Published, gold			2022-12-26	WOS:000769158400043
J	Dopelt, K; Bashkin, O; Asna, N; Davidovitch, N				Dopelt, Keren; Bashkin, Osnat; Asna, Noam; Davidovitch, Nadav			Health locus of control in cancer patient and oncologist decision-making: An exploratory qualitative study	PLOS ONE			English	Article							OF-LIFE; DEPRESSION; SCALES	Objective To investigate how cancer patients' and family members' perspective and health locus of control are presented in clinical encounter decision-making. Methods Semi-structured in-depth interviews were carried out with 16 cancer patients and 6 family members living in Israel (n = 22). Interviews were transcribed verbatim, and data were analyzed using thematic analysis. Results Following the health locus of control model, the findings were divided into an external and internal locus of control themes, and we added a theme regarding shared decision-making. Internal locus of control sub-themes included asking for a second opinion, negotiating with the doctor, asking questions, looking for information, and fighting for their rights. External locus of control sub-themes included powerful others, oncologists, and fate. The dominant approach of most of the interviewees was an external locus of control. Women demonstrated more external locus of control than men. On the direct question of who should decide on treatment-the doctor, the patient, or both jointly-the answers ranged from only the doctor (n = 8) to together (n = 7) to only the patient (n = 8). Conclusions This study provides insights into different aspects of locus of control in the clinical encounter involving cancer patients. The findings reflect the need to devote comprehensive attention to cancer patients' perceptions and experiences in the clinical encounter. A patient-centered care approach and a personalized framework for decision-making in cancer care are essential to achieving better treatment outcomes. Further research can engage in the development and validation of an up-to-date health locus of control questionnaire for cancer patients based on the findings of this study.	[Dopelt, Keren; Bashkin, Osnat] Ashkelon Acad Coll, Dept Publ Hlth, Ashqelon, Israel; [Dopelt, Keren; Davidovitch, Nadav] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Asna, Noam] Ziv Med Ctr, Oncol Inst, Safed, Israel	Ben Gurion University; Ziv Medical Center	Dopelt, K (corresponding author), Ashkelon Acad Coll, Dept Publ Hlth, Ashqelon, Israel.; Dopelt, K (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel.	dopelt@bgu.ac.il		Dopelt, Keren/0000-0003-4922-4155	National Institute for Health Services Research and Health Policy, Israel [141/2018]	National Institute for Health Services Research and Health Policy, Israel	This work was supported by the National Institute for Health Services Research and Health Policy, Israel [Grant number 141/2018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts JWF, 2015, PSYCHO-ONCOLOGY, V24, P950, DOI 10.1002/pon.3748; Arraras JI, 2002, PSYCHOL HEALTH MED, V7, P181, DOI [10.1080/13548500120116139, DOI 10.1080/13548500120116139]; Bailo L, 2019, ECANCERMEDICALSCIENC, V13, DOI 10.3332/ecancer.2019.912; Brincks AM, 2010, PSYCHOL HEALTH MED, V15, P720, DOI 10.1080/13548506.2010.498921; Brown AJ, 2017, SUPPORT CARE CANCER, V25, P1985, DOI 10.1007/s00520-017-3605-z; Covvey JR, 2019, SUPPORT CARE CANCER, V27, P1613, DOI 10.1007/s00520-019-04675-7; Ebel MD, 2015, J CANCER RES CLIN, V141, P1449, DOI 10.1007/s00432-015-1940-3; Gibek K, 2019, WSPOLCZESNA ONKOL, V23, P115, DOI 10.5114/wo.2019.85638; Goldzweig G, 2016, PSYCHOL HEALTH MED, V21, P601, DOI 10.1080/13548506.2016.1140902; Haltaufderheide J, 2019, ONCOLOGIST, V24, P555, DOI 10.1634/theoncologist.2017-0615; Hashimoto H, 2004, PATIENT EDUC COUNS, V55, P236, DOI 10.1016/j.pec.2003.09.010; Henselmans I, 2015, JAMA ONCOL, V1, P1169, DOI 10.1001/jamaoncol.2015.3081; Institute of Medicine, 2013, PARTNERING PATIENTS; Jung KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052457; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Katz SJ, 2013, JAMA-J AM MED ASSOC, V310, P1559, DOI 10.1001/jama.2013.278944; Keinki C, 2016, J CANCER EDUC, V31, P610, DOI 10.1007/s13187-015-0860-x; Koenig AM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01086; Lin CC, 2005, PSYCHO-ONCOL, V14, P376, DOI 10.1002/pon.854; Marton G, 2021, PSYCHOL HEALTH MED, V26, P260, DOI 10.1080/13548506.2020.1748211; O'Hea EL, 2009, ETHNIC DIS, V19, P192; Rocque G, 2019, J PALLIAT CARE, V34, P29, DOI 10.1177/0825859718810723; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Sharif SP, 2017, EUR J ONCOL NURS, V27, P28, DOI 10.1016/j.ejon.2017.01.005; Shkedi A., 2003, WORDS TRY TOUCH QUAL; Smith MA, 2016, ORTHOP NURS, V35, P144, DOI 10.1097/NOR.0000000000000243; WALLSTON KA, 1994, J PERS ASSESS, V63, P534, DOI 10.1207/s15327752jpa6303_10; Wallston KA, 2005, J HEALTH PSYCHOL, V10, P623, DOI 10.1177/1359105305055304; Wallston KA, 1989, SOCIAL PSYCHOL HLTH, P65; Williams EN, 2009, PSYCHOTHER RES, V19, P576, DOI 10.1080/10503300802702113	30	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263086	10.1371/journal.pone.0263086	http://dx.doi.org/10.1371/journal.pone.0263086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085354	Green Published, gold			2022-12-26	WOS:000779379600111
J	Zhang, C; Zhao, W; Duvall, SW; Kowallis, KA; Childers, WS				Zhang, Chao; Zhao, Wei; Duvall, Samuel W.; Kowallis, Kimberly A.; Childers, W. Seth			Regulation of the activity of the bacterial histidine kinase PleC by the scaffolding protein PodJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCALIZATION FACTOR; PHASE-SEPARATION; CELL; DOMAINS; LIGHT; ATP; ATTACHMENT; EXPRESSION; SENSOR	Scaffolding proteins can customize the response of signaling networks to support cell development and behaviors. PleC is a bifunctional histidine kinase whose signaling activity coordinates asymmetric cell division to yield a motile swarmer cell and a stalked cell in the gram-negative bacterium Caulobacter crescentus. Past studies have shown that PleC's switch in activity from kinase to phosphatase correlates with a change in its subcellular localization pattern from diffuse to localized at the new cell pole. Here we investigated how the bacterial scaffolding protein PodJ regulates the subcellular positioning and activity of PleC. We reconstituted the PleC-PodJ signaling complex through both heterologous expressions in Escherichia coli and in vitro studies. In vitro, PodJ phase separates as a biomolecular condensate that recruits PleC and inhibits its kinase activity. We also constructed an in vivo PleC-CcaS chimeric histidine kinase reporter assay and demonstrated using this method that PodJ leverages its intrinsically disordered region to bind to PleC's PAS sensory domain and regulate PleC-CcaS signaling. Regulation of the PleC-CcaS was most robust when PodJ was concentrated at the cell poles and was dependent on the allosteric coupling between PleC-CcaS's PAS sensory domain and its downstream histidine kinase domain. In conclusion, our in vitro biochemical studies suggest that PodJ phase separation may be coupled to changes in PleC enzymatic function. We propose that this coupling of phase separation and allosteric regulation may be a generalizable phenomenon among enzymes associated with biomolecular condensates.& nbsp;	[Zhang, Chao; Zhao, Wei; Duvall, Samuel W.; Kowallis, Kimberly A.; Childers, W. Seth] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Childers, WS (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	wschild@pitt.edu	Zhang, Chao/AHC-8871-2022; Childers, Seth/I-6063-2017	Zhang, Chao/0000-0002-3836-151X; Duvall, Samuel/0000-0002-3133-7592; Kowallis, Kimberly/0000-0003-3038-0596; Childers, Seth/0000-0003-1160-7767	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This research was funded through the University of Pittsburgh Start-up funds to W. S. C.	Al-Husini N, 2020, MOL CELL, V78, P670, DOI 10.1016/j.molcel.2020.04.001; Al-Husini N, 2018, MOL CELL, V71, P1027, DOI 10.1016/j.molcel.2018.08.003; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Aretakis James R., 2019, MSYSTEMS, V4; Azaldegui CA, 2021, BIOPHYS J, V120, P1123, DOI 10.1016/j.bpj.2020.09.023; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Blair JA, 2013, STRUCTURE, V21, P1590, DOI 10.1016/j.str.2013.06.024; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Buschiazzo A, 2019, ANNU REV MICROBIOL, V73, P507, DOI 10.1146/annurev-micro-091018-054627; Chen JC, 2006, EMBO J, V25, P377, DOI 10.1038/sj.emboj.7600935; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Cohan MC, 2020, TRENDS BIOCHEM SCI, V45, P668, DOI 10.1016/j.tibs.2020.04.011; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999; Curtis PD, 2012, MOL MICROBIOL, V84, P712, DOI 10.1111/j.1365-2958.2012.08055.x; Del Medico L, 2020, P NATL ACAD SCI USA, V117, P9546, DOI 10.1073/pnas.1920143117; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; ELY B, 1991, METHOD ENZYMOL, V204, P372; Emenecker R. J., 2021, METAPREDICT FAST ACC, V2021; Fare CM, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.210137; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guilhas B, 2020, MOL CELL, V79, P293, DOI 10.1016/j.molcel.2020.06.034; Harami GM, 2020, P NATL ACAD SCI USA, V117, P26206, DOI 10.1073/pnas.2000761117; Heinkel F., 2019, PROC NATL; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hinz AJ, 2003, MOL MICROBIOL, V47, P929, DOI 10.1046/j.1365-2958.2003.03349.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holmes JA, 2016, P NATL ACAD SCI USA, V113, P12490, DOI 10.1073/pnas.1602380113; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Ladouceur AM, 2020, P NATL ACAD SCI USA, V117, P18540, DOI 10.1073/pnas.2005019117; Lasker K, 2020, NAT MICROBIOL, V5, P418, DOI 10.1038/s41564-019-0647-7; Lawler ML, 2006, MOL MICROBIOL, V59, P301, DOI 10.1111/j.1365-2958.2005.04935.x; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lyon AS, 2021, NAT REV MOL CELL BIO, V22, P215, DOI 10.1038/s41580-020-00303-z; MacCready JS, 2020, MOL BIOL EVOL, V37, P1434, DOI 10.1093/molbev/msz308; Mann TH, 2018, P NATL ACAD SCI USA, V115, pE7166, DOI 10.1073/pnas.1808543115; Mann TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11454; Mehringer J, 2021, CELL REP PHYS SCI, V2, DOI 10.1016/j.xcrp.2021.100343; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monterroso B, 2019, EMBO REP, V20, DOI 10.15252/embr.201845946; Nakajima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37595; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Pattanayak GK, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108032; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Peeples W, 2021, NAT CHEM BIOL, V17, P693, DOI 10.1038/s41589-021-00801-x; Perez AM, 2017, MBIO, V8, DOI 10.1128/mBio.02238-16; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robles-Ramos M.A., 1868, BBA-MOL CELL RES; Saurabh S, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm6570; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tibble RW, 2021, NAT CHEM BIOL, V17, P615, DOI 10.1038/s41589-021-00774-x; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; Wang JF, 2021, ACS SYNTH BIOL, V10, P1605, DOI 10.1021/acssynbio.1c00090; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wunder T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07624-w; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	67	1	1	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101683	10.1016/j.jbc.2022.101683	http://dx.doi.org/10.1016/j.jbc.2022.101683			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35124010	Green Published, gold			2022-12-26	WOS:000793560400012
J	Banker, RMW; Lipovac, J; Stachowicz, JJ; Gold, DA				Banker, Roxanne M. W.; Lipovac, Jacob; Stachowicz, John J.; Gold, David A.			Sodium molybdate does not inhibit sulfate-reducing bacteria but increases shell growth in the Pacific oyster Magallana gigas	PLOS ONE			English	Article							EASTERN OYSTER; CRASSOSTREA-VIRGINICA; MICROBIAL MATS; GEN. NOV.; REDUCTION; HYPOTHESIS; PROTEINS; SILVA	Recent work on microbe-host interactions has revealed an important nexus between the environment, microbiome, and host fitness. Marine invertebrates that build carbonate skeletons are of particular interest in this regard because of predicted effects of ocean acidification on calcified organisms, and the potential of microbes to buffer these impacts. Here we investigate the role of sulfate-reducing bacteria, a group well known to affect carbonate chemistry, in Pacific oyster (Magallana gigas) shell formation. We reared oyster larvae to 51 days post fertilization and exposed organisms to control and sodium molybdate conditions, the latter of which is thought to inhibit bacterial sulfate reduction. Contrary to expectations, we found that sodium molybdate did not uniformly inhibit sulfate-reducing bacteria in oysters, and oysters exposed to molybdate grew larger shells over the experimental period. Additionally, we show that microbiome composition, host gene expression, and shell size were distinct between treatments earlier in ontogeny, but became more similar by the end of the experiment. Although additional testing is required to fully elucidate the mechanisms, our work provides preliminary evidence that M. gigas is capable of regulating microbiome dysbiosis caused by environmental perturbations, which is reflected in shell development.	[Banker, Roxanne M. W.; Lipovac, Jacob; Gold, David A.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Stachowicz, John J.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Banker, Roxanne M. W.] Calif Acad Sci, Dept Invertebrate Zool & Geol, San Francisco, CA 94118 USA	University of California System; University of California Davis; University of California System; University of California Davis; California Academy of Sciences	Banker, RMW; Gold, DA (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.; Banker, RMW (corresponding author), Calif Acad Sci, Dept Invertebrate Zool & Geol, San Francisco, CA 94118 USA.	rbanker@ucdavis.edu; dgold@ucdavis.edu			University of California Davis Microbiome Special Research Program	University of California Davis Microbiome Special Research Program	Thank you very much to Hog Island Oyster Company for supplying us with animals for this project. Thanks also to Karl Menard and the Aquatic Resources Group at the Bodega Marine Laboratory, and especially Joe Newman who lent his time and expertise to the project. Thank you to Dr. Tessa M. Hill who allowed us to use instruments and space in her lab, and to Sarah Merolla who provided technical assistance running the machines. Thank you to Dr. David Coil, who provided feedback on an early version of this manuscript. Thanks also to Dominic Dickerson, who assisted with animal husbandry. And finally, thank you to our funding source, the University of California Davis Microbiome Special Research Program.	Aguilar-Barajas E, 2011, BIOMETALS, V24, P687, DOI 10.1007/s10534-011-9421-x; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Banker RMW, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00407; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Biswas K, 2009, BIOMETALS, V22, P131, DOI 10.1007/s10534-008-9198-8; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Bushnell B, 2014, LBNL7065E; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Cavalcanti GS, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5064-4; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; Cho Sang-Man, 2011, Korean Journal of Malacology, V27, P223; Chung YJ, 2013, PSYCHOMETRIKA, V78, P685, DOI 10.1007/s11336-013-9328-2; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Davidova IA, 2016, INT J SYST EVOL MICR, V66, P1242, DOI 10.1099/ijsem.0.000864; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Jesus EB., 2015, BRAZILIAN J PET GAS, V9, P95, DOI [10.5419/bjpg2015-0010, DOI 10.5419/BJPG2015-0010]; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donelan SC, 2021, ECOL APPL, V31, DOI 10.1002/eap.2315; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Ettinger CL, 2017, PEERJ, V5, DOI 10.7717/peerj.3246; Flieder M, 2021, ISME J, V15, P3159, DOI 10.1038/s41396-021-00992-0; FRUND C, 1992, APPL ENVIRON MICROB, V58, P70; Gallagher KL, 2012, GEOBIOLOGY, V10, P518, DOI 10.1111/j.1472-4669.2012.00342.x; Grieneisen L, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0598; Guido A, 2014, GEOBIOLOGY, V12, P265, DOI 10.1111/gbi.12084; Gupta A, 2020, J ENVIRON SCI HEAL A, V55, P464, DOI 10.1080/10934529.2019.1709362; Gupta A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02882; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halevy I, 2012, SCIENCE, V337, P331, DOI 10.1126/science.1220224; Hernandez-Eugenio G, 2002, INT J SYST EVOL MICR, V52, P1217, DOI 10.1099/ijs.0.01992-0; Johnstone MB, 2015, J EXP MAR BIOL ECOL, V463, P8, DOI 10.1016/j.jembe.2014.10.014; Johnstone MB, 2008, J EXP ZOOL PART B, V310B, P227, DOI 10.1002/jez.b.21206; JORGENSEN BB, 1994, FEMS MICROBIOL ECOL, V13, P303, DOI 10.1016/0168-6496(94)90068-X; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Louca S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0420-9; Lowe MR, 2017, J SHELLFISH RES, V36, P683, DOI 10.2983/035.036.0318; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Myers JM, 2007, TISSUE CELL, V39, P247, DOI 10.1016/j.tice.2007.03.006; Nichols RG, 2021, HUM GENET, V140, P747, DOI 10.1007/s00439-020-02237-0; Ogle D.H., 2017, R PACKAGE VERSION 0, V17, P636; Patidar SK, 2005, BIORESOURCE TECHNOL, V96, P1215, DOI 10.1016/j.biortech.2004.11.001; Paul VG, 2017, APPL GEOCHEM, V78, P250, DOI 10.1016/j.apgeochem.2017.01.010; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Starke R, 2021, MICROB ECOL, V81, P535, DOI 10.1007/s00248-020-01586-7; Tan K, 2020, SCI TOTAL ENVIRON, V701, DOI 10.1016/j.scitotenv.2019.134794; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Oppen MJH, 2019, NAT REV MICROBIOL, V17, P557, DOI 10.1038/s41579-019-0223-4; Vermeij GJ, 2020, PALAEONTOLOGY, V63, P1035, DOI 10.1111/pala.12503; Vermeij GJ, 2014, PALEOBIOLOGY, V40, P1, DOI 10.1666/13002; Visscher PT, 2000, GEOLOGY, V28, P919, DOI 10.1130/0091-7613(2000)028<0919:MOOSRC>2.3.CO;2; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Webster NS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19324; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkins LGE, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000533; Woodhams DC, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-019-1908-8; Yang Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42694-w; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Z., 2010, INT ENCY ED, V3, P304, DOI [10.1016/B978-0-08-044894-7.01348-8, DOI 10.1016/B978-0-08-044894-7.01348-8]	73	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262939	10.1371/journal.pone.0262939	http://dx.doi.org/10.1371/journal.pone.0262939			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139090	Green Published, gold			2022-12-26	WOS:000821499100018
J	Egloff, C; Couffignal, C; Cordier, AG; Deruelle, P; Sibiude, J; Anselem, O; Benachi, A; Luton, D; Mandelbrot, L; Vauloup-Fellous, C; Vivanti, AJ; Picone, O				Egloff, Charles; Couffignal, Camille; Cordier, Anne Gael; Deruelle, Philippe; Sibiude, Jeanne; Anselem, Olivia; Benachi, Alexandra; Luton, Dominique; Mandelbrot, Laurent; Vauloup-Fellous, Christelle; Vivanti, Alexandre J.; Picone, Olivier			Pregnant women's perceptions of the COVID-19 vaccine: A French survey	PLOS ONE			English	Article							PHYSIOLOGICAL-CHANGES	Introduction Pregnant women are at increased risk for COVID-19, and COVID-19 vaccine is the most promising solution to overcome the current pandemic. This study was conducted to evaluate pregnant women's perceptions and acceptance of COVID-19 vaccination. Materials & methods A cross-sectional study was conducted from February 18 to April 5 2021. An anonymous survey was distributed in 7 French obstetrics departments to all pregnant women before a prenatal visit. All pregnant women attending a follow-up consultation were asked to participate in the study. An anonymous web survey was available through a QR code and participants were asked whether or not they would agree to be vaccinated against SARS-CoV-2, and why. The questionnaire included questions on the patients' demographics and their knowledge of COVID-19 vaccines. Results Of the 664 pregnant women who completed the questionnaire, 29.5% (95% CI 27.7; 31.3) indicated they would agree to be vaccinated against COVID-19. The main reason for not agreeing was being more afraid of potential side effects of the SARS-CoV-2 vaccine on the fetus than of COVID-19. Factors influencing acceptance of vaccination were: being slightly older, multiparity, having discussed it with a caregiver and acceptance of the influenza vaccine. Discussion Nearly one-third of pregnant women in this population would be willing to be vaccinated. In addition to studies establishing fetal safety, public health agencies and healthcare professionals should provide accurate information about the safety of COVID-19 vaccines.	[Egloff, Charles; Sibiude, Jeanne; Mandelbrot, Laurent; Picone, Olivier] Hop Louis Mourier, AP HP Nord, Serv Gynecol Obstet, Colombes, France; [Egloff, Charles; Sibiude, Jeanne; Luton, Dominique; Mandelbrot, Laurent; Picone, Olivier] Univ Paris, Paris, France; [Egloff, Charles; Sibiude, Jeanne; Mandelbrot, Laurent; Picone, Olivier] IAME, INSERM, Paris, France; [Couffignal, Camille; Sibiude, Jeanne; Luton, Dominique; Mandelbrot, Laurent; Picone, Olivier] FHU PREMA, Paris, France; [Couffignal, Camille] Hop Bichat Claude Bernard, AP HP, Clin Res Biostat & Epidemiol Dept, Paris, France; [Cordier, Anne Gael; Benachi, Alexandra; Vauloup-Fellous, Christelle; Vivanti, Alexandre J.] Univ Paris Saclay, INSERM U1193, Villejuif, France; [Cordier, Anne Gael; Benachi, Alexandra; Vivanti, Alexandre J.] Paris Saclay Univ, Antoine Beclere Hosp, AP HP, Dept Obstet & Gynecol, Clamart, France; [Deruelle, Philippe] Hop Univ Strasbourg, Pole Gynecol Obstet, Strasbourg, France; [Anselem, Olivia] Ctr Univ Paris, Hop Cochin, AP HP, Maternite Port Royal, Paris, France; [Luton, Dominique] Paris Univ, Bichat Hosp, AP HP, Serv Gynecol Obstet,FHU Prematur, Paris, France; [Vauloup-Fellous, Christelle; Picone, Olivier] Grp Rech Infect Pendant Grossesse GRIG, Velizy Villacoublay, France; [Vauloup-Fellous, Christelle] Univ Paris Saclay, Hop Paul Brousse, AP HP, Lab Virol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Picone, O (corresponding author), Hop Louis Mourier, AP HP Nord, Serv Gynecol Obstet, Colombes, France.; Picone, O (corresponding author), Univ Paris, Paris, France.; Picone, O (corresponding author), IAME, INSERM, Paris, France.; Picone, O (corresponding author), FHU PREMA, Paris, France.; Picone, O (corresponding author), Grp Rech Infect Pendant Grossesse GRIG, Velizy Villacoublay, France.	Olivier.picone@aphp.fr	Vivanti, Alexandre/AAN-1693-2020; Sibiude, Jeanne/GRS-5411-2022	Vivanti, Alexandre/0000-0002-4921-0047; Mandelbrot, Laurent/0000-0002-5883-7597				[Anonymous], PFIZER BIONTECH COVI; [Anonymous], 2021, STRATGIE VACCINALE L, P2021; [Anonymous], CORONAVIRUS CHIFFRES; Blondel B, 2017, J GYNECOL OBSTET HUM, V46, P701, DOI 10.1016/j.jogoh.2017.09.002; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Carbone L, 2021, AM J OBST GYNEC MFM, V3, DOI 10.1016/j.ajogmf.2021.100352; Ceulemans M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073367; Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107; Frederiksen MC, 2001, SEMIN PERINATOL, V25, P120, DOI 10.1053/sper.2001.24565; Gray KJ., 2021, MEDRXIV; Hacquin A.S., 2020, PSYARXIV, DOI 10.31234/osf.io/r8h6z; Hegewald MJ, 2011, CLIN CHEST MED, V32, P1, DOI 10.1016/j.ccm.2010.11.001; Huntley BJF, 2020, OBSTET GYNECOL, V136, P303, DOI 10.1097/AOG.0000000000004010; Ledford H, 2020, NATURE, V588, P205, DOI 10.1038/d41586-020-03441-8; Male V, 2021, NAT REV IMMUNOL, V21, P200, DOI 10.1038/s41577-021-00525-y; Martinez-Portilla RJ, 2021, ULTRASOUND OBST GYN, V57, P224, DOI 10.1002/uog.23575; Maykin MM, 2021, VACCINE, V39, P171, DOI 10.1016/j.vaccine.2020.12.007; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Rasmussen SA, 2021, JAMA-J AM MED ASSOC, V325, P1099, DOI 10.1001/jama.2021.1683; Robinson E, 2021, VACCINE, V39, P2024, DOI 10.1016/j.vaccine.2021.02.005; Rottenstreich A., 2021, MEDRXIV; Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17, 10.1056/NEJMx210016]; Skjefte M, 2021, EUR J EPIDEMIOL, V36, P197, DOI 10.1007/s10654-021-00728-6; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; Villar J, 2021, JAMA PEDIATR, V175, P817, DOI 10.1001/jamapediatrics.2021.1050; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046	26	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263512	10.1371/journal.pone.0263512	http://dx.doi.org/10.1371/journal.pone.0263512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130318	Green Published, gold			2022-12-26	WOS:000805530700034
J	Praznikar, J; Attygalle, NT				Praznikar, Jure; Attygalle, Nuwan Tharanga			Quantitative analysis of visual codewords of a protein distance matrix	PLOS ONE			English	Article							STRUCTURAL CLASSIFICATION; GYRATION; REPEATS	3D protein structures can be analyzed using a distance matrix calculated as the pairwise distance between all C alpha atoms in the protein model. Although researchers have efficiently used distance matrices to classify proteins and find homologous proteins, much less work has been done on quantitative analysis of distance matrix features. Therefore, the distance matrix was analyzed as gray scale image using KAZE feature extractor algorithm with Bag of Visual Words model. In this study, each protein was represented as a histogram of visual codewords. The analysis showed that a very small number of codewords (similar to 1%) have a high relative frequency (> 0.25) and that the majority of codewords have a relative frequency around 0.05. We have also shown that there is a relationship between the frequency of codewords and the position of the features in a distance matrix. The codewords that are more frequent are located closer to the main diagonal. Less frequent codewords, on the other hand, are located in the corners of the distance matrix, far from the main diagonal. Moreover, the analysis showed a correlation between the number of unique codewords and the 3D repeats in the protein structure. The solenoid and tandem repeats proteins have a significantly lower number of unique codewords than the globular proteins. Finally, the codeword histograms and Support Vector Machine (SVM) classifier were used to classify solenoid and globular proteins. The result showed that the SVM classifier fed with codeword histograms correctly classified 352 out of 354 proteins.	[Praznikar, Jure; Attygalle, Nuwan Tharanga] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Praznikar, Jure] Inst Jozef Stefan, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia	University of Primorska; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Praznikar, J (corresponding author), Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.; Praznikar, J (corresponding author), Inst Jozef Stefan, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia.	jure.praznikar@upr.si	Attygalle, Nuwan/HHD-3511-2022	Attygalle, Nuwan/0000-0001-8498-1923; Praznikar, Jure/0000-0003-1842-5181	Javna Agencija za Raziskovalno dejavnost RS [P1-0048, I0-0035-2790]	Javna Agencija za Raziskovalno dejavnost RS(Slovenian Research Agency - Slovenia)	JP was supported by Javna Agencija za Raziskovalno dejavnost RS, award number P1-0048 and I0-0035-2790. NTA was supported by Javna Agencija za Raziskovalno dejavnost RS, award number I0-0035-2790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriata LA, 2019, PROTEINS, V87, P1100, DOI 10.1002/prot.25787; Alcantarilla PF, 2012, LECT NOTES COMPUT SC, V7577, P214, DOI 10.1007/978-3-642-33783-3_16; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; [Anonymous], 2020, MATLAB VERSION 9 9 0; Chandonia JM, 2019, NUCLEIC ACIDS RES, V47, pD475, DOI 10.1093/nar/gky1134; Chandonia JM, 2017, J MOL BIOL, V429, P348, DOI 10.1016/j.jmb.2016.11.023; Choi IG, 2004, P NATL ACAD SCI USA, V101, P3797, DOI 10.1073/pnas.0308656100; Fournier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079894; GODZIK A, 1993, PROTEIN ENG, V6, P801, DOI 10.1093/protein/6.8.801; Han XS, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006969; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hayashida M, 2014, INT C SYST BIOL ISB; Hirsh L, 2016, AMINO ACIDS, V48, P1391, DOI 10.1007/s00726-016-2187-2; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Hou J, 2019, PROTEINS, V87, P1165, DOI 10.1002/prot.25697; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Hrabe T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-119; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Karim R, 2016, NOVEL EFFECTIVE SCOR; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Ma JL, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/269394; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Paladin L, 2021, NUCLEIC ACIDS RES, V49, pD452, DOI 10.1093/nar/gkaa1097; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Praznikar J, 2021, J BIOINF COMPUT BIOL, V19, DOI 10.1142/S021972002050050X; Senior AW, 2019, PROTEINS, V87, P1141, DOI 10.1002/prot.25834; Shi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083788; Sivic J, 2003, P 9 IEEE INT C COMPU, P2; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Tanner JJ, 2016, ACTA CRYSTALLOGR D, V72, P1119, DOI 10.1107/S2059798316013218; Tareen S.A.K., 2018 INT C COMP MATH, P1; Walsh I, 2012, BIOINFORMATICS, V28, P3257, DOI 10.1093/bioinformatics/bts550; Xu JB, 2019, PROTEINS, V87, P1069, DOI 10.1002/prot.25810; Yu J, 2013, NEUROCOMPUTING, V120, P355, DOI 10.1016/j.neucom.2012.08.061	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263566	10.1371/journal.pone.0263566	http://dx.doi.org/10.1371/journal.pone.0263566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120181	Green Published, gold			2022-12-26	WOS:000789273600054
J	Aljuhani, HE; Alshammari, GM; AlHadi, AN; Alabdulkarem, KB; Albader, OSM; Baig, MB; Yahya, MA				Aljuhani, Hind E.; Alshammari, Ghedeir M.; AlHadi, Ahmad N.; Alabdulkarem, Kholoud B.; Albader, Omar Sulaiman M.; Baig, Mirza B.; Yahya, Mohammed Abdo			Food habits and associated risk factors of depressed patients with cardiovascular disease	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MENTAL-DISORDERS; MAJOR DEPRESSION; HEART-DISEASE; DIET QUALITY; PREVALENCE; WOMEN; SYMPTOMATOLOGY; METAANALYSIS; CHOLESTEROL	The present study was carried out to investigate food habits and associated risk factors of depressed patients with cardiovascular disease in Riyadh city, Saudi Arabia. Depressed and healthy females (n = 30 each) and males (n = 30 each) aged 18-65 years were involved in this study. Sociodemographic, anthropometric proxies, and nutritional status were evaluated. Cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) levels of respondents' blood were determined. The respondents were varied according to demographic factors and anthropometric proxies. The majority of depressed males had higher values than healthy ones. The student t-test analysis showed that the average daily intake of fat especially saturated fat, by depressed respondents was higher than that of the healthy ones as well as the dietary requirement intake (DRI). The analysis of respondents' blood showed that the number of depressed females had higher abnormal HDL-c than males, who were observed to have an abnormal level of cholesterol and triglycerides. The correlation of daily nutrient intake and depression duration, depression severity, and age showed that the nutrients responsible for the extension and severity of depression were intake of food rich in dietary fat. Factors including demographics daily nutrient intake appeared to be associated with depression.	[Aljuhani, Hind E.; Alshammari, Ghedeir M.; Yahya, Mohammed Abdo] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh, Saudi Arabia; [AlHadi, Ahmad N.] King Saud Univ, King Saud Univ Med City, Coll Med, Psychiat Dept, Riyadh, Saudi Arabia; [Alabdulkarem, Kholoud B.] King Saud Univ, Coll Arts, Dept Social Studies, Riyadh, Saudi Arabia; [Albader, Omar Sulaiman M.] King Saud Univ, King Saud Med City, Riyadh, Saudi Arabia; [Baig, Mirza B.] King Saud Univ, Prince Sultan Inst Environm Water & Desert Res, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Saud Medical City; King Saud University; King Saud University	Alshammari, GM (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh, Saudi Arabia.	aghedeir@ksu.edu.sa	AlHadi, Ahmad N./I-2695-2013	AlHadi, Ahmad N./0000-0002-2298-3509; , ghedeir/0000-0002-2043-1209	King Saud University, Riyadh, Saudi Arabia [RSP2020/84]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	The authors extend thanks to the Researchers Supporting Project number (RSP2020/84), King Saud University, Riyadh, Saudi Arabia, for the support this work.	Abdelwahid HA, 2011, SAUDI MED J, V32, P948; Al-Qadhi W, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-190; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Antonogeorgos G, 2012, ANN EPIDEMIOL, V22, P630, DOI 10.1016/j.annepidem.2012.06.103; Appelhans BM, 2012, J ACAD NUTR DIET, V112, P693, DOI 10.1016/j.jand.2012.02.006; Ariyo AA, 2000, CIRCULATION, V102, P1773; Asal ARA, 2007, NEUROSCIENCES, V12, P8; Barter P, 2005, EUR HEART J SUPPL, V7, pF4, DOI 10.1093/eurheartj/sui036; Berk M, 2013, ACTA PSYCHIAT SCAND, V127, P38, DOI 10.1111/acps.12124; Bogavac-Stanojevic N, 2016, DRUG DEVELOP RES, V77, P374, DOI 10.1002/ddr.21330; Dolatian Atieh, 2017, Iran J Psychiatry, V12, P201; Doyle F, 2015, PSYCHOSOM MED, V77, P419, DOI 10.1097/PSY.0000000000000174; Fawcett J, 1998, J AFFECT DISORDERS, V51, P267, DOI 10.1016/S0165-0327(98)00224-9; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Gan ZY, 2012, J AFFECT DISORDERS, V136, P988, DOI 10.1016/j.jad.2011.06.046; Gross RW, 2005, PROSTAG OTH LIPID M, V77, P52, DOI 10.1016/j.prostaglandins.2004.09.005; Grossniklaus DA, 2010, J CARDIOVASC NURS, V25, P450, DOI 10.1097/JCN.0b013e3181d25433; Grosso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096905; Gupta A., 2013, IND MED GAZ, V147, P253; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lindeman S, 2000, ACTA PSYCHIAT SCAND, V102, P178, DOI 10.1034/j.1600-0447.2000.102003178.x; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Ljungberg T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051616; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lu J, 2008, J AFFECT DISORDERS, V111, P221, DOI 10.1016/j.jad.2008.02.018; Milaneschi Y, 2014, MOL PSYCHIATR, V19, P444, DOI 10.1038/mp.2013.36; Naqvi TZ, 2005, PSYCHOSOM MED, V67, pS15, DOI 10.1097/01.psy.0000164013.55453.05; Ovaskainen Y, 2009, PSYCHIAT RES, V167, P73, DOI 10.1016/j.psychres.2007.12.004; Parekh A, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5010005; Rabe-Jablonska J, 2000, Med Sci Monit, V6, P539; Riemer S, 2010, J AFFECT DISORDERS, V123, P173, DOI 10.1016/j.jad.2009.08.004; Riera-Sampol A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020585; Rutledge T, 2014, AM J MED, V127, P840, DOI 10.1016/j.amjmed.2014.04.011; Sanchez-Villegas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016268; Sanhueza C, 2013, J HUM NUTR DIET, V26, P56, DOI 10.1111/j.1365-277X.2012.01283.x; Schroder H, 2003, BRIT J NUTR, V90, P431, DOI 10.1079/BJN2003899; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Smith DR, 2016, INT J SPORT NUTR EXE, V26, P506, DOI 10.1123/ijsnem.2015-0317; Takeuchi T, 2009, DIABETES-METAB RES, V25, P762, DOI 10.1002/dmrr.1041; Trpkovic A, 2015, CRIT REV CL LAB SCI, V52, P70, DOI 10.3109/10408363.2014.992063; Uebelacker LA, 2003, J SOC PERS RELAT, V20, P757, DOI 10.1177/0265407503206003; Wendolowicz A., 2014, Progress in Health Sciences, V4, P58; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130	48	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263519	10.1371/journal.pone.0263519	http://dx.doi.org/10.1371/journal.pone.0263519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113956	gold, Green Published			2022-12-26	WOS:000823694700103
J	Ambruso, DR; Briones, NJ; Baroffio, AF; Murphy, JR; Tran, AD; Gowan, K; Sanford, B; Ellison, M; Jones, KL				Ambruso, Daniel R.; Briones, Natalie J.; Baroffio, Angelina F.; Murphy, John R.; Tran, Alexander D.; Gowan, Katherine; Sanford, Bridget; Ellison, Michael; Jones, Kenneth L.			In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; POLYMORPHONUCLEAR NEUTROPHILS; CLASS-II; IFN-GAMMA; ACTIVATION; RECOGNITION; INDUCTION; PEPTIDES; SURVIVAL; PATHWAY	The cytokine Interferon-gamma (IFN-gamma) exerts powerful immunoregulatory effects on the adaptive immune system and also enhances functions of the neutrophil (PMN). The clinical use of IFN-gamma has been driven by the finding that its administration to patients with chronic granulomatous disease (CGD) results in decreased incidence and severity of infections. However, IFN-gamma has no effect on the characteristic defect of CGD, the inability to convert oxygen to microbicidal metabolites including superoxide anion (O-2(-)) during the phagocytosis associated oxidative burst. We administered varying doses of IFN-gamma to adult volunteers and studied the effects on plasma drug levels and response molecules and PMNs isolated from blood drawn at intervals over a 96- hour period. Plasma concentrations of IFN-gamma, IP-10 and neopterin, and stimulated release of O-2(-) from PMNs exhibited dose- and time-dependent increases after IFN-gamma administration. Gene expression in PMNs was altered for 2775 genes; changes occurred rapidly after administration and returned to baseline in 24-36 hours. Several genes involved with neutrophil host defense were upregulated including those for components of the O-2(-) generating NADPH oxidase; innate-immune and Fc receptors; proteins involved in MHCI and II; a regulator of circulating PMN number; guanylate binding proteins; and a key enzyme in synthesis of an essential NOS cofactor. Coordinate changes were detected in protein levels of representative products from several of these genes. Lysates from isolated neutrophils also demonstrated a spike in NO following IFN-gamma administration. IFN-gamma appears to increase non-oxygen dependent microbicidal functions of PMNs which could provide strategies to compensate for deficiencies, explain its clinical benefit for CGD patients and expand therapeutic applications of IFN-gamma to other disorders.	[Ambruso, Daniel R.; Briones, Natalie J.; Baroffio, Angelina F.; Murphy, John R.; Tran, Alexander D.; Gowan, Katherine; Sanford, Bridget; Ellison, Michael; Jones, Kenneth L.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Ambruso, Daniel R.; Jones, Kenneth L.] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO 80045 USA; [Jones, Kenneth L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ambruso, DR (corresponding author), Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA.; Ambruso, DR (corresponding author), Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO 80045 USA.	Daniel.ambruso@cuanschutz.edu		Baroffio, Angelina/0000-0001-5147-073X; Murphy, John/0000-0002-9360-4481; Sanford, Bridget/0000-0002-2173-0198	Horizon Pharma Ireland Ltd.; Stacy True Memorial Trust Fund; NIH/NCATS Colorado CTSA Grant [UL1 TR002535]	Horizon Pharma Ireland Ltd.; Stacy True Memorial Trust Fund; NIH/NCATS Colorado CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported as an investigator-initiated protocol by funds from Horizon Pharma Ireland Ltd. (DRA), the Stacy True Memorial Trust Fund (DRA), and by NIH/NCATS Colorado CTSA Grant Number UL1 TR002535 (contents are the authors' sole responsibility and do not necessarily represent official NIH views). No funder websites available.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; COLOTTA F, 1992, BLOOD, V80, P2012; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; Ellison MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185956; Ellison MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136766; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128; FUCHS D, 1992, CRIT REV CL LAB SCI, V29, P307, DOI 10.3109/10408369209114604; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Green DS, 2017, J BIOL CHEM, V292, P13925, DOI 10.1074/jbc.R116.774745; JACK RM, 1988, J IMMUNOL, V140, P4286; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Leavey PJ, 1998, BLOOD, V92, P4366, DOI 10.1182/blood.V92.11.4366.423k23_4366_4374; LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; MALAWISTA SE, 1992, J CLIN INVEST, V90, P631, DOI 10.1172/JCI115903; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; NEUMAN E, 1992, J IMMUNOL, V148, P3520; Pollard KM, 2013, DISCOV MED, V16, P123; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Reali E, 1996, J LEUKOCYTE BIOL, V60, P207, DOI 10.1002/jlb.60.2.207; Schairer DO, 2012, VIRULENCE, V3, P271, DOI 10.4161/viru.20328; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Takashima A, 2015, J LEUKOCYTE BIOL, V98, P489, DOI 10.1189/jlb.1MR1014-502R; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wilmott R., 2012, KENDIG CHERNICKS DIS, V8th, P552	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263370	10.1371/journal.pone.0263370	http://dx.doi.org/10.1371/journal.pone.0263370			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113934	Green Published, gold			2022-12-26	WOS:000823694700084
J	Shawer, H; Cheng, CW; Bailey, MA				Shawer, Heba; Cheng, Chew W.; Bailey, Marc A.			Absence of association between host genetic mutations in the ORAI1 gene and COVID-19 fatality	PLOS ONE			English	Article							ACUTE LUNG INJURY; INHIBITION	The calcium ion channel ORAI1 has emerged as a promising therapeutic target for the Coronavirus Disease 19 (COVID-19)-associated pneumonia, and a pharmacological inhibitor of ORAI1 has now reached clinical trials for severe COVID-19 pneumonia. Whether ORAI1 itself is associated with an increased risk for severe COVID-19 presentation is still unknown. Here, we employed genetic association analysis to investigate the potential association of host genetic polymorphisms of ORAI1 with the risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and its associated COVID-19 fatality in UK Biobank participants from white British background. The analysis showed no significant association between ORAI1 variants and COVID-19 positivity or fatality, despite the well-established roles of ORAI1 in immune response and inflammation and the success of ORAI1 inhibition in clinical trials. Our results suggest that the host genetic polymorphisms of ORAI1 are unlikely to be implicated in the broad variability in symptoms severity among afflicted patients.	[Shawer, Heba; Cheng, Chew W.; Bailey, Marc A.] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England	University of Leeds	Bailey, MA (corresponding author), Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England.	m.a.bailey@leeds.ac.uk		Shawer, Heba/0000-0003-1813-427X; Cheng, Chew Weng/0000-0002-2873-0828	British Heart Foundation [FS/18/12/33270, FS/17/66/33480]; Leeds Cardiovascular Endowment	British Heart Foundation(British Heart Foundation); Leeds Cardiovascular Endowment	This work was supported by British Heart Foundation fellowships to MAB and HS (FS/18/12/33270, FS/17/66/33480) and Leeds Cardiovascular Endowment support to CWC.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; AlSamman M, 2020, AM J EMERG MED, V38, P2444, DOI 10.1016/j.ajem.2020.09.054; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Burkert FR, 2021, EUR HEART J-CASE REP, V5, DOI 10.1093/ehjcr/ytaa521; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cheng CW., 2020, GENETIC VARIANTS PIE, V6, DOI [10.1101/2020.06.01.20119651, DOI 10.1101/2020.06.01.20119651]; Cunningham JW, 2021, JAMA INTERN MED, V181, P379, DOI 10.1001/jamainternmed.2020.5313; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Hu J., 2020, MEDRXIV, DOI [10.1101/2020.11.05.20226761, DOI 10.1101/2020.11.05.20226761]; Kaufmann U, 2016, J IMMUNOL, V196, P573, DOI 10.4049/jimmunol.1501406; Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9; Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McGurnaghan SJ, 2021, LANCET DIABETES ENDO, V9, P82, DOI 10.1016/S2213-8587(20)30405-8; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Miller J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03220-x; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubens JH, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n385; Scherer SE, 2006, NATURE, V440, P346, DOI 10.1038/nature04569; Seeley EJ, 2013, J CLIN INVEST, V123, P1015, DOI 10.1172/JCI68093; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Sze S, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100630; Wang GY, 2016, INFLAMMATION, V39, P1049, DOI 10.1007/s10753-016-0335-1; Yu F, 2021, J CLIN IMMUNOL, V41, P1004, DOI 10.1007/s10875-021-01004-8; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263303	10.1371/journal.pone.0263303	http://dx.doi.org/10.1371/journal.pone.0263303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113933	Green Published, gold			2022-12-26	WOS:000823694700077
J	Auer, D				Auer, Daniel			Firing discrimination: Selective labor market responses of firms during the COVID-19 economic crisis	PLOS ONE			English	Article							FIXED-TERM CONTRACTS; STATISTICAL DISCRIMINATION; PERCEIVED OVERQUALIFICATION; RACIAL-DISCRIMINATION; IMMIGRANTS; UNEMPLOYMENT; ASSIMILATION; METAANALYSIS; PERFORMANCE; INTEGRATION	The speed of the economic downturn in the wake of the COVID-19 pandemic has been exceptional, causing mass layoffs-in Germany up to 30% of the workforce in some industries. Economic rationale suggests that the decision on which workers are fired should depend on productivity-related individual factors. However, from hiring situations we know that discrimination-i.e., decisions driven by characteristics unrelated to productivity-is widespread in Western labor markets. Drawing on representative survey data on forced layoffs and short-time work collected in Germany between April and December 2020, this study highlights that discrimination against immigrants is also present in firing situations. The analysis shows that employees with a migration background are significantly more likely to lose their job than native workers when otherwise healthy firms are unexpectedly forced to let go of part of their workforce, while firms make more efforts to substitute firing with short-time working schemes for their native workers. Adjusting for detailed job-related characteristics shows that the findings are unlikely to be driven by systematic differences in productivity between migrants and natives. Moreover, using industry-specific variation in the extent of the economic downturn, I demonstrate that layoff probabilities hardly differ across the less affected industries, but that the gap between migrants and natives increases with the magnitude of the shock. In the hardest-hit industries, job loss probability among migrants is three times higher than among natives. This confirms the hypothesis that firing discrimination puts additional pressure on the immigrant workforce in times of crisis.	[Auer, Daniel] Univ Mannheim, MZES, Mannheim, Germany	Ruprecht Karls University Heidelberg; University of Mannheim	Auer, D (corresponding author), Univ Mannheim, MZES, Mannheim, Germany.	daniel.auer@uni-mannheim.de		Auer, Daniel/0000-0003-4454-2365	Baden-Wurttemberg Ministry of Science, Research and the Arts; University of Mannheim	Baden-Wurttemberg Ministry of Science, Research and the Arts; University of Mannheim	The publication of this article was funded by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by the University of Mannheim.	Adams-Prassl A, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104245; Ahmad A, 2020, WORK EMPLOY SOC, V34, P826, DOI 10.1177/0950017020919670; Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Altonji JG, 2005, AM ECON REV, V95, P112, DOI 10.1257/000282805774670455; Altonji JG, 2001, Q J ECON, V116, P313, DOI 10.1162/003355301556329; Arrow K.J., 1973, DISCRIMINATION LABOR, P21; Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x; Auer D, 2019, IMISCOE RES, P221, DOI 10.1007/978-3-030-05671-1_9; Auer D, 2019, J ECON INEQUAL, V17, P285, DOI 10.1007/s10888-018-9401-2; Auer D, 2018, J ETHN MIGR STUD, V44, P341, DOI 10.1080/1369183X.2017.1304208; Baert S., 2021, IZA POLICY PAPER; Baert S., 2018, AUDIT STUDIES SCENES, DOI DOI 10.1007/978-3-319-71153-9_3; Baert S, 2015, ILR REV, V68, P467, DOI 10.1177/0019793915570873; Baldoni E, 2021, EUR REV AGRIC ECON, V48, P805, DOI 10.1093/erae/jbaa033; Ballarino G, 2015, INT MIGR, V53, P338, DOI 10.1111/imig.12105; Basso G., 2020, IZA DISCUSSION PAPER, DOI DOI 10.1787/400CF397-EN; Becker GS, 1957, EC DISCRIMINATION; Blanchard O, 2002, ECON J, V112, pF214, DOI 10.1111/1468-0297.00047; BMWi (Federal Ministry for Economic Affairs and Energy), 2019, ERNEUERBARE ENERGIEN; Boockmann B, 2008, LABOUR ECON, V15, P984, DOI 10.1016/j.labeco.2007.08.001; Borjas G., 2020, 27243 NBER, DOI [10.3386/w27243, DOI 10.3386/W27243]; Bratsberg B, 2018, ECONOMICA, V85, P124, DOI 10.1111/ecca.12244; Campos NF, 2020, EUR ECON REV, V129, DOI 10.1016/j.euroecorev.2020.103511; Card D, 2018, J LABOR ECON, V36, pS13, DOI 10.1086/694153; Carlsson M, 2014, IZA J MIGR, V3, DOI 10.1186/2193-9039-3-11; Cavounidis J, 2018, EUR J PUBLIC HEALTH, V28, P20, DOI 10.1093/eurpub/cky204; Cebolla-Boado H, 2015, J ETHN MIGR STUD, V41, P710, DOI 10.1080/1369183X.2014.936837; Chiswick BR, 2010, J POPUL ECON, V23, P353, DOI 10.1007/s00148-008-0230-7; Cinelli C, 2020, J R STAT SOC B, V82, P39, DOI 10.1111/rssb.12348; Clark A, 2009, OXFORD ECON PAP, V61, P207, DOI 10.1093/oep/gpn017; Coibion O., 2020, LABOR MARKETS COVID, DOI 10.3386/w27017; Cortes G.M., 2020, HETEROGENEOUS LABOR, DOI 10.17848/wp20-327; Couch KA., 2018, TRANSITIONS LABOR MA, V46, DOI [10.1108/S0147-9121201846, DOI 10.1108/S0147-9121201846]; Couch KA, 2010, DEMOGRAPHY, V47, P227, DOI 10.1353/dem.0.0086; Crossley TF, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104334; DeVaro J, 2018, IND RELAT, V57, P389, DOI 10.1111/irel.12211; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Ebner C, 2016, WORK EMPLOY SOC, V30, P436, DOI 10.1177/0950017015594096; Erdogan B, 2021, ANNU REV ORGAN PSYCH, V8, P259, DOI 10.1146/annurev-orgpsych-012420-055831; Eurostat, 2021, EUR LAB FORC SURV; Fasani F., 2020, BEING ON FRONTLINE I, P918; Fasani F, 2022, J ECON GEOGR, V22, P351, DOI 10.1093/jeg/lbab011; Federal Employment Agency, 2021, EFF COR CRIS LAB MAR; Federal Labor Court, 2009, EQ AGR 4 AZR 811 09; Federal Ministry of Justice, 2021, LAW PROT DISM 1 ABS; Federal Office of Statistics, 2021, CLASS EC IND 2008; Federal Office of Statistics, 2021, COLLECTIVE BARGAININ; Fernandez-Kranz D, 2015, OXFORD B ECON STAT, V77, P512, DOI 10.1111/obes.12073; Fontaine I, 2019, ECON LETT, V183, DOI 10.1016/j.econlet.2019.108612; Fossati F, 2020, RES SOC STRAT MOBIL, V65, DOI 10.1016/j.rssm.2019.100462; Gandini L, 2016, POPUL SPACE PLACE, V22, P441, DOI 10.1002/psp.1909; Gash V, 2008, EUR SOCIOL REV, V24, P651, DOI 10.1093/esr/jcn027; Gibbons R, 2005, J LABOR ECON, V23, P681, DOI 10.1086/491606; GIBBONS R, 1992, REV ECON STUD, V59, P515, DOI 10.2307/2297862; Giuliano L, 2011, J HUM RESOUR, V46, P26, DOI 10.1353/jhr.2011.0022; Guryan J, 2013, ECON J, V123, pF417, DOI 10.1111/ecoj.12080; Hagendoorn L, 1995, EUR REV SOC PSYCHOL, V6, P199, DOI [10.1080/14792779443000058, DOI 10.1080/14792779443000058]; Heizmann B, 2017, INT MIGR REV, V51, P475, DOI 10.1111/imre.12209; Hoynes H, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.3.27; Hu Y, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100528; ILO, ISCO08 ILO; Johnson GJ, 2000, J PSYCHOL, V134, P537, DOI 10.1080/00223980009598235; Kaas L, 2012, GER ECON REV, V13, P1, DOI 10.1111/j.1468-0475.2011.00538.x; Kalleberg AL, 2000, AM SOCIOL REV, V65, P256, DOI 10.2307/2657440; Kong E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104257; Kopp D., 2019, SHORT TIME WORK UNEM, P462, DOI [10.3929/ethz-b-000359533, DOI 10.3929/ETHZ-B-000359533]; Koren M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239113; Lang K, 2012, J ECON LIT, V50, P959, DOI 10.1257/jel.50.4.959; Lange F, 2007, J LABOR ECON, V25, P1, DOI 10.1086/508730; LARKEY LK, 1993, MANAGEMENT COMMUNICA, V7, P158, DOI DOI 10.1177/0893318993007002002; Lee AL, 2021, J OCCUP ORGAN PSYCH, V94, P80, DOI 10.1111/joop.12323; Lemieux T, 2009, Q J ECON, V124, P1, DOI 10.1162/qjec.2009.124.1.1; Light A, 2015, J HUM RESOUR, V50, P72; Lindbeck A, 2001, J ECON PERSPECT, V15, P165, DOI 10.1257/jep.15.1.165; Lippens L., 2020, 13523 IZA; Lippens L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246899; Ma C, 2020, J BUS RES, V118, P199, DOI 10.1016/j.jbusres.2020.06.041; Mansour H, 2012, J LABOR ECON, V30, P415, DOI 10.1086/663590; Mitaritonna C, 2017, EUR ECON REV, V96, P62, DOI 10.1016/j.euroecorev.2017.05.001; Moehring K., 2021, SOCARXIV PREPR, DOI [10.31235/osf.io/ m95df, DOI 10.31235/OSF.IO/M95DF]; Neumark D, 2018, J ECON LIT, V56, P799, DOI 10.1257/jel.20161309; OAXACA RL, 1994, J ECONOMETRICS, V61, P5, DOI 10.1016/0304-4076(94)90074-4; Oster E, 2019, J BUS ECON STAT, V37, P187, DOI 10.1080/07350015.2016.1227711; Pager D, 2009, ANN AM ACAD POLIT SS, V621, P70, DOI 10.1177/0002716208324628; Paggiaro A, 2013, DEMOGR RES, V28, P229, DOI 10.4054/DemRes.2013.28.8; PHELPS ES, 1972, AM ECON REV, V62, P659; Pinkston JC, 2006, IND LABOR RELAT REV, V59, P267, DOI 10.1177/001979390605900205; Platt L, 2020, FISC STUD, V41, P259, DOI 10.1111/1475-5890.12228; Qian Y, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100522; Quillian L, 2020, SOC FORCES, V99, P732, DOI 10.1093/sf/soaa026; Quillian L, 2017, P NATL ACAD SCI USA, V114, P10870, DOI 10.1073/pnas.1706255114; Raisi-Estabragh Z, 2020, J PUBLIC HEALTH-UK, V42, P451, DOI 10.1093/pubmed/fdaa095; Schmaus M, 2020, EUR SOCIOL REV, V36, P82, DOI 10.1093/esr/jcz044; SOEP, 2021, GERM SOC EC PAN; Swiss Federal Office of Statistics, 2021, PLAUS MED STAT DAT; Thijssen L, 2021, J ETHN MIGR STUD, V47, P1222, DOI 10.1080/1369183X.2019.1622793; U.S. Bureau of Labor Statistics, 2018, HEALTHC OCC; Vernby K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218044; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weichselbaumer D, 2020, ILR REV, V73, P600, DOI 10.1177/0019793919875707; Weinberg B.A., 2020, DETERMINANTS DISPARI, DOI [10.3386/w27132, DOI 10.3386/W27132]; Wright CF, 2019, J IND RELAT, V61, P157, DOI 10.1177/0022185618824137; Xu H, 2020, W27246 NAT BUR EC RE; Zschirnt E, 2016, J ETHN MIGR STUD, V42, P1115, DOI 10.1080/1369183X.2015.1133279; Zwysen W, 2020, J ETHN MIGR STUD, V46, P200, DOI 10.1080/1369183X.2018.1498777	105	2	2	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262337	10.1371/journal.pone.0262337	http://dx.doi.org/10.1371/journal.pone.0262337			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100290	gold, Green Published			2022-12-26	WOS:000801937600011
J	Ellakany, P; Zuniga, RAA; El Tantawi, M; Brown, B; Aly, NM; Ezechi, O; Uzochukwu, B; Abeldano, GF; Ara, E; Ayanore, MA; Gaffar, B; Al-Khanati, NM; Ishabiyi, AO; Jafer, M; Khan, ATA; Khalid, Z; Lawal, FB; Lusher, J; Nzimande, NP; Osamika, BE; Quadri, MFA; Roque, M; Shamala, A; Al-Tammemi, AB; Yousaf, MA; Virtanen, JI; Nguyen, AL; Folayan, MO				Ellakany, Passent; Abeldano Zuniga, Roberto Ariel; El Tantawi, Maha; Brown, Brandon; Aly, Nourhan M.; Ezechi, Oliver; Uzochukwu, Benjamin; Abeldano, Giuliana Florencia; Ara, Eshrat; Amogre Ayanore, Martin; Gaffar, Balgis; Maher Al-Khanati, Nuraldeen; Omotola Ishabiyi, Anthonia; Jafer, Mohammed; Tu-Allah Khan, Abeedha; Khalid, Zumama; Barakat Lawal, Folake; Lusher, Joanne; Nzimande, Ntombifuthi P.; Emmanuel Osamika, Bamidele; Ali Quadri, Mir Faeq; Roque, Mark; Shamala, Anas; Al-Tammemi, Ala'a B.; Abrar Yousaf, Muhammad; Virtanen, Jorma I.; Nguyen, Annie Lu; Folayan, Morenike Oluwatoyin			Impact of the COVID-19 pandemic on student' sleep patterns, sexual activity, screen use, and food intake: A global survey	PLOS ONE			English	Article							HEALTH	Background The education sector experienced substantial impacts during the COVID-19 pandemic resulting from worldwide restrictions. Purpose To examine differences in the sleep patterns, sexual activity, screen use, and food intake of students and non-students during the COVID-19 pandemic. Methods This was a global cross-sectional study conducted in the second half of 2020 using multiple social media platforms to recruit study participants globally. A close-ended questionnaire was administered anonymously in English, French, Spanish, Portuguese, and Arabic to adults ages 18 and older. The outcome variables considered in analyses were changes in sleep pattern, sexual activity, screen use, and food intake. The explanatory variable was student status categorized as students vs. non-student. T-test, chi-square, and Mann Whitney U tests were used to assess differences between student and non-student populations. One logistic regression model was built for each outcome variable. Country of residence and country income level were included in the adjusted models. Results There were 17,008 participants of which 3,793 (22.3%) were students. Of the total sample, 4,889 (28.7%) reported changes in sleep, 4,642 (31.8%) reported increases in sexual activity, 10,278 (70.7%) reported increases in screen use, and 5,662 (40.2%) reported increases in food intake during the pandemic. Compared to non-students, students had significantly higher odds of reporting changes in sleep (AOR = 1.52), increases in sexual activity (AOR = 1.79), and increases in screen use (AOR = 1.36) but lower odds of reporting increase in food intake (AOR = 0.87). Conclusion Students displayed higher risk of experiencing changes in sleep, sexual behavior, and screen use during the COVID-19 pandemic. This has the potential to lead to broader adverse effects on students' overall wellbeing. The findings and implications raise further obligations on the education sector to put extra-curricular support systems in place that address COVID-19 related behavior changes that have the potential to adversely impact students' wellbeing.	[Ellakany, Passent; Abeldano Zuniga, Roberto Ariel; El Tantawi, Maha; Brown, Brandon; Aly, Nourhan M.; Ezechi, Oliver; Uzochukwu, Benjamin; Abeldano, Giuliana Florencia; Ara, Eshrat; Amogre Ayanore, Martin; Gaffar, Balgis; Maher Al-Khanati, Nuraldeen; Omotola Ishabiyi, Anthonia; Jafer, Mohammed; Tu-Allah Khan, Abeedha; Khalid, Zumama; Barakat Lawal, Folake; Lusher, Joanne; Nzimande, Ntombifuthi P.; Emmanuel Osamika, Bamidele; Ali Quadri, Mir Faeq; Roque, Mark; Shamala, Anas; Al-Tammemi, Ala'a B.; Abrar Yousaf, Muhammad; Virtanen, Jorma I.; Nguyen, Annie Lu; Folayan, Morenike Oluwatoyin] Mental Hlth & Wellness Study Grp, Oaxaca, Oaxaca, Mexico; [Ellakany, Passent] Imam Abdulrahman Bin Faisal Univ, Dept Substitut Dent Sci, Coll Dent, Dammam, Saudi Arabia; [Abeldano Zuniga, Roberto Ariel] Univ Sierra, Postgrad Dept, Oaxaca, Oaxaca, Mexico; [El Tantawi, Maha] Alexandria Univ, Fac Dent, Alexandria, Egypt; [Brown, Brandon] Nigerian Inst Med Res, Dept Clin Sci, Lagos, Nigeria; [Ezechi, Oliver] Univ Calif Riverside, Riverside Sch Med, Dept Social Med Populat & Publ Hlth, Riverside, CA USA; [Uzochukwu, Benjamin] Univ Nigeria Nsukka, UNN Enugu Campus, Nsukka, Nigeria; [Abeldano, Giuliana Florencia] Univ Sierra, Sch Med, Oaxaca, Oaxaca, Mexico; [Ara, Eshrat] Govt Coll Women, Srinagar, India; [Amogre Ayanore, Martin] Univ Hlth & Allied Sci, Dept Hlth Policy Planning & Management, Ho, Ghana; [Gaffar, Balgis] Imam Abdulrahman Bin Faisal Univ, Dept Prevent Dent Sci, Coll Dent, Dammam, Saudi Arabia; [Maher Al-Khanati, Nuraldeen] Syrian Private Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Damascus, Syria; [Omotola Ishabiyi, Anthonia] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Ctr Rural Hlth, Durban, South Africa; [Jafer, Mohammed] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Promot, Maastricht, Netherlands; [Tu-Allah Khan, Abeedha; Khalid, Zumama] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Barakat Lawal, Folake] Univ Ibadan, Dept Periodontol & Community Dent, Ibadan, Nigeria; [Barakat Lawal, Folake] Univ Ibadan, Univ Coll Hosp, Ibadan, Nigeria; [Lusher, Joanne] Regents Univ London, London, England; [Nzimande, Ntombifuthi P.] Univ Szeged, Dept Econ & Human Geog, Szeged, Hungary; [Emmanuel Osamika, Bamidele] Univ Ibadan, Dept Child Oral Hlth, Ibadan, Nigeria; [Ali Quadri, Mir Faeq] Jazan Univ, Dept Prevent Dent Sci, Coll Dent, Dent Publ Hlth, Jizan, Saudi Arabia; [Roque, Mark] Taibah Univ, Matern & Childhood Nursing Dept, Coll Nursing, Madinah, Saudi Arabia; [Shamala, Anas] Univ Sci & Technol, Dept Prevent & Biomed Sci, Fac Dent, Sanaa, Yemen; [Al-Tammemi, Ala'a B.] Univ Debrecen, Doctoral Sch Hlth Sci, Debrecen, Hungary; [Abrar Yousaf, Muhammad] Univ Punjab, Inst Zool, Lahore, Pakistan; [Virtanen, Jorma I.] Univ Turku, Fac Med, Turku, Finland; [Nguyen, Annie Lu] Univ Southern Calif, Keck Sch Med, Dept Family Med, Los Angeles, CA USA; [Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Nigeria	Imam Abdulrahman Bin Faisal University; Egyptian Knowledge Bank (EKB); Alexandria University; University of California System; University of California Riverside; University of Nigeria; Imam Abdulrahman Bin Faisal University; University of Kwazulu Natal; Maastricht University; University of Punjab; University of Ibadan; University of Ibadan; University College Hospital, Ibadan; Szeged University; University of Ibadan; Jazan University; Taibah University; University of Debrecen; University of Punjab; University of Turku; University of Southern California; Obafemi Awolowo University	Ellakany, P (corresponding author), Mental Hlth & Wellness Study Grp, Oaxaca, Oaxaca, Mexico.; Ellakany, P (corresponding author), Imam Abdulrahman Bin Faisal Univ, Dept Substitut Dent Sci, Coll Dent, Dammam, Saudi Arabia.	pellakany@iau.edu.sa	Tantawi, Maha El/K-4336-2014; Osamika, Bamidele Emmanuel/GXV-9426-2022; Shamala, Anas/GQA-6717-2022; Al-Tammemi, MD, MPH, Ala'a B./AAB-4737-2021; Al-Khanati, Nuraldeen/AAG-3463-2019; Yousaf, Muhammad Abrar/AAG-2759-2021; Quadri, Mir Faeq Ali/T-2574-2017	Tantawi, Maha El/0000-0003-4989-6584; Shamala, Anas/0000-0003-3439-5453; Al-Tammemi, MD, MPH, Ala'a B./0000-0003-0862-0186; Al-Khanati, Nuraldeen/0000-0001-9069-5069; Virtanen, Jorma/0000-0001-6574-9942; , Zumama/0000-0002-9019-4771; Ayanore, Martin/0000-0002-4095-3047; ara, eshrat/0000-0002-1863-0495; Yousaf, Muhammad Abrar/0000-0001-8018-3895; Ellakany, Passent/0000-0002-2995-8111; Lawal, Folake/0000-0002-3193-387X; Quadri, Mir Faeq Ali/0000-0001-6349-6136; M. Aly, Nourhan/0000-0002-8729-2485				Akour A, 2020, AM J TROP MED HYG, V103, P2391, DOI 10.4269/ajtmh.20-0877; Al-Tammemi AB, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.562213; Ammar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240204; Andreeva E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4789-3; Bliwise DL., 2005, PRINCIPLES PRACTICE, V4th ed., P24; Bonal X, 2020, INT REV EDUC, V66, P635, DOI 10.1007/s11159-020-09860-z; Calvo-Sanz JA, 2020, CHRONOBIOL INT, V37, P1016, DOI 10.1080/07420528.2020.1781149; Casagrande M, 2020, SLEEP MED, V75, P12, DOI 10.1016/j.sleep.2020.05.011; Chattu VK, 2018, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010001; Choi B, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02117-1; Coakley KE, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00701-9; Colten HR., 2006, SLEEP DISORDERS SLEE, P1, DOI DOI 10.17226/11617; Constant A, 2018, APPETITE, V129, P186, DOI 10.1016/j.appet.2018.07.012; Cullinan J, 2021, INT J EDUC TECHNOL H, V18, DOI 10.1186/s41239-021-00262-1; Dawidziuk A, 2021, GLOB HEALTH-SCI PRAC, V9, P10, DOI 10.9745/GHSP-D-20-00455; Dawson LH, 2008, J SEX RES, V45, P225, DOI 10.1080/00224490801987457; Deckx Laura, 2018, Psychol Health Med, V23, P899, DOI 10.1080/13548506.2018.1446096; Doering N, 2020, J SEX RES, V57, P885, DOI 10.1080/00224499.2019.1578329; Eaton L, 2021, B WORLD HEALTH ORGAN, V99, P6, DOI 10.2471/BLT.21.020121; Evans DJR, 2020, ANAT SCI EDUC, V13, P279, DOI 10.1002/ase.1963; Flanagan EW, 2021, OBESITY, V29, P438, DOI 10.1002/oby.23066; Flaudias V, 2020, J BEHAV ADDICT, V9, P826, DOI 10.1556/2006.2020.00053; Foerster M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030518; Frehywot S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-4; Gordon-Messer D, 2013, J ADOLESCENT HEALTH, V52, P301, DOI 10.1016/j.jadohealth.2012.05.013; Green EL, 2021, NEW YORK TIME; Gruskin S, 2021, SEX REPROD HLTH MATT, V29, DOI 10.1080/26410397.2021.1881206; Guadagni Veronica, 2020, Front Glob Womens Health, V1, P585938, DOI 10.3389/fgwh.2020.585938; Hale L, 2018, CHILD ADOL PSYCH CL, V27, P229, DOI 10.1016/j.chc.2017.11.014; Herbenick D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181198; Ibarra François Peinado, 2020, Int. braz j urol., V46, P104, DOI [10.1590/S1677-5538.IBJU.2020.S116, 10.1590/s1677-5538.ibju.2020.s116]; Josephson A, 2021, NAT HUM BEHAV, V5, P557, DOI 10.1038/s41562-021-01096-7; Kelner M, 2020, SKYNEWS; Langford E, 2020, POLITICS HOME; Li C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197324; Li JX, 2018, SLEEP MED CLIN, V13, P1, DOI 10.1016/j.jsmc.2017.09.001; Luciano F, 2021, EUR J SPORT SCI, V21, P1459, DOI 10.1080/17461391.2020.1842910; Alvaro JL, 2019, SPAN J PSYCHOL, V22, DOI 10.1017/sjp.2018.68; Majumdar P, 2020, CHRONOBIOL INT, V37, P1191, DOI 10.1080/07420528.2020.1786107; Meurer WJ, 2017, JAMA-J AM MED ASSOC, V317, P1068, DOI 10.1001/jama.2016.20441; Mollaioli D, 2021, J SEX MED, V18, P35, DOI 10.1016/j.jsxm.2020.10.008; Morris JL, 2015, INT J GYNECOL OBSTET, V131, pS40, DOI 10.1016/j.ijgo.2015.02.006; Raghupathi V, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00156; Raj A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6340-6; Rajab MH, 2020, CUREUS, V12, DOI 10.7759/cureus.8966; Razzoli M, 2016, TRENDS ENDOCRIN MET, V27, P504, DOI 10.1016/j.tem.2016.04.007; Robinson E, 2020, OBES SCI PRACT, V6, P735, DOI 10.1002/osp4.442; Romero-Blanco C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186567; Sanchez-Caballero S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051547; Savage MJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062930; Schmidt Christina, 2012, Front Neurol, V3, P118, DOI 10.3389/fneur.2012.00118; Sharma AJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238761; The World Bank Group, 2016, WORLD BANK COUNTR LE; Wu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119607; Yuan S, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923767; Yuksel B, 2020, INT J GYNECOL OBSTET, V150, P98, DOI 10.1002/ijgo.13193; Zhai YS, 2020, LANCET PSYCHIAT, V7, pE22, DOI 10.1016/S2215-0366(20)30089-4	57	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262617	10.1371/journal.pone.0262617	http://dx.doi.org/10.1371/journal.pone.0262617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089943	gold, Green Published			2022-12-26	WOS:000769158400017
J	Rasheed, A; Sharifi, H; Wesson, P; Pashtoon, SJ; Tavakoli, F; Ghalekhani, N; Haghdoost, AA; Atarud, A; Banehsi, MR; Hamdard, N; Sadaat, SI; McFarland, W; Mirzazadeh, A				Rasheed, Abdul; Sharifi, Hamid; Wesson, Paul; Pashtoon, Sayed Jalal; Tavakoli, Fatemeh; Ghalekhani, Nima; Haghdoost, Ali Akbar; Atarud, Alim; Banehsi, Mohammad Reza; Hamdard, Naqibullah; Sadaat, Said Iftekhar; McFarland, Willi; Mirzazadeh, Ali			Mapping and population size estimates of people who inject drugs in Afghanistan in 2019: Synthesis of multiple methods	PLOS ONE			English	Article							TO-REACH POPULATIONS; CAPTURE-RECAPTURE; HIV	Introduction Mapping and population size estimates of people who inject drugs (PWID) provide information needed for monitoring coverage of programs and planning interventions. The objectives of this study were to provide the locations and numbers of PWID in eight cities in Afghanistan and extrapolate estimates for the country as a whole. Methods Multiple population size estimation methods were used, including key informant interviews for mapping and enumeration with reverse tracking, unique object and service multipliers, capture-recapture, and wisdom of the crowds. The results of the several methods were synthesized using the Anchored Multiplier-a Bayesian approach to produce point estimates and 95% credible intervals (CI). Using the prevalence of PWID in the eight cities and their correlation with proxy indicators, we extrapolated the PWID population size for all of Afghanistan. Results Key informants and field mapping identified 374 hotspots across the eight cities from December 29, 2018 to March 20, 2019. Synthesizing results of the multiple methods, the number of male PWID in the eight study cities was estimated to be 11,506 (95% CI 8,449-15,093), corresponding to 0.69% (95% CI 0.50-0.90) of the adult male population age 15-64 years. The total number of women who injected drugs was estimated at 484 (95% CI 356-633), corresponding to 0.03% (95% CI 0.02-0.04) of the adult female population. Extrapolating by proxy indicators, the total number of PWID in Afghanistan was estimated to be 54,782 (95% CI 40,250-71,837), men and 2,457 (95% CI 1,823-3,210) women. The total number of PWID in Afghanistan was estimated to be 57,207 (95% CI 42,049-75,005), which corresponds to 0.37% (95% CI 0.27-0.48) of the adult population age 15 to 64 years. Discussion This study provided estimates for the number of PWID in Afghanistan. These estimates can be used for advocating and planning services for this vulnerable at-risk population.	[Rasheed, Abdul; Pashtoon, Sayed Jalal] Youth Hlth & Dev Org, Kabul, Afghanistan; [Sharifi, Hamid; Tavakoli, Fatemeh; Ghalekhani, Nima; Haghdoost, Ali Akbar; Mirzazadeh, Ali] Kerman Univ Med Sci, Inst Futures Studies Hlth, HIV STI Surveillance Res Ctr & WHO Collaborating, Kerman, Iran; [Wesson, Paul; McFarland, Willi; Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Atarud, Alim] United Nat Dev Programme, Kabul, Afghanistan; [Banehsi, Mohammad Reza] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran; [Hamdard, Naqibullah; Sadaat, Said Iftekhar] Minist Publ Hlth, Kabul, Afghanistan	Kerman University of Medical Sciences; University of California System; University of California San Francisco; Kerman University of Medical Sciences	Mirzazadeh, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, HIV STI Surveillance Res Ctr & WHO Collaborating, Kerman, Iran.; Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	ali.mirzazadeh@ucsf.edu		Sadaat, Said Iftekhar/0000-0002-8936-1720				Anderson DR, 1999, BIRD STUDY, V46, P14; Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; [Anonymous], 2010, GUID EST SIZ POP MOS; Central Intelligence Agency (CIA), 2009, PAG SIZ BAS MAPS VIA; Dutta A, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9776-3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hall HI, 2006, AM J EPIDEMIOL, V164, P391, DOI 10.1093/aje/kwj216; Harooni MZ, 2022, INT J STD AIDS, V33, P282, DOI 10.1177/09564624211055299; Johns Hopkins Bloomberg School of Public Health, 2010, INT BEH BIOL SURV IB; Johns Hopkins Bloomberg School of Public Health ANACP, 2012, INT BEH BIOL SURV IB; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; Larney S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4785-7; Mateu-Gelabert P, 2018, CURR HIV-AIDS REP, V15, P324, DOI 10.1007/s11904-018-0406-z; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Nikfarjam A, 2016, INT J DRUG POLICY, V31, P147, DOI 10.1016/j.drugpo.2016.01.013; Paquette CE, 2018, INT J DRUG POLICY, V57, P104, DOI 10.1016/j.drugpo.2018.04.004; Rahimi J, 2020, ADDICTION, V115, P605, DOI 10.1111/add.14853; Rivest L-P., 2019, PACKAGE RC APTURE; Saif-ur-Rehman, 2007, LANCET, V370, P2167, DOI 10.1016/S0140-6736(07)61911-4; Sector SAHD, MAPP SIT ASS KEY POP; SGI-Global, 2015, AFGH NAT DRUG US SUR; Sharifi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182755; Strike C, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0212-3; Sulaberidze L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147413; UNODC, DRUG US SURV AFGH 20; Vadivoo S, 2008, AIDS, V22, pS137, DOI 10.1097/01.aids.0000343772.82647.2d; Wesson P, 2017, AIDS BEHAV, V21, P2188, DOI 10.1007/s10461-017-1678-9; Wesson PD, 2018, INT J EPIDEMIOL, V47, P1636, DOI 10.1093/ije/dyy132; worldometer, AFGH POP 2020; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262405	10.1371/journal.pone.0262405	http://dx.doi.org/10.1371/journal.pone.0262405			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089934	gold, Green Published			2022-12-26	WOS:000769158400015
J	Cao, LB; Zhu, CZ				Cao, Longbing; Zhu, Chengzhang			Personalized next-best action recommendation with multi-party interaction learning for automated decision-making	PLOS ONE			English	Article							GAME; GO	Y Automated next-best action recommendation for each customer in a sequential, dynamic and interactive context has been widely needed in natural, social and business decision-making. Personalized next-best action recommendation must involve past, current and future customer demographics and circumstances (states) and behaviors, long-range sequential interactions between customers and decision-makers, multi-sequence interactions between states, behaviors and actions, and their reactions to their counterpart's actions. No existing modeling theories and tools, including Markovian decision processes, user and behavior modeling, deep sequential modeling, and personalized sequential recommendation, can quantify such complex decision-making on a personal level. We take a data-driven approach to learn the next-best actions for personalized decision-making by a reinforced coupled recurrent neural network (CRN). CRN represents multiple coupled dynamic sequences of a customer's historical and current states, responses to decision-makers' actions, decision rewards to actions, and learns long-term multi-sequence interactions between parties (customer and decision-maker). Next-best actions are then recommended on each customer at a time point to change their state for an optimal decisionmaking objective. Our study demonstrates the potential of personalized deep learning of multi-sequence interactions and automated dynamic intervention for personalized decision-making in complex systems.	[Cao, Longbing; Zhu, Chengzhang] Univ Technol Sydney, Sydney, NSW, Australia	University of Technology Sydney	Cao, LB (corresponding author), Univ Technol Sydney, Sydney, NSW, Australia.	longbing.cao@uts.edu.au		cao, longbing/0000-0003-1562-9429	Australian Research Council [DP190101079, FT190100734]	Australian Research Council(Australian Research Council)	This work is partially sponsored by the Australian Research Council Discovery grant DP190101079 and Australian Research Council Future Fellowship (professor level) grant FT190100734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchus F, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P1160; Bacchus F, 1997, AAAI, P112; Bajor J.M., 2017, ICLR; Bellman R., 2013, DYNAMIC PROGRAMMING; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Boutilier C., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1096; Brafman R, 2017, ARXIV PREPRINT ARXIV; Cao L, 2015, ADV INFORM KNOWL PRO, P1, DOI 10.1007/978-1-4471-6551-4; Cao LB, 2016, ENGINEERING, V2, P212, DOI 10.1016/J.ENG.2016.02.013; Chakraborty B, 2014, ANNU REV STAT APPL, V1, P447, DOI 10.1146/annurev-statistics-022513-115553; Chen Q, 2020, PR INT CONF DATA SC, P692, DOI 10.1109/DSAA49011.2020.00079; Cheng H-T., 2016, P 1 WORKSHOP DEEP LE, DOI 10.1145/2988450.2988454; Cho K., 2014, C EMPIRICAL METHODS, P1724; Chou SY, 2016, PROCEEDINGS OF THE 10TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'16), P115, DOI 10.1145/2959100.2959156; Clarke AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123105; Du J., 2019, HELPFULNESS PREDICTI, P795; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Egorov M, 2017, J MACH LEARN RES, V18; FAGERBERG J, 1995, CAMBRIDGE J ECON, V19, P243; Friedrich J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002092; Gabaldon A, 2011, ARTIF INTELL, V175, P25, DOI 10.1016/j.artint.2010.04.012; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Han QW, 2018, PR INT CONF DATA SC, P481, DOI 10.1109/DSAA.2018.00062; Hausknecht M.J., 2015, AAAI FALL S; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Ishigaki T, 2018, INT J DATA SCI ANAL, V5, P233, DOI 10.1007/s41060-018-0099-9; Ji K, 2015, KNOWL-BASED SYST, V88, P134, DOI 10.1016/j.knosys.2015.07.039; Kingma D. P., 2015, P INT C LEARN REPR, P1; Korn CW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02750-3; Krawczyk B, 2016, PROG ARTIF INTELL, V5, P221, DOI 10.1007/s13748-016-0094-0; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15860-2; McDonald KR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09789-4; MINER FC, 1984, ORGAN BEHAV HUM PERF, V33, P112, DOI 10.1016/0030-5073(84)90014-X; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Peng M, 2018, WORLD WIDE WEB, V21, P89, DOI 10.1007/s11280-017-0456-y; Puterman ML., 2014, MARKOV DECISION PROC; Shu JG, 2021, IEEE T SERV COMPUT, V14, P235, DOI 10.1109/TSC.2018.2791601; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Taghia J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04723-6; Thiebaux S, 2006, J ARTIF INTELL RES, V25, P17, DOI 10.1613/jair.1676; Thrun M, 2020, PR INT CONF DATA SC, P479, DOI 10.1109/DSAA49011.2020.00062; van Hasselt H, 2016, AAAI CONF ARTIF INTE, P2094; Wang C., 2013, PROC INT JOINT C ART, P1736; Wang SJ, 2021, ACM COMPUT SURV, V54, DOI 10.1145/3465401; Wang W, 2021, ACM T INFORM SYST, V39, DOI 10.1145/3440874; Wang X., 2021, INT J DATA SCI ANAL, V2, P1, DOI DOI 10.1007/S41060-020-00241-1; WHITEHEAD SD, 1995, ARTIF INTELL, V73, P271, DOI 10.1016/0004-3702(94)00012-P; Zhang LM, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1405, DOI 10.1145/3041021.3051149; Zuo Y, 2015, IEEE COMPUT INTELL M, V10, P52, DOI 10.1109/MCI.2014.2369894	53	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263010	10.1371/journal.pone.0263010	http://dx.doi.org/10.1371/journal.pone.0263010			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085347	Green Published, gold, Green Submitted			2022-12-26	WOS:000779379600104
J	Nasir, N; Tajuddin, S; Khaskheli, S; Khan, N; Niamatullah, H; Nasir, N				Nasir, Noreen; Tajuddin, Salma; Khaskheli, Sarah; Khan, Naveera; Niamatullah, Hammad; Nasir, Nosheen			Clinical outcomes of immunomodulatory therapies in the management of COVID-19: A tertiary-care experience from Pakistan	PLOS ONE			English	Article								The pharmacological management of COVID-19 has evolved significantly and various immunomodulatory agents have been repurposed. However, the clinical efficacy has been variable and a search for cure for COVID-19 continues. A retrospective cohort study was conducted on 916 patients hospitalized with polymerase chain reaction (PCR)-confirmed COVID-19 between February 2020 and October 2020 at a tertiary care academic medical center in Karachi, Pakistan. The median age was 57 years (interquartile range (IQR) 46-66 years). The most common medications administered were Methylprednisolone (65.83%), Azithromycin (50.66%), and Dexamethasone (46.6%). Majority of the patients (70%) had at least two or more medications used in combination and the most frequent combination was methylprednisolone with azithromycin. Overall in-hospital mortality was 13.65% of patients. Mortality was found to be independently associated with age greater than or equal to 60 years (OR = 4.98; 95%CI: 2.78-8.91), critical illness on admission (OR = 13.75; 95%CI: 7.27-25.99), use of hydrocortisone (OR = 12.56; 95%CI: 6.93-22.7), Ferritin> = 1500(OR = 2.07; 95%CI: 1.18-3.62), Creatinine(OR = 2.33; 95%CI: 1.31-4.14) and D-Dimer> = 1.5 (OR = 2.27; 95%CI: 1.26-4.07). None of the medications whether used as monotherapy or in combination were found to have a mortality benefit. Our study highlights the desperate need for an effective drug for the management of critical COVID-19 which necessitates usage of multiple drug combinations in patients particularly Azithromycin which has long term implications for antibiotic resistance particularly in low-middle income countries.	[Nasir, Noreen; Tajuddin, Salma; Nasir, Nosheen] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Khaskheli, Sarah; Khan, Naveera; Niamatullah, Hammad] Aga Khan Univ, Med Coll, Karachi, Pakistan	Aga Khan University; Aga Khan University	Nasir, N (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.	Nosheen.nasir@aku.edu		, Nosheen/0000-0003-1610-8748; Khan, Naveera/0000-0001-5208-3600				Abate SM, 2021, ANN MED SURG, V64, DOI 10.1016/j.amsu.2021.102204; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Burnett GW, 2021, J ANESTH, V35, P366, DOI 10.1007/s00540-020-02860-1; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Coomes EA, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2141; Coppock D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252591; Edalatifard M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02808-2020; Ejaz H, 2020, J INFECT PUBLIC HEAL, V13, P1833, DOI 10.1016/j.jiph.2020.07.014; Fan XZ, 2021, INT J GEN MED, V14, P267, DOI 10.2147/IJGM.S290118; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Izda V, 2021, CLIN IMMUNOL, V222, DOI 10.1016/j.clim.2020.108634; Lee K, 2009, GLOB INST, P1; Liu JL, 2020, J MED VIROL, V92, P1484, DOI 10.1002/jmv.25965; Maxwell D, 2021, AM J TROP MED HYG, V105, P584, DOI 10.4269/ajtmh.21-0200; Melo AKG, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253894; Nasir N, 2021, ADV RESPIR MED, V89, P254, DOI 10.5603/ARM.a2021.0049; Novelli L, 2021, PANMINERVA MED, V63, P51, DOI 10.23736/S0031-0808.20.04063-X; Patrucco F, 2021, POL ARCH INTERN MED, V131, P854, DOI 10.20452/pamw.16077; Perrone F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02573-9; Jeronimo CMP, 2021, CLIN INFECT DIS, V72, pE373, DOI 10.1093/cid/ciaa1177; Prats-Uribe A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1038; Prescott HC, 2020, JAMA-J AM MED ASSOC, V324, P1292, DOI 10.1001/jama.2020.16747; Rosenthal N, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.29058; Saber-Ayad M, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13050096; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Sharifpour M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242400; Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849; Thorlund K, 2020, LANCET DIGIT HEALTH, V2, pE286, DOI 10.1016/S2589-7500(20)30086-8; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yao YM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00466-z; Yousefi H, 2021, BIOCHEM PHARMACOL, V183, DOI 10.1016/j.bcp.2020.114296	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262608	10.1371/journal.pone.0262608	http://dx.doi.org/10.1371/journal.pone.0262608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085312	gold, Green Published			2022-12-26	WOS:000779379600068
J	Jeon, M; Chauhan, KM; Szeto, GL; Kyoung, M; An, SG				Jeon, Miji; Chauhan, Krishna M.; Szeto, Gregory L.; Kyoung, Minjoung; An, Songon			Subcellular regulation of glucose metabolism through multienzyme glucosome assemblies by EGF-ERK1/2 signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLYSIS; IDENTIFICATION; ACTIVATION; COMPLEXES; KINASE; GROWTH; CELLS; MODEL	A multienzyme metabolic assembly for human glucose metabolism, namely the glucosome, has been previously demonstrated to partition glucose flux between glycolysis and building block biosynthesis in an assembly size-dependent manner. Among three different sizes of glucosome assem-blies, we have shown that large-sized glucosomes are func-tionally associated with the promotion of serine biosynthesis in the presence of epidermal growth factor (EGF). However, due to multifunctional roles of EGF in signaling pathways, it is unclear which EGF-mediated signaling pathways promote these large glucosome assemblies in cancer cells. In this study, we used Luminex multiplexing assays and high-content single-cell imaging to demonstrate that EGF triggers temporal acti-vation of extracellular signal-regulated kinases 1/2 (ERK1/2) in Hs578T cells. Subsequently, we found that treatments with a pharmacological inhibitor of ERK1/2, SCH772984, or short-hairpin RNAs targeting ERK1/2 promote the dissociation of large-sized assemblies to medium-sized assemblies in Hs578T cells. In addition, our Western blot analyses revealed that EGF treatment does not increase the expression levels of enzymes that are involved in both glucose metabolism and serine biosynthesis. The observed spatial transition of glucosome as-semblies between large and medium sizes appears to be mediated by the degree of dynamic partitioning of glucosome enzymes without changing their expression levels. Collectively, our study demonstrates that EGF-ERK1/2 signaling pathways play an important role in the upregulation of large-sized glu-cosomes in cancer cells, thus functionally governing the pro-motion of glycolysis-derived serine biosynthesis.	[Jeon, Miji; Chauhan, Krishna M.; Kyoung, Minjoung; An, Songon] Univ Maryland Baltimore Cty UMBC, Dept Chem & Biochem, Baltimore, MD USA; [Szeto, Gregory L.] Univ Maryland Baltimore Cty UMBC, Dept Chem Biochem & Environm Engn, Baltimore, MD USA; [Szeto, Gregory L.; Kyoung, Minjoung; An, Songon] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Program Oncol, Baltimore, MD USA; [Szeto, Gregory L.] Allen Inst Immunol, Seattle, WA 98109 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	An, SG (corresponding author), Univ Maryland Baltimore Cty UMBC, Dept Chem & Biochem, Baltimore, MD USA.; An, SG (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Program Oncol, Baltimore, MD USA.	san@umbc.edu		Szeto, Gregory/0000-0001-7604-1333; An, Songon/0000-0003-2189-7374	National Institutes of Health [R01GM125981, R03CA219609, R01GM134086, T32GM066706]; UMBC	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMBC	This work is supported by the National Institutes of Health: R01GM125981 (S. A.) , R03CA219609 (S. A.) , R01GM134086 (M. K.) , and T32GM066706 (M. J.) , as well as UMBC: Start-Up (G. L. S.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2019, METHOD ENZYMOL, V628, P1, DOI 10.1016/bs.mie.2019.06.013; Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Jeon M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20348-7; Kohnhorst CL, 2017, J BIOL CHEM, V292, P9191, DOI 10.1074/jbc.M117.783050; Lee JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00906-9; Li K, 2020, CELL RES, V30, P163, DOI 10.1038/s41422-019-0257-1; Li XJ, 2016, MOL CELL, V61, P705, DOI 10.1016/j.molcel.2016.02.009; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Locasale J. W., 2011, PHOSPHOGLYCERATE; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Morris E. J., 2013, CANCER DISCOV; Moschos SJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.92352; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Pacold M. E., 2016, PHGDH; Pegram LM, 2019, P NATL ACAD SCI USA, V116, P15463, DOI 10.1073/pnas.1906824116; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Walker JM, 2009, SPRINGER PROTOC HAND, P11, DOI 10.1007/978-1-59745-198-7_3; Waters KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034515; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Zhang J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13732; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	29	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101675	10.1016/j.jbc.2022.101675	http://dx.doi.org/10.1016/j.jbc.2022.101675			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35122791	gold, Green Published			2022-12-26	WOS:000791230900004
J	Kaur, S; Sang, Y; Aballay, A				Kaur, Supender; Sang, Yu; Aballay, Alejandro			Myotubularin-related protein protects against neuronal degeneration mediated by oxidative stress or infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-ANALYSIS; PHOSPHATASES; FAMILY; NEUROPATHY; MYOPATHY; DISTINCT; DEFECTS	Microbial infections have been linked to the onset and severity of neurodegenerative diseases such as amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's disease, but the underlying mechanisms remain largely unknown. Here, we used a genetic screen for genes involved in protection from infection-associated neurodegeneration and identified the gene mtm-10. We then validated the role of the encoded myotubularin-related protein, MTM-10, in protecting the dendrites of Caenorhabditis elegans from degeneration mediated by oxidative stress or Pseudomonas aeruginosa infection. Further experiments indicated that mtm-10 is expressed in the AWC neurons of C. elegans, where it functions in a cell autonomous manner to protect the dendrite degeneration caused by pathogen infection. We also confirm that the changes observed in the dendrites of the animals were not because of premature death or overall sickness. Finally, our studies indicated that mtm-10 functions in AWC neurons to preserve chemosensation after pathogen infection. These results reveal an essential role for myotubularin-related protein 10 in the protection of dendrite morphology and function against the deleterious effects of oxidative stress or infection.	[Kaur, Supender; Sang, Yu; Aballay, Alejandro] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR USA	Oregon Health & Science University	Aballay, A (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR USA.	aballay@ohsu.edu			National Institute of Health (NIH) [GM070977, AI156900]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health (NIH) grants GM070977 and AI156900 to A. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arendt T, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0187-1; Asti A, 2014, J ALZHEIMERS DIS, V39, P169, DOI 10.3233/JAD-131394; Baloyannis SJ, 2009, J NEUROL SCI, V283, P153, DOI 10.1016/j.jns.2009.02.370; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Baskoylu SN, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007682; Beilina A, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13266; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Caldwell KA, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.046110; Caldwell KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007227; Cao X, 2017, CELL REP, V21, P1442, DOI 10.1016/j.celrep.2017.10.050; Chen L, 2011, NEURON, V70, P51, DOI 10.1016/j.neuron.2011.02.039; Cook SJ, 2019, NATURE, V571, P63, DOI 10.1038/s41586-019-1352-7; Dehhaghi M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00466; DeVault L, 2018, GENE DEV, V32, P402, DOI 10.1101/gad.308270.117; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Kaur S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107662; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee SB, 2011, P NATL ACAD SCI USA, V108, P16795, DOI 10.1073/pnas.1113573108; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Lezi E, 2018, NEURON, V97, P125, DOI 10.1016/j.neuron.2017.12.001; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Pan CL, 2011, P NATL ACAD SCI USA, V108, P9274, DOI 10.1073/pnas.1011711108; Pareyson D, 2019, ANN NEUROL, V86, P55, DOI 10.1002/ana.25500; Rasakham K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102524; Robinson FL, 2008, P NATL ACAD SCI USA, V105, P4916, DOI 10.1073/pnas.0800742105; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scherer SS, 2006, ARCH NEUROL-CHICAGO, V63, P812, DOI 10.1001/archneur.63.6.812; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Swinehart BD, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00707-0; Tao JA, 2011, J NEUROSCI, V31, P5398, DOI 10.1523/JNEUROSCI.3826-10.2011; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Wang CY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106504118; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wu QL, 2015, J BIOL CHEM, V290, P29231, DOI 10.1074/jbc.M115.674259; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200	47	0	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101614	10.1016/j.jbc.2022.101614	http://dx.doi.org/10.1016/j.jbc.2022.101614			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35101447	gold, Green Published			2022-12-26	WOS:000789396300012
J	Riccaboni, M; Verginer, L				Riccaboni, Massimo; Verginer, Luca			The impact of the COVID-19 pandemic on scientific research in the life sciences	PLOS ONE			English	Article							CHALLENGES	The COVID-19 outbreak has posed an unprecedented challenge to humanity and science. On the one side, public and private incentives have been put in place to promptly allocate resources toward research areas strictly related to the COVID-19 emergency. However, research in many fields not directly related to the pandemic has been displaced. In this paper, we assess the impact of COVID-19 on world scientific production in the life sciences and find indications that the usage of medical subject headings (MeSH) has changed following the outbreak. We estimate through a difference-in-differences approach the impact of the start of the COVID-19 pandemic on scientific production using the PubMed database (3.6 Million research papers). We find that COVID-19-related MeSH terms have experienced a 6.5 fold increase in output on average, while publications on unrelated MeSH terms dropped by 10 to 12%. The publication weighted impact has an even more pronounced negative effect (-16% to -19%). Moreover, COVID-19 has displaced clinical trial publications (-24%) and diverted grants from research areas not closely related to COVID-19. Note that since COVID-19 publications may have been fast-tracked, the sudden surge in COVID-19 publications might be driven by editorial policy.	[Riccaboni, Massimo] IMT Sch Adv Studies Lucca, AXES, Lucca, Italy; [Verginer, Luca] Swiss Fed Inst Technol, Chair Syst Design D MTEC, Zurich, Switzerland	IMT School for Advanced Studies Lucca; Swiss Federal Institutes of Technology Domain; ETH Zurich	Verginer, L (corresponding author), Swiss Fed Inst Technol, Chair Syst Design D MTEC, Zurich, Switzerland.	lverginer@ethz.ch		Verginer, Luca/0000-0002-2952-6634				Brown A., 2020, EVALUATE PHARM 2021; Callaway E, 2020, NATURE, V588, P550, DOI 10.1038/d41586-020-03437-4; de Miguel M, 2020, CANCER-AM CANCER SOC, V126, P3907, DOI 10.1002/cncr.32980; Di Girolamo N, 2020, SCIENTOMETRICS, V125, P795, DOI 10.1007/s11192-020-03632-0; Fraser N., 2020, PREPRINTING COVID 19, V1, DOI [10.1101/2020.05.22.111294, DOI 10.1101/2020.05.22.111294]; Gabster BP, 2020, LANCET, V395, P1968, DOI 10.1016/S0140-6736(20)31412-4; Inno L, 2020, NAT ASTRON, V4, P1114, DOI 10.1038/s41550-020-01258-z; Janiaud P, 2021, COVID EVIDENCE LIVIN; Janiaud P, 2021, CAN J CARDIOL, V37, P1353, DOI 10.1016/j.cjca.2021.05.009; Lemus Kevin Bryan Jorge, 2020, INNOVATION CRISIS EV, DOI [10.2139/ssrn.3587973, DOI 10.2139/SSRN.3587973]; Padala PR, 2020, J AM GERIATR SOC, V68, pE14, DOI 10.1111/jgs.16500; PAGE L., 1998, 199966 STANF INFOLAB, P161; Peixoto T. P., 2014, FIGSHARE, DOI 10.6084/m9.figshare.1164194; Porter Simon, 2020, COVID 19 IS CHANGING; Ruiz-Real JL, 2020, HEALTH EDUC BEHAV, V47, P861, DOI 10.1177/1090198120958368; Seitz BM, 2020, P NATL ACAD SCI USA, V117, P27767, DOI 10.1073/pnas.2009787117; Shan J, 2020, CUREUS, V12, DOI 10.7759/cureus.11403; Viglione G, 2020, NATURE, V581, P365, DOI 10.1038/d41586-020-01294-9; Xue JZ, 2020, NAT REV DRUG DISCOV, V19, P662, DOI 10.1038/d41573-020-00150-9; Younes GA, 2020, SCI PUBL POLICY, V47, P733, DOI 10.1093/scipol/scaa028	20	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263001	10.1371/journal.pone.0263001	http://dx.doi.org/10.1371/journal.pone.0263001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139089	gold, Green Submitted, Green Published			2022-12-26	WOS:000821499100021
J	Kaur, H; Mukhopadhyay, L; Gupta, N; Aggarwal, N; Sangal, L; Potdar, V; Inbanathan, FY; Narayan, J; Gupta, S; Rana, S; Vijay, N; Singh, H; Kaur, J; Kumar, V; Kaundal, N; Abraham, P; Ravi, V				Kaur, Harmanmeet; Mukhopadhyay, Labanya; Gupta, Nivedita; Aggarwal, Neeraj; Sangal, Lucky; Potdar, Varsha; Inbanathan, Francis Yesuraj; Narayan, Jitendra; Gupta, Swati; Rana, Salaj; Vijay, Neetu; Singh, Harpreet; Kaur, Jasmine; Kumar, Vinit; Kaundal, Nirmal; Abraham, Priya; Ravi, Vasanthapuram			External quality assessment of COVID-19 real time reverse transcription PCR laboratories in India	PLOS ONE			English	Article								Sudden emergence and rapid spread of COVID-19 created an inevitable need for expansion of the COVID-19 laboratory testing network across the world. The strategy to test-track-treat was advocated for quick detection and containment of the disease. Being the second most populous country in the world, India was challenged to make COVID-19 testing available and accessible in all parts of the country. The molecular laboratory testing network was augmented expeditiously, and number of laboratories was increased from one in January 2020 to 2951 till mid-September, 2021. This rapid expansion warranted the need to have inbuilt systems of quality control/ quality assurance. In addition to the ongoing inter-laboratory quality control (ILQC), India implemented an External Quality Assurance Program (EQAP) with assistance from World Health Organization (WHO) and Royal College of Pathologists, Australasia. Out of the 953 open system rRTPCR laboratories in both public and private sector who participated in the first round of EQAP, 891(93.4%) laboratories obtained a passing score of > = 80%. The satisfactory performance of Indian COVID-19 testing laboratories has boosted the confidence of the public and policy makers in the quality of testing. ILQC and EQAP need to continue to ensure adherence of the testing laboratories to the desired quality standards.	[Kaur, Harmanmeet; Mukhopadhyay, Labanya; Gupta, Nivedita; Aggarwal, Neeraj; Narayan, Jitendra; Gupta, Swati; Rana, Salaj; Vijay, Neetu] Indian Council Med Res, Virol Unit, MoHFW, DHR, Delhi, India; [Sangal, Lucky; Inbanathan, Francis Yesuraj] WHO South East Asia Reg Off, Delhi, India; [Potdar, Varsha; Abraham, Priya] Indian Council Med Res, Natl Inst Virol, Pune, Maharashtra, India; [Singh, Harpreet; Kaur, Jasmine; Kumar, Vinit] Indian Council Med Res, Div Biomed Informat, Delhi, India; [Kaundal, Nirmal] WHO Country Off India, Delhi, India; [Ravi, Vasanthapuram] Natl Inst Mental Hlth & Neurosci, Bengaluru, Karnataka, India	Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Indian Council of Medical Research (ICMR); National Institute of Mental Health & Neurosciences - India	Gupta, N (corresponding author), Indian Council Med Res, Virol Unit, MoHFW, DHR, Delhi, India.	guptanivedita.hq@icmr.gov.in	Kumar, Vinit/GQP-7755-2022	Narayan, Jitendra/0000-0002-3797-9086; MUKHOPADHYAY, LABANYA/0000-0002-0721-0161				Andrews MA, 2020, INDIAN J MED RES, V151, P490, DOI 10.4103/ijmr.IJMR_2131_20; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Gupta N, 2020, INDIAN J MED RES, V151, P216, DOI 10.4103/ijmr.IJMR_594_20; ICMR, 2020, LIST MENT I AL ALL S; Indian Council of Medical Research, 2020, ICMR PORT TEST LAB Q; Indian Council of Medical Research, 2021, TOT OP IN IND TEST L; World Health Organization, OV QUAL SYST MOD; World Health Organization (WHO), LAB TEST 2019 NOV CO	8	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263736	10.1371/journal.pone.0263736	http://dx.doi.org/10.1371/journal.pone.0263736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134089	gold, Green Published			2022-12-26	WOS:000798968600031
J	Soobhug, AD; Jowaheer, H; Khan, NM; Reetoo, N; Meethoo-Badulla, K; Musango, L; Kokonendji, CC; Chutoo, A; Aries, N				Soobhug, Ashwinee Devi; Jowaheer, Homeswaree; Khan, Naushad Mamode; Reetoo, Neeshti; Meethoo-Badulla, Kursheed; Musango, Laurent; Kokonendji, Celestin C.; Chutoo, Azmi; Aries, Nawel			Re-analyzing the SARS-CoV-2 series using an extended integer-valued time series models: A situational assessment of the COVID-19 in Mauritius	PLOS ONE			English	Article							ZERO-INFLATED POISSON; GEOMETRIC INAR(1) PROCESS; PREDICTORS; REGRESSION; FREQUENCY; DEFLATION	This paper proposes some high-ordered integer-valued auto-regressive time series process of order p (INAR(p)) with Zero-Inflated and Poisson-mixtures innovation distributions, wherein the predictor functions in these mentioned distributions allow for covariate specification, in particular, time-dependent covariates. The proposed time series structures are tested suitable to model the SARs-CoV-2 series in Mauritius which demonstrates excess zeros and hence significant over-dispersion with non-stationary trend. In addition, the I NAR models allow the assessment of possible causes of COVID-19 in Mauritius. The results illustrate that the event of Vaccination and COVID-19 Stringency index are the most influential factors that can reduce the locally acquired COVID-19 cases and ultimately, the associated death cases. Moreover, the INAR(7) with Zero-inflated Negative Binomial innovations provides the best fitting and reliable Root Mean Square Errors, based on some short term forecasts. Undeniably, these information will hugely be useful to Mauritian authorities for implementation of comprehensive policies.	[Soobhug, Ashwinee Devi; Jowaheer, Homeswaree] Minist Finance Econ Planning & Dev, Stat Mauritius, Port Louis, Mauritius; [Khan, Naushad Mamode; Chutoo, Azmi] Univ Mauritius, Dept Econ & Stat, Moka, Mauritius; [Reetoo, Neeshti] Minist Educ Tertiary Educ Sci & Technol, Dept Hlth & Wellness, Vacoas Phoenix, Mauritius; [Meethoo-Badulla, Kursheed] Minist Hlth & Wellness, Communicable Dis Control Unit, Port Louis, Mauritius; [Musango, Laurent] World Hlth Org Country Representat Mauritius, Port Louis, Mauritius; [Kokonendji, Celestin C.] Univ Bourgogne Franche Comte, Lab Mathernat Besancon, UMR 6623, CNRS,UBFC, Besancon, France; [Kokonendji, Celestin C.] Univ Bangui, Dept Math, Bangui, Cent Afr Republ; [Aries, Nawel] Univ Sci & Technol Houari Boumediene, Fac Math, Algiers, Bab Ezzouar, Algeria	University of Mauritius; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Franche-Comte; University Science & Technology Houari Boumediene	Soobhug, AD (corresponding author), Minist Finance Econ Planning & Dev, Stat Mauritius, Port Louis, Mauritius.	soobhugn@gmail.com		Soobhug, Ashwinee Devi/0000-0002-3960-8924				Shah ASV, 2021, medRxiv, DOI 10.1101/2021.03.11.21253275; Abid R, 2021, ASTA-ADV STAT ANAL, V105, P1, DOI 10.1007/s10182-020-00375-4; Al-Osh M. A., 1987, J TIME SER ANAL, V8, P261, DOI DOI 10.1111/J.1467-9892.1987.TB00438.X; Bakouch HS, 2018, APPL MATH-CZECH, V63, P79, DOI 10.21136/AM.2018.0082-17; Barreto-Souza W, 2015, J TIME SER ANAL, V36, P839, DOI 10.1111/jtsa.12131; BBC, 2021, BBC NEWS 1221; Billah MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242128; Bonat WH, 2018, STAT MODEL, V18, P24, DOI 10.1177/1471082X17715718; Bourguignon M, 2019, J APPL STAT, V46, P101, DOI 10.1080/02664763.2018.1458216; Bourguignon M, 2018, STAT INTERFACE, V11, P631, DOI 10.4310/SII.2018.v11.n4.a7; Bu R, 2008, J TIME SER ANAL, V29, P973, DOI 10.1111/j.1467-9892.2008.00590.x; Bu RJ, 2008, INT J FORECASTING, V24, P151, DOI 10.1016/j.ijforecast.2007.11.002; Bukhari Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155399; Centers for Disease Control and Prevention, 2021, CDC REAL WORLD STUD; Chang HS, 2002, J FAM VIOLENCE, V17, P273, DOI 10.1023/A:1016057328929; Chesneau C, 2021, J APPL STAT, V48, P124, DOI 10.1080/02664763.2019.1711364; Cho H, 2019, BZINB BIVARIATE ZERO; Chudik A., 2021, MEDRXIV; Conceicao KS, 2017, J STAT COMPUT SIM, V87, P1842, DOI 10.1080/00949655.2017.1289529; Cranford JA, 2010, PSYCHOL ADDICT BEHAV, V24, P386, DOI 10.1037/a0019801; DAVIES RB, 1973, BIOMETRIKA, V60, P415, DOI 10.2307/2334555; Dobricic S, 2020, SCI POLICY REPORT JO; Du J. G., 1991, J TIME SER ANAL, V12, P129, DOI [DOI 10.1111/J.1467-9892.1991.TB00073.X, DOI 10.1111/j.1467-9892.1991.tb00073.x, 10.1111/j.1467-9892.1991.tb00073.x]; Dyer O, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1000; El-Shaarawi AH, 2011, ENVIRONMETRICS, V22, P152, DOI 10.1002/env.1036; Gaunt RE, 2019, ANN I STAT MATH, V71, P163, DOI 10.1007/s10463-017-0629-6; Gauthier G., 1994, ANN SCI MATH QUEBEC, V18, P46; Goncalves E, 2016, STATISTICS-ABINGDON, V50, P558, DOI 10.1080/02331888.2015.1114622; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1068; Javali Shivalingappa B, 2010, Indian J Dent Res, V21, P480, DOI 10.4103/0970-9290.74210; Jazi MA, 2012, J TIME SER ANAL, V33, P954, DOI 10.1111/j.1467-9892.2012.00809.x; Jeewa T., 2021, OPINIOJURIS, P144; Jochmann M., 2017, ZIC BAYESIAN INFEREN; Joe H, 2019, ECONOMETRICS, V7, DOI 10.3390/econometrics7040043; Juno J., 2021, CONVERSATION; Khan NM, 2021, ALEX ENG J, V60, P2535, DOI 10.1016/j.aej.2020.12.047; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Latour A, 1997, ADV APPL PROBAB, V29, P228, DOI 10.2307/1427868; Latour A, 1998, J TIME SER ANAL, V19, P439, DOI [10.1111/1467-9892.00102, DOI 10.1111/1467-9892.00102]; Linka K, 2020, COMPUT MECH, V66, P1035, DOI [10.1007/s00466-020-01880-8, 10.1101/2020.05.01.20088047]; Liu P., 2020, MEDRXIV; Lorenz J, COVID 19 VACCINES RE, P2021; Mackesy-Amiti ME, 2011, ADDICTION, V106, P601, DOI 10.1111/j.1360-0443.2010.03251.x; Mamode Khan N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235730; McCord ES, 2007, AUST NZ J CRIMINOL, V40, P43, DOI 10.1375/acri.40.1.43; MCKENZIE E, 1986, ADV APPL PROBAB, V18, P679, DOI 10.2307/1427183; MCKENZIE E, 1988, ADV APPL PROBAB, V20, P822, DOI 10.2307/1427362; Moller TA, 2020, STAT MODEL, V20, P127, DOI 10.1177/1471082X18800514; Moller TA, 2018, METHODOL COMPUT APPL, V20, P589, DOI 10.1007/s11009-017-9577-0; Murphy J., 2021, PHARM TIMES; Musango L, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005372; Perumean-Chaney SE, 2013, J STAT COMPUT SIM, V83, P1671, DOI 10.1080/00949655.2012.668550; Petted RR, 2019, INT J BIOSTAT, V15, DOI 10.1515/ijb-2018-0119; Ristic MM, 2009, J STAT PLAN INFER, V139, P2218, DOI 10.1016/j.jspi.2008.10.007; Ritchie H, 2021, OUR WORLD DATA COVID; Scotto MG, 2015, STAT MODEL, V15, P590, DOI 10.1177/1471082X15584701; Sellers KF, 2016, J MULTIVARIATE ANAL, V150, P152, DOI 10.1016/j.jmva.2016.04.007; STEUTEL FW, 1979, ANN PROBAB, V7, P893, DOI 10.1214/aop/1176994950; Tyagi R., 2020, RES SQUARE, V1, DOI [10.21203/rs.3.rs-45937/v1, DOI 10.21203/RS.3.RS-45937/V1]; Wang L, 2020, COMMUN INF SYST, V20, P23; Wei&beta; CH., 2018, INTRO DISCRETE VALUE, P304; Yang M, 2018, ZIM ZERO INFLATED MO; Yip KCH, 2005, INSUR MATH ECON, V36, P153, DOI 10.1016/j.insmatheco.2004.11.002; Zhang H., 2020, TRANSMISSIBILITY COV, DOI [10.21203/rs.3.rs-17715/v1, DOI 10.21203/RS.3.RS-17715/V1]; Zhu FK, 2012, J STAT PLAN INFER, V142, P826, DOI 10.1016/j.jspi.2011.10.002; Zuur Alain F., 2009, P1	67	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263515	10.1371/journal.pone.0263515	http://dx.doi.org/10.1371/journal.pone.0263515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134059	gold, Green Published			2022-12-26	WOS:000798968600016
J	Uzma, M; Iqbal, A; Hasnain, S				Uzma, Malika; Iqbal, Atia; Hasnain, Shahida			Drought tolerance induction and growth promotion by indole acetic acid producing Pseudomonas aeruginosa in Vigna radiata	PLOS ONE			English	Article							ACC-DEAMINASE; WATER-STRESS; SALT-STRESS; PUTIDA UW4; L.; RHIZOBACTERIA; IMPROVE; PLANTS; IDENTIFICATION; ACCUMULATION	Drought accompanied with reduced precipitation is one of the key manacles to global agricultural throughput and is expected to escalate further hence posing major challenges to future food safety. For a sustainable agricultural environment, drought resistant plant growth promoting rhizobacteria (PGPR) are new encouraging prospect, which are inexpensive and have no side effects, as those of synthetic fertilizers. In the present study, five strains of Pseudomonas aeruginosa, the strain MK513745, strain MK513746, strain MK513747, strain MK513748, and strain MK513749 were used as drought tolerant PGPR with multiple traits of IAA production, N fixation, P solubilization, siderophore producing capabilities. The strain MK513745 and strain MK513749 produced higher quantities of indole acetic acid (116 +/- 0.13 and 108 +/- 0.26 mu g ml(-1)). MK513749 yielded 12 different indole compounds in GCMS analysis. The strain MK513748 yielded maximum S.I. (3.33mm) for phosphate solubilizing test. Maximum nitrogen concentration was produced (0.18 mu g ml(-1)) by strain MK513746. Percent siderophore units ranged from 2.65% to 2.83% as all five pseudomonas strains were siderophore positive. In all growth experiments of plant microbe interaction two varieties of Vigna radiata (AZRI-06, NM-11) plants inoculated with P. aeruginosa strains under drought stress responded significantly (P<0.05) better than control stressed plants. Maximum shoot length was enhanced up-to 125%, pod/plant 172%, number of grains 65%, 100 seed weight 95%, 100 seed straw weight 124% and total yield 293% were recorded in plants inoculated with drought stress tolerant PGPR in both varieties as compared to respective stressed control plants. Photosynthetic activity, membrane stability (45%), water content (68%) and antioxidant efficacy (19%) were improved with PGPR inoculations. The variety NM-11 (V2) was more tolerant to drought stress with inoculations of Pseudomonas strains than AZRI-06 (V1). Inoculations with these indole acetic acid producing strains would be suitable for plant growth promotion in areas facing water deficiency.	[Uzma, Malika; Iqbal, Atia] Women Univ, Dept Microbiol & Mol Genet, Multan, Pakistan; [Hasnain, Shahida] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan	University of Punjab	Uzma, M (corresponding author), Women Univ, Dept Microbiol & Mol Genet, Multan, Pakistan.	malikauzma@gmail.com						Ahmad M, 2013, BRAZ J MICROBIOL, V44, P1341, DOI 10.1590/S1517-83822013000400045; Ahmad M, 2013, PLANT PHYSIOL BIOCH, V63, P170, DOI 10.1016/j.plaphy.2012.11.024; Ahmad M, 2012, ANN MICROBIOL, V62, P1321, DOI 10.1007/s13213-011-0380-9; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Ali S., 2017, FUNCTIONAL IMPORTANC, p89?105; Altaf MM, 2021, SOIL NITROGEN ECOLOG, V62, P327; Alzarqaa A., 2014, SUSTAINABLE IRRIGATI, V185, P89; Anguiano-Cabello J. C., 2017, American Journal of Plant Sciences, V8, P171, DOI 10.4236/ajps.2017.82013; [Anonymous], 2018, WORLD FACTS WORLD FA; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Arshad M, 2008, PEDOSPHERE, V18, P611, DOI 10.1016/S1002-0160(08)60055-7; Barnawal D, 2012, PLANT PHYSIOL BIOCH, V58, P227, DOI 10.1016/j.plaphy.2012.07.008; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Berg G., 2013, NEXT GENERATION BIOP; Bergey D.H., 1994, BERGEYS MANUAL DETER; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Bot A.J., 2000, WORLD SOIL RESOUR RE, V90; BUSSE MD, 1989, APPL ENVIRON MICROB, V55, P2431, DOI 10.1128/AEM.55.10.2431-2436.1989; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chandra D, 2018, PEDOSPHERE, V28, P227, DOI 10.1016/S1002-0160(18)60013-X; Chandra P, 2021, PEDOSPHERE, V31, P496, DOI 10.1016/S1002-0160(20)60092-3; Chauhan YS., 2010, PHYSL MUNGBEAN DEV M; Chen CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41564; Cheng ZY, 2007, CAN J MICROBIOL, V53, P912, DOI 10.1139/W07-050; Danish S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42374-9; Defez R, 2017, MICROB ECOL, V74, P441, DOI 10.1007/s00248-017-0948-4; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; FAO, 2007, PAK FAO EM; FLOWER DJ, 1986, PLANT CELL ENVIRON, V9, P33, DOI 10.1111/j.1365-3040.1986.tb01720.x; Gamalero E, 2010, J APPL MICROBIOL, V108, P236, DOI 10.1111/j.1365-2672.2009.04414.x; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Govind Gupta, 2015, Journal of Microbial and Biochemical Technology, V7, P96; Gusain Y. S., 2015, African Journal of Biotechnology, V14, P764; Hasanuzzaman M, 2012, CROP STRESS AND ITS MANAGEMENT: PERSPECTIVES AND STRATEGIES, P261, DOI 10.1007/978-94-007-2220-0_8; Hosseini A., 2014, IJABE, V8; Huang HL, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00800; Hussain MB, 2014, INT J AGRIC BIOL, V16, P3; Ihsan MZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00795; Imran A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00859; Islam F, 2016, PLANT GROWTH REGUL, V80, P23, DOI 10.1007/s10725-015-0142-y; Jalili F, 2009, J PLANT PHYSIOL, V166, P667, DOI 10.1016/j.jplph.2008.08.004; Jenks M.A, 2007, ADV MOL BREEDING DRO; Jha C.K., 2015, E3 J AGR RES DEV, V5, P108, DOI DOI 10.13140/RG.2.1.5171.2164; Kang SM, 2014, J PLANT INTERACT, V9, P673, DOI 10.1080/17429145.2014.894587; Kasim WA, 2013, J PLANT GROWTH REGUL, V32, P122, DOI 10.1007/s00344-012-9283-7; Khan N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38702-8; Liu P, 2015, ENVIRON EXP BOT, V111, P42, DOI 10.1016/j.envexpbot.2014.10.006; Mahmood S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00876; Maliha Rashid, 2004, Pakistan Journal of Biological Sciences, V7, P187, DOI 10.3923/pjbs.2004.187.196; Marulanda A, 2010, PLANTA, V232, P533, DOI 10.1007/s00425-010-1196-8; Matsuo M, 2015, MOL PLANT, V8, P1253, DOI 10.1016/j.molp.2015.03.011; Mhamdi A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164376; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Mohanty P, 2021, FRONT SUSTAIN FOOD S, V5, DOI 10.3389/fsufs.2021.667150; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nadeem SM, 2010, SOIL SCI SOC AM J, V74, P533, DOI 10.2136/sssaj2008.0240; Nair RR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01842; Nawaz H, 2021, J INTEGR AGR, V20, P87, DOI 10.1016/S2095-3119(20)63184-7; Ngumbi E, 2016, APPL SOIL ECOL, V105, P109, DOI 10.1016/j.apsoil.2016.04.009; Nitika Rana, 2020, GLOBAL PERSPECTIVES, P1; Niu XG, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02580; Pan FS, 2017, ENVIRON SCI POLLUT R, V24, P9350, DOI 10.1007/s11356-017-8565-9; Pataczek L., 2018, American Journal of Plant Sciences, V9, P1577, DOI 10.4236/ajps.2018.97115; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Pramer D., 1956, EXPT SOIL MICROBIOLO, V107; Pratap A., 2019, DEV CLIMATE SMART MU, DOI [10.1007/978-3-319-96932-9_5, DOI 10.1007/978-3-319-96932-9_5]; Raza A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22084281; Rolli E, 2015, ENVIRON MICROBIOL, V17, P316, DOI 10.1111/1462-2920.12439; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salehi M., 2017, ASIAN J BIOL SCI, V434, P80, DOI DOI 10.3923/ajbs.2017.80.89; Salem A. H., 2013, Acta Agronomica Hungarica, V61, P55, DOI 10.1556/AAgr.61.2013.1.6; Sarwar M., 2014, WORLD J AGR SCI, V2, P040; Shahzad SM, 2013, EUR J SOIL BIOL, V57, P27, DOI 10.1016/j.ejsobi.2013.04.002; Siddikee MA, 2011, PLANT PHYSIOL BIOCH, V49, P427, DOI 10.1016/j.plaphy.2011.01.015; Song J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247309; Suleman M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204408; Sun ZK, 2017, PLANT SOIL, V419, P1, DOI 10.1007/s11104-017-3218-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8030442; TIEN TM, 1979, APPL ENVIRON MICROB, V37, P1016, DOI 10.1128/AEM.37.5.1016-1024.1979; Uddin S, 2021, J AGR FOOD RES, V4, DOI 10.1016/j.jafr.2021.100140; Vejan P, 2016, MOLECULES, V21, DOI 10.3390/molecules21050573; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; World health organization, 2018, 469 SIT REP; Yang X., 2021, HORTICULTURAE, V7, P1; Zahir ZA, 2011, BIOL FERT SOILS, V47, P457, DOI 10.1007/s00374-011-0551-7; Zhang PF, 2019, MOLECULES, V24, DOI 10.3390/molecules24071411	90	5	5	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262932	10.1371/journal.pone.0262932	http://dx.doi.org/10.1371/journal.pone.0262932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120147	Green Published, gold			2022-12-26	WOS:000789273600016
J	Eggmann, S; Irincheeva, I; Luder, G; Verra, ML; Moser, A; Bastiaenen, CHG; Jakob, SM				Eggmann, Sabrina; Irincheeva, Irina; Luder, Gere; Verra, Martin L.; Moser, Andre; Bastiaenen, Caroline H. G.; Jakob, Stephan M.			Cardiorespiratory response to early rehabilitation in critically ill adults: A secondary analysis of a randomised controlled trial	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; VENTILATED PATIENTS; EARLY MOBILIZATION; PHYSICAL-ACTIVITY; THERAPY; PATIENT; ICU; FEASIBILITY; EXERCISE	Introduction Early rehabilitation is indicated in critically ill adults to counter functional complications. However, the physiological response to rehabilitation is poorly understood. This study aimed to determine the cardiorespiratory response to rehabilitation and to investigate the effect of explanatory variables on physiological changes during rehabilitation and recovery. Methods In a prospectively planned, secondary analysis of a randomised controlled trial conducted in a tertiary, mixed intensive care unit (ICU), we analysed the 716 physiotherapy-led, pragmatic rehabilitation sessions (including exercise, cycling and mobilisation). Participants were previously functionally independent, mechanically ventilated, critically ill adults (n = 108). Physiological data (2-minute medians) were collected with standard ICU monitoring and indirect calorimetry, and their medians calculated for baseline (30min before), training (during physiotherapy) and recovery (15min after). We visualised physiological trajectories and investigated explanatory variables on their estimated effect with mixed-effects models. Results This study found a large range of variation within and across participants' sessions with clinically relevant variations (>10%) occurring in more than 1 out of 4 sessions in mean arterial pressure, minute ventilation (MV) and oxygen consumption (VO2), although early rehabilitation did not generally affect physiological values from baseline to training or recovery. Active patient participation increased MV (mean difference 0.71/min [0.4-1.0, p<0.001]) and VO2 (23ml/min [95%CI: 13-34, p<0.001]) during training when compared to passive participation. Similarly, session type 'mobilisation' increased heart rate (6.6bpm [2.1-11.2, p = 0.006]) during recovery when compared to 'exercise'. Other modifiable explanatory variables included session duration, mobilisation level and daily medication, while non-modifiable variables were age, gender, body mass index and the daily Sequential Organ Failure Assessment. Conclusions A large range of variation during rehabilitation and recovery mirrors the heterogenous interventions and patient reactions. This warrants close monitoring and individual tailoring, whereby the best option to stimulate a cardiorespiratory response seems to be active patient participation, shorter session durations and mobilisation.	[Eggmann, Sabrina; Luder, Gere; Verra, Martin L.] Bern Univ Hosp, Dept Physiotherapy, Inselspital, Bern, Switzerland; [Eggmann, Sabrina; Bastiaenen, Caroline H. G.] Maastricht Univ, Dept Epidemiol, Res Line Functioning Participat & Rehabil CAPHRI, Maastricht, Netherlands; [Irincheeva, Irina; Moser, Andre] Univ Bern, CTU Bern, Bern, Switzerland; [Jakob, Stephan M.] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; Maastricht University; University of Bern; University of Bern; University Hospital of Bern	Eggmann, S (corresponding author), Bern Univ Hosp, Dept Physiotherapy, Inselspital, Bern, Switzerland.; Eggmann, S (corresponding author), Maastricht Univ, Dept Epidemiol, Res Line Functioning Participat & Rehabil CAPHRI, Maastricht, Netherlands.	sabrina.eggmann@insel.ch	Eggmann, Sabrina/J-2951-2019	Eggmann, Sabrina/0000-0002-7379-7343; Luder, Gere/0000-0003-4742-4225; Moser, Andre/0000-0001-7178-6539	Swiss Foundation for Physiotherapy Science	Swiss Foundation for Physiotherapy Science	This research has been funded from the PhD Grant 2018 given by the Swiss Foundation for Physiotherapy Science (http://www.physiotherapiewissenschaften.ch/) and received by SE. The foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt J, 2016, NEUROLOGY, V86, P2138, DOI 10.1212/WNL.0000000000002459; Bienvenu OJ, 2018, INTENS CARE MED, V44, P38, DOI 10.1007/s00134-017-5009-4; Black C, 2020, PHYSIOTHERAPY, V107, P169, DOI 10.1016/j.physio.2019.06.008; Bourdin G, 2010, RESP CARE, V55, P400; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chen J, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.569679; Collings N, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/1471-2253-15-1; Denehy L, 2017, INTENS CARE MED, V43, P86, DOI 10.1007/s00134-016-4513-2; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Dubb R, 2016, ANN AM THORAC SOC, V13, P724, DOI 10.1513/AnnalsATS.201509-586CME; Eggmann S., 2015, PHYSIOTHERAPY, V101, pe344, DOI [10.1016/j.physio.2015.03.553, DOI 10.1016/J.PHYSIO.2015.03.553]; Eggmann S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229725; Eggmann S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207428; Eggmann S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1533-8; Genc A, 2014, CRIT CARE NURS Q, V37, P152, DOI 10.1097/CNQ.0000000000000013; Gustafson OD, 2018, CRIT CARE MED, V46, P1769, DOI 10.1097/CCM.0000000000003347; Hickmann CE, 2018, CRIT CARE MED, V46, P1436, DOI 10.1097/CCM.0000000000003263; Hodgson C, 2014, HEART LUNG, V43, P19, DOI 10.1016/j.hrtlng.2013.11.003; MAKIVIRTA A, 1991, COMPUT METH PROG BIO, V34, P139, DOI 10.1016/0169-2607(91)90039-V; Medrinal C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2030-0; Nydahl P, 2020, CLIN NUTR, V39, P2442, DOI 10.1016/j.clnu.2019.10.028; Nydahl P, 2017, ANN AM THORAC SOC, V14, P766, DOI 10.1513/AnnalsATS.201611-843SR; Nydahl P, 2016, NURS CRIT CARE, V21, P323, DOI 10.1111/nicc.12134; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pires-Neto RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074182; Rebel A, 2019, AUST CRIT CARE, V32, P139, DOI 10.1016/j.aucc.2018.03.004; Reid JC, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0349-x; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Stiller Kathy, 2004, Physiotherapy Theory and Practice, V20, P175, DOI 10.1080/09593980490487474; Supinski GS, 2020, CRIT CARE MED, V48, P1595, DOI 10.1097/CCM.0000000000004544; Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0; Umei N, 2016, INTENS CRIT CARE NUR, V35, P16, DOI 10.1016/j.iccn.2016.02.001; van Willigen Z, 2020, PHYSIOTHERAPY, V109, P102, DOI 10.1016/j.physio.2020.01.003; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Wintermann GB, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0295-7; World Health Organization, REHABILITATION; Zafiropoulos B, 2004, AUST J PHYSIOTHER, V50, P95, DOI 10.1016/S0004-9514(14)60101-X	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262779	10.1371/journal.pone.0262779	http://dx.doi.org/10.1371/journal.pone.0262779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113899	gold, Green Published			2022-12-26	WOS:000823694700035
J	Lewis, G; Towlson, C; Roversi, P; Domogalla, C; Herrington, L; Barrett, S				Lewis, Glyn; Towlson, Christopher; Roversi, Pietro; Domogalla, Chris; Herrington, Lee; Barrett, Steve			Quantifying volume and high-speed technical actions of professional soccer players using foot-mounted inertial measurement units	PLOS ONE			English	Article							TRAINING-LOAD; PERFORMANCE; QUANTIFICATION; KICKING; STRAIN; INJURY	Aims The aims of the study were two-fold: i) examine the validity and reliability of high-speed kicking actions using foot-mounted inertial measurement unit's (IMU), ii) quantify soccer players within-microcycle and inter-positional differences in both the frequency and speed of technical actions. Methods During the in-season phase (25 weeks) of the UK domestic season, 21 professional soccer player ball releases, high-speed ball releases and ball release index were analysed. Pearson product-moment correlation coefficient and confidence intervals were used to determine the validity between the systems, whilst a general linear mixed model analysis approach was used to establish estimated marginal mean values for total ball releases, high-speed ball releases and ball release index. Results Good concurrent validity was observed for ball release velocity and high-speed kicks against a high-speed camera (r(2) = 0.96, CI 0.93-0.98). Ball releases, high-speed ball releases and ball release index all showed main effects for fixture proximity (p>0.001), playing positions (p>0.001) and across different training categories (p>0.001). The greatest high-speed ball releases were observed on a match-day (MD)+1 (17.6 +/- 11.9; CI- 16.2 to 19) and MD-2 (16.8 +/- 15; CI- 14.9 to 18.7), with MD+1 exhibiting the highest number of ball releases (161.1 +/- 51.2; CI- 155.0 to 167.2) and ball release index (145.5 +/- 45.2; CI- 140.1 to 150.9) across all fixture proximities. Possessions (0.3 +/- 0.9; CI- 0.3 to 0.4) and small-sided games (1.4 +/- 1.6; CI- 1.4 to 1.5), had the lowest values for high-speed ball releases with technical (6.1 +/- 7.2; CI- 5.7 to 6.6) and tactical (10.0 +/- 10.5; CI- 6.9 to 13.1) drills showing the largest high-speed ball releases. Conclusions The present study provides novel information regarding the quantification of technical actions of professional soccer players. Insights into absolute and relative frequency and intensity of releases in different drill types, provide practitioners with valuable information on technical outputs that can be manipulated during the process of planning training programmes to produce desired outcomes. Both volume and speed of ball release actions should be measured, when monitoring the technical actions in training according to fixture proximity, drill type and player position to permit enhanced training prescription.	[Lewis, Glyn; Roversi, Pietro; Domogalla, Chris] Norwich City FC, Performance & Med Dept, Norwich, Norfolk, England; [Lewis, Glyn; Herrington, Lee] Univ Salford, Sport Sci Dept, Norwich, Norfolk, England; [Towlson, Christopher] Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull, Yorks, England; [Barrett, Steve] PlayerMaker, Sport Sci Performance Anal Res & Coaching SPARC, London, England	University of Salford; University of Hull	Towlson, C (corresponding author), Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull, Yorks, England.	c.towlson@hull.ac.uk	Roversi, Pietro/GXN-2789-2022	Barrett, Steve/0000-0002-6751-9937				Ade JD, 2021, SCI MED FOOTBALL, V5, P6, DOI 10.1080/24733938.2020.1789202; Akenhead R, 2016, INT J SPORT PHYSIOL, V11, P587, DOI 10.1123/ijspp.2015-0331; Akenhead R, 2013, J SCI MED SPORT, V16, P556, DOI 10.1016/j.jsams.2012.12.005; Barrett S, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10228149; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Boyd LJ, 2013, INT J SPORT PHYSIOL, V8, P44, DOI 10.1123/ijspp.8.1.44; Bradley PS, 2018, INT J SPORT PHYSIOL, V13, P656, DOI 10.1123/ijspp.2017-0433; Buchheit M, 2014, J SPORT SCI, V32, P1844, DOI 10.1080/02640414.2014.942687; Carling C, 2014, J SPORT SCI, V32, P2, DOI 10.1080/02640414.2013.807352; Carling C, 2013, SPORTS MED, V43, P655, DOI 10.1007/s40279-013-0055-8; Hagglund M, 2013, AM J SPORT MED, V41, P327, DOI 10.1177/0363546512470634; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hills SP, 2020, J STRENGTH COND RES, V34, P2805, DOI 10.1519/JSC.0000000000003721; Hopkins W., 1998, MED SCI SPORTS EXERC, V30, P125; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Lees A, 2010, J SPORT SCI, V28, P805, DOI 10.1080/02640414.2010.481305; Lutz J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010059; Malone JJ, 2020, SCI MED FOOTBALL, V4, P82, DOI 10.1080/24733938.2019.1679871; Malone JJ, 2015, INT J SPORT PHYSIOL, V10, P489, DOI 10.1123/ijspp.2014-0352; Marris J, 2022, SCI MED FOOTBALL, V6, P203, DOI 10.1080/24733938.2021.1910333; Miles J., 2001, APPL REGRESSION CORR; Murphy SJ, 2018, CURR SPORT MED REP, V17, P187, DOI 10.1249/JSR.0000000000000490; Navandar A, 2018, J SPORT MED PHYS FIT, V58, P1815, DOI 10.23736/S0022-4707.18.07852-0; O'Donoghue P., 2007, INT J PERF ANAL SPOR, V7, P35; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Owen AL, 2017, SCI MED FOOTBALL, V1, P216, DOI 10.1080/24733938.2017.1334958; Radman I, 2016, EUR J APPL PHYSIOL, V116, P373, DOI 10.1007/s00421-015-3293-7; Roberts SJ, 2020, J SPORT SCI, V38, P1454, DOI 10.1080/02640414.2019.1609894; Robertson PS, 2020, J SPORT SCI, V38, P2118, DOI 10.1080/02640414.2020.1774143; Schielzeth H, 2020, METHODS ECOL EVOL, V11, P1141, DOI 10.1111/2041-210X.13434; Stevens TGA, 2017, SCI MED FOOTBALL, V1, P117, DOI 10.1080/24733938.2017.1282163; Torreblanca-Martinez V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227214; Towlson C, 2021, SCI MED FOOTBALL, V5, P280, DOI 10.1080/24733938.2020.1862419; Ueblacker P, 2015, KNEE SURG SPORT TR A, V23, P2590, DOI 10.1007/s00167-014-3177-0; Vanrenterghem J, 2017, SPORTS MED, V47, P2135, DOI 10.1007/s40279-017-0714-2; Verheul J, 2020, SCI MED FOOTBALL, V4, P246, DOI 10.1080/24733938.2019.1709654; Walker EJ, 2016, J SCI MED SPORT, V19, P177, DOI 10.1016/j.jsams.2015.01.013; Wass J, 2020, SCI MED FOOTBALL, V4, P142, DOI 10.1080/24733938.2019.1682183; Whitehead S, 2018, SPORTS MED, V48, P2549, DOI 10.1007/s40279-018-0965-6	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263518	10.1371/journal.pone.0263518	http://dx.doi.org/10.1371/journal.pone.0263518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113962	Green Published, gold			2022-12-26	WOS:000823694700102
J	Marques, AD; Moura, AR; Hora, EC; Brito, EDC; Oliviera, LS; Feitosa, IR; Freitas, FF; Lima, MS; Barreto, IDD; Santos, MO; da Silva, AM; Lima, CA				Marques, Adriane Dorea; Moura, Alex Rodrigues; Hora, Evania Curvelo; Costa Brito, Erika de Abreu; Oliviera, Leonardo Souto; Feitosa, Ionara Rodrigues; Freitas, Flavia Fernandes; Lima, Marcela Sampaio; de Carvalho Barreto, Ikaro Daniel; Santos, Marceli Oliveira; da Silva, Angela Maria; Lima, Carlos Anselmo			Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study	PLOS ONE			English	Article							STAGE-I; WOMEN; AGE; STATISTICS; REGISTRIES; FEATURES; TRENDS; TUMOR	Breast cancer is a major health problem worldwide. Analysis of breast cancer epidemiology in emerging countries enables assessment of prognostic factors, cancer care quality, and the equity of resource distribution. We aimed to estimate the overall (OS) and cancer-specific survival (SS) of breast cancer patients in the northeastern Brazilian state of Sergipe to identify independent prognostic factors. We analyzed a cohort for the factors age at diagnosis, place of residence, time to treatment, staging, and molecular classification, using the Kaplan-Meier method, log-rank test, Pearson's chi-squared test and Cox regression model. The outcome was the vital status at the end of the study. Our analysis showed an OS probability of 0.72 and an SS probability of 0.75. In multivariate analysis, time to treatment within 60 days, stage IV, and triple-negative classification remained independent prognostic factors for both OS [unadjusted hazard ratio (HRp) 1.50 (1.21; 1.86), HRp 16.56 (8.35; 32.85), and HRp 2.73 (1.73; 4.29), respectively] and SS [HRp 1.43 (1.13; 1.81), HRp 20.53 (9.45; 44.56), and HRp 3.14 (1.88; 5.26), respectively]. Better survival was demonstrated for the following patients: those receiving their first treatment after 60 days, with an OS of 52.5 months (51.2; 53.8) and SS of 53.5 months (52.3; 54.7); stage I patients, with an OS of 58.8 months (57.7; 60.0) and SS of 59.2 months (58.1; 60.3); patients without nodal metastasis, with an OS of 54.2 months (53.0; 55.4) and SS of 55.6 months (54.5; 56.7); and patients with luminal A classification, with an OS of 56.8 months (55.0; 58.5) and SS of 57.8 months (56.2; 59.4). This study identified independent prognostic factors and that OS and SS were lower for patients from Sergipe than for patients in high-income areas. Therefore, determining the profiles of breast cancer patients in this population will inform specific cancer care.	[Marques, Adriane Dorea; Moura, Alex Rodrigues; Hora, Evania Curvelo; Costa Brito, Erika de Abreu; Lima, Marcela Sampaio; da Silva, Angela Maria; Lima, Carlos Anselmo] Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil; [Marques, Adriane Dorea; Moura, Alex Rodrigues; Hora, Evania Curvelo; Costa Brito, Erika de Abreu; Oliviera, Leonardo Souto; Feitosa, Ionara Rodrigues; Freitas, Flavia Fernandes; Lima, Marcela Sampaio; da Silva, Angela Maria; Lima, Carlos Anselmo] Fed Univ Sergipe EBSERH, Univ Hosp, Aracaju, Sergipe, Brazil; [de Carvalho Barreto, Ikaro Daniel] Univ Fed Rural Pernambuco, Biometr & Appl Stat Grad Program, Recife, PE, Brazil; [Santos, Marceli Oliveira] CONPREV Brazilian Natl Canc Inst, Rio De Janeiro, RJ, Brazil; [Lima, Carlos Anselmo] Hosp Based Canc Registry HUSE SES, Aracaju, Sergipe, Brazil	Universidade Federal de Sergipe; Universidade Federal Rural de Pernambuco (UFRPE)	Marques, AD (corresponding author), Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil.; Marques, AD (corresponding author), Fed Univ Sergipe EBSERH, Univ Hosp, Aracaju, Sergipe, Brazil.	adrianemarques19@gmail.com		MARQUES, ADRIANE/0000-0002-7075-8170	Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe - FAPITEC/SE [019.203.00961/2018-2]	Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe - FAPITEC/SE	We declare that this research was conducted with the partial support of a Research Development Grant from the Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe -FAPITEC/SE Protocol: 019.203.00961/2018-2 (https://fapitec.se.gov.br/), awarded to one of the co-authors, CAL, and used solely to sponsor data collection in the cancer registry. Neither CAL nor any other co-author received any salary from the funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors did not receive any specific funding for this work. There was no additional external funding received for this study.	Abreu E, 2002, REV BRAS CANCEROL, V48, P113; Al-thoubaity FK, 2020, ANN MED SURG, V49, P44, DOI 10.1016/j.amsu.2019.11.021; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Alvarenga FV., 2017, REV M DICA MINAS GER, V27, P17; [Anonymous], EST 2020 INC CANC BR; [Anonymous], 2012, INCA I NACL CANC J A; Basilio RLS., 2011, SOBREVIDA MULH UNPUB, P113; Boyle P, 2008, WORLD CANC REPORT 20; BRASIL, 2012, LEI 12 732 2012 PUB; Brasil. Ministerio da Saude, DEP INF SUS DATASUS; Brito Claudia, 2009, Rev. Saúde Pública, V43, P481, DOI 10.1590/S0034-89102009000300012; Cirqueira MB, 2011, FEMINA, V39, P499; de Moraes Anaelena Braganca, 2006, Cad Saude Publica, V22, P2219, DOI 10.1590/S0102-311X2006001000028; Eisenberg ALA., 2000, REV BRAS CANCEROL, V46, P63; Eisenberg ALA., 1998, CANC MAMA FATORES PR; Eisenberg ALA., 2000, REV BRAS MASTOLOGIA, V10, P75; Elston CW., 1996, ANN M US CANADIAN AC, P1; Fayer Vívian Assis, 2016, Rev. bras. epidemiol., V19, P766, DOI 10.1590/1980-5497201600040007; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferraz RD, 2017, CIENC SAUDE COLETIVA, V22, P3743, DOI 10.1590/1413-812320172211.05092016; Freitas Júnior Ruffo de, 2017, Rev. Col. Bras. Cir., V44, P435, DOI 10.1590/0100-69912017005003; Grosclaude P, 2001, BREAST CANCER RES TR, V70, P137, DOI 10.1023/A:1012974728007; Grybachl S. M., 2018, Experimental Oncology, V40, P243; Hofelmann DA, 2014, CIENC SAUDE COLETIVA, V19, P1813, DOI 10.1590/1413-81232014196.03062013; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Leal YA, 2016, SALUD PUBLICA MEXICO, V58, P309, DOI 10.21149/spm.v58i2.7802; Makdissi FB., 2019, MASTOLOGY, V29, P37; Mendonça Gulnar Azevedo e Silva, 2004, Cad. Saúde Pública, V20, P1232, DOI 10.1590/S0102-311X2004000500017; Ayala ALM, 2019, CIENC SAUDE COLETIVA, V24, P1537, DOI 10.1590/1413-81232018244.16722017; Moraes Anaelena Bragança de, 2006, Cad. Saúde Pública, V22, P2219, DOI 10.1590/S0102-311X2006001000028; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; PEREIRA H, 1995, HISTOPATHOLOGY, V27, P219, DOI 10.1111/j.1365-2559.1995.tb00213.x; Robles Sylvia C, 2002, Rev Panam Salud Publica, V11, P178, DOI 10.1590/S1020-49892002000300007; Sant M, 2006, INT J CANCER, V119, P2417, DOI 10.1002/ijc.22160; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Simon SD, 2019, BREAST, V44, P113, DOI 10.1016/j.breast.2019.01.008; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; Sousa Samara Maria Moura Teixeira, 2019, Saúde debate, V43, P727, DOI 10.1590/0103-1104201912206; Wittekind C, 2017, TNM CLASSIFICATION M; World Health Organization-International Agency for Research on Cancer, 2012, GLOBOCAN 2012 ESTIMA; Zuo TT, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0250-3	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263222	10.1371/journal.pone.0263222	http://dx.doi.org/10.1371/journal.pone.0263222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113931	Green Published, gold			2022-12-26	WOS:000823694700064
J	Schultz, JR; Slifkin, AB; Schearer, EM				Schultz, John R.; Slifkin, Andrew B.; Schearer, Eric M.			Controlling an effector with eye movements: The effect of entangled sensory and motor responsibilities	PLOS ONE			English	Article							HAND COORDINATION; HEAD; ARM; INTERFACE; VISION; INDIVIDUALS; PERFORMANCE; TRACKING; PEOPLE; TARGET	Restoring arm and hand function has been indicated by individuals with tetraplegia as one of the most important factors for regaining independence. The overall goal of our research is to develop assistive technologies that allow individuals with tetraplegia to control functional reaching movements. This study served as an initial step toward our overall goal by assessing the feasibility of using eye movements to control the motion of an effector in an experimental environment. We aimed to understand how additional motor requirements placed on the eyes affected eye-hand coordination during functional reaching. We were particularly interested in how eye fixation error was affected when the sensory and motor functions of the eyes were entangled due to the additional motor responsibility. We recorded participants' eye and hand movements while they reached for targets on a monitor. We presented a cursor at the participant's point of gaze position which can be thought of as being similar to the control of an assistive robot arm. To measure eye fixation error, we used an offline filter to extract eye fixations from the raw eye movement data. We compared the fixations to the locations of the targets presented on the monitor. The results show that not only are humans able to use eye movements to direct the cursor to a desired location (1.04 +/- 0.15 cm), but they can do so with error similar to that of the hand (0.84 +/- 0.05 cm). In other words, despite the additional motor responsibility placed on the eyes during direct eye-movement control of an effector, the ability to coordinate functional reaching movements was unaffected. The outcomes of this study support the efficacy of using the eyes as a direct command input for controlling movement.	[Schultz, John R.; Schearer, Eric M.] Cleveland State Univ, Mech Engn Ctr Human Machine Syst, Cleveland, OH 44115 USA; [Slifkin, Andrew B.] Cleveland State Univ, Dept Psychol, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Schultz, JR (corresponding author), Cleveland State Univ, Mech Engn Ctr Human Machine Syst, Cleveland, OH 44115 USA.	j.r.schultz12@vikes.csuohio.edu			Ohio Department of Higher Education	Ohio Department of Higher Education	Schearer, E.M. (PI) received the grant award entitled "Controlling Functional Reaching with Eye and Head Movements of People with High Cervical Spinal Cord Injuries." from the Ohio Department of Higher Education. The award effective dates are 6/1/2020 -5/31/2022. Grant numbers are not assigned by the Ohio Department of Higher Education. More information can be found here: https://icorpsohio.org/apply/https://www.ohiohighered.org/grants-rfps The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; AL-Quraishi MS, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103342; Alonso R, 2013, ERGONOMICS, V56, P246, DOI 10.1080/00140139.2012.744473; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; BALLARD DH, 1992, CVGIP-IMAG UNDERSTAN, V56, P3, DOI 10.1016/1049-9660(92)90081-D; Beaudoin M, 2018, CAN J OCCUP THER, V85, P397, DOI 10.1177/0008417418820878; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Bilyea A, 2017, MED ENG PHYS, V49, P1, DOI 10.1016/j.medengphy.2017.06.038; Center NSCIS, 2009, NATL SPINAL CORD INJ; Chung CS, 2013, J SPINAL CORD MED, V36, P273, DOI 10.1179/2045772313Y.0000000132; Cio YSLK, 2019, IEEE T NEUR SYS REH, V27, P2344, DOI 10.1109/TNSRE.2019.2950619; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cotti J, 2011, BEHAV BRAIN RES, V218, P248, DOI 10.1016/j.bbr.2010.12.002; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Desmurget M, 2005, J EXP PSYCHOL HUMAN, V31, P1510, DOI 10.1037/0096-1523.31.6.1510; Duchowski A., 2007, EYE TRACKING METHODO; Dunkelberger N, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113274; Gopal A, 2015, J NEUROPHYSIOL, V113, P2033, DOI 10.1152/jn.00802.2014; Gopura RARC, 2016, ROBOT AUTON SYST, V75, P203, DOI 10.1016/j.robot.2015.10.001; Hawley M.S., 2002, BRIT J OCCUP THER, V65, P15, DOI [10.1177/030802260206500104, DOI 10.1177/030802260206500104]; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; JACOB RJK, 1991, ACM T INFORM SYST, V9, P152, DOI 10.1145/123078.128728; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kim J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006296; Majaranta P., 2014, ADV PHYSL COMPUTING, P39, DOI DOI 10.1007/978-1-4471-6392-3_3; Mao XQ, 2017, COMPUT INTEL NEUROSC, V2017, DOI 10.1155/2017/1742862; McMullen DP, 2014, IEEE T NEUR SYS REH, V22, P784, DOI 10.1109/TNSRE.2013.2294685; Memberg WD, 2014, ARCH PHYS MED REHAB, V95, P1201, DOI 10.1016/j.apmr.2014.01.028; Mougharbel Imad, 2013, 2013 Science and Information Conference (SAI), P597; Olsson P., 2007, REAL TIME OFFLINE FI; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Shafti A, 2019, IEEE INT CONF ROBOT, P863, DOI 10.1109/ICRA.2019.8793804; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Simpson T, 2008, IEEE T BIO-MED ENG, V55, P2050, DOI 10.1109/TBME.2008.921161; Stewart AM, 2017, IFAC PAPERSONLINE, V50, P15169, DOI 10.1016/j.ifacol.2017.08.2266; Thaler L, 2013, VISION RES, V76, P31, DOI 10.1016/j.visres.2012.10.012; Tonet O, 2008, J NEUROSCI METH, V167, P91, DOI 10.1016/j.jneumeth.2007.03.015; Van der Heide LA, 2014, PROSTHET ORTHOT INT, V38, P287, DOI 10.1177/0309364613498538; vanDonkelaar P, 1997, NEUROREPORT, V8, P2139, DOI 10.1097/00001756-199707070-00010; VERCHER JL, 1994, EXP BRAIN RES, V99, P507; Wang MY, 2018, IEEE INT C INT ROBOT, P2355, DOI 10.1109/IROS.2018.8594045; Williams MR, 2008, IEEE T NEUR SYS REH, V16, P485, DOI 10.1109/TNSRE.2008.2006216	44	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263440	10.1371/journal.pone.0263440	http://dx.doi.org/10.1371/journal.pone.0263440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113943	Green Published, gold			2022-12-26	WOS:000823694700094
J	Vinas-Noguera, M; Csatlosova, K; Simoncicova, E; Bogi, E; Ujhazy, E; Dubovicky, M; Belovicova, K				Vinas-Noguera, Mireia; Csatlosova, Kristina; Simoncicova, Eva; Bogi, Ezster; Ujhazy, Eduard; Dubovicky, Michal; Belovicova, Kristina			Sex- and age- dependent effect of pre-gestational chronic stress and mirtazapine treatment on neurobehavioral development of Wistar rat offspring	PLOS ONE			English	Article							MATERNAL-BEHAVIOR; PRENATAL STRESS; HIPPOCAMPAL NEUROGENESIS; PROGRAMS NEUROENDOCRINE; PERINATAL EXPOSURE; SPATIAL MEMORY; Y-MAZE; DEPRESSION; RESPONSES; ANTIDEPRESSANTS	Hormonal fluctuations, such as the perinatal period, may increase susceptibility of women to depression, which in turn exert a negative impact on child's neurodevelopment, becoming a risk factor in development of neuropsychiatric disorders. Moreover, the use of antidepressants during this critical period presents a serious health concern for both the mother and the child, due to the consequences of treatment in terms of the reliability and safety for the proper neurodevelopment of the organism being not well known. Atypical antidepressants, such as mirtazapine, that targets both serotonergic and noradrenergic systems in the central nervous system (CNS), represent a novel focus of research due to its unique pharmacological profile. The aim of this work was to study the effects of maternal depression and/or perinatal antidepressant mirtazapine treatment on the neurobehavioral development of the offspring. Pre-gestationally chronically stressed or non-stressed Wistar rat dams were treated with either mirtazapine (10 mg/kg/day) or vehicle during pregnancy and lactation followed by analysis of offspring's behavior at juvenile and adolescent age. We found mirtazapine induced significant alterations of nursing behavior. In offspring, pregestational stress (PS) had an anxiogenic effect on adolescent males (p <= 0.05) and increased their active behavior in forced swim test (p <= 0.01). Interaction between pregestational stress and mirtazapine treatment variously induced anxiolytic changes of juvenile (p <= 0.05) and adolescent (p <= 0.05) females and impairment of spatial memory (p <= 0.01) in adolescent females as well. Hippocampal density of synaptophysin, pre-synaptic protein marker, was decreased mainly by mirtazapine treatment. In conclusion, our results show mirtazapine induced significant alterations in maternal behavior and several sex- and age-dependent changes in neurobehavioral development of offspring caused by both prenatal mirtazapine treatment and/or chronic pregestational stress.	[Vinas-Noguera, Mireia; Csatlosova, Kristina; Bogi, Ezster; Ujhazy, Eduard; Dubovicky, Michal; Belovicova, Kristina] Slovak Acad Sci, Ctr Expt Med, Inst Expt Pharmacol & Toxicol, Bratislava, Slovakia; [Vinas-Noguera, Mireia] Comenius Univ, Fac Nat Sci, Bratislava, Slovakia; [Csatlosova, Kristina] Comenius Univ, Jessenius Fac Med, Martin, Slovakia; [Simoncicova, Eva] Univ Victoria, Div Med Sci, Victoria, BC, Canada	Slovak Academy of Sciences; Comenius University Bratislava; Comenius University Bratislava; University of Victoria	Vinas-Noguera, M (corresponding author), Slovak Acad Sci, Ctr Expt Med, Inst Expt Pharmacol & Toxicol, Bratislava, Slovakia.; Vinas-Noguera, M (corresponding author), Comenius Univ, Fac Nat Sci, Bratislava, Slovakia.	exfamivi@savba.sk		, Mireia/0000-0001-9061-1099	VEGA Scientific Agency [VEGA 2/0124/19]; APVV grant of Slovak Republic [APVV-19-0435]	VEGA Scientific Agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); APVV grant of Slovak Republic	The study was supported by the VEGA Scientific Agency (VEGA 2/0124/19) and APVV grant of Slovak Republic (APVV-19-0435).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afadlal S, 2010, NEUROSCI LETT, V470, P24, DOI 10.1016/j.neulet.2009.12.046; Aichhorn W, 2004, AM J PSYCHIAT, V161, P2325, DOI 10.1176/appi.ajp.161.12.2325; [Anonymous], EUTHANASIA EXPT ANIM; [Anonymous], DEPRESSION; [Anonymous], MIRTAZAPINE DOSAGE G; Anttila SAK, 2001, CNS DRUG REV, V7, P249; Armario A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00137; Belovic K, 2021, BEHAV BRAIN RES, V398, DOI 10.1016/j.bbr.2020.112944; Belovicova Kristina, 2017, Interdiscip Toxicol, V10, P40, DOI 10.1515/intox-2017-0006; Benard-Laribiere A, 2018, BRIT J CLIN PHARMACO, V84, P1764, DOI 10.1111/bcp.13608; Biala YN, 2011, HIPPOCAMPUS, V21, P1114, DOI 10.1002/hipo.20825; Bodi N, 2017, LUPUS, V26, P1378, DOI 10.1177/0961203317701845; Bogi E, 2019, BEHAV BRAIN RES, V375, DOI 10.1016/j.bbr.2019.112131; Brummelte S, 2012, NEUROPHARMACOLOGY, V62, P406, DOI 10.1016/j.neuropharm.2011.08.017; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P258, DOI 10.1111/j.1365-2826.2010.01969.x; Buckwalter J G, 2001, Prog Brain Res, V133, P303; Buckwalter JG, 1999, PSYCHONEUROENDOCRINO, V24, P69; Burke HM, 2013, STRESS, V16, P469, DOI 10.3109/10253890.2013.791276; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Carvalho-Netto EF, 2011, PHYSIOL BEHAV, V104, P242, DOI 10.1016/j.physbeh.2011.01.024; Ceniceros LC, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.641795; Chen WH, 2014, PHARMACOL BIOCHEM BE, V117, P25, DOI 10.1016/j.pbb.2013.11.034; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Conrad CD, 2003, NEUROBIOL LEARN MEM, V79, P32, DOI 10.1016/S1074-7427(02)00018-7; Cui YF, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00102; Czarzasta K, 2019, PHYSIOL BEHAV, V199, P258, DOI 10.1016/j.physbeh.2018.11.024; DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Eiland L, 2013, NEUROSCIENCE, V249, P162, DOI 10.1016/j.neuroscience.2012.10.048; Fawcett J, 1998, J AFFECT DISORDERS, V51, P267, DOI 10.1016/S0165-0327(98)00224-9; Frokjaer VG, 2015, BIOL PSYCHIAT, V78, P534, DOI 10.1016/j.biopsych.2015.04.015; Furuse K, 2019, J AFFECT DISORDERS, V247, P97, DOI 10.1016/j.jad.2019.01.007; Gemmel M, 2018, NEUROSCI BIOBEHAV R, V85, P102, DOI 10.1016/j.neubiorev.2017.04.023; Gemmel M, 2018, NEUROPHARMACOLOGY, V128, P168, DOI 10.1016/j.neuropharm.2017.10.009; Gemmel M, 2018, BEHAV BRAIN RES, V339, P222, DOI 10.1016/j.bbr.2017.11.038; Gemmel M, 2017, PSYCHONEUROENDOCRINO, V84, P159, DOI 10.1016/j.psyneuen.2017.07.480; Gemmel M, 2016, NEUROSCIENCE, V327, P32, DOI 10.1016/j.neuroscience.2016.03.068; Grundwald NJ, 2015, PSYCHONEUROENDOCRINO, V62, P204, DOI 10.1016/j.psyneuen.2015.08.010; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Herlenius E, 2001, EARLY HUM DEV, V65, P21, DOI 10.1016/S0378-3782(01)00189-X; Holm KJ, 1999, DRUGS, V57, P607, DOI 10.2165/00003495-199957040-00010; Holmes SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09562-7; Hutchison SM., 2020, REPROD TOXICOL; Jankord R, 2011, ENDOCRINOLOGY, V152, P629, DOI 10.1210/en.2010-0658; Jezova D, 2019, CURR PROTEIN PEPT SC, V20, P1112, DOI 10.2174/1389203720666190704151254; Vasquez FDJ, 2020, ACTA NEUROBIOL EXP, V80, P331, DOI 10.21307/ane-2020-029; Klier CM, 2007, AM J PSYCHIAT, V164, P348, DOI 10.1176/appi.ajp.164.2.348-a; Kott JM, 2019, BEHAV BRAIN RES, V366, P1, DOI 10.1016/j.bbr.2019.03.003; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Kristensen JH, 2007, BRIT J CLIN PHARMACO, V63, P322, DOI 10.1111/j.1365-2125.2006.02773.x; Leung VSY, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000712; Levy F, 2016, ANN ENDOCRINOL-PARIS, V77, P114, DOI 10.1016/j.ando.2016.04.002; Lim S, 2019, BEHAV BRAIN RES, V359, P304, DOI 10.1016/j.bbr.2018.11.008; Liu J, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00631-3; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Mandolini GM, 2020, J AFFECT DISORDERS, V261, P271, DOI 10.1016/j.jad.2019.08.007; Millard SJ., 2019, PERINATAL EXPOSURE F; Miyagawa K, 2011, NEUROSCI RES, V70, P111, DOI 10.1016/j.neures.2011.02.002; Molenaar NM, 2018, AUST NZ J PSYCHIAT, V52, P320, DOI 10.1177/0004867418762057; Molendijk ML, 2019, BEHAV BRAIN RES, V364, P1, DOI 10.1016/j.bbr.2019.02.005; Moraczewski J AK., TRICYCLIC ANTIDEPRES; Morley-Fletcher S, 2003, BRAIN RES, V989, P246, DOI 10.1016/S0006-8993(03)03293-1; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Oosterhof CA, 2016, BRAIN RES, V1642, P409, DOI 10.1016/j.brainres.2016.04.032; Oyola MG, 2017, STRESS, V20, P476, DOI 10.1080/10253890.2017.1369523; Pawluski JL, 2015, NEUROSCIENCE, V290, P379, DOI 10.1016/j.neuroscience.2015.01.048; Pawluski JL, 2019, FRONT NEUROENDOCRIN, V53, DOI 10.1016/j.yfrne.2019.03.001; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Rauggi R, 2005, INT J NEUROPSYCHOPH, V8, P369, DOI 10.1017/S1461145705005146; Rayen I, 2015, PSYCHOPHARMACOLOGY, V232, P1231, DOI 10.1007/s00213-014-3758-0; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Richetto J, 2014, J REPROD IMMUNOL, V104, P20, DOI 10.1016/j.jri.2014.03.005; Rosenqvist MA, 2019, J CHILD PSYCHOL PSYC, V60, P665, DOI 10.1111/jcpp.12990; Sahoo Jasmita, 2010, Sci Pharm, V78, P451, DOI 10.3797/scipharm.1004-02; Schepanski S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02186; Schneider LE, 2017, J NEUROTRAUM, V34, P2982, DOI 10.1089/neu.2016.4665; Schoretsanitis G, 2021, PROG NEURO-PSYCHOPH, V107, DOI 10.1016/j.pnpbp.2020.110228; Schoretsanitis G, 2019, ARCH WOMEN MENT HLTH, V22, P383, DOI 10.1007/s00737-018-0905-3; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Senzai Y, 2019, NEUROSCI RES, V140, P43, DOI 10.1016/j.neures.2018.11.003; Serpeloni F, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00269; Simons SSH, 2019, STRESS, V22, P654, DOI 10.1080/10253890.2019.1608945; Simplice FH, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/974308; Sitruk-Ware R, 2018, CLIMACTERIC, V21, P315, DOI 10.1080/13697137.2018.1463982; Slavich GM, 2019, PSYCHOPHARMACOLOGY, V236, P3063, DOI 10.1007/s00213-019-05326-9; Smit M, 2016, EUR NEUROPSYCHOPHARM, V26, P126, DOI 10.1016/j.euroneuro.2015.06.014; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Sprowles JLN, 2017, INT J DEV NEUROSCI, V61, P92, DOI 10.1016/j.ijdevneu.2017.06.004; Sprowles JLN, 2016, INT J DEV NEUROSCI, V54, P39, DOI 10.1016/j.ijdevneu.2016.08.007; Talbot L, 2016, ANAEST INTENS CARE M, V17, P341, DOI 10.1016/j.mpaic.2016.04.010; Thion MS, 2017, CURR OPIN NEUROBIOL, V47, P121, DOI 10.1016/j.conb.2017.10.004; Thompson; CMP, 1999, SYCHIATRY INTERPERS, V60, P2; Tonn P, 2009, J CLIN PSYCHOPHARM, V29, P191, DOI 10.1097/JCP.0b013e318199f17e; Uguz F, 2019, BREASTFEED MED, V14, P131, DOI 10.1089/bfm.2018.0197; Volpi-Abadie J, 2013, OCHSNER J, V13, P533; Weinstock M, 2017, NEUROBIOL STRESS, V6, P3, DOI 10.1016/j.ynstr.2016.08.004; Whittaker AL, 2014, APPL ANIM BEHAV SCI, V151, P1, DOI 10.1016/j.applanim.2013.11.001; Wichman CL, 2015, PRIM CARE COMPANION, DOI [10.4088/PCC.15f01776, DOI 10.4088/PCC.15F01776]; Wikenius E, 2019, NORD J PSYCHIAT, V73, P257, DOI 10.1080/08039488.2019.1613446; Wislowska-Stanek A, 2019, BEHAV BRAIN RES, V359, P181, DOI 10.1016/j.bbr.2018.10.027; Xu LP, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104586; Yagi S, 2019, NEUROPSYCHOPHARMACOL, V44, P200, DOI 10.1038/s41386-018-0208-4; Yang R, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112172; Youssef M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40868-0; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170	109	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0255546	10.1371/journal.pone.0255546	http://dx.doi.org/10.1371/journal.pone.0255546			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113878	gold, Green Published			2022-12-26	WOS:000823694700004
J	Xu, YF; He, XY; Wang, SZ; Sun, BF; Jia, RB; Chai, PW; Li, F; Yang, Y; Ge, SF; Jia, RB; Yang, YG; Fan, XQ				Xu, Yangfan; He, Xiaoyu; Wang, Shanzheng; Sun, Baofa; Jia, Ruobing; Chai, Peiwei; Li, Fang; Yang, Ying; Ge, Shengfang; Jia, Renbing; Yang, Yun-Gui; Fan, Xianqun			The m(6)A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation	ONCOGENE			English	Article							CONJUNCTIVAL MELANOMA; MALIGNANT-MELANOMA; HITS-CLIP; RNA; EXPRESSION; PROMOTES; DIFFERENTIATION; ACTIVATION; TISSUE; MODEL	N-6-methyladenosine (m(6)A) is the most universal internal RNA modification on messenger RNAs and regulates the fate and functions of m(6)A-modified transcripts through m(6)A-specific binding proteins. Nevertheless, the functional role and potential mechanism of the m(6)A reading proteins in ocular melanoma tumorigenicity, especially cancer stem-like cell (CSC) properties, remain to be elucidated. Herein, we demonstrated that the m(6)A reading protein YTHDF3 promotes the translation of the target transcript CTNNB1, contributing to ocular melanoma propagation and migration through m(6)A methylation. YTHDF3 is highly expressed in ocular melanoma stem-like cells and abundantly enriched in ocular melanoma tissues, which is related to poor clinical prognosis. Moreover, YTHDF3 is required for the maintenance of CSC properties and tumor initiation capacity in ocular melanoma both in vitro and in vivo. Ocular melanoma cells with targeted YTHDF3 knockdown exhibited inhibitory tumor proliferation and migration abilities. Transcriptome-wide mapping of m(6)A peaks and YTHDF3 binding peaks on mRNAs revealed a key target gene candidate, CTNNB1. Mechanistically, YTHDF3 enhances CTNNB1 translation through recognizing and binding the m(6)A peaks on CTNNB1 mRNA.	[Xu, Yangfan; He, Xiaoyu; Jia, Ruobing; Chai, Peiwei; Li, Fang; Ge, Shengfang; Jia, Renbing; Fan, Xianqun] Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China; [Xu, Yangfan; He, Xiaoyu; Jia, Ruobing; Chai, Peiwei; Li, Fang; Ge, Shengfang; Jia, Renbing; Fan, Xianqun] Shanghai Key Lab Orbital Dis & Ocular Oncol, Shanghai, Peoples R China; [Wang, Shanzheng; Sun, Baofa; Yang, Ying; Yang, Yun-Gui] Chinese Acad Sci, Collaborat Innovat Ctr Genet & Dev, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing, Peoples R China; [Wang, Shanzheng; Sun, Baofa; Yang, Ying; Yang, Yun-Gui] China Natl Ctr Bioinformat, Beijing, Peoples R China; [Wang, Shanzheng; Sun, Baofa; Yang, Ying; Yang, Yun-Gui] Univ Chinese Acad Sci, Sino Danish Coll, Beijing, Peoples R China; [Sun, Baofa; Yang, Ying; Yang, Yun-Gui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Fan, XQ (corresponding author), Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China.; Fan, XQ (corresponding author), Shanghai Key Lab Orbital Dis & Ocular Oncol, Shanghai, Peoples R China.; Yang, YG (corresponding author), Chinese Acad Sci, Collaborat Innovat Ctr Genet & Dev, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing, Peoples R China.; Yang, YG (corresponding author), China Natl Ctr Bioinformat, Beijing, Peoples R China.; Yang, YG (corresponding author), Univ Chinese Acad Sci, Sino Danish Coll, Beijing, Peoples R China.; Yang, YG (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.	ygyang@big.ac.cn; fanxq@sjtu.edu.cn	Yang, Ying/GRO-4537-2022	Yang, Ying/0000-0002-8104-5985	National Key Research and Development Plan [2017YFE0196300]; National Natural Science Foundation of China [81772875, U1932135, 82073889]; Science and Technology Commission of Shanghai [20DZ2270800, 19JC1410200]; Clinical Research Plan of SHDC [SHDC2020CR1009A]	National Key Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Clinical Research Plan of SHDC	We express our sincere thanks for all the patients participated in our study and wish them good health. This work was supported by the National Key Research and Development Plan (2017YFE0196300), the National Natural Science Foundation of China (81772875, U1932135, 82073889), the Clinical Research Plan of SHDC (SHDC2020CR1009A), the Science and Technology Commission of Shanghai (20DZ2270800 and 19JC1410200).	Angeloni V, 2015, SEMIN CANCER BIOL, V31, P43, DOI 10.1016/j.semcancer.2014.08.004; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braun KM, 2008, CELL STEM CELL, V2, P406, DOI 10.1016/j.stem.2008.04.011; Chang GQ, 2020, CANCER CELL, V38, P857, DOI 10.1016/j.ccell.2020.10.004; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; de Waard NE, 2015, OCUL ONCOL PATHOL, V1, P182, DOI 10.1159/000371555; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Gao YF, 2019, CELL RES, V29, P767, DOI 10.1038/s41422-019-0210-3; Giraud J, 2016, CANCER RES, V76, P3618, DOI 10.1158/0008-5472.CAN-15-1497; Han B, 2020, EMBO REP, V21, DOI 10.15252/embr.201949229; Hsu PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1336-6; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jia RB, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1088-x; Jin B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01173-x; Kalirai H, 2011, INVEST OPHTH VIS SCI, V52, P8458, DOI 10.1167/iovs.11-7379; Katoh M, 2017, INT J ONCOL, V51, P1357, DOI 10.3892/ijo.2017.4129; Lai CY, 2012, CANCER RES, V72, P5111, DOI 10.1158/0008-5472.CAN-12-0624; Larsen AC, 2016, ACTA OPHTHALMOL, V94, P1, DOI 10.1111/aos.13100; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li P, 2020, AUTOPHAGY, V16, P1186, DOI 10.1080/15548627.2019.1659614; Li ZR, 2018, CELL RES, V28, P904, DOI 10.1038/s41422-018-0072-0; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1119-7; Liu LW, 2019, J CANCER, V10, P5447, DOI 10.7150/jca.35053; Mackiewicz J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0456-1; Meyer KD, 2019, NAT METHODS, V16, P1275, DOI 10.1038/s41592-019-0570-0; Missotten GS, 2005, INVEST OPHTH VIS SCI, V46, P75, DOI 10.1167/iovs.04-0344; Moore AR, 2018, CELL REP, V22, P2455, DOI 10.1016/j.celrep.2018.01.081; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Murphy GF, 2014, MOL ASPECTS MED, V39, P33, DOI 10.1016/j.mam.2013.10.003; Newel F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11107-x; Ni W, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1079-y; Paris J, 2019, CELL STEM CELL, V25, P137, DOI 10.1016/j.stem.2019.03.021; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rappa G, 2013, EXP CELL RES, V319, P810, DOI 10.1016/j.yexcr.2013.01.003; Shah A, 2017, BIOINFORMATICS, V33, P566, DOI 10.1093/bioinformatics/btw653; Shang QF, 2019, EPIGENOMICS-UK, V11, P787, DOI 10.2217/epi-2019-0029; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Shidal C, 2019, CANCER RES, V79, P3622, DOI 10.1158/0008-5472.CAN-18-2659; Shields CL, 2000, ARCH OPHTHALMOL-CHIC, V118, P1497; Smit KN, 2020, PROG RETIN EYE RES, V75, DOI 10.1016/j.preteyeres.2019.100800; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Sun Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12733-1; Terai K, 2018, STEM CELLS, V36, P1154, DOI 10.1002/stem.2835; Tuomaala S, 2002, INVEST OPHTH VIS SCI, V43, P3399; Vu LP, 2019, CANCER DISCOV, V9, P25, DOI 10.1158/2159-8290.CD-18-0959; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Yang J, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758834018757175; Yang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10669-0; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1070-7; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhang Sisi, 2018, Yichuan, V40, P1044, DOI 10.16288/j.yczz.18-178; Zhang Y, 2019, P NATL ACAD SCI USA, V116, P976, DOI 10.1073/pnas.1812536116; Zhang Z, 2017, NUCLEIC ACIDS RES, V45, pD18, DOI 10.1093/nar/gkw1060; Zhao L, 2020, J CELL MOL MED, V24, P511, DOI 10.1111/jcmm.14758; Zhou JF, 2017, THERANOSTICS, V7, P1447, DOI 10.7150/thno.17451	66	9	9	4	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1281	1297		10.1038/s41388-021-02146-0	http://dx.doi.org/10.1038/s41388-021-02146-0		FEB 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	35110680				2022-12-26	WOS:000749991400001
J	Barrows, JK; Van Dyke, MW				Barrows, John K.; Van Dyke, Michael W.			Biolayer interferometry for DNA-protein interactions	PLOS ONE			English	Article							BIOSENSOR	Biolayer interferometry (BLI) is a widely utilized technique for determining macromolecular interaction dynamics in real time. Using changes in the interference pattern of white light reflected off a biosensor tip, BLI can determine binding parameters for protein-protein (e.g., antibody-substrate kinetics) or protein-small molecule (e.g., drug discovery) interactions. However, a less-appreciated application for BLI analysis is DNA-protein interactions. DNA-binding proteins play an immense role in cellular biology, controlling critical processes including transcription, DNA replication, and DNA repair. Understanding how proteins interact with DNA often provides important insight into their biological function, and novel technologies to assay DNA-protein interactions are of broad interest. Currently, a detailed protocol utilizing BLI for DNA-protein interactions is lacking. In the following protocol, we describe the use of BLI and biotinylated-DNA probes to determine the binding kinetics of a transcription factor to a specific DNA sequence. The experimental steps include the generation of biotinylated-DNA probes, the execution of the BLI experiment, and data analysis by scientific graphing and statistical software (e.g., GraphPad Prism). Although the example experiment used throughout this protocol involves a prokaryotic transcription factor, this technique can be easily translated to any DNA-binding protein. Pitfalls and potential solutions for investigating DNA-binding proteins by BLI are also presented.	[Barrows, John K.; Van Dyke, Michael W.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University	Barrows, JK; Van Dyke, MW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	jbarro51@kennesaw.edu; mvandyk2@kennesaw.edu	Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002; Barrows, John/0000-0003-0906-1574	National Institutes of Health [1R15GM104833-01]; National Science Foundation [1714778, 2041202]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	Protocol development was supported by grants from the National Institutes of Health (MWVD, 1R15GM104833-01) and the National Science Foundation (MWVD, 1714778 and MWVD, 2041202). MWVD is a Foundation Fellow in Biochemistry at Kennesaw State University. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; [Anonymous], 2021, PRISM 9 CURVE FITTIN; Ciesielski GL, 2016, METHODS MOL BIOL, V1351, P223, DOI 10.1007/978-1-4939-3040-1_17; Kim GB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021171118; Muller-Esparza H, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00098; Noy-Porat Tal, 2021, STAR Protoc, V2, P100836, DOI 10.1016/j.xpro.2021.100836; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Van Dyke MW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159408; Wartchow CA, 2011, J COMPUT AID MOL DES, V25, P669, DOI 10.1007/s10822-011-9439-8; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wong KC, 2018, ISCIENCE, V7, P198, DOI 10.1016/j.isci.2018.09.003	12	3	3	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263322	10.1371/journal.pone.0263322	http://dx.doi.org/10.1371/journal.pone.0263322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108320	Green Published, gold			2022-12-26	WOS:000775890100057
J	Berntsen, J; Rimestad, J; Lassen, JT; Tran, D; Kragh, MF				Berntsen, Jorgen; Rimestad, Jens; Lassen, Jacob Theilgaard; Tran, Dang; Kragh, Mikkel Fly			Robust and generalizable embryo selection based on artificial intelligence and time-lapse image sequences	PLOS ONE			English	Article							PREDICTIVE TOOL; LIVE BIRTH; PREGNANCY; IMPLANTATION; MORPHOLOGY; ANEUPLOIDY; MODEL; MORPHOKINETICS; CLASSIFICATION; INCUBATION	Assessing and selecting the most viable embryos for transfer is an essential part of in vitro fertilization (IVF). In recent years, several approaches have been made to improve and automate the procedure using artificial intelligence (AI) and deep learning. Based on images of embryos with known implantation data (KID), AI models have been trained to automatically score embryos related to their chance of achieving a successful implantation. However, as of now, only limited research has been conducted to evaluate how embryo selection models generalize to new clinics and how they perform in subgroup analyses across various conditions. In this paper, we investigate how a deep learning-based embryo selection model using only time-lapse image sequences performs across different patient ages and clinical conditions, and how it correlates with traditional morphokinetic parameters. The model was trained and evaluated based on a large dataset from 18 IVF centers consisting of 115,832 embryos, of which 14,644 embryos were transferred KID embryos. In an independent test set, the AI model sorted KID embryos with an area under the curve (AUC) of a receiver operating characteristic curve of 0.67 and all embryos with an AUC of 0.95. A clinic hold-out test showed that the model generalized to new clinics with an AUC range of 0.60-0.75 for KID embryos. Across different subgroups of age, insemination method, incubation time, and transfer protocol, the AUC ranged between 0.63 and 0.69. Furthermore, model predictions correlated positively with blastocyst grading and negatively with direct cleavages. The fully automated iDAScore v1.0 model was shown to perform at least as good as a state-of-the-art manual embryo selection model. Moreover, full automatization of embryo scoring implies fewer manual evaluations and eliminates biases due to inter- and intraobserver variation.	[Berntsen, Jorgen; Rimestad, Jens; Lassen, Jacob Theilgaard; Kragh, Mikkel Fly] Vitrolife AS, Aarhus, Denmark; [Tran, Dang] Harrison AI, Sydney, NSW, Australia; [Kragh, Mikkel Fly] Aarhus Univ, Dept Elect & Comp Engn, Aarhus, Denmark	Aarhus University	Berntsen, J (corresponding author), Vitrolife AS, Aarhus, Denmark.	jberntsen@vitrolife.com		Kragh, Mikkel/0000-0002-0829-1450; Berntsen, Jorgen/0000-0002-5976-1002				Adolfsson E, 2018, J BRAS REPROD ASSIST, V22, P228, DOI 10.5935/1518-0557.20180042; Ahlstrom A, 2011, HUM REPROD, V26, P3289, DOI 10.1093/humrep/der325; Alikani M, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1246; Apter S, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoaa008; Arnab A, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P6816, DOI 10.1109/ICCV48922.2021.00676; Barrie A, 2017, FERTIL STERIL, V107, P613, DOI 10.1016/j.fertnstert.2016.11.014; Bertasius G, 2021, PR MACH LEARN RES, V139; Bormann CL, 2020, FERTIL STERIL, V113, P781, DOI 10.1016/j.fertnstert.2019.12.004; Campbell A, 2013, REPROD BIOMED ONLINE, V27, P140, DOI 10.1016/j.rbmo.2013.04.013; Campbell A, 2013, REPROD BIOMED ONLINE, V26, P477, DOI 10.1016/j.rbmo.2013.02.006; Caron Mathilde, 2020, ARXIV200609882; Carreira J, 2017, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2017.502; Chavez-Badiola A, 2020, HUM REPROD, V35, P482, DOI 10.1093/humrep/dez263; Chavez-Badiola A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61357-9; Chen T.J., 2019, FERTILITY REPROD, V01, P51, DOI DOI 10.1142/S2661318219500051; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; Conaghan J, 2013, FERTIL STERIL, V100, P412, DOI 10.1016/j.fertnstert.2013.04.021; Coticchio G, 2019, HUM REPROD UPDATE, V25, P422, DOI 10.1093/humupd/dmz008; Csaba P, 2017, REPROD BIOMED ONLINE, V35, P511, DOI 10.1016/j.rbmo.2017.06.022; Devries T., 2017, IMPROVED REGULARIZAT; Fishel S, 2019, REPROD BIOMEDICINE; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gardner DK, 2003, PLACENTA, V24, pS5, DOI 10.1016/S0143-4004(03)00136-X; Giusti A, 2010, I S BIOMED IMAGING, P1261, DOI 10.1109/ISBI.2010.5490225; Goodfellow I., 2013, P 30 INT C INT C MAC; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Herrero J, 2013, FERTIL STERIL, V99, P1030, DOI 10.1016/j.fertnstert.2013.01.089; Kajhoj TQ, 2016, LANGUAGE EMBRYOLOGY; Kan-Tor Y, 2020, ADV INTELL SYST-GER, V2, DOI 10.1002/aisy.202000080; Kanakasabapathy MK, 2019, LAB CHIP, V19, P4139, DOI 10.1039/c9lc00721k; Khosravi P, 2018, ROBUST AUTOMATED ASS, DOI [10.1101/394882v1, DOI 10.1101/394882V1]; Khosravi P, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0096-y; Kingma DP., 2014, ADAM METHOD STOCHAST; Kirkegaard K, 2014, REPROD BIOMED ONLINE, V29, P156, DOI 10.1016/j.rbmo.2014.04.011; Kragh MF, 2022, IEEE T MED IMAGING, V41, P465, DOI 10.1109/TMI.2021.3116986; Kragh MF, 2019, COMPUT BIOL MED, V115, DOI 10.1016/j.compbiomed.2019.103494; Kragh MF, 2021, J ASSIST REPROD GEN, V38, P1675, DOI 10.1007/s10815-021-02254-6; Lin TY, 2020, IEEE T PATTERN ANAL, V42, P318, DOI 10.1109/TPAMI.2018.2858826; Curchoe CL, 2020, FERTIL STERIL, V114, P921, DOI 10.1016/j.fertnstert.2020.09.159; Magdi Y, 2019, ARCH GYNECOL OBSTET, V300, P1479, DOI 10.1007/s00404-019-05335-1; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Milewski R, 2017, REPRODUCTION, V154, pR37, DOI 10.1530/REP-17-0004; Minasi MG, 2016, HUM REPROD, V31, P2245, DOI 10.1093/humrep/dew183; Motato Y, 2016, FERTIL STERIL, V105, P376, DOI 10.1016/j.fertnstert.2015.11.001; Ng N.H., 2018, ICLR WORKSH; Petersen BM, 2016, HUM REPROD, V31, P2231, DOI 10.1093/humrep/dew188; Pribenszky C, 2010, REPROD BIOMED ONLINE, V21, P533, DOI 10.1016/j.rbmo.2010.04.015; Ramsing NB, 2007, FERTIL STERIL, V88, pS38, DOI 10.1016/j.fertnstert.2007.07.135; Reignier A, 2019, J ASSIST REPROD GEN, V36, P2279, DOI 10.1007/s10815-019-01567-x; Rienzi L, 2019, FERTIL STERIL, V112, P1080, DOI 10.1016/j.fertnstert.2019.07.1322; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rocha JC, 2017, IJCCI 2017, P354; Shapiro BS, 2008, FERTIL STERIL, V90, P302, DOI 10.1016/j.fertnstert.2007.06.062; Smith LN, 2019, PROC SPIE, V11006, DOI 10.1117/12.2520589; Steyerberg EW., 2019, CLIN PREDICTION MODE; Storr A, 2017, HUM REPROD, V32, P307, DOI 10.1093/humrep/dew330; Sundvall L, 2013, HUM REPROD, V28, P3215, DOI 10.1093/humrep/det366; Tran D, 2019, HUM REPROD, V34, P1011, DOI 10.1093/humrep/dez064; VerMilyea M, 2020, HUM REPROD, V35, P770, DOI 10.1093/humrep/deaa013; Vitrolife, 2019, KIDSCORE D5 DEC SUPP, P1; Wang Y, 2013, LECT NOTES COMPUT SC, V8150, P460, DOI 10.1007/978-3-642-40763-5_57; Zhan QS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166398	62	5	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262661	10.1371/journal.pone.0262661	http://dx.doi.org/10.1371/journal.pone.0262661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108306	gold, Green Published, Green Submitted			2022-12-26	WOS:000775890100032
J	Likindikoki, SL; Meyrowitsch, DW; Mizinduko, MM; Ishungisa, AM; Tersbol, BP; Leyna, GH; Moen, K; Makyao, N; Lange, T; Leshabari, MT; Mmbaga, EJ				Likindikoki, Samuel L.; Meyrowitsch, Dan W.; Mizinduko, Mucho M.; Ishungisa, Alexander M.; Tersbol, Britt P.; Leyna, Germana H.; Moen, Kare; Makyao, Neema; Lange, Theis; Leshabari, Melkizedeck T.; Mmbaga, Elia J.			Socio-cognitive factors influencing access to HIV prevention services among people who inject drugs in Dar es Salaam, Tanzania: An integrated bio-behavioural survey	PLOS ONE			English	Article							RISK BEHAVIORS; PREVALENCE; EPIDEMIOLOGY; HEALTH; USERS	Introduction People who inject drugs (PWID) in Sub-Saharan Africa have limited access to comprehensive HIV services. While it is important to inform programming, knowledge about factors influencing access to comprehensive HIV services is scarce. We assessed the proportions of PWID with access to HIV prevention services and associated socio-cognitive factors in Tanzania. Methods A cross-sectional survey was conducted among PWID between October and December 2017 in Dar es Salaam, Tanzania. Data on access to HIV prevention services, demographics and selected socio-cognitive factors were collected through structured face-to-face interviews. Weighted descriptive and forward selection multivariable logistics regression analyses were done to assess independent associations between HIV prevention services and predictors of interest. The results were two tailed and a p-value of less than 0.05 was considered statistically significant. Results The study included 611 PWID (males: 94.4%) with a median age of 34 years (Interquartile Range (IQR), 29-38). A large majority of participants reported to have access to condoms (87.8%), sterile needles/syringes (72.8%) and ever tested for HIV (66.0%). About half (52.0%) reported to have used condoms in the past one month and about a third (28.5%) accessed a peer educator. The odds of testing for HIV decreased among participants who perceived their HIV risk to be high (aOR = 0.29; 95%CI: 0.17-0.49) and those experienced sexual violence (aOR = 0.60; 95%CI 0.37-0.98). However, the odds of testing for HIV increased among participants with secondary level of education (aOR = 2.16; 95%CI: 1.06-5.55), and those who reported having correct comprehensive HIV knowledge (CCHK) (aOR = 1.63; 95%CI 1.12-2.41). The odds of access to condoms increased among females (aOR = 2.23; 95%CI: 1.04-5.02) but decreased among participants with secondary level of education (aOR = 0.41; 95%CI: 0.19-0.84), an income of >TZS 200,000 (aOR = 0.39; 95%CI: 0.23-0.66) and those who perceived their HIV risk to be high (aOR = 0.13; 95%CI: 0.03-0.36). The odds of access to peer educators was higher among participants with primary (aOR = 1.61; 95%CI: 1.01-2.26), and secondary (aOR = 2.71; 95%CI: 1.39-5.33) levels of education. The odds of access to sterile needle and syringe decreased among participants who perceived their HIV risk to be high (aOR = 0.11;95%CI 0.05-0.22), and low-medium (aOR = 0.25;95%CI 0.11-0.52) but increased among those with primary level of education (aOR = 1.72;95%CI 1.06-2.78). Conclusion Access to condom, HIV testing, sterile needles and syringes were relatively high among PWID. However, condom use and access to peer educators was relatively low. HIV knowledge and risk perception, gender, education, and sexual violence influenced access to HIV prevention services. There is an urgent need to address the identified socio-cognitive factors and scale up all aspects of HIV prevention services to fast-track attainment of the 2025 UNAIDS goals and ending the HIV epidemic.	[Likindikoki, Samuel L.; Mizinduko, Mucho M.; Leyna, Germana H.; Mmbaga, Elia J.] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Likindikoki, Samuel L.] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat & Mental Hlth, Dar Es Salaam, Tanzania; [Meyrowitsch, Dan W.; Tersbol, Britt P.] Univ Copenhagen, Global Hlth Sect, Dept Publ Hlth, Copenhagen, Denmark; [Ishungisa, Alexander M.; Leshabari, Melkizedeck T.] Muhimbili Univ Hlth & Allied Sci, Dept Behav Sci, Dar Es Salaam, Tanzania; [Leyna, Germana H.] Tanzania Food & Nutr Ctr, Dar Es Salaam, Tanzania; [Moen, Kare; Mmbaga, Elia J.] Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway; [Makyao, Neema] Natl AIDS Control Programme, Minist Hlth, Community Dev Gender Children & Elderly, Dodoma, Tanzania; [Lange, Theis] Univ Copenhagen, Sect Biostat, Dept Publ Hlth, Copenhagen, Denmark	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; University of Copenhagen; Muhimbili University of Health & Allied Sciences; University of Oslo; University of Copenhagen	Likindikoki, SL (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.; Likindikoki, SL (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Psychiat & Mental Hlth, Dar Es Salaam, Tanzania.	likindikoki@gmail.com		Meyrowitsch, Dan/0000-0003-1108-8987; Likindikoki, Samuel/0000-0002-1642-3206; Lange, Theis/0000-0001-6807-8347				[Anonymous], 2018, GLOBAL STATE HARM RE; [Anonymous], 2014, GAP REP; Armstrong G, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-151; Bertoni N, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-5; Center for Disease Control and Prevention, 2017, SLEEP, P1; Centers for Disease Control and Prevention, 2017, SEXUALLY TRANSMITTED; Cornford C, 2016, BRIT J GEN PRACT, V66, P286, DOI 10.3399/bjgp16X685333; Daley DC, 2013, J FOOD DRUG ANAL, V21, pS73, DOI 10.1016/j.jfda.2013.09.038; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Des Jarlais DC, 2009, CURR OPIN HIV AIDS, V4, P308, DOI 10.1097/COH.0b013e32832bbc6f; Dragisic Tatjana, 2015, Mater Sociomed, V27, P188, DOI 10.5455/msm.2015.27.188-191; Etudo O, 2017, AIDS CARE, V29, P953, DOI 10.1080/09540121.2016.1271936; European Centre for Disease Prevention and Control`, 2019, HIV PEOPL WHO INJ DR; Fernandes RM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4210-2; Fettig J, 2014, INFECT DIS CLIN N AM, V28, P323, DOI 10.1016/j.idc.2014.05.001; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Gowda GS, 2019, INDIAN J PSYCHOL MED, V41, P138, DOI 10.4103/IJPSYM.IJPSYM_152_18; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jamieson D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20917; Lang K, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-35; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Likindikoki SL, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00364-5; Loeliger KB, 2016, ADDICT BEHAV, V53, P31, DOI 10.1016/j.addbeh.2015.09.013; Marshall BDL, 2009, SEX TRANSM INFECT, V85, P121, DOI 10.1136/sti.2008.032524; Miller T., 2008, DHHS PUB, V07-4298; Mmbaga EJ, 2017, SEX TRANSM DIS, V44, P79, DOI 10.1097/OLQ.0000000000000555; Myers B., 2012, BARRIERS ANTIRETROVI, P1; Nambiar D, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-308; National Bureau of Statistics (NBS) [Tanzania] and ICF Macro, 2011, TANZ DEM HLTH SURV 2; Paquette CE, 2018, INT J DRUG POLICY, V57, P104, DOI 10.1016/j.drugpo.2018.04.004; Scheibe A, 2016, INT J DRUG POLICY, V30, P107, DOI 10.1016/j.drugpo.2016.01.004; Schulte MT, 2013, PUBLIC HEALTH REV, V35; Sypsa V, 2017, J INFECT DIS, V215, P1496, DOI 10.1093/infdis/jix100; Nguyen TMT, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0191-8; Tanzania Ministry of Health Community Development Gender Elderly and Children National AIDS Control Program (NACP), 2014, TANZ NAT GUID COMPR; Tanzania. National AIDS Control Programme (NACP)`, 2014, CONS EST KEY POP SIZ; Terlikbayeva A, 2013, DRUG ALCOHOL DEPEN, V132, pS61, DOI 10.1016/j.drugalcdep.2013.07.007; UNAIDS, 2019, GLOB AIDS MON; UNAIDS, 2019, TARG SETT IMP RES NE; UNAIDS, 2014, HELP END AIDS EP; United Nations Department of Economic and Social Affairs PD, 2018, WORLDS CIT 2018 WORL, P34; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2019, UNAIDS DAT 2019, P476; Warren EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198680; WHO UNODC UNAIDS`, 2009, TU ACC HIV PREV TREA; Williams ML, 2007, AIDS BEHAV, V11, P137, DOI 10.1007/s10461-006-9102-x; Woodak A., 2004, EVIDENCE ACTION TECH, P61; World Health Organization, 2016, POL BRIEF CONS GUID; World Health Organization (WHO)`, 2015, WHO EXP PUBL HLTH AP	50	0	0	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0261500	10.1371/journal.pone.0261500	http://dx.doi.org/10.1371/journal.pone.0261500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089928	gold, Green Published			2022-12-26	WOS:000769158400008
J	Carvalho, SB; Gomes, RA; Pfenninger, A; Fischer, M; Strotbek, M; Isidro, IA; Tugcu, N; Gomes-Alves, P				Carvalho, Sofia B.; Gomes, Ricardo A.; Pfenninger, Anja; Fischer, Martina; Strotbek, Michaela; Isidro, Ines A.; Tugcu, Nihal; Gomes-Alves, Patricia			Multi attribute method implementation using a High Resolution Mass Spectrometry platform: From sample preparation to batch analysis	PLOS ONE			English	Article							MULTIATTRIBUTE METHOD; MONOCLONAL-ANTIBODY; GLYCOSYLATION; OXIDATION	Quality control of biopharmaceuticals such as monoclonal antibodies (mAbs) has been evolving and becoming more challenging as the requirements of the regulatory agencies increase due to the demanding complexity of products under evaluation. Mass Spectrometry (MS)-based methods such as the multi-attribute method (MAM) are being explored to achieve a deeper understanding of the attributes critical for the safety, efficacy, and quality of these products. MAM uses high mass accuracy/high-resolution MS data that enables the direct and simultaneous monitoring of relevant product quality attributes (PQAs, in particular, chemical modifications) in a single workflow, replacing several orthogonal methods, reducing time and costs associated with these assays. Here we describe a MAM implementation process using a QTOF high resolution platform. Method implementation was accomplished using NIST (National Institute for Standards and Technology) mAb reference material and an in-process mAb sample. PQAs as glycosylation profiles, methionine oxidation, tryptophan dioxidation, asparagine deamidation, pyro-Glu at N-terminal and glycation were monitored. Focusing on applications that require batch analysis and high-throughput, sample preparation and LC-MS parameters troubleshooting are discussed. This MAM workflow was successfully explored as reference analytical tool for comprehensive characterization of a downstream processing (DSP) polishing platform and for a comparability study following technology transfer between different laboratories.	[Carvalho, Sofia B.; Gomes, Ricardo A.; Isidro, Ines A.; Gomes-Alves, Patricia] Inst Biol Expt & Tecnol, iBET, Oeiras, Portugal; [Carvalho, Sofia B.; Gomes, Ricardo A.; Isidro, Ines A.; Gomes-Alves, Patricia] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, ITQB NOVA, Oeiras, Portugal; [Pfenninger, Anja; Fischer, Martina; Strotbek, Michaela] Sanofi R&D, Biol Dev, Ind Pk Hochst, Frankfurt, Germany; [Tugcu, Nihal] Sanofi, Global CMC Dev, Mammalian Platform, Framingham, MA USA	Universidade Nova de Lisboa; Sanofi-Aventis; Sanofi-Aventis	Gomes-Alves, P (corresponding author), Inst Biol Expt & Tecnol, iBET, Oeiras, Portugal.; Gomes-Alves, P (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, ITQB NOVA, Oeiras, Portugal.	palves@ibet.pt	Gomes-Alves, Patrícia I/F-7875-2011; Gomes-Alves, Patrícia/AAH-5643-2021; Isidro, Ines A/D-2028-2013; Gomes, Ricardo/E-8379-2012	Gomes-Alves, Patrícia I/0000-0001-7245-6785; Gomes-Alves, Patrícia/0000-0001-7245-6785; Isidro, Ines A/0000-0002-0237-5805; Gomes, Ricardo/0000-0001-7155-0059	iNOVA4Health [UIDB/04462/2020, UIDP/04462/2020]; Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia, Tecnologia e Ensino Superior	iNOVA4Health; Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia, Tecnologia e Ensino Superior(Portuguese Foundation for Science and Technology)	This work was funded by iNOVA4Health UIDB/04462/2020 and UIDP/04462/2020, a program financially supported by Fundacao para a Ciencia e Tecnologia/Ministe ' rio da Ciencia, Tecnologia e Ensino Superior, through national funds is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banker DD., 2001, CURR CLIN PHARMACOL, P651, DOI [10.2174/1574884712666170809124728, DOI 10.2174/1574884712666170809124728]; Beck A, 2013, ANAL CHEM, V85, P715, DOI 10.1021/ac3032355; Berkowitz SA, 2012, NAT REV DRUG DISCOV, V11, P527, DOI 10.1038/nrd3746; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Castelli MS, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.535; Fekete S, 2016, ANAL CHEM, V88, P480, DOI 10.1021/acs.analchem.5b04561; Gomes RA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219156; International Conference on Harmonisation, 2009, ICH HARMONIZED TRIPA; Jakes C, 2021, J AM SOC MASS SPECTR, V32, P1998, DOI 10.1021/jasms.0c00432; Kaplon H, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1703531; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; Li WZ, 2015, ACS SYM SER, V1201, P119; Lin TJ, 2019, MABS-AUSTIN, V11, P1, DOI 10.1080/19420862.2018.1531965; Mo JJ, 2018, MABS-AUSTIN, V10, P406, DOI 10.1080/19420862.2018.1438796; Mouchahoir T, 2021, J AM SOC MASS SPECTR, V32, P913, DOI 10.1021/jasms.0c00415; Oshinbolu S, 2018, TRAC-TREND ANAL CHEM, V101, P120, DOI 10.1016/j.trac.2017.10.026; Ranbaduge Nilini, BEST PRACTICES ATTRI; Ren D, 2020, TRENDS BIOTECHNOL, V38, P1051, DOI 10.1016/j.tibtech.2020.06.007; Rogers RS, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0168-3; Rogers RS, 2015, MABS-AUSTIN, V7, P881, DOI 10.1080/19420862.2015.1069454; Sciex AB, 2020, CHARACTERIZATION CHA, DOI [10.1021/acs.analchem.0c00185, DOI 10.1021/ACS.ANALCHEM.0C00185]; Shi RL, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1739825; Song YE, 2021, J CHROMATOGR B, V1166, DOI 10.1016/j.jchromb.2021.122540; Strlic M, 1999, ACTA CHIM SLOV, V46, P555; Tajiri-Tsukada M, 2020, BIOENGINEERED, V11, P984, DOI 10.1080/21655979.2020.1814683; Wang T, 2017, ANAL CHEM, V89, P3562, DOI 10.1021/acs.analchem.6b04856; Wang Y, 2016, MABS-AUSTIN, V8, P1477, DOI 10.1080/19420862.2016.1226715; Xu WC, 2017, MABS-AUSTIN, V9, P1186, DOI 10.1080/19420862.2017.1364326; Xu XB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223899; Zhang Y, 2017, BIOANALYSIS, V9, P499, DOI 10.4155/bio-2017-0004; Zhang ZQ, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1783062; Zhang Zoe, DETECTION DEFINITION	32	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262711	10.1371/journal.pone.0262711	http://dx.doi.org/10.1371/journal.pone.0262711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085302	Green Published, gold			2022-12-26	WOS:000779379600075
J	Gruner, S; Khassine, I				Gruener, Sven; Khassine, Ilia			Is there a link between endowment inequality and deception? - an analysis of students and chess players	PLOS ONE			English	Article							UNITED-STATES; PREFERENCES; AVERSION; PUNISHMENT	YY This paper investigates experimentally the relationship between inequality in endowment and deception. Our basic design is adopted from Gneezy (2005): two players interact in a deception game. It is common knowledge that player 1 has private information about the payoffs for both players of two alternative actions. Player 1 sends a message to player 2, indicating which alternative putatively will end up in a higher payoff for player 2. The message, which can either be true or false, does not affect the payoffs of the players. Player 2 has no information about the payoffs. However, player 2 selects one of the two alternatives A or B, which is payoff-relevant for both players. Our paper adds value to the literature by extending Gneezy (2005) in two ways. First, we systematically vary the initial endowment of players 1 and 2 (common knowledge to both of them). Second, we do not limit ourselves to the standard population of university students but also recruit chess players that are not enrolled in any degree program. Doing so, we want to find out if our results remain robust over a non-standard subject population which is known to be experienced to some extent in strategic interactions. Our main findings are: (i) non-students behave more honestly than students, (ii) students are more likely to trust the opponent's message, and (iii) students and non-students behave differently to variation in initial endowment.	[Gruener, Sven] Martin Luther Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nutr Sci, Chair Agribusiness Management, Halle, Germany; [Khassine, Ilia] Univ Leipzig, Fac Econ & Management Sci, Leipzig, Germany	Martin Luther University Halle Wittenberg; Leipzig University	Khassine, I (corresponding author), Univ Leipzig, Fac Econ & Management Sci, Leipzig, Germany.	iliakhassine@gmail.com		Gruener, Sven/0000-0001-5794-7076	German Research Foundation (DFG, German Research Foundation) [388911356]	German Research Foundation (DFG, German Research Foundation)(German Research Foundation (DFG))	The financial support of the German Research Foundation (DFG, German Research Foundation - 388911356) is acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler J, 2019, ECONOMETRICA, V87, P1115, DOI 10.3982/ECTA14673; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Alatas V, 2009, EXP ECON, V12, P113, DOI 10.1007/s10683-008-9207-3; Anderson J, 2013, EXP ECON, V16, P170, DOI 10.1007/s10683-012-9327-7; Berggren N, 2011, J ECON BEHAV ORGAN, V80, P459, DOI 10.1016/j.jebo.2011.05.002; Birkelund J, 2020, J ECON BEHAV ORGAN, V170, P355, DOI 10.1016/j.jebo.2019.12.014; Bolton GE, 2010, AM ECON REV, V100, P628, DOI 10.1257/aer.100.1.628; Camerer C.F., 2015, HDB EXPT EC METHODOL, P249; Charness G, 2019, EXP ECON, V22, P155, DOI 10.1007/s10683-018-9584-1; Cohn A, 2016, CURR OPIN PSYCHOL, V12, P17, DOI 10.1016/j.copsyc.2016.04.019; Cooper D.J., 2007, ADV EC ANAL POLICY, V6, P1; Cooper David J., 2015, HDB EXPT EC, V2, P217; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dhami S., 2016, FDN BEHAV EC ANAL; Duesenberry J.S., 1949, INCOME SAVING THEORY, DOI 10.2307/2226615; Dyer JH, 2003, ORGAN SCI, V14, P57, DOI 10.1287/orsc.14.1.57.12806; Ettinger D, 2010, AM ECON J-MICROECON, V2, P1, DOI 10.1257/mic.2.1.1; Falk A, 2013, J EUR ECON ASSOC, V11, P839, DOI 10.1111/jeea.12019; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E, 2006, AM ECON REV, V96, P1912, DOI 10.1257/aer.96.5.1912; Frank R. H., 1985, CHOOSING RIGHT POND; Frechette G.R., 2015, HDB EXPT EC, V2, P435; FrUchette G.R., 2015, HDB EXPT EC METHODOL, P360, DOI DOI 10.1093/ACPROF:OSO/9780195328325.003.0019; Galeotti F, 2017, J ECON BEHAV ORGAN, V142, P451, DOI 10.1016/j.jebo.2017.08.007; Gino F, 2009, PSYCHOL SCI, V20, P1153, DOI 10.1111/j.1467-9280.2009.02421.x; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Grolleau G, 2016, MANAGE SCI, V62, P3428, DOI 10.1287/mnsc.2015.2313; Guala F., 2005, METHODOLOGY EXPT EC; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; John LK, 2014, ORGAN BEHAV HUM DEC, V123, P101, DOI 10.1016/j.obhdp.2013.08.002; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1093/qje/120.3.963; Piketty T., 2014, CAPITAL 21 CENTURY; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rodriguez-Lara I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204392; Schmitt M, 2009, PSYCHOL RUNDSCH, V60, P8, DOI 10.1026/0033-3042.60.1.8; Simon H. A., 1957, MODELS MAN; Sutter M, 2009, ECON J, V119, P47, DOI 10.1111/j.1468-0297.2008.02205.x; Utikal V, 2013, J ECON BEHAV ORGAN, V85, P108, DOI 10.1016/j.jebo.2012.11.011; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Zucman G, 2019, ANNU REV ECON, V11, P109, DOI 10.1146/annurev-economics-080218-025852	43	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262144	10.1371/journal.pone.0262144	http://dx.doi.org/10.1371/journal.pone.0262144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085259	Green Published, Green Submitted, gold			2022-12-26	WOS:000779379600038
J	Kassongo, J; Shahsavari, E; Ball, AS				Kassongo, Josue; Shahsavari, Esmaeil; Ball, Andrew S.			Substrate-to-inoculum ratio drives solid-state anaerobic digestion of unamended grape marc and cheese whey	PLOS ONE			English	Article							CO-DIGESTION; ORGANIC FRACTION; METHANE PRODUCTION; WASTE-WATER; BIOGAS PRODUCTION; LIGNOCELLULOSIC BIOMASS; YARD TRIMMINGS; FOOD; SLUDGE; FEEDSTOCK	Inoculation dose is a key operational parameter for the solid-state anaerobic digestion (SS-AD) of lignocellulosic biomass, maximum methane recovery, and stable digester performance. The novelty of this study was the co-digestion of unamended full-strength grape marc and cheese whey for peak methane extraction at variable inoculation levels. An acclimatised digestate from a preceding anaerobic treatment was used as a downstream inoculum. The impact of inoculum size (wet weight) was evaluated at 0/10, 5/5, 7/3 and 9/1 substrate-to-inoculum (S/I) ratios, corresponding to an initial concentration of 20-30% total solids (TS) in digesters over 58 days at 45 degrees C. The optimal 7/3 S/I produced the highest cumulative methane yield, 6.45 L CH4 kg(-1) VS, coinciding with the lowest initial salinity at 11%; the highest volumetric methane productivity rate of 0.289 +/- 0.044 L CH4 L-Work(-1) d(-1); the highest average COD/N ratio of 9.88; the highest final pH of 9.13, and a maximum 15.07% elemental carbon removal; for a lag time of 9.4 days. This study identified an optimal inoculation dose and opens up an avenue for the direct co-digestion of grape marc and cheese whey without requirements for substrate pretreatment, thus improving the overall bioenergy profile of the winery and dairy joint resource recovery operations.	[Kassongo, Josue; Shahsavari, Esmaeil; Ball, Andrew S.] RMIT Univ, ARC Training Ctr Transformat Australias Biosolids, Sch Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Kassongo, J (corresponding author), RMIT Univ, ARC Training Ctr Transformat Australias Biosolids, Sch Sci, Melbourne, Vic, Australia.	s3695235@student.rmit.edu.au		Kassongo, Josue/0000-0002-3142-8048	Commonwealth Government of Australia; Research Training Program Scholarship	Commonwealth Government of Australia(Australian Government); Research Training Program Scholarship	The authors would like to thank the Commonwealth Government of Australia for having provided financial support through the Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Guendouz A, 2012, BIORESOURCE TECHNOL, V111, P55, DOI 10.1016/j.biortech.2012.01.174; Aceves-Lara CA, 2012, WATER SCI TECHNOL, V65, P1281, DOI 10.2166/wst.2012.703; Agdag ON, 2007, J HAZARD MATER, V140, P75, DOI 10.1016/j.jhazmat.2006.06.059; BORJA R, 1995, ENVIRON POLLUT, V88, P13, DOI 10.1016/0269-7491(95)91043-K; Borowski S, 2015, INT BIODETER BIODEGR, V105, P106, DOI 10.1016/j.ibiod.2015.08.022; Brown D, 2012, BIORESOURCE TECHNOL, V124, P379, DOI 10.1016/j.biortech.2012.08.051; Buswell A.M., 1930, B ILLINOIS STATE WAT; Carlu E., 2019, BIOGAS OPPORTUNITIES; Carrere H, 2016, BIORESOURCE TECHNOL, V199, P386, DOI 10.1016/j.biortech.2015.09.007; Carucci G, 2005, J ENVIRON ENG, V131, P1037, DOI 10.1061/(ASCE)0733-9372(2005)131:7(1037); Ceron-Vivas A, 2019, REV FAC ING-UNIV ANT, P88, DOI 10.17533/udea.redin.20190627; Cherosky P.B., 2012, ANAEROBIC DIGESTION; Cordoba V, 2016, J ENVIRON CHEM ENG, V4, P115, DOI 10.1016/j.jece.2015.11.003; Corno L, 2014, BIOTECHNOL ADV, V32, P1535, DOI 10.1016/j.biotechadv.2014.10.006; Cui ZF, 2011, BIORESOURCE TECHNOL, V102, P9432, DOI 10.1016/j.biortech.2011.07.062; Da Ros C, 2017, J ENVIRON MANAGE, V203, P745, DOI 10.1016/j.jenvman.2016.03.029; Da Ros C, 2016, BIOMASS BIOENERG, V91, P150, DOI 10.1016/j.biombioe.2016.05.017; Dai XH, 2016, BIORESOURCE TECHNOL, V216, P323, DOI 10.1016/j.biortech.2016.05.100; Del Borghi A, 1999, BIOPROCESS ENG, V20, P553, DOI 10.1007/s004490050628; Dinuccio E, 2010, BIORESOURCE TECHNOL, V101, P3780, DOI 10.1016/j.biortech.2009.12.113; Eaton A. D., 2005, STANDARD METHODS EXA; El Hadj TB, 2009, WATER SCI TECHNOL, V59, P1153, DOI 10.2166/wst.2009.100; Fabbri A, 2015, WASTE MANAGE, V36, P156, DOI 10.1016/j.wasman.2014.11.022; Fitamo T, 2017, WATER RES, V118, P261, DOI 10.1016/j.watres.2017.04.012; Forster-Carneiro T, 2007, BIORESOURCE TECHNOL, V98, P3195, DOI 10.1016/j.biortech.2006.07.008; Garcia-Lomillo J, 2017, COMPR REV FOOD SCI F, V16, P3, DOI 10.1111/1541-4337.12238; Ge XM, 2016, BIORESOURCE TECHNOL, V205, P239, DOI 10.1016/j.biortech.2016.01.050; Hartmann H, 2004, WASTE MANAGE RES, V22, P35, DOI 10.1177/0734242X04042748; Hartmann H., 2002, CODIGESTION ORGANIC, P181; Holliger C, 2016, WATER SCI TECHNOL, V74, P2515, DOI 10.2166/wst.2016.336; Hupfauf S, 2020, BIORESOURCE TECHNOL, V300, DOI 10.1016/j.biortech.2019.122671; Jankowska E, 2018, CHEM ENG J, V345, P395, DOI 10.1016/j.cej.2018.03.180; Kafle GK, 2014, J ENVIRON MANAGE, V133, P293, DOI 10.1016/j.jenvman.2013.12.006; Kafle GK, 2013, BIORESOURCE TECHNOL, V127, P326, DOI 10.1016/j.biortech.2012.09.032; Kassongo J, 2020, BIOMASS BIOENERG, V143, DOI 10.1016/j.biombioe.2020.105880; Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x; Khalid A, 2011, WASTE MANAGE, V31, P1737, DOI 10.1016/j.wasman.2011.03.021; Kim HW, 2003, WASTE MANAGE RES, V21, P515, DOI 10.1177/0734242X0302100604; Koch K, 2019, FRONT ENV SCI-SWITZ, V7, DOI 10.3389/fenvs.2019.00178; Lee DH, 2009, WASTE MANAGE, V29, P876, DOI 10.1016/j.wasman.2008.06.033; Li YB, 2011, RENEW SUST ENERG REV, V15, P821, DOI 10.1016/j.rser.2010.07.042; Li YQ, 2013, BIORESOURCE TECHNOL, V149, P406, DOI 10.1016/j.biortech.2013.09.091; Liew LN, 2012, BIOMASS BIOENERG, V46, P125, DOI 10.1016/j.biombioe.2012.09.014; Lin RC, 2017, BIORESOURCE TECHNOL, V239, P345, DOI 10.1016/j.biortech.2017.05.017; Lin YQ, 2014, BIORESOURCE TECHNOL, V169, P468, DOI 10.1016/j.biortech.2014.07.020; Liu CF, 2008, BIORESOURCE TECHNOL, V99, P882, DOI 10.1016/j.biortech.2007.01.013; Lo YM, 2007, BIOPROCESSING FOR VALUE-ADDED PRODUCTS FROM RENEWABLE RESOURCES: NEW TECHNOLOGIES AND APPLICATIONS, P559, DOI 10.1016/B978-044452114-9/50023-2; Ma XG, 2019, APPL BIOCHEM BIOTECH, V189, P884, DOI 10.1007/s12010-019-03035-9; Mata-Alvarez J, 2014, RENEW SUST ENERG REV, V36, P412, DOI 10.1016/j.rser.2014.04.039; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; Maya-Altamira L, 2008, WATER RES, V42, P2195, DOI 10.1016/j.watres.2007.11.033; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Motte JC, 2013, BIORESOURCE TECHNOL, V144, P141, DOI 10.1016/j.biortech.2013.06.057; Neves L, 2008, WASTE MANAGE, V28, P965, DOI 10.1016/j.wasman.2007.03.031; Neves L, 2004, PROCESS BIOCHEM, V39, P2019, DOI 10.1016/j.procbio.2003.10.002; Nielfa A, 2015, Biotechnol Rep (Amst), V5, P14, DOI 10.1016/j.btre.2014.10.005; Nolla-Ardevol V, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicp.2015.00597, 10.3389/fmicb.2015.00597]; Oh G, 2008, J CHEM TECHNOL BIOT, V83, P1204, DOI 10.1002/jctb.1923; Pastor-Poquet V, 2018, WATER RES, V142, P501, DOI 10.1016/j.watres.2018.06.016; Pavan P, 2000, WATER SCI TECHNOL, V41, P165, DOI 10.2166/wst.2000.0264; Pellera FM, 2017, J ENVIRON CHEM ENG, V5, P352, DOI 10.1016/j.jece.2016.12.009; Ponsa S, 2011, BIOSYST ENG, V108, P352, DOI 10.1016/j.biosystemseng.2011.01.007; Prazeres AR, 2012, J ENVIRON MANAGE, V110, P48, DOI 10.1016/j.jenvman.2012.05.018; Puyuelo B, 2011, CHEMOSPHERE, V85, P653, DOI 10.1016/j.chemosphere.2011.07.014; Qiao S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12732; Raposo F, 2006, PROCESS BIOCHEM, V41, P1444, DOI 10.1016/j.procbio.2006.01.012; Roati C., 2012, American Journal of Environmental Sciences, V8, P291, DOI 10.3844/ajessp.2012.291.296; Robles A, 2016, WATER SCI TECHNOL, V73, P2294, DOI 10.2166/wst.2016.031; Sawyerr N, 2019, J ECOL ENG, V20, P103, DOI 10.12911/22998993/108652; Shi J, 2014, BIORESOURCE TECHNOL, V157, P188, DOI 10.1016/j.biortech.2014.01.089; Supaphol S, 2011, BIORESOURCE TECHNOL, V102, P4021, DOI 10.1016/j.biortech.2010.11.124; Tian T, 2017, BIORESOURCE TECHNOL, V224, P41, DOI 10.1016/j.biortech.2016.10.058; Tyagi VK, 2018, RENEW SUST ENERG REV, V93, P380, DOI 10.1016/j.rser.2018.05.051; Viggi CC, 2014, ENVIRON SCI TECHNOL, V48, P7536, DOI 10.1021/es5016789; Wang H, 2010, BIODEGRADATION, V21, P135, DOI 10.1007/s10532-009-9288-5; Wang ZJ, 2013, BIORESOURCE TECHNOL, V144, P281, DOI 10.1016/j.biortech.2013.06.106; Ward AJ, 2008, BIORESOURCE TECHNOL, V99, P7928, DOI 10.1016/j.biortech.2008.02.044; Xu FQ, 2016, BIORESOURCE TECHNOL, V200, P753, DOI 10.1016/j.biortech.2015.10.103; Xu FQ, 2014, BIORESOURCE TECHNOL, V173, P168, DOI 10.1016/j.biortech.2014.09.090; Xu FQ, 2013, WASTE MANAGE, V33, P26, DOI 10.1016/j.wasman.2012.08.006; Xu FQ, 2012, BIORESOURCE TECHNOL, V118, P219, DOI 10.1016/j.biortech.2012.04.102; Zhang PU, 2008, FUEL PROCESS TECHNOL, V89, P485, DOI 10.1016/j.fuproc.2007.11.013; Zhang Y, 2017, J CHEM TECHNOL BIOT, V92, P2392, DOI 10.1002/jctb.5246; Zhao J, 2014, BIORESOURCE TECHNOL, V156, P176, DOI 10.1016/j.biortech.2014.01.011; Zhao JW, 2017, WASTE MANAGE, V67, P308, DOI 10.1016/j.wasman.2017.05.016	85	3	3	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262940	10.1371/journal.pone.0262940	http://dx.doi.org/10.1371/journal.pone.0262940			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085345	Green Published, gold			2022-12-26	WOS:000779379600100
J	Minwuyelet, F; Mulugeta, H; Tsegaye, D; Lake, B; Getie, A; Tsegaye, B; Mullu, G				Minwuyelet, Fentahun; Mulugeta, Henok; Tsegaye, Dejene; Lake, Benalfew; Getie, Asmare; Tsegaye, Baye; Mullu, Getachew			Quality of life and associated factors among patients with epilepsy at specialized hospitals, Northwest Ethiopia; 2019	PLOS ONE			English	Article								Background Epilepsy is a chronic non-communicable brain disorder and the second most burdensome disease in terms of disability-adjusted life years which is characterized by recurrent epileptic seizures, and a constant threat to the quality of life of the patient. Nearly 80% of people with epilepsy live in low- and middle-income countries and the risk of premature death in people with epilepsy is up to three times higher than for the general population. In many parts of the world, people with epilepsy and their families suffer from stigma and discrimination. This study was aimed to assess the quality of life and associated factors among adult people living with epilepsy using the world health organization quality of life assessment tool. Methods Institution-based cross-sectional study design was conducted on 419 epileptic patients using a systematic random sampling technique. The data were collected using the WHOQOL-BREF questionnaire. The data were entered into EpiData version 3.1 and exported to SPSS version 25 software for further analysis and bivariate and multivariable binary logistic regression analyses were done to identify factors associated with the dependent variable. The level of significance was declared as P value <0.05. Result A total of 402 epileptic patients with a median age of 28 years were involved in the study. The result of this study was revealed that 47.8% (95% CI: 42%, 52%) of the respondents had poor quality of life. Respondents who were in the middle age group (AOR = 0.36, 95% CI: 0.19, 0.70), lower educational level (AOR = 3.11, 95%CI: 1.35, 7.15), those who had low drug adherence (AOR = 8.36, 95%CI: (2.41, 28.98) comorbid anxiety, (AOR = 3.63, 95% CI: 2.55, 8.42) and depression (AOR = 3.85, 95% CI: 2.16, 6.82) were found to be significantly associated with poor quality of life of epilepsy patients. Conclusion This study revealed that almost one in two epileptic patients had poor quality of life. Age of the respondents, lower educational level, comorbid anxiety and depression, and lower adherence to drugs were significantly associated with poor quality of life. Therefore, health institutions and clinicians should not focus only on the treatment of the disease itself rather they should address diseases' impact on the quality of life of patients.	[Minwuyelet, Fentahun; Mulugeta, Henok; Tsegaye, Dejene; Lake, Benalfew] Debre Markos Univ, Coll Hlth Sci, Dept Nursing, Debre Markos, Ethiopia; [Getie, Asmare] Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia; [Tsegaye, Baye] Wolkite Univ, Coll Med & Hlth Sci, Dept Nursing, Wolkite, Ethiopia; [Mullu, Getachew] Debre Markos Univ, Coll Hlth Sci, Dept Midwifery, Debre Markos, Ethiopia	Arba Minch University	Getie, A (corresponding author), Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia.	asmaregetie2017@gmail.com		Tsegaye, Dejen/0000-0002-3285-3855; Getie, Asmare/0000-0002-4078-0078				Abadiga M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4720-3; [Anonymous], 2014, PLOS ONE, V99; [Anonymous], 2014, ETHIOPIA SCI J PUBLI, V2, P378; [Anonymous], 2018, GLOBAL J MED RES, V18; [Anonymous], 2014, J ELSEVIER; [Anonymous], 2015, HINDAWI PUBLISHING C; [Anonymous], 2005, EPILEPSY WHO EUROPEA; [Anonymous], 2000, L S COMPREHENSIVE PH, V8th; [Anonymous], 2018, J PSYCHIAT MENT, V3; [Anonymous], 2020, ETHIOP J HEALTH DEV, V16, P235; [Anonymous], 2010, BEA TRADING LTD, V10, P100, DOI [10.1248/bpb.33.1176, DOI 10.1248/BPB.33.1176]; [Anonymous], 2012, J GLOB HEALTH, V2; [Anonymous], 2015, JOURNA PUBLIC HLTH N, V3, P20; [Anonymous], 2018, FRONTIERS J; [Anonymous], 2013, EPILEPSY CURR; [Anonymous], 2011, EPILEPSY ETHIOPIA; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Jovel CAE, 2016, EPILEPSY RES, V127, P168, DOI 10.1016/j.eplepsyres.2016.08.031; Espinso C., 2018, J ELSEVIER, V56, P56; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Gebremeskel M., 2021, J MULTIDISCIP HEALTH, V13, DOI [10.2147/JMDH.S270137, DOI 10.2147/JMDH.S270137]; Grant AC, 2013, EPILEPSY BEHAV, V27, P283, DOI 10.1016/j.yebeh.2013.01.031; IeIla, 2004, EPILEPSY OUT SHADOW; Jennum P, 2011, EPILEPSIA, V52, P949, DOI 10.1111/j.1528-1167.2010.02946.x; Kinyanjui DWC, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-98; Kubota H, 2010, EPILEPSY BEHAV, V18, P381, DOI 10.1016/j.yebeh.2010.04.045; Mbuba CK, 2012, EPILEPSY BEHAV, V24, P81, DOI 10.1016/j.yebeh.2012.02.019; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mutluay FK, 2016, J PHYS THER SCI, V28, P240, DOI 10.1589/jpts.28.240; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; S.A Up, 2008, QUAL LIF FACT SHEET; Saadi A, 2016, SEIZURE-EUR J EPILEP, V39, P44, DOI 10.1016/j.seizure.2016.05.001; Shakirullah A.N., 2014, INT J CLIN EXP NEURO, V2, P29, DOI DOI 10.12691/IJCEN-2-2-3; Singh P., 2017, INT J RES MED SCI, V5, P452, DOI [10.18203/2320-6012.ijrms20170024, DOI 10.18203/2320-6012.IJRMS20170024]; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Tegegne MT., 2014, SCI J PUBLIC HLTH, V2, P378; Tsai Y-F., 2016, J ELSEVIER, DOI [10.1016/j.yebeh.2016.02.019, DOI 10.1016/J.YEBEH.2016.02.019]; World Health Organization Executive Board 136th Session, 2015, GLOB BURD EP NEED CO; World Health Organization (WHO), 2015, EPILEPSY WIKO; World health organization (WHO), 2019, GLOB REP EP; Yadegary MA, 2015, EPILEPSY BEHAV, V50, P108, DOI 10.1016/j.yebeh.2015.04.051	41	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262814	10.1371/journal.pone.0262814	http://dx.doi.org/10.1371/journal.pone.0262814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085331	gold, Green Published			2022-12-26	WOS:000779379600084
J	Kim, A; Koo, JH; Lee, JM; Joo, MS; Kim, TH; Kim, H; Jun, DW; Kim, SG				Kim, Ayoung; Koo, Ja Hyun; Lee, Jung Min; Joo, Min Sung; Kim, Tae Hyun; Kim, Hyunsung; Jun, Dae Won; Kim, Sang Geon			NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury	FASEB JOURNAL			English	Article						CHOP; ER stress; liver disease; NRF2; SIRT3	ENDOPLASMIC-RETICULUM; MITOCHONDRIAL DYSFUNCTION; FATTY LIVER; NRF2; APOPTOSIS; ACTIVATION	Chronic endoplasmic reticulum (ER) stress in hepatocytes plays a role in the pathogenesis of nonalcoholic fatty liver disease. Therefore, given the association between oxidative stress, mitochondrial dysfunction, and ER stress, our study investigated the role of NRF2-mediated SIRT3 activation in ER stress. SIRT3, a sirtuin, was predicted as the target of NRF2 based on bioinformatic analyses and animal experiments. Nrf2 abrogation diminished mitochondrial DNA content in hepatocytes with Ppargc1 alpha and Cpt1a inhibition, whereas its overexpression enhanced oxygen consumption. Further, chromatin immunoprecipitation and luciferase reporter assays indicated that NRF2 induced SIRT3 through the antioxidant responsive element (ARE) sites comprising the -641 to -631 bp and -419 to -409 bp regions. In tunicamycin-induced ER stress conditions and liver injury animal models following ER stress, NRF2 levels were highly correlated with SIRT3. Nrf2 deficiency enhanced the tunicamycin-mediated induction of CHOP, which was attenuated by Sirt3 overexpression. Further, Sirt3 delivery to hepatocytes in Nrf2 knockout mice prevented tunicamycin from increasing mortality by decreasing ER stress. SIRT3 was upregulated in livers of patients with nonalcoholic liver diseases, whereas lower SIRT3 expression coincided with more severe disease conditions. Taken together, our findings indicated that NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced injury, which may contribute to the inhibition of liver disease progression.	[Kim, Ayoung; Kim, Sang Geon] Dongguk Univ Seoul, Coll Pharm, Ilsandong Gu Dongguk Ro 32, Goyang Si 10326, Gyeonggi Do, South Korea; [Kim, Ayoung; Kim, Sang Geon] Dongguk Univ Seoul, Integrated Res Inst Drug Dev, Goyang Si, South Korea; [Kim, Ayoung; Koo, Ja Hyun; Lee, Jung Min; Joo, Min Sung; Kim, Tae Hyun] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kim, Ayoung; Koo, Ja Hyun; Lee, Jung Min; Joo, Min Sung; Kim, Tae Hyun] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kim, Tae Hyun] Sookmyung Womens Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kim, Hyunsung] Hanyang Univ, Dept Pathol, Sch Med, Seoul, South Korea; [Jun, Dae Won] Hanyang Univ, Internal Med, Sch Med, Seoul, South Korea	Dongguk University; Dongguk University; Seoul National University (SNU); Seoul National University (SNU); Sookmyung Women's University; Hanyang University; Hanyang University	Kim, SG (corresponding author), Dongguk Univ Seoul, Coll Pharm, Ilsandong Gu Dongguk Ro 32, Goyang Si 10326, Gyeonggi Do, South Korea.	sgkim@dongguk.edu	Koo, Ja Hyun/GQP-5440-2022; Jun, Dae Won/O-4529-2017	Koo, Ja Hyun/0000-0001-5738-1105; Joo, Min Sung/0000-0001-7857-8302; Kim, Ayoung/0000-0003-2754-0536; Jun, Dae Won/0000-0002-2875-6139	National Research Foundation of Korea (NRF) [2021R1A2B5B03086265, 2021R1A6A3A01087745, 2021R1C1C1013323, 2021R1A4A5033289]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2021R1A2B5B03086265, 2021R1A6A3A01087745, 2021R1C1C1013323 and 2021R1A4A5033289	Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y; Booth DM, 2016, MOL CELL, V63, P240, DOI 10.1016/j.molcel.2016.05.040; Borkham-Kamphorst E, 2018, CELL SIGNAL, V51, P72, DOI 10.1016/j.cellsig.2018.07.005; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Clementino M, 2019, TOXICOL SCI, V169, P224, DOI 10.1093/toxsci/kfz032; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Han CY, 2018, CELL REP, V24, P2985, DOI 10.1016/j.celrep.2018.07.068; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kilanczyk E, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165895; Kim TH, 2018, J CLIN INVEST, V128, P5587, DOI [10.1172/JCI97831, 10.1172/jci97831]; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Liu JX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.564; Mohs A, 2021, J HEPATOL, V74, P638, DOI 10.1016/j.jhep.2020.09.037; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang TS, 2019, MOL CELL, V75, P823, DOI 10.1016/j.molcel.2019.06.008; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Yan WJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00116; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Zhang HH, 2016, MOL CELL BIOCHEM, V420, P95, DOI 10.1007/s11010-016-2771-5; Zhang J, 2020, THERANOSTICS, V10, P8315, DOI 10.7150/thno.45922; Zhang Z, 2018, CHEM-BIOL INTERACT, V296, P76, DOI 10.1016/j.cbi.2018.09.007	35	2	2	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22170	10.1096/fj.202101470R	http://dx.doi.org/10.1096/fj.202101470R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35104011				2022-12-26	WOS:000761250800034
J	Lee, B; Oh, Y; Cho, E; DiAntonio, A; Cavalli, V; Shin, JE; Choi, HW; Cho, Y				Lee, Bohm; Oh, Yeonsoo; Cho, Eunhye; DiAntonio, Aaron; Cavalli, Valeria; Shin, Jung Eun; Choi, Hae Woong; Cho, Yongcheol			FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGENERATION; PATHWAY; LOCALIZATION; REGENERATION; ISOMERASES; DISTINCT; PROGRAM; STRESS; HDAC5	The dual leucine zipper kinase (DLK) is a key regulator of axon regeneration and degeneration in response to neuronal injury; however, regulatory mechanisms of the DLK function via its interacting proteins are largely unknown. To better understand the molecular mechanism of DLK function, we performed yeast two-hybrid screening analysis and identified FK506-binding protein-like (FKBPL, also known as WAF-1/ CIP1 stabilizing protein 39) as a DLK-binding protein. FKBPL binds to the kinase domain of DLK and inhibits its kinase activity. In addition, FKBPL induces DLK protein degradation through ubiquitin-dependent pathways. We further assessed other members in the FKBP protein family and found that FK506-binding protein 8 (FKBP8) also induced DLK degradation. We identified the lysine 271 residue in the kinase domain as a major site of DLK ubiquitination and SUMO3 conjugation and was thus responsible for regulating FKBP8-mediated proteasomal degradation that was inhibited by the substitution of the lysine 271 to arginine. FKBP8-mediated degradation of DLK is mediated by autophagy pathway because knockdown of Atg5 inhibited DLK destabilization. We show that in vivo overexpression of FKBP8 delayed the pro-gression of axon degeneration and suppressed neuronal death after axotomy in sciatic and optic nerves. Taken together, this study identified FKBPL and FKBP8 as novel DLK-interacting proteins that regulate DLK stability via the ubiquitin-proteasome and lysosomal protein degradation pathways.	[Lee, Bohm; Oh, Yeonsoo; Cho, Eunhye; Choi, Hae Woong; Cho, Yongcheol] Korea Univ, Dept Life Sci, Seoul, South Korea; [DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St. Louis, MO USA; [DiAntonio, Aaron] Washington Univ, Needleman Ctr Neurometab & Axonal Therapeut, Sch Med, St. Louis, MO USA; [Cavalli, Valeria] Washington Univ, Sch Med, Dept Neurosci, St. Louis, MO USA; [Cavalli, Valeria] Washington Univ, Ctr Regenerat Med, Sch Med, St. Louis, MO USA; [Cavalli, Valeria] Washington Univ, Hope Ctr Neurol Disorders, Sch Med, St. Louis, MO USA; [Choi, Hae Woong] Dong A Univ Coll Med, Dept Mol Neurosci, Busan, South Korea; [Choi, Hae Woong] Grad Sch Dong A Univ, Dept Translat Biomed Sci, Busan, South Korea	Korea University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Dong A University	Choi, HW; Cho, Y (corresponding author), Korea Univ, Dept Life Sci, Seoul, South Korea.	haewoongchoi@korea.ac.kr; ycho77@korea.ac.kr		Choi, Hae Woong/0000-0001-9372-1875; Shin, Jung Eun/0000-0002-8502-7979; Lee, Bohm/0000-0003-0887-2703	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2019R1A2C1005380, 2016R1A5A2007009, 2020R1C1C1011074]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2019R1A2C1005380 to Y. C., 2016R1A5A2007009 and 2020R1C1C1011074 to J. E. S.) .	Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Cho Y, 2014, J BIOL CHEM, V289, P15820, DOI 10.1074/jbc.M113.536607; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; DiAntonio A, 2019, PAIN, V160, pS17, DOI 10.1097/j.pain.0000000000001528; Fernandes KA, 2014, NEUROBIOL DIS, V69, P108, DOI 10.1016/j.nbd.2014.05.015; Geden MJ, 2016, CURR OPIN NEUROBIOL, V39, P108, DOI 10.1016/j.conb.2016.05.002; Ghartey-Kwansah G, 2018, BMC DEV BIOL, V18, DOI 10.1186/s12861-018-0167-3; HEITMAN J, 1992, NEW BIOL, V4, P448; Holland SM, 2016, P NATL ACAD SCI USA, V113, P763, DOI 10.1073/pnas.1514123113; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Jeon Y, 2021, MOL NEUROBIOL, V58, P750, DOI 10.1007/s12035-020-02155-2; Jin YS, 2019, ANNU REV CELL DEV BI, V35, P501, DOI 10.1146/annurev-cellbio-100617-062644; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Larhammar M, 2017, ELIFE, V6, DOI 10.7554/eLife.20725; Lee B., 2021, PROMOTING AXON REGEN, DOI [10.1101/2021.02.19.431965, DOI 10.1101/2021.02.19.431965]; Lee J, 2020, P NATL ACAD SCI USA, V117, P15955, DOI 10.1073/pnas.1920829117; Lim GGY, 2017, EMBO REP, V18, P864, DOI 10.15252/embr.201744313; Martin DDO, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39968-8; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Misaka T, 2018, J MOL CELL CARDIOL, V114, P93, DOI 10.1016/j.yjmcc.2017.11.004; Montersino A, 2015, MOL MEMBR BIOL, V32, P179, DOI 10.1080/09687688.2016.1182652; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Niu JW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108365; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Shin JE, 2019, NEUROBIOL DIS, V127, P178, DOI 10.1016/j.nbd.2019.02.001; Shin JE, 2018, J COMP NEUROL, V526, P1195, DOI 10.1002/cne.24404; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Summers DW, 2020, MOL NEUROBIOL, V57, P1146, DOI 10.1007/s12035-019-01796-2; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Tong MM, 2016, CURR MOL PHARMACOL, V9, P48, DOI 10.2174/1874467208666150519113541; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Welsbie DS, 2018, INVEST OPHTH VIS SCI, V59; Yoo SM, 2020, FASEB J, V34, P2944, DOI 10.1096/fj.201901735R	38	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101647	10.1016/j.jbc.2022.101647	http://dx.doi.org/10.1016/j.jbc.2022.101647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35101451	Green Published, gold			2022-12-26	WOS:000789261900004
J	Wang, H; Gao, T; Zhou, Y; Ren, JH; Guo, JH; Zeng, JW; Xiao, Y; Zhang, Y; Feng, Y				Wang, Hao; Gao, Teng; Zhou, Yu; Ren, Junhui; Guo, Junhua; Zeng, Jianwei; Xiao, Yu; Zhang, Yi; Feng, Yue			Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE REVEALS; STRUCTURAL BASIS; RESOURCE	Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins provide prokaryotes with nucleic acid-based adaptive immunity against infections of mobile genetic elements, including phages. To counteract this immune process, phages have evolved various anti-CRISPR (Acr) proteins which deactivate CRISPR-Cas-based immunity. However, the mechanisms of many of these Acr-mediated inhibitions are not clear. Here, we report the crystal structure of AcrIF13 and explore its inhibi-tion mechanism. The structure of AcrIF13 is unique and dis-plays a negatively charged surface. Additionally, biochemical studies identified that AcrIF13 interacts with the type I-F CRISPR-Cas surveillance complex (Csy complex) to block target DNA recognition and that the Cas5f-8f tail and Cas7.6f subunit of the Csy complex are specific binding targets of AcrIF13. Further mutational studies demonstrated that several negatively charged residues of AcrIF13 and positively charged residues of Cas8f and Cas7f of the Csy complex are involved in AcrIF13-Csy binding. Together, our findings provide mecha-nistic insights into the inhibition mechanism of AcrIF13 and further suggest the prevalence of the function of Acr proteins as DNA mimics.	[Wang, Hao; Gao, Teng; Ren, Junhui; Guo, Junhua; Zhang, Yi; Feng, Yue] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing Key Lab Bioproc, Beijing, Peoples R China; [Zhou, Yu] Natl Inst Biol Sci, Beijing, Peoples R China; [Zeng, Jianwei; Xiao, Yu] Tsinghua Univ, Minist Educ Key Lab Prot Sci, Tsinghua Peking Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol,Tsinghua Pekin, Beijing, Peoples R China	Beijing University of Chemical Technology; National Institute of Biological Sciences, Beijing; Tsinghua University	Feng, Y (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing Key Lab Bioproc, Beijing, Peoples R China.	fengyue@mail.buct.edu.cn	Feng, Yue/HGE-4589-2022	Feng, Yue/0000-0002-1576-1385; Gao, Teng/0000-0002-2305-5800; Zeng, Jianwei/0000-0002-6880-3366	National Natural Science Foundation of China [32171274, 31822012, 32000901]; National Key Research and Development Program of China [2017YFA0506500, 2019YFC1200500, 2019YFC1200502]; Beijing Natural Science Foundation [5204038]; Beijing Nova Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	We would like to thank the staff at beamlines BL17U1 and BL19U1 of the Shanghai Synchrotron Radiation Facility for their assistance with data collection. We would like to thank the Tsinghua University Branch of China National Center for Protein Sciences Beijing and Shilong Fan for providing facility support for X-ray diffraction of the crystal samples. The authors would like to thank Mrs Wu Yao (State Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese Academy of Sciences) for assistance in the microscale thermophoresis experiment. This work was supported by National Natural Science Foundation of China (32171274, 31822012, and 32000901) , the National Key Research and Development Program of China (2017YFA0506500, 2019YFC1200500, and 2019YFC1200502) , the Beijing Natural Science Foundation (5204038) , and the Beijing Nova Program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2018, CRISPR J, V1, P304, DOI 10.1089/crispr.2018.0043; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Davidson AR, 2020, ANNU REV BIOCHEM, V89, P309, DOI 10.1146/annurev-biochem-011420-111224; Dong C, 2018, NUCLEIC ACIDS RES, V46, pD393, DOI 10.1093/nar/gkx835; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gabel C, 2021, NUCLEIC ACIDS RES, V49, P584, DOI 10.1093/nar/gkaa1199; Guo TW, 2017, CELL, V171, P414, DOI 10.1016/j.cell.2017.09.006; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hirschi M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16512-1; Kim I, 2020, NUCLEIC ACIDS RES, V48, P9959, DOI 10.1093/nar/gkaa690; Koonin EV, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0087; Liu X., 2021, NUCLEIC ACIDS RES, V49, P10178; Lu WT, 2021, NUCLEIC ACIDS RES, V49, P3381, DOI 10.1093/nar/gkab092; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Niu YY, 2020, MOL CELL, V80, P512, DOI 10.1016/j.molcel.2020.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinilla-Redondo R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19415-3; Rollins MF, 2019, MOL CELL, V74, P132, DOI 10.1016/j.molcel.2019.02.001; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zhang KM, 2020, P NATL ACAD SCI USA, V117, P7176, DOI 10.1073/pnas.1922638117; Zhang WZ, 2019, NUCL SCI TECH, V30, DOI 10.1007/s41365-019-0683-2	28	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101636	10.1016/j.jbc.2022.101636	http://dx.doi.org/10.1016/j.jbc.2022.101636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085557	Green Published, gold			2022-12-26	WOS:000789261900003
J	Yang, CR; Ding, HJ; Yu, M; Zhou, FH; Han, CY; Liang, R; Zhang, XY; Zhang, XL; Meng, FJ; Wang, S; Li, DD; Sun, WZ; Meng, B; Zhou, XF				Yang, Chun-Rui; Ding, Hong-Jun; Yu, Miao; Zhou, Fiona-H; Han, Chen-Yang; Liang, Rui; Zhang, Xiao-Yang; Zhang, Xiang-Lian; Meng, Fan-Jie; Wang, Shuo; Li, De-Dong; Sun, Wei-Zong; Meng, Bin; Zhou, Xin-Fu			proBDNF/p75NTR promotes rheumatoid arthritis and inflammatory response by activating proinflammatory cytokines	FASEB JOURNAL			English	Article						inflammation; p75NTR; pain; proBDNF; rheumatoid arthritis	P75 NEUROTROPHIN RECEPTOR; NERVE GROWTH-FACTOR; T-CELLS; PAIN; THERAPY; SYSTEM; LOCALIZATION; PATHOGENESIS; CONTRIBUTES; DISSECTION	P75 pan-neurotrophin receptor (p75NTR) is an important receptor for the role of neurotrophins in survival and death of neurons during development and after nerve injury. Our previous research found that the precursor of brain-derived neurotrophic factor (proBDNF) regulates pain as an inflammatory mediator. The current understanding of the role of proBDNF/p75NTR signaling pathway in inflammatory arthritis pain and rheumatoid arthritis (RA) is unclear. We recruited 20 RA patients, 20 healthy donors (HDs), and 10 osteoarthritis (OA) patients. Hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) of proBDNF and p75NTR in synovial membrane were performed and evaluated. We next examined the mRNA and protein expression of proBDNF/p75NTR signaling pathway in peripheral blood mononuclear cells (PBMCs) and synovial tissue. ELISA and flow cytometry were assessed between the blood of RA patients and HD. To induce RA, collagen-induced arthritis (CIA) were induced in mice. We found over-synovitis of RA synovial membrane compared to OA controls in histologic sections. P75NTR and sortilin mRNA, and proBDNF protein level were significantly increased in PBMCs of RA patients compared with the HD. Consistently, ELISA showed that p75NTR, sortilin, tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and interleukin-10 (IL-10) levels in the serum of RA patients were increased compared with HD and p75NTR, sortilin were positively correlated with Disease Activity Score in 28 joints (DAS28). In addition, using flow cytometry we showed that the increased levels of proBDNF and p75NTR characterized in CD4(+) and CD8(+) T cells of RA patients were subsequently reversed with methotrexate (MTX) treatment. Furthermore, we found pathological changes, inflammatory pain, upregulation of the mRNA and protein expression of proBDNF/p75NTR signaling pathway, and upregulation of inflammatory cytokines in spinal cord using a well-established CIA mouse model. We showed intravenous treatment of recombinant p75ECD-Fc that biologically blocked all inflammatory responses and relieved inflammatory pain of animals with CIA. Our findings showed the involvement of proBDNF/p75NTR pathway in the RA inflammatory response and how blocking it with p75ECD-Fc may be a promising therapeutic treatment for RA.	[Yang, Chun-Rui; Ding, Hong-Jun] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin, Peoples R China; [Yang, Chun-Rui; Liang, Rui; Zhang, Xiao-Yang; Zhang, Xiang-Lian] Tianjin Med Univ, Dept Pathol, Hosp 2, Tianjin, Peoples R China; [Ding, Hong-Jun] Tianjin Publ Secur Profess Coll, Tianjin, Peoples R China; [Yu, Miao; Meng, Bin] Tianjin Med Univ, Dept Pathol, Canc Inst & Hosp, Tianjin, Peoples R China; [Zhou, Fiona-H] Univ Adelaide, Fac Hlth Sci, Sch Med, Adelaide, SA, Australia; [Han, Chen-Yang] Tianjin Med Univ, Pain Treatment Ctr, Hosp 2, Tianjin, Peoples R China; [Meng, Fan-Jie; Wang, Shuo] Tianjin Med Univ, Dept Thorac Surg, Hosp 2, Tianjin, Peoples R China; [Li, De-Dong] Tianjin Med Univ, Dept Anesthesiol, Hosp 2, Tianjin, Peoples R China; [Sun, Wei-Zong] Tianjin Med Univ, Dept Orthoped, Hosp 2, Tianjin, Peoples R China; [Zhou, Xin-Fu] Univ South Australia, Clin & Hlth Sci, Hlth & Biomed Innovat, Adelaide, SA 5000, Australia	Tianjin University; Tianjin Medical University; Tianjin Medical University; University of Adelaide; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of South Australia	Meng, B (corresponding author), Tianjin Med Univ, Dept Pathol, Canc Inst & Hosp, Tianjin, Peoples R China.; Zhou, XF (corresponding author), Univ South Australia, Clin & Hlth Sci, Hlth & Biomed Innovat, Adelaide, SA 5000, Australia.	mengbin@tjmu.com; xin-fu.zhou@unisa.edu.au	Zhou, Xin-Fu/F-4119-2013	Zhou, Xin-Fu/0000-0002-8687-0175	Science & Technology Development Fund of Tianjin Education Commission for Higher Education [2018KJ086]; Youth Fund of the Second Hospital of Tianjin Medical University [2020ydey06]; National Natural Science Foundation of China [81660302]	Science & Technology Development Fund of Tianjin Education Commission for Higher Education; Youth Fund of the Second Hospital of Tianjin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grant from the Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2018KJ086), by the Youth Fund of the Second Hospital of Tianjin Medical University (2020ydey06) to CRY and by the National Natural Science Foundation of China (81660302) to RL	Ashraf S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0996-z; Bai YY, 2016, NEUROPSYCHOPHARMACOL, V41, P2882, DOI 10.1038/npp.2016.100; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Charalampopoulos I, 2012, CELL REP, V2, P1563, DOI 10.1016/j.celrep.2012.11.009; Deinhardt K, 2014, NEUROPHARMACOLOGY, V76, P603, DOI 10.1016/j.neuropharm.2013.04.054; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Dusedau HP, 2019, GLIA, V67, P193, DOI 10.1002/glia.23553; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Fleitas C, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0411-6; Friedman B, 2019, JOINT BONE SPINE, V86, P301, DOI 10.1016/j.jbspin.2018.07.004; Ho IHT, 2019, THERANOSTICS, V9, P1651, DOI 10.7150/thno.29703; Hu ZL, 2021, THERANOSTICS, V11, P715, DOI 10.7150/thno.51390; Huang CC, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12560; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kelliny S, 2021, EUR J DRUG METAB PH, V46, P235, DOI 10.1007/s13318-020-00662-0; Kelliny S, 2020, CURR DRUG METAB, V21, P235, DOI 10.2174/1389200221666200502015203; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Lai NS, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041841; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Li CQ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-27; Linker RA, 2015, EUR J IMMUNOL, V45, P1326, DOI 10.1002/eji.201444985; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Luo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27171; Luo RY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01850-0; MacDonald IJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082877; MALLETT S, 1991, IMMUNOL TODAY, V12, P220, DOI 10.1016/0167-5699(91)90033-P; Meeker R, 2014, J NEUROIMMUNE PHARM, V9, P615, DOI 10.1007/s11481-014-9566-9; Minnone G, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000441; Nataraj NB, 2013, CLIN EXP IMMUNOL, V171, P155, DOI 10.1111/cei.12009; Nygaard G, 2020, NAT REV RHEUMATOL, V16, P316, DOI 10.1038/s41584-020-0413-5; Orange DE, 2018, ARTHRITIS RHEUMATOL, V70, P690, DOI 10.1002/art.40428; Patel MK, 2018, J ANAESTH CLIN PHARM, V34, P111, DOI 10.4103/joacp.JOACP_389_15; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; Rogers ML, 2010, J NEUROIMMUNOL, V226, P93, DOI 10.1016/j.jneuroim.2010.05.040; Saadipour K, 2018, J NEUROCHEM, V144, P302, DOI 10.1111/jnc.14206; Sajanti A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72061-z; Schett G, 2021, NAT REV RHEUMATOL, V17, P135, DOI 10.1038/s41584-020-00543-5; Schnitzer TJ, 2019, JAMA-J AM MED ASSOC, V322, P37, DOI 10.1001/jama.2019.8044; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Shen LL, 2018, MOL PSYCHIATR, V23, P1813, DOI 10.1038/s41380-018-0071-z; Shen WY, 2020, FASEB J, V34, P2541, DOI 10.1096/fj.201901905RR; Shu Y, 2017, CLIN REV ALLERG IMMU, V52, P260, DOI 10.1007/s12016-016-8590-3; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Triaille C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.593083; Wang Z, 2019, NEUROTOX RES, V36, P540, DOI 10.1007/s12640-019-00081-3; Weyand CM, 2021, NAT IMMUNOL, V22, P10, DOI 10.1038/s41590-020-00816-x; Yang SJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb0606; Zhang CH, 2021, BIOMED REP, V14, DOI 10.3892/br.2020.1392; Zhao GQ, 2017, MOL NEUROBIOL, V54, P5573, DOI 10.1007/s12035-016-0098-6; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x	54	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22180	10.1096/fj.202101558R	http://dx.doi.org/10.1096/fj.202101558R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129860	Green Accepted, hybrid			2022-12-26	WOS:000761250800021
J	Khanchandani, H; El-Zoka, AA; Kim, SH; Tezins, U; Vogel, D; Sturm, A; Raabe, D; Gault, B; Stephenson, LT				Khanchandani, Heena; El-Zoka, Ayman A.; Kim, Se-Ho; Tezins, Uwe; Vogel, Dirk; Sturm, Andreas; Raabe, Dierk; Gault, Baptiste; Stephenson, Leigh T.			Laser-equipped gas reaction chamber for probing environmentally sensitive materials at near atomic scale	PLOS ONE			English	Article							HYDROGEN EMBRITTLEMENT; SURFACE-REACTIONS; STEEL; PRECIPITATION; TOMOGRAPHY; NICKEL	Numerous metallurgical and materials science applications depend on quantitative atomic-scale characterizations of environmentally-sensitive materials and their transient states. Studying the effect upon materials subjected to thermochemical treatments in specific gaseous atmospheres is of central importance for specifically studying a material's resistance to certain oxidative or hydrogen environments. It is also important for investigating catalytic materials, direct reduction of an oxide, particular surface science reactions or nanoparticle fabrication routes. This manuscript realizes such experimental protocols upon a thermochemical reaction chamber called the "Reacthub" and allows for transferring treated materials under cryogenic & ultrahigh vacuum (UHV) workflow conditions for characterisation by either atom probe or scanning Xe+/electron microscopies. Two examples are discussed in the present study. One protocol was in the deuterium gas charging (25 kPa D-2 at 200 degrees C) of a high-manganese twinning-induced-plasticity (TWIP) steel and characterization of the ingress and trapping of hydrogen at various features (grain boundaries in particular) in efforts to relate this to the steel's hydrogen embrittlement susceptibility. Deuterium was successfully detected after gas charging but most contrast originated from the complex ion FeOD+ signal and the feature may be an artefact. The second example considered the direct deuterium reduction (5 kPa D-2 at 700 degrees C) of a single crystal wustite (FeO) sample, demonstrating that under a standard thermochemical treatment causes rapid reduction upon the nanoscale. In each case, further studies are required for complete confidence about these phenomena, but these experiments successfully demonstrate that how an ex-situ thermochemical treatment can be realised that captures environmentally-sensitive transient states that can be analysed by atomic-scale by atom probe microscope.	[Khanchandani, Heena; El-Zoka, Ayman A.; Kim, Se-Ho; Tezins, Uwe; Vogel, Dirk; Sturm, Andreas; Raabe, Dierk; Gault, Baptiste; Stephenson, Leigh T.] Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, Dusseldorf, Germany; [Gault, Baptiste] Imperial Coll, Dept Mat, South Kensington, London, England	Max Planck Society; Imperial College London	Stephenson, LT (corresponding author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, Dusseldorf, Germany.	l.stephenson@mpie.de		Stephenson, Leigh/0000-0002-7852-2509; Khanchandani, Heena/0000-0001-5503-920X	European Research Council [ERC-CoG-SHINE-771602]	European Research Council(European Research Council (ERC)European Commission)	B.G. acknowledges support from his ERC-CoG-SHINE-771602 grant (European Research Council -https://erc.europa.eu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka H, 2020, DIAM RELAT MATER, V101, DOI 10.1016/j.diamond.2019.107609; An DY, 2020, INT J PLASTICITY, V126, DOI 10.1016/j.ijplas.2019.11.004; [Anonymous], 2002, MEAS SCI TECHNOL, V13, P229; Barrera O, 2018, J MATER SCI, V53, P6251, DOI 10.1007/s10853-017-1978-5; Blavette D, 2014, EUR PHYS J-APPL PHYS, V68, DOI 10.1051/epjap/2014140060; Breen AJ, 2020, ACTA MATER, V188, P108, DOI 10.1016/j.actamat.2020.02.004; Broderick S., 2020, TRACKING STRUCTURAL, V23, P2015; Cairney JM., 2020, CORRELATIVE UHV CRYO, V25, P2494; Chang YH, 2019, NEW J PHYS, V21, DOI 10.1088/1367-2630/ab1c3b; Chang YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08752-7; Chen YS, 2019, INT J HYDROGEN ENERG, V44, P32280, DOI 10.1016/j.ijhydene.2019.09.232; Cockayne B., 1974, PLATIN MET REV, V18, P86; De Cooman BC, 2011, NEW TRENDS AND DEVELOPMENTS IN AUTOMOTIVE SYSTEM ENGINEERING, P101; Dumpala S, 2014, ULTRAMICROSCOPY, V141, P16, DOI 10.1016/j.ultramic.2014.03.002; Dumpala S., 2020, IN SITU DEUTERIUM CH, V21, P2014; Dumpala S., 2013, MICROSC MICROANAL, V19, P396; Felfer PJ, 2012, MICROSC RES TECHNIQ, V75, P484, DOI 10.1002/jemt.21081; Gault B., 2012, SPRINGER SERIES MAT; Gemma R, 2011, J ALLOY COMPD, V509, pS872, DOI 10.1016/j.jallcom.2010.11.122; Gu HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00251-3; Haley D, 2017, ARXIV 1711 06667V1; Haley D, 2019, MICROSC MICROANAL, V25, P410, DOI 10.1017/S1431927618016240; Herbig M, 2015, ULTRAMICROSCOPY, V153, P32, DOI 10.1016/j.ultramic.2015.02.003; Inkson BJ, 2004, J MICROSC-OXFORD, V214, P252, DOI 10.1111/j.0022-2720.2004.01344.x; Kim S-H., 2020, SSRN ELECT J; Kolli RP, 2017, ADV STRUCT CHEM IMAG, V3, DOI 10.1186/s40679-017-0043-4; Koyama M, 2017, INT J HYDROGEN ENERG, V42, P12706, DOI 10.1016/j.ijhydene.2017.02.214; Kulkarni DD, 2011, ACS APPL MATER INTER, V3, P710, DOI 10.1021/am1010173; Lambeets SV, 2020, TOP CATAL, V63, P1606, DOI 10.1007/s11244-020-01367-z; Lee JA, 2012, WOODHEAD PUBL MATER, P624; Lefebvre-Ulrikson W., 2016, ATOM PROBE TOMOGRAPH; McCarroll IE, 2020, MATER TODAY ADV, V7, DOI 10.1016/j.mtadv.2020.100090; Medeiros JM, 2018, ULTRAMICROSCOPY, V190, P1, DOI 10.1016/j.ultramic.2018.04.002; Medouni I, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80140-4; Ohaeri E, 2018, INT J HYDROGEN ENERG, V43, P14584, DOI 10.1016/j.ijhydene.2018.06.064; Perea DE, 2017, ADV STRUCT CHEM IMAG, V3, DOI 10.1186/s40679-017-0045-2; Prosa TJ, 2017, MICROSC MICROANAL, V23, P194, DOI 10.1017/S1431927616012642; Raabe D, 2019, NATURE, V575, P64, DOI 10.1038/s41586-019-1702-5; Reddy SM, 2020, GEOSTAND GEOANAL RES, V44, P5, DOI 10.1111/ggr.12313; Rezende MC, 2015, INT J HYDROGEN ENERG, V40, P17075, DOI 10.1016/j.ijhydene.2015.07.053; Sarkar R, 2015, SCI REP-UK, V5, DOI 10.1038/srep16345; Shearing PR, 2011, ELECTROCHEM SOLID ST, V14, pB117, DOI 10.1149/1.3615824; Sofronis P, 2006, AIP CONF PROC, V837, P64, DOI 10.1063/1.2213060; Stephenson LT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209211; Takahashi J, 2012, SCRIPTA MATER, V67, P213, DOI 10.1016/j.scriptamat.2012.04.022; Takahashi J, 2010, SCRIPTA MATER, V63, P261, DOI 10.1016/j.scriptamat.2010.03.012; TSONG TT, 1983, J CHEM PHYS, V78, P4763, DOI 10.1063/1.445276; Wnuk JD, 2009, J PHYS CHEM C, V113, P2487, DOI 10.1021/jp807824c; WSA, 2020, WORLD STEEL FIG, P1	50	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262543	10.1371/journal.pone.0262543	http://dx.doi.org/10.1371/journal.pone.0262543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139091	Green Submitted, Green Published, gold			2022-12-26	WOS:000821499100009
J	Frost, R				Frost, Richard			Re-evaluation of NCGR Davis Ficus carica and palmata SSR profiles	PLOS ONE			English	Article								To date all public records of F. carica SSR profiles are from NCGR Davis. Prior studies of this data have not been received well because several of the stated relationships do not match what is observed in the field. Upon examination of the prior authors methods it is found that the 1979 Nei similarity measures are not valid distance metrics for the profiles thus invalidating their analysis of genetic distance. Further, the data are tensor in nature and it is shown here that "flattening the data" for use in a vector method will change the problem under study. Consequently the present analysis focuses on geometric, statistical, and biostatistical tensor-based methods-finding that only the latter produces results matching what is manually observed among the profiles. Combining this with historical breeding records and morphologic observations reveals that a modest portion of the profiled accessions are mislabeled-and also reveals the existence of previously undocumented close relations. Another area of concern in the prior studies is the statistical partitioning of the complete graph of distances to define clades. In the present analysis it is shown that genetic clades cannot be defined in this profile collection due to lack of cohesion in nearest neighbor components. It is also shown that it is presently intractable to significantly rectify gaps in the sample population by profile enrichment because the number of individuals in an entire population within the estimated profile distribution exceeds 10(14). The profiles themselves are found to have very few occurrences of common values between the 15 loci and thus according to Fisher's theory of epistatic variance no correlation to phenotype attributes is expected-a result verified by the original investigators. Therefore further discovery of appropriate markers is needed to fully capture geno- and pheno-type characteristics in F. carica and F. palmata SSR profiles.	[Frost, Richard] Frost Concepts, Vista, CA 92083 USA		Frost, R (corresponding author), Frost Concepts, Vista, CA 92083 USA.	tangent.vectors@gmail.com		Frost, Richard/0000-0002-0214-4230				Aradhya MK, 2010, GENETICA, V138, P681, DOI 10.1007/s10709-010-9442-3; CONDIT IRA J., 1955, HILGARDIA, V23, P323; CONDIT IRA J., 1941, HILGARDIA, V14, P1; Dangl GS., PLANT IDENTIFICATION; Dunford N., 1958, LINEAR OPERATORS 1; Fisher, 1958, GENETICAL THEORY NAT; Giraldo E, 2005, J HORTIC SCI BIOTECH, V80, P217, DOI 10.1080/14620316.2005.11511920; Godsil C., 2013, ALGEBRAIC GRAPH THEO; GRIN-Global, US NATL PLANT GERMPL; HUNTER J. K., 2001, APPL ANAL; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Knap T, 2018, GENET RESOUR CROP EV, V65, P1503, DOI 10.1007/s10722-018-0634-5; Mackiewicz D, 2010, J THEOR BIOL, V267, P186, DOI 10.1016/j.jtbi.2010.08.022; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Spanoghe M, 2015, POTATO RES, V58, P43, DOI 10.1007/s11540-014-9271-3; Stewart GW, 1996, AFTERNOTES NUMERICAL; Stover E, 2008, ACTA HORTIC, P57, DOI 10.17660/ActaHortic.2008.798.6; Triola M. F., 2001, ELEMENTARY STAT; Wolfram S, 2015, ELEMENTARY INTRO WOL; Wunsch A, 2002, EUPHYTICA, V125, P59, DOI 10.1023/A:1015723805293	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263715	10.1371/journal.pone.0263715	http://dx.doi.org/10.1371/journal.pone.0263715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130323	Green Published, gold			2022-12-26	WOS:000805530700047
J	Gaillard, C; Verger, EO; Dury, S; Dop, MC; El Ati, J				Gaillard, Cedric; Verger, Eric O.; Dury, Sandrine; Dop, Marie Claude; El Ati, Jalila		MEDINA Study Grp	Farm production diversity and women's dietary diversity: Evidence from central Tunisia	PLOS ONE			English	Article							AGRICULTURAL PRODUCTION; NUTRITION; CONSUMPTION; HOUSEHOLD; BANGLADESH; PROGRESS; TIME	In the context of studies on the effects of agricultural production diversity, there are debates in the scientific community as to the level of diversification appropriate for improving dietary diversity. In Tunisia, agriculture is a strategic sector for the economy and a critical pillar of its food sovereignty. Using instrumental variable methods to account for endogeneity, we have estimated the association between agricultural production diversity and women's dietary diversity among smallholder farming households in the Sidi Bouzid governorate (central Tunisia). Although we found a low level of agricultural production diversity and a fairly diversified diet among women, we observed a systematic weak positive association between five different indicators of agricultural production diversity and women's dietary diversity. We observed a stronger positive association between women's dietary diversity and women being more educated and households being wealthier. Neither diversity of food supplies in food markets nor market distance were associated with women's dietary diversity, whereas we observed a higher level of consumption of some products (dairy) when they were produced on the farm.	[Gaillard, Cedric; Dury, Sandrine] UMR MOISA, CIRAD, F-34398 Montpellier, France; [Gaillard, Cedric; Verger, Eric O.; Dury, Sandrine] Univ Montpellier, Inst Agro, INRAE, CIHEAM IAMM,IRD,MoISA,CIRAD, Montpellier, France; [Dop, Marie Claude] Univ Montpellier, SupAgro, NUTRIPASS, IRD, Montpellier, France; [El Ati, Jalila] INNTA Natl Inst Nutr & Food Technol, SURVEN Nutr Surveillance & Epidemiol Tunisia Res, Tunis, Tunisia	CIRAD; CIHEAM; CIHEAM IAM Montpellier; CIRAD; INRAE; Institut Agro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire	Gaillard, C (corresponding author), UMR MOISA, CIRAD, F-34398 Montpellier, France.; Gaillard, C (corresponding author), Univ Montpellier, Inst Agro, INRAE, CIHEAM IAMM,IRD,MoISA,CIRAD, Montpellier, France.	cedric.gaillard@cirad.fr	Gaillard, Cedric/HDN-8574-2022; Verger, Eric/J-9163-2016; AMIOT, Marie Josephe/M-1203-2017	Gaillard, Cedric/0000-0002-4676-3586; Verger, Eric/0000-0002-8689-8290; AMIOT, Marie Josephe/0000-0003-4563-4587	Agence Nationale de la Recherche (ANR, French National Research Agency) as part of the MEDINA research project [ANR-12-TMED-0004-01]; INNTA (Tunisian National Institute of Nutrition and Food Technology); Bioversity International	Agence Nationale de la Recherche (ANR, French National Research Agency) as part of the MEDINA research project(French National Research Agency (ANR)); INNTA (Tunisian National Institute of Nutrition and Food Technology); Bioversity International	This work was supported by the Agence Nationale de la Recherche (ANR, French National Research Agency) as part of the MEDINA research project, 'Promoting sustainable food systems in the Mediterranean for good nutrition and health' (ANR-12-TMED-0004-01); INNTA (Tunisian National Institute of Nutrition and Food Technology); and Bioversity International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi MM, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0442-6; Adubra L, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz002; Amara M, 2018, SOC INDIC RES, V137, P113, DOI 10.1007/s11205-017-1602-8; Ambikapathi R, 2019, PUBLIC HEALTH NUTR, V22, P2110, DOI 10.1017/S136898001900051X; Angel-Urdinola Diego F., LABOR POLICY PROMOTE; Bellon MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162535; Bellows AL, 2020, FOOD NUTR BULL, V41, P50, DOI 10.1177/0379572119892405; Berti PR, 2015, P NATL ACAD SCI USA, V112, pE5656, DOI 10.1073/pnas.1517006112; Bogard JR, 2018, GLOB FOOD SECUR-AGR, V16, P54, DOI 10.1016/j.gfs.2017.09.004; Centre National des Etudes Agricoles, 2007, ET STRATG DVEL DUR L; Chebbi HE, 2019, RAPPORT SYNTHSE LAGR, P99; de Janvry A, 2006, EC STUD INEQUAL SOC, V1, P155; Dillon A, 2015, J DEV STUD, V51, P976, DOI 10.1080/00220388.2015.1018902; Dop MC, 2020, PUBLIC HEALTH NUTR, V23, P782, DOI 10.1017/S1368980019003409; Doukh MK, 2018, ATLAS GOUVERNORAT SI; Economist Intelligence Unit, 2019, GLOB FOOD SECUR-AGR; El Ati J, 2007, TABLE COMPOSITION AL; El Ati J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048153; ESHA-Research-Inc, 2003, FOOD PROC SOFTW; FAO, 2017, END POV HUNG INV AGR; FAO and FHI 360, 2016, MIN DIET DIV WOM GUI; Ferchiou A., 2017, THESIS MONTPELLIER; Ferchiou A, 2015, SUSTAINABLE FOOD PRO; Figueroa JL, 2018, 9 MENA RP INT IFPRI; Foscolou A, 2018, MATURITAS, V118, P60, DOI 10.1016/j.maturitas.2018.10.013; Freedman DA, 2006, AM STAT, V60, P299, DOI 10.1198/000313006X152207; Gaillard C., 2018, CAH AGRIC, V27, P1; Gebhardt S.E., 2008, USDA NATL NUTR DATAB; Ghali S., 2018, TAQEEM IMPACT REPORT; Hanmer L, 2018, GENDER LABOR MARKETS; Harris-Fry H., 2020, MATERN CHILD NUTR, V16, DOI [10.1111/mcn.12995, DOI 10.1111/MCN.12995]; Hirvonen K, 2017, WORLD DEV, V95, P303, DOI 10.1016/j.worlddev.2017.02.031; Hjertholm KG., 2019, FOOD NUTR RES, V63; INS, 2014, REC GEN POP HAB 2014; Institut National de la Sant, 2020, SANT TUN RSULT LENQ, P368; Jellali Z, 2016, THESIS I NATL AGRONO; Jones AD, 2018, J NUTR, V148, P1625, DOI 10.1093/jn/nxy166; Jones AD, 2017, NUTR REV, V75, P769, DOI 10.1093/nutrit/nux040; Kadiyala S, 2014, ANN NY ACAD SCI, V1331, P43, DOI 10.1111/nyas.12477; Kefi F., 2017, THESIS MONTPELLIER; Kennedy G., 2013, GUID MEAS HOUS IND D; Komatsu H, 2018, FOOD POLICY, V79, P256, DOI 10.1016/j.foodpol.2018.07.002; Kruse M., 2019, THESIS GEORG AUGUST; Lourme-Ruiz A, 2021, FOOD SECUR, V13, P329, DOI 10.1007/s12571-020-01137-5; Luckett BG, 2015, PUBLIC HEALTH NUTR, V18, P2479, DOI 10.1017/S136898001500169X; Mansour M, 2014, EMERGING TECHNOLOGIE, P485, DOI DOI 10.1016/B978-0-12-800875-1.00021-1; Mehraban N, 2021, GLOB FOOD SECUR-AGR, V28, DOI 10.1016/j.gfs.2021.100502; Ministre du dveloppement de linvestissement et de la coopration internationale, 2016, PLAN DVEL 20162022 R; Mouelhi RBA, 2017, WOMEN TUNISIAN LABOR; Muthini D, 2020, FOOD POLICY, V97, DOI 10.1016/j.foodpol.2020.101956; Nicholson CF, 2020, NAT FOOD, V1, P541, DOI 10.1038/s43016-020-00142-3; Palma G., 2012, OL AGINEUX CORPS GRA, V19, P283; Pellegrini L, 2014, CAN J DEV STUD, V35, P211, DOI 10.1080/02255189.2014.898580; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Safa G, 2020, J AFR EARTH SCI, V168, DOI 10.1016/j.jafrearsci.2020.103849; Sanchez-Quintela S, 2020, OLIVE OIL NW TUNISIA; Sibhatu KT, 2018, FOOD POLICY, V77, P1, DOI 10.1016/j.foodpol.2018.04.013; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Stevens B, 2017, PUBLIC HEALTH NUTR, V20, P121, DOI [10.1017/S136898001600183X, 10.1017/s136898001600183x]; Stock J., 2005, IDENTIFICATION INFER, P109, DOI [DOI 10.1017/CBO9780511614491.007, 10.1017/CBO9780511614491.007]; STRAUSS J, 1984, J DEV ECON, V14, P77, DOI 10.1016/0304-3878(84)90044-0; Tanyeri-Abur A., 2015, SUSTAINABILITY AGRO, P3, DOI DOI 10.1007/978-3-319-16357-4; Tessier S, 2010, PUBLIC HEALTH NUTR, V13, P1410, DOI 10.1017/S1368980010000601; Traissac P, 2016, PUBLIC HEALTH NUTR, V19, P1428, DOI 10.1017/S1368980016000689; Trijsburg L, 2019, NUTR REV, V77, P515, DOI 10.1093/nutrit/nuz017; Verger EO, 2021, ADV NUTR, V12, P1659, DOI 10.1093/advances/nmab009; Verger EO, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00030; World Bank, 2014, UNFINISHED REVOLUTIO; World Food Programme, 2018, TUN COUNTR STRAT PLA; World Health Organization, 2004, VIT MIN REQ HUM NUTR; Zanello G, 2019, FOOD POLICY, V87, DOI 10.1016/j.foodpol.2019.101731; Zlaoui M., 2019, Journal of New Sciences, V63, P3989	73	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263276	10.1371/journal.pone.0263276	http://dx.doi.org/10.1371/journal.pone.0263276			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130282	gold, Green Published			2022-12-26	WOS:000805530700024
J	Barranco-Trabi, J; Morgan, S; Singh, S; Hill, J; Kayatani, A; Mank, V; Nesmith, H; Omara, H; Tripoli, L; Lustik, M; Masel, J; Chi, S; Ngauy, V				Barranco-Trabi, Javier; Morgan, Stephen; Singh, Seema; Hill, Jimmy; Kayatani, Alexander; Mank, Victoria; Nesmith, Holly; Omara, Heather; Tripoli, Louis; Lustik, Michael; Masel, Jennifer; Chi, Sharon; Ngauy, Viseth			Persons tested for SAR-CoV-2 at a military treatment facility in Hawaii	PLOS ONE			English	Article								Health inequalities based on race are well-documented, and the COVID-19 pandemic is no exception. Despite the advances in modern medicine, access to health care remains a primary determinant of health outcomes, especially for communities of color. African-Americans and other minorities are disproportionately at risk for infection with COVID-19, but this problem extends beyond access alone. This study sought to identify trends in race-based disparities in COVID-19 in the setting of universal access to care. Tripler Army Medical Center (TAMC) is a Department of Defense Military Treatment Facility (DoD-MTF) that provides full access to healthcare to active duty military members, beneficiaries, and veterans. We evaluated the characteristics of individuals diagnosed with SARS-CoV-2 infection at TAMC in a retrospective, case-controlled (1:1) study. Most patients (69%) had received a COVID-19 test within 3 days of symptom onset. Multivariable logistic regression analyses were used to identify factors associated with testing positive and to estimate adjusted odds ratios. African-American patients and patients who identified as "Other" ethnicities were two times more likely to test positive for SARS-CoV-2 relative to Caucasian patients. Other factors associated with testing positive include: younger age, male gender, previous positive test, presenting with >3 symptoms, close contact with a COVID-19 positive patient, and being a member of the US Navy. African-Americans and patients who identify as "Other" ethnicities had disproportionately higher rates of positivity of COVID-19. Although other factors contribute to increased test positivity across all patient populations, access to care does not appear to itself explain this discrepancy with COVID-19.	[Barranco-Trabi, Javier; Mank, Victoria; Tripoli, Louis] Tripler Army Med Ctr, Dept Internal Med, Honolulu, HI 96859 USA; [Morgan, Stephen; Singh, Seema; Hill, Jimmy] Tripler Army Med Ctr, Dept Infect Control, Honolulu, HI 96859 USA; [Kayatani, Alexander] Tripler Army Med Ctr, Dept Microbiol, Honolulu, HI 96859 USA; [Nesmith, Holly; Omara, Heather] Tripler Army Med Ctr, Dept Family Med, Honolulu, HI 96859 USA; [Lustik, Michael] Tripler Army Med Ctr, Dept Clin Invest, Honolulu, HI 96859 USA; [Masel, Jennifer; Chi, Sharon; Ngauy, Viseth] Tripler Army Med Ctr, Dept Infect Dis, Honolulu, HI 96859 USA	United States Department of Defense; United States Army; United States Department of Defense; United States Army; United States Department of Defense; United States Army; United States Department of Defense; United States Army; United States Department of Defense; United States Army; United States Department of Defense; United States Army	Barranco-Trabi, J (corresponding author), Tripler Army Med Ctr, Dept Internal Med, Honolulu, HI 96859 USA.	javier.j.barranco@gmail.com		Tripoli, Louis/0000-0001-7816-9525; Barranco-Trabi, Javier/0000-0003-1351-7503				[Anonymous], 2020, STAT DEP DEF DOM TRA; Coronaviruses, NAT I ALL INF DIS; Drucker DJ, 2021, CELL METAB, V33, P479, DOI 10.1016/j.cmet.2021.01.016; Kirshblum SC, 2020, PM&R, V12, P1009, DOI 10.1002/pmrj.12454; Puylaert CAJ, 2020, ANN SURG, V272, P919, DOI 10.1097/SLA.0000000000004218	5	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263472	10.1371/journal.pone.0263472	http://dx.doi.org/10.1371/journal.pone.0263472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120186	Green Published, gold			2022-12-26	WOS:000789273600042
J	Wu, CS; Zhong, J; Lin, L; Chen, YP; Xue, YJ; Shi, P				Wu, Chongshu; Zhong, Jing; Lin, Lin; Chen, Yanping; Xue, Yunjing; Shi, Peng			Segmentation of HE-stained meningioma pathological images based on pseudo-labels	PLOS ONE			English	Article							CLASSIFICATION	Biomedical research is inseparable from the analysis of various histopathological images, and hematoxylin-eosin (HE)-stained images are one of the most basic and widely used types. However, at present, machine learning based approaches of the analysis of this kind of images are highly relied on manual labeling of images for training. Fully automated processing of HE-stained images remains a challenging task due to the high degree of color intensity, size and shape uncertainty of the stained cells. For this problem, we propose a fully automatic pixel-wise semantic segmentation method based on pseudo-labels, which concerns to significantly reduce the manual cell sketching and labeling work before machine learning, and guarantees the accuracy of segmentation. First, we collect reliable training samples in a unsupervised manner based on K-means clustering results; second, we use full mixup strategy to enhance the training images and to obtain the U-Net model for the nuclei segmentation from the background. The experimental results based on the meningioma pathology image dataset show that the proposed method has good performance and the pathological features obtained statistically based on the segmentation results can be used to assist in the clinical grading of meningiomas. Compared with other machine learning strategies, it can provide a reliable reference for clinical research more effectively.	[Wu, Chongshu; Shi, Peng] Fujian Normal Univ, Coll Comp & Cyber Secur, Fuzhou, Fujian, Peoples R China; [Zhong, Jing; Chen, Yanping] Fujian Prov Canc Hosp, Radiol & Pathol Dept, Fuzhou, Fujian, Peoples R China; [Lin, Lin; Xue, Yunjing] Fujian Med Univ Union Hosp, Dept Radiol, Fuzhou, Fujian, Peoples R China; [Shi, Peng] Digit Fujian Internet Of Things Lab Environm Moni, Fujian, Peoples R China	Fujian Normal University	Shi, P (corresponding author), Fujian Normal Univ, Coll Comp & Cyber Secur, Fuzhou, Fujian, Peoples R China.; Shi, P (corresponding author), Digit Fujian Internet Of Things Lab Environm Moni, Fujian, Peoples R China.	pshi@fjnu.edu.cn	Lin, Lin/GVT-2323-2022	Lin, Lin/0000-0001-6304-2249	Fujian Science and Technology Innovation Joint Fund [2018Y9112]; Fujian Health Science Research Talent Training Project [2019-ZQN-17]	Fujian Science and Technology Innovation Joint Fund; Fujian Health Science Research Talent Training Project	This work was supported by the Fujian Science and Technology Innovation Joint Fund (2018Y9112) and the Fujian Health Science Research Talent Training Project (2019-ZQN-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alom ZM, 2018, P IEEE NATL AEROSPAC; Badrinarayanan V., 2015, IEEE T PATTERN ANAL, DOI [DOI 10.1109/TPAMI.2016.2644615, DOI 10.1103/PHYSREVX.5.041024]; Chen H, 2017, MED IMAGE ANAL, V36, P135, DOI 10.1016/j.media.2016.11.004; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cox JA., 1961, CA MED, V94, P277; Cui Y, 2016, P 2016 IEEE INT C BI; Gong LH, 2018, CHINESE MED J-PEKING, V131, P32, DOI 10.4103/0366-6999.221274; Hu H, 2013, CHINESE MED J-PEKING, V126, P3921, DOI 10.3760/cma.j.issn.0366-6999.20123368; Jiang H., 2012, INT J NEUROL NEUROSU, V6, P511; Kumar N, 2020, IEEE T MED IMAGING, V39, P1380, DOI 10.1109/TMI.2019.2947628; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lopez Carlos, 2012, Stud Health Technol Inform, V179, P155; Lu C, 2012, ANAL QUANT CYTOL, V34, P296; Mahmood F, 2020, IEEE T MED IMAGING, V39, P3257, DOI 10.1109/TMI.2019.2927182; Mittal H, 2019, SWARM EVOL COMPUT, V45, P15, DOI 10.1016/j.swevo.2018.12.005; Oktay O, 2018, ARXIV180403999; Pan XP, 2019, IEEE ACCESS, V7, P110674, DOI 10.1109/ACCESS.2019.2934486; Qu AP, 2015, SCI CHINA INFORM SCI, V58, DOI 10.1007/s11432-014-5277-3; Qu H, 2019, LECT NOTES COMPUT SC, V11764, P378, DOI 10.1007/978-3-030-32239-7_42; Ronneberger O., 2015, INT C MEDICAL IMAGE, V9351, P234, DOI [10.1007/978-3-319-24574-4_28, DOI 10.1007/978-3-319-24574-4_28], Patent No. [ArXiv150504597Cs, 150504597]; Shi P, 2017, SCI CHINA INFORM SCI, V60, DOI 10.1007/s11432-016-9018-7; Shi P, 2016, 2016 8TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY IN MEDICINE AND EDUCATION (ITME), P99, DOI [10.1109/ITME.2016.190, 10.1109/ITME.2016.0031]; Strzelecki M, 2013, NUCL INSTRUM METH A, V702, P137, DOI 10.1016/j.nima.2012.09.006; SUN T, 1994, PATTERN RECOGN LETT, V15, P341, DOI 10.1016/0167-8655(94)90082-5; Taheri S, 2017, P SPIE MED IM FLOR; Tareef A, 2018, IEEE T MED IMAGING, V37, P2044, DOI 10.1109/TMI.2018.2815013; Van Vliet JL, 1998, P 14 INT C PATTERN R; Wang H., 2022, P AAAI C ARTIFICIAL, V36, P2441, DOI [10.1609/aaai.v36i3.20144, DOI 10.1609/AAAI.V36I3.20144]; Zeng ZT, 2019, IEEE ACCESS, V7, P21420, DOI 10.1109/ACCESS.2019.2896920; Zhang XF, 2015, MED IMAGE ANAL, V26, P306, DOI 10.1016/j.media.2015.10.005	30	2	2	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263006	10.1371/journal.pone.0263006	http://dx.doi.org/10.1371/journal.pone.0263006			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120175	gold, Green Published			2022-12-26	WOS:000789273600018
J	Yan, XL; Yang, L; Zhang, YN; Han, WY; Duan, Y				Yan, Xinlei; Yang, Le; Zhang, Yanni; Han, Wenying; Duan, Yan			Effect of collagen casing on the quality characteristics of fermented sausage	PLOS ONE			English	Article							DRY SAUSAGES	Objective Fermented sausage is popular all over the world for its rich nutrition and unique flavor. Sausage casing is one of the key factors affecting the quality of fermented sausage. However, there is little information involved in this field. Methods In this study, collagen casings were used as a wrapping material, and natural casings (pig casings) were used as a control. The effects of the two types of casings on biogenic amine content and other quality characteristics of fermented sausage were analyzed with increasing the storage time. Results The results showed that with storage time increasing, the hardness and gumminess of fermented sausage in collagen casing (CC) group were higher than those in pig casing (PC) group (P<0.05), while the elasticity in CC group was lower than that in PC group (P<0.05). In the processing and storage period, there was no significant difference in the type and content of flavor substances between the two groups. More importantly, the contents of tryptamine, putrescine, cadaverine, histamine, tyramine and phenyethylamine in fermented sausage of CC group were lower than those in PC group (P<0.05). Conclusion In conclusion, this study revealed that CC could improve the quality characteristics of fermented sausage and reduce the content of biogenic amines in fermented sausage, which provides a theoretical basis for the choice of casings in industrial production in the future.	[Yan, Xinlei; Yang, Le; Zhang, Yanni; Han, Wenying; Duan, Yan] Inner Mongolia Agr Univ, Coll Food Sci & Engn, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University	Duan, Y (corresponding author), Inner Mongolia Agr Univ, Coll Food Sci & Engn, Hohhot, Inner Mongolia, Peoples R China.	duanyannmg@outlook.com			Food Science and Engineering College Science and Technology Plan Project of Inner Mongolia Agricultural University, China [SPKJ201904]; Inner Mongolia Natural Science Foundation Program of China [2021MS03012]	Food Science and Engineering College Science and Technology Plan Project of Inner Mongolia Agricultural University, China; Inner Mongolia Natural Science Foundation Program of China	This work was funded by Food Science and Engineering College Science and Technology Plan Project of Inner Mongolia Agricultural University, China (SPKJ201904) (https://spy.imau.edu.cn/)and Inner Mongolia Natural Science Foundation Program of China (No.2021MS03012) (http://kjt.nmg.gov.cn/).And Yan D received them. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algahtani FD, 2020, J FOOD QUALITY, V2020, DOI 10.1155/2020/8718179; Batpho K, 2017, FOOD CONTROL, V73, P1342, DOI 10.1016/j.foodcont.2016.10.053; BRADY PL, 1985, J FOOD SCI, V50, P300; Chen Q, 2021, MEAT SCI, V172, DOI 10.1016/j.meatsci.2020.108338; Chen Q, 2017, LWT-FOOD SCI TECHNOL, V77, P389, DOI 10.1016/j.lwt.2016.11.075; Chen XF, 2019, INT J BIOL MACROMOL, V135, P959, DOI 10.1016/j.ijbiomac.2019.05.182; Dosoky NS, 2019, MOLECULES, V24, DOI 10.3390/molecules24234244; Duan MY., 2021, FOOD SCI, P1, DOI [10.7506/spkx1002-6630-20210901-004, DOI 10.7506/SPKX1002-6630-20210901-004]; Esmaeilzadeh P., 2012, World Applied Sciences Journal, V18, P493; Feng CH, 2020, FOODS, V9, DOI 10.3390/foods9081089; Garbowska M, 2020, MATERIALS, V13, DOI 10.3390/ma13081835; Ge QF, 2019, LWT-FOOD SCI TECHNOL, V101, P513, DOI 10.1016/j.lwt.2018.11.081; Han Huiqing, 2015, Journal of Nanjing Forestry University, V39, P99, DOI 10.3969/j.issn.1000-2006.2015.05.016; Harper BA, 2012, FOOD RES INT, V49, P494, DOI 10.1016/j.foodres.2012.07.043; Hilbig J, 2020, FOOD RES INT, V137, DOI 10.1016/j.foodres.2020.109661; Jia W, 2020, FOOD CHEM, V321, DOI 10.1016/j.foodchem.2020.126723; Kim HS, 2019, J FUNCT FOODS, V52, P424, DOI 10.1016/j.jff.2018.11.033; Ledesma E, 2015, FOOD CONTROL, V51, P195, DOI 10.1016/j.foodcont.2014.11.025; Liu YL, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.611260; Luan XX, 2021, FOOD RES INT, V144, DOI 10.1016/j.foodres.2021.110351; Luo YL, 2019, STUDY FLAVOR DIFFERE; Marcos B, 2020, MEAT SCI, V169, DOI 10.1016/j.meatsci.2020.108184; Parente E, 2001, J APPL MICROBIOL, V90, P882, DOI 10.1046/j.1365-2672.2001.01322.x; Pisacane V, 2015, INT J FOOD MICROBIOL, V207, P57, DOI 10.1016/j.ijfoodmicro.2015.04.029; Sade E, 2020, INT J FOOD MICROBIOL, V313, DOI 10.1016/j.ijfoodmicro.2019.108379; Serio A, 2020, FOODS, V9, DOI 10.3390/foods9091286; Skaljac S, 2018, INT J FOOD PROP, V21, P667, DOI 10.1080/10942912.2018.1453837; Suurs P, 2020, TRENDS FOOD SCI TECH, V102, P91, DOI 10.1016/j.tifs.2020.06.011; Wen RX, 2021, LWT-FOOD SCI TECHNOL, V142, DOI 10.1016/j.lwt.2021.110982; Xiao YQ, 2020, FOOD RES INT, V135, DOI 10.1016/j.foodres.2020.109247; Ya H, 2007, MEAT IND, V10, P17; [杨桠楠 Yang Yanan], 2016, [海洋科学, Marine Sciences], V40, P138; Zajac M, 2021, J SCI FOOD AGR, V101, P6001, DOI 10.1002/jsfa.11254; Zhu XX, 2018, INT J FOOD SCI TECH, V53, P88, DOI 10.1111/ijfs.13561	34	0	0	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263389	10.1371/journal.pone.0263389	http://dx.doi.org/10.1371/journal.pone.0263389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113961	Green Published, gold			2022-12-26	WOS:000823694700089
J	Yang, CX; Qiao, T; Yu, J; Wang, HY; Guo, YS; Salameh, J; Metterville, J; Parsi, S; Yusuf, I; Brown, RH; Cai, HB; Xu, ZS				Yang, Chunxing; Qiao, Tao; Yu, Jia; Wang, Hongyan; Guo, Yansu; Salameh, Johnny; Metterville, Jake; Parsi, Sepideh; Yusuf, Issa; Brown, Robert H.; Cai, Huaibin; Xu, Zuoshang			Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DEGENERATION; DNA-BINDING PROTEIN; STRESS GRANULE DYNAMICS; ALS-LINKED TDP-43; IN MOUSE MODEL; TRANSGENIC MICE; MUTANT TDP-43; GENE-EXPRESSION; MESSENGER-RNA	Modestly increased expression of transactive response DNA binding protein (TDP-43) gene have been reported in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neuromuscular diseases. However, whether this modest elevation triggers neurodegeneration is not known. Although high levels of TDP-43 overexpression have been modeled in mice and shown to cause early death, models with low-level overexpression that mimic the human condition have not been established. In this study, transgenic mice over-expressing wild type TDP-43 at less than 60% above the endogenous CNS levels were constructed, and their phenotypes analyzed by a variety of techniques, including biochemical, molecular, histological, behavioral techniques and electromyography. The TDP-43 transgene was expressed in neurons, astrocytes, and oligodendrocytes in the cortex and predominantly in astrocytes and oligodendrocytes in the spinal cord. The mice developed a reproducible progressive weakness ending in paralysis in mid-life. Detailed analysis showed similar to 30% loss of large pyramidal neurons in the layer V motor cortex; in the spinal cord, severe demyelination was accompanied by oligodendrocyte injury, protein aggregation, astrogliosis and microgliosis, and elevation of neuroinflammation. Surprisingly, there was no loss of lower motor neurons in the lumbar spinal cord despite the complete paralysis of the hindlimbs. However, denervation was detected at the neuromuscular junction. These results demonstrate that low-level TDP-43 overexpression can cause diverse aspects of ALS, including late-onset and progressive motor dysfunction, neuroinflammation, neurodegeneration. Our findings suggest that persistent modest elevations in TDP-43 expression can lead to ALS and other neurological disorders involving TDP-43 proteinopathy. Because of the predictable and progressive clinical paralytic phenotype, this transgenic mouse model will be useful in preclinical trial of therapeutics targeting neurological disorders associated with elevated levels of TDP-43.	[Yang, Chunxing; Qiao, Tao; Wang, Hongyan; Guo, Yansu; Parsi, Sepideh; Yusuf, Issa; Xu, Zuoshang] Univ Massachusetts, Med Sch, Dept Biochem & Mol Biotechnol, Worcester, MA 01605 USA; [Yu, Jia; Cai, Huaibin] NIA, Transgen Sect, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Salameh, Johnny; Metterville, Jake; Brown, Robert H.] Univ Massachusetts, Dept Neurol, Med Sch, Worcester, MA USA; [Brown, Robert H.; Xu, Zuoshang] Univ Massachusetts, RNA Therapeut Inst, Med Sch, Worcester, MA 01605 USA; [Brown, Robert H.; Xu, Zuoshang] Univ Massachusetts, Neurosci Program, Med Sch, Worcester, MA 01605 USA; [Yang, Chunxing] CoWin Biosci, Shrewsbury, MA USA; [Qiao, Tao] Astellas Pharma, Marlborough, MA USA; [Yu, Jia] Beijing Geriatr Hosp, Inst Geriatr & Rehabil, Beijing, Peoples R China; [Guo, Yansu] Capital Med Univ, Xuanwu Hosp, Beijing Geriatr Healthcare Ctr, Beijing, Peoples R China; [Salameh, Johnny] Amer Univ Beirut, Dept Neurol, Med Ctr AUBMC, Beirut, Lebanon	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Astellas Pharmaceuticals; Capital Medical University; American University of Beirut	Xu, ZS (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Biotechnol, Worcester, MA 01605 USA.; Xu, ZS (corresponding author), Univ Massachusetts, RNA Therapeut Inst, Med Sch, Worcester, MA 01605 USA.; Xu, ZS (corresponding author), Univ Massachusetts, Neurosci Program, Med Sch, Worcester, MA 01605 USA.	Zuoshang.xu@umassmed.edu	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108; Parsi, Sepideh/0000-0001-6396-5190	National Institute on Aging [AG000946]; National Natural Science Foundation of China, China [81971200]; ALS Association; Angel Fund for ALS Research; ALS Finding A Cure; ALSOne; deBourgknecht ALS Research Fund; Cellucci Fund for ALS Research; Max Rosenfeld Fund for ALS Research; NINDS [R01NS088698, RO1-NS111990]; NIH/NINDS [RO1-NS101895]; Packard Center for ALS Research at Johns Hopkins	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); ALS Association; Angel Fund for ALS Research; ALS Finding A Cure; ALSOne; deBourgknecht ALS Research Fund; Cellucci Fund for ALS Research; Max Rosenfeld Fund for ALS Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Packard Center for ALS Research at Johns Hopkins	This work was supported by grants from the intramural research programs of National Institute on Aging (AG000946) to HC, by the National Natural Science Foundation of China, China (No. 81971200) to YG, by the ALS Association, the Angel Fund for ALS Research, ALS Finding A Cure, ALSOne, the deBourgknecht ALS Research Fund, and the Max Rosenfeld and Cellucci Funds for ALS Research, NINDS R01NS088698 and RO1-NS111990 to RHB, and by NIH/NINDS RO1-NS101895, the ALS Association, and the Packard Center for ALS Research at Johns Hopkins to ZX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Austin JA, 2014, P NATL ACAD SCI USA, V111, P4309, DOI 10.1073/pnas.1317317111; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Budini M, 2012, BRAIN RES, V1462, P139, DOI 10.1016/j.brainres.2012.02.031; Budini M, 2011, J MOL NEUROSCI, V45, P473, DOI 10.1007/s12031-011-9573-8; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Cascella R, 2016, J BIOL CHEM, V291, P19437, DOI 10.1074/jbc.M116.737726; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Donde A, 2019, ACTA NEUROPATHOL, V138, P813, DOI 10.1007/s00401-019-02042-8; Ebstein SY, 2019, CELL REP, V26, P364, DOI 10.1016/j.celrep.2018.12.045; Esmaeili MA, 2013, INT J EXP PATHOL, V94, P56, DOI 10.1111/iep.12006; Fratta P, 2018, EMBO J, V37, DOI 10.15252/embj.201798684; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Gitcho MA, 2009, ACTA NEUROPATHOL, V118, P633, DOI 10.1007/s00401-009-0571-7; Gordon D, 2019, NEUROBIOL DIS, V121, P148, DOI 10.1016/j.nbd.2018.09.024; Guo YS, 2012, BRAIN RES, V1460, P88, DOI 10.1016/j.brainres.2012.04.003; Haidet-Phillips AM, 2013, EXP NEUROL, V250, P250, DOI 10.1016/j.expneurol.2013.10.004; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Hatzipetros T, 2014, BRAIN RES, V1584, P59, DOI 10.1016/j.brainres.2013.10.013; Huang C, 2012, J CLIN INVEST, V122, P107, DOI 10.1172/JCI59130; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Janssens J, 2013, MOL NEUROBIOL, V48, P22, DOI 10.1007/s12035-013-8427-5; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Koyama A, 2016, NUCLEIC ACIDS RES, V44, P5820, DOI 10.1093/nar/gkw499; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Mitchell JC, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0212-4; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishino K, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0776-5; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Philips Thomas, 2015, Curr Protoc Pharmacol, V69, DOI 10.1002/0471141755.ph0567s69; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rinchetti P, 2018, MOL NEUROBIOL, V55, P2617, DOI 10.1007/s12035-017-0537-z; Rohan Z, 2014, NEURODEGENER DIS, V14, P117, DOI 10.1159/000362929; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940; Suk TR, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00397-1; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Varas R, 2019, CURR PHARM DESIGN, V25, P4755, DOI 10.2174/1381612825666191216125725; Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; White MA, 2018, NAT NEUROSCI, V21, P552, DOI 10.1038/s41593-018-0113-5; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wolozin B, 2019, NEURON, V102, P265, DOI 10.1016/j.neuron.2019.03.041; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu ZS, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-27; Xu ZS, 2014, RARE DIS, V2, DOI 10.4161/21675511.2014.944443; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111	78	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0255710	10.1371/journal.pone.0255710	http://dx.doi.org/10.1371/journal.pone.0255710			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113871	Green Submitted, Green Published, gold			2022-12-26	WOS:000823694700005
J	Bognini, JD; Samadoulougou, S; Ouedraogo, M; Smart, F; Kankoye, DT; Sankoh, O; Kirakoya-Samadoulougou, F				Bognini, Joel Dofinissery; Samadoulougou, Sekou; Ouedraogo, Mady; Smart, Francis; Kankoye, David Tiga; Sankoh, Osman; Kirakoya-Samadoulougou, Fati			What are the trends in seeking health care for fever in children under-five in Sierra Leone? evidence from four population-based studies before and after the free health care initiative	PLOS ONE			English	Article							ILLNESS	Background In 2010, the government of Sierra Leone implemented the Free Health Care Initiative (FHCI) in the country with the objective of reducing the high maternal, infant, and child mortality rates and improving general health indicators. The objective of this study was to assess the trends in the prevalence of health care-seeking and to identify the determinants of healthcare service utilization by caregivers of children younger than five years. Methods The analysis of health-care-seeking behavior was done using data from four population-based surveys in Sierra Leone before (2008) and after (2013, 2016, 2019) the FHCI was implemented. Care-seeking behavior was assessed with regard to caregivers seeking care for children under-five in the two weeks prior to each survey. We compared the percentages of healthcare-seeking behavior change and identify factors associated with healthcare-seeking using a modified Poisson regression model with generalized estimating equations. Results In 2008, a total of 1208 children with fever were recorded, compared with 2823 children in 2013, 1633 in 2016, and 1464 in 2019. Care-seeking for children with fever was lowest in 2008 (51%; 95% CI (46.4-55.5)) than in 2013 (71.5%; 95% CI (68.4-74.5)), 2016 (70.3%; 95% CI (66.6-73.8)), and 2019 (74.6%; 95% CI (71.6-77.3)) (p < 0.001). Care-seeking in 2013, 2016 and 2019 was at least 1.4 time higher than in 2008 (p < 0.001) after adjusting for mother's age, wealth, religion, education level, household head and the child's age. Care-seeking was lowest for children older than 12 months, mothers older than 35 years, children living in the poorest households, and in the northern region. A trend was observed for the sex of the household head. The level of care-seeking was lowest when the household head was a man. Conclusions The increase in healthcare-seeking for children under-five with fever followed the introduction of the FHCI in Sierra Leone. Care-seeking for fever varied by the child's age, caregiver's age, household wealth, the sex of the household head and region. Maintaining the FHCI with adequate strategies to address other barriers beyond financial ones is essential to reduce disparities between age groups, regions and, households.	[Bognini, Joel Dofinissery] Ctr Natl Rech Sci & Technol, Inst Rech Sci Sante, Unite Rech Clin Nanoro, Ouagadougou, Burkina Faso; [Samadoulougou, Sekou] Laval Univ, Ctr Res Planning & Dev CRAD, Quebec City, PQ, Canada; [Samadoulougou, Sekou] Quebec Heart & Lung Inst, Evaluat Platform Obes Prevent, Quebec City, PQ, Canada; [Ouedraogo, Mady] Inst Natl Stat & Demog INSD, Ouagadougou, Burkina Faso; [Smart, Francis] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Kankoye, David Tiga] Ctr Natl Rech & Format Sur Paludisme CNRFP, Ouagadougou, Burkina Faso; [Sankoh, Osman] Stat Sierra Leone, Freetown, Sierra Leone; [Sankoh, Osman] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Kirakoya-Samadoulougou, Fati] Univ Libre Bruxelles ULB, Ctr Rech Epidemiol Biostat & Rech Clin, Ecole Sante Publ, Brussels, Belgium	Laval University; Quebec Heart & Lung Institute; Ministry of Health & Sanitation Sierra Leone; University of Witwatersrand; Universite Libre de Bruxelles	Samadoulougou, S (corresponding author), Laval Univ, Ctr Res Planning & Dev CRAD, Quebec City, PQ, Canada.; Samadoulougou, S (corresponding author), Quebec Heart & Lung Inst, Evaluat Platform Obes Prevent, Quebec City, PQ, Canada.; Kirakoya-Samadoulougou, F (corresponding author), Univ Libre Bruxelles ULB, Ctr Rech Epidemiol Biostat & Rech Clin, Ecole Sante Publ, Brussels, Belgium.	ouindpanga-sekou.samadoulougou.1@ulaval.ca; fati.kirakoya@ulb.be	BOGNINI, Joel Dofinissery/GVS-0859-2022	Bognini, Joel Dofinisery/0000-0002-8465-2895	Fonds de recherche du quebec - sante (FRQS), postdoctoral fellowship	Fonds de recherche du quebec - sante (FRQS), postdoctoral fellowship	Fonds de recherche du quebec - sante (FRQS), postdoctoral fellowship, Dr Sekou Samadoulougou.	Action Against Hunger ACF International., 2015, REINF I CAP TREATM A; [Anonymous], 2017, WHO INT MAN CHILDH I; Arthur E, 2019, AFR DEV REV, V31, P87, DOI 10.1111/1467-8268.12365; Bedford KJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100038; Cr B, 2011, TROPICAL MED INT HLT, V16; Feigin V.L., 2019, LANCET NEUROL, V18, P459, DOI [DOI 10.1136/BMJ.L94, DOI 10.1136/bmj.l94]; Garchitorena A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000762; Jalloh MB, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4181-3; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Koroma D, 2006, 2004 POPULATION HOUS; Lungu EA, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1913-9; Mary K, 2006, EVALUATION UNDP ASSI; Mason E, 2009, LANCET, V374, P782, DOI 10.1016/S0140-6736(09)61452-5; Ministry of Health and Sanitation, 2014, COMPR EPI MULT PLAN; Ministry of Health and Sanitation, 2017, HUMAN RESOURCES HLTH; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; Nathaniel-Wurie L, 2012, J EPIDEMIOL COMMUN H, V66, pA51, DOI 10.1136/jech-2012-201753.132; Queen A, 2015, S E EUR J PUBLIC HLT, P3; Sallam SA, 2016, INT J HEALTH SCI-IJH, V10, P239; Sanyang, 2019, INT J AFRICA NURS SC, V11, P100175, DOI [10.1016/j.ijans.2019.100175, DOI 10.1016/J.IJANS.2019.100175]; Simieneh MM, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3897-4; Statistics Sierra Leone SSL, 2019, S LEON DEM HLTH SURV; Statistics Sierra Leone SSL International ICF., 2014, S LEON DEM HLTH SURV; Statistics Sierra Leone SSL Macro ICF., 2009, SIERR LEON DEM HLTH; Treacy L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188280; UNICEF WHO World Bank Group UN, 2020, LEVELS TRENDS CHILD; Weyer J, 2015, NICD COMMUN DIS SURV, V13, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, PRIM HLTH CAR ROAD U, V2019, P162; WHO, 2012, CHOL S LEON GUIN; WHO, S LEON STAT; Witter S, 2018, INT J HEALTH PLAN M, V33, P434, DOI 10.1002/hpm.2484	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263364	10.1371/journal.pone.0263364	http://dx.doi.org/10.1371/journal.pone.0263364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108338	Green Published, gold			2022-12-26	WOS:000775890100062
J	Zelekha, Y; Kave, G				Zelekha, Yaron; Kave, Gitit			Entrepreneurial tendency across the adult lifespan	PLOS ONE			English	Article							PERSONALITY-TRAITS; SELF-EMPLOYMENT; AGE; DEMOGRAPHICS; METAANALYSIS; CHILDHOOD; GROWTH; BIG-5; WORK	This study examines whether age associates with entrepreneurship tendencies across the lifespan, after taking into account aspects of personality that affect entrepreneurship. Participants (N = 963) aged 18-81, including 200 actual entrepreneurs, completed questionnaires about entrepreneurship tendency, personality traits, and attachment orientations. Results show that age is associated with a reduced tendency to engage in entrepreneurial activity. However, this decline is quite limited, it weakens with age, and is absent after age 50. In addition, the negative association of age with entrepreneurial tendency is smaller in participants with above-median entrepreneurship tendency scores relative to those with below-median scores, and it disappears in actual entrepreneurs. Furthermore, most of the traits that have been previously associated with entrepreneurial tendencies, especially Openness to Experience and Extraversion, remain unchanged with age, accounting for the stability of entrepreneurial tendency over time. The results have implications for policy makers who wish to encourage older adults to engage in entrepreneurial activity.	[Zelekha, Yaron] Ono Acad Coll, Kiryat Ono, Israel; [Kave, Gitit] Open Univ, Raanana, Israel; [Zelekha, Yaron] Ono Acad Coll, Fac Business Adm, Kiryat Ono, Israel; [Kave, Gitit] Open Univ, Dept Educ & Psychol, Raanana, Israel	Open University Israel; Open University Israel	Zelekha, Y (corresponding author), Ono Acad Coll, Kiryat Ono, Israel.; Zelekha, Y (corresponding author), Ono Acad Coll, Fac Business Adm, Kiryat Ono, Israel.	yaronzl@013.net.il		Kave, Gitit/0000-0002-4950-5507				Ahmetoglu G, 2011, PERS INDIV DIFFER, V51, P1028, DOI 10.1016/j.paid.2011.08.016; Ainsworth S, 2008, ORGANIZATION, V15, P389, DOI 10.1177/1350508408088536; Albert Steven M, 2012, Neurosci Neuroecon, V2012, DOI 10.2147/NAN.S27184; Allik J, 2004, EUR J PERSONALITY, V18, P445, DOI 10.1002/per.524; Altonji JG, 2005, J POLIT ECON, V113, P151, DOI 10.1086/426036; Alvarez SA, 2001, J MANAGE, V27, P755, DOI 10.1177/014920630102700609; Ardichvili A, 2003, J BUS VENTURING, V18, P105, DOI 10.1016/S0883-9026(01)00068-4; Blank S., 2012, STARTUP OWNERS MANUA; Blank S., 2005, 4 STEPS EPIPHANY SUC, Vfifth; Blank S, 2013, HARVARD BUS REV, V91, P64; Brandstatter H, 2011, PERS INDIV DIFFER, V51, P222, DOI 10.1016/j.paid.2010.07.007; Branje SJT, 2007, EUR J PERSONALITY, V21, P45, DOI 10.1002/per.596; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Brooks C, 2018, INT REV FINANC ANAL, V56, P52, DOI 10.1016/j.irfa.2017.12.008; Brush CG, 2001, ACAD MANAGE EXEC, V15, P64, DOI 10.5465/AME.2001.4251394; Caliendo M, 2014, SMALL BUS ECON, V42, P787, DOI 10.1007/s11187-013-9514-8; Chiu WCK, 2001, HUM RELAT, V54, P629; Colombier N, 2008, SMALL BUS ECON, V30, P423, DOI 10.1007/s11187-007-9059-9; Colombo MG, 2005, RES POLICY, V34, P795, DOI 10.1016/j.respol.2005.03.010; Costa PT, 2019, ANNU REV PSYCHOL, V70, P423, DOI 10.1146/annurev-psych-010418-103244; Curran J, 2001, WORK EMPLOY SOC, V15, P889, DOI 10.1017/S0950017001008893; De Fruyt F, 2006, J PERS SOC PSYCHOL, V91, P538, DOI 10.1037/0022-3514.91.3.538; Delmar F., 2000, ENTREP REGION DEV, V12, P1, DOI DOI 10.1080/089856200283063; Donnellan AB, 2008, PSYCHOL AGING, V23, P558, DOI 10.1037/a0012897; Dunn T, 2000, J LABOR ECON, V18, P282, DOI 10.1086/209959; Eckhardt JT, 2003, J MANAGE, V29, P333, DOI 10.1177/014920630302900304; Gielnik MM, 2018, J APPL PSYCHOL, V103, P1067, DOI 10.1037/apl0000322; Halvorsen CJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217971; Hart M., 2004, PAPER PRESENTED RENT; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John O.P., 1991, BIG 5 INVENTORY VERS; Kanfer R, 2004, ACAD MANAGE REV, V29, P440, DOI 10.2307/20159053; Kautonen T, 2017, J BUS VENTURING, V32, P318, DOI 10.1016/j.jbusvent.2017.02.005; Kautonen T, 2011, SMALL BUS ECON, V37, P219, DOI 10.1007/s11187-009-9238-y; Kautonen T, 2014, SMALL BUS ECON, V42, P579, DOI 10.1007/s11187-013-9489-5; Kibler E, 2015, J SMALL BUS MANAGE, V53, P193, DOI 10.1111/jsbm.12194; Lamb ME, 2002, CHILD DEV, V73, P1517, DOI 10.1111/1467-8624.00487; Lamotte O, 2013, APPL ECON LETT, V20, P1206, DOI 10.1080/13504851.2013.799747; Leutner F, 2014, PERS INDIV DIFFER, V63, P58, DOI 10.1016/j.paid.2014.01.042; Levesque M, 2006, J BUS VENTURING, V21, P177, DOI 10.1016/j.jbusvent.2005.04.003; Levesque M, 2011, STRATEG ENTREP J, V5, P269, DOI 10.1002/sej.117; Liang J, 2018, J POLIT ECON, V126, pS140, DOI 10.1086/698750; Lindquist MJ, 2015, J LABOR ECON, V33, P269, DOI 10.1086/678493; Lounsbury JW, 2016, J MANAGE PSYCHOL, V31, P434, DOI 10.1108/JMP-03-2014-0092; Mallett O, 2015, WORK EMPLOY SOC, V29, P250, DOI 10.1177/0950017014546666; McCrae RR, 2002, J PERS SOC PSYCHOL, V83, P1456, DOI 10.1037//0022-3514.83.6.1456; MorBarak ME, 1995, INT J AGING HUM DEV, V41, P325, DOI 10.2190/VGTG-EPK6-Q4BH-Q67Q; Neumark D, 2018, J ECON LIT, V56, P799, DOI 10.1257/jel.20161309; Obschonka M, 2013, J PERS SOC PSYCHOL, V105, P104, DOI 10.1037/a0032275; OECD, 2012, POL BRIEF SEN ENTR; Pullmann H, 2006, EUR J PERSONALITY, V20, P447, DOI 10.1002/per.611; Rauch A, 2007, EUR J WORK ORGAN PSY, V16, P353, DOI 10.1080/13594320701595438; Rauch A, 2013, ENTREP THEORY PRACT, V37, P923, DOI 10.1111/j.1540-6520.2011.00487.x; Reynolds P.D, 2002, GLOBAL ENTREPRENEURS; Reynolds P. D., 2001, GLOBAL ENTREPRENEURS; Ries E, 2011, LEAN STARTUP CONSTAN; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Sarasvathy S.D., 2009, EFFECTUATION ELEMENT; Sarasvathy SD, 2001, ACAD MANAGE REV, V26, P243, DOI 10.2307/259121; Schaper, 2004, J ENTERPRISING CULTU, V12, P147, DOI [10.1142/s0218495804000087, DOI 10.1142/S0218495804000087]; Sexton DL., 1985, J BUSINESS VENTURING, V1, P129, DOI [10.1016/0883-9026(85)90012-6, DOI 10.1016/0883-9026(85)90012-6]; Shane S.A., 2003, GEN THEORY ENTREPREN, DOI [10.4337/9781781007990, DOI 10.4337/9781781007990]; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Unger JM, 2011, J BUS VENTURING, V26, P341, DOI 10.1016/j.jbusvent.2009.09.004; Zelekha Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0261108; Zelekha Y, 2018, J EVOL ECON, V28, P495, DOI 10.1007/s00191-018-0570-8; Zelekha Y, 2014, SMALL BUS ECON, V42, P747, DOI 10.1007/s11187-013-9496-6; Zelekha Y, 2013, KYKLOS, V66, P438, DOI 10.1111/kykl.12031; Zhao H, 2006, J APPL PSYCHOL, V91, P259, DOI 10.1037/0021-9010.91.2.259; Zhao H, 2010, J MANAGE, V36, P381, DOI 10.1177/0149206309335187	70	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262856	10.1371/journal.pone.0262856	http://dx.doi.org/10.1371/journal.pone.0262856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108309	gold, Green Published			2022-12-26	WOS:000775890100041
J	Borba, RS; Hoover, SE; Currie, RW; Giovenazzo, P; Guarna, MM; Foster, LJ; Zayed, A; Pernal, SF				Borba, Renata S.; Hoover, Shelley E.; Currie, Robert W.; Giovenazzo, Pierre; Guarna, M. Marta; Foster, Leonard J.; Zayed, Amro; Pernal, Stephen F.			Phenomic analysis of the honey bee pathogen-web and its dynamics on colony productivity, health and social immunity behaviors	PLOS ONE			English	Article							DEFORMED WING VIRUS; MITE VARROA-JACOBSONI; HYMENOPTERA APIDAE COLONIES; APIS-MELLIFERA L.; HYGIENIC BEHAVIOR; POPULATION-GROWTH; ECTOPARASITIC MITE; INFESTATION LEVELS; SACBROOD VIRUS; BROOD DISEASES	Many pathogens and parasites have evolved to overwhelm and suppress their host's immune system. Nevertheless, the interactive effects of these agents on colony productivity and wintering success have been relatively unexplored, particularly in large-scale phenomic studies. As a defense mechanism, honey bees have evolved remarkable social behaviors to defend against pathogen and parasite challenges, which reduce the impact of disease and improve colony health. To investigate the complex role of pathogens, parasites and social immunity behaviors in relation to colony productivity and outcomes, we extensively studied colonies at several locations across Canada for two years. In 2016 and 2017, colonies founded with 1-year-old queens of diverse genetic origin were evaluated, which represented a generalized subset of the Canadian bee population. During each experimental year (May through April), we collected phenotypic data and sampled colonies for pathogen analysis in a standardized manner. Measures included: colony size and productivity (colony weight, cluster size, honey production, and sealed brood population), social immunity traits (hygienic behavior, instantaneous mite population growth rate, and grooming behavior), as well as quantification of gut parasites (Nosema spp., and Lotmaria passim), viruses (DWV-A, DWV-B, BQCV and SBV) and external parasites (Varroa destructor). Our goal was to examine: 1) correlations between pathogens and colony phenotypes; 2) the dynamics of pathogens and parasites on colony phenotypes and productivity traits; and 3) the effects of social immunity behaviors on colony pathogen load. Our results show that colonies expressing high levels of some social immunity behaviors were associated with low levels of pathogens/parasites, including viruses, Nosema spp., and V. destructor. In addition, we determined that elevated viral and Nosema spp. levels were associated with low levels of colony productivity, and that five out of six pathogenic factors measured were negatively associated with colony size and weight in both fall and spring periods. Finally, this study also provides information about the incidence and abundance of pathogens, colony phenotypes, and further disentangles their inter-correlation, so as to better understand drivers of honey bee colony health and productivity.	[Borba, Renata S.; Guarna, M. Marta; Pernal, Stephen F.] Agr & Agri Food Canada, Beaverlodge Res Farm, Beaverlodge, AB, Canada; [Borba, Renata S.; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Hoover, Shelley E.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada; [Currie, Robert W.] Univ Manitoba, Dept Entomol, Winnipeg, MB, Canada; [Giovenazzo, Pierre] Univ Laval, Fac Sci & Genie, Dept Biol, Quebec City, PQ, Canada; [Zayed, Amro] York Univ, Dept Biol, Toronto, ON, Canada; [Borba, Renata S.] Alberta Beekeepers Commiss, Edmonton, AB, Canada	Agriculture & Agri Food Canada; University of British Columbia; University of Lethbridge; University of Manitoba; Laval University; York University - Canada	Borba, RS; Pernal, SF (corresponding author), Agr & Agri Food Canada, Beaverlodge Res Farm, Beaverlodge, AB, Canada.; Borba, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	rsborba1@gmail.com; steve.pernal@agr.gc.ca		Hoover, Shelley/0000-0001-9462-7039; giovenazzo, pierre/0000-0002-8080-4935; Foster, Leonard/0000-0001-8551-4817	LargeScale Applied Research Project Grant from Genome Canada; Genome British Columbia; Genome Alberta; Genome Prairie; Ontario Genomics; Genome Quebec [227Bee]; University of British Columbia; British Columbia Ministry of Agriculture, Food and Fisheries; British Columbia Honey Producers Association; Bruker Daltonics; Alberta Crop Industry Development Fund; Manitoba Agriculture, Food and Rural Initiatives (MAFRI); York University; Ontario Ministry of Agriculture, Food and Rural Affairs; Ontario Ministry of Colleges and Universities; Ontario Beekeepers Association; Centre de recherche en sciences animales de Deschambault	LargeScale Applied Research Project Grant from Genome Canada; Genome British Columbia; Genome Alberta; Genome Prairie; Ontario Genomics; Genome Quebec; University of British Columbia; British Columbia Ministry of Agriculture, Food and Fisheries; British Columbia Honey Producers Association; Bruker Daltonics; Alberta Crop Industry Development Fund; Manitoba Agriculture, Food and Rural Initiatives (MAFRI); York University; Ontario Ministry of Agriculture, Food and Rural Affairs; Ontario Ministry of Colleges and Universities; Ontario Beekeepers Association; Centre de recherche en sciences animales de Deschambault	This work was supported by a LargeScale Applied Research Project Grant from Genome Canada, Genome British Columbia, Genome Alberta, Genome Prairie, Ontario Genomics and Genome Quebec through the "BeeOMICS" Project (227Bee) awarded to LJF/AZ/SFP/SEH/MMG/RWC/PG. Additional cash and in-kind co-funding was provided by: the University of British Columbia; the British Columbia Ministry of Agriculture, Food and Fisheries; the British Columbia Honey Producers Association; Bruker Daltonics; the Alberta Crop Industry Development Fund; Manitoba Agriculture, Food and Rural Initiatives (MAFRI); York University; the Ontario Ministry of Agriculture, Food and Rural Affairs; the Ontario Ministry of Colleges and Universities; the Ontario Beekeepers Association; and the Centre de recherche en sciences animales de Deschambault.	Al Toufailia HM, 2014, J APICULT RES, V53, P555, DOI 10.3896/IBRA.1.53.5.10; Alburaki M, 2018, INSECTS, V9, DOI 10.3390/insects9020065; ANDERSON DL, 1992, J ECON ENTOMOL, V85, P47, DOI 10.1093/jee/85.1.47; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Andino GK, 2011, APIDOLOGIE, V42, P481, DOI 10.1007/s13592-011-0004-1; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; BAILEY L, 1972, ANN APPL BIOL, V72, P27, DOI 10.1111/j.1744-7348.1972.tb01268.x; BAILEY L, 1969, ANN APPL BIOL, V63, P483, DOI 10.1111/j.1744-7348.1969.tb02844.x; Bailey L., 1991, HONEY BEE PATHOLOGY; Bermejo FJO, 1997, APIDOLOGIE, V28, P105, DOI 10.1051/apido:19970301; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; BOOT WJ, 1993, J APICULT RES, V32, P167, DOI 10.1080/00218839.1993.11101302; BOOT WJ, 1994, B ENTOMOL RES, V84, P3, DOI 10.1017/S0007485300032168; Borba RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11689-w; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; CALATAYUD F, 1993, EXP APPL ACAROL, V17, P889, DOI 10.1007/BF02328065; capabees, CANADIAN ASS PROFESS; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Currie R., 1998, BEEKEEPING W CANADA, P103, DOI DOI 10.5962/BHL.TITLE.102763; Currie RW, 2008, CAN J ZOOL, V86, P1059, DOI 10.1139/Z08-083; Currie RW, 2006, CAN ENTOMOL, V138, P238; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Danka RG, 2013, APIDOLOGIE, V44, P447, DOI 10.1007/s13592-013-0195-8; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DEJONG D, 1982, APIDOLOGIE, V13, P297, DOI 10.1051/apido:19820308; Desai SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159615; Desai SD, 2016, CAN ENTOMOL, V148, P22, DOI 10.4039/tce.2015.23; Desai SD, 2015, BEHAV ECOL SOCIOBIOL, V69, P1527, DOI 10.1007/s00265-015-1965-2; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Doke MA, 2019, J ECON ENTOMOL, V112, P525, DOI 10.1093/jee/toy377; Eccles L., 2016, CANADIAN BEST MANAGE; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Giacobino A, 2017, RES VET SCI, V112, P1, DOI 10.1016/j.rvsc.2017.01.001; Gisder S, 2017, J INVERTEBR PATHOL, V147, P51, DOI 10.1016/j.jip.2016.07.010; Glenny W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182814; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Guarna MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08464-2; Guzman-Novoa E, 2012, J INVERTEBR PATHOL, V110, P314, DOI 10.1016/j.jip.2012.03.020; Harris JW, 2003, ENVIRON ENTOMOL, V32, P1305, DOI 10.1603/0046-225X-32.6.1305; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Ibrahim A, 2006, APIDOLOGIE, V37, P31, DOI 10.1051/apido:2005052; Invernizzi C, 2011, NEOTROP ENTOMOL, V40, P28, DOI 10.1590/S1519-566X2011000100004; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; KOVAC H, 1988, J APICULT RES, V27, P230, DOI 10.1080/00218839.1988.11100808; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Little CM, 2016, J APICULT RES, V54, P378, DOI 10.1080/00218839.2016.1159068; Lodesani M, 2002, J APPL ENTOMOL, V126, P130, DOI 10.1046/j.1439-0418.2002.00615.x; MacInnis CI, 2020, J ECON ENTOMOL, V113, P2069, DOI 10.1093/jee/toaa170; Mariani Fernando, 2012, Zootecnia Trop., V30, P081; Martin SJ, 1997, J APICULT RES, V36, P113, DOI 10.1080/00218839.1997.11100937; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin-Hernandez R, 2018, ENVIRON MICROBIOL, V20, P1302, DOI 10.1111/1462-2920.14103; Mondragon L, 2006, APIDOLOGIE, V37, P67, DOI 10.1051/apido:2005053; Moosbeckhofer R., 1997, Apidologie, V28, P193; MORETTO G, 1993, REV BRAS GENET, V16, P71; Mukezangango J., 2017, 12715E AGR AGR FOOD; Natsopoulou ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05596-3; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Pritchard DJ, 2016, J APICULT RES, V55, P38, DOI 10.1080/00218839.2016.1196016; R Core Team, 2020, R LANG ENV STAT COMP; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Ribbands C.R., 1953, BEHAV SOCIAL LIFE HO; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; ROTHENBUHLER WC, 1964, ANIM BEHAV, V12, P578, DOI 10.1016/0003-3472(64)90082-X; Schoning C, 2012, J EXP BIOL, V215, P264, DOI 10.1242/jeb.062562; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Spivak M, 1998, BEE WORLD, V79, P124, DOI 10.1080/0005772X.1998.11099394; Spivak M, 1998, BEE WORLD, V79, P169, DOI 10.1080/0005772X.1998.11099408; Spivak M, 2001, J ECON ENTOMOL, V94, P326, DOI 10.1603/0022-0493-94.2.326; Statistics Canada, PROD VAL HON TABL 32, DOI [10.25318/3210035301-eng, DOI 10.25318/3210035301-ENG]; SZABO TI, 1987, J APICULT RES, V26, P47, DOI 10.1080/00218839.1987.11100734; SZABO TI, 1989, APIDOLOGIE, V20, P157, DOI 10.1051/apido:19890206; WOYKE J, 1984, J APICULT RES, V23, P148, DOI 10.1080/00218839.1984.11100624; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710	87	2	2	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263273	10.1371/journal.pone.0263273	http://dx.doi.org/10.1371/journal.pone.0263273			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100308	gold, Green Published			2022-12-26	WOS:000801937600041
J	Feng, YF; Cai, WH; Yue, HY; Xu, JL; Lin, Y; Chen, JX; Hu, ZJ				Feng, Yifan; Cai, Weihong; Yue, Haoyu; Xu, Jianlong; Lin, Yan; Chen, Jiaxin; Hu, Zijun			An improved X-means and isolation forest based methodology for network traffic anomaly detection	PLOS ONE			English	Article							SERVICE	Anomaly detection in network traffic is becoming a challenging task due to the complexity of large-scale networks and the proliferation of various social network applications. In the actual industrial environment, only recently obtained unlabelled data can be used as the training set. The accuracy of the abnormal ratio in the training set as prior knowledge has a great influence on the performance of the commonly used unsupervised algorithms. In this study, an anomaly detection algorithm based on X-means and iForest is proposed, named X-iForest, which clusters the standard Euclidean distance between the abnormal points and the normal cluster centre to achieve secondary filtering by using X-means. We compared X-iForest with seven mainstream unsupervised algorithms in terms of the AUC and anomaly detection rates. A large number of experiments showed that X-iForest has notable advantages over other algorithms and can be well applied to anomaly detection of large-scale network traffic data.	[Feng, Yifan; Cai, Weihong; Yue, Haoyu; Xu, Jianlong; Chen, Jiaxin; Hu, Zijun] Shantou Univ, Coll Engn, Shantou, Guangdong, Peoples R China; [Lin, Yan] Sangfor Technol Inc, Shenzhen, Guangdong, Peoples R China	Shantou University	Cai, WH (corresponding author), Shantou Univ, Coll Engn, Shantou, Guangdong, Peoples R China.	whcai@stu.edu.cn		Feng, Yifan/0000-0002-6671-4941	Science and Technology Planning Project of Guangdong Province [2016B010124012, 2019B010116001]	Science and Technology Planning Project of Guangdong Province	Grant numbers: 2016B010124012; Weihong Cai reveived award; Full name of funder: Science and Technology Planning Project of Guangdong Province; Grantees played a role in study design, data collection and analysis, publication decisions and manuscript preparation. Grant numbers: 2019B010116001; Weihong Cai reveived award; Full name of funder:Science and Technology Planning Project of Guangdong Province; Grantees played a role in study design, data collection and analysis, publication decisions and manuscript preparation.	Abbasi M, 2021, COMPUT COMMUN, V170, P19, DOI 10.1016/j.comcom.2021.01.021; Abdelltif AA, 2018, IEEE COMMUN MAG, V56, P106, DOI 10.1109/MCOM.2018.1701016; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Agrawal S, 2015, PROCEDIA COMPUT SCI, V60, P708, DOI 10.1016/j.procs.2015.08.220; Ahmed M, 2016, J NETW COMPUT APPL, V60, P19, DOI 10.1016/j.jnca.2015.11.016; Ahmed S, 2019, IEEE T INF FOREN SEC, V14, P2765, DOI 10.1109/TIFS.2019.2902822; Alsini R, 2021, CONSTR BUILD MATER, V270, DOI 10.1016/j.conbuildmat.2020.121396; Bishop C. M, 2006, PATTERN RECOGNITION; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Cai WH, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19122749; Chaudhary R, 2019, IEEE T VEH TECHNOL, V68, P12329, DOI 10.1109/TVT.2019.2948222; Chen HS, 2020, ADV ENG INFORM, V46, DOI 10.1016/j.aei.2020.101139; Chomboon K, 2015, INT C IND APPL ENG 2; Hoang DH, 2018, INT CONF ADV COMMUN, P381; Ding Z., 2013, IFAC P, V46, P12, DOI [DOI 10.3182/20130902-3-CN-3020.00044, 10.3182/20130902-3-CN-3020.00044]; Du X, 2019, IEEE ACCESS, V7, P87760, DOI 10.1109/ACCESS.2019.2925778; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Goldstein M., 2012, KI 2012 POSTER, P59, DOI DOI 10.1007/978-3-642-21329-8_4; Hariri S, 2021, IEEE T KNOWL DATA EN, V33, P1479, DOI 10.1109/TKDE.2019.2947676; He ZY, 2003, PATTERN RECOGN LETT, V24, P1641, DOI 10.1016/S0167-8655(03)00003-5; Kim KH, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122877; Kim TY, 2018, EXPERT SYST APPL, V106, P66, DOI 10.1016/j.eswa.2018.04.004; Lee W, 1998, PROCEEDINGS OF THE SEVENTH USENIX SECURITY SYMPOSIUM, P79; Lee WK, 2000, ARTIF INTELL REV, V14, P533, DOI 10.1023/A:1006624031083; Lingren Wang, 2019, Artificial Intelligence and Security. 5th International Conference, ICAIS 2019. Proceedings: Lecture Notes in Computer Science (LNCS 11634), P632, DOI 10.1007/978-3-030-24271-8_56; Liu FT, 2008, IEEE DATA MINING, P413, DOI 10.1109/ICDM.2008.17; Michalak M, 2021, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION APPLICATIONS AND METHODS (ICPRAM), P523, DOI 10.5220/0010238205230530; Paulauskas N, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8111251; PELLEG D, 2000, P 17 INT C MACH LEAR; Puggini L, 2018, ENG APPL ARTIF INTEL, V67, P126, DOI 10.1016/j.engappai.2017.09.021; Ronao CA, 2017, INT J DISTRIB SENS N, V13, DOI 10.1177/1550147716683687; Spiekermann D, 2021, COMPUT NETW, V192, DOI 10.1016/j.comnet.2021.108017; Susto G. A., 2017, P 28 ANN SEMI ADV SE; Wang HF, 2021, MEASUREMENT, V185, DOI 10.1016/j.measurement.2021.110064; Wang YB, 2020, IEEE T INSTRUM MEAS, V69, P2734, DOI 10.1109/TIM.2019.2926688; Wei GL, 2021, SOFT COMPUT, V25, P1147, DOI 10.1007/s00500-020-05210-1; Xing GL, 2021, IEEE COMMUN MAG, V59, P98, DOI 10.1109/MCOM.001.2000368; Xu D, 2017, INT SYM COMPUT INTEL, P287, DOI 10.1109/ISCID.2017.202; Yu JS, 2014, INT CONF CLOUD COMPU, P140, DOI 10.1109/CCIS.2014.7175718; Zhou L, 2021, J MANUF PROCESS, V68, P843, DOI 10.1016/j.jmapro.2021.06.005; Zhou X., 2018, 10 INT C INTELLIGENT, Vvol 1, P142	41	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263423	10.1371/journal.pone.0263423	http://dx.doi.org/10.1371/journal.pone.0263423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100305	Green Published, gold			2022-12-26	WOS:000801937600048
J	Hamdy, O; Mohammed, HS				Hamdy, Omnia; Mohammed, Haitham S.			Variations in tissue optical parameters with the incident power of an infrared laser	PLOS ONE			English	Article							BIOLOGICAL TISSUE; LIGHT-PROPAGATION; TURBID MEDIA; FLUENCE RATE; ROC; DISCRIMINATION; WAVELENGTH; SKIN	Infrared (IR) lasers are extensively utilized as an effective tool in many medical practices. Nevertheless, light penetration into the inspected tissue, which is highly affected by tissue optical properties, is a crucial factor for successful optical procedures. Although the optical properties are highly wavelength-dependent, they can be affected by the power of the incident laser. The present study demonstrates a considerable change in the scattering and absorption coefficients as a result of varying the incident laser power probing into biological samples at a constant laser wavelength (808 nm). The optical parameters were investigated using an integrating sphere and Kubelka-Munk model. Additionally, fluence distribution at the sample's surface was modeled using COMSOL-multiphysics software. The experimental results were validated using Receiver Operating Characteristic (ROC) curves and Monte-Carlo simulation. The results showed that tissue scattering coefficient decreases as the incident laser power increases while the absorption coefficient experienced a slight change. Moreover, the penetration depth increases with the optical parameters. The reduction in the scattering coefficients leads to wider and more diffusive fluence rate distribution at the tissue surface. The simulation results showed a good agreement with the experimental data and revealed that tissue anisotropy may be responsible for this scattering reduction. The present findings could be considered in order for the specialists to accurately specify the laser optical dose in various biomedical applications.	[Hamdy, Omnia] Cairo Univ, Natl Inst Laser Enhanced Sci, Engn Applicat Lasers Dept, Giza, Egypt; [Mohammed, Haitham S.] Cairo Univ, Fac Sci, Biophys Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Hamdy, O (corresponding author), Cairo Univ, Natl Inst Laser Enhanced Sci, Engn Applicat Lasers Dept, Giza, Egypt.	omnia@niles.edu.eg	Hamdy, Omnia/GLS-7895-2022	Hamdy, Omnia/0000-0002-8662-1451; Mohammed, Haitham S./0000-0002-6055-9514				Abuelmakarem Hala S., 2020, Journal of Physics: Conference Series, V1472, DOI 10.1088/1742-6596/1472/1/012001; Ash C, 2017, LASER MED SCI, V32, P1909, DOI 10.1007/s10103-017-2317-4; Atif M, 2011, OPT SPECTROSC+, V111, P107, DOI 10.1134/S0030400X11070022; Azimipour M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.075001; Barbora A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245350; Bashkatov AN, 2011, J INNOV OPT HEAL SCI, V4, P9, DOI 10.1142/S1793545811001319; Boas D.A., 2011, HDB BIOMEDICAL OPTIC; Bordin-Aykroyd S., 2019, EC DENT SCI, V18, P2303; Calin MA, 2013, J CANCER RES CLIN, V139, P1083, DOI 10.1007/s00432-013-1423-3; Chang J, 2018, NEUROPSYCHIATRY-LOND, V8, P477; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; CILESIZ IF, 1993, APPL OPTICS, V32, P477, DOI 10.1364/AO.32.000477; Dompe C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061724; Dubrovskii VA., 2011, CELL TISSUE BIOL, V5, P520, DOI [10.1134/S1990519X1105004X, DOI 10.1134/S1990519X1105004X]; Firdous S., 2005, INT J CANC RES, V1, P10; Fukutomi D, 2016, OPT REV, V23, P291, DOI 10.1007/s10043-015-0161-y; Genina Elina A., 2015, [Journal of Biomedical Photonics & Engineering, Journal of Biomedical Photonics & Engineering], V1, P22; Goncalves L, 2014, REVSTAT-STAT J, V12, P1; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hamdy O., 2019, P NILES 2019 NOV INT, DOI [10.1109/NILES.2019.8909332, DOI 10.1109/NILES.2019.8909332]; Hamdy O., 2020, J PUBLIC HLTH INT, V2, P13, DOI [10.14302/issn.2641, DOI 10.14302/ISSN.2641]; Hamdy O, 2021, OPTIK, V247, DOI 10.1016/j.ijleo.2021.167981; Hamdy O, 2021, LASER MED SCI, V36, P803, DOI 10.1007/s10103-020-03098-9; Hamdy O, 2020, ANAL METHODS-UK, V12, P2093, DOI [10.1039/d0ay00324g, 10.1039/D0AY00324G]; Hamdy O, 2018, CAIRO INT BIOM ENG, P53, DOI 10.1109/CIBEC.2018.8641819; Hamdy O, 2017, MATERIALS, V10, DOI 10.3390/ma10091104; Hamdy O, 2017, OPTIK, V140, P1004, DOI 10.1016/j.ijleo.2017.05.039; Hamdy O, 2016, CAIRO INT BIOM ENG, P98, DOI 10.1109/CIBEC.2016.7836129; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Ishii K, 2008, PROC SPIE, V6991, DOI 10.1117/12.781607; JAYWANT S, 1993, P SOC PHOTO-OPT INS, V1882, P218, DOI 10.1117/12.148080; Jelinkova H, 2013, WOODH PUB SER ELECT, P1, DOI 10.1533/9780857097545; KEY H, 1991, PHYS MED BIOL, V36, P591, DOI 10.1088/0031-9155/36/5/003; Kim S, 2014, LASER MED SCI, V29, P637, DOI 10.1007/s10103-013-1376-4; KOTTLER F, 1960, J OPT SOC AM, V50, P483, DOI 10.1364/JOSA.50.000483; Lee K, 2011, WORLD J CLIN ONCOL, V2, P64, DOI 10.5306/wjco.v2.i1.64; Lepselter J, 2004, J Dermatolog Treat, V15, P72, DOI 10.1080/09546630310023152; Mahdy S, 2022, LASER MED SCI, V37, P1855, DOI 10.1007/s10103-021-03440-9; Manuel L., 2019, OPTICAL CLEARING MET; Markolf NH., 2007, LASER TISSUE INTERAC; Mohammed HS, 2016, LASER MED SCI, V31, P1651, DOI 10.1007/s10103-016-2033-5; Nachabe R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3611010; Nam BH, 2002, STAT IND TECHNOL, P267; Niemz M.H., 2019, LASER TISSUE INTERAC, V4th ed.; O'Sullivan TD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071311; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; Samaneh R., 2015, BIOSCI BIOTECH RES A, V12, P217, DOI [10.13005/bbra/1626, DOI 10.13005/BBRA/1626, DOI 10.13005/bbra/162610]; Soleimanzad H, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.4.049802; Sterenborg HJCM., 2013, HDB PHOTOMEDICINE; Streiner DL, 2007, CAN J PSYCHIAT, V52, P121, DOI 10.1177/070674370705200210; Striebel M., 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Tuchin VV, 2009, PROC SPIE, V7179, DOI 10.1117/12.812164; TUCHIN VV, 1994, OPT ENG, V33, P3178, DOI 10.1117/12.178900; Tuchin VV, 2007, TISSUE OPTICS LIGHT; Vanyukov V, 2015, EFFECTS NONLINEAR LI; VINING DJ, 1992, RADIOGRAPHICS, V12, P1147, DOI 10.1148/radiographics.12.6.1439017; Wang L.V., 2012, BIOMEDICAL OPTICS PR; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wei HJ, 2003, WORLD J GASTROENTERO, V9, P2068, DOI 10.3748/wjg.v9.i9.2068; Wilkinson C, 2010, J ANAT, V216, P235, DOI 10.1111/j.1469-7580.2009.01182.x; Zhang Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.077003; Zhu CG, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050902; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	63	4	4	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263164	10.1371/journal.pone.0263164	http://dx.doi.org/10.1371/journal.pone.0263164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100314	gold, Green Published			2022-12-26	WOS:000801937600037
J	Liao, YA; Chang, YK; Wang, SM; Chang, HC				Liao, Yian; Chang, Yi-Kai; Wang, Shuo-Meng; Chang, Hong-Chiang			Ceiling effect of clomiphene citrate on the testosterone to estradiol ratio in eugonadal infertile men	PLOS ONE			English	Article							SECONDARY HYPOGONADISM; THERAPY	Introduction The testosterone to estradiol ratio (T/E2 ratio) reportedly exerts a stronger effect on semen quality and sexual desire than does testosterone alone. Clomiphene citrate is a selective estrogen receptor modulator that has long been used as an empirical treatment option in the management of idiopathic oligozoospermia. Clomiphene may change the hypothalamus-pituitary-gonad axis and result in the alteration of the T/E2 ratio. No reliable data are available regarding the change in the T/E2 ratio after clomiphene use in eugonadism. Methods This study included 24 male patients who were diagnosed with idiopathic infertility with eugonadism. They all received clomiphene citrate (25 mg/day) as empirical treatment. Blood tests for serum testosterone, estradiol, prolactin, luteinizing hormone, and follicle stimulating hormone were performed before and after 4 weeks of clomiphene use. Paired t-tests were used to evaluate the significance of the hormone level change. Results Overall, the patients' T/E2 ratio did not increase significantly after clomiphene use. In the subgroup analysis, the T/E2 ratio of patients with a baseline ratio of <200 increased significantly after clomiphene use. Conclusions Clomiphene citrate may significantly increase the T/E2 ratio in eugonadal men under the premise of its ceiling effect (T/E2 ratio < 200), providing practitioners with guidance on the use of clomiphene in this demographic.	[Liao, Yian; Chang, Yi-Kai; Wang, Shuo-Meng; Chang, Hong-Chiang] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chang, HC (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	changhong@ntu.edu.tw						Abhyankar N, 2016, FERTIL STERIL, V106, pE239, DOI 10.1016/j.fertnstert.2016.07.690; Chua ME, 2013, ANDROLOGY-US, V1, P749, DOI 10.1111/j.2047-2927.2013.00107.x; Goldstein SR, 2000, HUM REPROD UPDATE, V6, P212, DOI 10.1093/humupd/6.3.212; Gong YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061598; Guay AT, 2003, INT J IMPOT RES, V15, P156, DOI 10.1038/sj.ijir.3900981; GUAY AT, 1995, J CLIN ENDOCR METAB, V80, P3546, DOI 10.1210/jc.80.12.3546; Hussein A, 2005, J ANDROL, V26, P787, DOI 10.2164/jandrol.04180; Moskovic DJ, 2012, BJU INT, V110, P1524, DOI 10.1111/j.1464-410X.2012.10968.x; Ribeiro RS, 2011, ARQ BRAS ENDOCRINOL, V55, P266, DOI 10.1590/S0004-27302011000400005; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Shabsigh A, 2005, J SEX MED, V2, P716, DOI 10.1111/j.1743-6109.2005.00075.x; Tan RS, 2003, FERTIL STERIL, V79, P203, DOI 10.1016/S0015-0282(02)04550-8; Taylor F, 2010, J SEX MED, V7, P269, DOI 10.1111/j.1743-6109.2009.01454.x; Willets AE, 2013, REPROD SCI, V20, P739, DOI 10.1177/1933719112466304	14	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262924	10.1371/journal.pone.0262924	http://dx.doi.org/10.1371/journal.pone.0262924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100304	gold, Green Submitted, Green Published			2022-12-26	WOS:000801937600026
J	He, XY; Hua, Y; Li, Q; Zhu, W; Pan, Y; Yang, YL; Li, XY; Wu, MX; Wang, JY; Gan, XQ				He, Xinyu; Hua, Yue; Li, Qian; Zhu, Wei; Pan, Yu; Yang, Yilin; Li, Xinyang; Wu, Mengxiao; Wang, Jiyong; Gan, Xiaoqing			FNDC5/irisin facilitates muscle-adipose-bone connectivity through ubiquitination-dependent activation of runt-related transcriptional factors RUNX1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING IRISIN; WHITE ADIPOCYTES; TISSUE; FAT; WWP2; PALATOGENESIS; METABOLISM; OBESITY; PRDM16; FGF21	In the past decade, the cleavage protein irisin derived from fibronectin type III domain-containing protein 5 (FNDC5) in exercise-stimulated skeletal muscle has increasingly become a biomarker associated with metabolic syndrome and osteoporosis in humans. However, it is unclear how this protein facilitates muscle-adipose-bone connectivity in metabolic and skeletal homeostasis. In this study, we unexpectedly observed that the FNDC5 gene can be markedly activated during the differentiation of brown adipocytes but not white adipocytes, and that FNDC5 is specifically expressed in mouse brown adipose tissues (BATs). But unlike it in the skeletal muscles, the expression of FNDC5/irisin in BAT is promoted by cold exposure rather than exercise in mice. Analysis of promoter activity and chromatin immunoprecipitation further showed that peroxisome proliferator-activated receptor gamma coactivator1 alpha and thyroid hormone receptors cooperate on the FNDC5 gene promoter to induce its transcription. We found that FNDC5/irisin stimulates the runt-related transcriptional factors RUNX1/2 via a focal adhesion kinase-dependent pathway in both bone and subcutaneous white adipose tissues. Mechanistically, focal adhesion kinase is stimulated by FNDC5/irisin and then facilitates E3 ubiquitin-protein ligase WW domain- containing protein 2 to ubiquitinate and subsequently activate RUNX1/2, culminating in the activation of osteoblast-related or thermogenesis-related genes. Interestingly, the PR domain containing protein 16 that is crucial for subcutaneous white adipose "browning " and skeletal development was found to form a complex with RUNX1/2 in a WW domain-containing protein 2-dependent manner. These findings elucidate a signaling mechanism by which FNDC5/irisin supports the muscle-adipose-bone connectivity, especially BAT-bone connectivity.	[He, Xinyu; Hua, Yue; Li, Qian; Zhu, Wei; Pan, Yu; Yang, Yilin; Li, Xinyang; Wu, Mengxiao; Wang, Jiyong; Gan, Xiaoqing] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China	Fudan University	Wang, JY; Gan, XQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China.	jiyongwang@fudan.edu.cn; xiaoqinggan@fudan.edu.cn			National Natural Science Foundation of China [31872829]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding and additional information-This work was sponsored by the National Natural Science Foundation of China (grant no.: 31872829 [to G. X. Q.] ) .	Al-Daghri NM, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0224-5; Allah AMA, 2018, PROTEIN PEPTIDE LETT, V25, P560, DOI 10.2174/0929866525666180508120653; Anastasilakis AD, 2014, OSTEOPOROSIS INT, V25, P1633, DOI 10.1007/s00198-014-2673-x; Backstrom S, 2002, J MOL BIOL, V322, P259, DOI 10.1016/S0022-2836(02)00702-7; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bousmpoula A, 2019, GYNECOL ENDOCRINOL, V35, P803, DOI 10.1080/09513590.2019.1594761; Bredella MA, 2014, BONE, V58, P55, DOI 10.1016/j.bone.2013.10.007; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Colaianni G., 2015, PROC; Colaianni G, 2021, J BONE MINER RES, V36, P305, DOI 10.1002/jbmr.4192; Colaianni G, 2019, PEDIATR RES, V85, P484, DOI 10.1038/s41390-019-0278-y; Colaianni G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02557-8; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Ellefsen S., 2014, EUR J APPL MICROBIOL; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Faienza MF, 2018, DIABETES RES CLIN PR, V141, P10, DOI 10.1016/j.diabres.2018.03.046; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Greaves M, 2018, NAT REV CANCER, V18, P471, DOI 10.1038/s41568-018-0015-6; Grygiel-Gorniak B, 2017, EUR REV MED PHARMACO, V21, P4687; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jia J, 2019, WORLD J CLIN CASES, V7, P1444, DOI 10.12998/wjcc.v7.i12.1444; Karampatsou SI, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041274; Karsenty G, 2017, ENDOCR PRACT, V23, P1270, DOI 10.4158/EP171966.RA; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lee P, 2013, OSTEOPOROSIS INT, V24, P1513, DOI 10.1007/s00198-012-2110-y; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Li Q, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00562-17; Liu T. Y., 2016, FATTY ACID; Luo YY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74588-7; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Munoz IYM, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/7816806; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Oguri Y, 2020, CELL, V182, P563, DOI 10.1016/j.cell.2020.06.021; Ott C. E., 2010, DELETIONS; Bonfante ILP, 2017, EUR J SPORT SCI, V17, P629, DOI 10.1080/17461391.2017.1296025; Palermo A., 2015, IRISIN IS ASS OSTEOP; Ponrartana S, 2012, J CLIN ENDOCR METAB, V97, P2693, DOI 10.1210/jc.2012-1589; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rabiee F, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00413-3; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Staiger H., 2013, PLOS; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Vadala G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061478; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang FS, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090810; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiong Y, 2019, FASEB J, V33, P5876, DOI 10.1096/fj.201801754RR; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zhu W, 2017, J BIOL CHEM, V292, P11178, DOI 10.1074/jbc.M116.772277; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	55	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101679	10.1016/j.jbc.2022.101679	http://dx.doi.org/10.1016/j.jbc.2022.101679			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35124008	gold, Green Published			2022-12-26	WOS:000791230900005
J	Lu, CJ; Meng, Y; Wang, YL; Zhang, T; Yang, GF; Mo, MH; Ji, KF; Liang, LM; Zou, CG; Zhang, KQ				Lu, Chao-Jun; Meng, Yang; Wang, Yan-Li; Zhang, Tao; Yang, Gui-Fang; Mo, Ming-He; Ji, Kai-Fang; Liang, Lian-Ming; Zou, Cheng-Gang; Zhang, Ke-Qin			Survival and infectivity of second-stage root-knot nematode Meloidogyne incognita juveniles depend on lysosome-mediated lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RESERVES; REPRODUCTION; BIOGENESIS; STARVATION; EXPANSION; SEQUENCE; FIELD; SPP.	Adaptation to nutrient deprivation depends on the activation of metabolic programs to use reserves of energy. When outside a host plant, second-stage juveniles (J2) of the root knot nematode (Meloidogyne spp.), an important group of pests responsible for severe losses in the production of crops (e.g., rice, wheat, and tomato), are unable to acquire food. Although lipid hydrolysis has been observed in J2 nematodes, its role in fitness and the underlying mechanisms remain unknown. Using RNA-seq analysis, here, we demonstrated that in the absence of host plants, the pathway for the biosynthesis of polyunsaturated fatty acids was upregulated, thereby increasing the production of arachidonic acid in middle-stage J2 Meloidogyne incognita worms. We also found that arachidonic acid upregulated the expression of the transcription factor hlh-30b, which in turn induced lysosomal biogenesis. Lysosomes promoted lipid hydrolysis via a lysosomal lipase, LIPL-1. Furthermore, our data demonstrated that blockage of lysosomal lipolysis reduced both lifespan and locomotion of J2 worms. Strikingly, disturbance of lysosomal lipolysis resulted in a decline in infectivity of these juveniles on tomato roots. Our findings not only reveal the molecular mechanism of lipolysis in J2 worms but also suggest potential novel strategies for the management of root-knot nematode pests.	[Lu, Chao-Jun; Meng, Yang; Zhang, Tao; Yang, Gui-Fang; Mo, Ming-He; Ji, Kai-Fang; Liang, Lian-Ming; Zou, Cheng-Gang; Zhang, Ke-Qin] Yunnan Univ, State Key Lab Conservat & Utilizat BioResources, Kunming, Yunnan, Peoples R China; [Wang, Yan-Li] Yunnan Univ, Ctr Life Sci, Sch Life Sci, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Zou, CG; Zhang, KQ (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat BioResources, Kunming, Yunnan, Peoples R China.	chgzou@ynu.edu.cn; kqzhang@ynu.edu.cn		Zou, Cheng-Gang/0000-0001-5519-4402	National Natural Science Foundation of China [U1802233]; Ministry of Education of PR China & Yunnan University [C176280101]; Department of Science and Technology of Yunnan Province [202102AE090042-02-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of PR China & Yunnan University; Department of Science and Technology of Yunnan Province	We thank Dr Heng Jian (China Agricultural University) for M. incognita strain. We are grateful to Dr Jianping Xu (McMaster University, Canada) for his critical reading of this article and Dr Bin Liang (Yunnan University) for his technical assistance for GC-MS. This work was supported by a grant from the National Natural Science Foundation of China (U1802233) , a Joint project from the Ministry of Education of PR China & Yunnan University (C176280101) , and a grant from the Department of Science and Technology of Yunnan Province (202102AE090042-02-08) .	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adam MAM, 2008, PHYSIOL MOL PLANT P, V72, P21, DOI 10.1016/j.pmpp.2008.05.002; Bakhetia M, 2005, MOL PLANT MICROBE IN, V18, P1099, DOI 10.1094/MPMI-18-1099; Barker K.R, 1989, ADV TREATISE MELOIDO, V1, P47; BARRETT J, 1968, NATURE, V218, P1267, DOI 10.1038/2181267a0; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; Chen J, 2017, ELIFE, V6, DOI 10.7554/eLife.31268; Chen SY, 2000, J NEMATOL, V32, P117; Chen YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10475-8; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Christophers AEP, 1997, NEMATOLOGICA, V43, P117, DOI 10.1163/004725997X00089; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Das S., 2011, AGR SCI RES J, V1, P102; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Dutta TK, 2011, NEMATOLOGY, V13, P509, DOI 10.1163/138855410X528262; Folick A, 2015, SCIENCE, V347, P83, DOI 10.1126/science.1258857; Ghosh A, 2015, J BIOL CHEM, V290, P10309, DOI 10.1074/jbc.M114.610659; GOODELL PB, 1989, J NEMATOL, V21, P328; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Ijani ASM, 2000, EUR J PLANT PATHOL, V106, P1, DOI 10.1023/A:1008788805581; Jo H, 2009, CELL METAB, V9, P440, DOI 10.1016/j.cmet.2009.04.004; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Oka Y, 2002, NEMATOLOGY, V4, P65, DOI 10.1163/156854102760082212; OTEIFA BAKIR A., 1955, PLANT DIS REPORTER, V39, P902; Patel MN, 1997, PARASITOLOGY, V114, P489, DOI 10.1017/S0031182096008748; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Perry RN, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P1, DOI 10.1079/9781845936877.0000; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Rocha FD, 2015, NEMATOLOGY, V17, P345, DOI 10.1163/15685411-00002871; Rocha FD, 2010, NEMATOLOGY, V12, P365, DOI 10.1163/138855409X12548945788367; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Schulze RJ, 2020, P NATL ACAD SCI USA, V117, P32443, DOI 10.1073/pnas.2011442117; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shivakumara TN, 2019, NEMATOLOGY, V21, P267, DOI 10.1163/15685411-00003212; STOREY RMJ, 1984, ANN APPL BIOL, V104, P511, DOI 10.1111/j.1744-7348.1984.tb03034.x; Su L., 2015, SCI REP-UK, V5, P1; Tao J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501372; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torto B, 2018, J AGR FOOD CHEM, V66, P8672, DOI 10.1021/acs.jafc.8b01940; VANGUNDY SD, 1967, PHYTOPATHOLOGY, V57, P559; Wang Z., 2019, CELL SCI, V132; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107	54	0	0	8	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101637	10.1016/j.jbc.2022.101637	http://dx.doi.org/10.1016/j.jbc.2022.101637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085555	gold, Green Published			2022-12-26	WOS:000789261900010
J	Fan, CN; Qi, QJ; Chen, X; Ge, SC				Fan, Chaonan; Qi, Qingjie; Chen, Xi; Ge, Shaocheng			Study on the characteristics of induced airflow and particle dispersion based on the multivariate two-factor model	PLOS ONE			English	Article							DUST; DIFFUSION; MINE	To examine the diffusion characteristics of airflow and dust particles, a multi-factor and multi-level physical self-developed testing system is established. In this study, bunker height, chute angle, feeding speed, coal granularity, and belt speed are selected as independent variables, and airflow velocity and dust concentration are the response variables. The two-factor interactive model is established to analyze the primary and secondary relationship between the independent variables and the response variables. The results demonstrate a denser contour distribution of three-dimensional curved surfaces, suggesting an obvious interaction between the factors. The bunker height increases from 0.75 m to 1.15 m, the maximum increment of the induced airflow velocity at the outlet of the guide chute is observed to be 0.35 m/s, meanwhile, and with the increase in the feed speed from 2t/h to 8t/h, the increment of the induced airflow velocity at the outlet of the guide chute is recorded to be 51%. The coal granularity and bunker height depicted the highest influence on induced air velocity and dust concentration, and the feeding speed proved to be the secondary parameter. This two-factor interactive model can accurately forecast the actual values with a deviation of the calculated values limited to 9%. These research results support the existing research and provide a theoretical foundation to guide the dust control at belt conveyor transfer stations.	[Fan, Chaonan; Qi, Qingjie] Liaoning Tech Univ, Coll Safety Engn & Technol, Fuxing, Liaoning, Peoples R China; [Fan, Chaonan; Chen, Xi; Ge, Shaocheng] Taiyuan Univ Technol, Coll Safety & Emergency Management Engn, Taiyuan, Shanxi, Peoples R China	Liaoning Technical University; Taiyuan University of Technology	Chen, X (corresponding author), Taiyuan Univ Technol, Coll Safety & Emergency Management Engn, Taiyuan, Shanxi, Peoples R China.	chenxi01@tyut.edu.cn		chen, xi/0000-0001-6029-7596	National Natural Science Foundation of China [52174195 51704145]; Doctoral Start-up Foundation of Liaoning Province [20170520086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Start-up Foundation of Liaoning Province	The authors gratefully acknowledge the financial supports by the National Natural Science Foundation of China [52174195 51704145,] and Doctoral Start-up Foundation of Liaoning Province [20170520086]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansart R, 2009, CHEM ENG J, V152, P415, DOI 10.1016/j.cej.2009.04.070; Chen XL, 2012, INT J MINER PROCESS, V110, P101, DOI 10.1016/j.minpro.2012.04.008; [陈曦 Chen Xi], 2015, [煤炭学报, Journal of China Coal Society], V40, P603; Chen XL, 2015, INT J MULTIPHAS FLOW, V69, P42, DOI 10.1016/j.ijmultiphaseflow.2014.09.010; Cheng WM, 2016, PROCESS SAF ENVIRON, V104, P240, DOI 10.1016/j.psep.2016.09.004; Gol'tsov AB, 2019, REFRACT IND CERAM+, V59, P671, DOI 10.1007/s11148-019-00294-1; Hemeon W.D.L, 1963, PLANT PROCESS VENTIL, DOI 10.1080/00022470.1963.10468167; Hua Y, 2018, POWDER TECHNOL, V334, P117, DOI 10.1016/j.powtec.2018.04.059; Li SH, 2017, ADV POWDER TECHNOL, V28, P3213, DOI 10.1016/j.apt.2017.10.003; Li XC, 2016, POWDER TECHNOL, V291, P159, DOI 10.1016/j.powtec.2015.12.021; Li XC, 2015, ADV POWDER TECHNOL, V26, P236, DOI 10.1016/j.apt.2014.10.003; Liu Z, 2007, PARTICUL SCI TECHNOL, V25, P357, DOI 10.1080/02726350701484006; Logachev IN, 2020, POWDER TECHNOL, V373, P323, DOI 10.1016/j.powtec.2020.06.055; Logachev KI, 2019, BUILD ENVIRON, V151, P338, DOI 10.1016/j.buildenv.2019.01.039; Moreno T, 2019, INT J COAL GEOL, V203, P52, DOI 10.1016/j.coal.2019.01.006; PLINKE MAE, 1991, AM IND HYG ASSOC J, V52, P521, DOI 10.1202/0002-8894(1991)052<0521:EEOFTA>2.0.CO;2; Varona Marcela, 2018, Biomed., V38, P467, DOI 10.7705/biomedica.v38i4.4183; Wang HT, 2019, POWDER TECHNOL, V342, P149, DOI 10.1016/j.powtec.2018.09.099; Wypych P, 2005, CHEM ENG PROCESS, V44, P323, DOI 10.1016/j.cep.2004.02.026; Wypych PW, 2006, PARTICUL SCI TECHNOL, V24, P165, DOI 10.1080/02726350500544216; Xu G, 2018, SCI TOTAL ENVIRON, V639, P1060, DOI 10.1016/j.scitotenv.2018.05.182; Yuan Z, 2015, SAFETY SCI, V74, P79, DOI 10.1016/j.ssci.2014.12.002; Zhou G, 2018, POWDER TECHNOL, V339, P354, DOI 10.1016/j.powtec.2018.07.078; Zhou Q, 2018, POWDER TECHNOL, V326, P7, DOI 10.1016/j.powtec.2017.12.002	24	0	0	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263740	10.1371/journal.pone.0263740	http://dx.doi.org/10.1371/journal.pone.0263740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134066	gold, Green Published			2022-12-26	WOS:000798968600032
J	Tsoumani, M; Regent, L; Warner, A; Gallop, K; Patel, R; Ryan, R; Vereda, A; Acaster, S; DunnGalvin, A; Byrne, A				Tsoumani, Marina; Regent, Lynne; Warner, Amena; Gallop, Katy; Patel, Ram; Ryan, Robert; Vereda, Andrea; Acaster, Sarah; DunnGalvin, Audrey; Byrne, Aideen			Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-RELATED QUALITY; FOOD ALLERGY; FATAL ANAPHYLAXIS; HOSPITAL ANXIETY; PREVALENCE; SENSITIZATION; AVOIDANCE	The Allergy to Peanuts imPacting Emotions And Life study (APPEAL) explored the psychosocial burden of living with self-reported peanut allergy experienced by children, teenagers, adults and caregivers in the UK and Ireland. A two-stage (quantitative survey and qualitative interview [APPEAL-1]), cross-sectional study of the psychosocial burden of peanut allergy (APPEAL-2) was conducted. Quantitative data were evaluated using descriptive statistics and qualitative data were analysed using MAXQDA software. A conceptual model specific to UK and Ireland was developed using the concepts identified during the analysis. A total of 284 adults in the UK and Ireland completed the APPEAL-1 survey and 42 individuals participated in APPEAL-2. Respondents reported that peanut allergy restricts their choices in various situations, especially with regard to choosing food when eating out (87% moderately or severely restricted), choosing where to eat (82%), special occasions (76%) and when buying food from a shop (71%). Fifty-two percent of survey participants and 40% of interview participants reported being bullied because of PA. Psychological impact of peanut allergy included feeling at least moderate levels of frustration (70%), uncertainty (79%), and stress (71%). The qualitative analysis identified three different types of coping strategies (daily monitoring or vigilance, communication and planning) and four main areas of individuals' lives that are impacted by peanut allergy (social activities, relationships, emotions and work [adults and caregivers only]). The extent of the impact reported varied substantially between participants, with some reporting many negative consequences of living with peanut allergy and others feeling it has minimal impact on their health-related quality of life. This large survey and interview study highlight the psychosocial burden of peanut allergy for adults, teenagers, children and caregivers in the UK and Ireland. The analysis demonstrates the wide variation in level of impact of peanut allergy and the unmet need for those individuals who experience a substantial burden from living with peanut allergy.	[Tsoumani, Marina] Univ Manchester, Div Infect Immun & Resp Med, NIHR Manchester Biomed Res Ctr,Sch Biol Sci, Manchester Acad Hlth Sci Ctr,Manchester Univ Hosp, Manchester, Lancs, England; [Regent, Lynne] Anaphylaxis Campaign, Farnborough, Hants, England; [Warner, Amena] Allergy UK, Sidcup, Kent, England; [Gallop, Katy; Acaster, Sarah] Acaster Lloyd Consulting, London, England; [Patel, Ram] Brainsell Ltd, London, England; [Ryan, Robert; Vereda, Andrea] Nestle Hlth Sci Co, Aimmune Therapeut, London, England; [DunnGalvin, Audrey] Univ Coll Cork, Sch Appl Psychol, Cork, Ireland; [DunnGalvin, Audrey] Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Byrne, Aideen] Trinity Coll Dublin, Allergy Dept, Childrens Hlth Ireland, Dublin, Ireland; [Byrne, Aideen] Trinity Coll Dublin, Paediat & Child Hlth, Dublin, Ireland	University of Manchester; University College Cork; University College Cork; Trinity College Dublin; Trinity College Dublin	DunnGalvin, A (corresponding author), Univ Coll Cork, Sch Appl Psychol, Cork, Ireland.; DunnGalvin, A (corresponding author), Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland.	A.DunnGalvin@ucc.ie	Gallop, Katy/GOE-4627-2022	BYRNE, AIDEEN/0000-0001-7136-9364	Aimmune Therapeutics	Aimmune Therapeutics	This work was supported by Aimmune Therapeutics. Authors Robert Ryan and Andrea Vereda are employed by Aimmune Therapeutics. Brainsell Ltd received funding from Aimmune Therapaeutics for conducting the APPEAL-1 survey and for analytical support. Author Ram Patel is employed by Brainsell. Acaster Lloyd Consulting received funding from Aimmune Therapeutics for conducting the study. Authors Katy Gallop and Sarah Acaster are employed by Acaster Lloyd Consulting. The specific roles of these authors are articulated in the 'author contributions' section. The funders provided support in the form of salaries to these authors or consultant fees to the employers of these authors and were involved in the study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Acaster S, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-00477-3; Acaster S, 2020, CLIN EXP ALLERGY, V50, P1249, DOI 10.1111/cea.13727; Blumchen K, 2020, ALLERGY, V75, P2920, DOI 10.1111/all.14414; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Breeman S, 2015, QUAL LIFE RES, V24, P391, DOI 10.1007/s11136-014-0763-z; Couratier P, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-00481-7; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; DunnGalvin A, 2015, ALLERGY, V70, P1039, DOI 10.1111/all.12614; DunnGalvin A, 2009, ALLERGY, V64, P560, DOI 10.1111/j.1398-9995.2008.01862.x; DunnGalvin A, 2020, CLIN EXP ALLERGY, V50, P1238, DOI 10.1111/cea.13719; DunnGalvin A, 2020, ALLERGY, V75, P2899, DOI 10.1111/all.14363; Flokstra-de Blok BMJ, 2010, ALLERGY, V65, P238, DOI 10.1111/j.1398-9995.2009.02121.x; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Hourihane JO, 2007, J ALLERGY CLIN IMMUN, V119, P1197, DOI 10.1016/j.jaci.2006.12.670; Kelleher MM, 2016, J ALLERGY CLIN IMMUN, V137, P1111, DOI 10.1016/j.jaci.2015.12.1312; Kerr C, 2010, EXPERT REV PHARM OUT, V10, P269, DOI 10.1586/ERP.10.30; Nowak-Wegrzyn A, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2021.100512; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Pouessel G, 2018, PEDIAT ALLERG IMM-UK, V29, P101, DOI 10.1111/pai.12828; Primeau MN, 2000, CLIN EXP ALLERGY, V30, P1135, DOI 10.1046/j.1365-2222.2000.00889.x; Ramsey NB, 2019, J ALLER CL IMM-PRACT, V7, P2241, DOI 10.1016/j.jaip.2019.04.025; Roy KM, 2011, CLIN PEDIATR, V50, P1045, DOI 10.1177/0009922811412584; Saleh-Langenberg J, 2015, ALLERGY, V70, P616, DOI 10.1111/all.12582; Turner PJ, 2017, J ALLER CL IMM-PRACT, V5, P1169, DOI 10.1016/j.jaip.2017.06.031; Venter C, 2015, J ALLERGY CLIN IMMUN, V135, pAB38, DOI 10.1016/j.jaci.2014.12.1053; Wassenberg J, 2012, PEDIAT ALLERG IMM-UK, V23, P412, DOI 10.1111/j.1399-3038.2012.01310.x; Williams NA, 2015, QUAL LIFE RES, V24, P1369, DOI 10.1007/s11136-014-0862-x; Woods RK, 2002, ANN ALLERG ASTHMA IM, V88, P183, DOI 10.1016/S1081-1206(10)61994-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0262851	10.1371/journal.pone.0262851	http://dx.doi.org/10.1371/journal.pone.0262851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130296	Green Published, gold			2022-12-26	WOS:000805530700012
J	Arsalidou, M; Skuratov, N; Khalezov, E; Bernstein, A; Burnaev, E; Sharaev, M				Arsalidou, Marie; Skuratov, Nikolay; Khalezov, Evgeny; Bernstein, Alexander; Burnaev, Evgeny; Sharaev, Maxim			Effects of age, gender, and hemisphere on cerebrovascular hemodynamics in children and young adults: Developmental scores and machine learning classifiers	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DOPPLER SONOGRAPHY; VERTEBRAL ARTERIES; GESTATIONAL-AGE; VELOCITIES; DEPENDENCE; VOLUME	A constant blood supply to the brain is required for mental function. Research with Doppler ultrasonography has important clinical value and burgeoning potential with machine learning applications in studies predicting gestational age and vascular aging. Critically, studies on ultrasound metrics in school-age children are sparse and no machine learning study to date has used color duplex ultrasonography to predict age and classify age-group. The purpose of our study is two-fold: first to document cerebrovascular hemodynamics considering age, gender, and hemisphere in three arteries; and second to construct machine learning models that can predict and classify the age and age-group of a participant using ultrasonography metrics. We record peak systolic, end-diastolic, and time-averaged maximum velocities bilaterally in internal carotid, vertebral, and middle cerebral arteries from 821 participants. Results confirm that ultrasonography values decrease with age and reveal that gender and hemispheres show more similarities than differences, which depend on age, artery, and metric. Machine learning algorithms predict age and classifier models distinguish cerebrovascular hemodynamics between children and adults. Blood velocities, rather than blood vessel diameters, are more important for classifier models, and common and distinct variables contribute to age classification models for males and females.	[Arsalidou, Marie; Khalezov, Evgeny] HSE Univ, Moscow, Russia; [Arsalidou, Marie] York Univ, Toronto, ON, Canada; [Skuratov, Nikolay; Bernstein, Alexander; Burnaev, Evgeny; Sharaev, Maxim] Skolkovo Inst Sci & Technol, Res Ctr AI, Moscow, Russia; [Burnaev, Evgeny] AIRI, Moscow, Russia	HSE University (National Research University Higher School of Economics); York University - Canada; Skolkovo Institute of Science & Technology	Arsalidou, M (corresponding author), HSE Univ, Moscow, Russia.; Arsalidou, M (corresponding author), York Univ, Toronto, ON, Canada.	marie.arsalidou@gmail.com	Sharaev, Maksim/L-9769-2016; Arsalidou, Marie/I-7204-2015	Sharaev, Maksim/0000-0002-5670-2891; Arsalidou, Marie/0000-0001-9879-3894	Russian Science Foundation [17-18-01047]; Analytical center under the RF Government [000000D730321P5Q0002, 70-2021-00145]	Russian Science Foundation(Russian Science Foundation (RSF)); Analytical center under the RF Government	Support is gratefully acknowledged in part from the Russian Science Foundation #17-18-01047 (https://rscf.ru/) to MA. Part of the work devoted to the application of machine learning models was made within funding from the Analytical center under the RF Government (subsidy agreement 000000D730321P5Q0002, Grant No. 70-2021-00145 02.11.2021). No additional external funding was received for this study.	Aaslid R., 1986, TRANSCRANIAL DOPPLER, P60; Acock AC, 2005, J MARRIAGE FAM, V67, P1012, DOI 10.1111/j.1741-3737.2005.00191.x; ADAMS RJ, 1990, AM J PEDIAT HEMATOL, V12, P277; Albayrak R, 2007, J CLIN ULTRASOUND, V35, P27, DOI 10.1002/jcu.20301; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Amin-Hanjani S, 2015, J CEREBR BLOOD F MET, V35, P312, DOI 10.1038/jcbfm.2014.203; Andreev A., 2018, PATTERN RECOGN, P306; Arsalidou M, 2017, BRAIN IMAGING BEHAV, V11, P1214, DOI 10.1007/s11682-016-9592-8; Bakker MJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-43; Beunen GP, 2006, FOOD NUTR BULL, V27, pS244, DOI 10.1177/15648265060274S508; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Brattain LJ, 2018, ABDOM RADIOL, V43, P786, DOI 10.1007/s00261-018-1517-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, RANDOM FORESTS, V45, P5; Burnaev E, 2015, PROC SPIE, V9875, DOI 10.1117/12.2228523; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Demirkaya S, 2008, TOHOKU J EXP MED, V214, P145, DOI 10.1620/tjem.214.145; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Barrientos-Guerra JD, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2019.104595; Drucker H, 1997, ADV NEUR IN, V9, P155; Fedintsev A, 2017, AGING-US, V9, P1280, DOI 10.18632/aging.101227; Forster V, 2018, NEPHROL DIAL TRANSPL, V33, P1622; GROLIMUND P, 1988, ULTRASOUND MED BIOL, V14, P191, DOI 10.1016/0301-5629(88)90139-1; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; He H, 2008, 2008 IEEE INT JOINT; Hoaglin DC, 1983, UNDERSTANDING ROBUST, V3; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Krakauskaite S, 2018, ACTA NEUROCHIR SUPPL, V126, P269, DOI 10.1007/978-3-319-65798-1_53; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; Levi Gil, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P34, DOI 10.1109/CVPRW.2015.7301352; Lin KL, 2007, BRAIN DEV-JPN, V29, P64, DOI 10.1016/j.braindev.2006.06.003; Liu A, 2007, INT C DAT MIN, P2528; Liu W, 2011, LECT NOTES ARTIF INT, V6635, P345, DOI 10.1007/978-3-642-20847-8_29; Mohri M., 2018, FDN MACHINE LEARNING; Namburete AIL, 2015, MED IMAGE ANAL, V21, P72, DOI 10.1016/j.media.2014.12.006; Nithyashri J, 2012, 2012 FOURTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTING (ICOAC); Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894; Pascual-Leone J., 2021, WORKING MIND MEANING; PASCUALL.J, 1970, ACTA PSYCHOL, V32, P301, DOI 10.1016/0001-6918(70)90108-3; Patel N, 2016, PHYSIOL MEAS, V37, P1485, DOI 10.1088/0967-3334/37/9/1485; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P827, DOI 10.1097/00004647-199609000-00007; Simaeva IN, 2019, BALT REG, V11, P76, DOI 10.5922/2079-8555-2019-1-6; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tahir MA, 2012, PATTERN RECOGN, V45, P3738, DOI 10.1016/j.patcog.2012.03.014; Tegeler CH, 2013, J NEUROIMAGING, V23, P466, DOI 10.1111/j.1552-6569.2012.00711.x; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wu C, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002657; Yu HF, 2011, MACH LEARN, V85, P41, DOI 10.1007/s10994-010-5221-8	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263106	10.1371/journal.pone.0263106	http://dx.doi.org/10.1371/journal.pone.0263106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0W8MA	35120173	Green Published, gold			2022-12-26	WOS:000789273600020
J	Torsahakul, C; Israsena, N; Khramchantuk, S; Ratanavaraporn, J; Dhitavat, S; Rodprasert, W; Nantavisai, S; Sawangmake, C				Torsahakul, Chutirat; Israsena, Nipan; Khramchantuk, Supaporn; Ratanavaraporn, Juthamas; Dhitavat, Sirakarnt; Rodprasert, Watchareewan; Nantavisai, Sirirat; Sawangmake, Chenphop			Bio-fabrication of stem-cell-incorporated corneal epithelial and stromal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regeneration	PLOS ONE			English	Article							AMNIOTIC MEMBRANE TRANSPLANTATION; OCULAR SURFACE RECONSTRUCTION; ENZYMATIC DEGRADATION; PROGENITOR CELLS; TISSUE; SCAFFOLDS; EXPRESSION; MIGRATION; CULTURE; GROWTH	Corneal grafts are the imperative clinical treatment for canine corneal blindness. To serve the growing demand, this study aimed to generate tissue-engineered canine cornea in part of the corneal epithelium and underlying stroma based on canine limbal epithelial stem cells (cLESCs) seeded silk fibroin/gelatin (SF/G) film and canine corneal stromal stem cells (cCSSCs) seeded SF/G scaffold, respectively. Both cell types were successfully isolated by collagenase I. SF/G corneal films and stromal scaffolds served as the prospective substrates for cLESCs and cCSSCs by promoting cell adhesion, cell viability, and cell proliferation. The results revealed the upregulation of tumor protein P63 (P63) and ATP-binding cassette super-family G member 2 (Abcg2) of cLESCs as well as Keratocan (Kera), Lumican (Lum), aldehyde dehydrogenase 3 family member A1 (Aldh3a1) and Aquaporin 1 (Aqp1) of differentiated keratocytes. Moreover, immunohistochemistry illustrated the positive staining of tumor protein P63 (P63), aldehyde dehydrogenase 3 family member A1 (Aldh3a1), lumican (Lum) and collagen I (Col-I), which are considerable for native cornea. This study manifested a feasible platform to construct tissue-engineered canine cornea for functional grafts and positively contributed to the body of knowledge related to canine corneal stem cells.	[Torsahakul, Chutirat] Chulalongkorn Univ, Grad program Vet Biosci, Fac Vet Sci, Bangkok, Thailand; [Torsahakul, Chutirat; Rodprasert, Watchareewan; Nantavisai, Sirirat; Sawangmake, Chenphop] Chulalongkorn Univ, Vet Stem Cell & Bioengn Res Unit, Fac Vet Sci, Bangkok, Thailand; [Torsahakul, Chutirat; Rodprasert, Watchareewan; Nantavisai, Sirirat; Sawangmake, Chenphop] Chulalongkorn Univ, Vet Stem Cell & Bioengn Innovat Ctr VSCBIC, Fac Vet Sci, Bangkok, Thailand; [Israsena, Nipan] Chulalongkorn Univ, Stem Cell & Cell Therapy Res Unit, Fac Med, Bangkok, Thailand; [Israsena, Nipan] Chulalongkorn Univ, Dept Pharmacol, Fac Med, Bangkok, Thailand; [Khramchantuk, Supaporn] King Chulalongkorn Mem Hosp, Excellence Ctr Stem Cell & Cell Therapy, Thai Red Cross Soc, Bangkok, Thailand; [Ratanavaraporn, Juthamas] Chulalongkorn Univ, Biomed Engn Program, Fac Engn, Bangkok, Thailand; [Ratanavaraporn, Juthamas] Chulalongkorn Univ, Biomed Engn Res Ctr, Fac Engn, Bangkok, Thailand; [Ratanavaraporn, Juthamas] Chulalongkorn Univ, Biomed Engn Med & Hlth Res Unit, Fac Engn, Bangkok, Thailand; [Dhitavat, Sirakarnt] Chulalongkorn Univ, Dept Physiol, Biochem Unit, Fac Vet Sci, Bangkok, Thailand; [Nantavisai, Sirirat] Chulalongkorn Univ, Acad Affairs, Fac Vet Sci, Bangkok, Thailand; [Sawangmake, Chenphop] Chulalongkorn Univ, Dept Pharmacol, Fac Vet Sci, Bangkok, Thailand; [Sawangmake, Chenphop] Chulalongkorn Univ, Ctr Excellence Regenerat Dent CERD, Fac Dent, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Sawangmake, C (corresponding author), Chulalongkorn Univ, Vet Stem Cell & Bioengn Res Unit, Fac Vet Sci, Bangkok, Thailand.; Sawangmake, C (corresponding author), Chulalongkorn Univ, Vet Stem Cell & Bioengn Innovat Ctr VSCBIC, Fac Vet Sci, Bangkok, Thailand.; Sawangmake, C (corresponding author), Chulalongkorn Univ, Dept Pharmacol, Fac Vet Sci, Bangkok, Thailand.; Sawangmake, C (corresponding author), Chulalongkorn Univ, Ctr Excellence Regenerat Dent CERD, Fac Dent, Bangkok, Thailand.	chenphop.s@chula.ac.th		Sawangmake, Chenphop/0000-0003-2619-9487	100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; 90th Anniversary Chulalongkorn University Fund; Veterinary Stem Cell and Bioengineering Research Unit, Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University; Chulalongkorn University [CU_GR_62_98_21_15]; Faculty of Veterinary Science; Chulalongkorn Academic Advancement into Its 2nd Century Project; Center of Excellence for Regenerative Dentistry(CERD), Faculty of Dentistry, Chulalongkorn University; Veterinary Stem Cell and Bioengineering Research Unit, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; Government Research Fund	100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; 90th Anniversary Chulalongkorn University Fund; Veterinary Stem Cell and Bioengineering Research Unit, Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University; Chulalongkorn University(Chulalongkorn University); Faculty of Veterinary Science; Chulalongkorn Academic Advancement into Its 2nd Century Project; Center of Excellence for Regenerative Dentistry(CERD), Faculty of Dentistry, Chulalongkorn University; Veterinary Stem Cell and Bioengineering Research Unit, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; Government Research Fund	CT was supported by the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; the 90th Anniversary Chulalongkorn University Fund; and Veterinary Stem Cell and Bioengineering Research Unit, Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University. JR was supported by Chulalongkorn University: CU_GR_62_98_21_15. CS was supported by research supporting grant of the Faculty of Veterinary Science; Chulalongkorn Academic Advancement into Its 2nd Century Project; Center of Excellence for Regenerative Dentistry(CERD), Faculty of Dentistry, Chulalongkorn University; Veterinary Stem Cell and Bioengineering Research Unit, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; and Government Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arcelli R, 2009, VET RES COMMUN, V33, pS169, DOI 10.1007/s11259-009-9284-6; Bakhshandeh H, 2011, INT J NANOMED, V6, P1509, DOI 10.2147/IJN.S19011; Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Bertoldi M, 2016, SEQUESTRO CORNEALE F; BIRK DE, 1986, INVEST OPHTH VIS SCI, V27, P1470; Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045; Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068; Chantong N, 2019, J SURFACTANTS DETERG, V22, P1395, DOI 10.1002/jsde.12298; Chen SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45100-7; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen Z, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa92d2; Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x; de Oliveira RC, 2020, EXP EYE RES, V197, DOI 10.1016/j.exer.2020.108090; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doughty MJ, 2015, CLIN EXP OPTOM, V98, P218, DOI 10.1111/cxo.12253; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Forni MF, 2013, CURR EYE RES, V38, P27, DOI 10.3109/02713683.2012.733053; Foster James W., 2015, SCI REP-UK, V5, P1; Funderburgh ML, 2005, FASEB J, V19, P1371, DOI 10.1096/fj.04-2770fje; Ghezzi CE, 2015, TISSUE ENG PART B-RE, V21, P278, DOI [10.1089/ten.teb.2014.0397, 10.1089/ten.TEB.2014.0397]; Gosselin EA, 2018, J TISSUE ENG REGEN M, V12, P285, DOI 10.1002/term.2499; Gouveia RM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040347; He XY, 2011, INVEST OPHTH VIS SCI, V52, P731, DOI 10.1167/iovs.10-5723; Heo SJ, 2018, J ORTHOP RES, V36, P808, DOI 10.1002/jor.23772; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; Kafarnik C, 2020, STEM CELLS DEV, V29, P425, DOI 10.1089/scd.2019.0163; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Kondo M, 1997, AM J RESP CELL MOL, V16, P62, DOI 10.1165/ajrcmb.16.1.8998080; Kumar A, 2018, INVEST OPHTH VIS SCI, V59, P3728, DOI 10.1167/iovs.18-23824; Lakshman N, 2010, EXP EYE RES, V90, P350, DOI 10.1016/j.exer.2009.11.016; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5; Liu Min, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P736; Maggs D. J., 2012, SLATTERS FUNDAMENTAL; Maharajan VS, 2007, CLIN EXP OPHTHALMOL, V35, P140, DOI 10.1111/j.1442-9071.2006.01408.x; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Merindano MD., 2003, EUROPEAN J ANATOMY, V6, P133; Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009; Morita M, 2015, VET OPHTHALMOL, V18, P59, DOI 10.1111/vop.12147; Nam E, 2015, VET OPHTHALMOL, V18, P317, DOI 10.1111/vop.12241; Niu GG, 2014, BIOMATERIALS, V35, P4005, DOI 10.1016/j.biomaterials.2014.01.033; Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Neill Dan G, 2017, Canine Genet Epidemiol, V4, P5, DOI 10.1186/s40575-017-0045-5; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Ruiz-Ederra J, 2009, EXP EYE RES, V89, P159, DOI 10.1016/j.exer.2009.03.002; Sah M. K., 2010, International Journal of Environmental Science and Development, V1, P404; Secker G., 2009, STEM CELL RES COMMUN, DOI [10.3824/stembook.1.48.1, DOI 10.3824/STEMBOOK.1.48.1]; Sridhar MS, 2018, INDIAN J OPHTHALMOL, V66, P190, DOI 10.4103/ijo.IJO_646_17; Taylor ZD, 2015, IEEE T THZ SCI TECHN, V5, P170, DOI 10.1109/TTHZ.2015.2392619; Tidu A, 2018, BIOMATER SCI-UK, V6, P1492, DOI 10.1039/c7bm01163f; Tucker N, 2005, INVESTIGATIVE OPHTHA, V46, P4252; TUFT SJ, 1990, EYE, V4, P389, DOI 10.1038/eye.1990.53; Turner SM, 2005, VET OPHTHALMOLOGY MA; Utheim O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118517; Vongsakul S, 2009, THAI J VET MED, V39, P135; Wang SR, 2017, BIOMATERIALS, V112, P1, DOI 10.1016/j.biomaterials.2016.09.030; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wilkie DA, 1997, VET CLIN N AM-SMALL, V27, P1067, DOI 10.1016/S0195-5616(97)50104-5; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Withavatpongtorn N, 2021, MEMBRANES-BASEL, V11, DOI 10.3390/membranes11110824; Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078; Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.TEA.2012.0545, 10.1089/ten.tea.2012.0545]; Wu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093012; Yang Z, 2012, J DIGEST DIS, V13, P168, DOI 10.1111/j.1751-2980.2011.00566.x; Yoon Jinny J, 2014, World J Stem Cells, V6, P391, DOI 10.4252/wjsc.v6.i4.391	75	0	0	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263141	10.1371/journal.pone.0263141	http://dx.doi.org/10.1371/journal.pone.0263141			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120168	gold, Green Published			2022-12-26	WOS:000789273600024
J	Blackowicz, MJ; Bell, M; Echeverri, J; Harenski, K; Broman, ME				Blackowicz, Michael J.; Bell, Max; Echeverri, Jorge; Harenski, Kai; Broman, Marcus E.			Cost-effectiveness of the TherMax blood warmer during continuous renal replacement therapy	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; ECONOMIC-EVALUATION; BODY-TEMPERATURE; MORTALITY; HYPOTHERMIA; SURVIVAL; SEPSIS; FEVER; MODALITY	Hypothermia is a common adverse event during continuous renal replacement therapy (CRRT), affecting multiple organ systems and increasing risk of poor health outcomes among patients with acute kidney injury (AKI) undergoing CRRT. TheraMax blood warmers are the next generation of extracorporeal blood warmers which reduce risk of hypothermia during CRRT. The purpose of this study is to elucidate the potential health economic impacts of avoiding CRRT-induced hypothermia by using the novel TherMax blood warming device. This study compares health care costs associated with use of the new TherMax blood warmer unit integrated with the PrisMax system compared to CRRT with a standalone blood warming device to avoid hypothermia in continuous renal replacement therapy (CRRT). An economic model was developed in which relevant health states for each intervention were normothermia, hypothermia, discharge, and death. Clinical inputs and costs were obtained from a combination of retrospective chart review and publicly available summary estimates. The proportion of AKI patients treated with CRRT who became hypothermic (<36 degrees C) during CRRT treatment was 34.5% in the TherMax group compared to 71.9% in the 'standalone warmer' group. Given the 78.7-year average life expectancy in the US and the assumed average patient age at discharge/death of 65.4 years, the total life-years gained by avoiding mortality related to hypothermia was 9.0 in the TherMax group compared to 8.0 in the 'standalone warmer' group. Cost per life-year gained was $8,615 in the TherMax group versus $10,115 in the 'standalone warmer' group for a difference of -$1,501 favoring TherMax. The incremental cost-effectiveness ratio was negative, indicating superior cost-effectiveness for TherMax versus 'standalone warmer'. The TherMax blood warming device used with the PrisMax system is associated with lower risk of hypothermia, which our model indicates leads to lower costs, lower risk of mortality due to hypothermia, and superior cost-effectiveness.	[Blackowicz, Michael J.; Echeverri, Jorge; Harenski, Kai] Baxter Healthcare Corp, Deerfield, IL 60015 USA; [Bell, Max] Karolinska Univ Hosp, Dept Perioperat Med & Intens Care, Stockholm, Sweden; [Bell, Max] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Broman, Marcus E.] Skane Univ Hosp, Perioperat & Intens Care, Lund, Sweden	Baxter International Inc; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Lund University; Skane University Hospital	Blackowicz, MJ (corresponding author), Baxter Healthcare Corp, Deerfield, IL 60015 USA.	michael_blackowicz@baxter.com	Bell, Max/F-5409-2013	Bell, Max/0000-0001-7464-0324	Baxter Healthcare; Skane University Hospital	Baxter Healthcare; Skane University Hospital	This study was funded by Baxter Healthcare and Skane University Hospital in the form of consultancy grants for authors Bell and Broman. Baxter Healthcare also provided support in the form of salaries for authors Blackowicz, Echeverri, and Harenski. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoundi A, 2015, BLOOD PURIFICAT, V39, P333, DOI 10.1159/000380903; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Bell M, 2020, ACTA ANAESTH SCAND, V64, P1162, DOI 10.1111/aas.13616; BRIVET F, 1994, CRIT CARE MED, V22, P533, DOI 10.1097/00003246-199403000-00029; Broman M, 2018, ACTA ANAESTH SCAND, V62, P648, DOI 10.1111/aas.13061; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; Collister D, 2017, CLIN J AM SOC NEPHRO, V12, P1733, DOI 10.2215/CJN.00950117; De Smedt DM, 2012, NEPHROL DIAL TRANSPL, V27, P4095, DOI 10.1093/ndt/gfs410; Erkens R, 2020, MED PRIN PRACT, V29, P389, DOI 10.1159/000505126; Ethgen O, 2015, NEPHROL DIAL TRANSPL, V30, P54, DOI 10.1093/ndt/gfu314; Foundation KF. . Kaiser Family Foundation., 2021, POPULATION DISTRIBUT; Healthcare B.,, 2021, BAXT PROD CAT; Henning DJ, 2017, CRIT CARE MED, V45, pE575, DOI 10.1097/CCM.0000000000002311; Honore PM, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03316-4; Hoste EAJ, 2018, NAT REV NEPHROL, V14, P607, DOI 10.1038/s41581-018-0052-0; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Inaba K, 2009, WORLD J SURG, V33, P864, DOI 10.1007/s00268-009-9936-2; Klarenbach S, 2009, INT J TECHNOL ASSESS, V25, P331, DOI 10.1017/S0266462309990134; Kramer AA, 2017, CRIT CARE MED, V45, P1457, DOI 10.1097/CCM.0000000000002563; Kushimoto S, 2019, CRIT CARE MED, V47, P691, DOI 10.1097/CCM.0000000000003688; Lascarrou JB, 2019, NEW ENGL J MED, V381, P2327, DOI 10.1056/NEJMoa1906661; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P10, DOI 10.1164/ajrccm.151.1.7812538; Park S, 2020, CRIT CARE MED, V48, P1462, DOI 10.1097/CCM.0000000000004493; Ruetzler K, 2018, HAND CLINIC, V157, P687, DOI 10.1016/B978-0-444-64074-1.00041-0; Rumbus Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170152; Saran R, 2020, AM J KIDNEY DIS, V75, pSVI, DOI 10.1053/j.ajkd.2019.09.003; Shimazui T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02976-6; Sunden-Cullberg J, 2017, CRIT CARE MED, V45, P591, DOI 10.1097/CCM.0000000000002249; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281, DOI 10.1177/039139880703000402; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Garay OU, 2019, VALUE HEALTH REG ISS, V20, P142, DOI 10.1016/j.vhri.2019.03.008; Wald R, 2014, CRIT CARE MED, V42, P868, DOI 10.1097/CCM.0000000000000042; Wu VC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000933; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Young PJ, 2012, INTENS CARE MED, V38, P437, DOI 10.1007/s00134-012-2478-3	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263054	10.1371/journal.pone.0263054	http://dx.doi.org/10.1371/journal.pone.0263054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113881	Green Published, gold			2022-12-26	WOS:000823694700051
J	Horlait, M; De Regge, M; Baes, S; Eeckloo, K; Leys, M				Horlait, Melissa; De Regge, Melissa; Baes, Saskia; Eeckloo, Kristof; Leys, Mark			Exploring non-physician care professionals' roles in cancer multidisciplinary team meetings: A qualitative study	PLOS ONE			English	Article							CLINICAL DECISION-MAKING; GYNECOLOGICAL ONCOLOGY; BREAST-CANCER; EXPERIENCES; SPECIALIST; MANAGEMENT; NURSE; WORKING	The growing complexity of cancer care necessitates collaboration among different professionals. This interprofessional collaboration improves cancer care delivery and outcomes. Treatment decision-making within the context of a multidisciplinaire team meeting (MDTMs) may be seen as a particular form of interprofessional collaboration. Various studies on cancer MDTMs highlight a pattern of suboptimal information sharing between attendants. To overcome the lack of non-medical, patient-based information, it might be recommended that non-physician care professionals play a key patient advocacy role within cancer MDTMs. This study aims to explore non-physician care professionals' current and aspired role within cancer MDTMs. Additionally, the perceived hindering factors for these non-physician care professionals to fulfil their specific role are identified. The analysis focuses on nurses, specialist nurses, head nurses, psychologists, social workers, a head of social workers and data managers. The results show that non-physician care professionals play a limited role during case discussions in MDTMs. Neither do they actively participate in the decision-making process. Barriers perceived by non-physician care professionals are classified on two main levels: 1) team-related barriers (factors internally related to the team) and 2) external barriers (factors related to healthcare management and policy). A group of non-physician care professionals also belief that their information does not add value in the decision-making proces and as such, they underestimate their own role in MDTMs. To conclude, a change of culture is needed towards an interdisciplinary collaboration in which knowledge and expertise of different professions are equally assimilated into an integrated perspective to guarantee a true patient-centred approach for cancer MDTMs.	[Horlait, Melissa; Baes, Saskia; Leys, Mark] Vrije Univ Brussel, Fac Med & Pharm, Dept Publ Hlth, Brussels, Belgium; [De Regge, Melissa] Univ Ghent, Fac Econ & Business Adm, Dept Mkt Innovat & Org, Ghent, Belgium; [De Regge, Melissa; Eeckloo, Kristof] Ghent Univ Hosp, Strateg Policy Cell, Ghent, Belgium; [Eeckloo, Kristof] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Horlait, M (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, Dept Publ Hlth, Brussels, Belgium.	melissa.horlait@vub.be		Horlait, Melissa/0000-0003-1899-7518				Amir Z, 2004, Eur J Oncol Nurs, V8, P306, DOI 10.1016/j.ejon.2003.12.011; Amundsen A, 2018, PATIENT EDUC COUNS, V101, P399, DOI 10.1016/j.pec.2017.10.001; Atwal Anita, 2006, Int J Nurs Pract, V12, P359, DOI 10.1111/j.1440-172X.2006.00595.x; Baes S, 2020, INT J CARE COORD, V23, P107, DOI 10.1177/2053434520959678; Blazeby JM, 2006, ANN ONCOL, V17, P457, DOI 10.1093/annonc/mdj102; Bohmeier B, 2021, PATIENT EDUC COUNS, V104, P792, DOI 10.1016/j.pec.2020.09.007; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chirgwin J, 2010, J ONCOL PRACT, V6, P294, DOI 10.1200/JOP.2010.000017; Cook O, 2019, EUR J ONCOL NURS, V41, P7, DOI 10.1016/j.ejon.2019.05.004; Coombs M, 2004, J ADV NURS, V46, P245, DOI 10.1111/j.1365-2648.2004.02984.x; Coulter A., 2015, INT J PERS CENT MED, V5, P6; Covvey JR, 2019, SUPPORT CARE CANCER, V27, P1613, DOI 10.1007/s00520-019-04675-7; Dew K, 2015, QUAL HEALTH RES, V25, P397, DOI 10.1177/1049732314553010; Dubois C, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12822; English R, 2012, BREAST J, V18, P459, DOI 10.1111/j.1524-4741.2012.01270.x; Friese CR, 2005, ONCOL NURS FORUM, V32, P765, DOI 10.1188/05.ONF.765-772; Gagliardi AR, 2011, SURG ONCOL, V20, P146, DOI 10.1016/j.suronc.2011.06.004; Gray R Gordon B., 2017, CANC RES UK; Gro&beta;mann C., 2012, GEBURTSH FRAUENHEILK, V72, pP7, DOI [10.1055/s-0032-1318528, DOI 10.1055/S-0032-1318528]; Hahlweg P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139921; Hollunder S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4841-4; Horlait M, 2019, J MULTIDISCIP HEALTH, V12, P159, DOI 10.2147/JMDH.S196660; Kidger J, 2009, BJOG-INT J OBSTET GY, V116, P511, DOI 10.1111/j.1471-0528.2008.02066.x; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kobleder A, 2017, J CLIN NURS, V26, P4890, DOI 10.1111/jocn.13966; Lamb BW, 2013, ANN SURG ONCOL, V20, P1408, DOI 10.1245/s10434-012-2676-9; Lamb BW, 2013, J AM COLL SURGEONS, V217, P412, DOI 10.1016/j.jamcollsurg.2013.04.035; Lamb BW, 2011, ANN SURG ONCOL, V18, P2116, DOI 10.1245/s10434-011-1675-6; Lamb BW, 2011, INT J UROL NURS, V5, P59, DOI 10.1111/j.1749-771X.2011.01119.x; Lanceley A, 2008, INT J GYNECOL CANCER, V18, P215, DOI 10.1111/j.1525-1438.2007.00991.x; Luft LeeAnne M, 2017, Can Med Educ J, V8, pe109; Mashima PA, 2021, AM J SPEECH-LANG PAT, V30, P1598, DOI 10.1044/2021_AJSLP-20-00313; Monas L, 2017, ISR J HEALTH POLICY, V6, DOI 10.1186/s13584-017-0186-8; Munro AJ, 2015, CLIN ONCOL-UK, V27, P728, DOI 10.1016/j.clon.2015.08.008; Petri L, 2010, NURS FORUM, V45, P73, DOI 10.1111/j.1744-6198.2010.00167.x; Punshon G, 2017, CLIN NURSE SPEC, V31, P210, DOI 10.1097/NUR.0000000000000308; Raine R, 2014, BMJ QUAL SAF, V23, P867, DOI 10.1136/bmjqs-2014-002818; Rajan S, 2013, BRIT J CANCER, V108, P2442, DOI 10.1038/bjc.2013.267; Rosell L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2990-4; Singh R, 2018, J REHABIL MED, V50, P673, DOI 10.2340/16501977-2364; Soukup T, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2020.0024; Soukup T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027303; Soukup T, 2016, ANN SURG ONCOL, V23, P4410, DOI 10.1245/s10434-016-5347-4; Soukup T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003885; Suter E, 2009, J INTERPROF CARE, V23, P41, DOI 10.1080/13561820802338579; Taylor C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0488-2; Van Belle S, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2007.07489.x; van Leeunven AF, 2004, J PAIN SYMPTOM MANAG, V28, P351, DOI 10.1016/j.jpainsymman.2004.01.005; Veliz AR, 2020, JBI EVID SYNTH, V18, P1285, DOI 10.11124/JBISRIR-D-19-00103; VGC AASRCF, CONS CRIT REP QUAL S; Wallace IG., 2017, THESIS UCL; Wallace I, 2019, EUR J ONCOL NURS, V43, DOI 10.1016/j.ejon.2019.101674; Wood JJ, 2008, COLORECTAL DIS, V10, P769, DOI 10.1111/j.1463-1318.2007.01464.x; World Health Organization, 2010, FRAM ACT INT ED COLL, DOI DOI 10.1111/J.1741-1130.2007.00144.X	54	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263611	10.1371/journal.pone.0263611	http://dx.doi.org/10.1371/journal.pone.0263611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113976	Green Published, gold			2022-12-26	WOS:000823694700111
J	Sadleir, KR; Popovic, J; Khatri, A; Vassar, R				Sadleir, Katherine R.; Popovic, Jelena; Khatri, Ammaarah; Vassar, Robert			Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BETA-SECRETASE; PRECURSOR PROTEIN; CALCIUM DYSREGULATION; NEURON LOSS; PLAQUES; DISRUPTION; CHANNELS; MICE; IDENTIFICATION	Dysregulation of calcium homeostasis has been hypothesized to play a role in Alzheimer's disease (AD) pathogenesis. Increased calcium levels can impair axonal transport, disrupt synaptic transmission, and ultimately lead to cell death. Given the potential role of calcium dyshomeostasis in AD, there is interest in testing the ability of already approved drugs targeting various calcium channels to affect amyloid pathology and other aspects of disease. The objective of this study was to test the effects of FDA-approved L-type calcium channel antagonist nimodipine on amyloid accumulation and dystrophic neurite formation in 5XFAD mice, a mouse model of amyloid pathology. 5XFAD transgenic mice and non-transgenic littermates were treated with vehicle or nimodipine-containing chow from two to eight months of age, then brains were harvested and amyloid pathology assessed by immunoblot and immunofluorescence microscopy analyses. Nimodipine was well tolerated and crossed the blood brain barrier, as expected, but there was no effect on A beta accumulation or on the relative amount of neuritic dystrophy, as assessed by either immunoblot, dot blot or immunofluorescence imaging of A beta 42 and dystrophic neurite marker LAMP1. While we conclude that nimodipine treatment is not likely to improve amyloid pathology or decrease neuritic dystrophy in AD, it is worth noting that nimodipine did not worsen the phenotype suggesting its use is safe in AD patients.	[Sadleir, Katherine R.; Popovic, Jelena; Khatri, Ammaarah; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Sadleir, KR; Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	krdoherty@northwestern.edu; r-vassar@northwestern.edu		, Katherine/0000-0001-8310-841X	National Institute on Aging [R01 AG030142]; Baila Foundation; National Cancer Institute [NCI CCSG P30 CA060553]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Baila Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RV-R01 AG030142, National Institute on Aging, https://www.nia.nih.gov/RV -no grant number given, The Baila Foundation, no website available Robert H Lurie Comprehensive Cancer, NCI CCSG P30 CA060553, National Cancer Institute, https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Arancio O, 2017, ALZHEIMERS DEMENT, V13, P178, DOI 10.1016/j.jalz.2016.12.006; Bailey JM, 2013, NEUROTOXICOLOGY, V37, P108, DOI 10.1016/j.neuro.2013.03.011; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Chiozzi P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42931-2; COHEN MW, 1991, J NEUROSCI, V11, P1032; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Elmaleh DR, 2019, J ALZHEIMERS DIS, V71, P715, DOI 10.3233/JAD-190507; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Fritze J, 1995, J NEURAL TRANSM-SUPP, P439; Gottle Peter, 2019, Neurol Res Pract, V1, P21, DOI 10.1186/s42466-019-0026-0; Gowrishankar S, 2015, P NATL ACAD SCI USA, V112, pE3699, DOI 10.1073/pnas.1510329112; Hanyu H, 2007, INT J GERIATR PSYCH, V22, P1264, DOI 10.1002/gps.1851; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y; Hoffman DJ, 2016, NEUROTOXICOLOGY, V54, P127, DOI 10.1016/j.neuro.2016.04.009; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ishii M, 2019, J NEUROSCI, V39, P8816, DOI 10.1523/JNEUROSCI.0617-19.2019; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Khachaturian Z.S., 1984, HDB STUDIES PSYCHIAT, P7; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; LANGLEY MS, 1989, DRUGS, V37, P669, DOI 10.2165/00003495-198937050-00004; LARKIN JG, 1992, EPILEPSIA, V33, P760, DOI 10.1111/j.1528-1157.1992.tb02358.x; Lerdkrai C, 2018, P NATL ACAD SCI USA, V115, pE1279, DOI 10.1073/pnas.1714409115; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lopez-Arrieta J M, 2002, Cochrane Database Syst Rev, pCD000147; Marcantoni M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay0167; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Morich FJ, 1996, CLIN DRUG INVEST, V11, P185, DOI 10.2165/00044011-199611040-00001; Neuner SM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00035; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Popovic N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00562; Rocchi A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006962; Sadleir KR, 2021, CURR ALZHEIMER RES, V18, P283, DOI 10.2174/1567205018666210713125333; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sadleir KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101643; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Schampel A, 2017, P NATL ACAD SCI USA, V114, pE3295, DOI 10.1073/pnas.1620052114; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sha Sharon J, 2017, Alzheimers Dement (N Y), V3, P507, DOI 10.1016/j.trci.2017.08.002; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; TOLLEFSON GD, 1990, BIOL PSYCHIAT, V27, P1133, DOI 10.1016/0006-3223(90)90050-C; Tomassoni D, 2008, CLIN EXP HYPERTENS, V30, P744, DOI 10.1080/10641960802580232; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Xie H, 2013, J NEUROSCI, V 33, P17042, DOI 10.1523/JNEUROSCI.1836-13.2013; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263332	10.1371/journal.pone.0263332	http://dx.doi.org/10.1371/journal.pone.0263332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108319	Green Published, gold			2022-12-26	WOS:000775890100058
J	Jeong, HS; Lee, DH; Kim, SH; Lee, CH; Shin, HM; Kim, HR; Cho, CH				Jeong, Han-Seok; Lee, Da-Hye; Kim, Seung-Hoon; Lee, Chang-Han; Shin, Hyun Mu; Kim, Hang-Rae; Cho, Chung-Hyun			Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1	ONCOGENE			English	Article							VON-WILLEBRAND-FACTOR; TIGHT JUNCTION PROTEINS; VASCULAR-PERMEABILITY; STAT3 ACTIVATION; PLASMA-LEVELS; CANCER; SECRETION; INFLAMMATION; PLATELETS; INSIGHTS	Diabetes mellitus (DM) characterized by hyperglycemia is a chronic metabolic disorder that leads to many symptoms and vascular complications. Despite the close association between DM and cancer progression, the response and role of endothelial cells (ECs) under diabetic conditions in tumor metastasis remain to be elucidated. In this study, we sought to determine whether and how ECs under diabetic conditions contribute to tumor metastasis. We have taken advantage of syngeneic mouse tumor models of Lewis lung carcinoma (LLC) and melanoma (B16F10) cells and a streptozotocin (STZ)-induced hyperglycemia model. We demonstrated that hyperglycemia increased the metastasis of LLC and B16F10 cells in an experimental metastasis model with an intravenous injection of the tumor cells. We also found that hyperglycemia promoted lung metastasis of tumor cells by increasing the adhesiveness of ECs to facilitate the adhesion of tumor cells to ECs rather than affecting the metastatic behavior of tumor cells themselves. From the analysis of gene expression in primary lung ECs from STZ-treated mice, we identified that vWF promoted the adhesion of tumor cells to ECs and the transendothelial migration of tumor cells. Mechanistically, hyperglycemia-induced oxidative stress in ECs, and increased oxidative stress enhanced vWF expression in ECs through an increase in the transcription factor GATA1. These results provide evidence for the role of vWF in ECs in promoting hyperglycemia-induced tumor metastasis and potential therapeutic targets for the regulation of vWF expression in ECs and hyperglycemia-induced tumor metastasis.	[Jeong, Han-Seok; Lee, Da-Hye; Kim, Seung-Hoon; Lee, Chang-Han; Shin, Hyun Mu; Kim, Hang-Rae; Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea; [Jeong, Han-Seok; Lee, Da-Hye; Kim, Seung-Hoon; Lee, Chang-Han; Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 03080, South Korea; [Shin, Hyun Mu] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon 25159, South Korea; [Kim, Hang-Rae] Seoul Natl Univ, Dept Anat & Cell Biol, Seoul 03080, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 03080, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Cho, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea.; Cho, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 03080, South Korea.; Cho, CH (corresponding author), Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 03080, South Korea.	iamhyun@snu.ac.kr		Kim, Hang-Rae/0000-0002-3983-6193	National Research Foundation of Korea - Korea government [2020R1A2C1008008]; SNUH Research Fund [0420210290]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government); SNUH Research Fund	We appreciate Dr. Kyong Soo Park for technical assistance in insulin supplementation experiments. This work is supported by funding from the National Research Foundation of Korea grant funded by the Korea government (2020R1A2C1008008 to CHC) and the SNUH Research Fund (0420210290 to CHC).	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Avdonin PV, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020196; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Blann AD, 2011, PROSTATE, V71, P1047, DOI 10.1002/pros.21319; Carstensen B, 2016, DIABETOLOGIA, V59, P980, DOI 10.1007/s00125-016-3884-9; Chan Norman N, 2003, Med Sci Monit, V9, pCR297; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; De Ceunynck K, 2013, BLOOD, V121, P270, DOI 10.1182/blood-2012-07-442285; Dmitrieva NI, 2014, P NATL ACAD SCI USA, V111, P6485, DOI 10.1073/pnas.1404809111; Drummond GR, 2014, TRENDS ENDOCRIN MET, V25, P452, DOI 10.1016/j.tem.2014.06.012; Dymkowska D, 2014, ARCH BIOCHEM BIOPHYS, V542, P7, DOI 10.1016/j.abb.2013.11.008; Fainsod-Levi T, 2017, CELL REP, V21, P2384, DOI 10.1016/j.celrep.2017.11.010; Fan C, 2009, J BIOL CHEM, V284, P23331, DOI 10.1074/jbc.M109.036079; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Franchini M, 2013, THROMB RES, V131, P290, DOI 10.1016/j.thromres.2013.01.015; Franses JW, 2013, INT J CANCER, V133, P1334, DOI 10.1002/ijc.28146; GADDUCCI A, 1994, GYNECOL ONCOL, V53, P352, DOI 10.1006/gyno.1994.1146; Garcia-Roman J, 2013, CANCER LETT, V335, P259, DOI 10.1016/j.canlet.2013.03.005; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; He H, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01531; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ikemura M, 2017, ANTICANCER RES, V37, P5463, DOI 10.21873/anticanres.11975; Ikemura M, 2013, J CONTROL RELEASE, V170, P191, DOI 10.1016/j.jconrel.2013.05.028; Jafar N, 2016, AM J MED SCI, V351, P201, DOI 10.1016/j.amjms.2015.11.011; Jeon HY, 2019, FASEB J, V33, P750, DOI 10.1096/fj.201800723R; KARPATKIN S, 1988, J CLIN INVEST, V81, P1012, DOI 10.1172/JCI113411; Kim KJ, 2017, ONCOGENE, V36, P5445, DOI 10.1038/onc.2017.148; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Li NL, 2016, INT J CANCER, V138, P2078, DOI 10.1002/ijc.29847; Li WJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1309-6; Liu J, 2009, J THROMB HAEMOST, V7, P1384, DOI 10.1111/j.1538-7836.2009.03501.x; Lou ZK, 2018, MOL MED REP, V17, P2479, DOI 10.3892/mmr.2017.8124; Marini A, 2018, P NATL ACAD SCI USA, V115, P6219, DOI 10.1073/pnas.1718531115; MORDES DB, 1983, DIABETES, V32, P876, DOI 10.2337/diabetes.32.9.876; Morganti M, 2000, BIOMED PHARMACOTHER, V54, P431, DOI 10.1016/S0753-3322(00)00006-8; NICHOLS TC, 1995, P NATL ACAD SCI USA, V92, P2455, DOI 10.1073/pnas.92.7.2455; Noh Y, 2019, INT J CANCER, V144, P1530, DOI 10.1002/ijc.31870; O'Sullivan JM, 2018, SEMIN THROMB HEMOST, V44, P159, DOI 10.1055/s-0037-1607352; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Pilch J, 2002, J BIOL CHEM, V277, P21930, DOI 10.1074/jbc.M201630200; Rohsig LM, 2001, BRAZ J MED BIOL RES, V34, P1125; Sadler JE, 2013, BLOOD, V121, P2583, DOI 10.1182/blood-2013-02-482000; Scappaticcio L, 2017, ENDOCRINE, V56, P231, DOI 10.1007/s12020-016-1216-y; Schwachtgen JL, 1997, ONCOGENE, V15, P3091, DOI 10.1038/sj.onc.1201502; Seligman BGS, 2000, DIABETES CARE, V23, P1395, DOI 10.2337/diacare.23.9.1395; Spratt DE, 2016, INT J RADIAT ONCOL, V94, P523, DOI 10.1016/j.ijrobp.2015.11.007; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takano M, 2002, AM J PHYSIOL-HEART C, V283, pH2054, DOI 10.1152/ajpheart.01001.2001; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Terraube V, 2007, THROMB RES, V120, pS64, DOI 10.1016/S0049-3848(07)70132-9; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; VISCHER UM, 1995, BLOOD, V85, P3164, DOI 10.1182/blood.V85.11.3164.bloodjournal85113164; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Wang JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37130-4; Wang WS, 2005, WORLD J GASTROENTERO, V11, P2166, DOI 10.3748/wjg.v11.i14.2166; Xiang YZ, 2015, BLOOD, V125, P3377, DOI 10.1182/blood-2015-01-620278; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yun JH, 2021, J CELL PHYSIOL, V236, P7058, DOI 10.1002/jcp.30373; Yun JH, 2017, J CELL PHYSIOL, V232, P1123, DOI 10.1002/jcp.25575; Zheng Y, 2016, AM J PATHOL, V186, P1081, DOI 10.1016/j.ajpath.2015.12.020	64	1	1	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1634	1646		10.1038/s41388-022-02207-y	http://dx.doi.org/10.1038/s41388-022-02207-y		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35094008				2022-12-26	WOS:000750486500003
J	Oehm, AW; Merle, R; Tautenhahn, A; Jensen, KC; Mueller, KE; Feist, M; Zablotski, Y				Oehm, Andreas W.; Merle, Roswitha; Tautenhahn, Annegret; Jensen, K. Charlotte; Mueller, Kerstin-Elisabeth; Feist, Melanie; Zablotski, Yury			Identifying cow - level factors and farm characteristics associated with locomotion scores in dairy cows using cumulative link mixed models	PLOS ONE			English	Article							BODY CONDITION SCORE; RISK-FACTORS; PROPORTIONAL ODDS; DIGITAL CUSHION; REPRODUCTIVE-PERFORMANCE; MILK-PRODUCTION; HERD-LEVEL; LAMENESS; CATTLE; SYSTEMS	Lameness is a tremendous problem in intensively managed dairy herds all over the world. It has been associated with considerable adverse effects on animal welfare and economic viability. The majority of studies have evaluated factors associated with gait disturbance by categorising cows into lame and non-lame. This procedure yet entails a loss of information and precision. In the present study, we extend the binomial response to five categories acknowledging the ordered categorical nature of locomotion assessments, which conserves a higher level of information. A cumulative link mixed modelling approach was used to identify factors associated with increasing locomotion scores. The analysis revealed that a low body condition, elevated somatic cell count, more severe hock lesions, increasing parity, absence of pasture access, and poor udder cleanliness were relevant variables associated with higher locomotion scores. Furthermore, distinct differences in the locomotion scores assigned were identified in regard to breed, observer, and season. Using locomotion scores rather than a dichotomised response variable uncovers more refined relationships between gait disturbances and associated factors. This will help to understand the intricate nature of gait disturbances in dairy cows more deeply.	[Oehm, Andreas W.; Zablotski, Yury] Ludwig Maximilians Univ Munchen, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany; [Merle, Roswitha; Jensen, K. Charlotte] Free Univ Berlin, Inst Vet Epidemiol & Biostat, Berlin, Germany; [Tautenhahn, Annegret; Mueller, Kerstin-Elisabeth] Free Univ Berlin, Clin Ruminants & Swine, Fac Vet Med, Berlin, Germany; [Jensen, K. Charlotte] Univ Vet Med, Fdn, Clin Cattle, Hannover, Germany	University of Munich; Free University of Berlin; Free University of Berlin; University of Veterinary Medicine Hannover, Foundation	Oehm, AW (corresponding author), Ludwig Maximilians Univ Munchen, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany.	Andreas.Oehm@outlook.com		Stock, Annegret/0000-0001-6998-5555; Oehm, Andreas/0000-0002-2709-8541; Zablotski, Yury/0000-0001-6928-4089; Merle, Roswitha/0000-0002-8688-2926				Adams AE, 2017, J DAIRY SCI, V100, P2119, DOI 10.3168/jds.2016-11517; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alsaaod M, 2017, J DAIRY SCI, V100, P8330, DOI 10.3168/jds.2017-12760; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Amory JR, 2006, J DAIRY SCI, V89, P1509, DOI 10.3168/jds.S0022-0302(06)72218-4; Baird LG, 2009, J DAIRY SCI, V92, P2174, DOI 10.3168/jds.2008-1333; Barker ZE, 2018, J DAIRY SCI, V101, P6310, DOI 10.3168/jds.2016-12172; Berry SL, 2001, VET CLIN N AM-FOOD A, V17, P129, DOI 10.1016/S0749-0720(15)30058-X; Blackie N, 2013, J DAIRY SCI, V96, P3564, DOI 10.3168/jds.2012-5597; Borderas TF, 2004, J DAIRY SCI, V87, P2085, DOI 10.3168/jds.S0022-0302(04)70026-0; Bran JA, 2019, PREV VET MED, V172, DOI 10.1016/j.prevetmed.2019.104773; Brenninkmeyer C, 2013, PREV VET MED, V109, P236, DOI 10.1016/j.prevetmed.2012.10.014; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Channon AJ, 2009, VET REC, V164, P388, DOI 10.1136/vr.164.13.388; Chapinal N, 2009, J DAIRY SCI, V92, P581, DOI 10.3168/jds.2008-1533; Chapinal N, 2013, J DAIRY SCI, V96, P318, DOI 10.3168/jds.2012-5940; Charfeddine N, 2017, J DAIRY SCI, V100, P653, DOI 10.3168/jds.2016-11434; Christensen R.H.B., 2015, TUTOR R PACKAGE ORDI; Christensen RHB, **DATA OBJECT**; Cook N.B., 2007, P 46 ANN M NAT MAST, P31; Dobson H, 2008, ANIMAL, V2, P1104, DOI 10.1017/S175173110800236X; Dolecheck K, 2018, ANIMAL, V12, P1462, DOI [10.1017/S1751731118000575, 10.1017/s1751731118000575]; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Eluru N, 2015, ANAL METHODS ACCID R, V8, P1, DOI 10.1016/j.amar.2015.04.002; Foditsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146718; Fullerton AS, 2012, SOC SCI RES, V41, P182, DOI 10.1016/j.ssresearch.2011.09.003; Greene W.H., 2010, MODELING ORDERED CHO, DOI [10.1017/CBO9780511845062, DOI 10.1017/CBO9780511845062]; Griffiths BE, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00065; Grimm K, 2019, J DAIRY SCI, V102, P2453, DOI 10.3168/jds.2018-15035; Groenevelt M, 2014, VET J, V201, P283, DOI 10.1016/j.tvjl.2014.05.017; Gruber L, 2014, ANIMAL, V8, P58, DOI 10.1017/S1751731113001894; Haskell MJ, 2006, J DAIRY SCI, V89, P4259, DOI 10.3168/jds.S0022-0302(06)72472-9; Hedeker D, 2015, PREV SCI, V16, P997, DOI 10.1007/s11121-014-0495-x; Hernandez-Mendo O, 2007, J DAIRY SCI, V90, P1209, DOI 10.3168/jds.S0022-0302(07)71608-9; Heuwieser W., 1992, MILCHPRAXIS, V30, P10; Hirst WM, 2002, PREV VET MED, V55, P37, DOI 10.1016/S0167-5877(02)00058-2; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Horseman SV, 2014, ANIM WELFARE, V23, P157, DOI 10.7120/09627286.23.2.157; Hut PR, 2021, J DAIRY SCI, V104, P4746, DOI 10.3168/jds.2020-19200; Huxley JN, 2012, VET J, V193, P610, DOI 10.1016/j.tvjl.2012.06.039; Kielland C, 2009, J DAIRY SCI, V92, P5487, DOI 10.3168/jds.2009-2293; Kim JH, 2019, KOREAN J ANESTHESIOL, V72, P558, DOI 10.4097/kja.19087; King MTM, 2017, J DAIRY SCI, V100, P4818, DOI 10.3168/jds.2016-12281; Kritzinger F., 2009, GESUND FIT BRINGT OP, P1; Kritzinger F., 2009, GESUND FIT BRINGT OP; Li KW, 2004, SAFETY SCI, V42, P547, DOI 10.1016/j.ssci.2003.08.006; Linden TC, 2009, J DAIRY SCI, V92, P2580, DOI [10.3168/jds.2008-1603, 10.3168/jds.2008-1827]; Livesey CT, 2002, VET REC, V150, P677, DOI 10.1136/vr.150.22.677; Lobeck KM, 2011, J DAIRY SCI, V94, P5469, DOI 10.3168/jds.2011-4363; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Martin R., 2014, TIERARZTLICHE BESTAN, V3rd ed; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McInerney J, 1996, J AGR ECON, V47, P295, DOI 10.1111/j.1477-9552.1996.tb00695.x; Merle R, 2012, BERL MUNCH TIERARZTL, V125, P52, DOI 10.2376/0005-9366-125-52; Microsoft Corporation, 2016, MICR EXC VERS 16 32; Mingolla C, 2019, PREV VET MED, V169, DOI 10.1016/j.prevetmed.2019.104695; Moreira TF, 2019, J DAIRY SCI, V102, P10369, DOI 10.3168/jds.2018-16215; Newsome R, 2016, J DAIRY SCI, V99, P4512, DOI 10.3168/jds.2015-10202; Newsome RF, 2021, J DAIRY SCI, V104, P6238, DOI 10.3168/jds.2020-19388; Newsome RF, 2017, J DAIRY SCI, V100, P4759, DOI 10.3168/jds.2016-12013; O'Connell AA, 2011, J MOD APPL STAT METH, V10, P139, DOI 10.22237/jmasm/1304223240; O'Connor AH, 2020, J DAIRY SCI, V103, P9238, DOI 10.3168/jds.2019-17103; O'Connor AH, 2020, PREV VET MED, V181, DOI 10.1016/j.prevetmed.2020.105077; O'Connor AH, 2019, J DAIRY SCI, V102, P8332, DOI 10.3168/jds.2018-15719; O'Driscoll K, 2015, J DAIRY SCI, V98, P1685, DOI 10.3168/jds.2014-8199; Oehm AW, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.601640; Oehm AW, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2095-2; Oehme B, 2019, J DAIRY SCI, V102, P10119, DOI 10.3168/jds.2018-16183; Oehme B, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1579-9; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; R Core Team, 2020, R LANG ENV STAT COMP; Raber M, 2004, VET J, V167, P258, DOI 10.1016/S1090-0233(03)00053-4; Radostits OMG C.C., 2007, VET MED TXB DIS CATT, P621; Raber M, 2006, VET J, V172, P173, DOI 10.1016/j.tvjl.2005.03.009; Randall LV, 2015, J DAIRY SCI, V98, P3766, DOI 10.3168/jds.2014-8863; Regula G, 2004, PREV VET MED, V66, P247, DOI 10.1016/j.prevetmed.2004.09.004; RStudio Team, 2019, RSTUDIO INT DEV ENV; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; Sanders AH, 2009, J DAIRY SCI, V92, P3165, DOI 10.3168/jds.2008-1799; Sankey SS, 1998, COMMUN STAT-SIMUL C, V27, P871, DOI 10.1080/03610919808813515; Sasidharan L, 2014, ACCIDENT ANAL PREV, V72, P330, DOI 10.1016/j.aap.2014.07.025; Schlageter-Tello A, 2015, J DAIRY SCI, V98, P8623, DOI 10.3168/jds.2014-9059; Schlageter-Tello A, 2014, PREV VET MED, V116, P12, DOI 10.1016/j.prevetmed.2014.06.006; Schulz T, 2016, TIERAERZTL PRAX G N, V44, P5, DOI 10.15653/TPG-150534; Setia MS, 2016, INDIAN J DERMATOL, V61, P261, DOI 10.4103/0019-5154.182410; Shabalina T, 2020, J DAIRY SCI, V103, P583, DOI 10.3168/jds.2019-16985; Somers JR, 2015, IRISH VET J, V68, DOI 10.1186/s13620-015-0043-4; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Tarlton JF, 2003, CATTLE PRACT, V11, P81; Tarlton JF, 2002, VET J, V163, P196, DOI 10.1053/tvjl.2001.0651; Tay R, 2011, INT J SUSTAIN TRANSP, V5, P233, DOI 10.1080/15568318.2010.497547; Telezhenko E, 2017, J DAIRY SCI, V100, P6494, DOI 10.3168/jds.2016-12208; Van Hertem T, 2014, J DAIRY SCI, V97, P4852, DOI 10.3168/jds.2013-7576; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Vergara CF, 2014, J DAIRY SCI, V97, P4127, DOI 10.3168/jds.2012-6440; VERMUNT JJ, 1995, BRIT VET J, V151, P391, DOI 10.1016/S0007-1935(95)80128-6; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Washington SP., 2010, ANASTASOPOULOS STAT, V2nd ed; Weigele HC, 2018, J DAIRY SCI, V101, P2370, DOI 10.3168/jds.2017-13120; Westin R, 2016, J DAIRY SCI, V99, P3732, DOI 10.3168/jds.2015-10414; Westin R, 2016, J DAIRY SCI, V99, P551, DOI [10.3168/jds.2015-9737, 10.3168/jds]; Whay HR, 2017, VET CLIN N AM-FOOD A, V33, P153, DOI 10.1016/j.cvfa.2017.02.008; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384; Wilson JP, 2021, J DAIRY SCI, V104, P7026, DOI 10.3168/jds.2020-19843; Winckler C., 2009, WELFARE QUALITY ASSE; Yan T, 2006, J DAIRY SCI, V89, P1031, DOI 10.3168/jds.S0022-0302(06)72170-1	108	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263294	10.1371/journal.pone.0263294	http://dx.doi.org/10.1371/journal.pone.0263294			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089972	Green Published, gold			2022-12-26	WOS:000769158400049
J	Shabbir, U; Tyagi, A; Ham, HJ; Oh, DH				Shabbir, Umair; Tyagi, Akanksha; Ham, Hun Ju; Oh, Deog-Hwan			Comprehensive profiling of bioactive compounds in germinated black soybeans via UHPLC-ESI-QTOF-MS/MS and their anti-Alzheimer's activity	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHENOLIC-ACIDS; ACETYLCHOLINESTERASE; ISOFLAVONES; ANTICHOLINESTERASE; SPROUTS; GABA	Black soybeans contain several bioactive compounds and commonly consumed due to their health-related activities but rarely cultivated as edible sprouts. The present study investigated the changes that occurred during germination in two new genotypes black soybeans. Raw and germinated seeds were tested against in vitro Alzheimer's disease (AD) biomarkers, including oxidative stress, inflammatory factors and cholinesterase enzymes as well as gamma -aminobutyric acid (GABA) levels. Sprouts significantly inhibited the cholinesterase enzymes and inflammatory factors (protein denaturation, proteinase and lipoxygenase) than seeds. An increase in phenolic, flavonoid and GABA (10-folds) content and antioxidant capacity (ABTS, DPPH, and FRAP) was observed in germinated seeds. However, anthocyanin content was decreased in sprouts. UHPLC-ESI-QTOF-MS2 metabolites profiling approach identified 22 compounds including amino acids, peptides, fatty acids, and polyphenols. Among identified compounds, daidzein, genistein, gallic acid, spermidine, L-asparagine, and L-lysine exhibited the highest increase after germination. The current study reveals that germination of black soybeans have promising potential to inhibit/prevent AD and can be used to develop functional foods.	[Shabbir, Umair; Tyagi, Akanksha; Oh, Deog-Hwan] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Coll Agr & Life Sci, Chunchon, South Korea; [Ham, Hun Ju] Kangwon Natl Univ, Dept Environm Biol, Coll Agr & Life Sci, Chunchon, South Korea	Kangwon National University; Kangwon National University	Oh, DH (corresponding author), Kangwon Natl Univ, Dept Food Sci & Biotechnol, Coll Agr & Life Sci, Chunchon, South Korea.	deoghwa@kangwon.ac.kr	Shabbir, Umair/AAP-4842-2021	DeogHwan, Oh/0000-0002-7472-0436				Brown R. A., 2016, Omega-3 fatty acids: keys to nutritional health, P413; 임정연, 2016, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V32, P567; Truong DH, 2019, J FOOD QUALITY, DOI 10.1155/2019/8178294; Nguemnang SFD, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3612481; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eum HL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232159; Ferhat M, 2017, PHARM BIOL, V55, P324, DOI 10.1080/13880209.2016.1238488; Ghotbi G, 2020, BIOORG CHEM, V103, DOI 10.1016/j.bioorg.2020.104186; Gunathilake KDPP, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040107; Guo XB, 2012, J AGR FOOD CHEM, V60, P11050, DOI 10.1021/jf304443u; Huang GC, 2017, LWT-FOOD SCI TECHNOL, V75, P488, DOI 10.1016/j.lwt.2016.09.029; Jabir NR, 2018, CNS NEUROSCI THER, V24, P753, DOI 10.1111/cns.12971; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Kandasamy S, 2021, INT J BIOL MACROMOL, V185, P750, DOI 10.1016/j.ijbiomac.2021.06.176; Kim MY, 2016, FOOD SCI BIOTECHNOL, V25, P1551, DOI 10.1007/s10068-016-0240-2; Lee Ki Yeon, 2016, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V31, P335; Li SL, 2020, LWT-FOOD SCI TECHNOL, V125, DOI 10.1016/j.lwt.2020.109264; Liu TB, 2015, J I BREWING, V121, P163, DOI 10.1002/jib.196; Ofosu FK, 2021, FOOD CHEM, V337, DOI 10.1016/j.foodchem.2020.127788; Ren Q, 2017, INT J FOOD PROP, V20, P2877, DOI 10.1080/10942912.2016.1256303; Salazar AM, 2021, NEUROBIOL AGING, V97, P129, DOI 10.1016/j.neurobiolaging.2020.10.013; Saliu JA, 2017, PHARM BIOL, V55, P252, DOI 10.1080/13880209.2016.1258426; Sato H, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.00023; Shabbir U, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10091370; Shabbir U, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020690; Shabbir U, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010196; Song J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47057-z; Suganthy N, 2016, PHARM BIOL, V54, P118, DOI 10.3109/13880209.2015.1017886; Sutharut J., 2012, INT FOOD RES J, V19; Suzuki H, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.586166; Tabassum S., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Xiang JL, 2019, FOOD CHEM, V295, P214, DOI 10.1016/j.foodchem.2019.05.058; Yamashita Y, 2020, FOOD FUNCT, V11, P7321, DOI 10.1039/d0fo01092h; Yamatsu A., 2020, SIC SIC, V48, P461; Zeng ZC, 2019, FOOD CHEM, V271, P114, DOI 10.1016/j.foodchem.2018.07.180	35	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0263274	10.1371/journal.pone.0263274	http://dx.doi.org/10.1371/journal.pone.0263274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZT4WP	35089980	Green Published, gold			2022-12-26	WOS:000769158400048
J	Kondo, T; Koroki, K; Kanzaki, H; Kobayashi, K; Kiyono, S; Nakamura, M; Kanogawa, N; Saito, T; Ogasawara, S; Ooka, Y; Nakamoto, S; Chiba, T; Arai, M; Kato, J; Kuboki, S; Ohtsuka, M; Kato, N				Kondo, Takayuki; Koroki, Keisuke; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Saito, Tomoko; Ogasawara, Sadahisa; Ooka, Yoshihiko; Nakamoto, Shingo; Chiba, Tetsuhiro; Arai, Makoto; Kato, Jun; Kuboki, Satoshi; Ohtsuka, Masayuki; Kato, Naoya			Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma	PLOS ONE			English	Article							CHRONIC LIVER-FAILURE; CIRRHOSIS; MANAGEMENT; INFLAMMATION; MORTALITY	Background/Aims Organ failure in patients with acute decompensation (AD) is a defining characteristic of acute-on-chronic liver failure (ACLF). However, the clinical features of AD during the long-term clinical course of hepatocellular carcinoma (HCC) are still poorly understood. This study aimed to clarify features and impact of AD/ACLF on the prognosis of patients after treatment for HCC. Methods This retrospective study enrolled 556 consecutive patients who were initially diagnosed with HCC, and analyses were conducted taking into account HCC treatment type, HCC stage, and presence or absence of cirrhosis. Results During follow-up, 299 patients with AD were hospitalized. AD occurrence is closely related to prognosis, regardless of the presence or absence of cirrhosis and HCC stage, and early-onset AD (within 90 days after HCC treatment) has negative impact on prognosis. In the intermediate-advanced-stage group, surgical resection had a positive impact on AD incidence post-treatment. After systemic therapy for HCC, renal impairment was the predictive factors for AD development. The 28/90-day mortality rate was higher among 41 cases (13.7%) with AD who exhibited ACLF as compared with cases without ACLF. AD without cirrhosis had similar ACLF incidence and short-term mortality, compared to AD with cirrhosis. The prognostic model using a decision-tree-based approach, which includes ACLF, bilirubin level, HCC progression, and MELD score is useful for predicting 90- or 28-day mortality after AD diagnosis. Conclusions Careful management of patients with HCC who are hospitalized with AD is necessary, considering ACLF, HCC progression, and liver function.	[Kondo, Takayuki; Koroki, Keisuke; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Saito, Tomoko; Ogasawara, Sadahisa; Ooka, Yoshihiko; Nakamoto, Shingo; Chiba, Tetsuhiro; Arai, Makoto; Kato, Jun; Kato, Naoya] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan; [Kobayashi, Kazufumi; Ogasawara, Sadahisa] Chiba Univ Hosp, Translat Res & Dev Ctr, Chiba, Japan; [Arai, Makoto] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan; [Kuboki, Satoshi; Ohtsuka, Masayuki] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University	Kondo, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan.	takakondonaika@yahoo.co.jp	Ogasawara, Sadahisa/GRF-7061-2022; Kondo, Takayuki/CAA-3616-2022	Ogasawara, Sadahisa/0000-0002-6540-9064; Kondo, Takayuki/0000-0002-1075-9876				Arizumi T, 2015, LIVER CANCER, V4, P253, DOI 10.1159/000367743; Arroyo V, 2020, NEW ENGL J MED, V382, P2137, DOI 10.1056/NEJMra1914900; Arroyo V, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.41; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Augustin S, 2009, CLIN GASTROENTEROL H, V7, P1347, DOI 10.1016/j.cgh.2009.08.011; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Claria J, 2016, HEPATOLOGY, V64, P1249, DOI 10.1002/hep.28740; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hsieh WY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42577; Huang YW, 2014, HEPATOLOGY, V60, P807, DOI 10.1002/hep.27212; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Klein LM, 2020, LIVER TRANSPLANT, V26, P227, DOI 10.1002/lt.25675; Macdonald S, 2018, HEPATOLOGY, V67, P989, DOI 10.1002/hep.29581; Mahmud N, 2019, HEPATOLOGY, V69, P2150, DOI 10.1002/hep.30494; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Ogasawara S, 2014, ONCOLOGY-BASEL, V87, P330, DOI 10.1159/000365993; Piano S, 2017, J HEPATOL, V67, P1177, DOI 10.1016/j.jhep.2017.07.008; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Sarin SK, 2014, HEPATOL INT, V8, P453, DOI 10.1007/s12072-014-9580-2; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Wan SZ, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/5193028; Xavier SA, 2018, EUR J GASTROEN HEPAT, V30, P652, DOI 10.1097/MEG.0000000000001087; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yim SY, 2016, LIVER INT, V36, P445, DOI 10.1111/liv.12960; Zhang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122158	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0261619	10.1371/journal.pone.0261619	http://dx.doi.org/10.1371/journal.pone.0261619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085277	Green Published, gold			2022-12-26	WOS:000779379600027
J	Stewart, S; Phipps-Green, A; Gamble, GD; Stamp, LK; Taylor, WJ; Neogi, T; Merriman, TR; Dalbeth, N				Stewart, Sarah; Phipps-Green, Amanda; Gamble, Greg D.; Stamp, Lisa K.; Taylor, William J.; Neogi, Tuhina; Merriman, Tony R.; Dalbeth, Nicola			Is repeat serum urate testing superior to a single test to predict incident gout over time?	PLOS ONE			English	Article							HYPERURICEMIA; EPIDEMIOLOGY; DESIGN; RISK	Elevated serum urate is the most important causal risk factor for developing gout. However, in longitudinal cohort studies, a small proportion of people with normal urate levels develop gout and the majority of those with high urate levels do not. These observations may be due to subsequent variations in serum urate over time. Our analysis examined whether single or repeat testing of serum urate more accurately predicts incident gout over time. Individual participant data from three publicly-available cohorts were included. Data from paired serum urate measures 3-5 years apart, followed by an assessment of gout incidence 5-6 years from the second urate measure were used to calculate the predictive ability of four measures of serum urate on incident gout: the first measure, the second measure, the average of the two measures, and the highest of the two measures. Participants with prevalent gout prior to the second measure were excluded. Receiver operator characteristic (ROC) curves and area under the curve (AUC) statistics were computed to compare the four measures. A total of 16,017 participants were included across the three cohorts, with a mean follow-up from the first serum urate test of 9.3 years (range 8.9-10.1 years). Overall, there was a small increase in the mean serum urate between the first and second measures (322 mu mol/L (5.42 mg/dL) vs. 340 mu mol/L (5.71 mg/dL), P<0.001) which were a mean of 3.5 years apart, but the first and second measures were highly correlated (r = 0.81, P<0.001). No differences were observed in the predictive ability of incident gout between the four measures of serum urate measurement with ROC curve AUC statistics ranging between 0.81 (95% confidence intervals: 0.78-0.84) and 0.84 (95% confidence intervals: 0.81-0.87). These data show that repeat serum urate testing is not superior to a single measure of serum urate for prediction of incident gout over approximately one decade.	[Stewart, Sarah; Gamble, Greg D.; Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland, New Zealand; [Phipps-Green, Amanda; Merriman, Tony R.] Univ Otago Dunedin, Dept Med, Dunedin Cent, Dunedin, New Zealand; [Stamp, Lisa K.] Univ Otago Christchurch, Dept Med, Christchurch Cent City, Christchurch, New Zealand; [Taylor, William J.] Univ Otago Wellington, Dept Med, Wellington, New Zealand; [Neogi, Tuhina] Boston Univ, Sch Med, Boston, MA 02118 USA; [Merriman, Tony R.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA	University of Auckland; University of Otago; University of Otago; Boston University; University of Alabama System; University of Alabama Birmingham	Stewart, S (corresponding author), Univ Auckland, Dept Med, Auckland, New Zealand.	sarah.stewart@auckland.ac.nz	Phipps-Green, Mandy/HDN-5829-2022	Phipps-Green, Mandy/0000-0002-1763-9623; Stewart, Sarah/0000-0002-9318-5627; Gamble, Greg/0000-0003-0412-3203	Health Research Council of New Zealand; Auckland Medical Research Foundation [1318001]	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation	This study was funded by a grant from the Health Research Council of New Zealand (no.19-232) (ND, TM, LK), and a grant from the Auckland Medical Research Foundation (no. 1318001) (SS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund L, 2012, UPSALA J MED SCI, V117, P279, DOI 10.3109/03009734.2012.668143; Bhole V, 2010, ARTHRITIS RHEUM-US, V62, P1069, DOI 10.1002/art.27338; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Caraguel Charles G B, 2013, Evid Based Med, V18, P125, DOI 10.1136/eb-2013-101243; Dalbeth N, 2018, ANN RHEUM DIS, V77, P1048, DOI 10.1136/annrheumdis-2017-212288; Dalbeth N, 2016, ARTHRIT CARE RES, V68, P1894, DOI 10.1002/acr.22896; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; DEVGUN MS, 1992, J CLIN PATHOL, V45, P110, DOI 10.1136/jcp.45.2.110; Duskin-Bitan H, 2014, CLIN RHEUMATOL, V33, P549, DOI 10.1007/s10067-014-2520-7; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GLYNN RJ, 1983, ARTHRITIS RHEUM-US, V26, P87, DOI 10.1002/art.1780260115; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; HALL AP, 1967, AM J MED, V42, P27, DOI 10.1016/0002-9343(67)90004-6; SIMONS LA, 1983, AUST NZ J MED, V13, P391, DOI 10.1111/j.1445-5994.1983.tb04489.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	15	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263175	10.1371/journal.pone.0263175	http://dx.doi.org/10.1371/journal.pone.0263175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104298	gold, Green Published			2022-12-26	WOS:000749789300002
J	Gonias, SL; Banki, MA; Azmoon, P; Romero, HK; Sigurdson, CJ; Mantuano, E; Campana, WM				Gonias, Steven L.; Banki, Michael A.; Azmoon, Pardis; Romero, Haylie K.; Sigurdson, Christina J.; Mantuano, Elisabetta; Campana, Wendy M.			Cellular prion protein in human plasma-derived extracellular vesicles promotes neurite outgrowth via the NMDA receptor-LRP1 receptor system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOME-MEDIATED TRANSFER; MECHANISM; LRP1; CELLS; CALRETICULIN; ENDOCYTOSIS; TRAFFICKING; PHYSIOLOGY; CORECEPTOR; ASTROCYTES	Exosomes and other extracellular vesicles (EVs) participate in cell-cell communication. Herein, we isolated EVs from human plasma and demonstrated that these EVs activate cell signaling and promote neurite outgrowth in PC-12 cells. Analysis of human plasma EVs purified by sequential ultra centrifugation using tandem mass spectrometry indicated the presence of multiple plasma proteins, including alpha(2)-macro-globulin, which is reported to regulate PC-12 cell physiology. We therefore further purified EVs by molecular exclusion or phosphatidylserine affinity chromatography, which reduced plasma protein contamination. EVs subjected to these additional purification methods exhibited unchanged activity in PC-12 cells, even though alpha(2)-macroglobulin was reduced to undetectable levels. Nonpathogenic cellular prion protein (PrPC) was carried by human plasma EVs and essential for the effects of EVs on PC-12 cells, as EV-induced cell signaling and neurite outgrowth were blocked by the PrPC-specific antibody, POM2. In addition, inhibitors of the N-methyl-D-aspartate (NMDA) receptor (NMDA-R) and low-density lipoprotein receptor-related protein-1 (LRP1) blocked the effects of plasma EVs on PC-12 cells, as did silencing of Lrp1 or the gene encoding the GluN1 NMDA-R subunit (Grin1). These results implicate the NMDA-R-LRP1 complex as the receptor system responsible for mediating the effects of EV-associated PrPC. Finally, EVs harvested from rat astrocytes carried PrPC and replicated the effects of human plasma EVs on PC-12 cell signaling. We conclude that interaction of EV-associated PrPC with the NMDA-R-LRP1 complex in target cells represents a novel mechanism by which EVs may participate in intercellular communication in the nervous system.	[Gonias, Steven L.; Banki, Michael A.; Azmoon, Pardis; Sigurdson, Christina J.; Mantuano, Elisabetta] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92103 USA; [Romero, Haylie K.; Campana, Wendy M.] Univ Calif San Diego, Dept Anesthesiol, Program Neurosci, La Jolla, CA USA; [Campana, Wendy M.] San Diego Vet Adm Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92103 USA.	sgonias@health.ucsd.edu		Azmoon, Pardis/0000-0002-1512-5581; Banki, Michael/0000-0002-8910-4695	National Institutes of Health [R01 HL136395, R01 NS097590]; Veterans Administration [I01 RX003363]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs)	This work was supported by grants R01 HL136395 (to S. L. G.) and R01 NS097590 (to S. L. G. and W. M. C.) from the National Institutes of Health and grant I01 RX003363 from the Veterans Administration (to W. M. C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin L, 2016, J CELL SCI, V129, P3878, DOI 10.1242/jcs.183137; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Brifault C, 2017, J BIOL CHEM, V292, P18699, DOI 10.1074/jbc.M117.798413; Bucan V, 2019, MOL NEUROBIOL, V56, P1812, DOI 10.1007/s12035-018-1172-z; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cheng L, 2018, MOL ASPECTS MED, V60, P62, DOI 10.1016/j.mam.2017.11.011; Ching RC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1017-8; D'Arrigo G, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12114; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; GANROT PO, 1966, CLIN CHIM ACTA, V14, P493, DOI 10.1016/0009-8981(66)90037-4; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; HALL PK, 1978, BIOCHEM J, V173, P27, DOI 10.1042/bj1730027; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hooper NM, 2008, BIOCHEM SOC T, V36, P1272, DOI 10.1042/BST0361272; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kang YT, 2019, SMALL, V15, DOI 10.1002/smll.201903600; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; LAZARINI F, 1994, MOL BRAIN RES, V22, P268, DOI 10.1016/0169-328X(94)90055-8; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopez-Verrilli MA, 2016, NEUROSCIENCE, V320, P129, DOI 10.1016/j.neuroscience.2016.01.061; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2022, J IMMUNOL, V208, P85, DOI 10.4049/jimmunol.2100412; Mantuano E, 2020, J BIOL CHEM, V295, P14178, DOI 10.1074/jbc.RA120.013779; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Matsumoto A, 2017, J PHARM SCI-US, V106, P168, DOI 10.1016/j.xphs.2016.07.022; Mattei V, 2020, J NEUROCHEM, V152, P468, DOI 10.1111/jnc.14891; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Pontecorvi P, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1657-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Romeo R, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.642521; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sadri M, 2022, GLIA, V70, P256, DOI 10.1002/glia.24098; Sharma R, 2017, BRIT J CANCER, V117, P545, DOI 10.1038/bjc.2017.183; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0	67	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101642	10.1016/j.jbc.2022.101642	http://dx.doi.org/10.1016/j.jbc.2022.101642			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090893	gold, Green Published			2022-12-26	WOS:000789261900002
J	Wang, YL; Liu, H; Zhang, RX; Xiang, YY; Lu, JF; Xia, B; Peng, L; Wu, JW				Wang, Yongliang; Liu, Huan; Zhang, Ruixin; Xiang, Yuyao; Lu, Junfeng; Xia, Bo; Peng, Liang; Wu, Jiangwei			AdipoRon exerts opposing effects on insulin sensitivity via fibroblast growth factor 21-mediated time-dependent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-ALPHA; SHORT LIFE; ADIPONECTIN; PROTEIN; OXIDATION; AGONIST	Increasing evidence has shown that AdipoRon, a synthetic adiponectin receptor agonist, is involved in the regulation of whole-body insulin sensitivity and energy homeostasis. How-ever, the mechanisms underlying these alterations remain un-clear. Here, using hyperinsulinemic-euglycemic clamp and isotopic tracing techniques, we show that short-term (10 days) AdipoRon administration indirectly inhibits lipolysis in white adipose tissue via increasing circulating levels of fibroblast growth factor 21 in mice fed a high-fat diet. This led to reduced plasma-free fatty acid concentrations and improved lipid-induced whole-body insulin resistance. In contrast, we found that long-term (20 days) AdipoRon administration directly exacerbated white adipose tissue lipolysis, increased hepatic gluconeogenesis, and impaired the tricarboxylic acid cycle in the skeletal muscle, resulting in aggravated whole-body insulin resistance. Together, these data provide new insights into the comprehensive understanding of multifaceted functional complexity of AdipoRon.	[Wang, Yongliang; Liu, Huan; Zhang, Ruixin; Xiang, Yuyao; Lu, Junfeng; Xia, Bo; Wu, Jiangwei] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Shaanxi, Peoples R China; [Peng, Liang] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China	Northwest A&F University - China; China-Japan Friendship Hospital	Xia, B; Wu, JW (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Shaanxi, Peoples R China.; Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China.	imed23@nwafu.edu.cn; pengliang8028@163.com; wujiangwei@nwafu.edu.cn	Liu, Huan/HIK-2282-2022; Lu, Junfeng/AFN-9843-2022	Lu, Junfeng/0000-0002-2640-8595; Wang, Yongliang/0000-0002-1494-0496; Peng, Liang/0000-0001-8377-0833	National Key Research and Development Program of China [2021YFF1000602]; National Natural Science Foundation of China [31902137, 81970713, 82170817]; Beijing Municipal Natural Science Foundation of China [7222160]; Chinese Universities Scientific Fund from Northwest AF University [2452018049]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation of China; Chinese Universities Scientific Fund from Northwest AF University	We thank all members of our laboratory for their help. This work was supported by the National Key Research and Development Program of China (grant no.: 2021YFF1000602), National Natural Science Foundation of China (grant nos.: 31902137, 81970713, and 82170817), Beijing Municipal Natural Science Foundation of China (grant no.: 7222160), and Chinese Universities Scientific Fund (grant no.: 2452018049) from Northwest A&F University. We also thank the Life Science Research Core Services NWAFU (Xiaorui Liu) for assistance with immunofluorescence.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Camporez JP, 2017, P NATL ACAD SCI USA, V114, pE11285, DOI 10.1073/pnas.1716990115; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Choi SR, 2018, METABOLISM, V85, P348, DOI 10.1016/j.metabol.2018.02.004; Holland WL, 2013, SCIENCE, V342, P1460, DOI 10.1126/science.1249077; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu XL, 2019, ACTA BIOCH BIOPH SIN, V51, P20, DOI 10.1093/abbs/gmy152; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Iwabu M, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00116; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Liu XY, 2017, J CELL PHYSIOL, V232, P1893, DOI 10.1002/jcp.25735; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Okada-Iwabu M, 2015, DIABETES METAB J, V39, P363, DOI 10.4093/dmj.2015.39.5.363; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Perry RJ, 2019, P NATL ACAD SCI USA, V116, P13670, DOI 10.1073/pnas.1901795116; Perry RJ, 2018, CELL, V172, P234, DOI 10.1016/j.cell.2017.12.001; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wang YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010011; Xiang YY, 2020, BIOCHEM BIOPH RES CO, V532, P605, DOI 10.1016/j.bbrc.2020.08.099; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yu J, 2019, NEUROCHEM RES, V44, P1678, DOI 10.1007/s11064-019-02794-5; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014	27	2	2	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101641	10.1016/j.jbc.2022.101641	http://dx.doi.org/10.1016/j.jbc.2022.101641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090894	Green Published, gold			2022-12-26	WOS:000789261900001
J	Wu, DC; Gowathaman, R; Pierce, BG; Mariuzza, RA				Wu, Daichao; Gowathaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.			T cell receptors employ diverse strategies to target a p53 cancer neoantigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOTHERAPY; THERAPY; LANDSCAPE; AFFINITY; DESIGN	Adoptive cell therapy with tumor-specific T cells can mediate durable cancer regression. The prime target of tumor specific T cells are neoantigens arising from mutations in self proteins during malignant transformation. To understand T cell recognition of cancer neoantigens at the atomic level, we studied oligoclonal T cell receptors (TCRs) that recognize a neoepitope arising from a driver mutation in the p53 oncogene (p53R175H) presented by the major histocompatibility complex class I molecule HLA-A2. We previously reported the structures of three p53R175H-specific TCRs (38-10, 12-6, and 1a2) bound to p53R175H and HLA-A2. The structures showed that these TCRs discriminate between WT and mutant p53 by forming extensive interactions with the R175H mutation. Here, we report the structure of a fourth p53R175H-specific TCR (611) in complex with p53R175H and HLA-A2. In contrast to 3810, 12-6, and 1a2, TCR 6-11 makes no direct contacts with the R175H mutation, yet is still able to distinguish mutant from WT p53. Structure-based in silico mutagenesis revealed that the 60-fold loss in 6-11 binding affinity for WT p53 compared to p53R175H is mainly due to the higher energetic cost of desolvating R175 in the WT p53 peptide during complex formation than H175 in the mutant. This indirect strategy for preferential neoantigen recognition by 6-11 is fundamentally different from the direct strategies employed by other TCRs and highlights the multiplicity of solutions to recognizing p53R175H with sufficient selectivity to mediate T cell killing of tumor but not normal cells.	[Wu, Daichao; Gowathaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, WM Keck Lab Struct Biol, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Wu, Daichao] Univ South China, Hengyang Med Sch, Dept Histol & Embryol, Hengyang, Hunan, Peoples R China; [Wu, Daichao; Gowathaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD USA	University of South China; University System of Maryland; University of Maryland College Park	Mariuzza, RA (corresponding author), Univ Maryland, WM Keck Lab Struct Biol, Inst Biosci & Biotechnol Res, Rockville, MD USA.; Mariuzza, RA (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD USA.	rmariuzz@umd.edu		Pierce, Brian/0000-0003-4821-0368; Wu, Daichao/0000-0003-2086-0190	National Institutes of Health [GM126299, AI129893]; Natural Science Foundation of China [32100985]; Natural Science Foundation of Hunan Province [2021JJ40456]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This work was supported by National Institutes of Health Grants GM126299 (to B. G. P.) and AI129893 (to R. A. M.), by Natural Science Foundation of China Grant 32100985 (to D. W.), and by Natural Science Foundation of Hunan Province Grant 2021JJ40456 (to D. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentzen A. K., 2019, IMMUNOONCOL TECHNOL, V2, P1; Culshaw A, 2017, NAT IMMUNOL, V18, P1228, DOI 10.1038/ni.3850; Dudley ME, 2013, J CLIN ONCOL, V31, P2152, DOI 10.1200/JCO.2012.46.6441; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gowthaman R, 2019, BIOINFORMATICS, V35, P5323, DOI 10.1093/bioinformatics/btz517; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Haidar JN, 2009, PROTEINS, V74, P948, DOI 10.1002/prot.22203; Hsiue EHC, 2021, SCIENCE, V371, P1009, DOI 10.1126/science.abc8697; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Lo W, 2019, CANCER IMMUNOL RES, V7, P534, DOI 10.1158/2326-6066.CIR-18-0686; Malekzadeh P, 2019, J CLIN INVEST, V129, P1109, DOI 10.1172/JCI123791; McGranahan N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax7918; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierce BG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003478; Pierce BG, 2013, PROTEIN SCI, V22, P35, DOI 10.1002/pro.2181; Reinink P, 2019, J IMMUNOL, V203, P3395, DOI 10.4049/jimmunol.1900872; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Sim MJW, 2020, P NATL ACAD SCI USA, V117, P12826, DOI 10.1073/pnas.1921964117; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Wu DC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16755-y; Yang XB, 2017, J BIOL CHEM, V292, P18618, DOI 10.1074/jbc.M117.810382; Yin R, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009380; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859	38	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101684	10.1016/j.jbc.2022.101684	http://dx.doi.org/10.1016/j.jbc.2022.101684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124005	gold, Green Published			2022-12-26	WOS:000789400700002
J	Xu, Y; Miller, PC; Ren, MD; Nargis, T; Rajan, S; Schlame, M; Phoon, CKL; Hussain, MM				Xu, Yang; Miller, Paighton C.; Ren, Mindong; Nargis, Titli; Rajan, Sujith; Schlame, Michael; Phoon, Colin K. L.; Hussain, M. Mahmood			LPGAT1 controls the stearate/palmitate ratio of phosphatidylethanolamine and phosphatidylcholine in sn-1 specific remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-COMPOSITION; N-METHYLTRANSFERASE; LIVER MICROSOMES; DENSITY; PHOSPHATIDYLINOSITOL; ACYLTRANSFERASE; IDENTIFICATION; METHYLATION; EXPRESSION; SECRETION	Most mammalian phospholipids contain a saturated fatty acid at the sn-1 carbon atom and an unsaturated fatty acid at the sn-2 carbon atom of the glycerol backbone group. While the sn-2 linked chains undergo extensive remodeling by deacylation and reacylation (Lands cycle), it is not known how the composition of saturated fatty acids is controlled at the sn1 position. Here, we demonstrate that lysophosphatidylglycerol acyltransferase 1 (LPGAT1) is an sn-1 specific acyltransferase that controls the stearate/palmitate ratio of phosphatidylethanolamine (PE) and phosphatidylcholine. Bacterially expressed murine LPGAT1 transferred saturated acyl-CoAs specifically into the sn-1 position of lysophosphatidylethanolamine (LPE) rather than lysophosphatidylglycerol and preferred stearoylCoA over palmitoyl-CoA as the substrate. In addition, genetic ablation of LPGAT1 in mice abolished 1-LPE:stearoyl-CoA acyltransferase activity and caused a shift from stearate to palmitate species in PE, dimethyl-PE, and phosphatidylcholine. Lysophosphatidylglycerol acyltransferase 1 KO mice were leaner and had a shorter life span than their littermate controls. Finally, we show that total lipid synthesis was reduced in isolated hepatocytes of LPGAT1 knockout mice. Thus, we conclude that LPGAT1 is an sn-1 specific LPE acyltransferase that controls the stearate/palmitate homeostasis of PE and the metabolites of the PE methylation pathway and that LPGAT1 plays a central role in the regulation of lipid biosynthesis with implications for body fat content and longevity.	[Xu, Yang; Ren, Mindong; Schlame, Michael] New York Univ, Dept Anesthesiol, Grossman Sch Med, New York, NY USA; [Miller, Paighton C.; Phoon, Colin K. L.] New York Univ, Dept Pediat, Grossman Sch Med, New York, NY USA; [Ren, Mindong; Schlame, Michael] New York Univ, Dept Cell Biol, Grossman Sch Med, New York, NY USA; [Nargis, Titli; Rajan, Sujith; Hussain, M. Mahmood] New York Univ, Dept Fdn Med, Long Isl Sch Med, Mineola, NY USA	New York University; New York University; New York University	Schlame, M (corresponding author), New York Univ, Dept Anesthesiol, Grossman Sch Med, New York, NY USA.; Schlame, M (corresponding author), New York Univ, Dept Cell Biol, Grossman Sch Med, New York, NY USA.	michael.schlame@med.nyu.edu	rajan, sujith/AFW-0548-2022; Rajan, Sujith/GLR-8662-2022	rajan, sujith/0000-0002-8376-0587; 	U.S. National Institutes of Health (NIH) [GM115593, DK121490, HL137202, HL158054]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by U.S. National Institutes of Health (NIH) grant GM115593 (to M. S.) and grants DK121490, HL137202, and HL158054 (to M. M. H.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Hiramine Y, 2010, J LIPID RES, V51, P1424, DOI 10.1194/jlr.M002584; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P380, DOI 10.1016/0005-2760(72)90052-5; Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; Kawana H, 2019, BBA-MOL CELL BIOL L, V1864, P1053, DOI 10.1016/j.bbalip.2019.02.008; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Le Guedard M, 2009, FEBS J, V276, P6412, DOI 10.1111/j.1742-4658.2009.07355.x; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; Liu GY, 2019, J BIOL CHEM, V294, P10146, DOI 10.1074/jbc.RA119.008766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; RUSTOW B, 1988, BIOCHIM BIOPHYS ACTA, V961, P364, DOI 10.1016/0005-2760(88)90083-5; Schlame M, 2020, J LIPID RES, V61, P95, DOI 10.1194/jlr.D119000318; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; THOMPSON W, 1986, BIOCHIM BIOPHYS ACTA, V876, P379, DOI 10.1016/0005-2760(86)90023-8; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P184, DOI 10.1016/0005-2760(91)90093-W; Traurig MT, 2013, OBESITY, V21, P193, DOI 10.1002/oby.20243; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Wang LQ, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01346-z; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Zhang XY, 2019, CELL MOL GASTROENTER, V7, P763, DOI 10.1016/j.jcmgh.2019.02.002	33	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101685	10.1016/j.jbc.2022.101685	http://dx.doi.org/10.1016/j.jbc.2022.101685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35131264	Green Published, gold			2022-12-26	WOS:000789400700005
J	Zheng, DJ; Nakabayashi, M; Asano, Y				Zheng, Daijun; Nakabayashi, Makoto; Asano, Yasuhisa			Structural characterization of Linum usitatissimum hydroxynitrile lyase: A new cyanohydrin decomposition mechanism involving a cyano-zinc complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ALCOHOL-DEHYDROGENASE; ALPHA-HYDROXYNITRILE LYASE; CRYSTAL-STRUCTURE; MANIHOT-ESCULENTA; MOLECULAR-CLONING; CATALYTIC MECHANISM; SORGHUM-BICOLOR; ACTIVE-SITE; FORMALDEHYDE DEHYDROGENASE; COLORIMETRIC DETERMINATION	Hydroxynitrile lyase from Linum usitatissimum (LuHNL) is an enzyme involved in the catabolism of cyanogenic glycosides to release hydrogen cyanide upon tissue damage. This enzyme strictly conserves the substrate-and NAD(H)-binding domains of Zn2(+)-containing alcohol dehydrogenase (ADH); however, there is no evidence suggesting that LuHNL possesses ADH activity. Herein, we determined the ligand-free 3D structure of LuHNL and its complex with acetone cyanohydrin and (R)-2-butanone cyanohydrin using X-ray crystallography. These structures reveal that an A-form NAD(+)& nbsp;is tightly but not covalently bound to each subunit of LuHNL. The restricted movement of the NAD(+)& nbsp;molecule is due to the "sandwich structure " on the adenine moiety of NAD(+). Moreover, the structures and mutagenesis analysis reveal a novel reaction mechanism for cyanohydrin decomposition involving the cyano-zinc complex and hydrogen-bonded interaction of the hydroxyl group of cyanohydrin with Glu323/Thr65 and H2O/ Lys162 of LuHNL. The deprotonated Lys162 and protonated Glu323 residues are presumably stabilized by a partially desolvated microenvironment. In summary, the substrate binding geometry of LuHNL provides insights into the differences in activities of LuHNL and ADH, and identifying this novel reaction mechanism is an important contribution to the study of hydroxynitrile lyases.	[Zheng, Daijun; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan; [Zheng, Daijun; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama, Japan; [Nakabayashi, Makoto] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan	Toyama Prefectural University; Toyama Prefectural University	Asano, Y (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan.; Asano, Y (corresponding author), Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama, Japan.	asano@pu-toyama.ac.jp	Asano, Yasuhisa/K-5898-2016	Asano, Yasuhisa/0000-0003-3645-3952	Japan Society for Promotion of Science [17H06169]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful for the funding support from the Grant-in-Aid for Scientific Research (S) from the Japan Society for Promotion of Science (Grant No. 17H06169) awarded to Y. A.	Andexer J, 2007, ANGEW CHEM INT EDIT, V46, P8679, DOI 10.1002/anie.200701455; Andexer JN, 2012, CHEMBIOCHEM, V13, P1932, DOI 10.1002/cbic.201200239; Asano Y, 2005, BIOSCI BIOTECH BIOCH, V69, P2349, DOI 10.1271/bbb.69.2349; Asano Y, 2011, PROTEIN ENG DES SEL, V24, P607, DOI 10.1093/protein/gzr030; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENNER SA, 1982, EXPERIENTIA, V38, P633, DOI 10.1007/BF02327092; Breithaupt H, 1999, J MOL CATAL B-ENZYM, V6, P315, DOI 10.1016/S1381-1177(98)00109-X; Chen FF, 2015, BIOCHIMIE, V108, P33, DOI 10.1016/j.biochi.2014.10.023; CUTLER AJ, 1981, ARCH BIOCHEM BIOPHYS, V212, P468, DOI 10.1016/0003-9861(81)90389-1; Dadashipour M, 2015, P NATL ACAD SCI USA, V112, P10605, DOI 10.1073/pnas.1508311112; Dadashipour M, 2011, ACS CATAL, V1, P1121, DOI 10.1021/cs200325q; Dadashipour M, 2011, J BIOTECHNOL, V153, P100, DOI 10.1016/j.jbiotec.2011.02.004; Dadashipour M, 2011, PROTEIN EXPRES PURIF, V77, P92, DOI 10.1016/j.pep.2010.12.010; Diaz-Sanchez AG, 2011, BIOCHEM J, V439, P443, DOI 10.1042/BJ20110376; Dreveny I, 2002, PROTEIN SCI, V11, P292, DOI 10.1110/ps.38102; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Dreveny I, 2009, BIOCHEMISTRY-US, V48, P3370, DOI 10.1021/bi802162s; DRUM DE, 1970, BIOCHEMISTRY-US, V9, P4078, DOI 10.1021/bi00823a008; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukuta Y, 2011, BIOSCI BIOTECH BIOCH, V75, P214, DOI 10.1271/bbb.100187; Gartler G, 2007, J BIOTECHNOL, V129, P87, DOI 10.1016/j.jbiotec.2006.12.009; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Gruber K, 2004, J POLYM SCI POL CHEM, V42, P479, DOI 10.1002/pola.10845; Gruber K, 2004, J BIOL CHEM, V279, P20501, DOI 10.1074/jbc.M401575200; Hajnal I, 2013, FEBS J, V280, P5815, DOI 10.1111/febs.12501; Hasslacher M, 1996, J BIOL CHEM, V271, P5884, DOI 10.1074/jbc.271.10.5884; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUGHES J, 1994, ARCH BIOCHEM BIOPHYS, V311, P496, DOI 10.1006/abbi.1994.1267; Hughes J, 1997, BIOTECHNOL BIOENG, V53, P332, DOI 10.1002/(SICI)1097-0290(19970205)53:3&lt;332::AID-BIT12&gt;3.0.CO;2-M; Hussain Z, 2012, APPL ENVIRON MICROB, V78, P2053, DOI 10.1128/AEM.06899-11; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; KOLTHOFF IM, 1951, J AM CHEM SOC, V73, P390, DOI 10.1021/ja01145a129; Krezel A, 2016, ARCH BIOCHEM BIOPHYS, V611, P3, DOI 10.1016/j.abb.2016.04.010; LAMBERT JL, 1975, ANAL CHEM, V47, P916, DOI 10.1021/ac60356a036; Lanfranchi E, 2017, SCI REP-UK, V7, DOI 10.1038/srep46738; Lauble H, 2002, BIOCHEMISTRY-US, V41, P12043, DOI 10.1021/bi020300o; Lauble H, 2002, PROTEIN SCI, V11, P65, DOI 10.1110/ps.ps.33702; Lauble H, 2001, ACTA CRYSTALLOGR D, V57, P194, DOI 10.1107/S0907444900015766; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MAGONET E, 1992, BIOCHEM J, V287, P361, DOI 10.1042/bj2870361; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Motojima F, 2021, FEBS J, V288, P1679, DOI 10.1111/febs.15490; Motojima F, 2018, FEBS J, V285, P313, DOI 10.1111/febs.14339; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakano S, 2014, BBA-PROTEINS PROTEOM, V1844, P2059, DOI 10.1016/j.bbapap.2014.09.004; Nuylert A, 2020, ACS OMEGA, V5, P27896, DOI 10.1021/acsomega.0c03070; Nuylert A, 2017, CHEMBIOCHEM, V18, P257, DOI 10.1002/cbic.201600447; Pasternak K, 2010, J ELEMENTOL, V15, P601; Pavkov-Keller T, 2016, J BIOTECHNOL, V235, P24, DOI 10.1016/j.jbiotec.2016.04.013; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rubach JK, 2002, BIOCHEMISTRY-US, V41, P15770, DOI 10.1021/bi026581h; Rudyk O, 2014, REDOX BIOL, V2, P803, DOI 10.1016/j.redox.2014.06.005; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P10778, DOI 10.1021/bi0257639; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Sharma M, 2005, ENZYME MICROB TECH, V37, P279, DOI 10.1016/j.enzmictec.2005.04.013; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Tanaka N, 2002, J MOL BIOL, V324, P519, DOI 10.1016/S0022-2836(02)01066-5; Trummler K, 1997, J BIOL CHEM, V272, P4770, DOI 10.1074/jbc.272.8.4770; Trummler K, 1998, PLANT SCI, V139, P19, DOI 10.1016/S0168-9452(98)00173-3; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Ueatrongchit T, 2008, BIOSCI BIOTECH BIOCH, V72, P1513, DOI 10.1271/bbb.80023; Wagner UG, 1996, STRUCTURE, V4, P811, DOI 10.1016/S0969-2126(96)00088-3; WAJANT H, 1993, PLANT SCI, V89, P127, DOI 10.1016/0168-9452(93)90120-O; WAJANT H, 1994, PLANT MOL BIOL, V26, P735, DOI 10.1007/BF00013758; WAJANT H, 1995, PLANT SCI, V108, P1, DOI 10.1016/0168-9452(95)04118-E; Wajant H, 1996, J BIOL CHEM, V271, P25830, DOI 10.1074/jbc.271.42.25830; Weston J, 2009, PATAIS CHEM FUNCTION, P315; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Wiedner R, 2014, COMPUT STRUCT BIOTEC, V10, P58, DOI 10.1016/j.csbj.2014.07.002; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wymore T, 2007, BIOCHEMISTRY-US, V46, P9495, DOI 10.1021/bi700555g; Xie PGT, 1999, PROTEIN SCI, V8, P2639; XU LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P256, DOI 10.1016/0003-9861(88)90634-0; Yahashiri A, 2014, BIOCHEMISTRY-US, V53, P881, DOI 10.1021/bi401583f; Yamaguchi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20190-x; YEMM RS, 1986, ARCH BIOCHEM BIOPHYS, V247, P440, DOI 10.1016/0003-9861(86)90604-1; Zhai ZY, 2019, J IND MICROBIOL BIOT, V46, P887, DOI 10.1007/s10295-019-02162-w; Zhao GJ, 2011, J BIOSCI BIOENG, V112, P321, DOI 10.1016/j.jbiosc.2011.06.015	83	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101650	10.1016/j.jbc.2022.101650	http://dx.doi.org/10.1016/j.jbc.2022.101650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101448	gold, Green Published			2022-12-26	WOS:000794865600007
J	Meacham, MC; Nobles, AL; Tompkins, DA; Thrul, J				Meacham, Meredith C.; Nobles, Alicia L.; Tompkins, D. Andrew; Thrul, Johannes			"I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums	PLOS ONE			English	Article							SOCIAL NETWORKING; USE DISORDER; DRONABINOL; MANAGEMENT; DEPENDENCE; SYMPTOMS; DEATHS; LAWS	A growing body of research has reported on the potential opioid-sparing effects of cannabis and cannabinoids, but less is known about specific mechanisms. The present research examines cannabis-related posts in two large online communities on the Reddit platform ("subreddits") to compare mentions of naturalistic cannabis use by persons self-identifying as actively using opioids versus persons in recovery. We extracted all posts mentioning cannabis-related keywords (e.g., "weed", "cannabis", "marijuana") from December 2015 through August 2019 from an opioid use subreddit and an opioid recovery subreddit. To investigate how cannabis is discussed at-scale, we identified and compared the most frequent phrases in cannabis-related posts in each subreddit using term-frequency-inverse document frequency (TF-IDF) weighting. To contextualize these findings, we also conducted a qualitative content analysis of 200 random posts (100 from each subreddit). Cannabis-related posts were about twice as prevalent in the recovery subreddit (n = 908; 5.4% of 16,791 posts) than in the active opioid use subreddit (n = 4,224; 2.6% of 159,994 posts, p < .001). The most frequent phrases from the recovery subreddit referred to time without using opioids and the possibility of using cannabis as a "treatment." The most frequent phrases from the opioid subreddit referred to concurrent use of cannabis and opioids. The most common motivations for using cannabis were to manage opioid withdrawal symptoms in the recovery subreddit, often in conjunction with anti-anxiety and GI-distress "comfort meds," and to enhance the "high" when used in combination with opioids in the opioid subreddit. Despite limitations in generalizability from pseudonymous online posts, this examination of reports of naturalistic cannabis use in relation to opioid use identified withdrawal symptom management as a common motivation. Future research is warranted with more structured assessments that examines the role of cannabis and cannabinoids in addressing both somatic and affective symptoms of opioid withdrawal.	[Meacham, Meredith C.; Tompkins, D. Andrew] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Nobles, Alicia L.] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA; [Thrul, Johannes] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Thrul, Johannes] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; [Thrul, Johannes] La Trobe Univ, Ctr Alcohol Policy Res, Melbourne, Vic, Australia	University of California System; University of California San Francisco; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; La Trobe University	Meacham, MC (corresponding author), Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA.	Meredith.meacham@ucsf.edu		Meacham, Meredith/0000-0001-5752-767X	U.S. National Institute of Drug Abuse [K01DA046697, K25DA049944, R21DA047520, R21 DA048175]	U.S. National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This research was supported by U.S. National Institute of Drug Abuse grants K01DA046697 (MCM), K25DA049944 (ALN), R21DA047520 (DAT), and R21 DA048175 (JT). URL: https://www.drugabuse.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DI, 2018, EUR J INTERN MED, V49, P7, DOI 10.1016/j.ejim.2018.01.003; Alexa, 2020, TRAFF STAT; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Bagra I, 2018, J ADDICT MED, V12, P315, DOI 10.1097/ADM.0000000000000406; Baumgartner Jason, 2020, ARXIV200108435; Bergeria CL, 2020, J SUBST ABUSE TREAT, V113, DOI 10.1016/j.jsat.2020.108005; Bisaga A, 2015, DRUG ALCOHOL DEPEN, V154, P38, DOI 10.1016/j.drugalcdep.2015.05.013; Boehnke KF, 2016, J PAIN, V17, P739, DOI 10.1016/j.jpain.2016.03.002; Bruneau A, 2021, DRUG ALCOHOL DEPEN, V225, DOI 10.1016/j.drugalcdep.2021.108787; Budney AJ, 1998, ADDICTION, V93, P493, DOI 10.1046/j.1360-0443.1998.9344935.x; Bunting AM, 2021, DRUG ALCOHOL DEPEN, V222, DOI 10.1016/j.drugalcdep.2021.108672; Butehorn L, 2017, ALTERN COMPLEMENT TH, V23, P228, DOI DOI 10.1089/act.2017.29139.lbu; Campbell G, 2018, INT REV PSYCHIATR, V30, P91, DOI 10.1080/09540261.2018.1509842; Carter J, 2019, ADDICT SCI CLIN PRAC, V14, DOI 10.1186/s13722-019-0149-1; Ceasar RC, 2021, DRUG ALCOHOL DEPEN, V219, DOI 10.1016/j.drugalcdep.2020.108421; Chancellor S, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300354; Chancellor S, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3174240; Cinnamon Bidwell L, 2018, Addict Behav Rep, V8, P102, DOI 10.1016/j.abrep.2018.08.004; Cooke AC, 2019, INT J DRUG POLICY, V63, P23, DOI 10.1016/j.drugpo.2018.09.002; Costello KL, 2017, J ASSOC INF SCI TECH, V68, P2439, DOI 10.1002/asi.23880; Croff R, 2019, J BEHAV HEALTH SER R, V46, P330, DOI 10.1007/s11414-018-9616-9; Csete J, 2019, AM J PUBLIC HEALTH, V109, P419, DOI 10.2105/AJPH.2018.304852; D'Agostino AR, 2017, DRUG ALCOHOL DEPEN, V181, P5, DOI 10.1016/j.drugalcdep.2017.09.010; Deering DEA, 2011, ADDICT BEHAV, V36, P636, DOI 10.1016/j.addbeh.2011.01.004; Dunning T., 1993, Computational Linguistics, V19, P61; Enghoff O, 2019, INT J DRUG POLICY, V73, P210, DOI 10.1016/j.drugpo.2019.01.023; Epstein DH, 2015, AM J ADDICTION, V24, P323, DOI 10.1111/ajad.12183; Franklyn AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187633; Hall NY, 2021, DRUG ALCOHOL DEPEN, V221, DOI 10.1016/j.drugalcdep.2021.108651; Hurd YL, 2019, AM J PSYCHIAT, V176, P911, DOI 10.1176/appi.ajp.2019.18101191; Ilgen MA, 2013, DRUG ALCOHOL DEPEN, V132, P654, DOI 10.1016/j.drugalcdep.2013.04.019; Knopf A, 2019, FILTER; Kosten TR, 2019, AM J ADDICTION, V28, P55, DOI 10.1111/ajad.12862; Kral AH, 2015, DRUG ALCOHOL DEPEN, V153, P236, DOI 10.1016/j.drugalcdep.2015.05.014; Krawczyk N, 2018, SUBST ABUS, V39, P404, DOI 10.1080/08897077.2018.1439798; Lake S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233463; Lake S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002967; Leas EC, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13853; Lister JJ, 2020, AM J DRUG ALCOHOL AB, V46, P273, DOI 10.1080/00952990.2019.1694536; Livingston MD, 2017, AM J PUBLIC HEALTH, V107, P1827, DOI [10.2105/AJPH.2017.304059, 10.2105/ajph.2017.304059]; Lofwall MR, 2016, DRUG ALCOHOL DEPEN, V164, P143, DOI 10.1016/j.drugalcdep.2016.05.002; Matsuo A., 2018, J OPEN SOURCE SOFTW, V3, P774, DOI [10.21105/joss.00774, DOI 10.21105/JOSS.00774]; McBrien Heather, 2019, CMAJ Open, V7, pE665, DOI 10.9778/cmajo.20190026; Meacham MC, 2018, DRUG ALCOHOL DEPEN, V188, P364, DOI 10.1016/j.drugalcdep.2018.03.041; Meier MH, 2017, DRUG ALCOHOL DEPEN, V179, P25, DOI 10.1016/j.drugalcdep.2017.06.015; Pew Research Center, 2019, SOC MED FACT SHEET; Powell D, 2018, J HEALTH ECON, V58, P29, DOI 10.1016/j.jhealeco.2017.12.007; Rayson P., 2000, WORKSH COMP CORP, DOI DOI 10.3115/1117729.1117730; Reboussin BA, 2020, DRUG ALCOHOL DEPEN, V215, DOI 10.1016/j.drugalcdep.2020.108182; Reiman A, 2017, CANNABIS CANNABINOID, V2, P160, DOI 10.1089/can.2017.0012; Rosic T, 2021, HARM REDUCT J, V18, DOI 10.1186/s12954-021-00468-6; Scavone JL, 2013, NEUROSCIENCE, V248, P637, DOI 10.1016/j.neuroscience.2013.04.034; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Shover CL, 2019, P NATL ACAD SCI USA, V116, P12624, DOI 10.1073/pnas.1903434116; Shulman M., 2018, AM OPIOID EPIDEMIC P, P249; Socias ME, 2018, ADDICTION, V113, P2250, DOI 10.1111/add.14398; Sowles SJ, 2017, SUBST ABUS, V38, P477, DOI 10.1080/08897077.2017.1354956; Tofighi B, 2019, SUBST USE MISUSE, V54, P2409, DOI 10.1080/10826084.2019.1653324; Tucker JS, 2020, DRUG ALCOHOL DEPEN, V214, DOI 10.1016/j.drugalcdep.2020.108188; Wasserman DA, 1998, DRUG ALCOHOL DEPEN, V52, P183, DOI 10.1016/S0376-8716(98)00092-1; Wiese B, 2018, CANNABIS CANNABINOID, V3, P179, DOI 10.1089/can.2018.0022; Wu LT, 2016, DRUG ALCOHOL DEPEN, V169, P117, DOI 10.1016/j.drugalcdep.2016.10.015; Zarrabi AJ, 2020, NEW ENGL J MED, V382, P1876, DOI 10.1056/NEJMp2003095	63	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263583	10.1371/journal.pone.0263583	http://dx.doi.org/10.1371/journal.pone.0263583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134074	gold, Green Published			2022-12-26	WOS:000798968600020
J	Wu, Y; Zhu, YH; Xie, NN; Wang, H; Wang, FF; Zhou, J; Qu, F				Wu, Yan; Zhu, Yuhang; Xie, Ningning; Wang, Hui; Wang, Fangfang; Zhou, Jue; Qu, Fan			A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis	PLOS ONE			English	Article							EXPRESSION	Objective Endometriosis is a common benign disease in women of reproductive age. Qu's formula (QUF) is a patented Chinese herbal medicine for treating endometriosis that has been proven to be effective in treating and preventing the recurrence of endometriosis. This study is aimed to discover its molecular mechanism and to explore the potential drug Methods A QUF target and endometriosis-related gene set was identified by the Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM) databases and five disease-gene databases. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed, and a protein-protein interaction (PPI) network was established to discover the potential mechanism. MalaCards was searched for targets and signaling pathways related to endometriosis, and the search results were also used to identify the key factors in QUF. Molecular docking was performed to visualize the interactions between the effective molecules and proteins encoded by critical genes. Cell experiments and molecular dynamics (MD) simulations were used to further validate the therapeutic effects of the active compounds in QUF on endometriosis. Results A compound-target network with 117 nodes (94 genes and 23 active compounds) and 224 edges was generated. The results of GO and KEGG analyses indicated that QUF could act by regulating the immune response, apoptosis and proliferation, oxidative stress, and angiogenesis. VEGFA, CXCL8, CCL2, IL1B and PTGS2 were selected for molecular docking analysis from two critical subnetworks with high correlation scores in MalaCards, and the active compounds of QUF had binding potential and high affinity for them. The mRNA expression levels of CCL2, IL1B and PTGS2-significantly decreased after treatment with quercetin. MD simulations showed that the combinations of quercetin and these proteins were relatively stable. Conclusion The network pharmacological strategy integrates molecular docking to unravel the molecular mechanism by which QUF protects against endometriosis. Our findings not only confirm the clinical effectiveness of QUF but also provide a foundation for further experimental study.	[Wu, Yan; Zhu, Yuhang; Xie, Ningning; Wang, Fangfang; Qu, Fan] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Hui] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Rehabil & Sports Med Res Inst Zhejiang Prov, Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhou, Jue] Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Zhejiang Gongshang University	Qu, F (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Zhou, J (corresponding author), Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	juezhou@zjgsu.edu.cn; syqufan@zju.edu.cn	wang, fang/GYD-4295-2022; Qu, Fan/S-6928-2016	Qu, Fan/0000-0003-1851-1514	National Natural Science Foundation of China (NSFC) [81973900, 81874480, 82074476]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) (81973900 by JZ, 81874480 by FQ, 82074476 by FQ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafort C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011031.pub3; Becker CM, 2017, FERTIL STERIL, V108, P125, DOI 10.1016/j.fertnstert.2017.05.004; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Bergqvist A, 2001, FERTIL STERIL, V75, P489, DOI 10.1016/S0015-0282(00)01752-0; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Fu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009881.pub2; Gazvani R, 2002, REPRODUCTION, V123, P217, DOI 10.1530/rep.0.1230217; Hu C, 2014, CLIMACTERIC, V17, P410, DOI 10.3109/13697137.2013.876618; Ji XY, 2011, J ETHNOPHARMACOL, V134, P624, DOI 10.1016/j.jep.2011.01.003; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Lai ZZ, 2019, INT J BIOL SCI, V15, P2783, DOI 10.7150/ijbs.35128; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Mari-Alexandre J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215322; Rappaport N, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat018; Rocha ALL, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/859619; Saunders PTK, 2021, CELL, V184, P2807, DOI 10.1016/j.cell.2021.04.041; Seguella L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133240; Tesone M, 2008, GYNECOL OBSTET INVES, V66, P10, DOI 10.1159/000148026; Ulukus M, 2009, FERTIL STERIL, V91, P687, DOI 10.1016/j.fertnstert.2007.12.067; Wang HX, 2021, PEERJ, V9, DOI 10.7717/peerj.11087; Wang X, 2021, INT J MED SCI, V18, P2401, DOI 10.7150/ijms.55789; Weng Q, 2015, INT J CLIN EXP MED, V8, P11307; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang F, 2018, CURR MED SCI, V38, P499, DOI 10.1007/s11596-018-1906-1; Zheng WL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00147; Zondervan KT, 2020, NEW ENGL J MED, V382, P1244, DOI 10.1056/NEJMra1810764; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	27	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263614	10.1371/journal.pone.0263614	http://dx.doi.org/10.1371/journal.pone.0263614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130311	gold, Green Published			2022-12-26	WOS:000805530700041
J	Agarwal, A; Khandelwal, A; Pal, K; Khare, NK; Jadhav, V; Gurjar, M; Punatar, S; Gokarn, A; Bonda, A; Nayak, L; Kannan, S; Gota, V; Khattry, N; Mittra, I				Agarwal, Anshul; Khandelwal, Aakanksha; Pal, Kavita; Khare, Naveen Kumar; Jadhav, Vishal; Gurjar, Murarilal; Punatar, Sachin; Gokarn, Anant; Bonda, Avinash; Nayak, Lingaraj; Kannan, Sadhana; Gota, Vikram; Khattry, Navin; Mittra, Indraneel			A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)	PLOS ONE			English	Article							CELL-FREE CHROMATIN; HEALTHY CELLS; DNA; MUCOSITIS; DAMAGE	Background Transplant related toxicity is a major therapeutic challenge. We have previously reported that the toxicity of chemotherapy is largely not directly because of the drugs themselves; rather it is mainly due to DNA damage, apoptosis and hyper-inflammation triggered by cell-free chromatin particles that are released because of drug-induced host cell death. Cell-free chromatin particles can be inactivated by free-radicals which are generated when the nutraceuticals resveratrol and copper are administered orally. We investigated if a combination of resveratrol and copper would reduce transplant related toxicities in an exploratory, prospective dose-escalation study. Patients and methods Twenty-five patients with multiple myeloma were enrolled between March 2017 to August 2019. Patients were divided into 3 groups: control (Group 1, N = 5) received vehicle alone; group 2 (N = 15) received resveratrol-copper at dose level I (resveratrol = 5.6 mg and copper = 560 ng); group 3 (N = 5) received resveratrol-copper at dose level II (resveratrol = 50 mg and copper = 5 mu g). The dose was given twice daily with the first dose administered 48 hours before administering melphalan and continued until day +21 post-transplant. Common Terminology Criteria for Adverse Events version 4.02 was used to assess toxicities which included oral mucositis, nausea, vomiting and diarrhea. Measurement of inflammatory cytokines was done by ELISA. Results All patients (100%) in the control group developed grade 3/4 oral mucositis compared to 8/20 (40%) in both resveratrol-copper group 2 plus group 3 combined (P = 0.039). Reduction in inflammatory cytokines: salivary TNF - alpha (p = 0.012) and IL-1 beta (p = 0.009) in dose level I but not in dose level II was observed. Conclusions A combination of resveratrol-copper reduced transplant related toxicities in patients with multiple myeloma receiving high dose melphalan. We conclude that relatively inexpensive nutraceuticals may be useful as adjuncts to chemotherapy to reduce its toxicity.	[Agarwal, Anshul; Punatar, Sachin; Gokarn, Anant; Bonda, Avinash; Nayak, Lingaraj; Khattry, Navin] Tata Mem Hosp, Dept Med Oncol, Bone Marrow Transplant Unit, Adv Ctr Treatment, Navi Mumbai, Maharashtra, India; [Agarwal, Anshul; Khandelwal, Aakanksha; Pal, Kavita; Khare, Naveen Kumar; Jadhav, Vishal; Gurjar, Murarilal; Punatar, Sachin; Gokarn, Anant; Bonda, Avinash; Nayak, Lingaraj; Kannan, Sadhana; Gota, Vikram; Khattry, Navin; Mittra, Indraneel] Homi Bhabha Natl Inst, Mumbai, Maharashtra, India; [Khandelwal, Aakanksha; Pal, Kavita; Khare, Naveen Kumar; Jadhav, Vishal; Mittra, Indraneel] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Translat Res Lab, Navi Mumbai, Maharashtra, India; [Gota, Vikram] Tata Mem Hosp, Clin Pharmacol Lab, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Kannan, Sadhana] Tata Mem Hosp, Dept Biostat, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Homi Bhabha National Institute; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Mittra, I (corresponding author), Homi Bhabha Natl Inst, Mumbai, Maharashtra, India.; Mittra, I (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Translat Res Lab, Navi Mumbai, Maharashtra, India.	imittra@actrec.gov.in			Tata Memorial Centre	Tata Memorial Centre	The study was supported by Tata Memorial Centre awarded to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J ONCOL PRACT, V4, P277, DOI 10.1200/JOP.0868502; Berger Ann M., 1997, P2714; Blijlevens NMA, 2000, BONE MARROW TRANSPL, V25, P1269, DOI 10.1038/sj.bmt.1702447; Borowski B, 1994, Eur J Cancer B Oral Oncol, V30B, P93, DOI 10.1016/0964-1955(94)90059-0; Bost M, 2016, J TRACE ELEM MED BIO, V35, P107, DOI 10.1016/j.jtemb.2016.02.006; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Fukuhara K, 1998, BIOORG MED CHEM LETT, V8, P3187, DOI 10.1016/S0960-894X(98)00585-X; Kaneko N, 2019, INFLAMM REGEN, V39, DOI 10.1186/s41232-019-0101-5; Kirolikar S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1181-x; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Liu ZJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01374; Mittra I, 2017, ANN ONCOL, V28, P2119, DOI 10.1093/annonc/mdx318; Mittra I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229017; Mittra I, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.15; Mittra I, 2015, J BIOSCIENCES, V40, P91, DOI 10.1007/s12038-015-9508-6; Nooka AK, 2014, BIOL BLOOD MARROW TR, V20, P852, DOI 10.1016/j.bbmt.2014.02.025; Raghuram GV, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060407; RAHMAN QI, 1990, NUMER MATH, V57, P123, DOI 10.1007/BF01386402; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Subramaniam Siddharth, 2015, F1000Res, V4, P1145, DOI 10.12688/f1000research.7202.1; Diaz-Gerevini GT, 2016, NUTRITION, V32, P174, DOI 10.1016/j.nut.2015.08.017; Tripathy BK, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020163; WINGARD JR, 1991, ORAL SURG ORAL MED O, V72, P419, DOI 10.1016/0030-4220(91)90552-N	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262212	10.1371/journal.pone.0262212	http://dx.doi.org/10.1371/journal.pone.0262212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120140	Green Published, gold			2022-12-26	WOS:000789273600007
J	Chura-Chambi, RM; Prieto-da-Silva, ARD; Di Lela, MM; Oliveira, JE; Abreu, PEA; Meireles, LR; de Andrade, HF; Morganti, L				Chura-Chambi, Rosa Maria; De Brandao Prieto-da-Silva, Alvaro Rossan; Di Lela, Matheus Martins; Oliveira, Joao Ezequiel; Antonia Abreu, Patricia Estima; Meireles, Luciana Regina; de Andrade Junior, Heitor Franco; Morganti, Ligia			High level SARS-CoV-2 nucleocapsid refolding using mild condition for inclusion bodies solubilization: Application of high pressure at pH 9.0	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; PROTEIN; EXPRESSION; RESPONSES	SARS-CoV-2 Nucleocapsid (N) is the most abundant viral protein expressed in host samples and is an important antigen for diagnosis. N is a 45 kDa protein that does not present disulfide bonds. Intending to avoid non-specific binding of SARS-CoV-2 N to antibodies from patients who previously had different coronaviruses, a 35 kDa fragment of N was expressed without a conserved motif in E. coli as inclusion bodies (N122-419-IB). Culture media and IB washing conditions were chosen to obtain N122-419-IB with high yield (370 mg/L bacterial culture) and protein purity (90%). High pressure solubilizes protein aggregates by weakening hydrophobic and ionic interactions and alkaline pH promotes solubilization by electrostatic repulsion. The association of pH 9.0 and 2.4 kbar promoted efficient solubilization of N122-419-IB without loss of native-like tertiary structure that N presents in IB. N122-419 was refolded with a yield of 85% (326 mg/L culture) and 95% purity. The refolding process takes only 2 hours and the protein is ready for use after pH adjustment, avoiding the necessity of dialysis or purification. Antibody binding of COVID-19-positive patients sera to N122-419 was confirmed by Western blotting. ELISA using N122-419 is effective in distinguishing between sera presenting antibodies against SARS-CoV-2 from those who do not. To the best of our knowledge, the proposed condition for IB solubilization is one of the mildest described. It is possible that the refolding process can be extended to a wide range of proteins with high yields and purity, even those that are sensible to very alkaline pH.	[Chura-Chambi, Rosa Maria; Di Lela, Matheus Martins; Oliveira, Joao Ezequiel; Morganti, Ligia] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, SP, Brazil; [De Brandao Prieto-da-Silva, Alvaro Rossan] Inst Butantan, Lab Genet, Sao Paulo, SP, Brazil; [Antonia Abreu, Patricia Estima] Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil; [Meireles, Luciana Regina; de Andrade Junior, Heitor Franco] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Protozool, Sao Paulo, SP, Brazil	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo	Morganti, L (corresponding author), IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, SP, Brazil.	lmorganti@ipen.br	Prieto, Alvaro/G-8505-2017; Morganti, Ligia/K-4352-2014	Prieto, Alvaro/0000-0003-0289-9809; Morganti, Ligia/0000-0002-7870-1793				Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Amrun SN, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102911; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024; Chura-Chambi RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211162; Crisman RI, 2009, BIOTECHNOL BIOENG, V102, P483, DOI 10.1002/bit.22082; Das D, 2006, J VIROL METHODS, V137, P343, DOI 10.1016/j.jviromet.2006.06.029; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; JENSEN EB, 1990, BIOTECHNOL BIOENG, V36, P1, DOI 10.1002/bit.260360102; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Lau SKP, 2004, J CLIN MICROBIOL, V42, P2884, DOI 10.1128/JCM.42.7.2884-2889.2004; Li G, 2021, PROTEIN EXPRES PURIF, V186, DOI 10.1016/j.pep.2021.105908; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luo HB, 2004, BIOPHYS CHEM, V112, P15, DOI 10.1016/j.bpc.2004.06.008; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; Meireles LR, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2290; Nguyen A, 2020, J VIROL, V94, DOI 10.1128/JVI.00510-20; Noorimotlagh Z, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106738; Oliveira BA, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062044, 10.1590/s1678-9946202062044]; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Rathore AS, 2013, J CHEM TECHNOL BIOT, V88, P1794, DOI 10.1002/jctb.4152; da Silva CMR, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0486-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Satarker S, 2020, ARCH MED RES, V51, P482, DOI 10.1016/j.arcmed.2020.05.012; Tan YJ, 2004, CLIN DIAGN LAB IMMUN, V11, P362, DOI 10.1128/CDLI.11.2.362-371.2004; Tilocca B, 2020, MICROBES INFECT, V22, P188, DOI 10.1016/j.micinf.2020.04.002; Wang YL, 2004, BIOCHEMISTRY-US, V43, P11103, DOI 10.1021/bi049194b; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yongsawatdigul J, 2004, J FOOD SCI, V69, pC499, DOI 10.1111/j.1365-2621.2004.tb13642.x	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262591	10.1371/journal.pone.0262591	http://dx.doi.org/10.1371/journal.pone.0262591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113919	gold, Green Published			2022-12-26	WOS:000823694700028
J	Kasprak, A; Jackson, PR; Lindroth, EM; Lund, JW; Ziegeweid, JR				Kasprak, Alan; Jackson, P. Ryan; Lindroth, Evan M.; Lund, J. William; Ziegeweid, Jeffrey R.			The role of hydraulic and geomorphic complexity in predicting invasive carp spawning potential: St. Croix River, Minnesota and Wisconsin, United States	PLOS ONE			English	Article							ASIAN CARP; GRASS CARP; LAKES; 1D; ILLINOIS; MODELS; TRANSPORT	Since they were first introduced to the United States more than 50 years ago, invasive carp have rapidly colonized rivers of the Mississippi River Basin, with detrimental effects on native aquatic species. Their continued range expansion, and potential for subsequent invasion of the Great Lakes, has led to increased concern for the susceptibility of as-yet uncom-promised lotic and lentic systems in the central United States. Because invasive carp eggs and larvae must drift in the river current for the first several days following spawning, numerical drift modeling has emerged as a useful technique for determining whether certain river systems and reaches have the potential to support suspension-to-hatching survival of invasive carp eggs, a critical first step in recruitment. Here we use one such numerical modeling approach, the Fluvial Egg Drift Simulator (FluEgg), to estimate bighead carp (Hypophthal-michthys nobilis) egg hatching success and larval retention in a 47.8-kilometer (km) reach of the multi-thread St. Croix River, Minnesota and Wisconsin, United States. We explore three approaches for obtaining the hydraulic data required by FluEgg, parameterizing the model with either (a) field hydraulic data collected within the main channel during a high-flow event, or hydraulic data output from a one-dimensional hydrodynamic model with both (b) steady, and (c) unsteady flows. We find that the three approaches, along with the range of water temperatures and discharge used in simulations, produce vastly different predictions of streamwise transport and in-river egg hatching probability (0% for field data, 0 to 96% for steady-state hydraulic modeling, and 1.8 to 65% for unsteady modeling). However, all FluEgg simulations, regardless of the source of hydraulic data, predicted that no larvae reach the gas bladder inflation stage within the study reach where nursery habitat is abundant. Overall, these results indicate that the lower St. Croix River is suitable for invasive carp spawning and egg suspension until hatching for a range of discharge and water temperatures. These results highlight the role of complex channel hydraulics and morphology, particularly multi-thread reaches, and their inclusion in ecohydraulic-suitability modeling to determine susceptibility of river systems for invasive carp reproduction. Our work also emphasizes the scientific value of multi-dimensional hydrodynamic models that can capture the spatial heterogeneity of flow fields in geomorphically complex rivers. This work may help to guide management efforts based on the targeted monitoring and control and improve invasive carp egg and larvae sampling efficiency.	[Kasprak, Alan] US Geol Survey, Cent Midwest Water Sci Ctr, Iowa City, IA 52242 USA; [Jackson, P. Ryan; Lindroth, Evan M.] US Geol Survey, Cent Midwest Water Sci Ctr, Urbana, IL USA; [Lund, J. William; Ziegeweid, Jeffrey R.] US Geol Survey, Upper Midwest Water Sci Ctr, Mounds View, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Kasprak, A (corresponding author), US Geol Survey, Cent Midwest Water Sci Ctr, Iowa City, IA 52242 USA.	akasprak@fortlewis.edu		Lund, J. William/0000-0002-8830-4468; Jackson, P. Ryan/0000-0002-3154-6108; Ziegeweid, Jeffrey/0000-0001-7797-3044	Minnesota Department of Natural Resources [GC19NE00LZ90900]	Minnesota Department of Natural Resources	This study was funded by the Minnesota Department of Natural Resources (dnr.state.mn.us; #GC19NE00LZ90900). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Publication of results was a requirement of funding.	[Anonymous], 2010, C RES SERVICE REPORT, DOI 10.1016/j.envres.2010.07.00220691969; Brierley GJ, 2000, ENVIRON MANAGE, V25, P661, DOI 10.1007/s002670010052; Brunner G.W., 2021, HEC RAS RIVER ANAL S; Chapman D.C., 2011, 20115076 USGS; Chapman DC, 2013, J GREAT LAKES RES, V39, P547, DOI 10.1016/j.jglr.2013.09.019; Coulter AA, 2013, FRESHWATER BIOL, V58, P1029, DOI 10.1111/fwb.12106; Cudmore B., 2017, CAN SCI ADVIS SECR; Cudmore B., 2011, 2011114 CAN SCI ADV; Cudmore B., 2004, CAN MANUSCR REP FISH; Deters JE, 2013, ENVIRON BIOL FISH, V96, P617, DOI 10.1007/s10641-012-0052-z; Dimitriadis P, 2016, J HYDROL, V534, P478, DOI 10.1016/j.jhydrol.2016.01.020; Domanski MM., 2020, **DATA OBJECT**, DOI 10.5066/P93UCQR2; Embke HS, 2019, CAN J FISH AQUAT SCI, V76, P597, DOI 10.1139/cjfas-2018-0047; Garcia T., 2016, EOS T AM GEOPHYS UN, pEP51B; Garcia T., 2015, J GREAT LAKES RES, DOI [10.1016/j.jglr.2014.12.023, DOI 10.1016/J.JGLR.2014.12.023]; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; George AE., 2017, T AM FISH SOC; George AE., 2015, J APPL ICHTHYOL; George AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119023; George AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073829; Granato G.E., 2017, US GEOL SURV OPEN FI, P17; Horritt MS, 2002, J HYDROL, V268, P87, DOI 10.1016/S0022-1694(02)00121-X; Hunt R.J., 2013, SIMULATION CLIMATE C, P118, DOI [10.3133/sir20135159, DOI 10.3133/SIR20135159]; Huser BJ., 2016, HYDROBIOLOGIA; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Jackson PR, US GEOL SURV DATA RE, DOI 10.5066/P93K0UUI; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jirsa M. A., 2011, GEOLOGIC MAP MINNESO; Jowett IG, 2012, ECOL ENG, V48, P92, DOI 10.1016/j.ecoleng.2011.06.036; Kasprak A., 2019, EARTH SURF DYNAM; Kasprak A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150293; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Lenz BN., 2004, US GEOL SURV WATER R; Lougheed VL., 2011, CAN J FISH AQUAT SCI, DOI [10.1139/f2011-123, DOI 10.1139/F2011-123]; Minnesota Department of Natural Resources (MNDNR), 2022, STATE FISHING REGULA; Murphy EA., 2013, SCI INVESTIGATIONS R; Novotny EV, 2007, J HYDROL, V334, P319, DOI 10.1016/j.jhydrol.2006.10.011; Pilgrim JM., 1998, J AM WATER RESOUR AS; Prada AF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208326; Rhoads BL., 2013, EARTH SURF PROC LAND; Saleh F, 2013, J HYDROL, V476, P169, DOI 10.1016/j.jhydrol.2012.10.027; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Simulation Research Group at Lawrence Berkeley National Laboratory and Building Systems Laboratory at University of Illinois Urbana-Champaign, 2015, ENERGYPLUS DOC V8 4; Soong DT., 2017, TRANSACTIONS, pEP43A; U.S. Army Corps of Engineers, 2020, UPP MISS RIV PHAS 4; U.S. Geological Survey, 2021, GAUG REC CROIX RIV; U.S. Geological Survey, 2021, GAGING RECORD CROIX; U.S. Geological Survey, MINN FULL STAT LID D; Walker JF., 2003, US GEOL SURV WATER R, P37; Wheaton JM, 2015, GEOMORPHOLOGY, V248, P273, DOI 10.1016/j.geomorph.2015.07.010; Wieringa JG., 2017, J GREAT LAKES RES; Williams RD, 2013, WATER RESOUR RES, V49, P5183, DOI 10.1002/wrcr.20391; Williams RD., 2016, GEOGR COMPASS; Wilson C., 2014, MANAG BIOL INVASIONS; Wittmann ME, 2014, CAN J FISH AQUAT SCI, V71, P992, DOI 10.1139/cjfas-2013-0537; Xcel Energy, 2020, STCROIX FALLS HYDR G; Yi B., 1988, GEZHOUBA WATER CONTR; Zhu ZD, 2018, ECOL MODEL, V384, P53, DOI 10.1016/j.ecolmodel.2018.06.003	58	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263052	10.1371/journal.pone.0263052	http://dx.doi.org/10.1371/journal.pone.0263052			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113891	gold, Green Published			2022-12-26	WOS:000823694700050
J	Kawai, Y; Ozawa, N; Fukuda, T; Suzuki, N; Mikata, K				Kawai, Yuto; Ozawa, Naoya; Fukuda, Takako; Suzuki, Noriyuki; Mikata, Kazuki			Development of an efficient antimicrobial susceptibility testing method with species identification by Nanopore sequencing of 16S rRNA amplicons	PLOS ONE			English	Article								While amplicon sequencing of 16S rRNA is a common method for studying microbial community, it has been difficult to identify genera and species using next-generation sequencers to examine some regions (e.g., V3-V4 of 16S rRNA) because of the short read lengths. However, the advent of third-generation sequencers has made it possible to analyze the full length of the 16S rRNA gene, which allowed for species level identification at low cost. In this study, we evaluated the accuracy of the identification with a third-generation sequencer, MinION from Oxford Nanopore Technologies, using nine indigenous bacteria that can pose problems with food poisoning and opportunistic infections as an example. We demonstrated that Enterococcus faecalis and Enterococcus hirae could be identified at the species level with an accuracy of 96.4% to 97.5%. We also demonstrated that the absolute counts of various bacteria could be determined by spiking the sample with a bacterium as an internal standard. Then, we tested whether this convenient bacterial identification method could evaluate the antibiotic sensitivities of multiple bacteria simultaneously. In order to evaluate antimicrobial susceptibility, a mock community, an artificial mixture of the nine bacterial strains, was prepared and cultured in the presence of the antibiotics ofloxacin or chloramphenicol, and the 16S rRNAs were analyzed by using Nanopore sequencer. We confirmed that antibiotic-induced cell count reductions could be measured simultaneously by quantifying the abundances of various bacteria in the mock community before and after culture. It was thus shown that the antibiotic sensitivities of multiple bacteria could be evaluated simultaneously, with distinction made between bactericidal action and bacteriostatic action. This methodology would allow rapid evaluation of antibiotic activity spectrum at the species level containing a wide variety of bacteria, such as biofilm bacteria and gut microbiota.	[Kawai, Yuto; Ozawa, Naoya; Fukuda, Takako; Suzuki, Noriyuki; Mikata, Kazuki] Sumitomo Chem Co Ltd, Biosci Res Lab, Osaka, Japan	Sumitomo Chem Co Ltd	Suzuki, N (corresponding author), Sumitomo Chem Co Ltd, Biosci Res Lab, Osaka, Japan.	suzukin7@sc.sumitomo-chem.co.jp						Abundo MEC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0241732; Arwiyanto Triwidodo, 1993, Annals of the Phytopathological Society of Japan, V59, P114, DOI 10.3186/jjphytopath.59.114; Baker JL, 2017, TRENDS MICROBIOL, V25, P362, DOI 10.1016/j.tim.2016.12.012; Balaban NQ, 2019, NAT REV MICROBIOL, V17, P441, DOI 10.1038/s41579-019-0196-3; Barbosa MS, 2016, FOOD CONTROL, V60, P103, DOI 10.1016/j.foodcont.2015.07.029; Benitez-Paez A, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix043; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Clinical and Laboratory Standards Institute, 2018, METH DIL ANT SUSC TE, V11th; Credito K, 2007, ANTIMICROB AGENTS CH, V51, P1504, DOI 10.1128/AAC.01455-06; Cusco A., 2018, F1000RESEARCH, P7, DOI [10.12688/f1000research.13350.2, DOI 10.12688/F1000RESEARCH.13350.2]; Edwards A., 2016, BIORXIV, P1, DOI [10.1101/073965, DOI 10.1101/073965]; Fujiyoshi S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69450-9; Iturbe-Espinoza P, 2021, FOLIA MICROBIOL, V66, P597, DOI 10.1007/s12223-021-00866-0; Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Mitsuhashi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05772-5; Negash AW, 2020, INT J MICROBIOL, V2020, DOI 10.1155/2020/4374891; Noakes MT, 2019, NAT BIOTECHNOL, V37, P651, DOI 10.1038/s41587-019-0096-0; Nodake Y, 2015, J DERMATOL SCI, V79, P119, DOI 10.1016/j.jdermsci.2015.05.001; Pekala A, 2018, AQUACULTURE, V486, P285, DOI 10.1016/j.aquaculture.2017.12.028; Ragupathi N. K. Devanga, 2018, New Microbes and New Infections, V21, P58, DOI 10.1016/j.nmni.2017.09.003; RAHAL JJ, 1979, ANTIMICROB AGENTS CH, V16, P13, DOI 10.1128/AAC.16.1.13; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Schumacher A, 2018, EUR J CLIN MICROBIOL, V37, P187, DOI 10.1007/s10096-017-3089-2; Stokes JM, 2019, NAT METHODS, V16, P303, DOI 10.1038/s41592-019-0333-y; Goncalves AT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59747-0; TODD PA, 1991, DRUGS, V42, P825, DOI 10.2165/00003495-199142050-00008; Tourlousse DM, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw984; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	33	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262912	10.1371/journal.pone.0262912	http://dx.doi.org/10.1371/journal.pone.0262912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113894	gold, Green Published			2022-12-26	WOS:000823694700041
J	Wang, Q; Niu, G; Gan, X; Cai, QL				Wang, Qi; Niu, Geng; Gan, Xu; Cai, Qiaoling			Green returns to education: Does education affect pro-environmental attitudes and behaviors in China?	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; HEALTH; TEMPERATURE; HOUSEHOLDS; MORTALITY; POLLUTION; CHOICE; VALUES	Using microdata from the Chinese General Social Survey (CGSS 2010), this paper investigates whether there are green returns to education in China, where educational attainment promotes pro-environmental attitudes and behaviors. We establish causality by exploiting the exogenous variation induced by the implementation of the Compulsory Schooling Law (CSL) in China. We find evidence that educational attainment is associated with higher levels of pro-environmental attitudes and behaviors, and these estimates are robust to various robustness checks. Further analysis reveals that the acquisition of environmental knowledge is the channel that drives the effect of education on pro-environmental attitudes and behaviors. Finally, the effects of education are heterogeneous across individuals.	[Wang, Qi] Sichuan Univ, Business Sch, Chengdu, Sichuan, Peoples R China; [Niu, Geng; Cai, Qiaoling] Southwestern Univ Finance & Econ, Res Inst Econ & Management, Chengdu, Sichuan, Peoples R China; [Gan, Xu] Huazhong Univ Sci & Technol, Sch Management, Wuhan, Hubei, Peoples R China	Sichuan University; Southwestern University of Finance & Economics - China; Huazhong University of Science & Technology	Gan, X (corresponding author), Huazhong Univ Sci & Technol, Sch Management, Wuhan, Hubei, Peoples R China.	xgan@hust.edu.cn						Albouy V, 2009, J HEALTH ECON, V28, P155, DOI 10.1016/j.jhealeco.2008.09.003; Amore MD, 2019, J ENVIRON ECON MANAG, V94, P254, DOI 10.1016/j.jeem.2019.02.001; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Banks J, 2012, ECON J, V122, P418, DOI 10.1111/j.1468-0297.2012.02499.x; Black SE, 2018, REV FINANC, V22, P951, DOI 10.1093/rof/rfy005; Bybee RW, 2008, J SCI EDUC TECHNOL, V17, P566, DOI 10.1007/s10956-008-9124-4; Card D, 2001, ECONOMETRICA, V69, P1127, DOI 10.1111/1468-0262.00237; Chankrajang T, 2017, ECOL ECON, V131, P434, DOI 10.1016/j.ecolecon.2016.09.015; Chen SY, 2018, J ENVIRON ECON MANAG, V92, P465, DOI 10.1016/j.jeem.2018.10.002; Chen XG, 2019, J ENVIRON ECON MANAG, V95, P257, DOI 10.1016/j.jeem.2017.07.009; Clark D, 2013, AM ECON REV, V103, P2087, DOI 10.1257/aer.103.6.2087; Cui Y, 2019, J COMP ECON, V47, P669, DOI 10.1016/j.jce.2019.04.001; Dee TS, 2004, J PUBLIC ECON, V88, P1697, DOI 10.1016/j.jpubeco.2003.11.002; Fang H., 2012, RETURNS ED CHINA EVI; Huang W., 2015, UNDERSTANDING EFFECT; INGLEHART R, 1995, PS, V28, P57, DOI 10.2307/420583; Kotchen MJ, 2013, ENERG POLICY, V55, P617, DOI 10.1016/j.enpol.2012.12.058; Lange F., 2006, HDB EC ED, V1, P459; Liang YH, 2019, CHINA ECON REV, V54, P324, DOI 10.1016/j.chieco.2019.01.006; Lu S, 2013, INT J PSYCHOL, V48, P1135, DOI 10.1080/00207594.2012.743666; Lutz W, 2014, SCIENCE, V346, P1061, DOI 10.1126/science.1257975; Ma G, 2013, ENERG POLICY, V56, P591, DOI 10.1016/j.enpol.2013.01.024; Mannberg A, 2014, ENERG POLICY, V74, P286, DOI 10.1016/j.enpol.2014.08.029; Maslow A. H., 1970, J TRANSPERSONAL PSY, V2nd; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; McMahon WW, 2004, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF EDUCATION, P211; Meyer A, 2015, ECOL ECON, V116, P108, DOI 10.1016/j.ecolecon.2015.04.018; Moretti E., 2004, HDB REGIONAL URBAN E, V4, P2243; Ngobo PV, 2011, J RETAILING, V87, P90, DOI 10.1016/j.jretai.2010.08.001; Oreopoulos P, 2011, J ECON PERSPECT, V25, P159, DOI 10.1257/jep.25.1.159; Ponce P, 2019, ECOL ECON, V160, P105, DOI 10.1016/j.ecolecon.2019.02.012; Rummel R.J., 1988, APPL FACTOR ANAL; Staiger D. O., 1994, INSTRUMENTAL VARIABL; Steg L, 2014, J ENVIRON PSYCHOL, V38, P104, DOI 10.1016/j.jenvp.2014.01.002; Tu M, 2020, J DEV ECON, V143, DOI 10.1016/j.jdeveco.2019.102402; VANLIERE KD, 1980, PUBLIC OPIN QUART, V44, P181; Vlek C, 2007, J SOC ISSUES, V63, P1, DOI 10.1111/j.1540-4560.2007.00493.x; Wang CH, 2018, J ENVIRON ECON MANAG, V92, P54, DOI 10.1016/j.jeem.2018.08.004; Wen LM, 2011, INT J MED INFORM, V80, P406, DOI 10.1016/j.ijmedinf.2011.03.001; Xie SQ, 2014, CHINA ECON REV, V29, P1, DOI 10.1016/j.chieco2013.12.003; Xu CB, 2021, ENVIRON DEV, V37, DOI 10.1016/j.envdev.2020.100608; Xu P, 2012, FOOD CONTROL, V28, P74, DOI 10.1016/j.foodcont.2012.04.008; Yu XM, 2019, J ENVIRON ECON MANAG, V96, P195, DOI 10.1016/j.jeem.2019.05.004; Zhang L, 2012, ENERG POLICY, V51, P514, DOI 10.1016/j.enpol.2012.08.053; Zhang P, 2018, J ENVIRON ECON MANAG, V88, P1, DOI 10.1016/j.jeem.2017.11.001; Zheng SQ, 2013, J ECON LIT, V51, P731, DOI 10.1257/jel.51.3.731	47	2	2	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0263383	10.1371/journal.pone.0263383	http://dx.doi.org/10.1371/journal.pone.0263383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113928	gold, Green Published			2022-12-26	WOS:000823694700088
J	Wang, XY; Dorjee, T; Chen, YR; Gao, F; Zhou, YJ				Wang, Xiaoyang; Dorjee, Tashi; Chen, Yiru; Gao, Fei; Zhou, Yijun			The complete chloroplast genome sequencing analysis revealed an unusual IRs reduction in three species of subfamily Zygophylloideae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; TRANSFER-RNA GENES; PLASTID GENOME; SSR-MARKERS; TRNASCAN-SE; NDH GENES; EVOLUTION; DIVERGENCE; PHYLOGENY; ORGANIZATION	Tetraena mongolica, Zygophyllum xanthoxylon, and Z. fabago are three typical dryland plants with important ecological values in subfamily Zygophylloideae of Zygophyllaceae. Studies on the chloroplast genomes of them are favorable for understanding the diversity and phylogeny of Zygophyllaceae. Here, we sequenced and assembled the whole chloroplast genomes of T. mongolica, Z. xanthoxylon, and Z. fabago, and performed comparative genomic and phylogenetic analysis. The total size, structure, gene content and orders of these three chloroplast genomes were similar, and the three chloroplast genomes exhibited a typical quadripartite structure with a large single-copy region (LSC; 79,696-80,291 bp), a small single-copy region (SSC; 16,462-17,162 bp), and two inverted repeats (IRs; 4,288-4,413 bp). A total of 107 unique genes were identified from the three chloroplast genomes, including 70 protein-coding genes, 33 tRNAs, and 4 rRNAs. Compared with other angiosperms, the three chloroplast genomes were significantly reduced in overall length due to an unusual 16-24 kb shrinkage of IR regions and loss of the 11 genes which encoded subunits of NADH dehydrogenase. Genome-wide comparisons revealed similarities and variations between the three species and others. Phylogenetic analysis based on the three chloroplast genomes supported the opinion that Zygophyllaceae belonged to Zygophyllales in Fabids, and Z. xanthoxylon and Z. fabago belonged to Zygophyllum. The genome-wide comparisons revealed the similarity and variations between the chloroplast genomes of the three Zygophylloideae species and other plant species. This study provides a valuable molecular biology evidence for further studies of phylogenetic status of Zygophyllaceae.	[Wang, Xiaoyang; Dorjee, Tashi; Chen, Yiru; Gao, Fei; Zhou, Yijun] Minzu Univ China, Natl Ethn Affairs Commiss, Key Lab Ecol & Environm Minor Areas, Beijing, Peoples R China; [Wang, Xiaoyang; Dorjee, Tashi; Chen, Yiru; Gao, Fei; Zhou, Yijun] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China	Minzu University of China	Gao, F; Zhou, YJ (corresponding author), Minzu Univ China, Natl Ethn Affairs Commiss, Key Lab Ecol & Environm Minor Areas, Beijing, Peoples R China.; Gao, F; Zhou, YJ (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China.	gaofei@muc.edu.cn; zhouyijun@muc.edu.cn		Wang, Xiaoyang/0000-0003-2029-853X	National Natural Science Foundation of China [31770363, 31670335]; Ministry of Education of China through 111 project; Ministry of Education of China through "Double First-Class" project [B08044, Yldxxk201819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China through 111 project; Ministry of Education of China through "Double First-Class" project	This work was supported by the National Natural Science Foundation of China (Grant number 31770363 and 31670335) by YZ, and the Ministry of Education of China through 111 and "Double First-Class" projects (Grant number B08044 and Yldxxk201819) by YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah, 2021, ECOL EVOL, V11, P7810, DOI 10.1002/ece3.7614; Abdullah, 2020, J MOL EVOL, V88, P562, DOI 10.1007/s00239-020-09958-w; Abdullah, 2021, J SYST EVOL, V59, P388, DOI 10.1111/jse.12585; Anderson W.R., 1982, BRITTONIA, V34, P268, DOI [10.2307/2806386, DOI 10.2307/2806386]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bellstedt DU, 2008, MOL PHYLOGENET EVOL, V47, P932, DOI 10.1016/j.ympev.2008.02.019; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; BYRNE M, 1994, HEREDITY, V73, P18, DOI 10.1038/hdy.1994.94; Chase MW, 2000, TAXON, V49, P685, DOI 10.2307/1223971; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dong WL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030716; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Ge XJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-1; GOLENBERG EM, 1993, MOL PHYLOGENET EVOL, V2, P52, DOI 10.1006/mpev.1993.1006; Grassi F, 2002, VITIS, V41, P157; Gu CH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020525; Hall T., 2011, GERF B BIOSCI, V2, P60; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huang JL, 2010, J SYST EVOL, V48, P240, DOI 10.1111/j.1759-6831.2010.00080.x; Jin JJ, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02154-5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunnimalaiyaan M, 1997, NUCLEIC ACIDS RES, V25, P3681, DOI 10.1093/nar/25.18.3681; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lei WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21669; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13401-4; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Ma X, 2019, MITOCHONDRIAL DNA B, V4, P1030, DOI 10.1080/23802359.2019.1584066; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; MASONGAMER RJ, 1995, MOL BIOL EVOL, V12, P371; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Park I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112726; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Ruhlman TA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0484-7; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P141, DOI 10.1093/nar/10.1.141; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wang XQ, 2000, MOL BIOL EVOL, V17, P773, DOI 10.1093/oxfordjournals.molbev.a026356; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu HM, 2020, MITOCHONDRIAL DNA B, V5, P3494, DOI 10.1080/23802359.2020.1825132; Xu LR, 1998, ZYGOPHYLLACEAE, V43; Zhou LH, 2008, ZYGOPHYLLACEAE, V11; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	69	4	4	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263253	10.1371/journal.pone.0263253	http://dx.doi.org/10.1371/journal.pone.0263253			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108324	Green Published, gold			2022-12-26	WOS:000775890100055
J	Pan, YW; Ying, ZX; Nobis, MP; Hersperger, AM; Shi, C; Ge, G				Pan, Yi-Wen; Ying, Zhi-Xia; Nobis, Michael P.; Hersperger, Anna M.; Shi, Chen; Ge, Gang			Effect of soil spatial configuration on Trifolium repens varies with resource amount	PLOS ONE			English	Article							NUTRIENT AVAILABILITY; CLONAL INTEGRATION; MORPHOLOGICAL PLASTICITY; ROOT PROLIFERATION; HETEROGENEITY; PLANT; RESPONSES; PLACEMENT; BENEFITS; SCALE	Soil spatial heterogeneity involves nutrients being patchily distributed at a range of scales and is prevalent in natural habitats. However, little is known about the effect of soil spatial configurations at the small scale on plant foraging behavior and plant growth under different resource amounts. Here, we experimentally investigated how a stoloniferous species, Trifolium repens, responded to varied resource amounts and spatial configuration combinations. Plant foraging behavior (i.e., the orientation of the primary stolon, mean length of the primary stolon, foraging precision, and foraging scale) and plant growth (i.e., total biomass, root biomass, shoot biomass, and root/shoot) were compared among differently designed configurations of soil resources in different amounts. The relationships of foraging behavior and plant biomass were analyzed. The results showed that the effect of the spatial configuration of soil resources on Trifolium repens depended on the resource amount. Specifically, when the total resource amount was low, fragmented soil patches promoted root foraging and increased Trifolium repens plant biomass; however, when the total resource amount was high, the soil spatial configuration did not affect foraging behavior or plant growth. Our results also showed that plant growth was facilitated by root foraging scale to adapt to low resource amounts. We conclude that the spatial configuration of soil resources at small scales affects whole plant growth, which is mediated by a distinct foraging strategy. These findings contribute to a better understanding of how the growth strategy of clonal plants responds to heterogeneous environments caused by different resource amounts and its spatial configurations.	[Pan, Yi-Wen; Ge, Gang] Nanchang Univ, Sch Environm & Chem Engn, Key Lab Poyang Lake Environm & Resource Utilizat, Minist Educ, Nanchang, Jiangxi, Peoples R China; [Pan, Yi-Wen; Nobis, Michael P.; Hersperger, Anna M.] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Ying, Zhi-Xia; Shi, Chen; Ge, Gang] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China	Nanchang University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Nanchang University	Ge, G (corresponding author), Nanchang Univ, Sch Environm & Chem Engn, Key Lab Poyang Lake Environm & Resource Utilizat, Minist Educ, Nanchang, Jiangxi, Peoples R China.; Ge, G (corresponding author), Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China.	gge@ncu.edu.cn		Nobis, Michael/0000-0003-3285-1590	National Natural Science Foundation of China [31860120]; Innovation fund project for graduate students of Nanchang University [CX2019008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation fund project for graduate students of Nanchang University	This work was supported by the National Natural Science Foundation of China [grant number: 31860120] and by an Innovation fund project for graduate students of Nanchang University [grant number: CX2019008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer SG, 2004, OECOLOGIA, V139, P617, DOI 10.1007/s00442-004-1541-3; Bao GZ, 2020, FUNCT PLANT BIOL, V47, P50, DOI 10.1071/FP19072; Bittebiere AK, 2012, AM J BOT, V99, P646, DOI 10.3732/ajb.1100487; Bliss KM, 2002, NEW PHYTOL, V154, P409, DOI 10.1046/j.1469-8137.2002.00389.x; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Cai LP, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02738-0; CAMPBELL BD, 1991, OECOLOGIA, V87, P532, DOI 10.1007/BF00320417; Chen D, 2019, SCI TOTAL ENVIRON, V657, P1568, DOI 10.1016/j.scitotenv.2018.12.099; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; de Kroon H, 2012, J ECOL, V100, P6, DOI 10.1111/j.1365-2745.2011.01906.x; Dong BC, 2015, J PLANT ECOL, V8, P91, DOI 10.1093/jpe/rtu003; Douds DD, 2008, COMPOST SCI UTIL, V16, P52; Einsmann JC, 1999, J ECOL, V87, P609, DOI 10.1046/j.1365-2745.1999.00376.x; Fransen B, 2001, J ECOL, V89, P711, DOI 10.1046/j.0022-0477.2001.00589.x; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Giehl RFH, 2014, PLANT PHYSIOL, V166, P509, DOI 10.1104/pp.114.245225; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Huang QQ, 2018, SCI TOTAL ENVIRON, V643, P1232, DOI 10.1016/j.scitotenv.2018.06.294; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Jafari M, 2019, CELL J, V20, P604, DOI 10.22074/cellj.2019.5992; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; Kume T, 2006, ANN BOT-LONDON, V98, P1271, DOI 10.1093/aob/mcl216; Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242; Liang JF, 2020, OECOLOGIA, V193, P155, DOI 10.1007/s00442-020-04660-6; Liu YJ, 2017, PLANT SOIL, V421, P353, DOI 10.1007/s11104-017-3472-x; Liu YJ, 2017, ECOL RES, V32, P287, DOI 10.1007/s11284-017-1435-6; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; Maestre FT, 2007, ECOLOGY, V88, P501, DOI 10.1890/06-0421; Maestre FT, 2005, NEW PHYTOL, V168, P637, DOI 10.1111/j.1469-8137.2005.01547.x; Mommer L, 2011, PLANT SOIL, V344, P347, DOI 10.1007/s11104-011-0752-8; Qian YQ, 2014, J PLANT GROWTH REGUL, V33, P214, DOI 10.1007/s00344-013-9365-1; Rajaniemi TK, 2004, OECOLOGIA, V141, P519, DOI 10.1007/s00442-004-1666-4; RCore Team, 2020, R LANG ENV STAT COMP; Sammul M, 2011, FOLIA GEOBOT, V46, P137, DOI 10.1007/s12224-010-9097-y; SLADE AJ, 1987, J ECOL, V75, P95, DOI 10.2307/2260538; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Varin S, 2009, PLANT SOIL, V317, P189, DOI 10.1007/s11104-008-9800-4; Wang MZ., 2021, J PLANT ECOL; Wang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00753; Wang ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058602; Weijschede J, 2006, NEW PHYTOL, V172, P655, DOI 10.1111/j.1469-8137.2006.01885.x; Welham CVJ, 2002, OECOLOGIA, V130, P231, DOI 10.1007/s004420100791; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; Wijesinghe DK, 2001, J ECOL, V89, P972, DOI 10.1111/j.1365-2745.2001.00618.x; Xie XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107114	46	0	0	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0263290	10.1371/journal.pone.0263290	http://dx.doi.org/10.1371/journal.pone.0263290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100326	gold, Green Published			2022-12-26	WOS:000801937600042
J	Gobert, GN; McManus, DP; McMullan, G; Creevey, CJ; Carson, J; Jones, MK; Nawaratna, SSK; Weerakoon, KG; You, H				Gobert, Geoffrey N.; McManus, Donald P.; McMullan, Geoff; Creevey, Christopher J.; Carson, Jack; Jones, Malcolm K.; Nawaratna, Sujeevi S. K.; Weerakoon, Kosala G.; You, Hong			Adult schistosomes have an epithelial bacterial population distinct from the surrounding mammalian host blood	PLOS ONE			English	Article							TEGUMENT SURFACE-MEMBRANES; PROTEOMIC ANALYSIS; GUT MICROBIOTA; MANSONI; INFECTION; PROTEINS	Background Schistosomiasis is a neglected tropical parasitic and chronic disease affecting hundreds of millions of people. Adult schistosomes reside in the blood stream of the definitive mammalian host. These helminth parasites possess two epithelial surfaces, the tegument and the gastrodermis, both of which interact with the host during immune evasion and in nutrient uptake. Methods Female ARC Swiss mice (4-6 weeks old) were infected percutaneously with Schistosoma japonicum cercariae freshly shed from Oncomelania hupensis quadrasi snails (Philippines strain). Fluorescent in situ hybridisation (FISH) was performed by using fresh adult S. japonicum perfused from those infected mice. Adult S. japonicum worms were processed to isolate the tegument from the carcass containing the gastrodermis; blood and bile were collected individually from infected and uninfected mice. Total DNA extracted from all those samples were used for microbiome profiling. Results FISH and microbiome profiling showed the presence of bacterial populations on two epithelial surfaces of adult worms, suggesting they were distinct not only from the host blood but also from each other. Whereas microbial diversity was reduced overall in the parasite epithelial tissues when compared with that of host blood, specific bacterial taxa, including Anoxybacillus and Escherichia, were elevated on the tegument. Minimal differences were evident in the microbiome of host blood during an active infection, compared with that of control uninfected blood. However, sampling of bile from infected animals identified some differences compared with controls, including elevated levels of Limnohabitans, Clostridium and Curvibacter. Conclusions Using FISH and microbial profiling, we were able to demonstrate, for the first time, that bacteria are presented on the epithelial surfaces of adult schistosomes. These schistosome surface-associated bacteria, which are distinct from the host blood microenvironment, should be considered as a new and important component of the host-schistosome interaction. The importance of individual bacterial species in relation to schistosome parasitism needs further elucidation.	[Gobert, Geoffrey N.; McMullan, Geoff; Creevey, Christopher J.; Carson, Jack] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [McManus, Donald P.; Nawaratna, Sujeevi S. K.; Weerakoon, Kosala G.; You, Hong] QIMR Berghofer Med Res Inst, Immunol Dept, Mol Parasitol Lab, Brisbane, Qld, Australia; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Nawaratna, Sujeevi S. K.] Griffith Univ, Sch Med, Gold Coast, Australia; [Weerakoon, Kosala G.] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Parasitol, Saliyapura, Sri Lanka	Queens University Belfast; QIMR Berghofer Medical Research Institute; University of Queensland; Griffith University; Rajarata University of Sri Lanka	Gobert, GN (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.; You, H (corresponding author), QIMR Berghofer Med Res Inst, Immunol Dept, Mol Parasitol Lab, Brisbane, Qld, Australia.	g.gobert@qub.ac.uk; hong.you@qimrberghofer.edu.au	Creevey, Christopher James/A-1836-2013; You, Hong/AAB-4649-2020; Jones, Malcolm K/A-1097-2009	Creevey, Christopher James/0000-0001-7183-1555; You, Hong/0000-0002-8790-7793; Jones, Malcolm K/0000-0002-0035-6141; Gobert, Geoffrey/0000-0001-5884-6453; McManus, Donald/0000-0001-6443-1449	National Health and Medical Research Council (NHMRC) of Australia [ID613671, APP1037304, APP1098244]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The financial support from the National Health and Medical Research Council (NHMRC) of Australia (Grant numbers: ID613671; APP1037304; APP1098244) is acknowledged. The funding body had no input into the design, analysis, or interpretation of data and in writing the manuscript.	Abruzzi A, 2011, ADV PARASIT, V77, P1, DOI 10.1016/B978-0-12-391429-3.00005-8; Barnhill AE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-123; Braschi S, 2006, PROTEOMICS, V6, P1471, DOI 10.1002/pmic.200500368; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000686; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carson JP, 2018, TRENDS PARASITOL, V34, P524, DOI 10.1016/j.pt.2018.02.005; Christensen H, 1999, APPL ENVIRON MICROB, V65, P1753; Chuah C, 2016, INT J PARASITOL, V46, P239, DOI 10.1016/j.ijpara.2015.12.004; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dheilly NM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00050-17; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Figueiredo BCP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00022; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Floudas A, 2019, INFECT IMMUN, V87, DOI [10.1128/IAI.00275-19, 10.1128/iai.00275-19]; Gentile ME, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007045; Gobert GN, 2003, INT J PARASITOL, V33, P1561, DOI 10.1016/S0020-7519(03)00255-8; Gordon CA, 2020, INT J PARASITOL, V50, P217, DOI 10.1016/j.ijpara.2019.12.008; Gordon CA, 2016, ADV PARASIT, V91, P311, DOI 10.1016/bs.apar.2015.12.002; HOCKLEY D J, 1973, International Journal for Parasitology, V3, P13, DOI 10.1016/0020-7519(73)90004-0; Hu Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.569727; Itthitaetrakool U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165798; Jenkins TP, 2019, TRENDS PARASITOL, V35, P13, DOI 10.1016/j.pt.2018.10.007; Jenkins TP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33937-3; Jenkins TP, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-30412-x, 10.1038/s41598-018-33937-3]; Jiang YY, 2021, PARASITE, V28, DOI 10.1051/parasite/2020074; Jimenez E, 2014, MICROBIOLOGYOPEN, V3, P937, DOI 10.1002/mbo3.218; Jones MK, 2004, BIOESSAYS, V26, P752, DOI 10.1002/bies.20058; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Lesaffer G, 2003, NEPHROL DIAL TRANSPL, V18, P1299, DOI 10.1093/ndt/gfg107; Li JV, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-179; Lim JH, 2007, AM J ROENTGENOL, V188, P1596, DOI 10.2214/AJR.06.1172; Long T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040045; Majrashi SA, 2018, SAUDI MED J, V39, P725, DOI 10.15537/smj.2018.7.22018; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McLaren DJ., 1980, SCHISTOSOMA MANSONI, P229; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; MELHEM RF, 1984, INFECT IMMUN, V44, P274, DOI 10.1128/IAI.44.2.274-281.1984; Molinero N, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0712-8; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; Nawaratna SSK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15069; Nawaratna SSK, 2014, MOL BIOCHEM PARASIT, V196, P82, DOI 10.1016/j.molbiopara.2014.08.002; Nawaratna SSK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001043; Neves LX, 2020, J PROTEOME RES, V19, P314, DOI 10.1021/acs.jproteome.9b00531; Paisse S, 2016, TRANSFUSION, V56, P1138, DOI 10.1111/trf.13477; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Pearson MS, 2020, METHODS MOL BIOL, V2151, P85, DOI 10.1007/978-1-0716-0635-3_8; Posteraro P, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0325-6; Reddick LE, 2014, MOL CELL, V54, P321, DOI 10.1016/j.molcel.2014.03.010; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; ROBERTS SM, 1983, MOL BIOCHEM PARASIT, V9, P105, DOI 10.1016/0166-6851(83)90104-4; Saltykova IV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004809; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Sotillo J, 2015, INT J PARASITOL, V45, P505, DOI 10.1016/j.ijpara.2015.03.004; Sripa B, 2018, ADV PARASIT, V102, P73, DOI 10.1016/bs.apar.2018.08.003; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wang QH, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0629-2; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; White EC, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap7399; Whittle E, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03266; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao L, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2524-7; Zhao YQ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00352; Zhu XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00992-1	71	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0263188	10.1371/journal.pone.0263188	http://dx.doi.org/10.1371/journal.pone.0263188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085360	Green Published, gold			2022-12-26	WOS:000779379600127
J	Belanger, C; Cardinal, T; Leduc, E; Viger, RS; Pilon, N				Belanger, Catherine; Cardinal, Tatiana; Leduc, Elizabeth; Viger, Robert S.; Pilon, Nicolas			CHARGE syndrome-associated proteins FAM172A and CHD7 influence male sex determination and differentiation through transcriptional and alternative splicing mechanisms	FASEB JOURNAL			English	Article						alternative splicing; CHARGE syndrome; CHD7; FAM172A; Sex reversal; transcription	EPIGENETIC REGULATION; GENE-EXPRESSION; SERTOLI-CELLS; MOUSE; MUTATIONS; GATA4; PROLIFERATION; PROMOTER; BINDING; TARGET	To gain further insight into chromatin-mediated regulation of mammalian sex determination, we analyzed the role of the CHARGE syndrome-associated proteins FAM172A and CHD7. This study is based on our prior discoveries that a subset of corresponding mutant mice display complete male-to-female sex reversal, and that both of these proteins regulate co-transcriptional alternative splicing in neural crest cells. Here, we report that FAM172A and CHD7 are present in the developing gonads when sex determination normally occurs in mice. The interactome of FAM172A in pre-Sertoli cells again suggests a role at the chromatin-spliceosome interface, like in neural crest cells. Accordingly, analysis of Fam172a-mutant pre-Sertoli cells revealed transcriptional and splicing dysregulation of hundreds of genes. Many of these genes are similarly affected in Chd7-mutant pre-Sertoli cells, including several known key regulators of sex determination and subsequent formation of testis cords. Among them, we notably identified Sry as a direct transcriptional target and WNT pathway-associated Lef1 and Tcf7l2 as direct splicing targets. The identified molecular defects are also associated with the abnormal morphology of seminiferous tubules in mutant postnatal testes. Altogether, our results thus identify FAM172A and CHD7 as new players in the regulation of male sex determination and differentiation in mice, and further highlight the importance of chromatin-mediated regulatory mechanisms in these processes.	[Belanger, Catherine; Cardinal, Tatiana; Leduc, Elizabeth; Pilon, Nicolas] Univ Quebec Montreal UQAM, Dept Sci Biol, Mol Genet Dev Lab, Montreal, PQ, Canada; [Belanger, Catherine; Cardinal, Tatiana; Leduc, Elizabeth; Pilon, Nicolas] Univ Quebec Montreal, Fdn Courtois CERMO FC, Ctr Excellence Rech Sur Malad Orphelines, Montreal, PQ, Canada; [Viger, Robert S.] Univ Laval, CHU Quebec, Ctr Rech, Ctr Rech Reprod Dev & Sante Intergenerat CRDSI,Re, Quebec City, PQ, Canada; [Viger, Robert S.] Univ Laval, Fac Med, Dept Obstet Gynecol & Reprod, Quebec City, PQ, Canada; [Pilon, Nicolas] Univ Montreal, Dept Pediat, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; Laval University; Laval University; Universite de Montreal	Pilon, N (corresponding author), Univ Quebec Montreal, Dept Sci Biol, Fdn Courtois, 141 Ave President Kennedy, Montreal, PQ H2X 3Y7, Canada.; Pilon, N (corresponding author), Univ Quebec Montreal, Ctr Excellence Rech Malad Orphelines, Fdn Courtois, 141 Ave President Kennedy, Montreal, PQ H2X 3Y7, Canada.	pilon.nicolas@uqam.ca			Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [PJT-152933]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT-152933	Anderzen-Carlsson A, 2015, J PEDIATR NURS, V30, P6, DOI 10.1016/j.pedn.2014.09.008; Bagheri-Fam S, 2017, ENDOCRINOLOGY, V158, P3832, DOI 10.1210/en.2017-00674; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Balasubramanian R, 2017, AM J MED GENET C, V175, P507, DOI 10.1002/ajmg.c.31585; Bao LS, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0627-7; Batsukh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052640; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Belanger C, 2018, P NATL ACAD SCI USA, V115, pE620, DOI 10.1073/pnas.1715378115; Bergman JEH, 2008, EUR J MED GENET, V51, P417, DOI 10.1016/j.ejmg.2008.03.003; Bergman JEH, 2010, EUR J HUM GENET, V18, P171, DOI 10.1038/ejhg.2009.158; Berube-Simard FA, 2019, TRANSCR-AUSTIN, V10, P21, DOI 10.1080/21541264.2018.1521213; Capel B, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.60; Cardinal T, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009008; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Chen SR, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137117; Chen SR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105379; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; Deveson IW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700731; Domingos JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204182; Feng WJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14758; Garcia-Moreno SA, 2018, MOL CELL ENDOCRINOL, V468, P19, DOI 10.1016/j.mce.2018.01.009; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Husu E, 2013, CLIN GENET, V83, P125, DOI 10.1111/j.1399-0004.2012.01884.x; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kasah S, 2018, J ANAT, V233, P755, DOI 10.1111/joa.12889; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kuroki S, 2018, MOL CELL ENDOCRINOL, V468, P31, DOI 10.1016/j.mce.2017.12.006; Kuroki S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007034; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Miyawaki S, 2020, SCIENCE, V370, P121, DOI 10.1126/science.abb6430; Pierucci-Alves F, 2001, BIOL REPROD, V65, P1392, DOI 10.1095/biolreprod65.5.1392; Pilon N, 2003, BIOL REPROD, V68, P1098, DOI 10.1095/biolreprod.102.010884; Pilon N, 2008, DEV DYNAM, V237, P1133, DOI 10.1002/dvdy.21496; Planells B, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5572-x; Qiu C, 2019, J MOL CELL BIOL, V11, P170, DOI 10.1093/jmcb/mjy029; Ragan DC, 1999, J UROLOGY, V161, P622, DOI 10.1016/S0022-5347(01)61984-0; Rahmoun M, 2017, NUCLEIC ACIDS RES, V45, P7191, DOI 10.1093/nar/gkx328; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Sab AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029038; Sanchez-Ferras O, 2014, BBA-GENE REGUL MECH, V1839, P546, DOI 10.1016/j.bbagrm.2014.04.023; Schmahl J, 2000, DEVELOPMENT, V127, P65; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Shoji Yasuko, 2014, Clin Pediatr Endocrinol, V23, P45, DOI 10.1297/cpe.23.45; Soret R, 2015, J CLIN INVEST, V125, P4483, DOI 10.1172/JCI83178; Stevant I, 2019, TRENDS GENET, V35, P346, DOI 10.1016/j.tig.2019.02.004; Stromland K, 2005, AM J MED GENET A, V133A, P331, DOI 10.1002/ajmg.a.30563; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Viger RS, 1998, DEVELOPMENT, V125, P2665; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Young RM, 2019, ELIFE, V8, DOI 10.7554/eLife.51447; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265; Zhao L, 2018, MOL CELL ENDOCRINOL, V478, P84, DOI 10.1016/j.mce.2018.07.010; Zheng ZZ, 2019, RNA BIOL, V16, P809, DOI 10.1080/15476286.2019.1590177	64	0	0	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22176	10.1096/fj.202100837RR	http://dx.doi.org/10.1096/fj.202100837RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129866	hybrid, Green Published			2022-12-26	WOS:000761250800039
J	Jin, M; Zhang, HM; Wu, MX; Wang, Z; Chen, XF; Guo, MY; Zhou, RN; Yang, H; Qian, JM				Jin, Meng; Zhang, Huimin; Wu, Meixu; Wang, Zheng; Chen, Xuanfu; Guo, Mingyue; Zhou, Runing; Yang, Hong; Qian, Jiaming			Colonic interleukin-22 protects intestinal mucosal barrier and microbiota abundance in severe acute pancreatitis	FASEB JOURNAL			English	Article						acute pancreatitis; CD177; colonic injury; interleukin-22; intestinal barrier dysfunction; microbiota	DEFINITIONS; INNATE; MICE	Intestinal barrier dysfunction plays a critical role in the pathophysiology of many diseases including severe acute pancreatitis (SAP). Interleukin-22 (IL-22) is a critical regulator of intestinal epithelial homeostasis. However, the mechanism, origin site, and characteristics of IL-22 in the intestinal barrier dysfunction remains elusive. Studies were conducted in patients with SAP and SAP mice model. SAP mice model was induced by intraductal infusion of 5% taurocholic acid. The level and source of IL-22 were analyzed by flow cytometry. The effect of IL-22 in SAP-associated intestinal injury were examined through knockout of IL-22 (IL-22(-/-)) or administration of recombinant IL-22 (rIL-22). IL-22 increased in the early phase of SAP but declined more quickly than that of proinflammatory cytokines, such as IL-6 and TNF-alpha. CD177(+) neutrophils contributed to IL-22 expression in SAP. IL-22 was activated in the colon rather than the small intestine during SAP. Deletion of IL-22 worse the severity of colonic injury, whereas administration of rIL-22 reduced colonic injury. Mechanistically, IL-22 ameliorates the intestinal barrier dysfunction in SAP through decreasing colonic mucosal permeability, upregulation of E-cadherin and ZO-1 expression, activation of pSTAT3/Reg3 pathway and restoration of fecal microbiota abundance. This study revealing that early decreased colonic IL-22 aggravates intestinal mucosal barrier dysfunction and microbiota dysbiosis in SAP. Colonic IL-22 is likely a promising treating target in the early phase of SAP management. Research in context Evidence before this study Intestinal barrier dysfunction plays a critical role in the pathophysiology of severe acute pancreatitis (SAP). Interleukin-22 (IL-22) is a critical regulator of intestinal epithelial homeostasis. However, the mechanism, origin site and characteristics of IL-22 in the intestinal barrier dysfunction remains elusive. Added value of this study Firstly, we determined the dynamic expression profile of IL-22 in SAP and found that IL-22 was mostly activated in the pancreas and colon and decreased earlier than proinflammatory cytokines. CD177(+) neutrophils contributed to IL-22 expression in SAP. Furthermore, we found that IL-22 ameliorates intestinal barrier dysfunction in SAP through decreasing colonic mucosal permeability, upregulation of E-cadherin and ZO-1 expression, activation of pSTAT3/Reg3 pathway and restoration of fecal microbiota abundance. Implications of all the available evidence This study highlights the role of colonic injury and colonic IL-22 in SAP. IL-22 is likely a promising treating target in the early phase of SAP management.	[Jin, Meng; Zhang, Huimin; Wu, Meixu; Wang, Zheng; Chen, Xuanfu; Guo, Mingyue; Zhou, Runing; Yang, Hong; Qian, Jiaming] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gastroenterol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Yang, H; Qian, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gastroenterol, Beijing 100730, Peoples R China.	YangH@pumch.cn; qianjiaming1957@126.com	Zhang, Hui/HHN-8494-2022		Health Research and Special Projects Grant of China [201002020, 201502005]; National Natural Science Funding [81570505]; Beijing Natural Science Funding [7202161]; 2010 National Clinical Specialty Projects; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-12M-3-001]; Zhejiang Provincial Natural Science Foundation [LQ21H030008]	Health Research and Special Projects Grant of China; National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Funding; 2010 National Clinical Specialty Projects; CAMS Innovation Fund for Medical Sciences (CIFMS); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by the Health Research and Special Projects Grant of China (Nos. 201002020, No.201502005), the National Natural Science Funding (No. 81570505), the Beijing Natural Science Funding (No. 7202161), the 2010 National Clinical Specialty Projects and the CAMS Innovation Fund for Medical Sciences (CIFMS, 2016--12M--3--001), and the Zhejiang Provincial Natural Science Foundation (LQ21H030008).	Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Blaser AR, 2012, INTENS CARE MED, V38, P384, DOI 10.1007/s00134-011-2459-y; Cen ME, 2018, APOPTOSIS, V23, P377, DOI 10.1007/s10495-018-1464-9; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Garg PK, 2019, GASTROENTEROLOGY, V156, P2008, DOI 10.1053/j.gastro.2018.12.041; Geng H, 2018, GASTROENTEROLOGY, V155, P144, DOI 10.1053/j.gastro.2018.03.058; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Habtezion A, 2019, GASTROENTEROLOGY, V156, P1941, DOI 10.1053/j.gastro.2018.11.082; Hwang S, 2020, HEPATOLOGY, V72, P412, DOI 10.1002/hep.31031; Ji YF, 2017, QUANT IMAG MED SURG, V7, P641, DOI 10.21037/qims.2017.12.03; Lanfranca MP, 2020, GASTROENTEROLOGY, V158, P1417, DOI 10.1053/j.gastro.2019.12.010; Li XY, 2020, WORLD J GASTROENTERO, V26, P2187, DOI 10.3748/wjg.v26.i18.2187; Merilainen S, 2013, ULTRASTRUCT PATHOL, V37, P127, DOI 10.3109/01913123.2012.745638; Miranda-Aquino T, 2016, REV GASTROENTEROL ME, V81, P230, DOI 10.1016/j.rgmx.2015.09.003; Mizoguchi A, 2018, J GASTROENTEROL, V53, P465, DOI 10.1007/s00535-017-1401-7; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Powell N, 2020, GUT, V69, P578, DOI 10.1136/gutjnl-2019-318483; Sun JK, 2013, SURG TODAY, V43, P506, DOI 10.1007/s00595-013-0496-6; van Baal MC, 2014, PANCREATOLOGY, V14, P470, DOI 10.1016/j.pan.2014.10.002; Xuan XY, 2018, PANCREATOLOGY, V18, P231, DOI 10.1016/j.pan.2018.02.014; Xue J, 2012, GASTROENTEROLOGY, V143, P1670, DOI 10.1053/j.gastro.2012.08.051; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhou GX, 2018, GUT, V67, P1052, DOI 10.1136/gutjnl-2016-313535	24	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22174	10.1096/fj.202101371R	http://dx.doi.org/10.1096/fj.202101371R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35137988				2022-12-26	WOS:000761250800033
J	Xia, YJ; Wu, QY; Mak, SH; Liu, EYL; Zheng, BZY; Dong, TTX; Pi, RB; Tsim, KWK				Xia, Yingjie; Wu, Qiyun; Mak, Shinghung; Liu, Etta Y. L.; Zheng, Brody Z. Y.; Dong, Tina T. X.; Pi, Rongbiao; Tsim, Karl W. K.			Regulation of acetylcholinesterase during the lipopolysaccharide-induced inflammatory responses in microglial cells	FASEB JOURNAL			English	Article						acetylcholinesterase; Alzheimer disease; CAP; microglia; neuroinflammation	RICH-MEMBRANE-ANCHOR; NF-KAPPA-B; ALZHEIMERS-DISEASE; NICOTINIC RECEPTOR; INDUCED NEUROINFLAMMATION; CHOLINERGIC SYSTEM; GENE-EXPRESSION; TNF-ALPHA; PROTEIN; ACTIVATION	The non-classical function of acetylcholine (ACh) has been reported in neuroinflammation that represents the modulating factor in immune responses via activation of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR), i.e., a cholinergic anti-inflammatory pathway (CAP). Acetylcholinesterase (AChE), an enzyme for ACh hydrolysis, has been proposed to have a non-classical function in immune cells. However, the involvement of AChE in neuroinflammation is unclear. Here, cultured BV2 cell, a microglial cell line, and primary microglia from rats were treated with lipopolysaccharide (LPS) to induce inflammation and to explore the regulation of AChE during this process. The expression profiles of AChE, alpha 7 nAChR, and choline acetyltransferase (ChAT) were revealed in BV2 cells. The expression of AChE (G4 form) was induced significantly in LPS-treated BV2 cells: the induction was triggered by NF-kappa B and cAMP signaling. Moreover, ACh or alpha 7 nAChR agonist suppressed the LPS-induced production of pro-inflammatory cytokines, as well as the phagocytosis of microglia, by activating alpha 7 nAChR and followed by the regulation of NF-kappa B and CREB signaling. The ACh-induced suppression of inflammation was abolished in AChE overexpressed cells, but did not show a significant change in AChE mutant (enzymatic activity knockout) transfected cells. These results indicate that the neuroinflammation-regulated function of AChE may be mediated by controlling the ACh level in the brain system.	[Xia, Yingjie; Wu, Qiyun; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Shenzhen Key Lab Edible & Med Bioresources, SRI, Shenzhen, Peoples R China; [Xia, Yingjie; Wu, Qiyun; Mak, Shinghung; Liu, Etta Y. L.; Zheng, Brody Z. Y.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Div Life Sci, Hong Kong, Peoples R China; [Pi, Rongbiao] Sun Yat Sen Univ, Sch Med, Guangzhou, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Sun Yat Sen University	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Key Lab Edible & Med Bioresources, SRI, Shenzhen, Peoples R China.	botsim@ust.hk			Shenzhen Science and Technology Committee Research Grant [JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174, CKFW20160829 16015476]; China Post-doctoral Science Foundation [2019M653087]; Zhongshan Municipal Bureau of Science and Technology [ZSST20SC03]; Guangzhou Science and Technology Committee Research Grant [GZSTI16SC02, GZSTI17SC02]; Hong Kong RGC [T13-607/12R, 16100921]; Hong Kong Innovation Technology Fund [UIM/340, UIM/385, ITS/500/18FP, TCPD/17e9]; Health and Medical Research Fund of Hong Kong [HMRF18SC06, COVID190213]	Shenzhen Science and Technology Committee Research Grant; China Post-doctoral Science Foundation(China Postdoctoral Science Foundation); Zhongshan Municipal Bureau of Science and Technology; Guangzhou Science and Technology Committee Research Grant; Hong Kong RGC(Hong Kong Research Grants Council); Hong Kong Innovation Technology Fund; Health and Medical Research Fund of Hong Kong	Shenzhen Science and Technology Committee Research Grant, Grant/Award Number: JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174 and CKFW20160829 16015476; China Post--doctoral Science Foundation, Grant/Award Number: 2019M653087; Zhongshan Municipal Bureau of Science and Technology, Grant/Award Number: ZSST20SC03; Guangzhou Science and Technology Committee Research Grant, Grant/Award Number: GZSTI16SC02 and GZSTI17SC02; Hong Kong RGC, Grant/Award Number: T13--607/12R and 16100921; Hong Kong Innovation Technology Fund, Grant/Award Number: UIM/340, UIM/385, ITS/500/18FP and TCPD/17e9; Health and Medical Research Fund of Hong Kong, Grant/Award Number: HMRF18SC06 and COVID190213	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; BENAZIZALOYA R, 1993, P NATL ACAD SCI USA, V90, P2471, DOI 10.1073/pnas.90.6.2471; Bond CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004846; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broide RS, 1996, J NEUROSCI, V16, P2956; Burghaus L, 2000, MOL BRAIN RES, V76, P385; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Chaubourt E., 1998, Journal of Physiology Paris, V92, P420, DOI 10.1016/S0928-4257(99)80032-1; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Choi RCY, 2000, NEUROREPORT, V11, P801, DOI 10.1097/00001756-200003200-00029; Choi RCY, 2001, MOL CELL NEUROSCI, V17, P732, DOI 10.1006/mcne.2001.0968; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598; Das UN, 2007, MED SCI MONITOR, V13, pRA214; De Miranda BR, 2015, MOL PHARMACOL, V87, P1021, DOI 10.1124/mol.114.095398; DELAPORTE S, 1993, J NEUROL SCI, V117, P92, DOI 10.1016/0022-510X(93)90160-Z; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Fujii T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01085; Gnatek Y, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00066; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; Greenfield SA, 2004, J NEUROCHEM, V90, P325, DOI 10.1111/j.1471-4159.2004.02494.x; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hows MEP, 2002, J NEUROSCI METH, V121, P33, DOI 10.1016/S0165-0270(02)00228-5; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hwang J, 2010, NEUROPHARMACOLOGY, V58, P1122, DOI 10.1016/j.neuropharm.2010.02.003; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; Kawashima K, 2003, LIFE SCI, V72, P2101, DOI 10.1016/S0024-3205(03)00068-7; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; King JR, 2017, FEBS OPEN BIO, V7, P1350, DOI 10.1002/2211-5463.12270; Li JM, 2020, EXP EYE RES, V195, DOI 10.1016/j.exer.2020.108003; Li M, 2016, INFLAMMATION, V39, P1681, DOI 10.1007/s10753-016-0402-7; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lian H, 2016, BIOPROTOC, V6, P21; Licastro F, 2000, J NEUROIMMUNOL, V103, P97, DOI 10.1016/S0165-5728(99)00226-X; Liu EYL, 2020, ACTA PHARMACOL SIN B, V10, P1926, DOI 10.1016/j.apsb.2020.05.005; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Reale M, 2004, J NEUROIMMUNOL, V148, P162, DOI 10.1016/j.jneuroim.2003.11.003; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Slevin M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02124; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; Uutela P, 2005, RAPID COMMUN MASS SP, V19, P2950, DOI 10.1002/rcm.2160; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; von Bernhardi R, 2003, NEUROBIOL DIS, V14, P447, DOI 10.1016/j.nbd.2003.08.014; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu QY, 2020, FASEB J, V34, P8941, DOI 10.1096/fj.202000708R; Wu YJ, 2021, INFLAMMATION, V44, P821, DOI 10.1007/s10753-020-01396-6; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065; Xue XD, 2017, ADV SCI, V4, DOI 10.1002/advs.201700229; Yamada M, 2018, CURR OPIN PHARMACOL, V40, P18, DOI 10.1016/j.coph.2017.12.003; Yao NW, 2017, EXP THER MED, V13, P2193, DOI 10.3892/etm.2017.4271; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Zhang QC, 2017, AM J TRANSL RES, V9, P971	73	5	5	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22189	10.1096/fj.202101302RR	http://dx.doi.org/10.1096/fj.202101302RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35129858				2022-12-26	WOS:000761250800028
J	Engelstad, P; Jarnevich, CS; Hogan, T; Sofaer, HR; Pearse, IS; Sieracki, JL; Frakes, N; Sullivan, J; Young, NE; Prevey, JS; Belamaric, P; LaRoe, J				Engelstad, Peder; Jarnevich, Catherine S.; Hogan, Terri; Sofaer, Helen R.; Pearse, Ian S.; Sieracki, Jennifer L.; Frakes, Neil; Sullivan, Julia; Young, Nicholas E.; Prevey, Janet S.; Belamaric, Pairsa; LaRoe, Jillian			INHABIT: A web-based decision support tool for invasive plant species habitat visualization and assessment across the contiguous United States	PLOS ONE			English	Article							DISTRIBUTIONS; POLICY; MODELS	Narrowing the communication and knowledge gap between producers and users of scientific data is a longstanding problem in ecological conservation and land management. Decision support tools (DSTs), including websites or interactive web applications, provide platforms that can help bridge this gap. DSTs can most effectively disseminate and translate research results when producers and users collaboratively and iteratively design content and features. One data resource seldom incorporated into DSTs are species distribution models (SDMs), which can produce spatial predictions of habitat suitability. Outputs from SDMs can inform management decisions, but their complexity and inaccessibility can limit their use by resource managers or policy makers. To overcome these limitations, we present the Invasive Species Habitat Tool (INHABIT), a novel, web-based DST built with R Shiny to display spatial predictions and tabular summaries of habitat suitability from SDMs for invasive plants across the contiguous United States. INHABIT provides actionable science to support the prevention and management of invasive species. Two case studies demonstrate the important role of end user feedback in confirming INHABIT's credibility, utility, and relevance.	[Engelstad, Peder; Young, Nicholas E.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Jarnevich, Catherine S.; Sofaer, Helen R.; Pearse, Ian S.; Sullivan, Julia; Prevey, Janet S.; Belamaric, Pairsa; LaRoe, Jillian] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Hogan, Terri; Sieracki, Jennifer L.] Natl Pk Serv, Ft Collins, CO USA; [Frakes, Neil] Natl Pk Serv, Joshua Tree Natl Pk, Twentynine Palms, CA USA; [Sofaer, Helen R.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, Hilo, HI USA; [Frakes, Neil] Bur Land Management, Ely, NV USA; [Belamaric, Pairsa] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Engelstad, P (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	peder.engelstad@colostate.edu		Engelstad, Peder/0000-0002-3681-9216	U.S. Geological Survey Invasive Species Program; U.S. Geological Survey Core Science Systems (CSS): Science Analytics and Synthesis; U.S. Fish and Wildlife Service	U.S. Geological Survey Invasive Species Program(United States Geological Survey); U.S. Geological Survey Core Science Systems (CSS): Science Analytics and Synthesis; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this project was provided by the U.S. Geological Survey Invasive Species Program (https://www.usgs.gov/ecosystems/invasive-species-program), the U.S. Geological Survey Core Science Systems (CSS): Science Analytics and Synthesis (https://www.usgs.gov/core-science-systems/science-analytics-andsynthesis/about), and the U.S. Fish and Wildlife Service (http://www.fws.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariotakis M, 2019, SCI TOTAL ENVIRON, V694, DOI 10.1016/j.scitotenv.2019.133681; Chang W., 2019, R package version 1.4.0; Cook G, 2019, FORESTS, V10, DOI 10.3390/f10020108; Crall AW, 2013, ECOL APPL, V23, P60, DOI 10.1890/12-0465.1; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Diez E, 2011, ENVIRON MODELL SOFTW, V26, P317, DOI 10.1016/j.envsoft.2010.04.003; EDDMapS, 2021, EARL DET DISTR MAPP; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Enquist CAF, 2017, FRONT ECOL ENVIRON, V15, P541, DOI 10.1002/fee.1733; Feng X, 2017, TROP CONSERV SCI, V10, DOI 10.1177/1940082917724133; GBIF.org, 2022, GLOBAL BIODIVERSITY, DOI [10.15468/dl.mhw3mk, DOI 10.15468/DL.UNJ8U6]; Gibson FL, 2017, ENVIRON SCI POLICY, V70, P1, DOI 10.1016/j.envsci.2017.01.002; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Harrity EJ, 2020, BIOL CONSERV, V250, DOI 10.1016/j.biocon.2020.108734; Jarnevich CS., 2021, INHABIT SPECIES POTE, DOI [10.1371/journal.pone.0256633, DOI 10.1371/JOURNAL.PONE.0256633]; Jarvis DH, 2017, AGRICULTURE-BASEL, V7, DOI 10.3390/agriculture7080069; Kass JM, 2018, METHODS ECOL EVOL, V9, P1151, DOI 10.1111/2041-210X.12945; McHenry J, 2019, GLOBAL CHANGE BIOL, V25, P4208, DOI 10.1111/gcb.14828; Morisette JT, 2017, SOC NATUR RESOUR, V30, P1158, DOI 10.1080/08941920.2017.1290178; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Rose D., 2017, RES IDEAS OUTCOMES, V3, DOI [10.3897/rio.3.e21074, DOI 10.3897/RIO.3.E21074]; Sofaer HR, 2019, BIOSCIENCE, V69, P544, DOI 10.1093/biosci/biz045; Sofaer HR, 2019, METHODS ECOL EVOL, V10, P565, DOI 10.1111/2041-210X.13140; Stewart A, 2014, SCAND J FOREST RES, V29, P144, DOI 10.1080/02827581.2013.849358; Valle D, 2019, CONSERV BIOL, V33, P1448, DOI 10.1111/cobi.13305; van Kerkhoff L, 2006, ANNU REV ENV RESOUR, V31, P445, DOI 10.1146/annurev.energy.31.102405.170850; Wszola LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188244; Young NE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229253	28	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0263056	10.1371/journal.pone.0263056	http://dx.doi.org/10.1371/journal.pone.0263056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134065	gold, Green Published			2022-12-26	WOS:000798968600008
J	Myojin, S; Pak, K; Sako, M; Kobayashi, T; Takahashi, T; Sunagawa, T; Tsuboi, N; Ishikura, K; Kubota, M; Kubota, M; Igarashi, T; Morioka, I; Miyairi, I				Myojin, Shota; Pak, Kyongsun; Sako, Mayumi; Kobayashi, Tohru; Takahashi, Takuri; Sunagawa, Tomimasa; Tsuboi, Norihiko; Ishikura, Kenji; Kubota, Masaya; Kubota, Mitsuru; Igarashi, Takashi; Morioka, Ichiro; Miyairi, Isao			Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study	PLOS ONE			English	Article							FOSFOMYCIN TREATMENT; O157 INFECTIONS; CHILDREN; MANAGEMENT; EPIDEMIOLOGY; PREVENTION; GUIDELINES; OUTBREAK	Background The role of antibiotics in the treatment of Shiga toxin-producing Escherichia coli (STEC) infection is controversial. Objectives To evaluate the association between treatment (antibiotics, antidiarrheal agents, and probiotics) for STEC infection and hemolytic uremic syndrome (HUS) development. Patients and methods We performed a population-based matched case-control study using the data from the National Epidemiological Surveillance of Infectious Diseases (NESID) between January 1, 2017 and December 31, 2018. We identified all patients with STEC infection and HUS as cases and matched patients with STEC infection without HUS as controls, with a case-control a ratio of 1:5. Further medical information was obtained by a standardized questionnaire. Multivariable conditional logistic regression model was used. Results 7760 patients with STEC infection were registered in the NESID. 182 patients with HUS and 910 matched controls without HUS were selected. 90 patients with HUS (68 children and 22 adults) and 371 patients without HUS (266 children and 105 adults) were included in the main analysis. The matched ORs of any antibiotics and fosfomycin for HUS in children were 0.56 (95% CI 0.32-0.98), 0.58 (0.34-1.01). The matched ORs for HUS were 2.07 (1.07-4.03), 0.86 (0.46-1.61) in all ages treated with antidiarrheal agent and probiotics. Conclusions Antibiotics, especially fosfomycin, may prevent the development of HUS in children, while use of antidiarrheal agents should be avoided.	[Myojin, Shota; Miyairi, Isao] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Infect Dis, Tokyo, Japan; [Myojin, Shota; Morioka, Ichiro] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Pak, Kyongsun] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Dept Data Sci, Biostat Unit, Tokyo, Japan; [Sako, Mayumi] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Dept Clin Res Promot, Tokyo, Japan; [Kobayashi, Tohru] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Dept Data Sci, Tokyo, Japan; [Takahashi, Takuri; Sunagawa, Tomimasa] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Tsuboi, Norihiko] Natl Ctr Child Hlth & Dev, Dept Crit Care & Anesthesia, Div Crit Care Med, Tokyo, Japan; [Ishikura, Kenji] Kitasato Univ, Sch Med, Dept Pediat, Sagamihara, Kanagawa, Japan; [Kubota, Masaya] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Neurol, Tokyo, Japan; [Kubota, Mitsuru] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Tokyo, Japan; [Igarashi, Takashi] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Miyairi, Isao] Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan	National Center for Child Health & Development - Japan; Nihon University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Institute of Infectious Diseases (NIID); National Center for Child Health & Development - Japan; Kitasato University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Hamamatsu University School of Medicine	Miyairi, I (corresponding author), Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Infect Dis, Tokyo, Japan.; Miyairi, I (corresponding author), Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan.	miyairi@hama-med.ac.jp		Kubota, Masaya/0000-0002-8299-4867	Ministry of Health, Labour and Welfare, Japan [H30-Shinko-00]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant from the Ministry of Health, Labour and Welfare, Japan (H30-Shinko-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e12; Byrne L, 2014, J MED MICROBIOL, V63, P1181, DOI 10.1099/jmm.0.075895-0; CIMOLAI N, 1994, CLIN NEPHROL, V42, P85; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; Freedman SB, 2018, NEW ENGL J MED, V379, P2015, DOI [10.1056/NEJMoa1802597, 10.1056/nejmoa1802597]; Freedman SB, 2016, CLIN INFECT DIS, V62, P1251, DOI 10.1093/cid/ciw099; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; Giordano M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091649; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Igarashi T, 2014, CLIN EXP NEPHROL, V18, P525, DOI 10.1007/s10157-014-0995-9; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Infectious Disease Surveillance Center National Institute of Infectious Diseases, 2018, INFECT AGENTS SURVEI, V39, P82; Infectious Disease Surveillance Center National Institute of Infectious Diseases, 2019, INFECT AGENTS SURVEI, V40, P82; Joseph A, 2020, TOXINS, V12, DOI 10.3390/toxins12020067; Kakoullis L, 2019, J INFECTION, V79, P75, DOI 10.1016/j.jinf.2019.05.018; Kimmitt PT, 1999, LANCET, V353, P1588, DOI 10.1016/S0140-6736(99)00621-2; Kita F, 2010, J CLIN PHARM THER, V35, P87, DOI 10.1111/j.1365-2710.2009.01074.x; Launders N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009933; Lynn RM, 2005, EMERG INFECT DIS, V11, P590, DOI 10.3201/eid1104.040833; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; McKee RS, 2020, CLIN INFECT DIS, V70, P1643, DOI 10.1093/cid/ciz432; Okubo Y, 2019, J PEDIATR GASTR NUTR, V68, P13, DOI 10.1097/MPG.0000000000002115; Ong KL, 2012, CLIN INFECT DIS, V54, pS424, DOI 10.1093/cid/cis208; Rivas M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0002-2013; Shiomi M, 1999, PEDIATR INT, V41, P228, DOI 10.1046/j.1442-200X.1999.4121038.x; Smith KE, 2012, PEDIATR INFECT DIS J, V31, P37, DOI 10.1097/INF.0b013e31823096a8; Szajewska H, 2014, J PEDIATR GASTR NUTR, V58, P531, DOI 10.1097/MPG.0000000000000320; Tajiri H, 2015, INT J ANTIMICROB AG, V46, P586, DOI 10.1016/j.ijantimicag.2015.08.006; Takeda T, 1998, JPN J MED SCI BIOL, V51, pS124, DOI 10.7883/yoken1952.51.Supplement1_S124; Tarr GAM, 2018, INT J MED MICROBIOL, V308, P921, DOI 10.1016/j.ijmm.2018.06.009; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Thorpe CM, 2004, CLIN INFECT DIS, V38, P1298, DOI 10.1086/383473; Vally H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-63; WHO Collaborating Centre for Drug Statistics Methodology, INT LANG DRUG UT RES; Williams DM, 2002, ARCH PEDIAT ADOL MED, V156, P893, DOI 10.1001/archpedi.156.9.893; Wong CS, 2012, CLIN INFECT DIS, V55, P33, DOI 10.1093/cid/cis299	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263349	10.1371/journal.pone.0263349	http://dx.doi.org/10.1371/journal.pone.0263349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120154	Green Published, gold			2022-12-26	WOS:000789273600033
J	Shibata, T; Oishi, S; Mizuno, A; Ohmori, T; Okamura, T; Kashiwagi, H; Sakashita, A; Kishi, T; Obara, H; Kakuma, T; Fukumoto, Y				Shibata, Tatsuhiro; Oishi, Shogo; Mizuno, Atsushi; Ohmori, Takashi; Okamura, Tomonao; Kashiwagi, Hideyuki; Sakashita, Akihiro; Kishi, Takuya; Obara, Hitoshi; Kakuma, Tatsuyuki; Fukumoto, Yoshihiro			Evaluation of the effectiveness of the physician education program on primary palliative care in heart failure	PLOS ONE			English	Article							TASK-FORCE; DIFFICULTIES; ASSOCIATION; MANAGEMENT	Major cardiology societies' guidelines support integrating palliative care into heart failure (HF) care. This study aimed to identify the effectiveness of the HEart failure Palliative care Training program for comprehensive care providers (HEPT), a physician education program on primary palliative care in HF. We performed a pre- and post-test survey to evaluate HEPT outcomes. Physician-reported practices, difficulties and knowledge were evaluated using the Palliative Care Self-Reported Practices Scale in HF (PCPS-HF), Palliative Care Difficulties Scale in HF (PCDS-HF), and Palliative care knowledge Test in HF (PT-HF), respectively. Structural equation models (SEM) were used to estimate path coefficients for PCPS-HF, PCDS-HF, and PT-HF. A total of 207 physicians participated in the HEPT between February 2018 and July 2019, and 148 questionnaires were ultimately analyzed. The total PCPS-HF, PCDS-HF, and PT-HF scores were significantly improved 6 months after HEPT completion (61.1 vs 67.7, p<0.001, 54.9 vs 45.1, p<0.001, and 20.8 vs 25.7, p<0.001, respectively). SEM analysis showed that for pre-post difference (Dif) PCPS-HF, "clinical experience of more than 14 years" and pre-test score had significant negative effects (-2.31, p = 0.048, 0.52, p<0.001, respectively). For Dif PCDS-HF, >= "28 years old or older" had a significant positive direct effect (13.63, p<0.001), although the pre-test score had a negative direct effect (-0.56, p<0.001). For PT-HF, "involvement in more than 50 HF patients' treatment in the past year" showed a positive direct effect (0.72, p = 0.046), although the pre-test score showed a negative effect (-0.78, p<0.001). Physicians who completed the HEPT showed significant improvements in practice, difficulty, and knowledge scales in HF palliative care.	[Shibata, Tatsuhiro; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka, Japan; [Oishi, Shogo; Sakashita, Akihiro] Himeji Cardiovasc Ctr, Dept Cardiol, Himeji, Hyogo, Japan; [Mizuno, Atsushi] St Lukes Int Hosp, Dept Cardiovasc Med, Tokyo, Japan; [Mizuno, Atsushi] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Mizuno, Atsushi] Univ Penn, Penn Med Nudge Unit, Philadelphia, PA 19104 USA; [Mizuno, Atsushi] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Ohmori, Takashi; Okamura, Tomonao; Kashiwagi, Hideyuki] Iizuka Hosp, Dept Transit & Palliat Care, Fukuoka, Japan; [Sakashita, Akihiro] Kobe Univ, Sch Med, Dept Palliat Med, Kobe, Hyogo, Japan; [Kishi, Takuya] Int Univ Hlth & Welf, Fac Hlth & Welf Sci Fukuoka, Fukuoka, Japan; [Obara, Hitoshi; Kakuma, Tatsuyuki] Kurume Univ, Sch Med, Biostat Ctr, Kurume, Fukuoka, Japan	Kurume University; St. Luke's International Hospital; Juntendo University; University of Pennsylvania; University of Pennsylvania; Kobe University; International University of Health & Welfare; Kurume University	Fukumoto, Y (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Fukuoka, Japan.	fukumoto_yoshihiro@med.kurume-u.ac.jp		Ohmori, Takashi/0000-0002-9446-6498	Sasakawa Health Foundation; Cardiovascular Research Fund; AMED, Japan [JP18ek0210072]	Sasakawa Health Foundation; Cardiovascular Research Fund; AMED, Japan	This research was supported by grants from the Sasakawa Health Foundation (T.S.), the Cardiovascular Research Fund (T.S.), and AMED under Grant Number JP18ek0210072 (A.M.), Japan. The funders had no role in study design, data collection, and analysis, decision to publish, and preparation of the manuscript.	Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Brannstrom M, 2014, EUR J HEART FAIL, V16, P1142, DOI 10.1002/ejhf.151; Braun LT, 2016, CIRCULATION, V134, pE198, DOI 10.1161/CIR.0000000000000438; Crousillat DR, 2018, J AM COLL CARDIOL, V71, P1391, DOI 10.1016/j.jacc.2018.02.019; Goodlin SJ, 2009, J AM COLL CARDIOL, V54, P386, DOI 10.1016/j.jacc.2009.02.078; Hamatani Y, 2020, CIRC J, V84, P584, DOI 10.1253/circj.CJ-19-0225; Ioroi T, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115621313; Jessup M, 2015, J AM COLL CARDIOL, V65, P1866, DOI 10.1016/j.jacc.2015.03.031; Kavalieratos D, 2017, J AM COLL CARDIOL, V70, P1919, DOI 10.1016/j.jacc.2017.08.036; Kuragaichi T, 2018, CIRC J, V82, P1336, DOI 10.1253/circj.CJ-17-1305; Mizuno A, 2020, J CARDIOL, V76, P177, DOI 10.1016/j.jjcc.2020.02.010; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Munoz-Mendoza J, 2015, J AM COLL CARDIOL, V65, P750, DOI 10.1016/j.jacc.2014.12.030; Nakazawa Y, 2018, CANCER-AM CANCER SOC, V124, P626, DOI 10.1002/cncr.31071; Nakazawa Y, 2010, J PALLIAT MED, V13, P427, DOI 10.1089/jpm.2009.0289; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rogers JG, 2017, J AM COLL CARDIOL, V70, P332, DOI 10.1016/j.jacc.2017.05.030; Schenker Y, 2015, JAMA-J AM MED ASSOC, V314, P1565, DOI 10.1001/jama.2015.11217; Sidebottom AC, 2015, J PALLIAT MED, V18, P134, DOI 10.1089/jpm.2014.0192; Tsutsui H, 2019, CIRC J, V83, P2084, DOI 10.1253/circj.CJ-19-0342; Wong FKY, 2016, HEART, V102, P1100, DOI 10.1136/heartjnl-2015-308638; Yamamoto R, 2015, J PALLIAT MED, V18, P45, DOI 10.1089/jpm.2014.0122; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0263523	10.1371/journal.pone.0263523	http://dx.doi.org/10.1371/journal.pone.0263523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120191	Green Published, gold			2022-12-26	WOS:000789273600050
J	Sivapalan, P; Borresen, SW; Eklof, J; Klose, M; Holm, FS; Feldt-Rasmussen, U; Rossing, M; Jorgensen, NR; Marvig, RL; Saeed, MI; Wilcke, T; Seersholm, N; Mathioudakis, AG; Vestbo, J; Jensen, JUS				Sivapalan, Pradeesh; Borresen, Stina Willemoes; Ekloef, Josefin; Klose, Marianne; Holm, Freja S.; Feldt-Rasmussen, Ulla; Rossing, Maria; Jorgensen, Niklas R.; Marvig, Rasmus L.; Saeed, Mohamad Isam; Wilcke, Torgny; Seersholm, Niels; Mathioudakis, Alexander G.; Vestbo, Jorgen; Jensen, Jens-Ulrik Staehr			Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; GENETIC ASSOCIATIONS; BCLI POLYMORPHISM; IN-VIVO; SENSITIVITY; ASTHMA; EXPRESSION; BETA	Background Single-nucleotide polymorphisms (SNPs) of the glucocorticoid receptor (GR) gene NR3C1 have been associated with an altered sensitivity to glucocorticoids, and thus may alter the therapeutic effects of glucocorticoids. We investigated the prevalence of adrenal suppression after treatment with glucocorticoids and evaluated whether GR SNPs were associated with altered risks of adrenal suppression and metabolic disorders in patients with chronic obstructive pulmonary disease (COPD). Methods In an observational prospective cohort study, we recruited 78 patients with severe COPD receiving 5 days glucocorticoid treatment for an exacerbation of COPD. In total, 55% of these patients were also receiving regular inhaled corticosteroids (ICS). Adrenal function was evaluated with a corticotropin test 30 days after the exacerbation. Patients were genotyped for Bcl1, N363S, ER22/23EK, and 9 beta SNPs. Results The prevalence of adrenal suppression (corticotropin-stimulated plasma-cortisol <= 420 nmol/L) 30 days after glucocorticoid treatment was 4/78 (5%). There was no difference between carriers and non-carriers of the polymorphisms (Bcl1, 9 beta, ER22/23K, and N363S) in corticotropin stimulated plasma-cortisol concentrations. In the haplotype analyses, we included the 50 patients who had a high-sensitivity (76%), a low-sensitivity (4%), or a wild-type (20%) GR haplotype. There was no difference in the frequency of adrenal suppression or metabolic disorders between the two stratified groups: (a) high-sensitivity (Bcl1 and/or N363S) haplotypes vs. (b) low-sensitivity (9 beta and/or ER22/23K) plus wild-type haplotypes (p > 0.05). Carriers of the high-sensitivity GR gene haplotype exhibited a steeper decline in stimulated P-cortisol with increased ICS dose (slope, -1.35 vs. 0.94; p = 0.17), compared to the group with low-sensitivity or wild-type haplotypes, respectively. Conclusions In total, 5% of patients exhibited insufficient adrenal function. The Bcl1 and N363S polymorphisms did not seem to increase the risk of glucocorticoid suppression or metabolic disorders in adults treated with glucocorticoids for COPD exacerbations.	[Sivapalan, Pradeesh; Ekloef, Josefin; Holm, Freja S.; Saeed, Mohamad Isam; Wilcke, Torgny; Seersholm, Niels; Jensen, Jens-Ulrik Staehr] Univ Copenhagen, Herlev & Gentofte Hosp, Sect Resp Med, Dept Med, Hellerup, Denmark; [Sivapalan, Pradeesh] Univ Copenhagen, Zealand Hosp, Dept Internal Med, Roskilde, Denmark; [Borresen, Stina Willemoes; Klose, Marianne; Feldt-Rasmussen, Ulla] Copenhagen Univ Hosp, Dept Med Endocrinol & Metab, Rigshosp, Copenhagen, Denmark; [Feldt-Rasmussen, Ulla; Jorgensen, Niklas R.; Jensen, Jens-Ulrik Staehr] Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark; [Rossing, Maria; Marvig, Rasmus L.] Copenhagen Univ Hosp, Ctr Genom Med, Rigshosp, Copenhagen, Denmark; [Jorgensen, Niklas R.] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark; [Mathioudakis, Alexander G.; Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Mathioudakis, Alexander G.; Vestbo, Jorgen] Manchester Univ NHS Fdn Trust, North West Lung Ctr, Manchester, Lancs, England	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Manchester	Sivapalan, P (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Sect Resp Med, Dept Med, Hellerup, Denmark.; Sivapalan, P (corresponding author), Univ Copenhagen, Zealand Hosp, Dept Internal Med, Roskilde, Denmark.	pradeesh.sivapalan.02@regionh.dk	Mathioudakis, Alexander G./I-2733-2019	Mathioudakis, Alexander G./0000-0002-4675-9616; Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Jensen, Jens Ulrik/0000-0003-4036-0521; Hassager, Freja Staehr/0000-0002-3390-6111; Saeed, Mohamad Isam/0000-0002-9246-7630; Marvig, Rasmus L./0000-0002-5267-3173	Danish Regions Medical Fund [5894/16]; Danish Council for Independent Research [6110-00268B]; Herlev-Gentofte University hospital; HerlevGentofte Hospital; Novo Nordisk Fund; Skibsreder Per Henriksen, R. & Hustru's Foundation; Eva Madura's Foundation; Research Foundation of Copenhagen University Hospital, Rigshospitalet; National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC)	Danish Regions Medical Fund; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Herlev-Gentofte University hospital; HerlevGentofte Hospital; Novo Nordisk Fund(Novo Nordisk); Skibsreder Per Henriksen, R. & Hustru's Foundation; Eva Madura's Foundation; Research Foundation of Copenhagen University Hospital, Rigshospitalet; National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR))	This study was funded by the Danish Regions Medical Fund (5894/16), the Danish Council for Independent Research (6110-00268B) and Herlev-Gentofte University hospital. The research salary of PS was sponsored by HerlevGentofte Hospital. The research salary of UFR was sponsored by an unrestricted research grant from the Novo Nordisk Fund. The research salary of SWB was sponsored by Skibsreder Per Henriksen, R. & Hustru's Foundation; Eva Madura's Foundation; and The Research Foundation of Copenhagen University Hospital, Rigshospitalet. Alexander G. Mathioudakis and Jorgen Vestbo are supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Borresen SW, 2020, RHEUMATOLOGY, V59, P2764, DOI 10.1093/rheumatology/keaa011; Borresen SW., 2020, J ENDOCR SOC, V4, DOI [10.1210/jendso/bvaa046.585, DOI 10.1210/JENDSO/BVAA046.585]; Dinsen S, 2013, EUR J INTERN MED, V24, P714, DOI 10.1016/j.ejim.2013.05.014; Eurofins, EUR GEN EUR GEN; Geelen CC, 2013, J CLIN ENDOCR METAB, V98, pE595, DOI 10.1210/jc.2012-3442; Giordano R, 2012, CLIN ENDOCRINOL, V77, P863, DOI 10.1111/j.1365-2265.2012.04439.x; Gjerstad JK, 2018, STRESS, V21, P403, DOI 10.1080/10253890.2018.1470238; Hamid QA, 1999, AM J RESP CRIT CARE, V159, P1600, DOI 10.1164/ajrccm.159.5.9804131; Hawcutt DB, 2018, LANCET RESP MED, V6, P442, DOI 10.1016/S2213-2600(18)30058-4; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Jewell CM, 2016, AM J PHYSIOL-ENDOC M, V311, pE741, DOI 10.1152/ajpendo.00105.2016; Keskin O, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-018-0239-2; Keskin O, 2016, PEDIAT ALLERG IMM-UK, V27, P507, DOI 10.1111/pai.12566; Klose M., 2016, END ABSTR, V3947, DOI [10.1530/endoabs.41.EP22, DOI 10.1530/ENDOABS.41.EP22]; Klose M, 2007, J CLIN ENDOCR METAB, V92, P1326, DOI 10.1210/jc.2006-1791; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Manenschijn L, 2009, ANN NY ACAD SCI, V1179, P179, DOI 10.1111/j.1749-6632.2009.05013.x; McCormack Mark, 2011, N Engl J Med, V364, P1134, DOI 10.1056/NEJMoa1013297; McEvoy CE, 1998, AM J RESP CRIT CARE, V157, P704, DOI 10.1164/ajrccm.157.3.9703080; Nicolaides NC, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-71; Quax RAM, 2015, RHEUMATOL INT, V35, P1325, DOI 10.1007/s00296-015-3235-z; Rosmond Roland, 2008, J Cardiometab Syndr, V3, P132, DOI 10.1111/j.1559-4572.2008.00008.x; Schuetz P, 2015, EUR J ENDOCRINOL, V173, P19, DOI 10.1530/EJE-15-0182; Schwabe K, 2009, EUR J MED RES, V14, P210, DOI 10.1186/2047-783X-14-S4-210; Singh D., 2019, EUR RESPIR J EUR RESPIR J; Sivapalan P, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000407; Sousa AR, 2000, J ALLERGY CLIN IMMUN, V105, P943, DOI 10.1067/mai.2000.106486; van Oosten MJM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3118; van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; Walters JAE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub4	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2022	17	2							e0262898	10.1371/journal.pone.0262898	http://dx.doi.org/10.1371/journal.pone.0262898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0W8MA	35120172	Green Published, gold			2022-12-26	WOS:000789273600015
J	Damalas, D; Stamouli, C; Fotiadis, N; Kikeri, M; Kousteni, V; Mantopoulou-Palouka, D				Damalas, Dimitrios; Stamouli, Caterina; Fotiadis, Nikolaos; Kikeri, Maria; Kousteni, Vasiliki; Mantopoulou-Palouka, Danai			The Gyaros island marine reserve: A biodiversity hotspot in the eastern Mediterranean Sea	PLOS ONE			English	Article							PROTECTED AREA; MPA	Since July 2019, Gyaros island in the central Aegean Sea, enjoys the status of a partial Marine Protected Area (MPA), allowing for exploitation by small-scale fishers following specific spatio-temporal restrictions. The need for assessing the effectiveness of the MPA in the future, led MAVA Foundation to fund a knowledge survey project aiming to serve as a baseline for future reference. A series of experimental fishing surveys took place with static nets, the outcomes of which are presented herein. From June 2018 to September 2020, a series of 8 fishing excursions with a total of 40 experimental fishing sets with bottom static nets were realized in 5 set locations around Gyaros island, inside the MPA protection zone. A total of 75 species were identified; the most abundant species, in terms of biomass, being: parrotfish-Sparisoma cretense, red scorpionfish-Scorpaena scrofa, common spiny lobster-Palinurus elephas, red porgy-Pagrus pagrus, little tunny--Euthynnus alletteratus, Mediterranean moray-Muraena helena, lesser spotted dogfish -Scyliorhinus canicula, forkbeard-Phycis phycis, surmullet-Mullus surmuletus, common cuttlefish-Sepia officinalis and common Pandora-Pagellus erythrinus. A comparison with similar data in adjacent areas outside the MPA allowed for assessing the effectiveness of the MPA based on four indicators: species diversity index, species relative biomass index, key predator species abundance, and alien fish abundance. Based solely on the experimental fishing trials, the MPA seems to be functioning, since both species diversity and abundance were higher within the protected area. However, its performance may still not be considered as optimal, as this is indicated by the large proportion of undersized key predators (e.g. groupers), although more abundant and larger than the ones residing outside the MPA.	[Damalas, Dimitrios] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Iraklion, Greece; [Stamouli, Caterina; Fotiadis, Nikolaos; Kikeri, Maria; Mantopoulou-Palouka, Danai] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Athens, Greece; [Kousteni, Vasiliki] Hellen Agr Org Demeter, Fisheries Res Inst, Kavala, Greece	Hellenic Centre for Marine Research; Hellenic Centre for Marine Research	Damalas, D (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Iraklion, Greece.	shark@hcmr.gr	Kousteni, Vasiliki/AAM-5351-2020	Kousteni, Vasiliki/0000-0003-3455-5357	MAVA Foundation under the specific grant "Gyaros MPA fisheries knowledge survey: assessing a pristine Mediterranean biodiversity hotspot" [17114]	MAVA Foundation under the specific grant "Gyaros MPA fisheries knowledge survey: assessing a pristine Mediterranean biodiversity hotspot"	This study was funded by the MAVA Foundation under the specific grant "Gyaros MPA fisheries knowledge survey: assessing a pristine Mediterranean biodiversity hotspot" (Grant Agreement 17114). https://mava-foundation.org/NO:	Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Boubekri I, 2016, OCEAN COAST MANAGE, V130, P277, DOI 10.1016/j.ocecoaman.2016.06.021; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 1994, CHANGE MARINE COMMUN; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; CYCLADES Life, LIFE12NATGR000688 CY; Dendrinos P., 2020, DELIVERABLE ACTION A, DOI [10.3390/e22121388, DOI 10.3390/E22121388]; Dimarchopoulou D., 2018, FISHERIES STOCKS FLE; Dimitriadis C, 2018, ESTUAR COAST SHELF S, V207, P223, DOI 10.1016/j.ecss.2018.04.012; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Giakoumi S, 2019, ECOL APPL, V29, DOI 10.1002/eap.1809; Goni R., 2011, MARINE PROTECTED ARE, P73; Gorley C.K., 2006, GETTING STARTED PRIM; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Guidetti P, 2010, FISH RES, V101, P180, DOI 10.1016/j.fishres.2009.10.006; Hastie T.J., 1990, GEN ADDITIVE MODELS; Karamanlidis AA, 2013, 20 BIENN C BIOL MAR, P9; Kavadas S, 2013, MEDITERR MAR SCI, V14, P109, DOI 10.12681/mms.324; Kleitou P, 2021, AQUAT CONSERV, V31, P2870, DOI 10.1002/aqc.3669; Mavruk S, 2018, MAR POLICY, V87, P141, DOI 10.1016/j.marpol.2017.10.018; Mom/Dendrinos P, 2018, LIFE12NATGR000688; Olsen EM, 2013, 18 EUR MAR BOARD; Partnership for Interdisciplinary Studies of Coastal Oceans and University of Nice Sophia Antipolis, 2016, SCI MAR PROT AR, V3rd; R Core Team, 2020, R LANG ENV STAT COMP; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Shannon CE, 1997, M D COMPUT, V14, P306; Sini M, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00599; Tonioli FC, 2011, NOAA TECHNICAL MEMOR, P69; Tzanatos E., 2015, LIFE CYCLADESLIFE; Unal V, 2019, FROM CATASTROPHE TO RECOVERY: STORIES OF FISHERY MANAGEMENT SUCCESS, P509; Vassilopoulou V., 2007, P251; WARWICK RM, 1986, MAR BIOL, V92, P557, DOI 10.1007/BF00392515; Hackradt CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098206; Wood S. N., 2006, GEN ADDITIVE MODELS, DOI [DOI 10.1201/9781420010404, 10.1201/9781420010404]; WWF, 2021, FIN REP SEC GYAR MPA; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	38	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262943	10.1371/journal.pone.0262943	http://dx.doi.org/10.1371/journal.pone.0262943			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113916	Green Published, gold			2022-12-26	WOS:000823694700044
J	Weinrich, JM; Lenz, A; Schon, G; Behzadi, C; Molwitz, I; Henes, FO; Schoennagel, BP; Adam, G; von Kodolitsch, Y; Bannas, P				Weinrich, Julius Matthias; Lenz, Alexander; Schoen, Gerhard; Behzadi, Cyrus; Molwitz, Isabel; Henes, Frank Oliver; Schoennagel, Bjoern Philip; Adam, Gerhard; von Kodolitsch, Yskert; Bannas, Peter			Magnetic resonance angiography derived predictors of progressive dilatation and surgery of the aortic root in Marfan syndrome	PLOS ONE			English	Article							SIZE; AGE; COMPLICATIONS; DIMENSIONS; STIFFNESS; DILATION; CHILDREN; DISEASE; GROWTH; 3D	Background To identify magnetic resonance (MR) angiography derived predictors of progressive dilatation and surgery of the aortic root in Marfan syndrome. Material and methods We retrospectively included 111 patients (32.7 +/- 16.5 years, range: 7-75 years) with a total of 446 MR angiographies. Aortic diameter growth rates of the entire thoracic aorta and Zscores were estimated from annual diameter measurements. Aortic root shape was subdivided into three different types: (T0) normal; (T1) localized dilatation; (T2) generalized aortic root dilatation. Aortic diameter, Z-score, age, and aortic root shape at baseline were tested as predictors of aortic root dilatation using a multivariate logistic regression model. Results The highest aortic growth rate was observed at the level of the sinuses of Valsalva. Higher aortic root diameters and Z-scores at baseline predicted an increased growth of the aortic root (p = 0.003 and p<0.001). Young age (<30 years) was a predictor for the increase of Z-scores when compared to patients >= 30 years (p = 0.019). 25/111 patients (22.5%) had a T0 aortic root shape, 59/111 patients (53.2%) had a T1 aortic root shape, and 27/111 patients (24.3%) had a T2 aortic root shape. Aortic root shape did not predict further aortic growth (p>0.05). However, significantly more patients undergoing surgery had a generalized aortic dilatation (19/28, 76.9%) than a localized aortic root dilatation (9/28, 32.1%) (p = 0.001). Conclusion Larger baseline aortic root diameter and Z-score as well as young age predict solely progressive aortic root dilatation in Marfan patients. MR angiography derived type of aortic root shape does not predict aortic growth, but patients with generalized aortic root dilatation are referred more frequently for aortic surgery.	[Weinrich, Julius Matthias; Lenz, Alexander; Behzadi, Cyrus; Molwitz, Isabel; Henes, Frank Oliver; Schoennagel, Bjoern Philip; Adam, Gerhard; Bannas, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany; [Schoen, Gerhard] Univ Hosp Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [von Kodolitsch, Yskert] Univ Hosp Hamburg Eppendorf, Univ Heart Ctr Hamburg, Dept Cardiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Weinrich, JM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.	j.weinrich@uke.de	Molwitz, Isabel/AHE-7872-2022	Molwitz, Isabel/0000-0003-4542-0140; Weinrich, Julius/0000-0002-5119-6563				Aburawi EH, 2007, EUR HEART J, V28, P376, DOI 10.1093/eurheartj/ehl457; Bannas P, 2013, INT J CARDIOL, V167, P190, DOI 10.1016/j.ijcard.2011.12.041; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Curtis Alexander E, 2016, Aorta (Stamford), V4, P124, DOI 10.12945/j.aorta.2016.16.014; den Hartog AW, 2013, RADIOLOGY, V269, P369, DOI 10.1148/radiol.13122310; Devereux RB, 2012, AM J CARDIOL, V110, P1189, DOI 10.1016/j.amjcard.2012.05.063; Elkinany S, 2021, AM J CARDIOL, V143, P145, DOI 10.1016/j.amjcard.2020.12.025; Groenink M, 1998, HEART, V80, P163, DOI 10.1136/hrt.80.2.163; Groenink M, 1999, HEART, V82, P499, DOI 10.1136/hrt.82.4.499; Groenink M, 1998, AM J CARDIOL, V82, P203, DOI 10.1016/S0002-9149(98)00315-4; Groth M, 2012, EUR J RADIOL, V81, P762, DOI 10.1016/j.ejrad.2011.01.071; Guala A, 2019, EUR HEART J, V40, P2047, DOI 10.1093/eurheartj/ehz191; Hanneman K, 2016, RADIOGRAPHICS, V36, P19, DOI 10.1148/rg.2016150053; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Holloway B J, 2011, Br J Radiol, V84 Spec No 3, pS338, DOI 10.1259/bjr/30655825; Hoskoppal A, 2018, PEDIATR CARDIOL, V39, P1453, DOI 10.1007/s00246-018-1916-6; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kaiser T, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-56; Khosla S, 2014, BRIT J SURG, V101, P1350, DOI 10.1002/bjs.9578; Kornbluth M, 1999, AM J CARDIOL, V84, P753, DOI 10.1016/S0002-9149(99)00430-0; Lazarevic AM, 2006, INT J CARDIOL, V106, P177, DOI 10.1016/j.ijcard.2005.01.040; Legget ME, 1996, HEART, V75, P389, DOI 10.1136/hrt.75.4.389; Lenz A, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00608-0; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Meijboom LJ, 2000, INT J CARDIAC IMAG, V16, P161, DOI 10.1023/A:1006429603062; Mendoza DD, 2011, ANN THORAC SURG, V92, P904, DOI 10.1016/j.athoracsur.2011.03.130; MURDOCH JL, 1972, NEW ENGL J MED, V286, P804, DOI 10.1056/NEJM197204132861502; Nollen GJ, 2004, EUR HEART J, V25, P1146, DOI 10.1016/j.ehj.2004.04.033; Prakash A, 2015, CIRCULATION, V132, P595, DOI 10.1161/CIRCULATIONAHA.114.014934; ROMAN MJ, 1993, J AM COLL CARDIOL, V22, P1470, DOI 10.1016/0735-1097(93)90559-J; ROMAN MJ, 1987, ANN INTERN MED, V106, P800, DOI 10.7326/0003-4819-106-6-800; Schoenhoff FS, 2019, J THORAC CARDIOV SUR, V157, P2150, DOI 10.1016/j.jtcvs.2018.10.089; Schoenhoff FS, 2017, ANN CARDIOTHORAC SUR, V6, P662, DOI 10.21037/acs.2017.09.14; Sheikhzadeh S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0203-8; Teixido-Tura G, 2014, INT J CARDIOL, V171, P56, DOI 10.1016/j.ijcard.2013.11.044; van Karnebeek CDM, 2001, ARCH DIS CHILD, V84, P129, DOI 10.1136/adc.84.2.129; Veldhoen S, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0394-y; Veldhoen S, 2015, EUR RADIOL, V25, P872, DOI 10.1007/s00330-014-3457-6; VETTER U, 1990, EUR J PEDIATR, V149, P452, DOI 10.1007/BF01959393; von Knobelsdorff-Brenkenhoff F, 2014, EUR HEART J-CARD IMG, V15, P651, DOI 10.1093/ehjci/jet263; von Kodolitsch Y, 2016, J MULTIDISCIP HEALTH, V9, P587, DOI 10.2147/JMDH.S93680; Von Kodolitsch Y, 2015, APPL CLIN GENET, V8, P137, DOI 10.2147/TACG.S60472; Weinrich JM, 2020, ROFO-FORTSCHR RONTG, V192, P50, DOI 10.1055/a-0914-3321; Whitlock MC, 2015, JACC-CARDIOVASC IMAG, V8, P1094, DOI 10.1016/j.jcmg.2015.08.001	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2022	17	2							e0262826	10.1371/journal.pone.0262826	http://dx.doi.org/10.1371/journal.pone.0262826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2V2QB	35113893	gold, Green Published			2022-12-26	WOS:000823694700039
J	Bilodeau, SM; Schwartz, AWH; Xu, BF; Pauca, VP; Silman, MR				Bilodeau, Stephanie M.; Schwartz, Austin W. H.; Xu, Binfeng; Pauca, V. Paul; Silman, Miles R.			A low-cost, long-term underwater camera trap network coupled with deep residual learning image analysis	PLOS ONE			English	Article							CORAL-REEF FISHES; ACOUSTIC CAMERAS; BIODIVERSITY; SYSTEM; TOOL	Understanding long-term trends in marine ecosystems requires accurate and repeatable counts of fishes and other aquatic organisms on spatial and temporal scales that are difficult or impossible to achieve with diver-based surveys. Long-term, spatially distributed cameras, like those used in terrestrial camera trapping, have not been successfully applied in marine systems due to limitations of the aquatic environment. Here, we develop methodology for a system of low-cost, long-term camera traps (Dispersed Environment Aquatic Cameras), deployable over large spatial scales in remote marine environments. We use machine learning to classify the large volume of images collected by the cameras. We present a case study of these combined techniques' use by addressing fish movement and feeding behavior related to halos, a well-documented benthic pattern in shallow tropical reefscapes. Cameras proved able to function continuously underwater at deployed depths (up to 7 m, with later versions deployed to 40 m) with no maintenance or monitoring for over five months and collected a total of over 100,000 images in time-lapse mode (by 15 minutes) during daylight hours. Our ResNet-50-based deep learning model achieved 92.5% overall accuracy in sorting images with and without fishes, and diver surveys revealed that the camera images accurately represented local fish communities. The cameras and machine learning classification represent the first successful method for broad-scale underwater camera trap deployment, and our case study demonstrates the cameras' potential for addressing questions of marine animal behavior, distributions, and large-scale spatial patterns.	[Bilodeau, Stephanie M.; Schwartz, Austin W. H.; Silman, Miles R.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Bilodeau, Stephanie M.; Schwartz, Austin W. H.; Silman, Miles R.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27109 USA; [Xu, Binfeng; Pauca, V. Paul] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA; [Bilodeau, Stephanie M.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	Wake Forest University; Wake Forest University; Wake Forest University; University System of Georgia; Georgia Institute of Technology	Bilodeau, SM (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.; Bilodeau, SM (corresponding author), Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27109 USA.; Bilodeau, SM (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.	sbilodeau@gatech.edu	Bilodeau, Stephanie M/ABD-9567-2021	Bilodeau, Stephanie M/0000-0002-8818-5534	Wake Forest University Center for Energy, Environment, and Sustainability [2018-007]; Wake Forest University Richter Scholarship; Sullivan Scholarship; Wake Forest University Vecellio Grant	Wake Forest University Center for Energy, Environment, and Sustainability; Wake Forest University Richter Scholarship; Sullivan Scholarship; Wake Forest University Vecellio Grant	This work was supported by grant #2018-007 to MRS and SMB from the Wake Forest University Center for Energy, Environment, and Sustainability (https://cees.wfu.edu), a Wake Forest University Richter Scholarship (https://ureca.wfu.edu), Sullivan Scholarship (https://biology.wfu.edu), and Undergraduate Research Fellowship (https://ureca.wfu.edu/) to AWHS, and a Wake Forest University Vecellio Grant (https://biology.wfu.edu) to SMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2020, ICES J MAR SCI, V77, P2396, DOI 10.1093/icesjms/fsaa169; Aguzzi J, 2015, REV FISH BIOL FISHER, V25, P463, DOI 10.1007/s11160-015-9387-9; Aguzzi J, 2019, ENVIRON SCI TECHNOL, V53, P6616, DOI 10.1021/acs.est.9b00409; Beaudrot L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002357; Bicknell AWJ, 2016, FRONT ECOL ENVIRON, V14, P424, DOI 10.1002/fee.1322; Bilodeau S. M., 2019, THESIS WAKE FOREST U; Bilodeau SM, 2021, LANDSCAPE ECOL, V36, P1605, DOI 10.1007/s10980-021-01239-1; BOHNSACK JA, 1989, B MAR SCI, V44, P631; Boom BJ, 2014, ECOL INFORM, V23, P83, DOI 10.1016/j.ecoinf.2013.10.006; Boski M, 2017, 2017 10TH INTERNATIONAL WORKSHOP ON MULTIDIMENSIONAL (ND) SYSTEMS (NDS); Boussarie G, 2016, RIVER RES APPL, V32, P1392, DOI 10.1002/rra.2984; Brooks Edward J., 2011, Endangered Species Research, V13, P231, DOI 10.3354/esr00331; Burkepile DE, 2013, OIKOS, V122, P306, DOI 10.1111/j.1600-0706.2012.20716.x; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Chabanet P, 2012, J EXP MAR BIOL ECOL, V430, P10, DOI 10.1016/j.jembe.2012.06.024; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Corgnati L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122124; Corgnati L, 2014, 2014 ICPR WORKSHOP ON COMPUTER VISION FOR ANALYSIS OF UNDERWATER IMAGERY (CVAUI 2014), P1, DOI 10.1109/CVAUI.2014.12; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Del-Rio J, 2020, IEEE ACCESS, V8, P33163, DOI 10.1109/ACCESS.2020.2973771; Delauney L, 2009, SPRINGER SER BIOFILM, V4, P119, DOI 10.1007/7142_2008_9; Ditria EM, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00429; Giles JW, 2005, IEEE MILIT COMMUN C, P1700; Hammerschlag N, 2015, ECOLOGY, V96, P2117, DOI 10.1890/14-2113.1; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Howard J., 2018, FASTAI; Jones RE, 2021, FISH RES, V243, DOI 10.1016/j.fishres.2021.106092; Kassambara A, 2019, PIPE FRIENDLY FRAMEW; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; Ko D, 2018, ANAL LURING CHARACTE, V13, P4; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Layman CA, 2013, ECOLOGY, V94, P530, DOI 10.1890/12-0705.1; Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Marini S, 2015, OCEANS 2015 GENOVA, P1; Marini S, 2018, MEASUREMENT, V126, P72, DOI 10.1016/j.measurement.2018.05.035; Marini S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32089-8; Martignac F, 2015, FISH FISH, V16, P486, DOI 10.1111/faf.12071; McCauley DJ, 2016, J EXP MAR BIOL ECOL, V482, P128, DOI 10.1016/j.jembe.2016.04.012; Mccoy JC, 2011, J WILDLIFE MANAGE, V75, P472, DOI 10.1002/jwmg.54; Menard A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038450; Mortazavi H, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/7/074025; Niedballa J, 2016, METHODS ECOL EVOL, V7, P1457, DOI 10.1111/2041-210X.12600; Norouzzadeh MS, 2018, P NATL ACAD SCI USA, V115, pE5716, DOI 10.1073/pnas.1719367115; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Overholtzer KL, 1999, MAR ECOL PROG SER, V177, P177, DOI 10.3354/meps177177; Patil JS, 2007, BIOFOULING, V23, P215, DOI 10.1080/08927010701275598; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; RCore Team, 2020, R LANG ENV STAT COMP; Rinker TW, 2019, qdap: Quantitative discourse analysis package [, DOI 10.5281/ zenodo.11124; Rowcliffe JM, 2017, REMOTE SENS ECOL CON, V3, P107, DOI 10.1002/rse2.65; Rowcliffe JM, 2014, CAMERA TRAPPING: WILDLIFE MANAGEMENT AND RESEARCH, P317; SALE PF, 1984, ECOLOGY, V65, P409, DOI 10.2307/1941404; Sheehan EV, 2020, ENVIRON MONIT ASSESS, V192, DOI 10.1007/s10661-019-7980-4; Siddiqui SA, 2018, ICES J MAR SCI, V75, P374, DOI 10.1093/icesjms/fsx109; Steenweg R, 2017, FRONT ECOL ENVIRON, V15, P26, DOI 10.1002/fee.1448; STODDART D. R., 1962, ATOLL RES BULL, V87, P1; THOMPSON SK, 1994, BIOMETRICS, V50, P712, DOI 10.2307/2532785; Villon S, 2018, ECOL INFORM, V48, P238, DOI 10.1016/j.ecoinf.2018.09.007; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Wilby A, 2016, OCEANS 2016 MTS IEEE, P1; Williams Kresimir, 2014, Methods in Oceanography, V11, P1, DOI 10.1016/j.mio.2015.01.003; Xue YX, 2015, APPL SURF SCI, V357, P60, DOI 10.1016/j.apsusc.2015.08.232; Zuazo A, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20216281; Zurowietz M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207498	69	2	2	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263377	10.1371/journal.pone.0263377	http://dx.doi.org/10.1371/journal.pone.0263377			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108340	Green Submitted, gold, Green Published			2022-12-26	WOS:000775890100064
J	Liu, LM; Fu, QS; Li, TT; Shao, K; Zhu, X; Cong, YZ; Zhao, XY				Liu, Limin; Fu, Qingsong; Li, Tiantian; Shao, Kai; Zhu, Xing; Cong, Yingzi; Zhao, Xiaoyun			Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency	PLOS ONE			English	Article							METABOLISM; RESISTANCE; FIBROSIS; OBESITY; RISK; MICE	The incidence of nonalcoholic fatty liver disease (NAFLD) in postmenopausal women has increased significantly. Estrogen plays a very important role in NAFLD, but whether NAFLD in premenopausal women was caused by estrogen deficiency was unknown. Thus, it is of great clinical significance to explore the mechanism of NAFLD in premenopausal women. Gut microbiota and its metabolites short chain fatty acids (SCFA) have been shown to play important roles in the development of NAFLD. In this study, we investigated the impact of gut microbiota and SCFA in NAFLD patients and mice caused by estrogen deficiency. We showed that premenopause NAFLD patients had much lower estrogen levels. Estrogen deficient mice, due to ovariectomy (OVX), suffered more severe liver steatosis with an elevated body weight, abdominal fat weight, serum triglycerides and deterioration in hepatic steatosis. Altered gut microbiota composition and decreased butyrate content were found in NAFLD patients and in OVX mice. Furthermore, fecal microbiota transplantation (FMT) or supplementing with butyrate alleviated NAFLD in OVX mice. The production of antimicrobial peptides (AMP) Reg3 gamma, beta-defensins and the expression of intestinal epithelial tight junction, including ZO-1 and Occluding-5, were decreased in the OVX mice compared to control mice. Upregulation of PPAR-gamma and VLDLR, downregulation of PPAR-alpha indicated that OVX mice suffered from abnormal lipid metabolism. These data indicate that changes in the gut microbiota and SCFA caused by estrogen reduction, together with a disorder in AMP production and lipid metabolism, promote NAFLD, thus provide SCFAs derived from microbiota as new therapeutic targets for the clinical prevention and treatment of NAFLD.	[Liu, Limin; Fu, Qingsong; Li, Tiantian; Shao, Kai; Zhao, Xiaoyun] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Med Expt Ctr, Qingdao, Peoples R China; [Liu, Limin; Fu, Qingsong; Li, Tiantian; Shao, Kai; Zhao, Xiaoyun] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Qingdao,Key Lab Mitochondrial Med, Qingdao, Peoples R China; [Zhu, Xing] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Pathol, Qingdao, Peoples R China; [Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; Shandong University; Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Fu, QS; Zhao, XY (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Med Expt Ctr, Qingdao, Peoples R China.; Fu, QS; Zhao, XY (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Qingdao,Key Lab Mitochondrial Med, Qingdao, Peoples R China.	18561812532@163.com; llm18561816628@163.com	liu, li/HGC-0900-2022		Key Scientific Research Fund of Qilu Hospital (Qingdao), Shandong University	Key Scientific Research Fund of Qilu Hospital (Qingdao), Shandong University	This work was supported by the Key Scientific Research Fund of Qilu Hospital (Qingdao), Shandong University.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chen D, 2017, FOOD FUNCT, V8, P4619, DOI [10.1039/c7fo01024a, 10.1039/C7FO01024A]; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; Ding YF, 2019, PHARMACOL RES, V141, P521, DOI 10.1016/j.phrs.2019.01.029; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Kapoor E, 2017, MAYO CLIN PROC, V92, P1552, DOI 10.1016/j.mayocp.2017.08.004; Karim M F, 2015, Mymensingh Med J, V24, P873; Kozakowski J, 2017, MENOPAUSE REV, V16, P61, DOI 10.5114/pm.2017.68594; Kreznar JH, 2017, CELL REP, V18, P1739, DOI 10.1016/j.celrep.2017.01.062; Lai CY, 2019, ALIMENT PHARM THER, V49, P354, DOI 10.1111/apt.15116; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; Martinez MN, 2012, J LIPID RES, V53, P379, DOI 10.1194/jlr.M019752; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Michail S, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu002; Pingitore A, 2017, DIABETES OBES METAB, V19, P257, DOI 10.1111/dom.12811; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quigley EM, 2013, EXPERT REV GASTROENT, V7, P723, DOI 10.1586/17474124.2013.848167; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Sharpton SR, 2019, HEPATOL COMMUN, V3, P29, DOI 10.1002/hep4.1284; Sun B, 2018, J AGR FOOD CHEM, V66, P7633, DOI 10.1021/acs.jafc.8b01189; Vyas D, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/932928; Wagner JD, 1998, J CLIN ENDOCR METAB, V83, P896, DOI 10.1210/jc.83.3.896; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhao Y, 2018, MUCOSAL IMMUNOL, V11, P752, DOI 10.1038/mi.2017.118; Zhou D, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0183-1	34	4	4	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0262855	10.1371/journal.pone.0262855	http://dx.doi.org/10.1371/journal.pone.0262855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D3HO	35108315	gold, Green Published, Green Submitted			2022-12-26	WOS:000775890100040
J	Yuan, ZS; Liu, F; He, SB; Zhou, LL; Pan, H				Yuan, Zong-sheng; Liu, Fang; He, Shi-bin; Zhou, Li-li; Pan, Hui			Community structure and diversity characteristics of rhizosphere and root endophytic bacterial community in different Acacia species	PLOS ONE			English	Article							PLANT-GROWTH; FRESH-WATER; MICROBIOME; EXUDATION; HEALTH	Rhizosphere and endophytic microbiota significantly affect plant growth and development by influencing nutrient uptake and stress tolerance. Herein, root and rhizosphere soil of Acacia species were collected and analyzed to compare the structural differences of the rhizosphere and root endophytic bacterial communities. High-throughput 16S rRNA gene sequencing technology was employed to analyze the rhizosphere and root endophytic bacterial communities. A total of 4249 OTUs were identified following sequence analysis. The rhizosphere soil contained significantly more OTUs than the root soil. Principal component analysis (PCA) and hierarchical cluster analysis indicated that bacterial communities exhibited significant specificity in the rhizosphere and root soil of different Acacia species. The most dominant phylum in the rhizosphere soil was Acidobacteria, followed by Proteobacteria and Actinobacteria, whereas the dominant phylum in the root soil was Proteobacteria, followed by Actinobacteria and Acidobacteria. Among the various Acacia species, specific bacterial communities displayed different abundance. We systematically described the core bacteria in the rhizosphere and root endophytic bacterial communities and predicted their relevant functions. The type and abundance of specific bacteria were correlated with the nutrient absorption and metabolism of the Acacia species. This study addresses the complex host-microbe interactions and explores the rhizosphere and root bacterial community structure of different Acacia species. These results provide new insights into the role of rhizosphere and root endophytic bacterial communities on the growth and reproduction of Acacia, thus informing future efforts towards sustainable development and utilization of Acacia.	[Yuan, Zong-sheng; Zhou, Li-li; Pan, Hui] Minjiang Univ, Inst Oceanog, Fuzhou, Peoples R China; [Liu, Fang] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [He, Shi-bin] Zhangpu Zhongxi State Owned Forest Yard, Zhangzhou, Peoples R China	Minjiang University; Fujian Agriculture & Forestry University	Yuan, ZS; Pan, H (corresponding author), Minjiang Univ, Inst Oceanog, Fuzhou, Peoples R China.	yuanzs369@163.com; fjpanhui@126.com		Yuan, Zongsheng/0000-0002-5306-3318	Forestry Science and Technology Project of Fujian Province [16/2019]	Forestry Science and Technology Project of Fujian Province	This research was funded by the Forestry Science and Technology Project of Fujian Province, grant number 16/2019. The author of this paper is the host of the funding.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Boland DJ, 1984, FOREST TREES AUSTR; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Pereira APD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180371; Orozco-Mosqueda MD, 2018, MICROBIOL RES, V208, P25, DOI 10.1016/j.micres.2018.01.005; Xuan DT, 2012, BIOL FERT SOILS, V48, P217, DOI 10.1007/s00374-011-0618-5; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Zagatto MRG, 2019, FOREST ECOL MANAG, V433, P240, DOI 10.1016/j.foreco.2018.11.008; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Igiehon NO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040574; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Lebeis SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00287; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Liu F, 2017, ARCH MICROBIOL, V199, P1259, DOI 10.1007/s00203-017-1397-7; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lu D., 2015, J FUJIAN FORESTRY CO; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P9, DOI 10.1046/j.1462-2920.1999.00005.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mercado-Blanco J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01006; Muller DB, 2016, ANNU REV GENET, V50, P211, DOI 10.1146/annurev-genet-120215-034952; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pereira A, 2021, MICROB ECOL, V81, P14, DOI 10.1007/s00248-020-01552-3; Pereira APA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00655; Quiza L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00507; Schlaeppi K, 2015, MOL PLANT MICROBE IN, V28, P212, DOI 10.1094/MPMI-10-14-0334-FI; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Zan N., 2015, TROPICAL FORESTRY, V43, P41; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhu SS, 2016, APPL SOIL ECOL, V107, P324, DOI 10.1016/j.apsoil.2016.07.009	44	2	2	10	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2022	17	1							e0262909	10.1371/journal.pone.0262909	http://dx.doi.org/10.1371/journal.pone.0262909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P3UI	35100276	gold, Green Published			2022-12-26	WOS:000801937600024
J	Ma, Y; Zhang, HB; Chen, C; Liu, LX; Ding, T; Wang, Y; Ma, DC; Ling, XL; Chen, XH; Li, JP; Zhong, GS; Ru, GQ; Zhang, L; Tang, JM				Ma, Yan; Zhang, Haibo; Chen, Cheng; Liu, Lixin; Ding, Ting; Wang, Ying; Ma, Dachang; Ling, Xiaoling; Chen, Xiaohua; Li, Jianping; Zhong, Guansheng; Ru, Guoqing; Zhang, Lei; Tang, Jianming			TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; UBIQUITIN LIGASE TRIM32; STAT3; PHOSPHORYLATION; PROLIFERATION; RADIOTHERAPY; DEGRADATION; ACTIVATION; PROGNOSIS; ENZYME	Radioresistance is common in the treatment of triple-negative breast cancer (TNBC), but the molecular mechanisms involved remain unclear. Herein, we reveal that tripartite motif-containing protein 32 (TRIM32) is upregulated in TNBC and is negatively associated with survival of TNBC patients. Radiotherapy resulted in enhanced expression of TRIM32, whereas TRIM32 depletion reduced TNBC radioresistance in vitro and in vivo. Mechanistically, radiotherapy promoted the association between TRIM32 and nuclear STAT3, which suppressed TC45-induced dephosphorylation of STAT3, resulting in increased STAT3 transcriptional activation and TNBC radioresistance. Finally, we demonstrated that TRIM32 and STAT3 phosphorylation are co-expressed in TNBC tissues. Moreover, high expression of TRIM32 and STAT3 phosphorylation is positively linked to poor prognosis of TNBC patients. Our study demonstrates that TRIM32 is a novel target for predicting radioresistance in TNBC patients.	[Ma, Yan; Chen, Xiaohua; Tang, Jianming] Lanzhou Univ, Hosp 1, Dept Radiat Oncol, Lanzhou 730000, Gansu, Peoples R China; [Zhang, Haibo; Wang, Ying] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Oncol Ctr,Dept Radiat Oncol, Hangzhou 310014, Zhejiang, Peoples R China; [Chen, Cheng; Ma, Dachang] Lanzhou Univ, Hosp 1, Dept Breast Surg, Lanzhou 730000, Gansu, Peoples R China; [Liu, Lixin] Lanzhou Univ, Hosp 1, Dept Thorac Surg, Lanzhou 730000, Gansu, Peoples R China; [Ding, Ting] Yiyang Cent Hosp, Dept Endocrinol, Yiyang 413000, Hunan, Peoples R China; [Ling, Xiaoling] Lanzhou Univ, Hosp 1, Dept Oncol, Lanzhou 730000, Gansu, Peoples R China; [Li, Jianping] Shanghai Bioegene Co Ltd, Shanghai 200003, Peoples R China; [Zhong, Guansheng] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Breast Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Ru, Guoqing] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Dept Pathol, Hangzhou 310014, Zhejiang, Peoples R China; [Zhang, Lei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Radiat Oncol, Shanghai 200127, Peoples R China	Lanzhou University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Lanzhou University; Lanzhou University; Lanzhou University; Zhejiang University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Shanghai Jiao Tong University	Tang, JM (corresponding author), Lanzhou Univ, Hosp 1, Dept Radiat Oncol, Lanzhou 730000, Gansu, Peoples R China.; Zhang, L (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Radiat Oncol, Shanghai 200127, Peoples R China.	hrbmuzl@126.com; 15900792812@163.com	Li, Jing/GYU-5036-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022	Zhang, Haibo/0000-0002-5134-4167	National Natural Science Foundation of China [82003236]; Zhejiang Provincial Nature Science Foundation of China [LY20H160044]; Gansu Provincial National Science Foundation for Distinguished Young Scholars [21JR7RA389]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Nature Science Foundation of China; Gansu Provincial National Science Foundation for Distinguished Young Scholars	This study was supported, in part, by grants from the National Natural Science Foundation of China (Grant number: 82003236 to Haibo Zhang), Zhejiang Provincial Nature Science Foundation of China (Grant number: LQ20H160063 to Jianming Tang), Gansu Provincial National Science Foundation for Distinguished Young Scholars (Grant number: 21JR7RA389 to Jianming Tang), Zhejiang Provincial Nature Science Foundation of China (Grant number: LY20H160044 to Ying Wang).	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Bi ZF, 2020, ADV SCI, V7, DOI 10.1002/advs.202000915; Brett-Morris A, 2014, CANCER RES, V74, P6925, DOI 10.1158/0008-5472.CAN-14-1249; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cui XP, 2016, MOL CELL BIOCHEM, V421, P127, DOI 10.1007/s11010-016-2793-z; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Gillison ML, 2019, LANCET, V393, P40, DOI 10.1016/S0140-6736(18)32779-X; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; He KY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003900; He L, 2019, CANCER MANAG RES, V11, P5765, DOI 10.2147/CMAR.S213663; He MY, 2018, CRIT REV ONCOL HEMAT, V131, P96, DOI 10.1016/j.critrevonc.2018.09.004; Horn EJ, 2004, CARCINOGENESIS, V25, P157, DOI 10.1093/carcin/bgh003; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; Lazzari E, 2016, INT J BIOCHEM CELL B, V79, P469, DOI 10.1016/j.biocel.2016.07.023; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu J, 2014, CELL DEATH DIFFER, V21, P1792, DOI 10.1038/cdd.2014.121; Lu L, 2018, ONCOGENE, V37, P5292, DOI 10.1038/s41388-018-0340-y; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Okawa T, 1999, Gan To Kagaku Ryoho, V26 Suppl 1, P15; Park SY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1405-7; Qiu LY, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03021-y; Sang YZ, 2018, CANCER RES, V78, P1792, DOI 10.1158/0008-5472.CAN-17-2774; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Wang J, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7297631; Wang ML, 2020, CELL DEATH DIFFER, V27, P1286, DOI 10.1038/s41418-019-0415-5; Wang XH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01120; Wang YM, 2014, MOL CELL, V53, P752, DOI 10.1016/j.molcel.2014.01.020; Wang Y, 2020, CELL DEATH DIFFER, V27, P695, DOI 10.1038/s41418-019-0381-y; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Yin HM, 2019, J CELL BIOCHEM, V120, P5232, DOI 10.1002/jcb.27798; Zhao TT, 2018, J CANCER, V9, P1349, DOI 10.7150/jca.22390; Zhou ZC, 2014, GASTROENTEROLOGY, V147, P1043, DOI 10.1053/j.gastro.2014.07.021	36	1	1	6	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2022	41	11					1589	1599		10.1038/s41388-022-02204-1	http://dx.doi.org/10.1038/s41388-022-02204-1		JAN 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZQ8WH	35091679				2022-12-26	WOS:000749073300004
J	Nolan, SO; Hodges, SL; Binder, MS; Smith, GD; Okoh, JT; Jefferson, TS; Escobar, B; Lugo, JN				Nolan, Suzanne O.; Hodges, Samantha L.; Binder, Matthew S.; Smith, Gregory D.; Okoh, James T.; Jefferson, Taylor S.; Escobar, Brianna; Lugo, Joaquin N.			Dietary rescue of adult behavioral deficits in the Fmr1 knockout mouse	PLOS ONE			English	Article							HIGH-FAT DIET; FRAGILE-X-SYNDROME; ELEVATED PLUS-MAZE; FISH-OIL; DOUBLE-BLIND; ACID LEVELS; AUTISM; MICE; SUPPLEMENTATION; OMEGA-3-FATTY-ACIDS	The current study aimed to further address important questions regarding the therapeutic efficacy of omega-3 fatty acids for various behavioral and neuroimmune aspects of the Fmr1 phenotype. To address these questions, our experimental design utilized two different omega-3 fatty acid administration timepoints, compared to both standard laboratory chow controls ("Standard") and a diet controlling for the increase in fat content ("Control Fat"). In the first paradigm, post-weaning supplementation (after postnatal day 21) with the omega-3 fatty acid diet ("Omega-3") reversed deficits in startle threshold, but not deficits in prepulse inhibition, and the effect on startle threshold was not specific to the Omega-3 diet. However, post-weaning supplementation with both experimental diets also impaired acquisition of a fear response, recall of the fear memory and contextual fear conditioning compared to the Standard diet. The post-weaning Omega-3 diet reduced hippocampal expression of IL-6 and this reduction of IL-6 was significantly associated with diminished performance in the fear conditioning task. In the perinatal experimental paradigm, the Omega-3 diet attenuated hyperactivity and acquisition of a fear response. Additionally, perinatal exposure to the Control Fat diet (similar to a "Western" diet) further diminished nonsocial anxiety in the Fmr1 knockout. This study provides significant evidence that dietary fatty acids throughout the lifespan can significantly impact the behavioral and neuroimmune phenotype of the Fmr1 knockout model.	[Nolan, Suzanne O.; Binder, Matthew S.; Okoh, James T.; Jefferson, Taylor S.; Escobar, Brianna; Lugo, Joaquin N.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Hodges, Samantha L.; Smith, Gregory D.; Lugo, Joaquin N.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA	Baylor University; Baylor University	Lugo, JN (corresponding author), Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA.; Lugo, JN (corresponding author), Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA.	joaquin_lugo@baylor.edu		Lugo, Joaquin/0000-0001-6874-8718				Amminger GP, 2007, BIOL PSYCHIAT, V61, P551, DOI 10.1016/j.biopsych.2006.05.007; [Anonymous], 1987, CURR PROBL PEDIATR, V17, P626; [Anonymous], 2002, ASM HDB, V12; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Ashwood P, 2010, BRAIN BEHAV IMMUN, V24, P898, DOI 10.1016/j.bbi.2010.01.008; Azzopardi E, 2018, J NEUROSCI, V38, P8798, DOI 10.1523/JNEUROSCI.0984-18.2018; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Baker KB, 2010, GENES BRAIN BEHAV, V9, P562, DOI 10.1111/j.1601-183X.2010.00585.x; Baker P, 1998, J AUTISM DEV DISORD, V28, P279, DOI 10.1023/A:1026004501631; BAUMGARDNER TL, 1995, PEDIATRICS, V95, P744; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Bongiovanni KD, 2007, PEDIATR RES, V62, P412, DOI 10.1203/PDR.0b013e31813cbeea; Bush DEA, 2007, J TRAUMA STRESS, V20, P413, DOI 10.1002/jts.20261; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Cordner ZA, 2015, PHYSIOL BEHAV, V152, P363, DOI 10.1016/j.physbeh.2015.06.008; Dansie LE, 2013, NEUROSCIENCE, V246, P186, DOI 10.1016/j.neuroscience.2013.04.058; De Felice C, 2012, GENES NUTR, V7, P447, DOI 10.1007/s12263-012-0285-7; Ding Q, 2014, BEHAV BRAIN RES, V271, P72, DOI 10.1016/j.bbr.2014.05.046; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Fortunato JJ, 2017, NUTRITION, V35, P119, DOI 10.1016/j.nut.2016.10.019; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; FRYNS JP, 1984, CLIN GENET, V25, P131; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Garay PA, 2013, BRAIN BEHAV IMMUN, V31, P54, DOI 10.1016/j.bbi.2012.07.008; Gruene TM, 2015, ELIFE, V4, DOI 10.7554/eLife.11352; Hagerman RJ, 1997, WESTERN J MED, V166, P129; HAGERMAN RJ, 1989, AM J ORTHOPSYCHIAT, V59, P142, DOI 10.1111/j.1939-0025.1989.tb01641.x; HAGERMAN RJ, 1986, AM J MED GENET, V23, P359, DOI 10.1002/ajmg.1320230128; Han YMY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00011; Hartman RE, 2020, ADV NEUROBIOL, V24, P547, DOI 10.1007/978-3-030-30402-7_19; Hatton DD, 2002, AM J MED GENET, V108, P105, DOI 10.1002/ajmg.10216; Hodges SL, 2017, NEUROREPORT, V28, P1246, DOI 10.1097/WNR.0000000000000905; Hodges SL, 2017, BEHAV BRAIN RES, V332, P50, DOI 10.1016/j.bbr.2017.05.052; Ison JR, 1997, BEHAV NEUROSCI, V111, P1335, DOI 10.1037/0735-7044.111.6.1335; Jackson PA, 2012, BRIT J NUTR, V107, P1232, DOI 10.1017/S000711451100403X; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Labouesse MA, 2013, PSYCHONEUROENDOCRINO, V38, P2562, DOI 10.1016/j.psyneuen.2013.06.003; Lakdawalla DN, 2018, J ECON LIT, V56, P397, DOI 10.1257/jel.20161327; Lee LK, 2013, PSYCHOPHARMACOLOGY, V225, P605, DOI 10.1007/s00213-012-2848-0; Li Q, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.126; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Louhivuori V, 2011, NEUROBIOL DIS, V41, P469, DOI 10.1016/j.nbd.2010.10.018; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mankad D, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0010-7; Matsui F, 2018, NEUROSCIENCE, V371, P407, DOI 10.1016/j.neuroscience.2017.12.029; Mazereeuw G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.014; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Monsanto SP, 2016, NUTR RES, V36, P1031, DOI 10.1016/j.nutres.2016.06.002; Newacheck PW, 2005, ARCH PEDIAT ADOL MED, V159, P10, DOI 10.1001/archpedi.159.1.10; Nolan SO, 2021, DEV NEUROSCI-BASEL, V42, P94, DOI 10.1159/000509797; Nolan SO, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12611; Nolan Suzanne O, 2018, F1000Res, V7, P711, DOI 10.12688/f1000research.14969.1; Nolan SO, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.800; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ooi YP, 2017, PHARMACOPSYCHIATRY, V50, DOI 10.1055/s-0042-109400; Ouyang L, 2010, J INTELL DISABIL RES, V54, P918, DOI 10.1111/j.1365-2788.2010.01320.x; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Parellada M, 2017, EUR NEUROPSYCHOPHARM, V27, P1319, DOI 10.1016/j.euroneuro.2017.08.426; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pietropaolo S, 2014, PSYCHONEUROENDOCRINO, V49, P119, DOI 10.1016/j.psyneuen.2014.07.002; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Raison CL, 2018, BRAIN BEHAV IMMUN, V73, P1, DOI 10.1016/j.bbi.2018.06.008; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Reynolds CD, 2016, NEUROREPORT, V27, P1331, DOI 10.1097/WNR.0000000000000701; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P1, DOI 10.1054/plef.2000.0184; Sasaki A, 2014, NEUROSCIENCE, V272, P92, DOI 10.1016/j.neuroscience.2014.04.012; Schiavi S, 2022, NUTR NEUROSCI, V25, P898, DOI 10.1080/1028415X.2020.1819107; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Sullivan EL, 2015, HORM BEHAV, V76, P153, DOI 10.1016/j.yhbeh.2015.04.008; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Uutela M, 2012, GENES BRAIN BEHAV, V11, P513, DOI 10.1111/j.1601-183X.2012.00784.x; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; Vancassel S, 2001, PROSTAG LEUKOTR ESS, V65, P1, DOI 10.1054/plef.2001.0281; Veeraragavan S, 2011, PSYCHOPHARMACOLOGY, V217, P143, DOI 10.1007/s00213-011-2276-6; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Yehuda S, 2012, MED HYPOTHESES, V79, P456, DOI 10.1016/j.mehy.2012.06.021; Yui K, 2016, NEUROSCI LETT, V610, P223, DOI 10.1016/j.neulet.2015.11.006; Zugno AI, 2014, NEUROSCIENCE, V259, P223, DOI 10.1016/j.neuroscience.2013.11.049	83	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0262916	10.1371/journal.pone.0262916	http://dx.doi.org/10.1371/journal.pone.0262916			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089938	gold, Green Published, Green Submitted			2022-12-26	WOS:000769158400026
J	Admassu, W; Ayelign, B; Abebe, G; Tadesse, M				Admassu, Wasihun; Ayelign, Birhanu; Abebe, Gemeda; Tadesse, Mulualem			Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert((R)) MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia	PLOS ONE			English	Article							GENEXPERT MTB/RIF; DIAGNOSIS; IMPLEMENTATION; PULMONARY	Background Rapid diagnosis of tuberculosis (TB) and detection of drug resistance are very important for timely and appropriate management of patients. Xpert MTB/RIF assay is approved for use in TB and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert MTB/RIF assay under routine clinical settings with a heterogeneous group of patients and sample types in Ethiopia. Methods A retrospective study was carried out in 2220 presumptive TB cases at Jimma University Medical Center. Data were gathered from the registration logbook using formatted data extraction tools and double entered to epidata version 3.1 and further transported to SPSS version 20 for analysis. Associations were determined using the Chi-square test and P-value <0.05 was considered statistically significant. Results Of 2220 cases enrolled, 1665 (75%) were adults and the remaining 555 (25%) were children aged less than 14 years. The majority, 1964 (88.46%), had pulmonary manifestation and 256 (11.54%) had extrapulmonary involvements. The overall, frequency of Mycobacterium tuberculosis (MTB) was 9.3% (206/2220), among this 10.27% (171/1665) and 6.3% (35/555) were adults and children, respectively. M. tuberculosis was detected from 171 (8.75%) of pulmonary patients and 35 (13.28%) of extrapulmonary manifested patients. Out of 206 M. tuberculosis positive cases, 7(3.4%) were rifampicin-resistant: four from pulmonary tuberculosis (PTB) patients and three from EPTB patients. In the Chi-square test, the age group of 15-24 years, previous history of TB, pus/lymph node sample, and being HIV positive were significantly associated with TB positivity by Xpert MTB/RIF (P-value <0.001). Conclusion These data suggest that the overall frequency of M. tuberculosis and rifampicin resistance was found to be relatively low compared to the previous reports in Ethiopia. Nevertheless, better diagnostic tools and approaches are still vital to halt the burden of TB and drug-resistant TB in the country.	[Admassu, Wasihun] Jimma Univ Med Ctr, Immunol & Mol Biol Unit, Jimma, Ethiopia; [Ayelign, Birhanu] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Immunol & Mol Biol, Gondar, Ethiopia; [Abebe, Gemeda; Tadesse, Mulualem] Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Abebe, Gemeda; Tadesse, Mulualem] Jimma Univ, Fac Hlth Sci, Sch Med Lab Sci, Jimma, Ethiopia	University of Gondar; Jimma University; Jimma University	Ayelign, B (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Immunol & Mol Biol, Gondar, Ethiopia.	birhanuayelign42@gmail.com	Abebe, Gemeda/AAB-8789-2019	Abebe, Gemeda/0000-0002-7172-9136				Abebe Gemeda, 2012, BMC Res Notes, V5, P225, DOI 10.1186/1756-0500-5-225; Ali H, 2012, ETHIOP J HEALTH SCI, V22, P70; Arega B, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3943-1; Derbie A, 2016, ETHIOP J HEALTH DEV, V30, P60; Diriba G, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0554-4; Jaleta KN, 2017, INFECT DRUG RESIST, V10, P185, DOI 10.2147/IDR.S135935; Lawn SD, 2012, EXPERT REV ANTI-INFE, V10, P631, DOI [10.1586/ERI.12.43, 10.1586/eri.12.43]; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lombardi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176186; Montales MT, 2015, RESPIR MED CASE REP, V16, P160, DOI 10.1016/j.rmcr.2015.10.006; Mulu Wondemagegn, 2017, BMC Res Notes, V10, P8, DOI 10.1186/s13104-016-2328-4; Nhu NTQ, 2014, J CLIN MICROBIOL, V52, P226, DOI 10.1128/JCM.01834-13; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Sehgal IS, 2016, J CLIN MICROBIOL, V54, P1133, DOI 10.1128/JCM.03205-15; Shi J, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1514381; Singh UB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149258; Srwar A., 2014, IOSR J DENT MED SCI, V13, P50; Tadesse M, 2016, INT J MYCOBACT, V5, P211, DOI 10.1016/j.ijmyco.2016.03.005; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; Workalemahu Bereket, 2013, BMC Res Notes, V6, P352, DOI 10.1186/1756-0500-6-352; Worku Hordofa M., 2015, CLIN MED RES, V4; World Health Organizatio, 2018, WHO 2018 GLOB TUB CO; World Health Organization, 2011, 9241501561 WHO; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11; Zignol M, 2016, NEW ENGL J MED, V375, P1081, DOI 10.1056/NEJMsr1512438	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262929	10.1371/journal.pone.0262929	http://dx.doi.org/10.1371/journal.pone.0262929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085337	Green Published, gold			2022-12-26	WOS:000779379600097
J	Urabe, T; Miyoshi, H; Narasaki, S; Yanase, YM; Uchida, K; Noguchi, S; Hide, M; Tsutsumi, Y; Sakai, N				Urabe, Tomoaki; Miyoshi, Hirotsugu; Narasaki, Soshi; Yanase, Yuhki M.; Uchida, Kazue; Noguchi, Soma; Hide, Michihiro; Tsutsumi, Yasuo; Sakai, Norio			Characterization of intracellular calcium mobilization induced by remimazolam, a newly approved intravenous anesthetic	PLOS ONE			English	Article							KETAMINE; ISOFLURANE; INFANT	Many anesthetics, including Propofol, have been reported to induce elevation of intracellular calcium, and we were interested to investigate the possible contribution of calcium elevation to the mechanism of the newly approved remimazolam actions. Remimazolam is an intravenous anesthetic first approved in Japan in July 2020, and is thought to exert its anesthetic actions via gamma-aminobutyric acid A (GABA(A)) receptors; however, the precise mechanisms of how remimazolam elevates intracellular calcium levels remains unclear. We examined the remimazolam-induced elevation of intracellular calcium using SHSY-5Y neuroblastoma cells, COS-7 cells, HEK293 cells, HeLa cells, and human umbilical vein endothelial cells (HUVECs) loaded with fluorescent dyes for live imaging. We confirmed that high concentrations of remimazolam (greater than 300 mu M) elevated intracellular calcium in a dose-dependent manner in these cells tested. This phenomenon was not influenced by elimination of extracellular calcium. The calcium elevation was abolished when intracellular or intraendoplasmic reticulum (ER) calcium was depleted by BAPTA-AM or thapsigargin, respectively, suggesting that calcium was mobilized from the ER. Inhibitors of G-protein coupled receptors (GPCRs)-mediated signals, including U-73122, a phospholipase C (PLC) inhibitor and xestospongin C, an inositol 1,4,5-triphosphate receptors (IP3R) antagonist, significantly suppressed remimazolam-induced calcium elevation, whereas dantrolene, a ryanodine receptor antagonist, did not influence remimazolam-induced calcium elevation. Meanwhile, live imaging of ER during remimazolam stimulation using ER-tracker showed no morphological changes. These results suggest that high doses of remimazolam increased intracellular calcium concentration in a dose-dependent manner in each cell tested, which was predicted to be caused by calcium mobilization from the ER. In addition, our studies using various inhibitors revealed that this calcium elevation might be mediated by the GPCRs-IP3 pathway. However, further studies are required to identify which type of GPCRs is involved.	[Urabe, Tomoaki; Miyoshi, Hirotsugu; Narasaki, Soshi; Tsutsumi, Yasuo] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Anesthesiol & Crit Care, Hiroshima, Japan; [Yanase, Yuhki M.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacotherapy, Hiroshima, Japan; [Uchida, Kazue; Hide, Michihiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Dermatol, Hiroshima, Japan; [Noguchi, Soma; Sakai, Norio] Hiroshima Univ, Dept Mol & Pharmacol Neurosci, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Hide, Michihiro] Hiroshima City Hiroshima Citizens Hosp, Dept Dermatol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima City Hospital	Miyoshi, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Anesthesiol & Crit Care, Hiroshima, Japan.	h-miyoshi@hiroshima-u.ac.jp		Miyoshi, Hirotsugu/0000-0002-1375-5344	Ministry of Education, Sports, and Culture [21K16560, 19H03409, 21K08948, 19K09353]; Takeda Science Foundation; Uehara Memorial Foundation; Japanese Smoking Research Association	Ministry of Education, Sports, and Culture; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japanese Smoking Research Association	We thank Mundipharma Japan and PAION Deutschland GmbH for the generous gift of remimazolam. This work was performed using equipment at the Radiation Research Center for Frontier Science, Natural Science Center for Basic Research and Development, Hiroshima University, and Biosignal Research Center, Kobe University, Japan. All authors approved the final version of the manuscript for publication.	Andropoulos DB, 2018, FETAL DIAGN THER, V43, P1, DOI 10.1159/000475928; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Brambrink AM, 2012, ANESTHESIOLOGY, V116, P372, DOI 10.1097/ALN.0b013e318242b2cd; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Kamegashira A, 2020, J DERMATOL, V47, P1293, DOI 10.1111/1346-8138.15516; McCann ME, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6459; Miyoshi H, 2015, ANESTH ANALG, V121, P994, DOI 10.1213/ANE.0000000000000886; Mizuno H, 2014, NEURON, V82, P365, DOI 10.1016/j.neuron.2014.02.026; Sheng XY, 2020, EUR J CLIN PHARMACOL, V76, P383, DOI 10.1007/s00228-019-02800-3; Sneyd JR, 2020, CURR OPIN ANESTHESIO, V33, P506, DOI 10.1097/ACO.0000000000000877; Urabe T, 2020, EUR J PHARMACOL, V884, DOI 10.1016/j.ejphar.2020.173303; von Kugelgen I, 2019, BRAIN RES BULL, V151, P12, DOI 10.1016/j.brainresbull.2019.03.010; Wang C, 2008, ANESTH ANALG, V106, P1643, DOI 10.1213/ane.ob013e3181732c01; Watanabe T, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/8845129; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wei HF, 2013, PROG NEURO-PSYCHOPH, V47, P156, DOI 10.1016/j.pnpbp.2013.05.009; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wesolowski AM, 2016, PHARMACOTHERAPY, V36, P1021, DOI 10.1002/phar.1806; Xiang Q, 2008, MED HYPOTHESES, V71, P868, DOI 10.1016/j.mehy.2008.07.035; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301	20	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	2							e0263395	10.1371/journal.pone.0263395	http://dx.doi.org/10.1371/journal.pone.0263395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YR1WR	35104283	Green Published, gold			2022-12-26	WOS:000749789300003
J	Fakhraldeen, SA; Berry, SM; Beebe, DJ; Roopra, A; Bisbach, CM; Spiegelman, VS; Niemi, NM; Alexander, CM				Fakhraldeen, Saja A.; Berry, Scott M.; Beebe, David J.; Roopra, Avtar; Bisbach, Celia M.; Spiegelman, Vladimir S.; Niemi, Natalie M.; Alexander, Caroline M.			Enhanced immunoprecipitation techniques for the identification of RNA-binding protein partners: IGF2BP1 interactions in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTOME-WIDE IDENTIFICATION; MESSENGER-RNA; CRD-BP; CODING REGION; BREAST-CANCER; PAR-CLIP; EXPRESSION; TARGETS; GROWTH; TRANSLATION	RNA-binding proteins (RBPs) regulate the expression of large cohorts of RNA species to produce programmatic changes in cellular phenotypes. To describe the function of RBPs within a cell, it is key to identify their mRNA-binding partners. This is often done by crosslinking nucleic acids to RBPs, followed by chemical release of the nucleic acid fragments for analysis. However, this methodology is lengthy, which involves complex processing with attendant sample losses, thus large amounts of starting materials and prone to artifacts. To evaluate potential alternative technologies, we tested "exclusion-based " purification of immunoprecipitates (IFAST or SLIDE) and report here that these methods can efficiently, rapidly, and specifically isolate RBP-RNA complexes. The analysis requires less than 1% of the starting material required for techniques that include crosslinking. Depending on the antibody used, 50% to 100% starting protein can be retrieved, facilitating the assay of endogenous levels of RBPs; the isolated ribonucleoproteins are subsequently analyzed using standard techniques, to provide a comprehensive portrait of RBP complexes. Using exclusion-based techniques, we show that the mRNA-binding partners for RBP IGF2BP1 in cultured mammary epithelial cells are enriched in mRNAs important for detoxifying superoxides (specifically glutathione peroxidase [GPX]-1 and GPX-2) and mRNAs encoding mitochondrial proteins. We show that these interactions are functionally significant, as loss of function of IGF2BP1 leads to destabilization of GPX mRNAs and reduces mitochondrial membrane potential and oxygen consumption. We speculate that this underlies a consistent requirement for IGF2BP1 for the expression of clonogenic activity in vitro.	[Fakhraldeen, Saja A.; Bisbach, Celia M.; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA; [Berry, Scott M.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA; [Spiegelman, Vladimir S.] Penn State Univ, Dept Pediat, Div Pediat Hematol Oncol, Coll Med, Hershey, PA USA; [Niemi, Natalie M.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO USA; [Fakhraldeen, Saja A.] Kuwait Inst Sci Res, Kuwait, Kuwait; [Berry, Scott M.] Univ Kentucky, Dept Mech Engn, Lexington, KY 40506 USA; [Bisbach, Celia M.] Promega Corp, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Washington University (WUSTL); Kuwait Institute for Scientific Research; University of Kentucky; Promega Corporation	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	cmalexander@wisc.edu		alexander, caroline/0000-0002-7830-8043; Fakhraldeen, Saja/0000-0003-3919-0270; Bisbach, Celia/0000-0001-6161-1401	Kuwait Foundation for the Advancement of Sciences [2013-6302-03]; Department of Defense Scholar Award [W81XWH-06-1-0491]; National Institute of Neurological Disorders and Stroke [R21NS095187]; National Cancer Institute [RO1CA121851]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1AR063361]	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); Department of Defense Scholar Award(United States Department of Defense); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	S. A. F. was supported by the Kuwait Foundation for the Advancement of Sciences under project no.: 2013-6302-03. This project was also supported by a Department of Defense Scholar Award (grant no.: W81XWH-06-1-0491; to C. M. A.), National Institute of Neurological Disorders and Stroke (grant no.: R21NS095187 [to A. R.], National Cancer Institute (grant no.: RO1CA186134 [to D. J. B.]), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant nos.: RO1AR063361 and National Cancer Institute RO1CA121851 [to V. S. S.]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ascano M, 2013, CURR OPIN GENET DEV, V23, P20, DOI 10.1016/j.gde.2013.01.003; Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Berry SM, 2014, J MOL DIAGN, V16, P297, DOI 10.1016/j.jmoldx.2014.01.004; Berry SM, 2014, INTEGR BIOL-UK, V6, P224, DOI 10.1039/c3ib40136g; Berry SM, 2014, ANAL BIOCHEM, V447, P133, DOI 10.1016/j.ab.2013.10.038; Berry SM, 2013, JALA-J LAB AUTOM, V18, P206, DOI 10.1177/2211068212462023; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Biegel JM, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.608816; Brigelius-Flohe R, 2020, ANTIOXID REDOX SIGN, V33, P498, DOI 10.1089/ars.2019.7905; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Casavant BP, 2014, ANAL CHEM, V86, P6355, DOI 10.1021/ac500574t; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; Chin EN, 2016, MOL CELL BIOL, V36, P871, DOI 10.1128/MCB.00800-15; Conway AE, 2016, CELL REP, V15, P666, DOI 10.1016/j.celrep.2016.03.052; Craig EA, 2012, J CELL SCI, V125, P5950, DOI 10.1242/jcs.115204; Cruz-Zaragoza LD, 2021, CELL, V184, P5824, DOI 10.1016/j.cell.2021.09.033; Dannenmann B., 2015, HIGH GLUTATHIONE GLU; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Devaux F, 2010, FEBS LETT, V584, P4273, DOI 10.1016/j.febslet.2010.09.030; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Doyle GA, 2000, CANCER RES, V60, P2756; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Elcheva IA, 2020, LEUKEMIA, V34, P1354, DOI 10.1038/s41375-019-0656-9; Eom T, 2003, J NEUROSCI, V23, P10433; Fakhraldeen SA, 2015, J BIOL CHEM, V290, P13386, DOI 10.1074/jbc.M115.655175; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Faye MD, 2015, ONCOGENE, V34, P1532, DOI 10.1038/onc.2014.90; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gerstberger S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6_1; Goel S., 2012, J BIOL CHEM, V287; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim T, 2018, MOL CARCINOGEN, V57, P678, DOI 10.1002/mc.22786; Kipp AP, 2017, ADV CANCER RES, V136, P109, DOI 10.1016/bs.acr.2017.07.004; Kloetgen A, 2015, BRIEF FUNCT GENOMICS, V14, P102, DOI 10.1093/bfgp/elu020; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moussavi-Harami SF, 2013, J PROTEOME RES, V12, P3393, DOI 10.1021/pr400225p; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Pla-Martin D, 2020, EMBO J, V39, DOI 10.15252/embj.2019102731; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Schaefer J., 2021, CELL, V82, P1; Scheibe M, 2012, NUCLEIC ACIDS RES, V40, P9897, DOI 10.1093/nar/gks746; Son MJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.74; Sperger Jamie M, 2017, Clin Cancer Res, V23, P746, DOI 10.1158/1078-0432.CCR-16-1021; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Van Nostrand EL, 2016, ADV EXP MED BIOL, V907, P1, DOI 10.1007/978-3-319-29073-7_1; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vellky JE, 2020, P NATL ACAD SCI USA, V117, P28092, DOI 10.1073/pnas.2008479117; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Woellhaf MW, 2014, BIOCHEM CELL BIOL, V92, P489, DOI 10.1139/bcb-2014-0029; Wu WT, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-00930-1; Yang F, 2014, FEBS J, V281, P802, DOI 10.1111/febs.12625; Yin R, 2022, CELL STEM CELL, V29, P149, DOI 10.1016/j.stem.2021.09.014; Zeliadt N., 2014, SCIENTIST	82	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101649	10.1016/j.jbc.2022.101649	http://dx.doi.org/10.1016/j.jbc.2022.101649			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35104504	gold, Green Published			2022-12-26	WOS:000794865600013
J	Li, D; Li, JY; Liu, HN; Zhai, LN; Hu, WL; Xia, N; Tang, TT; Jiao, J; Lv, BJ; Nie, SF; Hu, DS; Liao, YH; Yang, XP; Shi, GP; Cheng, X				Li, Dan; Li, Jingyong; Liu, Henan; Zhai, Luna; Hu, Wangling; Xia, Ni; Tang, Tingting; Jiao, Jiao; Lv, Bingjie; Nie, Shaofang; Hu, Desheng; Liao, Yuhua; Yang, Xiangping; Shi, Guo-Ping; Cheng, Xiang			Pathogenic Tconvs promote inflammatory macrophage polarization through GM-CSF and exacerbate abdominal aortic aneurysm formation	FASEB JOURNAL			English	Article						abdominal aortic aneurysm; CXCR6; GM-CSF; Tconvs	CHEMOKINE RECEPTOR CXCR6; REGULATORY T-CELLS; IFN-GAMMA; ACCUMULATION; LYMPHOCYTES; HOMEOSTASIS; EXPRESSION; PHENOTYPES; LEUKOCYTES; RESPONSES	Abdominal aortic aneurysms (AAAs) elicit massive inflammatory leukocyte recruitment to the aorta. CD4(+) T cells, which include regulatory T cells (Tregs) and conventional T cells (Tconvs), are involved in the progression of AAA. Tregs have been reported to limit AAA formation. However, the function and phenotype of the Tconvs found in AAAs remain poorly understood. We characterized aortic Tconvs by bulk RNA sequencing and discovered that Tconvs in aortic aneurysm highly expressed Cxcr6 and Csf2. Herein, we determined that the CXCR6/CXCL16 signaling axis controlled the recruitment of Tconvs to aortic aneurysms. Deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF), encoded by Csf2, markedly inhibited AAA formation and led to a decrease of inflammatory monocytes, due to a reduction of CCL2 expression. Conversely, the exogenous administration of GM-CSF exacerbated inflammatory monocyte infiltration by upregulating CCL2 expression, resulting in worsened AAA formation. Mechanistically, GM-CSF upregulated the expression of interferon regulatory factor 5 to promote M1-like macrophage differentiation in aortic aneurysms. Importantly, we also demonstrated that the GM-CSF produced by Tconvs enhanced the polarization of M1-like macrophages and exacerbated AAA formation. Our findings revealed that GM-CSF, which was predominantly derived from Tconvs in aortic aneurysms, played a pathogenic role in the progression of AAAs and may represent a potential target for AAA treatment.	[Li, Dan; Li, Jingyong; Liu, Henan; Zhai, Luna; Hu, Wangling; Xia, Ni; Tang, Tingting; Jiao, Jiao; Lv, Bingjie; Nie, Shaofang; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China; [Li, Dan; Li, Jingyong; Liu, Henan; Zhai, Luna; Hu, Wangling; Xia, Ni; Tang, Tingting; Jiao, Jiao; Lv, Bingjie; Nie, Shaofang; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Key Lab Biol Targeted Therapy,Educ Minist & Hubei, Wuhan, Peoples R China; [Hu, Desheng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Integrated Tradit Chinese & Western Med, Wuhan, Peoples R China; [Hu, Desheng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China; [Yang, Xiangping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Wuhan, Peoples R China; [Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Shi, Guo-Ping] Harvard Med Sch, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	nathancx@hust.edu.cn			National Natural Science Foundation of China (NSFC) [82030016, 81720108005, 81770503, 81400364, 81974037, 82000443]; National Heart, Lung, and Blood Institute [HL151627, HL157073]; National Institute of Neurological Disorders and Stroke [AG063839]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82030016; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81720108005; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770503; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81400364; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974037; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82000443; National Heart, Lung, and Blood Institute, Grant/Award Number: HL151627; National Heart, Lung, and Blood Institute, Grant/Award Number: HL157073; National Institute of Neurological Disorders and Stroke, Grant/Award Number: AG063839	Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Anzai A, 2017, J EXP MED, V214, P3293, DOI 10.1084/jem.20170689; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; BURGESS AW, 1980, BLOOD, V56, P947; Butcher MJ, 2016, INT IMMUNOL, V28, P255, DOI 10.1093/intimm/dxv068; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Collado A, 2018, CARDIOVASC RES, V114, P1764, DOI 10.1093/cvr/cvy135; Izquierdo MC, 2014, CYTOKINE GROWTH F R, V25, P317, DOI 10.1016/j.cytogfr.2014.04.002; Corbin AL, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax6085; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Dale MA, 2015, ARTERIOSCL THROM VAS, V35, P1746, DOI 10.1161/ATVBAHA.115.305269; Eberl G, 2018, TRENDS IMMUNOL, V39, P261, DOI 10.1016/j.it.2017.11.004; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Hamilton JA, 2020, J EXP MED, V217, DOI 10.1084/jem.20190945; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Latta M, 2007, IMMUNOLOGY, V121, P555, DOI 10.1111/j.1365-2567.2007.02603.x; Li JY, 2022, ADV SCI, V9, DOI 10.1002/advs.202104338; Li JY, 2019, ARTERIOSCL THROM VAS, V39, P446, DOI 10.1161/ATVBAHA.118.312023; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; MacRitchie N, 2020, CARDIOVASC RES, V116, P306, DOI 10.1093/cvr/cvz102; Mandai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065488; Mossanen JC, 2019, GASTROENTEROLOGY, V156, P1877, DOI 10.1053/j.gastro.2019.01.247; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nores GDG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04418-y; Ocana E, 2008, ATHEROSCLEROSIS, V200, P264, DOI 10.1016/j.atherosclerosis.2007.12.043; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Piper C, 2020, BLOOD, V135, P568, DOI 10.1182/blood.2019001696; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robinet P, 2018, ARTERIOSCL THROM VAS, V38, P292, DOI 10.1161/ATVBAHA.117.309524; Romain M, 2013, ARTERIOSCL THROM VAS, V33, P581, DOI 10.1161/ATVBAHA.112.300516; Sakalihasani N, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0030-7; Sampson UKA, 2014, GLOB HEART, V9, P159, DOI 10.1016/j.gheart.2013.12.009; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sho E, 2004, EXP MOL PATHOL, V76, P108, DOI 10.1016/j.yexmp.2003.11.003; Son BK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7994; Stock AT, 2016, J EXP MED, V213, P1983, DOI 10.1084/jem.20151853; Tao H, 2019, GASTROENTEROLOGY, V157, P1169, DOI 10.1053/j.gastro.2019.05.075; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Yamanouchi D, 2012, J VASC SURG, V56, P455, DOI 10.1016/j.jvs.2012.01.038; Ye P, 2013, J CLIN INVEST, V123, P2317, DOI 10.1172/JCI67356; Yodoi K, 2015, HYPERTENSION, V65, P889, DOI 10.1161/HYPERTENSIONAHA.114.04934; Zhan YF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02679; Zhao GZ, 2021, CARDIOVASC RES, V117, P1402, DOI 10.1093/cvr/cvaa214; Zhou Y, 2015, CARDIOVASC RES, V107, P98, DOI 10.1093/cvr/cvv119	57	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22172	10.1096/fj.202101576R	http://dx.doi.org/10.1096/fj.202101576R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35133017	Green Published			2022-12-26	WOS:000761250800031
J	Oo, A; Zandi, K; Shepard, C; Bassit, LC; Musall, K; Cho, YJ; Kim, DH; Schinazi, RF; Kim, B; Goh, SL				Oo, Adrian; Zandi, Keivan; Shepard, Caitlin; Bassit, Leda C.; Musall, Katie; Cho, Young-Jae; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek; Goh, Shu Ling			Elimination of Aicardi-Goutieres syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; I INTERFERON; INFECTED MACROPHAGES; C VIRUS; MUTATIONS; DNA; CELLS; HIV-1; RESPONSES; DEGRADATION	The lack of antiviral innate immune responses during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is characterized by limited production of interferons (IFNs). One protein associated with Aicardi-Goutieres syndrome, SAMHD1, has been shown to negatively regulate the IFN-1 signaling pathway. However, it is unclear whether elevated IFN signaling associated with genetic loss of SAMHD1 would affect SARS-CoV-2 replication. In this study, we established in vitro tissue culture model systems for SARS-CoV-2 and human coronavirus OC43 infections in which SAMHD1 protein expression was absent as a result of CRISPR-Cas9 gene KO or lentiviral viral protein X-mediated proteosomal degradation. We show that both SARS-CoV-2 and human coronavirus OC43 replications were suppressed in SAMHD1 KO 293T and differentiated THP-1 macrophage cell lines. Similarly, when SAMHD1 was degraded by virus-like particles in primary monocyte-derived macrophages, we observed lower levels of SARS-CoV-2 RNA. The loss of SAMHD1 in 293T and differentiated THP-1 cells resulted in upregulated gene expression of IFNs and innate immunity signaling proteins from several pathways, with STAT1 mRNA being the most prominently elevated ones. Furthermore, SARS-CoV-2 replication was significantly increased in both SAMHD1 WT and KO cells when expression and phosphorylation of STAT1 were downregulated by JAK inhibitor baricitinib, which over-rode the activated antiviral innate immunity in the KO cells. This further validates baricitinib as a treatment of SARS-CoV-2-infected patients primarily at the postviral clearance stage. Overall, our tissue culture model systems demonstrated that the elevated innate immune response and IFN activation upon genetic loss of SAMHD1 effectively suppresses SARS-CoV-2 replication.	[Oo, Adrian; Zandi, Keivan; Shepard, Caitlin; Bassit, Leda C.; Musall, Katie; Cho, Young-Jae; Schinazi, Raymond F.; Kim, Baek; Goh, Shu Ling] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kim, Dong-Hyun] Kyung Hee Univ, Coll Pharm, Dept Pharm, Seoul, South Korea; [Kim, Baek] Ctr Drug Discovery, Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Kyung Hee University; Children's Healthcare of Atlanta (CHOA)	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.; Kim, B (corresponding author), Ctr Drug Discovery, Childrens Healthcare Atlanta, Atlanta, GA USA.	baek.kim@emory.edu	Oo, Adrian/ABB-6800-2021	Oo, Adrian/0000-0002-2469-5391; Kim, Baek/0000-0001-7986-4335; Goh, Shu Ling/0000-0001-8575-6103	National Institutes of Health [AI136581, AI162633, AI141327, MH116695]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (grant nos.: AI136581 [to B. K.] , AI162633 [to B. K.] , AI141327 [to B. K.] , and MH116695 [to R. F. S.] ) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; AlBurtamani N, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13061161; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan RWY, 2013, J VIROL, V87, P6604, DOI 10.1128/JVI.00009-13; Cheemarla NR, 2021, J EXP MED, V218, DOI 10.1084/jem.20210583; Chen DY, 2021, J VIROL, V95, DOI 10.1128/JVI.00862-21; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE3798, DOI 10.1073/pnas.1801213115; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Clementi N, 2020, J INFECT DIS, V222, P722, DOI 10.1093/infdis/jiaa350; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Dang C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.650708; Desforges M, 2007, VIRUS RES, V130, P228, DOI 10.1016/j.virusres.2007.06.016; DHAWAN S, 1995, PATHOBIOLOGY, V63, P93, DOI 10.1159/000163939; Dorner T, 2020, LUPUS SCI MED, V7, DOI 10.1136/lupus-2020-000424; Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788; Fu WH, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100478; Goraya MU, 2020, MICROB PATHOGENESIS, V139, DOI 10.1016/j.micpath.2019.103919; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grant RA, 2021, NATURE, V590, DOI 10.1038/s41586-020-03148-w; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hollenbaugh JA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0063-2; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hosmillo M, 2020, MBIO, V11, DOI 10.1128/mBio.00215-20; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; La Rosee F, 2020, LEUKEMIA, V34, P1805, DOI 10.1038/s41375-020-0891-0; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Lenzi GM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0111-y; Li N, 2019, GENES IMMUN, V20, P234, DOI 10.1038/s41435-018-0028-x; Li Y, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104743; Lokugamage KG, 2020, J VIROL, V94, DOI 10.1128/JVI.01410-20; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.20211211; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Mantlo E, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104811; Marconi VC, 2021, LANCET RESP MED, V9, P1407, DOI 10.1016/S2213-2600(21)00331-3; Matthews K, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0209-9; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; Park BK, 2021, BIOMOL THER, V29, P273, DOI 10.4062/biomolther.2020.226; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Rebendenne A, 2021, J VIROL, V95, DOI 10.1128/JVI.02415-20; Ribero MS, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008737; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rincon-Arevalo H, 2022, EUR J IMMUNOL, V52, P138, DOI 10.1002/eji.202149575; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun LN, 2010, ACTA BIOCH BIOPH SIN, V42, P230, DOI 10.1093/abbs/gmq009; Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027; Tanaka Y, 2016, J RHEUMATOL, V43, P504, DOI 10.3899/jrheum.150613; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Titanji BK, 2021, CLIN INFECT DIS, V72, P1247, DOI 10.1093/cid/ciaa879; Trottier C, 2009, FASEB J, V23, P3203, DOI 10.1096/fj.09-129288; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Wei X, 2009, J INTERF CYTOK RES, V29, P171, DOI 10.1089/jir.2008.0040; White TE, 2017, HUM MUTAT, V38, P658, DOI 10.1002/humu.23201; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wichit S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071695; Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010; Zheng J, 2021, J INFECT DIS, V223, P785, DOI 10.1093/infdis/jiaa753; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	79	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101635	10.1016/j.jbc.2022.101635	http://dx.doi.org/10.1016/j.jbc.2022.101635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085552	gold, Green Published			2022-12-26	WOS:000789261900011
J	Javier, R; Wang, WX; Drumm, M; McCortney, K; Sarkaria, JN; Horbinski, C				Javier, Rodrigo; Wang, Wenxia; Drumm, Michael; McCortney, Kathleen; Sarkaria, Jann N.; Horbinski, Craig			The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma	PLOS ONE			English	Article							KETONE-BODIES; MUTATIONS; CANCER; METABOLISM; TUMORS; BRAIN	Infiltrative gliomas are the most common neoplasms arising in the brain, and remain largely incurable despite decades of research. A subset of these gliomas contains mutations in isocitrate dehydrogenase 1 (IDH1(mut)) or, less commonly, IDH2 (together called "IDHmut"). These mutations alter cellular biochemistry, and IDHmut gliomas are generally less aggressive than IDH wild-type (IDHwt) gliomas. Some preclinical studies and clinical trials have suggested that various forms of a ketogenic diet (KD), characterized by low-carbohydrate and high-fat content, may be beneficial in slowing glioma progression. However, adherence to a strict KD is difficult, and not all studies have shown promising results. Furthermore, no study has yet addressed whether IDHmut gliomas might be more sensitive to KD. The aim of the current study was to compare the effects of a unrestricted, cycling KD (weekly alternating between KD and standard diet) in preclinical models of IDHwt versus IDHmut gliomas. In vitro, simulating KD by treatment with the ketone body beta-hydroxybutyrate had no effect on the proliferation of patient-derived IDHwt or IDHmut glioma cells, either in low or normal glucose conditions. Likewise, an unrestricted, cycling KD had no effect on the in vivo growth of patient-derived IDHwt or IDHmut gliomas, even though the cycling KD did result in persistently elevated circulating ketones. Furthermore, this KD conferred no survival benefit in mice engrafted with Sleeping-Beauty transposase-engineered IDHmut or IDHwt glioma. These data suggest that neither IDHwt nor IDHmut gliomas are particularly responsive to an unrestricted, cycling form of KD.	[Javier, Rodrigo; Wang, Wenxia; Drumm, Michael; McCortney, Kathleen; Horbinski, Craig] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Javier, Rodrigo; Wang, Wenxia; Drumm, Michael; McCortney, Kathleen; Horbinski, Craig] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Northwestern Med Malnati Brain Tumor Inst, Chicago, IL 60611 USA; [Sarkaria, Jann N.] Mayo Clin, Rochester, MN USA; [Horbinski, Craig] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Mayo Clinic; Northwestern University; Feinberg School of Medicine	Horbinski, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA.; Horbinski, C (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Northwestern Med Malnati Brain Tumor Inst, Chicago, IL 60611 USA.; Horbinski, C (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	craig.horbinski@northwestern.edu		Horbinski, Craig/0000-0001-8340-9992	Northwestern University SPORE in Brain Tumor Research [P50CA221747]; Lou and Jean Malnati Brain Tumor Institute;  [R01NS102669];  [R01NS117104];  [R01NS118039]	Northwestern University SPORE in Brain Tumor Research; Lou and Jean Malnati Brain Tumor Institute; ; ; 	This work was supported by R01NS102669 (CH), R01NS117104 (CH), R01NS118039 (CH), the Northwestern University P50CA221747 SPORE in Brain Tumor Research, and the Lou and Jean Malnati Brain Tumor Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Biedermann J, 2019, CANCERS, V11, DOI 10.3390/cancers11122028; Brouns F, 2018, EUR J NUTR, V57, P1301, DOI 10.1007/s00394-018-1636-y; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Chung HY, 2017, J CANCER PREV, V22, P127, DOI 10.15430/JCP.2017.22.3.127; Ciusani E, 2021, NUTR CANCER, V73, P2315, DOI 10.1080/01635581.2020.1822423; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; De Feyter HM, 2016, NEURO-ONCOLOGY, V18, P1079, DOI 10.1093/neuonc/now088; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Foppiani A, 2021, NUTR CANCER, V73, P1004, DOI 10.1080/01635581.2020.1779759; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Garrett M, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0177-4; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horbinski C, 2013, ACTA NEUROPATHOL, V125, P621, DOI 10.1007/s00401-013-1106-9; Izquierdo-Garcia JL, 2015, CANCER RES, V75, P2999, DOI 10.1158/0008-5472.CAN-15-0840; Izquierdo-Garcia JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108289; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Khurshed M, 2017, ONCOTARGET, V8, P49165, DOI 10.18632/oncotarget.17106; Klement RJ, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-1337-2; Martin-McGill KJ, 2020, J NEURO-ONCOL, V147, P213, DOI 10.1007/s11060-020-03417-8; Miyata S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46217-5; Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004; Nunez FJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaq1427; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perez A, 2021, CANCER REP-US, V4, DOI 10.1002/cnr2.1383; Porper K, 2021, J NEURO-ONCOL, V153, P487, DOI 10.1007/s11060-021-03786-8; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Schreck KC, 2021, NEUROLOGY, V97, pE953, DOI 10.1212/WNL.0000000000012386; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Sperry J, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101453; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Unruh D., 2018, CLIN CANCER RES, V28, P1078; Vaubel RA, 2020, CLIN CANCER RES, V26, P1094, DOI 10.1158/1078-0432.CCR-19-0909; Waitkus MS, 2018, CANCER RES, V78, P36, DOI 10.1158/0008-5472.CAN-17-1352; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wenger KJ, 2020, CANCERS, V12, DOI 10.3390/cancers12123549; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhou LN, 2019, J PROTEOME RES, V18, P960, DOI 10.1021/acs.jproteome.8b00663; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5	45	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2022	17	2							e0257725	10.1371/journal.pone.0257725	http://dx.doi.org/10.1371/journal.pone.0257725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1L0FO	35134075	gold, Green Published			2022-12-26	WOS:000798968600001
J	Oliveira, AJ; Lopes, CS; Neto, GDM; de Sousa, GM; Paravidino, V; Rostila, M; Mediano, MFF; Griep, RH; do Vale, WS; Morgado, FFD				Oliveira, Aldair J.; Lopes, Claudia S.; Maranhao Neto, Geraldo de Albuquerque; de Sousa, Gustavo Mota; Paravidino, Vitor; Rostila, Mikael; Felix Mediano, Mauro Felippe; Griep, Rosane Harter; do Vale, Wesley Souza; da Rocha Morgado, Fabiane Frota			Psychosocial and environmental determinants of physical activity in a Brazilian public university employees - ELDAF: A prospective cohort study protocol	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SOCIAL SUPPORT; OLDER-ADULTS; GREEN AREAS; HEALTH; SATISFACTION; VALIDITY; WORKERS; STRESS; SCALE	Background Increased physical activity levels and their determinations are essential issues worldwide. The Longitudinal Study of Physical Activity Determinants (ELDAF) aims to understand the roles of psychosocial and environmental factors in workers' physical activity levels. Methods A prospective cohort study of non-faculty civil servants from a public university (approximately 1,200 individuals) will start in 2022 (baseline). The primary measurements will be accelerometer- and questionnaire-based physical activity, social support, social network, socioeconomic status, bereavement, job stress, body image, common mental disorders, depression, and neighborhood satisfaction. Additional measurements will include necessary sociodemographic, physical morbidity, lifestyle and anthropometric information. Participants' places of residence will be geocoded using complete addresses. All participants will furnish written, informed consent before the beginning of the study. Pilot studies were performed to identify and correct potential problems in the data collection instruments and procedures. ELDAF will be the first cohort study conducted in Latin America to investigate physical activity and its determinants.	[Oliveira, Aldair J.; de Sousa, Gustavo Mota; da Rocha Morgado, Fabiane Frota] Rural Fed Univ Rio de Janeiro, Lab Social Dimens Appl Phys Act & Sport LABSAFE, Seropedica, Brazil; [Lopes, Claudia S.; Paravidino, Vitor; do Vale, Wesley Souza] State Univ Rio de Janeiro UERJ, Dept Epidemiol, Inst Social Med, Rio De Janeiro, Brazil; [Maranhao Neto, Geraldo de Albuquerque] St Annes Univ Hosp Brno FNUSA, Int Clin Res Ctr ICRC, Brno, Czech Republic; [Rostila, Mikael] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden; [Rostila, Mikael] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden; [Felix Mediano, Mauro Felippe] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Griep, Rosane Harter] Oswaldo Cruz Inst, FIOCRUZ, Lab Hlth & Environm Educ, Rio De Janeiro, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade do Estado do Rio de Janeiro; St Anne's University Hospital Brno (FNUSA-ICRC); Stockholm University; Karolinska Institutet; Stockholm University; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Oliveira, AJ (corresponding author), Rural Fed Univ Rio de Janeiro, Lab Social Dimens Appl Phys Act & Sport LABSAFE, Seropedica, Brazil.	oliveira_aldair@ufrrj.br	Neto, Geraldo A Maranhao/I-4502-2012; J Oliveira, Aldair/AAE-7422-2022; Griep, Rosane Harter/E-3763-2013	Neto, Geraldo A Maranhao/0000-0001-6201-2080; J Oliveira, Aldair/0000-0002-2714-0615; Griep, Rosane Harter/0000-0002-6250-2036; Mediano, Mauro Felippe Felix/0000-0001-6369-3631	Carlos Chagas Filho Research Support Foundation of Rio de Janeiro State (FAPERJ) [E-26/010.002112/2016]	Carlos Chagas Filho Research Support Foundation of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	AJO Protocol number: E-26/010.002112/2016 Carlos Chagas Filho Research Support Foundation of Rio de Janeiro State (FAPERJ) The website: http://www.faperj.br The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MGD, 2004, REV SAUDE PUBL, V38, P164, DOI 10.1590/S0034-89102004000200003; Arredondo EM, 2016, AM J PREV MED, V50, P500, DOI 10.1016/j.amepre.2015.08.029; Barreto PA, 2019, REV SAUDE PUBL, V53, DOI 10.11606/s1518-8787.2019053001008; Luz TCB, 2011, CAD SAUDE PUBLICA, V27, pS390, DOI 10.1590/S0102-311X2011001500009; Callaway C., 1991, ANTHROPOMETRIC STAND; de Jong K, 2012, HEALTH PLACE, V18, P1374, DOI 10.1016/j.healthplace.2012.07.001; Dewulf B, 2016, GEOSPATIAL HEALTH, V11, P225, DOI 10.4081/gh.2016.411; dos Reisi MS, 2011, REV SAUDE PUBL, V45, P294, DOI 10.1590/S0034-89102011000200008; Druck MG., 2018, TERCEIRIZA O NO SERV, P113; Dzaye Omar, 2021, Am J Prev Cardiol, V5, P100148, DOI 10.1016/j.ajpc.2021.100148; Ferrario MM, 2019, EUR J PREV CARDIOL, V26, P1877, DOI 10.1177/2047487319852186; Gerovasili V, 2015, PREV MED, V81, P87, DOI 10.1016/j.ypmed.2015.08.005; Gu JK, 2016, ANN EPIDEMIOL, V26, P685, DOI 10.1016/j.annepidem.2016.08.004; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Leitaru N, 2019, J OCCUP ENVIRON MED, V61, pE56, DOI 10.1097/JOM.0000000000001516; Loef Bette, 2016, Prev Med Rep, V3, P30, DOI 10.1016/j.pmedr.2015.11.008; MARI JD, 1985, PSYCHOL MED, V15, P651; Matsudo S, 2001, REV BRAS ATIVIDADE F, V6, P5, DOI [10.12820/rbafs.v.6n2p5-18, DOI 10.12820/RBAFS.V.6N2P5-18]; McTiernan A, 2019, MED SCI SPORT EXER, V51, P1252, DOI 10.1249/MSS.0000000000001937; Miron C, 2018, INT DENT J, V68, P152, DOI 10.1111/idj.12361; Miron RW, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031353; Mok A, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2323; Myers MG, 2012, BLOOD PRESS MONIT, V17, P116, DOI 10.1097/MBP.0b013e3283540785; Najafabadi MG, 2020, WORK, V67, P281, DOI 10.3233/WOR-203278; Oliveira AJ, 2014, REV SAUDE PUBL, V48, P602, DOI 10.1590/S0034-8910.2014048005183; Oyeyemi AL, 2019, PHYSIOTHER THEOR PR, V35, P288, DOI 10.1080/09593985.2018.1443187; Perez LG, 2018, AM J HEALTH PROMOT, V32, P334, DOI 10.1177/0890117117742999; Pescatell LS, 2019, MED SCI SPORT EXER, V51, P1314, DOI 10.1249/MSS.0000000000001943; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI [10.1590/S0102-311X2013001200006, 10.1590/0102-311X00144612]; Schuch FB, 2018, AM J PSYCHIAT, V175, P631, DOI 10.1176/appi.ajp.2018.17111194; Soares-Miranda L, 2016, CIRCULATION, V133, P147, DOI 10.1161/CIRCULATIONAHA.115.018323; Spruce L, 2019, ASSOC OPER ROOM NURS, V110, P60, DOI 10.1002/aorn.12722; Swami V, 2011, BODY IMAGE, V8, P179, DOI 10.1016/j.bodyim.2011.01.001; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691	36	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2022	17	2							e0263385	10.1371/journal.pone.0263385	http://dx.doi.org/10.1371/journal.pone.0263385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1U6OX	35130293	gold, Green Published			2022-12-26	WOS:000805530700026
J	Salmani, N; Bagheri, I; Dadgari, A				Salmani, Naiire; Bagheri, Imane; Dadgari, Atena			Iranian nursing students experiences regarding the status of e-learning during COVID-19 pandemic	PLOS ONE			English	Article							PERSPECTIVES	Introduction With the emergence of the COVID-19 pandemic, universities immediately responded to protect students' lives by implementing e-learning in order to stop the spread of the communicable disease within the academic population. This study aimed to describe iranian nursing students' experiences of e-learning during the COVID-19 pandemic. Materials and methods The current study used a qualitative descriptive study. Ten nursing undergraduate students from a single Iranian university identified using purposive sampling methods. Face-to-face semi-structured interview conducted from May to July 2021 and analyzed through thematic analysis. Lincoln and Goba criteria were used to obtain data validity and reliability. Results Four themes emerged including"novelty of e-learning","advantages of e-learning", "disadvantages of e-learning"and"passage of time and the desire to return to face education". Participants evaluated e-learning as a novel method without proper infrastructure, it was initially confusing but became the new normal as their knowledge of the way to use it improved. Advantages included self-centered flexible learning and reduction in their concerns experienced with face-to-face learning. Disadvantages including changing the way they interact with teachers, decreasing interactions with classmates, problems with education files, superficial learning, hardware problems, family members' perceptions of the student role, interference of home affairs with e-learning, cheating on exams and assignments and being far away from the clinical context. Conclusion The findings revealed that e-learning has been introduced as a new method for the current research participants and despite the perceived benefits, these students believed that e-learning could supplement face education but not replace it.	[Salmani, Naiire; Dadgari, Atena] Shahid Sadoughi Univ Med Sci, Nursing Fac, Meybod Nursing Sch, Yazd, Iran; [Bagheri, Imane] Isfahan Univ Med Sci, Coll Nursing & Midwifery, Esfahan, Iran	Isfahan University Medical Science	Salmani, N (corresponding author), Shahid Sadoughi Univ Med Sci, Nursing Fac, Meybod Nursing Sch, Yazd, Iran.	n.salmani@ssu.ac.ir						Baczek M, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000024821; Bdair IA, 2021, TEACH LEARN NURS, V16, P220, DOI 10.1016/j.teln.2021.02.008; Chakraborty P, 2021, HUM BEHAV EMERG TECH, V3, P357, DOI 10.1002/hbe2.240; Chinelatto LA, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2133; Cypress BS, 2017, DIMENS CRIT CARE NUR, V36, P253, DOI 10.1097/DCC.0000000000000253; Dhawan S, 2020, J ED TECHNOL SYST, V49, P5, DOI [10.1177/0047239520934018, DOI 10.1177/0047239520934018]; Docherty A, 2006, EDUC PRIM CARE, V17, P343, DOI 10.1080/14739879.2006.11864084; Dost S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042378; Dyrbye L, 2009, MED TEACH, V31, P40, DOI 10.1080/01421590802366129; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hayat AA, BMC MED EDUC, V21, P1, DOI [10.1186/s12909-020-02436-3, DOI 10.1186/S12909-020-02436-3]; Kim JS, 2016, J CLIN NURS, V25, P2542, DOI 10.1111/jocn.13295; Kim MJ, 2021, CLIN SIMUL NURS, V60, P11, DOI 10.1016/j.ecns.2021.06.010; Langenau E, 2014, PATIENT EDUC COUNS, V96, P55, DOI 10.1016/j.pec.2014.04.016; Lion C., 2020, SABERES PRACTICAS, V5, P1; Longhurst GJ, 2020, ANAT SCI EDUC, V13, P298, DOI 10.1002/ase.1967; Mortazavi F, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_861_20; Mukhtar K, 2020, PAK J MED SCI, V36, pS27, DOI 10.12669/pjms.36.COVID19-S4.2785; Nurchis MC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124233; Opeyemi O. Z., 2019, GALORE INT J HLTH SC, V4, P23; Phutela N, 2020, J APPL RES HIGH EDUC, V12, P545, DOI 10.1108/JARHE-02-2019-0041; Ramos-Morcillo AJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155519; Rezaei R, 2018, IRAN J NURS MIDWIFE, V13, P1; Shawaqfeh MS, 2020, J MED EDUC CURRIC DE, V7, DOI 10.1177/2382120520963039; Shete AN, 2020, INT J HLTH SCI RES, V10, P319; Sindiani AM, 2020, ANN MED SURG, V59, P186, DOI 10.1016/j.amsu.2020.09.036; Spagnuolo G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062094; Stirling B, 2015, J NURS ED PRACT, V5, P40; Thapa P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253651; Urresti-Gundlach M, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1013-1; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Yang Y., 2004, ASS ED COMM TECHN 27	32	6	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2022	17	2							e0263388	10.1371/journal.pone.0263388	http://dx.doi.org/10.1371/journal.pone.0263388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D3HO	35108327	Green Published, gold			2022-12-26	WOS:000775890100066
J	Ma, GZ; Deng, YF; Qian, LX; Vallega, KA; Zhang, GJ; Deng, XM; Owonikoko, TK; Ramalingam, SS; Fang, DD; Zhai, YF; Sun, SY				Ma, Guangzhi; Deng, Yunfu; Qian, Luxi; Vallega, Karin A.; Zhang, Guojing; Deng, Xingming; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Fang, Douglas D.; Zhai, Yifan; Sun, Shi-Yong			Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both	ONCOGENE			English	Article							LUNG-CANCER; MODULATION	Treatment of EGFR-mutant non-small cell lung cancer (NSCLC) with mutation-selective third-generation EGFR-tyrosine kinase inhibitors (EGFR-TKIs) such as osimertinib has achieved remarkable success in the clinic. However, the immediate challenge is the emergence of acquired resistance, limiting the long-term remission of patients. This study suggests a novel strategy to overcome acquired resistance to osimertinib and other third-generation EGFR-TKIs through directly targeting the intrinsic apoptotic pathway. We found that osimertinib, when combined with Mcl-1 inhibition or Bax activation, synergistically decreased the survival of different osimertinib-resistant cell lines, enhanced the induction of intrinsic apoptosis, and inhibited the growth of osimertinib-resistant tumor in vivo. Interestingly, the triple-combination of osimertinib with Mcl-1 inhibition and Bax activation exhibited the most potent activity in decreasing the survival and inducing apoptosis of osimertinib-resistant cells and in suppressing the growth of osimertinib-resistant tumors. These effects were associated with increased activation of the intrinsic apoptotic pathway evidenced by augmented mitochondrial cytochrome C and Smac release. Hence, this study convincingly demonstrates a novel strategy for overcoming acquired resistance to osimertinib and other 3rd generation EGFR-TKIs by targeting activation of the intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation or both, warranting further clinical validation of this strategy.	[Ma, Guangzhi] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Sichuan, Peoples R China; [Ma, Guangzhi; Deng, Yunfu; Qian, Luxi; Vallega, Karin A.; Zhang, Guojing; Ramalingam, Suresh S.; Sun, Shi-Yong] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA; [Ma, Guangzhi; Deng, Yunfu; Qian, Luxi; Vallega, Karin A.; Zhang, Guojing; Deng, Xingming; Ramalingam, Suresh S.; Sun, Shi-Yong] Winship Canc Inst, Atlanta, GA 30322 USA; [Deng, Yunfu] Sichuan Univ, West China Hosp, Lung Canc Ctr, Chengdu, Sichuan, Peoples R China; [Qian, Luxi] Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Qian, Luxi] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Deng, Xingming] Emory Univ, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA; [Owonikoko, Taofeek K.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Owonikoko, Taofeek K.] Hillman Canc Ctr, Pittsburgh, PA USA; [Fang, Douglas D.; Zhai, Yifan] Ascentage Pharma Suzhou Co Ltd, Suzhou, Jiangsu, Peoples R China	Sichuan University; Emory University; Sichuan University; Nanjing Medical University; Nanjing Medical University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sun, SY (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA.; Sun, SY (corresponding author), Winship Canc Inst, Atlanta, GA 30322 USA.	ssun@emory.edu	Owonikoko, Taofeek/C-3012-2011	Owonikoko, Taofeek/0000-0002-7724-7728	Emory University Winship Cancer Institute lung cancer pilot fund; NIH/NCI [SPORE P50 CA217691]; Ascentage Pharma	Emory University Winship Cancer Institute lung cancer pilot fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ascentage Pharma(Dexcel Pharma)	We thank Dr. A. Hammond in our department for editing the manuscript. This work was supported by Emory University Winship Cancer Institute lung cancer pilot fund (to SYS), NIH/NCI SPORE P50 CA217691 (to XD) and a research fund from Ascentage Pharma (to SYS). TKO, SSR and SYS are Georgia Research Alliance Distinguished Cancer Scientists.	Carlisle JW, 2019, FUTURE ONCOL, V15, P805, DOI 10.2217/fon-2018-0626; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; Leonetti A, 2019, BRIT J CANCER, V121, P725, DOI 10.1038/s41416-019-0573-8; Li R, 2017, CANCER RES, V77, P3001, DOI 10.1158/0008-5472.CAN-16-2356; Negi A, 2021, EUR J MED CHEM, V210, DOI 10.1016/j.ejmech.2020.113038; Penn L Z, 2001, Curr Opin Investig Drugs, V2, P684; Piper-Vallillo AJ, 2020, J CLIN ONCOL, V38, P2926, DOI 10.1200/JCO.19.03123; Pogmore JP, 2021, J MED CHEM, V64, P5276, DOI 10.1021/acs.jmedchem.0c02200; Ramalingam SS, 2020, NEW ENGL J MED, V382, P41, DOI 10.1056/NEJMoa1913662; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Shah R, 2020, CLIN LUNG CANCER, V21, pE216, DOI 10.1016/j.cllc.2019.12.003; Shi PY, 2017, CLIN CANCER RES, V23, P6567, DOI 10.1158/1078-0432.CCR-17-1574; Shi PY, 2016, CANCER LETT, V380, P494, DOI 10.1016/j.canlet.2016.07.021; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Sun SY, 1997, CANCER RES, V57, P4931; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Walensky LD, 2019, NAT CHEM BIOL, V15, P657, DOI 10.1038/s41589-019-0306-6; Wang HL, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01079-1; Xin MG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5935; Zang HJ, 2020, CANCER-AM CANCER SOC, V126, P2024, DOI 10.1002/cncr.32744; Zhang LL, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188569; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819; Zong D, 2020, CANCER RES, V80, P2380, DOI 10.1158/0008-5472.CAN-19-3674	28	2	2	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1691	1700		10.1038/s41388-022-02200-5	http://dx.doi.org/10.1038/s41388-022-02200-5		JAN 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35102249				2022-12-26	WOS:000750409400002
J	Frank, DN; Qiu, Y; Cao, Y; Zhang, SG; Lu, L; Kofonow, JM; Robertson, CE; Liu, YQ; Wang, HB; Levens, CL; Kuhn, KA; Song, J; Ramakrishnan, VR; Lu, SL				Frank, Daniel N.; Qiu, Yue; Cao, Yu; Zhang, Shuguang; Lu, Ling; Kofonow, Jennifer M.; Robertson, Charles E.; Liu, Yanqiu; Wang, Haibo; Levens, Cassandra L.; Kuhn, Kristine A.; Song, John; Ramakrishnan, Vijay R.; Lu, Shi-Long			A dysbiotic microbiome promotes head and neck squamous cell carcinoma	ONCOGENE			English	Article							ARYL-HYDROCARBON RECEPTOR; GUT MICROBIOTA; ORAL-CANCER; TRYPTOPHAN; ASSOCIATION; METABOLITES; ACTIVATION; DIVERSITY; EFFICACY; MODELS	Recent studies have reported dysbiotic oral microbiota and tumor-resident bacteria in human head and neck squamous cell carcinoma (HNSCC). We aimed to identify and validate oral microbial signatures in treatment-naive HNSCC patients compared with healthy control subjects. We confirm earlier reports that the relative abundances of Lactobacillus spp. and Neisseria spp. are elevated and diminished, respectively, in human HNSCC. In parallel, we examined the disease-modifying effects of microbiota in HNSCC, through both antibiotic depletion of microbiota in an induced HNSCC mouse model (4-Nitroquinoline 1-oxide, 4NQO) and reconstitution of tumor-associated microbiota in a germ-free orthotopic mouse model. We demonstrate that depletion of microbiota delays oral tumorigenesis, while microbiota transfer from mice with oral cancer accelerates tumorigenesis. Enrichment of Lactobacillus spp. was also observed in murine HNSCC, and activation of the aryl-hydrocarbon receptor was documented in both murine and human tumors. Together, our findings support the hypothesis that dysbiosis promotes HNSCC development.	[Frank, Daniel N.; Kofonow, Jennifer M.; Robertson, Charles E.] Univ Colorado, Dept Med, Div Infect Dis, Anschutz Med Ctr, Aurora, CO 80045 USA; [Qiu, Yue; Cao, Yu; Zhang, Shuguang; Lu, Ling; Liu, Yanqiu; Wang, Haibo; Song, John; Ramakrishnan, Vijay R.; Lu, Shi-Long] Univ Colorado, Dept Otolaryngol Head & Neck Surg, Anschutz Med Ctr, Aurora, CO 80045 USA; [Qiu, Yue] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110122, Peoples R China; [Cao, Yu] China Med Univ, Univ Hosp 1, Dept Surg Oncol, Shenyang 110122, Peoples R China; [Levens, Cassandra L.; Kuhn, Kristine A.] Univ Colorado, Dept Med, Div Rheumatol, Anschutz Med Ctr, Aurora, CO USA; [Levens, Cassandra L.; Kuhn, Kristine A.] Univ Colorado, Dept Med, Mucosal Inflammat Program, Anschutz Med Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; China Medical University; China Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Frank, DN (corresponding author), Univ Colorado, Dept Med, Div Infect Dis, Anschutz Med Ctr, Aurora, CO 80045 USA.; Lu, SL (corresponding author), Univ Colorado, Dept Otolaryngol Head & Neck Surg, Anschutz Med Ctr, Aurora, CO 80045 USA.	daniel.frank@cuanschutz.edu; shi-long.lu@cuanschutz.edu			NIH-NIDCR [R56 DE028959]; NIH-NIAMS [R01 AR075033]; Cancer League of Colorado; Golfers Against Cancer; University of Colorado Cancer Center; University of Colorado GI and Liver Innate Immunity Program; NIH-NIDCD [K23 DC014747]	NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer League of Colorado; Golfers Against Cancer; University of Colorado Cancer Center; University of Colorado GI and Liver Innate Immunity Program; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by grants from NIH-NIDCR (R56 DE028959; SLL & DNF), NIH-NIAMS (R01 AR075033; KAK), the Cancer League of Colorado (SLL & DNF), Golfers Against Cancer (SLL & DNF), and the University of Colorado Cancer Center (SLL & DNF). DNF, CER, and JMK were supported in part by the University of Colorado GI and Liver Innate Immunity Program. VRR was supported in part by a Career Development Grant from the University of Colorado Cancer Center and NIH-NIDCD K23 DC014747 (VRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations.	Al-hebshi NN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02079-3; Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011; Alfano M, 2016, NAT REV UROL, V13, P77, DOI 10.1038/nrurol.2015.292; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andreeva NV, 2020, CURR OPIN MICROBIOL, V56, P118, DOI 10.1016/j.mib.2020.09.001; Bebek G, 2012, HUM MOL GENET, V21, P1557, DOI 10.1093/hmg/ddr593; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser MJ, 2008, CANCER PREV RES, V1, P15, DOI 10.1158/1940-6207.CAPR-08-0024; Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Bultman SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/carcin/bgt392; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chang H, 2006, TOXICOL SCI, V89, P205, DOI 10.1093/toxsci/kfj025; Chen X, 2020, MOL ONCOL, V14, P139, DOI 10.1002/1878-0261.12584; Chow LQM, 2020, NEW ENGL J MED, V382, P60, DOI 10.1056/NEJMra1715715; Cullin N, 2021, CANCER CELL, V39, P1317, DOI 10.1016/j.ccell.2021.08.006; Daniel CR, 2019, TRENDS CANCER, V5, P521, DOI 10.1016/j.trecan.2019.07.003; Du L, 2016, ONCOGENE, V35, P4641, DOI 10.1038/onc.2016.1; Elinav E, 2019, NAT REV CANCER, V19, P371, DOI 10.1038/s41568-019-0155-3; Fan XZ, 2018, GUT, V67, P120, DOI 10.1136/gutjnl-2016-312580; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Fox J., 2019, R COMPANION APPL REG, V.; Frank DN, 2021, J MED GENET, V58, P442, DOI 10.1136/jmedgenet-2020-106844; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ganly I, 2019, INT J CANCER, V145, P775, DOI 10.1002/ijc.32152; Gholizadeh P, 2016, BIOMED PHARMACOTHER, V84, P552, DOI 10.1016/j.biopha.2016.09.082; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gopalakrishnan V, 2018, CANCER CELL, V33, P570, DOI 10.1016/j.ccell.2018.03.015; Guerrero-Preston R, 2017, ONCOTARGET, V8, P110931, DOI 10.18632/oncotarget.20677; Guerrero-Preston R, 2016, ONCOTARGET, V7, P51320, DOI 10.18632/oncotarget.9710; Hayes RB, 2018, JAMA ONCOL, V4, P358, DOI 10.1001/jamaoncol.2017.4777; Healy CM, 2019, ORAL ONCOL, V89, P30, DOI 10.1016/j.oraloncology.2018.12.003; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Hold GL, 2015, NAT REV GASTRO HEPAT, V12, P128, DOI 10.1038/nrgastro.2015.25; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; Liu YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15207; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Ohtani N, 2015, SEMIN IMMUNOPATHOL, V37, P65, DOI 10.1007/s00281-014-0457-1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pfister DG, 2020, J NATL COMPR CANC NE, V18, P873, DOI 10.6004/jnccn.2020.0031; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; R Core Team, 2021, R LANGUAGE ENV STAT; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sfanos KS, 2018, NAT REV UROL, V15, P11, DOI 10.1038/nrurol.2017.167; Shay Elizabeth, 2020, Oncotarget, V11, P2375, DOI 10.18632/oncotarget.27629; Stanford EA, 2016, MOL CANCER RES, V14, P696, DOI 10.1158/1541-7786.MCR-16-0069; Stange J, 2013, SEMIN IMMUNOPATHOL, V35, P645, DOI 10.1007/s00281-013-0389-1; Statnikov A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-11; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Vickery TW., 2020, PROSTAGLANDINS LEUKO, V164; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Wie SM, 2017, MOL CANCER THER, V16, P1989, DOI 10.1158/1535-7163.MCT-17-0267; Wolf A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06361-2; Yu GQ, 2014, CANCER EPIDEM BIOMAR, V23, P735, DOI 10.1158/1055-9965.EPI-13-0855; Yu LX, 2017, NAT REV GASTRO HEPAT, V14, P527, DOI 10.1038/nrgastro.2017.72; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang L, 2007, ORAL ONCOL, V43, P693, DOI 10.1016/j.oraloncology.2006.08.008; Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918	84	4	4	9	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1269	1280		10.1038/s41388-021-02137-1	http://dx.doi.org/10.1038/s41388-021-02137-1		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	35087236	Green Accepted			2022-12-26	WOS:000749068000001
J	Joynt Maddox, KE; Reidhead, M; Grotzinger, J; McBride, T; Mody, A; Nagasako, E; Ross, W; Steensma, JT; Barker, AR				Joynt Maddox, Karen E.; Reidhead, Mat; Grotzinger, Joshua; McBride, Timothy; Mody, Aaloke; Nagasako, Elna; Ross, Will; Steensma, Joseph T.; Barker, Abigail R.			Understanding contributors to racial and ethnic inequities in COVID-19 incidence and mortality rates	PLOS ONE			English	Article							DISCRIMINATION	Background Racial inequities in Coronavirus 2019 (COVID-19) have been reported over the course of the pandemic, with Black, Hispanic/Latinx, and Native American individuals suffering higher case rates and more fatalities than their White counterparts. Methods We used a unique statewide dataset of confirmed COVID-19 cases across Missouri, linked with historical statewide hospital data. We examined differences by race and ethnicity in raw population-based case and mortality rates. We used patient-level regression analyses to calculate the odds of mortality based on race and ethnicity, controlling for comorbidities and other risk factors. Results As of September 10, 2020 there were 73,635 confirmed COVID-19 cases in the State of Missouri. Among the 64,526 case records (87.7% of all cases) that merged with prior demographic and health care utilization data, 12,946 (20.1%) were Non-Hispanic (NH) Black, 44,550 (69.0%) were NH White, 3,822 (5.9%) were NH Other/Unknown race, and 3,208 (5.0%) were Hispanic. Raw cumulative case rates for NH Black individuals were 1,713 per 100,000 population, compared with 2,095 for NH Other/Unknown, 903 for NH White, and 1,218 for Hispanic. Cumulative COVID-19-related death rates for NH Black individuals were 58.3 per 100,000 population, compared with 38.9 for NH Other/Unknown, 19.4 for NH White, and 14.8 for Hispanic. In a model that included insurance source, history of a social determinant billing code in the patient's claims, census block travel change, population density, Area Deprivation Index, and clinical comorbidities, NH Black race (OR 1.75, 1.51-2.04, p<0.001) and NH Other/Unknown race (OR 1.83, 1.36-2.46, p<0.001) remained strongly associated with mortality. Conclusions In Missouri, COVID-19 case rates and mortality rates were markedly higher among NH Black and NH Other/Unknown race than among NH White residents, even after accounting for social and clinical risk, population density, and travel patterns during COVID-19.	[Joynt Maddox, Karen E.] Washington Univ, Cardiovasc Div, Sch Med, St Louis, MO 63130 USA; [Joynt Maddox, Karen E.; McBride, Timothy; Barker, Abigail R.] Washington Univ, Inst Publ Hlth, Ctr Hlth Econ & Policy, St Louis, MO 63130 USA; [Joynt Maddox, Karen E.; Reidhead, Mat; Grotzinger, Joshua] Washington Univ, Brown Sch, St Louis, MO 63110 USA; [McBride, Timothy; Steensma, Joseph T.; Barker, Abigail R.] Missouri Hosp Assoc, Jefferson City, MO USA; [Mody, Aaloke] Washington Univ, Div Infect Dis, Sch Med, St Louis, MO 63130 USA; [Ross, Will] Washington Univ, Div Nephrol, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Joynt Maddox, KE (corresponding author), Washington Univ, Cardiovasc Div, Sch Med, St Louis, MO 63130 USA.; Joynt Maddox, KE (corresponding author), Washington Univ, Inst Publ Hlth, Ctr Hlth Econ & Policy, St Louis, MO 63130 USA.; Joynt Maddox, KE (corresponding author), Washington Univ, Brown Sch, St Louis, MO 63110 USA.	kjoyntmaddox@wustl.edu		Barker, Abigail/0000-0002-0826-5156; Ross, Will/0000-0002-8112-2979				Adhikari S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16938; [Anonymous], 2021, SAFEGRAPH DATA ACADE; Asch DA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.12842; Brody GH, 2015, J ADOLESCENT HEALTH, V56, P496, DOI 10.1016/j.jadohealth.2015.01.017; Centers for Disease Control and Prevention, 2020, COVIDVEW WEEKL SURV; Centers for Disease Control and Prevention, 2022, HLTH EQ CONS RAC ETH; Choi SWE, 2020, J HEALTH SOC BEHAV, V61, P96, DOI 10.1177/0022146520903282; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Figueroa JF, 2020, HEALTH AFFAIR, V39, P1984, DOI 10.1377/hlthaff.2020.01040; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Gould E., 2020, BLACK WORKERS FACE 2; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; Jha AK, 2011, HEALTH AFFAIR, V30, P1904, DOI 10.1377/hlthaff.2011.0027; Kabarriti R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19795; Kershaw KN, 2016, HEALTH PSYCHOL, V35, P343, DOI 10.1037/hea0000331; Knittel C.R., 2020, 27391 NBER; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003; Reidhead M., 2018, DECODING SOCIAL DETE, DOI [10.1097/PHH.0000000000000578, DOI 10.1097/PHH.0000000000000578]; Rentsch CT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003379; Rogers TN, 2020, WORLD MED HEALTH POL, V12, P311, DOI 10.1002/wmh3.358; Rubin-Miller L., 2020, COVID 19 RACIAL DISP; Stokes JE, 2020, J AGING SOC POLICY, V32, P416, DOI 10.1080/08959420.2020.1770031; Strickland Ora L, 2020, J Natl Black Nurses Assoc, V31, P1; Truong HP, 2020, MED CARE, V58, P1037, DOI 10.1097/MLR.0000000000001418; University of Wisconsin-Madison School of Medicine and Public Health-Health Innovation Program, AR DEPR IND 2015; US Census Bureau, AM COMMUNITY SURVEY; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039	29	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2022	17	1							e0260262	10.1371/journal.pone.0260262	http://dx.doi.org/10.1371/journal.pone.0260262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZT4WP	35089919	Green Published, gold			2022-12-26	WOS:000769158400003
J	Reynolds, RM; Weaver, SR; Nyman, AL; Eriksen, MP				Reynolds, Reed M.; Weaver, Scott R.; Nyman, Amy L.; Eriksen, Michael P.			Trust in COVID-19 information sources and perceived risk among smokers: A nationally representative survey	PLOS ONE			English	Article							SOCIAL TRUST; PERCEPTION; COMMUNICATION; MANAGEMENT; MODEL	Background Public health officials have classified smoking as a risk factor for COVID-19 disease severity. Smokers generally have less trust in health experts than do nonsmokers, leading to reduced risk perceptions. This study addresses smokers' trust in information sources about COVID-19 and how trust is associated with perceived COVID-19 susceptibility and severity among smokers. Methods and findings A nationally representative sample of 1,223 current smokers were surveyed between October and November 2020, indicating their level of trust in COVID-19 information sources, and their perceptions of risk from COVID-19. Multiple differences in trustworthiness emerged; smokers trusted their personal doctor for information about COVID-19 more than other information sources, while news media were generally distrusted. In addition, the FDA was trusted less than the NIH and CDC. Several "trust gaps" were observed, indicating disparities in levels of trust associated with gender, ethnicity, education, and political orientation, which had the strongest association with trust of all factors. Political orientation was also a significant predictor of COVID-19 risk perceptions, but there was no independent effect of political orientation when accounting for trust, which was predictive of all risk perception outcomes. Conclusions Trusted sources, such as personal doctors, may most effectively convey COVID-19 information across political orientations and sociodemographic groups. News media may be ineffective at informing smokers due to their low credibility. The results suggest that trust may explain the apparent effect of political orientation on COVID-19 risk perceptions. Implications for researchers, communication professionals, and policy makers are discussed.	[Reynolds, Reed M.; Weaver, Scott R.; Nyman, Amy L.; Eriksen, Michael P.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Reynolds, RM (corresponding author), Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.	rreynolds25@gsu.edu		Reynolds, Reed/0000-0003-1983-5035	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Research reported in this publication was supported by the Robert Wood Johnson Foundation. The sponsored played no role in the study design, data collection, analysis, decision to publish, or manuscript preparation. Information about the funder can be found at https://www.rwjf.org/.	Agley J, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10103-x; Ahuja R., 2018, PREV CHRONIC DIS, P15; Allen I, 2005, BRIT MED J, V331, P569, DOI 10.1136/bmj.331.7516.569; Bargain O, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104316; Barnidge M, 2020, COMMUN RES, V47, P82, DOI 10.1177/0093650217713066; Bollen KA, 2016, ANNU REV STAT APPL, V3, P375, DOI 10.1146/annurev-statistics-011516-012958; Brodeur A, 2021, J POPUL ECON, V34, P1321, DOI 10.1007/s00148-021-00848-z; Bronstein MV, 2021, EMBO REP, V22, DOI 10.15252/embr.202052282; de Bruin WB, 2020, J RISK UNCERTAINTY, V61, P177, DOI 10.1007/s11166-020-09336-3; Callegaro M, 2008, PUBLIC OPIN QUART, V72, P1008, DOI 10.1093/poq/nfn065; Chertok IRA, 2020, PUBLIC HEALTH NURS, V37, P854, DOI 10.1111/phn.12814; Chryssochoidis G, 2009, J RISK RES, V12, P137, DOI 10.1080/13669870802637000; Cvetkovich G, 2002, RISK ANAL, V22, P359, DOI 10.1111/0272-4332.00030; Dixon G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.29571; Dohle S., 2020, PSYCHARCHIVES, V15, P1, DOI [10.32872/spb.4315, DOI 10.32872/SPB.4315, DOI 10.31219/OSF.IO/W52NV]; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Ferrer RA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191994; Gopichandran V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004115; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Grande D, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.10918; Griesler PC, 1998, J ADOLESCENT HEALTH, V23, P167, DOI 10.1016/S1054-139X(98)00029-9; Groothuis PA, 1997, J RISK UNCERTAINTY, V15, P241, DOI 10.1023/A:1007757326382; Groseclose T, 2005, Q J ECON, V120, P1191, DOI 10.1162/003355305775097542; Hakulinen C, 2015, ADDICTION, V110, P1844, DOI 10.1111/add.13079; Hassell HJG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9344; Heydari ST, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10125-5; Hmielowski JD, 2014, PUBLIC UNDERST SCI, V23, P866, DOI 10.1177/0963662513480091; Ipsen C, 2021, DISABIL HEALTH J, V14, DOI 10.1016/j.dhjo.2021.101062; Jackson SE, 2021, NICOTINE TOB RES, V23, P1623, DOI 10.1093/ntr/ntab039; Jones CL, 2015, HEALTH COMMUN, V30, P566, DOI 10.1080/10410236.2013.873363; Kannan VD, 2018, PREV MED, V114, P95, DOI 10.1016/j.ypmed.2018.06.011; Kasperson JX, 2013, THE FEELING OF RISK, P345; Kerr J, 2021, PERS INDIV DIFFER, V179, DOI 10.1016/j.paid.2021.110892; Killgore WDS, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040339; Lobb AE, 2007, FOOD QUAL PREFER, V18, P384, DOI 10.1016/j.foodqual.2006.04.004; Lowe KE, 2021, JAMA INTERN MED, V181, P709, DOI 10.1001/jamainternmed.2020.8360; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Masiero Marianna, 2015, Int J High Risk Behav Addict, V4, pe20939, DOI 10.5812/ijhrba.20939; Mastro D., 2017, OXFORD RES ENCY COMM; Mourtgos SM, 2022, CRIMINOL PUBLIC POL, V21, P9, DOI 10.1111/1745-9133.12556; Niemiec E, 2021, EMBO REP, V22, DOI 10.15252/embr.202152500; Petty R. E., 1986, COMMUN PERSUATION, P1; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI 10.15585/mmwr.mm7020e2externalicon; Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988; Popova L, 2021, NICOTINE TOB RES, DOI 10.1093/ntr/ntab199; Pornpitakpan C, 2004, J APPL SOC PSYCHOL, V34, P243, DOI 10.1111/j.1559-1816.2004.tb02547.x; Rains SA, 2015, HEALTH COMMUN, V30, P339, DOI 10.1080/10410236.2013.858285; Ratnasari R.T., 2020, INT J INNOVATION CRE, V12, P1; Renn O, 1991, COMMUNICATING RISKS, V4, P175, DOI DOI 10.1007/978-94-009-1952-5_10; Reno C, 2021, INFECT DIS REP, V13, P712, DOI 10.3390/idr13030066; Reny TT, 2021, AM POLIT SCI REV, V115, P1499, DOI 10.1017/S0003055421000460; Reynolds R.M., 2020, INT ENCY MEDIA PSYCH, P1, DOI [10.1002/9781119011071.iemp0018, DOI 10.1002/9781119011071.IEMP0018]; Rhee M, 2009, ACAD MANAGE REV, V34, P146, DOI 10.5465/AMR.2009.35713324; Roederer T, 2021, LANCET PUBLIC HEALTH, V6, pE202, DOI 10.1016/S2468-2667(21)00001-3; Rosenberg ES, 2021, MMWR-MORBID MORTAL W, V70, P1306, DOI 10.15585/mmwr.mm7037a7; Schmidt Allison M, 2016, Tob Regul Sci, V2, P31; Siegel E, 2020, FORBES; Siegrist M, 2000, RISK ANAL, V20, P353, DOI 10.1111/0272-4332.203034; Siegrist M, 2005, J RISK RES, V8, P145, DOI 10.1080/1366987032000105315; Siegrist M, 1999, J APPL SOC PSYCHOL, V29, P2093, DOI 10.1111/j.1559-1816.1999.tb02297.x; Siegrist M, 2021, RISK ANAL, V41, P787, DOI 10.1111/risa.13675; Siegrist M, 2021, RISK ANAL, V41, P480, DOI 10.1111/risa.13325; SLOVIC P, 1991, SCIENCE, V254, P1603, DOI 10.1126/science.254.5038.1603; Sokol-Hessner P, 2019, CURR DIR PSYCHOL SCI, V28, P20, DOI 10.1177/0963721418806510; Soveri A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10643-w; STROM K, 1992, AM BEHAV SCI, V35, P375, DOI 10.1177/0002764292035004004; Sun YM, 2021, J SURG ONCOL, V123, pS30, DOI 10.1002/jso.26388; Tasnim Samia, 2020, J Prev Med Public Health, V53, P171, DOI 10.3961/jpmph.20.094; Todorov A., 2002, PERSUASION HDB DEV T, P195, DOI DOI 10.4135/9781412976046; Travaglino GA, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.565845; Tukachinsky R, 2015, J SOC ISSUES, V71, P17, DOI 10.1111/josi.12094; Tully T., 2021, NEW YORK TIMES; Weaver SR, 2017, SSM-POPUL HLTH, V3, P787, DOI 10.1016/j.ssmph.2017.09.003; Wong CML, 2020, J RISK RES, V23, P1021, DOI 10.1080/13669877.2020.1756386; Ye MX, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113517	76	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262097	10.1371/journal.pone.0262097	http://dx.doi.org/10.1371/journal.pone.0262097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085293	gold, Green Published			2022-12-26	WOS:000779379600037
J	Yu, FH; Huang, KJ; Wang, CT				Yu, Fu-Hsien; Huang, Kuo-Jung; Wang, Chin-Tien			Amino acid substitutions at the HIV-1 transframe region significantly impair virus infectivity	PLOS ONE			English	Article							NONNUCLEOSIDE REVERSE-TRANSCRIPTASE; TYPE-1 GAGPOL PRECURSOR; PROTEASE; PROTEINASE; CLEAVAGE; SPECIFICITY; GENERATION; INHIBITORS; PARTICLES; SEQUENCE	A transframe region within HIV-1 Gag-Pol (referred to as p6* or p6pol), directly linked to the protease (PR) N-terminus, plays a pivotal role in modulating PR activation. To identify specific p6* residues involved in PR activation, we created a series of p6* mutants by making substitutions for conserved p6* residues. Our results indicate that some p6* mutants were defective in terms of virus infectivity, despite displaying a wild-type virus particle processing pattern. Mutations at p6* F8 reduced virus infectivity associated with insufficient virus processing, due in part to impaired PR maturation and RT packaging. Our data strongly suggest that conserved Phe (F) residues at position 8 of p6* are involved in the PR maturation process.	[Yu, Fu-Hsien; Wang, Chin-Tien] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Yu, Fu-Hsien; Wang, Chin-Tien] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan; [Huang, Kuo-Jung; Wang, Chin-Tien] Taipei Vet Gen Hosp, Dept Med Res, Div Clin Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wang, CT (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Wang, CT (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan.; Wang, CT (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Div Clin Res, Taipei, Taiwan.	chintien@nycu.edu.tw		Wang, Chin-Tien/0000-0003-2231-4492	Taipei Veterans General Hospital [V106C-047, V107C-049, V108C034]; Taiwan Ministry of Science and Technology [106-2320-B-010-017-MY2, 1082320-B-010-030]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan Ministry of Science and Technology	CW received grants from Taipei Veterans General Hospital (V106C-047, V107C-049, V108C034) and the Taiwan Ministry of Science and Technology (106-2320-B-010-017-MY2, 1082320-B-010-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2005, BIOCHEMISTRY-US, V44, P9058, DOI 10.1021/bi0502588; Almog N, 1996, J VIROL, V70, P7228, DOI 10.1128/JVI.70.10.7228-7232.1996; Chatterjee A, 2005, J BIOL CHEM, V280, P11369, DOI 10.1074/jbc.M412603200; Chen N, 2001, J GEN VIROL, V82, P581, DOI 10.1099/0022-1317-82-3-581; Chen YL, 1997, J GEN VIROL, V78, P2497, DOI 10.1099/0022-1317-78-10-2497; Chiang CC, 2009, VIROLOGY, V383, P261, DOI 10.1016/j.virol.2008.10.027; Chiu HC, 2006, J GEN VIROL, V87, P2041, DOI 10.1099/vir.0.81601-0; FERRIS AL, 1990, VIROLOGY, V175, P456, DOI 10.1016/0042-6822(90)90430-Y; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Leiherer A, 2009, J VIROL, V83, P7210, DOI 10.1128/JVI.02603-08; Lindhofer H, 1995, VIROLOGY, V214, P624, DOI 10.1006/viro.1995.0074; LOEB DD, 1989, J VIROL, V63, P111, DOI 10.1128/JVI.63.1.111-121.1989; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Pan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032845; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Paulus C, 2004, VIROLOGY, V330, P271, DOI 10.1016/j.virol.2004.09.013; Paulus C, 1999, J BIOL CHEM, V274, P21539, DOI 10.1074/jbc.274.31.21539; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; Petropoulos C., 1997, RETROVIRAL TAXONOMY; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2003, J VIROL, V77, P366, DOI 10.1128/JVI.77.1.366-374.2003; PHYLIP LH, 1995, ADV EXP MED BIOL, V362, P467; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; STROP P, 1991, BIOCHEMISTRY-US, V30, P3437, DOI 10.1021/bi00228a013; Swanstrom R, 1997, RETROVIRUSES; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Tien CF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191372; Wondrak EM, 1996, J BIOL CHEM, V271, P4477, DOI 10.1074/jbc.271.8.4477; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yu FH, 2021, VIRUS RES, V295, DOI 10.1016/j.virusres.2020.198258; Yu FH, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0413-6; Yu FH, 2017, J VIROL, V91, DOI 10.1128/JVI.00103-17; Yu FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127974; ZYBARTH G, 1994, J VIROL, V68, P240, DOI 10.1128/JVI.68.1.240-250.1994	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2022	17	1							e0262477	10.1371/journal.pone.0262477	http://dx.doi.org/10.1371/journal.pone.0262477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I4GM	35085286	Green Published, gold			2022-12-26	WOS:000779379600058
